PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kuehn, BM				Kuehn, Bridget M.			New Treatment Approved for Adults and Children With Pompe Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2021	326	11					1000	1000		10.1001/jama.2021.15589	http://dx.doi.org/10.1001/jama.2021.15589			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ4IM	34546313				2022-12-28	WOS:000702170600006
J	Kuehn, BM				Kuehn, Bridget M.			"Collaborative Communities" Tackle Device Development Challenges	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2021	326	11					1000	1000		10.1001/jama.2021.14964	http://dx.doi.org/10.1001/jama.2021.14964			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ4IM	34546313				2022-12-28	WOS:000702170600008
J	Liang, TJ; Feld, JJ; Cox, AL; Rice, CM				Liang, T. Jake; Feld, Jordan J.; Cox, Andrea L.; Rice, Charles M.			Controlled Human Infection Model - Fast Track to HCV Vaccine?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEPATITIS-C VIRUS; GENOTYPE 1; CULTURE; VELPATASVIR; SOFOSBUVIR; FAILURE		[Liang, T. Jake] NIDDK, Liver Dis Branch, NIH, Bldg 10-9B16,10 Ctr Dr, Bethesda, MD 20892 USA; [Cox, Andrea L.] Johns Hopkins Univ, Div Infect Dis, Baltimore, MD USA; [Feld, Jordan J.] Univ Toronto, Toronto Gen Hosp, Toronto Ctr Liver Dis, Toronto, ON, Canada; [Rice, Charles M.] Rockefeller Univ, Lab Virol & Infect Dis, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Johns Hopkins University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Rockefeller University	Liang, TJ (corresponding author), NIDDK, Liver Dis Branch, NIH, Bldg 10-9B16,10 Ctr Dr, Bethesda, MD 20892 USA.	jliang@nih.gov						Bailey JR, 2019, GASTROENTEROLOGY, V156, P418, DOI 10.1053/j.gastro.2018.08.060; Bourliere M, 2017, NEW ENGL J MED, V376, P2134, DOI 10.1056/NEJMoa1613512; Burm R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01032; Chu CM, 1999, GUT, V45, P613, DOI 10.1136/gut.45.4.613; Cox A, 2020, CLIN INFECT DIS, V71, P2986, DOI 10.1093/cid/ciaa640; Deterding K, 2009, Z GASTROENTEROL, V47, P531, DOI 10.1055/s-0028-1109149; Feld JJ, 2015, NEW ENGL J MED, V373, P2599, DOI 10.1056/NEJMoa1512610; Feld JJ, 2020, LANCET GASTROENTEROL, V5, P649, DOI 10.1016/S2468-1253(20)30081-9; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Hatanaka T, 2019, INTERNAL MED, V58, P2969, DOI 10.2169/internalmedicine.2982-19; Kato T, 2008, HEPATOLOGY, V48, P732, DOI 10.1002/hep.22422; Krawczyk M, 2018, AM J GASTROENTEROL, V113, P1062, DOI 10.1038/s41395-018-0078-8; Liang TJ, 2018, NEW ENGL J MED, V378, P1169, DOI 10.1056/NEJMp1716871; Liang TJ, 2013, NAT MED, V19, P869, DOI 10.1038/nm.3183; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; MacParland SA, 2009, HEPATOLOGY, V49, P1431, DOI 10.1002/hep.22802; Major M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao4496; Matthews GV, 2021, J HEPATOL, V75, P829, DOI 10.1016/j.jhep.2021.04.056; Naggie S, 2019, CLIN INFECT DIS, V69, P514, DOI 10.1093/cid/ciy913; Omland LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022476; Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007; Page K, 2021, NEW ENGL J MED, V384, P541, DOI 10.1056/NEJMoa2023345; Perez S, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008181; Schwartz RE, 2012, P NATL ACAD SCI USA, V109, P2544, DOI 10.1073/pnas.1121400109; Shah SK, 2020, SCIENCE, V368, P832, DOI 10.1126/science.abc1076; Torres HA, 2018, HEPATOLOGY, V67, P36, DOI 10.1002/hep.29344; Veerapu NS, 2014, J CLIN INVEST, V124, P3469, DOI 10.1172/JCI73104; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Woolley AE, 2019, NEW ENGL J MED, V380, P1606, DOI 10.1056/NEJMoa1812406; Yi M, 2014, J VIROL, V88, P3678, DOI 10.1128/JVI.03540-13; Zeuzem S, 2018, NEW ENGL J MED, V378, P354, DOI 10.1056/NEJMoa1702417	31	7	7	3	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2021	385	13					1235	1240		10.1056/NEJMsb2109093	http://dx.doi.org/10.1056/NEJMsb2109093			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UT0EM	34551234				2022-12-28	WOS:000697798600019
J	El Sahly, HM; Baden, LR; Essink, B; Doblecki-Lewis, S; Martin, JM; Anderson, EJ; Campbell, TB; Clark, J; Jackson, LA; Fichtenbaum, CJ; Zervos, M; Rankin, B; Eder, F; Feldman, G; Kennelly, C; Han-Conrad, L; Levin, M; Neuzil, KM; Corey, L; Gilbert, P; Janes, H; Follmann, D; Marovich, M; Polakowski, L; Mascola, JR; Ledgerwood, JE; Graham, BS; August, A; Clouting, H; Deng, W; Han, S; Leav, B; Manzo, D; Pajon, R; Schodel, F; Tomassini, JE; Zhou, H; Miller, J				El Sahly, H. M.; Baden, L. R.; Essink, B.; Doblecki-Lewis, S.; Martin, J. M.; Anderson, E. J.; Campbell, T. B.; Clark, J.; Jackson, L. A.; Fichtenbaum, C. J.; Zervos, M.; Rankin, B.; Eder, F.; Feldman, G.; Kennelly, C.; Han-Conrad, L.; Levin, M.; Neuzil, K. M.; Corey, L.; Gilbert, P.; Janes, H.; Follmann, D.; Marovich, M.; Polakowski, L.; Mascola, J. R.; Ledgerwood, J. E.; Graham, B. S.; August, A.; Clouting, H.; Deng, W.; Han, S.; Leav, B.; Manzo, D.; Pajon, R.; Schodel, F.; Tomassini, J. E.; Zhou, H.; Miller, J.		COVE Study Grp	Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COVID-19; BNT162B2	BACKGROUND At interim analysis in a phase 3, observer-blinded, placebo-controlled clinical trial, the mRNA-1273 vaccine showed 94.1% efficacy in preventing coronavirus disease 2019 (Covid-19). After emergency use of the vaccine was authorized, the protocol was amended to include an open-label phase. Final analyses of efficacy and safety data from the blinded phase of the trial are reported. METHODS We enrolled volunteers who were at high risk for Covid-19 or its complications; participants were randomly assigned in a 1:1 ratio to receive two intramuscular injections of mRNA-1273 (100 mu g) or placebo, 28 days apart, at 99 centers across the United States. The primary end point was prevention of Covid-19 illness with onset at least 14 days after the second injection in participants who had not previously been infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The data cutoff date was March 26, 2021. RESULTS The trial enrolled 30,415 participants; 15,209 were assigned to receive the mRNA-1273 vaccine, and 15,206 to receive placebo. More than 96% of participants received both injections, 2.3% had evidence of SARS-CoV-2 infection at baseline, and the median follow-up was 5.3 months in the blinded phase. Vaccine efficacy in preventing Covid-19 illness was 93.2% (95% confidence interval [CI], 91.0 to 94.8), with 55 confirmed cases in the mRNA-1273 group (9.6 per 1000 person-years; 95% CI, 7.2 to 12.5) and 744 in the placebo group (136.6 per 1000 person-years; 95% CI, 127.0 to 146.8). The efficacy in preventing severe disease was 98.2% (95% CI, 92.8 to 99.6), with 2 cases in the mitNA-1273 group and 106 in the placebo group, and the efficacy in preventing asymptomatic infection starting 14 days after the second injection was 63.0% (95% CI, 56.6 to 68.5), with 214 cases in the mRNA-1273 group and 498 in the placebo group. Vaccine efficacy was consistent across ethnic and racial groups, age groups, and participants with coexisting conditions. No safety concerns were identified. CONCLUSIONS The mRNA-1273 vaccine continued to be efficacious in preventing Covid-19 illness and severe disease at more than 5 months, with an acceptable safety profile, and protection against asymptomatic infection was observed.	[El Sahly, H. M.] Baylor Coll Med, Houston, TX 77030 USA; [Kennelly, C.] Javara, The Woodlands, TX USA; [Baden, L. R.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [August, A.; Clouting, H.; Deng, W.; Han, S.; Leav, B.; Manzo, D.; Pajon, R.; Schodel, F.; Tomassini, J. E.; Zhou, H.; Miller, J.] Moderna, Cambridge, MA USA; [Essink, B.; Eder, F.] Meridian Clin Res, Baton Rouge, LA USA; [Doblecki-Lewis, S.] Univ Miami, Miami, FL USA; [Rankin, B.] DeLand Clin Res Unit, Deland, FL USA; [Martin, J. M.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Anderson, E. J.] Emory Univ, Sch Med, Atlanta, GA USA; [Campbell, T. B.] Univ Colorado, Sch Med, Aurora, CO USA; [Clark, J.] Univ Calif Los Angeles, Los Angeles, CA USA; [Han-Conrad, L.] Wake Res Med Ctr Clin Res, San Diego, CA USA; [Jackson, L. A.] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA; [Corey, L.; Gilbert, P.; Janes, H.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Fichtenbaum, C. J.] Univ Cincinnati, Cincinnati, OH USA; [Zervos, M.] Henry Ford Hlth Syst, Detroit, MI USA; [Feldman, G.] Vitalink Res, Greenville, SC USA; [Levin, M.] Wake Res, Clin Res Ctr Nevada, Las Vegas, NV USA; [Neuzil, K. M.] Univ Maryland, College Pk, MD 20742 USA; [Mascola, J. R.; Ledgerwood, J. E.; Graham, B. S.] NIH, Vaccine Res Ctr, Bldg 10, Bethesda, MD 20892 USA; [Follmann, D.; Marovich, M.; Polakowski, L.] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Baylor College of Medicine; Harvard University; Brigham & Women's Hospital; University of Miami; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Emory University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Los Angeles; Kaiser Permanente; Fred Hutchinson Cancer Center; University System of Ohio; University of Cincinnati; Henry Ford Health System; Henry Ford Hospital; University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	El Sahly, HM (corresponding author), Dept Mol Virol & Microbiol, BCM MS280, Houston, TX 77030 USA.; El Sahly, HM (corresponding author), Dept Med, BCM MS280, Houston, TX 77030 USA.; Baden, LR (corresponding author), Brigham & Womens Hosp, Div Infect Dis, 15 Francis St,PBB A4, Boston, MA 02115 USA.	hana.elsahly@bcm.edu; lbaden@bwh.harvard.edu	Kilgore, Paul E/L-1462-2013	Kilgore, Paul E/0000-0003-3214-4482; Whitham, Tarik/0000-0002-8112-8000; Setaro, Alessandra/0000-0002-7286-2123; Huaman, Moises/0000-0002-6839-5809; Novack, Lewis/0000-0001-7508-1720; Anderson, Evan/0000-0002-1576-4420; Park Chang, Jun Bai/0000-0002-3338-8043; Eickhoff, Chris/0000-0002-5161-3603; Clark, Jesse/0000-0001-5862-6530; Gay, Cynthia/0000-0002-3620-3059; George, Sarah/0000-0002-9699-1042; Petrie, Mark/0000-0002-6333-9496; Feeley, Monica/0000-0002-6498-4403; El Sahly, Hana/0000-0003-0489-0074	Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority [75A50120C00034]; National Institute of Allergy and Infectious Diseases (NIAID) [UM1 AI 68614HVTN, UM1 AI 68635, UM1 AI 68618, UM1 AI 68619, UM1 AI 68636, UM1 AI148684-03]	Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority (contract 75A50120C00034), and by the National Institute of Allergy and Infectious Diseases (NIAID). The NIAID provides grant funding to the HIV Vaccine Trials Network (HVTN) Leadership and Operations Center (UM1 AI 68614HVTN), the Statistics and Data Management Center (UM1 AI 68635), the HVTN Laboratory Center (UM1 AI 68618), the HIV Prevention Trials Network Leadership and Operations Center (UM1 AI 68619), the AIDS Clinical Trials Group Leadership and Operations Center (UM1 AI 68636), and the Infectious Diseases Clinical Research Consortium leadership group 5 (UM1 AI148684-03).	Abu-Raddad LJ, 2021, NEW ENGL J MED, V385, P187, DOI 10.1056/NEJMc2104974; Ali K, 2021, NEW ENGL J MED, V385, P2241, DOI 10.1056/NEJMoa2109522; [Anonymous], 2020, MATERNAL NEONATAL CH; [Anonymous], 2021, JOHNSON JOHNSON COVI; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891; Collier ARY, 2021, JAMA-J AM MED ASSOC, V325, P2370, DOI 10.1001/jama.2021.7563; Corbett KS, 2020, NATURE, V586, P567, DOI 10.1038/s41586-020-2622-0; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; Frenck RW, 2021, NEW ENGL J MED, V385, P239, DOI 10.1056/NEJMoa2107456; Haas EJ, 2021, LANCET, V397, P1819, DOI 10.1016/S0140-6736(21)00947-8; Hadjadj J., 2021, IMMUNOGENICITY BNT16, DOI [10.1101/2021.08.08.21261766v1, DOI 10.1101/2021.08.08.21261766V1]; Haidar G., 2021, IMMUNOGENICITY COVID, DOI [10.1101/2021.06.28.21259576v1, DOI 10.1101/2021.06.28.21259576V1]; Jones NK, 2021, ELIFE, V10, DOI 10.7554/eLife.68808; Marshall M, 2021, PEDIATRICS, V148, DOI 10.1542/peds.2021-052478; Pawlowski C, 2021, MED-CAMBRIDGE, V2, P979, DOI 10.1016/j.medj.2021.06.007; Planas D, 2021, NAT MED, V27, P917, DOI 10.1038/s41591-021-01318-5; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Sadoff J, 2021, NEW ENGL J MED, V384, P1824, DOI 10.1056/NEJMoa2034201; Shimabukuro TT, 2021, OBSTET GYNECOL SURV, V76, P729, DOI [10.1056/NEJMoa2104983, 10.1097/01.ogx.0000802676.57373.17, 10.1056/NEJMx210016]; Skowronski DM, 2021, NEW ENGL J MED, V384, P1576, DOI 10.1056/NEJMc2036242; Tande AJ., 2021, CLIN INFECT DIS; Tenforde MW, 2022, CLIN INFECT DIS, V74, P1515, DOI [10.1093/cid/ciab687, 10.1101/2021.07.08.21259776]; Tenforde MW, 2021, MMWR-MORBID MORTAL W, V70, P674, DOI 10.15585/mmwr.mm7018e1; Thompson MG, 2021, NEW ENGL J MED, V385, P320, DOI 10.1056/NEJMoa2107058; Thompson MG, 2021, MMWR-MORBID MORTAL W, V70, P495, DOI 10.15585/mmwr.mm7013e3	26	184	186	4	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 4	2021	385	19					1774	1785		10.1056/NEJMoa2113017	http://dx.doi.org/10.1056/NEJMoa2113017		SEP 2021	12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WR0CF	34551225	Green Published, Bronze			2022-12-28	WOS:000697804800001
J	Elmarakeby, HA; Hwang, J; Arafeh, R; Crowdis, J; Gang, S; Liu, D; AlDubayan, SH; Salari, K; Kregel, S; Richter, C; Arnoff, TE; Park, J; Hahn, WC; Van Allen, EM				Elmarakeby, Haitham A.; Hwang, Justin; Arafeh, Rand; Crowdis, Jett; Gang, Sydney; Liu, David; AlDubayan, Saud H.; Salari, Keyan; Kregel, Steven; Richter, Camden; Arnoff, Taylor E.; Park, Jihye; Hahn, William C.; M. Van Allen, Eliezer			Biologically informed deep neural network for prostate cancer discovery	NATURE			English	Article							INTEGRATIVE CLINICAL GENOMICS; ANDROGEN-RECEPTOR; MDM2; PATHWAY; P53; GENE; SUMOYLATION; EXPRESSION	The determination of molecular features that mediate clinically aggressive phenotypes in prostate cancer remains a major biological and clinical challenge(1,2). Recent advances in interpretability of machine learning models as applied to biomedical problems may enable discovery and prediction in clinical cancer genomics(3-5). Here we developed P-NET-a biologically informed deep learning model-to stratify patients with prostate cancer by treatment-resistance state and evaluate molecular drivers of treatment resistance for therapeutic targeting through complete model interpretability. We demonstrate that P-NET can predict cancer state using molecular data with a performance that is superior to other modelling approaches. Moreover, the biological interpretability within P-NET revealed established and novel molecularly altered candidates, such as MDM4 and FGFR1, which were implicated in predicting advanced disease and validated in vitro. Broadly, biologically informed fully interpretable neural networks enable preclinical discovery and clinical prediction in prostate cancer and may have general applicability across cancer types.	[Elmarakeby, Haitham A.; Arafeh, Rand; Crowdis, Jett; Gang, Sydney; Liu, David; AlDubayan, Saud H.; Salari, Keyan; Richter, Camden; Arnoff, Taylor E.; Park, Jihye; Hahn, William C.; M. Van Allen, Eliezer] Dana Farber Canc Inst, Boston, MA 02115 USA; [Elmarakeby, Haitham A.; Arafeh, Rand; Crowdis, Jett; Liu, David; AlDubayan, Saud H.; Salari, Keyan; Arnoff, Taylor E.; Park, Jihye; Hahn, William C.; M. Van Allen, Eliezer] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Elmarakeby, Haitham A.] Al Azhar Univ, Cairo, Egypt; [Hwang, Justin] Univ Minnesota, Div Hematol Oncol & Transplantat, Minneapolis, MN USA; [Salari, Keyan] Harvard Med Sch, Massachusetts Gen Hosp, Dept Urol, Boston, MA 02115 USA; [Kregel, Steven] Univ Illinois, Dept Pathol, Chicago, IL USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Egyptian Knowledge Bank (EKB); Al Azhar University; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Van Allen, EM (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.; Van Allen, EM (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	eliezerm_vanallen@dfci.harvard.edu		Liu, David/0000-0003-0346-5033; Hwang, Justin/0000-0003-1686-7103; Gang, Sydney/0000-0003-0410-7262; Elmarakeby, Haitham/0000-0002-4315-4347	Fund for Innovation in Cancer Informatics; Mark Foundation Emerging Leader Award; PCF-Movember Challenge Award; Physician Research Award of the US Department of Defense [PC200150]; NIH [U01 CA233100, U01 CA176058]	Fund for Innovation in Cancer Informatics; Mark Foundation Emerging Leader Award; PCF-Movember Challenge Award; Physician Research Award of the US Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Fund for Innovation in Cancer Informatics (H.A.E. and E.M.V.A.), Mark Foundation Emerging Leader Award (E.M.V.), PCF-Movember Challenge Award (H.A.E. and E.M.V.A.), Physician Research Award (PC200150) of the US Department of Defense (S.H.A.), NIH U01 CA233100 (E.M.V.A.) and U01 CA176058 (W.C.H.)	Abida W, 2019, P NATL ACAD SCI USA, V116, P11428, DOI 10.1073/pnas.1902651116; Aggarwal R, 2018, J CLIN ONCOL, V36, P2492, DOI 10.1200/JCO.2017.77.6880; Ancona M, 2017, ARXIV PREPRINT ARXIV, P1; Armenia J, 2018, NAT GENET, V50, P645, DOI 10.1038/s41588-018-0078-z; Bluemn EG, 2017, CANCER CELL, V32, P474, DOI 10.1016/j.ccell.2017.09.003; Chen WS, 2019, EUR UROL, V76, P562, DOI 10.1016/j.eururo.2019.03.020; Chen ZB, 2015, INT J MOL SCI, V16, P4560, DOI 10.3390/ijms16034560; Chopra Harman, 2018, Oncotarget, V9, P6270, DOI 10.18632/oncotarget.23569; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dettmers T., 2019, SPARSE NETWORKS SCRA; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Farah E, 2019, J BIOL CHEM, V294, P8543, DOI 10.1074/jbc.RA118.006983; Feng FY, 2016, NEOPLASIA, V18, P213, DOI 10.1016/j.neo.2016.01.006; Frankle J., 2018, ARXIV180303635; Fraser M, 2017, NATURE, V541, P359, DOI 10.1038/nature20788; Ge C, 2016, ONCOGENE, V35, P366, DOI 10.1038/onc.2015.91; Graves B, 2012, P NATL ACAD SCI USA, V109, P11788, DOI 10.1073/pnas.1203789109; Gundem G, 2015, NATURE, V520, P353, DOI 10.1038/nature14347; Haas BJ, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1842-9; Han GC, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.17.00140; Han S., 2015, ARXIV150602626; Hao J, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2500-z; Hieronymus H, 2014, P NATL ACAD SCI USA, V111, P11139, DOI 10.1073/pnas.1411446111; Howard TP, 2019, CANCER RES, V79, P2404, DOI 10.1158/0008-5472.CAN-18-3066; Hwang JH, 2019, CELL REP, V29, P2355, DOI 10.1016/j.celrep.2019.10.068; Kingma D.P., 2014, ARXIV, DOI DOI 10.48550/ARXIV.1412.6980; Kuenzi BM, 2020, CANCER CELL, V38, P672, DOI 10.1016/j.ccell.2020.09.014; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Leite KRM, 2001, MODERN PATHOL, V14, P428, DOI 10.1038/modpathol.3880330; Levine AJ, 2020, NAT REV CANCER, V20, P471, DOI 10.1038/s41568-020-0262-1; Lex A, 2014, IEEE T VIS COMPUT GR, V20, P1983, DOI 10.1109/TVCG.2014.2346248; Li H., 2016, INT C LEARN REPR ICL, DOI DOI 10.48550/ARXIV.1608.08710; Lundberg SM, 2017, ADV NEUR IN, V30; Ma JZ, 2018, NAT METHODS, V15, P290, DOI [10.1038/NMETH.4627, 10.1038/nmeth.4627]; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Murdoch WJ, 2019, P NATL ACAD SCI USA, V116, P22071, DOI 10.1073/pnas.1900654116; NAVONE NM, 1993, J NATL CANCER I, V85, P1657, DOI 10.1093/jnci/85.20.1657; Pei DS, 2012, ONCOTARGET, V3, P228; Quigley DA, 2018, CELL, V174, P758, DOI 10.1016/j.cell.2018.06.039; Ribeiro MT, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1135, DOI 10.1145/2939672.2939778; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Robinson DR, 2017, NATURE, V548, P297, DOI 10.1038/nature23306; Rodrigues DN, 2018, J CLIN INVEST, V128, P4441, DOI [10.1172/JCI121924, 10.1172/JCI125184]; Schlomm T, 2008, MODERN PATHOL, V21, P1371, DOI 10.1038/modpathol.2008.104; Sharma A, 2010, J CLIN INVEST, V120, P4478, DOI 10.1172/JCI44239; Shrikumar A, 2017, PR MACH LEARN RES, V70; Sondka Z, 2018, NAT REV CANCER, V18, P696, DOI 10.1038/s41568-018-0060-1; Sutinen P, 2014, NUCLEIC ACIDS RES, V42, P8310, DOI 10.1093/nar/gku543; Tovar C, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-49; Yang JH, 2019, CELL, V177, P1649, DOI 10.1016/j.cell.2019.04.016; Zhang Z, 2003, P NATL ACAD SCI USA, V100, P11636, DOI 10.1073/pnas.1934692100; Zhao SG, 2020, NAT GENET, V52, P778, DOI 10.1038/s41588-020-0648-8	55	27	28	19	88	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 14	2021	598	7880					348	+		10.1038/s41586-021-03922-4	http://dx.doi.org/10.1038/s41586-021-03922-4		SEP 2021	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG7FA	34552244	hybrid, Green Published			2022-12-28	WOS:000698366900002
J	Lee, JY; Jun, H; Soma, S; Nakazono, T; Shiraiwa, K; Dasgupta, A; Nakagawa, T; Xie, JYL; Chavez, J; Romo, R; Yungblut, S; Hagihara, M; Murata, K; Igarashi, KM				Lee, Jason Y.; Jun, Heechul; Soma, Shogo; Nakazono, Tomoaki; Shiraiwa, Kaori; Dasgupta, Ananya; Nakagawa, Tatsuki; Xie, Jiayun L.; Chavez, Jasmine; Romo, Rodrigo; Yungblut, Sandra; Hagihara, Meiko; Murata, Koshi; Igarashi, Kei M.			Dopamine facilitates associative memory encoding in the entorhinal cortex	NATURE			English	Article							HIPPOCAMPAL; CELLS; COORDINATION; INFORMATION; PREDICTION; CIRCUITRY; REWARD; MAPS; RATS	Mounting evidence shows that dopamine in the striatum is critically involved in reward-based reinforcement learning(1,2). However, it remains unclear how dopamine reward signals influence the entorhinal-hippocampal circuit, another brain network that is crucial for learning and memory(3-5). Here, using cell-type-specific electrophysiological recording(6), we show that dopamine signals from the ventral tegmental area and substantia nigra control the encoding of cue-reward association rules in layer 2a fan cells of the lateral entorhinal cortex (LEC). When mice learned novel olfactory cue-reward associations using a pre-learned association rule, spike representations of LEC fan cells grouped newly learned rewarded cues with a pre-learned rewarded cue, but separated them from a pre-learned unrewarded cue. Optogenetic inhibition of fan cells impaired the learning of new associations while sparing the retrieval of pre-learned memory. Using fibre photometry, we found that dopamine sends novelty-induced reward expectation signals to the LEC. Inhibition of LEC dopamine signals disrupted the associative encoding of fan cells and impaired learning performance. These results suggest that LEC fan cells represent a cognitive map of abstract task rules, and that LEC dopamine facilitates the incorporation of new memories into this map.	[Lee, Jason Y.; Jun, Heechul; Soma, Shogo; Nakazono, Tomoaki; Shiraiwa, Kaori; Dasgupta, Ananya; Nakagawa, Tatsuki; Xie, Jiayun L.; Chavez, Jasmine; Romo, Rodrigo; Yungblut, Sandra; Igarashi, Kei M.] Univ Calif Irvine, Dept Anat & Neurobiol, Sch Med, Irvine, CA 92717 USA; [Hagihara, Meiko; Murata, Koshi] Univ Fukui, Div Brain Struct & Funct, Fac Med Sci, Fukui, Japan; [Soma, Shogo] Kyoto Prefectural Univ Med, Dept Mol Cell Physiol, Kyoto, Japan; [Nakazono, Tomoaki] Fukushima Med Univ, Dept Syst Neurosci, Fukushima, Japan	University of California System; University of California Irvine; University of Fukui; Kyoto Prefectural University of Medicine; Fukushima Medical University	Igarashi, KM (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Sch Med, Irvine, CA 92717 USA.	kei.igarashi@uci.edu	Nakazono, Tomoaki/GQZ-7784-2022	Nakazono, Tomoaki/0000-0001-5816-4348; Soma, Shogo/0000-0002-7381-9477; NAKAGAWA, Tatsuki/0000-0002-1625-4334; Igarashi, Kei/0000-0002-5635-169X; Murata, Koshi/0000-0002-6425-3053	NIH R01 grants [R01MH121736, R01AG063864, R01AG066806]; PRESTO grant from Japan Science and Technology Agency [JPMJPR1681]; Brain Research Foundation Fay-Frank Seed Grant [BRFSG-2017-04]; Whitehall Foundation Research Grant [2017-08-01]; BrightFocus Foundation Research grant [A2019380S]; Alzheimer's Association Research Grant [AARG-17-532932]; New Vision Research Investigator Award [CCAD201902]; University of California, Irvine Medical Scientist Training Program (MSTP) [T32GM008620]; NIH F31 grant [1F31AG069500]	NIH R01 grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PRESTO grant from Japan Science and Technology Agency; Brain Research Foundation Fay-Frank Seed Grant; Whitehall Foundation Research Grant; BrightFocus Foundation Research grant; Alzheimer's Association Research Grant; New Vision Research Investigator Award; University of California, Irvine Medical Scientist Training Program (MSTP)(University of California System); NIH F31 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank N. Uchida and M. Watabe-Uchida for their mentorship, including support in setting up optogenetic recording and photometry experiments and providing discussions throughout the course of this project; R. Amo and H. Matsumoto in the Uchida laboratory for their help with setting up the behaviour and photometry experiments; T. Viaclovsky, A. Bramian and M. Savadkohighodjanaki in the Igarashi laboratory for technical assistance; and M. P. Witter, A. Treves, H. T. Ito, B. McNaughton, C. Gall and G. Lynch for providing comments on the work. The work was supported by NIH R01 grants (R01MH121736, R01AG063864, R01AG066806), a PRESTO grant from Japan Science and Technology Agency (JPMJPR1681), a Brain Research Foundation Fay-Frank Seed Grant (BRFSG-2017-04), a Whitehall Foundation Research Grant (2017-08-01), a BrightFocus Foundation Research grant (A2019380S), an Alzheimer's Association Research Grant (AARG-17-532932) and a New Vision Research Investigator Award (CCAD201902) to K.M.I. H.J. was supported by the University of California, Irvine Medical Scientist Training Program (MSTP) (T32GM008620) and an NIH F31 grant (1F31AG069500).	Behrens TEJ, 2018, NEURON, V100, P490, DOI 10.1016/j.neuron.2018.10.002; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Chuong AS, 2014, NAT NEUROSCI, V17, P1123, DOI 10.1038/nn.3752; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Cunningham JP, 2014, NAT NEUROSCI, V17, P1500, DOI 10.1038/nn.3776; FALLON JH, 1978, J COMP NEUROL, V180, P509, DOI 10.1002/cne.901800308; HOKFELT T, 1974, SCIENCE, V184, P177, DOI 10.1126/science.184.4133.177; Igarashi KM, 2014, NATURE, V510, P143, DOI 10.1038/nature13162; Igarashi KM, 2012, J NEUROSCI, V32, P7970, DOI 10.1523/JNEUROSCI.0154-12.2012; Kakade S, 2002, NEURAL NETWORKS, V15, P549, DOI 10.1016/S0893-6080(02)00048-5; Kitamura T, 2014, SCIENCE, V343, P896, DOI 10.1126/science.1244634; KUDO Y, 1992, NEUROSCIENCE, V50, P619, DOI 10.1016/0306-4522(92)90451-7; Kvitsiani D, 2013, NATURE, V498, P363, DOI 10.1038/nature12176; Leitner FC, 2016, NAT NEUROSCI, V19, P935, DOI 10.1038/nn.4303; Li YD, 2017, NAT NEUROSCI, V20, P559, DOI 10.1038/nn.4517; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Menegas W, 2017, ELIFE, V6, DOI 10.7554/eLife.21886; Mori K, 2006, PHYSIOL REV, V86, P409, DOI 10.1152/physrev.00021.2005; Moser EI, 2014, NAT REV NEUROSCI, V15, P466, DOI 10.1038/nrn3766; Nilssen ES, 2018, J NEUROSCI, V38, P9712, DOI 10.1523/JNEUROSCI.1290-18.2018; Ohara S, 2019, FRONT SYST NEUROSCI, V13, DOI 10.3389/fnsys.2019.00054; Russo AA, 2020, NEURON, V107, P745, DOI 10.1016/j.neuron.2020.05.020; Sano H, 2003, J NEUROSCI, V23, P9078; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Surmeli G, 2015, NEURON, V88, P1040, DOI 10.1016/j.neuron.2015.10.041; Swanson LW, 1987, HDB CHEM NEUROANATOM, P125; Takeuchi T, 2016, NATURE, V537, P357, DOI 10.1038/nature19325; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Vandrey B, 2020, CURR BIOL, V30, P169, DOI 10.1016/j.cub.2019.11.027; Watabe-Uchida M, 2017, ANNU REV NEUROSCI, V40, P373, DOI 10.1146/annurev-neuro-072116-031109; Witter MP, 2004, RAT NERVOUS SYSTEM, V3rd; Yagishita S, 2014, SCIENCE, V345, P1616, DOI 10.1126/science.1255514	37	13	14	13	56	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 14	2021	598	7880					321	+		10.1038/s41586-021-03948-8	http://dx.doi.org/10.1038/s41586-021-03948-8		SEP 2021	25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG7FA	34552245	Green Accepted			2022-12-28	WOS:000698366900007
J	Sherman, J; McGain, F; Lem, M; Mortimer, F; Jonas, WB; MacNeill, AJ				Sherman, Jodi; McGain, Forbes; Lem, Melissa; Mortimer, Frances; Jonas, Wayne B.; MacNeill, Andrea J.			Net zero healthcare: a call for clinician action	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PLANETARY HEALTH		[Sherman, Jodi] Yale Sch Med, Dept Anesthesiol, New Haven, CT 06510 USA; [McGain, Forbes] Western Hlth, Melbourne, Vic, Australia; [McGain, Forbes] Univ Melbourne, Dept Crit Care, Melbourne, Vic, Australia; [McGain, Forbes] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia; [Lem, Melissa] Univ British Columbia, Dept Family Practice, Vancouver, BC, Canada; [Mortimer, Frances] Ctr Sustainable Healthcare, Oxford, England; [Jonas, Wayne B.] Samueli Integrat Hlth Programs, Corona Del Mar, CA USA; [Jonas, Wayne B.] Georgetown Univ, Sch Med, Washington, DC USA; [Jonas, Wayne B.] Uniformed Serv Univ Hlth Sci, Bethesda, MD USA; [MacNeill, Andrea J.] Univ British Columbia, Dept Surg, Vancouver, BC, Canada	Yale University; University of Melbourne; University of Sydney; University of British Columbia; Georgetown University; Uniformed Services University of the Health Sciences - USA; University of British Columbia	Sherman, J (corresponding author), Yale Sch Med, Dept Anesthesiol, New Haven, CT 06510 USA.	jodi.sherman@yale.edu		MacNeill, Andrea/0000-0001-6836-0000				Amalberti R, 2020, BMJ QUAL SAF, V29, P60, DOI 10.1136/bmjqs-2019-009443; Buckley R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12631-6; Eckelman MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157014; Egger G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/731685; El Omrani O, 2020, MED TEACH, V42, P1107, DOI 10.1080/0142159X.2020.1796949; Elshaug AG, 2017, LANCET, V390, P191, DOI 10.1016/S0140-6736(16)32586-7; Emanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114; Fleming-Dutra KE, 2016, JAMA-J AM MED ASSOC, V315, P1864, DOI 10.1001/jama.2016.4151; Grady D, 2010, ARCH INTERN MED, V170, P749, DOI 10.1001/archinternmed.2010.90; Hendee WR, 2010, RADIOLOGY, V257, P240, DOI 10.1148/radiol.10100063; Jonas WB, 2020, J FAM PRACTICE, V69, P493, DOI 10.12788/jfp.0110; Lown Institute, 2017, RIGHT CAR SER LANC; MacNeill AJ, 2021, LANCET PLANET HEALTH, V5, pE66, DOI 10.1016/S2542-5196(21)00005-X; MacNeill AJ, 2020, HEALTH AFFAIR, V39, P2088, DOI 10.1377/hlthaff.2020.01118; Masson-Delmotte V., 2018, CONTEXT STRENGTHENIN, DOI DOI 10.1017/CBO9781107415324; McGinnis JM, 2002, HEALTH AFFAIR, V21, P78, DOI 10.1377/hlthaff.21.2.78; Pollack LA, 2014, CLIN INFECT DIS, V59, pS97, DOI 10.1093/cid/ciu542; Powers BW, 2020, JAMA-J AM MED ASSOC, V324, P1603, DOI 10.1001/jama.2020.17534; Qaseem A, 2020, ANN INTERN MED, V173, P739, DOI 10.7326/M19-3602; Saini V, 2017, LANCET, V390, P178, DOI 10.1016/S0140-6736(16)30947-3; Sherman JD, 2020, RESOUR CONSERV RECY, V161, DOI 10.1016/j.resconrec.2020.104882; Sherman JD, 2019, JAMA-J AM MED ASSOC, V322, P1043, DOI 10.1001/jama.2019.10823; University of Wisconsin Population Health Institute, COUNT HLTH RANK ROAD; Wabnitz KJ, 2020, LANCET, V396, P1471, DOI 10.1016/S0140-6736(20)32039-0; Waters H, 2020, COSTS CHRONIC DIS US; Watts N, 2021, LANCET, V397, P129, DOI 10.1016/S0140-6736(20)32290-X; Zuegge KL, 2019, ANESTH ANALG, V128, pE97, DOI 10.1213/ANE.0000000000003771	27	12	12	4	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 20	2021	374								n1323	10.1136/bmj.n1323	http://dx.doi.org/10.1136/bmj.n1323			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ1DH	34544732	Green Published, hybrid			2022-12-28	WOS:000701952000008
J	Pearlman, B; Lodebo, BT				Pearlman, Brian; Lodebo, Bereket T.			Renin secreting tumour: a rare cause of secondary hypertension	LANCET			English	Editorial Material									[Pearlman, Brian; Lodebo, Bereket T.] WellStar Atlanta Med Ctr, Atlanta, GA 30312 USA; [Pearlman, Brian] Emory Sch Med, Atlanta, GA USA; [Pearlman, Brian] Med Coll Georgia, Augusta, GA 30912 USA	WellStar Atlanta Medical Center; Emory University; University System of Georgia; Augusta University	Pearlman, B (corresponding author), WellStar Atlanta Med Ctr, Atlanta, GA 30312 USA.	brianpearlman3@hotmail.com							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 18	2021	398	10305					1074	1074						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	US3YI	34537092				2022-12-28	WOS:000697368600019
J	Limb, M				Limb, Matthew			BMJ Awards 2021: Respiratory team of the year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												limb@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2021	374								n2203	10.1136/bmj.n2203	http://dx.doi.org/10.1136/bmj.n2203			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YR5CL	34531227				2022-12-28	WOS:000750009400003
J	Nurse, P				Nurse, Paul			Biology must generate ideas as well as data	NATURE			English	Editorial Material									[Nurse, Paul] Royal Soc, London, England; [Nurse, Paul] Francis Crick Inst, London, England	Francis Crick Institute	Nurse, P (corresponding author), Royal Soc, London, England.; Nurse, P (corresponding author), Francis Crick Inst, London, England.	paul.nurse@crick.ac.uk							0	19	20	3	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 16	2021	597	7876					305	305		10.1038/d41586-021-02480-z	http://dx.doi.org/10.1038/d41586-021-02480-z			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UQ1MU	34522015				2022-12-28	WOS:000695836000001
J	Davidson, KW; Barry, MJ; Mangione, CM; Cabana, M; Caughey, AB; Davis, EM; Donahue, KE; Doubeni, CA; Krist, AH; Kubik, M; Li, L; Ogedegbe, G; Pbert, L; Silverstein, M; Simon, MA; Stevermer, J; Tseng, CW; Wong, JB				Davidson, Karina W.; Barry, Michael J.; Mangione, Carol M.; Cabana, Michael; Caughey, Aaron B.; Davis, Esa M.; Donahue, Katrina E.; Doubeni, Chyke A.; Krist, Alex H.; Kubik, Martha; Li, Li; Ogedegbe, Gbenga; Pbert, Lori; Silverstein, Michael; Simon, Melissa A.; Stevermer, James; Tseng, Chien-Wen; Wong, John B.		US Preventive Services Task Force	Screening for Chlamydia and Gonorrhea: US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							SEXUALLY-TRANSMITTED-DISEASES; PELVIC-INFLAMMATORY-DISEASE; NEISSERIA-GONORRHOEAE; TREATMENT GUIDELINES; TRACHOMATIS; INFECTION; SPECIMENS; WOMEN; MEN; VALIDATION	ImportanceChlamydia and gonorrhea are among the most common sexually transmitted infections in the US. Infection rates are highest among adolescents and young adults of both sexes. Chlamydial and gonococcal infections in women are usually asymptomatic and may lead to pelvic inflammatory disease and its associated complications. Newborns of pregnant persons with untreated infection may develop neonatal chlamydial pneumonia or gonococcal or chlamydial ophthalmia. Infection in men may lead to urethritis and epididymitis. Both types of infection can increase risk of acquiring or transmitting HIV. ObjectiveTo update its 2014 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for chlamydia and gonorrhea in sexually active adolescents and adults, including pregnant persons. PopulationAsymptomatic, sexually active adolescents and adults, including pregnant persons. Evidence AssessmentThe USPSTF concludes with moderate certainty that screening for chlamydia in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection has moderate net benefit. The USPSTF concludes with moderate certainty that screening for gonorrhea in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection has moderate net benefit. The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men. RecommendationThe USPSTF recommends screening for chlamydia in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection. (B recommendation) The USPSTF recommends screening for gonorrhea in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection. (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men. (I statement) This 2021 Recommendation Statement from the US Preventive Services Task Force recommends that all sexually active women 24 years or younger and women 25 years or older at increased risk for infection be screened for chlamydia (B recommendation) and gonorrhea (B recommendation) and concludes that current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men (I statement).	[Davidson, Karina W.] Northwell Hlth, Feinstein Inst Med Res, Manhasset, NY USA; [Barry, Michael J.] Harvard Med Sch, Boston, MA 02115 USA; [Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA USA; [Cabana, Michael] Albert Einstein Coll Med, New York, NY USA; [Caughey, Aaron B.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Davis, Esa M.] Univ Pittsburgh, Pittsburgh, PA USA; [Donahue, Katrina E.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Doubeni, Chyke A.] Mayo Clin, Rochester, MN USA; [Krist, Alex H.] Fairfax Family Practice Residency, Fairfax, VA USA; [Krist, Alex H.] Virginia Commonwealth Univ, Richmond, VA USA; [Kubik, Martha] George Mason Univ, Fairfax, VA 22030 USA; [Li, Li] Univ Virginia, Charlottesville, VA USA; [Ogedegbe, Gbenga] NYU, New York, NY USA; [Pbert, Lori] Univ Massachusetts, Sch Med, Worcester, MA USA; [Silverstein, Michael] Boston Univ, Boston, MA 02215 USA; [Simon, Melissa A.] Northwestern Univ, Chicago, IL 60611 USA; [Stevermer, James] Univ Missouri, Columbia, MO USA; [Tseng, Chien-Wen] Univ Hawaii, Honolulu, HI 96822 USA; [Tseng, Chien-Wen] Pacific Hlth Res & Educ Inst, Honolulu, HI USA; [Wong, John B.] Tufts Univ, Sch Med, Boston, MA 02111 USA	Northwell Health; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles; Yeshiva University; Oregon Health & Science University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; Mayo Clinic; Virginia Commonwealth University; George Mason University; University of Virginia; New York University; University of Massachusetts System; University of Massachusetts Worcester; Boston University; Northwestern University; University of Missouri System; University of Missouri Columbia; University of Hawaii System; Pacific Health Research & Education Institute; Tufts University	Davidson, KW (corresponding author), Northwell Hlth, Feinstein Inst Med Res, 130 E 59th St,Ste 14C, New York, NY 10032 USA.	chair@uspstf.net	Davidson, Karina/GWC-0996-2022	Davidson, Karina/0000-0002-9162-477X; Wong, John/0000-0003-4203-9010				[Anonymous], Routine tests during pregnancy; [Anonymous], SEXUALLY TRANSMITTED; [Anonymous], FDA clears first diagnostic tests for extragenital testing for chlamydia and gonorrhea; [Anonymous], 2021, PROC MAN; [Anonymous], CLIN PREV SERV; [Anonymous], 2021, CHLAM GON SYPH; Barrow RY, 2020, MMWR RECOMM REP, V68, P1, DOI 10.15585/mmwr.rr6805a1; BERGER RE, 1978, NEW ENGL J MED, V298, P301, DOI 10.1056/NEJM197802092980603; Berry L, 2017, J MED MICROBIOL, V66, P134, DOI 10.1099/jmm.0.000428; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V315, P2321, DOI 10.1001/jama.2016.5824; Brunham RC, 2015, NEW ENGL J MED, V372, P2039, DOI 10.1056/NEJMra1411426; Cantor A., 2021, AHRQ PUBLICATION; Cantor A, 2021, JAMA-J AM MED ASSOC, V326, P957, DOI 10.1001/jama.2021.10577; Curry SJ, 2018, JAMA-J AM MED ASSOC, V320, P911, DOI 10.1001/jama.2018.11785; Falasinnu T, 2016, PREV MED, V89, P51, DOI 10.1016/j.ypmed.2016.04.001; Falasinnu T, 2016, SEX TRANSM INFECT, V92, P12, DOI 10.1136/sextrans-2014-051992; Falasinnu T, 2014, SEX TRANSM DIS, V41, P732, DOI 10.1097/OLQ.0000000000000205; Fang JY, 2008, J PEDIATR ADOL GYNEC, V21, P355, DOI 10.1016/j.jpag.2008.03.010; Farley TA, 2003, PREV MED, V36, P502, DOI 10.1016/S0091-7435(02)00058-0; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Hammerschlag MR, 2011, CLIN INFECT DIS, V53, pS99, DOI 10.1093/cid/cir699; Hocking JS, 2018, LANCET, V392, P1413, DOI 10.1016/S0140-6736(18)31816-6; JACOBS NF, 1975, ANN INTERN MED, V82, P7, DOI 10.7326/0003-4819-82-1-7; Javanbakht M, 2018, SEX TRANSM DIS, V45, P588, DOI [10.1097/OLQ.0000000000000822, 10.1097/olq.0000000000000822]; Kalichman SC, 2011, SEX TRANSM INFECT, V87, P183, DOI 10.1136/sti.2010.047514; Kimberlin DWK, 2018, RED BOOK 2018 REPORT, P1046; Korenromp EL, 2002, INT J STD AIDS, V13, P91, DOI 10.1258/0956462021924712; Kreisel KM, 2021, SEX TRANSM DIS, V48, P208, DOI 10.1097/OLQ.0000000000001355; Krist AH, 2020, JAMA-J AM MED ASSOC, V324, P2415, DOI 10.1001/jama.2020.22980; Krist AH, 2020, JAMA-J AM MED ASSOC, V324, P674, DOI 10.1001/jama.2020.13095; Lavoue V, 2014, SEX TRANSM DIS, V41, P470, DOI 10.1097/OLQ.0000000000000153; LeFevre ML, 2014, ANN INTERN MED, V161, P902, DOI 10.7326/M14-1981; McConaghy JR, 2016, AM FAM PHYSICIAN, V94, P723; Miller WC, 2000, AM J PREV MED, V18, P115, DOI 10.1016/S0749-3797(99)00146-4; Murray PJ, 2014, PEDIATRICS, V134, pE302, DOI 10.1542/peds.2014-1024; Nye MB, 2019, SEX TRANSM INFECT, V95, P87, DOI 10.1136/sextrans-2018-053545; Oakeshott P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1642; Ostergaard L, 2000, CLIN INFECT DIS, V31, P951, DOI 10.1086/318139; Owens DK, 2019, JAMA-J AM MED ASSOC, V322, P349, DOI 10.1001/jama.2019.9365; Owens DK, 2019, JAMA-J AM MED ASSOC, V321, P2326, DOI 10.1001/jama.2019.6587; Owens DK, 2019, JAMA-J AM MED ASSOC, V321, P2203, DOI 10.1001/jama.2019.6390; Papp JR, 2014, MMWR RECOMM REP, V63, P1; Reekie J, 2018, CLIN INFECT DIS, V66, P437, DOI 10.1093/cid/cix769; RYAN GM, 1990, AM J OBSTET GYNECOL, V162, P34, DOI 10.1016/0002-9378(90)90815-O; Schachter J, 2003, J CLIN MICROBIOL, V41, P3784, DOI 10.1128/JCM.41.8.3784-3789.2003; Schoeman SA, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8013; Scholes D, 1996, NEW ENGL J MED, V334, P1362, DOI 10.1056/NEJM199605233342103; Shrier LA, 2004, AM J OBSTET GYNECOL, V190, P654, DOI 10.1016/j.ajog.2003.09.063; Siu AL, 2016, ANN INTERN MED, V164, P279, DOI 10.7326/M15-2886; Skidmore S, 2008, SEX TRANSM INFECT, V84, P277, DOI 10.1136/sti.2007.029587; St Cyr S, 2020, MMWR-MORBID MORTAL W, V69, P1911, DOI 10.15585/mmwr.mm6950a6; Stamm WE, 2008, SEXUALLY TRANSMITTED, P575; Stewart CMW, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8107; Sultan B, 2016, J CLIN MICROBIOL, V54, P650, DOI 10.1128/JCM.02460-15; Tao G, 2008, SEX TRANSM DIS, V35, P167, DOI 10.1097/OLQ.0b013e3181585be5; US Preventive Serv Task Force, 2020, JAMA-J AM MED ASSOC, V323, P970, DOI 10.1001/jama.2020.1123; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; Workowski KA, 2021, MMWR RECOMM REP, V70, P1	58	18	18	3	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2021	326	10					949	956		10.1001/jama.2021.14081	http://dx.doi.org/10.1001/jama.2021.14081			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UW4LI	34519796	Bronze			2022-12-28	WOS:000700129100014
J	Luo, HY; Lu, J; Bai, YX; Mao, T; Wang, J; Fan, QX; Zhang, YP; Zhao, KL; Chen, ZD; Gao, SG; Li, JC; Fu, ZC; Gu, KS; Liu, ZH; Wu, L; Zhang, XD; Feng, JF; Niu, ZX; Ba, Y; Zhang, HL; Liu, Y; Zhang, L; Min, XH; Huang, J; Cheng, Y; Wang, D; Shen, Y; Yang, Q; Zou, JJ; Xu, RH				Luo, Huiyan; Lu, Jin; Bai, Yuxian; Mao, Teng; Wang, Jun; Fan, Qingxia; Zhang, Yiping; Zhao, Kuaile; Chen, Zhendong; Gao, Shegan; Li, Jiancheng; Fu, Zhichao; Gu, Kangsheng; Liu, Zhihua; Wu, Lin; Zhang, Xiaodong; Feng, Jifeng; Niu, Zuoxing; Ba, Yi; Zhang, Helong; Liu, Ying; Zhang, Li; Min, Xuhong; Huang, Jing; Cheng, Ying; Wang, Dong; Shen, Yu; Yang, Qing; Zou, Jianjun; Xu, Rui-Hua		ESCORT-1st Investigators	Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma: The ESCORT-1st Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OPEN-LABEL; CANCER; MULTICENTER; PACLITAXEL; CISPLATIN; PEMBROLIZUMAB; RECURRENT; THERAPY	Key PointsQuestionDoes the addition of camrelizumab to chemotherapy improve outcomes when used as first-line treatment for patients with advanced or metastatic esophageal squamous cell carcinoma? FindingsIn this randomized clinical trial that included 596 patients with advanced or metastatic esophageal squamous cell carcinoma, camrelizumab combined with chemotherapy, compared with placebo and chemotherapy, significantly improved overall survival (15.3 vs 12.0 months, respectively; hazard ratio for death, 0.70) and progression-free survival (6.9 vs 5.6 months, respectively; hazard ratio for disease progression or death, 0.56). MeaningAmong patients with advanced or metastatic esophageal squamous cell carcinoma, an initial treatment strategy of camrelizumab combined with chemotherapy, compared with placebo and chemotherapy, resulted in improved overall survival and progression-free survival. ImportanceStandard first-line therapy for advanced or metastatic esophageal carcinoma is chemotherapy, but the prognosis remains poor. Camrelizumab (an anti-programmed death receptor 1 [PD-1] antibody) showed antitumor activity in previously treated advanced or metastatic esophageal squamous cell carcinoma. ObjectiveTo evaluate the efficacy and adverse events of camrelizumab plus chemotherapy vs placebo plus chemotherapy as a first-line treatment in advanced or metastatic esophageal squamous cell carcinoma. Design, Setting, and ParticipantsThis randomized, double-blind, placebo-controlled, multicenter, phase 3 trial (ESCORT-1st study) enrolled patients from 60 hospitals in China between December 3, 2018, and May 12, 2020 (final follow-up, October 30, 2020). A total of 751 patients were screened and 596 eligible patients with untreated advanced or metastatic esophageal squamous cell carcinoma were randomized. InterventionsPatients were randomized 1:1 to receive either camrelizumab 200 mg (n=298) or placebo (n=298), combined with up to 6 cycles of paclitaxel (175 mg/m(2)) and cisplatin (75 mg/m(2)). All treatments were given intravenously every 3 weeks. Main Outcomes and MeasuresCoprimary end points were overall survival (significance threshold, 1-sided P<.02) and progression-free survival (significance threshold, 1-sided P<.005). ResultsOf the 596 patients randomized (median age, 62 years [interquartile range, 56-67 years]; 523 men [87.8%]), 1 patient in the placebo-chemotherapy group did not receive planned treatment. A total of 490 patients (82.2%) had discontinued the study treatment. The median follow-up was 10.8 months. The overall survival for the camrelizumab-chemotherapy group was a median of 15.3 months (95% CI, 12.8-17.3; 135 deaths) vs a median of 12.0 months (95% CI, 11.0-13.3; 174 deaths) for the placebo-chemotherapy group (hazard ratio [HR] for death, 0.70 [95% CI, 0.56-0.88]; 1-sided P=.001). Progression-free survival for camrelizumab plus chemotherapy was a median of 6.9 months (95% CI, 5.8-7.4; 199 progression or deaths) vs 5.6 months (95% CI, 5.5-5.7; 229 progression or deaths) for the placebo-chemotherapy group (HR for progression or death, 0.56 [95% CI, 0.46-0.68]; 1-sided P<.001). Treatment-related adverse events of grade 3 or higher occurred in 189 patients (63.4%) in the camrelizumab-chemotherapy group and 201 (67.7%) in the placebo-chemotherapy group, including treatment-related deaths among 9 patients (3.0%) and 11 patients (3.7%), respectively. Conclusions and RelevanceAmong patients with advanced or metastatic esophageal squamous cell carcinoma, the addition of camrelizumab to chemotherapy, compared with placebo and chemotherapy, significantly improved overall survival and progression-free survival. Trial RegistrationClinicalTrials.gov Identifier: NCT03691090 This clinical trial compares overall and progression-free survival of patients with advanced or metastatic esophageal squamous cell carcinoma randomized to camrelizumab plus chemotherapy or to placebo plus chemotherapy.	[Luo, Huiyan; Xu, Rui-Hua] Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Peoples R China; [Luo, Huiyan; Xu, Rui-Hua] Chinese Acad Med Sci, Res Unit Precis Diag & Treatment Gastrointestinal, Guangzhou, Peoples R China; [Lu, Jin] Sichuan Canc Hosp, Chengdu, Peoples R China; [Bai, Yuxian] Harbin Med Univ, Canc Hosp, Harbin, Peoples R China; [Mao, Teng] Shanghai Chest Hosp, Shanghai, Peoples R China; [Wang, Jun] Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China; [Fan, Qingxia] Zhengzhou Univ, Affiliated Hosp, Zhengzhou, Peoples R China; [Zhang, Yiping] Zhejiang Canc Hosp, Hangzhou, Peoples R China; [Zhao, Kuaile] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China; [Chen, Zhendong] Anhui Med Univ, Affiliated Hosp 2, Hefei, Peoples R China; [Gao, Shegan] Henan Univ Sci & Technol, Affiliated Hosp 1, Luoyang, Peoples R China; [Li, Jiancheng] Fujian Prov Canc Hosp, Fuzhou, Peoples R China; [Fu, Zhichao] Hosp Joint Logist Support Force, Fuzhou, Peoples R China; [Gu, Kangsheng] Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China; [Liu, Zhihua] Jiangxi Prov Canc Hosp, Nanchang, Jiangxi, Peoples R China; [Wu, Lin] Hunan Canc Hosp, Changsha, Peoples R China; [Zhang, Xiaodong] Peking Univ Canc Hosp & Inst, Beijing, Peoples R China; [Feng, Jifeng] Jiangsu Canc Hosp, Nanjing, Peoples R China; [Niu, Zuoxing] Shandong Univ, Shandong Canc Hosp, Jinan, Peoples R China; [Ba, Yi] Tianjin Med Univ, Canc Inst & Hosp, Tianjin, Peoples R China; [Zhang, Helong] Air Force Med Univ, Affiliated Hosp 2, Xian, Peoples R China; [Liu, Ying] Henan Canc Hosp, Zhengzhou, Peoples R China; [Zhang, Li] Chongqing Three Gorges Cent Hosp, Chongqing, Peoples R China; [Min, Xuhong] Anhui Chest Hosp, Hefei, Peoples R China; [Huang, Jing] Chinese Acad Med Sci, Canc Hosp, Beijing, Peoples R China; [Cheng, Ying] Jilin Canc Hosp, Changchun, Peoples R China; [Wang, Dong] Army Med Ctr PLA, Chongqing, Peoples R China; [Shen, Yu; Yang, Qing; Zou, Jianjun] Jiangsu Hengrui Pharmaceut Co Ltd, Shanghai, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Chinese Academy of Medical Sciences - Peking Union Medical College; Harbin Medical University; Shanghai Jiao Tong University; Hebei Medical University; Zhengzhou University; Zhejiang Cancer Hospital; Fudan University; Anhui Medical University; Henan University of Science & Technology; Anhui Medical University; Peking University; Nanjing Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Tianjin Medical University; Air Force Military Medical University; Zhengzhou University; Chongqing Three Gorges University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Xu, RH (corresponding author), Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Med Oncol,Collaborat Innovat Ctr Canc Med, 651 Dongfeng Rd E, Guangzhou 510060, Peoples R China.	xurh@sysucc.org.cn	骆, 卉妍/GWR-3383-2022; Xu, Rui-Hua/AAW-4766-2021	骆, 卉妍/0000-0001-6312-9299; Xu, Rui-Hua/0000-0001-9771-8534; Gu, Kangsheng/0000-0002-5800-5256				Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Burtness B, 2019, LANCET, V394, P1915, DOI 10.1016/S0140-6736(19)32591-7; Cocks K, 2008, EUR J CANCER, V44, P1793, DOI 10.1016/j.ejca.2008.05.008; European Organization for Research and Treatment of Cancer, QUALITY LIFE; Fang WF, 2018, LANCET ONCOL, V19, P1338, DOI 10.1016/S1470-2045(18)30495-9; Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Huang J, 2020, LANCET ONCOL, V21, P832, DOI 10.1016/S1470-2045(20)30110-8; JENNISON C, 1984, CONTROL CLIN TRIALS, V5, P33, DOI 10.1016/0197-2456(84)90148-X; Kato K, 2020, ANN ONCOL, V31, pS1192, DOI 10.1016/j.annonc.2020.08.2298; Kato K, 2019, LANCET ONCOL, V20, P1506, DOI 10.1016/S1470-2045(19)30626-6; Kojima T, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.20.01888; Kulangara K, 2019, ARCH PATHOL LAB MED, V143, P330, DOI 10.5858/arpa.2018-0043-OA; Liu Y, 2016, AM J CANCER RES, V6, P2345; National Comprehensive Cancer Network, 2021, ESOPH ESOPH JUNCT CA; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Petrasch S, 1998, BRIT J CANCER, V78, P511, DOI 10.1038/bjc.1998.524; Qin SK, 2020, LANCET ONCOL, V21, P571, DOI 10.1016/S1470-2045(20)30011-5; Song YQ, 2019, CLIN CANCER RES, V25, P7363, DOI 10.1158/1078-0432.CCR-19-1680; Sun S, 2019, ONCOL RES TREAT, V42, P115, DOI 10.1159/000495700; Wang F, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00886-2; Wileyto EP, 2013, BIOSTATISTICS, V14, P340, DOI 10.1093/biostatistics/kxs043; Yamamoto S, 2020, FUTURE ONCOL, V16, P2673, DOI 10.2217/fon-2020-0545; Zhang HZ, 2012, CHIN J CANCER, V31, P281, DOI 10.5732/cjc.011.10390; Zhang XD, 2008, AM J CLIN ONCOL-CANC, V31, P29, DOI 10.1097/COC.0b013e3181131ca9; Zhou CC, 2021, LANCET RESP MED, V9, P305, DOI 10.1016/S2213-2600(20)30365-9	26	88	90	37	96	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2021	326	10					916	925		10.1001/jama.2021.12836	http://dx.doi.org/10.1001/jama.2021.12836			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UW4LI	34519801	Green Published, Bronze			2022-12-28	WOS:000700129100011
J	Rochester, CL; Spruit, MA; Holland, AE				Rochester, Carolyn L.; Spruit, Martijn A.; Holland, Anne E.			Pulmonary Rehabilitation in 2021	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COPD	This JAMA Insights Clinical Update provides an overview of pulmonary rehabilitation, including patient candidacy, the process and components, and expected outcomes.				carolyn.rochester@yale.edu						Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Global Initiative for Chronic Obstructive Lung Disease, 2020, GLOBAL STRATEGY DIAG; Granger CL, 2019, RESPIROLOGY, V24, P879, DOI 10.1111/resp.13562; Holland AE, 2017, THORAX, V72, P57, DOI 10.1136/thoraxjnl-2016-208514; Lindenauer PK, 2020, JAMA-J AM MED ASSOC, V323, P1813, DOI 10.1001/jama.2020.4437; McCarthy B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003793.pub3; Puhan MA, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005305.pub4; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rochester CL, 2015, AM J RESP CRIT CARE, V192, P1373, DOI 10.1164/rccm.201510-1966ST; Spruit MA, 2013, AM J RESP CRIT CARE, V188, pE13, DOI 10.1164/rccm.201309-1634ST	10	3	3	4	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2021	326	10					969	969		10.1001/jama.2021.6560	http://dx.doi.org/10.1001/jama.2021.6560			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UW4LI	34519811				2022-12-28	WOS:000700129100017
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: Trouble with the new normal	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2021	374								n2223	10.1136/bmj.n2223	http://dx.doi.org/10.1136/bmj.n2223			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WP7CH	34521697	Bronze			2022-12-28	WOS:000713284400012
J	Zapata-Caballero, CA; Ramirez-Santes, VH				Zapata-Caballero, Carlos A.; Ramirez-Santes, Victor H.			Placenta Increta	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Placenta Increta A 26-year-old woman with two prior cesarean deliveries presented in preterm labor. Placental vessels were visualized on the uterine walls during surgery. Placenta increta was diagnosed by histopathological analysis.	[Zapata-Caballero, Carlos A.; Ramirez-Santes, Victor H.] Inst Nacl Perinatol, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico	Zapata-Caballero, CA (corresponding author), Inst Nacl Perinatol, Mexico City, DF, Mexico.	dr.zapatacaballero@outlook.com		Zapata-Caballero, Carlos/0000-0001-6940-7528					0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2021	385	12					1124	1124		10.1056/NEJMicm2109363	http://dx.doi.org/10.1056/NEJMicm2109363		SEP 2021	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UQ4IT	34506088				2022-12-28	WOS:000694804300001
J	Tanne, JH				Tanne, Janice Hopkins			Study that finds good sex clears a stuffed nose as well as a decongestant wins Ig Nobel prize for medicine	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Beseris EA, 2020, INTEGR ORGANISM BIOL, V2, DOI 10.1093/iob/obaa005; Blavatskyy PR, 2021, ECON TRANSIT I CHANG, V29, P361, DOI 10.1111/ecot.12272; Bulut OC, 2023, ENT-EAR NOSE THROAT, V102, P40, DOI 10.1177/0145561320981441; Corbetta A, 2018, PHYS REV E, V98, DOI 10.1103/PhysRevE.98.062310; MULRENNAN JA, 1971, J ECON ENTOMOL, V64, P1196, DOI 10.1093/jee/64.5.1196; Murakami H, SCI ADV, V7; Radcliffe RW, 2021, J WILDLIFE DIS, V57, P357, DOI 10.7589/2019-08-202; Satari L, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73913-4; Schotz S, P FON 2012; Schotz S., 2016, MELODY HUMAN CAT COM; Schotz S, 2013, P FON, P65; Schotz S, P FON 2011, P51; Stonner C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203044; van de Weijer Schotz S., 2014, P 7 INT C SPE PROS D; Wicker J, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1295, DOI 10.1145/2578726.2578744	15	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2021	374								n2230	10.1136/bmj.n2230	http://dx.doi.org/10.1136/bmj.n2230			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	US1IY	34507974				2022-12-28	WOS:000697191000009
J	Limb, M				Limb, Matthew			The BMJ Awards 2021: Workforce and wellbeing team of the year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												limb@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2021	374								n2151	10.1136/bmj.n2151	http://dx.doi.org/10.1136/bmj.n2151			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ3VV	34503956				2022-12-28	WOS:000702137100011
J	Kornilov, O				Kornilov, Oleg			A quantum vortex made of atoms	SCIENCE			English	Editorial Material									[Kornilov, Oleg] Max Born Inst, Max Born Str 2A, D-12489 Berlin, Germany	Max Born Institute for Nonlinear Optics & Short Term Spectroscopy	Kornilov, O (corresponding author), Max Born Inst, Max Born Str 2A, D-12489 Berlin, Germany.	kornilov@mbi-berlin.de						ALLEN L, 1992, PHYS REV A, V45, P8185, DOI 10.1103/PhysRevA.45.8185; KEITH DW, 1988, PHYS REV LETT, V61, P1580, DOI 10.1103/PhysRevLett.61.1580; Kunitski M, 2015, SCIENCE, V348, P551, DOI 10.1126/science.aaa5601; Luski A, 2021, SCIENCE, V373, P1105; SCHOLLKOPF W, 1994, SCIENCE, V266, P1345, DOI 10.1126/science.266.5189.1345; Shen YJ, 2019, LIGHT-SCI APPL, V8, DOI 10.1038/s41377-019-0194-2; Uchida M, 2010, NATURE, V464, P737, DOI 10.1038/nature08904; Vanacore GM, 2019, NAT MATER, V18, P573, DOI 10.1038/s41563-019-0336-1	8	0	0	2	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2021	373	6559					1084	1084		10.1126/science.abk1565	http://dx.doi.org/10.1126/science.abk1565			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UL8QT	34516852				2022-12-28	WOS:000692910300027
J	Mellado, W; Willis, DE				Mellado, Wilfredo; Willis, Dianna E.			Stressing out translation	SCIENCE			English	Editorial Material							MARIE-TOOTH DISEASE; NEUROPATHY; MUTATIONS; FEATURES		[Mellado, Wilfredo; Willis, Dianna E.] Burke Neurol Inst, White Plains, NY 10605 USA; [Willis, Dianna E.] Weill Cornell Med, Feil Family Brain & Mind Res Inst, New York, NY USA	Cornell University	Mellado, W (corresponding author), Burke Neurol Inst, White Plains, NY 10605 USA.	wim2007@med.cornell.edu; diw2004@med.cornell.edu						Alexandrova J, 2015, RNA BIOL, V12, P1301, DOI 10.1080/15476286.2015.1086866; Antonellis A, 2006, J NEUROSCI, V26, P10397, DOI 10.1523/JNEUROSCI.1671-06.2006; Costa-Mattioli M, 2020, SCIENCE, V368, P384, DOI 10.1126/science.aat5314; Froelich CA, 2011, BIOCHEMISTRY-US, V50, P7132, DOI 10.1021/bi200989h; Gomez MAR, 2020, RNA, V26, P910, DOI 10.1261/rna.071720.119; Inglis AJ, 2019, P NATL ACAD SCI USA, V116, P4946, DOI 10.1073/pnas.1813352116; Ishimura R, 2016, ELIFE, V5, DOI 10.7554/eLife.14295; Barreto LCLS, 2016, NEUROEPIDEMIOLOGY, V46, P157, DOI 10.1159/000443706; Nangle LA, 2007, P NATL ACAD SCI USA, V104, P11239, DOI 10.1073/pnas.0705055104; Spaulding E. L, 2021, SCIENCE, V373, P1156; Storkebaum E, 2016, BIOESSAYS, V38, P818, DOI 10.1002/bies.201600052; Storkebaum E, 2009, P NATL ACAD SCI USA, V106, P11782, DOI 10.1073/pnas.0905339106; Wallen RC, 2013, CURR OPIN GENET DEV, V23, P302, DOI 10.1016/j.gde.2013.02.002; Wei N, 2019, J BIOL CHEM, V294, P5321, DOI 10.1074/jbc.REV118.002955; Zuko A, 2021, SCIENCE, V373, P1161	15	3	3	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2021	373	6559					1089	1090		10.1126/science.abk3261	http://dx.doi.org/10.1126/science.abk3261			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UL8QT	34516848				2022-12-28	WOS:000692910300031
J	Li, TC; Fu, TM; Wong, KKL; Li, HJ; Xie, QJ; Luginbuhl, DJ; Wagner, MJ; Betzig, E; Luo, LQ				Li, Tongchao; Fu, Tian-Ming; Wong, Kenneth Kin Lam; Li, Hongjie; Xie, Qijing; Luginbuhl, David J.; Wagner, Mark J.; Betzig, Eric; Luo, Liqun			Cellular bases of olfactory circuit assembly revealed by systematic time-lapse imaging	CELL			English	Article							FLP RECOMBINASE; RETINAL AXONS; DROSOPHILA; GROWTH; NEURONS; MAP; EXPRESSION; ORGANIZES; OUTGROWTH; PIONEER	Neural circuit assembly features simultaneous targeting of numerous neuronal processes from constituent neuron types, yet the dynamics is poorly understood. Here, we use the Drosophila olfactory circuit to investigate dynamic cellular processes by which olfactory receptor neurons (ORNs) target axons precisely to specific glomeruli in the ipsi- and contralateral antennal lobes. Time-lapse imaging of individual axons from 30 ORN types revealed a rich diversity in extension speed, innervation timing, and ipsilateral branch locations and identified that ipsilateral targeting occurs via stabilization of transient interstitial branches. Fast imaging using adaptive optics-corrected lattice light-sheet microscopy showed that upon approaching target, many ORN types exhibiting "exploring branches" consisted of parallel microtubule-based terminal branches emanating from an F-actin-rich hub. Antennal nerve ablations uncovered essential roles for bilateral axons in contralateral target selection and for ORN axons to facilitate dendritic refinement of postsynaptic partner neurons. Altogether, these observations provide cellular bases for wiring specificity establishment.	[Li, Tongchao; Wong, Kenneth Kin Lam; Li, Hongjie; Xie, Qijing; Luginbuhl, David J.; Wagner, Mark J.; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA; [Fu, Tian-Ming; Betzig, Eric] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20417 USA; [Betzig, Eric] Univ Calif Berkeley, Helen Wills Neurosci Inst, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Betzig, Eric] Univ Calif Berkeley, Helen Wills Neurosci Inst, Howard Hughes Med Inst, Dept Phys, Berkeley, CA 94720 USA; [Betzig, Eric] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Li, TC; Luo, LQ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA.	tongchal@stanford.edu; lluo@stanford.edu	; Fu, Tian-Ming/B-1741-2018	Luo, Liqun/0000-0001-5467-9264; Fu, Tian-Ming/0000-0001-6265-0859; , Kin Lam/0000-0002-5597-4051; Wagner, Mark/0000-0003-1816-6407	Yingwei Cui and Hui Zhao Neuroscience Fund; NIH [1K99DC01883001, R01-DC005982]	Yingwei Cui and Hui Zhao Neuroscience Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank N. Ozel and R. Hiesinger for their advice on the explant culture; T. Lecuit, L. Lavis, M. Freeman, Y. Aso, and Bloomington Drosophila Stock Center for reagents; Y. Ge for assistance on fly work; J. Baruni, T. Brown, P. Dong, D. Friedmann, L. Lavis, J. Li, Z. Li, C. McLaughlin, D. Milkie, D. Pederick, K. Shen, Y. Takeo, G. Upadhyayula, R. Zhong for discussions; and T. Lee for sharing equipment at Janelia Research Campus. T.L. and L.L. thank the Yingwei Cui and Hui Zhao Neuroscience Fund for support. H.L. was a Stanford Neuroscience Institute interdisciplinary postdoctoral scholar. E.B. and L.L. are HHMI investigators. This work was supported by NIH (1K99DC01883001 to T.L. and R01-DC005982 to L.L.).	Akin O, 2016, ELIFE, V5, DOI 10.7554/eLife.20762; Bak M, 2003, DEVELOPMENT, V130, P4999, DOI 10.1242/dev.00713; BENTLEY D, 1983, NATURE, V304, P62, DOI 10.1038/304062a0; Berns DS, 2018, NATURE, V554, P328, DOI 10.1038/nature25463; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; Chen F, 2014, SCIENCE, V343, P186, DOI 10.1126/science.1241442; Corballis MC, 2009, PHILOS T R SOC B, V364, P867, DOI 10.1098/rstb.2008.0232; Dent EW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001800; Endo K, 2007, NAT NEUROSCI, V10, P153, DOI 10.1038/nn1832; Fygenson D.K., 1997, PHYS REV LETT, V22, P769; GODEMENT P, 1994, J NEUROSCI, V14, P7024; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Grieder NC, 2000, DEVELOPMENT, V127, P4253; Grimm JB, 2017, METHODS MOL BIOL, V1663, P179, DOI 10.1007/978-1-4939-7265-4_15; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Haas K, 2006, P NATL ACAD SCI USA, V103, P12127, DOI 10.1073/pnas.0602670103; HARRIS WA, 1987, DEVELOPMENT, V101, P123; Harrison RG, 1910, J EXP ZOOL, V9, P787, DOI 10.1002/jez.1400090405; Hong WZ, 2014, GENETICS, V196, P17, DOI 10.1534/genetics.113.154336; Hong WZ, 2012, NATURE, V484, P201, DOI 10.1038/nature10926; Hutson LD, 2002, NEURON, V33, P205, DOI 10.1016/S0896-6273(01)00579-7; Ito K, 1998, LEARN MEMORY, V5, P52; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Joo WJ, 2013, NEURON, V78, P673, DOI 10.1016/j.neuron.2013.03.022; Kalil K, 2014, NAT REV NEUROSCI, V15, P7, DOI 10.1038/nrn3650; Kohl J, 2014, P NATL ACAD SCI USA, V111, pE3805, DOI 10.1073/pnas.1411087111; Kolodkin AL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001727; Langen M, 2015, CELL, V162, P120, DOI 10.1016/j.cell.2015.05.055; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li TC, 2016, ELIFE, V5, DOI 10.7554/eLife.15258; Lin Chi-Hung, 1994, Current Opinion in Neurobiology, V4, P640, DOI 10.1016/0959-4388(94)90004-3; Liu TL, 2018, SCIENCE, V360, DOI 10.1126/science.aaq1392; Lodato S, 2015, TRENDS NEUROSCI, V38, P117, DOI 10.1016/j.tins.2014.11.003; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Ozel MN, 2015, ELIFE, V4, DOI 10.7554/eLife.10721; Okumura M, 2016, GENES CELLS, V21, P53, DOI 10.1111/gtc.12321; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Potter CJ, 2010, CELL, V141, P536, DOI 10.1016/j.cell.2010.02.025; Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566; Rusan NM, 2007, J CELL BIOL, V177, P13, DOI 10.1083/jcb.200612140; Sagasti A, 2005, CURR BIOL, V15, P804, DOI 10.1016/j.cub.2005.03.048; Sanchez-Soriano N, 2010, DEV NEUROBIOL, V70, P58, DOI 10.1002/dneu.20762; Sanes JR, 2020, CELL, V181, P1434, DOI 10.1016/j.cell.2020.05.046; Santos TE, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107907; SENECOFF JF, 1988, J MOL BIOL, V201, P405, DOI 10.1016/0022-2836(88)90147-7; Smith CJ, 2010, DEV BIOL, V345, P18, DOI 10.1016/j.ydbio.2010.05.502; Stork T, 2014, NEURON, V83, P388, DOI 10.1016/j.neuron.2014.06.026; Sutcliffe B, 2017, GENETICS, V205, P1399, DOI 10.1534/genetics.116.199281; Swanson L. W, 2011, BRAIN ARCHITECTURE U; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang K, 2014, NAT METHODS, V11, P625, DOI [10.1038/NMETH.2925, 10.1038/nmeth.2925]; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Wong HHW, 2017, NEURON, V95, P852, DOI 10.1016/j.neuron.2017.07.016; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; Xie QJ, 2021, ELIFE, V10, DOI 10.7554/eLife.63450; Yates PA, 2001, J NEUROSCI, V21, P8548, DOI 10.1523/JNEUROSCI.21-21-08548.2001; Yost HJ, 1998, DEV GENET, V23, P159	62	6	6	10	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 30	2021	184	20					5107	+		10.1016/j.cell.2021.08.030	http://dx.doi.org/10.1016/j.cell.2021.08.030		OCT 2021	29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	WC7PG	34551316	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000704445700008
J	Kaufman, AM				Kaufman, Adam M.			Photons and qubits get a better connection	SCIENCE			English	Editorial Material							QUANTUM NETWORK; ENTANGLEMENT		[Kaufman, Adam M.] Univ Colorado, Dept Phys, JILA, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Kaufman, AM (corresponding author), Univ Colorado, Dept Phys, JILA, Boulder, CO 80309 USA.	adammicahkaufman@gmail.com						Awschalom D, 2021, PRX QUANTUM, V2, DOI 10.1103/PRXQuantum.2.017002; Axline CJ, 2018, NAT PHYS, V14, P705, DOI 10.1038/s41567-018-0115-y; Bernien H, 2013, NATURE, V497, P86, DOI 10.1038/nature12016; Chaneliere T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.093604; Covey JP, 2019, PHYS REV APPL, V11, DOI 10.1103/PhysRevApplied.11.034044; Dordevic T, 2021, SCIENCE, V373, P1511, DOI 10.1126/science.abi9917; Hucul D, 2015, NAT PHYS, V11, P37, DOI [10.1038/nphys3150, 10.1038/NPHYS3150]; Kurpiers P, 2018, NATURE, V558, P264, DOI 10.1038/s41586-018-0195-y; Magnard P, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.260502; Matsukevich DN, 2004, SCIENCE, V306, P663, DOI 10.1126/science.1103346; Muralidharan S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20463; Ritter S, 2012, NATURE, V484, P195, DOI 10.1038/nature11023; Tiecke TG, 2014, NATURE, V508, P241, DOI 10.1038/nature13188; Welte S, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.210503	15	1	1	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2021	373	6562			SI		1436	1437		10.1126/science.abk2617	http://dx.doi.org/10.1126/science.abk2617			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU7LJ	34554808				2022-12-28	WOS:000698977800027
J	Perkel, JM				Perkel, Jeffrey M.			PROTEOMICS AT THE SINGLE-CELL LEVEL	NATURE			English	Editorial Material						Proteomics; Biological techniques; Computational biology and bioinformatics												Brunner A.-D., 2021, PREPRINT BIORXIV, DOI [10.1101/2020.12.22.423933, DOI 10.1101/2020.12.22.423933]; Budnik B, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1547-5; Cong YZ, 2021, CHEM SCI, V12, P1001, DOI 10.1039/d0sc03636f; Ctortecka C., 2021, PREPRINT BIORXIV, DOI [10.1101/2021.02.11.430601, DOI 10.1101/2021.02.11.430601]; Guo G, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23461-w; Hartlmayr D., 2021, PREPRINT BIORXIV, DOI [10.1101/2021.04.14.439828, DOI 10.1101/2021.04.14.439828]; Leduc A., 2021, PREPRINT BIORXIV, DOI [10.1101/2021.04.24.441211, DOI 10.1101/2021.04.24.441211]; Li Jiaming, 2021, PRIDE, DOI 10.1021/acs.jproteome.1c00168; Mund A., 2021, PREPRINT BIORXIV, DOI [10.1101/2021.01.25.427969, DOI 10.1101/2021.01.25.427969]; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Piehowski PD, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13858-z; Smith L. M., 2020, PREPRINT, DOI [10.20944/preprints202010.0368.v1, DOI 10.20944/PREPRINTS202010.0368.V1]; Specht H, 2021, GENOME BIOL, V22, DOI 10.1186/s13059-021-02267-5; Woo J., 2021, PREPRINT BIORXIV, DOI [10.1101/2021.02.17.431689, DOI 10.1101/2021.02.17.431689]; Zhu Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03367-w	15	21	21	16	77	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2021	597	7877					580	582		10.1038/d41586-021-02530-6	http://dx.doi.org/10.1038/d41586-021-02530-6			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	US3WS	34545225				2022-12-28	WOS:000697364400004
J	[Anonymous]				[Anonymous]			Update to living WHO guideline on drugs for covid-19	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	5	5	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2021	374								n2219	10.1136/bmj.n2219	http://dx.doi.org/10.1136/bmj.n2219			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ1JE	34556469				2022-12-28	WOS:000701967300004
J	Best, J				Best, Jo			What's Health Data Research UK doing to help tackle covid-19?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VACCINATION					jo.best@journalist.com						Hippisley-Cox J, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1931; Vallance P, 2020, LETTER 1028; Vasileiou E, 2021, LANCET, V397, P1646, DOI 10.1016/S0140-6736(21)00677-2	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 22	2021	374								n2280	10.1136/bmj.n2280	http://dx.doi.org/10.1136/bmj.n2280			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WQ2LU	34551909	Bronze			2022-12-28	WOS:000713652600009
J	Feng, SL; Zhu, PA; Zheng, HX; Zhan, HY; Chen, C; Li, JQ; Wang, LQ; Yao, X; Liu, YH; Wang, ZK				Feng, Shile; Zhu, Pingan; Zheng, Huanxi; Zhan, Haiyang; Chen, Chen; Li, Jiaqian; Wang, Liqiu; Yao, Xi; Liu, Yahua; Wang, Zuankai			Three-dimensional capillary ratchet-induced liquid directional steering	SCIENCE			English	Article							WATER; SURFACE; TRANSPORT	Conventional understanding has it that a liquid deposited on a surface tends to move along directions that reduce surface energy, which is mainly dictated by surface properties rather than liquid properties, such as surface tension. Achieving well-controlled directional steering remains challenging because the liquid-solid interaction mainly occurs in the two-dimensional (2D) domain. We show that the spreading direction of liquids with different surface tensions can be tailored by designing 3D capillary ratchets that create an asymmetric and 3D spreading profile both in and out of the surface plane. Such directional steering is also accompanied by self-propulsion and high flow velocity, all of which are preferred in liquid transport.	[Feng, Shile; Zhu, Pingan; Zheng, Huanxi; Li, Jiaqian; Wang, Zuankai] City Univ Hong Kong, Dept Mech Engn, Hong Kong 999077, Peoples R China; [Feng, Shile; Zhan, Haiyang; Chen, Chen; Liu, Yahua] Dalian Univ Technol, Key Lab Precis & Nontradit Machining Technol, Minist Educ, Dalian 116024, Peoples R China; [Wang, Liqiu] Univ Hong Kong, Dept Mech Engn, Hong Kong 999077, Peoples R China; [Yao, Xi] City Univ Hong Kong, Dept Biomed Sci, Hong Kong 999077, Peoples R China; [Wang, Zuankai] City Univ Hong Kong, Ctr Nat Inspired Engn, Hong Kong 999077, Peoples R China	City University of Hong Kong; Dalian University of Technology; University of Hong Kong; City University of Hong Kong; City University of Hong Kong	Wang, ZK (corresponding author), City Univ Hong Kong, Dept Mech Engn, Hong Kong 999077, Peoples R China.; Wang, ZK (corresponding author), City Univ Hong Kong, Ctr Nat Inspired Engn, Hong Kong 999077, Peoples R China.	zuanwang@city.edu.hk	Li, Jiaqian/HGE-4168-2022; Zhu, Pingan/K-4965-2019; Wang, Liqiu/C-1901-2009; Wang, Zuankai/D-1555-2009	Li, Jiaqian/0000-0001-6655-6069; Zhu, Pingan/0000-0001-5847-1831; Wang, Liqiu/0000-0002-6514-4211; Wang, Zuankai/0000-0002-3510-1122; Liu, Yahua/0000-0003-4671-698X; Feng, Shile/0000-0002-8900-685X; haiyang, zhan/0000-0002-9664-7284				Bico J, 2001, EUROPHYS LETT, V55, P214, DOI 10.1209/epl/i2001-00402-x; Bird JC, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.234501; CHAUDHURY MK, 1992, SCIENCE, V256, P1539, DOI 10.1126/science.256.5063.1539; Chen HW, 2016, NATURE, V532, P85, DOI 10.1038/nature17189; Choi W, 2009, J COLLOID INTERF SCI, V339, P208, DOI 10.1016/j.jcis.2009.07.027; Chu KH, 2010, NAT MATER, V9, P413, DOI [10.1038/nmat2726, 10.1038/NMAT2726]; Comanns P, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0415; Daniel S, 2001, SCIENCE, V291, P633, DOI 10.1126/science.291.5504.633; Feng SL, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb4540; Li CX, 2019, P NATL ACAD SCI USA, V116, P12704, DOI 10.1073/pnas.1821493116; Li J., 2020, SMALL, V16; Li JQ, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao3530; Li J, 2016, NAT PHYS, V12, P606, DOI [10.1038/nphys3643, 10.1038/NPHYS3643]; Linke H, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.154502; Liu CC, 2014, ACS NANO, V8, P1321, DOI 10.1021/nn404761q; Liu TY, 2014, SCIENCE, V346, P1096, DOI 10.1126/science.1254787; Liu YF, 2020, SMALL, V16, DOI 10.1002/smll.201901819; Lv CJ, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.026101; Malvadkar NA, 2010, NAT MATER, V9, P1023, DOI 10.1038/NMAT2864; Park KC, 2016, NATURE, V531, P78, DOI 10.1038/nature16956; Prakash M, 2008, SCIENCE, V320, P931, DOI 10.1126/science.1156023; Seemann R, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/1/016601; Stone HA, 2004, ANNU REV FLUID MECH, V36, P381, DOI 10.1146/annurev.fluid.36.050802.122124; Sun QQ, 2019, NAT MATER, V18, P936, DOI 10.1038/s41563-019-0440-2; Tian XL, 2016, ADV MATER, V28, P10652, DOI 10.1002/adma.201602714; Tuteja A, 2007, SCIENCE, V318, P1618, DOI 10.1126/science.1148326; Tyree MT, 2003, NATURE, V423, P923, DOI 10.1038/423923a; Wang JZ, 2004, NAT MATER, V3, P171, DOI 10.1038/nmat1073; Wang QB, 2015, P NATL ACAD SCI USA, V112, P9247, DOI 10.1073/pnas.1506874112; Washburn EW, 1921, PHYS REV, V17, P273, DOI 10.1103/PhysRev.17.273; Wu L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14366-1; Zheng S, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201800832; Zheng YM, 2010, NATURE, V463, P640, DOI 10.1038/nature08729; Zhu PA, 2018, MATER HORIZ, V5, P1156, DOI 10.1039/c8mh00964c	34	79	80	163	549	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2021	373	6561					1344	+		10.1126/science.abg7552	http://dx.doi.org/10.1126/science.abg7552			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	US5SK	34529472				2022-12-28	WOS:000697488600046
J	Martin, TD; Patel, RS; Cook, DR; Choi, MY; Patil, A; Liang, AC; Li, MZ; Haigis, KM; Elledge, SJ				Martin, Timothy D.; Patel, Rupesh S.; Cook, Danielle R.; Choi, Mei Yuk; Patil, Ajinkya; Liang, Anthony C.; Li, Mamie Z.; Haigis, Kevin M.; Elledge, Stephen J.			The adaptive immune system is a major driver of selection for tumor suppressor gene inactivation	SCIENCE			English	Article							BREAST-CANCER; TISSUE-SPECIFICITY; CELL-LINES; G-PROTEINS; MUTATIONS; PROMOTES; IDENTIFICATION; MACROPHAGES; LANDSCAPE; HOMOLOG	During tumorigenesis, tumors must evolve to evade the immune system and do so by disrupting the genes involved in antigen processing and presentation or up-regulating inhibitory immune checkpoint genes. We performed in vivo CRISPR screens in syngeneic mouse tumor models to examine requirements for tumorigenesis both with and without adaptive immune selective pressure. In each tumor type tested, we found a marked enrichment for the loss of tumor suppressor genes (TSGs) in the presence of an adaptive immune system relative to immunocompromised mice. Nearly one-third of TSGs showed preferential enrichment, often in a cancer- and tissue-specific manner. These results suggest that clonal selection of recurrent mutations found in cancer is driven largely by the tumor's requirement to avoid the adaptive immune system.	[Martin, Timothy D.; Patel, Rupesh S.; Choi, Mei Yuk; Patil, Ajinkya; Liang, Anthony C.; Li, Mamie Z.; Elledge, Stephen J.] Harvard Med Sch, Brigham & Womens Hosp, Howard Hughes Med Inst, Div Genet,Dept Genet, Boston, MA 02115 USA; [Cook, Danielle R.; Haigis, Kevin M.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Cook, Danielle R.; Haigis, Kevin M.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Cook, Danielle R.; Haigis, Kevin M.] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Elledge, SJ (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Howard Hughes Med Inst, Div Genet,Dept Genet, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu		Elledge, Stephen/0000-0001-7923-6283; Liang, Anthony/0000-0002-8792-8260; Li, Mamie/0000-0002-7188-1330; Patil, Ajinkya/0000-0003-1080-1146; Patel, Rupesh/0000-0001-5792-5969; Martin, Timothy/0000-0002-4870-3624				Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Blagih J, 2020, CELL REP, V30, P481, DOI 10.1016/j.celrep.2019.12.028; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Campbell PJ, 2020, NATURE, V578, P82, DOI 10.1038/s41586-020-1969-6; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; Candido JB, 2018, CELL REP, V23, P1448, DOI 10.1016/j.celrep.2018.03.131; Castiello L, 2018, CANCER IMMUNOL RES, V6, P658, DOI 10.1158/2326-6066.CIR-17-0675; Castle JC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-190; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Chun E, 2015, CELL REP, V12, P244, DOI 10.1016/j.celrep.2015.06.024; Cichowski K, 1999, SCIENCE, V286, P2172, DOI 10.1126/science.286.5447.2172; Copeland NG, 2010, NAT REV CANCER, V10, P696, DOI 10.1038/nrc2916; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; DER CJ, 1982, P NATL ACAD SCI-BIOL, V79, P3637, DOI 10.1073/pnas.79.11.3637; DEXTER DL, 1978, CANCER RES, V38, P3174; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Fujimoto H, 2009, INT J CANCER, V125, P1276, DOI 10.1002/ijc.24378; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Ghandi M, 2019, NATURE, V569, P503, DOI 10.1038/s41586-019-1186-3; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; GRISWOLD DP, 1975, CANCER, V36, P2441, DOI 10.1002/1097-0142(197512)36:6<2441::AID-CNCR2820360627>3.0.CO;2-P; Haigis KM, 2019, SCIENCE, V363, P1150, DOI 10.1126/science.aaw3472; Han K, 2020, NATURE, V580, P136, DOI 10.1038/s41586-020-2099-x; Han P, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00251; Hao QY, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00589-8; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Ishizuka JJ, 2019, NATURE, V565, P43, DOI 10.1038/s41586-018-0768-9; Jaynes JM, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aax6337; Kaneda MM, 2016, CANCER DISCOV, V6, P870, DOI 10.1158/2159-8290.CD-15-1346; Katlinski KV, 2017, CANCER CELL, V31, P194, DOI 10.1016/j.ccell.2017.01.004; Kelly P, 2006, P NATL ACAD SCI USA, V103, P8173, DOI 10.1073/pnas.0510254103; LaFleur MW, 2018, J IMMUNOL, V200, P375, DOI 10.4049/jimmunol.1701044; Lan Q, 2019, ONCOGENE, V38, P2814, DOI 10.1038/s41388-018-0624-2; LARSSON C, 1988, NATURE, V332, P85, DOI 10.1038/332085a0; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Lawson KA, 2020, NATURE, V586, P120, DOI 10.1038/s41586-020-2746-2; LI FP, 1969, ANN INTERN MED, V71, P747, DOI 10.7326/0003-4819-71-4-747; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Loganathan SK, 2020, SCIENCE, V367, P1264, DOI 10.1126/science.aax0902; Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; MATSUSHIMA K, 1989, J EXP MED, V169, P1485, DOI 10.1084/jem.169.4.1485; Maximov V, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10458-9; Maziarz M, 2020, J BIOL CHEM, V295, P16897, DOI 10.1074/jbc.AC120.014698; Miao D, 2018, SCIENCE, V359, P801, DOI 10.1126/science.aan5951; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; MOORE DH, 1971, NATURE, V229, P611, DOI 10.1038/229611a0; Muppidi JR, 2014, NATURE, V516, P254, DOI 10.1038/nature13765; Nam GH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04607-9; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; O'Hayre M, 2016, ONCOGENE, V35, P3771, DOI 10.1038/onc.2015.442; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; PARADA LF, 1982, NATURE, V297, P474, DOI 10.1038/297474a0; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Sack LM, 2018, CELL, V173, P499, DOI 10.1016/j.cell.2018.02.037; Saigi M, 2019, ONCOGENE, V38, P5921, DOI 10.1038/s41388-019-0855-x; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Schramek D, 2014, SCIENCE, V343, P309, DOI 10.1126/science.1248627; Schrors B, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01195; Solimini NL, 2012, SCIENCE, V337, P104, DOI 10.1126/science.1219580; STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0; Tomatsu S, 2009, HUM MUTAT, V30, P511, DOI 10.1002/humu.20828; Tsherniak A, 2017, CELL, V170, P564, DOI 10.1016/j.cell.2017.06.010; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wu YT, 2018, INT J MIN SCI TECHNO, V28, P359, DOI 10.1016/j.ijmst.2018.03.008; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Zhang JF, 2018, NATURE, V553, P91, DOI 10.1038/nature25015	72	35	35	8	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2021	373	6561					1327	+		10.1126/science.abg5784	http://dx.doi.org/10.1126/science.abg5784			61	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	US5SK	34529489				2022-12-28	WOS:000697488600043
J	Rao, F; Tao, XT				Rao, Feng; Tao, Xutang			Homogeneous neuromorphic hardware	SCIENCE			English	Editorial Material									[Rao, Feng; Tao, Xutang] Shenzhen Univ, Coll Mat Sci & Engn, Shenzhen 518060, Peoples R China; [Tao, Xutang] Shandong Univ, State Key Lab Crystal Mat, Jinan 250100, Shandong, Peoples R China	Shenzhen University; Shandong University	Rao, F (corresponding author), Shenzhen Univ, Coll Mat Sci & Engn, Shenzhen 518060, Peoples R China.	fengrao@szu.edu.cn; txt@sdu.edu.cn			National Natural Science Foundation of China [52032006, 51932004, 61975098]; Basic and Applied Basic Research Foundation of Guangdong [2020B1515120008]; Science andTechnology Foundation of Shenzhen [JCYJ20180507182248605]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic and Applied Basic Research Foundation of Guangdong; Science andTechnology Foundation of Shenzhen	F.R. thanks the National Natural Science Foundation of China (52032006), the Basic and Applied Basic Research Foundation of Guangdong (2020B1515120008), and the Science andTechnology Foundation of Shenzhen (JCYJ20180507182248605). X.T. thanks the National Natural Science Foundation of China (51932004,61975098).	Burr GW, 2017, ADV PHYS-X, V2, P89, DOI 10.1080/23746149.2016.1259585; Chang K, 2016, SCIENCE, V353, P274, DOI 10.1126/science.aad8609; Ding KY, 2019, SCIENCE, V366, P210, DOI 10.1126/science.aay0291; Hong X, 2016, J PHYS-CONDENS MAT, V28, DOI 10.1088/0953-8984/28/10/103003; Kapur P, 2002, IEEE T ELECTRON DEV, V49, P590, DOI 10.1109/16.992867; Lee HJ, 2020, SCIENCE, V369, P1343, DOI 10.1126/science.aba0067; Liu CS, 2020, NAT NANOTECHNOL, V15, P545, DOI 10.1038/s41565-020-0724-3; Rao F, 2017, SCIENCE, V358, P1423, DOI 10.1126/science.aao3212; Scott JF, 2007, SCIENCE, V315, P954, DOI 10.1126/science.1129564; Tong L, 2021, SCIENCE, V373, P1353, DOI 10.1126/science.abg3161; Wong HSP, 2015, NAT NANOTECHNOL, V10, P191, DOI 10.1038/nnano.2015.29; Xia QF, 2019, NAT MATER, V18, P309, DOI 10.1038/s41563-019-0291-x	12	1	1	14	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2021	373	6561					1310	1311		10.1126/science.abl4110	http://dx.doi.org/10.1126/science.abl4110			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	US5SK	34529469				2022-12-28	WOS:000697488600028
J	Golden, CD; Koehn, JZ; Shepon, A; Passarelli, S; Free, CM; Viana, DF; Matthey, H; Eurich, JG; Gephart, JA; Fluet-Chouinard, E; Nyboer, EA; Lynch, AJ; Kjellevold, M; Bromage, S; Charlebois, P; Barange, M; Vannuccini, S; Cao, L; Kleisner, KM; Rimm, EB; Danaei, G; DeSisto, C; Kelahan, H; Fiorella, KJ; Little, DC; Allison, EH; Fanzo, J; Thilsted, SH				Golden, Christopher D.; Koehn, J. Zachary; Shepon, Alon; Passarelli, Simone; Free, Christopher M.; Viana, Daniel F.; Matthey, Holger; Eurich, Jacob G.; Gephart, Jessica A.; Fluet-Chouinard, Etienne; Nyboer, Elizabeth A.; Lynch, Abigail J.; Kjellevold, Marian; Bromage, Sabri; Charlebois, Pierre; Barange, Manuel; Vannuccini, Stefania; Cao, Ling; Kleisner, Kristin M.; Rimm, Eric B.; Danaei, Goodarz; DeSisto, Camille; Kelahan, Heather; Fiorella, Kathryn J.; Little, David C.; Allison, Edward H.; Fanzo, Jessica; Thilsted, Shakuntala H.			Aquatic foods to nourish nations	NATURE			English	Article							FISH; METAANALYSIS; COUNTRIES; DEMAND	Despite contributing to healthy diets for billions of people, aquatic foods are often undervalued as a nutritional solution because their diversity is often reduced to the protein and energy value of a single food type ('seafood' or 'fish')(1-4). Here we create a cohesive model that unites terrestrial foods with nearly 3,000 taxa of aquatic foods to understand the future impact of aquatic foods on human nutrition. We project two plausible futures to 2030: a baseline scenario with moderate growth in aquatic animal-source food (AASF) production, and a high-production scenario with a 15-million-tonne increased supply of AASFs over the business-as-usual scenario in 2030, driven largely by investment and innovation in aquaculture production. By comparing changes in AASF consumption between the scenarios, we elucidate geographic and demographic vulnerabilities and estimate health impacts from diet-related causes. Globally, we find that a high-production scenario will decrease AASF prices by 26% and increase their consumption, thereby reducing the consumption of red and processed meats that can lead to diet-related non-communicable diseases(5,6) while also preventing approximately 166 million cases of inadequate micronutrient intake. This finding provides a broad evidentiary basis for policy makers and development stakeholders to capitalize on the potential of aquatic foods to reduce food and nutrition insecurity and tackle malnutrition in all its forms.	[Golden, Christopher D.; Shepon, Alon; Passarelli, Simone; Viana, Daniel F.; Bromage, Sabri; Rimm, Eric B.; Kelahan, Heather] Harvard TH Chan Sch Publ Hearth, Dept Nutr, Boston, MA 02115 USA; [Golden, Christopher D.] Harvard TH Chan Sch Publ Hearth, Dept Environm Hearth, Boston, MA 02115 USA; [Golden, Christopher D.; Danaei, Goodarz] Harvard TH Chan Sch Publ Hearth, Dept Global Hearth & Populat, Boston, MA 02115 USA; [Koehn, J. Zachary] Stanford Univ, Ctr Ocean Solut, Stanford, CA 94305 USA; [Shepon, Alon] Tel Aviv Univ, Porter Sch Environm & Earth Sci, Dept Environm Studies, Tel Aviv, Israel; [Shepon, Alon] Tel Aviv Univ, Steinhardt Museum Nat Hist, Tel Aviv, Israel; [Free, Christopher M.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Free, Christopher M.; Eurich, Jacob G.] Univ Calif Santa Barbara, Marine Sci Inst, Santa Barbara, CA 93106 USA; [Viana, Daniel F.] Conservat Int, Betty & Gordon Moore Ctr Sci, Arlington, VA USA; [Matthey, Holger] Univ Calif Santa Barbara, Food & Agr Org, Markets & Trade Div, Santa Barbara, CA 93106 USA; [Eurich, Jacob G.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Gephart, Jessica A.] Amer Univ, Dept Environm Sci, Washington, DC 20016 USA; [Fluet-Chouinard, Etienne] Stanford Univ, Dept Earth Syst Sci, Stanford, CA 94305 USA; [Nyboer, Elizabeth A.] Carleton Univ, Dept Biol, Ottawa, ON, Canada; [Lynch, Abigail J.] US Geol Survey, Natl Climate Adaptat Sci Ctr, 959 Natl Ctr, Reston, VA 22092 USA; [Kjellevold, Marian] Inst Marine Res, Bergen, Norway; [Charlebois, Pierre; Barange, Manuel; Vannuccini, Stefania] Div Food & Agr Org United Nations FAO, Fisheries & Aquacurture Div, Rome, Italy; [Cao, Ling] Shanghai Jiao Tong Univ, Sch Oceanog, Shanghai, Peoples R China; [Kleisner, Kristin M.] Environm Def Fund, New York, NY USA; [Danaei, Goodarz] Harvard TH Chan Sch Publ Hearth, Dept Epidemiol, Boston, MA USA; [DeSisto, Camille] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Fiorella, Kathryn J.] Cornell Univ, Dept Populat Med & Diagnost Sci, Ithaca, NY USA; [Fiorella, Kathryn J.] Cornell Univ, Publ Hearth Program, Ithaca, NY USA; [Little, David C.] Univ Stirling, Inst Aquaculture, Stirling, Scotland; [Allison, Edward H.; Thilsted, Shakuntala H.] WorldFish, Bayan Lepas, Malaysia; [Fanzo, Jessica] Johns Hopkins Univ, Bloomberg Sch Publ Hearth, Washington, DC USA; [Fanzo, Jessica] Johns Hopkins Univ, Nitze Sch Adv Int Studies, Washington, DC USA	Stanford University; Tel Aviv University; Tel Aviv University; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Conservation International; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; American University; Stanford University; Carleton University; United States Department of the Interior; United States Geological Survey; Institute of Marine Research - Norway; Shanghai Jiao Tong University; Environmental Defense Fund; Duke University; Cornell University; Cornell University; University of Stirling; CGIAR; Worldfish; Johns Hopkins University; Johns Hopkins University	Golden, CD (corresponding author), Harvard TH Chan Sch Publ Hearth, Dept Nutr, Boston, MA 02115 USA.; Golden, CD (corresponding author), Harvard TH Chan Sch Publ Hearth, Dept Environm Hearth, Boston, MA 02115 USA.; Golden, CD (corresponding author), Harvard TH Chan Sch Publ Hearth, Dept Global Hearth & Populat, Boston, MA 02115 USA.	golden@hsph.harvard.edu	Free, Christopher Michael/AAC-5103-2019; Eurich, Dr. Jacob G./K-8598-2019; Fanzo, Jessica/HCH-3533-2022; Bromage, Sabri/H-6676-2016; Gephart, Jessica/HCH-3165-2022; Cao, Ling/I-9429-2012; Kjellevold, Marian/C-2973-2012	Free, Christopher Michael/0000-0002-2557-8920; Eurich, Dr. Jacob G./0000-0003-1764-7524; Bromage, Sabri/0000-0002-6552-4871; Fluet-Chouinard, Etienne/0000-0003-4380-2153; Passarelli, Simone/0000-0003-1044-3393; Shepon, Alon/0000-0002-4345-8957; Kjellevold, Marian/0000-0001-7070-5784; Golden, Christopher/0000-0002-2258-7493; Thilsted, Shakuntala/0000-0002-4041-1651	Builders Initiative; MAVA Foundation; Oak Foundation; Walton Family Foundation; National Science Foundation [CNH 1826668]; John and Katie Hansen Family Foundation; National Institutes of Health Departmental Training Grant in Academic Nutrition [2T32DK007703-26]	Builders Initiative; MAVA Foundation; Oak Foundation; Walton Family Foundation; National Science Foundation(National Science Foundation (NSF)); John and Katie Hansen Family Foundation; National Institutes of Health Departmental Training Grant in Academic Nutrition	This paper is part of the Blue Food Assessment (BFA) (https://www.bluefood.earth/), a comprehensive examination of the role of aquatic foods in building healthy, sustainable and equitable food systems. The BFA was supported financially by the Builders Initiative, the MAVA Foundation, the Oak Foundation and the Walton Family Foundation, and has benefitted from the intellectual input of the wider group of scientists leading other components of the BFA. We are also grateful for the financial support of the National Science Foundation (CNH 1826668 to C.D.G., J.A.G. and J.G.E.) and the John and Katie Hansen Family Foundation (C.D.G. and D.F.V.). Support was provided to SP and HK by a National Institutes of Health Departmental Training Grant in Academic Nutrition (2T32DK007703-26). This work was also undertaken as part of the CGIAR Research Program (CRP) on Fish Agri-Food Systems (FISH), led by WorldFish and contributing to the WorldFish 2030 Research and Innovation Strategy: Aquatic Foods for Healthy People and Planet and the One CGIAR. This work is a product of the new Planetary Health laboratory at the Harvard T. H. Chan School of Public Health. For data sharing, visualization support and comments on study design, analysis and early drafts of writing, we thank J. Schmidhuber, H. Lescinsky, A. Afshin, T. Beal, S. Pires, A. Dekkers, M. Moursi, H. Embke, A. Robertson, J. J. Hallo and K. Manning. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the US Government.	Afshin A, 2019, LANCET, V393, P1958, DOI 10.1016/S0140-6736(19)30041-8; Ahern M., 2021, ROLE AQUATIC FOODS S, P3; Allen L., 2006, GUIDELINES FOOD FORT; [Anonymous], 2018, MEAT FISH DAIR PROD; [Anonymous], 2020, GLOB NUTR REP ACT EQ; [Anonymous], 2021, FISHSTATJ; Bennett A, 2021, AMBIO, V50, P981, DOI 10.1007/s13280-020-01451-4; Bernhardt JR, 2021, P NATL ACAD SCI USA, V118, DOI [10.1073/pnas.1917487118, 10.1073/pnas.191748711]; Bernstein AS, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2019-0999; Byrd KA, 2021, PUBLIC HEALTH NUTR, V24, P476, DOI 10.1017/S1368980020003857; Carriquiry AL, 1999, PUBLIC HEALTH NUTR, V2, P23, DOI 10.1017/S1368980099000038; Chua H.-W., 2014, ENCY QUALITY LIFE WE, P6047; Committee on World Food Security, 2021, 2021477REV1 VGSYN CF; Costello C, 2020, NATURE, V588, P95, DOI 10.1038/s41586-020-2616-y; Dekkers ALM, 2014, J NUTR, V144, P2083, DOI 10.3945/jn.114.191288; Delignette-Muller ML, 2015, J STAT SOFTW, V64, P1, DOI 10.18637/jss.v064.i04; Dey MM, 2008, AUST J AGR RESOUR EC, V52, P321, DOI 10.1111/j.1467-8489.2008.00418.x; Doets EL, 2013, ANN NUTR METAB, V62, P311, DOI 10.1159/000346968; FAO, 2020, STAT WORLDS FOR 2020, DOI [10.4060/ca9229en, 10.4060/ca9229-n, DOI 10.4060/CA9229-N]; FAO/WHO, 2001, JOINT FAO WHO EXP CO; Fluet-Chouinard E, 2018, P NATL ACAD SCI USA, V115, P7623, DOI 10.1073/pnas.1721097115; Gallet Craig A., 2009, Aquaculture Economics and Management, V13, P235, DOI 10.1080/13657300903123985; Gelcich S., NAT FOOD; Gephart J. A., NATURE, DOI [10.1038/s41586-021-03889-2, DOI 10.1038/S41586-021-03889-2]; Gibbons L, 2021, LEVELS TRENDS CHILD; Gibson RS, 2016, FOOD NUTR BULL, V37, P443, DOI 10.1177/0379572116652252; Golden C. D., 2021, Aquatic Food Composition Database, DOI 10.7910/DVN/KI0NYM; Golden C, 2016, NATURE, V534, P317, DOI 10.1038/534317a; Hicks CC, 2019, NATURE, V574, P95, DOI 10.1038/s41586-019-1592-6; Hirvonen K, 2020, LANCET GLOB HEALTH, V8, pE59, DOI 10.1016/S2214-109X(19)30447-4; Institute of Medicine, 1998, DIET REF INT THIAM R; Institute of Medicine (US) Subcommittee on Interpretation and Uses of Dietary Reference Intakes; Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, 2000, DRI DIETARY REFERENC; Isaacs M., 2016, AGR FOOD SECURITY, V5, P1, DOI DOI 10.1186/S40066-016-0073-5; Lala-Pritchard T., 2020, 2030 RES INNOVATION; Manson JE, 2019, NEW ENGL J MED, V380, P23, DOI 10.1056/NEJMoa1811403; Mensah GA, 2019, J AM COLL CARDIOL, V74, P2529, DOI 10.1016/j.jacc.2019.10.009; Murray CJL, 2020, LANCET, V396, P1223, DOI 10.1016/S0140-6736(20)30752-2; Naylor R. L., NAT COMMUN; OECD/FAO, 2020, OECD FAO AGR OUTLOOK, DOI [10.1787/19428846-en, DOI 10.1787/19428846-EN]; Otten J.J., 2006, DIETARY REFERENCE IN, DOI DOI 10.17226/11537; Pieralli S, 2021, J AGR ECON, V72, P370, DOI 10.1111/1477-9552.12406; Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI [10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557]; Rimm EB, 2018, CIRCULATION, V138, pE35, DOI [10.1161/CIR.0000000000000574, 10.1161/cir.0000000000000574]; Roman-Vinas B, 2009, BRIT J NUTR, V101, pS6, DOI 10.1017/S0007114509990535; Schmidhuber J, 2018, LANCET PLANET HEALTH, V2, pE353, DOI 10.1016/S2542-5196(18)30170-0; Smith MR, 2018, NAT CLIM CHANGE, V8, P834, DOI 10.1038/s41558-018-0253-3; Smith MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146976; Vermeulen SJ, 2020, ANN NY ACAD SCI, V1478, P3, DOI 10.1111/nyas.14446; Victora CG, 2021, LANCET, V397, P1388, DOI 10.1016/S0140-6736(21)00394-9; Willett W, 2019, LANCET, V393, P447, DOI 10.1016/S0140-6736(18)31788-4; Youn SJ, 2014, GLOB FOOD SECUR-AGR, V3, P142, DOI 10.1016/j.gfs.2014.09.005; Zhao LG, 2016, EUR J CLIN NUTR, V70, P155, DOI 10.1038/ejcn.2015.72	52	67	67	41	118	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 14	2021	598	7880					315	+		10.1038/s41586-021-03917-1	http://dx.doi.org/10.1038/s41586-021-03917-1		SEP 2021	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG7FA	34526720	Bronze			2022-12-28	WOS:000696175300009
J	Kanth, P; Inadomi, JM				Kanth, Priyanka; Inadomi, John M.			Screening and prevention of colorectal cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Review							FECAL IMMUNOCHEMICAL TESTS; OCCULT BLOOD-TEST; ADENOMA DETECTION RATE; SOCIETY TASK-FORCE; SESSILE SERRATED ADENOMAS; LYNCH-SYNDROME; COLON-CANCER; FOLLOW-UP; QUALITY INDICATORS; ARTIFICIAL-INTELLIGENCE	Mortality from colorectal cancer is reduced through screening and early detection; moreover, removal of neoplastic lesions can reduce cancer incidence. While understanding of the risk factors, pathogenesis, and precursor lesions of colorectal cancer has advanced, the cause of the recent increase in cancer among young adults is largely unknown. Multiple invasive, semi- and non-invasive screening modalities have emerged over the past decade. The current emphasis on quality of colonoscopy has improved the effectiveness of screening and prevention, and the role of new technologies in detection of neoplasia, such as artificial intelligence, is rapidly emerging. The overall screening rates in the US, however, are suboptimal, and few interventions have been shown to increase screening uptake. This review provides an overview of colorectal cancer, the current status of screening efforts, and the tools available to reduce mortality from colorectal cancer.	[Kanth, Priyanka] Univ Utah, Div Gastroenterol, Salt Lake City, UT 84112 USA; [Kanth, Priyanka] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Inadomi, John M.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Kanth, P (corresponding author), Univ Utah, Div Gastroenterol, Salt Lake City, UT 84112 USA.; Kanth, P (corresponding author), Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.	priyanka.kanth@hsc.utah.edu						Abualkhair WH, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.20407; Adam M., GENEREVIEWS; Aleksandrova K, 2017, INT J EPIDEMIOL, V46, P1823, DOI 10.1093/ije/dyx174; ALLISON JE, 1990, ANN INTERN MED, V112, P328, DOI 10.7326/0003-4819-112-5-328; Allison JE, 1996, NEW ENGL J MED, V334, P155, DOI 10.1056/NEJM199601183340304; Amitay EL, 2019, JNCI-J NATL CANCER I, V111, P475, DOI 10.1093/jnci/djy170; Amlani B, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233490; Anderson JC, 2018, AM J GASTROENTEROL, V113, P1750, DOI 10.1038/s41395-018-0402-3; Anderson JC, 2017, GASTROINTEST ENDOSC, V85, P1188, DOI 10.1016/j.gie.2017.01.020; Anderson R, 2020, GASTROENTEROLOGY, V158, P1287, DOI 10.1053/j.gastro.2019.12.031; [Anonymous], 2018, CI5PLUS IARC CANCERB; Antelo M, 2019, INT J CANCER, V145, P705, DOI 10.1002/ijc.32160; Arnold M, 2020, GASTROENTEROLOGY, V159, P335, DOI 10.1053/j.gastro.2020.02.068; Arnold M, 2017, GUT, V66, P683, DOI 10.1136/gutjnl-2015-310912; Atkin W, 2017, LANCET, V389, P1299, DOI 10.1016/S0140-6736(17)30396-3; Barua I, 2021, ENDOSCOPY, V53, P277, DOI 10.1055/a-1201-7165; Berzin TM, 2020, GASTROINTEST ENDOSC, V92, P951, DOI 10.1016/j.gie.2020.06.035; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Bosch LJW, 2019, AM J GASTROENTEROL, V114, P1909, DOI 10.14309/ajg.0000000000000445; Bouvard V, 2015, LANCET ONCOL, V16, P1599, DOI 10.1016/S1470-2045(15)00444-1; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brenner DR, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.8090; Brenner H, 2013, EUR J CANCER, V49, P3049, DOI 10.1016/j.ejca.2013.04.023; Brown SR, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006439.pub4; Burn J, 2020, LANCET, V395, P1855, DOI 10.1016/S0140-6736(20)30366-4; Burn J, 2008, NEW ENGL J MED, V359, P2567, DOI 10.1056/NEJMoa0801297; Burnett-Hartman AN, 2019, CANCER CAUSE CONTROL, V30, P747, DOI 10.1007/s10552-019-01181-3; Burr N, 2019, ENDOSC INT OPEN, V7, pE728, DOI 10.1055/a-0809-5233; Burt RW, 2000, GASTROENTEROLOGY, V119, P837, DOI 10.1053/gast.2000.16508; Byrne MF, 2019, GUT, V68, P94, DOI 10.1136/gutjnl-2017-314547; Cancer Research UK, CANC INC COMM CANC; Carnahan LR, 2021, J CANCER EDUC, V36, P567, DOI 10.1007/s13187-019-01666-4; Cavicchi M, 2019, DIGEST DIS SCI, V64, P3579, DOI 10.1007/s10620-019-05808-y; Centers for Disease Control and Prevention, 2020, US CANC STAT COL CAN; Chambers AC, 2020, BRIT J SURG, V107, P595, DOI 10.1002/bjs.11486; Chang LC, 2017, CLIN GASTROENTEROL H, V15, P872, DOI 10.1016/j.cgh.2016.07.029; Chiang TH, 2014, GASTROENTEROLOGY, V147, P1317, DOI 10.1053/j.gastro.2014.08.043; Chiang TH, 2011, CAN MED ASSOC J, V183, P1474, DOI 10.1503/cmaj.101248; Chittleborough TJ, 2020, DIS COLON RECTUM, V63, P903, DOI 10.1097/DCR.0000000000001631; Chiu HM, 2013, CLIN GASTROENTEROL H, V11, P832, DOI 10.1016/j.cgh.2013.01.013; Chubak J., 2015, ASPIRIN USE PREVENTI; Church TR, 2014, GUT, V63, P317, DOI 10.1136/gutjnl-2012-304149; Church TR, 1997, JNCI-J NATL CANCER I, V89, P1440, DOI 10.1093/jnci/89.19.1440; Clark G, 2021, GUT, V70, P106, DOI 10.1136/gutjnl-2019-320297; Clarke CA, 2020, CANCER EPIDEM BIOMAR, V29, P895, DOI 10.1158/1055-9965.EPI-19-1366; Cock C, 2019, DIGEST DIS SCI, V64, P2555, DOI 10.1007/s10620-019-05569-8; Coleman HG, 2015, CANCER EPIDEM BIOMAR, V24, P1373, DOI 10.1158/1055-9965.EPI-15-0085; Cooper GS, 2018, CANCER-AM CANCER SOC, V124, P3876, DOI 10.1002/cncr.31660; Corley DA, 2017, JAMA-J AM MED ASSOC, V317, P1631, DOI 10.1001/jama.2017.3634; Corley DA, 2014, NEW ENGL J MED, V370, P1298, DOI 10.1056/NEJMoa1309086; Coronado GD, 2018, JAMA INTERN MED, V178, P1174, DOI 10.1001/jamainternmed.2018.3629; de Klerk CM, 2019, LANCET GASTROENTEROL, V4, P111, DOI 10.1016/S2468-1253(18)30319-4; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; de Wijkerslooth TR, 2012, AM J GASTROENTEROL, V107, P1570, DOI 10.1038/ajg.2012.249; Dejea CM, 2018, SCIENCE, V359, P592, DOI 10.1126/science.aah3648; Demb J, 2020, CLIN GASTROENTEROL H, V18, P1691, DOI 10.1016/j.cgh.2019.11.042; Derbyshire E, 2018, ENDOSCOPY, V50, P861, DOI 10.1055/a-0584-7138; Dougherty MK, 2018, JAMA INTERN MED, V178, P1645, DOI 10.1001/jamainternmed.2018.4637; Eaglehouse YL, 2020, JNCI-J NATL CANCER I, V112, P410, DOI 10.1093/jnci/djz135; East JE, 2017, GUT, V66, P1181, DOI 10.1136/gutjnl-2017-314005; Eliakim R, 2009, ENDOSCOPY, V41, P1026, DOI 10.1055/s-0029-1215360; Erichsen R, 2013, AM J GASTROENTEROL, V108, P1332, DOI 10.1038/ajg.2013.175; Espenschied CR, 2017, J CLIN ONCOL, V35, P2568, DOI 10.1200/JCO.2016.71.9260; Faivre J, 2004, GASTROENTEROLOGY, V126, P1674, DOI 10.1053/j.gastro.2004.02.018; Fedewa SA, 2017, ANN INTERN MED, V166, P857, DOI 10.7326/M16-1154; Feletto E, 2019, CANCER EPIDEM BIOMAR, V28, P83, DOI 10.1158/1055-9965.EPI-18-0523; Ferrat E, 2013, BRIT J CANCER, V109, P1437, DOI 10.1038/bjc.2013.476; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Garcia-Solano J, 2010, HUM PATHOL, V41, P1359, DOI 10.1016/j.humpath.2010.04.002; Garrett WS, 2019, SCIENCE, V364, P1133, DOI 10.1126/science.aaw2367; Gausman V, 2020, CLIN GASTROENTEROL H, V18, P2752, DOI 10.1016/j.cgh.2019.10.009; Georgiou A, 2019, CANCERS, V11, DOI 10.3390/cancers11101558; Giardiello FM, 2014, AM J GASTROENTEROL, V109, P1159, DOI 10.1038/ajg.2014.186; Gies A, 2018, GASTROENTEROLOGY, V154, P93, DOI 10.1053/j.gastro.2017.09.018; Greenspan M, 2013, AM J GASTROENTEROL, V108, P1286, DOI 10.1038/ajg.2013.149; Greuter MJE, 2016, CANCER EPIDEM BIOMAR, V25, P135, DOI 10.1158/1055-9965.EPI-15-0592; Gupta S, 2020, CANCER-AM CANCER SOC, V126, P3013, DOI 10.1002/cncr.32851; Gupta S, 2019, J NATL COMPR CANC NE, V17, P1033, DOI 10.6004/jnccn.2019.0044; Gupta S, 2014, AM J PREV MED, V47, P417, DOI 10.1016/j.amepre.2014.04.020; Hanna K, 2019, INT J COLORECTAL DIS, V34, P1879, DOI 10.1007/s00384-019-03402-2; Hariharan R, 2020, BMJ OPEN GASTROENTER, V7, DOI 10.1136/bmjgast-2019-000355; Hassan C, 2021, GASTROINTEST ENDOSC, V93, P77, DOI 10.1016/j.gie.2020.06.059; He XS, 2018, GASTROENTEROLOGY, V155, P355, DOI 10.1053/j.gastro.2018.04.019; Hemoccultfobt.com, PAT INSTR HEM SLID T; Holowatyj AN, 2016, J CLIN ONCOL, V34, P2148, DOI 10.1200/JCO.2015.65.0994; Hundt S, 2009, ANN INTERN MED, V150, P162, DOI 10.7326/0003-4819-150-3-200902030-00005; Idos G, 2018, CLIN GASTROENTEROL H, V16, P181, DOI 10.1016/j.cgh.2017.11.010; Imperiale TF, 2019, ANN INTERN MED, V170, P319, DOI 10.7326/M18-2390; Imperiale TF, 2014, NEW ENGL J MED, V370, P1287, DOI 10.1056/NEJMoa1311194; Inadomi JM, 2012, ARCH INTERN MED, V172, P575, DOI 10.1001/archinternmed.2012.332; Itoh M, 1996, J Med Screen, V3, P66; Jasperson KW, 2010, GASTROENTEROLOGY, V138, P2044, DOI 10.1053/j.gastro.2010.01.054; Jass JR, 2005, NAT CLIN PRACT ONCOL, V2, P398, DOI 10.1038/ncponc0248; Jones RM, 2010, AM J PREV MED, V38, P508, DOI 10.1016/j.amepre.2010.01.021; Jover R, 2011, GASTROENTEROLOGY, V140, P1174, DOI 10.1053/j.gastro.2010.12.035; Kahi CJ, 2014, GASTROENTEROLOGY, V146, P718, DOI 10.1053/j.gastro.2013.11.050; Kaminski MF, 2017, GASTROENTEROLOGY, V153, P98, DOI 10.1053/j.gastro.2017.04.006; Kaminski MF, 2010, NEW ENGL J MED, V362, P1795, DOI 10.1056/NEJMoa0907667; Kastrinos F, 2017, J CLIN ONCOL, V35, P2165, DOI 10.1200/JCO.2016.69.6120; Keswani RN, 2015, AM J GASTROENTEROL, V110, P1134, DOI 10.1038/ajg.2015.103; Klair JS, 2020, ENDOSCOPY, V52, P61, DOI 10.1055/a-1031-5672; Knight JR, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.140586; Kolb JM, 2017, GASTROENTEROLOGY, V153, P646, DOI 10.1053/j.gastro.2017.05.060; Konrad G, 2010, CAN FAM PHYSICIAN, V56, P229; Kroijer R, 2019, COLORECTAL DIS, V21, P532, DOI 10.1111/codi.14557; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Kwong TNY, 2018, GASTROENTEROLOGY, V155, P383, DOI 10.1053/j.gastro.2018.04.028; Ladabaum U, 2020, GASTROENTEROLOGY, V158, P418, DOI 10.1053/j.gastro.2019.06.043; Lee JK, 2014, ANN INTERN MED, V160, P171, DOI 10.7326/M13-1484; Lee YC, 2019, CLIN GASTROENTEROL H, V17, P1332, DOI 10.1016/j.cgh.2018.10.041; Levi Z, 2011, INT J CANCER, V128, P2415, DOI 10.1002/ijc.25574; Levin TR, 2018, GASTROENTEROLOGY, V155, P1383, DOI 10.1053/j.gastro.2018.07.017; Lieberman A, 2019, CANCER EPIDEM BIOMAR, V28, P1902, DOI 10.1158/1055-9965.EPI-19-0039; Lin JS, 2016, JAMA-J AM MED ASSOC, V315, P2576, DOI 10.1001/jama.2016.3332; Lin OS, 2006, JAMA-J AM MED ASSOC, V295, P2357, DOI 10.1001/jama.295.20.2357; Loomans-Kropp HA, 2019, J CANCER EPIDEMIOL, V2019, DOI 10.1155/2019/9841295; Low EE, 2020, GASTROENTEROLOGY, V159, P492, DOI 10.1053/j.gastro.2020.01.004; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Martin J, 2017, AM J MED, V130, DOI 10.1016/j.amjmed.2016.07.028; McCullough ML, 2019, JNCI-J NATL CANCER I, V111, P158, DOI 10.1093/jnci/djy087; Meester RGS, 2016, CLIN GASTROENTEROL H, V14, P1445, DOI 10.1016/j.cgh.2016.05.017; Meester RGS, 2015, CANCER-AM CANCER SOC, V121, P2281, DOI 10.1002/cncr.29336; Meester RGS, 2015, JAMA-J AM MED ASSOC, V313, P2349, DOI [10.1001/jama.2015.6251, 10.1001/ja]; Meester RGS, 2015, ANN EPIDEMIOL, V25, P208, DOI 10.1016/j.annepidem.2014.11.011; Mehta RS, 2017, JAMA ONCOL, V3, P921, DOI 10.1001/jamaoncol.2016.6374; Mima K, 2016, GUT, V65, P1973, DOI 10.1136/gutjnl-2015-310101; Montminy EM, 2019, PREV MED, V120, P78, DOI 10.1016/j.ypmed.2018.12.004; Mori Y, 2018, ANN INTERN MED, V169, P357, DOI 10.7326/M18-0249; Morikawa T, 2005, GASTROENTEROLOGY, V129, P422, DOI 10.1053/j.gastro.2005.05.056; Morris EJA, 2015, GUT, V64, P1248, DOI 10.1136/gutjnl-2014-308362; Nagata K, 2017, AM J GASTROENTEROL, V112, P163, DOI 10.1038/ajg.2016.478; Nagtegaal IDAM., 2019, WHO CLASSIFICATION T, P158; Nakazato M., 2006, JMAJ - Japan Medical Association Journal, V49, P203; Nguyen LH, 2020, GASTROENTEROLOGY, V158, P291, DOI 10.1053/j.gastro.2019.08.059; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; North American Association of Central Cancer Registries, INC DAT CIN PROD FIL; O'Brien MJ, 2015, HISTOPATHOLOGY, V66, P49, DOI 10.1111/his.12564; Ohki D, 2018, WORLD J GASTRO ONCOL, V10, P82, DOI 10.4251/wjgo.v10.i3.82; Parasa S, 2020, GASTROINTEST ENDOSC, V92, P938, DOI 10.1016/j.gie.2020.04.044; Park DI, 2010, AM J GASTROENTEROL, V105, P2017, DOI 10.1038/ajg.2010.179; Payne SR, 2014, CLIN GASTROENTEROL H, V12, P1119, DOI 10.1016/j.cgh.2013.11.034; Petimar J, 2019, CANCER EPIDEM BIOMAR, V28, P1469, DOI 10.1158/1055-9965.EPI-19-0165; Phipps AI, 2015, GASTROENTEROLOGY, V148, P77, DOI 10.1053/j.gastro.2014.09.038; Phipps AI, 2012, CANCER EPIDEM BIOMAR, V21, P1792, DOI 10.1158/1055-9965.EPI-12-0674; Pilonis ND, 2020, ANN INTERN MED, V173, P81, DOI 10.7326/M19-2477; Provenzale D, 2020, NATL COMPREHENSIVE C; Provenzale D, 2018, J NATL COMPR CANC NE, V16, P939, DOI 10.6004/jnccn.2018.0067; Qaseem A, 2019, ANN INTERN MED, V171, P643, DOI 10.7326/M19-0642; Quintero E, 2014, GASTROENTEROLOGY, V147, P1021, DOI 10.1053/j.gastro.2014.08.004; Quintero E, 2012, NEW ENGL J MED, V366, P697, DOI [10.1056/NEJMoa1108895, 10.1056/NEJMx150040]; Rau TT, 2014, VIRCHOWS ARCH, V464, P663, DOI 10.1007/s00428-014-1569-7; Rex DK, 2002, AM J GASTROENTEROL, V97, P1296, DOI 10.1016/S0002-9270(02)04168-0; Rex DK, 2006, AM J GASTROENTEROL, V101, P873, DOI 10.1111/j.1572-0241.2006.00673.x; Rex DK, 2018, GASTROINTEST ENDOSC, V88, P335, DOI 10.1016/j.gie.2018.02.043; Rex DK, 2017, AM J GASTROENTEROL, V112, P1016, DOI 10.1038/ajg.2017.174; Rex DK, 2015, GASTROENTEROLOGY, V148, P948, DOI 10.1053/j.gastro.2015.01.025; Rex DK, 2015, GASTROINTEST ENDOSC, V81, P31, DOI 10.1016/j.gie.2014.07.058; Rex DK, 2012, AM J GASTROENTEROL, V107, P1315, DOI 10.1038/ajg.2012.161; Robertson DJ, 2017, GASTROINTEST ENDOSC, V85, P2, DOI 10.1016/j.gie.2016.09.025; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Rubenstein JH, 2015, GASTROENTEROLOGY, V149, P777, DOI 10.1053/j.gastro.2015.07.036; Rutter CM, 2012, CANCER CAUSE CONTROL, V23, P289, DOI 10.1007/s10552-011-9878-5; Rutter MD, 2018, GASTROENTEROLOGY, V155, P909, DOI 10.1053/j.gastro.2018.05.038; Samadder NJ, 2014, GASTROENTEROLOGY, V146, P950, DOI 10.1053/j.gastro.2014.01.013; San Miguel Y, 2021, GASTROENTEROLOGY, V160, P1997, DOI 10.1053/j.gastro.2021.01.219; Sawhney MS, 2006, GASTROENTEROLOGY, V131, P1700, DOI 10.1053/j.gastro.2006.10.022; Schramm C, 2018, ENDOSCOPY, V50, P993, DOI 10.1055/a-0598-4477; Schreuders EH, 2015, GUT, V64, P1637, DOI 10.1136/gutjnl-2014-309086; Selby K, 2018, ANN INTERN MED, V169, P439, DOI 10.7326/M18-0244; Shapiro JA, 2017, AM J GASTROENTEROL, V112, P1728, DOI 10.1038/ajg.2017.285; Shaukat A, 2021, AM J GASTROENTEROL, V116, P458, DOI 10.14309/ajg.0000000000001122; Shaukat A, 2013, NEW ENGL J MED, V369, P1106, DOI 10.1056/NEJMoa1300720; Siegel RL, 2020, CA-CANCER J CLIN, V70, P7, DOI [10.3322/caac.21601, 10.3322/caac.21590]; Siegel RL, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw322; Singh S, 2014, AM J GASTROENTEROL, V109, P1375, DOI 10.1038/ajg.2014.171; Snover DC, 2011, HUM PATHOL, V42, P1, DOI 10.1016/j.humpath.2010.06.002; Snover DC, 2010, WHO CLASSIFICATION T, P160; Song MY, 2020, LANCET GASTROENTEROL, V5, P537, DOI 10.1016/S2468-1253(20)30009-1; Spada C, 2016, CLIN GASTROENTEROL H, V14, P1533, DOI 10.1016/j.cgh.2016.04.038; Stoffel EM, 2018, GASTROENTEROLOGY, V154, P897, DOI 10.1053/j.gastro.2017.11.004; Sung JJY, 2019, AM J GASTROENTEROL, V114, P322, DOI 10.14309/ajg.0000000000000133; Syngal S, 2015, AM J GASTROENTEROL, V110, P223, DOI 10.1038/ajg.2014.435; Tarver T, 2012, J CONS HLTH INTERNET, V16, P366, DOI 10.1080/15398285.2012.701177; Tinmouth J, 2015, GUT, V64, P1327, DOI 10.1136/gutjnl-2014-308074; Tramontano AC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231599; Turati F, 2017, EUR J CANCER, V85, P86, DOI 10.1016/j.ejca.2017.08.015; Turner JK, 2013, HISTOPATHOLOGY, V62, P916, DOI 10.1111/his.12110; Tziatzios G, 2020, GASTROINTEST ENDOSC, V91, P1027, DOI 10.1016/j.gie.2019.12.052; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; US Preventive Services Taskforce, 2021, COL CANC SCREEN; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Vuik FER, 2019, GUT, V68, P1820, DOI 10.1136/gutjnl-2018-317592; Wang L, 2018, GASTROENTEROLOGY, V154, P540, DOI 10.1053/j.gastro.2017.10.006; Wang P, 2019, GUT, V68, P1813, DOI 10.1136/gutjnl-2018-317500; Wender Richard, 2020, Gastrointest Endosc Clin N Am, V30, P499, DOI 10.1016/j.giec.2020.02.013; Williams R, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.36; Win AK, 2017, CANCER EPIDEM BIOMAR, V26, P404, DOI [10.1158/1055-9965.EPI-16-0693, 10.1158/1055-9965.epi-16-0693]; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Wolf AMD, 2018, CA-CANCER J CLIN, V68, P250, DOI 10.3322/caac.21457; Wong MCS, 2019, INTEST RES, V17, P317, DOI 10.5217/ir.2019.00021; Yurgelun MB, 2017, J CLIN ONCOL, V35, P1086, DOI 10.1200/JCO.2016.71.0012; Zauber AG, 2015, DIGEST DIS SCI, V60, P681, DOI 10.1007/s10620-015-3600-5; Zhao SB, 2019, GASTROENTEROLOGY, V156, P1661, DOI 10.1053/j.gastro.2019.01.260	205	38	40	6	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 15	2021	374								n1855	10.1136/bmj.n1855	http://dx.doi.org/10.1136/bmj.n1855			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WI5RJ	34526356				2022-12-28	WOS:000708417000001
J	Kenter, MJH; Cohen, AF				Kenter, Marcel J. H.; Cohen, Adam F.			Poloxamer 188 vs Placebo for Painful Vaso-occlusive Episodes in Children and Adults With Sickle Cell Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Kenter, Marcel J. H.] LUMC Paul Janssen Futurelab, Leiden, Netherlands; [Cohen, Adam F.] LUMC, Zernikedreef 8, NL-2333 CK Leiden, Netherlands; [Cohen, Adam F.] Ctr Human Drug Res, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC)	Cohen, AF (corresponding author), LUMC, Zernikedreef 8, NL-2333 CK Leiden, Netherlands.	ac@chdr.nl						Casella JF, 2021, JAMA-J AM MED ASSOC, V325, P1513, DOI 10.1001/jama.2021.3414; van Meer L, 2014, BRIT J CLIN PHARMACO, V77, P947, DOI 10.1111/bcp.12282; Yusuf S, 1997, CIRCULATION, V96, P192	3	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2021	326	10					974	975		10.1001/jama.2021.11097	http://dx.doi.org/10.1001/jama.2021.11097			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UW4LI	34519809				2022-12-28	WOS:000700129100019
J	Jose, A; Schaefer, AW; Roveda, AC; Transue, WJ; Choi, SK; Ding, ZQ; Gennis, RB; Solomon, EI				Jose, Anex; Schaefer, Andrew W.; Roveda, Antonio C., Jr.; Transue, Wesley J.; Choi, Sylvia K.; Ding, Ziqiao; Gennis, Robert B.; Solomon, Edward, I			The three-spin intermediate at the O-O cleavage and proton-pumping junction in heme-Cu oxidases	SCIENCE			English	Article							PULSED CYTOCHROME BO; PEROXY INTERMEDIATE; HYDROGEN-PEROXIDE; RESONANCE RAMAN; O-2 REDUCTION; SITE; ACTIVATION; STATE; SPECTROSCOPY; COMPLEXES	Understanding the mechanistic coupling of molecular oxygen reduction and proton pumping for adenosine triphosphate synthesis during cellular respiration is the primary goal of research on heme-copper oxidases-the terminal complex in the membrane-bound electron transport chain. Cleavage of the oxygen-oxygen bond by the heme-copper oxidases forms the key intermediate PM, which initiates proton pumping. This intermediate is now experimentally defined by variable-temperature, variable-field magnetic circular dichroism spectroscopy on a previously unobserved excited state feature associated with its heme iron(IV)-oxo center. These data provide evidence that the iron(IV)-oxo in PM is magnetically coupled to both a copper(II) and a cross-linked tyrosyl radical in the active site. These results provide new insight into the oxygen-oxygen bond cleavage and proton-pumping mechanisms of heme-copper oxidases.	[Jose, Anex; Schaefer, Andrew W.; Roveda, Antonio C., Jr.; Transue, Wesley J.; Solomon, Edward, I] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Choi, Sylvia K.; Ding, Ziqiao; Gennis, Robert B.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Solomon, Edward, I] Stanford Univ, SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA	Stanford University; University of Illinois System; University of Illinois Urbana-Champaign; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Solomon, EI (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.; Solomon, EI (corresponding author), Stanford Univ, SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA.	solomone@stanford.edu	Roveda, Antonio Carlos/B-6119-2015	Roveda, Antonio Carlos/0000-0001-9409-8093; Solomon, Edward/0000-0003-0291-3199; Ding, Ziqiao/0000-0002-0824-4734; Transue, Wesley/0000-0001-7445-5663; Jose, Anex/0000-0002-4924-7886; Schaefer, Andrew/0000-0001-6565-920X	National Institutes of Health [R01DK031450]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]; Ruth L. Kirschstein National Research Service Award [F32GM131602]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study received funding from the National Institutes of Health grant R01DK031450 (to E.I.S.); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES), Finance Code 001 (to A.C.R.); and the Ruth L. Kirschstein National Research Service Award F32GM131602 (to W.J.T.).	Adam SM, 2018, CHEM REV, V118, P10840, DOI 10.1021/acs.chemrev.8b00074; Belevich I, 2006, NATURE, V440, P829, DOI 10.1038/nature04619; Blomberg MRA, 2016, BIOCHEMISTRY-US, V55, P489, DOI 10.1021/acs.biochem.5b01205; Brittain T, 1996, FEBS LETT, V399, P21, DOI 10.1016/S0014-5793(96)01253-7; Brunold TC, 2000, J AM CHEM SOC, V122, P8511, DOI 10.1021/ja000264l; Budiman K, 2004, BIOCHEMISTRY-US, V43, P11709, DOI 10.1021/bi048898i; CHANCE B, 1975, J BIOL CHEM, V250, P9226; Du WGH, 2019, INORG CHEM, V58, P13933, DOI 10.1021/acs.inorgchem.9b01840; Du WGH, 2015, INORG CHEM, V54, P7272, DOI 10.1021/acs.inorgchem.5b00700; FABIAN M, 1995, BIOCHEMISTRY-US, V34, P13802, DOI 10.1021/bi00042a011; Faxen K, 2005, NATURE, V437, P286, DOI 10.1038/nature03921; FOOTE N, 1989, BIOCHEM J, V261, P515, DOI 10.1042/bj2610515; Frisch M. J., 2019, GAUSSIAN 16 REVISION; Gamelin DR, 1998, J AM CHEM SOC, V120, P5246, DOI 10.1021/ja973161k; Gorbikova EA, 2008, J BIOL CHEM, V283, P34907, DOI 10.1074/jbc.M803511200; Hadt RG, 2014, J AM CHEM SOC, V136, P15034, DOI 10.1021/ja508361h; Ishigami I, 2019, P NATL ACAD SCI USA, V116, P3572, DOI 10.1073/pnas.1814526116; Iwaki M, 2006, BIOCHEMISTRY-US, V45, P10873, DOI 10.1021/bi061114b; Jose A., SPECTROSCOPIC DATA D, DOI [10.5281/zenodo.4961011, DOI 10.5281/ZENODO.4961011]; Jose A., ZENODO, DOI [10.5281/zenodo.4961011, DOI 10.5281/ZENODO.4961011]; Kaila VRI, 2009, BBA-BIOENERGETICS, V1787, P221, DOI 10.1016/j.bbabio.2009.01.002; Kamaraj K, 2003, J AM CHEM SOC, V125, P6028, DOI 10.1021/ja034263f; Karpefors M, 2000, BIOCHEMISTRY-US, V39, P14664, DOI 10.1021/bi0013748; Liang RB, 2016, P NATL ACAD SCI USA, V113, P7420, DOI 10.1073/pnas.1601982113; Lu JX, 2014, P NATL ACAD SCI USA, V111, P12414, DOI 10.1073/pnas.1407187111; Makinen M. W., 1983, IRON PORPHYRINS, P215; MOODY AJ, 1994, EUR J BIOCHEM, V226, P731, DOI 10.1111/j.1432-1033.1994.tb20102.x; MORGAN JE, 1995, BIOCHEMISTRY-US, V34, P15633, DOI 10.1021/bi00048a005; Nagano Y, 2006, J AM CHEM SOC, V128, P14560, DOI 10.1021/ja061507y; Neese F, 1999, INORG CHEM, V38, P1847, DOI 10.1021/ic981264d; Oda K, 2004, FEBS LETT, V570, P161, DOI 10.1016/j.febslet.2004.06.036; Oganesyan VS, 2010, J BIOL INORG CHEM, V15, P1255, DOI 10.1007/s00775-010-0683-5; Pinakoulaki E, 2013, J BIOL CHEM, V288, P20261, DOI 10.1074/jbc.M113.468488; Poiana F, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700279; Proshlyakov DA, 2000, SCIENCE, V290, P1588, DOI 10.1126/science.290.5496.1588; Proshlyakov DA, 2004, BBA-BIOENERGETICS, V1655, P282, DOI 10.1016/j.bbabio.2003.10.014; Proshlyakov DA, 1998, P NATL ACAD SCI USA, V95, P8020, DOI 10.1073/pnas.95.14.8020; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Schaefer AW, 2019, J AM CHEM SOC, V141, P10068, DOI 10.1021/jacs.9b04271; Schaefer AW, 2017, J AM CHEM SOC, V139, P7958, DOI 10.1021/jacs.7b03292; Schulz C., 1979, Journal de Physique Colloque, V40, pC2/534, DOI 10.1051/jphyscol:19792185; SCHULZ CE, 1984, BIOCHEMISTRY-US, V23, P4743, DOI 10.1021/bi00315a033; Shimada A, 2020, J BIOL CHEM, V295, P5818, DOI 10.1074/jbc.RA119.009596; Szundi I, 2007, BIOCHEMISTRY-US, V46, P12568, DOI 10.1021/bi700728g; Transue W. J., 2021, wtransue/mcdps: Initial particle swarm MCD fitting routine, DOI 10.5281/zenodo.4969304; Uchida T, 2000, BIOCHEMISTRY-US, V39, P6669, DOI 10.1021/bi992538r; Wikstrom M, 2018, CHEM REV, V118, P2469, DOI 10.1021/acs.chemrev.7b00664; YAMAGUCHI K, 1988, CHEM PHYS LETT, V149, P537, DOI 10.1016/0009-2614(88)80378-6; Yap LL, 2006, J BIOL CHEM, V281, P16879, DOI 10.1074/jbc.M602544200; Yosca TH, 2014, J AM CHEM SOC, V136, P9124, DOI 10.1021/ja503588n; Yoshikawa S, 2015, CHEM REV, V115, P1936, DOI 10.1021/cr500266a; Yu MA, 2012, J AM CHEM SOC, V134, P4753, DOI 10.1021/ja210535w	52	5	5	10	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2021	373	6560					1225	+		10.1126/science.abh3209	http://dx.doi.org/10.1126/science.abh3209			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UP5RB	34516790	Green Accepted			2022-12-28	WOS:000695436000026
J	Wise, J				Wise, Jacqui			Health and social care tax to be introduced across UK	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Gulland A, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4261	1	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 8	2021	374								n2207	10.1136/bmj.n2207	http://dx.doi.org/10.1136/bmj.n2207			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UR3BY	34497092				2022-12-28	WOS:000696628700001
J	Cohen, J; Agel, L; Barlow, M; Garfinkel, CI; White, I				Cohen, Judah; Agel, Laurie; Barlow, Mathew; Garfinkel, Chaim, I; White, Ian			Linking Arctic variability and change with extreme winter weather in the United States	SCIENCE			English	Article							POLAR VORTEX; COLD WINTERS; SEA-ICE; AMPLIFICATION; CIRCULATION; ATMOSPHERE	The Arctic is warming at a rate twice the global average and severe winter weather is reported to be increasing across many heavily populated mid-latitude regions, but there is no agreement on whether a physical link exists between the two phenomena. We use observational analysis to show that a lesser-known stratospheric polar vortex (SPV) disruption that involves wave reflection and stretching of the SPV is linked with extreme cold across parts of Asia and North America, including the recent February 2021 Texas cold wave, and has been increasing over the satellite era. We then use numerical modeling experiments forced with trends in autumn snow cover and Arctic sea ice to establish a physical link between Arctic change and SPV stretching and related surface impacts.	[Cohen, Judah] Atmospher & Environm Res Inc, Lexington, MA 02421 USA; [Cohen, Judah] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Agel, Laurie; Barlow, Mathew] Univ Massachusetts, Dept Environm Earth & Atmospher Sci, Lowell, MA USA; [Garfinkel, Chaim, I; White, Ian] Hebrew Univ Jerusalem, Inst Earth Sci, Edmond J Safra Campus, Jerusalem, Israel	Atmospheric & Environmental Research; Massachusetts Institute of Technology (MIT); University of Massachusetts System; University of Massachusetts Lowell; Hebrew University of Jerusalem	Cohen, J (corresponding author), Atmospher & Environm Res Inc, Lexington, MA 02421 USA.; Cohen, J (corresponding author), MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA.	jcohen@aer.com	garfinkel, chaim I/AAA-1134-2020	garfinkel, chaim I/0000-0001-7258-666X; /0000-0002-7762-4482; Barlow, Mathew/0000-0002-7612-3811	National Science Foundation [PLR-1901352]; NSF [AGS-1657921]; European Research Council under the European Union [677756]; NOAA [NA20OAR4310424]	National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); European Research Council under the European Union(European Research Council (ERC)); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	J.C. is supported by the National Science Foundation grant PLR-1901352. L.A. and M.B. received supported from NSF AGS-1657921 and NOAA NA20OAR4310424. C.I.G. and I.W. acknowledge the support of a European Research Council starting grant under the European Union Horizon 2020 research and innovation programme (grant agreement no. 677756).	Ashley WS, 2020, NAT CLIM CHANGE, V10, P539, DOI 10.1038/s41558-020-0774-4; Blackport R, 2019, NAT CLIM CHANGE, V9, P697, DOI 10.1038/s41558-019-0551-4; Cohen J, 2020, NAT CLIM CHANGE, V10, P20, DOI 10.1038/s41558-019-0662-y; Cohen J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02992-9; Cohen J, 2014, NAT GEOSCI, V7, P627, DOI [10.1038/NGEO2234, 10.1038/ngeo2234]; Cohen J, 2013, OCEANOGRAPHY, V26, P152; Coumou D, 2015, SCIENCE, V348, P324, DOI 10.1126/science.1261768; Coumou D, 2012, NAT CLIM CHANGE, V2, P491, DOI 10.1038/NCLIMATE1452; Doss-Gollin J, 2021, ENVIRON RES LETT, V16, DOI 10.1088/1748-9326/ac0278; Garfinkel CI, 2020, J CLIMATE, V33, P5611, DOI 10.1175/JCLI-D-19-0181.1; Garfinkel CI, 2017, GEOPHYS RES LETT, V44, P374, DOI 10.1002/2016GL072035; Garfinkel CI, 2010, J CLIMATE, V23, P3282, DOI 10.1175/2010JCLI3010.1; Gramling C, 2015, SCIENCE, V347, P818, DOI 10.1126/science.347.6224.818; Henderson GR, 2018, NAT CLIM CHANGE, V8, P954, DOI 10.1038/s41558-018-0295-6; Kintisch E, 2014, SCIENCE, V344, P250, DOI 10.1126/science.344.6181.250; Kodera K, 2013, J GEOPHYS RES-ATMOS, V118, P8333, DOI 10.1002/jgrd.50650; Kodera K, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034575; Kretschmer M., 2020, WEATHER CLIM DYN, V1, P715, DOI DOI 10.5194/WCD-1-715-2020; Kretschmer M., 2018, ATMOS SCI, V1, P1; Kretschmer M, 2018, B AM METEOROL SOC, V99, P49, DOI 10.1175/BAMS-D-16-0259.1; Kug JS, 2015, NAT GEOSCI, V8, P759, DOI [10.1038/NGEO2517, 10.1038/ngeo2517]; Lu ZZ, 2020, J CLIMATE, V33, P527, DOI 10.1175/JCLI-D-18-0861.1; Martius O, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038776; McKenna C. M., 2017, GEOPHYS RES LETT, V44; Nath D, 2014, ADV ATMOS SCI, V31, P851, DOI 10.1007/s00376-013-3195-8; NEWSON RL, 1973, NATURE, V241, P39, DOI 10.1038/241039b0; Overland JE, 2021, ENVIRON RES LETT, V16, DOI 10.1088/1748-9326/abdb5d; Overland J, 2015, J CLIMATE, V28, P7917, DOI 10.1175/JCLI-D-14-00822.1; Serreze MC, 2009, CRYOSPHERE, V3, P11, DOI 10.5194/tc-3-11-2009; Shepherd TG, 2016, SCIENCE, V353, P989, DOI 10.1126/science.aag2349; Smith KL, 2011, J CLIMATE, V24, P6185, DOI 10.1175/JCLI-D-11-00055.1; Vihma T, 2014, SURV GEOPHYS, V35, P1175, DOI 10.1007/s10712-014-9284-0; Wallace JM, 2014, SCIENCE, V343, P729, DOI 10.1126/science.343.6172.729; Wegmann M, 2020, EARTH SYST DYNAM, V11, P509, DOI 10.5194/esd-11-509-2020; Wegmann M, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/5/054015; White I. P., 2021, Zenodo, DOI 10.5281/zenodo.4523199; Zhang JK, 2016, NAT CLIM CHANGE, V6, P1094, DOI [10.1038/nclimate3136, 10.1038/NCLIMATE3136]; Zheng F, 2022, ADV ATMOS SCI, V39, P546, DOI 10.1007/s00376-021-1033-y	39	39	39	17	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2021	373	6559					1116	1121		10.1126/science.abi9167	http://dx.doi.org/10.1126/science.abi9167			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UL8QT	34516838				2022-12-28	WOS:000692910300042
J	Frankenberg, C; Yin, Y; Byrne, B; He, LY; Gentine, P				Frankenberg, Christian; Yin, Yi; Byrne, Brendan; He, Liyin; Gentine, Pierre			Comment on "Recent global decline of CO2 fertilization effects on vegetation photosynthesis" COMMENT	SCIENCE			English	Editorial Material								Wang et al. (Research Articles, 11 December 2020, p. 1295), using photosynthesis proxies from long-term satellite records, report a significant decline in CO2 fertilization effects. We find that small systematic biases in Advanced Very High Resolution Radiometer (AVHRR) data affect their analysis to the degree that the key finding is not robust. Caution is recommended when using AVHRR to detect changes in nearinfrared reflectance of vegetation (NIRv) trends and vegetation indices.	[Frankenberg, Christian; Yin, Yi; He, Liyin] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91001 USA; [Frankenberg, Christian; Byrne, Brendan] CALTECH, Jet Prop Lab, Pasadena, CA 91001 USA; [Gentine, Pierre] Columbia Univ, Earth Inst, Dept Earth & Environm Engn, New York, NY USA; [Gentine, Pierre] Columbia Univ, Data Sci Inst, New York, NY USA	California Institute of Technology; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Columbia University; Columbia University	Frankenberg, C (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91001 USA.; Frankenberg, C (corresponding author), CALTECH, Jet Prop Lab, Pasadena, CA 91001 USA.	cfranken@caltech.edu	Frankenberg, Christian/A-2944-2013; Gentine, Pierre/C-1495-2013	Frankenberg, Christian/0000-0002-0546-5857; Gentine, Pierre/0000-0002-0845-8345	NASA [80NSSC18K0895, 80NSSC19M0129]; NASA; NASA OCO2/3 science team program [NNH17ZDA001N-OCO2]	NASA(National Aeronautics & Space Administration (NASA)); NASA(National Aeronautics & Space Administration (NASA)); NASA OCO2/3 science team program	D Supported by NASA grants 80NSSC18K0895 and 80NSSC19M0129 (C.F., L.H., and Y.Y.) and NASA OCO2/3 science team program NNH17ZDA001N-OCO2 (B.B.). B. B.'s research was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. Our analysis code and supplementary figures are available at http://dx.doi.org/10.22002/D1.1976.	Bacour C, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11101166; Badgley G, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602244; Bhatt R, 2016, J ATMOS OCEAN TECH, V33, P2499, DOI 10.1175/JTECH-D-16-0044.1; Cihlar J, 1998, J GEOPHYS RES-ATMOS, V103, P23163, DOI 10.1029/98JD00050; De Kauwe MG, 2016, NAT CLIM CHANGE, V6, P892, DOI 10.1038/nclimate3105; Friedlingstein P, 2019, EARTH SYST SCI DATA, V11, P1783, DOI 10.5194/essd-11-1783-2019; Giglio L., 2020, SCI REMOTE SENS, V2; Humphrey V, 2018, NATURE, V560, P628, DOI 10.1038/s41586-018-0424-4; Lucht W, 2002, SCIENCE, V296, P1687, DOI 10.1126/science.1071828; Magney TS, 2020, GEOPHYS RES LETT, V47, DOI 10.1029/2020GL091098; Schimel D, 2015, GLOBAL CHANGE BIOL, V21, P1762, DOI 10.1111/gcb.12822; Wang SH, 2020, SCIENCE, V370, P1295, DOI 10.1126/science.abb7772	12	10	12	6	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2021	373	6562			SI				abg2947	10.1126/science.abg2947	http://dx.doi.org/10.1126/science.abg2947			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU7LJ	34554806	Green Submitted			2022-12-28	WOS:000698977800001
J	McKee, M				McKee, Martin			Has the UK government given up the fight to protect and promote health? How should we respond when it seems that our government is giving up?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[McKee, Martin] London Sch Hyg & Trop Med, London, England	University of London; London School of Hygiene & Tropical Medicine	McKee, M (corresponding author), London Sch Hyg & Trop Med, London, England.							Case A, 2020, DEATHS DESPAIR FUTUR, DOI [10.2307/j.ctvpr7rb2, DOI 10.2307/J.CTVPR7RB2]; Feshbach M, 1993, ECOCIDE USSR; Hiam L, 2020, BRIT MED BULL, V133, P4, DOI 10.1093/bmb/ldz041; Koltai J, 2020, AM J PUBLIC HEALTH, V110, P401, DOI 10.2105/AJPH.2019.305488; Lang T, 2018, J PUBLIC HEALTH-UK, V40, pE608, DOI 10.1093/pubmed/fdy073; McKee M, 2006, INT J EPIDEMIOL, V35, P1398, DOI 10.1093/ije/dyl237; Office for National Statistics, COMP ALL CAUS MORT E; Tapper J., 2021, GUARDIAN 0801; Woodcock A, 2021, INDEPENDENT 0914	9	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2021	374								n2292	10.1136/bmj.n2292	http://dx.doi.org/10.1136/bmj.n2292			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UZ1JE	34556470				2022-12-28	WOS:000701967300015
J	Strong, C; Hall, J; Wilson, G; Carney, K				Strong, Catherine; Hall, Julia; Wilson, George; Carney, Kate			Common intestinal stoma complaints	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Strong, Catherine; Hall, Julia; Wilson, George; Carney, Kate] Northumbria Healthcare Trust, Cramlington, England		Carney, K (corresponding author), Northumbria Healthcare Trust, Cramlington, England.	kate.carney@northumbria-healthcare.nhs.uk						Aljorfi AA, 2020, SURG RES PRACT, V2020; Villafranca JJA, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0034-z; Burch J., 2011, NURS TIMES, V107, P20; Catena F, 2019, WORLD J EMERG SURG, V14, DOI 10.1186/s13017-019-0240-7; Danielsen AK, 2013, COLORECTAL DIS, V15, pE276, DOI 10.1111/codi.12197; Hong KS, 2014, ANN SURG TREAT RES, V86, P152, DOI 10.4174/astr.2014.86.3.152; Kim Justin T, 2006, Clin Colon Rectal Surg, V19, P207, DOI 10.1055/s-2006-956441; Krouse R, 2007, J SURG RES, V138, P79, DOI 10.1016/j.jss.2006.04.033; Kwiatt M, 2013, CLIN COLON RECT SURG, V26, P112, DOI 10.1055/s-0033-1348050; Lyon CC, 2000, BRIT J DERMATOL, V143, P1248, DOI 10.1046/j.1365-2133.2000.03896.x; Rowe Kyle M, 2020, Proc (Bayl Univ Med Cent), V33, P218, DOI 10.1080/08998280.2020.1712926	11	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2021	374								n2310	10.1136/bmj.n2310	http://dx.doi.org/10.1136/bmj.n2310			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ1JE	34556482				2022-12-28	WOS:000701967300008
J	Whitaker, KE; Williams, CC; Mowla, L; Spilker, JS; Toft, S; Narayanan, D; Pope, A; Magdis, GE; van Dokkum, PG; Akhshik, M; Bezanson, R; Brammer, GB; Leja, J; Man, AL; Nelson, EJ; Richard, J; Pacifici, C; Sharon, K; Valentino, F				Whitaker, Katherine E.; Williams, Christina C.; Mowla, Lamiya; Spilker, Justin S.; Toft, Sune; Narayanan, Desika; Pope, Alexandra; Magdis, Georgios E.; van Dokkum, Pieter G.; Akhshik, Mohammad; Bezanson, Rachel; Brammer, Gabriel B.; Leja, Joel; Man, Allison; Nelson, Erica J.; Richard, Johan; Pacifici, Camilla; Sharon, Keren; Valentino, Francesco			Quenching of star formation from a lack of inflowing gas to galaxies	NATURE			English	Article							STELLAR POPULATION SYNTHESIS; QUIESCENT GALAXIES; ELLIPTIC GALAXIES; DUST; FRACTIONS; I.	Star formation in half of massive galaxies was quenched by the time the Universe was 3 billion years old(1). Very low amounts of molecular gas seem to be responsible for this, at least in some cases(2-7), although morphological gas stabilization, shock heating or activity associated with accretion onto a central supermassive black hole are invoked in other cases(8-11). Recent studies of quenching by gas depletion have been based on upper limits that are insufficiently sensitive to determine this robustly(2-7), or stacked emission with its problems of averaging(8,9). Here we report 1.3 mm observations of dust emission from 6 strongly lensed galaxies where star formation has been quenched, with magnifications of up to a factor of 30. Four of the six galaxies are undetected in dust emission, with an estimated upper limit on the dust mass of 0.0001 times the stellar mass, and by proxy (assuming a Milky Way molecular gas-to-dust ratio) 0.01 times the stellar mass in molecular gas. This is two orders of magnitude less molecular gas per unit stellar mass than seen in star forming galaxies at similar redshifts(12-14). It remains difficult to extrapolate from these small samples, but these observations establish that gas depletion is responsible for a cessation of star formation in some fraction of high-redshift galaxies. The authors report 1.3 mm observations of dust emission from strongly lensed galaxies where star formation is quenched, demonstrating that gas depletion is responsible for the cessation of star formation in some high-redshift galaxies.	[Whitaker, Katherine E.; Pope, Alexandra] Univ Massachusetts, Dept Astron, Amherst, MA 01003 USA; [Whitaker, Katherine E.; Toft, Sune; Narayanan, Desika; Magdis, Georgios E.; Valentino, Francesco] Cosm Dawn Ctr DAWN, Copenhagen, Denmark; [Williams, Christina C.] Univ Arizona, Steward Observ, Tucson, AZ USA; [Mowla, Lamiya] Univ Toronto, Dunlap Inst Astron & Astrophys, Toronto, ON, Canada; [Spilker, Justin S.] Univ Texas Austin, Dept Astron, RLM 15308, Austin, TX 78712 USA; [Toft, Sune; Magdis, Georgios E.; Valentino, Francesco] Univ Copenhagen, Niels Bohr Inst, Copenhagen, Denmark; [Narayanan, Desika] Univ Florida, Dept Astron, Gainesville, FL 32611 USA; [Magdis, Georgios E.] Tech Univ Denmark, DTU Space, Lyngby, Denmark; [van Dokkum, Pieter G.] Yale Univ, Dept Astron, New Haven, CT 06511 USA; [Akhshik, Mohammad] Univ Connecticut, Dept Phys, Storrs, CT USA; [Bezanson, Rachel] Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15260 USA; [Bezanson, Rachel] Univ Pittsburgh, PITT PACC, Pittsburgh, PA USA; [Leja, Joel] Penn State Univ, Dept Astron & Astrophys, 525 Davey Lab, University Pk, PA 16802 USA; [Leja, Joel] Penn State Univ, Inst Computat & Data Sci, University Pk, PA 16802 USA; [Leja, Joel] Penn State Univ, Inst Gravitat & Cosmos, University Pk, PA 16802 USA; [Man, Allison] Univ British Columbia, Dept Phys & Astron, Vancouver, BC, Canada; [Nelson, Erica J.] Univ Colorado, Dept Astrophys & Planetary Sci, Boulder, CO 80309 USA; [Richard, Johan] Univ Lyon 1, Univ Lyon, ENS Lyon, CNRS,Ctr Rech Astrophys Lyon UMR5574, St Genis Laval, France; [Pacifici, Camilla] Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA; [Sharon, Keren] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Arizona; University of Toronto; University of Texas System; University of Texas Austin; University of Copenhagen; Niels Bohr Institute; State University System of Florida; University of Florida; Technical University of Denmark; Yale University; University of Connecticut; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of British Columbia; University of Colorado System; University of Colorado Boulder; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Space Telescope Science Institute; University of Michigan System; University of Michigan	Whitaker, KE (corresponding author), Univ Massachusetts, Dept Astron, Amherst, MA 01003 USA.; Whitaker, KE (corresponding author), Cosm Dawn Ctr DAWN, Copenhagen, Denmark.	kwhitaker@astro.umass.edu	Magdis, Georgios/L-5366-2019; Valentino, Francesco/AHC-7409-2022	Magdis, Georgios/0000-0002-4872-2294; Valentino, Francesco/0000-0001-6477-4011; Pope, Alexandra/0000-0001-8592-2706; Mowla, Lamiya A./0000-0002-8530-9765; Brammer, Gabriel/0000-0003-2680-005X; Toft, Sune/0000-0003-3631-7176; Whitaker, Katherine/0000-0001-7160-3632; Leja, Joel/0000-0001-6755-1315				Akhshik M, 2021, ASTROPHYS J LETT, V907, DOI 10.3847/2041-8213/abd416; Akhshik M, 2020, ASTROPHYS J, V900, DOI 10.3847/1538-4357/abac62; Aravena M, 2020, ASTROPHYS J, V901, DOI 10.3847/1538-4357/ab99a2; Bezanson R, 2019, ASTROPHYS J LETT, V873, DOI 10.3847/2041-8213/ab0c9c; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; Caliendo JN, 2021, ASTROPHYS J LETT, V910, DOI 10.3847/2041-8213/abe132; Calzetti D, 2000, ASTROPHYS J, V533, P682, DOI 10.1086/308692; Chabrier G, 2003, PUBL ASTRON SOC PAC, V115, P763, DOI 10.1086/376392; Cheung E, 2016, NATURE, V533, P504, DOI 10.1038/nature18006; Ciotti L, 2007, ASTROPHYS J, V665, P1038, DOI 10.1086/519833; Conroy C, 2009, ASTROPHYS J, V699, P486, DOI 10.1088/0004-637X/699/1/486; Daddi E, 2010, ASTROPHYS J, V713, P686, DOI 10.1088/0004-637X/713/1/686; Decarli R, 2016, ASTROPHYS J, V833, DOI 10.3847/1538-4357/833/1/70; Dekel A, 2006, MON NOT R ASTRON SOC, V368, P2, DOI 10.1111/j.1365-2966.2006.10145.x; Dekel A, 2009, NATURE, V457, P451, DOI 10.1038/nature07648; Ebeling H, 2018, ASTROPHYS J LETT, V852, DOI 10.3847/2041-8213/aa9fee; Franco M, 2020, ASTRON ASTROPHYS, V643, DOI 10.1051/0004-6361/202038312; Genzel R, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/1/20; Gobat R, 2018, NAT ASTRON, V2, P239, DOI 10.1038/s41550-017-0352-5; Greve TR, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/1/101; Hayashi M, 2018, ASTROPHYS J, V856, DOI 10.3847/1538-4357/aab3e7; Johansson D, 2011, ASTRON ASTROPHYS, V527, DOI 10.1051/0004-6361/201016138; Johansson PH, 2009, ASTROPHYS J LETT, V697, pL38, DOI 10.1088/0004-637X/697/1/L38; Keres D, 2005, MON NOT R ASTRON SOC, V363, P2, DOI 10.1111/j.1365-2966.2005.09451.x; Kriek M, 2013, ASTROPHYS J LETT, V775, DOI 10.1088/2041-8205/775/1/L16; Lagos CD, 2015, MON NOT R ASTRON SOC, V448, P1271, DOI 10.1093/mnras/stu2763; Lee B, 2018, ASTROPHYS J, V853, DOI 10.3847/1538-4357/aaa40f; Leja J, 2019, ASTROPHYS J, V877, DOI 10.3847/1538-4357/ab1d5a; Li Q, 2019, MON NOT R ASTRON SOC, V490, P1425, DOI 10.1093/mnras/stz2684; Li ZH, 2019, ASTROPHYS J, V879, DOI 10.3847/1538-4357/ab1f68; Magdis GE, 2021, ASTRON ASTROPHYS, V647, DOI 10.1051/0004-6361/202039280; Man A, EXQUISITELY DEEP VIE; Morishita T, 2021, ASTROPHYS J, V908, DOI 10.3847/1538-4357/abd800; Muzzin A, 2013, ASTROPHYS J, V777, DOI 10.1088/0004-637X/777/1/18; Newman AB, 2018, ASTROPHYS J, V862, DOI 10.3847/1538-4357/aacd4d; Rudnick G, 2017, ASTROPHYS J, V849, DOI 10.3847/1538-4357/aa87b2; Sage LJ, 2007, ASTROPHYS J, V657, P232, DOI 10.1086/510577; Saintonge A, 2017, ASTROPHYS J SUPPL S, V233, DOI 10.3847/1538-4365/aa97e0; Saintonge A, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/1/2; Salim S, 2018, ASTROPHYS J, V859, DOI 10.3847/1538-4357/aabf3c; Salmon B, 2016, ASTROPHYS J, V827, DOI 10.3847/0004-637X/827/1/20; Sargent MT, 2015, ASTROPHYS J LETT, V806, DOI 10.1088/2041-8205/806/1/L20; Scoville N, 2016, ASTROPHYS J, V820, DOI 10.3847/0004-637X/820/2/83; Scoville N, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/2/84; Silverman JD, 2015, ASTROPHYS J LETT, V812, DOI 10.1088/2041-8205/812/2/L23; Smercina A, 2018, ASTROPHYS J, V855, DOI 10.3847/1538-4357/aaafcd; Smith MWL, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/2/123; Spilker J, 2018, ASTROPHYS J, V860, DOI 10.3847/1538-4357/aac438; Spilker JS, 2016, ASTROPHYS J, V832, DOI 10.3847/0004-637X/832/1/19; Suess KA, 2017, ASTROPHYS J LETT, V846, DOI 10.3847/2041-8213/aa85dc; Tacconi LJ, 2008, ASTROPHYS J, V680, P246, DOI 10.1086/587168; Tacconi LJ, 2018, ASTROPHYS J, V853, DOI 10.3847/1538-4357/aaa4b4; Tacconi LJ, 2010, NATURE, V463, P781, DOI 10.1038/nature08773; Tadaki K, 2017, ASTROPHYS J, V834, DOI 10.3847/1538-4357/834/2/135; Thomas D, 2005, ASTROPHYS J, V621, P673, DOI 10.1086/426932; Toft S, 2017, NATURE, V546, P510, DOI 10.1038/nature22388; Valentino F, 2020, ASTROPHYS J, V889, DOI 10.3847/1538-4357/ab64dc; Whitaker KE, 2014, ASTROPHYS J, V795, DOI 10.1088/0004-637X/795/2/104; Whitaker KE, 2013, ASTROPHYS J LETT, V770, DOI 10.1088/2041-8205/770/2/L39; Williams CC, 2021, ASTROPHYS J, V908, DOI 10.3847/1538-4357/abcbf6; Zavala JA, 2019, ASTROPHYS J, V887, DOI 10.3847/1538-4357/ab5302; Zhang CP, 2019, ASTROPHYS J LETT, V884, DOI 10.3847/2041-8213/ab4ae4	63	11	11	1	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2021	597	7877					485	+		10.1038/s41586-021-03806-7	http://dx.doi.org/10.1038/s41586-021-03806-7			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UW6NQ	34552255	Green Submitted			2022-12-28	WOS:000700270400011
J	Zhu, HT; Gouaux, E				Zhu, Hongtao; Gouaux, Eric			Architecture and assembly mechanism of native glycine receptors	NATURE			English	Article							SIZE-EXCLUSION CHROMATOGRAPHY; CRYOELECTRON MICROSCOPY; ACETYLCHOLINE-RECEPTOR; BINDING-PROPERTIES; CRYO-EM; SUBUNIT; STOICHIOMETRY; IDENTIFICATION; REGION	Glycine receptors (GlyRs) are pentameric, 'Cys-loop' receptors that form chloride-permeable channels and mediate fast inhibitory signalling throughout the central nervous system(1,2). In the spinal cord and brainstem, GlyRs regulate locomotion and cause movement disorders when mutated(2,3). However, the stoichiometry of native GlyRs and the mechanism by which they are assembled remain unclear, despite extensive investigation(4-8). Here we report cryo-electron microscopy structures of native GlyRs from pig spinal cord and brainstem, revealing structural insights into heteromeric receptors and their predominant subunit stoichiometry of 4 alpha:1 beta. Within the heteromeric pentamer, the beta(+)-alpha(-) interface adopts a structure that is distinct from the alpha(+)-alpha(-) and alpha(+)-beta(-) interfaces. Furthermore, the beta-subunit contains a unique phenylalanine residue that resides within the pore and disrupts the canonical picrotoxin site. These results explain why inclusion of the beta-subunit breaks receptor symmetry and alters ion channel pharmacology. We also find incomplete receptor complexes and, by elucidating their structures, reveal the architectures of partially assembled alpha-trimers and alpha-tetramers.	[Zhu, Hongtao; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97201 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.; Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97201 USA.	gouauxe@ohsu.edu			Louisiana State University School of Medicine Office of the Dean; NIH [U24GM129547, 5R01 GM100400]; Office of Biological and Environmental Research	Louisiana State University School of Medicine Office of the Dean; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank L. Sivilotti, F. Jalali-Yazdi, C. Sun and R. Hallford for discussions and suggestions; L. Vaskalis for assistance with figures; J. Guidry for assisting with the proteomics work; and D. Claxton and D. Cawley for the monoclonal antibody. The LSUHSC Proteomics Core is supported by the Louisiana State University School of Medicine Office of the Dean. A portion of this research was supported by NIH grant U24GM129547 and performed at the PNCC at OHSU and accessed through EMSL (grid.436923.9), a DOE Office of Science User Facility sponsored by the Office of Biological and Environmental Research. This work was supported by NIH grant 5R01 GM100400 to E.G. E.G. is an investigator of the Howard Hughes Medical Institute.	Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BLOUNT P, 1989, NEURON, V3, P349, DOI 10.1016/0896-6273(89)90259-6; Burzomato V, 2003, RECEPTOR CHANNEL, V9, P353, DOI 10.3109/714041016; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cook N., 2002, CURR PROTOC PROTEIN; Du J, 2015, NATURE, V526, P224, DOI 10.1038/nature14853; Durisic N, 2012, J NEUROSCI, V32, P12915, DOI 10.1523/JNEUROSCI.2050-12.2012; Dutertre S, 2012, J BIOL CHEM, V287, P40216, DOI 10.1074/jbc.R112.408229; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; GRAHAM D, 1985, BIOCHEMISTRY-US, V24, P990, DOI 10.1021/bi00325a027; GREEN WN, 1993, CELL, V74, P57, DOI 10.1016/0092-8674(93)90294-Z; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Henderson R, 2013, P NATL ACAD SCI USA, V110, P18037, DOI 10.1073/pnas.1314449110; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Jakobi AJ, 2017, ELIFE, V6, DOI 10.7554/eLife.27131; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Klausberger T, 2001, J BIOL CHEM, V276, P16024, DOI 10.1074/jbc.M009508200; Kloda JH, 2007, MOL PHARMACOL, V71, P483, DOI 10.1124/mol.106.028662; KUHSE J, 1993, NEURON, V11, P1049, DOI 10.1016/0896-6273(93)90218-G; Kumar A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17364-5; LANGOSCH D, 1988, P NATL ACAD SCI USA, V85, P7394, DOI 10.1073/pnas.85.19.7394; Legendre P, 2001, CELL MOL LIFE SCI, V58, P760, DOI 10.1007/PL00000899; Liu S, 2018, CELL RES, V28, P958, DOI 10.1038/s41422-018-0077-8; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Masiulis S, 2019, NATURE, V565, P454, DOI 10.1038/s41586-018-0832-5; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phulera S, 2018, ELIFE, V7, DOI 10.7554/eLife.39383; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Shan Q, 2001, J NEUROCHEM, V76, P1109, DOI 10.1046/j.1471-4159.2001.00124.x; Shan Q, 2012, J BIOL CHEM, V287, P21244, DOI 10.1074/jbc.M111.337741; SHIANG R, 1993, NAT GENET, V5, P351, DOI 10.1038/ng1293-351; Todorovic J, 2010, P NATL ACAD SCI USA, V107, P7987, DOI 10.1073/pnas.1001845107; TOYOSHIMA C, 1990, J CELL BIOL, V111, P2623, DOI 10.1083/jcb.111.6.2623; Walsh RM, 2018, NATURE, V557, P261, DOI 10.1038/s41586-018-0081-7; Yang Z, 2012, BIOCHEMISTRY-US, V51, P5229, DOI 10.1021/bi300063m; Yu HL, 2021, NEURON, V109, P2707, DOI 10.1016/j.neuron.2021.08.019; Yu J, 2021, CELL, V184, P957, DOI 10.1016/j.cell.2021.01.026; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	45	15	14	1	13	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 18	2021	599	7885					513	+		10.1038/s41586-021-04022-z	http://dx.doi.org/10.1038/s41586-021-04022-z		SEP 2021	22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WZ6DP	34555840	Green Accepted			2022-12-28	WOS:000714336600001
J	[Anonymous]				[Anonymous]			Seven days in medicine: 15-21 September 2021	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2021	374								n2309	10.1136/bmj.n2309	http://dx.doi.org/10.1136/bmj.n2309			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ1JE	34556473				2022-12-28	WOS:000701967300016
J	Rubin, R				Rubin, Rita			COVID-19 Testing Moves Out of the Clinic and Into the Home	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	7	7	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 12	2021	326	14					1362	1364		10.1001/jama.2021.15679	http://dx.doi.org/10.1001/jama.2021.15679		SEP 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WH8VN	34550303	Bronze			2022-12-28	WOS:000698779100001
J	Iacobucci, G				Iacobucci, Gareth			BMA demands meeting with health secretary to tackle abuse of GPs	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci G, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2316	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 21	2021	374								n2333	10.1136/bmj.n2333	http://dx.doi.org/10.1136/bmj.n2333			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	WA4GB	34548315				2022-12-28	WOS:000702844100002
J	Kuehn, BM				Kuehn, Bridget M.			US Health System Ranks Last Among High-Income Countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2021	326	11					999	999		10.1001/jama.2021.15468	http://dx.doi.org/10.1001/jama.2021.15468			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ4IM	34546292				2022-12-28	WOS:000702170600005
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: Has your weight changed recently?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk						Aveyard P, 2016, LANCET, V388, P2492, DOI 10.1016/S0140-6736(16)31893-1; Gardner R, 2019, PEDIATR RES, V86, P522, DOI 10.1038/s41390-019-0414-8; Lewis E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g6845	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 21	2021	374								n2301	10.1136/bmj.n2301	http://dx.doi.org/10.1136/bmj.n2301			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WA4GB	34548291	Bronze			2022-12-28	WOS:000702844100006
J	[Anonymous]				[Anonymous]			Beethoven's Deafness (Reprinted from Ann Otol, vol 67, pg 192-206, 1958)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		LARKIN E, 1971, P ROY SOC MED, V64, P493, DOI 10.1177/003591577106400518; McCABE B F, 1958, Ann Otol Rhinol Laryngol, V67, P192; NAIKEN VS, 1971, ANN INTERN MED, V74, P995, DOI 10.7326/0003-4819-74-6-995	3	0	0	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2021	326	11					1075	1075		10.1001/jama.2020.18134	http://dx.doi.org/10.1001/jama.2020.18134			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ4IM	34546309				2022-12-28	WOS:000702170600033
J	Looi, MK				Looi, Mun-Keat			Sixty seconds on ... Nicki Minaj	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Minaj Nicki, 2021, BBC NEWS 0916	1	1	1	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 20	2021	374								n2311	10.1136/bmj.n2311	http://dx.doi.org/10.1136/bmj.n2311			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ1DH	34544683	Bronze			2022-12-28	WOS:000701952000010
J	Jain, M				Jain, Mahima			The "shadow pandemic" of domestic violence	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VAGINAL DISCHARGE; WOMEN; MORBIDITY	Covid restrictions have led to a notable increase in domestic violence worldwide. Mahima Jain reports on the situation in India				mhmajain@gmail.com						Amin A, PREVENTING VIOLENCE; [Anonymous], 2011, VIOL WOM PREV DAT SU; BYRNE P, 1984, BRIT J PSYCHIAT, V144, P28, DOI 10.1192/bjp.144.1.28; Daley D, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-2819-0; Kumar P, PLOS ONE, V16; McCauley M, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000625; Mlambo-Ngcuka P., 2020, VIOLENCE WOMEN GIRLS; Patel V, 2005, INT J EPIDEMIOL, V34, P853, DOI 10.1093/ije/dyi072; Sen S, 2020, HINDU; Stephenson R, 2006, INT FAM PLAN PERSPEC, V32, P201, DOI 10.1363/3220106; Vishwanath S, 2000, SEX TRANSM INFECT, V76, P303, DOI 10.1136/sti.76.4.303; World Health Organization, HLTH RESP GEND BAS V; World Health Organization Violence against Women Prevalence Estimates, 2018, VIOLENCE WOMEN PREVA	13	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2021	374								n2166	10.1136/bmj.n2166	http://dx.doi.org/10.1136/bmj.n2166			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WP7CH	34521630	Bronze			2022-12-28	WOS:000713284400009
J	Carlino, MS; Larkin, J; Long, GV				Carlino, Matteo S.; Larkin, James; Long, Georgina V.			Immune checkpoint inhibitors in melanoma	LANCET			English	Review							PREEXISTING AUTOIMMUNE DISORDERS; NIVOLUMAB PLUS IPILIMUMAB; INDIVIDUAL PATIENT DATA; METASTATIC MELANOMA; BRAIN METASTASES; POOLED ANALYSIS; ADJUVANT NIVOLUMAB; ADVERSE EVENTS; DOUBLE-BLIND; OPEN-LABEL	Immune checkpoint inhibitors target the dysfunctional immune system, to induce cancer-cell killing by CD8-positive T cells. Immune checkpoint inhibitors, specifically anti-CTLA4 and anti-PD-1 antibodies, have revolutionised the management of many cancers, particularly advanced melanoma, for which tumour regression and long-term durable cancer control is possible in nearly 50% of patients, compared with less than 10% historically. Despite the absence of adequately powered trial data, combined anti-CTLA4 and anti-PD-1 checkpoint inhibition has the highest 5-year overall survival rate of all therapies in advanced melanoma, and has high activity in melanoma brain metastases. A phase 3 study has shown the addition of an anti-LAG3 antibody to nivolumab improves progression-free survival, but its effect on overall survival and how this combination compares to combined anti-CTLA4 and anti-PD-1 checkpoint inhibition is unknown. At present, there are no highly sensitive and specific biomarkers of response to immune checkpoint inhibitors, and clinical factors, such as volume and sites of disease, serum lactate dehydrogenase, and BRAF mutation status, are used to select initial therapy for patients with advanced melanoma. Immune checkpoint inhibitors can induce autoimmune toxicities by virtue of their mechanism of action. These toxicities, termed immune-related adverse events, occur most frequently with combined anti-CTLA4 and anti-PD-1 checkpoint inhibition; can have a variety of presentations; can affect any organ system (most often the skin, colon, endocrine system, and liver); and appear to mimic classic autoimmune diseases. Immune-related adverse events require prompt recognition and management, which may be different from the autoimmune disease it mimics. Immune checkpoint inhibitors appear to be safe for use in patients with HIV, viral hepatitis, and patients with mild-to-moderate pre-existing autoimmune diseases. Patients with organ transplants can respond to immune checkpoint inhibitors but have a high chance of transplant loss. PD-1 inhibitors are now an established standard of care as adjuvant therapy in high-risk resected stage III or IV melanoma. Neoadjuvant checkpoint inhibition for resectable stage III melanoma, which is currently limited to clinical trials, is emerging as a highly effective therapy.	[Carlino, Matteo S.; Long, Georgina V.] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia; [Carlino, Matteo S.] Blacktown Hosp, Dept Med Oncol, Sydney, NSW, Australia; [Carlino, Matteo S.] Westmead Hosp, Dept Med Oncol, Sydney, NSW, Australia; [Larkin, James] Royal Marsden NHS Fdn Trust, London, England; [Long, Georgina V.] Royal North Shore & Mater Hosp, Sydney, NSW, Australia	Melanoma Institute Australia; University of Sydney; Blacktown & Mount Druitt Hospital; University of Sydney; Royal Marsden NHS Foundation Trust; Royal North Shore Hospital	Long, GV (corresponding author), Univ Sydney, Melanoma Inst Australia, Sydney, NSW 2060, Australia.	georgina.long@sydney.edu.au	Carlino, Matteo/GRS-7198-2022; Long, Georgina/C-1771-2013	Carlino, Matteo/0000-0002-7861-4104; Larkin, James/0000-0001-5569-9523; Long, Georgina/0000-0001-8894-3545	National Institute of Health Research/Institute of Cancer Research Biomedical Research Centre for cancer; NHMRC Practitioner Fellowship; Melanoma Institute Australia; University of Sydney Medical Foundation	National Institute of Health Research/Institute of Cancer Research Biomedical Research Centre for cancer; NHMRC Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Melanoma Institute Australia; University of Sydney Medical Foundation(University of Sydney)	JL is supported by National Institute of Health Research/Institute of Cancer Research Biomedical Research Centre for cancer. GVL is supported by NHMRC Practitioner Fellowship, Melanoma Institute Australia, and the University of Sydney Medical Foundation.	Aguirre LE, 2019, ONCOLOGIST, V24, P394, DOI 10.1634/theoncologist.2018-0195; Amaria RN, 2019, LANCET ONCOL, V20, pE378, DOI 10.1016/S1470-2045(19)30332-8; Ascierto PA, 2020, ANN ONCOL, V31, pS1173, DOI 10.1016/j.annonc.2020.08.2275; Ascierto PA, 2016, LANCET ONCOL, V17, P1248, DOI 10.1016/S1470-2045(16)30122-X; Ascierto PA, 2019, NAT MED, V25, P941, DOI 10.1038/s41591-019-0448-9; Atkins MB, 1999, J CLIN ONCOL, V17, P2105, DOI 10.1200/JCO.1999.17.7.2105; Blank CU, 2018, NAT MED, V24, P1655, DOI 10.1038/s41591-018-0198-0; Bowyer S, 2016, BRIT J CANCER, V114, P1084, DOI 10.1038/bjc.2016.107; Brahmer JR, 2018, J CLIN ONCOL, V36, P1714, DOI 10.1200/JCO.2017.77.6385; Brown LJ, 2020, J CLIN ONCOL, V38; Cadino MS, 2015, CRIT REV ONCOL HEMAT, V96, P385, DOI 10.1016/j.critrevonc.2015.08.021; Carlino MS, 2020, CLIN CANCER RES, V26, P5086, DOI 10.1158/1078-0432.CCR-20-0177; Carlino MS, 2018, EUR J CANCER, V101, P236, DOI 10.1016/j.ejca.2018.06.034; Carlino MS, 2012, CANCER J, V18, P208, DOI 10.1097/PPO.0b013e31824b2890; Cristescu R, 2018, SCIENCE, V362, P197, DOI 10.1126/science.aar3593; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; D'Angelo SP, 2017, J CLIN ONCOL, V35, P226, DOI 10.1200/JCO.2016.67.9258; da Silva IP, 2021, LANCET ONCOL, V22, P836, DOI 10.1016/S1470-2045(21)00097-8; da Silva IP, 2020, CANCER-AM CANCER SOC, V126, P86, DOI 10.1002/cncr.32522; da Silva IP, 2019, CLIN CANCER RES, V25, P1272, DOI 10.1158/1078-0432.CCR-18-1680; Davies MA, 2017, LANCET ONCOL, V18, P863, DOI 10.1016/S1470-2045(17)30429-1; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dummer R, 2018, LANCET ONCOL, V19, P1315, DOI 10.1016/S1470-2045(18)30497-2; Eggermont AMM, 2016, NEW ENGL J MED, V375, P1845, DOI 10.1056/NEJMoa1611299; Eggermont AMM, 2020, JAMA ONCOL, V6, P519, DOI 10.1001/jamaoncol.2019.5570; Eggermont AMM, 2018, NEW ENGL J MED, V378, P1789, DOI 10.1056/NEJMoa1802357; Ferreira JL, 2021, CANCER IMMUNOL IMMUN, V70, P299, DOI 10.1007/s00262-020-02664-y; Gide TN, 2019, CANCER CELL, V35, P238, DOI 10.1016/j.ccell.2019.01.003; Gide TN, 2018, CLIN CANCER RES, V24, P1260, DOI 10.1158/1078-0432.CCR-17-2267; Goldberg SB, 2016, LANCET ONCOL, V17, P976, DOI 10.1016/S1470-2045(16)30053-5; Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236; Gutzmer R, 2020, LANCET, V395, P1835, DOI 10.1016/S0140-6736(20)30934-X; Haanen J, 2020, ANN ONCOL, V31, P724, DOI 10.1016/j.annonc.2020.03.285; Haanen JBAG, 2017, ANN ONCOL, V28, P119, DOI 10.1093/annonc/mdx225; Hodi FS, 2016, J CLIN ONCOL, V34, P1510, DOI 10.1200/JCO.2015.64.0391; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hong AM, 2021, EUR J CANCER, V142, P10, DOI 10.1016/j.ejca.2020.10.013; Hua C, 2016, JAMA DERMATOL, V152, P45, DOI 10.1001/jamadermatol.2015.2707; Hugo W, 2015, CELL, V162, P1271, DOI 10.1016/j.cell.2015.07.061; Ives NJ, 2017, EUR J CANCER, V82, P171, DOI 10.1016/j.ejca.2017.06.006; Jansen YJL, 2019, ANN ONCOL, V30, P1154, DOI 10.1093/annonc/mdz110; Johnson DB, 2016, JAMA ONCOL, V2, P234, DOI 10.1001/jamaoncol.2015.4368; Kalialis LV, 2009, MELANOMA RES, V19, P275, DOI 10.1097/CMR.0b013e32832eabd5; Khoja L, 2017, ANN ONCOL, V28, P2377, DOI 10.1093/annonc/mdx286; Klemen ND, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0672-3; Kugel CH, 2018, CLIN CANCER RES, V24, P5347, DOI 10.1158/1078-0432.CCR-18-1116; Kumar V, 2020, ONCOLOGIST, V25, P505, DOI 10.1634/theoncologist.2019-0659; Larkin J, 2019, NEW ENGL J MED, V381, P1535, DOI 10.1056/NEJMoa1910836; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Lebbe C, 2019, J CLIN ONCOL, V37, P867, DOI 10.1200/JCO.18.01998; Lipson EJ, P AM SOC CLIN ONCOL, V39, P9503; Liu D, 2019, NAT MED, V25, P1916, DOI 10.1038/s41591-019-0654-5; Liu J, 2016, CANCER DISCOV, V6, P1382, DOI 10.1158/2159-8290.CD-16-0577; Long GV, 2021, CANCER RES, V81; Long GV, 2019, LANCET ONCOL, V20, P1083, DOI 10.1016/S1470-2045(19)30274-8; Long GV, 2018, LANCET ONCOL, V19, P672, DOI 10.1016/S1470-2045(18)30139-6; Long GV, 2017, JAMA ONCOL, V3, P1511, DOI 10.1001/jamaoncol.2017.1588; Long GV, 2016, LANCET ONCOL, V17, P1743, DOI 10.1016/S1470-2045(16)30578-2; Margolin K, 2012, LANCET ONCOL, V13, P459, DOI 10.1016/S1470-2045(12)70090-6; McQuade JL, 2018, LANCET ONCOL, V19, P310, DOI 10.1016/S1470-2045(18)30078-0; Menzies AM, 2017, ANN ONCOL, V28, P368, DOI 10.1093/annonc/mdw443; Menzies AM, 2021, NAT MED, V27, P301, DOI 10.1038/s41591-020-01188-3; Mitchell TC, 2018, J CLIN ONCOL, V36, P3223, DOI 10.1200/JCO.2018.78.9602; Mohiuddin JJ, 2021, JNCI-J NATL CANCER I, V113, P162, DOI 10.1093/jnci/djaa057; Nakamura Y, 2020, ANN ONCOL, V31, P1198, DOI 10.1016/j.annonc.2020.05.031; Nathan P, 2020, ESMO VIRT C SEPT 19; Owen CN, 2021, ANN ONCOL, V32, P917, DOI 10.1016/j.annonc.2021.03.204; Owen CN, 2020, ANN ONCOL, V31, P1075, DOI DOI 10.1016/j.annonc.2020.04.471; Pollack MH, 2018, ANN ONCOL, V29, P250, DOI 10.1093/annonc/mdx642; Puzanov I, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0300-z; Puzanov I, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.2511; Ridolfi L, 2020, J GERIATR ONCOL, V11, P515, DOI 10.1016/j.jgo.2019.12.012; Robert C, 2019, NEW ENGL J MED, V381, P626, DOI 10.1056/NEJMoa1904059; Robert C, 2019, LANCET ONCOL, V20, P1239, DOI 10.1016/S1470-2045(19)30388-2; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Santini FC, 2018, CANCER IMMUNOL RES, V6, P1093, DOI 10.1158/2326-6066.CIR-17-0755; Schadendorf D, 2015, J CLIN ONCOL, V33, P1889, DOI 10.1200/JCO.2014.56.2736; Tan AC, 2018, ANN ONCOL, V29, P2115, DOI 10.1093/annonc/mdy330; Tawbi HA, 2018, NEW ENGL J MED, V379, P722, DOI 10.1056/NEJMoa1805453; Tawbi HAH, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.9501; Tetzlaff MT, 2018, ANN ONCOL, V29, P1861, DOI 10.1093/annonc/mdy226; Thompson JF, 2009, LANCET, V374, P362, DOI 10.1016/S0140-6736(09)61397-0; Tio M, 2018, EUR J CANCER, V104, P137, DOI 10.1016/j.ejca.2018.09.017; Uldrick TS, 2019, JAMA ONCOL, V5, P1332, DOI 10.1001/jamaoncol.2019.2244; Vilain RE, 2017, CLIN CANCER RES, V23, P5024, DOI 10.1158/1078-0432.CCR-16-0698; Wang DY, 2018, JAMA ONCOL, V4, P1721, DOI 10.1001/jamaoncol.2018.3923; Weber J, 2017, NEW ENGL J MED, V377, P1824, DOI 10.1056/NEJMoa1709030; Weber JS, 2019, ANN ONCOL, V30, P533; Weber JS, 2017, J CLIN ONCOL, V35, P785, DOI 10.1200/JCO.2015.66.1389; Weber JS, 2012, J CLIN ONCOL, V30, P2691, DOI 10.1200/JCO.2012.41.6750; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Wykes MN, 2018, NAT REV IMMUNOL, V18, P91, DOI 10.1038/nri.2017.112; Xu W, 2019, MELANOMA RES, V29, P333, DOI 10.1097/CMR.0000000000000586; Zhang XY, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0808-5; Zimmer L, 2020, LANCET, V395, P1558, DOI 10.1016/S0140-6736(20)30417-7; Zimmer L, 2017, EUR J CANCER, V75, P47, DOI 10.1016/j.ejca.2017.01.009	98	112	113	43	64	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 11	2021	398	10304					1002	1014						13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UP1FQ	34509219	Green Published			2022-12-28	WOS:000695130500026
J	Kmietowicz, Z				Kmietowicz, Zosia			Covid-19: "Health in all policies" will help protect world from future pandemics, says commission	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci G., BMJ-BRIT MED J, V372, pN724; Pan-European Commission on Health and Sustainable Development, 2021, DRAW LIGHT PAND NEW	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2021	374								n2217	10.1136/bmj.n2217	http://dx.doi.org/10.1136/bmj.n2217			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	US1IY	34507969	Bronze			2022-12-28	WOS:000697191000006
J	Virta, P				Virta, Pasi			More versatile synthesis of oligonucleotides	SCIENCE			English	Editorial Material									[Virta, Pasi] Univ Turku, Dept Chem, Turku 20500, Finland	University of Turku	Virta, P (corresponding author), Univ Turku, Dept Chem, Turku 20500, Finland.	pamavi@utu.fi			American Chemical Society (ACS) Green Chemistry Institute Pharmaceutical Roundtable (GCIPR)	American Chemical Society (ACS) Green Chemistry Institute Pharmaceutical Roundtable (GCIPR)	This article was written with the support of the American Chemical Society (ACS) Green Chemistry Institute Pharmaceutical Roundtable (GCIPR) (www.acsgcipr.org).	Andrews BI, 2021, J ORG CHEM, V86, P49, DOI 10.1021/acs.joc.0c02291; BEAUCAGE SL, 1981, TETRAHEDRON LETT, V22, P1859, DOI 10.1016/S0040-4039(01)90461-7; Crameri A., 2019, PCT Patent, Patent No. [WO2019121500A1, 2019121500]; FROEHLER BC, 1986, NUCLEIC ACIDS RES, V14, P5399, DOI 10.1093/nar/14.13.5399; GAREGG PJ, 1986, TETRAHEDRON LETT, V27, P4051, DOI 10.1016/S0040-4039(00)84908-4; Huang YZ, 2021, SCIENCE, V373, P1265, DOI 10.1126/science.abi9727; Iwamoto N, 2017, NAT BIOTECHNOL, V35, P845, DOI 10.1038/nbt.3948; Knouse KW, 2018, SCIENCE, V361, P1234, DOI 10.1126/science.aau3369; Lonnberg H, 2017, BEILSTEIN J ORG CHEM, V13, P1368, DOI 10.3762/bjoc.13.134; Molina Alejandro Gimenez, 2019, Curr Protoc Nucleic Acid Chem, V77, pe82, DOI 10.1002/cpnc.82; Reese CB, 2005, ORG BIOMOL CHEM, V3, P3851, DOI 10.1039/b510458k; Sanghvi YS, 2001, PURE APPL CHEM, V73, P175, DOI 10.1351/pac200173010175; Rozenblum GT, 2016, EXPERT OPIN DRUG DIS, V11, P127, DOI 10.1517/17460441.2016.1126244	13	0	0	8	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2021	373	6560					1196	1197		10.1126/science.abk3478	http://dx.doi.org/10.1126/science.abk3478			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UP5RB	34516804				2022-12-28	WOS:000695436000012
J	Klunemann, M; Andrejev, S; Blasche, S; Mateus, A; Phapale, P; Devendran, S; Vappiani, J; Simon, B; Scott, TA; Kafkia, E; Konstantinidis, D; Zirngibl, K; Mastrorilli, E; Banzhaf, M; Mackmull, MT; Hoevelmann, F; Nesme, L; Brochado, AR; Maier, L; Bock, T; Periwal, V; Kumar, M; Kim, Y; Tramontano, M; Schultz, C; Beck, M; Hennig, J; Zimmermann, M; Sevin, DC; Cabreiro, F; Savitski, MM; Bork, P; Typas, A; Patil, KR				Kluenemann, Martina; Andrejev, Sergej; Blasche, Sonja; Mateus, Andre; Phapale, Prasad; Devendran, Saravanan; Vappiani, Johanna; Simon, Bernd; Scott, Timothy A.; Kafkia, Eleni; Konstantinidis, Dimitrios; Zirngibl, Katharina; Mastrorilli, Eleonora; Banzhaf, Manuel; Mackmull, Marie-Therese; Hoevelmann, Felix; Nesme, Leo; Brochado, Ana Rita; Maier, Lisa; Bock, Thomas; Periwal, Vinita; Kumar, Manjeet; Kim, Yongkyu; Tramontano, Melanie; Schultz, Carsten; Beck, Martin; Hennig, Janosch; Zimmermann, Michael; Sevin, Daniel C.; Cabreiro, Filipe; Savitski, Mikhail M.; Bork, Peer; Typas, Athanasios; Patil, Kiran R.			Bioaccumulation of therapeutic drugs by human gut bacteria	NATURE			English	Article							CANCER DRUG; MICROBIOTA; METABOLISM; IDENTIFICATION; METABOLOMICS; INFORMATION; SEARCH; ALTERS; IMPACT; TARGET	Bacteria in the gut can modulate the availability and efficacy of therapeutic drugs. However, the systematic mapping ofthe interactions between drugs and bacteria has only started recently' and the main underlying mechanism proposed is the chemical transformation of drugs by microorganisms (biotransformation). Here we investigated the depletion of 15 structurally diverse drugs by 25 representative strains of gut bacteria. This revealed 70 bacteria-drug interactions, 29 of which had not to our knowledge been reported before. Over half of the new interactions can be ascribed to bioaccumulation; that is, bacteria storing the drug intracellularly without chemically modifying it, and in most cases without the growth ofthe bacteria being affected. As a case in point, we studied the molecular basis of bioaccumulation of the widely used antidepressant duloxetine by using click chemistry, thermal proteome profiling and metabolomics. We find that duloxetine bindsto several metabolic enzymes and changes the metabolite secretion of the respective bacteria. When tested in a defined microbial community of accumulators and non-accumulators, duloxetine markedly altered the composition of the community through metabolic cross-feeding. We further validated our findings in an animal model, showing that bioaccumulating bacteria attenuate the behavioural response of Caenorhabditis elegansto duloxetine. Together, our results show that bioaccumulation by gut bacteria may be a common mechanism that alters drug availability and bacterial metabolism, with implications for microbiota composition, pharmacokinetics, side effects and drug responses, probably in an individual manner.	[Kluenemann, Martina; Andrejev, Sergej; Blasche, Sonja; Mateus, Andre; Phapale, Prasad; Devendran, Saravanan; Simon, Bernd; Konstantinidis, Dimitrios; Zirngibl, Katharina; Mastrorilli, Eleonora; Banzhaf, Manuel; Mackmull, Marie-Therese; Hoevelmann, Felix; Nesme, Leo; Brochado, Ana Rita; Maier, Lisa; Bock, Thomas; Periwal, Vinita; Kumar, Manjeet; Kim, Yongkyu; Tramontano, Melanie; Schultz, Carsten; Beck, Martin; Hennig, Janosch; Zimmermann, Michael; Savitski, Mikhail M.; Bork, Peer; Typas, Athanasios; Patil, Kiran R.] European Mol Biol Lab, Heidelberg, Germany; [Blasche, Sonja; Kafkia, Eleni; Zirngibl, Katharina; Periwal, Vinita; Patil, Kiran R.] Med Res Council Toxicol Unit, Cambridge, England; [Vappiani, Johanna; Sevin, Daniel C.] GraxoSmithKrine R&D, Cellzome, Heidelberg, Germany; [Scott, Timothy A.; Cabreiro, Filipe] UCL, Inst Struct & Mol Biol, London, England; [Cabreiro, Filipe] Imperial Coll London, Inst Clin Sci, London, England; [Bork, Peer] Max Delbruck Ctr Mol Med, Berlin, Germany; [Bork, Peer] Yonsei Univ, Yonsei Frontier Lab YFL, Seoul, South Korea; [Bork, Peer] Univ Wurzburg, Bioctr, Dept Bioinformat, Wurzburg, Germany; [Kluenemann, Martina] Evonik Operat GmbH, Essen, Germany; [Andrejev, Sergej; Tramontano, Melanie] German Canc Res Ctr, Heidelberg, Germany; [Banzhaf, Manuel] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Mackmull, Marie-Therese] Swiss Fed Inst Technol, Zurich, Switzerland; [Nesme, Leo] Mol Hlth GmbH, Heidelberg, Germany; [Brochado, Ana Rita] Univ Wurzburg, Wurzburg, Germany; [Maier, Lisa] Univ Tubingen, Tubingen, Germany; [Bock, Thomas] Univ Basel, Biozentrum, Basel, Switzerland; [Schultz, Carsten] Oregon Hlth & Sci Univ, Chem Physiol & Biochem Dept, Portland, OR 97201 USA; [Beck, Martin] Max Planck Inst Biophys, Frankfurt, Germany; [Hennig, Janosch] Univ Bayreuth, Biophys Chem Dept, Bayreuth, Germany; [Cabreiro, Filipe] Univ Cologne, CECAD, Cologne, Germany	European Molecular Biology Laboratory (EMBL); UK Research & Innovation (UKRI); Medical Research Council UK (MRC); GlaxoSmithKline; Cellzome GmbH; University of London; Birkbeck University London; University College London; Imperial College London; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Yonsei University; University of Wurzburg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Birmingham; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Wurzburg; Eberhard Karls University of Tubingen; University of Basel; Oregon Health & Science University; Max Planck Society; University of Bayreuth; University of Cologne	Bork, P; Typas, A; Patil, KR (corresponding author), European Mol Biol Lab, Heidelberg, Germany.; Patil, KR (corresponding author), Med Res Council Toxicol Unit, Cambridge, England.; Bork, P (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.; Bork, P (corresponding author), Yonsei Univ, Yonsei Frontier Lab YFL, Seoul, South Korea.; Bork, P (corresponding author), Univ Wurzburg, Bioctr, Dept Bioinformat, Wurzburg, Germany.	bork@embl.de; typas@embl.de; kp533@cam.ac.uk	Bork, Peer/F-1813-2013; Maier, Lisa/ABH-1893-2021; Mastrorilli, Eleonora/H-3872-2018; Beck, Martin/B-5589-2011	Bork, Peer/0000-0002-2627-833X; Maier, Lisa/0000-0002-6473-4762; Tramontano, Dr. Melanie/0000-0001-6407-527X; Simon, Bernd/0000-0003-0164-5516; Kafkia, Eleni/0000-0001-9550-4487; Typas, Athanasios/0000-0002-0797-9018; Mastrorilli, Eleonora/0000-0003-2127-4150; Bock, Thomas Klaus Christian/0000-0002-9314-5318; Andrejev, Sergej/0000-0002-7875-0261; Klunemann, Martina/0000-0002-1602-5371; Mateus, Andre/0000-0001-6870-0677; Hennig, Janosch/0000-0001-5214-7002; Beck, Martin/0000-0002-7397-1321; PERIWAL, VINITA/0000-0002-3583-0413; Konstantinidis, Dimitrios/0000-0002-2134-6823; Mackmull, Marie-Therese/0000-0003-2928-1144; Scott, Timothy/0000-0001-7042-8609; PHAPALE, PRASAD/0000-0002-9487-597X	European Union's Horizon 2020 research and innovation programme [686070]; UK Medical Research Council [MC_UU_00025/11]; EMBL interdisciplinary postdoctoral program	European Union's Horizon 2020 research and innovation programme; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EMBL interdisciplinary postdoctoral program	This project was supported by the European Union's Horizon 2020 research and innovation programme under the grant agreement number 686070, and by the UK Medical Research Council (project number MC_UU_00025/11). A.M., L.M., M.T. and V.P. were supported by the EMBL interdisciplinary postdoctoral program. We thank EMBL Genomics, Metabolomics and Proteomics core facilities for their support in respective analyses.	Alexander JL, 2017, NAT REV GASTRO HEPAT, V14, P356, DOI 10.1038/nrgastro.2017.20; Bae W, 2000, BIOTECHNOL BIOENG, V70, P518, DOI 10.1002/1097-0290(20001205)70:5<518::AID-BIT6>3.0.CO;2-5; Becher I, 2016, NAT CHEM BIOL, V12, P908, DOI [10.1038/NCHEMBIO.2185, 10.1038/nchembio.2185]; BRENNER S, 1974, GENETICS, V77, P71; Brochado AR, 2018, NATURE, V559, P259, DOI 10.1038/s41586-018-0278-9; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; CHHABRA RS, 1979, ENVIRON HEALTH PERSP, V33, P61, DOI 10.2307/3429073; CHRYSTAL EJT, 1980, ANTIMICROB AGENTS CH, V18, P566, DOI 10.1128/AAC.18.4.566; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Congeevaram S, 2007, J HAZARD MATER, V146, P270, DOI 10.1016/j.jhazmat.2006.12.017; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dent R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036889, 10.1371/journal.pone.0037135]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503; Fenner K, 2013, SCIENCE, V341, P752, DOI 10.1126/science.1236281; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Franken H, 2015, NAT PROTOC, V10, P1567, DOI 10.1038/nprot.2015.101; Fuhrer T, 2011, ANAL CHEM, V83, P7074, DOI 10.1021/ac201267k; Fuller AT, 1937, LANCET, V1, P194; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GOLDMAN P, 1974, AM J CLIN NUTR, V27, P1348; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Gulde R, 2018, ENVIRON SCI TECHNOL, V52, P52, DOI 10.1021/acs.est.7b03556; Haiser HJ, 2014, GUT MICROBES, V5, P233, DOI 10.4161/gmic.27915; He L, 2015, ANAL CHEM, V87, P11361, DOI 10.1021/acs.analchem.5b02721; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hughes CS, 2019, NAT PROTOC, V14, P68, DOI 10.1038/s41596-018-0082-x; Hughes CS, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145625; Jackson MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05184-7; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; KHAN AKA, 1983, CLIN SCI, V64, P349, DOI 10.1042/cs0640349; Klaassen CD, 2015, DRUG METAB DISPOS, V43, P1505, DOI 10.1124/dmd.115.065698; Koppel N, 2018, ELIFE, V7, DOI [10.7554/eLife.33953, 10.7554/elife.33953]; Koppel N, 2017, SCIENCE, V356, DOI 10.1126/science.aag2770; Macedo D, 2017, J AFFECT DISORDERS, V208, P22, DOI 10.1016/j.jad.2016.09.012; Mahieu NG, 2016, CURR OPIN CHEM BIOL, V30, P87, DOI 10.1016/j.cbpa.2015.11.009; Mahmood S, 2016, CRIT REV BIOTECHNOL, V36, P639, DOI 10.3109/07388551.2015.1004518; Maier L, 2018, NATURE, V555, P623, DOI 10.1038/nature25979; Maier L, 2017, CURR OPIN MICROBIOL, V39, P128, DOI 10.1016/j.mib.2017.11.001; Mateus A, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20188242; Ortmayr K, 2017, ANALYST, V142, P80, DOI 10.1039/c6an01342b; Ponomarova O, 2017, CELL SYST, V5, P345, DOI 10.1016/j.cels.2017.09.002; Porollo A, 2014, SOURCE CODE BIOL MED, V9, DOI 10.1186/1751-0473-9-19; Rakoff-Nahoum S, 2014, CURR BIOL, V24, P40, DOI 10.1016/j.cub.2013.10.077; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Sharon G, 2016, CELL, V167, P915, DOI 10.1016/j.cell.2016.10.027; SHU YZ, 1991, XENOBIOTICA, V21, P737, DOI 10.3109/00498259109039513; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Sousa T, 2008, INT J PHARMACEUT, V363, P1, DOI 10.1016/j.ijpharm.2008.07.009; Spanogiannopoulos P, 2016, NAT REV MICROBIOL, V14, P273, DOI 10.1038/nrmicro.2016.17; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Aoki Kiyoko F, 2005, Curr Protoc Bioinformatics, VChapter 1, DOI [10.1002/0471250953.bi0112s38, 10.1002/0471250953.bi0112s11]; Tramontano M, 2018, NAT MICROBIOL, V3, P514, DOI 10.1038/s41564-018-0123-9; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Vinaixa M, 2012, METABOLITES, V2, P775, DOI 10.3390/metabo2040775; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089; Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345; Zhang F, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00485; Zimmermann M, 2019, NATURE, V570, P462, DOI 10.1038/s41586-019-1291-3	63	60	61	72	210	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2021	597	7877					533	+		10.1038/s41586-021-03891-8	http://dx.doi.org/10.1038/s41586-021-03891-8		SEP 2021	23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UW6NQ	34497420				2022-12-28	WOS:000693875600003
J	Luski, A; Segev, Y; David, R; Bitton, O; Nadler, H; Barnea, AR; Gorlach, A; Cheshnovsky, O; Kaminer, I; Narevicius, E				Luski, Alon; Segev, Yair; David, Rea; Bitton, Ora; Nadler, Hila; Barnea, A. Ronny; Gorlach, Alexey; Cheshnovsky, Ori; Kaminer, Ido; Narevicius, Edvardas			Vortex beams of atoms and molecules	SCIENCE			English	Article							ORBITAL ANGULAR-MOMENTUM; DIFFRACTION; RESONANCES	Angular momentum plays a central role in quantum mechanics, recurring in every length scale from the microscopic interactions of light and matter to the macroscopic behavior of superfluids. Vortex beams, carrying intrinsic orbital angular momentum (OAM), are now regularly generated with elementary particles such as photons and electrons. Thus far, the creation of a vortex beam of a nonelementary particle has never been demonstrated experimentally. We present vortex beams of atoms and molecules, formed by diffracting supersonic beams of helium atoms and dimers off transmission gratings. This method is general and could be applied to most atomic and molecular gases. Our results may open new frontiers in atomic physics, using the additional degree of freedom of OAM to probe collisions and alter fundamental interactions.	[Luski, Alon; Segev, Yair; David, Rea; Bitton, Ora; Nadler, Hila; Narevicius, Edvardas] Weizmann Inst Sci, Fac Chem, Rehovot, Israel; [Barnea, A. Ronny; Cheshnovsky, Ori] Tel Aviv Univ, Sch Chem, Sackler Fac Exact Sci, Tel Aviv, Israel; [Gorlach, Alexey; Kaminer, Ido] Technion Israel Inst Technol, Dept Elect & Comp Engn, Haifa, Israel; [Segev, Yair] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA	Weizmann Institute of Science; Tel Aviv University; Technion Israel Institute of Technology; University of California System; University of California Berkeley	Narevicius, E (corresponding author), Weizmann Inst Sci, Fac Chem, Rehovot, Israel.	edn@weizmann.ac.il		Barnea, Ronny/0000-0003-0482-6216; Luski, Alon/0000-0002-1314-309X; /0000-0003-2691-1892	European Research Council H2020 Program; Minerva Foundation	European Research Council H2020 Program; Minerva Foundation	European Research Council H2020 Program and the Minerva Foundation.	Abo-Shaeer JR, 2001, SCIENCE, V292, P476, DOI 10.1126/science.1060182; ALLEN L, 1992, PHYS REV A, V45, P8185, DOI 10.1103/PhysRevA.45.8185; [Anonymous], 1990, SUPERFLUIDITY SUPERC; Arndt M, 1999, NATURE, V401, P680, DOI 10.1038/44348; Barreiro JT, 2008, NAT PHYS, V4, P282, DOI 10.1038/nphys919; Beche A, 2016, MICRON, V80, P34, DOI 10.1016/j.micron.2015.07.011; Berkhout GCG, 2009, J OPT A-PURE APPL OP, V11, DOI 10.1088/1464-4258/11/9/094021; Bliokh KY, 2017, PHYS REP, V690, P1, DOI 10.1016/j.physrep.2017.05.006; Brand C, 2015, NAT NANOTECHNOL, V10, P845, DOI [10.1038/nnano.2015.179, 10.1038/NNANO.2015.179]; Bruhl R, 2002, EUROPHYS LETT, V59, P357, DOI 10.1209/epl/i2002-00202-4; Cappelletti RL, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.090402; CHAPMAN MS, 1995, PHYS REV LETT, V74, P4783, DOI 10.1103/PhysRevLett.74.4783; Clark CW, 2015, NATURE, V525, P504, DOI 10.1038/nature15265; Even U, 2000, J CHEM PHYS, V112, P8068, DOI 10.1063/1.481405; Fein YY, 2019, NAT PHYS, V15, P1242, DOI 10.1038/s41567-019-0663-9; Gargiulo S., 2021, ARXIV210205718V1NUCL; Gorlach AA, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.180401; Grisenti RE, 1999, PHYS REV LETT, V83, P1755, DOI 10.1103/PhysRevLett.83.1755; Harris J, 2015, NAT PHYS, V11, P629, DOI [10.1038/nphys3404, 10.1038/NPHYS3404]; HE H, 1995, PHYS REV LETT, V75, P826, DOI 10.1103/PhysRevLett.75.826; HECKENBERG NR, 1992, OPT QUANT ELECTRON, V24, pS951, DOI 10.1007/BF01588597; Henson AB, 2012, SCIENCE, V338, P234, DOI 10.1126/science.1229141; Jankunas J, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4919369; Kaminer I, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.011006; Karlovets D, 2021, NEW J PHYS, V23, DOI 10.1088/1367-2630/abeacc; KEITH DW, 1988, PHYS REV LETT, V61, P1580, DOI 10.1103/PhysRevLett.61.1580; Keller C, 2000, OPT COMMUN, V179, P129, DOI 10.1016/S0030-4018(00)00528-9; Lembessis VE, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.053616; Lloyd SM, 2017, REV MOD PHYS, V89, DOI 10.1103/RevModPhys.89.035004; Lloyd S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.074802; Luria K, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3244085; Luski A., 2021, ZENODO, DOI [10.5281/zenodo.4917316, DOI 10.5281/ZENODO.4917316]; Madan I, 2020, APPL PHYS LETT, V116, DOI 10.1063/1.5143008; Madison KW, 2000, PHYS REV LETT, V84, P806, DOI 10.1103/PhysRevLett.84.806; Matthews MR, 1999, PHYS REV LETT, V83, P2498, DOI 10.1103/PhysRevLett.83.2498; Padgett MJ, 2017, OPT EXPRESS, V25, P11265, DOI 10.1364/OE.25.011265; Raunhardt M, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2904563; Schmiegelow CT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12998; SCHOLLKOPF W, 1994, SCIENCE, V266, P1345, DOI 10.1126/science.266.5189.1345; Shen YJ, 2019, LIGHT-SCI APPL, V8, DOI 10.1038/s41377-019-0194-2; Tavabi AH, 2021, PHYS REV LETT, V126, DOI 10.1103/PhysRevLett.126.094802; Uchida M, 2010, NATURE, V464, P737, DOI 10.1038/nature08904; Vanacore GM, 2019, NAT MATER, V18, P573, DOI 10.1038/s41563-019-0336-1; Verbeeck J, 2010, NATURE, V467, P301, DOI 10.1038/nature09366; Zare R. N., 1988, ANGULAR MOMENTUM UND	53	11	11	5	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2021	373	6559					1105	+		10.1126/science.abj2451	http://dx.doi.org/10.1126/science.abj2451			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UL8QT	34516841	Green Submitted			2022-12-28	WOS:000692910300040
J	Tran, AN; Lim, JK				Tran, Ashley N.; Lim, Joseph K.			In the Clinic Care of the Patient With Abnormal Liver Test Results	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							AMERICAN ASSOCIATION; PRACTICE GUIDELINE; MANAGEMENT; DIAGNOSIS; DISEASE; FIBROSIS		[Tran, Ashley N.; Lim, Joseph K.] Yale Univ, Sch Med, New Haven, CT 06520 USA	Yale University	Tran, AN (corresponding author), Yale Univ, Sch Med, New Haven, CT 06520 USA.				American College of Physicians	American College of Physicians	American College of Physicians.	Al Ghamdi Sarah S, 2018, J Can Assoc Gastroenterol, V1, P54, DOI 10.1093/jcag/gwy012; American Association for the Study of Liver Diseases and Infectious Diseases Society of America, REC TEST MAN TREAT H; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; [Anonymous], 2015, J HEPATOL, V63, P237, DOI 10.1016/j.jhep.2015.04.006; [Anonymous], 1995, ABN LIV FUNCT TESTS; Bacon BR, 2011, HEPATOLOGY, V54, P328, DOI 10.1002/hep.24330; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Crabb DW, 2020, HEPATOLOGY, V71, P306, DOI 10.1002/hep.30866; Giboney PT, 2005, AM FAM PHYSICIAN, V71, P1105; Gochanour Eric, 2020, Clin Liver Dis (Hoboken), V15, P125, DOI 10.1002/cld.902; Hyun Kim Bo, 2018, Clin Liver Dis (Hoboken), V12, P1, DOI 10.1002/cld.732; Kamar N, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.86; Kamath PS, 1996, MAYO CLIN PROC, V71, P1089, DOI 10.4065/71.11.1089; Kim W Ray, 2008, Gastroenterology, V135, P1010, DOI 10.1053/j.gastro.2008.07.040; Kwo PY, 2017, AM J GASTROENTEROL, V112, P18, DOI 10.1038/ajg.2016.517; Lim JK, 2017, GASTROENTEROLOGY, V152, P1536, DOI 10.1053/j.gastro.2017.03.017; Lindor KD, 2019, HEPATOLOGY, V69, P394, DOI 10.1002/hep.30145; Lominadze Zurabi, 2018, Clin Liver Dis (Hoboken), V12, P96, DOI 10.1002/cld.742; Loomba R, 2020, GUT, V69, P1343, DOI 10.1136/gutjnl-2018-317593; Manns MP, 2010, HEPATOLOGY, V51, P2193, DOI 10.1002/hep.23584; Newsome PN, 2018, GUT, V67, P6, DOI 10.1136/gutjnl-2017-314924; Papastergiou V, 2012, ANN GASTROENTEROL, V25, P218; Pratt DS, 2000, NEW ENGL J MED, V342, P1266, DOI 10.1056/NEJM200004273421707; Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370; Roberts EA, 2008, HEPATOLOGY, V47, P2089, DOI 10.1002/hep.22261; Simon TG, 2020, J HEPATOL, V72, P1062, DOI 10.1016/j.jhep.2019.12.022; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Staatz CE, 2007, CLIN PHARMACOKINET, V46, P13, DOI 10.2165/00003088-200746010-00002; Summa Keith C, 2019, Clin Liver Dis (Hoboken), V14, P5, DOI 10.1002/cld.755; Terrault Norah A, 2018, Clin Liver Dis (Hoboken), V12, P33, DOI 10.1002/cld.728; Torres-Duran M, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-018-0856-9; Venkatesh SK, 2015, ABDOM IMAGING, V40, P766, DOI 10.1007/s00261-015-0347-6; Woreta TA, 2014, MED CLIN N AM, V98, P1, DOI 10.1016/j.mcna.2013.09.005	33	1	1	1	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP	2021	174	9					ITC129	U44		10.7326/AITC202109210	http://dx.doi.org/10.7326/AITC202109210			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XA5GQ	34516271				2022-12-28	WOS:000720675500015
J	Reif, J; Heun-Johnson, H; Tysinger, B; Lakdawalla, D				Reif, Julian; Heun-Johnson, Hanke; Tysinger, Bryan; Lakdawalla, Darius			Measuring the COVID-19 Mortality Burden in the United States A Microsimulation Study	ANNALS OF INTERNAL MEDICINE			English	Article							CONSEQUENCES; BENEFITS; OBESITY; RISK	Background: Fully assessing the mortality burden of the COVID-19 pandemic requires measuring years of life lost (YLLs) and accounting for quality-of-life differences. Objective: To measure YLLs and quality-adjusted life-years (QALYs) lost from the COVID-19 pandemic, by age, sex, race/ethnicity, and comorbidity. Design: State-transition microsimulation model. Data Sources: Health and Retirement Study, Panel Study of Income Dynamics, data on excess deaths from the Centers for Disease Control and Prevention, and nursing home death counts from the Centers for Medicare & Medicaid Services. Target Population: U.S. population aged 25 years and older. Time Horizon: Lifetime. Perspective: Individual. Intervention: COVID-19 pandemic through 13 March 2021. Outcome Measures: YLLs and QALYs lost per 10 000 persons in the population. The estimates account for the age, sex, and race/ethnicity of decedents, along with obesity, smoking behavior, lung disease, heart disease, diabetes, cancer, stroke, hypertension, dementia, and nursing home residence. Results of Base-Case Analysis: The COVID-19 pandemic resulted in 6.62 million QALYs lost (9.08 million YLLs) through 13 March 2021, with 3.6 million (54%) lost by those aged 25 to 64 years. The greatest toll was on Black and Hispanic communities, especially among men aged 65 years or older, who lost 1138 and 1371 QALYs, respectively, per 10 000 persons. Absent the pandemic, 38% of decedents would have had average or above-average life expectancies for their subgroup defined by age, sex, and race/ethnicity. Results of Sensitivity Analysis: Accounting for uncertainty in risk factors for death from COVID-19 yielded similar results. Limitation: Estimates may vary depending on assumptions about mortality and quality-of-life projections. Conclusion: Beyond excess deaths alone, the COVID-19 pandemic imposed a greater life expectancy burden on persons aged 25 to 64 years, including those with average or above-average life expectancies, and a disproportionate burden on Black and Hispanic communities.	[Reif, Julian] Univ Illinois, Champaign, IL USA; [Reif, Julian; Lakdawalla, Darius] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Heun-Johnson, Hanke; Tysinger, Bryan; Lakdawalla, Darius] Univ Southern Calif, Los Angeles, CA 90007 USA; [Reif, Julian] Univ Illinois, Gies Coll Business, Dept Finance, 515 East Gregory St, Champaign, IL 61820 USA; [Heun-Johnson, Hanke; Tysinger, Bryan; Lakdawalla, Darius] Univ Southern Calif, Schaeffer Ctr Hlth Policy & Econ, Sol Price Sch Publ Policy, 635 Downey Way,VPD 312,VPD 514K,VPD 414K, Los Angeles, CA 90089 USA	University of Illinois System; University of Illinois Urbana-Champaign; National Bureau of Economic Research; University of Southern California; University of Illinois System; University of Illinois Urbana-Champaign; University of Southern California	Lakdawalla, D (corresponding author), Univ Southern Calif, Schaeffer Ctr Hlth Policy & Econ, Sch Pharm, 635 Downey Way,VPD 414K, Los Angeles, CA 90089 USA.; Lakdawalla, D (corresponding author), Univ Southern Calif, Sol Price Sch Publ Policy, 635 Downey Way,VPD 414K, Los Angeles, CA 90089 USA.	heunjohn@usc.edu; btysinge@usc.edu; dlakdawa@usc.edu	Lakdawalla, Darius/B-4409-2011; Tysinger, Bryan/S-8166-2019	Lakdawalla, Darius/0000-0001-5934-8042; Tysinger, Bryan/0000-0002-8497-3664; Heun-Johnson, Hanke/0000-0002-4101-2492	National Institute on Aging [1R01AG062277]	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By grant 1R01AG062277 from the National Institute on Aging.	[Anonymous], 2020, HLTH RET STUD; [Anonymous], 2021, PAN STUD INC DYN; Arias Elizabeth, 2020, Natl Vital Stat Rep, V69, P1; Attema AE, 2014, ENCY QUALITY LIFE WE, DOI [10.1007/978-94-007-0753-5_3839, DOI 10.1007/978-94-007-0753-5_3839]; Bhaskaran K, 2021, LANCET REG HEALTH-EU, V6, DOI 10.1016/j.lanepe.2021.100109; Bhattacharya J, 2004, NBER FR HLTH POL RES, P75; Blaylock B., 2015, ESSAYS USE MICROSIMU; Centers for Disease Control and Prevention, VAR PROP; Centers for Disease Control and Prevention, VACC DEM TRENDS; Centers for Medicare & Medicaid Services, COVID 19 NURS HOM DA; Dzau VJ, 2015, LANCET, V385, P2118, DOI 10.1016/S0140-6736(15)60722-X; Elledge SJ, 2020, 2 50000000 PERSON YE, DOI [10.1101/2020.10.18.20214783, DOI 10.1101/2020.10.18.20214783]; GBD, 2020, GLOBAL BURDEN DIS CO; Goldman D, 2010, NATL TAX J, V63, P307, DOI 10.17310/ntj.2010.2.07; Goldman DP, 2013, HEALTH AFFAIR, V32, P1698, DOI 10.1377/hlthaff.2013.0052; Goldman DP, 2011, HEALTH AFFAIR, V30, P84, DOI 10.1377/hlthaff.2009.1056; Goldman DP, 2009, AM J PUBLIC HEALTH, V99, P2096, DOI 10.2105/AJPH.2009.172627; Goldman DP, 2005, HEALTH AFFAIR, V24, pW5R5; Holford TR, 2014, JAMA-J AM MED ASSOC, V311, P164, DOI 10.1001/jama.2013.285112; Jin J, 2021, NAT MED, V27, P264, DOI 10.1038/s41591-020-01191-8; Johansson-Stenman O, 2011, HEALTH ECON, V20, P723, DOI 10.1002/hec.1627; Lakdawalla DN, 2009, HEALTH AFFAIR, V28, pW138, DOI 10.1377/hlthaff.28.1.w138; Lakdawalla DN, 2005, HEALTH AFFAIR, V24, pW5R30, DOI 10.1377/hlthaff.W5.R30; Leaf DE, 2021, HEALTH ECON, V30, P52, DOI 10.1002/hec.4169; Michaud PC, 2012, J HEALTH ECON, V31, P630, DOI 10.1016/j.jhealeco.2012.04.006; Mitra AK, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124392; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008; Quast T, 2020, J PUBLIC HEALTH-UK, V42, P717, DOI 10.1093/pubmed/fdaa159; Snider JT, 2014, AM J HEALTH PROMOT, V28, P218, DOI 10.4278/ajhp.121116-QUAN-561; Social Security Administration, 2016, 2016 ANN REP BOARD T; Tysinger B., 2020, INT J MICROSIMULATIO, V13, P54, DOI [10.34196/IJM.00225, DOI 10.34196/IJM.00225]; Watkins DA, 2017, NEW ENGL J MED, V377, P713, DOI 10.1056/NEJMoa1603693; Wetzler HP, COVID 19 HOW MANY YE, DOI [10.1101/2020.06.08.20050559, DOI 10.1101/2020.06.08.20050559]; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Yanez ND, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09826-8	37	3	3	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC	2021	174	12					1700	+		10.7326/M21-2239	http://dx.doi.org/10.7326/M21-2239			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XS0OD	34543588	Green Published			2022-12-28	WOS:000732617000021
J	Fojo, AT; Schnure, M; Kasaie, P; Dowdy, DW; Shah, M				Fojo, Anthony Todd; Schnure, Melissa; Kasaie, Parastu; Dowdy, David W.; Shah, Maunank			What Will It Take to End HIV in the United States? A Comprehensive, Local-Level Modeling Study	ANNALS OF INTERNAL MEDICINE			English	Article							INJECTION-DRUG USERS; SEXUAL-BEHAVIOR; ANTIRETROVIRAL PROPHYLAXIS; RACIAL DISPARITIES; INFECTION; MEN; FREQUENCY; HEALTH; CARE; PREVENTION	Background: The Ending the HIV Epidemic (EHE) initiative aims to reduce incident HIV infections by 90% over a span of 10 years. The intensity of interventions needed to achieve this for local epidemics is unclear. Objective: To estimate the effect of HIV interventions at the city level. Design: A compartmental model of city-level HIV transmission stratified by age, race, sex, and HIV risk factor was developed and calibrated. Setting: 32 priority metropolitan statistical areas (MSAs). Patients: Simulated populations in each MSA. Intervention: Combinations of HIV testing and preexposure prophylaxis (PrEP) coverage among those at risk for HIV, plus viral suppression in persons with diagnosed HIV infection. Measurements: The primary outcome was the projected reduction in incident cases from 2020 to 2030. Results: Absent intervention, HIV incidence was projected to decrease by 19% across all 32 MSAs. Modest increases in testing (1.25-fold per year), PrEP coverage (5 percentage points), and viral suppression (10 percentage points) across the population could achieve reductions of 34% to 67% by 2030. Twenty-five percent PrEP coverage, testing twice a year on average, and 90% viral suppression among young Black and Hispanic men who have sex with men (MSM) achieved similar reductions (13% to 68%). Including all MSM and persons who inject drugs could reduce incidence by 48% to 90%. Thirteen of 32 MSAs could achieve greater than 90% reductions in HIV incidence with large-scale interventions that include heterosexuals. A web application with location-specific results is publicly available (www.jheem. org). Limitation: The COVID-19 pandemic was not represented. Conclusion: Large reductions in HIV incidence are achievable with substantial investment, but the EHE goals will be difficult to achieve in most locations. An interactive model that can help policymakers maximize the effect in their local environments is presented.	[Fojo, Anthony Todd; Shah, Maunank] Johns Hopkins Univ, Sch Med, 1830 East Monument St,Room 8060, Baltimore, MD 21205 USA; [Schnure, Melissa; Kasaie, Parastu; Dowdy, David W.] Johns Hopkins Bloomberg, Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Fojo, AT (corresponding author), Johns Hopkins Univ, Sch Med, 1830 East Monument St,Room 8060, Baltimore, MD 21205 USA.	anthony.fojo@jhmi.edu		Shah, Maunank/0000-0002-0979-2388; Schnure, Melissa/0000-0003-2745-3715; Dowdy, David/0000-0003-0481-7475	National Institutes of Health [K08MH118094, K01AI138853, T32HL007024]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	By grants K08MH118094, K01AI138853, and T32HL007024 fromthe National Institutes of Health.	Abma Joyce C, 2017, Natl Health Stat Report, P1; AIDSVu, 2018, LOC DAT TENN; Andrieu C, 2008, STAT COMPUT, V18, P343, DOI 10.1007/s11222-008-9110-y; [Anonymous], 2005, CDC WOND ONL DAT; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Biondi BE, 2020, AM J ADDICTION, V29, P249, DOI 10.1111/ajad.13051; Bohl DD, 2011, SEX TRANSM INFECT, V87, P616, DOI 10.1136/sextrans-2011-050103; Bradley H, 2019, AIDS BEHAV, V23, P557, DOI 10.1007/s10461-019-02442-7; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Bruneau J, 1997, AM J EPIDEMIOL, V146, P994, DOI 10.1093/oxfordjournals.aje.a009240; Centers for Disease Control and Prevention, 2013, SURV SUPPL REP, V18, P1; Centers for Disease Control and Prevention, 2020, HIV SURVEILLANCE REP, V31; Centers for Disease Control and Prevention, 2014, HIV SURVEILLANCE S, V19, P1; Centers for Disease Control and Prevention, 2013, HIV SURV SUPPL REP B; Centers for Disease Control and Prevention, 2016, HIV SURVEILLANCE S, V21, P1; Centers for Disease Control and Prevention, NCHHSTP ATLASPLUS; Centers for Disease Control and Prevention, 2019, HIV SURVEILLANCE S; Centers for Disease Control and Prevention, 2015, HIV SURVEILLANCE S, P20; Centers for Disease Control and Prevention, 2020, HIV SURVEILLANCE S, V25; Centers for Disease Control and Prevention, 2018, HIV SURVEILLANCE S, V23; Centers for Disease Control and Prevention, 2017, HIV SURVEILLANCE S, V22; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Chow EPF, 2016, SEX HEALTH, V13, P451, DOI 10.1071/SH16055; Eisinger RW, 2019, JAMA-J AM MED ASSOC, V321, P451, DOI 10.1001/jama.2018.21167; Fauci AS, 2019, JAMA-J AM MED ASSOC, V321, P844, DOI 10.1001/jama.2019.1343; Fojo AT, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx172; Fujimoto K, 2015, AIDS BEHAV, V19, P996, DOI 10.1007/s10461-014-0842-8; Giroir BP, 2020, AM J PUBLIC HEALTH, V110, P22, DOI 10.2105/AJPH.2019.305380; Glick SN, 2018, DRUG ALCOHOL DEPEN, V182, P86, DOI 10.1016/j.drugalcdep.2017.10.011; Granich R, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002253; Grey Jeremy A, 2016, JMIR Public Health Surveill, V2, pe14, DOI 10.2196/publichealth.5365; Haario H, 2001, BERNOULLI, V7, P223, DOI 10.2307/3318737; Hagan H, 2000, J SUBST ABUSE TREAT, V19, P247, DOI 10.1016/S0740-5472(00)00104-5; Hamilton DT, 2015, EPIDEMICS-NETH, V11, P56, DOI 10.1016/j.epidem.2015.02.003; Hochstatter KR, 2021, AIDS BEHAV, V25, P354, DOI 10.1007/s10461-020-02976-1; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Huo DZ, 2006, ADDICTION, V101, P1606, DOI 10.1111/j.1360-0443.2006.01577.x; Jamil MS, 2017, LANCET HIV, V4, pE241, DOI 10.1016/S2352-3018(17)30023-1; Jarlais DCD, 1996, LANCET, V348, P987, DOI 10.1016/S0140-6736(96)02536-6; Jenness SM, 2021, J INFECT DIS, V223, P1019, DOI 10.1093/infdis/jiab051; Jenness SM, 2020, AIDS, V34, P2103, DOI 10.1097/QAD.0000000000002681; Jenness SM, 2010, AIDS PATIENT CARE ST, V24, P175, DOI 10.1089/apc.2009.0227; Katz DA, 2018, JAIDS-J ACQ IMM DEF, V78, P505, DOI [10.1097/QAI.0000000000001709, 10.1097/qai.0000000000001709]; Keitt TH, 2017, ODEINTR C ODE SOLVER; Knight GM, 2016, INT J INFECT DIS, V42, P17, DOI 10.1016/j.ijid.2015.10.024; Lindau ST, 2007, NEW ENGL J MED, V357, P762, DOI 10.1056/NEJMoa067423; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Marshall BDL, 2018, LANCET HIV, V5, pE498, DOI 10.1016/S2352-3018(18)30097-3; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Monterroso ER, 2000, J ACQ IMMUN DEF SYND, V25, P63, DOI 10.1097/00126334-200009010-00009; Mustanski B, 2015, AIDS BEHAV, V19, P1037, DOI 10.1007/s10461-014-0955-0; Nosyk B, 2020, LANCET HIV, V7, pE491, DOI 10.1016/S2352-3018(20)30033-3; Nosyk B, 2019, CLIN INFECT DIS, V69, P2195, DOI 10.1093/cid/ciz1015; Panagiotoglou D, 2018, AIDS BEHAV, V22, P3071, DOI 10.1007/s10461-018-2166-6; Pathela P, 2006, ANN INTERN MED, V145, P416, DOI 10.7326/0003-4819-145-6-200609190-00005; Pathela P, 2020, JAIDS-J ACQ IMM DEF, V83, P357, DOI 10.1097/QAI.0000000000002274; Pinto RM, 2020, AIDS BEHAV, V24, P2486, DOI 10.1007/s10461-020-02893-3; Pitasi MA, 2018, MMWR-MORBID MORTAL W, V67, P677, DOI 10.15585/mmwr.mm6724a2; R Development Core Team, 2009, R LANG ENV STAT COMP; Rolle CP, 2019, AIDS BEHAV, V23, P296, DOI 10.1007/s10461-019-02654-x; Shah M, 2016, LANCET HIV, V3, pE140, DOI 10.1016/S2352-3018(16)00007-2; Shah M, 2016, CLIN INFECT DIS, V62, P220, DOI 10.1093/cid/civ801; Shilo G, 2020, J SEX MED, V17, P1827, DOI 10.1016/j.jsxm.2020.07.085; Shover CL, 2018, AM J PUBLIC HEALTH, V108, P1408, DOI 10.2105/AJPH.2018.304623; Smith MK, 2018, EPIDEMIOL INFECT, V146, DOI 10.1017/S0950268818002042; Stephenson R, 2021, AIDS BEHAV, V25, P40, DOI 10.1007/s10461-020-03024-8; Strathdee SA, 1999, J URBAN HEALTH, V76, P448, DOI 10.1007/BF02351502; Swamidass P.M., 2000, ENCY PRODUCTION MANU, P462, DOI [10.1007/1-4020-0612-8_580, DOI 10.1007/1-4020-0612-8_580]; The Joint United Nations Programme on HIV/AIDS, 2014, FAST TRACK END AIDS; Twenge JM, 2017, ARCH SEX BEHAV, V46, P433, DOI 10.1007/s10508-016-0798-z; U.S. Department of Health and Human Services Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality, 2014, NAT SURV DRUG US HLT; US Public Health Service, 2017, PREEXP PROPH PREV HI, DOI DOI 10.1016/S0040-4039(01)91800-3; Zang X, 2021, CLIN INFECT DIS, V72, pE828, DOI 10.1093/cid/ciaa1547; Zang X, 2020, MED DECIS MAKING, V40, P3, DOI 10.1177/0272989X19889356	74	4	4	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV	2021	174	11					1542	+		10.7326/M21-1501	http://dx.doi.org/10.7326/M21-1501			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YI2OV	34543589	Green Accepted			2022-12-28	WOS:000743694300019
J	Ali, SH				Ali, Saleem H.			Ten Patterns That Explain the Universe	SCIENCE			English	Book Review									[Ali, Saleem H.] Univ Delaware, Dept Geog & Spatial Sci, Newark, DE 19716 USA	University of Delaware	Ali, SH (corresponding author), Univ Delaware, Dept Geog & Spatial Sci, Newark, DE 19716 USA.	saleem@alum.mit.edu						ANDERSON PW, 1972, SCIENCE, V177, P393, DOI 10.1126/science.177.4047.393; Kauffman S., 1996, HOME UNIVERSE; Kauffman S.A., 1993, ORIGINS ORDER; Quammen D., 2018, TANGLED TREE	4	0	0	2	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2021	373	6562			SI		1448	1448		10.1126/science.abj8932	http://dx.doi.org/10.1126/science.abj8932			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU7LJ	34554785				2022-12-28	WOS:000698977800033
J	Limb, M				Limb, Matthew			The BMJ Awards 2021: Digital innovation team of the year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material															UCL Global Business School for Health	UCL Global Business School for Health	The award for the digital innovation team of the year is sponsored by UCL Global Business School for Health.		0	0	0	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2021	374								n2269	10.1136/bmj.n2269	http://dx.doi.org/10.1136/bmj.n2269			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ1JE	34556468				2022-12-28	WOS:000701967300003
J	Gruber, J				Gruber, June			The End of Trauma: How the New Science of Resilience Is Changing How We Think About PTSD	SCIENCE			English	Book Review									[Gruber, June] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Gruber, J (corresponding author), Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA.	june.gruber@colorado.edu						Bonanno G.A., 2021, END TRAUMA NEW SCI R, V1st	1	1	1	2	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2021	373	6561					1315	1315						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	US5SK	34529470				2022-12-28	WOS:000697488600030
J	Burger, ML; Cruz, AM; Crossland, GE; Gaglia, G; Ritch, CC; Blatt, SE; Bhutkar, A; Canner, D; Kienka, T; Tavana, SZ; Barandiaran, AL; Garmilla, A; Schenkel, JM; Hillman, M; Kobara, ID; Li, A; Jaeger, AM; Hwang, WL; Westcott, PMK; Manos, MP; Holovatska, MM; Hodi, FS; Regev, A; Santagata, S; Jacks, T				Burger, Megan L.; Cruz, Amanda M.; Crossland, Grace E.; Gaglia, Giorgio; Ritch, Cecily C.; Blatt, Sarah E.; Bhutkar, Arjun; Canner, David; Kienka, Tamina; Tavana, Sara Z.; Barandiaran, Alexia L.; Garmilla, Andrea; Schenkel, Jason M.; Hillman, Michelle; Kobara, Izumi de los Rios; Li, Amy; Jaeger, Alex M.; Hwang, William L.; Westcott, Peter M. K.; Manos, Michael P.; Holovatska, Marta M.; Hodi, F. Stephen; Regev, Aviv; Santagata, Sandro; Jacks, Tyler			Antigen dominance hierarchies shape TCF1(+) progenitor CD8 T cell phenotypes in tumors	CELL			English	Article							NEOANTIGEN LANDSCAPE; CHECKPOINT BLOCKADE; LUNG-CANCER; MELANOMA; IMMUNOTHERAPY; PEPTIDE; DIFFERENTIATION; IMMUNODOMINANCE; REGULATORS; EXPRESSION	CD8 T cell responses against different tumor neoantigens occur simultaneously, yet little is known about the interplay between responses and its impact on T cell function and tumor control. In mouse lung adenocarcinoma, we found that immunodominance is established in tumors, wherein CD8 T cell expansion is predominantly driven by the antigen that most stably binds MHC. T cells responding to subdominant antigens were enriched for a TCF1(+) progenitor phenotype correlated with response to immune checkpoint blockade (ICB) therapy. However, the subdominant T cell response did not preferentially benefit from ICB due to a dysfunctional subset of TCF1(+) cells marked by CCR6 and Tc17 differentiation. Analysis of human samples and sequencing datasets revealed that CCR6(+) TCF1(+) cells exist across human cancers and are not correlated with ICB response. Vaccination eliminated CCR6(+) TCF1(+) cells and dramatically improved the subdominant response, highlighting a strategy to optimally engage concurrent neoantigen responses against tumors.	[Burger, Megan L.; Cruz, Amanda M.; Crossland, Grace E.; Blatt, Sarah E.; Bhutkar, Arjun; Canner, David; Kienka, Tamina; Tavana, Sara Z.; Barandiaran, Alexia L.; Garmilla, Andrea; Schenkel, Jason M.; Hillman, Michelle; Kobara, Izumi de los Rios; Li, Amy; Jaeger, Alex M.; Hwang, William L.; Westcott, Peter M. K.; Regev, Aviv; Jacks, Tyler] MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Cruz, Amanda M.; Canner, David; Li, Amy; Regev, Aviv; Jacks, Tyler] MIT, Dept Biol, Cambridge, MA 02139 USA; [Gaglia, Giorgio; Ritch, Cecily C.; Schenkel, Jason M.; Santagata, Sandro] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Gaglia, Giorgio; Ritch, Cecily C.; Santagata, Sandro] Harvard Med Sch, Ludwig Ctr Harvard, Boston, MA 02115 USA; [Gaglia, Giorgio; Ritch, Cecily C.; Santagata, Sandro] Harvard Med Sch, Dept Syst Biol, Lab Syst Pharmacol, Boston, MA 02115 USA; [Hwang, William L.; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Hwang, William L.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Manos, Michael P.; Holovatska, Marta M.; Hodi, F. Stephen] Dana Farber Canc Inst, Melanoma Dis Ctr, Boston, MA 02215 USA; [Manos, Michael P.; Holovatska, Marta M.; Hodi, F. Stephen] Harvard Med Sch, Boston, MA 02215 USA; [Manos, Michael P.; Holovatska, Marta M.; Hodi, F. Stephen] Dana Farber Canc Inst, Ctr Immunooncol, Boston, MA 02215 USA; [Hodi, F. Stephen] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Regev, Aviv] Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA; [Santagata, Sandro] Dana Farber Canc Inst, Dept Oncol Pathol, Boston, MA 02215 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Roche Holding; Genentech; Harvard University; Dana-Farber Cancer Institute	Jacks, T (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Jacks, T (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.	tjacks@mit.edu		Zoghi Tavana, Sara/0000-0002-4654-7955; Ritch, Cecily/0000-0001-7651-0419	Howard Hughes Medical Institute; Ludwig Center at Harvard [U54 (CA225088)]; NIH [T32HL007627]; NCI Cancer Center [P30-CA1405]; Bridge Project; Koch Institute for Integrative Cancer Research at MIT; Jane Coffin Childs Memorial Fund	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ludwig Center at Harvard; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Bridge Project; Koch Institute for Integrative Cancer Research at MIT; Jane Coffin Childs Memorial Fund	We would like to acknowledge R. Herbst, T. Delorey, D. Phillips, the Broad Genomics Platform, and the Whitehead Institute Genomics Technology Core for assistance with scRNA-seq; C. Backlund for input on vaccination techniques; Koch Institute's Robert A. Swanson Biotechnology Center for assistance with flow cytometry and histology; K. Yee, J. Texeira, K. Anderson, K. Mercer, and M. Magendantz for administrative and logistical support; and S. Spranger, M. Birnbaum, C. Jin, and B. Eskiocak for their insightful intellectual input. This work was supported by Howard Hughes Medical Institute (to T.J.), Ludwig Center at Harvard (to S.S.), NIH U54 (CA225088 to S.S.), NIH (T32HL007627 to G.G.), NCI Cancer Center (Support Grant P30-CA1405), Bridge Project, a partnership between the Koch Institute for Integrative Cancer Research at MIT and the Dana-Farber/Harvard Cancer Center (to T.J. and S.S.), and fellowship awards from Jane Coffin Childs Memorial Fund for Medical Research and Ludwig Center for Molecular Oncology at MIT (to M.L.B.). T.J. is a David H. Koch Professor of Biology and Daniel K. Ludwig Scholar.	Anagnostou V, 2017, CANCER DISCOV, V7, P264, DOI 10.1158/2159-8290.CD-16-0828; Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Andreatta M, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23324-4; [Anonymous], 2020, UMAP UNIFORM MANIFOL; Baldarelli RM, 2021, NUCLEIC ACIDS RES, V49, pD924, DOI 10.1093/nar/gkaa914; Bentzen AK, 2018, NAT BIOTECHNOL, V36, P1191, DOI 10.1038/nbt.4303; Berg S, 2019, NAT METHODS, V16, P1226, DOI 10.1038/s41592-019-0582-9; Bolotin DA, 2017, NAT BIOTECHNOL, V35, P908, DOI 10.1038/nbt.3979; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cao JY, 2019, NATURE, V566, P496, DOI 10.1038/s41586-019-0969-x; Carreno BM, 2015, SCIENCE, V348, P803, DOI 10.1126/science.aaa3828; Chang SH, 2014, P NATL ACAD SCI USA, V111, P5664, DOI 10.1073/pnas.1319051111; De Meo P., 2011, Proceedings of the 2011 11th International Conference on Intelligent Systems Design and Applications (ISDA), P88, DOI 10.1109/ISDA.2011.6121636; De Tomaso D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12235-0; Du ZM, 2019, NAT PROTOC, V14, P2900, DOI 10.1038/s41596-019-0206-y; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; DuPage M, 2011, CANCER CELL, V19, P72, DOI 10.1016/j.ccr.2010.11.011; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Eisen HN, 2012, P NATL ACAD SCI USA, V109, P4580, DOI 10.1073/pnas.1201586109; Engels B, 2013, CANCER CELL, V23, P516, DOI 10.1016/j.ccr.2013.03.018; Gu M., 2016, ROBUSTGASP ROBUST GA; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Guo XY, 2018, NAT MED, V24, P978, DOI 10.1038/s41591-018-0045-3; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Harris CR, 2020, NATURE, V585, P357, DOI 10.1038/s41586-020-2649-2; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Hollingsworth RE, 2019, NPJ VACCINES, V4, DOI 10.1038/s41541-019-0103-y; Howarth M, 2004, P NATL ACAD SCI USA, V101, P11737, DOI 10.1073/pnas.0306294101; Hudson WH, 2019, IMMUNITY, V51, P1043, DOI 10.1016/j.immuni.2019.11.002; Hurley N, 2009, IEEE T INFORM THEORY, V55, P4723, DOI 10.1109/TIT.2009.2027527; Jin CC, 2019, CELL, V176, P998, DOI 10.1016/j.cell.2018.12.040; Kadomoto S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155186; Keenan TE, 2019, NAT MED, V25, P389, DOI 10.1038/s41591-019-0382-x; Kurtulus S, 2019, IMMUNITY, V50, P181, DOI 10.1016/j.immuni.2018.11.014; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lin JR, 2018, ELIFE, V7, DOI 10.7554/eLife.31657; Linehan JL, 2018, CELL, V172, P784, DOI 10.1016/j.cell.2017.12.033; Linette GP, 2019, P NATL ACAD SCI USA, V116, P23662, DOI 10.1073/pnas.1906026116; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Mckinney W., 2010, P PYTH SCI C, P51, DOI DOI 10.25080/MAJORA-92BF1922-00A; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Milo I, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat1435; Neuwirth Erich, 2014, CRAN; Ott PA, 2020, CELL, V183, P347, DOI 10.1016/j.cell.2020.08.053; Ott PA, 2017, NATURE, V547, P217, DOI 10.1038/nature22991; Parish IA, 2009, BLOOD, V113, P4575, DOI 10.1182/blood-2008-10-185223; Peng TY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14836; Peters B, 2020, ANNU REV IMMUNOL, V38, P123, DOI 10.1146/annurev-immunol-082119-124838; Philip M, 2022, NAT REV IMMUNOL, V22, P209, DOI 10.1038/s41577-021-00574-3; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Rashid R, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0332-y; Rosenthal R, 2019, NATURE, V567, P479, DOI 10.1038/s41586-019-1032-7; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Sahin U, 2017, NATURE, V547, P222, DOI 10.1038/nature23003; Saini SK, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau9039; Sanchez-Rivera FJ, 2014, NATURE, V516, P428, DOI 10.1038/nature13906; Schenkel J.M., 2021, IMMUNITY; Scheper W, 2019, NAT MED, V25, P89, DOI 10.1038/s41591-018-0266-5; Schreiber H, 2002, SEMIN CANCER BIOL, V12, P25, DOI 10.1006/scbi.2001.0401; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; Schumacher TN, 2019, ANNU REV IMMUNOL, V37, P173, DOI 10.1146/annurev-immunol-042617-053402; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Simoni Y, 2018, NATURE, V557, P575, DOI 10.1038/s41586-018-0130-2; Spranger S, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-3; Srenathan U, 2016, IMMUNOL LETT, V178, P20, DOI 10.1016/j.imlet.2016.05.001; Stoeckius M, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1603-1; Stronen E, 2016, SCIENCE, V352, P1337, DOI 10.1126/science.aaf2288; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Toubal A, 2019, NAT REV IMMUNOL, V19, P643, DOI 10.1038/s41577-019-0191-y; Traag VA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41695-z; Tran E, 2017, NAT IMMUNOL, V18, P255, DOI 10.1038/ni.3682; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Verdegaal EME, 2016, NATURE, V536, P91, DOI 10.1038/nature18945; Verykokakis M, 2007, J BIOL CHEM, V282, P30285, DOI 10.1074/jbc.M704428200; Warnes GR, 2015, GPLOTS VARIOUS R PRO; Wells DK, 2020, CELL, V183, P818, DOI 10.1016/j.cell.2020.09.015; Wu P, 2014, IMMUNITY, V40, P785, DOI 10.1016/j.immuni.2014.03.013; Wu TD, 2020, NATURE, V579, P274, DOI 10.1038/s41586-020-2056-8; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005; Yost KE, 2019, NAT MED, V25, P1251, DOI 10.1038/s41591-019-0522-3; Zacharakis N, 2018, NAT MED, V24, P724, DOI 10.1038/s41591-018-0040-8; Zander R, 2019, IMMUNITY, V51, P1028, DOI 10.1016/j.immuni.2019.10.009; Zhao JJ, 2020, J EXP MED, V217, DOI 10.1084/jem.20190297; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	94	25	25	4	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 16	2021	184	19					4996	+		10.1016/j.cell.2021.08.020	http://dx.doi.org/10.1016/j.cell.2021.08.020		SEP 2021	45	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	WC7PA	34534464	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000704445100014
J	Rimmer, A				Rimmer, Abi			How can I manage conflict in my team?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Shonk K., 2020, 6 GUID GETT YES	1	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 13	2021	374								n2215	10.1136/bmj.n2215	http://dx.doi.org/10.1136/bmj.n2215			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UR8KQ	34518164	Bronze			2022-12-28	WOS:000696991500012
J	O'Neill, ME; Orf, L; Heymsfield, GM; Halbert, K				O'Neill, Morgan E.; Orf, Leigh; Heymsfield, Gerald M.; Halbert, Kelton			Hydraulic jump dynamics above supercell thunderstorms	SCIENCE			English	Article							STRATOSPHERIC WATER-VAPOR; CONVECTION; TEMPERATURE; SIMULATION; GENERATION; CIRRUS; OZONE; RADAR; DEEP	The strongest supercell thunderstorms typically feature an above-anvil cirrus plume (AACP), which is a plume of ice and water vapor in the lower stratosphere that occurs downwind of the ambient stratospheric flow in the lee of overshooting deep convection. AACP-origin hydration of the stratosphere has a poorly constrained role in ozone destruction and surface warming. In this study, we use large eddy simulations corroborated by radar observations to understand the physics of AACP generation. We show that the overshooting top of a simulated supercell can act as a topographic obstacle and drive a hydraulic jump downstream at the tropopause, similar to a windstorm moving down the slope of a mountain but without solid topography. Once the jump is established, water vapor injection deep into the stratosphere may exceed 7 tonnes per second.	[O'Neill, Morgan E.] Stanford Univ, Dept Earth Syst Sci, Stanford, CA 94305 USA; [Orf, Leigh; Halbert, Kelton] Univ Wisconsin, Space Sci & Engn Ctr, Madison, WI USA; [Orf, Leigh] Cooperat Inst Meteorol Satellite Studies, Madison, WI USA; [Heymsfield, Gerald M.] NASA, Goddard Space Flight Ctr, Greenbelt, MD USA	Stanford University; University of Wisconsin System; University of Wisconsin Madison; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	O'Neill, ME (corresponding author), Stanford Univ, Dept Earth Syst Sci, Stanford, CA 94305 USA.	morgan.e.oneill@gmail.com	; Orf, Leigh/D-2195-2016	Heymsfield, Gerald/0000-0001-6298-0233; Orf, Leigh/0000-0002-2677-6427; Halbert, Kelton/0000-0001-6898-2731	NSF [AGS-1832327, OAC-1663954, ATM20006]; NASA Precipitation Measurement Mission (PMM); Ground Validation program	NSF(National Science Foundation (NSF)); NASA Precipitation Measurement Mission (PMM); Ground Validation program	O. was supported in part by NSF grants AGS1832327 and OAC-1663954. L.O.'s access to the NSF-sponsored Frontera supercomputer was provided by the Texas Advanced Computing Center via grant ATM20006. G.M.H. was funded by the NASA Precipitation Measurement Mission (PMM) and Ground Validation program.	Akhalkatsi M, 2009, Q J ROY METEOR SOC, V135, P935, DOI 10.1002/qj.421; Anderson JG, 2017, P NATL ACAD SCI USA, V114, pE4905, DOI 10.1073/pnas.1619318114; Bedka K, 2018, WEATHER FORECAST, V33, P1159, DOI 10.1175/WAF-D-18-0040.1; Bedka K, 2010, J APPL METEOROL CLIM, V49, P181, DOI 10.1175/2009JAMC2286.1; Bryan GH, 2002, MON WEATHER REV, V130, P2917, DOI 10.1175/1520-0493(2002)130<2917:ABSFMN>2.0.CO;2; Chaboureau JP, 2007, ATMOS CHEM PHYS, V7, P1731, DOI 10.5194/acp-7-1731-2007; Chemel C, 2009, MON WEATHER REV, V137, P2493, DOI 10.1175/2008MWR2666.1; CLARK TL, 1977, J ATMOS SCI, V34, P1715, DOI 10.1175/1520-0469(1977)034<1715:OTEASO>2.0.CO;2; Corti T, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033641; Dauhut T, 2015, ATMOS SCI LETT, V16, P135, DOI 10.1002/asl2.534; DEARDORFF JW, 1980, BOUND-LAY METEOROL, V18, P495, DOI 10.1007/BF00119502; Dessler AE, 2013, P NATL ACAD SCI USA, V110, P18087, DOI 10.1073/pnas.1310344110; Doyle JD, 2002, J ATMOS SCI, V59, P186, DOI 10.1175/1520-0469(2002)059<0186:TDOMWI>2.0.CO;2; DURRAN DR, 1990, METEOR MON, V23, P59; DURRAN DR, 1986, J ATMOS SCI, V43, P2527, DOI 10.1175/1520-0469(1986)043<2527:ALADWP>2.0.CO;2; DURRAN DR, 1987, J ATMOS SCI, V44, P3402, DOI 10.1175/1520-0469(1987)044<3402:ALADWP>2.0.CO;2; Forster PMD, 1999, GEOPHYS RES LETT, V26, P3309, DOI 10.1029/1999GL010487; FUJITA TT, 1982, J METEOROL SOC JPN, V60, P355, DOI 10.2151/jmsj1965.60.1_355; Hassim MEE, 2010, ATMOS CHEM PHYS, V10, P9833, DOI 10.5194/acp-10-9833-2010; Hertenstein RF, 2005, TELLUS A, V57, P117, DOI 10.1111/j.1600-0870.2005.00099.x; Heymsfield GM, 2013, J APPL METEOROL CLIM, V52, P1851, DOI 10.1175/JAMC-D-12-0144.1; HEYMSFIELD GM, 1983, J ATMOS SCI, V40, P1740, DOI 10.1175/1520-0469(1983)040<1740:ULSOOT>2.0.CO;2; HEYMSFIELD GM, 1988, MON WEATHER REV, V116, P2200, DOI 10.1175/1520-0493(1988)116<2200:SOCOMS>2.0.CO;2; Homeyer CR, 2017, J ATMOS SCI, V74, P1617, DOI 10.1175/JAS-D-16-0269.1; Homeyer CR, 2014, J ATMOS SCI, V71, P332, DOI 10.1175/JAS-D-13-079.1; Jensen MP, 2016, B AM METEOROL SOC, V97, P1667, DOI 10.1175/BAMS-D-14-00228.1; KLEMP JB, 1978, J ATMOS SCI, V35, P1070, DOI 10.1175/1520-0469(1978)035<1070:TSOTDC>2.0.CO;2; Lane TP, 2003, J ATMOS SCI, V60, P1297, DOI 10.1175/1520-0469(2003)60<1297:AIOTGM>2.0.CO;2; Liu XM, 2010, ATMOS CHEM PHYS, V10, P8267, DOI 10.5194/acp-10-8267-2010; ONeill M. E., 2021, ZENODO, DOI [10.5281/zenodo.4584086, DOI 10.5281/ZENODO.4584086]; Orf L., 2021, DRYAD, DOI [10.5061/dryad.xsj3tx9fw, DOI 10.5061/DRYAD.XSJ3TX9FW]; Orf L, 2017, B AM METEOROL SOC, V98, P45, DOI 10.1175/BAMS-D-15-00073.1; Schecter DA, 2008, J ATMOS SCI, V65, P685, DOI 10.1175/2007JAS2384.1; Shindell DT, 2001, GEOPHYS RES LETT, V28, P1551, DOI 10.1029/1999GL011197; Smith CA, 2001, GEOPHYS RES LETT, V28, P179, DOI 10.1029/2000GL011846; Smith JB, 2017, J GEOPHYS RES-ATMOS, V122, P9529, DOI 10.1002/2017JD026831; SMITH RB, 1987, J ATMOS SCI, V44, P269, DOI 10.1175/1520-0469(1987)044<0269:AOOTYB>2.0.CO;2; SMITH RB, 1985, J ATMOS SCI, V42, P2597, DOI 10.1175/1520-0469(1985)042<2597:OSDW>2.0.CO;2; Solomon S, 2010, SCIENCE, V327, P1219, DOI 10.1126/science.1182488; Trapp RJ, 2007, P NATL ACAD SCI USA, V104, P19719, DOI 10.1073/pnas.0705494104; Wang PK, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002581; Wicker LJ, 2002, MON WEATHER REV, V130, P2088, DOI 10.1175/1520-0493(2002)130<2088:TSMFEM>2.0.CO;2	42	6	6	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2021	373	6560					1248	+		10.1126/science.abh3857	http://dx.doi.org/10.1126/science.abh3857			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UP5RB	34516791				2022-12-28	WOS:000695436000031
J	Best, J				Best, Jo			Doctors' organisations, neutrality, and the assisted dying debate	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jo.best@journalist.com						[Anonymous], 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1494; Association for Palliative Medicine, 2015, DOCT CAR DYING PEOPL; Australian Medical Association, 2017, EUTH PHYS ASS SUIC; Australian Medical Association, 2016, EUTH PHYS ASS SUIC 2; Blackmer J, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l415; BMA, 2021, ANN REPR M 2021 AGEN; Iacobucci G, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l1340; Kmietowicz Z, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3486; Rimmer A, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m708; Smith M., 2021, YOUGOV 0804; Sulmasy D, 2018, J GEN INTERN MED, V33, P1394, DOI 10.1007/s11606-018-4424-8; Torjesen I, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3936	12	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2021	374								n2075	10.1136/bmj.n2075	http://dx.doi.org/10.1136/bmj.n2075			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ3VV	34497072				2022-12-28	WOS:000702137100003
J	Lai, D; Lee, J; He, SH				Lai, Debbie; Lee, Jennifer; He, Shuhan			Emoji for the Medical Community-Challenges and Opportunities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lai, Debbie] UCL, Div Psychol & Language Sci, London, England; [Lee, Jennifer] Emojinat & Unicode Consortium, Mountain View, CA USA; [He, Shuhan] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [He, Shuhan] Massachusetts Gen Hosp, Lab Comp Sci, Dept Internal Med, Ctr Innovat Digital Healthcare, Boston, MA 02114 USA; [He, Shuhan] Harvard Med Sch, Boston, MA 02115 USA	University of London; University College London; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	He, SH (corresponding author), Dept Emergency Med, 55 Fruit St, Boston, MA 02114 USA.	she@mgh.harvard.edu	He, Shuhan/AAF-1764-2020	He, Shuhan/0000-0002-9902-5077				[Anonymous], 2019, EMOJI TREND REPORT 2; Buchholz K., 2020, WORLD EC FORUM; Evans V., 2020, LINKEDIN MAR; Garra G, 2010, ACAD EMERG MED, V17, P50, DOI 10.1111/j.1553-2712.2009.00620.x; Hall L, 2016, PROCEEDINGS OF THE 15TH INTERNATIONAL CONFERENCE ON INTERACTION DESIGN AND CHILDREN (IDC2016), P311, DOI 10.1145/2930674.2930719; Hollander JE, 2020, NEW ENGL J MED, V382, P1679, DOI 10.1056/NEJMp2003539; Horwitz LI, 2013, JAMA INTERN MED, V173, P1715, DOI 10.1001/jamainternmed.2013.9318; Phelps EA, 2006, PSYCHOL SCI, V17, P292, DOI 10.1111/j.1467-9280.2006.01701.x; Stonbraker S, 2020, J AM MED INFORM ASSN, V27, P212, DOI 10.1093/jamia/ocz189	9	5	6	4	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2021	326	9					795	796		10.1001/jama.2021.8409	http://dx.doi.org/10.1001/jama.2021.8409			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ7LK	34547099				2022-12-28	WOS:000696242100002
J	Al-Samkari, H; Leaf, RK; Goodarzi, K				Al-Samkari, Hanny; Leaf, Rebecca Karp; Goodarzi, Katayoon			Transient Thrombocytopenia With Glycoprotein-Specific Platelet Autoantibodies After Ad26.COV2.S Vaccination: A Case Report	ANNALS OF INTERNAL MEDICINE			English	Letter									[Al-Samkari, Hanny; Leaf, Rebecca Karp; Goodarzi, Katayoon] Harvard Med Sch, Boston, MA 02115 USA; [Al-Samkari, Hanny; Leaf, Rebecca Karp; Goodarzi, Katayoon] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Al-Samkari, H (corresponding author), Massachusetts Gen Hosp, Div Hematol Oncol, Zero Emerson Pl Suite 118 Off 112, Boston, MA 02114 USA.	hal-samkari@mgh.harvard.edu		Al-Samkari, Hanny/0000-0001-6175-1383	Harvard KL2/Catalyst Medical Research Investigator Training Award; American Society of Hematology Scholar Award	Harvard KL2/Catalyst Medical Research Investigator Training Award; American Society of Hematology Scholar Award	Dr. Al-Samkari is the recipient of the Harvard KL2/Catalyst Medical Research Investigator Training Award and the American Society of Hematology Scholar Award.	Schultz NH, 2021, NEW ENGL J MED, V384, P2124, DOI 10.1056/NEJMoa2104882	1	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV	2021	174	11					1632	+		10.7326/L21-0427	http://dx.doi.org/10.7326/L21-0427			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YI2OV	34516272	Green Published			2022-12-28	WOS:000743694300035
J	Bhaumik, S; Gopalakrishnan, M; Meena, P				Bhaumik, Soumyadeep; Gopalakrishnan, Maya; Meena, Priti			Mitigating the chronic burden of snakebite: turning the tide for survivors	LANCET			English	Editorial Material							ACUTE KIDNEY INJURY		[Bhaumik, Soumyadeep] George Inst Global Hlth, Injury Div, New Delhi, India; [Bhaumik, Soumyadeep] Univ New South Wales, George Inst Global Hlth, Fac Med, Sydney, NSW, Australia; [Gopalakrishnan, Maya] All India Inst Med Sci, Dept Internal Med, Jodhpur, Rajasthan, India; [Meena, Priti] All India Inst Med Sci, Dept Nephrol, Bhubaneswar 751019, Odisha, India	George Institute for Global Health; University of New South Wales Sydney; University of Sydney; All India Institute of Medical Sciences (AIIMS) Jodhpur; All India Institute of Medical Sciences (AIIMS) Bhubaneswar	Meena, P (corresponding author), All India Inst Med Sci, Dept Nephrol, Bhubaneswar 751019, Odisha, India.	pritimn@gmail.com		Bhaumik, Soumyadeep/0000-0001-9579-4453				Bhattacharya S, 2020, AM J TROP MED HYG, V103, P1388, DOI 10.4269/ajtmh.20-0161; Bhaumik S, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-004131; Chapman N, 2020, NEGLECTED DIS RES DE; Habib AG, 2018, TOXICON, V150, P115, DOI 10.1016/j.toxicon.2018.05.009; Hamill LC, 2019, T ROY SOC TROP MED H, V113, P828, DOI 10.1093/trstmh/trz036; Herath HMNJ, 2012, POSTGRAD MED J, V88, P138, DOI 10.1136/postgradmedj-2011-130225; Jayawardana S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005103; Kasturiratne Anuradhani, 2021, Toxicon X, V9-10, P100074, DOI 10.1016/j.toxcx.2021.100074; Priyamvada PS, 2020, CLIN KIDNEY J, V13, P564, DOI 10.1093/ckj/sfz055; van Oirschot Janneke, 2021, Toxicon X, V9-10, P100075, DOI 10.1016/j.toxcx.2021.100075; Waiddyanatha S, 2019, TOXINS, V11, DOI 10.3390/toxins11040193; Waikhom R, 2012, RENAL FAILURE, V34, P271, DOI 10.3109/0886022X.2011.647297; WHO, 2019, SNAK ENV A STRAT PRE; World Health Organization, 2021, SNAK ENV	14	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 16	2021	398	10309					1389	1390		10.1016/S0140-6736(21)01905-X	http://dx.doi.org/10.1016/S0140-6736(21)01905-X		OCT 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	WI0TQ	34537105				2022-12-28	WOS:000708080400006
J	Cevik, M; Grubaugh, ND; Iwasaki, A; Openshaw, P				Cevik, Muge; Grubaugh, Nathan D.; Iwasaki, Akiko; Openshaw, Peter			COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants Comment	CELL			English	Editorial Material								As the SARS-CoV-2 pandemic evolves, new variants continue to emerge. Some highly transmissible variants, such as Delta, also raised concerns about the effectiveness provided by current vaccines. Understanding immunological correlates of protection and how laboratory findings correspond to clinical effectiveness is imperative to shape future vaccination strategies.	[Cevik, Muge] Univ St Andrews, Sch Med, Div Infect & Global Hlth, St Andrews, Fife, Scotland; [Grubaugh, Nathan D.; Iwasaki, Akiko] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA; [Grubaugh, Nathan D.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Grubaugh, Nathan D.] Yale Univ, Yale Inst Global Hlth, New Haven, CT USA; [Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunol, New Haven, CT 06520 USA; [Iwasaki, Akiko] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Openshaw, Peter] Imperial Coll London, Natl Heart & Lung Inst, London, England	University of St Andrews; Yale University; Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Imperial College London	Cevik, M (corresponding author), Univ St Andrews, Sch Med, Div Infect & Global Hlth, St Andrews, Fife, Scotland.	mc349@st-andrews.ac.uk		Cevik, Muge/0000-0003-1133-3874				Abu-Raddad LJ, 2021, NEW ENGL J MED, V385, P187, DOI 10.1056/NEJMc2104974; Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891; Braun K., 2021, LTD WITHIN HOST DIVE; Corbett Kizzmekia S, 2021, bioRxiv, DOI 10.1101/2021.05.21.445189; Dejnirattisai W, 2021, CELL, V184, P2939, DOI 10.1016/j.cell.2021.03.055; Geers D, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abj1750; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Lucas C., 2021, MEDRXIV, DOI [10.1101/2021.07.14.21260307, DOI 10.1101/2021.07.14.21260307]; Madhi SA, 2021, NEW ENGL J MED, V384, P1885, DOI 10.1056/NEJMoa2102214; Reynolds CJ, 2021, SCIENCE, V372, P1418, DOI 10.1126/science.abh1282; Stamatatos L, 2021, SCIENCE, V372, P1413, DOI 10.1126/science.abg9175; Tan AT, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108728; Tarke A, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100355; Tregoning JS, 2021, NAT REV IMMUNOL, V21, P626, DOI 10.1038/s41577-021-00592-1	14	58	59	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 30	2021	184	20					5077	5081		10.1016/j.cell.2021.09.010	http://dx.doi.org/10.1016/j.cell.2021.09.010		OCT 2021	5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	WC7PG	34534444	Green Published, Bronze			2022-12-28	WOS:000704445700003
J	Viner, RM; Koirala, A				Viner, Russell M.; Koirala, Archana			Daily antigen testing to reduce disruption when schools return	LANCET			English	Editorial Material									[Viner, Russell M.] UCL Great Ormond St Inst Child Hlth, London WC1N 1EH, England; [Koirala, Archana] Natl Ctr Immunisat Res & Surveillance Vaccine Pre, Sydney, NSW, Australia	University of London; University College London; University of Sydney	Viner, RM (corresponding author), UCL Great Ormond St Inst Child Hlth, London WC1N 1EH, England.	r.viner@ucl.ac.uk	Viner, Russell/A-1441-2009	Viner, Russell/0000-0003-3047-2247				Macartney K, 2020, LANCET CHILD ADOLESC, V4, P807, DOI 10.1016/S2352-4642(20)30251-0; Madewell ZJ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.31756; National Centre for Immunisation Research and Surveliance, 2020, COVID 19 SCH EARL CH; UK Government, 2021, COR COVID 19 UK CAS; Ulyte A, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n616; Viner R., 2021, IMPACTS SCH CLOSURES, DOI [10.1101/2021.02.10.21251526v1, DOI 10.1101/2021.02.10.21251526]; Vohra D., 2021, MATHEMATICA, V26; Walsh S, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2021-053371; Young BC, 2021, LANCET, V398, P1217, DOI 10.1016/S0140-6736(21)01908-5	9	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 2	2021	398	10307					1196	1197		10.1016/S0140-6736(21)02092-4	http://dx.doi.org/10.1016/S0140-6736(21)02092-4		SEP 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	WC6VF	34534515	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000704393000003
J	Dikopoltsev, A; Harder, TH; Lustig, E; Egorov, OA; Beierlein, J; Wolf, A; Lumer, Y; Emmerling, M; Schneider, C; Hofling, S; Segev, M; Klembt, S				Dikopoltsev, Alex; Harder, Tristan H.; Lustig, Eran; Egorov, Oleg A.; Beierlein, Johannes; Wolf, Adriana; Lumer, Yaakov; Emmerling, Monika; Schneider, Christian; Hoefling, Sven; Segev, Mordechai; Klembt, Sebastian			Topological insulator vertical-cavity laser array	SCIENCE			English	Article							PHASE-LOCKED ARRAYS; OPERATION	Topological insulator lasers are arrays of semiconductor lasers that exploit fundamental features of topology to force all emitters to act as a single coherent laser. In this study, we demonstrate a topological insulator vertical-cavity surface-emitting laser (VCSEL) array. Each VCSEL emits vertically, but the in-plane coupling between emitters in the topological-crystalline platform facilitates coherent emission of the whole array. Our topological VCSEL array emits at a single frequency and displays interference, highlighting that the emitters are mutually coherent. Our experiments exemplify the power of topological transport of light: The light spends most of its time oscillating vertically, but the small in-plane coupling is sufficient to force the array of individual emitters to act as a single laser.	[Dikopoltsev, Alex; Lustig, Eran; Lumer, Yaakov; Segev, Mordechai] Technion, Phys Dept, IL-32000 Haifa, Israel; [Harder, Tristan H.; Beierlein, Johannes; Wolf, Adriana; Emmerling, Monika; Hoefling, Sven; Klembt, Sebastian] Univ Wurzburg, Tech Phys, Wilhelm Conrad Rontgen Res Ctr Complex Mat Syst, D-97074 Wurzburg, Germany; [Harder, Tristan H.; Beierlein, Johannes; Wolf, Adriana; Emmerling, Monika; Hoefling, Sven; Klembt, Sebastian] Univ Wurzburg, Wurzburg Dresden Cluster Excellence Ct Qmat, D-97074 Wurzburg, Germany; [Egorov, Oleg A.] Friedrich Schiller Univ Jena, ITFO, Abbe Ctr Photon, D-07743 Jena, Germany; [Schneider, Christian] Carl von Ossietzky Univ Oldenburg, Inst Phys, D-26129 Oldenburg, Germany	Technion Israel Institute of Technology; University of Wurzburg; University of Wurzburg; Friedrich Schiller University of Jena; Carl von Ossietzky Universitat Oldenburg	Segev, M (corresponding author), Technion, Phys Dept, IL-32000 Haifa, Israel.; Klembt, S (corresponding author), Univ Wurzburg, Tech Phys, Wilhelm Conrad Rontgen Res Ctr Complex Mat Syst, D-97074 Wurzburg, Germany.; Klembt, S (corresponding author), Univ Wurzburg, Wurzburg Dresden Cluster Excellence Ct Qmat, D-97074 Wurzburg, Germany.	msegev@technion.ac.il; sebastian.klembt@uni-wuerzburg.de	Lustig, Eran/GQB-1082-2022	Lustig, Eran/0000-0002-5207-0225; Beierlein, Johannes/0000-0003-3421-5547; Dikopoltsev, Alex/0000-0001-5765-7730	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [789339]; German Research Foundation (DFG) through the Wurzburg-Dresden Cluster of Excellence on Complexity and Topology in Quantum Matter "ct.qmat" [EXC 2147, 390858490]; doctoral training program "Elitenetzwerk Bayern"; German Academic Scholarship Foundation; State of Bavaria	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program(European Research Council (ERC)); German Research Foundation (DFG) through the Wurzburg-Dresden Cluster of Excellence on Complexity and Topology in Quantum Matter "ct.qmat"(German Research Foundation (DFG)); doctoral training program "Elitenetzwerk Bayern"; German Academic Scholarship Foundation; State of Bavaria	M.S. gratefully acknowledges an Advanced Grant from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreement no. 789339). The Wurzburg group acknowledges financial support from the German Research Foundation (DFG) through the Wurzburg-Dresden Cluster of Excellence on Complexity and Topology in Quantum Matter "ct.qmat" (EXC 2147, project ID 390858490). T.H.H. and S.H. acknowledge funding from the doctoral training program "Elitenetzwerk Bayern." T.H.H. acknowledges support from the German Academic Scholarship Foundation. The Wurzburg team furthermore acknowledges support from the State of Bavaria.	ACKLEY DE, 1983, APPL PHYS LETT, V42, P152, DOI 10.1063/1.93856; Amelio I, 2020, PHYS REV X, V10, DOI 10.1103/PhysRevX.10.041060; Bahari B, 2017, SCIENCE, V358, P636, DOI 10.1126/science.aao4551; Bandres MA, 2018, SCIENCE, V359, DOI 10.1126/science.aar4005; Barik S, 2018, SCIENCE, V359, P666, DOI 10.1126/science.aaq0327; BOTEZ D, 1983, APPL PHYS LETT, V43, P1096, DOI 10.1063/1.94239; Choi JH, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23718-4; Debernardi P, 2002, IEEE J QUANTUM ELECT, V38, P73, DOI 10.1109/3.973322; DeFreez R. K., 1989, IEEE Photonics Technology Letters, V1, P209, DOI 10.1109/68.36044; di Sopra FM, 2000, APPL PHYS LETT, V77, P2283, DOI 10.1063/1.1316772; Edeltraud G., 2003, SPATIO TEMPORAL DYNA; Edeltraud G., 2003, SPATIO TEMPORAL DYNA; Francis D, 1998, ELECTRON LETT, V34, P2132, DOI 10.1049/el:19981517; Fu LA, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.106802; Hafezi M, 2011, NAT PHYS, V7, P907, DOI [10.1038/NPHYS2063, 10.1038/nphys2063]; Harari G., 2016, C LAS EL CLEO OSA OP; Harari G., 2016, C LAS EL CLEO OSA TE; Harari G, 2018, SCIENCE, V359, DOI 10.1126/science.aar4003; Liu YGN, 2021, CONF LASER ELECTR, DOI 10.1038/s41567-021-01185-4; Miller M, 2001, IEEE PHOTONIC TECH L, V13, P173, DOI 10.1109/68.914311; ORENSTEIN M, 1991, APPL PHYS LETT, V58, P804, DOI 10.1063/1.105218; ORENSTEIN M, 1992, APPL PHYS LETT, V60, P1535, DOI 10.1063/1.107243; Pasienski M, 2008, OPT EXPRESS, V16, P2176, DOI 10.1364/OE.16.002176; Saito H, 1996, APPL PHYS LETT, V69, P3140, DOI 10.1063/1.116808; Schwartz T, 2007, NATURE, V446, P52, DOI 10.1038/nature05623; Shao ZK, 2020, NAT NANOTECHNOL, V15, P67, DOI 10.1038/s41565-019-0584-x; Siroki G, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.041408; Sun X.-C., 2020, PHYS REV LETT, V125; Sun XC, 2021, PHYS REV B, V103, DOI 10.1103/PhysRevB.103.245305; WANG SS, 1988, APPL PHYS LETT, V52, P1774, DOI 10.1063/1.99622; WINFUL HG, 1988, APPL PHYS LETT, V53, P1894, DOI 10.1063/1.100363; WINFUL HG, 1992, PHYS REV A, V46, P6093, DOI 10.1103/PhysRevA.46.6093; Wittek S, 2017, CONF LASER ELECTR; Wu LH, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.223901; Yang YT, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.217401; Yang ZJ, 2020, PHYS REV X, V10, DOI 10.1103/PhysRevX.10.011059; Yang ZQ, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.013903; Zeng YQ, 2020, NATURE, V578, P246, DOI 10.1038/s41586-020-1981-x	38	27	28	28	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2021	373	6562			SI		1514	+		10.1126/science.abj2232	http://dx.doi.org/10.1126/science.abj2232			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU7LJ	34554782				2022-12-28	WOS:000698977800051
J	Limb, M				Limb, Matthew			BMJ Awards 2021: Quality improvement team of the year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2021	374								n2267	10.1136/bmj.n2267	http://dx.doi.org/10.1136/bmj.n2267			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ1JE	34556480				2022-12-28	WOS:000701967300013
J	Bastani, H; Drakopoulos, K; Gupta, V; Vlachogiannis, I; Hadjicristodoulou, C; Lagiou, P; Magiorkinis, G; Paraskevis, D; Tsiodras, S				Bastani, Hamsa; Drakopoulos, Kimon; Gupta, Vishal; Vlachogiannis, Ioannis; Hadjicristodoulou, Christos; Lagiou, Pagona; Magiorkinis, Gkikas; Paraskevis, Dimitrios; Tsiodras, Sotirios			Efficient and targeted COVID-19 border testing via reinforcement learning	NATURE			English	Article								Throughout the coronavirus disease 2019 (COVID-19) pandemic, countries have relied on a variety of ad hoc border control protocols to allow for non-essential travel while safeguarding public health, from quarantining all travellers to restricting entry from select nations on the basis of population-level epidemiological metrics such as cases, deaths or testing positivity rates(1,2). Here we report the design and performance of a reinforcement learning system, nicknamed Eva. In the summer of 2020, Eva was deployed across all Greek borders to limit the influx of asymptomatic travellers infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and to inform border policies through real-time estimates of COVID-19 prevalence. In contrast to country-wide protocols, Eva allocated Greece's limited testing resources on the basis of incoming travellers' demographic information and testing results from previous travellers. By comparing Eva's performance against modelled counterfactual scenarios, we show that Eva identified 1.85 times as many asymptomatic, infected travellers as random surveillance testing, with up to 2-4 times as many during peak travel, and 1.25-1.45 times as many asymptomatic, infected travellers as testing policies that utilize only epidemiological metrics. We demonstrate that this latter benefit arises, at least partially, because population-level epidemiological metrics had limited predictive value for the actual prevalence of SARS-CoV-2 among asymptomatic travellers and exhibited strong country-specific idiosyncrasies in the summer of 2020. Our results raise serious concerns on the effectiveness of country-agnostic internationally proposed border control policies(3) that are based on population-level epidemiological metrics. Instead, our work represents a successful example of the potential of reinforcement learning and real-time data for safeguarding public health. A study reports the design and performance of a reinforcement learning algorithm that enabled efficient and targeted SARS-CoV-2 testing of passengers travelling to Greece in the summer of 2020.	[Bastani, Hamsa] Univ Penn, Wharton Sch, Dept Operat Informat & Decis, Philadelphia, PA 19104 USA; [Drakopoulos, Kimon; Gupta, Vishal] Univ Southern Calif, Marshall Sch Business, Dept Data Sci & Operat, Los Angeles, CA 90007 USA; [Vlachogiannis, Ioannis] AgentRisk, Los Angeles, CA USA; [Hadjicristodoulou, Christos] Univ Thessaly, Dept Hyg & Epidemiol, Larisa, Greece; [Lagiou, Pagona; Magiorkinis, Gkikas; Paraskevis, Dimitrios] Natl & Kapodistrian Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, Athens, Greece; [Tsiodras, Sotirios] Natl & Kapodistrian Univ Athens, Med Sch, Attikon Univ Hosp, Dept Internal Med, Athens, Greece	University of Pennsylvania; University of Southern California; University of Thessaly; Athens Medical School; National & Kapodistrian University of Athens; National & Kapodistrian University of Athens; University Hospital Attikon	Drakopoulos, K (corresponding author), Univ Southern Calif, Marshall Sch Business, Dept Data Sci & Operat, Los Angeles, CA 90007 USA.	drakopou@marshall.usc.edu		Tsiodras, Sotirios/0000-0002-0463-4321; Paraskevis, Dimitrios/0000-0001-6167-7152	National Science Foundation [CMMI-1661732]	National Science Foundation(National Science Foundation (NSF))	We thank all members of the Greek COVID-19 taskforce, the Greek Prime Minister K. Mitsotakis, the Ministry of Digital Governance, the General Secretariat for Civil Protection, the Ministry of Health, the National Public Health Organization, the development team from Cytech and the border control agents, doctors, nurses and laboratory personnel that contributed to Eva's deployment. We also thank O. Bastani for discussions and analysis on constructing custom risk metrics from public data. V.G. was partially supported by the National Science Foundation through NSF grant CMMI-1661732.	Agrawal S., 2014, PROC 15 ACM C EC COM, P989, DOI [10.1145/2600057.2602844, DOI 10.1145/2600057.2602844.URL]; Agrawal S., 2013, INT C MACH LEARN, P127, DOI DOI 10.5555/3042817.3043073; Amat F, 2018, 12TH ACM CONFERENCE ON RECOMMENDER SYSTEMS (RECSYS), P487, DOI 10.1145/3240323.3241729; Auer P., 2002, J MACHINE LEARNING R, V3, P397, DOI [DOI 10.4271/610369, 10.5555/944919.944941]; Bastani H, 2020, OPER RES, V68, P276, DOI 10.1287/opre.2019.1902; Besbes O., 2014, ADV NEURAL INFORM PR, P199; Cevik M, 2021, LANCET MICROBE, V2, pE13, DOI 10.1016/S2666-5247(20)30172-5; Chu W., 2011, P 14 INT C AI STAT A, P208; Council of the European Union, 2020, COUNCIL RECOMMENDATI; Davies NG, 2020, NAT MED, V26, P1205, DOI 10.1038/s41591-020-0962-9; Davies SE, 2016, INT AFF, V92, P1041, DOI 10.1111/1468-2346.12704; DEVINE OJ, 1994, EPIDEMIOLOGY, V5, P622, DOI 10.1097/00001648-199411000-00010; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Dorfman R, 1943, ANN MATH STAT, V14, P436, DOI 10.1214/aoms/1177731363; Durand A., 2018, MACHINE LEARNING HEA, P67; European Commission, 2020, DRAFT COUNC REC COOR; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Gao Z., 2019, ADV NEURAL INFORM PR, V32, P503; GITTINS JC, 1979, J ROY STAT SOC B MET, V41, P148; GREENLAND S, 1991, EPIDEMIOLOGY, V2, P387, DOI 10.1097/00001648-199109000-00015; Gutin E., 2016, ADV NEURAL INFORM PR, V29, P3153; Hasell J, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-00688-8; Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7; Imbens GW, 2015, CAUSAL INFERENCE FOR STATISTICS, SOCIAL, AND BIOMEDICAL SCIENCES: AN INTRODUCTION, P1, DOI 10.1017/CBO9781139025751; LAI TL, 1985, ADV APPL MATH, V6, P4, DOI 10.1016/0196-8858(85)90002-8; Li Lihong, 2010, P 19 INT C WORLD WID, DOI DOI 10.1145/1772690.1772758; Luo H., 2018, C LEARN THEOR, P1739; Ministry of Civil Protection and Ministry of Tourism Hellenic Republic, 2020, PROT ARR GREEC; Perchet V, 2016, ANN STAT, V44, P660, DOI 10.1214/15-AOS1381; Phipps SJ, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.200909; Ritchie H., 2020, CO2 GREENHOUSE GAS E; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Tewari A., 2017, MOBILE HLTH, P495; Thompson WR, 1933, BIOMETRIKA, V25, P285, DOI 10.2307/2332286; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; World Travel and Tourism Council, 2020, REC SCEN 2020 EC IMP; Wu SP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17972-1	37	11	11	5	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 4	2021	599	7883					108	+		10.1038/s41586-021-04014-z	http://dx.doi.org/10.1038/s41586-021-04014-z		SEP 2021	9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WR3QA	34551425	hybrid			2022-12-28	WOS:000709351900001
J	Morgan, M				Morgan, Matt			Matt Morgan: Bursting FOAM's bubble	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Morgan, Matt] Univ Hosp Wales, Cardiff, S Glam, Wales	Cardiff University	Morgan, M (corresponding author), Univ Hosp Wales, Cardiff, S Glam, Wales.	mmorgan@bmj.com							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 22	2021	374								n2284	10.1136/bmj.n2284	http://dx.doi.org/10.1136/bmj.n2284			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WQ2LU	34551891	Bronze			2022-12-28	WOS:000713652600008
J	Mahase, E				Mahase, Elisabeth			Ethnic minority women and babies: outcomes worsen, and CQC demands action	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Kmietowicz Z, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2266; Maternity Action, 2021, WORR FAIL ADM NHS MA; O'Dowd A, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1712; Royal College of Obstetricians and Gynaecologists (RCOG), COR INF PREGN INF PR	4	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 21	2021	374								n2317	10.1136/bmj.n2317	http://dx.doi.org/10.1136/bmj.n2317			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WA4GB	34548276				2022-12-28	WOS:000702844100014
J	Hapca, S; Ramsay, G; Murchie, P; Ahmed, I				Hapca, Sandra; Ramsay, George; Murchie, Peter; Ahmed, Irfan			Biliary colic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GALLSTONE DISEASE; PAIN; CHOLECYSTECTOMY; ASSOCIATION; MANAGEMENT		[Hapca, Sandra] Univ Aberdeen, Sch Med & Dent, Aberdeen AB25 2ZD, Scotland; [Ramsay, George] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland; [Murchie, Peter] Univ Aberdeen, Acad Gen Practice, Inst Appl Hlth Sci, Aberdeen, Scotland; [Ahmed, Irfan] NHS Grampian, Aberdeen Royal Infirm, Dept Gen Surg, Aberdeen, Scotland	University of Aberdeen; University of Aberdeen; University of Aberdeen; University of Aberdeen	Hapca, S (corresponding author), Univ Aberdeen, Sch Med & Dent, Aberdeen AB25 2ZD, Scotland.	sandra.hapca@nhs.scot	Ahmed, Irfan/HHD-1948-2022	Murchie, Peter/0000-0001-9968-5991; Hapca, Sandra/0000-0001-5056-2499				Abraham S, 2014, AM FAM PHYSICIAN, V89, P795; Ahmed I, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-039781; Berhane T, 2006, SCAND J GASTROENTERO, V41, P93, DOI 10.1080/00365520510023990; Bortoff GA, 2000, RADIOGRAPHICS, V20, P751, DOI 10.1148/radiographics.20.3.g00ma16751; Brazzelli M, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18550; Dayoub EJ, 2015, MAYO CLIN PROC, V90, P1165, DOI 10.1016/j.mayocp.2015.06.007; Festi D, 1999, HEPATOLOGY, V30, P839, DOI 10.1002/hep.510300401; Fraquelli M, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006390.pub2; Hazra N, 2014, BRIT J GEN PRACT, V64, pE295, DOI 10.3399/bjgp14X679732; Isherwood J, 2019, SURG-J R COLL SURG E, V17, P33, DOI 10.1016/j.surge.2018.04.001; Jaunoo SS, 2010, INT J SURG, V8, P15, DOI 10.1016/j.ijsu.2009.10.008; Kiriyama S, 2013, J HEPATO-BIL-PAN SCI, V20, P24, DOI 10.1007/s00534-012-0561-3; Kratzer W, 1999, J CLIN ULTRASOUND, V27, P1, DOI 10.1002/(SICI)1097-0096(199901)27:1<1::AID-JCU1>3.0.CO;2-H; Madden AM, 2017, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD012608, DOI 10.1002/14651858.CD012608]; McGee S., 2018, EVIDENCE BASED PHYS, V4th, P451; National Institute for Health and Care Excellence, 2019, CKS GALLST; National Institute for Health and Care Excellence, 2014, GALLST DIS DIAGN MAN; Royal College of Surgeons of England, 2016, GALLST COMM GUID; Ruhl CE, 2000, HEPATOLOGY, V31, P299, DOI 10.1002/hep.510310206; Rumsey S, 2017, ANZ J SURG, V87, P232, DOI 10.1111/ans.13907; Sandblom G, 2015, HPB, V17, P239, DOI 10.1111/hpb.12356; Shabanzadeh DM, 2016, GASTROENTEROLOGY, V150, P156, DOI 10.1053/j.gastro.2015.09.002; Sharara AI, 2010, CLIN GASTROENTEROL H, V8, P1077, DOI 10.1016/j.cgh.2010.08.021; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Talley NJ, 2001, BRIT MED J, V323, P1294, DOI 10.1136/bmj.323.7324.1294; Wudel LJ, 2002, J SURG RES, V102, P50, DOI 10.1006/jsre.2001.6322	26	0	0	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 13	2021	374								n2085	10.1136/bmj.n2085	http://dx.doi.org/10.1136/bmj.n2085			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UR8KQ	34518165				2022-12-28	WOS:000696991500011
J	Daniels, JP				Daniels, Joe Parkin			Earthquake compounds Haiti's health challenges	LANCET			English	Editorial Material																			0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 11	2021	398	10304					944	945						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UP1FQ	34509222				2022-12-28	WOS:000695130500008
J	Brown, EFC; Gudiksen, KL; King, JS				Fuse Brown, Erin C.; Gudiksen, Katherine L.; King, Jaime S.			State Public Option Plans - Too Modest to Improve Affordability?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fuse Brown, Erin C.] Georgia State Univ, Coll Law, Atlanta, GA 30303 USA; [Gudiksen, Katherine L.] Univ Calif San Francisco, Hastings Coll Law, San Francisco, CA 94102 USA; [King, Jaime S.] Univ Auckland, Auckland Law Sch, Auckland, New Zealand	University System of Georgia; Georgia State University; University of California System; University of California San Francisco; University of Auckland	Brown, EFC (corresponding author), Georgia State Univ, Coll Law, Atlanta, GA 30303 USA.			King, Jaime/0000-0001-5698-107X				Campbell C., 2021, BILL HLTH 0524; Fuse Brown EC., HARVARD J LEGIS; Hansard S, 2020, PUBLIC OPTION EXPT H; Medicare Payment Advisory Commission, 2019, MED PAYM POL C MARCH	4	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2021	385	12					1057	1059		10.1056/NEJMp2111356	http://dx.doi.org/10.1056/NEJMp2111356		SEP 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UQ4IT	34506089				2022-12-28	WOS:000694804200001
J	Bisht, K				Bisht, Karishma			A ghost author speaks up	SCIENCE			English	Editorial Material									[Bisht, Karishma] Princeton Univ, Princeton, NJ 08544 USA	Princeton University	Bisht, K (corresponding author), Princeton Univ, Princeton, NJ 08544 USA.	SciCareerEditor@aaas.org	Bisht, Karishma/AAT-7074-2020; Bisht, Karishma/ABG-2629-2021	Bisht, Karishma/0000-0002-9088-1141; Bisht, Karishma/0000-0002-9088-1141					0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2021	373	6560					1274	1274						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UP5RB	34516799				2022-12-28	WOS:000695436000036
J	Li, Y; Simmler, LD; Van Zessen, R; Flakowski, J; Wan, JX; Deng, F; Li, YLeeeeeee; Nautiyal, KM; Pascoli, V; Luescher, C				Li, Yue; Simmler, Linda D.; Van Zessen, Ruud; Flakowski, Jerome; Wan, Jin-Xia; Deng, Fei; Li, Yu-Long; Nautiyal, Katherine M.; Pascoli, Vincent; Luescher, Christian			Synaptic mechanism underlying serotonin modulation of transition to cocaine addiction	SCIENCE			English	Article							DOUBLE-BLIND; PLASTICITY; CITALOPRAM; DEPENDENCE; DOPAMINE; REWARD; MODEL	Compulsive drug use despite adverse consequences defines addiction. While mesolimbic dopamine signaling is sufficient to drive compulsion, psychostimulants such as cocaine also boost extracellular serotonin (5-HT) by inhibiting reuptake. We used SERT Met172 knockin (SertKI) mice carrying a transporter that no longer binds cocaine to abolish 5-HT transients during drug self-administration. SertKI mice showed an enhanced transition to compulsion. Conversely, pharmacologically elevating 5-HT reversed the inherently high rate of compulsion transition with optogenetic dopamine self-stimulation. The bidirectional effect on behavior is explained by presynaptic depression of orbitofrontal cortex-to-dorsal striatum synapses induced by 5-HT via 5-HT1B receptors. Consequently, in projection-specific 5-HT1B receptor knockout mice, the fraction of individuals compulsively self-administering cocaine was elevated.	[Li, Yue; Simmler, Linda D.; Van Zessen, Ruud; Flakowski, Jerome; Pascoli, Vincent; Luescher, Christian] Univ Geneva, Med Fac, Dept Basic Neurosci, CH-1211 Geneva, Switzerland; [Wan, Jin-Xia; Deng, Fei; Li, Yu-Long] Peking Univ, Sch Life Sci, State Key Lab Membrane Biol, Beijing 100871, Peoples R China; [Wan, Jin-Xia; Deng, Fei; Li, Yu-Long] Peking Univ, IDG McGovern Inst Brain Res, Beijing 100871, Peoples R China; [Nautiyal, Katherine M.] Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; [Luescher, Christian] Geneva Univ Hosp, Dept Clin Neurosci, Clin Neurol, CH-1211 Geneva, Switzerland	University of Geneva; Peking University; Peking University; Dartmouth College; University of Geneva	Luescher, C (corresponding author), Univ Geneva, Med Fac, Dept Basic Neurosci, CH-1211 Geneva, Switzerland.; Luescher, C (corresponding author), Geneva Univ Hosp, Dept Clin Neurosci, Clin Neurol, CH-1211 Geneva, Switzerland.	christian.luscher@unige.ch						Boureau YL, 2011, NEUROPSYCHOPHARMACOL, V36, P74, DOI 10.1038/npp.2010.151; Cameron LP, 2021, NATURE, V589, P474, DOI 10.1038/s41586-020-3008-z; Corre J, 2018, ELIFE, V7, DOI 10.7554/eLife.39945; Dolen G, 2013, NATURE, V501, P179, DOI 10.1038/nature12518; Flakowski J., 2021, ZENODO, DOI [10.5281/zenodo.5091499, DOI 10.5281/ZENODO.5091499]; Fletcher PJ, 2002, NEUROPSYCHOPHARMACOL, V27, P576; GRABOWSKI J, 1995, J CLIN PSYCHOPHARM, V15, P163, DOI 10.1097/00004714-199506000-00004; Kirby LG, 2011, NEUROPHARMACOLOGY, V61, P421, DOI 10.1016/j.neuropharm.2011.03.022; Liechti ME, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14043; Liu ZX, 2014, NEURON, V81, P1360, DOI 10.1016/j.neuron.2014.02.010; Lottem E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03438-y; Luscher C, 2006, PLOS MED, V3, P2005, DOI 10.1371/journal.pmed.0030437; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Luscher C, 2021, ANNU REV NEUROSCI, V44, P173, DOI 10.1146/annurev-neuro-092920-123905; Luscher C, 2016, ANNU REV NEUROSCI, V39, P257, DOI 10.1146/annurev-neuro-070815-013920; Mathur BN, 2011, J NEUROSCI, V31, P7402, DOI 10.1523/JNEUROSCI.6250-10.2011; Moeller FG, 2007, AM J DRUG ALCOHOL AB, V33, P367, DOI 10.1080/00952990701313686; Muller CP, 2015, BEHAV BRAIN RES, V277, P146, DOI 10.1016/j.bbr.2014.04.007; Nackenoff AG, 2016, NEUROPSYCHOPHARMACOL, V41, P1733, DOI 10.1038/npp.2015.335; Nautiyal KM, 2015, NEURON, V86, P813, DOI 10.1016/j.neuron.2015.03.041; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; Pascoli V, 2018, NATURE, V564, P366, DOI 10.1038/s41586-018-0789-4; Pascoli V, 2015, NEURON, V88, DOI 10.1016/j.neuron.2015.10.017; Pelloux Y, 2012, NEUROPSYCHOPHARMACOL, V37, P2505, DOI 10.1038/npp.2012.111; Rocha BA, 1998, NATURE, V393, P175, DOI 10.1038/30259; Scholze P, 2000, J PHARMACOL EXP THER, V293, P870; Simmler LD, 2013, BRIT J PHARMACOL, V168, P458, DOI 10.1111/j.1476-5381.2012.02145.x; Simmler LD, 2019, ACS CHEM NEUROSCI, V10, P3053, DOI 10.1021/acschemneuro.9b00005; Simmler LD, 2017, BRIT J PHARMACOL, V174, P2716, DOI 10.1111/bph.13899; Tao R, 2002, J PHARMACOL EXP THER, V303, P704, DOI 10.1124/jpet.102.038133; Thompson B. J., P NATL ACAD SCI; Thompson BJ, 2011, P NATL ACAD SCI USA, V108, P3785, DOI 10.1073/pnas.1011920108; Vayalapalli S, 2011, AM J ADDICTION, V20, P485, DOI 10.1111/j.1521-0391.2011.00162.x; Yucel M, 2019, ADDICTION, V114, P1095, DOI 10.1111/add.14424	34	8	8	6	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2021	373	6560					1252	+		10.1126/science.abi9086	http://dx.doi.org/10.1126/science.abi9086			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UP5RB	34516792	Green Accepted			2022-12-28	WOS:000695436000032
J	Spaulding, EL; Hines, TJ; Bais, P; Tadenev, ALD; Schneider, R; Jewett, D; Pattavina, B; Pratt, SL; Morelli, KH; Stum, MG; Hill, DP; Gobet, C; Pipis, M; Reilly, MM; Jennings, MJ; Horvath, R; Bai, Y; Shy, ME; Alvarez-Castelao, B; Schuman, EM; Bogdanik, LP; Storkebaum, E; Burgess, RW				Spaulding, E. L.; Hines, T. J.; Bais, P.; Tadenev, A. L. D.; Schneider, R.; Jewett, D.; Pattavina, B.; Pratt, S. L.; Morelli, K. H.; Stum, M. G.; Hill, D. P.; Gobet, C.; Pipis, M.; Reilly, M. M.; Jennings, M. J.; Horvath, R.; Bai, Y.; Shy, M. E.; Alvarez-Castelao, B.; Schuman, E. M.; Bogdanik, L. P.; Storkebaum, E.; Burgess, R. W.			The integrated stress response contributes to tRNA synthetase-associated peripheral neuropathy	SCIENCE			English	Article							PROTEIN TRANSLATION; IDENTIFICATION; PROTEOMES; MUTATION; NEURONS; MODELS	Dominant mutations in ubiquitously expressed transfer RNA (tRNA) synthetase genes cause axonal peripheral neuropathy, accounting for at least six forms of Charcot-Marie-Tooth (CMT) disease. Genetic evidence in mouse and Drosophila models suggests a gain-of-function mechanism. In this study, we used in vivo, cell type-specific transcriptional and translational profiling to show that mutant tRNA synthetases activate the integrated stress response (ISR) through the sensor kinase GCN2 (general control nonderepressible 2). The chronic activation of the ISR contributed to the pathophysiology, and genetic deletion or pharmacological inhibition of Gcn2 alleviated the peripheral neuropathy. The activation of GCN2 suggests that the aberrant activity of the mutant tRNA synthetases is still related to translation and that inhibiting GCN2 or the ISR may represent a therapeutic strategy in CMT.	[Spaulding, E. L.; Hines, T. J.; Bais, P.; Tadenev, A. L. D.; Schneider, R.; Jewett, D.; Pattavina, B.; Pratt, S. L.; Morelli, K. H.; Stum, M. G.; Hill, D. P.; Bogdanik, L. P.; Burgess, R. W.] Jackson Lab, Bar Harbor, ME 04609 USA; [Spaulding, E. L.; Morelli, K. H.; Burgess, R. W.] Univ Maine, Grad Sch Biomed Sci & Engn, Orono, ME 04469 USA; [Pratt, S. L.; Burgess, R. W.] Tufts Univ, Grad Sch Biomed Sci, Neurosci Program, Boston, MA 02111 USA; [Gobet, C.] Ecole Polytech Fed Lausanne EPFL, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Pipis, M.; Reilly, M. M.] UCL Queen Sq Inst Neurol, Dept Neuromuscular Dis, MRC Ctr Neuromuscular Dis, London, England; [Jennings, M. J.; Horvath, R.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Bai, Y.; Shy, M. E.] Univ Iowa, Carver Coll Med, Dept Neurol, Iowa City, IA 52242 USA; [Alvarez-Castelao, B.; Schuman, E. M.] Max Planck Inst Brain Res, Frankfurt, Germany; [Storkebaum, E.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Mol Neurobiol, Nijmegen, Netherlands; [Storkebaum, E.] Radboud Univ Nijmegen, Fac Sci, Nijmegen, Netherlands; [Spaulding, E. L.] Mt Desert Isl Biol Lab, Bar Harbor, ME 04609 USA; [Morelli, K. H.] Univ Calif San Diego, Cellular & Mol Med, La Jolla, CA 92093 USA; [Stum, M. G.] ClearH2O Inc, Portland, ME 04101 USA; [Alvarez-Castelao, B.] Univ Complutense Madrid, Vet Sch, Dept Biochem, Madrid, Spain	Jackson Laboratory; University of Maine System; University of Maine Orono; Tufts University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of London; University College London; University of Cambridge; University of Iowa; Max Planck Society; Radboud University Nijmegen; Radboud University Nijmegen; Mount Desert Island Biological Laboratory; University of California System; University of California San Diego; Complutense University of Madrid	Burgess, RW (corresponding author), Jackson Lab, Bar Harbor, ME 04609 USA.; Burgess, RW (corresponding author), Univ Maine, Grad Sch Biomed Sci & Engn, Orono, ME 04469 USA.; Burgess, RW (corresponding author), Tufts Univ, Grad Sch Biomed Sci, Neurosci Program, Boston, MA 02111 USA.	robert.burgess@jax.org	Alvarez-castelao, Beatriz/ABG-8826-2021; Storkebaum, Erik/B-5389-2017; Hines, Timothy/AAC-9190-2022	Storkebaum, Erik/0000-0002-9519-5642; Hines, Timothy/0000-0002-0594-7354; Pattavina, Blaine/0000-0002-9154-8519; Tadenev, Abigail/0000-0003-0801-8267; Burgess, Robert/0000-0002-9229-3407; Pratt, Samia/0000-0002-2555-5120	National Institutes of Health (NIH) [R37 NS054154, R01 NS113583, U54 OD020351]; Paul E. Kelly Foundation; NIH [U54 NS065712-08, F31 NS100328]; National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre; European Research Council (ERC) under the European Union [743216]; Muscular Dystrophy Association [MDA479773]; EU Joint Programme Neuro-degenerative Disease Research [JPND] [ZonMW 733051075, ZonMW 733051073]; ERC consolidator grant [ERC-2017-COG 770244]; Radala Foundation for ALS Research; Medical Research Council (UK) [MR/N025431/1, MR/V009346/1]; ERC [309548]; Newton Fund [MR/N027302/1]; Evelyn Trust [19/14]; Lily Foundation; MRC [MR/S005021/1]; NIHR Cambridge Biomedical Research Centre [BRC-1215-20014]; Wellcome Trust [109915/Z/15/Z]; Wellcome Trust Pathfinder Scheme [201064/Z/16/Z]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul E. Kelly Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre; European Research Council (ERC) under the European Union(European Research Council (ERC)); Muscular Dystrophy Association(Muscular Dystrophy Association); EU Joint Programme Neuro-degenerative Disease Research [JPND]; ERC consolidator grant(European Research Council (ERC)); Radala Foundation for ALS Research; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ERC(European Research Council (ERC)European Commission); Newton Fund; Evelyn Trust; Lily Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Pathfinder Scheme	R.W.B. was supported by the National Institutes of Health (NIH) (R37 NS054154, R01 NS113583, and U54 OD020351) and the Paul E. Kelly Foundation. E.L.S. was supported by NIH F31 NS100328. M.E.S. and M.M.R. were supported by NIH U54 NS065712-08. M.M.R. is also supported by the National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre. E.M.S. received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (no. 743216). E.S. was supported by the Muscular Dystrophy Association (MDA479773); the EU Joint Programme Neuro-degenerative Disease Research [JPND; ZonMW 733051075 (TransNeuro) and ZonMW 733051073 (LocalNMD)]; an ERC consolidator grant (ERC-2017-COG 770244); and the Radala Foundation for ALS Research. R.H. is a Wellcome Trust Investigator (109915/Z/15/Z) and is supported by the Medical Research Council (UK) (MR/N025431/1 and MR/V009346/1); the ERC (309548); the Wellcome Trust Pathfinder Scheme (201064/Z/16/Z); the Newton Fund (MR/N027302/1); the Evelyn Trust (19/14); the Lily Foundation; an MRC strategic award to establish an International Centre for Genomic Medicine in Neuromuscular Diseases (ICGNMD) (MR/S005021/1); and the NIHR Cambridge Biomedical Research Centre (BRC-1215-20014). The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care.	Achilli F, 2009, DIS MODEL MECH, V2, P359, DOI 10.1242/dmm.002527; Alvarez-Castelao B, 2017, NAT BIOTECHNOL, V35, P1196, DOI 10.1038/nbt.4016; Antonellis A, 2008, ANNU REV GENOM HUM G, V9, P87, DOI 10.1146/annurev.genom.9.081307.164204; Cox GA, 1998, NEURON, V21, P1327, DOI 10.1016/S0896-6273(00)80652-2; Dieterich DC, 2007, NAT PROTOC, V2, P532, DOI 10.1038/nprot.2007.52; FERRI GL, 1990, BRAIN RES, V515, P331, DOI 10.1016/0006-8993(90)90618-L; Inglis AJ, 2019, P NATL ACAD SCI USA, V116, P4946, DOI 10.1073/pnas.1813352116; Ishimura R, 2016, ELIFE, V5, DOI 10.7554/eLife.14295; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Le Pichon CE, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00021; Linda Hans, 2011, Front Neurol, V2, P30, DOI 10.3389/fneur.2011.00030; Misawa H, 2012, J NEUROSCI RES, V90, P732, DOI 10.1002/jnr.22813; Morelli KH, 2019, J CLIN INVEST, V129, P5568, DOI 10.1172/JCI130600; Motley WW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002399; Nakamura A, 2018, P NATL ACAD SCI USA, V115, pE7776, DOI 10.1073/pnas.1805523115; Niehues S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8520; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Seburn KL, 2006, NEURON, V51, P715, DOI 10.1016/j.neuron.2006.08.027; Spaulding EL, 2016, J NEUROSCI, V36, P3254, DOI 10.1523/JNEUROSCI.1762-15.2016; Starkey ML, 2009, J COMP NEUROL, V513, P51, DOI 10.1002/cne.21944; Stifani N, 2014, FRONT CELL NEUROSCI, V8, P1, DOI 10.3389/fncel.2014.00293; Storkebaum E, 2016, BIOESSAYS, V38, P818, DOI 10.1002/bies.201600052; Wei N, 2019, J BIOL CHEM, V294, P5321, DOI 10.1074/jbc.REV118.002955; ZHANG X, 1993, EUR J NEUROSCI, V5, P1510, DOI 10.1111/j.1460-9568.1993.tb00219.x; Zhou YQ, 2019, J CLIN INVEST, V129, P1756, DOI 10.1172/JCI124194; Zuko A, 2021, SCIENCE, V373, P1161	27	18	18	2	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2021	373	6559					1156	+		10.1126/science.abb3414	http://dx.doi.org/10.1126/science.abb3414			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UL8QT	34516839	Green Accepted			2022-12-28	WOS:000692910300051
J	Dolgin, E				Dolgin, Elie			THE TANGLED HISTORY OF MRNA VACCINES	NATURE			English	News Item							CYTOTOXIC T-LYMPHOCYTES; IN-VIVO; CELLS; TRANSLATION; INDUCTION; VITRO											Aldrich C, 2021, VACCINE, V39, P1310, DOI 10.1016/j.vaccine.2020.12.070; Boczkowski D, 1996, J EXP MED, V184, P465, DOI 10.1084/jem.184.2.465; CONRY RM, 1995, CANCER RES, V55, P1397; DIMITRIADIS GJ, 1978, NATURE, V274, P923, DOI 10.1038/274923a0; Geall AJ, 2012, P NATL ACAD SCI USA, V109, P14604, DOI 10.1073/pnas.1209367109; Hoerr I, 2000, EUR J IMMUNOL, V30, P1; Jeffs LB, 2005, PHARM RES-DORDR, V22, P362, DOI 10.1007/s11095-004-1873-z; JIRIKOWSKI GF, 1992, SCIENCE, V255, P996, DOI 10.1126/science.1546298; Kariko K, 1998, BBA-BIOMEMBRANES, V1369, P320, DOI 10.1016/S0005-2736(97)00238-1; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kariko K, 1999, GENE THER, V6, P1092, DOI 10.1038/sj.gt.3300930; Kremsner PG, 2021, WIEN KLIN WOCHENSCHR, V133, P931, DOI 10.1007/s00508-021-01922-y; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; Malone, 1989, FOCUS, V11, P61; MALONE RW, 1989, P NATL ACAD SCI USA, V86, P6077, DOI 10.1073/pnas.86.16.6077; MARTINON F, 1993, EUR J IMMUNOL, V23, P1719, DOI 10.1002/eji.1830230749; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; OSTRO MJ, 1978, NATURE, V274, P921, DOI 10.1038/274921a0; Probst J, 2007, GENE THER, V14, P1175, DOI 10.1038/sj.gt.3302964; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918	22	86	85	15	78	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 16	2021	597	7876					318	324		10.1038/d41586-021-02483-w	http://dx.doi.org/10.1038/d41586-021-02483-w			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UQ1MU	34522017				2022-12-28	WOS:000695836000015
J	Patel, PD; Patel, P; Liang, YY; Meiring, JE; Misiri, T; Mwakiseghile, F; Tracy, JK; Masesa, C; Msuku, H; Banda, D; Mbewe, M; Henrion, M; Adetunji, F; Simiyu, K; Rotrosen, E; Birkhold, M; Nampota, N; Nyirenda, OM; Kotloff, K; Gmeiner, M; Dube, Q; Kawalazira, G; Laurens, MB; Heyderman, RS; Gordon, MA; Neuzil, KM				Patel, Priyanka D.; Patel, Pratiksha; Liang, Yuanyuan; Meiring, James E.; Misiri, Theresa; Mwakiseghile, Felistas; Tracy, J. Kathleen; Masesa, Clemens; Msuku, Harrison; Banda, David; Mbewe, Maurice; Henrion, Marc; Adetunji, Fiyinfolu; Simiyu, Kenneth; Rotrosen, Elizabeth; Birkhold, Megan; Nampota, Nginache; Nyirenda, Osward M.; Kotloff, Karen; Gmeiner, Markus; Dube, Queen; Kawalazira, Gift; Laurens, Matthew B.; Heyderman, Robert S.; Gordon, Melita A.; Neuzil, Kathleen M.		TyVAC Malawi Team	Safety and Efficacy of a Typhoid Conjugate Vaccine in Malawian Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CAPSULAR POLYSACCHARIDE VACCINE; BLOOD-STREAM INFECTION; SALMONELLA-TYPHI; PHASE-III; BLANTYRE; TRIAL; FEVER; OUTBREAK	Typhoid Vaccine in Malawian Children The efficacy of a Vi polysaccharide typhoid conjugate vaccine (Vi-TCV) was assessed in 28,130 Malawian children who were 9 months to 12 years of age. The incidence of blood culture-confirmed typhoid fever was significantly lower among children who received Vi-TCV than among those who received a control vaccine. Background Typhoid fever caused by multidrug-resistant H58 Salmonella Typhi is an increasing public health threat in sub-Saharan Africa. Methods We conducted a phase 3, double-blind trial in Blantyre, Malawi, to assess the efficacy of Vi polysaccharide typhoid conjugate vaccine (Vi-TCV). We randomly assigned children who were between 9 months and 12 years of age, in a 1:1 ratio, to receive a single dose of Vi-TCV or meningococcal capsular group A conjugate (MenA) vaccine. The primary outcome was typhoid fever confirmed by blood culture. We report vaccine efficacy and safety outcomes after 18 to 24 months of follow-up. Results The intention-to-treat analysis included 28,130 children, of whom 14,069 were assigned to receive Vi-TCV and 14,061 were assigned to receive the MenA vaccine. Blood culture-confirmed typhoid fever occurred in 12 children in the Vi-TCV group (46.9 cases per 100,000 person-years) and in 62 children in the MenA group (243.2 cases per 100,000 person-years). Overall, the efficacy of Vi-TCV was 80.7% (95% confidence interval [CI], 64.2 to 89.6) in the intention-to-treat analysis and 83.7% (95% CI, 68.1 to 91.6) in the per-protocol analysis. In total, 130 serious adverse events occurred in the first 6 months after vaccination (52 in the Vi-TCV group and 78 in the MenA group), including 6 deaths (all in the MenA group). No serious adverse events were considered by the investigators to be related to vaccination. Conclusions Among Malawian children 9 months to 12 years of age, administration of Vi-TCV resulted in a lower incidence of blood culture-confirmed typhoid fever than the MenA vaccine. (Funded by the Bill and Melinda Gates Foundation; ClinicalTrials.gov number, .)	[Patel, Priyanka D.; Patel, Pratiksha; Meiring, James E.; Misiri, Theresa; Mwakiseghile, Felistas; Masesa, Clemens; Msuku, Harrison; Banda, David; Mbewe, Maurice; Henrion, Marc; Gmeiner, Markus; Gordon, Melita A.] Malawi Liverpool Wellcome Program, Blantyre, Malawi; [Nampota, Nginache; Nyirenda, Osward M.] Blantyre Malaria Project, Blantyre, Malawi; [Dube, Queen] Queen Elizabeth Cent Hosp, Dept Paediat, Blantyre, Malawi; [Kawalazira, Gift] Blantyre Dist Council, Dist Hlth Off, Blantyre, Malawi; [Gordon, Melita A.] Kamuzu Univ Hlth Sci, Blantyre, Malawi; [Liang, Yuanyuan; Tracy, J. Kathleen; Adetunji, Fiyinfolu; Simiyu, Kenneth; Rotrosen, Elizabeth; Birkhold, Megan; Kotloff, Karen; Laurens, Matthew B.; Neuzil, Kathleen M.] Univ Maryland, Sch Med, Ctr Vaccine Dev & Global Hlth, Baltimore, MD 21201 USA; [Meiring, James E.] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England; [Masesa, Clemens; Henrion, Marc; Gmeiner, Markus] Univ Liverpool, Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Gordon, Melita A.] Univ Liverpool, Inst Infect Vet & Ecol Sci, Liverpool, Merseyside, England; [Heyderman, Robert S.] UCL, Div Infect & Immun, London, England	University of Malawi; University System of Maryland; University of Maryland Baltimore; University of Oxford; Liverpool School of Tropical Medicine; University of Liverpool; University of Liverpool; University of London; University College London	Gordon, MA (corresponding author), POB 30096, Blantyre 3, Malawi.	magordon@liverpool.ac.uk	; Laurens, Matthew/E-7293-2013	Gmeiner, Markus/0000-0002-1450-2955; Laurens, Matthew/0000-0003-3874-581X; Patel, Pratiksha/0000-0001-6174-4669				[Anonymous], 2008, Wkly Epidemiol Rec, V83, P49; [Anonymous], 2020, EUROPEAN COMMITTEE A; Antillon M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005376; Bilcke J, 2019, LANCET INFECT DIS, V19, P728, DOI 10.1016/S1473-3099(18)30804-1; Breiman RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029119; Britto CD, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006779; Burki T, 2018, LANCET INFECT DIS, V18, P258, DOI 10.1016/S1473-3099(18)30087-2; Carey ME., 2021, CLIN INFECT DIS, V72, P120; Feasey NA, 2015, CLIN INFECT DIS, V61, pS363, DOI 10.1093/cid/civ691; Feasey NA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003748; Fraser A, 2007, VACCINE, V25, P7848, DOI 10.1016/j.vaccine.2007.08.027; Global Burden of Disease Collaborative Network, 2020, TYPH FEV LEV 4 CAUS; Kabwama SN, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-4002-0; Klemm EJ, 2018, MBIO, V9, DOI 10.1128/mBio.00105-18; Klugman KP, 1996, VACCINE, V14, P435, DOI 10.1016/0264-410X(95)00186-5; KLUGMAN KP, 1987, LANCET, V2, P1165; Levine MM, 2011, CLIN INFECT DIS, V52, P349, DOI 10.1093/cid/ciq109; Marchello CS, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.01974-19; Marks F, 2017, LANCET GLOB HEALTH, V5, pE310, DOI 10.1016/S2214-109X(17)30022-0; Meiring JE, 2019, CLIN INFECT DIS, V68, pS146, DOI 10.1093/cid/ciy1110; Meiring JE, 2019, CLIN INFECT DIS, V68, pS50, DOI 10.1093/cid/ciy1103; Meiring JE, 2018, EXPERT REV VACCINES, V17, P673, DOI 10.1080/14760584.2018.1496825; Meiring JE, 2017, VACCINE, V35, P5081, DOI 10.1016/j.vaccine.2017.08.001; Musicha P, 2017, LANCET INFECT DIS, V17, P1042, DOI 10.1016/S1473-3099(17)30394-8; Mutai WC, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1332-3; N'cho HS, 2019, MMWR-MORBID MORTAL W, V68, P44, DOI 10.15585/mmwr.mm6802a5; Olaru ID, 2019, LANCET INFECT DIS, V19, P930, DOI 10.1016/S1473-3099(19)30425-6; Olgemoeller F, 2020, CLIN INFECT DIS, V71, pS96, DOI 10.1093/cid/ciaa405; Qadri F, 2021, LANCET, V398, P675, DOI 10.1016/S0140-6736(21)01124-7; Shakya M, 2019, NEW ENGL J MED, V381, P2209, DOI 10.1056/NEJMoa1905047; Tack B, 2019, CLIN INFECT DIS, V68, pS130, DOI 10.1093/cid/ciy1116; Theiss-Nyland K, 2019, CLIN INFECT DIS, V68, pS67, DOI 10.1093/cid/ciy1106; Wong VK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004781; Wong VK, 2015, NAT GENET, V47, P632, DOI 10.1038/ng.3281	34	13	13	2	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2021	385	12					1104	1115		10.1056/NEJMoa2035916	http://dx.doi.org/10.1056/NEJMoa2035916			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ4IT	34525285	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000696029600012
J	Evans, M; Williams, W; Graves, J; Shim, R; Tishkoff, S				Evans, Michele; Williams, Winfred; Graves, Jospeph; Shim, Ruth; Tishkoff, Sarah			Race in Medicine - Genetic Variation, Social Categories, and Paths to Health Equity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material; Early Access									[Evans, Michele] NIA, Bethesda, MD 20892 USA; [Graves, Jospeph] North Carolina A&T State Univ, Biol Sci, Greensboro, NC USA; [Shim, Ruth] Univ Calif Davis, Cultural Psychiat, Davis, CA 95616 USA; [Shim, Ruth] Univ Calif Davis, Div & Inclus Educ, Davis, CA 95616 USA; [Shim, Ruth] Sch Med, Davis, CA USA; [Tishkoff, Sarah] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Tishkoff, Sarah] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Tishkoff, Sarah] Univ Penn, Ctr Global Genom & Hlth Equ, Philadelphia, PA 19104 USA; [Williams, Winfred] Massachusetts Gen Hosp, Div Nephrol, Boston, MA 02114 USA; [Williams, Winfred] Harvard Med Sch, Med, Boston, MA 02115 USA; [Williams, Winfred] MGH, Ctr Divers & Inclus, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of North Carolina; North Carolina A&T State University; University of California System; University of California Davis; University of California System; University of California Davis; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Evans, M (corresponding author), NIA, Bethesda, MD 20892 USA.			Shim, Ruth/0000-0002-4509-590X; Williams, Winfred/0000-0001-9984-7102				Bonham VL, 2009, GENET MED, V11, P279, DOI 10.1097/GIM.0b013e318195aaf4; Crews DC, 2020, J AM SOC NEPHROL, V31, P1659, DOI 10.1681/ASN.2020060809; Crews DC, 2010, AM J KIDNEY DIS, V55, P992, DOI 10.1053/j.ajkd.2009.12.032; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Hoffman KM, 2016, P NATL ACAD SCI USA, V113, P4296, DOI 10.1073/pnas.1516047113; Kraus MW, 2019, PERSPECT PSYCHOL SCI, V14, P899, DOI 10.1177/1745691619863049; McGinnis JM, 2002, HEALTH AFFAIR, V21, P78, DOI 10.1377/hlthaff.21.2.78; Muuoz A.P., 2015, COLOR WEALTH BOSTON; Sirugo G, 2019, CELL, V177, P26, DOI 10.1016/j.cell.2019.02.048	9	7	7	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.												10.1056/NEJMp2113749	http://dx.doi.org/10.1056/NEJMp2113749		SEP 2021	15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ4LJ	34528770	Bronze			2022-12-28	WOS:000696036500001
J	Marshall, M				Marshall, Martin			Media attacks on GPs threaten the doctor-patient relationship	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								Criticisms of GPs commitment and professionalism are undermining patients' trust and confidence in their doctors	[Marshall, Martin] Royal Coll Gen Practitioners, London, England		Marshall, M (corresponding author), Royal Coll Gen Practitioners, London, England.								0	4	4	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2021	374								n2236	10.1136/bmj.n2236	http://dx.doi.org/10.1136/bmj.n2236			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WP7CH	34521620	Green Submitted			2022-12-28	WOS:000713284400003
J	Munro, C				Munro, Clara			Covid-19: Boys are more at risk of myocarditis after vaccination than of hospital admission for covid	BMJ-BRITISH MEDICAL JOURNAL			English	News Item														Munro, Clara/0000-0002-9607-8587				Barda N, 2021, NEW ENGL J MED, V385, P1078, DOI 10.1056/NEJMoa2110475; Hoeg T.B., 2021, SARS COV 2 MRNA VACC, DOI 10.1101/2021.08.30.21262866; Wise J, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1635	3	7	7	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2021	374								n2251	10.1136/bmj.n2251	http://dx.doi.org/10.1136/bmj.n2251			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WP7CH	34521646	Bronze			2022-12-28	WOS:000713284400006
J	Kmietowicz, Z				Kmietowicz, Zosia			Sixty seconds on ... sex	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Tanne JH, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2230	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 13	2021	374								n2237	10.1136/bmj.n2237	http://dx.doi.org/10.1136/bmj.n2237			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UR8KQ	34518167				2022-12-28	WOS:000696991500003
J	Walsh, BS; Bloomfield, D; Kesselheim, AS				Walsh, Bryan S.; Bloomfield, Doni; Kesselheim, Aaron S.			A Court Decision on "Skinny Labeling" Another Challenge for Less Expensive Drugs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Walsh, Bryan S.; Bloomfield, Doni; Kesselheim, Aaron S.] Harvard Med Sch, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med,Program Regulat Therapeut & Law PORTAL, Boston, MA 02115 USA; [Walsh, Bryan S.; Bloomfield, Doni; Kesselheim, Aaron S.] Harvard Med Sch, Ctr Bioeth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	akesselheim@bwh.harvard.edu			Commonwealth Fund; Arnold Ventures	Commonwealth Fund; Arnold Ventures	The authors were supported by grants from Commonwealth Fund and Arnold Ventures to support this work.	Amin T, 2012, HEALTH AFFAIR, V31, P2286, DOI 10.1377/hlthaff.2012.0107; Bloomfield, 2020, SPEECH DRUGS PATENT, DOI [10.2139/ssrn.3744403, DOI 10.2139/SSRN.3744403]; Kesselheim AS, 2016, JAMA-J AM MED ASSOC, V316, P858, DOI 10.1001/jama.2016.11237; Lutter R., GENERIC COMPETITION; Sacks CA, 2021, JAMA INTERN MED, V181, P16, DOI 10.1001/jamainternmed.2020.3588	5	3	3	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 12	2021	326	14					1371	1372		10.1001/jama.2021.0006	http://dx.doi.org/10.1001/jama.2021.0006		SEP 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WH8VN	34515733				2022-12-28	WOS:000696615400001
J	Gyawali, B; Rome, BN; Kesselheim, AS				Gyawali, Bishal; Rome, Benjamin N.; Kesselheim, Aaron S.			Regulatory and clinical consequences of negative confirmatory trials of accelerated approval cancer drugs: retrospective obser-vational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								OBJECTIVES To investigate the regulatory handling of cancer drugs that were granted accelerated approval by the US Food and Drug Administration (FDA) but failed to improve the primary endpoint in post-approval trials and to evaluate the extent to which negative post-approval trials changed the recommendations in treatment guidelines. DESIGN Retrospective observational study. SETTING FDA and National Comprehensive Cancer Network (NCCN) reports. INCLUDED DRUGS Cancer drugs that received accelerated approval from the FDA and had negative post-approval trials. MAIN OUTCOME MEASURES Regulatory outcomes, including withdrawal, conversion to regular approval, and no action. RESULTS 18 indications for 10 cancer drugs that received accelerated approval but failed to improve the primary endpoint in post-approval trials were identified. Of these, 11 (61%) were voluntarily withdrawn by the manufacturer and one (bevacizumab for breast cancer) was revoked by the FDA. Of the 11 withdrawals, six occurred in 2021 alone. The remaining six (33%) indications remain on the label. The NCCN guidelines provide a high level of endorsement (category 1 endorsement for one and category 2A endorsement for seven) for accelerated approval drugs that have failed post-approval trials, sometimes even after the approval has been withdrawn or revoked. CONCLUSION Cancer drug indications that received accelerated approval often remained on formal FDA approved drug labelling and continued to be recommended in clinical guidelines several years after statutorily required post approval trials showed no improvement in the primary efficacy endpoint. Clinical guidelines should better align with the results of post-approval trials of cancer drugs that received accelerated approval.	[Gyawali, Bishal] Queens Univ, Dept Publ Hlth Sci, Dept Oncol, Kingston, ON, Canada; [Gyawali, Bishal] Queens Univ, Div Canc Care & Epidemiol, Kingston, ON, Canada; [Gyawali, Bishal; Rome, Benjamin N.; Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, 75 Francis St, Boston, MA 02115 USA; [Gyawali, Bishal; Rome, Benjamin N.; Kesselheim, Aaron S.] Harvard Med Sch, Boston, MA 02115 USA	Queens University - Canada; Queens University - Canada; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Gyawali, B (corresponding author), Queens Univ, Dept Publ Hlth Sci, Dept Oncol, Kingston, ON, Canada.; Gyawali, B (corresponding author), Queens Univ, Div Canc Care & Epidemiol, Kingston, ON, Canada.; Gyawali, B (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, 75 Francis St, Boston, MA 02115 USA.; Gyawali, B (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	gyawali.bishal@queensu.ca		Gyawali, Bishal/0000-0001-7444-8594	Arnold Ventures; Ontario Institute for Cancer Research - government of Ontario	Arnold Ventures; Ontario Institute for Cancer Research - government of Ontario	Arnold Ventures funded this study. The funder had no role in the conceptualisation, design, analysis, and reporting of the study or in the decision to publish the manuscript. BG receives salary support from the Ontario Institute for Cancer Research funded by the government of Ontario.	Beaver JA, 2021, NEW ENGL J MED, V384, DOI 10.1056/NEJMp2104846; Beaver JA, 2018, JAMA ONCOL, V4, P849, DOI 10.1001/jamaoncol.2017.5618; Carpenter D, 2011, NEW ENGL J MED, V365, DOI [10.1056/NEJMp1107201, 10.1056/nejmp1107201]; FDA-NIH Biomarker Working Group, 2016, BEST BIOM ENDP OTH T; Gellad WF, 2017, NEW ENGL J MED, V376, P2001, DOI 10.1056/NEJMp1700446; Gyawali B, 2021, JAMA INTERN MED, V181, P1275, DOI 10.1001/jamainternmed.2021.4604; Gyawali B, 2020, ECLINICALMEDICINE, V21, DOI 10.1016/j.eclinm.2020.100332; Gyawali B, 2020, J NATL COMPR CANC NE, V18, P36, DOI 10.6004/jnccn.2019.7345; Gyawali B, 2019, JAMA INTERN MED, V179, P906, DOI 10.1001/jamainternmed.2019.0462; Gyawali B, 2018, NAT REV CLIN ONCOL, V15, P596, DOI 10.1038/s41571-018-0066-3; Herder M, 2019, MILBANK Q, V97, P820, DOI 10.1111/1468-0009.12413; Hwang TJ, 2019, INT J CANCER, V144, P1746, DOI 10.1002/ijc.31957; Larkin J, 2018, J CLIN ONCOL, V36, P383, DOI 10.1200/JCO.2016.71.8023; Prasad V, 2014, JAMA INTERN MED, V174, P1887, DOI 10.1001/jamainternmed.2014.5756; US Food and Drug Administration, 2021, FDA BRIEF FDA ONC DR; Wagner J, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k668	16	20	20	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2021	374								n1959	10.1136/bmj.n1959	http://dx.doi.org/10.1136/bmj.n1959			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ3VV	34497044	Green Published, hybrid			2022-12-28	WOS:000702137100008
J	Kamber, RA; Nishiga, Y; Morton, B; Banuelos, AM; Barkal, AA; Vences-Catalan, F; Gu, MX; Fernandez, D; Seoane, JA; Yao, D; Liu, K; Lin, SJ; Spees, K; Curtis, C; Jerby-Arnon, L; Weissman, IL; Sage, J; Bassik, MC				Kamber, Roarke A.; Nishiga, Yoko; Morton, Bhek; Banuelos, Allison M.; Barkal, Amira A.; Vences-Catalan, Felipe; Gu, Mingxin; Fernandez, Daniel; Seoane, Jose A.; Yao, David; Liu, Katherine; Lin, Sijie; Spees, Kaitlyn; Curtis, Christina; Jerby-Arnon, Livnat; Weissman, Irving L.; Sage, Julien; Bassik, Michael C.			Inter-cellular CRISPR screens reveal regulators of cancer cell phagocytosis	NATURE			English	Article							PROTEIN-COUPLED-RECEPTOR; MONOCLONAL-ANTIBODIES; MACROPHAGES; TRANSMEMBRANE; IMMUNOTHERAPY; MECHANISMS; RESISTANCE	Monoclonal antibody therapies targeting tumour antigens drive cancer cell elimination in large part by triggering macrophage phagocytosis of cancer cells1-7. However, cancer cells evade phagocytosis using mechanisms that are incompletely understood. Here we develop a platform for unbiased identification of factors that impede antibody-dependent cellular phagocytosis (ADCP) using complementary genome-wide CRISPR knockout and overexpression screens in both cancer cells and macrophages. In cancer cells, beyond known factors such as CD47, we identify many regulators of susceptibility to ADCP, including the poorly characterized enzyme adipocyte plasma membrane-associated protein (APMAP). We find that loss of APMAP synergizes with tumour antigen-targeting monoclonal antibodies and/or CD47-blocking monoclonal antibodies to drive markedly increased phagocytosis across a wide range of cancer cell types, including those that are otherwise resistant to ADCP. Additionally, we show that APMAP loss synergizes with several different tumour-targeting monoclonal antibodies to inhibit tumour growth in mice. Using genome-wide counterscreens in macrophages, we find that the G-protein-coupled receptor GPR84 mediates enhanced phagocytosis of APMAP-deficient cancer cells. This work reveals a cancer-intrinsic regulator of susceptibility to antibody-driven phagocytosis and, more broadly, expands our knowledge of the mechanisms governing cancer resistance to macrophage phagocytosis.	[Kamber, Roarke A.; Nishiga, Yoko; Morton, Bhek; Gu, Mingxin; Yao, David; Liu, Katherine; Lin, Sijie; Spees, Kaitlyn; Curtis, Christina; Jerby-Arnon, Livnat; Sage, Julien; Bassik, Michael C.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Nishiga, Yoko; Sage, Julien] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Nishiga, Yoko] Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA; [Banuelos, Allison M.; Barkal, Amira A.; Weissman, Irving L.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA; [Banuelos, Allison M.; Barkal, Amira A.; Weissman, Irving L.] Stanford Univ, Sch Med, Ludwig Ctr Canc Stem Cell Res & Med, Stanford, CA 94305 USA; [Banuelos, Allison M.; Barkal, Amira A.; Seoane, Jose A.; Curtis, Christina; Weissman, Irving L.; Sage, Julien; Bassik, Michael C.] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA; [Barkal, Amira A.] Stanford Univ, Stanford Med Scientist Training Program, Stanford, CA 94305 USA; [Vences-Catalan, Felipe] Stanford Univ, Sch Med, Dept Med, Div Oncol, Stanford, CA 94305 USA; [Fernandez, Daniel; Sage, Julien; Bassik, Michael C.] Stanford Univ, Program Chem Engn & Med Human Hearth ChEM H, Stanford, CA 94305 USA; [Fernandez, Daniel] Stanford Univ, Stanford ChEM H Macromol Struct Knowledge Ctr, Stanford, CA 94305 USA; [Seoane, Jose A.; Curtis, Christina] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Curtis, Christina] Stanford Univ, Program Canc Biol, Sch Med, Stanford, CA 94305 USA; [Jerby-Arnon, Livnat] Chan Zuckerberg Biohub, San Francisco, CA USA; [Weissman, Irving L.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford Cancer Institute; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Bassik, MC (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.; Bassik, MC (corresponding author), Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA.; Bassik, MC (corresponding author), Stanford Univ, Program Chem Engn & Med Human Hearth ChEM H, Stanford, CA 94305 USA.	bassik@stanford.edu	Liu, Katherine/GQA-3751-2022; Fernandez Fleischhauer, Daniel/F-5017-2013	Fernandez Fleischhauer, Daniel/0000-0002-6221-152X; Liu, Katherine/0000-0002-9616-9403	NIH Director's New Innovator award [1DP2HD084069-01]; Ludwig Institute for Cancer Research; NIH [CA213273, CA231997, R35CA220434-05, 1R01AI143889-01A1]; JSPS (JSPS); Stanford School of Medicine Dean's Postdoctoral Fellowship; Jane Coffin Childs Postdoctoral Fellowship; BWF	NIH Director's New Innovator award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JSPS (JSPS); Stanford School of Medicine Dean's Postdoctoral Fellowship; Jane Coffin Childs Postdoctoral Fellowship; BWF	We thank R. Levy, S. Levy, C. Bertozzi, J. Long, S. Dixon, P. Jackson, M. Smith, T. Wyss-Coray, A. Drainas, A. Derry, B. Smith, C. Delaveris, J. Shon, S. Wisnovsky, J. Donnelly, E. Zhang, T. Raveh, D. Vorselen, J. Carozza, M. Ellenberger, J. Chan, L. Jiang, R. Jian, M. Snyder, K. McNamara, R. Chen and members of the Bassik laboratory, including G. Hess, R. Levin, K. Han, K. Tsui, M. Haney, D. Morgens, J. Tycko, M. Dubreuil, K. Aloul, B. Ego and A. Li, for helpful discussions and experimental advice; and A. Sil for providing the J774 Cas9 line. Cell sorting for this project was done on instruments in the Stanford Shared FACS Facility, including an instrument purchased by the Parker Institute for Cancer Immunotherapy. This research was supported by an NIH Director's New Innovator award (1DP2HD084069-01) to M.C.B., by the Ludwig Institute for Cancer Research (J.S. and I.W.), the NIH (grants CA213273 and CA231997 to J.S., R35CA220434-05 and 1R01AI143889-01A1 to I.W.), the JSPS (JSPS overseas research fellowship to Y.N.), a Stanford School of Medicine Dean's Postdoctoral Fellowship to R.A.K. and a Jane Coffin Childs Postdoctoral Fellowship to R.A.K. L.J.A. is a Chan Zuckerberg Biohub Investigator and holds a Career Award at the Scientific Interface from BWF.	Ajona D, 2018, AM J RESP CRIT CARE, V197, P1164, DOI 10.1164/rccm.201703-0660OC; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Barkal AA, 2018, NAT IMMUNOL, V19, P76, DOI 10.1038/s41590-017-0004-z; Ben-David M, 2012, J MOL BIOL, V418, P181, DOI 10.1016/j.jmb.2012.02.042; BRODSKY FM, 1988, PHARMACEUT RES, V5, P1, DOI 10.1023/A:1015860525341; Chao MP, 2010, CELL, V142, P699, DOI 10.1016/j.cell.2010.07.044; Clynes R, 1998, P NATL ACAD SCI USA, V95, P652, DOI 10.1073/pnas.95.2.652; Cunha LD, 2018, CELL, V175, P429, DOI 10.1016/j.cell.2018.08.061; Delaveris CS, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2012408118; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Gao SL, 2020, J CELL MOL MED, V24, P8789, DOI 10.1111/jcmm.15515; Gerber H, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0660-3; Glennie MJ, 2007, MOL IMMUNOL, V44, P3823, DOI 10.1016/j.molimm.2007.06.151; Gont A, 2016, EUR J CANCER, V61, pS171, DOI 10.1016/S0959-8049(16)61607-6; Haney MS, 2018, NAT GENET, V50, P1716, DOI 10.1038/s41588-018-0254-1; Hicks MA, 2011, PROTEINS, V79, P3082, DOI 10.1002/prot.23135; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.19760; Ilhan A, 2008, BIOCHEM J, V414, P485, DOI 10.1042/BJ20080503; Itoh Y, 2008, GLYCOBIOLOGY, V18, P74, DOI 10.1093/glycob/cwm118; Jeng EE, 2019, CELL HOST MICROBE, V26, P551, DOI 10.1016/j.chom.2019.08.017; Jerby-Arnon L, 2021, NAT MED, V27, P289, DOI 10.1038/s41591-020-01212-6; Jerby-Arnon L, 2018, CELL, V175, P984, DOI 10.1016/j.cell.2018.09.006; Jiang SY, 2019, CANCER RES, V79, P3063, DOI 10.1158/0008-5472.CAN-18-3295; Khersonsky O, 2005, BIOCHEMISTRY-US, V44, P6371, DOI 10.1021/bi047440d; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lawson KA, 2020, NATURE, V586, P120, DOI 10.1038/s41586-020-2746-2; Liu NA, 2018, NATURE, V553, P228, DOI 10.1038/nature25179; Logtenberg MEW, 2019, NAT MED, V25, P612, DOI 10.1038/s41591-019-0356-z; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Macauley MS, 2014, NAT REV IMMUNOL, V14, P653, DOI 10.1038/nri3737; Maleki Leili Aghebati, 2013, Human Antibodies, V22, P9, DOI 10.3233/HAB-130266; Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270; Morgens DW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15178; Morgens DW, 2016, NAT BIOTECHNOL, V34, P634, DOI 10.1038/nbt.3567; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Neftel C, 2019, CELL, V178, P835, DOI 10.1016/j.cell.2019.06.024; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; O'Prey J, 2008, J VIROL, V82, P5933, DOI 10.1128/JVI.02273-07; Pathria P, 2019, TRENDS IMMUNOL, V40, P310, DOI 10.1016/j.it.2019.02.003; Purcell JW, 2018, CANCER RES, V78, P4059, DOI 10.1158/0008-5472.CAN-18-0327; Recio C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01419; Reimand J, 2016, NUCLEIC ACIDS RES, V44, pW83, DOI 10.1093/nar/gkw199; Ruffell B, 2015, CANCER CELL, V27, P462, DOI 10.1016/j.ccell.2015.02.015; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; SCHUTZE MP, 1994, EMBO J, V13, P1696, DOI 10.1002/j.1460-2075.1994.tb06434.x; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Sliwkowski MX, 2013, SCIENCE, V341, P1192, DOI 10.1126/science.1241145; Snyder KA, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0562-7; Sockolosky JT, 2016, P NATL ACAD SCI USA, V113, pE2646, DOI 10.1073/pnas.1604268113; Su SC, 2018, CELL, V175, P442, DOI 10.1016/j.cell.2018.09.007; Tanaka Y, 2007, J BIOL CHEM, V282, P5770, DOI 10.1074/jbc.M607340200; Tarbe NG, 2005, INT J CANCER, V117, P913, DOI 10.1002/ijc.21275; Taylor-Papadimitriou J, 2002, J MAMMARY GLAND BIOL, V7, P209, DOI 10.1023/A:1020360121451; Tsao LC, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131882; Wang JH, 2006, J BIOL CHEM, V281, P34457, DOI 10.1074/jbc.M608019200; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Weiskopf K, 2015, MABS-AUSTIN, V7, P303, DOI 10.1080/19420862.2015.1011450	63	28	28	12	140	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2021	597	7877					549	+		10.1038/s41586-021-03879-4	http://dx.doi.org/10.1038/s41586-021-03879-4		SEP 2021	32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UW6NQ	34497417	Green Accepted			2022-12-28	WOS:000695548800003
J	Malvania, N; Zhang, YC; Le, Y; Dubail, J; Rigol, M; Weiss, DS				Malvania, Neel; Zhang, Yicheng; Le, Yuan; Dubail, Jerome; Rigol, Marcos; Weiss, David S.			Generalized hydrodynamics in strongly interacting 1D Bose gases	SCIENCE			English	Article							SPIN	The dynamics of strongly interacting many-body quantum systems are notoriously complex and difficult to simulate. A recently proposed theory called generalized hydrodynamics (GHD) promises to efficiently accomplish such simulations for nearly integrable systems. We test GHD with bundles of ultracold one-dimensional (1D) Bose gases by performing large trap quenches in both the strong and intermediate coupling regimes. We find that theory and experiment agree well over dozens of trap oscillations, for average dimensionless coupling strengths that range from 0.3 to 9.3. Our results show that GHD can accurately describe the quantum dynamics of a 1D nearly integrable experimental system even when particle numbers are low and density changes are large and fast.	[Malvania, Neel; Zhang, Yicheng; Le, Yuan; Rigol, Marcos; Weiss, David S.] Penn State Univ, Dept Phys, 104 Davey Lab, University Pk, PA 16802 USA; [Dubail, Jerome] Univ Lorraine, CNRS, LPCT, F-54000 Nancy, France	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Weiss, DS (corresponding author), Penn State Univ, Dept Phys, 104 Davey Lab, University Pk, PA 16802 USA.	dsweiss@phys.psu.edu	Rigol, Marcos/B-3505-2008; Weiss, David S/B-7886-2010	Rigol, Marcos/0000-0002-5806-5873; Malvania, Neel/0000-0003-4220-6579; Le, Yuan/0000-0002-0261-5135; Zhang, Yicheng/0000-0002-4480-4508	NSF [PHY-2012039, PHY-2012145]; US Army Research Office [W911NF-16-0031-P00005]	NSF(National Science Foundation (NSF)); US Army Research Office	Supported by NSF grants PHY-2012039 (D.S.W., N.M., and Y.L.) and PHY-2012145 (Y.Z. and M.R.), and by US Army Research Office grant W911NF-16-0031-P00005 (D.S.W., N.M., and Y.L.). The computations were carried out at the Institute for Computational and Data Sciences at Penn State.	Bertini B, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.207201; Bethe H, 1931, Z PHYS, V71, P205, DOI 10.1007/BF01341708; Boll M, 2016, SCIENCE, V353, P1257, DOI 10.1126/science.aag1635; Bouchoule I, 2020, SCIPOST PHYS, V9, DOI 10.21468/SciPostPhys.9.4.044; Castro-Alvaredo OA, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.041065; Caux JS, 2019, SCIPOST PHYS, V6, DOI 10.21468/SciPostPhys.6.6.070; Caux JS, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.257203; Caux JS, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.175301; Cazalilla MA, 2011, REV MOD PHYS, V83, P1405, DOI 10.1103/RevModPhys.83.1405; Doyon B, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.195301; Dubail J., 2021, ZENODO; Friedman AJ, 2020, PHYS REV B, V101, DOI 10.1103/PhysRevB.101.180302; Fukuhara T, 2013, NATURE, V502, P76, DOI 10.1038/nature12541; Guan XW, 2013, REV MOD PHYS, V85, P1633, DOI 10.1103/RevModPhys.85.1633; Jepsen PN, 2020, NATURE, V588, P403, DOI 10.1038/s41586-020-3033-y; Kao W, 2021, SCIENCE, V371, P296, DOI 10.1126/science.abb4928; Kinoshita T, 2006, NATURE, V440, P900, DOI 10.1038/nature04693; Kinoshita T, 2004, SCIENCE, V305, P1125, DOI 10.1126/science.1100700; LIEB EH, 1963, PHYS REV, V130, P1605, DOI 10.1103/PhysRev.130.1605; Pagano G, 2014, NAT PHYS, V10, P198, DOI [10.1038/nphys2878, 10.1038/NPHYS2878]; Paredes B, 2004, NATURE, V429, P277, DOI 10.1038/nature02530; Peotta S, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.013621; Rigol, 2021, REPLICATION DATA GEN, DOI [10.7910/dvn/xyxmyb, DOI 10.7910/DVN/XYXMYB]; Rigol M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.240403; Rigol M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.050405; Riou JF, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.033401; Schemmer M, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.090601; Tang YJ, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.021030; Wilson JM, 2020, SCIENCE, V367, P1461, DOI 10.1126/science.aaz0242	33	33	33	2	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2021	373	6559					1129	1132		10.1126/science.abf0147	http://dx.doi.org/10.1126/science.abf0147			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UL8QT	34516835	Green Submitted			2022-12-28	WOS:000692910300045
J	Susila, H; Juric, S; Liu, L; Gawarecka, K; Chung, KS; Jin, S; Kim, SJ; Nasim, Z; Youn, G; Suh, MC; Yu, H; Ahn, JH				Susila, Hendry; Juric, Snjezana; Liu, Lu; Gawarecka, Katarzyna; Chung, Kyung Sook; Jin, Suhyun; Kim, Soo-Jin; Nasim, Zeeshan; Youn, Geummin; Suh, Mi Chung; Yu, Hao; Ahn, Ji Hoon			Florigen sequestration in cellular membranes modulates temperature-responsive flowering	SCIENCE			English	Article							PROTEIN; FT; LOCUS; TRAFFICKING; GENES	Plants respond to temperature changes bymodulating florigen activity to optimize the timing of flowering. We show that the Arabidopsis thaliana mobile florigen FLOWERING LOCUS T (FT) interacts with the negatively charged phospholipid phosphatidylglycerol (PG) at cellular membranes and binds the lipid bilayer. Perturbing PG biosynthesis in phloem companion cells leads to temperature-insensitive early flowering. Low temperatures facilitate FT sequestration in the cellular membrane of the companion cell, thus reducing soluble FT levels and delaying flowering. A mutant in PHOSPHATIDYLGLYCEROLPHOSPHATE SYNTHASE 1 accumulates more soluble FT at lower temperatures and exhibits reduced temperature sensitivity. Thus, cellular membranes sequester FT through their ability to bind the phospholipid PG, and this sequestration modulates the plant's response to temperature changes.	[Susila, Hendry; Juric, Snjezana; Gawarecka, Katarzyna; Chung, Kyung Sook; Jin, Suhyun; Kim, Soo-Jin; Nasim, Zeeshan; Youn, Geummin; Ahn, Ji Hoon] Korea Univ, Dept Life Sci, Seoul 02841, South Korea; [Juric, Snjezana] Ruder Bokovic Inst, Bilenicka Cesta 54, Zagreb 10000, Croatia; [Liu, Lu; Yu, Hao] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Liu, Lu; Yu, Hao] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117543, Singapore; [Liu, Lu] Shanghai Jiao Tong Univ, Sch Agr & Biol, Joint Ctr Single Cell Biol, Shanghai 200240, Peoples R China; [Suh, Mi Chung] Sogang Univ, Dept Life Sci, Seoul 04107, South Korea	Korea University; Rudjer Boskovic Institute; National University of Singapore; National University of Singapore; Shanghai Jiao Tong University; Sogang University	Ahn, JH (corresponding author), Korea Univ, Dept Life Sci, Seoul 02841, South Korea.	jahn@korea.ac.kr	Susila, Hendry/AAC-7421-2019; Juric, Snjezana/AFL-8446-2022; Ahn, Ji Hoon/A-4141-2011; Juric, Snjezana/AAG-8525-2022	Susila, Hendry/0000-0002-4621-064X; Ahn, Ji Hoon/0000-0003-0347-3922; Suh, Mi Chung/0000-0003-2860-4159; Liu, Lu/0000-0003-4353-1795; , Soo-Jin/0000-0003-3503-6129; Juric, Snjezana/0000-0002-0275-5656	National Research Foundation (NRF) of Korea - Korean government [NRF-2017R1A2B3009624]; Samsung Science and Technology Foundation [SSTF-BA1602-12]; Singapore National Research Foundation Investigatorship Programme [NRFNRFI2016-02]	National Research Foundation (NRF) of Korea - Korean government; Samsung Science and Technology Foundation(Samsung); Singapore National Research Foundation Investigatorship Programme(National Research Foundation, Singapore)	This work was supported by a National Research Foundation (NRF) of Korea grant funded by the Korean government (NRF-2017R1A2B3009624 to J.H.A.) and Samsung Science and Technology Foundation (SSTF-BA1602-12 to J.H.A). This work was also supported by the Singapore National Research Foundation Investigatorship Programme (NRFNRFI2016-02 to H.Y).	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Ahn JH, 2006, EMBO J, V25, P605, DOI 10.1038/sj.emboj.7600950; Armbruster U, 2013, PLANT CELL, V25, P2661, DOI 10.1105/tpc.113.113118; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Ho WWH, 2014, PLANT CELL, V26, P552, DOI 10.1105/tpc.113.115220; Jin S, 2021, SEMIN CELL DEV BIOL, V109, P20, DOI 10.1016/j.semcdb.2020.05.007; Kim HU, 2010, PLANT PHYSIOL, V153, P1135, DOI 10.1104/pp.110.157982; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Lee C, 2019, PLANT J, V99, P452, DOI 10.1111/tpj.14335; Legris M, 2017, PLANT J, V90, P683, DOI 10.1111/tpj.13467; Li Q, 2015, PLANT CELL, V27, P86, DOI 10.1105/tpc.114.134338; Lin YC, 2016, PLANT J, V88, P1022, DOI 10.1111/tpj.13311; Liu L, 2019, PLANT CELL, V31, P2475, DOI 10.1105/tpc.18.00960; Liu L, 2020, J INTEGR PLANT BIOL, V62, P1385, DOI 10.1111/jipb.13000; Liu L, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001313; Moreau P, 1998, PROG LIPID RES, V37, P371, DOI 10.1016/S0163-7827(98)00016-2; Nakamura Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4553; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Shen JB, 2013, MOL PLANT, V6, P1419, DOI 10.1093/mp/sst079; Sohn EJ, 2007, P NATL ACAD SCI USA, V104, P18801, DOI 10.1073/pnas.0708236104; Susila H, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103196; Taoka K, 2011, NATURE, V476, P332, DOI 10.1038/nature10272; Vallee BS, 2001, EUR J BIOCHEM, V268, P5831, DOI 10.1046/j.0014-2956.2001.02528.x; Xu CC, 2002, PLANT PHYSIOL, V129, P594, DOI 10.1104/pp.002725	25	18	21	20	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2021	373	6559					1137	1141		10.1126/science.abh4054	http://dx.doi.org/10.1126/science.abh4054			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UL8QT	34516842				2022-12-28	WOS:000692910300047
J	Zuko, A; Mallik, M; Thompson, R; Spaulding, EL; Wienand, AR; Been, M; Tadenev, ALD; van Bakel, N; Sijlmans, C; Santos, LA; Bussmann, J; Catinozzi, M; Das, S; Kulshrestha, D; Burgess, RW; Ignatova, Z; Storkebaum, E				Zuko, Amila; Mallik, Moushami; Thompson, Robin; Spaulding, Emily L.; Wienand, Anne R.; Been, Marije; Tadenev, Abigail L. D.; van Bakel, Nick; Sijlmans, Celine; Santos, Leonardo A.; Bussmann, Julia; Catinozzi, Marica; Das, Sarada; Kulshrestha, Divita; Burgess, Robert W.; Ignatova, Zoya; Storkebaum, Erik			tRNA overexpression rescues peripheral neuropathy caused by mutations in tRNA synthetase	SCIENCE			English	Article							PROTEIN TRANSLATION	Heterozygous mutations in six transfer RNA (tRNA) synthetase genes cause Charcot-Marie-Tooth (CMT) peripheral neuropathy. CMT mutant tRNA synthetases inhibit protein synthesis by an unknown mechanism. We found that CMT mutant gly(cyl)-tRNA synthetases bound tRNA(Gly) but failed to release it, resulting in tRNAGly sequestration. This sequestration potentially depleted the cellular tRNA(Gly) pool, leading to insufficient glycyl-tRNA(Gly) supply to the ribosome. Accordingly, we found ribosome stalling at glycine codons and activation of the integrated stress response (ISR) in affected motor neurons. Moreover, transgenic overexpression of tRNA(Gly) rescued protein synthesis, peripheral neuropathy, and ISR activation in Drosophila and mouse CMT disease type 2D (CMT2D) models. Conversely, inactivation of the ribosome rescue factor GTPBP2 exacerbated peripheral neuropathy. Our findings suggest a molecular mechanism for CMT2D, and elevating tRNA(Gly) levels may thus have therapeutic potential.	[Zuko, Amila; Mallik, Moushami; Wienand, Anne R.; Been, Marije; van Bakel, Nick; Sijlmans, Celine; Catinozzi, Marica; Kulshrestha, Divita; Storkebaum, Erik] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Mol Neurobiol, Nijmegen, Netherlands; [Zuko, Amila; Mallik, Moushami; Wienand, Anne R.; Been, Marije; van Bakel, Nick; Sijlmans, Celine; Catinozzi, Marica; Kulshrestha, Divita; Storkebaum, Erik] Radboud Univ Nijmegen, Fac Sci, Nijmegen, Netherlands; [Mallik, Moushami; Bussmann, Julia; Catinozzi, Marica; Kulshrestha, Divita; Storkebaum, Erik] Max Planck Inst Mol Biomed, Mol Neurogenet Lab, Munster, Germany; [Thompson, Robin; Santos, Leonardo A.; Das, Sarada; Ignatova, Zoya] Univ Hamburg, Dept Chem, Biochem & Mol Biol, Hamburg, Germany; [Spaulding, Emily L.; Tadenev, Abigail L. D.; Burgess, Robert W.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Spaulding, Emily L.; Burgess, Robert W.] Univ Maine, Grad Sch Biomed Sci & Engn, Orono, ME USA; [Spaulding, Emily L.] Mt Desert Isl Biol Lab, Bar Harbor, ME USA	Radboud University Nijmegen; Radboud University Nijmegen; Max Planck Society; University of Hamburg; Jackson Laboratory; University of Maine System; University of Maine Orono; Mount Desert Island Biological Laboratory	Storkebaum, E (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Mol Neurobiol, Nijmegen, Netherlands.; Storkebaum, E (corresponding author), Radboud Univ Nijmegen, Fac Sci, Nijmegen, Netherlands.; Storkebaum, E (corresponding author), Max Planck Inst Mol Biomed, Mol Neurogenet Lab, Munster, Germany.	erik.storkebaum@donders.ru.nl	Storkebaum, Erik/B-5389-2017	Storkebaum, Erik/0000-0002-9519-5642; Catinozzi, Marica/0000-0002-9211-9951; Tadenev, Abigail/0000-0003-0801-8267; Santos, Leonardo/0000-0001-5650-8098; van Bakel, Nick/0000-0002-3902-9914; Ignatova, Zoya/0000-0002-9478-8825; Wienand, Anne R./0000-0001-6711-4713; Been, Marije/0000-0003-3856-4605; Thompson, Robin J/0000-0003-4749-7707; Burgess, Robert/0000-0002-9229-3407	Max Planck Society; Donders Center for Neuroscience; Muscular Dystrophy Association [MDA479773]; EU Joint Programme-Neurodegenerative Disease Research [JPND] [ZonMW 733051075, ZonMW 733051073]; Radala Foundation; ERC [ERC-2017-COG 770244]; Deutsche Forschungsgemeinschaft (DFG) [IG73/14-2]; NIH [R01 NS054154, U54 OD020351]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Donders Center for Neuroscience; Muscular Dystrophy Association(Muscular Dystrophy Association); EU Joint Programme-Neurodegenerative Disease Research [JPND]; Radala Foundation; ERC(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Max Planck Society, the Donders Center for Neuroscience, the Muscular Dystrophy Association (MDA479773), the EU Joint Programme-Neurodegenerative Disease Research [JPND; ZonMW 733051075 (TransNeuro) and ZonMW 733051073 (LocalNMD)], the Radala Foundation, and an ERC consolidator grant (ERC-2017-COG 770244) to E.S., Deutsche Forschungsgemeinschaft (DFG, IG73/14-2) to Z.I., and NIH grants to R.W.B. (R01 NS054154 and U54 OD020351).	Achilli F, 2009, DIS MODEL MECH, V2, P359, DOI 10.1242/dmm.002527; Antonellis A, 2006, J NEUROSCI, V26, P10397, DOI 10.1523/JNEUROSCI.1671-06.2006; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; Erdmann I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8521; Froelich CA, 2011, BIOCHEMISTRY-US, V50, P7132, DOI 10.1021/bi200989h; Graille M, 2012, NAT REV MOL CELL BIO, V13, P727, DOI 10.1038/nrm3457; Harding HP, 2019, ELIFE, V8, DOI 10.7554/eLife.50149; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Inglis AJ, 2019, P NATL ACAD SCI USA, V116, P4946, DOI 10.1073/pnas.1813352116; Ishimura R, 2014, SCIENCE, V345, P455, DOI 10.1126/science.1249749; Joazeiro CAP, 2017, ANNU REV CELL DEV BI, V33, P343, DOI 10.1146/annurev-cellbio-111315-125249; Kuo ME, 2020, TRENDS GENET, V36, P105, DOI 10.1016/j.tig.2019.11.007; Morelli KH, 2019, J CLIN INVEST, V129, P5568, DOI 10.1172/JCI130600; Motley WW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002399; Nangle LA, 2007, P NATL ACAD SCI USA, V104, P11239, DOI 10.1073/pnas.0705055104; Niehues S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8520; SCHIMMEL P, 1987, ANNU REV BIOCHEM, V56, P125, DOI 10.1146/annurev.bi.56.070187.001013; Schuller AP, 2018, NAT REV MOL CELL BIO, V19, P526, DOI 10.1038/s41580-018-0011-4; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spaulding E. L, 2021, SCIENCE, V373, P1156; Storkebaum E, 2016, BIOESSAYS, V38, P818, DOI 10.1002/bies.201600052; Storkebaum E, 2009, P NATL ACAD SCI USA, V106, P11782, DOI 10.1073/pnas.0905339106; Wei N, 2019, J BIOL CHEM, V294, P5321, DOI 10.1074/jbc.REV118.002955; Wu CCC, 2020, CELL, V182, P404, DOI 10.1016/j.cell.2020.06.006	24	16	16	3	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2021	373	6559					1161	1165		10.1126/science.abb3356	http://dx.doi.org/10.1126/science.abb3356			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UL8QT	34516840	Green Accepted			2022-12-28	WOS:000692910300052
J	Wang, YX; Blau, HM				Wang, Yu Xin; Blau, Helen M.			Reversing aging for heart repair	SCIENCE			English	Editorial Material							CELLS; AMELIORATION		[Wang, Yu Xin; Blau, Helen M.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA	Stanford University	Blau, HM (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA.	hblau@stanford.edu		Wang, Yu Xin/0000-0001-8440-9388				Ahuja P, 2010, J CLIN INVEST, V120, P1494, DOI 10.1172/JCI38331; Bassat E, 2017, NATURE, V547, P179, DOI 10.1038/nature22978; Blau HM, 2011, JAMA-J AM MED ASSOC, V305, P87, DOI 10.1001/jama.2010.1938; Brady JJ, 2013, NAT CELL BIOL, V15, P1244, DOI 10.1038/ncb2835; Chen YP, 2021, SCIENCE, V373, P1537, DOI 10.1126/science.abg5159; Chiche A, 2017, CELL STEM CELL, V20, P407, DOI 10.1016/j.stem.2016.11.020; Hatzistergos KE, 2019, CIRC RES, V124, P1184, DOI 10.1161/CIRCRESAHA.118.314063; Lu YC, 2020, NATURE, V588, P124, DOI 10.1038/s41586-020-2975-4; Ocampo A, 2016, CELL, V167, P1719, DOI 10.1016/j.cell.2016.11.052; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Rand TA, 2018, CELL REP, V23, P361, DOI 10.1016/j.celrep.2018.03.057; Sarkar TJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15174-3; Soufi A, 2015, CELL, V161, P555, DOI 10.1016/j.cell.2015.03.017; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229	15	1	1	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2021	373	6562			SI		1439	1440		10.1126/science.abl8679	http://dx.doi.org/10.1126/science.abl8679			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU7LJ	34554769				2022-12-28	WOS:000698977800029
J	Tsui, JC; Onishi, S				Tsui, Jonathan C.; Onishi, Spencer			Symblepharon in Linear IgA Bullous Dermatosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Tsui, Jonathan C.; Onishi, Spencer] Geisinger Eye Inst, Danville, PA 17822 USA		Tsui, JC (corresponding author), Geisinger Eye Inst, Danville, PA 17822 USA.	jctsui7@gmail.com		Tsui, Jonathan/0000-0002-3186-6267					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2021	385	13					1219	1219		10.1056/NEJMicm2101873	http://dx.doi.org/10.1056/NEJMicm2101873			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UT0EM	34551231				2022-12-28	WOS:000697798600015
J	Oliver, D				Oliver, David			David Oliver: Social care plan furthers inequality and unfairness	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Age UK, MEANS MAN ENDS OLD W; Agyemang E, 2021, FINANCIAL TIMES SEP; HM Government, 2021, BUILD BACK BETT OUR; Institute for Government, LOC GOV FUND ENGL; Oliver D, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2227; Oliver D, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2745; Sibieta L, 2020, LARGER FUNDING CUTS	7	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 22	2021	374								n2294	10.1136/bmj.n2294	http://dx.doi.org/10.1136/bmj.n2294			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WQ2LU	34551908	Bronze			2022-12-28	WOS:000713652600003
J	Mallapaty, S				Mallapaty, Smriti			CHINA PREPARES TO TEST THORIUM-FUELLED NUCLEAR REACTOR	NATURE			English	News Item																			0	5	5	4	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 16	2021	597	7876					311	312		10.1038/d41586-021-02459-w	http://dx.doi.org/10.1038/d41586-021-02459-w			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UQ1MU	34504330				2022-12-28	WOS:000695836000009
J	Matschiner, M				Matschiner, Michael			Museum specimens tell the history of rhinoceroses	CELL			English	Editorial Material							EXTINCTION	Rhinoceroses are facing an uncertain future due to human-induced population-size reductions. In this issue of Cell, Liu et al. analyze rhinoceros genomes to study their past and find support for an early divergence between African and Asian species, signatures of past hybridization, and evidence of loss of genetic diversity.	[Matschiner, Michael] Univ Oslo, Nat Hist Museum, Oslo, Norway	University of Oslo	Matschiner, M (corresponding author), Univ Oslo, Nat Hist Museum, Oslo, Norway.	michael.matschiner@nhm.uio.no						Brook SM, 2012, BIOL CONSERV, V155, P59, DOI 10.1016/j.biocon.2012.06.008; Ceballos G, 2017, P NATL ACAD SCI USA, V114, pE6089, DOI 10.1073/pnas.1704949114; Fernando P, 2006, CONSERV GENET, V7, P439, DOI 10.1007/s10592-006-9139-4; IUCN (2021, IUCN RED LIST THREAT; Kosintsev P, 2019, NAT ECOL EVOL, V3, P31, DOI 10.1038/s41559-018-0722-0; Lagrot I, 2007, PACHYDERM, P19; Liu SL, 2021, CELL, V184, P4874, DOI 10.1016/j.cell.2021.07.032; Margaryan A, 2020, ZOOL J LINN SOC-LOND, V190, P372; Pusparini W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136643; Willerslev E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-95	10	0	0	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 16	2021	184	19					4841	4842		10.1016/j.cell.2021.08.026	http://dx.doi.org/10.1016/j.cell.2021.08.026		SEP 2021	2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	WC7PA	34499855	Bronze			2022-12-28	WOS:000704445100001
J	Kuehn, BM				Kuehn, Bridget M.			News From the Centers for Disease Control and Prevention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	4	4	2	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2021	326	10					902	902		10.1001/jama.2021.14237	http://dx.doi.org/10.1001/jama.2021.14237			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UW4LI	34519795	Bronze			2022-12-28	WOS:000700129100037
J	Hacker, JS				Hacker, Jacob S.			Medicare for More - Why We Still Need a Public Option and How to Get There	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hacker, Jacob S.] Yale Univ, New Haven, CT 06511 USA	Yale University	Hacker, JS (corresponding author), Yale Univ, New Haven, CT 06511 USA.			Hacker, Jacob/0000-0002-3686-2513				Alstott AL, 2019, PUBLIC OPTION EXPAND, P80; [Anonymous], 2020, BIDEN SANDERS UNITY; Hacker, 2020, MEMO; Hacker JS., 2001, COVERING AM REAL REM, P73; Young CL, 2019, BROOKINGS	5	0	0	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2021	385	12					1060	1062		10.1056/NEJMp2111494	http://dx.doi.org/10.1056/NEJMp2111494		SEP 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UQ4IT	34506090				2022-12-28	WOS:000694804000001
J	Grorud-Colvert, K; Sullivan-Stack, J; Roberts, C; Constant, V; Costa, BHE; Pike, EP; Kingston, N; Laffoley, D; Sala, E; Claudet, J; Friedlander, AM; Gill, DA; Lester, SE; Day, JC; Goncalves, EJ; Ahmadia, GN; Rand, M; Villagomez, A; Ban, NC; Gurney, GG; Spalding, AK; Bennett, NJ; Briggs, J; Morgan, LE; Moffitt, R; Deguignet, M; Pikitch, EK; Darling, ES; Jessen, S; Hameed, SO; Di Carlo, G; Guidetti, P; Harris, JM; Torre, J; Kizilkaya, Z; Agardy, T; Cury, P; Shah, NJ; Sack, K; Cao, L; Fernandez, M; Lubchenco, J				Grorud-Colvert, Kirsten; Sullivan-Stack, Jenna; Roberts, Callum; Constant, Vanessa; Horta E Costa, Barbara; Pike, Elizabeth P.; Kingston, Naomi; Laffoley, Dan; Sala, Enric; Claudet, Joachim; Friedlander, Alan M.; Gill, David A.; Lester, Sarah E.; Day, Jon C.; Goncalves, Emanuel J.; Ahmadia, Gabby N.; Rand, Matt; Villagomez, Angelo; Ban, Natalie C.; Gurney, Georgina G.; Spalding, Ana K.; Bennett, Nathan J.; Briggs, Johnny; Morgan, Lance E.; Moffitt, Russell; Deguignet, Marine; Pikitch, Ellen K.; Darling, Emily S.; Jessen, Sabine; Hameed, Sarah O.; Di Carlo, Giuseppe; Guidetti, Paolo; Harris, Jean M.; Torre, Jorge; Kizilkaya, Zafer; Agardy, Tundi; Cury, Philippe; Shah, Nirmal J.; Sack, Karen; Cao, Ling; Fernandez, Miriam; Lubchenco, Jane			The MPA Guide: A framework to achieve global goals for the ocean	SCIENCE			English	Review							MARINE PROTECTED AREAS; GREAT-BARRIER-REEF; FISHERIES MANAGEMENT; FISH POPULATIONS; BLUE CARBON; INDIRECT BENEFITS; LARVAL EXPORT; RED HIND; RESERVES; CONSERVATION	Marine Protected Areas (MPAs) are conservation tools intended to protect biodiversity, promote healthy and resilient marine ecosystems, and provide societal benefits. Despite codification of MPAs in international agreements, MPA effectiveness is currently undermined by confusion about the many MPA types and consequent wildly differing outcomes. We present a clarifying science-driven framework-The MPA Guide-to aid design and evaluation. The guide categorizes MPAs by stage of establishment and level of protection, specifies the resulting direct and indirect outcomes for biodiversity and human well-being, and describes the key conditions necessary for positive outcomes. Use of this MPA Guide by scientists, managers, policymakers, and communities can improve effective design, implementation, assessment, and tracking of existing and future MPAs to achieve conservation goals by using scientifically grounded practices.	[Grorud-Colvert, Kirsten; Sullivan-Stack, Jenna; Constant, Vanessa; Lubchenco, Jane] Oregon State Univ, Dept Integrat Biol, 3029 Cordley Hall, Corvallis, OR 97331 USA; [Roberts, Callum] Univ York, Dept Environm & Geog, York YO10 5DD, N Yorkshire, England; [Horta E Costa, Barbara] Univ Algarve, Ctr Marine Sci, CCMAR, Campus Gambelas, P-8005139 Faro, Portugal; [Pike, Elizabeth P.; Moffitt, Russell] Marine Conservat Inst, Marine Protect Atlas, Seattle, WA 98103 USA; [Kingston, Naomi; Deguignet, Marine] World Conservat Monitoring Ctr, UN Environm Programme, Cambridge, England; [Laffoley, Dan] Int Union Conservat Nat IUCN, IUCN World Commiss OnProtected Areas, CH-1196 Gland, Switzerland; [Sala, Enric] Natl Geog Soc, Washington, DC USA; [Claudet, Joachim] PSL Univ Paris, CRIOBE, Natl Ctr Sci Res, USR 3278 CNRS EPHE UPVD, F-75005 Paris, France; [Friedlander, Alan M.] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Friedlander, Alan M.] Natl Geog Soc, Pristine Seas, Washington, DC 20036 USA; [Gill, David A.] Duke Univ, Duke Univ Marine Lab, Nicholas Sch Environm, Beaufort, NC 28516 USA; [Lester, Sarah E.] Florida State Univ, Dept Geog, Tallahassee, FL 32306 USA; [Day, Jon C.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Goncalves, Emanuel J.] ISPA Inst Univ, Marine & Environm Sci Ctr MARE, P-1149041 Lisbon, Portugal; [Goncalves, Emanuel J.] Oceano Azul Fdn, Oceanario Lisboa, P-1990005 Lisbon, Portugal; [Ahmadia, Gabby N.] World Wildlife Fund, Ocean Conservat, Washington, DC 20037 USA; [Rand, Matt; Villagomez, Angelo; Briggs, Johnny] Pew Charitable Trusts, Pew Bertarelli Ocean Legacy Project, Washington, DC 20004 USA; [Ban, Natalie C.] Univ Victoria, Sch Environm Studies, Victoria, BC V8W 2Y2, Canada; [Gurney, Georgina G.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Spalding, Ana K.] Oregon State Univ, Sch Publ Policy, Corvallis, OR 97330 USA; [Spalding, Ana K.] Smithsonian Trop Res Inst, Panama City, Panama; [Spalding, Ana K.] Coiba Sci Stn Coiba AIP, Panama City, Panama; [Bennett, Nathan J.] Peopled Seas Initiat, Vancouver, BC, Canada; [Morgan, Lance E.] Marine Conservat Inst, Seattle, WA 98103 USA; [Pikitch, Ellen K.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Darling, Emily S.] Wildlife Conservat Soc, 2300 Southern Blvd, Bronx, NY 10460 USA; [Jessen, Sabine] Canadian Pk & Wilderness Soc, Natl Ocean Program, Ottawa, ON K2P 0A4, Canada; [Hameed, Sarah O.] Marine Conservat Inst, Blue Pk Program, Seattle, WA 98103 USA; [Di Carlo, Giuseppe] World Wide Fund Nat WWF Mediterranean, I-00198 Rome, Italy; [Guidetti, Paolo] Natl Inst Marine Biol Ecol & Biotechnol, Dept Integrat Marine Ecol EMI, Stn Zool A Dohrn, I-80121 Naples, Italy; [Guidetti, Paolo] CNR, Inst Study Anthrop Impact & Sustainabil Marine En, V16149, Genoa, Italy; [Harris, Jean M.] Nelson Mandela Univ, Inst Coastal & Marine Res CMR, Gomeroy Ave, ZA-6031 Port Elizabeth, South Africa; [Torre, Jorge] Comunidad & Biodiversidad AC, Isla del Peruano 215, Guaymas 85454, Sonora, Mexico; [Kizilkaya, Zafer] Mediterranean Conservat Soc, TR-35100 Izmir, Turkey; [Agardy, Tundi] Sound Seas, Colrain, MA 01340 USA; [Cury, Philippe] Montpellier Univ, MARBEC, IFREMER, CNRS,IRD, Sete, France; [Shah, Nirmal J.] Nat Seychelles, Ctr Environm & Educ Sanctuary Roche Caiman, Mahe, Seychelles; [Sack, Karen] Ocean Unite, Washington, DC 20007 USA; [Cao, Ling] Shanghai Jiao Tong Univ, Sch Oceanog, Shanghai 230000, Peoples R China; [Fernandez, Miriam] Pontificia Univ Catolica Chile, Estn Costera Invest Marinas Cruces, Santiago, Chile; [Fernandez, Miriam] Pontificia Univ Catolica Chile, Dept Ecol, Santiago, Chile; [Constant, Vanessa] Natl Acad Sci Engn & Med, 500 5th St NW, Washington, DC 20001 USA	Oregon State University; University of York - UK; Universidade do Algarve; United Nations Environment Programme; National Geographic Society; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); University of Hawaii System; National Geographic Society; Duke University; State University System of Florida; Florida State University; James Cook University; Instituto Superior Psicologia Aplicada (ISPA); World Wildlife Fund; University of Victoria; James Cook University; Oregon State University; Smithsonian Institution; Smithsonian Tropical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Wildlife Conservation Society; Stazione Zoologica Anton Dohrn di Napoli; Consiglio Nazionale delle Ricerche (CNR); Nelson Mandela University; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Shanghai Jiao Tong University; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; National Academies of Sciences, Engineering & Medicine	Grorud-Colvert, K (corresponding author), Oregon State Univ, Dept Integrat Biol, 3029 Cordley Hall, Corvallis, OR 97331 USA.	grorudck@oregonstate.edu	Claudet, Joachim/C-6335-2008; Pike, Elizabeth/GRS-0517-2022; Cao, Ling/I-9429-2012; Horta e Costa, Barbara/M-5261-2013	Claudet, Joachim/0000-0001-6295-1061; Pike, Elizabeth/0000-0001-8578-0605; Goncalves, Emanuel/0000-0002-3918-6215; Roberts, Callum/0000-0003-2276-4258; Hameed, Sarah/0000-0003-1697-614X; Horta e Costa, Barbara/0000-0002-9960-3893; Grorud-Colvert, Kirsten/0000-0002-4234-4499	Oceans 5; Kingfisher Foundation; David and Lucile Packard Foundation; Ocean Science Innovation Fund at Oregon State University; BiodivERsA; FCT-Foundation for Science and Technology [UID/MAR/04292/2018/2019, MARE/UIDB/MAR/04292/2020, MARE/UIDP/MAR/04292/2020]; Oceano Azul Foundation	Oceans 5; Kingfisher Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Ocean Science Innovation Fund at Oregon State University; BiodivERsA; FCT-Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Oceano Azul Foundation	This project was funded by Oceans 5, the Kingfisher Foundation, the David and Lucile Packard Foundation, and JL's Ocean Science Innovation Fund at Oregon State University. J.C. was supported by BiodivERsA. E.J.G. was supported by FCT-Foundation for Science and Technology through UID/MAR/04292/2018/2019, MARE/UIDB/MAR/04292/2020, and MARE/UIDP/MAR/04292/2020, and funds from the Oceano Azul Foundation.	Abesamis RA, 2005, ECOL APPL, V15, P1798, DOI 10.1890/05-0174; Abesamis RA, 2014, REV FISH BIOL FISHER, V24, P1033, DOI 10.1007/s11160-014-9362-x; Aburto-Oropeza O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023601; Agnetta D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210659; Ahmadia GN, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0275; Alcala AC, 2006, AMBIO, V35, P245, DOI 10.1579/05-A-054R1.1; Alexander SM, 2017, AQUAT CONSERV, V27, P1209, DOI 10.1002/aqc.2775; Allison GW, 2003, ECOL APPL, V13, pS8; Alongi DM, 2015, J MARINE SYST, V142, P25, DOI 10.1016/j.jmarsys.2014.09.010; Andrello M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16039; [Anonymous], 2018, REEF 2050 WAT QUAL I, P63; Armsworth PR, 2010, J APPL ECOL, V47, P36, DOI 10.1111/j.1365-2664.2009.01738.x; Assis J, 2021, SCI TOTAL ENVIRON, V773, DOI 10.1016/j.scitotenv.2021.145664; Atwood TB, 2015, NAT CLIM CHANGE, V5, P1038, DOI 10.1038/NCLIMATE2763; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Ban NC, 2019, NAT SUSTAIN, V2, P524, DOI 10.1038/s41893-019-0306-2; Barneche DR, 2018, SCIENCE, V360, P642, DOI 10.1126/science.aao6868; Barnes MD, 2018, NAT ECOL EVOL, V2, P759, DOI 10.1038/s41559-018-0501-y; Barnett LAK, 2015, ECOL LETT, V18, P1301, DOI 10.1111/ele.12524; Beets J, 1999, ENVIRON BIOL FISH, V55, P91, DOI 10.1023/A:1007404421518; Bennett NJ, 2019, CONSERV LETT, V12, DOI 10.1111/conl.12640; Bennett NJ, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12600; Bergstrom L, 2019, AMBIO, V48, P565, DOI 10.1007/s13280-018-1133-9; Bracciali C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040582; Brondizio E. S., 2019, GLOB ASS REP BIOD EC; Carr MH, 2017, AQUAT CONSERV, V27, P6, DOI 10.1002/aqc.2800; CBD, 2006, PROGRAMME WORK PROTE; CCAMLR, 2019, CCAMLR3823; CCAMLR, 2019, CCAMLR3821; Chuenpagdee R, 2013, MAR POLICY, V39, P234, DOI 10.1016/j.marpol.2012.10.016; Cinner JE, 2014, SOC NATUR RESOUR, V27, P994, DOI 10.1080/08941920.2014.918229; Claudet J, 2006, BIOL CONSERV, V130, P349, DOI 10.1016/j.biocon.2005.12.030; Claudet J, 2010, ECOL APPL, V20, P830, DOI 10.1890/08-2131.1; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Claudet J, 2021, MAR POLICY, V124, DOI 10.1016/j.marpol.2020.104379; Claudet J, 2020, ONE EARTH, V2, P380, DOI 10.1016/j.oneear.2020.03.008; Claudet J, 2019, NATURE, V570, P36, DOI 10.1038/d41586-019-01750-1; Costello MJ, 2014, BIOL CONSERV, V176, P289, DOI 10.1016/j.biocon.2014.04.023; Cote IM, 2001, J FISH BIOL, V59, P178, DOI 10.1006/jfbi.2001.1752; Cotou E, 2005, CONT SHELF RES, V25, P2521, DOI 10.1016/j.csr.2005.08.005; Crec'hriou R, 2010, FISH OCEANOGR, V19, P135, DOI 10.1111/j.1365-2419.2010.00533.x; Day JC, 2019, AQUAT CONSERV, V29, P9, DOI 10.1002/aqc.3115; de Madron XD, 2005, CONT SHELF RES, V25, P2387, DOI 10.1016/j.csr.2005.08.002; Di Franco A, 2018, BIOL CONSERV, V221, P175, DOI 10.1016/j.biocon.2018.03.012; Di Franco A, 2015, BIOL CONSERV, V192, P361, DOI 10.1016/j.biocon.2015.10.015; Di Lorenzo M, 2020, FISH FISH, V21, P906, DOI 10.1111/faf.12469; Di Lorenzo M, 2016, J NAT CONSERV, V32, P62, DOI 10.1016/j.jnc.2016.04.004; Diaz D, 2011, MAR ECOL PROG SER, V433, P149, DOI 10.3354/meps09182; Duarte CM, 2020, NATURE, V580, P39, DOI 10.1038/s41586-020-2146-7; DUARTE CM, 2017, FRONT MAR SCI, V4, DOI [10.3389/fmars.2017.00100, DOI 10.3389/FMARS.2017.00100]; Duffy JE, 2016, P NATL ACAD SCI USA, V113, P6230, DOI 10.1073/pnas.1524465113; Dwyer RG, 2020, CURR BIOL, V30, P480, DOI 10.1016/j.cub.2019.12.005; Costa BHE, 2019, MAR POLICY, V108, DOI 10.1016/j.marpol.2019.103553; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Emslie MJ, 2015, CURR BIOL, V25, P983, DOI 10.1016/j.cub.2015.01.073; Erisman B, 2017, FISH FISH, V18, P128, DOI 10.1111/faf.12132; Faure D., 2020, SPEECH OCCASION 30 S; Fox HE, 2012, CONSERV LETT, V5, P1, DOI 10.1111/j.1755-263X.2011.00207.x; Friedlander AM, 2019, AQUAT CONSERV, V29, P103, DOI 10.1002/aqc.3043; Friedlander AM, 2018, MAR POLLUT BULL, V135, P139, DOI 10.1016/j.marpolbul.2018.05.064; Gaines SD, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao1378; Garcia-Rubies A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073922; Garla RC, 2006, MAR BIOL, V149, P189, DOI 10.1007/s00227-005-0201-4; Giakoumi S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08850-w; Gill DA, 2019, ANNU REV ENV RESOUR, V44, P347, DOI 10.1146/annurev-environ-110718-032344; Gill DA, 2019, MARE PUBL SER, V19, P295, DOI 10.1007/978-3-319-76078-0_13; Gill DA, 2017, NATURE, V543, P665, DOI 10.1038/nature21708; Goetze JS, 2015, J EXP MAR BIOL ECOL, V462, P74, DOI 10.1016/j.jembe.2014.10.004; Gormley AM, 2012, J APPL ECOL, V49, P474, DOI 10.1111/j.1365-2664.2012.02121.x; Great Barrier Reef Marine Park Authority, INT ZON; Gremillet D, 2009, MAR ECOL PROG SER, V391, P121, DOI 10.3354/meps08212; Grorud-Colvert K, 2019, MAR POLICY, V105, P52, DOI 10.1016/j.marpol.2019.04.003; Grorud-Colvert K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102298; Gruss A, 2014, ICES J MAR SCI, V71, P435, DOI 10.1093/icesjms/fst028; Guidetti P, 2008, BIOL CONSERV, V141, P699, DOI 10.1016/j.biocon.2007.12.013; Guidetti P, 2007, CONSERV BIOL, V21, P540, DOI 10.1111/j.1523-1739.2007.00657.x; Guidetti P, 2006, ECOL APPL, V16, P963, DOI 10.1890/1051-0761(2006)016[0963:MRRLPI]2.0.CO;2; Guidetti P, 2010, CONSERV BIOL, V24, P312, DOI 10.1111/j.1523-1739.2009.01358.x; Gurney GG, 2019, BIOL CONSERV, V240, DOI 10.1016/j.biocon.2019.108298; Gurney GG, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0277; Gurney GG, 2014, GLOBAL ENVIRON CHANG, V26, P98, DOI 10.1016/j.gloenvcha.2014.04.003; Gustavsson M, 2014, MAR POLICY, V46, P91, DOI 10.1016/j.marpol.2014.01.005; Halpern BS, 2009, ENVIRON CONSERV, V36, P268, DOI 10.1017/S0376892910000032; Harasti D, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00208; Harris DL, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao4350; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Hattam CE, 2014, MAR POLICY, V45, P269, DOI 10.1016/j.marpol.2013.09.005; Hernandez CM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47161-0; Hixon MA, 2014, ICES J MAR SCI, V71, P2171, DOI 10.1093/icesjms/fst200; Hockings M., 2006, EVALUATING EFFECTIVE, V2nd, DOI https://doi.org/10.2305/IUCN.CH.2005.PAG.14.en; Hogg K, 2019, MARIT STUD, V18, P159, DOI 10.1007/s40152-019-00134-5; Costa BHE, 2016, MAR POLICY, V72, P192, DOI 10.1016/j.marpol.2016.06.021; Howard J, 2017, AQUAT CONSERV, V27, P100, DOI 10.1002/aqc.2809; International Union for the Conservation of Nature, 2020, MOT 066 GUID ID IND; IPCC, 2018, SUMMARY POLICYMAKERS; IUCN, 2019, GUIDELINES APPL IUCN, V2; IUCN; WCPA, 2018, APPL IUCNS GLOB CONS; IUCN World Commission on Protected Areas, 2008, EST MAR PROT AR NETW, P118; Jones KR, 2020, ONE EARTH, V2, P188, DOI 10.1016/j.oneear.2020.01.010; Jones KR, 2018, CURR BIOL, V28, P2506, DOI 10.1016/j.cub.2018.06.010; Kaiser MJ, 2007, CAN J FISH AQUAT SCI, V64, P1284, DOI 10.1139/F07-090; Kamat VR, 2014, HUM ORGAN, V73, P289, DOI 10.17730/humo.73.3.f43k115544761g0v; Kaplan-Hallam M, 2018, CONSERV BIOL, V32, P304, DOI 10.1111/cobi.12985; Kawaka JA, 2017, OCEAN COAST MANAGE, V135, P1, DOI 10.1016/j.ocecoaman.2016.10.013; Kelly ELA, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1899; Kikiloi K, 2017, COAST MANAGE, V45, P436, DOI 10.1080/08920753.2017.1373450; Koweek DA, 2018, ECOL APPL, V28, P1694, DOI 10.1002/eap.1771; Krause-Jensen D, 2016, NAT GEOSCI, V9, P737, DOI [10.1038/NGEO2790, 10.1038/ngeo2790]; Laffoley D, 2017, AQUAT CONSERV, V27, P130, DOI 10.1002/aqc.2783; Lamb JB, 2017, SCIENCE, V355, P731, DOI 10.1126/science.aal1956; Lauck T, 1998, ECOL APPL, V8, pS72, DOI 10.1890/1051-0761(1998)8[S72:ITPPIF]2.0.CO;2; Leisher C., 2007, NATURES INVESTMENT B; Lester SE, 2008, MAR ECOL PROG SER, V367, P49, DOI 10.3354/meps07599; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Ling SD, 2009, P NATL ACAD SCI USA, V106, P22341, DOI 10.1073/pnas.0907529106; Lockwood M, 2010, J ENVIRON MANAGE, V91, P754, DOI 10.1016/j.jenvman.2009.10.005; Lubchenco J, 2019, SCIENCE, V364, P911, DOI 10.1126/science.aay2241; Lubchenco J, 2015, SCIENCE, V350, P382, DOI 10.1126/science.aad5443; Luo SL, 2015, OCEAN COAST MANAGE, V103, P134, DOI 10.1016/j.ocecoaman.2014.08.008; Macedo HS, 2019, MAR POLICY, V99, P351, DOI 10.1016/j.marpol.2018.11.007; Manel S, 2019, TRENDS ECOL EVOL, V34, P342, DOI 10.1016/j.tree.2019.01.002; Manriquez PH, 2001, MAR ECOL PROG SER, V215, P201, DOI 10.3354/meps215201; Mariani G, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb4848; Marine Conservation Institute, 2020, ATL MAR PROT; Marine Conservation Institute, 2020, BLUEPARKS; Marshall DJ, 2019, FRONT ECOL ENVIRON, V17, P407, DOI 10.1002/fee.2075; Mascia MB, 2009, CONSERV BIOL, V23, P16, DOI 10.1111/j.1523-1739.2008.01050.x; Maxwell SM, 2020, SCIENCE, V367, P252, DOI 10.1126/science.aaz9327; McClanahan TR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1938; McKinnon AD, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00346; McLaren BW, 2015, J EXP MAR BIOL ECOL, V471, P153, DOI 10.1016/j.jembe.2015.06.002; McLeod E, 2009, FRONT ECOL ENVIRON, V7, P362, DOI 10.1890/070211; McNally CG, 2011, P NATL ACAD SCI USA, V108, P13945, DOI 10.1073/pnas.1101825108; Mellin C, 2016, ECOL LETT, V19, P629, DOI 10.1111/ele.12598; Miethe T, 2010, ICES J MAR SCI, V67, P412, DOI 10.1093/icesjms/fsp248; Mineur F, 2015, J SEA RES, V98, P91, DOI 10.1016/j.seares.2014.11.004; Miteva DA, 2015, ECOL ECON, V119, P127, DOI 10.1016/j.ecolecon.2015.08.005; Molloy PP, 2009, J APPL ECOL, V46, P743, DOI 10.1111/j.1365-2664.2009.01662.x; Mouillot D, 2008, BIOL CONSERV, V141, P1569, DOI 10.1016/j.biocon.2008.04.002; Moye M, 2004, FINANCING MARINE CON; Murray S, 2019, OCEAN COAST MANAGE, V182, DOI 10.1016/j.ocecoaman.2019.104920; Nash KL, 2016, FISH FISH, V17, P1029, DOI 10.1111/faf.12157; National Oceanic and Atmospheric Administration United States Fish and Wildlife Service Hawai`i Department of Land and Natural Resources, 2008, PAP MAR NAT MON MAN; Nemeth RS, 2005, MAR ECOL PROG SER, V286, P81, DOI 10.3354/meps286081; Nocito ES, 2020, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00835; Office of National Marine Sanctuaries National Oceanic and Atmospheric Administration United States Department of Commerce State of Hawai`i Hawai`i Department of Land and Natural Resources, 2020, HAW ISL HUMPB WHAL N; Olds AD, 2014, GLOBAL CHANGE BIOL, V20, P3050, DOI 10.1111/gcb.12606; OLEARY BC, 2016, CONSERV LETT, P1; Oracion EG, 2005, OCEAN COAST MANAGE, V48, P393, DOI 10.1016/j.ocecoaman.2005.04.013; Palau International Coral Reef Center-PICRC, PAL NAT MAR SANCT AC; Pelc RA, 2010, P NATL ACAD SCI USA, V107, P18266, DOI 10.1073/pnas.0907368107; Pendleton L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043542; Petruny LM, 2014, MAR POLLUT BULL, V85, P24, DOI 10.1016/j.marpolbul.2014.06.004; Pichegru L, 2010, BIOL LETTERS, V6, P498, DOI 10.1098/rsbl.2009.0913; Pieraccini M, 2017, AQUAT CONSERV, V27, P177, DOI 10.1002/aqc.2632; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; Pollock FJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102498; Powell EJ, 2019, J COAST CONSERV, V23, P1, DOI 10.1007/s11852-018-0632-y; Pressey RL, 2009, ORYX, V43, P464, DOI 10.1017/S0030605309990500; Reed D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13757; Reimer JM, 2021, NAT SUSTAIN, V4, P349, DOI 10.1038/s41893-020-00659-2; Roberts CM, 2017, P NATL ACAD SCI USA, V114, P6167, DOI 10.1073/pnas.1701262114; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Roberts CM, 2005, PHILOS T R SOC B, V360, P123, DOI 10.1098/rstb.2004.1578; Rogers-Bennett L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51114-y; Rogers-Bennett L, 2001, CONSERV BIOL, V15, P642, DOI 10.1046/j.1523-1739.2001.015003642.x; Russ GR, 2015, MAR ECOL PROG SER, V529, P233, DOI 10.3354/meps11246; Russ GR, 2011, ECOL APPL, V21, P241, DOI 10.1890/09-1197.1; Ruttenberg BI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021062; Saba GK, 2021, LIMNOL OCEANOGR, V66, P1639, DOI 10.1002/lno.11709; Sala E, 2001, FISHERIES, V26, P23, DOI 10.1577/1548-8446(2001)026<0023:RDONGS>2.0.CO;2; Sala E, 2021, NATURE, V592, DOI 10.1038/s41586-021-03371-z; Sala E, 2018, ICES J MAR SCI, V75, P1166, DOI 10.1093/icesjms/fsx059; Sala E, 2018, MAR POLICY, V91, P11, DOI 10.1016/j.marpol.2018.02.004; Sala E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058799; Sala E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032742; Schratzberger M, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00749; Sciberras M, 2015, FISH FISH, V16, P58, DOI 10.1111/faf.12044; Selden RL, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.1936; Sheehan L, 2019, WETLANDS, V39, P1317, DOI 10.1007/s13157-019-01137-y; Smith MD, 2006, CAN J FISH AQUAT SCI, V63, P153, DOI 10.1139/F05-205; Sordalen TK, 2018, EVOL APPL, V11, P963, DOI 10.1111/eva.12611; Strain EMA, 2019, DIVERS DISTRIB, V25, P9, DOI 10.1111/ddi.12838; Taylor BM, 2010, MAR ECOL PROG SER, V411, P243, DOI 10.3354/meps08672; Turnbull JW, 2018, BIODIVERS CONSERV, V27, P2217, DOI 10.1007/s10531-018-1532-z; UN [United Nations], 2017, 1 GLOB INT MAR ASS W, VI; UNEP-WCMC, 2020, WORLD DAT PROT AR PR; Unsworth RKF, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/2/024026; Vilas D., 2020, MAR POLICY, V123, DOI [10.1016/j.marpol.2020.104296, DOI 10.1016/J.MARP0L.2020.104296]; Wells S, 2016, AQUAT CONSERV, V26, P24, DOI 10.1002/aqc.2679; Williamson DH, 2014, ECOL EVOL, V4, P337, DOI 10.1002/ece3.934; Wilson KL, 2020, GLOBAL CHANGE BIOL, V26, P3251, DOI 10.1111/gcb.15094; Woodley S., 2012, PARKS, V18, P23, DOI DOI 10.2305/IUCN.CH.2012.PARKS-18-1.SW.EN; Zarate-Barrera TG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126627; Zupan M, 2018, FRONT ECOL ENVIRON, V16, P381, DOI 10.1002/fee.1934; Zupan M, 2018, BIOL CONSERV, V221, P237, DOI 10.1016/j.biocon.2018.03.013	196	56	56	47	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2021	373	6560							eabf0861	10.1126/science.abf0861	http://dx.doi.org/10.1126/science.abf0861			48	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UP5RB	34516798	Green Submitted, Green Published			2022-12-28	WOS:000695436000022
J	Wang, GHM; Man, KKC; Chang, WH; Liao, TC; Lai, ECC				Wang, Grace Hsin-Min; Man, Kenneth K. C.; Chang, Wei-Hung; Liao, Tzu-Chi; Lai, Edward Chia-Cheng			Use of antipsychotic drugs and cholinesterase inhibitors and risk of falls and fractures: self-controlled case series	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE ISCHEMIC-STROKE; HIP FRACTURE; PSYCHOTROPIC-DRUGS; ADVERSE OUTCOMES; OLDER-PEOPLE; DEMENTIA; ASSOCIATIONS; METAANALYSIS; BURDEN; HOSPITALIZATION	OBJECTIVE To evaluate the association between the use of antipsychotic drugs and cholinesterase inhibitors and the risk of falls and fractures in elderly patients with major neurocognitive disorders. DESIGN Self-controlled case series. SETTING Taiwan's National Health Insurance Database. PARTICIPANTS 15 278 adults, aged >= 65, with newly prescribed antipsychotic drugs and cholinesterase inhibitors, who had an incident fall or fracture between 2006 and 2017. Prescription records of cholinesterase inhibitors confirmed the diagnosis of major neurocognitive disorders; all use of cholinesterase inhibitors was reviewed by experts. MAIN OUTCOME MEASURES Conditional Poisson regression was used to derive incidence rate ratios and 95% confidence intervals for evaluating the risk of falls and fractures for different treatment periods: use of cholinesterase inhibitors alone, antipsychotic drugs alone, and a combination of cholinesterase inhibitors and antipsychotic drugs, compared with the non-treatment period in the same individual. A 14 day pretreatment period was defined before starting the study drugs because of concerns about confounding by indication. RESULTS The incidence of falls and fractures per 100 person years was 8.30 (95% confidence interval 8.14 to 8.46) for the non-treatment period, 52.35 (48.46 to 56.47) for the pretreatment period, and 10.55 (9.98 to 11.14), 10.34 (9.80 to 10.89), and 9.41 (8.98 to 9.86) for use of a combination of cholinesterase inhibitors and antipsychotic drugs, antipsychotic drugs alone, and cholinesterase inhibitors alone, respectively. Compared with the non-treatment period, the highest risk of falls and fractures was during the pretreatment period (adjusted incidence rate ratio 6.17, 95% confidence interval 5.69 to 6.69), followed by treatment with the combination of cholinesterase inhibitors and antipsychotic drugs (1.35, 1.26 to 1.45), antipsychotic drugs alone (1.33, 1.24 to 1.43), and cholinesterase inhibitors alone (1.17, 1.10 to 1.24). CONCLUSIONS The incidence of falls and fractures was high in the pretreatment period, suggesting that factors other than the study drugs, such as underlying diseases, should be taken into consideration when evaluating the association between the risk of falls and fractures and use of cholinesterase inhibitors and antipsychotic drugs. The treatment periods were also associated with a higher risk of falls and fractures compared with the non-treatment period, although the magnitude was much lower than during the pretreatment period. Strategies for prevention and close monitoring of the risk of falls are still necessary until patients regain a more stable physical and mental state.	[Wang, Grace Hsin-Min; Liao, Tzu-Chi; Lai, Edward Chia-Cheng] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Sch Pharm, Coll Med, Tainan, Taiwan; [Man, Kenneth K. C.] UCL Sch Pharm, Res Dept Practice & Policy, London, England; [Chang, Wei-Hung] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Psychiat, Coll Med, Tainan, Taiwan; [Chang, Wei-Hung] Natl Cheng Kung Univ Hosp, Dept Psychiat, Dou Liou Branch, Touliu, Yunlin, Taiwan	National Cheng Kung University; University of London; University College London; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital	Lai, ECC (corresponding author), Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Sch Pharm, Coll Med, Tainan, Taiwan.	edward_lai@mail.ncku.edu.tw	Man, Kenneth/AAD-2846-2019	Man, Kenneth/0000-0001-8645-1942; Wang, Grace Hsin-Min/0000-0001-7855-9590				Ali TB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144337; Bloch F, 2011, J AGING HEALTH, V23, P329, DOI 10.1177/0898264310381277; Brannstrom J, 2020, J AM MED DIR ASSOC, V21, P1636, DOI 10.1016/j.jamda.2020.06.047; Cao YJ, 2008, CLIN PHARMACOL THER, V83, P422, DOI 10.1038/sj.clpt.6100303; Carnahan RM, 2006, J CLIN PHARMACOL, V46, P1481, DOI 10.1177/0091270006292126; Chen CC, 2012, EPILEPSIA, V53, P283, DOI 10.1111/j.1528-1167.2011.03332.x; Chien WC, 2013, INT J INJ CONTROL SA, V20, P50, DOI 10.1080/17457300.2012.674042; Epstein NU, 2014, DRUG AGING, V31, P125, DOI 10.1007/s40266-013-0143-3; Fernando E, 2017, PHYSIOTHER CAN, V69, P161, DOI 10.3138/ptc.2016-14; Fick DM, 2019, J AM GERIATR SOC, V67, P674, DOI 10.1111/jgs.15767; Gill SS, 2009, ARCH INTERN MED, V169, P867, DOI 10.1001/archinternmed.2009.43; Green AR, 2019, DRUG AGING, V36, P289, DOI 10.1007/s40266-018-00630-z; Haw C, 2009, PSYCHIATR BULL, V33, P57, DOI 10.1192/pb.bp.107.017947; Hefny AF, 2016, AFR HEALTH SCI, V16, P554, DOI 10.4314/ahs.v16i2.24; Hsieh CY, 2019, CLIN EPIDEMIOL, V11, P349, DOI 10.2147/CLEP.S196293; Hsieh CY, 2015, J FORMOS MED ASSOC, V114, P254, DOI 10.1016/j.jfma.2013.09.009; Jin B, 2019, J NEUROL, V266, P2363, DOI 10.1007/s00415-019-09200-8; Johnell K, 2017, INT J GERIATR PSYCH, V32, P414, DOI 10.1002/gps.4483; Kim DH, 2011, J AM GERIATR SOC, V59, P1019, DOI 10.1111/j.1532-5415.2011.03450.x; Koponen M, 2017, J CLIN PSYCHIAT, V78, pE257, DOI 10.4088/JCP.15m10458; Lapeyre-Mestre M, 2016, DRUG AGING, V33, P865, DOI 10.1007/s40266-016-0414-x; Lee SH, 2017, OSTEOPOROSIS INT, V28, P1167, DOI 10.1007/s00198-016-3881-3; Leipzig RM, 1999, J AM GERIATR SOC, V47, P30, DOI 10.1111/j.1532-5415.1999.tb01898.x; Leucht S, 2016, SCHIZOPHRENIA BULL, V42, pS90, DOI 10.1093/schbul/sbv167; Lin Pei-Chao, 2018, J Pain Res, V11, P1589, DOI 10.2147/JPR.S172875; Lin YT, 2015, J FORMOS MED ASSOC, V114, P147, DOI 10.1016/j.jfma.2012.09.002; Lin YS, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006406; Liperoti R, 2007, J CLIN PSYCHIAT, V68, P929, DOI 10.4088/JCP.v68n0616; Liu CC, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025274; Lowry E, 2011, J AM MED DIR ASSOC, V12, P565, DOI 10.1016/j.jamda.2011.03.006; Masopust J, 2018, NEUROPSYCH DIS TREAT, V14, P1211, DOI 10.2147/NDT.S163842; Mathur MB, 2018, EPIDEMIOLOGY, V29, pE45, DOI 10.1097/EDE.0000000000000864; McDonald William M, 2017, Focus (Am Psychiatr Publ), V15, P4, DOI 10.1176/appi.focus.20160030; Mortensen SJ, 2020, CALCIFIED TISSUE INT, V107, P1, DOI 10.1007/s00223-020-00688-1; Ohno Y, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01045; Papola D, 2019, ACTA PSYCHIAT SCAND, V140, P227, DOI 10.1111/acps.13066; Parkkari J, 1999, CALCIFIED TISSUE INT, V65, P183; Petersen I, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4515; Pouwels S, 2009, OSTEOPOROSIS INT, V20, P1499, DOI 10.1007/s00198-008-0826-5; Pratt N, 2011, DRUG SAFETY, V34, P567, DOI 10.2165/11588470-000000000-00000; Salahudeen MS, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0029-9; Seppala LJ, 2018, J AM MED DIR ASSOC, V19, DOI 10.1016/j.jamda.2017.12.098; Sung SF, 2016, INT J CARDIOL, V215, P277, DOI 10.1016/j.ijcard.2016.04.069; Tampi RR, 2016, THER ADV CHRONIC DIS, V7, P229, DOI 10.1177/2040622316658463; Torstensson M, 2017, AGE AGEING, V46, P258, DOI 10.1093/ageing/afw209; Tune LE, 2001, J CLIN PSYCHIAT, V62, P11; UpToDate, 2020, 2 GEN ANT MED PHARM; Uusvaara J, 2011, DRUG AGING, V28, P131, DOI 10.2165/11585060-000000000-00000; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; Wang HK, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0175-2; Wei MY, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05207-4; Wilson NM, 2011, J AM GERIATR SOC, V59, P875, DOI 10.1111/j.1532-5415.2011.03386.x; Woolcott JC, 2009, ARCH INTERN MED, V169, P1952, DOI 10.1001/archinternmed.2009.357; Wu CS, 2020, J AFFECT DISORDERS, V260, P617, DOI 10.1016/j.jad.2019.09.044	54	5	5	3	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2021	374								n1925	10.1136/bmj.n1925	http://dx.doi.org/10.1136/bmj.n1925			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UZ3VV	34503972	Green Published, hybrid			2022-12-28	WOS:000702137100017
J	Daniels, JP				Daniels, Joe Parkin			Colombia struggles to cope with care in Venezuelan influx	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 1	2019	393	10187					2185	2186		10.1016/S0140-6736(19)31229-2	http://dx.doi.org/10.1016/S0140-6736(19)31229-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IB1HV	34509215				2022-12-28	WOS:000470017100009
J	Vallejo-Vaz, AJ; Stevens, CAT; Lyons, ARM; Dharmayat, KI; Freiberger, T; Hovingh, GK; Mata, P; Raal, FJ; Santos, RD; Soran, H; Watts, GF; Abifadel, M; Aguilar-Salinas, CA; Alhabib, KF; Alkhnifsawi, M; Almahmeed, W; Alnouri, F; Alonso, R; Al-Rasadi, K; Al-Sarraf, A; Al-Sayed, N; Araujo, F; Ashavaid, TF; Banach, M; Beliard, S; Benn, M; Binder, CJ; Bogsrud, MP; Bourbon, M; Chlebus, K; Corral, P; Davletov, K; Descamps, OS; Durst, R; Ezhov, M; Gaita, D; Genest, J; Groselj, U; Harada-Shiba, M; Holven, KB; Kayikcioglu, M; Khovidhunkit, W; Lalic, K; Latkovskis, G; Laufs, U; Liberopoulos, E; Lima-Martinez, MM; Lin, J; Maher, V; Marais, AD; Marz, W; Mirrakhimov, E; Miserez, AR; Mitchenko, O; Nawawi, H; Nordestgaard, BG; Panayiotou, AG; Paragh, G; Petrulioniene, Z; Pojskic, B; Postadzhiyan, A; Raslova, K; Reda, A; Reiner, Z; Sadiq, F; Sadoh, WE; Schunkert, H; Shek, AB; Stoll, M; Stroes, E; Su, TC; Subramaniam, T; Susekov, AV; Tilney, M; Tomlinson, B; Truong, TH; Tselepis, AD; Tybjaerg-Hansen, A; Cardenas, AV; Viigimaa, M; Wang, LY; Yamashita, S; Tokgozoglu, L; Catapano, AL; Ray, KK				Vallejo-Vaz, Antonio J.; Stevens, Christophe A. T.; Lyons, Alexander R. M.; Dharmayat, Kanika I.; Freiberger, Tomas; Hovingh, G. Kees; Mata, Pedro; Raal, Frederick J.; Santos, Raul D.; Soran, Handrean; Watts, Gerald F.; Abifadel, Marianne; Aguilar-Salinas, Carlos A.; Alhabib, Khalid F.; Alkhnifsawi, Mutaz; Almahmeed, Wael; Alnouri, Fahad; Alonso, Rodrigo; Al-Rasadi, Khalid; Al-Sarraf, Ahmad; Al-Sayed, Nasreen; Araujo, Francisco; Ashavaid, Tester F.; Banach, Maciej; Beliard, Sophie; Benn, Marianne; Binder, Christoph J.; Bogsrud, Martin P.; Bourbon, Mafalda; Chlebus, Krzysztof; Corral, Pablo; Davletov, Kairat; Descamps, Olivier S.; Durst, Ronen; Ezhov, Marat; Gaita, Dan; Genest, Jacques; Groselj, Urh; Harada-Shiba, Mariko; Holven, Kirsten B.; Kayikcioglu, Meral; Khovidhunkit, Weerapan; Lalic, Katarina; Latkovskis, Gustavs; Laufs, Ulrich; Liberopoulos, Evangelos; Lima-Martinez, Marcos M.; Lin, Jie; Maher, Vincent; Marais, A. David; Maerz, Winfried; Mirrakhimov, Erkin; Miserez, Andre R.; Mitchenko, Olena; Nawawi, Hapizah; Nordestgaard, Borge G.; Panayiotou, Andrie G.; Paragh, Gyorgy; Petrulioniene, Zaneta; Pojskic, Belma; Postadzhiyan, Arman; Raslova, Katarina; Reda, Ashraf; Reiner, Zeljko; Sadiq, Fouzia; Sadoh, Wilson Ehidiamen; Schunkert, Heribert; Shek, Aleksandr B.; Stoll, Mario; Stroes, Erik; Su, Ta-Chen; Subramaniam, Tavintharan; Susekov, Andrey V.; Tilney, Myra; Tomlinson, Brian; Truong, Thanh Huong; Tselepis, Alexandros D.; Tybjaerg-Hansen, Anne; Vazquez Cardenas, Alejandra; Viigimaa, Margus; Wang, Luya; Yamashita, Shizuya; Tokgozoglu, Lale; Catapano, Alberico L.; Ray, Kausik K.		EAS Familial Hypercholesterolaemia	Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)	LANCET			English	Article							PREVALENCE; CLINICIAN; GUIDANCE; INSIGHTS	Background The European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (FHSC) global registry provides a platform for the global surveillance of familial hypercholesterolaemia through harmonisation and pooling of multinational data. In this study, we aimed to characterise the adult population with heterozygous familial hypercholesterolaemia and described how it is detected and managed globally. Methods Using FHSC global registry data, we did a cross-sectional assessment of adults (aged 18 years or older) with a clinical or genetic diagnosis of probable or definite heterozygous familial hypercholesterolaemia at the time they were entered into the registries. Data were assessed overall and by WHO regions, sex, and index versus non-index cases. Findings Of the 61 612 individuals in the registry, 42 167 adults (21 999 [53.6%] women) from 56 countries were included in the study. Of these, 31 798 (75.4%) were diagnosed with the Dutch Lipid Clinic Network criteria, and 35 490 (84.2%) were from the WHO region of Europe. Median age of participants at entry in the registry was 46.2 years (IQR 34.3-58.0); median age at diagnosis of familial hypercholesterolaemia was 44.4 years (32.5-56.5), with 40.2% of participants younger than 40 years when diagnosed. Prevalence of cardiovascular risk factors increased progressively with age and varied by WHO region. Prevalence of coronary disease was 17.4% (2.1% for stroke and 5.2% for peripheral artery disease), increasing with concentrations of untreated LDL cholesterol, and was about two times lower in women than in men. Among patients receiving lipid-lowering medications, 16 803 (81.1%) were receiving statins and 3691 (21.2%) were on combination therapy, with greater use of more potent lipid-lowering medication in men than in women. Median LDL cholesterol was 5.43 mmol/L (IQR 4.32-6.72) among patients not taking lipid-lowering medications and 4.23 mmol/L (3.20-5.66) among those taking them. Among patients taking lipid-lowering medications, 2.7% had LDL cholesterol lower than 1.8 mmol/L; the use of combination therapy, particularly with three drugs and with proprotein convertase subtilisin-kexin type 9 inhibitors, was associated with a higher proportion and greater odds of having LDL cholesterol lower than 1.8 mmol/L. Compared with index cases, patients who were non-index cases were younger, with lower LDL cholesterol and lower prevalence of cardiovascular risk factors and cardiovascular diseases (all p<0.001). Interpretation Familial hypercholesterolaemia is diagnosed late. Guideline-recommended LDL cholesterol concentrations are infrequently achieved with single-drug therapy. Cardiovascular risk factors and presence of coronary disease were lower among non-index cases, who were diagnosed earlier. Earlier detection and greater use of combination therapies are required to reduce the global burden of familial hypercholesterolaemia. Copyright (C) 2021 Elsevier Ltd. All rights reserved.	[Vallejo-Vaz, Antonio J.; Stevens, Christophe A. T.; Lyons, Alexander R. M.; Dharmayat, Kanika I.; Ray, Kausik K.] Imperial Coll London, Sch Publ Hlth, Dept Primary Care & Publ Hlth, Imperial Ctr Cardiovasc Dis Prevent, London, England; [Freiberger, Tomas] Masaryk Univ, Ctr Cardiovasc Surg & Transplantat, Brno, Czech Republic; [Freiberger, Tomas] Masaryk Univ, Med Fac, Brno, Czech Republic; [Hovingh, G. Kees; Stroes, Erik] Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands; [Mata, Pedro] Fdn Hipercolesterolemia Familiar, Madrid, Spain; [Raal, Frederick J.] Univ Witwatersrand, Carbohydrate & Lipid Metab Res Unit, Fac Hlth Sci, Johannesburg, South Africa; [Santos, Raul D.] Univ Sao Paulo, Heart Inst InCor, Sao Paulo, Brazil; [Santos, Raul D.] Hosp Israelita Albert Einstein, Sao Paulo, Brazil; [Soran, Handrean] Manchester Univ NHS Fdn Trust, Manchester, Lancs, England; [Watts, Gerald F.] Univ Western Australia, Sch Med, Fac Hlth & Med Sci, Perth, WA, Australia; [Watts, Gerald F.] Royal Perth Hosp, Dept Cardiol, Lipid Disorders Clin, Cardiometab Serv, Perth, WA, Australia; [Abifadel, Marianne] St Joseph Univ, Lab Biochem & Mol Therapeut, Fac Pharm, Beirut, Lebanon; [Aguilar-Salinas, Carlos A.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Unidad Invest Enfermedades Metab, Mexico City, DF, Mexico; [Aguilar-Salinas, Carlos A.] Tecnol Monterrey, Escuela Med & Ciencias Salud, Monterrey, Mexico; [Alhabib, Khalid F.] King Saud Univ, Dept Cardiac Sci, Coll Med, King Fahad Cardiac Ctr, Riyadh, Saudi Arabia; [Alkhnifsawi, Mutaz] Univ Al Qadisiyah, Fac Med, Al Diwaniyah, Iraq; [Almahmeed, Wael] Cleveland Clin Abu Dhabi, Heart & Vasc Inst, Abu Dhabi, U Arab Emirates; [Alnouri, Fahad] Prince Sultan Cardiac Ctr, Adult Cardiol Dept, Cardiovasc Prevent Unit, Riyadh, Saudi Arabia; [Alonso, Rodrigo] Ctr Adv Metab Med & Nutr, Santiago, Chile; [Al-Rasadi, Khalid] Sultan Qaboos Univ, Dept Biochem, Coll Med & Hlth Sci, Muscat, Oman; [Al-Rasadi, Khalid] Sultan Qaboos Univ, Med Res Ctr, Muscat, Oman; [Al-Sarraf, Ahmad] Sabah Al Ahmad Cardiac Ctr, Kuwait, Kuwait; [Al-Sayed, Nasreen] Gulf Diabet & Endocrine Ctr, Manama, Bahrain; [Araujo, Francisco] Portuguese Atherosclerosis Soc, Lisbon, Portugal; [Ashavaid, Tester F.] PD Hinduja Hosp & Med Res Ctr, Mumbai, Maharashtra, India; [Banach, Maciej] Med Univ Lodz, Dept Hypertens, Lodz, Poland; [Banach, Maciej] Polish Mothers Mem Hosp Res Inst, Lodz, Poland; [Banach, Maciej] Univ Zielona Gora, Cardiovasc Res Ctr, Zielona Gora, Poland; [Beliard, Sophie] Aix Marseille Univ, AP HM, Hop Concept, Marseille, France; [Beliard, Sophie] Aix Marseille Univ, Ctr Rech Cardiovasc & Nutr C2VN, INSERM 1260, INRAE,UMR 1263, Marseille, France; [Benn, Marianne; Tybjaerg-Hansen, Anne] Univ Copenhagen, Rigshosp, Dept Clin Biochem, Copenhagen, Denmark; [Benn, Marianne; Tybjaerg-Hansen, Anne] Univ Copenhagen, Dept Clin Med, Fac Hlth & Med Sci, Copenhagen, Denmark; [Binder, Christoph J.] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Bogsrud, Martin P.; Holven, Kirsten B.] Oslo Univ Hosp, Natl Advisory Unit Familial Hypercholesterolemia, Oslo, Norway; [Bourbon, Mafalda] Inst Nacl Saude Doutor Ricardo Jorge, Dept Promocao Saude & Prevencao Doencas Nao Trans, Unidade Invest & Desenvolvimento, Grp Invest Cardiovasc, Lisbon, Portugal; [Bourbon, Mafalda] Univ Lisbon, Biosyst & Integrat Sci Inst BioISI, Fac Sci, Lisbon, Portugal; [Chlebus, Krzysztof] Med Univ Gdansk, Natl Ctr Familial Hypercholesterolaemia Gdansk, Dept Cardiol 1, Gdansk, Poland; [Corral, Pablo] FASTA Univ, Sch Med, Pharmacol Dept, Mar Del Plata, Argentina; [Davletov, Kairat] Al Farabi Kazakh Natl Univ, Res Hlth Inst, Alma Ata, Kazakhstan; [Descamps, Olivier S.] Ctr Hosp Jolimont, Ctr Rech Med Jolimont, Haine St Paul, Belgium; [Durst, Ronen] Hadassah Hebrew Univ, Cardiol Dept, Med Ctr, Jerusalem, Israel; [Durst, Ronen] Hadassah Hebrew Univ, Ctr Treatment & Prevent Atherosclerosis, Med Ctr, Jerusalem, Israel; [Ezhov, Marat] Minist Hlth Russian Federat, Natl Med Res Ctr Cardiol, Moscow, Russia; [Gaita, Dan] Univ Med & Farm Timisoara, Inst Boli Cardiovasc, Fundatia Cardioprevent, Timisoara, Romania; [Genest, Jacques] McGill Univ, Res Inst, Hlth Ctr, Montreal, PQ, Canada; [Groselj, Urh] Univ Med Ctr, Dept Pediat Endocrinol Diabet & Metab, Ljubljana, Slovenia; [Groselj, Urh] Univ Childrens Hosp Ljubljana, Ljubljana, Slovenia; [Groselj, Urh] Univ Ljubljana, Fac Med, Ljubljana, Slovenia; [Harada-Shiba, Mariko] Natl Cerebral & Cardiovasc Ctr Res Inst, Osaka, Japan; [Kayikcioglu, Meral] Ege Univ, Dept Cardiol, Med Sch, Izmir, Turkey; [Khovidhunkit, Weerapan] Chulalongkorn Univ, Dept Med, Fac Med, Bangkok, Thailand; [Khovidhunkit, Weerapan] King Chulalongkorn Mem Hosp, Bangkok, Thailand; [Lalic, Katarina] Univ Belgrade, Clin Endocrinol Diabet & Metab Dis, Fac Med, Belgrade, Serbia; [Latkovskis, Gustavs] Univ Latvia, Res Inst Cardiol & Regenerat Med, Pauls Stradins Clin Univ Hosp, Fac Med, Riga, Latvia; [Laufs, Ulrich] Univ Klinikum Leipzig, Klin & Poliklin Kardiol, Leipzig, Germany; [Liberopoulos, Evangelos] Univ Ioannina, Dept Internal Med, Fac Med, Ioannina, Greece; [Tselepis, Alexandros D.] Univ Ioannina, Atherothrombosis Res Ctr, Ioannina, Greece; [Lima-Martinez, Marcos M.] Univ Oriente, Nucleo Bolivar, Ciudad Bolivar, Venezuela; [Lin, Jie] Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing Anzhen Hosp, Beijing, Peoples R China; [Maher, Vincent] Tallaght Univ Hosp, Adv Lipid Management & Res Ctr ALMAR, Dublin, Ireland; [Marais, A. David] Univ Cape Town, Chem Pathol, Hlth Sci Fac, Cape Town, South Africa; [Maerz, Winfried] DACH Soc Prevent Heart & Circulatory Dis, Hamburg, Germany; [Maerz, Winfried] Heidelberg Univ, Med Fac Mannheim, Dept Internal Med 5, Mannheim, Germany; [Maerz, Winfried] Med Univ Graz, Klin Inst Med & Chem Labordiagnostik, Graz, Austria; [Maerz, Winfried] Synlab Holding Deutschland, Synlab Akad, Mannheim, Germany; [Maerz, Winfried] Synlab Holding Deutschland, Synlab Akad, Augsburg, Germany; [Mirrakhimov, Erkin] Kyrgyz State Med Acad, Bishkek, Kyrgyzstan; [Miserez, Andre R.] Diagene Res Inst, Reinach, Switzerland; [Miserez, Andre R.] Swiss Soc Familial Forms Hypercholesterolemia SST, Reinach, Switzerland; [Miserez, Andre R.] Univ Basel, Fac Med, Basel, Switzerland; [Mitchenko, Olena] Natl Acad Med Sci, Inst Cardiol, Dyslipidaemia Dept, Kiev, Ukraine; [Nawawi, Hapizah] Univ Teknol MARA UiTM, Inst Pathol, Lab & Forens Med I PPerForM, Sungai Buloh, Selangor, Malaysia; [Nawawi, Hapizah] Univ Teknol MARA UiTM, Fac Med, Sungai Buloh, Selangor, Malaysia; [Nordestgaard, Borge G.] Univ Copenhagen, Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Copenhagen, Denmark; [Panayiotou, Andrie G.] Cyprus Univ Technol, Cyprus Int Inst Environm & Publ Hlth, Limassol, Cyprus; [Paragh, Gyorgy] Univ Debrecen, Dept Internal Med, Fac Med, Debrecen, Hungary; [Petrulioniene, Zaneta] Vilnius Univ, Fac Med, Vilnius, Lithuania; [Petrulioniene, Zaneta] Vilnius Univ Hosp Santaros Klinikos, Vilnius, Lithuania; [Pojskic, Belma] Cantonal Hosp Zenica, Zenica, Bosnia & Herceg; [Postadzhiyan, Arman] Med Univ Sofia, Sofia, Bulgaria; [Raslova, Katarina] Slovak Med Univ Bratislava, Coordinat Ctr Familial Hyperlipidemias, Bratislava, Slovakia; [Reda, Ashraf] Menoufia Univ, Cardiol Dept, Fac Med, Al Minufiyah, Egypt; [Reiner, Zeljko] Univ Zagreb, Univ Hosp Ctr Zagreb, Dept Internal Med, Zagreb, Croatia; [Reiner, Zeljko] Univ Zagreb, Sch Med, Zagreb, Croatia; [Sadiq, Fouzia] Shifa e Tameer Millat Univ, Directorate Res, Islamabad, Pakistan; [Sadoh, Wilson Ehidiamen] Univ Benin, Dept Child Hlth, Teaching Hosp, Benin, Nigeria; [Schunkert, Heribert] Tech Univ Munich, German Heart Ctr Munich, Clin Heart & Circulatory Dis, Munich, Germany; [Schunkert, Heribert] German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Munich, Germany; [Shek, Aleksandr B.] Minist Hlth Republ Uzbekistan, Coronary Heart Dis & Atherosclerosis Dept, Republican Specialized Ctr Cardiol, Tashkent, Uzbekistan; [Stoll, Mario] Comis Nacl Salud Cardiovasc, GENYCO Program, Montevideo, Uruguay; [Su, Ta-Chen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Su, Ta-Chen] Natl Taiwan Univ Hosp, Dept Environm & Occupat Med, Taipei, Taiwan; [Subramaniam, Tavintharan] Admiralty Med Ctr, Singapore, Singapore; [Subramaniam, Tavintharan] Khoo Teck Puat Hosp, Yishun Hlth, Singapore, Singapore; [Susekov, Andrey V.] Minist Hlth, Acad Postgrad Med Educ, Fac Clin Pharmacol & Therapeut, Moscow, Russia; [Tilney, Myra] Mater Dei Hosp, Lipid Clin, Msida, Malta; [Tilney, Myra] Univ Malta, Fac Med & Surg, Dept Med, Msida, Malta; [Tomlinson, Brian] Macau Univ Sci & Technol, Fac Med, Macau, Peoples R China; [Truong, Thanh Huong] Hanoi Med Univ, Vietnam Natl Heart Inst, Bach Mai Hosp, Hanoi, Vietnam; [Truong, Thanh Huong] Hanoi Med Univ, Dept Cardiol, Hanoi, Vietnam; [Vazquez Cardenas, Alejandra] Univ Autonoma Guadalajara, Fac Med, Zapopan, Mexico; [Viigimaa, Margus] Tallinn Univ Technol, North Estonia Med Ctr, Tallinn, Estonia; [Wang, Luya] Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing Anzhen Hosp, Beijing, Peoples R China; [Yamashita, Shizuya] Rinku Gen Med Ctr, Osaka, Japan; [Tokgozoglu, Lale] Hacettepe Univ, Dept Cardiol, Ankara, Turkey; [Catapano, Alberico L.] Univ Milan, Dept Pharmacol & Biomol Sci, Ctr Epidemiol & Prevent Pharmacol, Lab Lipoproteins Immun & Atherosclerosis, Milan, Italy; [Catapano, Alberico L.] Ist Ricovero & Cura Carattere Sci IRCCS MultiMed, Milan, Italy	Imperial College London; Masaryk University Brno; Masaryk University Brno; University of Amsterdam; Academic Medical Center Amsterdam; University of Witwatersrand; Universidade de Sao Paulo; Hospital Israelita Albert Einstein; University of Western Australia; Royal Perth Hospital; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Tecnologico de Monterrey; King Saud University; University of Al-Qadisiyah; Cleveland Clinic Foundation; Prince Sultan Cardiac Center; Sultan Qaboos University; Sultan Qaboos University; Medical University Lodz; Polish Mother's Memorial Hospital - Research Institute; University of Zielona Gora; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Rigshospitalet; University of Copenhagen; University of Copenhagen; Medical University of Vienna; University of Oslo; Instituto Nacional de Saude Dr. Ricardo Jorge; BIOISI; Universidade de Lisboa; Fahrenheit Universities; Medical University Gdansk; Al-Farabi Kazakh National University; Groupe Jolimont; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Ministry of Health of the Russian Federation; National Medical Research Center of Cardiology; Victor Babes University of Medicine & Pharmacy, Timisoara; McGill University; University Medical Centre Ljubljana; University Medical Centre Ljubljana; University of Ljubljana; National Cerebral & Cardiovascular Center - Japan; Ege University; Chulalongkorn University; Chulalongkorn University; University of Belgrade; Pauls Stradins Clinical University Hospital; University of Latvia; Leipzig University; University of Ioannina; University of Ioannina; Capital Medical University; University of Cape Town; Ruprecht Karls University Heidelberg; Medical University of Graz; SYNLAB Group; SYNLAB Group; Kyrgyz State Medical Academy; Ministry of Health - Kyrgyzstan; University of Basel; University of Geneva; National Academy of Medical Sciences of Ukraine; National Scientific Center M.D. Strazhesko Institute of Cardiology of the National Academy of Medical Sciences of Ukraine; University of Copenhagen; Cyprus International Institute for Environmental & Public Health; Cyprus University of Technology; University of Debrecen; Vilnius University; Medical University Sofia; Slovak Medical University Bratislava; Egyptian Knowledge Bank (EKB); Menofia University; University of Zagreb; University of Zagreb; University of Benin; German Heart Centre Munich; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Ministry of Health of the Russian Federation; University of Malta; Macau University of Science & Technology; Hanoi Medical University; Hanoi Medical University; Universidad Autonoma de Guadalajara; Tallinn University of Technology; Capital Medical University; Hacettepe University; University of Milan	Vallejo-Vaz, AJ (corresponding author), Imperial Coll London, Dept Primary Care & Publ Hlth, London W6 8RP, England.	a.vallejo-vaz@imperial.ac.uk	RAZALI, SALMI/N-4684-2019; INAMO, Jocelyn/AGZ-1674-2022; YILMAZ, Mehmet Birhan/Y-1372-2019; Ramli, Anis Safura/K-3322-2014; Santos, Raul/A-1170-2010; Banach, Maciej/A-1271-2009; Rafla, Samir/AAW-7646-2020; Shaposhnik, Igor I./P-2221-2015; PEDERIVA, CRISTINA/AAS-2600-2021; Gurevich, Victor/H-2935-2013; Mirrakhimov, Erkin/E-6900-2017; Gurevich, Victor/AAP-7641-2020; Popović, Ljiljana/ABC-1897-2021; Yenercag, Mustafa/AAL-3873-2020; Passaro, Angelina/P-3401-2015; YILDIRIR, Aylin/A-4947-2018; Lupi, Alessandro/N-6114-2019; Groselj, Urh/AHD-6396-2022; Rafla, Samir M/R-1269-2019; Postadzhiyan, Arman/GRS-2161-2022; Vallejo-Vaz, Antonio J./AAT-9301-2021; KAYIKCIOGLU, Meral/AAH-6687-2020; Bendary, Ahmed/AAH-3619-2019; Gaita, Dan/AGT-0656-2022; Sadiq, Fouzia/V-2131-2018; Bendary, Mohamed/GWN-0780-2022; Nawawi, Hapizah/N-7446-2019; Mandraffino, Giuseppe/K-4346-2018; Raal, FJ/ABD-5111-2021; celik, Ahmet/AAA-6615-2021; Bourbon, Mafalda/K-6866-2014; Diaz Diaz, Jose luis/Q-2523-2015; Ghaleb, Youmna/S-8427-2018; FEDERICI, MASSIMO/G-9940-2012; Alves, Ana Catarina/K-6455-2014; Wasag, Bartosz/Q-9630-2018	RAZALI, SALMI/0000-0003-3955-2729; YILMAZ, Mehmet Birhan/0000-0002-8169-8628; Ramli, Anis Safura/0000-0002-9517-1413; Santos, Raul/0000-0002-9860-6582; Banach, Maciej/0000-0001-6690-6874; Rafla, Samir/0000-0001-8688-6532; Gurevich, Victor/0000-0002-6815-444X; Mirrakhimov, Erkin/0000-0003-2982-6108; Gurevich, Victor/0000-0002-6815-444X; Yenercag, Mustafa/0000-0002-0933-7852; Passaro, Angelina/0000-0001-8462-7000; YILDIRIR, Aylin/0000-0001-8750-5287; Lupi, Alessandro/0000-0003-3644-0449; Groselj, Urh/0000-0002-5246-9869; Rafla, Samir M/0000-0001-8688-6532; Vallejo-Vaz, Antonio J./0000-0001-7954-1253; Bendary, Ahmed/0000-0002-0161-3779; Sadiq, Fouzia/0000-0001-9399-6078; Bendary, Mohamed/0000-0002-6777-0240; Nawawi, Hapizah/0000-0003-4462-8484; Mandraffino, Giuseppe/0000-0003-0272-2237; Raal, FJ/0000-0002-9170-7938; celik, Ahmet/0000-0002-9417-7610; BENSO, Andrea Silvio/0000-0001-8060-2834; Beliard, Sophie/0000-0002-6000-5028; Bourbon, Mafalda/0000-0001-8843-3799; Diaz Diaz, Jose luis/0000-0002-9194-495X; ismail, zaliha/0000-0003-1144-4451; KOTSIS, VASILIOS/0000-0002-3755-8097; VALERO, RENE/0000-0002-2176-3280; Ghaleb, Youmna/0000-0003-1137-0210; FEDERICI, MASSIMO/0000-0003-4989-5194; Alves, Ana Catarina/0000-0003-3157-7542; Abdalsahib, Ali/0000-0002-6792-5767; Seeger, Werner/0000-0003-1946-0894; ALNOURI, FAHAD/0000-0002-2315-8367; Wasag, Bartosz/0000-0002-3634-7562; ABIFADEL, Marianne/0000-0001-7645-8323; Nordestgaard, Borge/0000-0002-1954-7220; Kovac, Jernej/0000-0003-3080-4838; Durst, Ronen/0000-0003-3559-1050; Ibrahim, Khairul Shafiq/0000-0002-0507-8865; Truong, Huong/0000-0003-0316-9330; Araujo, Francisco/0000-0002-6224-4866; Ferhatbegovic (Pojskic), Lamija/0000-0002-1728-0649; Teh, Lay Kek/0000-0002-2830-4263; Lewek, Joanna/0000-0001-8737-2453; kim, ngoc thanh/0000-0002-1623-2530; Postadzhiyan, Arman/0000-0001-7643-142X; STEVENS, CHRISTOPHE A.T./0000-0002-7129-8524; Erglis, Andrejs/0000-0002-3999-0182; Rega-Kaun, Gersina/0000-0002-3110-481X; Nizamov, Ulugbek/0000-0001-6171-7652; Kozarova, Miriam/0000-0001-5596-8965; Davletov, Kairat/0000-0001-8534-1899	Pfizer Independent Grant for Learning Change [16157823]; Amgen; Merck Sharp Dohme; Sanofi-Aventis; Daiichi Sankyo; Regeneron; National Institute for Health Research (NIHR) Imperial Biomedical Research Centre, UK; NIHR; Czech Ministry of Health [NU20-02-00261]; Canadian Institutes of Health Research; Austrian Heart Foundation; Tyrolean Regional Government; Gulf Heart Association	Pfizer Independent Grant for Learning Change; Amgen(Amgen); Merck Sharp Dohme(Merck & Company); Sanofi-Aventis(Sanofi-Aventis); Daiichi Sankyo(Daiichi Sankyo Company Limited); Regeneron(Regeneron); National Institute for Health Research (NIHR) Imperial Biomedical Research Centre, UK; NIHR(National Institute for Health Research (NIHR)); Czech Ministry of Health(Ministry of Health, Czech Republic); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Austrian Heart Foundation; Tyrolean Regional Government; Gulf Heart Association	The EAS FHSC is an academic initiative that has received funding from a Pfizer Independent Grant for Learning & Change 2014 (16157823) and from investigator-initiated research grants to the European Atherosclerosis Society-Imperial College London from Amgen, Merck Sharp & Dohme, Sanofi-Aventis, Daiichi Sankyo, and Regeneron. KKR acknowledges support from the National Institute for Health Research (NIHR) Imperial Biomedical Research Centre, UK. KID acknowledges support from a PhD Studentship from NIHR under the Applied Health Research programme for Northwest London, UK (the views expressed in this publication are those of the authors and not necessarily those of the National Health Service, the NIHR, or the Department of Health). TF was supported by a grant from the Czech Ministry of Health (NU20-02-00261). JG receives support from the Canadian Institutes of Health Research. The Austrian Familial Hypercholesterolaemia registry has been supported by funds from the Austrian Heart Foundation and the Tyrolean Regional Government. The Gulf Familial Hypercholesterolaemia registry was done under the auspices of the Gulf Heart Association.	Beheshti S, 2018, CIRCULATION, V138, P578, DOI 10.1161/CIRCULATIONAHA.118.033470; Beheshti SO, 2020, J AM COLL CARDIOL, V75, P2553, DOI 10.1016/j.jacc.2020.03.057; Besseling J, 2016, ATHEROSCLEROSIS, V246, P1, DOI 10.1016/j.atherosclerosis.2015.12.033; Besseling J, 2015, JAMA-J AM MED ASSOC, V313, P1029, DOI 10.1001/jama.2015.1206; Cuchel M, 2014, EUR HEART J, V35, P2146, DOI 10.1093/eurheartj/ehu274; Grundy SM, 2019, CIRCULATION, V139, pE1082, DOI 10.1161/CIR.0000000000000625; Haase A, 2012, CURR OPIN LIPIDOL, V23, P282, DOI 10.1097/MOL.0b013e3283556c33; Harada-Shiba M, 2018, J ATHEROSCLER THROMB, V25, P751, DOI 10.5551/jat.CR003; Hovland A, 2019, STROKE, V50, P172, DOI 10.1161/STROKEAHA.118.023456; Hu PW, 2020, CIRCULATION, V141, P1742, DOI 10.1161/CIRCULATIONAHA.119.044795; Huijgen R, 2010, HUM MUTAT, V31, P752, DOI 10.1002/humu.21258; Mach F, 2020, EUR HEART J, V41, P111, DOI [10.1093/eurheartj/ehz455, 10.15829/1560-4071-2020-3826]; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; de Isla LP, 2016, ARTERIOSCL THROM VAS, V36, P2004, DOI 10.1161/ATVBAHA.116.307514; Ruel I, 2018, CAN J CARDIOL, V34, P1210, DOI 10.1016/j.cjca.2018.05.015; Vallejo-Vaz AJ, 2018, ATHEROSCLEROSIS, V277, P234, DOI 10.1016/j.atherosclerosis.2018.08.051; Vallejo-Vaz AJ, 2016, ATHEROSCLEROSIS SUPP, V22, P1, DOI 10.1016/j.atherosclerosissup.2016.10.001; Watts GF, 2020, NAT REV CARDIOL, V17, P360, DOI 10.1038/s41569-019-0325-8; WHO, 1998, FAM HYP FH REP WHO C; Wilemon KA, 2020, JAMA CARDIOL, V5, P217, DOI 10.1001/jamacardio.2019.5173	20	47	47	11	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 6	2021	398	10312					1713	1725		10.1016/S0140-6736(21)01122-3	http://dx.doi.org/10.1016/S0140-6736(21)01122-3		NOV 2021	13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WT4SQ	34506743	Green Submitted			2022-12-28	WOS:000715856000025
J	Xu, YC; Huangyang, PW; Wang, Y; Xue, LR; Devericks, E; Nguyen, HG; Yu, XY; Oses-Prieto, JA; Burlingame, AL; Miglani, S; Goodarzi, H; Ruggero, D				Xu, Yichen; Huangyang, Peiwei; Wang, Ying; Xue, Lingru; Devericks, Emily; Nguyen, Hao G.; Yu, Xiuyan; Oses-Prieto, Juan A.; Burlingame, Alma L.; Miglani, Sohit; Goodarzi, Hani; Ruggero, Davide			ER alpha is an RNA-binding protein sustaining tumor cell survival and drug resistance	CELL			English	Article							ESTROGEN-RECEPTOR-ALPHA; BREAST-CANCER; MESSENGER-RNA; ENDOCRINE RESISTANCE; ESTRADIOL-RECEPTOR; READ ALIGNMENT; STRESS; TRANSLATION; ACTIVATION; PATHWAY	Estrogen receptor alpha (ER alpha) is a hormone receptor and key driver for over 70% of breast cancers that has been studied for decades as a transcription factor. Unexpectedly, we discover that ER alpha is a potent non-canonical RNA-binding protein. We show that ER alpha RNA binding function is uncoupled from its activity to bind DNA and critical for breast cancer progression. Employing genome-wide cross-linking immunoprecipitation (CLIP) sequencing and a functional CRISPRi screen, we find that ER alpha-associated mRNAs sustain cancer cell fitness and elicit cellular responses to stress. Mechanistically, ER alpha controls different steps of RNA metabolism. In particular, we demonstrate that ER alpha RNA binding mediates alternative splicing of XBP1 and translation of the eIF4G2 and MCL1 mRNAs, which facilitates survival upon stress conditions and sustains tamoxifen resistance of cancer cells. ER alpha is therefore a multifaceted RNA-binding protein, and this activity transforms our knowledge of post-transcriptional regulation underlying cancer development and drug response.	[Xu, Yichen; Huangyang, Peiwei; Wang, Ying; Xue, Lingru; Devericks, Emily; Nguyen, Hao G.; Miglani, Sohit; Goodarzi, Hani; Ruggero, Davide] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94158 USA; [Ruggero, Davide] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Huangyang, Peiwei; Wang, Ying; Xue, Lingru; Devericks, Emily; Nguyen, Hao G.; Miglani, Sohit; Goodarzi, Hani; Ruggero, Davide] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA; [Xu, Yichen] Zhejiang Univ, Coll Pharmaceut Sci, Inst Pharmacol & Toxicol, Hangzhou 310058, Peoples R China; [Yu, Xiuyan] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Breast Surg, Hangzhou 310009, Peoples R China; [Oses-Prieto, Juan A.; Burlingame, Alma L.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Miglani, Sohit; Goodarzi, Hani] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Zhejiang University; Zhejiang University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ruggero, D (corresponding author), Univ Calif San Francisco, Dept Urol, San Francisco, CA 94158 USA.; Ruggero, D (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.; Ruggero, D (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA.	davide.ruggero@ucsf.edu	HUANG, YANGPEIWEI/AAS-7683-2021	HUANG, YANGPEIWEI/0000-0002-9131-3891	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF) [NIH P41GM103481, 1S10OD016229]; Department of Defense; Prostate Cancer Foundation Young Investigator and Challenge grants; National Institutes of Health (NIH) [R01CA24098]; Damon Runyon Postdoctoral Fellowship [DRG 2288-16]; Zhejiang University; NIH [R01CA140456, P01 CA165997, R35CA242986]; American Cancer Society (Research Professor Award)	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF); Department of Defense(United States Department of Defense); Prostate Cancer Foundation Young Investigator and Challenge grants; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Postdoctoral Fellowship; Zhejiang University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society (Research Professor Award)(American Cancer Society)	We would like to thank members of the Ruggero laboratory, especially M. McMahon and X. Pang, as well as R.J. Schneider (NYU) for discussion of the project and M. Barna (Stanford University) for reading and critical discussion on the manuscript. We thank L. Gilbert (UCSF) for providing reagents and technical support for CRISPRi cloning and screen processes; L. Fish (UCSF) for providing technical support for HITS-CLIP experiments; S. Thomas and P.N. Munster (UCSF) for providing the TamRM cell line; B. Yang, Q. He, M. Ying, and Z. Zhou (Zhejiang University) for providing reagents and support; H. Wang, K.Z. Guiley, and V. Stojkovic (UCSF) for technical assistance; G. Giamas (University of Sussex) and J. Stebbing (Imperial College London) for providing GST-ERa constructs; and eFFECTOR for providing zotatifin. Mass spectrometry was provided by the Mass Spectrometry Resource at UCSF (A.L. Burlingame, Director), supported by the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF) and NIH P41GM103481 and 1S10OD016229. H.G.N. was supported by Department of Defense and Prostate Cancer Foundation Young Investigator and Challenge grants. H.G. has received research support from National Institutes of Health (NIH) R01CA24098. Y.X. was supported by the Damon Runyon Postdoctoral Fellowship (DRG 2288-16) and a start-up grant at Zhejiang University. D.R. has received research support from the NIH (R01CA140456, P01 CA165997, and R35CA242986) and the American Cancer Society (Research Professor Award).	Acconcia F, 2006, CANCER RES, V66, P11030, DOI 10.1158/0008-5472.CAN-06-2676; Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Andruska ND, 2015, P NATL ACAD SCI USA, V112, P4737, DOI 10.1073/pnas.1403685112; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Bose DA, 2017, CELL, V168, P135, DOI 10.1016/j.cell.2016.12.020; Cabodi S, 2004, J CELL SCI, V117, P1603, DOI 10.1242/jcs.01025; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Cavalcante RG, 2017, BIOINFORMATICS, V33, P2381, DOI 10.1093/bioinformatics/btx183; Chen X, 2021, NAT REV CANCER, V21, P71, DOI 10.1038/s41568-020-00312-2; Chen X, 2014, NATURE, V508, P103, DOI 10.1038/nature13119; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; Cook KL, 2014, FASEB J, V28, P3891, DOI 10.1096/fj.13-247353; Cory S, 2016, TRENDS CANCER, V2, P443, DOI 10.1016/j.trecan.2016.07.001; Costa-Mattioli M, 2020, SCIENCE, V368, P384, DOI 10.1126/science.aat5314; Davies MPA, 2008, INT J CANCER, V123, P85, DOI 10.1002/ijc.23479; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Fan P, 2007, CANCER RES, V67, P1352, DOI 10.1158/0008-5472.CAN-06-1020; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Fritsch RM, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702673200; Gaillard H, 2015, NAT REV CANCER, V15, P276, DOI 10.1038/nrc3916; Geter PA, 2017, GENE DEV, V31, P2235, DOI 10.1101/gad.305631.117; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gomez BP, 2007, FASEB J, V21, P4013, DOI 10.1096/fj.06-7990com; Guan SH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010728; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hanker AB, 2020, CANCER CELL, V37, P496, DOI 10.1016/j.ccell.2020.03.009; Hart LS, 2012, J CLIN INVEST, V122, P4621, DOI 10.1172/JCI62973; Hayes JD, 2020, CANCER CELL, V38, P167, DOI 10.1016/j.ccell.2020.06.001; Herviou P, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16168-x; Hetz C, 2015, NAT CELL BIOL, V17, P829, DOI 10.1038/ncb3184; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.19760; Howell SJ, 2004, BEST PRACT RES CL EN, V18, P47, DOI 10.1016/j.beem.2003.08.002; Ishmael FT, 2011, J IMMUNOL, V186, P1189, DOI 10.4049/jimmunol.1001794; Jeselsohn R, 2015, NAT REV CLIN ONCOL, V12, P573, DOI 10.1038/nrclinonc.2015.117; Jin Y, 2020, TRENDS CANCER, V6, P160, DOI 10.1016/j.trecan.2019.12.001; Kanakkanthara A, 2016, SCIENCE, V353, P1549, DOI 10.1126/science.aaf7463; Katzenellenbogen JA, 2018, NAT REV CANCER, V18, P377, DOI 10.1038/s41568-018-0001-z; Krug K, 2020, CELL, V183, P1436, DOI 10.1016/j.cell.2020.10.036; Kumar P, 2007, MOL ENDOCRINOL, V21, P1370, DOI 10.1210/me.2006-0360; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lanz RB, 1999, CELL, V97, P17, DOI 10.1016/S0092-8674(00)80711-4; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Liberman N, 2015, NUCLEIC ACIDS RES, V43, P3764, DOI 10.1093/nar/gkv205; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Liu YS, 2016, CELL, V165, P535, DOI 10.1016/j.cell.2016.03.014; Lombardi M, 2008, J CELL BIOL, V182, P327, DOI 10.1083/jcb.200712125; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu YY, 2014, MOL CELL, V55, P758, DOI 10.1016/j.molcel.2014.06.032; LYKKESFELDT AE, 1994, CANCER RES, V54, P1587; Marash L, 2008, MOL CELL, V30, P447, DOI 10.1016/j.molcel.2008.03.018; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; Metcalfe C, 2018, ANNU REV CANC BIOL, V2, P291, DOI 10.1146/annurev-cancerbio-030617-050512; Migliaccio A, 1996, EMBO J, V15, P1292, DOI 10.1002/j.1460-2075.1996.tb00471.x; Ming J, 2015, ONCOTARGET, V6, P40692, DOI 10.18632/oncotarget.5827; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Nguyen HG, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2036; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Papandreou I, 2011, BLOOD, V117, P1311, DOI 10.1182/blood-2010-08-303099; Pereira B, 2017, TRENDS CANCER, V3, P506, DOI 10.1016/j.trecan.2017.05.003; Raha P, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0533-z; Ramirez-Valle F, 2008, J CELL BIOL, V181, P293, DOI 10.1083/jcb.200710215; Rapino F, 2018, NATURE, V558, P605, DOI 10.1038/s41586-018-0243-7; Robert F, 2014, P NATL ACAD SCI USA, V111, P13421, DOI 10.1073/pnas.1402650111; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Shah A, 2017, BIOINFORMATICS, V33, P566, DOI 10.1093/bioinformatics/btw653; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Song RX, 2004, P NATL ACAD SCI USA, V101, P2076, DOI 10.1073/pnas.0308334100; Song RXD, 2005, TRENDS ENDOCRIN MET, V16, P347, DOI 10.1016/j.tem.2005.06.010; Song RXD, 2002, MOL ENDOCRINOL, V16, P116, DOI 10.1210/me.16.1.116; Terribilini M, 2007, NUCLEIC ACIDS RES, V35, pW578, DOI 10.1093/nar/gkm294; Trendel J, 2019, CELL, V176, P391, DOI 10.1016/j.cell.2018.11.004; Urra H, 2016, TRENDS CANCER, V2, P252, DOI 10.1016/j.trecan.2016.03.007; Van Nostrand EL, 2020, NATURE, V583, P711, DOI 10.1038/s41586-020-2077-3; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Weingarten-Gabbay S, 2014, ONCOGENE, V33, P611, DOI 10.1038/onc.2012.626; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Wouters BG, 2005, SEMIN CELL DEV BIOL, V16, P487, DOI 10.1016/j.semcdb.2005.03.009; Xu YC, 2020, ANNU REV CANC BIOL, V4, P437, DOI 10.1146/annurev-cancerbio-030419-033420; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Younesy H, 2016, BIOINFORMATICS, V32, P3324, DOI 10.1093/bioinformatics/btw382; Zhang CL, 2011, NAT BIOTECHNOL, V29, P607, DOI 10.1038/nbt.1873; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	96	33	33	10	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 30	2021	184	20					5215	+		10.1016/j.cell.2021.08.036	http://dx.doi.org/10.1016/j.cell.2021.08.036		OCT 2021	32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	WC7PG	34559986	Bronze, Green Accepted			2022-12-28	WOS:000704445700016
J	Le Tacon, M				Le Tacon, Matthieu			Strange bedfellows inside a superconductor	SCIENCE			English	Editorial Material									[Le Tacon, Matthieu] Karlsruhe Inst Technol KIT, Inst Quantum Mat & Technol, D-76131 Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Le Tacon, M (corresponding author), Karlsruhe Inst Technol KIT, Inst Quantum Mat & Technol, D-76131 Karlsruhe, Germany.	matthieu.letacon@kit.edu						Comin R, 2014, SCIENCE, V343, P390, DOI 10.1126/science.1242996; Frano A, 2020, J PHYS-CONDENS MAT, V32, DOI 10.1088/1361-648X/ab6140; Ghiringhelli G, 2012, SCIENCE, V337, P821, DOI 10.1126/science.1223532; Hussey NE, 2004, PHILOS MAG, V84, P2847, DOI 10.1080/14786430410001716944; Keimer B, 2015, NATURE, V518, P179, DOI 10.1038/nature14165; Kim HH, 2018, SCIENCE, V362, P1040, DOI 10.1126/science.aat4708; Timusk T, 1999, REP PROG PHYS, V62, P61, DOI 10.1088/0034-4885/62/1/002; Varma CM, 2020, REV MOD PHYS, V92, DOI 10.1103/RevModPhys.92.031001; Wahlberg E, 2021, SCIENCE, V373, P1506, DOI 10.1126/science.abc8372	9	0	0	1	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2021	373	6562			SI		1438	1439		10.1126/science.abi9685	http://dx.doi.org/10.1126/science.abi9685			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU7LJ	34554774				2022-12-28	WOS:000698977800028
J	He, LL; Sun, JH; Gao, YW; Li, B; Wang, YH; Dong, YL; An, WD; Li, H; Yang, B; Ge, YH; Zhang, XJC; Shi, YS; Zhao, Y				He, Lingli; Sun, Jiahui; Gao, Yiwei; Li, Bin; Wang, Yuhang; Dong, Yanli; An, Weidong; Li, Hang; Yang, Bei; Ge, Yuhan; Zhang, Xuejun Cai; Shi, Yun Stone; Zhao, Yan			Kainate receptor modulation by NETO2	NATURE			English	Article							CRYO-EM; AUXILIARY SUBUNITS; ACTIVATION; EXPRESSION; MECHANISM; AMPA; RECTIFICATION; CHANNELS; GLUR5	Glutamate-gated kainate receptors are ubiquitous in the central nervous system of vertebrates, mediate synaptic transmission at the postsynapse and modulate transmitter release at the presynapse(1-7). In the brain, the trafficking, gating kinetics and pharmacology of kainate receptors are tightly regulated by neuropilin and tolloid-like (NETO) proteins(8-11). Here we report cryo-electron microscopy structures of homotetrameric GluK2 in complex with NETO2 at inhibited and desensitized states, illustrating variable stoichiometry of GluK2-NETO2 complexes, with one or two NETO2 subunits associating with GluK2. We find that NETO2 accesses only two broad faces of kainate receptors, intermolecularly crosslinking the lower lobe of ATD(A/C), the upper lobe of LBDB/D and the lower lobe of LBDA/C, illustrating how NETO2 regulates receptor-gating kinetics. The transmembrane helix of NETO2 is positioned proximal to the selectivity filter and competes with the amphiphilic H1 helix after M4 for interaction with an intracellular cap domain formed by the M1-M2 linkers of the receptor, revealing how rectification is regulated by NETO2.	[He, Lingli; Gao, Yiwei; Li, Bin; Wang, Yuhang; Dong, Yanli; An, Weidong; Li, Hang; Yang, Bei; Zhang, Xuejun Cai; Zhao, Yan] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing, Peoples R China; [He, Lingli; Dong, Yanli; Yang, Bei; Zhao, Yan] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing, Peoples R China; [He, Lingli; Gao, Yiwei; Li, Bin; Wang, Yuhang; Dong, Yanli; An, Weidong; Li, Hang; Yang, Bei; Zhang, Xuejun Cai; Zhao, Yan] Univ Chinese Acad Sci, Coll Life Sci, Beijing, Peoples R China; [Sun, Jiahui; Ge, Yuhan; Shi, Yun Stone] Nanjing Univ, Sch Med, Model Anim Res Ctr, Minist Educ,Key Lab Model Anim Dis Study, Nanjing, Peoples R China; [Sun, Jiahui; Ge, Yuhan; Shi, Yun Stone] Nanjing Univ, Affiliated Drum Tower Hosp, Dept Neurol, State Key Lab Pharmaceut Biotechnol,Med Sch, Nanjing, Peoples R China; [Shi, Yun Stone] Nanjing Univ, Inst Brain Sci, Nanjing, Peoples R China; [Shi, Yun Stone] Nanjing Univ, Chem & Biomed Innovat Ctr, Nanjing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Nanjing University; Nanjing University; Nanjing University; Nanjing University	Zhang, XJC; Zhao, Y (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing, Peoples R China.; Zhao, Y (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing, Peoples R China.; Zhang, XJC; Zhao, Y (corresponding author), Univ Chinese Acad Sci, Coll Life Sci, Beijing, Peoples R China.; Shi, YS (corresponding author), Nanjing Univ, Sch Med, Model Anim Res Ctr, Minist Educ,Key Lab Model Anim Dis Study, Nanjing, Peoples R China.; Shi, YS (corresponding author), Nanjing Univ, Affiliated Drum Tower Hosp, Dept Neurol, State Key Lab Pharmaceut Biotechnol,Med Sch, Nanjing, Peoples R China.; Shi, YS (corresponding author), Nanjing Univ, Inst Brain Sci, Nanjing, Peoples R China.; Shi, YS (corresponding author), Nanjing Univ, Chem & Biomed Innovat Ctr, Nanjing, Peoples R China.	zhangc@ibp.ac.cn; yunshi@nju.edu.cn; zhaoy@ibp.ac.cn	Shi, Yun S/T-8845-2018; Gao, Yiwei/T-7401-2018; Shi, Yun/B-5623-2009	Gao, Yiwei/0000-0001-8169-9332; Shi, Yun/0000-0002-8842-9818; Sun, Jiahui/0000-0002-1375-9409; Dong, Yanli/0000-0002-7919-3276	Chinese Academy of Sciences Strategic Priority Research Program [XDB37030304, XDB37030301]; National Key R & D Program of China [2019YFA0801603]; National Natural Science Foundation of China [91849112, 31971134]; Natural Science Foundation of Jiangsu Province [BE2019707]; Fundamental Research Funds for the Central Universities [0903-14380029]	Chinese Academy of Sciences Strategic Priority Research Program; National Key R & D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	We thank X. Huang, B. Zhu, X. Li, L. Chen and other staff members at the Center for Biological Imaging (CBI), Core Facilities for Protein Science at the Institute of Biophysics, Chinese Academy of Science (IBP, CAS) for the support in cryo-EM data collection; N. Sheng for providing the cDNAs of GluK2 and NETO2; and Y. Wu for his research assistant service. This work is funded by the Chinese Academy of Sciences Strategic Priority Research Program (grant XDB37030304 to Y.Z. and grant XDB37030301 to X.C.Z.), the National Key R & D Program of China (2019YFA0801603 to Y.S.S.), the National Natural Science Foundation of China (91849112 to Y.S.S. and 31971134 to X.C.Z.), the Natural Science Foundation of Jiangsu Province (BE2019707 to Y.S.S.) and the Fundamental Research Funds for the Central Universities (0903-14380029 to Y.S.S.).	Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Appleton BA, 2007, EMBO J, V26, P4902, DOI 10.1038/sj.emboj.7601906; Bepler T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18952-1; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Briggs DC, 2015, J BIOL CHEM, V290, P28708, DOI 10.1074/jbc.M115.669838; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chen SS, 2017, CELL, V170, P1234, DOI 10.1016/j.cell.2017.07.045; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; Copits BA, 2012, NAT REV NEUROSCI, V13, P675, DOI 10.1038/nrn3335; Copits BA, 2011, J NEUROSCI, V31, P7334, DOI 10.1523/JNEUROSCI.0100-11.2011; Delano W.L., 2002, CCP4 NEWSLETTER PROC, V40, P82; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fisher JL, 2012, J NEUROSCI, V32, P12928, DOI 10.1523/JNEUROSCI.2211-12.2012; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; Khanra N, 2021, ELIFE, V10, DOI 10.7554/eLife.66097; KOHLER M, 1993, NEURON, V10, P491, DOI 10.1016/0896-6273(93)90336-P; Kumar J, 2011, NEURON, V71, P319, DOI 10.1016/j.neuron.2011.05.038; Kumari J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46770-z; Li YJ, 2019, J BIOL CHEM, V294, P17889, DOI 10.1074/jbc.RA119.008631; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Meyerson JR, 2016, NATURE, V537, P567, DOI 10.1038/nature19352; Meyerson JR, 2014, NATURE, V514, P328, DOI 10.1038/nature13603; Nayeem N, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130051; Pinheiro PS, 2013, CEREB CORTEX, V23, P323, DOI 10.1093/cercor/bhs022; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Straub C, 2011, J NEUROSCI, V31, P8078, DOI 10.1523/JNEUROSCI.0024-11.2011; Tang M, 2011, J NEUROSCI, V31, P10009, DOI 10.1523/JNEUROSCI.6617-10.2011; Tomita S, 2012, J PHYSIOL-LONDON, V590, P2217, DOI 10.1113/jphysiol.2011.221101; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Zhang DY, 2021, NATURE, V594, P454, DOI 10.1038/s41586-021-03613-0; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang W, 2009, NEURON, V61, P385, DOI 10.1016/j.neuron.2008.12.014; Zhao Y, 2016, NATURE, V536, P108, DOI 10.1038/nature18961; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	44	9	9	8	33	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 11	2021	599	7884					325	+		10.1038/s41586-021-03936-y	http://dx.doi.org/10.1038/s41586-021-03936-y		SEP 2021	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XC6YT	34552241				2022-12-28	WOS:000698366900005
J	Oxtoby, K				Oxtoby, Kathy			Blending patient care and academia: the consultant ophthalmologist	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								The ophthalmologist talks to Kathy Oxtoby about her dual role as a clinician and an academic, and how her parents influenced her career											0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 20	2021	374								n2218	10.1136/bmj.n2218	http://dx.doi.org/10.1136/bmj.n2218			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ1DH	34544727	Bronze			2022-12-28	WOS:000701952000006
J	Hippisley-Cox, J; Coupland, CAC; Mehta, N; Keogh, RH; Diaz-Ordaz, K; Khunti, K; Lyons, RA; Kee, F; Sheikh, A; Rahman, S; Valabhji, J; Harrison, EM; Sellen, P; Haq, N; Semple, MG; Johnson, PWM; Hayward, A; Nguyen-Van-Tam, JS				Hippisley-Cox, Julia; Coupland, Carol A. C.; Mehta, Nisha; Keogh, Ruth H.; Diaz-Ordaz, Karla; Khunti, Kamlesh; Lyons, Ronan A.; Kee, Frank; Sheikh, Aziz; Rahman, Shamim; Valabhji, Jonathan; Harrison, Ewen M.; Sellen, Peter; Haq, Nazmus; Semple, Malcolm G.; Johnson, Peter W. M.; Hayward, Andrew; Nguyen-Van-Tam, Jonathan S.			Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEMODIALYSIS; VALIDATION; INHIBITORS; DISEASE	OBJECTIVES To derive and validate risk prediction algorithms to estimate the risk of covid-19 related mortality and hospital admission in UK adults after one or two doses of covid-19 vaccination. DESIGN Prospective, population based cohort study using the QResearch database linked to data on covid-19 vaccination, SARS-CoV-2 results, hospital admissions, systemic anticancer treatment, radiotherapy, and the national death and cancer registries. SETTINGS Adults aged 19-100 years with one or two doses of covid-19 vaccination between 8 December 2020 and 15 June 2021. MAIN OUTCOME MEASURES Primary outcome was covid-19 related death. Secondary outcome was covid-19 related hospital admission. Outcomes were assessed from 14 days after each vaccination dose. Models were fitted in the derivation cohort to derive risk equations using a range of predictor variables. Performance was evaluated in a separate validation cohort of general practices. RESULTS Of 6 952 440 vaccinated patients in the derivation cohort, 5 150 310 (74.1%) had two vaccine doses. Of 2031 covid-19 deaths and 1929 covid-19 hospital admissions, 81 deaths (4.0%) and 71 admissions (3.7%) occurred 14 days or more after the second vaccine dose. The risk algorithms included age, sex, ethnic origin, deprivation, body mass index, a range of comorbidities, and SARS-CoV-2 infection rate. Incidence of covid-19 mortality increased with age and deprivation, male sex, and Indian and Pakistani ethnic origin. Cause specific hazard ratios were highest for patients with Down's syndrome (12.7-fold increase), kidney transplantation (8.1-fold), sickle cell disease (7.7-fold), care home residency (4.1-fold), chemotherapy (4.3-fold), HIV/AIDS (3.3-fold), liver cirrhosis (3.0-fold), neurological conditions (2.6-fold), recent bone marrow transplantation or a solid organ transplantation ever (2.5-fold), dementia (2.2-fold), and Parkinson's disease (2.2-fold). Other conditions with increased risk (ranging from 1.2-fold to 2.0-fold increases) included chronic kidney disease, blood cancer, epilepsy, chronic obstructive pulmonary disease, coronary heart disease, stroke, atrial fibrillation, heart failure, thromboembolism, peripheral vascular disease, and type 2 diabetes. A similar pattern of associations was seen for covid-19 related hospital admissions. No evidence indicated that associations differed after the second dose, although absolute risks were reduced. The risk algorithm explained 74.1% (95% confidence interval 71.1% to 77.0%) of the variation in time to covid-19 death in the validation cohort. Discrimination was high, with a D statistic of 3.46 (95% confidence interval 3.19 to 3.73) and C statistic of 92.5. Performance was similar after each vaccine dose. In the top 5% of patients with the highest predicted covid-19 mortality risk, sensitivity for identifying covid-19 deaths within 70 days was 78.7%. CONCLUSION This population based risk algorithm performed well showing high levels of discrimination for identifying those patients at highest risk of covid-19 related death and hospital admission after vaccination.	[Hippisley-Cox, Julia; Coupland, Carol A. C.] Univ Oxford, Nuffield Dept Primary Hlth Care Sci, Oxford, England; [Coupland, Carol A. C.; Nguyen-Van-Tam, Jonathan S.] Univ Nottingham, Sch Med, Div Primary Care, Nottingham, England; [Mehta, Nisha] NHS X, London, England; [Keogh, Ruth H.; Diaz-Ordaz, Karla] London Sch Hyg & Trop Med, Dept Med Stat, London, England; [Keogh, Ruth H.; Diaz-Ordaz, Karla] London Sch Hyg & Trop Med, Ctr Stat Methodol, London, England; [Khunti, Kamlesh] Univ Leicester, Diabet Res Ctr, Leicester, Leics, England; [Lyons, Ronan A.] Swansea Univ, Populat Data Sci, Swansea, W Glam, Wales; [Kee, Frank] Queens Univ, Belfast, Antrim, North Ireland; [Sheikh, Aziz; Harrison, Ewen M.] Univ Edinburgh, Usher Inst, Edinburgh, Midlothian, Scotland; [Rahman, Shamim; Sellen, Peter; Haq, Nazmus; Nguyen-Van-Tam, Jonathan S.] Dept Hlth & Social Care, England, England; [Valabhji, Jonathan; Johnson, Peter W. M.] NHS England & Improvement, London, England; [Semple, Malcolm G.] Univ Liverpool, Fac Hlth & Life Sci, Inst Infect Vet & Ecol Sci, NIHR Hlth Protect Res Unit, Liverpool, Merseyside, England; [Hayward, Andrew] UCL, Inst Epidemiol & Hlth Care, London, England	University of Oxford; University of Nottingham; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Leicester; Swansea University; Queens University Belfast; University of Edinburgh; University of Liverpool; University of London; University College London	Hippisley-Cox, J (corresponding author), Univ Oxford, Nuffield Dept Primary Hlth Care Sci, Oxford, England.	julia.hippisley-cox@phc.ox.ac.uk	Johnson, Peter/L-2403-2018; Hippisley-Cox, Julia/AAY-2788-2020; /ABC-9527-2021; Semple, Malcolm Gracie/A-8790-2008	Johnson, Peter/0000-0003-2306-4974; Hippisley-Cox, Julia/0000-0002-2479-7283; Valabhji, Jonathan/0000-0001-9756-4061; Semple, Malcolm Gracie/0000-0001-9700-0418; Keogh, Ruth/0000-0001-6504-3253; Khunti, Kamlesh/0000-0003-2343-7099	National Institute for Health Research (NIHR); John Fell Oxford University Press Research Fund; Cancer Research UK, through the Cancer Research UK Oxford Centre [C5255/A18085]; Oxford Wellcome Institutional Strategic Support Fund [204826/Z/16/Z]	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); John Fell Oxford University Press Research Fund; Cancer Research UK, through the Cancer Research UK Oxford Centre; Oxford Wellcome Institutional Strategic Support Fund	This study was funded by the National Institute for Health Research (NIHR) following a commission by the Chief Medical Officer for England. The researchers are independent from the NIHR. QResearch was supported by funds from the John Fell Oxford University Press Research Fund, grants from Cancer Research UK (grant C5255/A18085) , through the Cancer Research UK Oxford Centre, grants from the Oxford Wellcome Institutional Strategic Support Fund (204826/Z/16/Z) , during the conduct of the study. The funders had no role in considering the study design or in the collection, analysis, interpretation of data, writing of the report, or decision to submit the article for publication.	Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Bailey, 2021, BRIDGE IDEAL POINTS; Baker RJ, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0553-2; Cavdar C, 2003, SCAND J UROL NEPHROL, V37, P71, DOI 10.1080/00365590310008749; Clift AK, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3731; Clift AK, 2021, ANN INTERN MED, V174, P572, DOI 10.7326/M20-4986; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.1016/j.jclinepi.2014.11.010, 10.7326/M14-0697, 10.1136/bmj.g7594, 10.1186/s12916-014-0241-z, 10.1016/j.eururo.2014.11.025, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Collins GS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4181; Collins GS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2442; Collins GS, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2584; Coviello V, 2004, STATA J, V4, P103, DOI 10.1177/1536867X0400400201; Dafni U, 2011, CIRC-CARDIOVASC QUAL, V4, P363, DOI 10.1161/CIRCOUTCOMES.110.957951; Gao M, 2021, LANCET DIABETES ENDO, V9, P350, DOI 10.1016/S2213-8587(21)00089-9; Garthwaite E, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1529-1; Goodhand, INFLIXIMAB IS ASS AL, V2021, DOI [10.1101/2021.03.25.21254335, DOI 10.1101/2021.03.25.21254335]; Hippisley-Cox J, 2005, BMJ-BRIT MED J, V330, P1366, DOI 10.1136/bmj.330.7504.1366; Hippisley-Cox J, 2020, PROTOCOL DEV EVALUAT, DOI [DOI 10.1101/2020.06.28.20141986, 10.1101/2020.06.28.20141986]; Hippisley-Cox J, 2020, HEART, V106, P1503, DOI [10.1136/heartjnl-2020-317393, 10.1136/heartjnl-2020-318312]; Hippisley-Cox J, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5019; Hippisley-Cox J, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j4208; Hippisley-Cox J, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2099; Hoes J, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00209; Kalbfleisch J.D., 1980, STAT ANAL FAILURE TI, DOI [10.1002/9781118032985, DOI 10.1002/9781118032985]; Katikireddi SV, 2021, J EPIDEMIOL COMMUN H, V75, P970, DOI 10.1136/jech-2020-216061; Kengne AP, 2014, LANCET DIABETES ENDO, V2, P19, DOI 10.1016/S2213-8587(13)70103-7; Lim SH, 2021, LANCET HAEMATOL, V8, pE542, DOI 10.1016/S2352-3026(21)00199-X; Little R.J.A., 2002, STAT ANAL MISSING DA, V2nd Edn, DOI [10.1002/9781119013563, DOI 10.1002/9781119013563]; Nafilyan V, 2021, LANCET DIGIT HEALTH, V3, pE425, DOI 10.1016/S2589-7500(21)00080-7; NHS Digital, 2021, COR SHIELD PAT LIST; Patone M, 2021, LANCET INFECT DIS, V21, P1518, DOI 10.1016/S1473-3099(21)00318-2; Pike MM, 2016, J CARDIOVASC TRANSL, V9, P214, DOI 10.1007/s12265-016-9687-z; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Remschmidt C, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0244-9; Royston P, 2006, STATA J, V6, P83, DOI 10.1177/1536867X0600600105; Sattar N, 2020, CIRCULATION, V142, P4, DOI 10.1161/CIRCULATIONAHA.120.047659; STEVENS CE, 1984, NEW ENGL J MED, V311, P496, DOI 10.1056/NEJM198408233110803; Townsend P, 1982, THE BLACK REPORT; UK Government, 2021, COVID 19 DEATHS UK 2; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Wall EC, 2021, LANCET, V397, P2331, DOI 10.1016/S0140-6736(21)01290-3; Wolbers M, 2014, BIOSTATISTICS, V15, P526, DOI 10.1093/biostatistics/kxt059; Zimmermann P, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00084-18	42	86	86	10	32	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2021	374								n2244	10.1136/bmj.n2244	http://dx.doi.org/10.1136/bmj.n2244			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WC6LC	34535466	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000704366700006
J	Ghiotto, A; Shih, EM; Pereira, GSSG; Rhodes, DA; Kim, B; Zang, JW; Millis, AJ; Watanabe, K; Taniguchi, T; Hone, JC; Wang, L; Dean, CR; Pasupathy, AN				Ghiotto, Augusto; Shih, En-Min; Pereira, Giancarlo S. S. G.; Rhodes, Daniel A.; Kim, Bumho; Zang, Jiawei; Millis, Andrew J.; Watanabe, Kenji; Taniguchi, Takashi; Hone, James C.; Wang, Lei; Dean, Cory R.; Pasupathy, Abhay N.			Quantum criticality in twisted transition metal dichalcogenides	NATURE			English	Article							MAGIC-ANGLE; HUBBARD-MODEL; SUPERCONDUCTIVITY; TEMPERATURE; INSULATOR; FIELD; SCATTERING; STATES; MOTT	Metal-to-insulator transitions are characterized in twisted WSe, revealing strange metal behaviour and quantum criticality at low temperatures. Near the boundary between ordered and disordered quantum phases, several experiments have demonstrated metallic behaviour that defies the Landau Fermi paradigm(1-5). In moire heterostructures, gate-tuneable insulating phases driven by electronic correlations have been recently discovered(6-23). Here, we use transport measurements to characterize metal-insulator transitions (MITs) in twisted WSe2 near half filling of the first moire subband. We find that the MIT as a function of both density and displacement field is continuous. At the metal-insulator boundary, the resistivity displays strange metal behaviour at low temperatures, with dissipation comparable to that at the Planckian limit. Further into the metallic phase, Fermi liquid behaviour is recovered at low temperature, and this evolves into a quantum critical fan at intermediate temperatures, before eventually reaching an anomalous saturated regime near room temperature. An analysis of the residual resistivity indicates the presence of strong quantum fluctuations in the insulating phase. These results establish twisted WSe2 as a new platform to study doping and bandwidth-controlled metal-insulator quantum phase transitions on the triangular lattice.	[Ghiotto, Augusto; Shih, En-Min; Pereira, Giancarlo S. S. G.; Zang, Jiawei; Millis, Andrew J.; Wang, Lei; Dean, Cory R.; Pasupathy, Abhay N.] Columbia Univ, Dept Phys, 538 W 120th St, New York, NY 10027 USA; [Rhodes, Daniel A.; Kim, Bumho; Hone, James C.] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA; [Millis, Andrew J.] Flatiron Inst, Ctr Computat Quantum Phys, New York, NY USA; [Watanabe, Kenji; Taniguchi, Takashi] Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan; [Wang, Lei] Nanjing Univ, Sch Phys, Natl Lab Solid State Microstruct, Nanjing, Peoples R China; [Pasupathy, Abhay N.] Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Div, Upton, NY 11973 USA	Columbia University; Columbia University; National Institute for Materials Science; Nanjing University; United States Department of Energy (DOE); Brookhaven National Laboratory	Wang, L; Dean, CR; Pasupathy, AN (corresponding author), Columbia Univ, Dept Phys, 538 W 120th St, New York, NY 10027 USA.; Wang, L (corresponding author), Nanjing Univ, Sch Phys, Natl Lab Solid State Microstruct, Nanjing, Peoples R China.; Pasupathy, AN (corresponding author), Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Div, Upton, NY 11973 USA.	leiwang@nju.edu.cn; cd2478@columbia.edu; apn2108@columbia.edu	Hone, James C/E-1879-2011; Kim, Bumho/ABB-9949-2021; Watanabe, Kenji/ABB-2135-2021; Wang, Lei/K-1160-2012	Hone, James C/0000-0002-8084-3301; Watanabe, Kenji/0000-0003-3701-8119; Wang, Lei/0000-0002-1919-9107; Ghiotto, Augusto/0000-0003-0860-9817; Zang, Jiawei/0000-0002-3671-9282; Shih, En-Min/0000-0001-8423-1428	National Science Foundation [DMR-2011738] Funding Source: Medline; US Department of Energy [DE-SC0019443] Funding Source: Medline	National Science Foundation(National Science Foundation (NSF)); US Department of Energy(United States Department of Energy (DOE))		Bruin JAN, 2013, SCIENCE, V339, P804, DOI 10.1126/science.1227612; Burg GW, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.197702; Cao Y, 2020, NATURE, V583, P215, DOI 10.1038/s41586-020-2260-6; Cao Y, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.076801; Cao Y, 2018, NATURE, V556, P80, DOI 10.1038/nature26154; Cao Y, 2018, NATURE, V556, P43, DOI 10.1038/nature26160; Chen GR, 2019, NAT PHYS, V15, P237, DOI 10.1038/s41567-018-0387-2; Chen SW, 2021, NAT PHYS, V17, P374, DOI 10.1038/s41567-020-01062-6; Giraldo-Gallo P, 2018, SCIENCE, V361, P479, DOI 10.1126/science.aan3178; Hao ZY, 2021, SCIENCE, V371, P1133, DOI 10.1126/science.abg0399; Hayes IM, 2016, NAT PHYS, V12, P916, DOI [10.1038/NPHYS3773, 10.1038/nphys3773]; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; Kerelsky A, 2019, NATURE, V572, P95, DOI 10.1038/s41586-019-1431-9; Kim K, 2016, NANO LETT, V16, P1989, DOI 10.1021/acs.nanolett.5b05263; Kormanyos A, 2015, 2D MATER, V2, DOI 10.1088/2053-1583/2/2/022001; Liu XM, 2020, NATURE, V583, P221, DOI 10.1038/s41586-020-2458-7; Motrunich OI, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.045105; Movva HCP, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.247701; Movva HCP, 2015, ACS NANO, V9, P10402, DOI 10.1021/acsnano.5b04611; Pan HN, 2021, PHYS REV LETT, V127, DOI 10.1103/PhysRevLett.127.096802; Pan HN, 2020, PHYS REV RES, V2, DOI 10.1103/PhysRevResearch.2.033087; Park JM, 2021, NATURE, V590, DOI 10.1038/s41586-021-03192-0; Paschen S, 2021, NAT REV PHYS, V3, P9, DOI 10.1038/s42254-020-00262-6; Regan EC, 2020, NATURE, V579, P359, DOI 10.1038/s41586-020-2092-4; Rubio-Verdu C., 2020, UNIVERSAL MOIRE NEMA; Sahebsara P, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.136402; Senthil T, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.045109; Sharma G., 2020, CARRIER TRANSPORT TH; Shen C, 2020, NAT PHYS, V16, P520, DOI 10.1038/s41567-020-0825-9; Szasz A, 2020, PHYS REV X, V10, DOI 10.1103/PhysRevX.10.021042; Taillefer L, 2010, ANNU REV CONDEN MA P, V1, P51, DOI 10.1146/annurev-conmatphys-070909-104117; Tang YH, 2020, NATURE, V579, P353, DOI 10.1038/s41586-020-2085-3; Varma CM, 2020, REV MOD PHYS, V92, DOI 10.1103/RevModPhys.92.031001; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; Wang L, 2020, NAT MATER, V19, P861, DOI 10.1038/s41563-020-0708-6; Xu SG, 2021, NAT PHYS, V17, P619, DOI 10.1038/s41567-021-01172-9; Yankowitz M, 2019, SCIENCE, V363, P1059, DOI 10.1126/science.aav1910; Zaanen J, 2004, NATURE, V430, P512, DOI 10.1038/430512a; Zhang ZM, 2020, NAT PHYS, V16, P1093, DOI 10.1038/s41567-020-0958-x	42	54	55	28	94	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 16	2021	597	7876					345	+		10.1038/s41586-021-03815-6	http://dx.doi.org/10.1038/s41586-021-03815-6			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UQ8UQ	34526705	Green Submitted			2022-12-28	WOS:000696334600007
J	Gouveia-Moraes, F; Campos, N				Gouveia-Moraes, Filipe; Campos, Nuno			Conjunctival Kaposi's Sarcoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gouveia-Moraes, Filipe; Campos, Nuno] Hosp Garcia Orta Almada, Almada, Portugal	Hospital Garcia de Orta	Gouveia-Moraes, F (corresponding author), Hosp Garcia Orta Almada, Almada, Portugal.	filipegouveia94@gmail.com	Gouveia-Moraes, Filipe/ABD-3513-2021	Gouveia-Moraes, Filipe/0000-0003-0584-9735					0	0	0	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2021	385	12							e36	10.1056/NEJMicm2105217	http://dx.doi.org/10.1056/NEJMicm2105217			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UQ4IT	34525288				2022-12-28	WOS:000696029600004
J	Wise, J				Wise, Jacqui			Cross government strategy needed to reduce health inequalities, says alliance	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Rimmer A, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4134	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 15	2021	374								n2275	10.1136/bmj.n2275	http://dx.doi.org/10.1136/bmj.n2275			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UY0UP	34526305				2022-12-28	WOS:000701248800002
J	Iacobucci, G				Iacobucci, Gareth			BMA moves to neutral position on assisted dying	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, GUARDIAN 0914; Chisholm J., 2020, BMA PHYS ASSISTED DY; Torjesen I, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3936; Williams RD, BMJ-BRIT MED J, V2021	4	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2021	374								n2262	10.1136/bmj.n2262	http://dx.doi.org/10.1136/bmj.n2262			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WP7CH	34521626				2022-12-28	WOS:000713284400007
J	Mahase, E				Mahase, Elisabeth			Chronic neglect of NHS contributed to excessive and tragic impact of the pandemic, says BMA council chair	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mahase E, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2234	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2021	374								n2241	10.1136/bmj.n2241	http://dx.doi.org/10.1136/bmj.n2241			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WP7CH	34521643	Bronze			2022-12-28	WOS:000713284400002
J	Robbins, MS				Robbins, Matthew S.			Poloxamer 188 vs Placebo for Painful Vaso-occlusive Episodes in Children and Adults With Sickle Cell Disease Reply	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							HEADACHE; MIGRAINE		[Robbins, Matthew S.] Weill Cornell Med Coll, Dept Neurol, New York, NY USA	Cornell University	Robbins, MS (corresponding author), Weill Cornell Med, 520 E 70th St,Starr Pavil 607, New York, NY 10021 USA.	mar9391@med.cornell.edu						Diener HC, 2015, CEPHALALGIA, V35, P465, DOI 10.1177/0333102414545895; Holland S, 2012, NEUROLOGY, V78, P1346, DOI 10.1212/WNL.0b013e3182535d0c; Loder E, 2013, HEADACHE, V53, P1651, DOI 10.1111/head.12233; Robbins MS, 2021, JAMA-J AM MED ASSOC, V325, P1874, DOI 10.1001/jama.2021.1640; Seminowicz DA, 2020, PAIN, V161, P1837, DOI 10.1097/j.pain.0000000000001860; Zhang NS, 2020, HEADACHE, V60, P309, DOI 10.1111/head.13723	6	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2021	326	10					977	+						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UW4LI	34519803				2022-12-28	WOS:000700129100032
J	Lee, S; Yu, Y; Trimpert, J; Benthani, F; Mairhofer, M; Richter-Pechanska, P; Wyler, E; Belenki, D; Kaltenbrunner, S; Pammer, M; Kausche, L; Firsching, TC; Dietert, K; Schotsaert, M; Martinez-Romero, C; Singh, G; Kunz, S; Niemeyer, D; Ghanem, R; Salzer, HJF; Paar, C; Mulleder, M; Uccellini, M; Michaelis, EG; Khan, A; Lau, A; Schonlein, M; Habringer, A; Tomasits, J; Adler, JM; Kimeswenger, S; Gruber, AD; Hoetzenecker, W; Steinkellner, H; Purfurst, B; Motz, R; Di Pierro, F; Lamprecht, B; Osterrieder, N; Landthaler, M; Drosten, C; Garcia-Sastre, A; Langer, R; Ralser, M; Eils, R; Reimann, M; Fan, DNY; Schmitt, CA				Lee, Soyoung; Yu, Yong; Trimpert, Jakob; Benthani, Fahad; Mairhofer, Mario; Richter-Pechanska, Paulina; Wyler, Emanuel; Belenki, Dimitri; Kaltenbrunner, Sabine; Pammer, Maria; Kausche, Lea; Firsching, Theresa C.; Dietert, Kristina; Schotsaert, Michael; Martinez-Romero, Carles; Singh, Gagandeep; Kunz, Severine; Niemeyer, Daniela; Ghanem, Riad; Salzer, Helmut J. F.; Paar, Christian; Mulleder, Michael; Uccellini, Melissa; Michaelis, Edward G.; Khan, Amjad; Lau, Andrea; Schonlein, Martin; Habringer, Anna; Tomasits, Josef; Adler, Julia M.; Kimeswenger, Susanne; Gruber, Achim D.; Hoetzenecker, Wolfram; Steinkellner, Herta; Purfurst, Bettina; Motz, Reinhard; Di Pierro, Francesco; Lamprecht, Bernd; Osterrieder, Nikolaus; Landthaler, Markus; Drosten, Christian; Garcia-Sastre, Adolfo; Langer, Rupert; Ralser, Markus; Eils, Roland; Reimann, Maurice; Fan, Dorothy N. Y.; Schmitt, Clemens A.			Virus-induced senescence is a driver and therapeutic target in COVID-19	NATURE			English	Article							NF-KAPPA-B; CELLULAR SENESCENCE; EARLY-STAGE; CELLS; SARS-COV-2; CHEMORESISTANCE; LYMPHOMAGENESIS; QUERCETIN; RELEASE; BETA	Derailed cytokine and immune cell networks account for the organ damage and the clinical severity of COVID-19 (refs. (1-4)). Here we show that SARS-CoV-2, like other viruses, evokes cellular senescence as a primary stress response in infected cells. Virus-induced senescence (VIS) is indistinguishable from other forms of cellular senescence and is accompanied by a senescence-associated secretory phenotype (SASP), which comprises pro-inflammatory cytokines, extracellular-matrix-active factors and pro-coagulatory mediators(5-7). Patients with COVID-19 displayed markers of senescence in their airway mucosa in situ and increased serum levels of SASP factors. In vitro assays demonstrated macrophage activation with SASP-reminiscent secretion, complement lysis and SASP-amplifying secondary senescence of endothelial cells, which mirrored hallmark features of COVID-19 such as macrophage and neutrophil infiltration, endothelial damage and widespread thrombosis in affected lung tissue(1,8,9). Moreover, supernatant from VIS cells, including SARS-CoV-2-induced senescence, induced neutrophil extracellular trap formation and activation of platelets and the clotting cascade. Senolytics such as navitoclax and a combination of dasatinib plus quercetin selectively eliminated VIS cells, mitigated COVID-19-reminiscent lung disease and reduced inflammation in SARS-CoV-2-infected hamsters and mice. Our findings mark VIS as a pathogenic trigger of COVID-19-related cytokine escalation and organ damage, and suggest that senolytic targeting of virus-infected cells is a treatment option against SARS-CoV-2 and perhaps other viral infections. Virus-induced senescence is a central pathogenic feature in COVID-19, and senolytics, which promote apoptosis of senescent cells, can reduce disease severity in hamsters,mice, as well as humans infected with SARS-CoV-2.	[Lee, Soyoung; Richter-Pechanska, Paulina; Belenki, Dimitri; Kausche, Lea; Lau, Andrea; Schonlein, Martin; Reimann, Maurice; Fan, Dorothy N. Y.; Schmitt, Clemens A.] Charite, Mol Krebsforschungszentrum MKFZ, Med Dept Hematol Oncol & Tumor Immunol, Berlin, Germany; [Lee, Soyoung; Wyler, Emanuel; Belenki, Dimitri; Kunz, Severine; Purfurst, Bettina; Landthaler, Markus; Schmitt, Clemens A.] Max Delbruck Ctr Mol Med, Helmholtz Assoc, Berlin, Germany; [Lee, Soyoung; Fan, Dorothy N. Y.; Schmitt, Clemens A.] Deutsch Konsortium Translat Krebsforsch German Ca, Berlin, Germany; [Yu, Yong; Benthani, Fahad; Mairhofer, Mario; Kaltenbrunner, Sabine; Pammer, Maria; Kimeswenger, Susanne; Hoetzenecker, Wolfram; Lamprecht, Bernd; Langer, Rupert; Schmitt, Clemens A.] Johannes Kepler Univ Linz, Med Fac, Linz, Austria; [Trimpert, Jakob; Adler, Julia M.; Osterrieder, Nikolaus] Free Univ Berlin, Inst Virol, Berlin, Germany; [Kausche, Lea; Ghanem, Riad; Schmitt, Clemens A.] Kepler Univ Hosp, Dept Hematol & Oncol, Linz, Austria; [Firsching, Theresa C.; Dietert, Kristina; Gruber, Achim D.] Free Univ Berlin, Inst Vet Pathol, Berlin, Germany; [Dietert, Kristina] Free Univ Berlin, Vet Ctr Resistance Res, Berlin, Germany; [Schotsaert, Michael; Martinez-Romero, Carles; Singh, Gagandeep; Uccellini, Melissa; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Schotsaert, Michael; Martinez-Romero, Carles; Singh, Gagandeep; Uccellini, Melissa; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Niemeyer, Daniela; Drosten, Christian] Charite, German Ctr Infect Res DZIF, Inst Virol, Berlin, Germany; [Salzer, Helmut J. F.; Lamprecht, Bernd] Kepler Univ Hosp, Dept Pulmonol, Linz, Austria; [Paar, Christian; Habringer, Anna; Tomasits, Josef] Kepler Univ Hosp, Lab Med, Linz, Austria; [Mulleder, Michael; Ralser, Markus] Charite, Core Facil High Throughput Mass Spectrometry, Berlin, Germany; [Mulleder, Michael; Ralser, Markus] Charite, Dept Biochem, Berlin, Germany; [Michaelis, Edward G.] Charite, Inst Pathol, Berlin, Germany; [Khan, Amjad] Univ Oxford, Dept Chem, Oxford, England; [Schonlein, Martin] Univ Med Ctr Hamburg Eppendorf, Dept Oncol Hematol & Bone Marrow Transplantat, Sect Pneumol, Hamburg, Germany; [Hoetzenecker, Wolfram] Kepler Univ Hosp, Dept Dermatol, Linz, Austria; [Steinkellner, Herta] Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, Vienna, Austria; [Motz, Reinhard; Langer, Rupert] Kepler Univ Hosp, Inst Pathol, Linz, Austria; [Di Pierro, Francesco] Velleja Res, Sci & Res Dept, Milan, Italy; [Di Pierro, Francesco] Fdn Poliambulanza, Digest Endoscopy, Brescia, Italy; [Osterrieder, Nikolaus] City Univ Hong Kong, Dept Infect Dis & Publ Hlth, Kowloon Tong, Hong Kong, Peoples R China; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Div Infect Dis, Dept Med, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Ralser, Markus] Francis Crick Inst, Mol Biol Metab Lab, London, England; [Eils, Roland] Charite, Ctr Digital Hlth, Berlin, Germany; [Eils, Roland] Berlin Inst Hlth BIH, Berlin, Germany; [Uccellini, Melissa] Regeneron Pharmaceut, New York, NY USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Johannes Kepler University Linz; Free University of Berlin; Kepler University Hospital; Free University of Berlin; Free University of Berlin; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Center for Infection Research; Kepler University Hospital; Kepler University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Oxford; University of Hamburg; University Medical Center Hamburg-Eppendorf; Kepler University Hospital; University of Natural Resources & Life Sciences, Vienna; Kepler University Hospital; City University of Hong Kong; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Francis Crick Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Regeneron	Schmitt, CA (corresponding author), Charite, Mol Krebsforschungszentrum MKFZ, Med Dept Hematol Oncol & Tumor Immunol, Berlin, Germany.; Schmitt, CA (corresponding author), Max Delbruck Ctr Mol Med, Helmholtz Assoc, Berlin, Germany.; Schmitt, CA (corresponding author), Deutsch Konsortium Translat Krebsforsch German Ca, Berlin, Germany.; Schmitt, CA (corresponding author), Johannes Kepler Univ Linz, Med Fac, Linz, Austria.; Schmitt, CA (corresponding author), Kepler Univ Hosp, Dept Hematol & Oncol, Linz, Austria.	clemens.schmitt@charite.de	Schmitt, Clemens A/S-9479-2017; Fan, Dorothy Ngo-yin/AAQ-2998-2020; Langer, Rupert/AAU-1174-2021; Lee, Soyoung/AHC-5032-2022; Eils, Roland/B-6121-2009; Landthaler, Markus/A-1427-2010; Singh, Gagandeep/L-8590-2019	Schmitt, Clemens A/0000-0002-4731-2226; Langer, Rupert/0000-0001-9491-3609; Lee, Soyoung/0000-0002-4614-2931; Eils, Roland/0000-0002-0034-4036; Landthaler, Markus/0000-0002-1075-8734; Singh, Gagandeep/0000-0003-3260-2631; Kimeswenger, Susanne/0000-0002-0443-8558; Trimpert, Jakob/0000-0003-1616-0810; Adler, Julia Maria/0000-0001-8147-0351; Benthani, Fahad/0000-0002-3283-307X; Salzer, Helmut J.F./0000-0003-0146-8310; Ralser, Markus/0000-0001-9535-7413; Osterrieder, Nikolaus/0000-0002-5313-2176; Schonlein, Martin/0000-0002-1010-0975; Kaltenbrunner, Sabine/0000-0002-2794-025X; Mulleder, Michael/0000-0001-9792-3861; Belenki, Dimitri/0000-0002-9004-9849; Firsching, Theresa/0000-0003-1378-4951; Wyler, Emanuel/0000-0002-9884-1806	Medical Faculty of the Johannes Kepler University, Linz, Austria; Deutsche Krebshilfe [7011377629]; Deutsche Forschungsgemeinschaft DFG [GO 2688/1-1 | SCHM 1633/11-1, SCHM 1633/9-1]; Forderverein Hamatologie und internistische Onkologie (Tyle Private Foundation, Linz, Austria); German BMBF e:Med programme project SeneSys [031L0189A]; German Research Council [SFB-TR84 Z01b]; Berlin School of Integrative Oncology (BSIO) graduate programme within the German Excellence Initiative; German Cancer Consortium (GCC); CRIP (Center for Research on Influenza Pathogenesis), a NIAID [HHSN272201400008C]; CRIPT (Center for Research on Influenza Pathogenesis and Transmission), a NIAID [75N93021C00014]; DARPA [HR0011-19-2-0020]; NIAID [U19AI142733, U19AI135972]; DoD [W81XWH-20-1-0270]; Fast Grant of the Mercatus Center; JPB Foundation; Open Philanthropy Project [2020-215611 (5384)]; Francis Crick Institute from Cancer Research UK [FC001134]; UK Medical Research Council [FC001134]; Wellcome Trust [FC001134]	Medical Faculty of the Johannes Kepler University, Linz, Austria; Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Forderverein Hamatologie und internistische Onkologie (Tyle Private Foundation, Linz, Austria); German BMBF e:Med programme project SeneSys(Federal Ministry of Education & Research (BMBF)); German Research Council(German Research Foundation (DFG)); Berlin School of Integrative Oncology (BSIO) graduate programme within the German Excellence Initiative; German Cancer Consortium (GCC); CRIP (Center for Research on Influenza Pathogenesis), a NIAID; CRIPT (Center for Research on Influenza Pathogenesis and Transmission), a NIAID; DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DoD(United States Department of Defense); Fast Grant of the Mercatus Center; JPB Foundation; Open Philanthropy Project; Francis Crick Institute from Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)	We thank S. Fukushi and M. Saijo, C. Ratswohl and K. de la Rosa, V. G. Gorgoulis, K. Hoffman and W. Brune, E. Schiebel for materials; F. Walper for their support in the BSL-3 facility; F. Kurth, P. Tauber-Lau, V. Demichev and L. E. Sander on behalf of the Charite PA-COVID-19 study group as well as members of the Charite Core Facility High-throughput Proteomics for data and measurements; S. Jangra, R. Rathnasinghe and R. Albrecht for support in the BSL-3 facility and procedures, and R. Cadagan for technical assistance; M. Almeder for handling patient samples; M. Recchia for the statistical analysis of the data from clinical trials; and members of the collaborating laboratories for discussions and editorial advice. This work was supported by grants to C.A.S. from the Medical Faculty of the Johannes Kepler University, Linz, Austria, the Deutsche Krebshilfe (no. 7011377629), the Deutsche Forschungsgemeinschaft DFG (GO 2688/1-1 | SCHM 1633/11-1, SCHM 1633/9-1), and the Forderverein Hamatologie und internistische Onkologie (Tyle Private Foundation, Linz, Austria), and to S.L. and C.A.S. by the German BMBF e:Med programme project SeneSys (no. 031L0189A). J. Trimpert and A.D.G. were funded by the German Research Council (grant SFB-TR84 Z01b). This interdisciplinary work was further made possible by the Berlin School of Integrative Oncology (BSIO) graduate programme funded within the German Excellence Initiative (with D.B. as a member of this programme) and the German Cancer Consortium (GCC). This research was also partly funded by CRIP (Center for Research on Influenza Pathogenesis), a NIAID funded Center of Excellence for Influenza Research and Surveillance (CEIRS, contract no. HHSN272201400008C) and CRIPT (Center for Research on Influenza Pathogenesis and Transmission), a NIAID-funded Center of Excellence for Influenza Research and Response (CEIRR, contract no. 75N93021C00014), by DARPA grant HR0011-19-2-0020, by supplements to NIAID grant U19AI142733, U19AI135972 and DoD grant W81XWH-20-1-0270, by a Fast Grant of the Mercatus Center and by the support of the JPB Foundation, the Open Philanthropy Project (research grant 2020-215611 (5384)) and anonymous donors to A.G.-S. M. Rasler is partly funded by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001134), the UK Medical Research Council (FC001134) and the Wellcome Trust (FC001134).	Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Baz-Martinez M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37007; Beigi R, 1999, AM J PHYSIOL-CELL PH, V276, pC267, DOI 10.1152/ajpcell.1999.276.1.C267; Bent EH, 2016, GENE DEV, V30, P1811, DOI 10.1101/gad.284851.116; Berlin DA, 2020, NEW ENGL J MED, V383, P2451, DOI 10.1056/NEJMcp2009575; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Camell CD, 2021, SCIENCE, V373, DOI 10.1126/science.abe4832; Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010; Chua RL, 2020, NAT BIOTECHNOL, V38, P970, DOI 10.1038/s41587-020-0602-4; Chuprin A, 2013, GENE DEV, V27, P2356, DOI 10.1101/gad.227512.113; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Demichev V, 2021, CELL SYST, V12, P780, DOI 10.1016/j.cels.2021.05.005; Di Pierro F, 2021, INT J GEN MED, V14, P2807, DOI 10.2147/IJGM.S318949; Di Pierro F, 2021, INT J GEN MED, V14, P2359, DOI 10.2147/IJGM.S318720; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dorr JR, 2013, NATURE, V501, P421, DOI 10.1038/nature12437; Dou ZX, 2017, NATURE, V550, P402, DOI 10.1038/nature24050; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Fridman AL, 2008, ONCOGENE, V27, P5975, DOI 10.1038/onc.2008.213; Gruber AD, 2020, AM J RESP CELL MOL, V63, P856, DOI 10.1165/rcmb.2020-0280LE; Hari P, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw0254; Haveri A, 2020, EUROSURVEILLANCE, V25, P16, DOI 10.2807/1560-7917.ES.2020.25.11.2000266; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Hsieh TH, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00375; Jing H, 2011, GENE DEV, V25, P2137, DOI 10.1101/gad.17620611; Jung SH, 2019, CELL DEATH DIFFER, V26, P245, DOI 10.1038/s41418-018-0114-7; Kang SJ, 2020, P NATL ACAD SCI USA, V117, P22351, DOI 10.1073/pnas.2010229117; Kirkland JL, 2020, J INTERN MED, V288, P518, DOI 10.1111/joim.13141; Kreye J, 2020, CELL, V183, P1058, DOI 10.1016/j.cell.2020.09.049; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Lee S, 2019, NAT CELL BIOL, V21, P94, DOI 10.1038/s41556-018-0249-2; Li X, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00072; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Martinez I, 2016, VIRULENCE, V7, P427, DOI 10.1080/21505594.2016.1144001; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4; Messner CB, 2020, CELL SYST, V11, P11, DOI 10.1016/j.cels.2020.05.012; Middleton EA, 2020, BLOOD, V136, P1169, DOI 10.1182/blood.2020007008; Milanovic M, 2018, NATURE, V553, P96, DOI 10.1038/nature25167; Nalbandian A, 2021, NAT MED, V27, P601, DOI 10.1038/s41591-021-01283-z; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nouailles G., 2020, LONGITUDINAL OMICS S, DOI 10.1101/2020.12.18.423524(2020; Osterrieder N, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12070779; Rathnasinghe Raveen, 2020, bioRxiv, DOI 10.1101/2020.07.06.190066; Reimann M, 2010, CANCER CELL, V17, P262, DOI 10.1016/j.ccr.2009.12.043; Roussel M, 2017, J LEUKOCYTE BIOL, V102, P437, DOI 10.1189/jlb.5MA1116-457R; Schleich K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17467-z; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Schmitt CA, 2000, NAT MED, V6, P1029, DOI 10.1038/79542; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Trimpert J, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108488; Veras FP, 2020, J EXP MED, V217, DOI 10.1084/jem.20201129; Wang PG, 2004, BIOCHEM BIOPH RES CO, V315, P439, DOI 10.1016/j.bbrc.2004.01.076; White KM, 2021, SCIENCE, V371, P926, DOI 10.1126/science.abf4058; Wiley CD, 2019, CELL REP, V28, P3329, DOI 10.1016/j.celrep.2019.08.049; Winkler ES, 2020, NAT IMMUNOL, V21, P1327, DOI 10.1038/s41590-020-0778-2; Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3; Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9; Xu XL, 2020, P NATL ACAD SCI USA, V117, P10970, DOI 10.1073/pnas.2005615117; Yu Y, 2018, CANCER CELL, V33, P322, DOI 10.1016/j.ccell.2018.01.002; Zhang XN, 2020, NATURE, V583, P437, DOI [10.1038/s41586-020-2355-0, 10.1007/s00521-020-05117-w]; Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344	68	65	65	12	67	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 11	2021	599	7884					283	+		10.1038/s41586-021-03995-1	http://dx.doi.org/10.1038/s41586-021-03995-1		SEP 2021	31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XC6YT	34517409	Bronze			2022-12-28	WOS:000709352000002
J	Rickhaus, P; de Vries, FK; Zhu, JH; Portoles, E; Zheng, GL; Masseroni, M; Kurzmann, A; Taniguchi, T; Watanabe, K; MacDonald, AH; Ihn, T; Ensslin, K				Rickhaus, Peter; de Vries, Folkert K.; Zhu, Jihang; Portoles, Elias; Zheng, Giulia; Masseroni, Michele; Kurzmann, Annika; Taniguchi, Takashi; Watanabe, Kenji; MacDonald, Allan H.; Ihn, Thomas; Ensslin, Klaus			Correlated electron-hole state in twisted double-bilayer graphene	SCIENCE			English	Article							SUPERCONDUCTIVITY; BANDS	When twisted to angles near 1 degrees, graphene multilayers provide a window on electron correlation physics. Here, we report the discovery of a correlated electron-hole state in double-bilayer graphene twisted to 2.37 degrees. At this angle, the moire states retain much of their isolated bilayer character, allowing their bilayer projections to be separately controlled by gates. We use this property to generate an energetic overlap between narrow isolated electron and hole bands with good nesting properties. Our measurements reveal the formation of ordered states with reconstructed Fermi surfaces, consistent with a density-wave state. This state can be tuned without introducing chemical dopants, enabling studies of correlated electron-hole states and their interplay with superconductivity.	[Rickhaus, Peter; de Vries, Folkert K.; Portoles, Elias; Zheng, Giulia; Masseroni, Michele; Kurzmann, Annika; Ihn, Thomas; Ensslin, Klaus] Swiss Fed Inst Technol, Solid State Phys Lab, CH-8093 Zurich, Switzerland; [Zhu, Jihang; MacDonald, Allan H.] Univ Texas Austin, Dept Phys, Austin, TX 78712 USA; [Taniguchi, Takashi; Watanabe, Kenji] Natl Inst Mat Sci, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan; [Ihn, Thomas; Ensslin, Klaus] Swiss Fed Inst Technol, Quantum Ctr, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Texas System; University of Texas Austin; National Institute for Materials Science; Swiss Federal Institutes of Technology Domain; ETH Zurich	Rickhaus, P (corresponding author), Swiss Fed Inst Technol, Solid State Phys Lab, CH-8093 Zurich, Switzerland.	peterri@phys.ethz.ch	MacDonald, Allan/M-9883-2019; Watanabe, Kenji/ABB-2135-2021	Watanabe, Kenji/0000-0003-3701-8119; Rickhaus, Peter/0000-0003-3828-8153; de Vries, Folkert Kornelis/0000-0001-6732-6513; Portoles, Elias/0000-0001-7202-777X; Kurzmann, Annika/0000-0001-5947-0400; Zheng, Giulia/0000-0003-3503-4940; Zhu, Jihang/0000-0002-0297-3012	European Graphene Flagship; Swiss National Science Foundation through NCCR Quantum Science; ERC Syngery Grant Quantropy; ETH Fellowship program; Elemental Strategy Initiative by Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST) [JPMJCR15F3]; National Science Foundation (NSF) through the Center for Dynamics and Control of Materials, an NSF Materials Research Science and Engineering Center (MRSEC) [DMR-1720595]; Welch Foundation [TBF1473]	European Graphene Flagship; Swiss National Science Foundation through NCCR Quantum Science; ERC Syngery Grant Quantropy; ETH Fellowship program; Elemental Strategy Initiative by Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); National Science Foundation (NSF) through the Center for Dynamics and Control of Materials, an NSF Materials Research Science and Engineering Center (MRSEC); Welch Foundation(The Welch Foundation)	We acknowledge financial support from the European Graphene Flagship and the Swiss National Science Foundation through NCCR Quantum Science and the ERC Syngery Grant Quantropy. P.R. acknowledges financial support from the ETH Fellowship program. Growth of hexagonal boron nitride crystals was supported by the Elemental Strategy Initiative conducted by Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and the Core Research for Evolutional Science and Technology (CREST) (JPMJCR15F3), Japan Science and Technology Agency (JST). A.H.M. and J.Z. were supported by the National Science Foundation (NSF) through the Center for Dynamics and Control of Materials, an NSF Materials Research Science and Engineering Center (MRSEC) under cooperative agreement no. DMR-1720595; and by the Welch Foundation under grant TBF1473.	Bistritzer R, 2011, P NATL ACAD SCI USA, V108, P12233, DOI 10.1073/pnas.1108174108; Burg GW, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.197702; Burg GW, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.177702; Cao Y, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.116804; Cao Y, 2018, NATURE, V556, P43, DOI 10.1038/nature26160; Chebrolu NR, 2019, PHYS REV B, V99, DOI 10.1103/PhysRevB.99.235417; Choi YW, 2019, PHYS REV B, V100, DOI 10.1103/PhysRevB.100.201402; Culchac FJ, 2020, NANOSCALE, V12, P5014, DOI 10.1039/c9nr10830k; de Vries FK, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.176801; Deng H, 2010, REV MOD PHYS, V82, P1489, DOI 10.1103/RevModPhys.82.1489; Du LJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01988-1; FESHBACH H, 1958, ANN PHYS-NEW YORK, V5, P357, DOI 10.1016/0003-4916(58)90007-1; Haddadi F, 2020, NANO LETT, V20, P2410, DOI 10.1021/acs.nanolett.9b05117; He MH, 2021, NAT PHYS, V17, P26, DOI 10.1038/s41567-020-1030-6; JEROME D, 1967, PHYS REV, V158, P462, DOI 10.1103/PhysRev.158.462; Khomskii D I, 2010, BASIC ASPECTS QUANTU; Kim K, 2016, NANO LETT, V16, P1989, DOI 10.1021/acs.nanolett.5b05263; Kogar A, 2017, SCIENCE, V358, P1315, DOI 10.1126/science.aam6432; Koshino M, 2019, PHYS REV B, V99, DOI 10.1103/PhysRevB.99.235406; Lee Y, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.126802; Li Z, 2019, NANO LETT, V19, P4960, DOI 10.1021/acs.nanolett.9b01123; Liu XM, 2020, NATURE, V583, P221, DOI 10.1038/s41586-020-2458-7; LOWDIN PO, 1962, J MATH PHYS, V3, P969, DOI 10.1063/1.1724312; Peierls R, 1930, ANN PHYS-BERLIN, V4, P121; Rickhaus P, 2021, SCRIPT REPOSITORY EL, DOI [10.5905/ethz-1007-405, DOI 10.5905/ETHZ-1007-405]; Rickhaus P, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay8409; Rickhaus P, 2019, NANO LETT, V19, P8821, DOI 10.1021/acs.nanolett.9b03660; Saito Y, 2020, NAT PHYS, V16, P926, DOI 10.1038/s41567-020-0928-3; Sanchez-Yamagishi JD, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.076601; Sharpe AL, 2019, SCIENCE, V365, P605, DOI 10.1126/science.aaw3780; Shen C, 2020, NAT PHYS, V16, P520, DOI 10.1038/s41567-020-0825-9; Spielman IB, 2000, PHYS REV LETT, V84, P5808, DOI 10.1103/PhysRevLett.84.5808; Stepanov P, 2020, NATURE, V583, P375, DOI 10.1038/s41586-020-2459-6; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; Wang ZF, 2019, NATURE, V574, P76, DOI 10.1038/s41586-019-1591-7; Yankowitz M, 2019, SCIENCE, V363, P1059, DOI 10.1126/science.aav1910	39	19	19	8	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2021	373	6560					1257	+		10.1126/science.abc3534	http://dx.doi.org/10.1126/science.abc3534			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UP5RB	34516786	Green Submitted			2022-12-28	WOS:000695436000033
J	Snead, WT; Gladfelter, AS				Snead, Wilton T.; Gladfelter, Amy S.			Getting droplets into shape	SCIENCE			English	Editorial Material							CONDENSATION; RNA		[Snead, Wilton T.; Gladfelter, Amy S.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA; [Gladfelter, Amy S.] Marine Biol Lab, Woods Hole, MA USA	University of North Carolina; University of North Carolina Chapel Hill; Marine Biological Laboratory - Woods Hole	Gladfelter, AS (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	amyglad@unc.edu			National Institutes of Health [R01-GM081506]; Howard Hughes Medical Institute (HHMI) Faculty Scholars program; Air Force Office of Scientific Research [FA9550-20-1-0241]; Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Fellowship from the National Institutes of Health [F32-GM136055]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute (HHMI) Faculty Scholars program; Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Fellowship from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	A.S.G.is a scientific advisor for Dewpoint Therapeutics. A.S.G.is supported by the National Institutes of Health (R01-GM081506),the Howard Hughes Medical Institute (HHMI) Faculty Scholars program, and the Air Force Office of Scientific Research (FA9550-20-1-0241). W.T.S. is supported by a Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Fellowship from the National Institutes of Health (F32-GM136055).	Alshareedah I, 2021, BIOPHYS J, V120, P1161, DOI 10.1016/j.bpj.2021.01.005; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Berry J, 2018, REP PROG PHYS, V80, DOI 10.1088/1361-6633/aaa61e; Fare CM, 2021, OPEN BIOL, V11, DOI 10.1098/rsob.210137; Fei JY, 2017, J CELL SCI, V130, P4180, DOI 10.1242/jcs.206854; Folkmann AW, 2021, SCIENCE, V373, P1218, DOI 10.1126/science.abg7071; Lee DSW, 2021, NAT PHYS, V17, P531, DOI 10.1038/s41567-020-01125-8; Pickering SU, 1907, J CHEM SOC, V91, P2001, DOI 10.1039/ct9079102001; Putnam A, 2019, NAT STRUCT MOL BIOL, V26, P220, DOI 10.1038/s41594-019-0193-2; Ranganathan S, 2020, ELIFE, V9, DOI 10.7554/eLife.56159; Tauber D, 2020, CELL, V180, P411, DOI 10.1016/j.cell.2019.12.031; Wang J, 2018, CELL, V174, P688, DOI 10.1016/j.cell.2018.06.006; Yamazaki T, 2018, MOL CELL, V70, P1038, DOI 10.1016/j.molcel.2018.05.019; Yang YQ, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00287; Zwicker D, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.012317	15	1	1	5	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2021	373	6560					1198	1199		10.1126/science.abl6282	http://dx.doi.org/10.1126/science.abl6282			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UP5RB	34516805				2022-12-28	WOS:000695436000014
J	Mahase, E				Mahase, Elisabeth			Mexico decriminalises abortion in unanimous Supreme Court vote	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Diaz L, 2021, REUTERS 0908; Dyer C, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l6145; Dyer O, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4965; Kitroeff N., 2021, NEW YORK TIMES; Sheridan M.B., 2021, WASH POST; Hopkins J, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2176	6	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 8	2021	374								n2216	10.1136/bmj.n2216	http://dx.doi.org/10.1136/bmj.n2216			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UR3BY	34497061				2022-12-28	WOS:000696628700003
J	Thelot, FA; Zhang, WY; Song, KK; Xu, C; Huang, J; Liao, MF				Thelot, Francois A.; Zhang, Wenyi; Song, KangKang; Xu, Chen; Huang, Jing; Liao, Maofu			Distinct allosteric mechanisms of first-generation MsbA inhibitors	SCIENCE			English	Article							ABC TRANSPORTERS; STRUCTURAL BASIS; SUBSTRATE; VISUALIZATION; OPTIMIZATION; NANODISCS; UPDATE; CHARMM	ATP-binding cassette (ABC) transporters couple adenosine 5'-triphosphate (ATP) hydrolysis to substrate transport across biological membranes. Although many are promising drug targets, their mechanisms of modulation by small-molecule inhibitors remain largely unknown. Two first-generation inhibitors of the MsbA transporter, tetrahydrobenzothiophene 1 (TBT1) and G247, induce opposite effects on ATP hydrolysis. Using single-particle cryo-electron microscopy and functional assays, we show that TBT1 and G247 bind adjacent yet separate pockets in the MsbA transmembrane domains. Two TBT1 molecules asymmetrically occupy the substrate-binding site, which leads to a collapsed inward-facing conformation with decreased distance between the nucleotide-binding domains (NBDs). By contrast, two G247 molecules symmetrically increase NBD distance in a wide inward-open state of MsbA. The divergent mechanisms of action of these MsbA inhibitors provide important insights into ABC transporter pharmacology.	[Thelot, Francois A.; Liao, Maofu] Harvard Med Sch, Blavatnik Inst, Dept Cell Biol, Boston, MA 02115 USA; [Thelot, Francois A.] Harvard Univ, Biol & Biomed Sci Program, Cambridge, MA 02138 USA; [Zhang, Wenyi; Huang, Jing] Westlake Univ, Key Lab Struct Biol Zhejiang Prov, Hangzhou, Peoples R China; [Zhang, Wenyi; Huang, Jing] Westlake Lab Life Sci & Biomed, Westlake AI Therapeut Lab, Hangzhou, Peoples R China; [Song, KangKang; Xu, Chen] Univ Massachusetts, Med Sch, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Song, KangKang; Xu, Chen] Univ Massachusetts, Cryo EM Core Facil, Med Sch, Worcester, MA 01605 USA	Harvard University; Harvard Medical School; Harvard University; Westlake University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Liao, MF (corresponding author), Harvard Med Sch, Blavatnik Inst, Dept Cell Biol, Boston, MA 02115 USA.	maofu_liao@hms.harvard.edu	; Huang, Jing/G-5320-2011	Liao, Maofu/0000-0002-3481-450X; Huang, Jing/0000-0001-9639-2907; Thelot, Francois/0000-0002-7439-2137	NIH grant from the NIGMS [R01 GM122797]; National Natural Science Foundation of China [21803057, 32171247]	NIH grant from the NIGMS; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	M.L. was supported by an NIH grant from the NIGMS (R01 GM122797), and J.H. was funded by the National Natural Science Foundation of China (grant nos. 21803057 and 32171247).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alam A, 2019, SCIENCE, V363, P753, DOI 10.1126/science.aav7102; Alam A, 2018, P NATL ACAD SCI USA, V115, pE1973, DOI 10.1073/pnas.1717044115; Alexander MK, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.01142-18, 10.1128/aac.01142-18]; Angiulli  G, 2020, ELIFE, V9, DOI 10.7554/eLife.53530; Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Denisov IG, 2017, CHEM REV, V117, P4669, DOI 10.1021/acs.chemrev.6b00690; Doerrler WT, 2001, J BIOL CHEM, V276, P11461, DOI 10.1074/jbc.C100091200; Eastman P, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005659; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Higgins CF, 2001, SCIENCE, V293, P1782, DOI 10.1126/science.1065588; Ho H, 2018, NATURE, V557, P196, DOI 10.1038/s41586-018-0083-5; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Jackson SM, 2018, NAT STRUCT MOL BIOL, V25, P333, DOI 10.1038/s41594-018-0049-1; Johnson ZL, 2017, CELL, V168, P1075, DOI 10.1016/j.cell.2017.01.041; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lewis VG, 2012, PROTOPLASMA, V249, P919, DOI 10.1007/s00709-011-0360-8; Li NN, 2017, CELL, V168, P101, DOI 10.1016/j.cell.2016.12.028; Li YY, 2019, NATURE, V567, P486, DOI 10.1038/s41586-019-1025-6; Locher KP, 2016, NAT STRUCT MOL BIOL, V23, P487, DOI 10.1038/nsmb.3216; McLean MA, 2018, ANNU REV BIOPHYS, V47, P107, DOI 10.1146/annurev-biophys-070816-033620; Mi W, 2017, NATURE, V549, P233, DOI 10.1038/nature23649; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Nosol K, 2020, P NATL ACAD SCI USA, V117, P26245, DOI 10.1073/pnas.2010264117; Olsen JA, 2020, NAT STRUCT MOL BIOL, V27, P62, DOI 10.1038/s41594-019-0354-3; Orlando BJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16155-2; Padayatti PS, 2019, STRUCTURE, V27, P1114, DOI 10.1016/j.str.2019.04.007; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plummer AM, 2021, ANNU REV PHYSIOL, V83, P153, DOI 10.1146/annurev-physiol-031620-094944; Punjani A, 2021, J STRUCT BIOL, V213, DOI 10.1016/j.jsb.2021.107702; Qian HW, 2017, CELL, V169, P1228, DOI 10.1016/j.cell.2017.05.020; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schorb M, 2019, NAT METHODS, V16, P471, DOI 10.1038/s41592-019-0396-9; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Shukla S, 2011, CURR DRUG TARGETS, V12, P621, DOI 10.2174/138945011795378540; Srikant S, 2019, NAT STRUCT MOL BIOL, V26, P792, DOI 10.1038/s41594-019-0280-4; Szollosi D, 2018, BBA-BIOMEMBRANES, V1860, P818, DOI 10.1016/j.bbamem.2017.10.028; Taylor NMI, 2017, NATURE, V546, P504, DOI 10.1038/nature22345; Terwilliger TC, 2020, NAT METHODS, V17, P923, DOI 10.1038/s41592-020-0914-9; Thelot F, 2020, CURR OPIN STRUC BIOL, V63, P26, DOI 10.1016/j.sbi.2020.03.005; Thomas C, 2020, FEBS LETT, V594, P3767, DOI 10.1002/1873-3468.13935; Thomas C, 2018, CURR OPIN STRUC BIOL, V51, P116, DOI 10.1016/j.sbi.2018.03.016; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wright J, 2018, BIOCHEM SOC T, V46, P1475, DOI 10.1042/BST20180146; Yang JY, 2013, NUCLEIC ACIDS RES, V41, pD1096, DOI 10.1093/nar/gks966; Zhang G, 2018, P NATL ACAD SCI USA, V115, P6834, DOI 10.1073/pnas.1804670115; Zhang Z, 2016, CELL, V167, P1586, DOI 10.1016/j.cell.2016.11.014; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	57	9	9	14	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 29	2021	374	6567			SI		580	+		10.1126/science.abi9009	http://dx.doi.org/10.1126/science.abi9009			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WS1IZ	34554829	Green Submitted, Green Accepted			2022-12-28	WOS:000714943400034
J	Gainor, JF				Gainor, Justin F.			Adjuvant PD-L1 blockade in non-small-cell lung cancer Comment	LANCET			English	Editorial Material									[Gainor, Justin F.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Gainor, JF (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.	jgainor@mgh.harvard.edu						Antonia SJ, 2018, NEW ENGL J MED, V379, P2342, DOI 10.1056/NEJMoa1809697; Antonia SJ, 2017, NEW ENGL J MED, V377, P1919, DOI 10.1056/NEJMoa1709937; Eggermont AMM, 2018, NEW ENGL J MED, V378, P1789, DOI 10.1056/NEJMoa1802357; Felip E, 2021, LANCET, V398, P1344, DOI 10.1016/S0140-6736(21)02098-5; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Goldstraw P, 2016, J THORAC ONCOL, V11, P39, DOI 10.1016/j.jtho.2015.09.009; Mok TSK, 2019, LANCET, V393, P1819, DOI 10.1016/S0140-6736(18)32409-7; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Thai AA, 2021, LANCET, V398, P535, DOI 10.1016/S0140-6736(21)00312-3; Wu YL, 2020, NEW ENGL J MED, V383, P1711, DOI 10.1056/NEJMoa2027071	10	2	2	2	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT	2021	398	10308					1281	1283		10.1016/S0140-6736(21)02100-0	http://dx.doi.org/10.1016/S0140-6736(21)02100-0		OCT 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	WE2YJ	34555332				2022-12-28	WOS:000705490300003
J	Griesemer, D; Xue, JR; Reilly, SK; Ulirsch, JC; Kukreja, K; Davis, JR; Kanai, M; Yang, DK; Butts, JC; Guney, MH; Luban, J; Montgomery, SB; Finucane, HK; Novina, CD; Tewhey, R; Sabeti, PC				Griesemer, Dustin; Xue, James R.; Reilly, Steven K.; Ulirsch, Jacob C.; Kukreja, Kalki; Davis, Joe R.; Kanai, Masahiro; Yang, David K.; Butts, John C.; Guney, Mehmet H.; Luban, Jeremy; Montgomery, Stephen B.; Finucane, Hilary K.; Novina, Carl D.; Tewhey, Ryan; Sabeti, Pardis C.			Genome-wide functional screen of 3 ' UTR variants uncovers causal variants for human disease and evolution	CELL			English	Article							RNA-BINDING PROTEIN; GENETIC-VARIATION; MESSENGER-RNAS; 3' UTRS; IDENTIFICATION; TRANSCRIPTOME; ASSOCIATION; RISK; ADAPTATIONS; ANNOTATION	3' untranslated region (3'UTR) variants are strongly associated with human traits and diseases, yet few have been causally identified. We developed the massively parallel reporter assay for 3'UTRs (MPRAu) to sensitively assay 12,173 3'UTR variants. We applied MPRAu to six human cell lines, focusing on genetic variants associated with genome-wide association studies (GWAS) and human evolutionary adaptation. MPRAu expands our understanding of 3'UTR function, suggesting that simple sequences predominately explain 3'UTR regulatory activity. We adapt MPRAu to uncover diverse molecular mechanisms at base pair resolution, including an adenylate-uridylate (AU)-rich element of LEPR linked to potential metabolic evolutionary adaptations in East Asians. We nominate hundreds of 3'UTR causal variants with genetically fine-mapped phenotype associations. Using endogenous allelic replacements, we characterize one variant that disrupts a miRNA site regulating the viral defense gene TRIM14 and one that alters PILRB abundance, nominating a causal variant underlying transcriptional changes in age-related macular degeneration.	[Griesemer, Dustin; Xue, James R.; Reilly, Steven K.; Ulirsch, Jacob C.; Kanai, Masahiro; Yang, David K.; Luban, Jeremy; Finucane, Hilary K.; Novina, Carl D.; Sabeti, Pardis C.] Broad Inst MIT & Harvard, Cambridge, MA 02143 USA; [Griesemer, Dustin; Kanai, Masahiro] Harvard Med Sch, Program Bioinformat & Integrat Genom, Boston, MA 02115 USA; [Griesemer, Dustin] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Xue, James R.; Reilly, Steven K.; Sabeti, Pardis C.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02143 USA; [Ulirsch, Jacob C.] Harvard Med Sch, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Ulirsch, Jacob C.; Kanai, Masahiro; Finucane, Hilary K.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Kukreja, Kalki] Harvard Univ, Dept Mol & Cell Biol, Cambridge, MA 02138 USA; [Davis, Joe R.] BigHat Biosci, San Carlos, CA 94070 USA; [Butts, John C.; Tewhey, Ryan] Jackson Lab, Bar Harbor, ME 04609 USA; [Butts, John C.; Tewhey, Ryan] Univ Maine, Grad Sch Biomed Sci & Engn, Orono, ME 04469 USA; [Guney, Mehmet H.; Luban, Jeremy] Univ Massachusetts, Program Mol Med, Med Sch, Worcester, MA 01655 USA; [Luban, Jeremy] Univ Massachusetts, Dept Biochem & Mol Pharmacol, Med Sch, Worcester, MA 01655 USA; [Montgomery, Stephen B.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Montgomery, Stephen B.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Novina, Carl D.] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA; [Novina, Carl D.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Tewhey, Ryan] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Sabeti, Pardis C.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Reilly, Steven K.] Yale Sch Med, Dept Genet, New Haven, CT 06510 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Jackson Laboratory; University of Maine System; University of Maine Orono; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Stanford University; Stanford University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Tufts University; Howard Hughes Medical Institute; Yale University	Xue, JR (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02143 USA.; Xue, JR (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02143 USA.	jxue@broadinstitute.org	Sabeti, Pardis/GQH-8610-2022; Kanai, Masahiro/AAD-6726-2021	Kanai, Masahiro/0000-0001-5165-4408; /0000-0003-4265-7935; Montgomery, Stephen/0000-0002-5200-3903; Ulirsch, Jacob/0000-0002-7947-0827; Luban, Jeremy/0000-0001-5650-4054; Butts, John/0000-0001-9456-4509; Davis, Joe/0000-0003-2544-388X; Reilly, Steven/0000-0003-3140-1483	ENCODE Functional Characterization Center grant [UM1HG009435]; Broad SPARC; Howard Hughes Medical Institute; NSF [DEB-1401237]; NIH-NIGMS [F30GM114940]; NIH-NHGRI [K99HG010669, F32HG009226, R00HG008179]; NIH-NIAID [R37AI147868]	ENCODE Functional Characterization Center grant; Broad SPARC; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NSF(National Science Foundation (NSF)); NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH-NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Schaffner, S. Gosai, S. Weingarten-Gabbay, A.E. Lin, D. Kotliar, C. Myhrvold, and C. Tomkins-Tinch for thoughtful conversations and help with editing the manuscript. We thank D.P. Bartel as well as his lab for thoughtful discussions. We thank I. Shlyakhter and J. Vitti for providing the CMS regions. This work was supported by an ENCODE Functional Characterization Center grant (UM1HG009435), Broad SPARC, and the Howard Hughes Medical Institute. D.G. was partially supported by DEB-1401237 from NSF and F30GM114940 from NIH-NIGMS. S.K.R. was partially supported by K99HG010669 from NIH-NHGRI and F32HG009226 from NIH-NHGRI. J.L. is supported by R37AI147868 from NIH-NIAID. R.T. is supported by R00HG008179 from NIH-NHGRI.	Abella V, 2017, NAT REV RHEUMATOL, V13, P100, DOI 10.1038/nrrheum.2016.209; Aguet F, 2020, SCIENCE, V369, P1318, DOI 10.1126/science.aaz1776; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Bakheet T, 2001, NUCLEIC ACIDS RES, V29, P246, DOI 10.1093/nar/29.1.246; Ban HJ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-26; Battle A, 2015, SCIENCE, V347, P664, DOI 10.1126/science.1260793; Benner C, 2016, BIOINFORMATICS, V32, P1493, DOI 10.1093/bioinformatics/btw018; Berkovits BD, 2015, NATURE, V522, P363, DOI 10.1038/nature14321; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Bogard N, 2019, CELL, V178, P91, DOI 10.1016/j.cell.2019.04.046; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Chen MX, 2016, MOL CELL, V64, P105, DOI 10.1016/j.molcel.2016.08.025; Chick JM, 2016, NATURE, V534, P500, DOI 10.1038/nature18270; Choi JY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16590-1; Clement K, 2019, NAT BIOTECHNOL, V37, P224, DOI 10.1038/s41587-019-0032-3; Dey KK, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2489-3; Dominguez D, 2018, MOL CELL, V70, P854, DOI 10.1016/j.molcel.2018.05.001; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fritsche LG, 2016, NAT GENET, V48, P134, DOI 10.1038/ng.3448; Galgano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003164; Grossman SR, 2013, CELL, V152, P703, DOI 10.1016/j.cell.2013.01.035; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Gusev A., 2014, SCHIZOPHRENIA WORKIN; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hoffpauir CT, 2020, J IMMUNOL, V205, P153, DOI 10.4049/jimmunol.1901511; Holcik M, 1997, P NATL ACAD SCI USA, V94, P2410, DOI 10.1073/pnas.94.6.2410; Kemp JP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004423; Kerimov N., 2021, EQTL CATALOGUE COMPE, DOI [10.1101/2020.01.29.924266, DOI 10.1101/2020.01.29.924266]; Kircher M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11526-w; Klein JC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10439-y; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Li H., 2013, PREPRINT, DOI DOI 10.48550/ARXIV.1303.3997; Li L, 2021, NAT GENET, V53, P994, DOI 10.1038/s41588-021-00864-5; Li X, 2017, NATURE, V550, P239, DOI 10.1038/nature24267; Litterman AJ, 2019, GENOME RES, V29, P896, DOI 10.1101/gr.242552.118; Liu S, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1322-z; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lundberg SM, 2017, ADV NEUR IN, V30; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Marbach D, 2016, NAT METHODS, V13, P366, DOI [10.1038/NMETH.3799, 10.1038/nmeth.3799]; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Miller CL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004263; Morris AR, 2008, MOL CELL BIOL, V28, P4093, DOI 10.1128/MCB.00155-08; Munzberg H, 2015, METABOLISM, V64, P13, DOI 10.1016/j.metabol.2014.09.010; Mukherjee N, 2019, NUCLEIC ACIDS RES, V47, P570, DOI 10.1093/nar/gky1185; Nouioua S, 2013, NEUROMUSCULAR DISORD, V23, P670, DOI 10.1016/j.nmd.2013.04.011; Oikonomou P, 2014, CELL REP, V7, P281, DOI 10.1016/j.celrep.2014.03.001; Orozco LD, 2020, CELL REP, V30, P1246, DOI 10.1016/j.celrep.2019.12.082; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Pembleton LW, 2013, MOL ECOL RESOUR, V13, P946, DOI 10.1111/1755-0998.12129; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Richardson K, 2013, AM J HUM GENET, V92, P5, DOI 10.1016/j.ajhg.2012.10.020; Sample PJ, 2019, NAT BIOTECHNOL, V37, P803, DOI 10.1038/s41587-019-0164-5; Sazzini M, 2014, HEREDITY, V113, P259, DOI 10.1038/hdy.2014.24; Schmiedel BJ, 2018, CELL, V175, P1701, DOI 10.1016/j.cell.2018.10.022; Shalem O, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005147; Shi YY, 2011, NAT GENET, V43, P1224, DOI 10.1038/ng.980; Siegel D.A., 2020, MASSIVELY PARALLEL A, DOI [10.1101/2020.02.12.945063, DOI 10.1101/2020.02.12.945063]; Slutskin IV, 2019, GENOME RES, V29, P1635, DOI 10.1101/gr.247312.118; Slutskin IV, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02980-z; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Steri M, 2017, NEW ENGL J MED, V376, P1615, DOI 10.1056/NEJMoa1610528; Tan P, 2017, MOL CELL, V68, P293, DOI 10.1016/j.molcel.2017.09.035; Tang WH, 2010, CIRC-CARDIOVASC GENE, V3, P179, DOI 10.1161/CIRCGENETICS.109.913426; Tewhey R, 2016, CELL, V165, P1519, DOI 10.1016/j.cell.2016.04.027; Tushev G, 2018, NEURON, V98, P495, DOI 10.1016/j.neuron.2018.03.030; Ulirsch JC, 2016, CELL, V165, P1530, DOI 10.1016/j.cell.2016.04.048; Urbut SM, 2019, NAT GENET, V51, P187, DOI 10.1038/s41588-018-0268-8; van Arensbergen J, 2019, NAT GENET, V51, P1160, DOI 10.1038/s41588-019-0455-2; Van Nostrand EL, 2016, NAT METHODS, V13, P508, DOI [10.1038/NMETH.3810, 10.1038/nmeth.3810]; Vlasova IA, 2008, MOL CELL, V29, P263, DOI 10.1016/j.molcel.2007.11.024; Wang G, 2020, J R STAT SOC B, V82, P1273, DOI 10.1111/rssb.12388; Wang Q.S., 2020, LEVERAGING SUPERVISE, DOI [10.1101/2020.10.20.347294, DOI 10.1101/2020.10.20.347294]; Wang W, 2021, J MACH LEARN RES, V22, P1; Ward LD, 2016, NUCLEIC ACIDS RES, V44, pD877, DOI 10.1093/nar/gkv1340; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; White EK, 2001, RNA, V7, P1855; Wiegerinck CL, 2014, GASTROENTEROLOGY, V147, P65, DOI 10.1053/j.gastro.2014.04.002; Wu XW, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00344; Zhao WX, 2014, NAT BIOTECHNOL, V32, P387, DOI 10.1038/nbt.2851; Zhou Z, 2014, P NATL ACAD SCI USA, V111, pE245, DOI 10.1073/pnas.1316941111	87	13	13	13	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 30	2021	184	20					5247	+		10.1016/j.cell.2021.08.025	http://dx.doi.org/10.1016/j.cell.2021.08.025		OCT 2021	33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	WC7PG	34534445	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000704445700018
J	Gymrek, E; Goren, A				Gymrek, Elissa; Goren, Alon			Missing heritability may be hiding in repeats	SCIENCE			English	Editorial Material							RISK		[Gymrek, Elissa] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Gymrek, Elissa; Goren, Alon] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Gymrek, E (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.; Gymrek, E (corresponding author), Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA.	mgymrek@ucsd.edu; agoren@ucsd.edu			NIH [DP5OD024577, R01HG010885]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Margoliash and A. Massarat for critical comments and acknowledge support from NIH grants DP5OD024577 and R01HG010885.	Beyter D, 2021, NAT GENET, V53, P779, DOI 10.1038/s41588-021-00865-4; Bunielloet A., 2019, NUCLEIC ACIDS RES, V47, pD1005; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Leffler EM, 2017, SCIENCE, V356, DOI 10.1126/science.aam6393; Li M, 2016, NAT MED, V22, P649, DOI 10.1038/nm.4096; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Mukamel RE, 2021, SCIENCE, V373, P1499, DOI [10.1126/science.abg8289, 10.1101/2021.01.19.427332]; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Song JHT, 2018, AM J HUM GENET, V103, P421, DOI 10.1016/j.ajhg.2018.07.011; Torkamani A, 2018, NAT REV GENET, V19, P581, DOI 10.1038/s41576-018-0018-x; van de Bunt M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005535; Visscher PM, 2017, AM J HUM GENET, V101, P5, DOI 10.1016/j.ajhg.2017.06.005	12	1	1	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2021	373	6562			SI		1440	1441		10.1126/science.abl7794	http://dx.doi.org/10.1126/science.abl7794			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU7LJ	34554784				2022-12-28	WOS:000698977800030
J	Kerlin, MP				Kerlin, Meeta Prasad			It Is What It Is	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kerlin, Meeta Prasad] Univ Penn, Perelman Sch Med, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA; [Kerlin, Meeta Prasad] Univ Penn, Perelman Sch Med, Palliat & Adv Illness Res Ctr, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Kerlin, MP (corresponding author), Univ Penn, Perelman Sch Med, Palliat & Adv Illness Res Ctr, 423 Guardian Dr,302 Blockley Hall, Philadelphia, PA 19104 USA.	prasadm@pennmedicine.upenn.edu							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2021	326	11					1007	1008		10.1001/jama.2021.14917	http://dx.doi.org/10.1001/jama.2021.14917			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ4IM	34546297				2022-12-28	WOS:000702170600012
J	Stokel-Walker, C				Stokel-Walker, Chris			The search for antivirals for covid-19	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												stokel@gmail.com						[Anonymous], 2021, PBS NEWS HOUR 0617; [Anonymous], 2020, ALCHEMY US HUMANS MA; [Anonymous], 2014, FINANCIAL TIMES 0409; Eccles R, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0281-8; Hsu J, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4457; Merck and Ridgeback, 2021, BIOTH PROV UPD PROGR; UK Research and Innovation, OUTC UK COV 19 THER	7	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 20	2021	374								n2165	10.1136/bmj.n2165	http://dx.doi.org/10.1136/bmj.n2165			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ1DH	34544682	Bronze			2022-12-28	WOS:000701952000001
J	Xu, JY; Mavranezouli, I; Kuznetsov, L; Murphy, MS; Healy, E				Xu, Jingyuan; Mavranezouli, Ifigeneia; Kuznetsov, Laura; Murphy, M. Stephen; Healy, Eugene		Guideline Comm	Management of acne vulgaris: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Xu, Jingyuan; Mavranezouli, Ifigeneia; Kuznetsov, Laura; Murphy, M. Stephen] Royal Coll Obstetricians & Gynaecologists, Natl Guideline Alliance, London, England; [Xu, Jingyuan] Univ Manchester, Manchester, Lancs, England; [Mavranezouli, Ifigeneia] UCL, Res Dept Clin Educ & Hlth Psychol, London, England; [Healy, Eugene] Univ Southampton, Southampton, Hants, England; [Healy, Eugene] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England	University of Manchester; University of London; University College London; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust	Xu, JY (corresponding author), Royal Coll Obstetricians & Gynaecologists, Natl Guideline Alliance, London, England.; Xu, JY (corresponding author), Univ Manchester, Manchester, Lancs, England.	j.xu@nhs.net	MAVRANEZOULI, IFIGENEIA/C-2430-2008	MAVRANEZOULI, IFIGENEIA/0000-0001-9095-3566; Healy, Eugene/0000-0001-5591-6970	National Guideline Alliance (NGA) at the Royal College of Obstetricians and Gynaecologists (RCOG) - NICE	National Guideline Alliance (NGA) at the Royal College of Obstetricians and Gynaecologists (RCOG) - NICE	IM, LK, and SM received support from the National Guideline Alliance (NGA) at the Royal College of Obstetricians and Gynaecologists (RCOG), which is commissioned and funded by NICE to develop clinical, public health and social care guidelines and write this BMJ summary. No authors received special funding from any other source to write this summary.	National Institute for Heath and Care Excellence, 2021, NG198 NICE NAT I HLT; Schofield J., 2009, SKIN CONDITIONS UK H; Vos T, 2013, LANCET, V381, P628	3	2	2	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 20	2021	374								n1800	10.1136/bmj.n1800	http://dx.doi.org/10.1136/bmj.n1800			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ1DH	34544730	Green Submitted, Green Accepted			2022-12-28	WOS:000701952000007
J	Choudhury, N				Choudhury, Nasreen			On my own but not alone	SCIENCE			English	Editorial Material								When I stumbled on the advertisement for the symposium, I couldn't wait to tell my colleagues. It looked like a great day of presentations highly relevant to our research, and I expected they would be eager to attend with me. To my disappointment, no one was interested. A year earlier, when I had just left my home country for a postdoc, I would not have considered going alone. Whom would I talk to and sit with? I would have spent the entire meeting feeling awkward and self-conscious, unable to focus on the science or networking opportunities. But I had grown. I had gained the confidence to strike out on my own.	[Choudhury, Nasreen] Rush Univ, Med Ctr, Chicago, IL 60612 USA	Rush University	Choudhury, N (corresponding author), Rush Univ, Med Ctr, Chicago, IL 60612 USA.	SciCareerEditor@aaas.org							0	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2021	373	6561					1406	1406						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	US5SK	34529463				2022-12-28	WOS:000697488600054
J	Davis, J				Davis, Jacky			It's more vital than ever that we have data to support the debate on assisted dying	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												drjcdavis@hotmail.com							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2021	374								n2173	10.1136/bmj.n2173	http://dx.doi.org/10.1136/bmj.n2173			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ3VV	34503950				2022-12-28	WOS:000702137100004
J	Jackson, ST				Jackson, Stephen T.			Transformational ecology and climate change	SCIENCE			English	Editorial Material							MANAGEMENT		[Jackson, Stephen T.] US Geol Survey, Southwest & South Cent Climate Adaptat Sci Ctr, Tucson, AZ 85721 USA; [Jackson, Stephen T.] Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA	United States Department of the Interior; United States Geological Survey; University of Arizona	Jackson, ST (corresponding author), US Geol Survey, Southwest & South Cent Climate Adaptat Sci Ctr, Tucson, AZ 85721 USA.; Jackson, ST (corresponding author), Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA.	stjackson@usgs.gov		Jackson, Stephen/0000-0002-1487-4652				Aplet GH, 2017, ECOSYST HEALTH SUST, V3, DOI 10.1002/ehs2.1261; Bradford JB, 2018, FRONT ECOL ENVIRON, V16, P295, DOI 10.1002/fee.1806; Coop JD, 2020, BIOSCIENCE, V70, P659, DOI 10.1093/biosci/biaa061; Enquist CAF, 2017, FRONT ECOL ENVIRON, V15, P541, DOI 10.1002/fee.1733; Fordham DA, 2020, SCIENCE, V369, P1072, DOI 10.1126/science.abc5654; Millar CI, 2015, SCIENCE, V349, P823, DOI 10.1126/science.aaa9933; Nolan C, 2018, SCIENCE, V361, P920, DOI 10.1126/science.aan5360; Norton B.G., 2015, SUSTAINABLE VALUES S; Schuurman G. W., 2021, BIOSCIENCE, DOI [10.1093/biosci/ biab067, DOI 10.1093/BIOSCI/BIAB067]; Shi LD, 2021, SCIENCE, V372, P1408, DOI 10.1126/science.abc8054; Stephens L, 2019, SCIENCE, V365, P897, DOI 10.1126/science.aax1192; Thompson LM, 2021, FISHERIES, V46, P8, DOI 10.1002/fsh.10506; Turner MG, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0105; WALTERS CJ, 1990, ECOLOGY, V71, P2060, DOI 10.2307/1938620	14	15	15	11	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2021	373	6559					1085	1086		10.1126/science.abj6777	http://dx.doi.org/10.1126/science.abj6777			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UL8QT	34516851				2022-12-28	WOS:000692910300028
J	Moghadas, SM; Sah, P; Shoukat, A; Meyers, LA; Galvani, AP				Moghadas, Seyed M.; Sah, Pratha; Shoukat, Affan; Meyers, Lauren Ancel; Galvani, Alison P.			Population Immunity Against COVID-19 in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							SARS-COV-2	Background: As of 28 July 2021, 60% of adults in the United States had been fully vaccinated against COVID-19, and more than 34 million cases had been reported. Given the uncertainty regarding undocumented infections, the population level of immunity against COVID-19 in the United States remains undetermined. Objective: To estimate the population immunity, defined as the proportion of the population that is protected against SARS-CoV-2 infection due to prior infection or vaccination. Design: Statistical and simulation modeling to estimate overall and age-specific population immunity. Setting: United States. Participants: Simulated age-stratified population representing U.S. demographic characteristics. Measurements: The true number of SARS-CoV-2 infections in the United States was inferred from data on reported deaths using age-specific infection-fatality rates (IFRs). Taking into account the estimates for vaccine effectiveness and protection against reinfection, the overall population immunity was determined as the sum of protection levels in vaccinated persons and those who were previously infected but not vaccinated. Results: Using age-specific IFR estimates from the Centers for Disease Control and Prevention, it was estimated that as of 15 July 2021, 114.9 (95% credible interval [CrI], 103.2 to 127.4) million persons had been infected with SARS-CoV-2 in the United States. The mean overall population immunity was 62.0% (CrI, 58.4% to 66.4%). Adults aged 65 years or older were estimated to have the highest immunity level (77.2% [CrI, 76.2% to 78.6%]), and children younger than 12 years had the lowest immunity level (17.9% [CrI, 14.4% to 21.9%]). Limitation: Publicly reported deaths may underrepresent actual deaths. Conclusion: As of 15 July 2021, the U.S. population immunity against COVID-19 may still have been insufficient to contain the outbreaks and safely revert to prepandemic social behavior. Primary Funding Source: National Science Foundation, National Institutes of Health, Notsew Orm Sands Foundation, Canadian Institutes of Health Research, and Natural Sciences and Engineering Research Council of Canada.	[Moghadas, Seyed M.] York Univ, Agent Based Modelling Lab, 4700 Keele St, Toronto, ON, Canada; [Sah, Pratha; Shoukat, Affan; Galvani, Alison P.] Yale Sch Publ Hlth, Yale Ctr Infect Dis Modeling & Anal, 135 Coll St,Suite 200, New Haven, CT 06510 USA; [Meyers, Lauren Ancel] Univ Texas Austin, Dept Integrat Biol, 1 Univ Stn C0990, Austin, TX 78712 USA; [Meyers, Lauren Ancel] Santa Fe Inst, Santa Fe, NM 87501 USA	York University - Canada; Yale University; University of Texas System; University of Texas Austin; The Santa Fe Institute	Galvani, AP (corresponding author), Yale Sch Publ Hlth, Yale Ctr Infect Dis Modeling & Anal, 135 Coll St,Suite 200, New Haven, CT 06510 USA.	alison.galvani@yale.edu		Sah, Pratha/0000-0001-8936-5871; Shoukat, Affan/0000-0001-9280-8311	National Science Foundation; National Institutes of Health; Notsew Orm Sands Foundation; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Notsew Orm Sands Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	National Science Foundation, National Institutes of Health, Notsew Orm Sands Foundation, Canadian Institutes of Health Research, and Natural Sciences and Engineering Research Council of Canada.	Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; Barmann J, 2021, SFIST           0727; Brown CM, 2021, MMWR-MORBID MORTAL W, V70, P1059, DOI 10.15585/mmwr.mm7031e2; Centers for Disease Control and Prevention, WEEKL UPD SEL DEM GE; Centers for Disease Control and Prevention, COVID DAT TRACK; Centers for Disease Control and Prevention, DELT VAR WHAT WE KNO; Centers for Disease Control and Prevention, INT CLIN CONS US COV; Centers for Disease Control and Prevention, SCI BRIEF COVID 19 V; Centers for Disease Control and Prevention, EST COVID 19 BURD; Centers for Disease Control and Prevention, COVID 19 PAND PLANN; Chodick G, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.15985; Cohen J., 2021, FORBES; GitHub, COV 19 DAT ONG REP D; Hall VJ, 2021, LANCET, V397, P1459, DOI 10.1016/S0140-6736(21)00675-9; Hansen CH, 2021, LANCET, V397, P1204, DOI 10.1016/S0140-6736(21)00575-4; Health Essentials, 2021, MUCH POP WILL NEED B; Iuliano A Danielle, 2021, Lancet Reg Health Am, V1, P100019, DOI 10.1016/j.lana.2021.100019; Moghadas Seyed M, 2021, Lancet Reg Health Am, V1, P100033, DOI 10.1016/j.lana.2021.100033; O'Driscoll M, 2020, NATURE, DOI 10.1038/s41586-020-2918-0; Pawlowski C, 2021, MED-CAMBRIDGE, V2, P979, DOI 10.1016/j.medj.2021.06.007; Russell RS, 2021, VIRAL IMMUNOL, V34, P211, DOI 10.1089/vim.2021.0075; Sadoff J, 2021, NEW ENGL J MED, V384, P2187, DOI 10.1056/NEJMoa2101544; Sanche S, 2020, EMERG INFECT DIS, V26, P1470, DOI 10.3201/eid2607.200282; US Food and Drug Administration, VACC REL BIOL PROD A; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7	25	7	7	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV	2021	174	11					1586	+		10.7326/M21-2721	http://dx.doi.org/10.7326/M21-2721			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YI2OV	34516275	Green Published			2022-12-28	WOS:000743694300023
J	Susoy, V; Hung, W; Witvliet, D; Whitener, JE; Wu, M; Park, CF; Graham, BJ; Zhen, M; Venkatachalam, V; Samuel, ADT				Susoy, Vladislav; Hung, Wesley; Witvliet, Daniel; Whitener, Joshua E.; Wu, Min; Park, Core Francisco; Graham, Brett J.; Zhen, Mei; Venkatachalam, Vivek; Samuel, Aravinthan D. T.			Natural sensory context drives diverse brain-wide activity during C. elegans mating	CELL			English	Article							NERVOUS-SYSTEM; BEHAVIOR; NEURONS; COORDINATE; CIRCUIT	Natural goal-directed behaviors often involve complex sequences of many stimulus-triggered components. Understanding how brain circuits organize such behaviors requires mapping the interactions between an animal, its environment, and its nervous system. Here, we use brain-wide neuronal imaging to study the full performance of mating by the C. elegans male. We show that as mating unfolds in a sequence of component behaviors, the brain operates similarly between instances of each component but distinctly between different components. When the full sensory and behavioral context is taken into account, unique roles emerge for each neuron. Functional correlations between neurons are not fixed but change with behavioral dynamics. From individual neurons to circuits, our study shows how diverse brain-wide dynamics emerge from the integration of sensory perception and motor actions in their natural context.	[Susoy, Vladislav; Witvliet, Daniel; Park, Core Francisco; Venkatachalam, Vivek; Samuel, Aravinthan D. T.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Hung, Wesley; Wu, Min; Zhen, Mei] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Whitener, Joshua E.; Venkatachalam, Vivek] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Susoy, Vladislav; Witvliet, Daniel; Park, Core Francisco; Graham, Brett J.; Venkatachalam, Vivek; Samuel, Aravinthan D. T.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Northeastern University; Harvard University	Susoy, V; Venkatachalam, V; Samuel, ADT (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.; Venkatachalam, V (corresponding author), Northeastern Univ, Dept Phys, Boston, MA 02115 USA.; Susoy, V; Venkatachalam, V; Samuel, ADT (corresponding author), Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA.	vladislav.susoy@fas.harvard.edu; v.venkatachalam@northeastern.edu; samuel@physics.harvard.edu		Samuel, Aravinthan/0000-0002-1672-8720; Susoy, Vladislav/0000-0002-0669-0087; Hung, Wesley/0000-0001-8488-7638; Venkatachalam, Vivek/0000-0002-2414-7416; Park, Core Francisco/0000-0002-9542-2913	NIH Office of Research Infrastructure Programs [P40 OD010440]; NSF [IOS-1452593]; NIH [R01 NS082525, R01 NS113119, UF1 NS111697]; Canadian Institutes of Health Research [154274]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2017-06738]; Burroughs Wellcome Fund	NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Burroughs Wellcome Fund(Burroughs Wellcome Fund)	We thank Alkmini Chalofti and Noah Milstein for help with neuronal tracking, Albert Lin for creating hpEx3931, Oliver Hobert for sharing strains, and Scott Emmons for sharing EM photographs of the male nervous system. We thank Scott Linderman, Paul Sternberg, Kenneth Blum, and members of the Samuel lab for their comments on the manuscript. Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). This work was supported by NSF (IOS-1452593), NIH (R01 NS082525, R01 NS113119, and UF1 NS111697), Canadian Institutes of Health Research (Foundation Scheme 154274), Natural Sciences and Engineering Research Council of Canada (RGPIN-2017-06738), and the Burroughs Wellcome Fund.	Adai AT, 2004, J MOL BIOL, V340, P179, DOI 10.1016/j.jmb.2004.04.047; Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Aicher C, 2015, J COMPLEX NETW, V3, P221, DOI 10.1093/comnet/cnu026; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Betzel R.F., 2018, BIORXIV355016; Briggman KL, 2008, ANNU REV NEUROSCI, V31, P271, DOI 10.1146/annurev.neuro.31.060407.125552; Candadai M, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00540; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; Cook SJ, 2019, NATURE, V571, P63, DOI 10.1038/s41586-019-1352-7; Correa PA, 2015, J NEUROSCI, V35, P9990, DOI 10.1523/JNEUROSCI.0940-15.2015; Doroquez DB, 2014, ELIFE, V3, DOI 10.7554/eLife.01948; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; GETTING PA, 1989, ANNU REV NEUROSCI, V12, P185, DOI 10.1146/annurev.neuro.12.1.185; Gomez-Marin A, 2014, NAT NEUROSCI, V17, P1455, DOI 10.1038/nn.3812; Hart MP, 2018, NATURE, V553, P165, DOI 10.1038/nature25192; Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; Kagoshima H, 2013, DEV BIOL, V380, P314, DOI 10.1016/j.ydbio.2013.04.009; Kalinka Alex T, 2011, Bioinformatics, V27, P2011, DOI 10.1093/bioinformatics/btr311; Kato S, 2015, CELL, V163, P656, DOI 10.1016/j.cell.2015.09.034; Kawano T, 2011, NEURON, V72, P572, DOI 10.1016/j.neuron.2011.09.005; Koo PK, 2011, J NEUROSCI, V31, P7497, DOI 10.1523/JNEUROSCI.6153-10.2011; Krakauer JW, 2017, NEURON, V93, P480, DOI 10.1016/j.neuron.2016.12.041; Kuhn M., 2020, PACKAGE CARET; LeBoeuf B, 2017, G3-GENES GENOM GENET, V7, P647, DOI 10.1534/g3.116.036756; LeBoeuf B, 2014, ELIFE, V3, DOI 10.7554/eLife.02938; Leighton DHW, 2014, P NATL ACAD SCI USA, V111, P17905, DOI 10.1073/pnas.1420439111; Linderman S. W., 2019, NEUROSCIENCE, DOI [10.1101/621540, DOI 10.1101/621540]; LIU KS, 1995, NEURON, V14, P79, DOI 10.1016/0896-6273(95)90242-2; Markowitz JE, 2018, CELL, V174, P44, DOI 10.1016/j.cell.2018.04.019; Mulcahy B, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00094; Narayan A, 2016, P NATL ACAD SCI USA, V113, pE1392, DOI 10.1073/pnas.1600786113; Nguyen JP, 2016, P NATL ACAD SCI USA, V113, pE1074, DOI 10.1073/pnas.1507110112; Noble LM, 2015, CURR BIOL, V25, P2730, DOI 10.1016/j.cub.2015.09.019; Oren-Suissa M, 2016, NATURE, V533, P206, DOI 10.1038/nature17977; Orfanidis S. J., 1995, INTRO SIGNAL PROCESS; Pinto L, 2019, NEURON, V104, P810, DOI 10.1016/j.neuron.2019.08.025; Qian J., 2020, PACKAGE GLMNET; SAMMON JW, 1969, IEEE T COMPUT, VC 18, P401, DOI 10.1109/T-C.1969.222678; Schilbach L, 2013, BEHAV BRAIN SCI, V36, P393, DOI 10.1017/S0140525X12000660; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schindelman G, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-26; Scholz M., 2018, PREDICTING NATURAL B, DOI [10.7554/eLife.66135, DOI 10.7554/ELIFE.66135]; Serrano-Saiz E, 2017, GENETICS, V206, P1251, DOI 10.1534/genetics.117.202127; Serrano-Saiz E, 2017, CURR BIOL, V27, P199, DOI 10.1016/j.cub.2016.11.045; Serrano-Saiz E, 2013, CELL, V155, P659, DOI 10.1016/j.cell.2013.09.052; Sherlekar AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060597; Simon JM, 2002, P NATL ACAD SCI USA, V99, P1598, DOI 10.1073/pnas.032225799; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Stringer C, 2019, SCIENCE, V364, P255, DOI 10.1126/science.aav7893; Styczynska-Soczka Katarzyna, 2015, Cilia, V4, P9, DOI 10.1186/s13630-015-0018-9; SULSTON JE, 1980, DEV BIOL, V78, P542, DOI 10.1016/0012-1606(80)90352-8; Susoy Vladislav, 2019, MicroPubl Biol, V2019, DOI 10.17912/micropub.biology.000091; Teramoto T, 2006, CELL CALCIUM, V40, P319, DOI 10.1016/j.ceca.2006.04.009; Venkatachalam V, 2016, P NATL ACAD SCI USA, V113, pE1082, DOI 10.1073/pnas.1507109113; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Whittaker AJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-33; Wolff C, 2018, ELIFE, V7, DOI 10.7554/eLife.34410; Zhen M, 2015, CURR OPIN NEUROBIOL, V33, P117, DOI 10.1016/j.conb.2015.03.009	61	7	7	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 30	2021	184	20					5122	+		10.1016/j.cell.2021.08.024	http://dx.doi.org/10.1016/j.cell.2021.08.024		OCT 2021	33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	WC7PG	34534446	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000704445700009
J	Evans, MK; Graves, JL; Shim, RS; Tishkoff, SA; Williams, WW				Evans, Michele K.; Graves, Joseph L., Jr.; Shim, Ruth S.; Tishkoff, Sarah A.; Williams, Winfred W.			Race in Medicine - Genetic Variation, Social Categories, and Paths to Health Equity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Evans, Michele K.] NIA, Bethesda, MD 20892 USA; [Evans, Michele K.] North Carolina Agr & Technol State Univ, Greensboro, NC USA; [Shim, Ruth S.] Univ Calif Davis, Cultural Psychiat, Davis, CA 95616 USA; [Shim, Ruth S.] Univ Calif Davis, Sch Med, Davis, CA 95616 USA; [Tishkoff, Sarah A.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Tishkoff, Sarah A.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Williams, Winfred W.] Massachusetts Gen Hosp, Div Nephrol, Boston, MA 02114 USA; [Williams, Winfred W.] Harvard Med Sch, Med, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of North Carolina; North Carolina A&T State University; University of California System; University of California Davis; University of California System; University of California Davis; University of Pennsylvania; University of Pennsylvania; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Evans, MK (corresponding author), NIA, Bethesda, MD 20892 USA.; Evans, MK (corresponding author), North Carolina Agr & Technol State Univ, Greensboro, NC USA.			Shim, Ruth/0000-0002-4509-590X; Williams, Winfred/0000-0001-9984-7102				Bonham VL, 2009, GENET MED, V11, P279, DOI 10.1097/GIM.0b013e318195aaf4; Crews DC, 2020, J AM SOC NEPHROL, V31, P1659, DOI 10.1681/ASN.2020060809; Crews DC, 2010, AM J KIDNEY DIS, V55, P992, DOI 10.1053/j.ajkd.2009.12.032; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Hoffman KM, 2016, P NATL ACAD SCI USA, V113, P4296, DOI 10.1073/pnas.1516047113; Kraus MW, 2019, PERSPECT PSYCHOL SCI, V14, P899, DOI 10.1177/1745691619863049; McGinnis JM, 2002, HEALTH AFFAIR, V21, P78, DOI 10.1377/hlthaff.21.2.78; Muuoz A.P., 2015, COLOR WEALTH BOSTON; Sirugo G, 2019, CELL, V177, P26, DOI 10.1016/j.cell.2019.02.048	9	7	7	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 30	2021	385	14												15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZG1PD	34528770	Bronze			2022-12-28	WOS:000760034300001
J	Bennett, MR; Bustos, D; Pigati, JS; Springer, KB; Urban, TM; Holliday, VT; Reynolds, SC; Budka, M; Honke, JS; Hudson, AM; Fenerty, B; Connelly, C; Martinez, PJ; Santucci, VL; Odess, D				Bennett, Matthew R.; Bustos, David; Pigati, Jeffrey S.; Springer, Kathleen B.; Urban, Thomas M.; Holliday, Vance T.; Reynolds, Sally C.; Budka, Marcin; Honke, Jeffrey S.; Hudson, Adam M.; Fenerty, Brendan; Connelly, Clare; Martinez, Patrick J.; Santucci, Vincent L.; Odess, Daniel			Evidence of humans in North America during the Last Glacial Maximum	SCIENCE			English	Article							FOOTPRINTS; MASS; AGE; GEOCHRONOLOGY; PRESERVATION; CONSTRAINTS; CHILDREN; HISTORY; ILERET; U-234	Archaeologists and researchers in allied fields have long sought to understand human colonization of North America. Questions remain about when and how people migrated, where they originated, and how their arrival affected the established fauna and landscape. Here, we present evidence from excavated surfaces in White Sands National Park (New Mexico, United States), where multiple in situ human footprints are stratigraphically constrained and bracketed by seed layers that yield calibrated radiocarbon ages between similar to 23 and 21 thousand years ago. These findings confirm the presence of humans in North America during the Last Glacial Maximum, adding evidence to the antiquity of human colonization of the Americas and providing a temporal range extension for the coexistence of early inhabitants and Pleistocene megafauna.	[Bennett, Matthew R.; Reynolds, Sally C.; Budka, Marcin] Bournemouth Univ, Inst Studies Landscapes & Human Evolut, Poole BH12 5BB, Dorset, England; [Bustos, David; Connelly, Clare; Martinez, Patrick J.] Natl Pk Serv, White Sands Natl Pk,POB 1086, Holloman AFB, NM 88330 USA; [Pigati, Jeffrey S.; Springer, Kathleen B.; Honke, Jeffrey S.; Hudson, Adam M.] US Geol Survey, Denver Fed Ctr, Box 25046,MS 980, Denver, CO 80225 USA; [Urban, Thomas M.] Cornell Univ, Dept Class, Ithaca, NY 14853 USA; [Urban, Thomas M.] Cornell Univ, Cornell Tree Ring Lab, Ithaca, NY 14853 USA; [Holliday, Vance T.] Univ Arizona, Sch Anthropol, POB 210030, Tucson, AZ 85721 USA; [Holliday, Vance T.; Fenerty, Brendan] Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA; [Santucci, Vincent L.] Natl Pk Serv, Geol Resources Div, 1849 C St NW, Washington, DC 20240 USA; [Odess, Daniel] Natl Pk Serv, Cultural Resources Directorate, Washington, DC 20240 USA	Bournemouth University; United States Department of the Interior; United States Department of the Interior; United States Geological Survey; Cornell University; Cornell University; University of Arizona; University of Arizona; United States Department of the Interior; United States Department of the Interior	Bennett, MR (corresponding author), Bournemouth Univ, Inst Studies Landscapes & Human Evolut, Poole BH12 5BB, Dorset, England.; Odess, D (corresponding author), Natl Pk Serv, Cultural Resources Directorate, Washington, DC 20240 USA.	mbennett@bournemouth.ac.uk; daniel_odess@nps.gov		Bustos, David/0000-0002-0309-7632; Pigati, Jeffrey/0000-0001-5843-6219; Reynolds, Sally/0000-0001-6313-6405; Honke, Jeffrey/0000-0003-4357-9297; Odess, Daniel/0000-0003-2391-8175	Natural Environment Research Council [NE/H004246/1, NE/M021459/1]; Argonaut Archaeological Research Fund (University of Arizona Foundation); US Geological Survey's Climate Research and Development Program; National Park Service [G14P20PG00274]; Cornell University [P20AC00605]; US Department of the Interior [P20AC00605]; Western National Parks Association	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Argonaut Archaeological Research Fund (University of Arizona Foundation); US Geological Survey's Climate Research and Development Program; National Park Service; Cornell University; US Department of the Interior; Western National Parks Association	M.R.B. acknowledges Natural Environment Research Council grants (NE/H004246/1 and NE/M021459/1). V.T.H. acknowledges the Argonaut Archaeological Research Fund (University of Arizona Foundation). Funding for J.S.P. and K.B.S. was provided by the US Geological Survey's Climate Research and Development Program and by the National Park Service through Interagency Agreement G14P20PG00274. T.M.U. acknowledges cooperative agreement P20AC00605 between Cornell University and the US Department of the Interior. D.B. and M.R.B. thank the Western National Parks Association for support. Author	ALEXANDER RM, 1984, AM J PHYS ANTHROPOL, V63, P23, DOI 10.1002/ajpa.1330630105; ALEXANDER RM, 1976, NATURE, V261, P129, DOI 10.1038/261129a0; Allen B.D., 2009, N M GEOL, V31, P9; Ashton N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088329; Becerra-Valdivia L, 2020, NATURE, V584, P93, DOI 10.1038/s41586-020-2491-6; Bennett M. R., 2021, BORDAR, DOI [10.18746/bmth.data.00000186, DOI 10.18746/BMTH.DATA.00000186]; Bennett M. R., READING PREHISTORIC, V2021, P15; Bennett M. R., 2021, US GEOLOGICAL SURVEY, DOI [10.5066/ P9ABZEM9, DOI 10.5066/P9ABZEM9]; Bennett MR, 2020, QUATERNARY SCI REV, V249, DOI 10.1016/j.quascirev.2020.106610; Bennett MR, 2014, J AFR EARTH SCI, V97, P331, DOI 10.1016/j.jafrearsci.2014.05.015; Bennett MR, 2009, SCIENCE, V323, P1197, DOI 10.1126/science.1168132; Bennett MR., 2018, DIGITAL TECHNOLOGY F; BISCHOFF JL, 1985, SCIENCE, V227, P1222, DOI 10.1126/science.227.4691.1222; Blaauw M, 2011, BAYESIAN ANAL, V6, P457, DOI 10.1214/ba/1339616472; Braje TJ, 2020, AM ANTIQUITY, V85, P1, DOI 10.1017/aaq.2019.80; Bronk Ramsey C., 2020, OXCAL V442; Broughton JM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07897-1; Bustos D, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar7621; Cheng H, 2013, EARTH PLANET SC LETT, V371, P82, DOI 10.1016/j.epsl.2013.04.006; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Dalton AS, 2020, QUATERNARY SCI REV, V234, DOI 10.1016/j.quascirev.2020.106223; Dawe RJ, 2017, QUATERN INT, V444, P56, DOI 10.1016/j.quaint.2017.03.062; de Onis M, 2003, INT J EPIDEMIOL, V32, P518, DOI 10.1093/ije/dyg099; De Onis M., 2015, ECOGS EBOOK CHILD AD; Delanghe D, 2002, MAR CHEM, V80, P79, DOI 10.1016/S0304-4203(02)00100-7; Dingwall HL, 2013, J HUM EVOL, V64, P556, DOI 10.1016/j.jhevol.2013.02.004; Duveau J, 2019, P NATL ACAD SCI USA, V116, P19409, DOI 10.1073/pnas.1901789116; Falkingham PL, 2011, J R SOC INTERFACE, V8, P1142, DOI 10.1098/rsif.2010.0634; Falkingham PL, 2018, PALAEONTOLOGY, V61, P469, DOI 10.1111/pala.12373; Ferraro JV, 2018, NATURE, V554, pE1, DOI 10.1038/nature25165; Ferreira AA, 2016, ANN HUM BIOL, V43, P293, DOI 10.1080/03014460.2016.1195445; Fiedel StuartJ., 2021, PALEOAMERICA, V7, P28; Francis P, 2020, BMJ OPEN SPORT EXERC, V6, DOI 10.1136/bmjsem-2019-000577; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hatala KG, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64095-0; Haynes R. R., 2000, BOT MISCELLANY, V18, P23; Heintzman PD, 2016, P NATL ACAD SCI USA, V113, P8057, DOI 10.1073/pnas.1601077113; Helm Charles W., 2018, Palaeontologia Africana, V53, P81; Holliday VT, 2008, QUATERNARY RES, V70, P11, DOI 10.1016/j.yqres.2008.02.009; Holliday VT, 2006, GEOARCHAEOLOGY, V21, P765, DOI 10.1002/gea.20139; Holliday VT, 2019, GEOMORPHOLOGY, V331, P92, DOI 10.1016/j.geomorph.2018.08.012; Hrdlicka A, 1935, AM J PHYS ANTHROPOL, V20, P235, DOI 10.1002/ajpa.1330200302; Kim JY, 2008, ICHNOS, V15, P126, DOI 10.1080/10420940802467868; Lesnek AJ, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar5040; Ludwig K.R., 2012, USERS MANUAL ISOPLOT, V5, P1, DOI DOI 10.1016/S0016-7037(98)00059-3; LUDWIG KR, 1985, ECON GEOL, V80, P1858, DOI 10.2113/gsecongeo.80.7.1858; Martin R., 1914, LEHRBUCH ANTHR, V2; Meltzer DJ, 2020, P NATL ACAD SCI USA, V117, P28555, DOI 10.1073/pnas.2015032117; Meltzer David J., 2015, GREAT PALEOLITHIC WA; Menking KM, 2018, QUATERNARY SCI REV, V200, P237, DOI 10.1016/j.quascirev.2018.09.030; Morse S.A., 2014, HUMAN FOOTPRINTS FOS; Morse SA, 2013, AM J PHYS ANTHROPOL, V151, P265, DOI 10.1002/ajpa.22276; Morse SA, 2010, QUATERNARY SCI REV, V29, P2571, DOI 10.1016/j.quascirev.2010.03.012; Natale V, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003735; Paquette S., 2009, TECHNICAL REPORT NAT; Potter B, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat5473; Raichlen DA, 2008, J HUM EVOL, V54, P112, DOI 10.1016/j.jhevol.2007.07.005; Reimer PJ, 2020, RADIOCARBON, V62, P725, DOI 10.1017/RDC.2020.41; Roach NT, 2016, SCI REP-UK, V6, DOI 10.1038/srep26374; Rudnick, 2003, TREATISE GEOCHEMISTR, V3, P1, DOI [10.1016/B0-08-043751-6/03016-4, DOI 10.1016/B0-08-043751-6/03016-4, 10.1016/B978-0-08-095975-7.00301-6.]; SHAW DM, 1976, GEOCHIM COSMOCHIM AC, V40, P73, DOI 10.1016/0016-7037(76)90195-2; Snyder RG., 1977, ANTHROPOMETRY INFANT; Springer KB, 2015, P NATL ACAD SCI USA, V112, P14522, DOI 10.1073/pnas.1513352112; STEIGER RH, 1977, EARTH PLANET SC LETT, V36, P359, DOI 10.1016/0012-821X(77)90060-7; Svensson A, 2008, CLIM PAST, V4, P47, DOI 10.5194/cp-4-47-2008; Taylor S. R., 1985, CONTINENTAL CRUST IT, DOI DOI 10.1002/GJ.3350210116; THURBER DL, 1965, SCIENCE, V149, P55, DOI 10.1126/science.149.3679.55; Tuttle R. H., 1987, LAETOLI PLIOCENE SIT, P60; Urban TM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52996-8; Vermeesch P, 2018, GEOSCI FRONT, V9, P1479, DOI 10.1016/j.gsf.2018.04.001; VOGEL JS, 1984, NUCL INSTRUM METH B, V5, P289, DOI 10.1016/0168-583X(84)90529-9; Waters MR, 2019, SCIENCE, V365, P138, DOI 10.1126/science.aat5447; Webb D, 2014, AM J PHYS ANTHROPOL, V155, P128, DOI 10.1002/ajpa.22561; Zhou AF, 2009, RADIOCARBON, V51, P529, DOI 10.1017/S0033822200055909	74	41	42	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2021	373	6562			SI		1528	+		10.1126/science.abg7586	http://dx.doi.org/10.1126/science.abg7586			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU7LJ	34554787	Green Accepted			2022-12-28	WOS:000698977800054
J	Liu, YC; Mao, XW; Krause, J; Fu, QM				Liu, Yichen; Mao, Xiaowei; Krause, Johannes; Fu, Qiaomei			Insights into human history from the first decade of ancient human genomics	SCIENCE			English	Review							COVERAGE NEANDERTHAL GENOME; POPULATION HISTORY; SEQUENCE; DNA; ADMIXTURE; ANCESTRY; ORIGINS; HOMININ; CAVE	Recent advancements in DNA sequencing technologies and laboratory preparation protocols have rapidly expanded the scope of ancient DNA research over the past decade, both temporally and geographically. Discoveries include interactions between archaic and modern humans as well as modern human population dynamics, including those coinciding with the Last Glacial Maximum and the settlement history of most world regions. This new type of data allows us to examine the deep past of human population dynamics and sharpen the current understanding of our present. The continued development in the ancient DNA field has transformed our understanding of human genetic history and will keep uncovering the further mysteries of our recent evolutionary past.	[Liu, Yichen; Mao, Xiaowei; Fu, Qiaomei] Chinese Acad Sci, Ctr Excellence Life & Paleoenvironm, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing 100044, Peoples R China; [Krause, Johannes] Max Planck Inst Evolutionary Anthropol, Deutsch Pl 6, D-04103 Leipzig, Germany; [Fu, Qiaomei] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Max Planck Society; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Fu, QM (corresponding author), Chinese Acad Sci, Ctr Excellence Life & Paleoenvironm, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing 100044, Peoples R China.; Fu, QM (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.	fuqiaomei@ivpp.ac.cn	liu, yang/HHY-8583-2022; Krause, Johannes/AFP-2642-2022; liu, yichen/GVT-6262-2022	Krause, Johannes/0000-0001-9144-3920; 	Chinese Academy of Sciences (CAS); Ministry of Finance of the People's Republic of China [XDB26000000, YSBR-019]; National Natural Science Foundation of China [41925009]; Tencent Foundation; Howard Hughes Medical Institute [55008731]; Shanghai Qi Zhi Institute	Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); Ministry of Finance of the People's Republic of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tencent Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Shanghai Qi Zhi Institute	This work was supported by the Chinese Academy of Sciences (CAS) and the Ministry of Finance of the People's Republic of China (XDB26000000 and YSBR-019), the National Natural Science Foundation of China (41925009), the Tencent Foundation (through the XPLORER PRIZE), the Howard Hughes Medical Institute (grant 55008731), and the Shanghai Qi Zhi Institute.	Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Bergstrom A, 2016, CURR BIOL, V26, P809, DOI 10.1016/j.cub.2016.01.028; Bergstrom A, 2021, NATURE, V590, P229, DOI 10.1038/s41586-021-03244-5; Chan EKF, 2019, NATURE, V575, P185, DOI 10.1038/s41586-019-1714-1; Chen L, 2020, CELL, V180, P677, DOI 10.1016/j.cell.2020.01.012; Choin J, 2021, NATURE, V592, P583, DOI 10.1038/s41586-021-03236-5; Durvasula A, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax5097; Flegontov P, 2019, NATURE, V570, P236, DOI 10.1038/s41586-019-1251-y; Fregel R, 2018, P NATL ACAD SCI USA, V115, P6774, DOI 10.1073/pnas.1800851115; Fu QM, 2016, NATURE, V534, P200, DOI 10.1038/nature17993; Fu Q, 2015, NATURE, V524, P216, DOI 10.1038/nature14558; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Goldberg A, 2017, P NATL ACAD SCI USA, V114, P2657, DOI 10.1073/pnas.1616392114; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gunz P, 2009, P NATL ACAD SCI USA, V106, P6094, DOI 10.1073/pnas.0808160106; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Hajdinjak M, 2021, NATURE, V592, P253, DOI 10.1038/s41586-021-03335-3; Harvati K, 2019, NATURE, V571, P500, DOI 10.1038/s41586-019-1376-z; Hublin JJ, 2020, NATURE, V581, P299, DOI 10.1038/s41586-020-2259-z; Hublin JJ, 2017, NATURE, V546, P289, DOI 10.1038/nature22336; Ioannidis AG, 2020, NATURE, V583, P572, DOI 10.1038/s41586-020-2487-2; Jeong C, 2020, CELL, V183, P890, DOI 10.1016/j.cell.2020.10.015; Jeong C, 2018, P NATL ACAD SCI USA, V115, pE11248, DOI 10.1073/pnas.1813608115; Ji Q., 2021, INNOVATION, V2; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lipson M, 2020, NATURE, V577, P665, DOI 10.1038/s41586-020-1929-1; Lipson M, 2018, CURR BIOL, V28, P1157, DOI 10.1016/j.cub.2018.02.051; Llorente MG, 2015, SCIENCE, V350, P820, DOI 10.1126/science.aad2879; Mafessoni F, 2020, P NATL ACAD SCI USA, V117, P15132, DOI 10.1073/pnas.2004944117; Mao X., CELL, V184; McColl H, 2018, SCIENCE, V361, P88, DOI 10.1126/science.aat3628; Narasimhan VM, 2019, SCIENCE, V365, P999, DOI 10.1126/science.aat7487; Nielsen R, 2017, NATURE, V541, P302, DOI 10.1038/nature21347; Ning C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16557-2; O'Connell JF, 2015, J ARCHAEOL SCI, V56, P73, DOI 10.1016/j.jas.2015.02.020; Olalde I, 2018, NATURE, V555, P190, DOI 10.1038/nature25738; Orlando L., 2021, NAT REV METHOD PRIME, V1, DOI DOI 10.1038/s43586-020-00011-0; Peter B. M., 2020, 100000 YEARS GENE FL, DOI [10.1101/2020.03.13.990523, DOI 10.1101/2020.03.13.990523]; Petr M, 2020, SCIENCE, V369, P1653, DOI 10.1126/science.abb6460; Posth C, 2018, NAT ECOL EVOL, V2, P731, DOI 10.1038/s41559-018-0498-2; Posth C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16046; Posth C, 2016, CURR BIOL, V26, P827, DOI 10.1016/j.cub.2016.01.037; Prendergast ME, 2019, SCIENCE, V365, P44, DOI 10.1126/science.aaw6275; Prufer K, 2021, NAT ECOL EVOL, V5, P820, DOI 10.1038/s41559-021-01443-x; Prufer K, 2017, SCIENCE, V358, P655, DOI 10.1126/science.aao1887; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Pugach I, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2022112118; Racimo F, 2015, NAT REV GENET, V16, P359, DOI 10.1038/nrg3936; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Rasmussen M, 2014, NATURE, V506, P225, DOI 10.1038/nature13025; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Scerri EML, 2018, TRENDS ECOL EVOL, V33, P582, DOI 10.1016/j.tree.2018.05.005; Seguin-Orlando A, 2014, SCIENCE, V346, P1113, DOI 10.1126/science.aaa0114; Sehlebusch CM, 2017, SCIENCE, V358, P652, DOI 10.1126/science.aao6266; Shinde V, 2019, CELL, V179, P729, DOI 10.1016/j.cell.2019.08.048; Sikora M, 2019, NATURE, V570, P182, DOI 10.1038/s41586-019-1279-z; Skoglund P, 2018, ANNU REV GENOM HUM G, V19, P381, DOI 10.1146/annurev-genom-083117-021749; Skoglund P, 2017, CELL, V171, P59, DOI 10.1016/j.cell.2017.08.049; Skoglund P, 2016, NATURE, V538, P510, DOI 10.1038/nature19844; Slon V, 2018, NATURE, V561, P113, DOI 10.1038/s41586-018-0455-x; Spyrou MA, 2019, NAT REV GENET, V20, P323, DOI 10.1038/s41576-019-0119-1; Svensson E., CURR BIOL, V31; Tobler R, 2017, NATURE, V544, P180, DOI 10.1038/nature21416; van de Loosdrecht M, 2018, SCIENCE, V360, P548, DOI 10.1126/science.aar8380; van der Valk T, 2021, NATURE, V591, P265, DOI 10.1038/s41586-021-03224-9; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vernot B, 2016, SCIENCE, V352, P235, DOI 10.1126/science.aad9416; Vicente M, 2020, CURR OPIN GENET DEV, V62, P8, DOI 10.1016/j.gde.2020.05.008; Villalba-Mouco V, 2019, CURR BIOL, V29, P1169, DOI 10.1016/j.cub.2019.02.006; Villanea FA, 2019, NAT ECOL EVOL, V3, P39, DOI 10.1038/s41559-018-0735-8; Wang CC, 2021, NATURE, V591, P413, DOI 10.1038/s41586-021-03336-2; Wang K, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz0183; Wang T., CELL, V184; Willerslev E, 2021, NATURE, V594, P356, DOI 10.1038/s41586-021-03499-y; Yang MA, 2020, SCIENCE, V369, P282, DOI 10.1126/science.aba0909; Yang MA, 2018, TRENDS GENET, V34, P184, DOI 10.1016/j.tig.2017.11.008; Yang MA, 2017, CURR BIOL, V27, P3202, DOI 10.1016/j.cub.2017.09.030; Yu H, 2020, CELL, V181, P1232, DOI 10.1016/j.cell.2020.04.037; Zeberg H, 2020, NATURE, V587, P610, DOI 10.1038/s41586-020-2818-3	80	9	10	27	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2021	373	6562			SI		1479	1484		10.1126/science.abi8202	http://dx.doi.org/10.1126/science.abi8202			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU7LJ	34554811				2022-12-28	WOS:000698977800044
J	Panofsky, A				Panofsky, Aaron			The Genetic Lottery: Why DNA Matters for Social Equality	SCIENCE			English	Book Review									[Panofsky, Aaron] Univ Calif Los Angeles, Inst Soc & Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Panofsky, A (corresponding author), Univ Calif Los Angeles, Inst Soc & Genet, Los Angeles, CA 90095 USA.	apanofsky@ucla.edu						Harden KP., 2021, GENETIC LOTTERY WHY, DOI 10.1515/9780691226705	1	1	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2021	373	6562			SI		1449	1449		10.1126/science.abl3851	http://dx.doi.org/10.1126/science.abl3851			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UU7LJ	34554805				2022-12-28	WOS:000698977800034
J	Ushijima, T; Clark, SJ; Tan, P				Ushijima, Toshikazu; Clark, Susan J.; Tan, Patrick			Mapping genomic and epigenomic evolution in cancer ecosystems	SCIENCE			English	Review							DNA METHYLATION; MUTATIONS; METASTASIS; LANDSCAPE; DEFINE; CELLS; EXPRESSION; CONVERGE; TUMORS	Cancer is a major cause of global mortality underpinned by genomic and epigenomic derangements. Here, we highlight the importance of multimodal data integration in understanding the molecular evolution of malignant cell states across the cancer life cycle. The widespread presence of driver mutations and epigenetic alterations in normal-appearing tissues is prompting a reassessment of how cancer initiation is defined. In later-stage cancers, studying the roles of clonal selection, epigenomic adaptation, and persister cells in metastasis and therapy resistance is an emerging field. Finally, the importance of tumor ecosystems in driving cancer development is being unraveled by single-cell and spatial technologies at unprecedented resolution. Improving cancer risk assessment and accelerating therapeutic discovery for patients will require robust, comprehensive, and integrated temporal, spatial, and multilevel tumor atlases across the cancer life cycle.	[Ushijima, Toshikazu] Natl Canc Ctr, Div Epigen, Tokyo 1040045, Japan; [Clark, Susan J.] Garvan Inst Med Res, Epigenet Res Lab, Genom & Epigenet Theme, Sydney, NSW 2010, Australia; [Clark, Susan J.] Univ New South Wales Sydney, Fac Med, St Vincents Clin Sch, Sydney, NSW 2010, Australia; [Tan, Patrick] Duke NUS Med Sch Singapore, Canc & Stem Cell Biol, Singapore 169857, Singapore; [Tan, Patrick] Genome Inst Singapore, Epigen & Epitranscript Regulat, Singapore 138672, Singapore; [Tan, Patrick] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Tan, Patrick] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore	National Cancer Center - Japan; Garvan Institute of Medical Research; University of New South Wales Sydney; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore	Ushijima, T (corresponding author), Natl Canc Ctr, Div Epigen, Tokyo 1040045, Japan.; Clark, SJ (corresponding author), Garvan Inst Med Res, Epigenet Res Lab, Genom & Epigenet Theme, Sydney, NSW 2010, Australia.; Clark, SJ (corresponding author), Univ New South Wales Sydney, Fac Med, St Vincents Clin Sch, Sydney, NSW 2010, Australia.; Tan, P (corresponding author), Duke NUS Med Sch Singapore, Canc & Stem Cell Biol, Singapore 169857, Singapore.; Tan, P (corresponding author), Genome Inst Singapore, Epigen & Epitranscript Regulat, Singapore 138672, Singapore.; Tan, P (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore.; Tan, P (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore.	tushijim@ncc.go.jp; s.clark@garvan.org.au; gmstanp@duke-nus.edu.sg	Clark, Susan J/B-2272-2008; Ushijima, Toshikazu/AAP-5742-2021	Clark, Susan J/0000-0001-5925-5030; Ushijima, Toshikazu/0000-0003-3405-7817; Tan, Patrick/0000-0002-0179-8048	AMED [JP20ck0106552h0001, JP20 ggm1310006h0001]; National Health and Medical Research (NHMRC) fellowship [1156408]; NHMRC [1147974, 1144574]; National Medical Research Council [NMRC/STaR/0026/2015]; Duke-NUS Medical School; Agency for Science, Technology and Research; Cancer Science Institute of Singapore; Open Fund-Large Collaborative grant [MOH-OFLCG18May-0003]	AMED; National Health and Medical Research (NHMRC) fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Duke-NUS Medical School; Agency for Science, Technology and Research(Agency for Science Technology & Research (A*STAR)); Cancer Science Institute of Singapore; Open Fund-Large Collaborative grant	T.U. is supported by AMED JP20ck0106552h0001 and JP20 ggm1310006h0001. S.J.C. is supported by a National Health and Medical Research (NHMRC) fellowship (no. 1156408) and NHMRC project grants (nos. 1147974 and 1144574). P.T. is supported by a National Medical Research Council grant (NMRC/STaR/0026/2015); an Open Fund-Large Collaborative grant (MOH-OFLCG18May-0003); Duke-NUS Medical School; the Agency for Science, Technology and Research; and the Cancer Science Institute of Singapore.	Achinger-Kawecka J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14098-x; Akdemir KC, 2020, NAT GENET, V52, P1178, DOI 10.1038/s41588-020-0708-0; Ali HR, 2020, NAT CANCER, V1, P163, DOI 10.1038/s43018-020-0026-6; Angelo M, 2014, NAT MED, V20, P436, DOI 10.1038/nm.3488; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Barthel FP, 2019, NATURE, V576, P112, DOI 10.1038/s41586-019-1775-1; Bertucci F, 2019, NATURE, V569, P560, DOI 10.1038/s41586-019-1056-z; Bian SH, 2018, SCIENCE, V362, P1060, DOI 10.1126/science.aao3791; Binnewies M, 2018, NAT MED, V24, P541, DOI 10.1038/s41591-018-0014-x; Cabrita R, 2020, NATURE, V577, P561, DOI 10.1038/s41586-019-1914-8; Camp JG, 2019, SCIENCE, V365, P1401, DOI 10.1126/science.aax6648; Campbell PJ, 2020, NATURE, V578, P82, DOI 10.1038/s41586-020-1969-6; Cipponi A, 2020, SCIENCE, V368, P1127, DOI 10.1126/science.aau8768; de Vries NL, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01254; Ding L, 2018, CELL, V173, P305, DOI 10.1016/j.cell.2018.03.033; Dominguez CX, 2020, CANCER DISCOV, V10, P232, DOI 10.1158/2159-8290.CD-19-0644; Ebright RY, 2020, SCIENCE, V367, P1468, DOI 10.1126/science.aay0939; Giesen C, 2014, NAT METHODS, V11, P417, DOI [10.1038/NMETH.2869, 10.1038/nmeth.2869]; Gong LQ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21795-z; Goveia J, 2020, CANCER CELL, V37, P21, DOI 10.1016/j.ccell.2019.12.001; Guo XY, 2018, NAT MED, V24, P978, DOI 10.1038/s41591-018-0045-3; Hu Z, 2020, NAT GENET, V52, P701, DOI 10.1038/s41588-020-0628-z; Huang KK, 2018, CANCER CELL, V33, P137, DOI 10.1016/j.ccell.2017.11.018; Jin X, 2020, NATURE, V588, P331, DOI 10.1038/s41586-020-2969-2; Kakiuchi N, 2021, NAT REV CANCER, V21, P239, DOI 10.1038/s41568-021-00335-3; Kakiuchi N, 2020, NATURE, V577, P260, DOI 10.1038/s41586-019-1856-1; Klotz R, 2020, CANCER DISCOV, V10, P86, DOI 10.1158/2159-8290.CD-19-0384; Lambrechts D, 2018, NAT MED, V24, P1277, DOI 10.1038/s41591-018-0096-5; Lee CK, 2019, SCIENCE, V363, P644, DOI 10.1126/science.aav0173; Lee I, 2020, NAT METHODS, V17, P1191, DOI 10.1038/s41592-020-01000-7; Lee J, 2020, EXP MOL MED, V52, P1428, DOI 10.1038/s12276-020-0420-2; Li RY, 2020, SCIENCE, V370, P82, DOI 10.1126/science.aba7300; Lim B, 2020, CANCER CELL, V37, P456, DOI 10.1016/j.ccell.2020.03.008; Loganathan SK, 2020, SCIENCE, V367, P1264, DOI 10.1126/science.aax0902; Maeda M, 2017, GUT, V66, P1721, DOI 10.1136/gutjnl-2016-313387; Martincorena I, 2018, SCIENCE, V362, P911, DOI 10.1126/science.aau3879; McDonald OG, 2017, NAT GENET, V49, P367, DOI 10.1038/ng.3753; Miao D, 2018, SCIENCE, V359, P801, DOI 10.1126/science.aan5951; Middleton G, 2020, NATURE, V583, P807, DOI 10.1038/s41586-020-2481-8; Morrow JJ, 2018, NAT MED, V24, P176, DOI 10.1038/nm.4475; Nanki K, 2020, NATURE, V577, P254, DOI 10.1038/s41586-019-1844-5; Olafsson S, 2020, CELL, V182, P672, DOI 10.1016/j.cell.2020.06.036; Pastushenko I, 2018, NATURE, V556, P463, DOI 10.1038/s41586-018-0040-3; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Phillips D, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.687673; Pidsley R, 2018, GENOME RES, V28, P625, DOI 10.1101/gr.229070.117; Pomerantz MM, 2020, NAT GENET, V52, P790, DOI 10.1038/s41588-020-0664-8; Priestley P, 2019, NATURE, V575, P210, DOI 10.1038/s41586-019-1689-y; Quinn JJ, 2021, SCIENCE, V371, P909, DOI 10.1126/science.abc1944; Ramachandran K, 2012, EPIGENOMICS-UK, V4, P243, DOI [10.2217/EPI.12.12, 10.2217/epi.12.12]; Razavi P, 2018, CANCER CELL, V34, P427, DOI 10.1016/j.ccell.2018.08.008; Rehman SK, 2021, CELL, V184, P226, DOI 10.1016/j.cell.2020.11.018; Reyna MA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14367-0; Rheinbay E, 2020, NATURE, V578, P102, DOI 10.1038/s41586-020-1965-x; Rosenthal R, 2019, NATURE, V567, P479, DOI 10.1038/s41586-019-1032-7; Rozenblatt-Rosen O, 2020, CELL, V181, P236, DOI 10.1016/j.cell.2020.03.053; Russo M, 2019, SCIENCE, V366, P1473, DOI 10.1126/science.aav4474; Satpathy AT, 2019, NAT BIOTECHNOL, V37, P925, DOI 10.1038/s41587-019-0206-z; Savas P, 2018, NAT MED, V24, P986, DOI 10.1038/s41591-018-0078-7; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Shen SS, 2020, CELL, V183, P860, DOI 10.1016/j.cell.2020.10.027; Shih DJH, 2020, NAT GENET, V52, P371, DOI 10.1038/s41588-020-0592-7; Song QQ, 2019, CANCER MED-US, V8, P3072, DOI 10.1002/cam4.2113; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Takeda DY, 2018, CELL, V174, P422, DOI 10.1016/j.cell.2018.05.037; Takeshima H, 2019, NPJ PRECIS ONCOL, V3, DOI 10.1038/s41698-019-0079-0; Tao Y, 2019, CANCER CELL, V35, P315, DOI 10.1016/j.ccell.2019.01.005; Wahl S, 2017, NATURE, V541, P81, DOI 10.1038/nature20784; Weinstein JA, 2019, CELL, V178, P229, DOI 10.1016/j.cell.2019.05.019; Wijewardhane N, 2021, CANCER CELL, V39, P125, DOI 10.1016/j.ccell.2020.11.002; Woolston A, 2019, CANCER CELL, V36, P35, DOI 10.1016/j.ccell.2019.05.013; Wu YT, 2018, INT J MIN SCI TECHNO, V28, P359, DOI 10.1016/j.ijmst.2018.03.008; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yamashita S, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0789-8; Yokoyama A, 2019, NATURE, V565, P312, DOI 10.1038/s41586-018-0811-x; Yoshida K, 2020, NATURE, V578, P266, DOI 10.1038/s41586-020-1961-1; Zhang D, 2019, NATURE, V574, P575, DOI 10.1038/s41586-019-1678-1; Zhao Q, 2018, CANCER RES, V78, P2370, DOI 10.1158/0008-5472.CAN-17-2728; Zhao SG, 2020, NAT GENET, V52, P778, DOI 10.1038/s41588-020-0648-8; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035	80	7	7	5	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2021	373	6562			SI		1474	+		10.1126/science.abh1645	http://dx.doi.org/10.1126/science.abh1645			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU7LJ	34554797				2022-12-28	WOS:000698977800043
J	Hutchings, M; Mous, R; Clausen, MR; Johnson, P; Linton, KM; Chamuleau, MED; Lewis, DJ; Balari, AS; Cunningham, D; Oliveri, RS; Elliott, B; DeMarco, D; Azaryan, A; Chiu, C; Li, T; Chen, KM; Ahmadi, T; Lugtenburg, PJ				Hutchings, Martin; Mous, Rogier; Clausen, Michael Roost; Johnson, Peter; Linton, Kim M.; Chamuleau, Martine E. D.; Lewis, David John; Balari, Anna Sureda; Cunningham, David; Oliveri, Roberto S.; Elliott, Brian; DeMarco, Dena; Azaryan, Ada; Chiu, Christopher; Li, Tommy; Chen, Kuo-mei; Ahmadi, Tahamtan; Lugtenburg, Pieternella J.			Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study	LANCET			English	Article							FOLLICULAR LYMPHOMA; RITUXIMAB; TRANSPLANTATION; BLINATUMOMAB; OUTCOMES; THERAPY; RISK	Background Patients with relapsed or refractory B-cell non-Hodgkin lymphoma have few treatment options. We aimed to establish the safety and recommended phase 2 dose of epcoritamab, a novel bispecific antibody that targets CD3 and CD20 and induces T-cell-mediated cytotoxic activity against CD20+ malignant B cells. Methods For the dose-escalation part of this phase 1/2 study, we enrolled adults (aged =18 years) with relapsed or refractory CD20+ B-cell non-Hodgkin lymphoma at ten sites across four countries (Denmark, the Netherlands, the UK, and Spain). Eligible patients received priming and intermediate doses followed by full doses of subcutaneous epcoritamab administered in 28-day cycles; each subsequent cohort involved escalation of the priming, intermediate, or full dose (0.0128-60 mg). The primary objectives were to determine the maximum tolerated dose and the recommended phase 2 dose. Safety, antitumour activity, pharmacokinetics, and immune biomarkers were also assessed. This study is registered with ClinicalTrials.gov, NCT03625037, with the dose-expansion part ongoing. Findings Between June 26, 2018, and July 14, 2020, we enrolled 73 patients with relapsed, progressive, or refractory CD20+ mature B-cell non-Hodgkin lymphoma. 68 patients received escalating full doses (0.0128-60 mg) of subcutaneous epcoritamab. No dose-limiting toxic effects were observed, and the maximum tolerated dose was not reached; the full dose of 48 mg was identified as the recommended phase 2 dose. All 68 patients received at least one dose of epcoritamab and were included in safety analyses: common adverse events were pyrexia (47 patients [69%]), primarily associated with cytokine release syndrome (CRS; 40 [59%], all grade 1-2), and injection site reactions (32 [47%]; 31 grade 1). There were no grade 3 or higher CRS events. No discontinuations occurred due to treatmentrelated adverse events or treatment-related deaths. Overall response rate in patients with relapsed or refractory diffuse large B-cell lymphoma was 68% (95% CI 45-86), with 45% achieving a complete response at full doses of 12-60 mg. At 48 mg, the overall response rate was 88% (47-100), with 38% achieving a complete response. Patients with relapsed or refractory follicular lymphoma had an overall response rate of 90% (55-100), with 50% achieving a complete response at full doses of 0.76-48 mg. Epcoritamab induced robust and sustained B-cell depletion, and CD4+ and CD8+ T-cell activation and expansion, with modest increases in cytokine levels. Interpretation Single-agent subcutaneous epcoritamab for treatment of patients with relapsed or refractory B-cell non-Hodgkin lymphoma merits investigation in ongoing phase 2 and phase 3 studies. Copyright (C) 2021 Elsevier Ltd. All rights reserved.	[Hutchings, Martin] Rigshosp, Dept Haematol, Copenhagen, Denmark; [Mous, Rogier] Univ Med Ctr Utrecht, Lunenburg Lymphoma Phase I II Consortium, HOVON LLPC, Utrecht, Netherlands; [Clausen, Michael Roost] Vejle Hosp, Vejle, Denmark; [Johnson, Peter] Univ Southampton, Canc Res UK, Canc Serv, Southampton, Hants, England; [Linton, Kim M.] Univ Manchester, Christie NHS Fdn Trust, Manchester Canc Res Ctr, Manchester, Lancs, England; [Chamuleau, Martine E. D.] Vrije Univ Amsterdam Med Ctr, Lunenburg Lymphoma Phase I II Consortium, HOVON LLPC, Amsterdam, Netherlands; [Lewis, David John] Plymouth Univ, Sch Med, Plymouth, Devon, England; [Balari, Anna Sureda] Univ Barcelona, Hosp Duran & Reynals, Inst Catala Oncol, IDIBELL, Barcelona, Spain; [Cunningham, David] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England; [Oliveri, Roberto S.] Genmab, Copenhagen, Denmark; [Elliott, Brian; DeMarco, Dena; Azaryan, Ada; Chiu, Christopher; Li, Tommy; Chen, Kuo-mei; Ahmadi, Tahamtan] Genmab, Princeton, NJ USA; [Lugtenburg, Pieternella J.] Erasmus MC, Inst Canc, Dept Hematol, Lunenburg Lymphoma Phase I II Consortium,HOVON LL, Rotterdam, Netherlands	Rigshospitalet; University of Copenhagen; Utrecht University; Utrecht University Medical Center; University of Southern Denmark; Lillebaelt Hospital; Cancer Research UK; University of Southampton; Christie NHS Foundation Trust; University of Manchester; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Plymouth; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; University of Barcelona; Royal Marsden NHS Foundation Trust; Genmab; Genmab; Erasmus University Rotterdam; Erasmus MC	Hutchings, M (corresponding author), Rigshosp, Dept Haematol, Phase 1 Unit, DK-2100 Copenhagen, Denmark.	martin.hutchings@regionh.dk	Hutchings, Martin/B-6959-2012; Johnson, Peter/L-2403-2018	Hutchings, Martin/0000-0003-3873-1741; Cunningham, David/0000-0001-5158-1069; Chiu, Christopher W./0000-0001-9744-991X; Johnson, Peter/0000-0003-2306-4974; Clausen, Michael Roost/0000-0003-3218-3633	Genmab; AbbVie	Genmab(Genmab); AbbVie(AbbVie)	Genmab and AbbVie.	Assouline SE, 2020, BLOOD, V136, DOI 10.1182/blood-2020-135839; Ayala E, 2012, CANCER CONTROL, V19, P175, DOI 10.1177/107327481201900302; Bannerji R, 2020, BLOOD, V136, DOI 10.1182/blood-2020-136659; Buhmann R, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-160; Casulo C, 2015, J CLIN ONCOL, V33, P2516, DOI 10.1200/JCO.2014.59.7534; Cheson BD, 2014, J CLIN ONCOL, V32, P3059, DOI 10.1200/JCO.2013.54.8800; Coiffier B, 2008, J CLIN ONCOL, V26, P2767, DOI 10.1200/JCO.2007.15.0177; Crump M, 2017, BLOOD, V130, P1800, DOI 10.1182/blood-2017-03-769620; Engelberts PJ, 2020, EBIOMEDICINE, V52, DOI 10.1016/j.ebiom.2019.102625; Fischer T, 2018, ANN HEMATOL, V97, P17, DOI 10.1007/s00277-017-3151-2; Gisselbrecht C, 2010, J CLIN ONCOL, V28, P4184, DOI 10.1200/JCO.2010.28.1618; Hutchings M, J CLIN ONCOL, V39, P1959; Jain T, 2019, BIOL BLOOD MARROW TR, V25, P2305, DOI 10.1016/j.bbmt.2019.08.015; Jurinovic V, 2016, BLOOD, V128, P1112, DOI 10.1182/blood-2016-05-717355; Kewalramani T, 2004, BLOOD, V103, P3684, DOI 10.1182/blood-2003-11-3911; Klener P, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184417; Lee DW, 2019, BIOL BLOOD MARROW TR, V25, P625, DOI 10.1016/j.bbmt.2018.12.758; Martin A, 2008, HAEMATOL-HEMATOL J, V93, P1829, DOI 10.3324/haematol.13440; Matasar MJ, 2020, BLOOD, V136, DOI 10.1182/blood-2020-135818; Neelapu SS, 2017, NEW ENGL J MED, V377, P2531, DOI 10.1056/NEJMoa1707447; Patel K, 2019, BLOOD, V134, DOI 10.1182/blood-2019-128564; Penalver FJ, 2019, CANCER MED-US, V8, P6955, DOI 10.1002/cam4.2555; Swerdlow SH, 2016, BLOOD, V127, P2375, DOI 10.1182/blood-2016-01-643569; Topp MS, 2014, J CLIN ONCOL, V32, P4134, DOI 10.1200/JCO.2014.56.3247; van der Horst HJ, 2021, BLOOD CANCER J, V11, DOI 10.1038/s41408-021-00430-6; Van Heertum RL, 2017, DRUG DES DEV THER, V11, P1719, DOI 10.2147/DDDT.S136988; van Imhoff GW, 2017, J CLIN ONCOL, V35, P544, DOI 10.1200/JCO.2016.69.0198; Viardot A, 2016, BLOOD, V127, P1410, DOI [10.1182/blood-2015-06-651380, 10.1182/blood-2015-06651380]; Wildes TM, 2008, BIOL BLOOD MARROW TR, V14, P840, DOI 10.1016/j.bbmt.2008.05.002; Yuan Y, 2016, CLIN CANCER RES, V22, P4291, DOI 10.1158/1078-0432.CCR-16-0592	30	47	48	2	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 25	2021	398	10306					1157	1169		10.1016/S0140-6736(21)00889-8	http://dx.doi.org/10.1016/S0140-6736(21)00889-8		SEP 2021	13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UX3WV	34508654	Green Submitted, Green Accepted			2022-12-28	WOS:000700774500025
J	Carter, RG; Mundorff, K; Risien, J; Bouwma-Gearhart, J; Bratsch-Prince, D; Brown, SA; Campbell, AL; Hartman, JC; Hasemann, CA; Hollenbeck, PJ; Lupiani, B; McCarty, OJT; McClure, ID; Mealey, K; Mimura, C; Romero, AJ; Sztajn, P; Van Egeren, L				Carter, Rich G.; Mundorff, Karl; Risien, Julie; Bouwma-Gearhart, Jana; Bratsch-Prince, Dawn; Brown, Sandra A.; Campbell, Almesha L.; Hartman, Joseph C.; Hasemann, Charles A.; Hollenbeck, Peter J.; Lupiani, Blanca; McCarty, Owen J. T.; McClure, Ian D.; Mealey, Katrina; Mimura, Carol; Romero, Andrea J.; Sztajn, Paola; Van Egeren, Laurie			Innovation, entrepreneurship, promotion, and tenure	SCIENCE			English	Editorial Material									[Carter, Rich G.] Oregon State Univ, Dept Chem, Corvallis, OR 97331 USA; [Mundorff, Karl] Oregon State Univ, Office Res, Corvallis, OR 97331 USA; [Risien, Julie] Oregon State Univ, STEM Res Ctr, Corvallis, OR USA; [Bouwma-Gearhart, Jana] Oregon State Univ, Coll Educ, Corvallis, OR USA; [Bratsch-Prince, Dawn] Iowa State Univ, Dept World Languages & Cultures, Ames, IA USA; [Brown, Sandra A.] Univ Calif San Diego, Dept Psychol, San Diego, CA USA; [Brown, Sandra A.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA USA; [Campbell, Almesha L.] Jackson State Univ, Div Res & Econ Dev, Jackson, MS USA; [Hartman, Joseph C.] Univ Massachusetts Lowell, Dept Mech Engn, Lowell, MA USA; [Hasemann, Charles A.] Michigan State Univ, MSU Innovat Ctr, E Lansing, MI USA; [Hollenbeck, Peter J.] Purdue Univ, Dept Biol Sci, W Lafayette, IN USA; [Lupiani, Blanca] Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX USA; [McCarty, Owen J. T.] Oregon Hlth & Sci Univ, Sch Biomed Engn, Portland, OR USA; [McClure, Ian D.] Univ Kentucky, Office Vice President Res, Lexington, KY USA; [Mealey, Katrina] Washington State Univ, Dept Vet Clin Sci, Pullman, WA USA; [Mimura, Carol] Univ Calif Berkeley, Office Intellectual Property & Ind Res Alliance, Berkeley, CA USA; [Romero, Andrea J.] Univ Arizona, Dept Family Stud & Human Dev, Tucson, AZ USA; [Sztajn, Paola] North Carolina State Univ, Coll Educ, Raleigh, NC USA; [Van Egeren, Laurie] Michigan State Univ, Univ Outreach & Engagement, E Lansing, MI USA	Oregon State University; Oregon State University; Oregon State University; Oregon State University; Iowa State University; University of California System; University of California San Diego; University of California System; University of California San Diego; Jackson State University; University of Massachusetts System; University of Massachusetts Lowell; Michigan State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Texas A&M University System; Texas A&M University College Station; Oregon Health & Science University; University of Kentucky; Washington State University; University of California System; University of California Berkeley; University of Arizona; University of North Carolina; North Carolina State University; Michigan State University	Carter, RG (corresponding author), Oregon State Univ, Dept Chem, Corvallis, OR 97331 USA.	rich.carter@oregonstate.edu		Sztajn, Paola/0000-0002-5270-6924	National Science Foundation [CNS-1936073]; Lemelson Foundation; VentureWell	National Science Foundation(National Science Foundation (NSF)); Lemelson Foundation; VentureWell	B. Wall, I.Tumer,andT. Ozkan-Haller are acknowledged for their work on the organizing committee.C. Lenhart and H. Cho are acknowledged for their efforts in survey data management and analysis. The participants in the PTIE effort from across our country are graciously acknowledged for their engagement, input, and support.The National Science Foundation (CNS-1936073) is graciously acknowledged for support of this work. Additional support for aspects of this work was provided by the Lemelson Foundation and VentureWell.	Anderson MS, 2010, J HIGH EDUC, V81, P366, DOI 10.1353/jhe.0.0095; Bouwma-Gearhart J., 2021, CHANGE, V53, P18; Bouwma-Gearhart J., 2021, J OPEN INNOV-TECHNOL, V7, P182, DOI [10.3390/joitmc7030182, DOI 10.3390/JOITMC7030182]; Boyer Ernest L., 2015, SCHOLARSHIP RECONSID; Clark J. H.C., 2020, INNOVATION IMPACT US; Cundiff JL, 2018, J HIGH EDUC, V89, P611, DOI 10.1080/00221546.2018.1437665; Genshaft J, 2016, TECHNOL INNOV, V17, P197, DOI 10.3727/194982416X14520374943103; Klein JT, 2017, RES POLICY, V46, P1055, DOI 10.1016/j.respol.2017.03.001; Marcus J., 2020, THINK U ARE MAKING L; Mendoza P, 2020, STUD HIGH EDUC, V45, P1474, DOI 10.1080/03075079.2018.1541451; Mintz S., 2019, INSIDE HIGH ED, V3; O'Meara K., 2010, HDB ENGAGED SCHOLARS, V1, P271; O'Meara K, 2011, INNOV HIGH EDUC, V36, P83, DOI 10.1007/s10755-010-9159-3; Sanberg PR, 2014, P NATL ACAD SCI USA, V111, P6542, DOI 10.1073/pnas.1404094111; The NationalAcademies of ScienceEngineering and Medicine, 2020, REENVISIONING PROMOT, DOI [10.17226/25742, DOI 10.17226/25742]	15	3	3	5	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2021	373	6561					1312	+		10.1126/science.abj2098	http://dx.doi.org/10.1126/science.abj2098			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	US5SK	34529484				2022-12-28	WOS:000697488600029
J	Gaffney, EM; Minteer, SD				Gaffney, Erin M.; Minteer, Shelley D.			A silver assist for microbial fuel cell power	SCIENCE			English	Editorial Material									[Gaffney, Erin M.; Minteer, Shelley D.] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Minteer, SD (corresponding author), Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA.	minteer@chem.utah.edu			Army Research Office MURI [W911NF1410263]	Army Research Office MURI(MURI)	We thank the Army Research Office MURI (grant W911NF1410263) for funding.	Cao BC, 2021, SCIENCE, V373, P1336, DOI 10.1126/science.abf3427; Chiranjeevi P, 2020, BIOTECHNOL ADV, V39, DOI 10.1016/j.biotechadv.2019.107468; Dong FY, 2021, CELL REP PHYS SCI, V2, DOI 10.1016/j.xcrp.2021.100444; Glaven SM, 2019, MICROB BIOTECHNOL, V12, P819, DOI 10.1111/1751-7915.13456; Grattieri M, 2017, J POWER SOURCES, V356, P310, DOI 10.1016/j.jpowsour.2016.11.090; Hernandez CA, 2020, FRONT ENV SCI-SWITZ, V8, DOI 10.3389/fenvs.2020.00044; Potter MC, 1911, P R SOC LOND B-CONTA, V84, P260, DOI 10.1098/rspb.1911.0073; Shrestha N, 2018, BIORESOURCE TECHNOL, V255, P318, DOI 10.1016/j.biortech.2018.01.151; Wang RW, 2021, ADV MATER, V33, DOI 10.1002/adma.202004051; Yaqoob AA, 2020, BIOCHEM ENG J, V164, DOI 10.1016/j.bej.2020.107779	10	3	3	11	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2021	373	6561					1308	1309		10.1126/science.abl3612	http://dx.doi.org/10.1126/science.abl3612			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	US5SK	34529473				2022-12-28	WOS:000697488600026
J	Ho, WJ; Wood, LD				Ho, Won Jin; Wood, Laura D.			Opposing roles of the immune system in tumors	SCIENCE			English	Editorial Material									[Ho, Won Jin] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD USA; [Wood, Laura D.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Wood, LD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21218 USA.	ldwood@jhmi.edu						Alonso-Curbelo D, 2021, NATURE, V590, DOI 10.1038/s41586-020-03147-x; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Del Poggetto E., 2021, SCIENCE, V373; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Gregory JL, 2006, J IMMUNOL, V177, P8072, DOI 10.4049/jimmunol.177.11.8072; Martin TD, 2021, SCIENCE, V373, P1327, DOI 10.1126/science.abg5784; Yadav D, 2013, GASTROENTEROLOGY, V144, P1252, DOI 10.1053/j.gastro.2013.01.068; Yin H, 2019, NAT REV CLIN ONCOL, V16, P281, DOI 10.1038/s41571-019-0166-8	8	3	3	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2021	373	6561					1306	1307		10.1126/science.abl5376	http://dx.doi.org/10.1126/science.abl5376			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	US5SK	34529483				2022-12-28	WOS:000697488600025
J	Langland, JT				Langland, James T.			A Review of the Diagnosis and Management of Headache	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Langland, James T.] Univ Minnesota, Dept Med, 1507 Franklin Ave SE, Minneapolis, MN 55414 USA	University of Minnesota System; University of Minnesota Twin Cities	Langland, JT (corresponding author), Univ Minnesota, Dept Med, 1507 Franklin Ave SE, Minneapolis, MN 55414 USA.	langl039@umn.edu						Ferrari A, 2018, CNS DRUGS, V32, P567, DOI 10.1007/s40263-018-0522-8; Li YX, 2020, PAIN RES MANAG, V2020, DOI 10.1155/2020/3825617; Linde K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001218.pub3; National Institute for Health and Care Excellence, 2021, EV REV PAIN MAN PROG; Robbins MS, 2021, JAMA-J AM MED ASSOC, V325, P1874, DOI 10.1001/jama.2021.1640	5	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2021	326	10					976	976		10.1001/jama.2021.11373	http://dx.doi.org/10.1001/jama.2021.11373			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UW4LI	34519806				2022-12-28	WOS:000700129100020
J	Wise, J				Wise, Jacqui			Covid-19: Booster doses to be offered to 30 million people in UK	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Wise J, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2160	1	10	10	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2021	374								n2261	10.1136/bmj.n2261	http://dx.doi.org/10.1136/bmj.n2261			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WP7CH	34521637	Bronze			2022-12-28	WOS:000713284400004
J	Amini, A; Khavari, A; Barthelat, F; Ehrlicher, AJ				Amini, Ali; Khavari, Adele; Barthelat, Francois; Ehrlicher, Allen J.			Centrifugation and index matching yield a strong and transparent bioinspired nacreous composite	SCIENCE			English	Article							FRACTURE-TOUGHNESS; LAMINATED GLASS; SURFACE-ENERGY; MECHANICS; STRENGTH; RESISTANT; BEHAVIOR; NETWORK; MOTHER; DESIGN	Glasses have numerous applications because of their exceptional transparency and stiffness; however, poor fracture, impact resistance, and mechanical reliability limit the range of their applications. Recent bioinspired glasses have shown superior mechanical performance, but they still suffer from reduced optical quality. Here, we present a nacreous glass composite that offers a combination of strength, toughness, and transparency. Micrometer-sized glass tablets and poly(methyl methacrylate) (PMMA) were mixed and structured by centrifugation, creating dense PMMA-glass layers. A transparent composite was created by tuning the refractive index of PMMA to that of glass and using chemical functionalization to create continuous interfaces. The fabrication method is robust and scalable, and the composite may prove to be a glass alternative in diverse applications.	[Amini, Ali; Khavari, Adele; Ehrlicher, Allen J.] McGill Univ, Dept Bioengn, Montreal, PQ H3A 0C3, Canada; [Amini, Ali; Barthelat, Francois; Ehrlicher, Allen J.] McGill Univ, Dept Mech Engn, Montreal, PQ H3A 0C3, Canada; [Barthelat, Francois] Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA; [Ehrlicher, Allen J.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 0C7, Canada; [Ehrlicher, Allen J.] McGill Univ, Dept Biomed Engn, Montreal, PQ H3A 2B4, Canada; [Ehrlicher, Allen J.] McGill Univ, Ctr Struct Biol, Montreal, PQ H3G 0B1, Canada; [Ehrlicher, Allen J.] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Khavari, Adele] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada	McGill University; McGill University; University of Colorado System; University of Colorado Boulder; McGill University; McGill University; McGill University; McGill University; University of British Columbia	Ehrlicher, AJ (corresponding author), McGill Univ, Dept Bioengn, Montreal, PQ H3A 0C3, Canada.; Ehrlicher, AJ (corresponding author), McGill Univ, Dept Mech Engn, Montreal, PQ H3A 0C3, Canada.; Ehrlicher, AJ (corresponding author), McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 0C7, Canada.; Ehrlicher, AJ (corresponding author), McGill Univ, Dept Biomed Engn, Montreal, PQ H3A 2B4, Canada.; Ehrlicher, AJ (corresponding author), McGill Univ, Ctr Struct Biol, Montreal, PQ H3G 0B1, Canada.; Ehrlicher, AJ (corresponding author), McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada.	allen.ehrlicher@mcgill.ca		Ehrlicher, Allen/0000-0003-3030-979X; Amini, Ali/0000-0003-4150-4005	NSERC [RGPIN/05843-2014, EQPEQ/472339-2015]; FRQNT; Canadian Foundation for Innovation [32749, 33122]; Canada Research Chairs Program	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); FRQNT; Canadian Foundation for Innovation(Canada Foundation for Innovation); Canada Research Chairs Program(Canada Research Chairs)	The authors acknowledge support from NSERC RGPIN/05843-2014 and EQPEQ/472339-2015, a FRQNT team grant, the Canadian Foundation for Innovation Projects nos. 32749 and 33122, and the Canada Research Chairs Program.	Almqvist N, 1999, MAT SCI ENG C-BIO S, V7, P37, DOI 10.1016/S0928-4931(98)00072-1; Askarinejad S, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0855; ASTM, 2015, D79003 ASTM, DOI [10.1520/D0790-03, DOI 10.1520/D0790-03]; ASTM E1820, ASTM INT, V2013, P1, DOI [10.1520/E1820-13, DOI 10.1520/E1820-13]; Balke T. S., 1972, THESIS MCMASTER U; Balke T. S., 1972, THESIS MCMASTER U; Barthelat F, 2007, EXP MECH, V47, P311, DOI 10.1007/s11340-007-9040-1; Barthelat F, 2007, J MECH PHYS SOLIDS, V55, P306, DOI 10.1016/j.jmps.2006.07.007; Barthelat F, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.7; Barthelat F, 2014, J MECH PHYS SOLIDS, V73, P22, DOI 10.1016/j.jmps.2014.08.008; Barthelat F, 2011, J MECH PHYS SOLIDS, V59, P829, DOI 10.1016/j.jmps.2011.01.001; Begley MR, 2012, J MECH PHYS SOLIDS, V60, P1545, DOI 10.1016/j.jmps.2012.03.002; Bohm J, 2004, ADV ENG MATER, V6, P52, DOI 10.1002/adem.200300542; Davidge RW, 1968, J MATER SCI, V3, P165, DOI 10.1007/BF00585484; Ebina T, 2007, ADV MATER, V19, P2450, DOI 10.1002/adma.200700162; El-Shami MM, 2012, ALEX ENG J, V51, P61, DOI 10.1016/j.aej.2012.07.008; Ernsberger F. M., 1980, TECHNIQUES STRENGTHE, V5; Ernsberger F. M, 1980, TECHNIQUES STRENGTHE, V5; Espinosa HD, 2009, PROG MATER SCI, V54, P1059, DOI 10.1016/j.pmatsci.2009.05.001; Fratzl P, 2016, CHEM SOC REV, V45, P252, DOI 10.1039/c5cs00598a; Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100; Gao XL, 2005, INT J SOLIDS STRUCT, V42, P1649, DOI 10.1016/j.ijsolstr.2004.08.020; Hanemann T, 2008, PROC SPIE, V6992, DOI 10.1117/12.778204; Harwood L.M., 1997, INTRO ORGANIC SPECTR, Vfirst; Herraez M, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0274; Huang XK, 2014, STRUCT ENG MECH, V52, P603, DOI 10.12989/sem.2014.52.3.603; JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056; Lawn P.R, 1993, CAMBRIDGE SOLID STAT, Vsecond; Le Ferrand H, 2015, NAT MATER, V14, P1172, DOI [10.1038/NMAT4419, 10.1038/nmat4419]; Liu YX, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201703277; Magrini T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10829-2; MINOR JE, 1990, J STRUCT ENG-ASCE, V116, P1030, DOI 10.1061/(ASCE)0733-9445(1990)116:4(1030); Mirkhalaf M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4166; MITAMURA Y, 1994, J BIOMED MATER RES, V28, P813, DOI 10.1002/jbm.820280708; Niebel TP, 2016, J MECH PHYS SOLIDS, V96, P133, DOI 10.1016/j.jmps.2016.06.011; Norville HS, 1998, J ENG MECH-ASCE, V124, P46, DOI 10.1061/(ASCE)0733-9399(1998)124:1(46); Petit F, 2007, ACTA MATER, V55, P2765, DOI 10.1016/j.actamat.2006.12.014; Podsiadlo P, 2008, J PHYS CHEM B, V112, P14359, DOI 10.1021/jp801492n; Rabiei R, 2010, ACTA BIOMATER, V6, P4081, DOI 10.1016/j.actbio.2010.04.008; Sander EA, 2009, J BIOMED MATER RES A, V88A, P322, DOI 10.1002/jbm.a.31847; SCOTT GE, 1988, ANGLE ORTHOD, V58, P5; WIEDERHORN SM, 1969, J AM CERAM SOC, V52, P99, DOI 10.1111/j.1151-2916.1969.tb13350.x; Wondraczek L, 2011, ADV MATER, V23, P4578, DOI 10.1002/adma.201102795; Yin Z, 2019, SCIENCE, V364, P1260, DOI 10.1126/science.aaw8988; Yin Z, 2018, ACTA BIOMATER, V75, P439, DOI 10.1016/j.actbio.2018.05.012; Zhang JJ, 2016, RESULTS PHYS, V6, P265, DOI 10.1016/j.rinp.2016.05.004	46	16	16	27	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2021	373	6560					1229	+		10.1126/science.abf0277	http://dx.doi.org/10.1126/science.abf0277			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UP5RB	34516787				2022-12-28	WOS:000695436000027
J	Wang, CQ; Sweeney, WR; Stone, AD; Yang, L				Wang, Changqing; Sweeney, William R.; Stone, A. Douglas; Yang, Lan			Coherent perfect absorption at an exceptional point	SCIENCE			English	Article							PARITY-TIME SYMMETRY; LASER	Recently, exceptional points, a degeneracy of open wave systems, have been observed in photonics, acoustics, and electronics. They have mainly been realized as a degeneracy of resonances; however, a degeneracy associated with the absorption of waves can exhibit distinct and interesting physical features. Here, we demonstrate such an absorbing exceptional point by engineering degeneracies in the absorption spectrum of dissipative optical microcavities. We experimentally distinguished the conditions to realize an absorbing exceptional point versus a resonant exceptional point. Furthermore, when the optical loss was tuned to achieve perfect absorption at an absorbing exceptional point, we observed its signature, an anomalously broadened line shape in the absorption spectrum. The distinct scattering properties of the absorbing exceptional point create opportunities for both fundamental study and applications of non-Hermitian degeneracies.	[Wang, Changqing; Yang, Lan] Washington Univ, Dept Elect & Syst Engn, St Louis, MO 63130 USA; [Sweeney, William R.; Stone, A. Douglas] Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA; [Sweeney, William R.; Stone, A. Douglas] Yale Univ, Yale Quantum Inst, New Haven, CT 06520 USA	Washington University (WUSTL); Yale University; Yale University	Yang, L (corresponding author), Washington Univ, Dept Elect & Syst Engn, St Louis, MO 63130 USA.	yang@seas.wustl.edu	yang, lan/GRJ-3120-2022		National Science Foundation (NSF) [EFMA1641109]; NSF Condensed Matter andMaterials Theory (CMMT) [DMR-1743235]; McDonnell International Scholars Academy	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); NSF Condensed Matter andMaterials Theory (CMMT); McDonnell International Scholars Academy	This work was supported by the National Science Foundation (NSF grant no. EFMA1641109). A.D.S. was supported by NSF Condensed Matter andMaterials Theory (CMMT) grant DMR-1743235. C.W. acknowledges fellowship support through the McDonnell International Scholars Academy.	Altuzarra C, 2017, ACS PHOTONICS, V4, P2124, DOI 10.1021/acsphotonics.7b00514; Baranov DG, 2017, NAT REV MATER, V2, DOI 10.1038/natrevmats.2017.64; Carmon T, 2004, OPT EXPRESS, V12, P4742, DOI 10.1364/OPEX.12.004742; Chen HZ, 2020, NAT PHYS, V16, P571, DOI 10.1038/s41567-020-0807-y; Chen W., 2020, ULTRAHIGH Q OPTICAL, P269; Chen WJ, 2017, NATURE, V548, P192, DOI 10.1038/nature23281; Choi Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04690-y; Chong YD, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.093902; Chong YD, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.053901; Doppler J, 2016, NATURE, V537, P76, DOI 10.1038/nature18605; El-Ganainy R, 2018, NAT PHYS, V14, P11, DOI 10.1038/NPHYS4323; Fan SH, 2012, SCIENCE, V335, DOI 10.1126/science.1216682; Fang X, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4870635; Feng L, 2017, NAT PHOTONICS, V11, P752, DOI 10.1038/s41566-017-0031-1; Feng L, 2014, SCIENCE, V346, P972, DOI 10.1126/science.1258479; Fleury R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6905; Guo A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.093902; Haus H. A., 1984, WAVES FIELDS OPTOELE; He LN, 2009, OPT EXPRESS, V17, P9571, DOI 10.1364/OE.17.009571; Hodaei H, 2017, NATURE, V548, P187, DOI 10.1038/nature23280; Hodaei H, 2014, SCIENCE, V346, P975, DOI 10.1126/science.1258480; Hokmabadi MP, 2019, NATURE, V576, P70, DOI 10.1038/s41586-019-1780-4; Jiang XF, 2020, LIGHT-SCI APPL, V9, DOI 10.1038/s41377-019-0239-6; Jing H, 2015, SCI REP-UK, V5, DOI 10.1038/srep09663; Krasnok A, 2019, ARXIV190411384PHYSIC; Krasnok A, 2019, ADV OPT PHOTONICS, V11, P892, DOI 10.1364/AOP.11.000892; Lai YH, 2019, NATURE, V576, P65, DOI 10.1038/s41586-019-1777-z; Li WX, 2020, J APPL PHYS, V128, DOI 10.1063/5.0020944; Li Y., 2019, ARXIV180904878PHYSIC; Li Y, 2019, SCIENCE, V364, P170, DOI 10.1126/science.aaw6259; Liu YM, 2020, APPL PHYS LETT, V116, DOI 10.1063/1.5142649; Lu H, 2018, PHYS REV APPL, V10, DOI 10.1103/PhysRevApplied.10.014006; Malara P, 2016, SCI REP-UK, V6, DOI 10.1038/srep28947; Miao P, 2016, SCIENCE, V353, P464, DOI 10.1126/science.aaf8533; Miri MA, 2019, SCIENCE, V363, P42, DOI 10.1126/science.aar7709; Noh H, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.186805; Ozdemir SK, 2019, NAT MATER, V18, P783, DOI 10.1038/s41563-019-0304-9; Park JH, 2020, NAT PHYS, V16, P462, DOI 10.1038/s41567-020-0796-x; Peng B, 2016, P NATL ACAD SCI USA, V113, P6845, DOI 10.1073/pnas.1603318113; Peng B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6082; Peng B, 2014, NAT PHYS, V10, P394, DOI [10.1038/nphys2927, 10.1038/NPHYS2927]; Peng P, 2016, NAT PHYS, V12, P1139, DOI [10.1038/NPHYS3842, 10.1038/nphys3842]; Pick A, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.224303; Pick A, 2017, OPT EXPRESS, V25, P12325, DOI 10.1364/OE.25.012325; Pye LN, 2017, OPT LETT, V42, P151, DOI 10.1364/OL.42.000151; Rao SM, 2014, OPT LETT, V39, P5345, DOI 10.1364/OL.39.005345; Roger T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8031; Rothenberg JM, 2016, OPT LETT, V41, P2537, DOI 10.1364/OL.41.002537; Scheel S, 2018, EPL-EUROPHYS LETT, V122, DOI 10.1209/0295-5075/122/34001; Shi CZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11110; Sweeney WR, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.093901; Tang WY, 2020, SCIENCE, V370, P1077, DOI 10.1126/science.abd8872; Wan WJ, 2011, SCIENCE, V331, P889, DOI 10.1126/science.1200735; Wang C., SILICON PHOTONICS, V2021, P323; Wang CQ, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2012982118; Wang CQ, 2020, NAT PHYS, V16, P334, DOI 10.1038/s41567-019-0746-7; Wang HM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15341-6; Wang HL, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9132738; Wiersig J, 2016, PHYS REV A, V93, DOI 10.1103/PhysRevA.93.033809; Wiersig J, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.203901; Wong ZJ, 2016, NAT PHOTONICS, V10, P796, DOI [10.1038/NPHOTON.2016.216, 10.1038/nphoton.2016.216]; Xu H, 2016, NATURE, V537, P80, DOI 10.1038/nature18604; Yang F, 2017, PHYS REV A, V96, DOI 10.1103/PhysRevA.96.053845; Yoon JW, 2018, NATURE, V562, P86, DOI 10.1038/s41586-018-0523-2; Zhang FX, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.053901; Zhang JF, 2012, LIGHT-SCI APPL, V1, DOI 10.1038/lsa.2012.18; Zhang J, 2018, NAT PHOTONICS, V12, P479, DOI 10.1038/s41566-018-0213-5; Zhang J, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.115407; Zhao J, 2020, PHYS REV APPL, V13, DOI 10.1103/PhysRevApplied.13.014053; Zhou HY, 2018, SCIENCE, V359, P1009, DOI 10.1126/science.aap9859	70	40	40	55	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2021	373	6560					1261	+		10.1126/science.abj1028	http://dx.doi.org/10.1126/science.abj1028			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UP5RB	34516794	Green Submitted			2022-12-28	WOS:000695436000034
J	Busse, JW; Vankrunkelsven, P; Zeng, LN; Heen, AF; Merglen, A; Campbell, F; Granan, LP; Aertgeerts, B; Buchbinder, R; Coen, M; Juurlink, D; Samer, C; Siemieniuk, RAC; Kumar, N; Cooper, L; Brown, J; Lytvyn, L; Zeraatkar, D; Wang, L; Guyatt, GH; Vandvik, P; Agoritsas, T				Busse, Jason W.; Vankrunkelsven, Patrick; Zeng, Linan; Heen, Anja Fog; Merglen, Arnaud; Campbell, Fiona; Granan, Lars-Petter; Aertgeerts, Bert; Buchbinder, Rachelle; Coen, Matteo; Juurlink, David; Samer, Caroline; Siemieniuk, Reed A. C.; Kumar, Nimisha; Cooper, Lynn; Brown, John; Lytvyn, Lyubov; Zeraatkar, Dena; Wang, Li; Guyatt, Gordon H.; Vandvik, Per; Agoritsas, Thomas			Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								CLINICAL QUESTION What is the role of medical cannabis or cannabinoids for people living with chronic pain due to cancer or non-cancer causes? CURRENT PRACTICE Chronic pain is common and distressing and associated with considerable socioeconomic burden globally. Medical cannabis is increasingly used to manage chronic pain, particularly in jurisdictions that have enacted policies to reduce use of opioids; however, existing guideline recommendations are inconsistent, and cannabis remains illegal for therapeutic use in many countries. RECOMMENDATION The guideline expert panel issued a weak recommendation to offer a trial of non-inhaled medical cannabis or cannabinoids, in addition to standard care and management (if not sufficient), for people living with chronic cancer or non-cancer pain. HOW THIS GUIDELINE WAS CREATED An international guideline development panel including patients, clinicians with content expertise, and methodologists produced this recommendation in adherence with standards for trustworthy guidelines using the GRADE approach. The MAGIC Evidence Ecosystem Foundation (MAGIC) provided methodological support. The panel applied an individual patient perspective. THE EVIDENCE This recommendation is informed by a linked series of four systematic reviews summarising the current body of evidence for benefits and harms, as well as patient values and preferences, regarding medical cannabis or cannabinoids for chronic pain. UNDERSTANDING THE RECOMMENDATION The recommendation is weak because of the close balance between benefits and harms of medical cannabis for chronic pain. It reflects a high value placed on small to very small improvements in self reported pain intensity, physical functioning, and sleep quality, and willingness to accept a small to modest risk of mostly self limited and transient harms. Shared decision making is required to ensure patients make choices that reflect their values and personal context. Further research is warranted and may alter this recommendation. [GRAPHICS]	[Busse, Jason W.] McMaster Univ, Michael G DeGroote Ctr Med Cannabis Res, Hamilton, ON, Canada; [Busse, Jason W.; Zeng, Linan; Siemieniuk, Reed A. C.; Lytvyn, Lyubov; Zeraatkar, Dena; Wang, Li; Guyatt, Gordon H.; Agoritsas, Thomas] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Busse, Jason W.; Wang, Li] McMaster Univ, Dept Anesthesia, Hamilton, ON, Canada; [Busse, Jason W.; Brown, John] Chron Pain Ctr Excellence Canadian Vet, Hamilton, ON, Canada; [Vankrunkelsven, Patrick] Belgian Ctr Evidence Based Med CEBAM, Leuven, Belgium; [Vankrunkelsven, Patrick] Katholieke Univ Leuven, Dept Publ Hlth & Primary Care, Leuven, Belgium; [Zeng, Linan] Sichuan Univ, West China Second Univ Hosp, Evidence Based Pharm Ctr, Pharm Dept, Chengdu, Sichuan, Peoples R China; [Heen, Anja Fog; Vandvik, Per] Innlandet Hosp Trust, Dept Med, Gjovik, Norway; [Merglen, Arnaud] Univ Geneva, Univ Hosp Geneva, Div Gen Pediat, Geneva, Switzerland; [Merglen, Arnaud] Univ Geneva, Fac Med, Geneva, Switzerland; [Campbell, Fiona] Univ Toronto, Dept Anesthesiol & Pain Med, Toronto, ON, Canada; [Granan, Lars-Petter] Oslo Univ Hosp, Div Emergencies & Crit Care, Dept Pain Management & Res, Oslo, Norway; [Aertgeerts, Bert] Katholieke Univ Leuven, Acad Ctr Gen Practice, Dept Publ Hlth & Primary Care, Leuven, Belgium; [Aertgeerts, Bert] Belgian Ctr Evidence Based Med, CEBAM, Cochrane, Belgium; [Buchbinder, Rachelle] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Buchbinder, Rachelle] Cabrini Inst, Monash Dept Clin Epidemiol, Melbourne, Vic, Australia; [Coen, Matteo] Geneva Univ Hosp, Div Gen Internal Med, Dept Med, Geneva, Switzerland; [Coen, Matteo] Univ Geneva, Unit Dev & Res Med Educ, Fac Med, Geneva, Switzerland; [Juurlink, David] Sunnybrook Hlth Sci Ctr, Div Clin Pharmacol & Toxicol, Toronto, ON, Canada; [Juurlink, David] Univ Toronto, Dept Med, Toronto, ON, Canada; [Juurlink, David] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Samer, Caroline] Geneva Univ Hosp, Div Clin Pharmacol & Toxicol, Geneva, Switzerland; [Samer, Caroline] Univ Geneva, Fac Med, Geneva, Switzerland; [Kumar, Nimisha] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Cooper, Lynn] Canadian Injured Workers Alliance, Thunder Bay, ON, Canada; [Zeraatkar, Dena] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Agoritsas, Thomas] Univ Hosp Geneva, Div Gen Internal Med, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva, Switzerland; [Agoritsas, Thomas] Univ Hosp Geneva, Div Clin Epidemiol, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva, Switzerland	McMaster University; McMaster University; McMaster University; KU Leuven; Sichuan University; Innlandet Hospital Trust; University of Geneva; University of Geneva; University of Toronto; University of Oslo; KU Leuven; Monash University; Cabrini Health; Monash University; University of Geneva; University of Geneva; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Hospital for Sick Children (SickKids); Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Geneva; University of Geneva; Indiana University System; Indiana University Bloomington; Harvard University; Harvard Medical School; University of Geneva; University of Geneva	Busse, JW (corresponding author), McMaster Univ, Michael G DeGroote Ctr Med Cannabis Res, Hamilton, ON, Canada.; Busse, JW (corresponding author), McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada.; Busse, JW (corresponding author), McMaster Univ, Dept Anesthesia, Hamilton, ON, Canada.; Busse, JW (corresponding author), Chron Pain Ctr Excellence Canadian Vet, Hamilton, ON, Canada.	bussejw@mcmaster.ca	Samer, Caroline/ABB-2447-2021; Zeraatkar, Dena/GNM-9600-2022; Busse, Jason/CAH-3696-2022; Cooper, Lynn Kerene/GMW-4135-2022; Coen, Matteo/AAO-3994-2020	Samer, Caroline/0000-0001-8178-0616; Busse, Jason/0000-0002-0178-8712; Coen, Matteo/0000-0002-6156-1691; Aertgeerts, Bert/0000-0003-1142-5402	Michael G DeGroote Centre for Medicinal Cannabis Research	Michael G DeGroote Centre for Medicinal Cannabis Research	The Michael G DeGroote Centre for Medicinal Cannabis Research funded the MAGIC Evidence Ecosystem Foundation to support the creation of this Rapid Recommendation. The central operating funding for the Michael G DeGroote Centre for Medicinal Cannabis Research is from a philanthropic gift to the Michael G DeGroote Initiative for Innovation in Healthcare. The centre receives no funding from industry.		0	26	27	5	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2021	374								n2040	10.1136/bmj.n2040	http://dx.doi.org/10.1136/bmj.n2040			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ3VV	34497062	Green Accepted			2022-12-28	WOS:000702137100016
J	Jones, H				Jones, Helen			BMJ Awards 2021: Stroke and cardiovascular team of the year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												hajones@dircon.co.uk							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2021	374								n2153	10.1136/bmj.n2153	http://dx.doi.org/10.1136/bmj.n2153			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ3VV	34503951				2022-12-28	WOS:000702137100001
J	Munkhbat, B; Canales, A; Kucukoz, B; Baranov, DG; Shegai, TO				Munkhbat, Battulga; Canales, Adriana; Kucukoz, Betul; Baranov, Denis G.; Shegai, Timur O.			Tunable self-assembled Casimir microcavities and polaritons	NATURE			English	Article							DER-WAALS FORCES; REPULSIVE CASIMIR; AGGREGATION; FABRICATION; WATER	Gold nanoflake pairs form by self-assembly in an aqueous ligand solution and offer stable and tunable microcavities by virtue of equilibrium between attractive Casimir forces and repulsive electrostatic forces. Spontaneous formation of ordered structures-self-assembly-is ubiquitous in nature and observed on different length scales, ranging from atomic and molecular systems to micrometre-scale objects and living matter(1). Self-ordering in molecular and biological systems typically involves short-range hydrophobic and van der Waals interactions(2,3). Here we introduce an approach to micrometre-scale self-assembly based on the joint action of attractive Casimir and repulsive electrostatic forces arising between charged metallic nanoflakes in an aqueous solution. This system forms a self-assembled optical Fabry-Perot microcavity with a fundamental mode in the visible range (long-range separation distance about 100-200 nanometres) and a tunable equilibrium configuration. Furthermore, by placing an excitonic material in the microcavity region, we are able to realize hybrid light-matter states (polaritons(4-6)), whose properties, such as coupling strength and eigenstate composition, can be controlled in real time by the concentration of ligand molecules in the solution and light pressure. These Casimir microcavities could find future use as sensitive and tunable platforms for a variety of applications, including opto-mechanics(7), nanomachinery(8) and cavity-induced polaritonic chemistry(9).	[Munkhbat, Battulga; Canales, Adriana; Kucukoz, Betul; Baranov, Denis G.; Shegai, Timur O.] Charmers Univ Technol, Dept Phys, Gothenburg, Sweden; [Baranov, Denis G.] Moscow Inst Phys & Technol, Ctr Photon & 2D Mat, Dorgoprudny, Russia	Chalmers University of Technology; Moscow Institute of Physics & Technology	Shegai, TO (corresponding author), Charmers Univ Technol, Dept Phys, Gothenburg, Sweden.	timurs@charmers.se	Baranov, Denis G./N-9736-2015; Munkhbat, Battulga/AAT-9452-2021	Baranov, Denis G./0000-0002-8071-1587; Munkhbat, Battulga/0000-0002-1923-0960; Canales Ramos, Adriana/0000-0002-9803-6559; Shegai, Timur/0000-0002-4266-3721				Baranov DG, 2018, ACS PHOTONICS, V5, P24, DOI 10.1021/acsphotonics.7b00674; Batista CAS, 2015, SCIENCE, V350, P138, DOI 10.1126/science.1242477; Berkhout A, 2020, ACS PHOTONICS, V7, P2799, DOI 10.1021/acsphotonics.0c01064; BIGGS S, 1994, J CHEM PHYS, V100, P8501, DOI 10.1063/1.466748; Bressi G, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.041804; Casimir H. B. G., 1948, P KON NED AKAD WET, V51, P793; Castellanos-Gomez A, 2014, 2D MATER, V1, DOI 10.1088/2053-1583/1/1/011002; Chen F, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.101801; Chen F, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.032113; Chen S, 2016, NANO-MICRO LETT, V8, P328, DOI 10.1007/s40820-016-0092-6; Cho YK, 2007, ADV FUNCT MATER, V17, P379, DOI 10.1002/adfm.200600846; DERJAGUIN B, 1993, PROG SURF SCI, V43, P30, DOI 10.1016/0079-6816(93)90013-L; DZYALOSHINSKII IE, 1961, ADV PHYS, V10, P165, DOI 10.1080/00018736100101281; Eichenfield M, 2009, NATURE, V459, P550, DOI 10.1038/nature08061; Gatemala H, 2015, CRYSTENGCOMM, V17, P5530, DOI 10.1039/c5ce00603a; Israelachvili J.N., 2015, INTERMOLECULAR SURFA; JOHNSON PB, 1972, PHYS REV B, V6, P4370, DOI 10.1103/PhysRevB.6.4370; Junginger A, 2020, OPT EXPRESS, V28, P485, DOI 10.1364/OE.380068; Kadirov MK, 2014, J PHYS CHEM C, V118, P19785, DOI 10.1021/jp503988a; Khitrova G, 2006, NAT PHYS, V2, P81, DOI 10.1038/nphys227; Lamoreaux SK, 1997, PHYS REV LETT, V78, P5, DOI 10.1103/PhysRevLett.78.5; Li RM, 2020, ACS OMEGA, V5, P4943, DOI 10.1021/acsomega.9b03823; Li YL, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.205422; LIFSHITZ EM, 1956, SOV PHYS JETP-USSR, V2, P73; Liu Y, 2013, CHEMOSPHERE, V92, P681, DOI 10.1016/j.chemosphere.2013.03.048; Meyer M, 2006, J PHYS CHEM B, V110, P6040, DOI 10.1021/jp055866b; Min Y., 2010, NANOSCIENCE TECHNOLO, P38; Munday JN, 2010, INT J MOD PHYS A, V25, P2252, DOI 10.1142/S0217751X10049529; Munday JN, 2009, NATURE, V457, P170, DOI 10.1038/nature07610; Rodrigues RB, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.100402; Rodriguez AW, 2015, ANN PHYS-BERLIN, V527, P45, DOI 10.1002/andp.201400160; Segelstein DJ, 1981, THESIS; Shegai T, 2011, ACS NANO, V5, P2036, DOI 10.1021/nn1031406; Tang L, 2017, NAT PHOTONICS, V11, P97, DOI [10.1038/NPHOTON.2016.254, 10.1038/nphoton.2016.254]; Thomas A, 2016, ANGEW CHEM INT EDIT, V55, P11462, DOI 10.1002/anie.201605504; Torma P, 2015, REP PROG PHYS, V78, DOI 10.1088/0034-4885/78/1/013901; VANBLOKLAND PHGM, 1978, J CHEM SOC FARAD T 1, V74, P2637, DOI 10.1039/f19787402637; VERWEY EJW, 1947, J PHYS COLLOID CHEM, V51, P631, DOI 10.1021/j150453a001; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Zhao RK, 2019, SCIENCE, V364, P984, DOI 10.1126/science.aax0916	40	20	20	19	55	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 9	2021	597	7875					214	+		10.1038/s41586-021-03826-3	http://dx.doi.org/10.1038/s41586-021-03826-3			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UO7ZA	34497392	Green Submitted			2022-12-28	WOS:000694909900001
J	Turnhout, E; Duncan, J; Candel, J; Maas, TY; Roodhof, AM; DeClerck, F; Watson, RT				Turnhout, Esther; Duncan, Jessica; Candel, Jeroen; Maas, Timo Y.; Roodhof, Anna M.; DeClerck, Fabrice; Watson, Robert T.			Do we need a new science-policy interface for food systems?	SCIENCE			English	Editorial Material							BIODIVERSITY; GOVERNANCE; PLATFORM		[Turnhout, Esther] Univ Twente, Sect Sci Technol & Policy Studies, Enschede, Netherlands; [Turnhout, Esther] Wageningen Univ, Forest & Nat Conservat Policy Grp, Wageningen, Netherlands; [Duncan, Jessica; Roodhof, Anna M.] Wageningen Univ, Rural Sociol Grp, Wageningen, Netherlands; [Candel, Jeroen] Wageningen Univ, Publ Adm & Policy Grp, Wageningen, Netherlands; [Maas, Timo Y.] PBL Netherlands Environm Assessment Agcy, The Hague, Netherlands; [DeClerck, Fabrice] OneCGIAR, Montpellier, France; [DeClerck, Fabrice] EAT Forum, Montpellier, France; [Watson, Robert T.] Univ East Anglia, Dept Environm, Norwich, Norfolk, England	University of Twente; Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; University of East Anglia	Turnhout, E (corresponding author), Univ Twente, Sect Sci Technol & Policy Studies, Enschede, Netherlands.; Turnhout, E (corresponding author), Wageningen Univ, Forest & Nat Conservat Policy Grp, Wageningen, Netherlands.	e.turnhout@utwente.nl	; Turnhout, Esther/K-9338-2017	Maas, Timo/0000-0002-9979-0588; Roodhof, Anna/0000-0002-0543-0953; Turnhout, Esther/0000-0002-2190-2076				Burlingame B., 2021, OPEN LETT FOOD SYSTE; Candel JJL, 2014, FOOD SECUR, V6, P585, DOI 10.1007/s12571-014-0364-2; Canfield M., FRONT SUSTAIN FOOD S, V5, P1; Diaz-Reviriego I, 2019, NAT SUSTAIN, V2, P457, DOI 10.1038/s41893-019-0290-6; Duncan J, 2018, FOOD SECUR, V10, P1411, DOI 10.1007/s12571-018-0852-x; European Commission, 2021, REC UN FOOD SYST SUM; Fresco L., 2020, FEED GROWING WORLD W; HLPE, 2020, FOOD SECURITY NUTR B; IAASTD 2008, 2008, EX SUMM SYNTH REP; Maas T. Y., 2021, ENV SCI POLICY, V123, P210; Pearce W, 2018, ENVIRON SCI POLICY, V80, P125, DOI 10.1016/j.envsci.2017.11.017; Turnhout E, 2014, ENVIRON PLANN A, V46, P581, DOI 10.1068/a4629; Turnhout Esther., 2019, ENV EXPERTISE CONNEC; Von Braun J., 2015, ZEF WORKING PAPER SE, V142; Vos R., 2015, 29 CDP	15	13	13	11	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2021	373	6559					1093	1095		10.1126/science.abj5263	http://dx.doi.org/10.1126/science.abj5263			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UL8QT	34516868				2022-12-28	WOS:000692910300034
J	Chen, YP; Luttmann, FF; Schoger, E; Scholer, HR; Zelarayan, LC; Kim, KP; Haigh, JJ; Kim, J; Braun, T				Chen, Yanpu; Luttmann, Felipe F.; Schoger, Eric; Schoeler, Hans R.; Zelarayan, Laura C.; Kim, Kee-Pyo; Haigh, Jody J.; Kim, Johnny; Braun, Thomas			Reversible reprogramming of cardiomyocytes to a fetal state drives heart regeneration in mice	SCIENCE			English	Article							MOUSE	Cardiomyocyte (CM) replacement is very slow in adultmammalian hearts, preventing regeneration of damaged myocardium. By contrast, fetal hearts display considerable regenerative potential owing to the presence of less mature CMs that still have the ability to proliferate. In this study, we demonstrate that heart-specific expression of Oct4, Sox2, Klf4, and c-Myc (OSKM) induces adult CMs to dedifferentiate, conferring regenerative capacity to adult hearts. Transient, CM-specific expression of OSKM extends the regenerative window for postnatal mouse hearts and induces a gene expression program in adult CMs that resembles that of fetal CMs. Extended expression of OSKM in CMs leads to cellular reprogramming and heart tumor formation. Short-term OSKM expression before and during myocardial infarction ameliorates myocardial damage and improves cardiac function, demonstrating that temporally controlled dedifferentiation and reprogramming enable cell cycle reentry of mammalian CMs and facilitate heart regeneration.	[Chen, Yanpu; Luttmann, Felipe F.; Kim, Johnny; Braun, Thomas] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodelling, Bad Nauheim, Germany; [Schoger, Eric; Zelarayan, Laura C.] Univ Med Ctr Goettingen UMG, Inst Pharmacol & Toxicol, Gottingen, Germany; [Schoger, Eric; Zelarayan, Laura C.] German Ctr Cardiovasc Res DZHK, Partner Site Gottingen, Gottingen, Germany; [Schoeler, Hans R.; Kim, Kee-Pyo] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Munster, Germany; [Kim, Kee-Pyo] Catholic Univ Korea, Coll Med, Dept Med Life Sci, Seoul, South Korea; [Haigh, Jody J.] Univ Manitoba, Rady Fac Hlth Sci, CancerCare Manitoba Res Inst, Dept Pharmacol & Therapeut, Winnipeg, MB, Canada; [Haigh, Jody J.] Univ Ghent, Flanders Inst Biotechnol, VIB, Ghent, Belgium; [Kim, Johnny; Braun, Thomas] German Ctr Cardiovasc Res DZHK, Partner Site Rhein Main, Bad Nauheim, Germany	Max Planck Society; German Centre for Cardiovascular Research; Max Planck Society; Catholic University of Korea; University of Manitoba; Flanders Institute for Biotechnology (VIB); Ghent University; German Centre for Cardiovascular Research	Kim, J; Braun, T (corresponding author), Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodelling, Bad Nauheim, Germany.; Kim, J; Braun, T (corresponding author), German Ctr Cardiovasc Res DZHK, Partner Site Rhein Main, Bad Nauheim, Germany.	johnny.kim@mpi-bn.mpg.de; thomas.braun@mpi-bn.mpg.de		haigh, jody/0000-0002-7319-8922; Schoger, Eric/0000-0002-5485-9828; Chen, Yanpu/0000-0001-7355-3480; Kim, Johnny/0000-0002-5226-5460; Scholer, Hans/0000-0003-2643-5136; Kim, Kee-Pyo/0000-0002-8666-8444	DFG [Excellence Cluster Cardio-Pulmonary Institute (CPI)] [SFB TRR81 TP A02, SFB 1213, SFB 1002 C07/INF]; German Center for Cardiovascular Research	DFG [Excellence Cluster Cardio-Pulmonary Institute (CPI)](German Research Foundation (DFG)); German Center for Cardiovascular Research	This work was supported by the DFG [Excellence Cluster Cardio-Pulmonary Institute (CPI), SFB TRR81 TP A02 and SFB 1213, TP A02 and B02, SFB 1002 C07/INF] and the German Center for Cardiovascular Research.	Abad M, 2013, NATURE, V502, P340, DOI 10.1038/nature12586; Ackers-Johnson M, 2016, CIRC RES, V119, P909, DOI 10.1161/CIRCRESAHA.116.309202; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bergmann O, 2015, CELL, V161, P1566, DOI 10.1016/j.cell.2015.05.026; Bywater MJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15552-x; Cui M, 2020, DEV CELL, V53, P102, DOI [10.1016/j.devcel.2020.02.019, 10.1016/j.devcel.2020.11.006]; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Haenebalcke L, 2013, CELL REP, V3, P335, DOI 10.1016/j.celrep.2013.01.016; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Itah R, 2004, LAB ANIM-UK, V38, P280, DOI 10.1258/002367704323133664; Kisby T, 2021, ADV THER-GERMANY, V4, DOI 10.1002/adtp.202000141; Kubin T, 2011, CELL STEM CELL, V9, P420, DOI 10.1016/j.stem.2011.08.013; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Mahmoud AI, 2014, NAT PROTOC, V9, P305, DOI 10.1038/nprot.2014.021; Nakada Y, 2017, NATURE, V541, P222, DOI 10.1038/nature20173; Nguyen NUN, 2020, CIRC RES, V127, DOI [10.1038/s41586-020-2228-6, 10.1161/res.127.suppl_1.MP161]; Patterson M, 2017, NAT GENET, V49, P1346, DOI 10.1038/ng.3929; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sadek H, 2020, CELL STEM CELL, V26, P7, DOI 10.1016/j.stem.2019.12.004; Takagawa J, 2007, J APPL PHYSIOL, V102, P2104, DOI 10.1152/japplphysiol.00033.2007; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Zhu YK, 2021, J MOL CELL CARDIOL, V152, P80, DOI 10.1016/j.yjmcc.2020.11.016	23	30	30	10	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2021	373	6562			SI		1537	+		10.1126/science.abg5159	http://dx.doi.org/10.1126/science.abg5159			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU7LJ	34554778				2022-12-28	WOS:000698977800056
J	Lappalainen, T; MacArthur, DG				Lappalainen, Tuuli; MacArthur, Daniel G.			From variant to function in human disease genetics	SCIENCE			English	Review							COMPLEX TRAITS	Over the next decade, the primary challenge in human genetics will be to understand the biological mechanisms by which genetic variants influence phenotypes, including disease risk. Although the scale of this challenge is daunting, better methods for functional variant interpretation will have transformative consequences for disease diagnosis, risk prediction, and the development of new therapies. An array of new methods for characterizing variant impact at scale, using patient tissue samples as well as in vitro models, are already being applied to dissect variantmechanisms across a range of human cell types and environments. These approaches are also increasingly being deployed in clinical settings. We discuss the rationale, approaches, applications, and future outlook for characterizing the molecular and cellular effects of genetic variants.	[Lappalainen, Tuuli] KTH Royal Inst Technol, Dept Gene Technol, Sci Life Lab, Stockholm, Sweden; [Lappalainen, Tuuli] New York Genome Ctr, New York, NY 10013 USA; [MacArthur, Daniel G.] Garvan Inst Med Res, Ctr Populat Genom, Sydney, NSW, Australia; [MacArthur, Daniel G.] UNSW Sydney, Sydney, NSW, Australia; [MacArthur, Daniel G.] Murdoch Childrens Res Inst, Ctr Populat Genom, Melbourne, Vic, Australia; [MacArthur, Daniel G.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA	Royal Institute of Technology; Garvan Institute of Medical Research; University of New South Wales Sydney; Murdoch Children's Research Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Lappalainen, T (corresponding author), KTH Royal Inst Technol, Dept Gene Technol, Sci Life Lab, Stockholm, Sweden.; Lappalainen, T (corresponding author), New York Genome Ctr, New York, NY 10013 USA.; MacArthur, DG (corresponding author), Garvan Inst Med Res, Ctr Populat Genom, Sydney, NSW, Australia.; MacArthur, DG (corresponding author), UNSW Sydney, Sydney, NSW, Australia.; MacArthur, DG (corresponding author), Murdoch Childrens Res Inst, Ctr Populat Genom, Melbourne, Vic, Australia.; MacArthur, DG (corresponding author), Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA.	tuuli.lappalainen@scilifelab.se; daniel.Macarthur@popubtiongenomics.org.au			KTH Royal Institute of Technology; NIH [U24HG011450, U01HG011755, R01GM122924, R01HL142028, R01AG057422, R01MH106842]; Garvan Institute of Medical Research; Murdoch Children's Research Institute; New York Genome Center	KTH Royal Institute of Technology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Garvan Institute of Medical Research; Murdoch Children's Research Institute; New York Genome Center	Supported by the KTH Royal Institute of Technology, New York Genome Center, and NIH grants R01GM122924, R01HL142028, R01AG057422, and R01MH106842 (T.L.) and the Garvan Institute of Medical Research, the Murdoch Children's Research Institute, and NIH grants U24HG011450 and U01HG011755 (D.G.M.).	Boyle EA, 2017, CELL, V169, P1177, DOI 10.1016/j.cell.2017.05.038; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Claussnitzer M, 2020, NATURE, V577, P179, DOI 10.1038/s41586-019-1879-7; Gazal S, 2018, NAT GENET, V50, P1600, DOI 10.1038/s41588-018-0231-8; Glassberg EC, 2019, GENETICS, V211, P757, DOI 10.1534/genetics.118.301833; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Sella G, 2019, ANNU REV GENOM HUM G, V20, P461, DOI 10.1146/annurev-genom-083115-022316; Wainschtein P., 2021, 588020 BIORXIV; Zeng J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21446-3	12	18	18	4	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2021	373	6562			SI		1464	+		10.1126/science.abi8207	http://dx.doi.org/10.1126/science.abi8207			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU7LJ	34554789				2022-12-28	WOS:000698977800041
J	Balikagala, B; Fukuda, N; Ikeda, M; Katuro, OT; Tachibana, SI; Yamauchi, M; Opio, W; Emoto, S; Anywar, DA; Kimura, E; Palacpac, NMQ; Odongo-Aginya, EI; Ogwang, M; Horii, T; Mita, T				Balikagala, Betty; Fukuda, Naoyuki; Ikeda, Mie; Katuro, Osbert T.; Tachibana, Shin-Ichiro; Yamauchi, Masato; Opio, Walter; Emoto, Sakurako; Anywar, Denis A.; Kimura, Eisaku; Palacpac, Nirianne M. Q.; Odongo-Aginya, Emmanuel, I; Ogwang, Martin; Horii, Toshihiro; Mita, Toshihiro			Evidence of Artemisinin-Resistant Malaria in Africa	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLASMODIUM-FALCIPARUM; CLEARANCE; UGANDA; CAMBODIA	Background In the six Southeast Asian countries that make up the Greater Mekong Subregion, Plasmodium falciparum has developed resistance to derivatives of artemisinin, the main component of first-line treatments for malaria. Clinical resistance to artemisinin monotherapy in other global regions, including Africa, would be problematic. Methods In this longitudinal study conducted in Northern Uganda, we treated patients who had P. falciparum infection with intravenous artesunate (a water-soluble artemisinin derivative) and estimated the parasite clearance half-life. We evaluated ex vivo susceptibility of the parasite using a ring-stage survival assay and genotyped resistance-related genes. Results From 2017 through 2019, a total of 14 of 240 patients who received intravenous artesunate had evidence of in vivo artemisinin resistance (parasite clearance half-life, >5 hours). Of these 14 patients, 13 were infected with P. falciparum parasites with mutations in the A675V or C469Y allele in the kelch13 gene. Such mutations were associated with prolonged parasite clearance half-lives (geometric mean, 3.95 hours for A675V and 3.30 hours for C469Y, vs. 1.78 hours for wild-type allele; P<0.001 and P=0.05, respectively). The ring-stage survival assay showed a higher frequency of parasite survival among organisms with the A675V allele than among those with the wild-type allele. The prevalence of parasites with kelch13 mutations increased significantly, from 3.9% in 2015 to 19.8% in 2019, due primarily to the increased frequency of the A675V and C469Y alleles (P<0.001 and P=0.004, respectively). Single-nucleotide polymorphisms flanking the A675V mutation in Uganda were substantially different from those in Southeast Asia. Conclusions The independent emergence and local spread of clinically artemisinin-resistant P. falciparum has been identified in Africa. The two kelch13 mutations may be markers for detection of these resistant parasites. (Funded by the Japan Society for the Promotion of Science and others.) Artemisinin-Resistant Malaria in Africa Artemisinin compounds are the backbone of global malaria treatment strategies, but resistant strains are emerging in Southeast Asia. In this report, the investigators report the emergence of artemisinin-resistant Plasmodium falciparum strains in Northern Uganda, with the predominant mutations observed in the kelch13 gene.	[Balikagala, Betty; Fukuda, Naoyuki; Ikeda, Mie; Tachibana, Shin-Ichiro; Yamauchi, Masato; Emoto, Sakurako; Mita, Toshihiro] Juntendo Univ, Dept Trop Med & Parasitol, Sch Med, Tokyo, Japan; [Balikagala, Betty] Juntendo Univ, Atopy Res Ctr, Grad Sch Med, Tokyo, Japan; [Kimura, Eisaku] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki, Japan; [Palacpac, Nirianne M. Q.; Horii, Toshihiro] Osaka Univ, Dept Malaria Vaccine Dev, Res Inst Microbial Dis, Osaka, Japan; [Katuro, Osbert T.] Mildmay Uganda, Nazibwa Hill, Kampala, Uganda; [Opio, Walter; Ogwang, Martin] Gulu Univ, St Marys Hosp Lacor, Gulu, Uganda; [Anywar, Denis A.; Odongo-Aginya, Emmanuel, I] Gulu Univ, Fac Med, Gulu, Uganda	Juntendo University; Juntendo University; Nagasaki University; Osaka University	Mita, T (corresponding author), Juntendo Univ, Dept Trop Med & Parasitol, Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	tmita@juntendo.ac.jp	, 美田敏宏/D-8494-2015	, 美田敏宏/0000-0001-8180-2344				ACTwatch Group and PACE, 2015, ACTWATCH STUD REF DO; Amaratunga C, 2019, BMC MED, V17, DOI 10.1186/s12916-018-1207-3; Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; Amato R, 2016, ELIFE, V5, DOI 10.7554/eLife.08714; [Anonymous], 2020, REPORT ANTIMALARIAL; [Anonymous], 2020, WORLD MALARIA REPORT; [Anonymous], 2015, GUID TREATM MAL; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Asua V, 2021, J INFECT DIS, V223, P985, DOI 10.1093/infdis/jiaa687; Asua V, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01818-18; Balikagala B, 2017, MALARIA J, V16, DOI 10.1186/s12936-016-1663-1; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Clinton Health Access Initiative UNITAID, 2019, INJ ART ASS REP; Conrad MD, 2019, LANCET INFECT DIS, V19, pE338, DOI 10.1016/S1473-3099(19)30261-0; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Flegg JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-339; Hawkes M, 2015, EMERG INFECT DIS, V21, P1237, DOI 10.3201/eid2107.150213; Huang F, 2015, J INFECT DIS, V212, P1629, DOI 10.1093/infdis/jiv249; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Ikeda M, 2018, EMERG INFECT DIS, V24, P718, DOI 10.3201/eid2404.170141; Kayiba NK, 2021, LANCET INFECT DIS, V21, pE82, DOI 10.1016/S1473-3099(20)30493-X; Kigozi SP, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-10007-w; Lee SA, 2006, J INFECT DIS, V193, P1160, DOI 10.1086/501473; Lu F, 2017, NEW ENGL J MED, V376, P991, DOI 10.1056/NEJMc1612765; McCallum FJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003571; Miotto O, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1009133; Miotto O, 2015, NAT GENET, V47, P226, DOI 10.1038/ng.3189; National Malaria Control Division, 2019, NAT MAL ANN REP 2017; Noedl H, 2009, NEW ENGL J MED, V361, P540, DOI 10.1056/NEJMc0900231; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Siddiqui FA, 2020, MBIO, V11, DOI 10.1128/mBio.01134-19; Talundzic E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004789; Uwimana A, 2021, LANCET INFECT DIS, V21, P1120, DOI 10.1016/S1473-3099(21)00142-0; Uwimana A, 2020, NAT MED, V26, P1602, DOI 10.1038/s41591-020-1005-2; van der Pluijm RW, 2019, LANCET INFECT DIS, V19, P952, DOI 10.1016/S1473-3099(19)30391-3; White LJ, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001823; White NJ, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1731-1; Witkowski B, 2013, LANCET INFECT DIS, V13, P1043, DOI 10.1016/S1473-3099(13)70252-4; Yeka A, 2012, ACTA TROP, V121, P184, DOI 10.1016/j.actatropica.2011.03.004	40	117	117	29	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2021	385	13					1163	1171		10.1056/NEJMoa2101746	http://dx.doi.org/10.1056/NEJMoa2101746			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UT0EM	34551228	Bronze			2022-12-28	WOS:000697798600010
J	Emanuel, EJ				Emanuel, Ezekiel J.			A Middle Ground for Accelerated Drug Approval-Lessons From Aducanumab	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FOOD		[Emanuel, Ezekiel J.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, 423 Guardian Dr,Blockley Hall,Ste 1412, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Emanuel, EJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, 423 Guardian Dr,Blockley Hall,Ste 1412, Philadelphia, PA 19104 USA.	zemanuel@upenn.edu						[Anonymous], 2021, CDER DRUG BIOL ACC A; Florko, 2021, FDA CALLS FEDERAL IN; Johnson JR, 2011, J NATL CANCER I, V103, P636, DOI 10.1093/jnci/djr062; Kim C, 2016, MAYO CLIN PROC, V91, P713, DOI 10.1016/j.mayocp.2016.02.012; Mahase E, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1898; Makin S, 2018, NATURE, V559, pS4, DOI 10.1038/d41586-018-05719-4; Pearson, 2021, STRENGTHENING ACCELE; Powell K, 2021, JAMA ONCOL, V7, P1607, DOI 10.1001/jamaoncol.2021.3046; Vitry Agnes, 2015, J Pharm Policy Pract, V8, P25, DOI 10.1186/s40545-015-0046-2	9	7	7	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 12	2021	326	14					1367	1368		10.1001/jama.2021.14861	http://dx.doi.org/10.1001/jama.2021.14861		SEP 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WH8VN	34554184				2022-12-28	WOS:000698780000002
J	Ghobadi, A; Bartlett, NL				Ghobadi, Armin; Bartlett, Nancy L.			CD3xCD20 bispecific T-cell redirectors for relapsed or refractory B-cell lymphoma	LANCET			English	Editorial Material									[Ghobadi, Armin; Bartlett, Nancy L.] Washington Univ, Sch Med, Siteman Canc Ctr, Div Oncol,Dept Med, St Louis, MO 63110 USA	Siteman Cancer Center; Washington University (WUSTL)	Ghobadi, A (corresponding author), Washington Univ, Sch Med, Siteman Canc Ctr, Div Oncol,Dept Med, St Louis, MO 63110 USA.	arminghobadi@wustl.edu		Bartlett, Nancy/0000-0001-8470-394X				Abramson JS, 2020, LANCET, V396, P839, DOI 10.1016/S0140-6736(20)31366-0; Bannerji R, 2019, BLOOD, V134, DOI 10.1182/blood-2019-122451; Bargou R, 2008, SCIENCE, V321, P974, DOI 10.1126/science.1158545; Choi BD, 2019, NAT BIOTECHNOL, V37, P1049, DOI 10.1038/s41587-019-0192-1; Hutchings M, 2021, LANCET, V398, P1157, DOI 10.1016/S0140-6736(21)00889-8; Lee DW, 2019, BIOL BLOOD MARROW TR, V25, P625, DOI 10.1016/j.bbmt.2018.12.758; Lussana F, 2021, J CLIN ONCOL, V39, P444, DOI 10.1200/JCO.20.01564; Neelapu SS, 2017, NEW ENGL J MED, V377, P2531, DOI 10.1056/NEJMoa1707447; Schuster SJ, 2019, BLOOD, V134, DOI 10.1182/blood-2019-123742; Schuster SJ, 2019, NEW ENGL J MED, V380, P45, DOI 10.1056/NEJMoa1804980; Singh A, 2021, BRIT J CANCER, V124, P1037, DOI 10.1038/s41416-020-01225-5; Suurs FV, 2019, PHARMACOL THERAPEUT, V201, P103, DOI 10.1016/j.pharmthera.2019.04.006; Wang MH, 2020, NEW ENGL J MED, V382, P1331, DOI 10.1056/NEJMoa1914347	13	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 25	2021	398	10306					1109	1110		10.1016/S0140-6736(21)01070-9	http://dx.doi.org/10.1016/S0140-6736(21)01070-9		SEP 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UX3WV	34508653				2022-12-28	WOS:000700774500004
J	Yen, H; Chang, JWC; Chung, WH; Chen, CB				Yen, Hsi; Chang, John Wen-Cheng; Chung, Wen-Hung; Chen, Chun-Bing			Multiple oral erosions and ulcers in a patient with malignant melanoma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CYTOMEGALOVIRUS		[Yen, Hsi; Chung, Wen-Hung; Chen, Chun-Bing] Chang Gung Mem Hosp, Drug Hypersensit Clin & Res Ctr, Dept Dermatol, Linkou, Taiwan; [Yen, Hsi; Chung, Wen-Hung; Chen, Chun-Bing] Chang Gung Mem Hosp, Drug Hypersensit Clin & Res Ctr, Dept Dermatol, Taipei, Taiwan; [Yen, Hsi; Chung, Wen-Hung; Chen, Chun-Bing] Chang Gung Mem Hosp, Drug Hypersensit Clin & Res Ctr, Dept Dermatol, Keelung, Taiwan; [Yen, Hsi; Chang, John Wen-Cheng; Chung, Wen-Hung; Chen, Chun-Bing] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Chang, John Wen-Cheng] Chang Gung Mem Hosp, Dept Internal Med, Div Hematol Oncol, Linkou Branch, Taoyuan, Taiwan; [Chang, John Wen-Cheng; Chung, Wen-Hung; Chen, Chun-Bing] Chang Gung Mem Hosp, Immune Oncol Ctr Excellence, Linkou, Taiwan; [Chung, Wen-Hung; Chen, Chun-Bing] Chang Gung Mem Hosp, Canc Vaccine & Immune Cell Therapy Core Lab, Linkou, Taiwan; [Chung, Wen-Hung; Chen, Chun-Bing] Xiamen Chang Gung Hosp, Dept Dermatol, Xiamen, Peoples R China; [Chung, Wen-Hung; Chen, Chun-Bing] Chang Gung Mem Hosp, Whole Genome Res Core Lab Human Dis, Taipei, Taiwan; [Chung, Wen-Hung; Chen, Chun-Bing] Chang Gung Mem Hosp, Genom Med Core Lab, Linkou, Taiwan; [Chen, Chun-Bing] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Chen, CB (corresponding author), Chang Gung Mem Hosp, Drug Hypersensit Clin & Res Ctr, Dept Dermatol, Linkou, Taiwan.; Chen, CB (corresponding author), Chang Gung Mem Hosp, Drug Hypersensit Clin & Res Ctr, Dept Dermatol, Taipei, Taiwan.; Chen, CB (corresponding author), Chang Gung Mem Hosp, Drug Hypersensit Clin & Res Ctr, Dept Dermatol, Keelung, Taiwan.; Chen, CB (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.; Chen, CB (corresponding author), Chang Gung Mem Hosp, Immune Oncol Ctr Excellence, Linkou, Taiwan.; Chen, CB (corresponding author), Chang Gung Mem Hosp, Canc Vaccine & Immune Cell Therapy Core Lab, Linkou, Taiwan.; Chen, CB (corresponding author), Xiamen Chang Gung Hosp, Dept Dermatol, Xiamen, Peoples R China.; Chen, CB (corresponding author), Chang Gung Mem Hosp, Whole Genome Res Core Lab Human Dis, Taipei, Taiwan.; Chen, CB (corresponding author), Chang Gung Mem Hosp, Genom Med Core Lab, Linkou, Taiwan.; Chen, CB (corresponding author), Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan.	chunbing.chen@gmail.com	Yen, Hsi/AAU-2491-2021	Yen, Hsi/0000-0002-2649-2563; Chung, Wen-Hung/0000-0003-1681-0959	Ministry of Science and Technology, Taiwan [MOST 108-2314-B-182A-006-MY3]; Chang Gung Memorial Hospital, Taiwan [CMRPG2J0221, CMRPG2J0222, NMRPG2J6012, NMRPG2J6013, CIRPG2I0011, CIRPG2I0012, CIRPG2I0013]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	The authors thank research grants support from the Ministry of Science and Technology, Taiwan (grant numbers MOST 108-2314-B-182A-006-MY3 to C.-B.C.) and Chang Gung Memorial Hospital, Taiwan (grant numbers CMRPG2J0221, CMRPG2J0222, NMRPG2J6012, NMRPG2J6013, CIRPG2I0011, CIRPG2I0012, CIRPG2I0013 to C.-B.C.).	Del Castillo M, 2016, CLIN INFECT DIS, V63, P1490, DOI 10.1093/cid/ciw539; Franklin C, 2017, EUR J CANCER, V86, P248, DOI 10.1016/j.ejca.2017.09.019; Kotton CN, 2018, TRANSPLANTATION, V102, P900, DOI 10.1097/TP.0000000000002191; Mortazavi H, 2016, INT J DENT, V2016, DOI 10.1155/2016/7278925; Redelman-Sidi G, 2018, CLIN MICROBIOL INFEC, V24, pS95, DOI 10.1016/j.cmi.2018.01.030; Resnik KS, 2000, AM J DERMATOPATH, V22, P397, DOI 10.1097/00000372-200010000-00003; Robert C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17670-y; Schlick K, 2015, INFECT AGENTS CANCER, V10, DOI 10.1186/s13027-015-0039-4	8	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2021	374								n1967	10.1136/bmj.n1967	http://dx.doi.org/10.1136/bmj.n1967			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ1JE	34556481				2022-12-28	WOS:000701967300012
J	Charo, RA				Charo, R. Alta			Vigilante Injustice - Deputizing and Weaponizing the Public to Stop Abortions	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Charo, R. Alta] Univ Wisconsin, Sch Law, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison	Charo, RA (corresponding author), Univ Wisconsin, Sch Law, Madison, WI 53705 USA.							Dixon L., 2021, TEXAS SENATE BILL 8; Mercurio MR, 2012, GA ST U LAW REV, V25, P835; National Advocates for Pregnant Women, PREGN LOSS; Noll, 2021, NEW YORK TIMES; Sammons, 1985, WASH POST	5	5	4	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 14	2021	385	16					1441	1443		10.1056/NEJMp2114886	http://dx.doi.org/10.1056/NEJMp2114886		SEP 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WG2CY	34551227	Bronze			2022-12-28	WOS:000697804600001
J	Aubrey, ML; Valdes, AS; Filip, MR; Connor, BA; Lindquist, KP; Neaton, JB; Karunadasa, HI				Aubrey, Michael L.; Valdes, Abraham Saldivar; Filip, Marina R.; Connor, Bridget A.; Lindquist, Kurt P.; Neaton, Jeffrey B.; Karunadasa, Hemamala, I			Directed assembly of layered perovskite heterostructures as single crystals	NATURE			English	Article							ELECTRON-HOLE EXCITATIONS; OPTICAL-PROPERTIES; QUASI-PARTICLE; HYDROGEN-BOND; HYBRID; SEMICONDUCTORS	Using organic molecules as directing groups, a wide range of perovskite heterostructures are shown to self-assemble in solution to yield single crystals. The precise stacking of different two-dimensional (2D) structures such as graphene and MoS2 has reinvigorated the field of 2D materials, revealing exotic phenomena at their interfaces(1,2). These unique interfaces are typically constructed using mechanical or deposition-based methods to build a heterostructure one monolayer at a time(2,3). By contrast, self-assembly is a scalable technique, where complex materials can selectively form in solution(4-6). Here we show a synthetic strategy for the self-assembly of layered perovskite-non-perovskite heterostructures into large single crystals in aqueous solution. Using bifunctional organic molecules as directing groups, we have isolated six layered heterostructures that form as an interleaving of perovskite slabs with a different inorganic lattice, previously unknown to crystallize with perovskites. In many cases, these intergrown lattices are 2D congeners of canonical inorganic structure types. To our knowledge, these compounds are the first layered perovskite heterostructures formed using organic templates and characterized by single-crystal X-ray diffraction. Notably, this interleaving of inorganic structures can markedly transform the band structure. Optical data and first principles calculations show that substantive coupling between perovskite and intergrowth layers leads to new electronic transitions distributed across both sublattices. Given the technological promise of halide perovskites(4), this intuitive synthetic route sets a foundation for the directed synthesis of richly structured complex semiconductors that self-assemble in water.	[Aubrey, Michael L.; Valdes, Abraham Saldivar; Connor, Bridget A.; Lindquist, Kurt P.; Karunadasa, Hemamala, I] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Filip, Marina R.] Univ Oxford, Dept Phys, Oxford, England; [Filip, Marina R.; Neaton, Jeffrey B.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Filip, Marina R.; Neaton, Jeffrey B.] Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA USA; [Neaton, Jeffrey B.] Kavli Energy NanoSci Inst Berkeley, Berkeley, CA USA; [Karunadasa, Hemamala, I] SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA	Stanford University; University of Oxford; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Karunadasa, HI (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.; Karunadasa, HI (corresponding author), SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA.	hemamala@stanford.edu	Filip, Marina/AAA-5508-2020	Filip, Marina/0000-0003-2925-172X; Aubrey, Michael/0000-0002-0740-0731; Lindquist, Kurt/0000-0002-2107-2455				AlShammari MB, 2018, CHEM PHYS LETT, V702, P8, DOI 10.1016/j.cplett.2018.04.051; [Anonymous], 2017, SAINT SADABS 8 38A; BRESE NE, 1991, ACTA CRYSTALLOGR B, V47, P192, DOI 10.1107/S0108768190011041; Campbell BJ, 2006, J APPL CRYSTALLOGR, V39, P607, DOI 10.1107/S0021889806014075; Connor BA, 2021, CHEM SCI, DOI 10.1039/d1sc01159f; Del Ben M, 2020, PROCEEDINGS OF SC20: THE INTERNATIONAL CONFERENCE FOR HIGH PERFORMANCE COMPUTING, NETWORKING, STORAGE AND ANALYSIS (SC20), DOI 10.1109/SC41405.2020.00008; Del Ben M, 2019, COMPUT PHYS COMMUN, V235, P187, DOI 10.1016/j.cpc.2018.09.003; DEPMEIER W, 1976, ACTA CRYSTALLOGR B, V32, P303, DOI 10.1107/S0567740876002872; Deslippe J, 2012, COMPUT PHYS COMMUN, V183, P1269, DOI 10.1016/j.cpc.2011.12.006; Dolomanov OV, 2009, J APPL CRYSTALLOGR, V42, P339, DOI 10.1107/S0021889808042726; Dou LT, 2015, SCIENCE, V349, P1518, DOI 10.1126/science.aac7660; Doudin B., 1990, Acta Crystallographica, Section B (Structural Science), VB46, P175, DOI 10.1107/S0108768189010281; Earnshaw A., 1997, CHEM ELEMENTS, P367; Giannozzi P, 2017, J PHYS-CONDENS MAT, V29, DOI 10.1088/1361-648X/aa8f79; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; Hwang HY, 2012, NAT MATER, V11, P103, DOI [10.1038/nmat3223, 10.1038/NMAT3223]; HYBERTSEN MS, 1986, PHYS REV B, V34, P5390, DOI 10.1103/PhysRevB.34.5390; Kamminga ME, 2016, CHEM MATER, V28, P4554, DOI 10.1021/acs.chemmater.6b00809; KING EJ, 1953, J AM CHEM SOC, V75, P2204, DOI 10.1021/ja01105a053; Komornicka D, 2014, CRYST GROWTH DES, V14, P5784, DOI 10.1021/cg501044n; Li J, 1999, COORDIN CHEM REV, V190, P707, DOI 10.1016/S0010-8545(99)00107-1; LOBO RF, 1995, J INCLUS PHENOM MOL, V21, P47; LUMBRERAS M, 1986, SOLID STATE IONICS, V20, P295, DOI 10.1016/0167-2738(86)90049-4; MACICEK J, 1994, ACTA CRYSTALLOGR C, V50, P1185, DOI 10.1107/S0108270194002027; Mercier N, 2004, CHEM COMMUN, P844, DOI 10.1039/b316847f; MERESSE A, 1989, ACTA CRYSTALLOGR C, V45, P194, DOI 10.1107/S0108270188003634; Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; NORD AG, 1976, ACTA CRYSTALLOGR B, V32, P982, DOI 10.1107/S0567740876004433; Novoselov KS, 2016, SCIENCE, V353, DOI 10.1126/science.aac9439; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Pietraszko A., 1992, POL J CHEM, V66, P2057; Plasseraud L, 2010, Z NATURFORSCH B, V65, P317, DOI 10.1515/znb-2010-0314; RAO CNR, 1985, ACCOUNTS CHEM RES, V18, P113, DOI 10.1021/ar00112a003; RENTZEPERIS PJ, 1958, ACTA CRYSTALLOGR, V11, P686, DOI 10.1107/S0365110X58001857; Rivera P, 2018, NAT NANOTECHNOL, V13, P1004, DOI 10.1038/s41565-018-0193-0; Rohlfing M, 2000, PHYS REV B, V62, P4927, DOI 10.1103/PhysRevB.62.4927; Rohlfing M, 1998, PHYS REV LETT, V81, P2312, DOI 10.1103/PhysRevLett.81.2312; Saparov B, 2016, CHEM REV, V116, P4558, DOI 10.1021/acs.chemrev.5b00715; Schaak RE, 2002, CHEM MATER, V14, P1455, DOI 10.1021/cm010689m; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Shi EZ, 2020, NATURE, V580, P614, DOI 10.1038/s41586-020-2219-7; SLATER JC, 1964, J CHEM PHYS, V41, P3199, DOI 10.1063/1.1725697; Smith MD, 2019, CHEM REV, V119, P3104, DOI 10.1021/acs.chemrev.8b00477; SPENCER JB, 1973, ACTA CRYSTALLOGR B, V29, P1923, DOI 10.1107/S0567740873005765; Stokes H. T., 2020, ISOTROPY SOFTWARE SU; STRINATI G, 1988, RIV NUOVO CIMENTO, V11, P1, DOI 10.1007/BF02725962; SUBRAMANIAN L, 1992, INORG CHEM, V31, P1021, DOI 10.1021/ic00032a019; Toby BH, 2013, J APPL CRYSTALLOGR, V46, P544, DOI 10.1107/S0021889813003531; Tulsky EG, 2001, CHEM MATER, V13, P1149, DOI 10.1021/cm0007858; van Setten MJ, 2018, COMPUT PHYS COMMUN, V226, P39, DOI 10.1016/j.cpc.2018.01.012; Viciu L, 2003, CHEM MATER, V15, P1480, DOI 10.1021/cm0208253; Wolf NR, 2021, ANGEW CHEM INT EDIT, V60, P16264, DOI 10.1002/anie.202016185; Wong FJ, 2014, J VAC SCI TECHNOL A, V32, DOI 10.1116/1.4879695	54	18	18	51	300	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 16	2021	597	7876					355	+		10.1038/s41586-021-03810-x	http://dx.doi.org/10.1038/s41586-021-03810-x			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UQ8UQ	34526708	Green Submitted			2022-12-28	WOS:000696334600009
J	Jones, H				Jones, Helen			BMJ Awards 2021: Diversity and inclusion team of the year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												hajones@dircon.co.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2021	374								n2199	10.1136/bmj.n2199	http://dx.doi.org/10.1136/bmj.n2199			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YR5CL	34531226	Bronze			2022-12-28	WOS:000750009400002
J	Limb, M				Limb, Matthew			BMJ Awards 2021: Primary care team of the year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												limb@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2021	374								n2205	10.1136/bmj.n2205	http://dx.doi.org/10.1136/bmj.n2205			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YR5CL	34531176	Bronze			2022-12-28	WOS:000750009400004
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Government lays out its "plan B" to protect NHS this winter	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		HM Government, 2021, COV 19 RESP AUT WINT	1	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 15	2021	374								n2270	10.1136/bmj.n2270	http://dx.doi.org/10.1136/bmj.n2270			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UY0UP	34526319	Bronze			2022-12-28	WOS:000701248800005
J	Mahase, E				Mahase, Elisabeth			Covid-19: Long covid must be recognised as occupational disease, says BMA	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2021	374								n2258	10.1136/bmj.n2258	http://dx.doi.org/10.1136/bmj.n2258			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WP7CH	34521686	Bronze			2022-12-28	WOS:000713284400013
J	Block, J				Block, Jennifer			Vaccinating people who have had covid-19: why doesn't natural immunity count in the US?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SARS-COV-2					writingblock@protonmail.com						[Anonymous], 2021, E COMMUNICATION 0304; [Anonymous], 2021, KFF COVID 19 VACC MO; [Anonymous], 2021, QUESTIONS ANSWERS EU; [Anonymous], 2021, MEDPAGE TODAY; [Anonymous], 2021, WALL STR J; [Anonymous], 2021, NEW YORK TIMES; Bertollini R, 2021, JAMA-J AM MED ASSOC, V326, P185, DOI 10.1001/jama.2021.9970; Block J, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1397; Cavanaugh AM, 2021, MMWR-MORBID MORTAL W, V70, P1081, DOI [10.15585/mmwr.mm7032e1, 10.15585/mmwr.mm7032e1externalicon]; CDC, 2021, NEW CDC STUD VACC OF; Centers For Disease Control and Prevention (CDC), 2020, EST DIS BURD COVID 1; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; FDA, 2021, PFIZ BIONTECH COV 19; FDA, 2021, ANT TEST IS NOT CURR; Ghandi M., 2021, TWITTER POST; Goldberg Y, 21255670 MEDRXIV, V2021, DOI [10.1101/2021.04.20.21255670, DOI 10.1101/2021.04.20.21255670]; Greaney AJ, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abi9915; Hall VJ, 2021, LANCET, V397, P1459, DOI 10.1016/S0140-6736(21)00675-9; Klausner J, 2021, MEDPAGE TODAY; Le Bert N, 2021, J EXP MED, V218, DOI 10.1084/jem.20202617; Lozano-Ojalvo D, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109570; Mathioudakis AG, 2021, LIFE-BASEL, V11, DOI 10.3390/life11030249; Menni C, 2021, LANCET INFECT DIS, V21, P939, DOI 10.1016/S1473-3099(21)00224-3; Murchu EO, 2022, REV MED VIROL, V32, DOI 10.1002/rmv.2260; New York Department of Health, 2021, SERVICE PROVIDERS FR; NIH, 2021, LAST IMM FOUND REC C; Redd Andrew D, 2021, Open Forum Infect Dis, V8, pofab143, DOI [10.1101/2021.02.11.21251585, 10.1093/ofid/ofab143]; Shrestha NK, 2021, MEDRXIV; Tarke Alison, 2021, bioRxiv, DOI 10.1101/2021.02.27.433180; UK Department of Health and Social Care, 2021, WHO CAN GET NHS COVI; Woodcock Janet, 2021, P MARKS DISC SUGG IN	31	20	20	2	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 13	2021	374								n2101	10.1136/bmj.n2101	http://dx.doi.org/10.1136/bmj.n2101			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UR8KQ	34518194	Bronze			2022-12-28	WOS:000696991500010
J	Kolbe, M; Schmutz, S; Seelandt, JC; Eppich, WJ; Schmutz, JB				Kolbe, Michaela; Schmutz, Sven; Seelandt, Julia Carolin; Eppich, Walter J.; Schmutz, Jan B.			Team debriefings in healthcare: aligning intention and impact	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AFTER-EVENT REVIEWS; PERFORMANCE; TOOL		[Kolbe, Michaela; Seelandt, Julia Carolin] Univ Hosp Zurich, Simulat Ctr, Zurich, Switzerland; [Kolbe, Michaela; Schmutz, Jan B.] Swiss Fed Inst Technol, Zurich, Switzerland; [Schmutz, Sven] Univ Hosp Bern, Inselspital, Bern, Switzerland; [Eppich, Walter J.] RCSI Univ Med & Hlth Sci, RCSI SIM Ctr Simulat Educ & Res, Dublin, Ireland	University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bern; University Hospital of Bern	Kolbe, M (corresponding author), Univ Hosp Zurich, Simulat Ctr, Zurich, Switzerland.; Kolbe, M (corresponding author), Swiss Fed Inst Technol, Zurich, Switzerland.	Michaela.Kolbe@usz.ch		Kolbe, Michaela/0000-0001-6654-6370; Seelandt, Julia C./0000-0002-9476-7194				Allen JA, 2018, AM PSYCHOL, V73, P504, DOI 10.1037/amp0000246; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; BALINT M, 1954, BRIT MED J, V1, P115, DOI 10.1136/bmj.1.4854.115; Bennett P, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2536; Biggs M., 2009, OXFORD HDB ANAL SOCI, P295; Caldas MP, 2021, J APPL PSYCHOL, V106, P29, DOI 10.1037/apl0000850; Chinnock B, 2017, ANN EMERG MED, V70, P320, DOI 10.1016/j.annemergmed.2017.07.005; Clark PR, 2019, J EMERG NURS, V45, P403, DOI 10.1016/j.jen.2018.11.009; Coggins A, 2021, MED TEACH, V43, P509, DOI 10.1080/0142159X.2020.1817349; Corbett N, 2012, JOGNN-J OBST GYN NEO, V41, P572, DOI 10.1111/j.1552-6909.2012.01374.x; DeChurch LA, 2010, J APPL PSYCHOL, V95, P32, DOI 10.1037/a0017328; DeRue DS, 2012, J APPL PSYCHOL, V97, P997, DOI 10.1037/a0028244; Devilly GJ, 2006, REV GEN PSYCHOL, V10, P318, DOI 10.1037/1089-2680.10.4.318; Diaz-Navarro C, 2021, TREND ANAESTHES CRIT; Dieckmann Peter, 2020, Adv Simul (Lond), V5, P3, DOI 10.1186/s41077-020-00121-5; Eddy ER, 2013, PERS PSYCHOL, V66, P975, DOI 10.1111/peps.12041; Ellis S, 2005, J APPL PSYCHOL, V90, P857, DOI 10.1037/0021-9010.90.5.857; Eppich W, 2015, SIMUL HEALTHC, V10, P106, DOI 10.1097/SIH.0000000000000072; Everly George S Jr, 2006, Int J Emerg Ment Health, V8, P93; Farrington R, 2019, CLIN TEACH, V16, P329, DOI 10.1111/tct.13055; Gougoulis A, 2020, J PAEDIATR CHILD H, V56, P1134, DOI 10.1111/jpc.14856; Greenberg N, 2008, J R Army Med Corps, V154, P124; Keiser NL, 2021, J APPL PSYCHOL, V106, P1007, DOI 10.1037/apl0000821; Kisely S, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1642; Kolbe M, 2020, BMJ SIMUL TECHNOL EN, V6, P164, DOI 10.1136/bmjstel-2019-000470; Kolbe Michaela, 2016, Adv Simul (Lond), V1, P29, DOI 10.1186/s41077-016-0029-7; Kolbe M, 2015, BEST PRACT RES-CLIN, V29, P87, DOI 10.1016/j.bpa.2015.01.002; Kolbe M, 2013, BMJ QUAL SAF, V22, P541, DOI 10.1136/bmjqs-2012-000917; Leong KBMSL, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018367; Levett-Jones Tracy, 2014, Nurse Educ Today, V34, pe58, DOI 10.1016/j.nedt.2013.09.020; Lown BA, 2010, ACAD MED, V85, P1073, DOI 10.1097/ACM.0b013e3181dbf741; Magyar J, 2010, EMERG MED AUSTRALAS, V22, P499, DOI 10.1111/j.1742-6723.2010.01345.x; Mullan PC, 2014, JAMA-J AM MED ASSOC, V312, P2333, DOI 10.1001/jama.2014.15741; National Health Service, 2021, PSYCH WELLB PRACT; Pelt MV, AANA J, V89, P1; Reiter-Palmon R, 2015, J OCCUP ORGAN PSYCH, V88, P322, DOI 10.1111/joop.12084; Richins MT, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01176; Rick J., 2004, CONSELLING WORK, P2; Rimmer A, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3004; Roberts NP, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006869.pub3; Rock LK., 2020, NEJM CATALYST, DOI [10.1056/CAT.20.0240, DOI 10.1056/CAT.20.0240]; Rose S, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000560; Rudolph Jenny W, 2007, Anesthesiol Clin, V25, P361, DOI 10.1016/j.anclin.2007.03.007; Salas E, 2008, JT COMM J QUAL PATIE, V34, P518, DOI 10.1016/S1553-7250(08)34066-5; Schmutz JB, 2017, ACAD MED, V92, P1555, DOI 10.1097/ACM.0000000000001688; Servotte Jean-Christophe, 2020, Adv Simul (Lond), V5, P32, DOI 10.1186/s41077-020-00150-0; Shalev A, 2017, NEW ENGL J MED, V376, P2459, DOI 10.1056/NEJMra1612499; Smith-Jentsch KA, SMALL GR RES; Snelgrove H, 2018, BMJ SIMUL TECHNOL EN, V4, P45, DOI 10.1136/bmjstel-2017-000281; Sweeney RE, 2020, ACAD MED, V95, P1089, DOI 10.1097/ACM.0000000000002999; Tannenbaum SI, 2021, BMJ QUAL SAF, V30, P59, DOI 10.1136/bmjqs-2020-011447; Tannenbaum SI, 2013, HUM FACTORS, V55, P231, DOI 10.1177/0018720812448394; Tarquinio C, 2016, ISSUES MENT HEALTH N, V37, P787, DOI 10.1080/01612840.2016.1224282; Tavares W, 2020, ACAD MED, V95, P1020, DOI 10.1097/ACM.0000000000002932; Teodorczuk A, 2021, MED EDUC, V55, P1225, DOI 10.1111/medu.14579; Van Overmeire R, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.020344; Vashdi DR, 2013, ACAD MANAGE J, V56, P945, DOI 10.5465/amj.2010.0501; Villado AJ, 2013, J APPL PSYCHOL, V98, P514, DOI 10.1037/a0031510; Vincent C., 2016, SAFER HEALTHCARE STR, DOI [10.1007/978-3-319-25559-0, DOI 10.1007/978-3-319-25559-0]; Weiss M, 2017, EUR J WORK ORGAN PSY, V26, P66, DOI 10.1080/1359432X.2016.1208652; Wesemann U, 2020, DISASTER MED PUBLIC, V14, P168, DOI 10.1017/dmp.2019.60; Wolfe H, 2014, CRIT CARE MED, V42, P1688, DOI 10.1097/CCM.0000000000000327; World Health Organization, 2019, GLOB PRACT ACT REV S; World Health Organization, 2012, PSYCHOL DEBRIEFING P; Zinns LE, 2020, PEDIATR EMERG CARE, V36, P147, DOI 10.1097/PEC.0000000000001111	65	7	7	2	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 13	2021	374								n2042	10.1136/bmj.n2042	http://dx.doi.org/10.1136/bmj.n2042			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UR8KQ	34518169				2022-12-28	WOS:000696991500007
J	Adashi, EY; Rubenstein, DS; Mossman, JA; Schon, EA; Cohen, IG				Adashi, Eli Y.; Rubenstein, Donald S.; Mossman, Jim A.; Schon, Eric A.; Cohen, I. Glenn			Mitochondrial disease: Replace or edit?	SCIENCE			English	Editorial Material							GENOME TRANSFER; GERMLINE; TRANSMISSION		[Adashi, Eli Y.] Brown Univ, Dept Med Sci, Providence, RI 02912 USA; [Rubenstein, Donald S.] Prisma Hlth Upstate, Greenville, SC USA; [Mossman, Jim A.] Aspen Neurosci, San Diego, CA USA; [Schon, Eric A.] Columbia Univ, Dept Neurol, New York, NY USA; [Schon, Eric A.] Columbia Univ, Dept Genet & Dev, New York, NY USA; [Cohen, I. Glenn] Harvard Univ, Harvard Law Sch, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA 02138 USA	Brown University; Greenville Health System; Columbia University; Columbia University; Harvard University	Adashi, EY (corresponding author), Brown Univ, Dept Med Sci, Providence, RI 02912 USA.	eli_adashi@brown.edu		Mossman, Jim/0000-0002-1402-2492				Aushev M, 2020, NATURE, V583, DOI 10.1038/d41586-020-01974-6; Chinnery PF, 2020, NEW ENGL J MED, V382, P1855, DOI 10.1056/NEJMcibr2002015; Cohen IG, 2016, SCIENCE, V353, P545, DOI 10.1126/science.aag2960; Gorman GS, 2015, NEW ENGL J MED, V372, P885, DOI 10.1056/NEJMc1500960; Hyslop LA, 2016, NATURE, V534, P383, DOI [10.1038/nature18303, 10.1038/nature183030]; Ma H, 2021, HUM REPROD, V36, P493, DOI 10.1093/humrep/deaa308; Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4; Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800; Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; Wallace DC, 2018, NAT GENET, V50, P1642, DOI 10.1038/s41588-018-0264-z; Wang T, 2014, CELL, V157, P1591, DOI 10.1016/j.cell.2014.04.042; Yamada M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21165880; Zhang J, 2017, REPROD BIOMED ONLINE, V34, P361, DOI 10.1016/j.rbmo.2017.01.013; Zuccaro MV, 2020, CELL, V183, P1650, DOI 10.1016/j.cell.2020.10.025	15	2	2	5	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2021	373	6560					1200	1201		10.1126/science.abg0491	http://dx.doi.org/10.1126/science.abg0491			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UP5RB	34516801				2022-12-28	WOS:000695436000015
J	Smith, JB				Smith, Jessica B.			Convective hydration of the stratosphere	SCIENCE			English	Editorial Material							WATER-VAPOR		[Smith, Jessica B.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	Harvard University	Smith, JB (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA.	jsmith@huarp.harvard.edu						Anderson JG, 2012, SCIENCE, V337, P835, DOI 10.1126/science.1222978; Bedka K, 2018, WEATHER FORECAST, V33, P1159, DOI 10.1175/WAF-D-18-0040.1; Cooney JW, 2018, J GEOPHYS RES-ATMOS, V123, P329, DOI 10.1002/2017JD027718; Frey W, 2015, ATMOS CHEM PHYS, V15, P6467, DOI 10.5194/acp-15-6467-2015; Hanisco TF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027899; Held IM, 2000, ANNU REV ENERG ENV, V25, P441, DOI 10.1146/annurev.energy.25.1.441; Homeyer CR, 2017, J ATMOS SCI, V74, P1617, DOI 10.1175/JAS-D-16-0269.1; Muller R, 2016, EARTHS FUTURE, V4, P25, DOI 10.1002/2015EF000321; Mullendore GL, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005059; O'Neill ME, 2021, SCIENCE, V373, P1248, DOI 10.1126/science.abh3857; Smith JB, 2017, J GEOPHYS RES-ATMOS, V122, P9529, DOI 10.1002/2017JD026831; Solomon S, 2010, SCIENCE, V327, P1219, DOI 10.1126/science.1182488; Trapp RJ, 2007, P NATL ACAD SCI USA, V104, P19719, DOI 10.1073/pnas.0705494104; Van Klooster SL, 2009, J CLIMATE, V22, P3317, DOI 10.1175/2009JCLI2697.1; Wang PK, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002581	15	3	3	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2021	373	6560					1194	1195		10.1126/science.abl8740	http://dx.doi.org/10.1126/science.abl8740			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UP5RB	34516802				2022-12-28	WOS:000695436000011
J	Limb, M				Limb, Matt			BMJ Awards 2021: Mental health team of the year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												limb@btinternet.com						University College London, PSYCH STUD	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2021	374								n2154	10.1136/bmj.n2154	http://dx.doi.org/10.1136/bmj.n2154			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UZ3VV	34503969				2022-12-28	WOS:000702137100009
J	Gruenewald, DA				Gruenewald, David Allan			Drifting Over the Horizon Navigating the End-of-Life Journey	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gruenewald, David Allan] Vet Affairs Puget Sound Hlth Care Syst, Geriatr & Extended Care Serv Line, Seattle, WA USA; [Gruenewald, David Allan] Univ Washington, Sch Med, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle	Gruenewald, DA (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, S-182-GEC,1660 S Columbian Way, Seattle, WA 98108 USA.	david.gruenewald@va.gov							0	0	0	2	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2021	326	9					811	812		10.1001/jama.2021.14031	http://dx.doi.org/10.1001/jama.2021.14031			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ7LK	34547083				2022-12-28	WOS:000696242100009
J	Coumou, D				Coumou, Dim			Stratospheric winds trigger cold spells	SCIENCE			English	Editorial Material							ARCTIC AMPLIFICATION		[Coumou, Dim] Vrije Univ Amsterdam, Inst Environm Studies IVM, Amsterdam, Netherlands; [Coumou, Dim] Royal Netherlands Meteorol Inst KNMI, De Bilt, Netherlands	Vrije Universiteit Amsterdam; Royal Netherlands Meteorological Institute	Coumou, D (corresponding author), Vrije Univ Amsterdam, Inst Environm Studies IVM, Amsterdam, Netherlands.; Coumou, D (corresponding author), Royal Netherlands Meteorol Inst KNMI, De Bilt, Netherlands.	d.coumou@vu.nl		Coumou, Dim/0000-0003-2155-8495				Baldwin MP, 2021, REV GEOPHYS, V59, DOI 10.1029/2020RG000708; Cohen J, 2020, NAT CLIM CHANGE, V10, P20, DOI 10.1038/s41558-019-0662-y; Cohen J, 2021, SCIENCE, V372, P1135, DOI 10.1126/science.372.6547.1135; Coumou D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05256-8; Doss-Gollin J, 2021, ENVIRON RES LETT, V16, DOI 10.1088/1748-9326/ac0278; Kretschmer M., 2020, WEATHER CLIM DYN, V1, P715, DOI DOI 10.5194/WCD-1-715-2020; Kretschmer M, 2018, NPJ CLIM ATMOS SCI, V1, DOI 10.1038/s41612-018-0054-4; Reichstein M, 2019, NATURE, V566, P195, DOI 10.1038/s41586-019-0912-1; Runge J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10105-3; Screen JA, 2014, NAT CLIM CHANGE, V4, P577, DOI [10.1038/NCLIMATE2268, 10.1038/nclimate2268]; Shepherd TG, 2016, SCIENCE, V353, P989, DOI 10.1126/science.aag2349; van Oldenborgh GJ, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/ab4867	12	1	1	2	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2021	373	6559					1091	1091		10.1126/science.abl9792	http://dx.doi.org/10.1126/science.abl9792			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UL8QT	34516849				2022-12-28	WOS:000692910300032
J	Pan, QS; Zhang, LX; Feng, R; Lu, QH; An, K; Chuang, AC; Poplawsky, JD; Liaw, PK; Lu, L				Pan, Qingsong; Zhang, Liangxue; Feng, Rui; Lu, Qiuhong; An, Ke; Chuang, Andrew Chihpin; Poplawsky, Jonathan D.; Liaw, Peter K.; Lu, Lei			Gradient cell-structured high-entropy alloy with exceptional strength and ductility	SCIENCE			English	Article							SHORT-RANGE ORDER; DEFORMATION MECHANISM; PLASTICITY; MICROSTRUCTURE; DISLOCATIONS; BOUNDARIES; BEHAVIORS; CRYSTALS; PROFILE	Similar to conventional materials, most multicomponent high-entropy alloys (HEAs) lose ductility as they gain strength. In this study, we controllably introduced gradient nanoscaled dislocation cell structures in a stable single-phase HEA with face-centered cubic structure, thus resulting in enhanced strength without apparent loss of ductility. Upon application of strain, the sample-level structural gradient induces progressive formation of a high density of tiny stacking faults (SFs) and twins, nucleating from abundant low-angle dislocation cells. Furthermore, the SF-induced plasticity and the resultant refined structures, coupled with intensively accumulated dislocations, contribute to plasticity, increased strength, and work hardening. These findings offer a promising paradigm for tailoring properties with gradient dislocation cells at the nanoscale and advance our fundamental understanding of the intrinsic deformation behavior of HEAs.	[Pan, Qingsong; Zhang, Liangxue; Lu, Qiuhong; Lu, Lei] Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, Shenyang 110016, Peoples R China; [Zhang, Liangxue] Univ Sci & Technol China, Sch Mat Sci & Engn, Shenyang 110016, Peoples R China; [Feng, Rui; An, Ke] Oak Ridge Natl Lab, Neutron Scattering Div, Oak Ridge, TN 37831 USA; [Chuang, Andrew Chihpin] Argonne Natl Lab, Adv Photon Source, Lemont, IL 60439 USA; [Poplawsky, Jonathan D.] Oak Ridge Natl Lab, Ctr Nanophases Mat Sci, Oak Ridge, TN 37831 USA; [Liaw, Peter K.] Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA	Chinese Academy of Sciences; Institute of Metal Research, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville	Lu, L (corresponding author), Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, Shenyang 110016, Peoples R China.	llu@imr.ac.cn	An, Ke/G-5226-2011; Poplawsky, Jonathan/Q-2456-2015	An, Ke/0000-0002-6093-429X; Chuang, Chihpin/0000-0003-0295-381X; Liaw, Peter/0000-0003-0185-3411; Zhang, Liangxue/0000-0002-3908-2117; Poplawsky, Jonathan/0000-0002-4272-7043				An K., 2012, VDRIVE DATA REDUCTIO; An K, 2011, METALL MATER TRANS A, V42A, P95, DOI 10.1007/s11661-010-0495-9; Asaro RJ, 2003, PHIL MAG LETT, V83, P733, DOI 10.1080/09500830310001614540; ASHBY MF, 1970, PHILOS MAG, V21, P399, DOI 10.1080/14786437008238426; Bagherifard S, 2009, SURF ENG, V25, P3, DOI 10.1179/026708408X334087; Balogh L, 2006, J APPL PHYS, V100, DOI 10.1063/1.2216195; Cantor B, 2004, MAT SCI ENG A-STRUCT, V375, P213, DOI 10.1016/j.msea.2003.10.257; Chen G, 2019, SCRIPTA MATER, V167, P95, DOI 10.1016/j.scriptamat.2019.04.002; Chen J, 2006, SCRIPTA MATER, V54, P1913, DOI 10.1016/j.scriptamat.2006.02.022; Chen XF, 2021, NATURE, V592, P712, DOI 10.1038/s41586-021-03428-z; Choudhuri D, 2018, MATER CHEM PHYS, V217, P308, DOI 10.1016/j.matchemphys.2018.05.050; De Cooman BC, 2018, ACTA MATER, V142, P283, DOI 10.1016/j.actamat.2017.06.046; Diao HY, 2019, MAT SCI ENG A-STRUCT, V742, P636, DOI 10.1016/j.msea.2018.11.055; Ding J, 2018, P NATL ACAD SCI USA, V115, P8919, DOI 10.1073/pnas.1808660115; Ding QQ, 2019, NATURE, V574, P223, DOI 10.1038/s41586-019-1617-1; Fang TH, 2011, SCIENCE, V331, P1587, DOI 10.1126/science.1200177; FLECK NA, 1994, ACTA METALL MATER, V42, P475, DOI 10.1016/0956-7151(94)90502-9; Gao H, 1999, J MECH PHYS SOLIDS, V47, P1239, DOI 10.1016/S0022-5096(98)00103-3; George EP, 2019, NAT REV MATER, V4, P515, DOI 10.1038/s41578-019-0121-4; Gludovatz B, 2014, SCIENCE, V345, P1153, DOI 10.1126/science.1254581; Guo W, 2019, ACTA MATER, V170, P176, DOI 10.1016/j.actamat.2019.03.024; Guo W, 2016, NANOTECHNOLOGY, V27, DOI 10.1088/0957-4484/27/25/254004; He BB, 2017, SCIENCE, V357, P1029, DOI 10.1126/science.aan0177; Hinds WC, 2022, AEROSOL TECHNOLOGY P, V3; Hirth J. P., 1982, THEORY DISLOCATIONS, V2; Huang HW, 2015, ACTA MATER, V87, P150, DOI 10.1016/j.actamat.2014.12.057; Hughes DA, 2003, SCRIPTA MATER, V48, P147, DOI 10.1016/S1359-6462(02)00358-5; Komarasamy M, 2015, MATER RES LETT, V3, P30, DOI 10.1080/21663831.2014.958586; KRONER E, 1958, Z PHYS, V151, P504, DOI 10.1007/bf01337948; Kubin LP, 2003, SCRIPTA MATER, V48, P119, DOI 10.1016/S1359-6462(02)00335-4; KUHN H., 2000, ASM HDB VOLUME 8 MEC, V10th; Kumar KS, 2003, ACTA MATER, V51, P5743, DOI 10.1016/j.actamat.2003.08.032; Kumar N, 2015, JOM-US, V67, P1007, DOI 10.1007/s11837-015-1385-9; Larson A. C., 1994, LAUR86748 LOS AL NAT, P86; Lee C, 2021, METALL MATER TRANS A, V52, P2033, DOI 10.1007/s11661-021-06197-6; Lee C, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz4748; Lee Y.L., 2005, FATIGUE TESTING ANAL, V13; Li QJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11464-7; Li WD, 2021, PROG MATER SCI, V118, DOI 10.1016/j.pmatsci.2021.100777; Li ZM, 2016, NATURE, V534, P227, DOI 10.1038/nature17981; Lin Y, 2018, ACTA MATER, V153, P279, DOI 10.1016/j.actamat.2018.04.065; Liu XC, 2013, SCIENCE, V342, P337, DOI 10.1126/science.1242578; Long JZ, 2019, ACTA MATER, V166, P56, DOI 10.1016/j.actamat.2018.12.018; Lu K, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.19; Lu K, 2009, SCIENCE, V324, P349, DOI 10.1126/science.1159610; Ma E, 2020, SCRIPTA MATER, V181, P127, DOI 10.1016/j.scriptamat.2020.02.021; Ma E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13311-1; Meyers M.A., 2009, MECH BEHAV MAT, V2; Meyers MA, 2006, PROG MATER SCI, V51, P427, DOI 10.1016/j.pmatsci.2005.08.003; Miller MK, 2007, SURF INTERFACE ANAL, V39, P262, DOI 10.1002/sia.2488; Mughrabi H, 2006, ACTA MATER, V54, P3417, DOI 10.1016/j.actamat.2006.03.047; MUGHRABI H, 1983, ACTA METALL MATER, V31, P1367, DOI 10.1016/0001-6160(83)90007-X; Naeem M, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax4002; Orowan E., 1948, S INTERNAL STRESS ME, P451; Otto F, 2013, ACTA MATER, V61, P5743, DOI 10.1016/j.actamat.2013.06.018; Peralta P., 2014, PHYS METALLURGY, V5th ed., P1765; Ribarik G, 2020, CRYSTALS, V10, DOI 10.3390/cryst10070623; Ribarik G, 2019, J MATER SCI TECHNOL, V35, P1508, DOI 10.1016/j.jmst.2019.01.014; Santodonato LJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06757-2; Sathiyamoorthi P, 2022, PROG MATER SCI, V123, DOI 10.1016/j.pmatsci.2020.100709; Thompson K, 2007, ULTRAMICROSCOPY, V107, P131, DOI 10.1016/j.ultramic.2006.06.008; TREACY MMJ, 1991, P R SOC-MATH PHYS SC, V433, P499, DOI 10.1098/rspa.1991.0062; Ungar T, 1999, J APPL CRYSTALLOGR, V32, P992, DOI 10.1107/S0021889899009334; Viladot D, 2013, J MICROSC-OXFORD, V252, P23, DOI 10.1111/jmi.12065; Wang FL, 2020, SCIENCE, V370, P95, DOI 10.1126/science.aba3722; Wang HT, 2013, SCRIPTA MATER, V68, P22, DOI 10.1016/j.scriptamat.2012.05.041; Wang JJ, 2019, ACTA MATER, V180, P231, DOI 10.1016/j.actamat.2019.09.021; Wang XL, 2006, PHYSICA B, V385, P673, DOI 10.1016/j.physb.2006.06.103; Wang YM, 2018, NAT MATER, V17, P63, DOI [10.1038/NMAT5021, 10.1038/nmat5021]; WARREN BE, 1959, PROG MET PHYS, V8, P147, DOI 10.1016/0502-8205(59)90015-2; Wilkens M., 1970, Physica Status Solidi A, V2, P359, DOI 10.1002/pssa.19700020224; Wu SW, 2017, MATER RES LETT, V5, P276, DOI 10.1080/21663831.2016.1257514; Wu XL, 2015, P NATL ACAD SCI USA, V112, P14501, DOI 10.1073/pnas.1517193112; Xu W, 2018, ACTA MATER, V152, P138, DOI 10.1016/j.actamat.2018.04.014; Xu XD, 2018, ACTA MATER, V144, P107, DOI 10.1016/j.actamat.2017.10.050; Yang J, 2019, J ALLOY COMPD, V795, P269, DOI 10.1016/j.jallcom.2019.04.333; Yang T, 2018, SCIENCE, V362, P933, DOI 10.1126/science.aas8815; Yeh J.W., 2016, HIGH ENTROPY ALLOYS, Vfirst, P51; Yeh JW, 2004, ADV ENG MATER, V6, P299, DOI 10.1002/adem.200300567; Zhang RP, 2020, NATURE, V581, P283, DOI 10.1038/s41586-020-2275-z; Zhang Y, 2014, PROG MATER SCI, V61, P1, DOI 10.1016/j.pmatsci.2013.10.001; Zhu YT, 2021, MATER RES LETT, V9, P1, DOI 10.1080/21663831.2020.1796836	82	105	105	155	492	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2021	374	6570					984	+		10.1126/science.abj8114	http://dx.doi.org/10.1126/science.abj8114			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XA6YJ	34554824	Green Submitted			2022-12-28	WOS:000720789200034
J	Hastie, KM; Li, HY; Bedinger, D; Schendel, SL; Dennison, SM; Li, K; Rayaprolu, V; Yu, XY; Mann, C; Zandonatti, M; Avalos, RD; Zyla, D; Buck, T; Hui, S; Shaffer, K; Hariharan, C; Yin, JY; Olmedillas, E; Enriquez, A; Parekh, D; Abraha, M; Feeney, E; Horn, GQ; Aldon, Y; Ali, H; Aracic, S; Cobb, RR; Federman, RS; Fernandez, JM; Glanville, J; Green, R; Grigoryan, G; Hernandez, AGL; Ho, DD; Huang, KYA; Ingraham, J; Jiang, WD; Kellam, P; Kim, C; Kim, M; Kim, HM; Kong, C; Krebs, SJ; Lan, F; Lang, GJ; Lee, S; Leung, CL; Liu, JL; Lu, YA; MacCamy, A; McGuire, AT; Palser, AL; Rabbitts, TH; Tehrani, ZR; Sajadi, MM; Sanders, RW; Sato, AK; Schweizer, L; Seo, J; Shen, BQ; Snitselaar, JL; Stamatatos, L; Tan, YC; Tomic, MT; van Gils, MJ; Youssef, S; Yu, J; Yuan, TZ; Zhang, Q; Peters, B; Tomaras, GD; Germann, T; Saphire, EO				Hastie, Kathryn M.; Li, Haoyang; Bedinger, Daniel; Schendel, Sharon L.; Dennison, S. Moses; Li, Kan; Rayaprolu, Vamseedhar; Yu, Xiaoying; Mann, Colin; Zandonatti, Michelle; Avalos, Ruben Diaz; Zyla, Dawid; Buck, Tierra; Hui, Sean; Shaffer, Kelly; Hariharan, Chitra; Yin, Jieyun; Olmedillas, Eduardo; Enriquez, Adrian; Parekh, Diptiben; Abraha, Milite; Feeney, Elizabeth; Horn, Gillian Q.; Aldon, Yoann; Ali, Hanif; Aracic, Sanja; Cobb, Ronald R.; Federman, Ross S.; Fernandez, Joseph M.; Glanville, Jacob; Green, Robin; Grigoryan, Gevorg; Hernandez, Ana G. Lujan; Ho, David D.; Huang, Kuan-Ying A.; Ingraham, John; Jiang, Weidong; Kellam, Paul; Kim, Cheolmin; Kim, Minsoo; Kim, Hyeong Mi; Kong, Chao; Krebs, Shelly J.; Lan, Fei; Lang, Guojun; Lee, Sooyoung; Leung, Cheuk Lun; Liu, Junli; Lu, Yanan; MacCamy, Anna; McGuire, Andrew T.; Palser, Anne L.; Rabbitts, Terence H.; Tehrani, Zahra Rikhtegaran; Sajadi, Mohammad M.; Sanders, Rogier W.; Sato, Aaron K.; Schweizer, Liang; Seo, Jimin; Shen, Bingqing; Snitselaar, Jonne L.; Stamatatos, Leonidas; Tan, Yongcong; Tomic, Milan T.; van Gils, Marit J.; Youssef, Sawsan; Yu, Jian; Yuan, Tom Z.; Zhang, Qian; Peters, Bjoern; Tomaras, Georgia D.; Germann, Timothy; Saphire, Erica Ollmann		CoVIC-DB Team	Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study	SCIENCE			English	Article								Antibody-based therapeutics and vaccines are essential to combat COVID-19 morbidity and mortality after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Multiple mutations in SARS-CoV-2 that could impair antibody defenses propagated in human-to-human transmission and spillover or spillback events between humans and animals. To develop prevention and therapeutic strategies, we formed an international consortium to map the epitope landscape on the SARS-CoV-2 spike protein, defining and structurally illustrating seven receptor binding domain (RBD)-directed antibody communities with distinct footprints and competition profiles. Pseudovirion-based neutralization assays reveal spike mutations, individually and clustered together in variants, that affect antibody function among the communities. Key classes of RBD-targeted antibodies maintain neutralization activity against these emerging SARS-CoV-2 variants. These results provide a framework for selecting antibody treatment cocktails and understanding how viral variants might affect antibody therapeutic efficacy.	[Hastie, Kathryn M.; Li, Haoyang; Schendel, Sharon L.; Rayaprolu, Vamseedhar; Yu, Xiaoying; Mann, Colin; Zandonatti, Michelle; Avalos, Ruben Diaz; Zyla, Dawid; Buck, Tierra; Hui, Sean; Shaffer, Kelly; Hariharan, Chitra; Yin, Jieyun; Olmedillas, Eduardo; Enriquez, Adrian; Parekh, Diptiben; Peters, Bjoern; Saphire, Erica Ollmann] La Jolla Inst Immunol, Ctr Infect Dis & Vaccine Res, 9420 Athena Circle, La Jolla, CA 92037 USA; [Bedinger, Daniel; Germann, Timothy] Carterra, 825 N 300 W Ste C309, Salt Lake City, UT 84103 USA; [Dennison, S. Moses; Li, Kan; Abraha, Milite; Feeney, Elizabeth; Horn, Gillian Q.; Tomaras, Georgia D.] Duke Univ, Ctr Human Syst Immunol, Dept Surg, Durham, NC 27701 USA; [Dennison, S. Moses; Li, Kan; Abraha, Milite; Feeney, Elizabeth; Horn, Gillian Q.; Tomaras, Georgia D.] Duke Univ, Dept Immunol, Ctr Human Syst Immunol, Durham, NC 27701 USA; [Dennison, S. Moses; Li, Kan; Abraha, Milite; Feeney, Elizabeth; Horn, Gillian Q.; Tomaras, Georgia D.] Duke Univ, Dept Mol Genet & Microbiol, Ctr Human Syst Immunol, Durham, NC 27701 USA; [Dennison, S. Moses; Li, Kan; Abraha, Milite; Feeney, Elizabeth; Horn, Gillian Q.; Tomaras, Georgia D.] Duke Univ, Duke Human Vaccine Inst, Durham, NC 27701 USA; [Aldon, Yoann; Sanders, Rogier W.; Snitselaar, Jonne L.; van Gils, Marit J.] Univ Amsterdam, Amsterdam Univ Med Ctr, Amsterdam Infect & Immun Inst, Dept Med Microbiol & Infect Prevent,Locat AMC, NL-1105 AZ Amsterdam, Netherlands; [Ali, Hanif; Rabbitts, Terence H.] Quadrucept Bio Ltd, Cambridge CB23 6DW, England; [Aracic, Sanja] Myrio Therapeut Pty Ltd, 1 Dalmore Dr, Scoresby, Vic 3179, Australia; [Cobb, Ronald R.] Natl Resilience Inc, 13200 NW Nano Ct, Alachua, FL 32615 USA; [Federman, Ross S.; Green, Robin; Grigoryan, Gevorg; Ingraham, John; Leung, Cheuk Lun] Generate Biomed Inc, 26 Landsdowne St, Cambridge, MA 02139 USA; [Fernandez, Joseph M.; Lan, Fei; Lu, Yanan] Activemotif Inc, 1914 Palomar Oaks Way,Suite 150, Carlsbad, CA 92008 USA; [Glanville, Jacob; Youssef, Sawsan] Centivax Inc, 201 Gateway Blvd,Floor 1, San Francisco, CA 94080 USA; [Hernandez, Ana G. Lujan; Sato, Aaron K.; Yuan, Tom Z.] Twist Biosci, 681 Gateway Blvd, San Francisco, CA 94080 USA; [Ho, David D.; Yu, Jian] Columbia Univ, Aaron Diamond AIDS Res Ctr, Vagelos Coll Phys & Surg, 701 West 168th St,HHSC 1102, New York, NY 10032 USA; [Huang, Kuan-Ying A.] Chang Gung Univ, Chang Gung Mem Hosp, Dept Pediat, Div Pediat Infect Dis, Taoyuan, Taiwan; [Huang, Kuan-Ying A.] Chang Gung Univ, Res Ctr Emerging Viral Infect, Taoyuan, Taiwan; [Jiang, Weidong; Liu, Junli] Shanghai Henlius Biotech Inc, 9-F,Innov Tower,Zone A,1801 Hongmei Rd, Shanghai, Peoples R China; [Kellam, Paul; Palser, Anne L.] Kymab Ltd, Bennet Bldg,Babraham Res Campus, Cambridge CB22 3AT, England; [Kellam, Paul] Imperial Coll, Dept Infect Dis, London SW7 2AZ, England; [Kim, Cheolmin; Kim, Minsoo; Kim, Hyeong Mi; Lee, Sooyoung; Seo, Jimin] Celltrion Inc, Dept Res & Dev, 23 Acad Ro, Incheon, South Korea; [Kong, Chao; Lang, Guojun; Tan, Yongcong] Sanyou Biopharmaceut Co Ltd, 188 Xinjunhuan Rd,Bldg 6B-C,3rd Floor, Shanghai 201114, Peoples R China; [Krebs, Shelly J.] Walter Reed Army Inst Res, Emerging Infect Dis Branch, Silver Spring, MD 20910 USA; [Lan, Fei] Fudan Univ, Inst Biomed Sci, Shanghai Key Lab Med Epigenet, Int Lab Med Epigenet & Metab, Shanghai, Peoples R China; [Lu, Yanan] AbCipher Biotechnol, 188 Xinjun Ring Rd,Bldg 2,4th Floor, Shanghai 201114, Peoples R China; [MacCamy, Anna; McGuire, Andrew T.; Stamatatos, Leonidas] Fred Hutchinson Canc Res Ctr, Vaccines & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Rabbitts, Terence H.] Inst Canc Res, Ctr Canc Drug Discovery, London SM2 5NG, England; [Tehrani, Zahra Rikhtegaran; Sajadi, Mohammad M.] Univ Maryland, Inst Human Virol, Div Clin Care & Res, Baltimore, MD 21201 USA; [Schweizer, Liang; Shen, Bingqing; Zhang, Qian] HiFiBiO Inc, 237 Putnam Ave, Cambridge, MA 02139 USA; [Tomic, Milan T.] Natl Resilience Inc, 2061 Challenger Dr, Alameda, CA 94501 USA; [Peters, Bjoern; Saphire, Erica Ollmann] Univ Calif San Diego, Dept Med, La Jolla, CA 92037 USA	La Jolla Institute for Immunology; Duke University; Duke University; Duke University; Duke University; University of Amsterdam; Columbia University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Imperial College London; Celltrion; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Fudan University; Fred Hutchinson Cancer Center; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University System of Maryland; University of Maryland Baltimore; University of California System; University of California San Diego	Saphire, EO (corresponding author), La Jolla Inst Immunol, Ctr Infect Dis & Vaccine Res, 9420 Athena Circle, La Jolla, CA 92037 USA.; Saphire, EO (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92037 USA.	erica@lji.org	van Gils, Marit J./H-4791-2019; Rabbitts, Terence/D-6262-2016; Yu, Xiaoying/J-2424-2015	van Gils, Marit J./0000-0003-3422-8161; Hui, Sean/0000-0002-9870-6823; Horn, Gillian/0000-0003-4571-1933; Sekaran, Moses/0000-0003-1198-9179; Bedinger, Daniel/0000-0001-5009-9369; , Mohammad/0000-0001-7798-3605; Zyla, Dawid/0000-0001-8471-469X; Rabbitts, Terence/0000-0002-4982-2609; Shaffer, Kelly C.L./0000-0002-6212-1428; Yu, Xiaoying/0000-0002-6778-5004; mann, Colin/0000-0003-0949-2075; Schendel, Sharon/0000-0002-5062-7261; KIM, MINSOO/0000-0003-4394-6528; Feeney, Elizabeth/0000-0002-4513-8658; LI, HAOYANG/0000-0003-3024-1350	Overton family for this urgent study (Coronavirus Immunotherapeutic Consortium), COVID-19 Therapeutics Accelerator [INV-006133]; Bill and Melinda Gates Foundation [OPP1210938]; GHR Foundation (Coronavirus Immunotherapeutic Consortium); NIH/NIAID [U19 AI142790-S1]; Emergent Ventures at the Mercatus Center, George Mason University; Early Postdoc Mobility Fellowship of the Swiss Translating Duke Health Immunology Initiative	Overton family for this urgent study (Coronavirus Immunotherapeutic Consortium), COVID-19 Therapeutics Accelerator; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); GHR Foundation (Coronavirus Immunotherapeutic Consortium); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Emergent Ventures at the Mercatus Center, George Mason University; Early Postdoc Mobility Fellowship of the Swiss Translating Duke Health Immunology Initiative	We gratefully acknowledge philanthropic support of the Overton family for this urgent study (Coronavirus Immunotherapeutic Consortium), COVID-19 Therapeutics Accelerator INV-006133 (Coronavirus Immunotherapeutic Consortium), Bill and Melinda Gates Foundation OPP1210938 (Coronavirus Immunotherapeutic Consortium), GHR Foundation (Coronavirus Immunotherapeutic Consortium), and NIH/NIAID grant U19 AI142790-S1 (Coronavirus Immunotherapeutic Consortium). We also acknowledge philanthropic support of C. Lee, FastGrants from Emergent Ventures at the Mercatus Center, George Mason University for support of essential instrumentation, and T.S. for support of the Saphire laboratory efforts during the pandemic (E.O.S.); Early Postdoc Mobility Fellowship of the Swiss Translating Duke Health Immunology Initiative (G.T.).	Barnes CO, 2020, NATURE, V588, P682, DOI 10.1038/s41586-020-2852-1; Baum A, 2020, SCIENCE, V370, P1110, DOI 10.1126/science.abe2402; Beasley MD, 2015, BIOTECHNOL J, V10, P783, DOI 10.1002/biot.201400560; Benton DJ, 2020, NATURE, V588, DOI 10.1038/s41586-020-2772-0; Cao YL, 2021, CELL RES, V31, P732, DOI 10.1038/s41422-021-00514-9; CDC, 2021, SARS COV 2 VAR CLASS; CDC, 2021, SCI BRIEF EM SARS CO; Cerutti G, 2021, CELL HOST MICROBE, V29, P819, DOI 10.1016/j.chom.2021.03.005; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen JH, 2020, J MOL BIOL, V432, P5212, DOI 10.1016/j.jmb.2020.07.009; Chi XY, 2020, SCIENCE, V369, P650, DOI 10.1126/science.abc6952; Collins F. S, 2020, THERAPEUTIC NEUTRALI; Greaney AJ, 2021, CELL HOST MICROBE, V29, P44, DOI 10.1016/j.chom.2020.11.007; Hansen J, 2020, SCIENCE, V369, P1010, DOI 10.1126/science.abd0827; Hodcroft E. B., 2021, NATURE, V595, P707; Hsieh CL, 2020, SCIENCE, V369, P1501, DOI 10.1126/science.abd0826; Huo JD, 2020, CELL HOST MICROBE, V28, P445, DOI [10.1016/j.chom.2020.06.010, 10.1016/j.chom.2020.07.002]; Kemp S A, 2020, medRxiv, DOI 10.1101/2020.12.05.20241927; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Li K, 2021, BIOPHYS J, V120, p265A; Liu HJ, 2020, IMMUNITY, V53, P1272, DOI 10.1016/j.immuni.2020.10.023; Liu LH, 2020, NATURE, V584, P450, DOI 10.1038/s41586-020-2571-7; Liu ZM, 2021, CELL HOST MICROBE, V29, P477, DOI 10.1016/j.chom.2021.01.014; McCallum M., 2021, BIORXIV 2021 01 14 4, DOI [10.1101/2021.01.14.426475, DOI 10.1101/2021.01.14.426475]; McCallum M, 2021, SCIENCE, V373, P648, DOI 10.1126/science.abi7994; McCallum M, 2021, CELL, V184, P2332, DOI [10.1016/j.cell.2021.03.028, 10.1101/2021.01.14.426475]; Miller A, 2020, MABS-AUSTIN, V12, DOI 10.1080/19420862.2020.1752529; Munnink BBO, 2021, SCIENCE, V371, P172, DOI 10.1126/science.abe5901; NIH, 2020, CLIN TRIALS MON ANT; Oreshkova N., 2020, EURO SURVEILL, V25; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Piccoli L, 2020, CELL, V183, P1024, DOI 10.1016/j.cell.2020.09.037; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Schaefer W, 2011, P NATL ACAD SCI USA, V108, P11187, DOI 10.1073/pnas.1019002108; Seydoux E, 2020, IMMUNITY, V53, P98, DOI 10.1016/j.immuni.2020.06.001; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sztain T, 2021, NAT CHEM, V13, P963, DOI [10.1038/s41557-021-00758-3, 10.1101/2021.02.15.431212]; Thomson EC, 2021, CELL, V184, P1171, DOI 10.1016/j.cell.2021.01.037; Tomic MT, 2019, TOXINS, V11, DOI 10.3390/toxins11040208; Tortorici MA, 2020, SCIENCE, V370, P950, DOI 10.1126/science.abe3354; van Dorp L., 2020, BIORXIV 2020 11 16 3, DOI [10.1101/2020.11.16.384743, DOI 10.1101/2020.11.16.384743]; Wan JK, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107918; Wang PF, 2021, NATURE, V593, P130, DOI 10.1038/s41586-021-03398-2; Wang Zijun, 2021, Nature, V592, P616, DOI [10.1038/s41586-021-03324-6, 10.1101/2021.01.15.426911]; Wec AZ, 2020, SCIENCE, V369, P731, DOI 10.1126/science.abc7424; Weisblum Y, 2020, ELIFE, V9, DOI 10.7554/eLife.61312; WHO, 2020, COVID 19 DENM; Wu NC, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108274; Yao HP, 2021, CELL RES, V31, P25, DOI 10.1038/s41422-020-00444-y; Yao HP, 2020, CELL, V183, P730, DOI 10.1016/j.cell.2020.09.018; Yuan M, 2021, SCIENCE, V373, P818, DOI 10.1126/science.abh1139; Yuan M, 2020, SCIENCE, V369, P1119, DOI 10.1126/science.abd2321; Zhang C, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20465-w; Zost SJ, 2020, NATURE, V584, P443, DOI 10.1038/s41586-020-2548-6; Zost SJ, 2020, NAT MED, V26, DOI [10.1038/s41591-020-0998-x, 10.1101/2020.05.12.091462]	55	99	101	19	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2021	374	6566					472	+		10.1126/science.abh2315	http://dx.doi.org/10.1126/science.abh2315			54	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WL2OU	34554826	Green Accepted, hybrid			2022-12-28	WOS:000710251800045
J	Cherubini, P				Cherubini, Paolo			Tree-ring dating of musical instruments	SCIENCE			English	Editorial Material							VIOLINS; WOOD		[Cherubini, Paolo] Swiss Fed Inst Forest, Snow & Landscape Res WSL, Dendrosci, Birmensdorf, Switzerland; [Cherubini, Paolo] Univ British Columbia, Dept Forest & Conservat Sci, Fac Forestry, Vancouver, BC, Canada	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of British Columbia	Cherubini, P (corresponding author), Swiss Fed Inst Forest, Snow & Landscape Res WSL, Dendrosci, Birmensdorf, Switzerland.; Cherubini, P (corresponding author), Univ British Columbia, Dept Forest & Conservat Sci, Fac Forestry, Vancouver, BC, Canada.	paolo.cherubini@wsl.ch	Cherubini, Paolo/N-9702-2013	Cherubini, Paolo/0000-0002-9809-250X				Bernabei M, 2017, J CULT HERIT, V27, pS55, DOI 10.1016/j.culher.2016.11.010; Bucur V., 2017, HDB MAT STRING MUSIC; Burckle Lloyd, 2003, Dendrochronologia, V21, P41, DOI 10.1078/1125-7865-00033; Cherubini P, 2021, CURR FOR REP, V7, P69, DOI 10.1007/s40725-021-00137-8; Corona E., 1980, Italia Forestale e Montana, V35, P112; Fritz C, 2017, P NATL ACAD SCI USA, V114, P5395, DOI 10.1073/pnas.1619443114; Grissino-Mayer HD, 2010, DENDROCHRONOLOGIA, V28, P149, DOI 10.1016/j.dendro.2009.09.003; Hill W. E., 1891, HISTORY FAMOUS VIOLI; Invernizzi C, 2021, COATINGS, V11, DOI 10.3390/coatings11010029; Jansen S, 2019, J ENVIRON MANAGE, V233, P308, DOI 10.1016/j.jenvman.2018.11.079; KLEIN P, 1986, HOLZFORSCHUNG, V40, P197, DOI 10.1515/hfsg.1986.40.4.197; Lauw A, 2021, J CULT HERIT, V48, P161, DOI 10.1016/j.culher.2020.11.011; Pollens S., 1999, J VIOLIN SOC AM, V16, P77; Schwarze FWMR, 2008, NEW PHYTOL, V179, P1095, DOI 10.1111/j.1469-8137.2008.02524.x; Tai HC, 2018, P NATL ACAD SCI USA, V115, P5926, DOI 10.1073/pnas.1800666115	15	3	3	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2021	373	6562			SI		1434	1436		10.1126/science.abj3823	http://dx.doi.org/10.1126/science.abj3823			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU7LJ	34554802				2022-12-28	WOS:000698977800026
J	Visscher, PM; Yengo, L; Cox, NJ; Wray, NR				Visscher, Peter M.; Yengo, Loic; Cox, Nancy J.; Wray, Naomi R.			Discovery and implications of polygenicity of common diseases	SCIENCE			English	Review							GENOME-WIDE ASSOCIATION; COMPLEX TRAITS; GENETIC ARCHITECTURE; CROHN-DISEASE; PREDICTION; RISK; HERITABILITY; SELECTION; VARIANT	The sequencing of the human genome has allowed the study of the genetic architecture of common diseases: the number of genomic variants that contribute to risk of disease and their joint frequency and effect size distribution. Common diseases are polygenic, with many loci contributing to phenotype, and the cumulative burden of risk alleles determines individual risk in conjunction with environmental factors. Most risk loci occur in noncoding regions of the genome regulating cell- and context-specific gene expression. Although the effect sizes of most risk alleles are small, their cumulative effects in individuals, quantified as a polygenic (risk) score, can identify people at increased risk of disease, thereby facilitating prevention or early intervention.	[Visscher, Peter M.; Yengo, Loic; Wray, Naomi R.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Cox, Nancy J.] Vanderbilt Univ, Vanderbilt Genet Inst, Med Ctr, Nashville, TN 37232 USA; [Cox, Nancy J.] Vanderbilt Univ, Div Genet Med, Med Ctr, Dept Med, Nashville, TN 37232 USA; [Wray, Naomi R.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia	University of Queensland; Vanderbilt University; Vanderbilt University; University of Queensland	Visscher, PM (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	peter.visscher@uq.edu.au	Visscher, Peter/ABB-6151-2020; Yengo, Loic/D-2692-2017; Wray, Naomi/C-8639-2015	Visscher, Peter/0000-0002-2143-8760; Yengo, Loic/0000-0002-4272-9305; Wray, Naomi/0000-0001-7421-3357	Australian Research Council [FL180100072, DE200100425]; Australian National Health and Medical Research Council [1113400, 1173790]; National Institutes of Health [U01HG0090086, U54MD010722, R01MH113362]	Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the Australian Research Council (grants FL180100072 and DE200100425), the Australian National Health and Medical Research Council (grants 1113400 and 1173790), and the National Institutes of Health (grants U01HG0090086, U54MD010722, and R01MH113362).	Abdellaoui A, 2019, NAT HUM BEHAV, V3, P1332, DOI 10.1038/s41562-019-0757-5; Becker J., 2021, NAT HUM BEHAV, DOI DOI 10.1038/s41562-021-01119-3; Boyle EA, 2017, CELL, V169, P1177, DOI 10.1016/j.cell.2017.05.038; Canela-Xandri O, 2018, NAT GENET, V50, P1593, DOI 10.1038/s41588-018-0248-z; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Craig JE, 2020, NAT GENET, V52, P160, DOI 10.1038/s41588-019-0556-y; Davies NM, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k601; Eales JM, 2021, NAT GENET, V53, P630, DOI 10.1038/s41588-021-00835-w; Eyre-Walker A, 2010, P NATL ACAD SCI USA, V107, P1752, DOI 10.1073/pnas.0906182107; Fahed AC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17374-3; Field Y, 2016, SCIENCE, V354, P760, DOI 10.1126/science.aag0776; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642; Gandal MJ, 2016, NAT NEUROSCI, V19, P1397, DOI 10.1038/nn.4409; Gazal S, 2018, NAT GENET, V50, P1600, DOI 10.1038/s41588-018-0231-8; Ge T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09718-5; Gonzalez-Serrano LE, 2019, J BIOL CHEM, V294, P5309, DOI 10.1074/jbc.REV118.002953; Graham DB, 2020, NATURE, V578, P527, DOI 10.1038/s41586-020-2025-2; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Harden KP, 2020, NAT HUM BEHAV, V4, P567, DOI 10.1038/s41562-020-0862-5; Haworth S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08219-1; Ho JWK, 2014, NATURE, V512, P449, DOI 10.1038/nature13415; Holland D, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008612; Hyman MC, 2021, HYPERTENSION, V77, P376, DOI 10.1161/HYPERTENSIONAHA.120.16191; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Khera AV, 2018, NAT GENET, V50, P1219, DOI 10.1038/s41588-018-0183-z; Kichaev G, 2019, AM J HUM GENET, V104, P65, DOI 10.1016/j.ajhg.2018.11.008; Kim S, 2007, ANNU REV BIOMED ENG, V9, P289, DOI 10.1146/annurev.bioeng.9.060906.152037; Kong A, 2018, SCIENCE, V359, P424, DOI 10.1126/science.aan6877; Kuchenbaecker KB, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw302; Lambert SA, 2021, NAT GENET, V53, P420, DOI 10.1038/s41588-021-00783-5; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lappalainen T., 2021, SCIENCE; Lecarpentier J, 2017, J CLIN ONCOL, V35, P2240, DOI 10.1200/JCO.2016.69.4935; Lee JM, 2019, CELL, V178, P887, DOI 10.1016/j.cell.2019.06.036; Lloyd-Jones LR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12653-0; Martin AR, 2019, NAT GENET, V51, P584, DOI 10.1038/s41588-019-0379-x; Mavaddat N, 2019, AM J HUM GENET, V104, P21, DOI 10.1016/j.ajhg.2018.11.002; McCarthy MI, 2017, DIABETOLOGIA, V60, P793, DOI 10.1007/s00125-017-4210-x; Niemi MEK, 2018, NATURE, V562, P268, DOI 10.1038/s41586-018-0566-4; O'Connor LJ, 2019, AM J HUM GENET, V105, P456, DOI 10.1016/j.ajhg.2019.07.003; Pasaniuc B, 2017, NAT REV GENET, V18, P117, DOI 10.1038/nrg.2016.142; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Schoech AP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08424-6; Sinnott-Armstrong N, 2021, ELIFE, V10, DOI 10.7554/eLife.58615; Sissler M, 2017, TRENDS MOL MED, V23, P693, DOI 10.1016/j.molmed.2017.06.002; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Speed D, 2017, NAT GENET, V49, P986, DOI 10.1038/ng.3865; Speidel L, 2019, NAT GENET, V51, P1321, DOI 10.1038/s41588-019-0484-x; Stern AJ, 2021, AM J HUM GENET, V108, P219, DOI 10.1016/j.ajhg.2020.12.005; Sweeney G, 1998, MOL CELL BIOCHEM, V182, P121, DOI 10.1023/A:1006805510749; Turley P, 2021, NEW ENGL J MED, V385, P78, DOI 10.1056/NEJMsr2105065; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Visscher PM, 2017, AM J HUM GENET, V101, P5, DOI 10.1016/j.ajhg.2017.06.005; Wray NR, 2019, GENETICS, V211, P1131, DOI 10.1534/genetics.119.301859; Yang JA, 2010, EUR J HUM GENET, V18, P1039, DOI 10.1038/ejhg.2009.177; Zeng J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21446-3; Zhang Q, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18534-1; Zhang Y, 2018, NAT GENET, V50, P1318, DOI 10.1038/s41588-018-0193-x; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	62	20	20	3	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2021	373	6562			SI		1468	1473		10.1126/science.abi8206	http://dx.doi.org/10.1126/science.abi8206			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU7LJ	34554790				2022-12-28	WOS:000698977800042
J	Zhu, ZC; Zeng, H; Myneni, RB; Chen, C; Zhao, Q; Zha, JJ; Zhan, SM; MacLachlan, I				Zhu, Zaichun; Zeng, Hui; Myneni, Ranga B.; Chen, Chi; Zhao, Qian; Zha, Junjun; Zhan, Simin; MacLachlan, Ian			Comment on "Recent global decline of CO2 fertilization effects on vegetation photosynthesis" COMMENT	SCIENCE			English	Editorial Material								Wang et al. (Research Articles, 11 December 2020, p. 1295) reported a large decrease in CO2 fertilization effect (CFE) across the globe during the period 1982-2015 and suggested that ecosystem models underestimate the rate of CFE decline. We find that their claims are artifacts of incorrect processing of satellite data and problematic methods for deriving and comparing CFE between satellite data and model simulations.	[Zhu, Zaichun; Zeng, Hui; Zhao, Qian; Zha, Junjun; Zhan, Simin; MacLachlan, Ian] Peking Univ, Shenzhen Grad Sch, Shenzhen 518055, Guangdong, Peoples R China; [Myneni, Ranga B.] Boston Univ, Dept Earth & Environm, Boston, MA 02215 USA; [Chen, Chi] Lawrence Berkeley Natl Lab, Dept Earth & Environm Sci, Berkeley, CA 94720 USA; [Chen, Chi] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	Peking University; University Town of Shenzhen; Boston University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Zhu, ZC (corresponding author), Peking Univ, Shenzhen Grad Sch, Shenzhen 518055, Guangdong, Peoples R China.	zhu.zaichun@pku.edu.cn	Zhu, Zaichun/ABD-2040-2021; Zhu, Zaichun/I-5374-2014; MacLachlan, Ian R/J-1839-2012; Myneni, Ranga B./AAU-6088-2021; Chen, Chi/AAS-8977-2020	Zhu, Zaichun/0000-0001-5235-5194; Zhu, Zaichun/0000-0001-5235-5194; MacLachlan, Ian R/0000-0002-8584-4063; Chen, Chi/0000-0002-8079-4079	National Natural Science Foundation of China [41901122]; NASA Earth Science Division; US Department of Energy Office of Science Biological and Environmental Research, Reducing Uncertainties in Biogeochemical Interactions through Synthesis and Computation Scientific Focus Area	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NASA Earth Science Division; US Department of Energy Office of Science Biological and Environmental Research, Reducing Uncertainties in Biogeochemical Interactions through Synthesis and Computation Scientific Focus Area	Supported by the National Natural Science Foundation of China (41901122). R.B.M. acknowledges with gratitude funding by NASA Earth Science Division. C.C. is supported by the US Department of Energy Office of Science Biological and Environmental Research, Reducing Uncertainties in Biogeochemical Interactions through Synthesis and Computation Scientific Focus Area.	Badgley G, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602244; Chen C, 2019, NAT SUSTAIN, V2, P122, DOI 10.1038/s41893-019-0220-7; Jiang CY, 2017, GLOBAL CHANGE BIOL, V23, P4133, DOI 10.1111/gcb.13787; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Liu Y, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG002084; Piao SL, 2020, NAT REV EARTH ENV, V1, P14, DOI 10.1038/s43017-019-0001-x; Verger A, 2014, IEEE J-STARS, V7, P3473, DOI 10.1109/JSTARS.2014.2328632; Wang SH, 2020, SCIENCE, V370, P1295, DOI 10.1126/science.abb7772; Xiao ZQ, 2016, IEEE T GEOSCI REMOTE, V54, P5301, DOI 10.1109/TGRS.2016.2560522; Yan K, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8050359; Zhu ZC, 2013, REMOTE SENS-BASEL, V5, P927, DOI 10.3390/rs5020927	11	6	7	20	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2021	373	6562			SI				abg5673	10.1126/science.abg5673	http://dx.doi.org/10.1126/science.abg5673			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU7LJ	34554772	Green Submitted			2022-12-28	WOS:000698977800003
J	Allaway, KC; Gabitto, MI; Wapinski, O; Saldi, G; Wang, CY; Bandler, RC; Wu, SJ; Bonneau, R; Fishell, G				Allaway, Kathryn C.; Gabitto, Mariano I.; Wapinski, Orly; Saldi, Giuseppe; Wang, Chen-Yu; Bandler, Rachel C.; Wu, Sherry Jingjing; Bonneau, Richard; Fishell, Gord			Genetic and epigenetic coordination of cortical interneuron development	NATURE			English	Article							GABAERGIC INTERNEURONS; DIVERSITY; NOMENCLATURE; CHROMATIN; FATE; SOX6; RNA	One of the hallmarks of the cerebral cortex is the extreme diversity of interneurons(1-3). The two largest subtypes of cortical interneurons, parvalbumin- and somatostatin-positive cells, are morphologically and functionally distinct in adulthood but arise from common lineages within the medial ganglionic eminence(4-11). This makes them an attractive model for studying the generation of cell diversity. Here we examine how developmental changes in transcription and chromatin structure enable these cells to acquire distinct identities in the mouse cortex. Generic interneuron features are first detected upon cell cycle exit through the opening of chromatin at distal elements. By constructing cell-type-specific gene regulatory networks, we observed that parvalbumin- and somatostatin-positive cells initiate distinct programs upon settling within the cortex. We used these networks to model the differential transcriptional requirement of a shared regulator, Mef2c, and confirmed the accuracy of our predictions through experimental loss-of-function experiments. We therefore reveal how a common molecular program diverges to enable these neuronal subtypes to acquire highly specialized properties by adulthood. Our methods provide a framework for examining the emergence of cellular diversity, as well as for quantifying and predicting the effect of candidate genes on cell-type-specific development.	[Allaway, Kathryn C.; Bandler, Rachel C.] NYU, Inst Neurosci, New York, NY USA; [Allaway, Kathryn C.; Saldi, Giuseppe; Wang, Chen-Yu; Bandler, Rachel C.; Wu, Sherry Jingjing; Fishell, Gord] Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA; [Allaway, Kathryn C.; Wapinski, Orly; Saldi, Giuseppe; Wang, Chen-Yu; Bandler, Rachel C.; Wu, Sherry Jingjing; Fishell, Gord] Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Gabitto, Mariano I.; Bonneau, Richard] Simons Fdn, Flatiron Inst, Ctr Computat Biol, New York, NY 10010 USA; [Saldi, Giuseppe; Bonneau, Richard] NYU, Dept Biol, New York, NY 10003 USA; [Bonneau, Richard] NYU, Ctr Data Sci, New York, NY 10011 USA	New York University; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; New York University; New York University	Fishell, G (corresponding author), Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA.; Fishell, G (corresponding author), Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA.; Bonneau, R (corresponding author), Simons Fdn, Flatiron Inst, Ctr Computat Biol, New York, NY 10010 USA.; Bonneau, R (corresponding author), NYU, Dept Biol, New York, NY 10003 USA.; Bonneau, R (corresponding author), NYU, Ctr Data Sci, New York, NY 10011 USA.	rbonneau@flatironinstitute.org; Gordon_Fishell@hms.harvard.edu	Bonneau, Richard/GZL-2900-2022; Bonneau, Richard/ABD-6737-2021	Saldi, Giuseppe-Antonio/0000-0002-9994-7354; Fishell, Gordon/0000-0002-9640-9278; Wang, Chen-Yu/0000-0002-3912-5113; Bonneau, Richard/0000-0003-4354-7906	National Institutes of Health (NIH) [1UG3MH120096-01, 5R01MH071679-15, F31NS103398, R01DK103358, R35GM122515, R01AI130945]; Simons Foundation; NSF-IOS [1546218]; NSF-CBET [1728858]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; NSF-IOS(National Science Foundation (NSF)); NSF-CBET(National Science Foundation (NSF))	We thank J. Dimidschstein, E. Favuzzi, D. Ginty, E. Macosko and E. Miraldi for feedback and discussion; N. Yusuf and M. Fernandez-Otero for technical assistance; R. Batista-Brito for providing mice for the Mef2c loss-of-function experiments; and C. Davis for sharing the CUT&RUN protocol and reagents. G.F. and K.C.A. acknowledge support from the following sources: National Institutes of Health (NIH) 1UG3MH120096-01 (G.F.), NIH 5R01MH071679-15 (G.F.) and NIH F31NS103398 (K.C.A.). R.B. and M.I.G. acknowledge support from the following sources: NIH R01DK103358, Simons Foundation, NSF-IOS 1546218, NIH R35GM122515, NSF-CBET 1728858 and NIH R01AI130945.	Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Au E, 2013, NEURON, V80, P1145, DOI 10.1016/j.neuron.2013.09.022; Azim E, 2009, NAT NEUROSCI, V12, P1238, DOI 10.1038/nn.2387; Barkas N, 2019, NAT METHODS, V16, P695, DOI 10.1038/s41592-019-0466-z; Batista-Brito R, 2009, NEURON, V63, P466, DOI 10.1016/j.neuron.2009.08.005; Batista-Brito R, 2009, CURR TOP DEV BIOL, V87, P81, DOI 10.1016/S0070-2153(09)01203-4; Castro DM, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006591; Cosgrove D, 2021, HUM MOL GENET, V30, P961, DOI 10.1093/hmg/ddaa213; DeFelipe J, 2013, NAT REV NEUROSCI, V14, P202, DOI 10.1038/nrn3444; Fang RX, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21583-9; Fogarty M, 2007, J NEUROSCI, V27, P10935, DOI 10.1523/JNEUROSCI.1629-07.2007; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Gabitto MI, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14497-5; Harrington AJ, 2016, ELIFE, V5, DOI 10.7554/eLife.20059; Harwell CC, 2015, NEURON, V87, P999, DOI 10.1016/j.neuron.2015.07.030; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; Ladstatter S, 2019, J CELL BIOL, V218, P70, DOI 10.1083/jcb.201807044; Liu N, 2018, CELL, V173, P430, DOI 10.1016/j.cell.2018.03.016; Ma S, 2020, CELL, V183, P1103, DOI 10.1016/j.cell.2020.09.056; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mayer C, 2018, NATURE, V555, P457, DOI 10.1038/nature25999; Mayer C, 2015, NEURON, V87, P989, DOI 10.1016/j.neuron.2015.07.011; Mi D, 2018, SCIENCE, V360, P81, DOI 10.1126/science.aar6821; Miyoshi G, 2011, CEREB CORTEX, V21, P845, DOI 10.1093/cercor/bhq155; Mo A, 2015, NEURON, V86, P1369, DOI 10.1016/j.neuron.2015.05.018; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Pai ELL, 2020, ELIFE, V9, DOI 10.7554/eLife.54903; Pai ELL, 2019, CELL REP, V26, P1157, DOI 10.1016/j.celrep.2019.01.031; Pliner H., 2017, CHROMATIN ACCESSIBIL; Preissl S, 2018, NAT NEUROSCI, V21, P432, DOI 10.1038/s41593-018-0079-3; Setty M, 2019, NAT BIOTECHNOL, V37, P451, DOI 10.1038/s41587-019-0068-4; Sinnamon JR, 2019, GENOME RES, V29, P857, DOI 10.1101/gr.243725.118; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Stroud H, 2020, NEURON, V107, P874, DOI 10.1016/j.neuron.2020.06.008; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Tirosh I, 2016, NATURE, V539, P309, DOI 10.1038/nature20123; Tremblay R, 2016, NEURON, V91, P260, DOI 10.1016/j.neuron.2016.06.033; Vong LH, 2005, GENESIS, V43, P43, DOI 10.1002/gene.20152; Wang YL, 2010, J NEUROSCI, V30, P5334, DOI 10.1523/JNEUROSCI.5963-09.2010; Wonders CP, 2008, DEV BIOL, V314, P127, DOI 10.1016/j.ydbio.2007.11.018; Yadav T, 2018, SCIENCE, V361, P1332, DOI 10.1126/science.aat8950; Zhu Q, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1802-4	43	15	15	4	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 30	2021	597	7878					693	+		10.1038/s41586-021-03933-1	http://dx.doi.org/10.1038/s41586-021-03933-1		SEP 2021	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UZ1UN	34552240	Green Accepted			2022-12-28	WOS:000698366900001
J	Dawoud, D; Naci, H; Ciani, O; Bujkiewicz, S				Dawoud, Dalia; Naci, Huseyin; Ciani, Oriana; Bujkiewicz, Sylwia			Raising the bar for using surrogate endpoints in drug regulation and health technology assessment	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DISEASE-FREE SURVIVAL; RANDOMIZED CONTROLLED-TRIALS; PROGRESSION-FREE SURVIVAL; CLINICAL-TRIALS; US FOOD; FDA APPROVAL; OUTCOMES; METAANALYSIS; VALIDATION; STRENGTH		[Dawoud, Dalia] Natl Inst Hlth & Care Excellence, Sci Policy & Res Programme, Sci Evidence & Analyt Directorate, London, England; [Naci, Huseyin] London Sch Econ & Polit Sci, Dept Hlth Policy, London, England; [Ciani, Oriana] SDA Bocconi, Ctr Res Hlth & Social Care Management, Milan, Italy; [Ciani, Oriana] Univ Exeter, Coll Med & Hlth, Exeter, Devon, England; [Bujkiewicz, Sylwia] Univ Leicester, Dept Hlth Sci, Biostat Res Grp, Leicester, Leics, England	National Institute for Health & Care Excellence; University of London; London School Economics & Political Science; Bocconi University; University of Exeter; University of Leicester	Naci, H (corresponding author), London Sch Econ & Polit Sci, Dept Hlth Policy, London, England.	H.Naci@lse.ac.uk	CIANI, ORIANA/D-1455-2015	CIANI, ORIANA/0000-0002-3607-0508	European Union's IMI and Horizon 2020 research and innovation programme; Medical Research Council; European Union's Horizon 2020 research and innovation programme	European Union's IMI and Horizon 2020 research and innovation programme; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union's Horizon 2020 research and innovation programme	DD is an employee of NICE, funded by grants from the European Union's IMI and Horizon 2020 research and innovation programme. SB has served as a paid consultant providing methodological advice to NICE, Roche and RTI Health Solutions. SB was supported by the Medical Research Council through the methodology research panel grants and has previously received research funding from European Federation of Pharmaceutical Industries & Associations (EFPIA) as part of unrelated European Union IMI GetReal project. HN previously received funding from the Pharmaceutical Group of the European Union for an unrelated systematic review on community pharmacists. HN currently receives funding from the Health Foundation on an unrelated project on pharmaceutical policy. OC received funding from the European Union's Horizon 2020 research and innovation programme. The views expressed in this article are those of the authors and do not necessarily reflect those of their employers or funders.	Abdel-Rahman O, 2018, IMMUNOTHERAPY-UK, V10, P139, DOI 10.2217/imt-2017-0115; Ackley SF, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n156; Alexander GC, 2021, JAMA-J AM MED ASSOC, V325, P1717, DOI 10.1001/jama.2021.3854; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bruce CS, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002873; Bujkiewicz S., 2019, NICE DSU TECHNICAL S; Bujkiewicz S, 2019, STAT MED, V38, P3322, DOI 10.1002/sim.8187; Bujkiewicz S, 2017, STAT METHODS MED RES, V26, P2287, DOI 10.1177/0962280215597260; Bujkiewicz S, 2016, STAT MED, V35, P1063, DOI 10.1002/sim.6776; Burzykowski T, 2001, J R STAT SOC C-APPL, V50, P405, DOI 10.1111/1467-9876.00244; Burzykowski T, 2010, EVALUATION SURROGATE, DOI [10.1007/b138566#about, DOI 10.1007/B138566#ABOUT]; Burzykowski T, 2008, J CLIN ONCOL, V26, P1987, DOI 10.1200/JCO.2007.10.8407; Buyse M, 2000, Biostatistics, V1, P49, DOI 10.1093/biostatistics/1.1.49; Buyse M, 2007, J CLIN ONCOL, V25, P5218, DOI 10.1200/JCO.2007.11.8836; Carpenter D, 2011, NEW ENGL J MED, V365, DOI [10.1056/NEJMp1107201, 10.1056/nejmp1107201]; Chang CY, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2031055; Chen EY, 2019, JAMA INTERN MED, V179, P642, DOI 10.1001/jamainternmed.2018.8351; Ciani O, 2021, MED DECIS MAKING, V41, P439, DOI 10.1177/0272989X21994553; Ciani O, 2016, NAT REV DRUG DISCOV, V15, DOI 10.1038/nrd.2016.81; Ciani O, 2015, J CLIN EPIDEMIOL, V68, P833, DOI 10.1016/j.jclinepi.2015.02.016; Ciani O, 2014, INT J TECHNOL ASSESS, V30, P312, DOI 10.1017/S0266462314000300; Daniels MJ, 1997, STAT MED, V16, P1965, DOI 10.1002/(SICI)1097-0258(19970915)16:17<1965::AID-SIM630>3.3.CO;2-D; Darrow JJ, 2020, JAMA-J AM MED ASSOC, V323, P164, DOI 10.1001/jama.2019.20288; Darrow JJ, 2015, NEW ENGL J MED, V372, P279, DOI 10.1056/NEJMhle1409465; Downing NS, 2014, JAMA-J AM MED ASSOC, V311, P368, DOI 10.1001/jama.2013.282034; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Garrido MV, 2009, INT J TECHNOL ASSESS, V25, P315, DOI 10.1017/S0266462309990213; Grigore B, 2020, PHARMACOECONOMICS, V38, P1055, DOI 10.1007/s40273-020-00935-1; Gyawali B, 2020, ECLINICALMEDICINE, V21, DOI 10.1016/j.eclinm.2020.100332; Gyawali B, 2019, JAMA INTERN MED, V179, P906, DOI 10.1001/jamainternmed.2019.0462; Harshman LC, 2018, CANCER-AM CANCER SOC, V124, P925, DOI 10.1002/cncr.31154; Haslam A, 2019, EUR J CANCER, V106, P196, DOI 10.1016/j.ejca.2018.11.012; Hughes MD, 1998, AIDS, V12, P1823, DOI 10.1097/00002030-199814000-00014; Hwang TJ, 2017, CLIN PHARMACOL THER, V102, P290, DOI 10.1002/cpt.705; Hwang TJ, 2019, INT J CANCER, V144, P1746, DOI 10.1002/ijc.31957; ICER, 2021, AD ALZH DIS FIN POL; Inker LA, 2016, AM J KIDNEY DIS, V68, P392, DOI 10.1053/j.ajkd.2016.02.042; Institut fur Qualitat und Wirtschaftlichkeit im Gesundheitswesen (IQWiG), 2011, AUSS SURR ONK; Institute of Medicine (US) Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease, 2010, EVALUATION BIOMARKER; Joffe MM, 2009, BIOMETRICS, V65, P530, DOI 10.1111/j.1541-0420.2008.01106.x; Kim C, 2016, MAYO CLIN PROC, V91, P713, DOI 10.1016/j.mayocp.2016.02.012; Kovic B, 2018, JAMA INTERN MED, V178, P1586, DOI 10.1001/jamainternmed.2018.4710; Kumar S, 2019, LANCET, V394, P281, DOI 10.1016/S0140-6736(19)31711-8; Medicines and Healthcare Products Regulatory Agency, 2021, INN LIC ACC PATHW; Naci H, 2017, JAMA-J AM MED ASSOC, V318, P626, DOI 10.1001/jama.2017.9415; National Institute for Health and Care Excellence, 2020, CHTE METH REV SOURC; National Institute for Health and Care Excellence, 2020, NICE METH HLTH TECHN; Neez E, 2020, CLIN PHARMACOL THER, V107, P541, DOI 10.1002/cpt.1669; Oba K, 2013, JNCI-J NATL CANCER I, V105, P1600, DOI 10.1093/jnci/djt270; Papanikos T, 2020, STAT MED, V39, P1103, DOI 10.1002/sim.8465; Petrelli F, 2017, J GASTROINTEST ONCOL, V8, P39, DOI 10.21037/jgo.2016.11.03; Powles T, 2018, LANCET, V391, P748, DOI 10.1016/S0140-6736(17)33297-X; Prasad V, 2015, JAMA INTERN MED, V175, P1389, DOI 10.1001/jamainternmed.2015.2829; Raphael MJ, 2019, JAMA ONCOL, V5, P1779, DOI 10.1001/jamaoncol.2019.3338; Sharma A, 2020, CIRCULATION, V141, P843, DOI 10.1161/CIRCULATIONAHA.119.041022; Sormani MP, 2010, NEUROLOGY, V75, P302, DOI 10.1212/WNL.0b013e3181ea15aa; Svensson S, 2013, JAMA INTERN MED, V173, P611, DOI 10.1001/jamainternmed.2013.3037; Tap WD, 2020, JAMA-J AM MED ASSOC, V323, P1266, DOI 10.1001/jama.2020.1707; Taylor RS, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13080; US Food & Drug Administration, 2021, TABL SURR ENDP BAS D; Wallach JD, 2018, CLIN TRIALS, V15, P219, DOI 10.1177/1740774518770648; Welton N, 2020, CHTE2020 SOURCES SYN; Xie WL, 2020, J CLIN ONCOL, V38, P3032, DOI 10.1200/JCO.19.03114; Yudkin JS, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7995; Zhang AD, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3284	65	13	13	3	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2021	374								n2191	10.1136/bmj.n2191	http://dx.doi.org/10.1136/bmj.n2191			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UR9HH	34526320	Green Accepted			2022-12-28	WOS:000697050400003
J	Dyer, O				Dyer, Owen			Covid-19: Unvaccinated face 11 times risk of death from delta variant, CDC data show	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Bajema KL, 2021, MMWR-MORBID MORTAL W, V70, P1294, DOI 10.15585/mmwr.mm7037e3; Grannis SJ, MORBIDITY MORTALITY; Puranik Arjun, 2021, medRxiv, DOI 10.1101/2021.08.06.21261707; Scobie HM, 2021, MMWR-MORBID MORTAL W	4	21	21	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2021	374								n2282	10.1136/bmj.n2282	http://dx.doi.org/10.1136/bmj.n2282			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WI4KS	34531181	Bronze			2022-12-28	WOS:000708331800003
J	Radwany, S				Radwany, Steven			Our Best Judgment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Radwany, Steven] Ohio State Univ, Wexner Med Ctr, Div Palliat Med, 1581 Dodd Dr,McCampbell Hall,Fifth Floor, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Radwany, S (corresponding author), Ohio State Univ, Wexner Med Ctr, Div Palliat Med, 1581 Dodd Dr,McCampbell Hall,Fifth Floor, Columbus, OH 43210 USA.	steven.radwany@osumc.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 12	2021	326	14					1373	1374		10.1001/jama.2021.16348	http://dx.doi.org/10.1001/jama.2021.16348		SEP 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WH8VN	34529008	Bronze			2022-12-28	WOS:000696615500001
J	Tebas, P; Roberts, CC; Muthumani, K; Reuschel, EL; Kudchodkar, SB; Zaidi, FI; White, S; Khan, AS; Racine, T; Choi, H; Boyer, J; Park, YK; Trottier, S; Remigio, C; Krieger, D; Spruill, SE; Bagarazzi, M; Kobinger, GP; Weiner, DB; Maslow, JN				Tebas, Pablo; Roberts, Christine C.; Muthumani, Kar; Reuschel, Emma L.; Kudchodkar, Sagar B.; Zaidi, Faraz, I; White, Scott; Khan, Amir S.; Racine, Trina; Choi, Hyeree; Boyer, Jean; Park, Young K.; Trottier, Sylvie; Remigio, Celine; Krieger, Diane; Spruill, Susan E.; Bagarazzi, Mark; Kobinger, Gary P.; Weiner, David B.; Maslow, Joel N.			Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANSMISSION; ELECTROPORATION; PROTECTION; CHALLENGE; INFECTION; PREGNANCY; OUTBREAK; EFFICACY; MOUSE	DNA Vaccine against ZIKV Infection There are no known specific therapies or vaccines to treat or prevent Zika virus infection. In this report, encouraging data are presented from a phase 1 study of a DNA vaccine against ZIKV infection. Background Although Zika virus (ZIKV) infection is typically self-limiting, other associated complications such as congenital birth defects and the Guillain-Barre syndrome are well described. There are no approved vaccines against ZIKV infection. Methods In this phase 1, open-label clinical trial, we evaluated the safety and immunogenicity of a synthetic, consensus DNA vaccine (GLS-5700) encoding the ZIKV premembrane and envelope proteins in two groups of 20 participants each. The participants received either 1 mg or 2 mg of vaccine intradermally, with each injection followed by electroporation (the use of a pulsed electric field to introduce the DNA sequence into cells) at baseline, 4 weeks, and 12 weeks. Results The median age of the participants was 38 years, and 60% were women; 78% were White and 22% Black; in addition, 30% were Hispanic. At the interim analysis at 14 weeks (i.e., after the third dose of vaccine), no serious adverse events were reported. Local reactions at the vaccination site (e.g., injection-site pain, redness, swelling, and itching) occurred in approximately 50% of the participants. After the third dose of vaccine, binding antibodies (as measured on enzyme-linked immunosorbent assay) were detected in all the participants, with geometric mean titers of 1642 and 2871 in recipients of 1 mg and 2 mg of vaccine, respectively. Neutralizing antibodies developed in 62% of the samples on Vero-cell assay. On neuronal-cell assay, there was 90% inhibition of ZIKV infection in 70% of the serum samples and 50% inhibition in 95% of the samples. The intraperitoneal injection of postvaccination serum protected 103 of 112 IFNAR knockout mice (bred with deletion of genes encoding interferon-alpha and interferon-beta receptors) (92%) that were challenged with a lethal dose of ZIKV-PR209 strain; none of the mice receiving baseline serum survived the challenge. Survival was independent of the neutralization titer. Conclusions In this phase 1, open-label clinical trial, a DNA vaccine elicited anti-ZIKV immune responses. Further studies are needed to better evaluate the safety and efficacy of the vaccine. (Funded by GeneOne Life Science and others; ZIKA-001 ClinicalTrials.gov number, .)	[Tebas, Pablo] Univ Penn, Div Infect Dis, Perelman Sch Med, Philadelphia, PA 19104 USA; [Muthumani, Kar; Reuschel, Emma L.; Kudchodkar, Sagar B.; Zaidi, Faraz, I; Choi, Hyeree; Weiner, David B.] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA; [White, Scott; Khan, Amir S.; Boyer, Jean; Bagarazzi, Mark] Inovio Pharmaceut, Plymouth Meeting, PA USA; [Roberts, Christine C.; Park, Young K.; Remigio, Celine; Spruill, Susan E.; Maslow, Joel N.] GeneOne Life Sci, Seoul, South Korea; [Racine, Trina; Trottier, Sylvie; Kobinger, Gary P.] Univ Laval, Infect Dis Res Ctr, Quebec City, PQ, Canada; [Krieger, Diane] QPS Miami Res Associates, Miami, FL USA; [Maslow, Joel N.] Morristown Med Ctr, Dept Med, Morristown, NJ USA	University of Pennsylvania; Pennsylvania Medicine; The Wistar Institute; Laval University; Atlantic Health System	Tebas, P (corresponding author), Univ Penn, Perelman Sch Med, 3610 Hamilton Walk,502 Johnson Pavil, Philadelphia, PA 19104 USA.	tebas@upenn.edu	Kudchodkar, Sagar/ABB-3493-2021; Muthumani, Kar/AAQ-4939-2020	Muthumani, Kar/0000-0002-6807-2065; Trottier, Sylvie/0000-0002-3986-5146; Roberts, Christine/0000-0003-4359-7946				Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157; Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]; [Anonymous], 2017, WHO UNICEF ZIKA VIRU; Bagarazzi ML, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004414; Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636; Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847; Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI [10.3201/eid2006.140138, 10.3201/eid2011.141380]; D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449; Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; ENDERS G, 1994, LANCET, V343, P1548, DOI 10.1016/S0140-6736(94)92943-2; Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297; FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Hirao LA, 2011, J INFECT DIS, V203, P95, DOI 10.1093/infdis/jiq017; Kalams SA, 2013, J INFECT DIS, V208, P818, DOI 10.1093/infdis/jit236; Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952; Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010; Maslow JN, 2017, VACCINE, V35, P5437, DOI 10.1016/j.vaccine.2017.02.015; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262; Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761; Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21; Muthumani K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7462; Nigro G, 2005, NEW ENGL J MED, V353, P1350, DOI 10.1056/NEJMoa043337; Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428; Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564; Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108; Shedlock DJ, 2013, MOL THER, V21, P1432, DOI 10.1038/mt.2013.61; Trimble CL, 2015, LANCET, V386, P2078, DOI 10.1016/S0140-6736(15)00239-1; Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11; Zhang NN, 2016, HUM VACC IMMUNOTHER, V12, P3107, DOI 10.1080/21645515.2016.1219004	33	14	14	1	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2021	385	12							e35	10.1056/NEJMoa1708120	http://dx.doi.org/10.1056/NEJMoa1708120			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ4IT	34525286	Green Accepted, Bronze			2022-12-28	WOS:000696029600001
J	Falsey, AR; Frenck, RW; Walsh, EE; Kitchin, N; Absalon, J; Gurtman, A; Lockhart, S; Bailey, R; Swanson, KA; Xu, X; Koury, K; Kalina, W; Cooper, D; Zou, J; Xie, XP; Xia, HJ; Tureci, O; Lagkadinou, E; Tompkins, KR; Shi, PY; Jansen, KU; Sahin, U; Dormitzer, PR; Gruber, WC				Falsey, Ann R.; Frenck, Robert W., Jr.; Walsh, Edward E.; Kitchin, Nicholas; Absalon, Judith; Gurtman, Alejandra; Lockhart, Stephen; Bailey, Ruth; Swanson, Kena A.; Xu, Xia; Koury, Kenneth; Kalina, Warren; Cooper, David; Zou, Jing; Xie, Xuping; Xia, Hongjie; Tuereci, Ozlem; Lagkadinou, Eleni; Tompkins, Kristin R.; Shi, Pei-Yong; Jansen, Kathrin U.; Sahin, Ugur; Dormitzer, Philip R.; Gruber, William C.			SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Falsey, Ann R.; Walsh, Edward E.] Univ Rochester, Rochester, NY 14627 USA; [Frenck, Robert W., Jr.] Cincinnati Childrens Hosp, Cincinnati, OH USA; [Kitchin, Nicholas; Lockhart, Stephen; Bailey, Ruth] Pfizer, Vaccine Res & Dev, Hurley, England; [Absalon, Judith; Gurtman, Alejandra; Swanson, Kena A.; Koury, Kenneth; Kalina, Warren; Cooper, David; Tompkins, Kristin R.; Jansen, Kathrin U.; Dormitzer, Philip R.; Gruber, William C.] Pfizer, Vaccine Res & Dev, Pearl River, NY USA; [Xu, Xia] Pfizer, Vaccine Res & Dev, Collegeville, PA USA; [Zou, Jing; Xie, Xuping; Xia, Hongjie; Shi, Pei-Yong] Univ Texas Med Branch, Galveston, TX 77555 USA; [Tuereci, Ozlem; Lagkadinou, Eleni; Sahin, Ugur] BioNTech, Mainz, Germany	University of Rochester; Cincinnati Children's Hospital Medical Center; Pfizer; Pfizer; Pfizer; University of Texas System; University of Texas Medical Branch Galveston; BioNTech SE	Falsey, AR (corresponding author), Univ Rochester, Rochester, NY 14627 USA.			Lockhart, Stephen/0000-0002-0805-2193	Pfizer; BioNTech	Pfizer(Pfizer); BioNTech	Supported by Pfizer and BioNTech.	Centers for Disease Control and Prevention, 2021, COVID DAT TRACK; Galli G, 2009, P NATL ACAD SCI USA, V106, P7962, DOI 10.1073/pnas.0903181106; Liu Yang, 2021, N Engl J Med, DOI 10.1056/NEJMc2102017; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Thomas SJ, 2021, NEW ENGL J MED, V385, P1761, DOI 10.1056/NEJMoa2110345	5	170	172	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 21	2021	385	17					1627	1629		10.1056/NEJMc2113468	http://dx.doi.org/10.1056/NEJMc2113468		SEP 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WJ4XG	34525276	Bronze, Green Published			2022-12-28	WOS:000696036800001
J	Robichaux, JP; Le, XN; Vijayan, RSK; Hicks, JK; Heeke, S; Elamin, YY; Lin, HY; Udagawa, H; Skoulidis, F; Tran, H; Varghese, S; He, JQ; Zhang, FH; Nilsson, MB; Hu, LM; Poteete, A; Rinsurongkawong, W; Zhang, XS; Ren, CH; Liu, XK; Hong, LZ; Zhang, JJ; Diao, LX; Madison, R; Schrock, AB; Saam, J; Raymond, V; Fang, BL; Wang, J; Ha, MJ; Cross, JB; Gray, JE; Heymach, JV				Robichaux, Jacqulyne P.; Le, Xiuning; Vijayan, R. S. K.; Hicks, J. Kevin; Heeke, Simon; Elamin, Yasir Y.; Lin, Heather Y.; Udagawa, Hibiki; Skoulidis, Ferdinandos; Tran, Hai; Varghese, Susan; He, Junqin; Zhang, Fahao; Nilsson, Monique B.; Hu, Lemei; Poteete, Alissa; Rinsurongkawong, Waree; Zhang, Xiaoshan; Ren, Chenghui; Liu, Xiaoke; Hong, Lingzhi; Zhang, Jianjun; Diao, Lixia; Madison, Russell; Schrock, Alexa B.; Saam, Jennifer; Raymond, Victoria; Fang, Bingliang; Wang, Jing; Ha, Min Jin; Cross, Jason B.; Gray, Jhanelle E.; Heymach, John, V			Structure-based classification predicts drug response in EGFR-mutant NSCLC	NATURE			English	Article							CELL LUNG-CANCER; 1ST-LINE TREATMENT; OPEN-LABEL; MUTATIONS; AFATINIB; RESISTANCE; SENSITIVITY; INHIBITORS; SURVIVAL; AZD9291	Epidermal growth factor receptor (EGFR) mutations typically occur in exons 18-21 and are established driver mutations in non-small cell lung cancer (NSCLC)(1-3). Targeted therapies are approved for patients with 'classical' mutations and a small number of other mutations(4-6). However, effective therapies have not been identified for additional EGFR mutations. Furthermore, the frequency and effects of atypical EGFR mutations on drug sensitivity are unknown(1,3,7-10). Here we characterize the mutational landscape in 16,715 patients with EGFR-mutant NSCLC, and establish the structure-function relationship of EGFR mutations on drug sensitivity. We found that EGFR mutations can be separated into four distinct subgroups on the basis of sensitivity and structural changes that retrospectively predict patient outcomes following treatment with EGFR inhibitors better than traditional exon-based groups. Together, these data delineate a structure-based approach for defining functional groups of EGFR mutations that can effectively guide treatment and clinical trial choices for patients with EGFR-mutant NSCLC and suggest that a structure-function-based approach may improve the prediction of drug sensitivity to targeted therapies in oncogenes with diverse mutations.	[Robichaux, Jacqulyne P.; Le, Xiuning; Heeke, Simon; Elamin, Yasir Y.; Udagawa, Hibiki; Skoulidis, Ferdinandos; Tran, Hai; Varghese, Susan; He, Junqin; Zhang, Fahao; Nilsson, Monique B.; Hu, Lemei; Poteete, Alissa; Liu, Xiaoke; Hong, Lingzhi; Zhang, Jianjun; Heymach, John, V] MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Vijayan, R. S. K.; Cross, Jason B.] MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX USA; [Hicks, J. Kevin] H Lee Moffitt Canc Ctr & Res Inst, Dept Individualized Canc Management, Tampa, FL USA; [Lin, Heather Y.; Ha, Min Jin] MD Anderson Canc Ctr, Dept Biostat, Houston, TX USA; [Rinsurongkawong, Waree] MD Anderson Canc Ctr, Quantitat Res Comp, Houston, TX USA; [Zhang, Xiaoshan; Ren, Chenghui; Fang, Bingliang] MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX USA; [Liu, Xiaoke] Sichuan Univ, West China Hosp, West China Med Sch, Dept Thorac Oncol, Chengdu, Sichuan, Peoples R China; [Diao, Lixia; Wang, Jing] MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX USA; [Madison, Russell; Schrock, Alexa B.] Fdn Med, Cambridge, MA USA; [Saam, Jennifer; Raymond, Victoria] Guardant Hearth, Redwood City, CA USA; [Gray, Jhanelle E.] H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; H Lee Moffitt Cancer Center & Research Institute; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Sichuan University; University of Texas System; UTMD Anderson Cancer Center; Foundation Medicine; H Lee Moffitt Cancer Center & Research Institute	Heymach, JV (corresponding author), MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA.	JHeymach@mdanderson.org	Hong, Lingzhi/GNO-9746-2022; Heeke, Simon/ABE-8156-2020	Heeke, Simon/0000-0002-5916-534X; Tran, Hai/0000-0003-4065-9355; ELAMIN, YASIR/0000-0002-5312-909X; Robichaux, Jacqulyne/0000-0001-8812-7054	University of Texas MD Anderson Lung Cancer Moon Shots Program; MD Anderson Cancer Center Support Grant [P30 CA016672]; Research Animal Support Facility (RASF); NIH [R01CA247975]; CPRIT-IIRA [RP200150]; NIH/NCI [R01CA234183, R01CA190628]; Lung SPORE [P50 CA070907-20]; David Bruton Jr Endowment; Rexanna Foundation for Fighting Lung Cancer [1U54CA224065-01]; Spectrum Pharmaceuticals; Hallman Fund; Stading Fund for EGFR inhibitor resistance; Gil and Dody Weaver Foundation; Richardson Fund for EGFR mutant lung cancer research; ASCO [CDA-57112]	University of Texas MD Anderson Lung Cancer Moon Shots Program; MD Anderson Cancer Center Support Grant; Research Animal Support Facility (RASF); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT-IIRA; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lung SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David Bruton Jr Endowment; Rexanna Foundation for Fighting Lung Cancer; Spectrum Pharmaceuticals; Hallman Fund; Stading Fund for EGFR inhibitor resistance; Gil and Dody Weaver Foundation; Richardson Fund for EGFR mutant lung cancer research; ASCO	We thank the patients, families and caregivers involved in the GEMINI protocol and the patient advocacy groups who have an essential role in patient care and research, including the Exon 20 Group. We also thank I. G. Munoz for critical review and editorial assistance. This work was supported by the generous philanthropic contributions to The University of Texas MD Anderson Lung Cancer Moon Shots Program and the MD Anderson Cancer Center Support Grant P30 CA016672 including animal housing and care in the Research Animal Support Facility (RASF). Additional support was contributed by NIH-R01CA247975, CPRIT-IIRA RP200150, NIH/NCI R01CA234183, NIH/NCI R01CA190628, Lung SPORE P50 CA070907-20, the David Bruton Jr Endowment, the Rexanna Foundation for Fighting Lung Cancer, 1U54CA224065-01, research support from Spectrum Pharmaceuticals (J.H.), the Hallman Fund, the Stading Fund for EGFR inhibitor resistance, the Gil and Dody Weaver Foundation, the Hanlon Fund, the Richardson Fund for EGFR mutant lung cancer research, and ASCO CDA-57112 (Y.Y.E.).	Breiman L., 1984, CLASSIFICATION REGRE; Chen YC, 2019, CANCER-AM CANCER SOC, V125, P3738, DOI 10.1002/cncr.32366; Cho JH, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.19.00931; Clark TA, 2018, J MOL DIAGN, V20, P686, DOI 10.1016/j.jmoldx.2018.05.004; Cross DAE, 2014, CANCER DISCOV, V4, P1046, DOI 10.1158/2159-8290.CD-14-0337; Finlay MRV, 2014, J MED CHEM, V57, P8249, DOI 10.1021/jm500973a; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Galili T, 2018, BIOINFORMATICS, V34, P1600, DOI 10.1093/bioinformatics/btx657; Klughammer B, 2016, J THORAC ONCOL, V11, P545, DOI 10.1016/j.jtho.2015.12.107; Kobayashi Y, 2015, CLIN CANCER RES, V21, P5305, DOI 10.1158/1078-0432.CCR-15-1046; Kosaka T, 2017, CANCER RES, V77, P2712, DOI 10.1158/0008-5472.CAN-16-3404; Le XN, 2018, CLIN CANCER RES, V24, P6195, DOI 10.1158/1078-0432.CCR-18-1542; Lee HJ, 2013, CANCER DISCOV, V3, P168, DOI 10.1158/2159-8290.CD-12-0357; Liu JF, 2018, CELL, V173, P400, DOI 10.1016/j.cell.2018.02.052; Liu XK, 2020, LUNG CANCER, V149, P33, DOI 10.1016/j.lungcan.2020.08.023; Ma CH, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01635; Massarelli E, 2013, LUNG CANCER, V80, P235, DOI 10.1016/j.lungcan.2013.01.018; Mok TS, 2018, J CLIN ONCOL, V36, P2244, DOI 10.1200/JCO.2018.78.7994; Ou SHI, 2017, LUNG CANCER, V108, P228, DOI 10.1016/j.lungcan.2017.04.003; Ramalingam SS, 2020, NEW ENGL J MED, V382, P41, DOI 10.1056/NEJMoa1913662; Robichaux JP, 2019, CANCER CELL, V36, P444, DOI 10.1016/j.ccell.2019.09.001; Robichaux JP, 2018, NAT MED, V24, P638, DOI 10.1038/s41591-018-0007-9; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Russo A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061431; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Shi JP, 2017, CHINESE J CANCER RES, V29, P543, DOI 10.21147/j.issn.1000-9604.2017.06.09; Soria JC, 2018, NEW ENGL J MED, V378, P113, DOI 10.1056/NEJMoa1713137; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Tamirat MZ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222814; Tamiya M, 2021, INVEST NEW DRUG, V39, P232, DOI 10.1007/s10637-020-00966-7; Thress KS, 2015, NAT MED, V21, P560, DOI 10.1038/nm.3854; Tsigelny IF, 2015, ONCOTARGET, V6, P6029, DOI 10.18632/oncotarget.3472; Uchibori K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14768; Vasconcelos P., 2020, JTO CLIN RES REPORTS, V1, P100051, DOI [DOI 10.1016/J.JTOCRR.2020.100051, 10.1016/j.jtocrr.2020.100051]; Vasconcelos Pedro E N S, 2021, JTO Clin Res Rep, V2, DOI 10.1016/j.jtocrr.2020.100105; Wang XF, 2019, J THORAC ONCOL, V14, pE85, DOI 10.1016/j.jtho.2019.01.015; Wu YL, 2014, LANCET ONCOL, V15, P213, DOI 10.1016/S1470-2045(13)70604-1; Yang JCH, 2015, LANCET ONCOL, V16, P830, DOI 10.1016/S1470-2045(15)00026-1; Yang JCH, 2020, J THORAC ONCOL, V15, P803, DOI 10.1016/j.jtho.2019.12.126; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8; Yang MM, 2016, INT J CANCER, V139, P171, DOI 10.1002/ijc.30047; Yasuda H, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007205; Yasuda H, 2012, LANCET ONCOL, V13, pE23, DOI 10.1016/S1470-2045(11)70129-2; Yoshikawa S, 2013, ONCOGENE, V32, P27, DOI 10.1038/onc.2012.21; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105	45	59	64	17	48	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 30	2021	597	7878					732	+		10.1038/s41586-021-03898-1	http://dx.doi.org/10.1038/s41586-021-03898-1		SEP 2021	25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UZ1UN	34526717	Green Published, hybrid			2022-12-28	WOS:000696175300003
J	Casassus, B				Casassus, Barbara			French to take legal action against drug regulator over levothyroxine	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2021	374								n2243	10.1136/bmj.n2243	http://dx.doi.org/10.1136/bmj.n2243			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WP7CH	34521625				2022-12-28	WOS:000713284400001
J	Christie, B				Christie, Bryan			Covid-19: Vaccine passports approved in Scotland despite criticism	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, PAIS; [Anonymous], 2021, CORONAVIRUS MANDATOR	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2021	374								n2229	10.1136/bmj.n2229	http://dx.doi.org/10.1136/bmj.n2229			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	US1IY	34507963	Bronze			2022-12-28	WOS:000697191000005
J	Dolgin, E				Dolgin, Elie			COVID vaccine immunity is waning - how much does that matter?	NATURE			English	News Item						Vaccines; Immunology; SARS-CoV-2												Bar-On YM, 2021, NEW ENGL J MED, V385, P1393, DOI 10.1056/NEJMoa2114255; Chemaitelly H., 2021, PREPRINT MEDRXIV, DOI [10.1101/2021.08.25.21262584(2021), DOI 10.1101/2021.08.25.21262584(2021)]; Goel R. R, 2021, PREPRINT BIORXIV, DOI [10.1101/2021.08.23.457229(2021, DOI 10.1101/2021.08.23.457229(2021]; Goldberg Y., 2021, PREPRINT MEDRXIV, DOI [10.1101/2021.08.24.21262423(2021, DOI 10.1101/2021.08.24.21262423(2021]; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Naaber P, 2021, LANCET REG HEALTH-EU, V10, DOI 10.1016/j.lanepe.2021.100208; Pegu A, 2021, SCIENCE, V373, P1372, DOI 10.1126/science.abj4176; Puranik A., 2021, PREPRINT MEDRXIV, DOI [10.1101/2021.09.04.21263115(2021), DOI 10.1101/2021.09.04.21263115(2021)]; Rella SA, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-95025-3; Thomas SJ, 2021, NEW ENGL J MED, V385, P1761, DOI 10.1056/NEJMoa2110345; Turner JS, 2021, NATURE, V595, P421, DOI 10.1038/s41586-021-03647-4	11	44	44	1	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 30	2021	597	7878					606	607		10.1038/d41586-021-02532-4	http://dx.doi.org/10.1038/d41586-021-02532-4			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UX8GG	34548661	Bronze			2022-12-28	WOS:000701076300005
J	Sang, YX; Huang, L; Wang, XH; Keenan, TF; Wang, CZ; He, Y				Sang, Yuxing; Huang, Ling; Wang, Xuhui; Keenan, Trevor F.; Wang, Chenzhi; He, Yue			Comment on "Recent global decline of CO2 fertilization effects on vegetation photosynthesis" COMMENT	SCIENCE			English	Editorial Material								Wang et al. (Research Articles, 11 December 2020, p. 1295) reported a large decline in the CO2 fertilization effect (CFE) on global photosynthesis, on the basis of changing regression coefficients of CO2 (beta) for satellite proxies/products of photosynthesis. We show that their methods cannot robustly estimate CFE, leading to incorrect attribution, and largely neglect CO2 effects on the photosynthetic enzyme ribulose-1,5bisphosphate carboxylase- oxygenase (RuBisCO).	[Sang, Yuxing; Huang, Ling; Wang, Xuhui; Wang, Chenzhi; He, Yue] Peking Univ, Coll Urban & Environm Sci, Sino French Inst Earth Syst Sci, Beijing 100871, Peoples R China; [Keenan, Trevor F.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Keenan, Trevor F.] Lawrence Berkeley Natl Lab, Earth & Environm Sci Area, Berkeley, CA 94720 USA	Peking University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Wang, XH (corresponding author), Peking Univ, Coll Urban & Environm Sci, Sino French Inst Earth Syst Sci, Beijing 100871, Peoples R China.	xuhui.wang@pku.edu.cn	Keenan, Trevor F./B-2744-2010; Keenan, Trevor/AAY-7786-2020; wang, xuhui/H-8605-2019	Keenan, Trevor F./0000-0002-3347-0258; Keenan, Trevor/0000-0002-3347-0258; wang, xuhui/0000-0003-0818-9816; He, Yue/0000-0002-7754-7026; Sang, Yuxing/0000-0003-0345-3788	National Key Research & Development Program of China [2019YFA0607302]; NSFC project Basic Science Center for Tibetan Plateau Earth System [41988101]; NASA Terrestrial Ecology Program IDS award [NNH17AE86I]	National Key Research & Development Program of China; NSFC project Basic Science Center for Tibetan Plateau Earth System; NASA Terrestrial Ecology Program IDS award	Supported by the National Key Research & Development Program of China (2019YFA0607302) and the NSFC project Basic Science Center for Tibetan Plateau Earth System (41988101). T.F.K. was supported by NASA Terrestrial Ecology Program IDS award NNH17AE86I.	Chen JM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12257-8; De Kauwe MG, 2016, NAT CLIM CHANGE, V6, P892, DOI 10.1038/nclimate3105; Huntzinger DN, 2013, GEOSCI MODEL DEV, V6, P2121, DOI 10.5194/gmd-6-2121-2013; Keenan TF, 2018, NAT CLIM CHANGE, V8, P825, DOI 10.1038/s41558-018-0258-y; Keenan TF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13428; Piao SL, 2020, NAT REV EARTH ENV, V1, P14, DOI 10.1038/s43017-019-0001-x; Ryu Y, 2019, REMOTE SENS ENVIRON, V223, P95, DOI 10.1016/j.rse.2019.01.016; Schimel D, 2015, P NATL ACAD SCI USA, V112, P436, DOI 10.1073/pnas.1407302112; Sitch S, 2015, BIOGEOSCIENCES, V12, P653, DOI 10.5194/bg-12-653-2015; Sun ZY, 2019, SCI TOTAL ENVIRON, V668, P696, DOI 10.1016/j.scitotenv.2019.03.025; Walker AP, 2021, NEW PHYTOL, V229, P2413, DOI 10.1111/nph.16866; Wang SH, 2020, SCIENCE, V370, P1295, DOI 10.1126/science.abb7772; Yuan WP, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax1396; Zhu ZC, 2016, NAT CLIM CHANGE, V6, P791, DOI [10.1038/NCLIMATE3004, 10.1038/nclimate3004]	14	6	8	16	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2021	373	6562			SI				abg4420	10.1126/science.abg4420	http://dx.doi.org/10.1126/science.abg4420			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU7LJ	34554773	Green Submitted, Bronze			2022-12-28	WOS:000698977800002
J	[Anonymous]				[Anonymous]			Sodium Sulfate-Based Tablets (Sutab) for Colonoscopy Preparation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint								This Medical Letter review summarizes the use of Sutab, an oral tablet formulation of sodium sulfate, magnesium sulfate, and potassium chloride for colon cleansing prior to colonoscopy in adults										di Palma JA, 2021, AM J GASTROENTEROL, V116, P319, DOI 10.14309/ajg.0000000000001020; Saltzman JR, 2015, GASTROINTEST ENDOSC, V81, P781, DOI 10.1016/j.gie.2014.09.048	2	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 12	2021	326	14					1431	1432		10.1001/jama.2021.3606	http://dx.doi.org/10.1001/jama.2021.3606		SEP 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WH8VN	34559178				2022-12-28	WOS:000698779300002
J	Ioannidis, AG; Blanco-Portillo, J; Sandoval, K; Hagelberg, E; Barberena-Jonas, C; Hill, AVS; Rodriguez-Rodriguez, JE; Fox, K; Robson, K; Haoa-Cardinali, S; Quinto-Cortes, CD; Miquel-Poblete, JF; Auckland, K; Parks, T; Sofro, ASM; avila-Arcos, MC; Sockell, A; Homburger, JR; Eng, C; Huntsman, S; Burchard, EG; Gignoux, CR; Verdugo, RA; Moraga, M; Bustamante, CD; Mentzer, AJ; Moreno-Estrada, A				Ioannidis, Alexander G.; Blanco-Portillo, Javier; Sandoval, Karla; Hagelberg, Erika; Barberena-Jonas, Carmina; Hill, Adrian V. S.; Rodriguez-Rodriguez, Juan Esteban; Fox, Keolu; Robson, Kathryn; Haoa-Cardinali, Sonia; Quinto-Cortes, Consuelo D.; Miquel-Poblete, Juan Francisco; Auckland, Kathryn; Parks, Tom; Sofro, Abdul Salam M.; avila-Arcos, Maria C.; Sockell, Alexandra; Homburger, Julian R.; Eng, Celeste; Huntsman, Scott; Burchard, Esteban G.; Gignoux, Christopher R.; Verdugo, Ricardo A.; Moraga, Mauricio; Bustamante, Carlos D.; Mentzer, Alexander J.; Moreno-Estrada, Andres			Paths and timings of the peopling of Polynesia inferred from genomic networks	NATURE			English	Article							COLONIZATION; PRECISION; ADMIXTURE; SETTLEMENT; EXPANSION; ISLANDS; EXTENT	Analysis of genomic networks from 430 modern individuals across 21 Pacific island populations reveals the human settlement history of Polynesia. Polynesia was settled in a series of extraordinary voyages across an ocean spanning one third of the Earth(1), but the sequences of islands settled remain unknown and their timings disputed. Currently, several centuries separate the dates suggested by different archaeological surveys(2-4). Here, using genome-wide data from merely 430 modern individuals from 21 key Pacific island populations and novel ancestry-specific computational analyses, we unravel the detailed genetic history of this vast, dispersed island network. Our reconstruction of the branching Polynesian migration sequence reveals a serial founder expansion, characterized by directional loss of variants, that originated in Samoa and spread first through the Cook Islands (Rarotonga), then to the Society (Totaiete ma) Islands (11th century), the western Austral (Tuha'a Pae) Islands and Tuamotu Archipelago (12th century), and finally to the widely separated, but genetically connected, megalithic statue-building cultures of the Marquesas (Te Henua 'Enana) Islands in the north, Raivavae in the south, and Easter Island (Rapa Nui), the easternmost of the Polynesian islands, settled in approximately ad 1200 via Mangareva.	[Ioannidis, Alexander G.] Stanford Univ, Inst Computat & Math Engn, Stanford, CA 94305 USA; [Ioannidis, Alexander G.; Blanco-Portillo, Javier; Sandoval, Karla; Barberena-Jonas, Carmina; Rodriguez-Rodriguez, Juan Esteban; Quinto-Cortes, Consuelo D.; Moreno-Estrada, Andres] CINVESTAV, Natl Lab Genom Biodivers LANGEBIO Adv Genom Unit, Guanajuato, Mexico; [Hagelberg, Erika] Univ Oslo, Dept Biosci, Oslo, Norway; [Hill, Adrian V. S.; Auckland, Kathryn; Parks, Tom] Univ Oxford, Wellcome Ctr Human Genet, Roosevelt Dr, Oxford, England; [Hill, Adrian V. S.] Univ Oxford, Jenner Inst, Nuffield Dept Med, Oxford, England; [Fox, Keolu] Univ Calif San Diego, Dept Anthropol, La Jolla, CA 92093 USA; [Robson, Kathryn] Univ Oxford, MRC Weatherall Inst Mol Med, Oxford, England; [Haoa-Cardinali, Sonia] Mata Ki Rangi Fdn, Hanga Roa, Easter Isl, Chile; [Miquel-Poblete, Juan Francisco] Pontificia Univ Catolica Chile, Fac Med, Dept Gastroenterol, Santiago, Chile; [Sofro, Abdul Salam M.] Yayasan Rumah Sakit Islam YARSI Univ, Dept Biochem, Fac Med, Jakarta, Indonesia; [avila-Arcos, Maria C.] UNAM Juriquilla, Int Lab Human Genome Res LIIGH, Queretaro, Mexico; [Sockell, Alexandra; Homburger, Julian R.; Bustamante, Carlos D.] Stanford Univ, Ctr Computat Evolutionary & Human Genom CEHG, Stanford, CA 94305 USA; [Eng, Celeste; Huntsman, Scott; Burchard, Esteban G.] Univ Calif San Francisco, Dept Med, Program Pharmaceut Sci & Pharmacogen, San Francisco, CA 94143 USA; [Gignoux, Christopher R.] Univ Colorado, Div Biomed Informat & Personalized Med, Denver, CO 80202 USA; [Verdugo, Ricardo A.; Moraga, Mauricio] Univ Chile, Inst Biomed Sci, Human Genet Program, Fac Med, Santiago, Chile; [Verdugo, Ricardo A.] Univ Chile, Translat Oncol Dept, Fac Med, Santiago, Chile; [Moraga, Mauricio] Univ Chile, Dept Anthropol, Fac Social Sci, Santiago, Chile; [Bustamante, Carlos D.] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Mentzer, Alexander J.] Univ Oxford, Big Data Inst, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford, England	Stanford University; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; University of Oslo; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Jenner Institute; University of California System; University of California San Diego; University of Oxford; Pontificia Universidad Catolica de Chile; Universidad Nacional Autonoma de Mexico; Stanford University; University of California System; University of California San Francisco; University of Colorado System; University of Colorado Denver; Universidad de Chile; Universidad de Chile; Universidad de Chile; Stanford University; University of Oxford	Ioannidis, AG (corresponding author), Stanford Univ, Inst Computat & Math Engn, Stanford, CA 94305 USA.; Ioannidis, AG; Moreno-Estrada, A (corresponding author), CINVESTAV, Natl Lab Genom Biodivers LANGEBIO Adv Genom Unit, Guanajuato, Mexico.	ioannidis@stanford.edu; andres.moreno@cinvestav.mx	Ávila-Arcos, Maria C./AGZ-3897-2022; Parks, Tom/D-7741-2013	Ávila-Arcos, Maria C./0000-0003-1691-1696; Rodriguez-Rodriguez, Juan Esteban/0000-0003-4706-2201; Parks, Tom/0000-0002-1163-8654; Barberena-Jonas, Carmina/0000-0001-7413-638X; Mentzer, Alexander/0000-0002-4502-2209; Hill, Adrian/0000-0003-0900-9629; Ioannidis, Alexander/0000-0002-4735-7803; Blanco-Portillo, Javier/0000-0003-3168-2756; Quinto-Cortes, Consuelo Dayzu/0000-0002-0338-3321	NLM NIH HHS [T15 LM007033] Funding Source: Medline; Wellcome Trust [106289/Z/14/Z] Funding Source: Medline	NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Wellcome Trust(Wellcome Trust)		Anderson A, 2019, J PAC ARCHAEOL, V10, P1; Belbin GM, 2021, CELL, V184, P2068, DOI 10.1016/j.cell.2021.03.034; Buck Te Rangi Hiroa P. H., 1938, VIKINGS SUNRISE; Claw KG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05188-3; Collerson KD, 2007, SCIENCE, V317, P1907, DOI 10.1126/science.1147013; Cook J., 1955, J CAPTAIN JAMES COOK; Di Piazza A, 2007, J ARCHAEOL SCI, V34, P1219, DOI 10.1016/j.jas.2006.10.013; Dickinson W.R., 2009, GSA TODAY, V19, P4, DOI DOI 10.1130/GSATG35A.1; Duncan RP, 2013, P NATL ACAD SCI USA, V110, P6436, DOI 10.1073/pnas.1216511110; Emory KP, 1939, J POLYNESIAN SOC, V48, P1; Fischer SR, 2001, OCEAN LINGUIST, V40, P112, DOI 10.1353/ol.2001.0005; Flenley J., 2003, ENIGMAS EASTER ISLAN; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Handy E.S. Craighill, 1923, NATIVE CULTURE MARQU, P5; HILL AVS, 1987, AM J HUM GENET, V40, P453; Hudjashov G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20026-8; Hunt T.L., 2011, STATUES WALKED; Hunt TL, 2008, J ISL COAST ARCHAEOL, V3, P140, DOI DOI 10.1080/15564890801990797; Ioannidis AG, 2020, NATURE, V583, P572, DOI 10.1038/s41586-020-2487-2; Kahoalii Keauokalani K., 1932, BERNICE P BISH MUS B, V206; Kirch P., 2001, HAWAIKI ANCESTRAL PO; Kirch P. V., 2017, ROAD WINDS; Kirch PV, 2015, ARCHAEOL OCEAN, V50, P23, DOI 10.1002/arco.5050; Leppala K, 2017, BIOINFORMATICS, V33, P1738, DOI 10.1093/bioinformatics/btx048; Lipson M, 2013, MOL BIOL EVOL, V30, P1788, DOI 10.1093/molbev/mst099; Low S., 2019, HAWAIKI RISING HOKUL; Martinsson-Wallin H, 2013, J ISL COAST ARCHAEOL, V8, P405, DOI 10.1080/15564894.2013.834009; McColl H, 2018, SCIENCE, V361, P88, DOI 10.1126/science.aat3628; Minster RL, 2016, NAT GENET, V48, P1049, DOI 10.1038/ng.3620; Mulrooney MA, 2013, J ARCHAEOL SCI, V40, P4377, DOI 10.1016/j.jas.2013.06.020; Mulrooney MA, 2011, P NATL ACAD SCI USA, V108, pE192, DOI 10.1073/pnas.1100447108; Nei M., 2000, MOL EVOLUTION PHYLOG, P352; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Peter BM, 2013, EVOLUTION, V67, P3274, DOI 10.1111/evo.12202; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; PIRAZZOLI PA, 1986, QUATERNARY RES, V25, P350, DOI 10.1016/0033-5894(86)90006-2; Posth C, 2018, NAT ECOL EVOL, V2, P731, DOI 10.1038/s41559-018-0498-2; Rolett Barry, 2002, ASIAN PERSPECT, V41, P182, DOI DOI 10.1353/ASI.2003.0009; Schmid MME, 2018, QUAT GEOCHRONOL, V48, P64, DOI 10.1016/j.quageo.2018.07.015; Skoglund P, 2016, NATURE, V538, P510, DOI 10.1038/nature19844; Slatkin M, 2012, GENETICS, V191, P171, DOI 10.1534/genetics.112.139022; SPRIGGS M, 1993, ANTIQUITY, V67, P200, DOI 10.1017/S0003598X00045324; Steadman DW, 2006, EXTINCTION BIOGEOGRA; Walworth M., 2015, LANGUAGE RAPA ITI; Walworth M, 2014, OCEAN LINGUIST, V53, P256, DOI 10.1353/ol.2014.0021; Wang CL, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1493; Weisler MI, 2016, P NATL ACAD SCI USA, V113, P8150, DOI 10.1073/pnas.1608130113; Whyte ALH, 2005, HUM BIOL, V77, P157, DOI 10.1353/hub.2005.0045; Wilmshurst JM, 2011, P NATL ACAD SCI USA, V108, P1815, DOI 10.1073/pnas.1015876108; Wollstein A, 2010, CURR BIOL, V20, P1983, DOI 10.1016/j.cub.2010.10.040; Zhan S, 2014, NATURE, V514, P317, DOI 10.1038/nature13812	53	11	11	1	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2021	597	7877					522	+		10.1038/s41586-021-03902-8	http://dx.doi.org/10.1038/s41586-021-03902-8			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU3OZ	34552258	Green Accepted			2022-12-28	WOS:000698710300004
J	Shimobayashi, SF; Ronceray, P; Sanders, DW; Haataja, MP; Brangwynne, CP				Shimobayashi, Shunsuke F.; Ronceray, Pierre; Sanders, David W.; Haataja, Mikko P.; Brangwynne, Clifford P.			Nucleation landscape of biomolecular condensates	NATURE			English	Article							PHASE-BEHAVIOR	All structures within living cells must form at the right time and place. This includes condensates such as the nucleolus, Cajal bodies and stress granules, which form via liquid-liquid phase separation of biomolecules, particularly proteins enriched in intrinsically disordered regions (IDRs)(1,2). In non-living systems, the initial stages of nucleated phase separation arise when thermal fluctuations overcome an energy barrier due to surface tension. This phenomenon can be modelled by classical nucleation theory (CNT), which describes how the rate of droplet nucleation depends on the degree of supersaturation, whereas the location at which droplets appear is controlled by interfacial heterogeneities(3,4). However, it remains unknown whether this framework applies in living cells, owing to the multicomponent and highly complex nature of the intracellular environment, including the presence of diverse IDRs, whose specificity of biomolecular interactions is unclear(5-8). Here we show that despite this complexity, nucleation in living cells occurs through a physical process similar to that in inanimate materials, but the efficacy of nucleation sites can be tuned by their biomolecular features. By quantitatively characterizing the nucleation kinetics of endogenous and biomimetic condensates in living cells, we find that key features of condensate nucleation can be quantitatively understood through a CNT-like theoretical framework. Nucleation rates can be substantially enhanced by compatible biomolecular (IDR) seeds, and the kinetics of cellular processes can impact condensate nucleation rates and specificity of location. This quantitative framework sheds light on the intracellular nucleation landscape, and paves the way for engineering synthetic condensates precisely positioned in space and time.	[Shimobayashi, Shunsuke F.; Sanders, David W.; Brangwynne, Clifford P.] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA; [Ronceray, Pierre] Princeton Univ, Ctr Phys Biol Funct, Princeton, NJ 08544 USA; [Ronceray, Pierre] Aix Marseille Univ, Univ Toulon, CNRS, CPT,Turing Ctr Living Syst, Marseille, France; [Haataja, Mikko P.] Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA; [Haataja, Mikko P.; Brangwynne, Clifford P.] Princeton Univ, Princeton Inst Sci & Technol Mat, Princeton, NJ 08544 USA; [Brangwynne, Clifford P.] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA	Princeton University; Princeton University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Princeton University; Princeton University; Howard Hughes Medical Institute; Princeton University	Brangwynne, CP (corresponding author), Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA.; Brangwynne, CP (corresponding author), Princeton Univ, Princeton Inst Sci & Technol Mat, Princeton, NJ 08544 USA.; Brangwynne, CP (corresponding author), Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA.	cbrangwy@princeton.edu	Ronceray, Pierre/R-9770-2016	Ronceray, Pierre/0000-0002-9012-7544; Sanders, David/0000-0002-1835-6895	Howard Hughes Medical Institute; AFOSR MURI [FA9550-20-1-0241]; Princeton Center for Complex Materials, an MRSEC [NSF DMR-2011750]; Princeton's School of Engineering and Applied Sciences; JSPS; NSF [PHY-1734030]; French Government programme 'Investissements d'Avenir' [ANR-16-CONV-0001]; Excellence Initiative of Aix-Marseille University-A*MIDEX	Howard Hughes Medical Institute(Howard Hughes Medical Institute); AFOSR MURI(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); Princeton Center for Complex Materials, an MRSEC; Princeton's School of Engineering and Applied Sciences; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NSF(National Science Foundation (NSF)); French Government programme 'Investissements d'Avenir'(French National Research Agency (ANR)); Excellence Initiative of Aix-Marseille University-A*MIDEX	We thank members of the Brangwynne laboratory for helpful discussions and comments on this manuscript. We thank laboratory members Y. Kim, M. Walls and D. Bracha for providing plasmids. This work was supported by the Howard Hughes Medical Institute, and grants from the AFOSR MURI (FA9550-20-1-0241), and the Princeton Center for Complex Materials, an MRSEC (NSF DMR-2011750). We also thank Princeton's School of Engineering and Applied Sciences for supporting this work through a Focused Research Team award. S.F.S. is supported by JSPS Postdoctoral Fellowships for Research Abroad. P.R. is supported by the NSF through the Center for the Physics of Biological Function (PHY-1734030), by the French Government programme 'Investissements d'Avenir' managed by the French National Research Agency (ANR-16-CONV-0001) and by the Excellence Initiative of Aix-Marseille University-A*MIDEX.	Aaron JS, 2018, J CELL SCI, V131, DOI 10.1242/jcs.211847; Auer S, 2001, NATURE, V409, P1020, DOI 10.1038/35059035; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Berry J, 2015, P NATL ACAD SCI USA, V112, pE5237, DOI 10.1073/pnas.1509317112; Bracha D, 2018, CELL, V175, P1467, DOI 10.1016/j.cell.2018.10.048; Cho WK, 2018, SCIENCE, V361, P412, DOI 10.1126/science.aar4199; Chong SS, 2018, SCIENCE, V361, DOI 10.1126/science.aar2555; Clouet E, 2009, ASM HDB; Colby R.H., 2003, POLYM PHYS; Honerkamp-Smith AR, 2009, BBA-BIOMEMBRANES, V1788, P53, DOI 10.1016/j.bbamem.2008.09.010; Kashchiev D., 2000, NUCLEATION; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kilic S, 2019, EMBO J, V38, DOI 10.15252/embj.2018101379; Lafontaine DLJ, 2021, NAT REV MOL CELL BIO, V22, P165, DOI 10.1038/s41580-020-0272-6; Martin EW, 2020, SCIENCE, V367, P694, DOI 10.1126/science.aaw8653; Mayoral E, 2014, SOFT MATTER, V10, P9054, DOI 10.1039/c4sm01981d; Mitrea DM, 2016, ELIFE, V5, DOI 10.7554/eLife.13571; Riback JA, 2020, NATURE, V581, P209, DOI 10.1038/s41586-020-2256-2; Sabari BR, 2018, SCIENCE, V361, DOI 10.1126/science.aar3958; Sanders DW, 2020, CELL, V181, P306, DOI 10.1016/j.cell.2020.03.050; Shevtsov SP, 2011, NAT CELL BIOL, V13, P167, DOI 10.1038/ncb2157; Shin Y, 2018, CELL, V175, P1481, DOI 10.1016/j.cell.2018.10.057; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Wang J, 2018, CELL, V174, P688, DOI 10.1016/j.cell.2018.06.006; Wei MT, 2020, NAT CELL BIOL, V22, P1187, DOI 10.1038/s41556-020-00578-6	25	30	31	16	59	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 18	2021	599	7885					503	+		10.1038/s41586-021-03905-5	http://dx.doi.org/10.1038/s41586-021-03905-5		SEP 2021	19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WZ6DP	34552246	Green Submitted			2022-12-28	WOS:000698366900003
J	Papamichail, K; Dubinsky, MC; Cheifetz, AS				Papamichail, Konstantinos; Dubinsky, Marla C.; Cheifetz, Adam S.			Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases RESPONSE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Papamichail, Konstantinos; Cheifetz, Adam S.] Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02215 USA; [Dubinsky, Marla C.] Icahn Sch Med Mt Sinai, Susan & Leonard Feinstein IBD Clin Ctr, New York, NY 10029 USA	Harvard University; Beth Israel Deaconess Medical Center; Icahn School of Medicine at Mount Sinai	Papamichail, K (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Inflammatory Bowel Dis, 330 Brookline Ave, Boston, MA 02215 USA.	kpapamic@bidmc.harvard.edu			National Institutes of Health/National Institute of Allergy and Infectious Diseases [U01AI144616-02S1]	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by grant U01AI144616-02S1 from the National Institutes of Health/National Institute of Allergy and Infectious Diseases. The funds were used for salary support for staff and materials to conduct the study.	Bader LI, 2017, SCAND J IMMUNOL, V86, P165, DOI 10.1111/sji.12572; Dhindsa BS, 2020, INDIAN J GASTROENTER, V39, P153, DOI 10.1007/s12664-020-01031-0; Papamichael K, 2019, EXPERT REV CLIN IMMU, V15, P837, DOI 10.1080/1744666X.2019.1630273; Papamichael K, 2019, CLIN GASTROENTEROL H, V17, P1655, DOI 10.1016/j.cgh.2019.03.037; Syversen SW, 2021, JAMA-J AM MED ASSOC, V325, P1744, DOI 10.1001/jama.2021.4172	5	2	2	2	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2021	326	11					1067	1068		10.1001/jama.2021.11477	http://dx.doi.org/10.1001/jama.2021.11477			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ4IM	34546306				2022-12-28	WOS:000702170600024
J	Mahase, E				Mahase, Elisabeth			Cancer outcomes-what's stalling progress in England?	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		BMA, 2021, NHS SHORT 50000 DOCT; Joyner L., 2021, HERES WHAT AVERAGE U; Mahase E, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n878; NHS England, NHS LONG TERM PLAN A; Nuffield Trust, 2021, CANC SURV RAT; Royal College of Radiologists, 2021, RAD WORKF CENS	6	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2021	374								n2295	10.1136/bmj.n2295	http://dx.doi.org/10.1136/bmj.n2295			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WC6LC	34535503				2022-12-28	WOS:000704366700005
J	Mahase, E				Mahase, Elisabeth			Covid-19: Booster dose reduces infections and severe illness in over 60s, Israeli study reports	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], OUR WORLD DATA; Mahase E, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1659; Mandel M, 2021, PROTECTION BNT162B2, DOI [10.1056/NEJMoa2114255, DOI 10.1056/NEJMOA2114255]; Taylor L, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1962; Wise J, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2261	5	7	7	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2021	374								n2297	10.1136/bmj.n2297	http://dx.doi.org/10.1136/bmj.n2297			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WC6LC	34535470	Bronze			2022-12-28	WOS:000704366700008
J	Bar-On, YM; Goldberg, Y; Mandel, M; Bodenheimer, O; Freedman, L; Kalkstein, N; Mizrahi, B; Alroy-Preis, S; Ash, N; Milo, R; Huppert, A				Bar-On, Yinon M.; Goldberg, Yair; Mandel, Micha; Bodenheimer, Omri; Freedman, Laurence; Kalkstein, Nir; Mizrahi, Barak; Alroy-Preis, Sharon; Ash, Nachman; Milo, Ron; Huppert, Amit			Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Third Dose of Covid-19 Vaccine in Israel Since July 30, 2021, more than a million fully vaccinated Israeli residents who were 60 years or age or older have received a third dose of the BNT162b2 mRNA vaccine. As of August 31, the rate of confirmed Covid-19 infection was lower in the booster group than in the nonbooster group by a factor of 11.3, and the rate of severe illness was lower by a factor of 19.5. Background On July 30, 2021, the administration of a third (booster) dose of the BNT162b2 messenger RNA vaccine (Pfizer-BioNTech) was approved in Israel for persons who were 60 years of age or older and who had received a second dose of vaccine at least 5 months earlier. Data are needed regarding the effect of the booster dose on the rate of confirmed coronavirus 2019 disease (Covid-19) and the rate of severe illness. Methods We extracted data for the period from July 30 through August 31, 2021, from the Israeli Ministry of Health database regarding 1,137,804 persons who were 60 years of age or older and had been fully vaccinated (i.e., had received two doses of BNT162b2) at least 5 months earlier. In the primary analysis, we compared the rate of confirmed Covid-19 and the rate of severe illness between those who had received a booster injection at least 12 days earlier (booster group) and those who had not received a booster injection (nonbooster group). In a secondary analysis, we evaluated the rate of infection 4 to 6 days after the booster dose as compared with the rate at least 12 days after the booster. In all the analyses, we used Poisson regression after adjusting for possible confounding factors. Results At least 12 days after the booster dose, the rate of confirmed infection was lower in the booster group than in the nonbooster group by a factor of 11.3 (95% confidence interval [CI], 10.4 to 12.3); the rate of severe illness was lower by a factor of 19.5 (95% CI, 12.9 to 29.5). In a secondary analysis, the rate of confirmed infection at least 12 days after vaccination was lower than the rate after 4 to 6 days by a factor of 5.4 (95% CI, 4.8 to 6.1). Conclusions In this study involving participants who were 60 years of age or older and had received two doses of the BNT162b2 vaccine at least 5 months earlier, we found that the rates of confirmed Covid-19 and severe illness were substantially lower among those who received a booster (third) dose of the BNT162b2 vaccine.	[Bar-On, Yinon M.; Milo, Ron] Weizmann Inst Sci, Dept Plant & Environm Sci, Rehovot, Israel; [Goldberg, Yair] Technion Israel Inst Technol, Haifa, Israel; [Mandel, Micha] Hebrew Univ Jerusalem, Jerusalem, Israel; [Bodenheimer, Omri; Alroy-Preis, Sharon; Ash, Nachman] Israel Minist Hlth, Jerusalem, Israel; [Freedman, Laurence; Huppert, Amit] Sheba Med Ctr, Gertner Inst Epidemiol & Hlth Policy Res, Biostat & Biomath Unit, Ramat Gan, Israel; [Kalkstein, Nir; Mizrahi, Barak] KI Res Inst, Kfar Malal, Israel; [Huppert, Amit] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel	Weizmann Institute of Science; Technion Israel Institute of Technology; Hebrew University of Jerusalem; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Goldberg, Y (corresponding author), Technion Israel Inst Technol, Fac Ind Engn & Management, IL-3200003 Haifa, Israel.	yairgo@technion.ac.il		Mizrahi, Barak/0000-0002-1053-4773				[Anonymous], 2021, PFIZER 0728; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; Goldberg Y., 2021, WANING IMMUNITY BNT1, DOI [10.1101/2021.08.24.21262423v1, DOI 10.1101/2021.08.24.21262423, DOI 10.1101/2021.08.24.21262423V1]; Haas EJ, 2021, LANCET, V397, P1819, DOI 10.1016/S0140-6736(21)00947-8; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Kleinman LC, 2009, HEALTH SERV RES, V44, P288, DOI 10.1111/j.1475-6773.2008.00900.x; Lustig Y, 2021, LANCET RESP MED, V9, P999, DOI 10.1016/S2213-2600(21)00220-4; McAloon C, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039652; Mizrahi B., 2021, CORRELATION SARS COV, DOI [10.1101/2021.07.29.21261317, DOI 10.1101/2021.07.29.21261317V1, DOI 10.1101/2021.07.29.21261317]; Muhsen K, 2021, LANCET REG HEALTH-EU, V7, DOI 10.1016/j.lanepe.2021.100130; Public Health England, 2020, GOV UK 1221; Puranik Arjun, 2021, medRxiv, DOI 10.1101/2021.08.06.21261707; R Development Core Team, 2009, R LANG ENV STAT COMP; Ritchie H., 2020, OURWORLD DATA; Tang P., 2021, MEDRXIV, DOI [10.1101/2021.08.11.21261885, DOI 10.1101/2021.08.11.21261885]; Wall EC, 2021, LANCET, V397, P2331, DOI 10.1016/S0140-6736(21)01290-3; Walsh EE, 2020, NEW ENGL J MED, V383, P2439, DOI 10.1056/NEJMoa2027906; Xin H, 2019, CLIN INFECT DIS, DOI [10.1093/cid/ciab501, DOI 10.1093/CID/CIAB501]	18	545	547	6	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2021	385	15					1393	1400		10.1056/NEJMoa2114255	http://dx.doi.org/10.1056/NEJMoa2114255		SEP 2021	8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XP7AB	34525275	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000696036600001
J	Iacobucci, G				Iacobucci, Gareth			Government is urged to tackle "punitive pension taxation" to stop doctors retiring early	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Moberly T, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1594	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 15	2021	374								n2279	10.1136/bmj.n2279	http://dx.doi.org/10.1136/bmj.n2279			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UY0UP	34526352				2022-12-28	WOS:000701248800008
J	Mahase, E				Mahase, Elisabeth			Medical students involved in sex work need better support, conference hears	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2021	374								n2247	10.1136/bmj.n2247	http://dx.doi.org/10.1136/bmj.n2247			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WP7CH	34521645				2022-12-28	WOS:000713284400011
J	Huang, YZ; Knouse, KW; Qiu, SJ; Hao, W; Padial, NM; Vantourout, JC; Zheng, B; Mercer, SE; Lopez-Ogalla, J; Narayan, R; Olson, RE; Blackmond, DG; Eastgate, MD; Schmidt, MA; McDonald, IM; Baran, PS				Huang, Yazhong; Knouse, Kyle W.; Qiu, Shenjie; Hao, Wei; Padial, Natalia M.; Vantourout, Julien C.; Zheng, Bin; Mercer, Stephen E.; Lopez-Ogalla, Javier; Narayan, Rohan; Olson, Richard E.; Blackmond, Donna G.; Eastgate, Martin D.; Schmidt, Michael A.; McDonald, Ivar M.; Baran, Phil S.			A P(V) platform for oligonucleotide synthesis	SCIENCE			English	Article							STEREOCONTROLLED SYNTHESIS; PHOSPHORODITHIOATE DNA; PHASE SYNTHESIS; PHOSPHOROTHIOATE)S; STEREOCHEMISTRY; ACRYLONITRILE; PROTECTION; EFFICIENT	The promise of gene-based therapies is being realized at an accelerated pace, with more than 155 active clinical trials and multiple U.S. Food and Drug Administration approvals for therapeutic oligonucleotides, by far most of which contain modified phosphate linkages. These unnatural linkages have desirable biological and physical properties but are often accessed with difficulty using phosphoramidite chemistry. We report a flexible and efficient [P(V)]-based platform that can install a wide variety of phosphate linkages at will into oligonucleotides. This approach uses readily accessible reagents and can install not only stereodefined or racemic thiophosphates but any combination of (S, R or rac)-PS with native phosphodiester (PO2) and phosphorodithioate (PS2) linkages into DNA and other modified nucleotide polymers. This platform easily accesses this diversity under a standardized coupling protocol with sustainably prepared, stable P(V) reagents.	[Huang, Yazhong; Mercer, Stephen E.; Olson, Richard E.; McDonald, Ivar M.] Bristol Myers Squibb, Small Mol Drug Discovery, Cambridge, MA 02142 USA; [Knouse, Kyle W.; Hao, Wei; Padial, Natalia M.; Vantourout, Julien C.; Lopez-Ogalla, Javier; Narayan, Rohan; Blackmond, Donna G.; Baran, Phil S.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Knouse, Kyle W.] Elsie Biotechnol, San Diego, CA 92121 USA; [Qiu, Shenjie; Zheng, Bin; Eastgate, Martin D.; Schmidt, Michael A.] Bristol Myers Squibb, Them Proc Dev, New Brunswick, NJ 08903 USA; [Padial, Natalia M.] Univ Valencia, Inst Mol Sci ICMol, Paterna 46980, Spain; [Lopez-Ogalla, Javier] Clarochem Ireland Ltd, Dublin 15, Ireland	Bristol-Myers Squibb; Scripps Research Institute; Bristol-Myers Squibb; University of Valencia	McDonald, IM (corresponding author), Bristol Myers Squibb, Small Mol Drug Discovery, Cambridge, MA 02142 USA.; Baran, PS (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.; Eastgate, MD; Schmidt, MA (corresponding author), Bristol Myers Squibb, Them Proc Dev, New Brunswick, NJ 08903 USA.	martin.eastgate@bms.com; michael.schmidt@bms.com; ivar.mcdonald@bms.com; pbaran@scripps.edu	VANTOUROUT, Julien/GVS-7119-2022; Qiu, Shenjie/AAI-6216-2020; M. Padial, Natalia/H-8121-2018; Lopez-Ogalla, Javier/K-6616-2014	Qiu, Shenjie/0000-0002-9341-3749; M. Padial, Natalia/0000-0001-6067-3360; Mercer, Stephen/0000-0003-4211-9002; Lopez-Ogalla, Javier/0000-0002-7061-0088; Huang, Yazhong/0000-0001-5551-2423; Vantourout, Julien Christian/0000-0002-0602-069X; Hao, Wei/0000-0001-9493-6894	Bristol Myers Squibb; NIGMS [GM106210]; NIH [GM-118176]; European Union [749359]; NSF SURF Program (TSRI)	Bristol Myers Squibb(Bristol-Myers Squibb); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); NSF SURF Program (TSRI)	This work was supported by Bristol Myers Squibb, NIGMS (GM106210), NIH (grant number GM-118176), Marie Sklodowska-Curie Global Fellowships (749359-EnanSET, N.M.P) within the European Union research and innovation framework program (2014-2020), and the NSF SURF Program (TSRI, R.N).	Andrews BI, 2021, J ORG CHEM, V86, P49, DOI 10.1021/acs.joc.0c02291; Bethge L., 2019, International Patent, Patent No. [WO/2019/092280, 2019092280]; Bethge L., 2019, International Patent, Patent No. [WO/2019/092280, 2019092280]; Bleicher K., 2019, International Patent, Patent No. [WO/2019/122282, 2019122282]; Brooks JL, 2017, TETRAHEDRON LETT, V58, P1050, DOI 10.1016/j.tetlet.2017.01.101; Byrne M, 2021, TRANSL VIS SCI TECHN, V10, DOI 10.1167/tvst.10.1.23; Capaldi DC, 2003, ORG PROCESS RES DEV, V7, P832, DOI 10.1021/op020090n; Caruthers MH, 2013, J BIOL CHEM, V288, P1420, DOI 10.1074/jbc.X112.442855; CARUTHERS MH, 1991, NUCLEOS NUCLEOT, V10, P47, DOI 10.1080/07328319108046435; Crooke ST, 2021, NAT REV DRUG DISCOV, V20, P427, DOI 10.1038/s41573-021-00162-z; Crooke ST, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100416; de Koning MC, 2006, ORG PROCESS RES DEV, V10, P1238, DOI 10.1021/op060133q; ECKSTEIN F, 1967, ANGEW CHEM INT EDIT, V6, P695, DOI 10.1002/anie.196706951; ECKSTEIN F, 1976, P NATL ACAD SCI USA, V73, P2987, DOI 10.1073/pnas.73.9.2987; Guga P., 2003, CURR PROTOC NUCL ACI, V14; Guga Piotr, 2003, Curr Protoc Nucleic Acid Chem, VChapter 4, DOI 10.1002/0471142700.nc0417s14; Guo X, 2021, ORG PROCESS RES DEV, V25, P318, DOI 10.1021/acs.oprd.0c00527; Hughes JP, 2011, BRIT J PHARMACOL, V162, P1239, DOI 10.1111/j.1476-5381.2010.01127.x; Iwamoto N, 2017, NAT BIOTECHNOL, V35, P845, DOI 10.1038/nbt.3948; Jahns H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7317; Khvorova A, 2017, NAT BIOTECHNOL, V35, P238, DOI 10.1038/nbt.3765; Knouse KW, 2018, SCIENCE, V361, P1234, DOI 10.1126/science.aau3369; LETSINGER RL, 1976, J AM CHEM SOC, V98, P3655, DOI 10.1021/ja00428a045; Liu YJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21112-8; MARSHALL WS, 1993, SCIENCE, V259, P1564, DOI 10.1126/science.7681216; MCBRIDE LJ, 1986, J AM CHEM SOC, V108, P2040, DOI 10.1021/ja00268a052; Oka N, 2003, J AM CHEM SOC, V125, P8307, DOI 10.1021/ja034502z; Oka N, 2008, J AM CHEM SOC, V130, P16031, DOI 10.1021/ja805780u; OKRUSZEK A, 1995, J ORG CHEM, V60, P6998, DOI 10.1021/jo00126a060; Ostergaard M. E., NUCL ACIDS RES; Ostergaard ME, 2020, NUCLEIC ACIDS RES, V48, P1691, DOI 10.1093/nar/gkaa031; PORRITT GM, 1990, TETRAHEDRON LETT, V31, P1319, DOI 10.1016/S0040-4039(00)88796-1; Radzikowska E, 2015, ORG BIOMOL CHEM, V13, P269, DOI 10.1039/c4ob01837k; Ravikumar VT, 2008, ORG PROCESS RES DEV, V12, P399, DOI 10.1021/op8000178; REESE CB, 1968, CHEM COMMUN, P767, DOI 10.1039/c19680000767; REESE CB, 1984, J CHEM SOC PERK T 1, P1263, DOI 10.1039/p19840001263; Sekine M, 2003, J ORG CHEM, V68, P5478, DOI 10.1021/jo034204k; Shimizu M., 2020, U.S. Patent, Patent No. [US/10696711, 10696711]; Shimizu M., 2020, U.S. Patent, Patent No. [US/10696711, 10696711]; Shimizu M. W., 2014, International Patent, Patent No. [WO/2014/010250A1, 2014010250]; Singh SK, 1998, CHEM COMMUN, P455, DOI 10.1039/a708608c; Stec WJ, 1998, J AM CHEM SOC, V120, P7156, DOI 10.1021/ja973801j; STEC WJ, 1995, J AM CHEM SOC, V117, P12019, DOI 10.1021/ja00154a001; STEC WJ, 1991, NUCLEIC ACIDS RES, V19, P5883, DOI 10.1093/nar/19.21.5883; Suchsland R, 2021, RSC ADV, V11, P3892, DOI 10.1039/d0ra10941j; Tredenick T., 2016, OLIGONUCLEOTIDES OPP; Wan WB, 2016, J MED CHEM, V59, P9645, DOI 10.1021/acs.jmedchem.6b00551; Wiesler WT, 1996, J ORG CHEM, V61, P4272, DOI 10.1021/jo960274y; WILK A, 1995, NUCLEIC ACIDS RES, V23, P530, DOI 10.1093/nar/23.3.530; Yang X., 2017, CURR PROTOC NUCL ACI, V70; Yang Xianbin, 2017, Curr Protoc Nucleic Acid Chem, V70, DOI 10.1002/cpnc.40	51	11	11	24	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2021	373	6560					1265	+		10.1126/science.abi9727	http://dx.doi.org/10.1126/science.abi9727			336	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UP5RB	34516793	Green Accepted			2022-12-28	WOS:000695436000035
J	Watanabe, T; Pfeil-Gardiner, O; Kahnt, J; Koch, J; Shima, S; Murphy, BJ				Watanabe, Tomohiro; Pfeil-Gardiner, Olivia; Kahnt, Joerg; Koch, Juergen; Shima, Seigo; Murphy, Bonnie J.			Three-megadalton complex of methanogenic electron-bifurcating and CO2-fixing enzymes	SCIENCE			English	Article							HETERODISULFIDE REDUCTION; FORMATE; ARCHAEA; H-2	The first reaction of the methanogenic pathway from carbon dioxide (CO2) is the reduction and condensation of CO2 to formyl-methanofuran, catalyzed by formyl-methanofuran dehydrogenase (Fmd). Strongly reducing electrons for this reaction are generated by heterodisulfide reductase (Hdr) in complex with hydrogenase or formate dehydrogenase (Fdh) using a flavin-based electron-bifurcation mechanism. Here, we report enzymological and structural characterizations of Fdh-Hdr-Fmd complexes from Methanospirillum hungatei. The complexes catalyze this reaction using electrons from formate and the reduced form of the electron carrier F-420. Conformational changes in HdrA mediate electron bifurcation, and polyferredoxin FmdF directly transfers electrons to the CO2 reduction site, as evidenced by methanofuran-dependent flavin-based electron bifurcation even without free ferredoxin, a diffusible electron carrier between Hdr and Fmd. Conservation of Hdr and Fmd structures suggests that this complex is common among hydrogenotrophic methanogens.	[Watanabe, Tomohiro; Koch, Juergen; Shima, Seigo] Max Planck Inst Terr Microbiol, Microbial Prot Struct Grp, D-35043 Marburg, Germany; [Pfeil-Gardiner, Olivia; Murphy, Bonnie J.] Max Planck Inst Biophys, Redox & Metalloprot Res Grp, D-60438 Frankfurt, Germany; [Kahnt, Joerg] Max Planck Inst Terr Microbiol, Core Facil Mass Spectrometry & Prote, D-35043 Marburg, Germany; [Watanabe, Tomohiro] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan	Max Planck Society; Max Planck Society; Max Planck Society; Hokkaido University	Shima, S (corresponding author), Max Planck Inst Terr Microbiol, Microbial Prot Struct Grp, D-35043 Marburg, Germany.; Murphy, BJ (corresponding author), Max Planck Inst Biophys, Redox & Metalloprot Res Grp, D-60438 Frankfurt, Germany.	shima@mpi-marburg.mpg.de; bonnie.murphy@biophys.mpg.de		Pfeil-Gardiner, Olivia/0000-0001-8095-0759; Murphy, Bonnie/0000-0001-6341-9368; Watanabe, Tomohiro/0000-0002-5397-2124	Max Planck Society; Deutsche Forschungsgemeinschaft [SH 87/1-1]; Alexander von Humboldt Foundation; Japan Society for the Promotion of Science	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work is supported by the Max Planck Society (to S.S. and B.J.M.) and Deutsche Forschungsgemeinschaft (SH 87/1-1 to S.S.) and fellowships from the Alexander von Humboldt Foundation and Japan Society for the Promotion of Science (T.W.).	Brodersen J, 1999, ARCH MICROBIOL, V171, P115, DOI 10.1007/s002030050686; Buckel W, 2018, CHEM REV, V118, P3862, DOI 10.1021/acs.chemrev.7b00707; Buckel W, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00401; Costa KC, 2013, J BACTERIOL, V195, P5160, DOI 10.1128/JB.00895-13; Costa KC, 2010, P NATL ACAD SCI USA, V107, P11050, DOI 10.1073/pnas.1003653107; Evans PN, 2019, NAT REV MICROBIOL, V17, P219, DOI 10.1038/s41579-018-0136-7; Halim MFA, 2021, APPL ENVIRON MICROB, V87, DOI 10.1128/AEM.02698-20; Kaster AK, 2011, P NATL ACAD SCI USA, V108, P2981, DOI 10.1073/pnas.1016761108; Lie TJ, 2012, P NATL ACAD SCI USA, V109, P15473, DOI 10.1073/pnas.1208779109; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Liu PF, 2014, APPL ENVIRON MICROB, V80, P4668, DOI 10.1128/AEM.01259-14; Milton RD, 2018, BIOCHEMISTRY-US, V57, P4848, DOI 10.1021/acs.biochem.8b00662; SCHMITZ RA, 1992, EUR J BIOCHEM, V209, P1013, DOI 10.1111/j.1432-1033.1992.tb17376.x; SETZKE E, 1994, EUR J BIOCHEM, V220, P139, DOI 10.1111/j.1432-1033.1994.tb18608.x; Shima S, 2020, ANNU REV MICROBIOL, V74, P713, DOI 10.1146/annurev-micro-011720-122807; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; Thauer RK, 2010, ANNU REV BIOCHEM, V79, P507, DOI 10.1146/annurev.biochem.030508.152103; Vitt S, 2014, J MOL BIOL, V426, P2813, DOI 10.1016/j.jmb.2014.05.024; Wagner T, 2017, SCIENCE, V357, P699, DOI 10.1126/science.aan0425; Wagner T, 2016, SCIENCE, V354, P114, DOI 10.1126/science.aaf9284; Yan Z, 2017, MBIO, V8, DOI 10.1128/mBio.02285-16	21	8	8	15	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2021	373	6559					1151	1155		10.1126/science.abg5550	http://dx.doi.org/10.1126/science.abg5550			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UL8QT	34516836				2022-12-28	WOS:000692910300050
J	Webster, P				Webster, Paul			UNAIDS survey aligns with so-called fourth 90 for HIV/AIDS	LANCET			English	Editorial Material																			0	17	21	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 1	2019	393	10187					2188	2188		10.1016/S0140-6736(19)31231-0	http://dx.doi.org/10.1016/S0140-6736(19)31231-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IB1HV	34509217				2022-12-28	WOS:000470017100011
J	Martin, DP; Weaver, S; Tegally, H; San, JE; Shank, SD; Wilkinson, E; Lucaci, AG; Giandhari, J; Naidoo, S; Pillay, Y; Singh, L; Lessells, RJ; Gupta, RK; Wertheim, JO; Nekturenko, A; Murrell, B; Harkins, GW; Lemey, P; MacLean, OA; Robertson, DL; de Oliveira, T; Pond, SLK				Martin, Darren P.; Weaver, Steven; Tegally, Houriiyah; San, James Emmanuel; Shank, Stephen D.; Wilkinson, Eduan; Lucaci, Alexander G.; Giandhari, Jennifer; Naidoo, Sureshnee; Pillay, Yeshnee; Singh, Lavanya; Lessells, Richard J.; Gupta, Ravindra K.; Wertheim, Joel O.; Nekturenko, Anton; Murrell, Ben; Harkins, Gordon W.; Lemey, Philippe; MacLean, Oscar A.; Robertson, David L.; de Oliveira, Tulio; Pond, Sergei L. Kosakovsky		NGS-SA; COVID-19 Genomics UK COG-UK	The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages	CELL			English	Article							RECEPTOR-BINDING DOMAIN; MUTATIONS	The independent emergence date in 2020 of the B.1.1.7, B.1.351, and P.1 lineages of SARS-CoV-2 prompted renewed concerns about the evolutionary capacity of this virus to overcome public health interventions and rising population immunity. Here, by examining patterns of synonymous and non-synonymous mutations that have accumulated in SARS-CoV-2 genomes since the pandemic began, we find that the emergence of these three "501Y lineages" coincided with a major global shift in the selective forces acting on various SARS-CoV-2 genes. Following their emergence, the adaptive evolution of 501Y lineage viruses has involved repeated selectively favored convergent mutations at 35 genome sites, mutations we refer to as the 501Y meta-signature. The ongoing convergence of viruses in many other lineages on this meta-signature suggests that it includes multiple mutation combinations capable of promoting the persistence of diverse SARS-CoV-2 lineages in the face of mounting host immune recognition.	[Martin, Darren P.] Univ Cape Town, Inst Infect Dis & Mol Med, Dept Integrat Biomed Sci, Div Computat Biol, ZA-7701 Cape Town, South Africa; [Weaver, Steven; Shank, Stephen D.; Lucaci, Alexander G.; Pond, Sergei L. Kosakovsky] Temple Univ, Dept Biol, Inst Genom & Evolutionary Med, Philadelphia, PA 19122 USA; [Tegally, Houriiyah; San, James Emmanuel; Wilkinson, Eduan; Giandhari, Jennifer; Naidoo, Sureshnee; Pillay, Yeshnee; Singh, Lavanya; Lessells, Richard J.; de Oliveira, Tulio] Univ KwaZulu Natal, Sch Lab Med & Med Sci, KwaZulu Natal Res Innovat & Sequencing Platform, ZA-4001 Durban, South Africa; [Gupta, Ravindra K.] Univ Cambridge, Clin Microbiol, Cambridge CB2 1TN, England; [Gupta, Ravindra K.] Africa Hlth Res Inst, ZA-4013 Kwa Zulu, South Africa; [Wertheim, Joel O.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Nekturenko, Anton] Penn State Univ, Dept Biochem & Mol Biol, State Coll, PA 16802 USA; [Murrell, Ben] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-14183 Stockholm, Sweden; [Harkins, Gordon W.] Univ Western Cape, South African Natl Bioinformat Inst, South African Med Res Council, Capac Dev Unit, ZA-7635 Bellville, South Africa; [Lemey, Philippe] Katholieke Univ Leuven, Rega Inst, Dept Microbiol Immunol & Transplantat, B-3000 Leuven, Belgium; [MacLean, Oscar A.; Robertson, David L.] Univ Glasgow, Ctr Virus Res, MRC, Glasgow 12 8QQ, Lanark, Scotland; [de Oliveira, Tulio] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	University of Cape Town; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Kwazulu Natal; University of Cambridge; Africa Health Research Institute; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Karolinska Institutet; South African Medical Research Council; University of the Western Cape; KU Leuven; University of Glasgow; University of Washington; University of Washington Seattle	Martin, DP (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, Dept Integrat Biomed Sci, Div Computat Biol, ZA-7701 Cape Town, South Africa.; Pond, SLK (corresponding author), Temple Univ, Dept Biol, Inst Genom & Evolutionary Med, Philadelphia, PA 19122 USA.; de Oliveira, T (corresponding author), Univ KwaZulu Natal, Sch Lab Med & Med Sci, KwaZulu Natal Res Innovat & Sequencing Platform, ZA-4001 Durban, South Africa.; de Oliveira, T (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	darrenpatrickmartin@gmail.com; tuliodna@gmail.com; spond@temple.edu	Martin, Darren/ABE-3614-2021; Murrell, Ben/AAM-1188-2021; Martin, Darren P/C-4599-2008	MacLean, Oscar/0000-0003-4919-4697; de Oliveira, Tulio/0000-0002-3027-5254; Weaver, Steven/0000-0002-6931-7191; Murrell, Ben/0000-0002-0393-4445; San, James Emmanuel/0000-0002-5736-664X	Wellcome Trust [222574/Z/21/Z, 220977/Z/20/Z, 2206298/Z/17/Z, 206369/Z/17/Z]; US National Institutes of Health [R01 AI134384, AI140970, R01 AI13599, 1U01Al152151-01, U24HG006941]; US National Science Foundation [RAPID 2027196 NSF/DBI]; UK Medical Research Council [MC_UU_1201412]; COG-UK (UK Research Innovation); COG-UK (National Institute of Health Research); COG-UK (Genome Research Limited operating as the Wellcome Sanger Institute); European Research Council [725422-ReservoirDOCS, 874850-MOOD]; South African Medical Research Council	Wellcome Trust(Wellcome Trust); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); COG-UK (UK Research Innovation); COG-UK (National Institute of Health Research); COG-UK (Genome Research Limited operating as the Wellcome Sanger Institute); European Research Council(European Research Council (ERC)European Commission); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We gratefully acknowledge all of the authors from the originating laboratories responsible for obtaining the specimens and the submitting laboratories where genetic sequence data were generated and shared via the GISAID Initiative, on which this research is based (Table S5). We thank Carolyn Williamson, Robert Wilkinson, Valarie Mizrahe, Jonathan Blackburn, and Nicola Mulder for reading and commenting on the manuscript. The Wellcome Trust funded D.P.M. (222574/Z/21/Z), D.L.R. (220977/Z/20/Z), P.L. (2206298/Z/17/Z), and O.A.M. (206369/Z/17/Z). The US National Institutes of Health funded S.L.K.P. (R01 AI134384 and AI140970), J.O.W. (R01 AI13599), G.W.H. (1U01Al152151-01), and J.E.S. and H.T. (via H3ABioNet U24HG006941). The US National Science Foundation funded S.L.K.P. (RAPID 2027196 NSF/DBI,BIO), The UK Medical Research Council funded D.L.R. (MC_UU_1201412) and COG-UK (via UK Research & Innovation, the National Institute of Health Research, and Genome Research Limited operating as the Wellcome Sanger Institute). The European Research Council funded P.L. (725422-ReservoirDOCS and 874850-MOOD). The South African Medical Research Council funded NGS-SA via the Strategic Health Innovation Partnerships Unit of the South African Medical Research Council and Department of Science and Innovation.	Althaus C.L., 2021, TALE 2 VARIANTS SPRE, DOI [10.1101/2021.02.23.21252268, DOI 10.1101/2021.02.23.21252268]; Annavajhala MK, 2021, NOVEL SARS COV 2 VAR, DOI 10.1101/2021.02.23.21252259; Campbell Katie M, 2020, bioRxiv, DOI 10.1101/2020.03.30.016931; Cele S, 2021, NATURE, V593, P142, DOI 10.1038/s41586-021-03471-w; Collier DA, 2021, NATURE, V593, P136, DOI 10.1038/s41586-021-03412-7; Cottam EM, 2011, AUTOPHAGY, V7, P1335, DOI 10.4161/auto.7.11.16642; de Oliveira T., 2021, NOVEL VARIANT INTERE, DOI [10.1101/2021.02.23, DOI 10.1101/2021.02.23]; Dearlove B, 2020, P NATL ACAD SCI USA, V117, P23652, DOI 10.1073/pnas.2008281117; Dudas G., 2021, TRAVEL DRIVEN EMERGE, DOI [10.1101/2021.05.04.21256637v1, DOI 10.1101/2021.05.04.21256637V1]; Elbe S, 2017, GLOB CHALL, V1, P33, DOI 10.1002/gch2.1018; Faria NR, 2021, SCIENCE, V372, P815, DOI [10.1126/science.abh2644Article, 10.1126/science.abh2644, 10.1101/2021.02.26.21252554]; Garcia-Beltran WF, 2021, CELL, V184, P2372, DOI [10.1016/j.cell.2021.03.013, 10.1101/2021.02.14.21251704, 10.1016/j.cell.2021.04.006]; Gard Nelson O.B., 2021, MOL DYNAMIC SIMULATI, DOI 10.1101/2021.01.13.426558; Garry R.F., 2021, SPIKE PROTEIN MUTATI; Garvin MR, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02191-0; Greaney AJ, 2021, CELL HOST MICROBE, V29, P463, DOI 10.1016/j.chom.2021.02.003; Greaney AJ, 2021, CELL HOST MICROBE, V29, P44, DOI 10.1016/j.chom.2020.11.007; Guo K., 2021, INTERFERON RESISTANC, DOI [10.1101/2021.03.20.436257, DOI 10.1101/2021.03.20.436257]; Hoffmann M, 2021, CELL, V184, P2384, DOI 10.1016/j.cell.2021.03.036; Horby P., 2021, NONPARAMETRIC ANAL F; Johnson BA, 2021, NATURE, V591, P293, DOI 10.1038/s41586-021-03237-4; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Pond SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/journal.pcbi.0020062; Kozlov AM, 2019, BIOINFORMATICS, V35, P4453, DOI 10.1093/bioinformatics/btz305; Lau SY, 2020, EMERG MICROBES INFEC, V9, P837, DOI 10.1080/22221751.2020.1756700; Lei XB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17665-9; Lubinski Bailey, 2021, bioRxiv, DOI 10.1101/2021.04.06.438731; Lucaci A.G., 2021, VIROLOGICALORG; MacLean OA, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001115; McCallum M., 2021, CELL, V184, P2332, DOI DOI 10.1016/j.cell.2021.03.028; Miorin L, 2020, P NATL ACAD SCI USA, V117, P28344, DOI 10.1073/pnas.2016650117; Murrell B, 2015, MOL BIOL EVOL, V32, P1365, DOI 10.1093/molbev/msv035; Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Nickle DC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000503; Peacock TP, 2021, J GEN VIROL, V102, DOI 10.1099/jgv.0.001584; Pearson CA., 2021, CMMID REPOSITORY; Plante JA, 2021, NATURE, V592, P116, DOI 10.1038/s41586-020-2895-3; Pond SLK, 2020, MOL BIOL EVOL, V37, P295, DOI 10.1093/molbev/msz197; Pond SLK, 2018, MOL BIOL EVOL, V35, P1812, DOI 10.1093/molbev/msy016; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Poon AFY, 2007, PLOS COMPUT BIOL, V3, P2279, DOI 10.1371/journal.pcbi.0030231; Public Health England, 2020, INV NOVEL SARS COV 2; Pybus OG, 2007, MOL BIOL EVOL, V24, P845, DOI 10.1093/molbev/msm001; Rambaut A., 2020, COVID 19 GENOMICS CO; Rambaut A, 2020, NAT MICROBIOL, V5, P1403, DOI 10.1038/s41564-020-0770-5; Rhee SY, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz135; Scheffler K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094534; Shinde V, 2021, NEW ENGL J MED, V384, P1899, DOI 10.1056/NEJMoa2103055; Simonsen M, 2008, LECT N BIOINFORMAT, V5251, P113, DOI 10.1007/978-3-540-87361-7_10; Starr TN, 2021, SCIENCE, V371, P850, DOI 10.1126/science.abf9302; Starr TN, 2020, CELL, V182, P1295, DOI 10.1016/j.cell.2020.08.012; Tablizo F.A., 2021, MEDRXIV, DOI [10.1101/2021.03.03.21252812, DOI 10.1101/2021.03.03.21252812]; Tegally H, 2021, NATURE, V592, P438, DOI 10.1038/s41586-021-03402-9; Thorne Lucy G, 2021, bioRxiv, DOI 10.1101/2021.06.06.446826; Volz E, 2021, NATURE, V593, P266, DOI 10.1038/s41586-021-03470-x; Wang PF, 2021, NATURE, V593, P130, DOI 10.1038/s41586-021-03398-2; Wang Zijun, 2021, Nature, V592, P616, DOI [10.1038/s41586-021-03324-6, 10.1101/2021.01.15.426911]; Wibmer CK, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01285-x, 10.1101/2021.01.18.427166]; Wu K, 2021, NEW ENGL J MED, V384, P1468, DOI 10.1056/NEJMc2102179; Xia HJ, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108234; Yuan M, 2021, SCIENCE, V373, P818, DOI 10.1126/science.abh1139; Zahradnik J., 2021, BIORXIV, DOI [10.1101/2021.01.06.425392, DOI 10.1101/2021.01.06.425392]; Zhang LZ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19808-4	66	54	55	5	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 30	2021	184	20					5189	+		10.1016/j.cell.2021.09.003	http://dx.doi.org/10.1016/j.cell.2021.09.003		OCT 2021	19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	WC7PG	34537136	Green Published, Bronze			2022-12-28	WOS:000704445700014
J	Hsu, C; Yang, W; Parikh, RV; Anderson, AH; Chen, TK; Cohen, DL; He, J; Mohanty, MJ; Lash, JP; Mills, KT; Muiru, AN; Parsa, A; Saunders, MR; Shafi, T; Townsend, RR; Waikar, SS; Wang, J; Wolf, M; Tan, TC; Feldman, HI; Go, AS				Hsu, C.; Yang, Wei; Parikh, Rishi V.; Anderson, Amanda H.; Chen, Teresa K.; Cohen, Debbie L.; He, Jiang; Mohanty, Madhumita J.; Lash, James P.; Mills, Katherine T.; Muiru, Anthony N.; Parsa, Afshin; Saunders, Milda R.; Shafi, Tariq; Townsend, Raymond R.; Waikar, Sushrut S.; Wang, J.; Wolf, Myles; Tan, Thida C.; Feldman, Harold I.; Go, Alan S.		CRIC Study Investigators	Race, Genetic Ancestry, and Estimating Kidney Function in CKD	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RENAL-INSUFFICIENCY COHORT; GLOMERULAR-FILTRATION-RATE; SERUM CREATININE; AFRICAN ANCESTRY; CYSTATIN-C; EQUATION; EPIDEMIOLOGY; DISEASE; GFR	Background The inclusion of race in equations to estimate the glomerular filtration rate (GFR) has become controversial. Alternative equations that can be used to achieve similar accuracy without the use of race are needed. Methods In a large national study involving adults with chronic kidney disease, we conducted cross-sectional analyses of baseline data from 1248 participants for whom data, including the following, had been collected: race as reported by the participant, genetic ancestry markers, and the serum creatinine, serum cystatin C, and 24-hour urinary creatinine levels. Results Using current formulations of GFR estimating equations, we found that in participants who identified as Black, a model that omitted race resulted in more underestimation of the GFR (median difference between measured and estimated GFR, 3.99 ml per minute per 1.73 m(2) of body-surface area; 95% confidence interval [CI], 2.17 to 5.62) and lower accuracy (percent of estimated GFR within 10% of measured GFR [P-10], 31%; 95% CI, 24 to 39) than models that included race (median difference, 1.11 ml per minute per 1.73 m(2); 95% CI, -0.29 to 2.54; P-10, 42%; 95% CI, 34 to 50). The incorporation of genetic ancestry data instead of race resulted in similar estimates of the GFR (median difference, 1.33 ml per minute per 1.73 m(2); 95% CI, -0.12 to 2.33; P-10, 42%; 95% CI, 34 to 50). The inclusion of non-GFR determinants of the serum creatinine level (e.g., body-composition metrics and urinary excretion of creatinine) that differed according to race reported by the participants and genetic ancestry did not eliminate the misclassification introduced by removing race (or ancestry) from serum creatinine-based GFR estimating equations. In contrast, the incorporation of race or ancestry was not necessary to achieve similarly statistically unbiased (median difference, 0.33 ml per minute per 1.73 m(2); 95% CI, -1.43 to 1.92) and accurate (P-10, 41%; 95% CI, 34 to 49) estimates in Black participants when GFR was estimated with the use of cystatin C. Conclusions The use of the serum creatinine level to estimate the GFR without race (or genetic ancestry) introduced systematic misclassification that could not be eliminated even when numerous non-GFR determinants of the serum creatinine level were accounted for. The estimation of GFR with the use of cystatin C generated similar results while eliminating the negative consequences of the current race-based approaches. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others.) Race, Genetic Ancestry, and Estimation of the GFR The use of race in equations that estimate the glomerular filtration rate is problematic. In this study, the use of the serum creatinine level to estimate the GFR without race (or genetic ancestry) introduced systematic misclassification. Estimating GFR with cystatin C generated similar results but eliminated negative consequences of race-based approaches.	[Hsu, C.; Muiru, Anthony N.; Go, Alan S.] Univ Calif San Francisco, Dept Med, Div Nephrol, San Francisco, CA 94143 USA; [Go, Alan S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA; [Hsu, C.; Parikh, Rishi V.; Tan, Thida C.; Go, Alan S.] Kaiser Permanente Northern Calif, Div Res, 2000 Broadway, Oakland, CA 94612 USA; [Go, Alan S.] Kaiser Permanente Bernard J Tyson Sch Med, Dept Hlth Syst Sci, Pasadena, CA USA; [Go, Alan S.] Stanford Univ, Sch Med, Dept Med, Div Nephrol, Palo Alto, CA 94304 USA; [Yang, Wei; Wang, J.; Feldman, Harold I.] Univ Penn, Dept Biostat Epidemiol & Informat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Yang, Wei; Wang, J.; Feldman, Harold I.] Univ Penn, Ctr Clin Epidemiol & Biostat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Cohen, Debbie L.] Univ Penn, Div Div Renal Electrolyte & Hypertens, Perelman Sch Med, Philadelphia, PA 19104 USA; [Townsend, Raymond R.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Anderson, Amanda H.; He, Jiang; Mills, Katherine T.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; [Anderson, Amanda H.; He, Jiang; Mills, Katherine T.] Tulane Univ, Translat Sci Inst, New Orleans, LA 70118 USA; [Chen, Teresa K.] Johns Hopkins Univ, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21205 USA; [Chen, Teresa K.] Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Parsa, Afshin] NIDDK, Div Kidney Urol & Hematol Dis, NIH, Bethesda, MD 20892 USA; [Mohanty, Madhumita J.] Wayne State Univ, Dept Internal Med, Div Nephrol, Detroit, MI 48202 USA; [Lash, James P.] Univ Illinois, Div Nephrol, Dept Med, Chicago, IL USA; [Saunders, Milda R.] Univ Chicago, Dept Med, Gen Internal Med Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Shafi, Tariq] Univ Mississippi, Med Ctr, Dept Med, Div Nephrol, Jackson, MS 39216 USA; [Waikar, Sushrut S.] Boston Univ, Sch Med, Nephrol Sect, Boston, MA 02118 USA; [Waikar, Sushrut S.] Boston Med Ctr, Boston, MA USA; [Wolf, Myles] Duke Univ, Sch Med, Dept Med, Div Nephrol, Durham, NC 27706 USA; [Wolf, Myles] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Kaiser Permanente; Kaiser Permanente; Stanford University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Tulane University; Tulane University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Wayne State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; University of Mississippi; University of Mississippi Medical Center; Boston University; Boston Medical Center; Duke University; Duke University	Go, AS (corresponding author), Kaiser Permanente Northern Calif, Div Res, 2000 Broadway, Oakland, CA 94612 USA.	alan.s.go@kp.org	He, Jiang/AAF-5303-2020	He, Jiang/0000-0002-8286-9652; Parikh, Rishi/0000-0002-1115-844X	National Institute of Diabetes and Digestive and Kidney Diseases [U01DK060990, U01DK060984, U01DK061022, U01DK061021, U01DK061028, U01DK060980, U01DK060963, U01DK060902, U24DK060990]; Clinical and Translational Science Awards [NIH/NCATS UL1TR000003]; Johns Hopkins University [UL1TR000424]; University of Maryland [GCRC M01RR16500]; Clinical and Translational Science Collaborative of Cleveland from the National Center for Advancing Translational Sciences component of the National Institutes of Health (NIH) [UL1TR000439]; NIH Roadmap for Medical Research, Michigan Institute for Clinical and Health Research [UL1TR000433]; University of Illinois at Chicago [UL1RR029879]; Tulane Center of Biomedical Research Excellence for Clinical and Translational Research in Cardiometabolic Diseases [P20GM109036]; Kaiser Permanente (NIH/NCRR UCSF-CTSI) [UL1RR024131]; Department of Internal Medicine, University of New Mexico School of Medicine [NM R01DK119199]	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Clinical and Translational Science Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University(Johns Hopkins University); University of Maryland; Clinical and Translational Science Collaborative of Cleveland from the National Center for Advancing Translational Sciences component of the National Institutes of Health (NIH); NIH Roadmap for Medical Research, Michigan Institute for Clinical and Health Research; University of Illinois at Chicago; Tulane Center of Biomedical Research Excellence for Clinical and Translational Research in Cardiometabolic Diseases; Kaiser Permanente (NIH/NCRR UCSF-CTSI); Department of Internal Medicine, University of New Mexico School of Medicine	Supported by a cooperative agreement with the National Institute of Diabetes and Digestive and Kidney Diseases (U01DK060990, U01DK060984, U01DK061022, U01DK061021, U01DK061028, U01DK060980, U01DK060963, U01DK060902, and U24DK060990) and by Clinical and Translational Science Awards to the Perelman School of Medicine at the University of Pennsylvania (NIH/NCATS UL1TR000003), Johns Hopkins University (UL1TR000424), University of Maryland (GCRC M01RR16500), Clinical and Translational Science Collaborative of Cleveland (UL1TR000439) from the National Center for Advancing Translational Sciences component of the National Institutes of Health (NIH) and the NIH Roadmap for Medical Research, Michigan Institute for Clinical and Health Research (UL1TR000433), University of Illinois at Chicago (UL1RR029879), Tulane Center of Biomedical Research Excellence for Clinical and Translational Research in Cardiometabolic Diseases (P20GM109036), Kaiser Permanente (NIH/NCRR UCSF-CTSI UL1RR024131), and the Department of Internal Medicine, University of New Mexico School of Medicine (NM R01DK119199).	Ahmed S, 2021, J GEN INTERN MED, V36, P464, DOI 10.1007/s11606-020-06280-5; Amutah BAC, 2021, NEW ENGL J MED, V384, P872, DOI 10.1056/NEJMms2025768; Anderson AH, 2012, AM J KIDNEY DIS, V60, P250, DOI 10.1053/j.ajkd.2012.04.012; Banda Y, 2015, GENETICS, V200, P1285, DOI 10.1534/genetics.115.178616; Blirup-Jensen S, 2008, SCAND J CLIN LAB INV, V68, P67, DOI 10.1080/00365510802150067; Coresh J, 1998, AM J KIDNEY DIS, V32, P32, DOI 10.1053/ajkd.1998.v32.pm9669421; Denker M, 2015, CLIN J AM SOC NEPHRO, V10, P2073, DOI 10.2215/CJN.04260415; Diao JA, 2021, NEW ENGL J MED, V384, P396, DOI 10.1056/NEJMp2028243; Diao JA, 2021, JAMA-J AM MED ASSOC, V325, P184, DOI 10.1001/jama.2020.22124; Eneanya ND, 2019, JAMA-J AM MED ASSOC, V322, P113, DOI 10.1001/jama.2019.5774; Feldman HI, 2003, J AM SOC NEPHROL, V14, pS148, DOI 10.1097/01.ASN.0000070149.78399.CE; Grubb A, 2014, CLIN CHEM, V60, P974, DOI 10.1373/clinchem.2013.220707; Grubbs V, 2020, CLIN J AM SOC NEPHRO, V15, P1201, DOI 10.2215/CJN.00690120; Hsu CY, 2002, KIDNEY INT, V61, P1567, DOI 10.1046/j.1523-1755.2002.00299.x; Inker LA, 2021, NEW ENGL J MED, V385, P1737, DOI 10.1056/NEJMoa2102953; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Levey AS, 2020, CLIN J AM SOC NEPHRO, V15, P1203, DOI 10.2215/CJN.12791019; Levey AS, 2020, JAMA INTERN MED, V180, P793, DOI 10.1001/jamainternmed.2020.0045; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Malina D, 2021, NEW ENGL J MED, V384, P474, DOI 10.1056/NEJMms2029562; MITCH WE, 1980, CLIN SCI, V58, P327, DOI 10.1042/cs0580327; Norris KC, 2021, JAMA-J AM MED ASSOC, V325, P135, DOI 10.1001/jama.2020.23373; Peralta CA, 2010, AM J NEPHROL, V31, P202, DOI 10.1159/000268955; Powe NR, 2020, JAMA-J AM MED ASSOC, V324, P737, DOI 10.1001/jama.2020.13378; Sehgal AR, 2020, ANN INTERN MED, V173, P1008, DOI 10.7326/M20-4951; Shin JI, 2020, J AM SOC NEPHROL, V31, P1847, DOI 10.1681/ASN.2019101119; Subar AF, 2001, AM J EPIDEMIOL, V154, P1089, DOI 10.1093/aje/154.12.1089; Taylor EN, 2007, J AM SOC NEPHROL, V18, P654, DOI 10.1681/ASN.2006080854; Udler MS, 2015, J AM SOC NEPHROL, V26, P1682, DOI 10.1681/ASN.2014050474; Vyas DA, 2020, NEW ENGL J MED, V383, P874, DOI 10.1056/NEJMms2004740; Witzig R, 1996, ANN INTERN MED, V125, P675, DOI 10.7326/0003-4819-125-8-199610150-00008	32	47	48	2	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 4	2021	385	19					1750	1760		10.1056/NEJMoa2103753	http://dx.doi.org/10.1056/NEJMoa2103753		SEP 2021	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WR0CF	34554660	Green Accepted, Bronze			2022-12-28	WOS:000698478900001
J	Maher, SM; Gee, JS; Cheadle, MJ; John, BE				Maher, Sarah M.; Gee, Jeffrey S.; Cheadle, Michael J.; John, Barbara E.			Three-dimensional magnetic stripes require slow cooling in fast-spread lower ocean crust	NATURE			English	Article							EAST PACIFIC RISE; HYDROTHERMAL CIRCULATION; OMAN OPHIOLITE; PITO DEEP; AXIS; CONSTRAINTS; CHARACTER; PETROLOGY; GENESIS; BENEATH	Earth's magnetic field is recorded as oceanic crust cools, generating lineated magnetic anomalies that provide the pattern of polarity reversals for the past 160 million years(1). In the lower (gabbroic) crust, polarity interval boundaries are proxies for isotherms that constrain cooling and hence crustal accretion. Seismic observations(2-4), geospeedometry(5-7) and thermal modelling(8-10) of fast-spread crust yield conflicting interpretations of where and how heat is lost near the ridge, a sensitive indicator of processes of melt transport and crystallization within the crust. Here we show that the magnetic structure of magmatically robust fast-spread crust requires that crustal temperatures near the dike-gabbro transition remain at approximately 500 degrees Celsius for 0.1 million years. Near-bottom magnetization solutions over two areas, separated by approximately 8 kilometres, highlight subhorizontal polarity boundaries within 200 metres of the dike-gabbro transition that extend 7-8 kilometres off-axis. Oriented samples with multiple polarity components provide direct confirmation of a corresponding horizontal polarity boundary across an area approximately one kilometre wide, and indicate slow cooling over three polarity intervals. Our results are incompatible with deep hydrothermal cooling within a few kilometres of the axis(2,7) and instead suggest a broad, hot axial zone that extends roughly 8 kilometres off-axis in magmatically robust fast-spread ocean crust. A record of Earth's magnetic field constructed from near-bottom magnetization observations and oriented samples provides three-dimensional imaging of magnetic stripes in fast-spread crust, and suggests slow cooling off-axis, as opposed to deep hydrothermal cooling close to the spreading ridge.	[Maher, Sarah M.; Gee, Jeffrey S.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Cheadle, Michael J.; John, Barbara E.] Univ Wyoming, Dept Geol & Geophys, Laramie, WY 82071 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Wyoming	Maher, SM (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	s1maher@ucsd.edu		Maher, Sarah/0000-0001-9454-0099				Benjamin SB, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001011; Boudier F, 1996, EARTH PLANET SC LETT, V144, P239, DOI 10.1016/0012-821X(96)00167-7; Brown TC, 2019, J PETROL, V60, P997, DOI 10.1093/petrology/egz022; Canales JP, 2012, NAT GEOSCI, V5, P279, DOI [10.1038/NGEO1377, 10.1038/ngeo1377]; CANDE SC, 1976, J GEOPHYS RES, V81, P4157, DOI 10.1029/JB081i023p04157; Carbotte SM, 2012, OCEANOGRAPHY, V25, P100, DOI 10.5670/oceanog.2012.08; Cheadle M. J., 2019, AGU FALL M; Chutas L. A. M., 2007, STRUCTURES UPPER OCE; Coogan LA, 2002, EARTH PLANET SC LETT, V199, P127, DOI 10.1016/S0012-821X(02)00554-X; Dunn RA, 2000, J GEOPHYS RES-SOL EA, V105, P23537, DOI 10.1029/2000JB900210; Faak K, 2016, GEOLOGY, V44, P115, DOI 10.1130/G37353.1; Gee J, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2000JB000062; GEE J, 1993, J GEOPHYS RES-SOL EA, V98, P11743, DOI 10.1029/93JB00932; Han SS, 2014, EARTH PLANET SC LETT, V390, P31, DOI 10.1016/j.epsl.2013.12.040; Hasenclever J, 2014, NATURE, V508, P508, DOI 10.1038/nature13174; Horst AJ, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2011JB008268; Karson J.A, 2005, INTERRIDGE NEWS, V14, P5; KIRSCHVINK JL, 1980, GEOPHYS J ROY ASTR S, V62, P699, DOI 10.1111/j.1365-246X.1980.tb02601.x; Korenaga J, 1998, EARTH PLANET SC LETT, V156, P1, DOI 10.1016/S0012-821X(98)00004-1; MACDONALD KC, 1983, J GEOPHYS RES, V88, P3403, DOI 10.1029/JB088iB04p03403; Maclennan J, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000605; Maher SM, 2020, GEOCHEM GEOPHY GEOSY, V21, DOI 10.1029/2019GC008671; Marjanovic M, 2014, NAT GEOSCI, V7, P825, DOI 10.1038/NGEO2272; MORGAN JP, 1993, J GEOPHYS RES-SOL EA, V98, P6283, DOI 10.1029/92JB02650; MORTON JL, 1985, J GEOPHYS RES-SOLID, V90, P1345, DOI 10.1029/JB090iB13p11345; NAAR DF, 1991, MAR GEOPHYS RES, V13, P287, DOI 10.1007/BF00366280; NAAR DF, 1991, J GEOPHYS RES-SOLID, V96, P7961, DOI 10.1029/90JB02398; Nagy L, 2017, P NATL ACAD SCI USA, V114, P10356, DOI 10.1073/pnas.1708344114; Neel L., 1949, ANN GEOPHYS, V5, P99; Ogg JG, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P85, DOI 10.1016/B978-0-444-59425-9.00005-6; Olsen N, 2003, EARTH PLANETS SPACE, V55, P11, DOI 10.1186/BF03352458; PARISO JE, 1993, J GEOPHYS RES-SOL EA, V98, P16013, DOI 10.1029/93JB00933; Perk NW, 2007, CONTRIB MINERAL PETR, V154, P575, DOI 10.1007/s00410-007-0210-z; PULLAIAH G, 1975, EARTH PLANET SC LETT, V28, P133, DOI 10.1016/0012-821X(75)90221-6; QUICK JE, 1993, J GEOPHYS RES-SOL EA, V98, P14015, DOI 10.1029/93JB00698; SCHOUTEN H, 1993, J GEOPHYS RES-SOL EA, V98, P6689, DOI 10.1029/92JB02749; Seton M, 2020, GEOCHEM GEOPHY GEOSY, V21, DOI 10.1029/2020GC009214; Sun CG, 2018, EARTH PLANET SC LETT, V487, P165, DOI 10.1016/j.epsl.2018.01.032; TAUXE L, 1991, J GEOPHYS RES-SOLID, V96, P11723, DOI 10.1029/91JB00572; Tivey MA, 1996, J GEOPHYS RES-SOL EA, V101, P20275, DOI 10.1029/96JB01307; VanTongeren JA, 2008, EARTH PLANET SC LETT, V267, P69, DOI 10.1016/j.epsl.2007.11.034; Violay M, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008884; WATSON GS, 1983, J STAT PLAN INFER, V8, P245, DOI 10.1016/0378-3758(83)90043-5; WILSON DS, 1981, GEOPHYS RES LETT, V8, P1051, DOI 10.1029/GL008i010p01051	44	6	6	7	24	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2021	597	7877					511	+		10.1038/s41586-021-03831-6	http://dx.doi.org/10.1038/s41586-021-03831-6			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UW6NQ	34552253				2022-12-28	WOS:000700270400014
J	Siemieniuk, RAC; Bartoszko, JJ; Martinez, JPD; Kum, E; Qasim, A; Zeraatkar, D; Izcovich, A; Mangala, S; Ge, L; Han, MA; Agoritsas, T; Arnold, D; Avila, C; Chu, DK; Couban, R; Cusano, E; Darzi, AJ; Devji, T; Foroutan, F; Ghadimi, M; Khamis, A; Lamontagne, F; Loeb, M; Miroshnychenko, A; Motaghi, S; Murthy, S; Mustafa, RA; Rada, G; Rochwerg, B; Switzer, C; Vandvik, PO; Vernooij, RWM; Wang, Y; Yao, L; Guyatt, GH; Brignardello-Petersen, R				Siemieniuk, Reed A. C.; Bartoszko, Jessica J.; Martinez, Juan Pablo Diaz; Kum, Elena; Qasim, Anila; Zeraatkar, Dena; Izcovich, Ariel; Mangala, Sophia; Ge, Long; Han, Mi Ah; Agoritsas, Thomas; Arnold, Donald; Avila, Camila; Chu, Derek K.; Couban, Rachel; Cusano, Ellen; Darzi, Andrea J.; Devji, Tahira; Foroutan, Farid; Ghadimi, Maryam; Khamis, Assem; Lamontagne, Francois; Loeb, Mark; Miroshnychenko, Anna; Motaghi, Sharhzad; Murthy, Srinivas; Mustafa, Reem A.; Rada, Gabriel; Rochwerg, Bram; Switzer, Charlotte; Vandvik, Per O.; Vernooij, Robin W. M.; Wang, Ying; Yao, Liang; Guyatt, Gordon H.; Brignardello-Petersen, Romina			Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CONVALESCENT PLASMA; GRADE; CERTAINTY; EFFICACY; SAFETY	OBJECTIVE To evaluate the efficacy and safety of antiviral antibody therapies and blood products for the treatment of novel coronavirus disease 2019 (covid-19). DESIGN Living systematic review and network meta-analysis, with pairwise meta-analysis for outcomes with insufficient data. DATA SOURCES WHO covid-19 database, a comprehensive multilingual source of global covid-19 literature, and six Chinese databases (up to 21 July 2021). STUDY SELECTION Trials randomising people with suspected, probable, or confirmed covid-19 to antiviral antibody therapies, blood products, or standard care or placebo. Paired reviewers determined eligibility of trials independently and in duplicate. METHODS After duplicate data abstraction, we performed random effects bayesian meta-analysis, including network meta-analysis for outcomes with sufficient data. We assessed risk of bias using a modification of the Cochrane risk of bias 2.0 tool. The certainty of the evidence was assessed using the grading of recommendations assessment, development, and evaluation (GRADE) approach. We meta-analysed interventions with >= 100 patients randomised or >= 20 events per treatment arm. RESULTS As of 21 July 2021, we identified 47 trials evaluating convalescent plasma (21 trials), intravenous immunoglobulin (IVIg) (5 trials), umbilical cord mesenchymal stem cells (5 trials), bamlanivimab (4 trials), casirivimab-imdevimab (4 trials), bamlanivimab-etesevimab (2 trials), control plasma (2 trials), peripheral blood non-haematopoietic enriched stem cells (2 trials), sotrovimab (1 trial), anti-SARS-CoV-2 IVIg (1 trial), therapeutic plasma exchange (1 trial), XAV-19 polyclonal antibody (1 trial), CT-P59 monoclonal antibody (1 trial) and INM005 polyclonal antibody (1 trial) for the treatment of covid-19. Patients with non-severe disease randomised to antiviral monoclonal antibodies had lower risk of hospitalisation than those who received placebo: casirivimab-imdevimab (odds ratio (OR) 0.29 (95% CI 0.17 to 0.47); risk difference (RD) -4.2%; moderate certainty), bamlanivimab (OR 0.24 (0.06 to 0.86); RD -4.1%; low certainty), bamlanivimab-etesevimab (OR 0.31 (0.11 to 0.81); RD -3.8%; low certainty), and sotrovimab (OR 0.17 (0.04 to 0.57); RD -4.8%; low certainty). They did not have an important impact on any other outcome. There was no notable difference between monoclonal antibodies. No other intervention had any meaningful effect on any outcome in patients with non-severe covid-19. No intervention, including antiviral antibodies, had an important impact on any outcome in patients with severe or critical covid-19, except casirivimab-imdevimab, which may reduce mortality in patients who are seronegative. CONCLUSION In patients with non-severe covid-19, casirivimab-imdevimab probably reduces hospitalisation; bamlanivimab-etesevimab, bamlanivimab, and sotrovimab may reduce hospitalisation. Convalescent plasma, IVIg, and other antibody and cellular interventions may not confer any meaningful benefit. SYSTEMATIC REVIEW REGISTRATION This review was not registered. The protocol established a priori is included as a data supplement.	[Siemieniuk, Reed A. C.; Bartoszko, Jessica J.; Martinez, Juan Pablo Diaz; Kum, Elena; Qasim, Anila; Zeraatkar, Dena; Mangala, Sophia; Agoritsas, Thomas; Chu, Derek K.; Darzi, Andrea J.; Ghadimi, Maryam; Loeb, Mark; Miroshnychenko, Anna; Motaghi, Sharhzad; Mustafa, Reem A.; Rochwerg, Bram; Switzer, Charlotte; Wang, Ying; Yao, Liang; Guyatt, Gordon H.] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON L8S 4L8, Canada; [Siemieniuk, Reed A. C.; Arnold, Donald; Chu, Derek K.; Loeb, Mark; Rochwerg, Bram; Guyatt, Gordon H.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Izcovich, Ariel] Hosp Aleman, Serv Clin Med, Buenos Aires, DF, Argentina; [Ge, Long] Lanzhou Univ, Evidence Based Social Sci Res Ctr, Sch Publ Hlth, Lanzhou, Gansu, Peoples R China; [Han, Mi Ah] Chosun Univ, Coll Med, Dept Prevent Med, Gwangju, South Korea; [Agoritsas, Thomas] Univ Hosp Geneva, Div Gen Internal Med, Geneva, Switzerland; [Agoritsas, Thomas] Univ Hosp Geneva, Div Clin Epidemiol, Geneva, Switzerland; [Avila, Camila; Rada, Gabriel] Epistemonikos Fdn, Santiago, Chile; [Couban, Rachel] McMaster Univ, Dept Anesthesia, Hamilton, ON, Canada; [Cusano, Ellen] Univ Calgary, Dept Med, Calgary, AB, Canada; [Devji, Tahira] Univ Toronto, Med Sch, Toronto, ON, Canada; [Foroutan, Farid] Univ Hlth Network, Ted Rogers Ctr Heart Res, Toronto, ON, Canada; [Khamis, Assem] Hull York Med Sch, Wolfson Palliat Care Res Ctr, Kingston Upon Hull, N Humberside, England; [Lamontagne, Francois] CHU Sherbrooke, Dept Med, Sherbrooke, PQ, Canada; [Lamontagne, Francois] CHU Sherbrooke, Ctr Rech, Sherbrooke, PQ, Canada; [Murthy, Srinivas] Univ British Columbia, Fac Med, Dept Pediat, Vancouver, BC, Canada; [Mustafa, Reem A.] Univ Kansas, Dept Med, Med Ctr, Kansas City, MO USA; [Vandvik, Per O.] Univ Oslo, Inst Hlth & Soc, Oslo, Norway; [Vernooij, Robin W. M.] Univ Med Ctr Utrecht, Dept Nephrol & Hypertens, Utrecht, Netherlands; [Vernooij, Robin W. M.] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	McMaster University; McMaster University; Hospital Aleman; University of Buenos Aires; Lanzhou University; Chosun University; University of Geneva; University of Geneva; McMaster University; University of Calgary; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Hull; University of York - UK; University of Sherbrooke; University of Sherbrooke; University of British Columbia; University of Kansas; University of Oslo; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Siemieniuk, RAC (corresponding author), McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON L8S 4L8, Canada.; Siemieniuk, RAC (corresponding author), McMaster Univ, Dept Med, Hamilton, ON, Canada.	reed.siemieniuk@medportal.ca	Zeraatkar, Dena/GNM-9600-2022; T, E/HII-8943-2022; Couban, Rachel/AAV-1568-2021	Couban, Rachel/0000-0001-8672-2845; Wang, Ying/0000-0002-2296-1991; Chu, Derek/0000-0001-8269-4496; Kum, Elena/0000-0002-6548-2632; Lamontagne, Francois/0000-0002-0360-3427; Qasim, Anila/0000-0001-9658-0078; Izcovich, Ariel/0000-0001-9053-4396; Siemieniuk, Reed/0000-0002-3725-3031; Arnold, Donald/0000-0003-0943-8853; Murthy, Srinivas/0000-0002-9476-839X	Canadian Institutes of Health Research [CIHR-IRSC:0579001321]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by the Canadian Institutes of Health Research (grant CIHR-IRSC:0579001321). The funders had no role in considering the study design or in the collection, analysis, interpretation of data, writing of the report, or decision to submit the article for publication.	ACTIV-3 TICO LY-CoV555 Study Grp, 2021, NEW ENGL J MED, V384, P905, DOI 10.1056/NEJMoa2033130; Agarwal A, CONVALESCENT PLASMA; Ali S, 2021, ECLINICALMEDICINE, V36, DOI 10.1016/j.eclinm.2021.100926; AlQahtani M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-89444-5; Avendano-Sola C., 2020, CONVALESCENT PLASMA, DOI [https://doi.org/10.1101/2020.08.26.20182444, 10.1101/2020.08.26.20182444, DOI 10.1101/2020.08.26.20182444]; Bajpai M., 2020, PREPRINT, DOI [10.25.20219337, 10.1101/2020.10.25.20219337, DOI 10.1101/2020.10.25.20219337]; Balcells ME, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003415; Bandopadhyay P, 2020, ABHISHAKE LAHIRI, DOI [10.1101/2020.09.21.20199109, DOI 10.1101/2020.09.21.20199109]; Bartoszko JJ, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n949; Bennett-Guerrero E, 2021, CRIT CARE MED, V49, P1015, DOI 10.1097/CCM.0000000000005066; Bozzo J, 2017, EXPERT REV ANTI-INFE, V15, P585, DOI 10.1080/14787210.2017.1328278; Brignardello-Petersen R, 2019, J CLIN EPIDEMIOL, V108, P77, DOI 10.1016/j.jclinepi.2018.11.025; Brignardello-Petersen R, 2018, J CLIN EPIDEMIOL, V93, P36, DOI 10.1016/j.jclinepi.2017.10.005; CADTH Covid-19 Pandemic, 2020, CONV PLASM THER TREA; Centers for Disease Control and Prevention, 2020, COVIDVIEW WEEKL SURV; Centers for Disease Control and Prevention, 2020, COVID 19 RES ART DOW; Centers for Disease Control and Prevention, 2020, DAIL UPD TOT WEEK ST; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Chen P, 2021, NEW ENGL J MED, V384, P229, DOI 10.1056/NEJMoa2029849; Cytel, 2020, GLOB COR COVID 19 CL; Daar E., 2021, C RETR OPP INF; Devasenapathy N, 2020, CAN MED ASSOC J, V192, pE745, DOI 10.1503/cmaj.200642; Dilogo IH, 2021, STEM CELL TRANSL MED, V10, P1279, DOI 10.1002/sctm.21-0046; Djulbegovic B, 2020, J CLIN EPIDEMIOL, V126, P164, DOI 10.1016/j.jclinepi.2020.07.002; Dougan M, 2021, NEW ENGL J MED, V385, P1382, DOI 10.1056/NEJMoa2102685; Elliott JH, 2017, J CLIN EPIDEMIOL, V91, P23, DOI 10.1016/j.jclinepi.2017.08.010; Eom JS, 2021, RES SQUARE, DOI DOI 10.21203/RS.3.RS-296518/V1; Epistemonikos Foundation, 2020, LIV EV REP COVID 19; Faqihi F, 2021, INT J ANTIMICROB AG, V57, DOI 10.1016/j.ijantimicag.2021.106334; Friedrich JO, 2011, J CLIN EPIDEMIOL, V64, P556, DOI 10.1016/j.jclinepi.2010.09.016; Gaborit B, 2021, ANTIMICROB AGENTS CH, V65, DOI 10.1128/AAC.01237-21; Gharbharan A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23469-2; Gharebaghi N, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05507-4; Gonzalez JLB, 2021, MEDRXIV, V2021, DOI [10.1101/2021.03.28.21254507, DOI 10.1101/2021.03.28.21254507]; Gottlieb RL, 2021, JAMA-J AM MED ASSOC, V325, P632, DOI 10.1001/jama.2021.0202; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P407, DOI 10.1016/j.jclinepi.2010.07.017; Hoffmann M, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109415; Horby PW, 2021, LANCET, V397, P2049, DOI 10.1016/S0140-6736(21)00897-7; Horby PW, 2021, LANCET, DOI [10.1101/2021.06.15.21258542, DOI 10.1101/2021.06.15.21258542V1]; Hultcrantz M, 2017, J CLIN EPIDEMIOL, V87, P4, DOI 10.1016/j.jclinepi.2017.05.006; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; Johns Hopkins University, 2020, COR RES CTR; Korper S, 2021, MEDRXIV2021051021256, V2021, DOI [10.1101/2021.05.10.21256192, DOI 10.1101/2021.05.10.21256192]; Lamontagne F, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n526; Lamontagne F, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3379; Lanzoni G, 2021, STEM CELL TRANSL MED, V10, P660, DOI 10.1002/sctm.20-0472; Li L, 2020, JAMA-J AM MED ASSOC, V324, P460, DOI 10.1001/jama.2020.10044; Libster R, 2021, NEW ENGL J MED, V384, P610, DOI 10.1056/NEJMoa2033700; Looney RJ, 2006, BEST PRACT RES CL HA, V19, P3, DOI 10.1016/j.beha.2005.01.032; Lopardo G, 2021, ECLINICALMEDICINE, V34, DOI 10.1016/j.eclinm.2021.100843; Mair-Jenkins J, 2015, J INFECT DIS, V211, P80, DOI 10.1093/infdis/jiu396; Marshall IJ, 2018, RES SYNTH METHODS, V9, P602, DOI 10.1002/jrsm.1287; Moher D, 2010, INT J SURG, V8, P658, DOI 10.1016/j.ijsu.2010.07.299; Murchu EO, 2022, ANN PHARMACOTHER, V56, P309, DOI 10.1177/10600280211028242; Norwegian Institute of Public Health, 2020, CO2 COSOURCES CONSUM; O'Donnell MR, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI150646; OBrien MP, SUBCUTANEOU REGEN CO, V2021; Page MJ, 2021, BMJ-BRIT MED J, V372, DOI [10.1136/bmj.n71, 10.1016/j.ijsu.2021.105906]; Planas D, 2021, NATURE, V596, P276, DOI 10.1038/s41586-021-03777-9; Pouladzadeh M, 2021, INTERN EMERG MED, V16, P2181, DOI 10.1007/s11739-021-02734-8; Pritchard M, 2020, ISARIC CLIN DATA REP, DOI [10.1101/2020.07.17.20155218, DOI 10.1101/2020.07.17.20155218]; Puhan MA, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5630; Raman RS, 2021, J INFECT DIS, V223, P1538, DOI 10.1093/infdis/jiab098; Ray Y., 2020, INFECT DIS EXCEPT HI, V2020, p11.25.20237883, DOI 10.1101/2020.11.25.20237883; Rover C, 2020, J STAT SOFTW, V93, P1, DOI 10.18637/jss.v093.i06; Sakoulas G, 2020, MEDRXIV, V2, DOI DOI 10.1101/2020.07.20.20157891; Salman OH, 2020, EGYPT J ANAESTH, V36, P264, DOI 10.1080/11101849.2020.1842087; Sarkis E, 2021, EARLY COVID19 TREATM, DOI [10.1101/2021.05.27.21257096, DOI 10.1101/2021.05.27.21257096]; Schandelmaier S, 2020, CAN MED ASSOC J, V192, pE901, DOI 10.1503/cmaj.200077; Sekine L, 2022, EUR RESPIR J, V59, DOI 10.1183/13993003.01471-2021; Shi L, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00488-5; Shu L, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-01875-5; Siemieniuk RA, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i5191; Siemieniuk RAC, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2980; Simonovich VA, 2021, NEW ENGL J MED, V384, P619, DOI 10.1056/NEJMoa2031304; Sterne JAC, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4898; Tabarsi P, 2021, INT IMMUNOPHARMACOL, V90, DOI 10.1016/j.intimp.2020.107205; Taylor PC, 2021, NAT REV IMMUNOL, V21, P382, DOI 10.1038/s41577-021-00542-x; The CONCOR-1 Study Group CONCOR-1 writing committeeBegin P, CONVALESCENT PLASMA, V2021; The REMAP-CAP InvestigatorsEstcourt LJ, MEDRXIV, V2021, DOI [10.1101/2021.06.11.21258760, DOI 10.1101/2021.06.11.21258760]; Torres Zambrano GM, 2020, FEATURES OUTCOMES SE, DOI [10.1101/2020.12.05.20244483, DOI 10.1101/2020.12.05.20244483]; Turner RM, 2015, STAT MED, V34, P984, DOI 10.1002/sim.6381; US Food & Drug Administration, 2021, CONV PLASM COVID 19; Valk SJ, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013600; van Griensven J, 2016, NEW ENGL J MED, V374, P33, DOI 10.1056/NEJMoa1511812; van Valkenhoef G, 2016, RES SYNTH METHODS, V7, P80, DOI 10.1002/jrsm.1167; Vandvik PO, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0596-4; Weinreich DM, REGEN COV ANTIBODY C, V2021; Weinreich DM, 2021, REGEN COV ANTIBODY C, V2021, DOI [10.1101/2021.06.09.21257915, DOI 10.1101/2021.06.09.21257915]; WHO-Worl Health Organization, 2020, CRIT REL COVID 19 PA; World Health Organization, 2021, THERAPEUTICS COVID 1; Yendry Ventura C, 2021, RES SQUARE, DOI [10.21203/rs.3.rs-558653/v1, DOI 10.21203/RS.3.RS-558653/V1]	93	33	33	4	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2021	374								n2231	10.1136/bmj.n2231	http://dx.doi.org/10.1136/bmj.n2231			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ1JE	34556486	Green Published, hybrid			2022-12-28	WOS:000701967300014
J	Carbone, F				Carbone, Fabrizio			An electron walks into a quantum bar...	SCIENCE			English	Editorial Material									[Carbone, Fabrizio] Ecole Polytech Fed, Inst Phys, Lausanne, Switzerland	Ecole Polytechnique Federale de Lausanne	Carbone, F (corresponding author), Ecole Polytech Fed, Inst Phys, Lausanne, Switzerland.	fabrizio.carbone@epfl.ch			ERC Consolidator grant ISCQuM	ERC Consolidator grant ISCQuM	We acknowledge funding from the ERC Consolidator grant ISCQuM.	Barwick B, 2009, NATURE, V462, P902, DOI 10.1038/nature08662; Dahan R., 2021, SCIENCE, V373; Di Giulio V, 2019, OPTICA, V6, P1524, DOI 10.1364/OPTICA.6.001524; de Abajo FJG, 2010, NANO LETT, V10, P1859, DOI 10.1021/nl100613s; Kfir O, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.103602; Lamb W. E., 1968, CTSQED681; Madan I, 2020, APPL PHYS LETT, V116, DOI 10.1063/1.5143008; Park ST, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.013851; Rotunno E., 2021, ARXIV210608955QUANTP	9	0	0	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2021	373	6561					1309	1310		10.1126/science.abl6366	http://dx.doi.org/10.1126/science.abl6366			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	US5SK	34529482				2022-12-28	WOS:000697488600027
J	Clutton-Brock, T				Clutton-Brock, Tim			Social evolution in mammals	SCIENCE			English	Review							LONG-TERM FIELD; PARENTAL INVESTMENT; SEXUAL SELECTION; REPRODUCTIVE SUCCESS; ECOLOGICAL CONSTRAINTS; INBREEDING DEPRESSION; GENETIC RELATEDNESS; SPERM COMPETITION; GROUP-SIZE; MOLE-RATS	Long-term, individual-based field studies, the application of genetic techniques, and phylogenetic reconstructions have led to substantial advances in our understanding of the diversity and evolution of mammalian breeding systems and their consequences. These studies show how differences in ecology, life histories, and phylogeny affect the distributions of breeding females and breeding males; how the distributions of both sexes affect the evolution of breeding systems and the composition and kinship structure of social groups; how differences in breeding systems and the social environment that individuals encounter affect the selection pressures operating on both sexes and the evolution of their behavior, physiology, and morphology; and how these differences affect the demography and dynamics of populations and their responses to variation in density, climate, and human impact.	[Clutton-Brock, Tim] Univ Cambridge, Dept Zool, Cambridge, England	University of Cambridge	Clutton-Brock, T (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	thcb@cam.ac.uk			European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [294494, 742808]; Human Frontier Science Program [RGP0051/2017]	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program(European Research Council (ERC)); Human Frontier Science Program(Human Frontier Science Program)	This research is part of a project that has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grants 294494 and 742808) and from the Human Frontier Science Program (grant RGP0051/2017).	[Anonymous], 2016, SOCIALITY IN BATS; Archie EA, 2006, P ROY SOC B-BIOL SCI, V273, P513, DOI 10.1098/rspb.2005.3361; Armitage Kenneth B., 2007, P356; Ashwell K. W. S., 2013, NEUROBIOLOGY MONOTRE, P1; Baird RW, 2000, CETACEAN SOCIETIES, P127; Baniel A, 2017, CURR BIOL, V27, P2163, DOI 10.1016/j.cub.2017.06.013; Bell MBV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5499; Bennett N.C., 2000, AFRICAN MOLE RATS EC; Berglund A, 2013, CURR ZOOL, V59, P564, DOI 10.1093/czoolo/59.4.564; Berube CH, 1996, BEHAV ECOL, V7, P60, DOI 10.1093/beheco/7.1.60; Blumstein DT, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.1934; Blumstein DT, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0349; Bowyer RT, 2020, ECOL EVOL, V10, P5160, DOI 10.1002/ece3.6246; Brett R.A., 1991, P97; Briga M, 2012, BIOL LETTERS, V8, P533, DOI 10.1098/rsbl.2012.0159; Brotherton Peter N. M., 2003, P42; Brotherton PNM, 1997, P ROY SOC B-BIOL SCI, V264, P675, DOI 10.1098/rspb.1997.0096; BROWN JL, 1969, WILSON BULL, V81, P293; BROWN WL, 1958, SYST ZOOL, V7, P157, DOI 10.2307/2411715; Burda H, 2000, BEHAV ECOL SOCIOBIOL, V47, P293, DOI 10.1007/s002650050669; Burland TM, 2002, P ROY SOC B-BIOL SCI, V269, P1025, DOI 10.1098/rspb.2002.1978; Cant Michael A., 2016, P318; CHAPMAN CA, 1995, BEHAV ECOL SOCIOBIOL, V36, P59, DOI 10.1007/BF00175729; Charmantier A, 2014, QUANTITATIVE GENETICS IN THE WILD, P1; Chowdhury S, 2015, AM J PHYS ANTHROPOL, V158, P501, DOI 10.1002/ajpa.22804; Clutton-Brock T., 2016, MAMMAL SOC; Clutton-Brock TH, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0074; Clutton-Brock TH, 2012, MOL ECOL, V21, P472, DOI 10.1111/j.1365-294X.2011.05232.x; Clutton-Brock TH, 2006, NATURE, V444, P1065, DOI 10.1038/nature05386; Clutton-Brock T.H., 1988, P325; Clutton-Brock T.H., 1991, P229; Clutton-Brock TH, 2006, BIOL LETTERS, V2, P513, DOI 10.1098/rsbl.2006.0531; Clutton-Brock T. H., 1991, MONOGRAPHS BEHAV ECO; Clutton-Brock TH, 2001, ANIM BEHAV, V61, P705, DOI 10.1006/anbe.2000.1631; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; Clutton-Brock T, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0310; Clutton-Brock Tim, 2016, P294; Clutton-Brock T, 2010, TRENDS ECOL EVOL, V25, P562, DOI 10.1016/j.tree.2010.08.002; CLUTTONBROCK TH, 1981, NATURE, V289, P487, DOI 10.1038/289487a0; CLUTTONBROCK TH, 1979, ANIM BEHAV, V27, P211, DOI 10.1016/0003-3472(79)90141-6; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; CLUTTONBROCK TH, 1995, ANIM BEHAV, V49, P1345, DOI 10.1006/anbe.1995.0166; CLUTTONBROCK TH, 1985, NATURE, V313, P131, DOI 10.1038/313131a0; CLUTTONBROCK TH, 1994, J APPL ECOL, V31, P521, DOI 10.2307/2404447; CLUTTONBROCK TH, 1993, ANIM BEHAV, V46, P1121, DOI 10.1006/anbe.1993.1302; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; CLUTTONBROCK TH, 1973, FOLIA PRIMATOL, V19, P368, DOI 10.1159/000155552; CluttonBrock TH, 1997, P ROY SOC B-BIOL SCI, V264, P1509, DOI 10.1098/rspb.1997.0209; Cohas A, 2009, BIOL LETTERS, V5, P313, DOI 10.1098/rsbl.2008.0760; Conradt L, 2000, ANIM BEHAV, V59, P1049, DOI 10.1006/anbe.2000.1409; Cooney R, 2000, P ROY SOC B-BIOL SCI, V267, P801, DOI 10.1098/rspb.2000.1074; Courchamp F, 1999, P ROY SOC B-BIOL SCI, V266, P557, DOI 10.1098/rspb.1999.0672; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Cram DL, 2019, BEHAV ECOL, V30, P1743, DOI 10.1093/beheco/arz143; Creel S., 2002, AFRICAN WILD DOG BEH; Darwin, 1859, ORIGINS SPECIES MEAN; Davies CS, 2016, SCI REP-UK, V6, DOI 10.1038/srep35492; DIFIORE A, 1994, P NATL ACAD SCI USA, V91, P9941, DOI 10.1073/pnas.91.21.9941; Dixson A.F., 2009, SEXUAL SELECTION ORI; Dobson FS, 2010, BEHAV ECOL, V21, P747, DOI 10.1093/beheco/arq048; Drea CM, 2007, HORM BEHAV, V51, P555, DOI 10.1016/j.yhbeh.2007.02.006; Dubuc C, 2019, ECOL EVOL, V9, P1127, DOI 10.1002/ece3.4801; Duncan C, 2019, AM NAT, V193, P841, DOI 10.1086/703113; Duncan C, 2018, ANIM BEHAV, V146, P113, DOI 10.1016/j.anbehav.2018.10.013; Dyble M, 2020, BEHAV ECOL, V31, P971, DOI 10.1093/beheco/araa043; Ebensperger LA, 2001, ACTA THERIOL, V46, P115, DOI 10.1007/BF03192423; Ebensperger LA, 2008, BEHAV PROCESS, V79, P85, DOI 10.1016/j.beproc.2008.05.006; Eisenberg J.F., 1987, P60; Eisenberg J.F., 1981, P1; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Estes R., 2014, GNUS WORLD SERENGETI; Federico V, 2020, AM NAT, V195, P1037, DOI 10.1086/708639; FITZGIBBON CD, 1990, ANIM BEHAV, V39, P1116, DOI 10.1016/S0003-3472(05)80784-5; Froy H, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0417; Funston PJ, 1998, ANIM BEHAV, V56, P1333, DOI 10.1006/anbe.1998.0884; Garber PA, 2016, AM J PRIMATOL, V78, P298, DOI 10.1002/ajp.22370; Garber Paul A., 1997, Evolutionary Anthropology, V5, P187, DOI 10.1002/(SICI)1520-6505(1997)5:6<187::AID-EVAN1>3.0.CO;2-A; Gienapp P, 2014, QUANTITATIVE GENETICS IN THE WILD, P254; Girman DJ, 1997, BEHAV ECOL SOCIOBIOL, V40, P187, DOI 10.1007/s002650050332; Griffin AS, 2003, BEHAV ECOL, V14, P472, DOI 10.1093/beheco/arg040; Groenewoud F, 2021, J ANIM ECOL, V90, P641, DOI 10.1111/1365-2656.13396; Gubernick DJ, 2000, P ROY SOC B-BIOL SCI, V267, P147, DOI 10.1098/rspb.2000.0979; Hager R, 2009, REPRODUCTIVE SKEW IN VERTEBRATES: PROXIMATE AND ULTIMATE CAUSES, P1, DOI 10.1017/CBO9780511641954; Hanson-Smith V, 2010, MOL BIOL EVOL, V27, P1988, DOI 10.1093/molbev/msq081; HARCOURT AH, 1981, NATURE, V293, P55, DOI 10.1038/293055a0; Hayes LD, 2017, J MAMMAL, V98, P600, DOI 10.1093/jmammal/gyx027; Honer OP, 2007, NATURE, V448, P798, DOI 10.1038/nature06040; HOFFMAN KA, 1995, DEV PSYCHOBIOL, V28, P399, DOI 10.1002/dev.420280705; Hofmann HA, 2014, TRENDS ECOL EVOL, V29, P581, DOI 10.1016/j.tree.2014.07.008; Holekamp KE, 1997, J MAMMAL, V78, P55, DOI 10.2307/1382638; Holekamp KE, 1996, J REPROD FERTIL, V108, P229; Hoogland J. L., 1995, BLACK TAILED PRAIRIE; Houslay TM, 2020, BEHAV ECOL, V31, P711, DOI 10.1093/beheco/araa015; HRDY SB, 1979, ETHOL SOCIOBIOL, V1, P13, DOI 10.1016/0162-3095(79)90004-9; Huchard E, 2016, NATURE, V533, P532, DOI 10.1038/nature17986; Huck M, 2005, AM J PHYS ANTHROPOL, V127, P449, DOI 10.1002/ajpa.20136; Huck M, 2020, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00472; Huisman J, 2016, P NATL ACAD SCI USA, V113, P3585, DOI 10.1073/pnas.1518046113; Irschick DJ, 2006, PHYSIOL BIOCHEM ZOOL, V79, P73, DOI 10.1086/498194; Isvaran K., 2020, FRONT ECOL EVOL, V8, P444; Isvaran K, 2020, RESONANCE, V25, P353, DOI 10.1007/s12045-020-0950-x; Iwasa Y, 1998, AM NAT, V151, P367, DOI 10.1086/286125; James WH, 1999, APPL ANIM BEHAV SCI, V65, P153, DOI 10.1016/S0168-1591(99)00054-4; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; JARMAN PJ, 1991, ADV STUD BEHAV, V20, P1; Jetz W, 2011, CURR BIOL, V21, P72, DOI 10.1016/j.cub.2010.11.075; Johnston SE, 2013, NATURE, V502, P93, DOI 10.1038/nature12489; Jungwirth A, 2019, AM NAT, V193, pE29, DOI 10.1086/700698; Kappeler PM, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aay1276; Kappeler PM, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0321; Kappeler PM, 1998, AM J PRIMATOL, V46, P7; Kappeler PM, 2002, P ROY SOC B-BIOL SCI, V269, P1755, DOI 10.1098/rspb.2002.2066; Kappeler PM, 2002, INT J PRIMATOL, V23, P707, DOI 10.1023/A:1015520830318; Kappeler PM, 1997, BIOL REV, V72, P111, DOI 10.1017/S0006323196004999; Klug H, 2018, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00030; Kokko H, 2008, J EVOLUTION BIOL, V21, P919, DOI 10.1111/j.1420-9101.2008.01540.x; KOMDEUR J, 1995, ANIM BEHAV, V49, P695; Kruuk LEB, 1999, P ROY SOC B-BIOL SCI, V266, P1655, DOI 10.1098/rspb.1999.0828; Kvarnemo C, 2018, BIOL REV, V93, P1795, DOI 10.1111/brv.12421; Lambert CT, 2018, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00139; Lande R., 2003, OXFORD SERIES ECOLOG; Lane JE, 2009, J ANIM ECOL, V78, P296, DOI 10.1111/j.1365-2656.2008.01502.x; Langergraber K, 2009, AM J PRIMATOL, V71, P840, DOI 10.1002/ajp.20711; Langergraber KE, 2007, P NATL ACAD SCI USA, V104, P7786, DOI 10.1073/pnas.0611449104; Larson SM, 2016, AM J PRIMATOL, V78, P315, DOI 10.1002/ajp.22408; Le Boeuf B.J., 1993, Symposia of the Zoological Society of London, V66, P149; le Boeuf B.J., 1988, P344; Lea AJ, 2018, P NATL ACAD SCI USA, V115, pE12163, DOI 10.1073/pnas.1811967115; LEBOEUF BJ, 1991, BEHAVIOUR, V116, P143, DOI 10.1163/156853990X00400; Lemaitre JF, 2020, MECH AGEING DEV, V192, DOI 10.1016/j.mad.2020.111377; Lemaitre JF, 2020, P NATL ACAD SCI USA, V117, P8546, DOI 10.1073/pnas.1911999117; Liker A, 2021, EVOLUTION, V75, P1636, DOI 10.1111/evo.14273; Lindenfors Patrik, 2007, P16; LOTT DF, 1981, Z TIERPSYCHOL, V56, P97; Lukas D, 2005, MOL ECOL, V14, P2181, DOI 10.1111/j.1365-294X.2005.02560.x; Lukas D, 2013, SCIENCE, V341, P526, DOI 10.1126/science.1238677; Lukas D, 2011, J EVOLUTION BIOL, V24, P2624, DOI 10.1111/j.1420-9101.2011.02385.x; Lukas D, 2020, BEHAV ECOL, V31, P943, DOI 10.1093/beheco/araa039; Lukas D, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0075; Lukas D, 2018, ECOL LETT, V21, P1129, DOI 10.1111/ele.13079; Lukas D, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160897; Lukas D, 2014, P NATL ACAD SCI USA, V111, pE1674, DOI 10.1073/pnas.1401012111; Lukas D, 2012, P ROY SOC B-BIOL SCI, V279, P2151, DOI 10.1098/rspb.2011.2468; Macdonald DW, 2019, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00341; Martins MJF, 2018, NATURE, V556, P366, DOI 10.1038/s41586-018-0020-7; Mayr E., 1963, ANIMAL SPECIES EVOLU; Melletti, 2020, BEARS OF THE WORLD, P21; Mitani JC, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P102, DOI 10.1017/CBO9780511606397.011; Mitani JC, 1996, AM J PRIMATOL, V38, P315, DOI 10.1002/(SICI)1098-2345(1996)38:4<315::AID-AJP3>3.0.CO;2-1; Moll RJ, 2009, COMPUT ELECTRON AGR, V66, P133, DOI 10.1016/j.compag.2009.01.001; Nichols HJ, 2012, MOL ECOL, V21, P5348, DOI 10.1111/mec.12015; Nielsen JF, 2012, MOL ECOL, V21, P2788, DOI 10.1111/j.1365-294X.2012.05565.x; Norouzzadeh MS, 2018, P NATL ACAD SCI USA, V115, pE5716, DOI 10.1073/pnas.1719367115; Opie C, 2013, P NATL ACAD SCI USA, V110, P13328, DOI 10.1073/pnas.1307903110; OWENSMITH N, 1993, J ANIM ECOL, V62, P428, DOI 10.2307/5192; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; Palombit Ryne A., 2012, P432; Perez-Gonzalez J, 2011, ANIM BEHAV, V82, P957, DOI 10.1016/j.anbehav.2011.07.023; Perrin N, 2012, MOL ECOL, V21, P443, DOI 10.1111/j.1365-294X.2011.05404.x; Petelle MB, 2015, J EVOLUTION BIOL, V28, P1840, DOI 10.1111/jeb.12700; Petty JMA, 2015, SCI REP-UK, V5, DOI 10.1038/srep09631; PLAVCAN JM, 1995, J HUM EVOL, V28, P245, DOI 10.1006/jhev.1995.1019; Plusquellec P, 2001, APPL ANIM BEHAV SCI, V72, P1, DOI 10.1016/S0168-1591(00)00198-2; Poindexter SA, 2020, CAM S BIO EVOL ANTHR, V86, P129; Port M, 2020, AM J PHYS ANTHROPOL, V173, P397, DOI 10.1002/ajpa.24123; PRICE K, 1993, BEHAV ECOL, V4, P144, DOI 10.1093/beheco/4.2.144; RALLS K, 1976, Q REV BIOL, V51, P245, DOI 10.1086/409310; RALLS K, 1977, AM NAT, V111, P917, DOI 10.1086/283223; Ramm SA, 2005, P ROY SOC B-BIOL SCI, V272, P949, DOI 10.1098/rspb.2004.3048; Roberts EK, 2012, SCIENCE, V335, P1222, DOI 10.1126/science.1213600; Rood J.P., 1986, P131; ROSSER AM, 1992, BEHAV ECOL, V3, P13, DOI 10.1093/beheco/3.1.13; Rubenstein D.I., 1986, P282; Rubenstein D. R., 2017, COMP SOCIAL EVOLUTIO; Rubenstein DR, 2015, CURR OPIN BEHAV SCI, V6, P154, DOI 10.1016/j.cobeha.2015.11.007; Rubenstein DR, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160147; Ruby JG, 2018, ELIFE, V7, DOI 10.7554/eLife.31157; Ruckstuhl KE, 2000, BEHAVIOUR, V137, P361, DOI 10.1163/156853900502123; Runcie DE, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0345; Russell AF, 2003, P NATL ACAD SCI USA, V100, P3333, DOI 10.1073/pnas.0636503100; Schacht R, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0309; Schradin C, 2020, BEHAV ECOL SOCIOBIOL, V74, DOI 10.1007/s00265-020-02896-z; Schradin C, 2017, J MAMMAL, V98, P670, DOI 10.1093/jmammal/gyx031; Schradin C, 2013, HORM BEHAV, V63, P136, DOI 10.1016/j.yhbeh.2012.10.004; Schradin C, 2012, MOL ECOL, V21, P541, DOI 10.1111/j.1365-294X.2011.05256.x; Schradin C, 2010, J ANIM ECOL, V79, P515, DOI 10.1111/j.1365-2656.2009.01651.x; Schulke O, 2003, ANIM BEHAV, V65, P331, DOI 10.1006/anbe.2003.2018; Shen SF, 2017, ECOL LETT, V20, P708, DOI 10.1111/ele.12774; SILK JB, 1981, ANIM BEHAV, V29, P1106, DOI 10.1016/S0003-3472(81)80063-2; Silk JB, 2007, SCIENCE, V317, P1347, DOI 10.1126/science.1140734; SMITH CC, 1970, ECOL MONOGR, V40, P349, DOI 10.2307/1942287; Smith JE, 2021, J ANIM ECOL, V90, P62, DOI 10.1111/1365-2656.13362; Smith JE, 2017, COMPARATIVE SOCIAL EVOLUTION, P284; SMITH JM, 1977, ANIM BEHAV, V25, P1, DOI 10.1016/0003-3472(77)90062-8; Snyder-Mackler N, 2012, P ROY SOC B-BIOL SCI, V279, P3788, DOI 10.1098/rspb.2012.0842; Solomon NG, 2003, J MAMMAL, V84, P1182, DOI 10.1644/BLe-013; Spong G, 2002, J EVOLUTION BIOL, V15, P945, DOI 10.1046/j.1420-9101.2002.00473.x; Spong GF, 2008, MOL ECOL, V17, P2287, DOI 10.1111/j.1365-294X.2008.03734.x; STOCKLEY P, 1993, FUNCT ECOL, V7, P560, DOI 10.2307/2390132; Stockley P, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0140; Stredulinsky EH, 2021, BEHAV ECOL SOCIOBIOL, V75, DOI 10.1007/s00265-021-02992-8; Strier KB, 2002, BEHAVIOUR, V139, P315, DOI 10.1163/156853902760102690; Swenson JE, 1997, NATURE, V386, P450, DOI 10.1038/386450a0; Tecot SR, 2016, AM J PRIMATOL, V78, P340, DOI 10.1002/ajp.22412; Thorley, 2018, THESIS U CAMBRIDGE C; Thorley J, 2018, ANIM BEHAV, V143, P9, DOI 10.1016/j.anbehav.2018.07.004; Treanore E, 2021, ANN ENTOMOL SOC AM, V114, P547, DOI 10.1093/aesa/saaa033; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Van Belle S, 2021, AM J PRIMATOL, V83, DOI 10.1002/ajp.23225; Van Horn RC, 2004, MOL ECOL, V13, P449, DOI 10.1046/j.1365-294X.2003.02071.x; van Schaik Carel P., 2000, P27, DOI 10.1017/CBO9780511542312.004; West HER, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11854; West SA, 2002, SCIENCE, V295, P1685, DOI 10.1126/science.1069043; Whitman K, 2004, NATURE, V428, P175, DOI 10.1038/nature02395; Wiley EM, 2016, ANIM BEHAV, V117, P187, DOI 10.1016/j.anbehav.2016.05.009; Williams G. C., 1966, P307; Wilson, 1974, SOCIOBIOLOGY NEW SYN; Wilson K, 2004, SOAY SHEEP: DYNAMICS AND SELECTION IN AN ISLAND POPULATION, P113; WITTENBERGER JF, 1980, ANNU REV ECOL SYST, V11, P197, DOI 10.1146/annurev.es.11.110180.001213; Wolff, 1991, DNA FINGERPRINTING A; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Woodroffe R, 2009, J ANIM ECOL, V78, P818, DOI 10.1111/j.1365-2656.2009.01545.x; WRANGHAM RW, 1980, Z TIERPSYCHOL, V54, P357; Young AJ, 2006, BIOL LETTERS, V2, P385, DOI 10.1098/rsbl.2006.0463; Young RL, 2019, P NATL ACAD SCI USA, V116, P1331, DOI 10.1073/pnas.1813775116	226	15	15	15	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2021	373	6561							eabc9699	10.1126/science.abc9699	http://dx.doi.org/10.1126/science.abc9699			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	US5SK	34529471	Green Submitted			2022-12-28	WOS:000697488600055
J	Coffey, KC; Diekema, DJ; Morgan, DJ				Coffey, K. C.; Diekema, Daniel J.; Morgan, Daniel J.			Interpreting SARS-CoV-2 Test Results	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Coffey, K. C.; Morgan, Daniel J.] VA Maryland Healthcare Syst, Baltimore, MD USA; [Coffey, K. C.; Morgan, Daniel J.] Univ Maryland, Sch Med, 10 S Pine St,MSTF 257-B, Baltimore, MD 21201 USA; [Diekema, Daniel J.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA	University System of Maryland; University of Maryland Baltimore; University of Iowa	Coffey, KC (corresponding author), Univ Maryland, Sch Med, 10 S Pine St,MSTF 257-B, Baltimore, MD 21201 USA.	karen.coffey@som.umaryland.edu		Diekema, Daniel/0000-0003-1273-0724				Abu-Raddad LJ, 2021, ECLINICALMEDICINE, V35, DOI 10.1016/j.eclinm.2021.100861; [Anonymous], 2020, FIND INV AN REP CAS; [Anonymous], 2021, INT GUID END IS PREC; Arias CA, 2020, IDSA GUIDELINES DIAG; Miller TE, 2020, FASEB J, V34, P13877, DOI 10.1096/fj.202001700RR; Pekosz A, 2021, CLIN INFECT DIS, V73, pE2861, DOI 10.1093/cid/ciaa1706; Prince-Guerra JL, 2021, MMWR-MORBID MORTAL W, V70, P100, DOI 10.15585/mmwr.mm7003e3; Rhoads D, 2021, CLIN INFECT DIS, V72, pE685, DOI 10.1093/cid/ciaa1199; Schuit E, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1676	9	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 19	2021	326	15					1528	1529		10.1001/jama.2021.16146	http://dx.doi.org/10.1001/jama.2021.16146		SEP 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WN1OX	34533581	Bronze			2022-12-28	WOS:000696615300001
J	Evrard, B; Qu, A; Dalibard, J; Gerbier, F				Evrard, Bertrand; Qu, An; Dalibard, Jean; Gerbier, Fabrice			Observation of fragmentation of a spinor Bose-Einstein condensate	SCIENCE			English	Article							SPONTANEOUS SYMMETRY-BREAKING; QUANTUM; ENTANGLEMENT; RECONSTRUCTION; INFORMATION; ENTROPY; STATES; GASES; PHASE	Weakly interacting Bose gases usually form Bose-Einstein condensates in which most particles occupy the same single-particle state. However, when this state cannot realize a continuous symmetry of the many-body Hamiltonian, a fragmented condensate exhibiting the expected symmetry may emerge. Here, we produced a three-fragment condensate for a mesoscopic spin-1 gas of about 100 atoms, with anti-ferromagnetic interactions and vanishing collective spin. Using a spin-resolved detection approaching single-atom resolution, we show that the reconstructed state is close to the expected manybody ground state, whereas one-body observables are the same as for a completely mixed state. Our results highlight how the interplay between symmetry and interactions generates entanglement in a mesoscopic quantum system.	[Evrard, Bertrand; Qu, An; Dalibard, Jean; Gerbier, Fabrice] Sorbonne Univ, ENS PSL Univ, Coll France, Lab Kastler Brossel,CNRS, F-75005 Paris, France	UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS)	Dalibard, J (corresponding author), Sorbonne Univ, ENS PSL Univ, Coll France, Lab Kastler Brossel,CNRS, F-75005 Paris, France.	jean.dalibard@college-de-france.fr	; Dalibard, Jean/M-5648-2015	Gerbier, Fabrice/0000-0003-1746-5149; Dalibard, Jean/0000-0001-8469-3913; QU, An/0000-0002-1162-6880; Evrard, Bertrand/0000-0003-1949-0241				ANDERSON PW, 1952, PHYS REV, V86, P694, DOI 10.1103/PhysRev.86.694; Ashhab S, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.023604; AZARIA P, 1993, PHYS REV LETT, V70, P2483, DOI 10.1103/PhysRevLett.70.2483; Barnett R, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.031602; BEEKMAN A. J., 2019, SCIPOST PHYS LECT NO, V11; BERNU B, 1992, PHYS REV LETT, V69, P2590, DOI 10.1103/PhysRevLett.69.2590; Buzek V, 1998, ANN PHYS-NEW YORK, V266, P454, DOI 10.1006/aphy.1998.5802; Carmichael H, 1991, OPEN SYSTEMS APPROAC, V18; Castin Y, 1997, PHYS REV A, V55, P4330, DOI 10.1103/PhysRevA.55.4330; Castin Y, 2001, CR ACAD SCI IV-PHYS, V2, P419, DOI 10.1016/S1296-2147(01)01183-0; D'Ariano GM, 2003, ADV IMAG ELECT PHYS, V128, P205, DOI 10.1016/S1076-5670(03)80065-4; De Sarlo L, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/11/113039; Demler E, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.163001; Einstein A., 1925, SITZUNGBER; Einstein A, 1925, SITZUNGBER; Evrard B., 2021, ZENODO; Evrard B., 2021, ZENODO, DOI [10.5281/zenodo.5070466, DOI 10.5281/ZENODO.5070466]; Evrard B, 2021, PHYS REV LETT, V126, DOI 10.1103/PhysRevLett.126.063401; FISHER MPA, 1989, PHYS REV B, V40, P546, DOI 10.1063/1.38820; Gessner M, 2018, ANN PHYS-NEW YORK, V390, P192, DOI 10.1016/j.aop.2018.01.013; Grassberger P., 2003, ARXIV; Ho TL, 2000, PHYS REV LETT, V84, P4031, DOI 10.1103/PhysRevLett.84.4031; Ho TL, 1998, PHYS REV LETT, V81, P742, DOI 10.1103/PhysRevLett.81.742; Imambekov A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.120405; Islam R, 2015, NATURE, V528, P77, DOI 10.1038/nature15750; Jaksch D, 1998, PHYS REV A, V58, P1450, DOI 10.1103/PhysRevA.58.1450; KAPLAN TA, 1990, PHYS REV B, V42, P4663, DOI 10.1103/PhysRevB.42.4663; Kawaguchi Y, 2012, PHYS REP, V520, P253, DOI 10.1016/j.physrep.2012.07.005; Koashi M, 2000, PHYS REV LETT, V84, P1066, DOI 10.1103/PhysRevLett.84.1066; Law CK, 1998, PHYS REV LETT, V81, P5257, DOI 10.1103/PhysRevLett.81.5257; Leggett AJ, 2001, REV MOD PHYS, V73, P307, DOI 10.1103/RevModPhys.73.307; Luo XY, 2017, SCIENCE, V355, P620, DOI 10.1126/science.aag1106; Lvovsky AI, 2004, J OPT B-QUANTUM S O, V6, pS556, DOI 10.1088/1464-4266/6/6/014; Mueller EJ, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.033612; NEUBERGER H, 1989, PHYS REV B, V39, P2608, DOI 10.1103/PhysRevB.39.2608; NOZIERES P, 1982, J PHYS-PARIS, V43, P1133, DOI 10.1051/jphys:019820043070113300; Nozieres P., 1995, BOSE EINSTEIN CONDEN, P15, DOI DOI 10.1017/CBO9780511524240.004; Ohmi T, 1998, J PHYS SOC JPN, V67, P1822, DOI 10.1143/JPSJ.67.1822; Peise J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7811; Qu A, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.033401; Schwemmer C, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.080403; Stamper-Kurn DM, 2013, REV MOD PHYS, V85, P1191, DOI 10.1103/RevModPhys.85.1191; Strobel H, 2014, SCIENCE, V345, P424, DOI 10.1126/science.1250147; Urizar-Lanz I, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.013626; van Wezel J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.230401; Vedral V, 2002, REV MOD PHYS, V74, P197, DOI 10.1103/RevModPhys.74.197; Yi S, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.011601; Zhao L, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.225302; Zhou F, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.080401	51	5	5	3	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2021	373	6561					1340	+		10.1126/science.abd8206	http://dx.doi.org/10.1126/science.abd8206			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	US5SK	34529460				2022-12-28	WOS:000697488600045
J	Cao, LW; Huang, C; Zhou, DC; Hu, YW; Lih, TM; Savage, SR; Krug, K; Clark, DJ; Schnaubelt, M; Chen, LJ; Leprevost, FD; Eguez, RV; Yang, WM; Pan, JB; Wen, B; Dou, YC; Jiang, W; Liao, YX; Shi, ZA; Terekhanova, NV; Cao, S; Lu, RJH; Li, YZ; Liu, RY; Zhu, HX; Ronning, P; Wu, YG; Wyczalkowski, MA; Easwaran, H; Danilova, L; Mer, AS; Yoo, S; Wang, JM; Liu, WK; Haibe-Kains, B; Thiagarajan, M; Jewell, SD; Hostetter, G; Newton, CJ; Li, QK; Roehr, MH; Fenyo, D; Wang, P; Nesvizhskii, AI; Mani, DR; Omenn, GS; Boja, ES; Mesri, M; Robles, AI; Rodriguez, H; Bathe, OF; Chan, DW; Hruban, RH; Ding, L; Zhang, B; Zhang, H				Cao, Liwei; Huang, Chen; Zhou, Daniel Cui; Hu, Yingwei; Lih, T. Mamie; Savage, Sara R.; Krug, Karsten; Clark, David J.; Schnaubelt, Michael; Chen, Lijun; Leprevost, Felipe da Veiga; Eguez, Rodrigo Vargas; Yang, Weiming; Pan, Jianbo; Wen, Bo; Dou, Yongchao; Jiang, Wen; Liao, Yuxing; Shi, Zhiao; Terekhanova, Nadezhda, V; Cao, Song; Lu, Rita Jui-Hsien; Li, Yize; Liu, Ruiyang; Zhu, Houxiang; Ronning, Peter; Wu, Yige; Wyczalkowski, Matthew A.; Easwaran, Hariharan; Danilova, Ludmila; Mer, Arvind Singh; Yoo, Seungyeul; Wang, Joshua M.; Liu, Wenke; Haibe-Kains, Benjamin; Thiagarajan, Mathangi; Jewell, Scott D.; Hostetter, Galen; Newton, Chelsea J.; Li, Qing Kay; Roehr, Michael H.; Fenyo, David; Wang, Pei; Nesvizhskii, Alexey, I; Mani, D. R.; Omenn, Gilbert S.; Boja, Emily S.; Mesri, Mehdi; Robles, Ana, I; Rodriguez, Henry; Bathe, Oliver F.; Chan, Daniel W.; Hruban, Ralph H.; Ding, Li; Zhang, Bing; Zhang, Hui		Clinical Proteomic Tumor Anal Cons	Proteogenomic characterization of pancreatic ductal adenocarcinoma	CELL			English	Article							SIGNATURES DATABASE; CANCER PROGRESSION; PROFILING REVEALS; STATISTICAL-MODEL; WHOLE-GENOME; DISCOVERY; BETA; GENE; IDENTIFICATION; MUTATIONS	Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer with poor patient survival. Toward understanding the underlying molecular alterations that drive PDAC oncogenesis, we conducted comprehensive proteogenomic analysis of 140 pancreatic cancers, 67 normal adjacent tissues, and 9 normal pancreatic ductal tissues. Proteomic, phosphoproteomic, and glycoproteomic analyses were used to characterize proteins and their modifications. In addition, whole-genome sequencing, whole-exome sequencing, methylation, RNA sequencing (RNA-seq), and microRNA sequencing (miRNA-seq) were performed on the same tissues to facilitate an integrated proteogenomic analysis and determine the impact of genomic alterations on protein expression, signaling pathways, and post-translational modifications. To ensure robust downstream analyses, tumor neoplastic cellularity was assessed via multiple orthogonal strategies using molecular features and verified via pathological estimation of tumor cellularity based on histological review. This integrated proteogenomic characterization of PDAC will serve as a valuable resource for the community, paving the way for early detection and identification of novel therapeutic targets.	[Cao, Liwei; Hu, Yingwei; Lih, T. Mamie; Clark, David J.; Schnaubelt, Michael; Chen, Lijun; Eguez, Rodrigo Vargas; Yang, Weiming; Pan, Jianbo; Li, Qing Kay; Wang, Pei; Chan, Daniel W.; Hruban, Ralph H.; Zhang, Hui] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21231 USA; [Huang, Chen; Savage, Sara R.; Wen, Bo; Dou, Yongchao; Jiang, Wen; Liao, Yuxing; Shi, Zhiao; Zhang, Bing] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Huang, Chen; Savage, Sara R.; Wen, Bo; Dou, Yongchao; Jiang, Wen; Liao, Yuxing; Shi, Zhiao; Zhang, Bing] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Zhou, Daniel Cui; Terekhanova, Nadezhda, V; Cao, Song; Lu, Rita Jui-Hsien; Li, Yize; Liu, Ruiyang; Zhu, Houxiang; Ronning, Peter; Wu, Yige; Wyczalkowski, Matthew A.; Ding, Li] Washington Univ, Dept Med, St Louis, MO 63130 USA; [Zhou, Daniel Cui; Terekhanova, Nadezhda, V; Cao, Song; Lu, Rita Jui-Hsien; Li, Yize; Liu, Ruiyang; Zhu, Houxiang; Ronning, Peter; Wu, Yige; Wyczalkowski, Matthew A.; Ding, Li] Washington Univ, McDonnell Genome Inst, St Louis, MO 63108 USA; [Krug, Karsten; Mani, D. R.] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA 02142 USA; [Leprevost, Felipe da Veiga; Nesvizhskii, Alexey, I] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Easwaran, Hariharan; Chan, Daniel W.; Hruban, Ralph H.; Zhang, Hui] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA; [Danilova, Ludmila] Johns Hopkins Univ, Dept Oncol, Baltimore, MD 21205 USA; [Mer, Arvind Singh; Haibe-Kains, Benjamin] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [Yoo, Seungyeul] Sema4, Stamford, CT 06902 USA; [Wang, Joshua M.; Liu, Wenke; Fenyo, David] NYU Grossman Sch Med, Inst Syst Genet, New York, NY 10016 USA; [Wang, Joshua M.; Liu, Wenke; Fenyo, David] NYU Grossman Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Haibe-Kains, Benjamin] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Thiagarajan, Mathangi] Frederick Natl Lab Canc Res, Leidos Biomed Res Inc, Frederick, MD 21702 USA; [Jewell, Scott D.; Hostetter, Galen; Newton, Chelsea J.] Van Andel Res Inst, Grand Rapids, MI 49503 USA; [Roehr, Michael H.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Roehr, Michael H.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Omenn, Gilbert S.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Boja, Emily S.; Mesri, Mehdi; Robles, Ana, I; Rodriguez, Henry] NCI, Off Canc Clin Prote Res, Bethesda, MD 20892 USA; [Bathe, Oliver F.] Univ Calgary, Cumming Sch Med, Dept Surg, Calgary, AB, Canada; [Bathe, Oliver F.] Univ Calgary, Cumming Sch Med, Dept Oncol, Calgary, AB, Canada; [Hruban, Ralph H.] Johns Hopkins Univ, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21231 USA	Johns Hopkins University; Baylor College of Medicine; Baylor College of Medicine; Washington University (WUSTL); Washington University (WUSTL); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Van Andel Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Calgary; University of Calgary; Johns Hopkins University	Zhang, H (corresponding author), Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21231 USA.; Zhang, B (corresponding author), Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA.; Zhang, B (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Ding, L (corresponding author), Washington Univ, Dept Med, St Louis, MO 63130 USA.; Ding, L (corresponding author), Washington Univ, McDonnell Genome Inst, St Louis, MO 63108 USA.; Zhang, H (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA.	lding@wustl.edu; bing.zhang@bcm.edu; huizhang@jhu.edu	Li, Yize/HCI-9317-2022; Yoo, Seungyeul/GOJ-7783-2022; Wen, Bo/I-1259-2019; Shabunin, Alexey/AFE-8506-2022; Li, Yize/ABB-9226-2021; da Veiga Leprevost, Felipe/D-6905-2013	Wen, Bo/0000-0003-2261-3150; Shabunin, Alexey/0000-0002-4230-8033; Li, Yize/0000-0003-1074-281X; Long, Jiang/0000-0003-0010-5067; Wu, Yige/0000-0001-7727-901X; huang, chen/0000-0003-2777-7365; McGarvey, Peter/0000-0002-8312-6017; Jiang, Wen/0000-0001-9154-633X; Yoo, Seungyeul/0000-0001-5616-2293; Minoo, Parham/0000-0003-1057-0042; Lu, Rita Jui-Hsien/0000-0002-7434-6544; Robles, Ana/0000-0001-5019-4374; da Veiga Leprevost, Felipe/0000-0002-8228-5374	National Cancer Institute (NCI) Cinical Proteomic Tumor Analysis Consortium (CPTAC), National Institutes of Health (NIH) [U24CA210955, U24CA210985, U24CA210986, U24CA210954, U24CA 210967, U24CA210972, U24CA210979, U24CA210993, U01CA214114, U01 CA214116, U01CA214125]; NIH [P30CA008748, P30ES017885]; Troper Wojcicki Foundation; Rolfe Pancreatic Cancer Foundation; Evelyn Grollman Glick Scholar Award	National Cancer Institute (NCI) Cinical Proteomic Tumor Analysis Consortium (CPTAC), National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Troper Wojcicki Foundation; Rolfe Pancreatic Cancer Foundation; Evelyn Grollman Glick Scholar Award	This work was supported by the National Cancer Institute (NCI) Cinical Proteomic Tumor Analysis Consortium (CPTAC), National Institutes of Health (NIH) grants U24CA210955, U24CA210985, U24CA210986, U24CA210954, U24CA 210967, U24CA210972, U24CA210979, U24CA210993, U01CA214114, U01 CA214116, and U01CA214125. A part of this research was funded through NIH grants P30CA008748 and P30ES017885, the Troper Wojcicki Foundation, the Rolfe Pancreatic Cancer Foundation, and the Evelyn Grollman Glick Scholar Award.	Aguirre AJ, 2017, CANCER CELL, V32, P185, DOI 10.1016/j.ccell.2017.07.007; Akagi J, 2001, INT J ONCOL, V18, P1085; Allen E, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aak9679; Annan DAM, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093238; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Aran D, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1349-1; Arntfield ME, 2011, BIOESSAYS, V33, P582, DOI 10.1002/bies.201100015; Auton A., 2015, NATURE, V7571, P68, DOI 10.1038/nature15393; Aznar S, 2001, MOL BIOL CELL, V12, P3282, DOI 10.1091/mbc.12.10.3282; Babiceanu M, 2016, NUCLEIC ACIDS RES, V44, P2859, DOI 10.1093/nar/gkw032; Bailey MH, 2018, CELL, V173, P371, DOI [10.1016/j.cell.2018.02.060, 10.1016/j.cell.2018.07.034]; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Balachandran VP, 2019, GASTROENTEROLOGY, V156, P2056, DOI 10.1053/j.gastro.2018.12.038; Balli D, 2017, CLIN CANCER RES, V23, P3129, DOI 10.1158/1078-0432.CCR-16-2128; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Beauchemin N, 2013, CANCER METAST REV, V32, P643, DOI 10.1007/s10555-013-9444-6; Becht E, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1070-5; Becker AE, 2014, WORLD J GASTROENTERO, V20, P11182, DOI 10.3748/wjg.v20.i32.11182; Beel S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17226-0; Benelli M, 2012, BIOINFORMATICS, V28, P3232, DOI 10.1093/bioinformatics/bts617; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENSON P F, 1961, Cereb Palsy Bull, V3, P510; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; Bieberich Erhard, 2014, Adv Neurobiol, V9, P47, DOI 10.1007/978-1-4939-1154-7_3; Blumenthal RD, 2005, CANCER RES, V65, P8809, DOI 10.1158/0008-5472.CAN-05-0420; Blumenthal RD, 2005, CANCER IMMUNOL IMMUN, V54, P315, DOI 10.1007/s00262-004-0597-6; Boecker W, 2020, HISTOCHEM CELL BIOL, V154, P97, DOI 10.1007/s00418-020-01864-y; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Cai J, 2018, J CANCER, V9, P4449, DOI 10.7150/jca.25926; CALDAS C, 1994, NAT GENET, V8, P27, DOI 10.1038/ng0994-27; Cancer Genome Atlas Research Network, 2013, Nat Genet, V45, P1113, DOI 10.1038/ng.2764; Cao LW, 2018, NAT PROTOC, V13, P1196, DOI 10.1038/nprot.2018.024; Chan-Seng-Yue M, 2020, NAT GENET, V52, P231, DOI 10.1038/s41588-019-0566-9; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Cho KC, 2020, ANAL CHEM, V92, P4217, DOI 10.1021/acs.analchem.9b04418; Christensen JG, 2020, J INTERN MED, V288, P183, DOI 10.1111/joim.13057; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Clark DJ, 2019, CELL, V179, P964, DOI 10.1016/j.cell.2019.10.007; Clark DJ, 2018, J PROTEOME RES, V17, P2205, DOI 10.1021/acs.jproteome.8b00165; Collisson EA, 2019, NAT REV GASTRO HEPAT, V16, P207, DOI 10.1038/s41575-019-0109-y; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Leprevost FD, 2020, NAT METHODS, V17, P869, DOI 10.1038/s41592-020-0912-y; de la Cruz-Lopez KG, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01143; De la Mota-Peynado A, 2011, J BIOL CHEM, V286, P13603, DOI 10.1074/jbc.M110.181743; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Djomehri SI, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15283-z; Duan GY, 2015, NUCLEIC ACIDS RES, V43, pD531, DOI 10.1093/nar/gku1009; Ducreux M, 2019, SEMIN ONCOL, V46, P28, DOI 10.1053/j.seminoncol.2018.12.003; Elia AR, 2018, CLIN CANCER RES, V24, P2171, DOI 10.1158/1078-0432.CCR-17-2210; Elyada E, 2019, CANCER DISCOV, V9, P1102, DOI 10.1158/2159-8290.CD-19-0094; Eser S, 2014, BRIT J CANCER, V111, P817, DOI 10.1038/bjc.2014.215; Eshghi ST, 2016, SCI REP-UK, V6, DOI 10.1038/srep37189; Fan Gaofeng, 2020, Small GTPases, V11, P155, DOI 10.1080/21541248.2017.1379931; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Furuse J, 2017, EXPERT OPIN EMERG DR, V22, P77, DOI 10.1080/14728214.2017.1293648; Gao QS, 2018, CELL REP, V23, P227, DOI 10.1016/j.celrep.2018.03.050; Garnham R, 2019, ONCOL LETT, V18, P983, DOI 10.3892/ol.2019.10458; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Gillette MA, 2020, CELL, V182, P200, DOI 10.1016/j.cell.2020.06.013; Goggins M, 1998, AM J PATHOL, V152, P1501; Golan T, 2019, NEW ENGL J MED, V381, P317, DOI 10.1056/NEJMoa1903387; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Gonzalez C, 2014, J NEUROSCI, V34, P10924, DOI 10.1523/JNEUROSCI.0084-14.2014; Gonzalez-Borja I, 2019, CANCERS, V11, DOI 10.3390/cancers11081052; Govindan SV, 2009, CLIN CANCER RES, V15, P6052, DOI 10.1158/1078-0432.CCR-09-0586; Haas BJ, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1842-9; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Harsha HC, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000046; Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008; Herr P, 2020, MOL CELL PROTEOMICS, V19, P608, DOI 10.1074/mcp.RA120.001938; Hessmann E, 2020, PHYSIOL REV, V100, P1707, DOI 10.1152/physrev.00042.2019; Hilmi M, 2018, WORLD J GASTROENTERO, V24, P2137, DOI 10.3748/wjg.v24.i20.2137; Ho WJ, 2020, NAT REV CLIN ONCOL, V17, P527, DOI 10.1038/s41571-020-0363-5; Hobbs GA, 2020, CANCER DISCOV, V10, P104, DOI 10.1158/2159-8290.CD-19-1006; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hruban RH, 2019, J PATHOL, V248, P131, DOI 10.1002/path.5260; Hsieh CC, 2017, ONCOTARGET, V8, P7691, DOI 10.18632/oncotarget.13845; Hu YW, 2018, ANAL CHEM, V90, P8065, DOI 10.1021/acs.analchem.8b01137; Huang C, 2021, CANCER CELL, V39, P361, DOI 10.1016/j.ccell.2020.12.007; Huang KL, 2018, CELL, V173, P355, DOI 10.1016/j.cell.2018.03.039; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/nmeth.3252, 10.1038/NMETH.3252]; Iorio F, 2016, CELL, V166, P740, DOI 10.1016/j.cell.2016.06.017; Janes MR, 2018, CELL, V172, P578, DOI 10.1016/j.cell.2018.01.006; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim H, 2007, BIOINFORMATICS, V23, P1495, DOI 10.1093/bioinformatics/btm134; Kim J, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah5583; Kim S, 2018, NAT METHODS, V15, P591, DOI 10.1038/s41592-018-0051-x; Klein D, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00367; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kong AT, 2017, NAT METHODS, V14, P513, DOI [10.1038/NMETH.4256, 10.1038/nmeth.4256]; Krug K, 2019, MOL CELL PROTEOMICS, V18, P576, DOI 10.1074/mcp.TIR118.000943; Krug K, 2020, CELL, V183, P1436, DOI 10.1016/j.cell.2020.10.036; Lee H, 2019, BMB REP, V52, P415, DOI 10.5483/BMBRep.2019.52.7.152; Lenkiewicz E, 2020, CANCER RES, V80, P4324, DOI 10.1158/0008-5472.CAN-20-0078; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li MS, 2017, BIOINFORMATICS, V33, P2131, DOI 10.1093/bioinformatics/btx129; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lih T.M., 2019, BIORXIV, DOI [10.1101/746123, DOI 10.1101/746123]; Liu J, 2007, PROTEOME SCI, V5, DOI 10.1186/1477-5956-5-3; Lurie E, 2020, ONCOGENESIS, V9, DOI 10.1038/s41389-020-00245-3; Macauley MS, 2014, J BIOL CHEM, V289, P35149, DOI 10.1074/jbc.M114.606517; Manoli S, 2019, CANCERS, V11, DOI 10.3390/cancers11020135; Maurer C, 2019, GUT, V68, P1034, DOI 10.1136/gutjnl-2018-317706; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mertins P, 2018, NAT PROTOC, V13, P1632, DOI 10.1038/s41596-018-0006-9; Moffitt RA, 2015, NAT GENET, V47, P1168, DOI 10.1038/ng.3398; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Najahi-Missaoui W, 2019, PHARMACOL RES PERSPE, V7, DOI 10.1002/prp2.518; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; O'Kane GM, 2020, CLIN CANCER RES, V26, P4901, DOI 10.1158/1078-0432.CCR-19-3724; Onuchic V, 2016, CELL REP, V17, P2075, DOI 10.1016/j.celrep.2016.10.057; Pandey R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54545-9; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Pelosi E, 2017, BIOMEDICINES, V5, DOI 10.3390/biomedicines5040065; Perfetto L, 2016, NUCLEIC ACIDS RES, V44, pD548, DOI 10.1093/nar/gkv1048; Petrova V, 2018, ONCOGENESIS, V7, DOI 10.1038/s41389-017-0011-9; Polzien L, 2011, J BIOL CHEM, V286, P17934, DOI 10.1074/jbc.M110.177345; Puleo F, 2018, GASTROENTEROLOGY, V155, P1999, DOI 10.1053/j.gastro.2018.08.033; Quante AS, 2016, CANCER MED-US, V5, P2649, DOI 10.1002/cam4.767; Radeva MY, 2018, ACTA PHYSIOL, V222, DOI 10.1111/apha.12860; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Rane CK, 2019, SEMIN CANCER BIOL, V54, P40, DOI 10.1016/j.semcancer.2018.01.006; Ranzinger R, 2011, NUCLEIC ACIDS RES, V39, pD373, DOI 10.1093/nar/gkq1014; Ren LW, 2019, CANCER MED-US, V8, P7032, DOI 10.1002/cam4.2587; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roth Marc T, 2020, F1000Res, V9, DOI 10.12688/f1000research.21981.1; Ruckert MT, 2019, CELL MOL LIFE SCI, V76, P2571, DOI 10.1007/s00018-019-03095-4; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Sapalidis K, 2019, J CANCER, V10, P5162, DOI 10.7150/jca.36300; Sava GP, 2020, CANCER METAST REV, V39, P805, DOI 10.1007/s10555-020-09885-8; Schaaf MB, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0061-0; Schubert M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02391-6; Scott AD, 2019, BIOINFORMATICS, V35, P865, DOI 10.1093/bioinformatics/bty649; Semenova G, 2017, BIOCHEM SOC T, V45, P79, DOI 10.1042/BST20160134; Shteynberg DD, 2019, J PROTEOME RES, V18, P4262, DOI 10.1021/acs.jproteome.9b00205; Singhi AD, 2019, GASTROENTEROLOGY, V156, P2024, DOI 10.1053/j.gastro.2019.01.259; Stevenson RP, 2012, J CELL SCI, V125, P1073, DOI 10.1242/jcs.093799; Strickland LA, 2009, J PATHOL, V218, P380, DOI 10.1002/path.2545; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun SS, 2019, CLIN PROTEOM, V16, DOI 10.1186/s12014-019-9254-0; Suzuki O, 2019, PATHOL INT, V69, P441, DOI 10.1111/pin.12834; Tao HT, 2020, AM J TRANSL RES, V12, P612; Thomas JK, 2014, CANCER BIOL THER, V15, P963, DOI 10.4161/cbt.29188; Thompson ED, 2020, MODERN PATHOL, V33, P2544, DOI 10.1038/s41379-020-0629-6; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Tsou CC, 2015, NAT METHODS, V12, P258, DOI [10.1038/NMETH.3255, 10.1038/nmeth.3255]; Turei D, 2016, NAT METHODS, V13, P965, DOI 10.1038/nmeth.4077; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Uprety D, 2020, CANCER TREAT REV, V89, DOI 10.1016/j.ctrv.2020.102070; Vajaria BN, 2016, PATHOL ONCOL RES, V22, P443, DOI 10.1007/s12253-015-0033-6; van Erning FN, 2018, ACTA ONCOL, V57, P1655, DOI 10.1080/0284186X.2018.1518593; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; Vasaikar S, 2019, CELL, V177, P1035, DOI 10.1016/j.cell.2019.03.030; Vatansever S, 2020, COMPUT STRUCT BIOTEC, V18, P1000, DOI 10.1016/j.csbj.2020.04.003; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Wang L.B., 2021, CANCER CELL, V39, P20; Wang SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159102; Wenger CD, 2013, J PROTEOME RES, V12, P1377, DOI 10.1021/pr301024c; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089; Wojcik EJ, 2006, ONCOGENE, V25, P2773, DOI 10.1038/sj.onc.1209306; Xi RB, 2016, NUCLEIC ACIDS RES, V44, P6274, DOI 10.1093/nar/gkw491; Yang GL, 2018, ANAL CHEM, V90, P14294, DOI 10.1021/acs.analchem.8b03520; Yang WM, 2020, NAT PROTOC, V15, P2589, DOI 10.1038/s41596-020-0345-1; Yang WM, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20188486; Yang YP, 2015, J CLIN INVEST, V125, P3335, DOI 10.1172/JCI83871; Ye Diana Zi, 2012, Cell Logist, V2, P105; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yeo D, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2057-z; Yoo M, 2015, BIOINFORMATICS, V31, P3069, DOI 10.1093/bioinformatics/btv313; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Yu FC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17921-y; Yuan J, 2015, SCI REP-UK, V5, DOI 10.1038/srep17663; Yue TT, 2011, PROTEOMICS, V11, P3665, DOI 10.1002/pmic.201000827; Yuen A, 2014, HYPOXIA, V2, P91, DOI 10.2147/HP.S52636; Zhang H, 2003, NAT BIOTECHNOL, V21, P660, DOI 10.1038/nbt827; Zhang H, 2016, CELL, V166, P755, DOI 10.1016/j.cell.2016.05.069; Zhang J, 2017, ONCOTARGET, V8, P105905, DOI 10.18632/oncotarget.22450; Zhang J, 2016, GENOME RES, V26, P108, DOI 10.1101/gr.186114.114; Zhou W, 2014, J PATHOL, V234, P502, DOI 10.1002/path.4412	187	60	62	10	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 16	2021	184	19					5031	+		10.1016/j.cell.2021.08.023	http://dx.doi.org/10.1016/j.cell.2021.08.023		SEP 2021	48	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	WC7PA	34534465	Green Accepted, hybrid			2022-12-28	WOS:000704445100016
J	North, CS; Sorg, EM; Youn, S; Chu, JT				North, Carol S.; Sorg, Emily M.; Youn, SooJeong; Chu, Jacqueline T.			Case 28-2021: A 37-Year-Old Woman with Covid-19 and Suicidal Ideation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ETHNIC DISPARITIES; UNITED-STATES; HEALTH; HOSPITALIZATIONS; INFECTION	A Woman with Covid-19 and Suicidal Ideation A 37-year-old woman was admitted to the hospital because of suicidal ideation during the Covid-19 pandemic. She had presented with symptoms consistent with Covid-19 on two previous occasions and had been asked to quarantine at home. During the third evaluation, when she was asked to quarantine at home, she expressed suicidal ideation. Management decisions were made.	[North, Carol S.] Univ Texas Southwestern Med Ctr Dallas, Metrocare Serv, Dallas, TX 75390 USA; [North, Carol S.] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Sorg, Emily M.; Youn, SooJeong] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Chu, Jacqueline T.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Sorg, Emily M.; Youn, SooJeong] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Chu, Jacqueline T.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	North, CS (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Metrocare Serv, Dallas, TX 75390 USA.; North, CS (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA.							Alegria M, 2007, SOC SCI MED, V65, P214, DOI 10.1016/j.socscimed.2007.03.026; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], 2021, WHAT WE CAN PROM HLT; Asmundson GJG, 2021, J ANXIETY DISORD, V78, DOI 10.1016/j.janxdis.2021.102368; Berlin J, 2020, TEX MED, V116, P32; do Nascimento IB, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239235; Bronfenbrenner U., 1992, 6 THEORIES CHILD DEV, P187, DOI DOI 10.1037/10518-046; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV EX; Calzada EJ, 2013, J FAM ISSUES, V34, P1696, DOI 10.1177/0192513X12460218; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; Divani AA, 2020, CURR NEUROL NEUROSCI, V20, DOI 10.1007/s11910-020-01079-7; Girones-Bredy CE, 2020, EMERGENCIAS, V32, P194; Fisher M., 2011, SOUNDINGS J POLITICS, V48, P123; Fotheringham P, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10244-7; Gasmi A, 2021, MOL NEUROBIOL, V58, P944, DOI 10.1007/s12035-020-02070-6; Gillett G, 2020, BMJ CASE REP, V13, DOI 10.1136/bcr-2020-239191; Greiner T, 2020, EUR ARCH PSY CLIN N, V270, P107, DOI 10.1007/s00406-019-01058-1; Harmer B, 2021, STATPEARLS; Kappert K, 2020, BIOMARKERS, V25, P616, DOI 10.1080/1354750X.2020.1797880; Knuesel S, 2021, J HOSP MED, V16, P109, DOI 10.12788/jhm.3542; Krogstad J.M., 2020, HISPANICS MORE LIKEL; Ma Y, 2020, MICROBES INFECT, V22, P212, DOI 10.1016/j.micinf.2020.04.011; McKnight-Eily LR, 2021, MMWR-MORBID MORTAL W, V70, P162, DOI 10.15585/mmwr.mm7005a3externalicon; Moscicki E K, 1995, Int Psychogeriatr, V7, P137; North CS, 2021, BEHAV SCI-BASEL, V11, DOI 10.3390/bs11010007; North CS, 2017, TEXTBOOK OF DISASTER PSYCHIATRY, 2ND EDITION, P27; North CS, 2016, PSYCHIATRY, V79, P130, DOI 10.1080/00332747.2016.1155926; North CS, 2013, JAMA-J AM MED ASSOC, V310, P507, DOI 10.1001/jama.2013.107799; Pence BD, 2020, GEROSCIENCE, V42, P1051, DOI 10.1007/s11357-020-00213-0; Podewils LJ, 2020, MMWR-MORBID MORTAL W, V69, P1812, DOI 10.15585/mmwr.mm6948a3externalicon; Ramirez-Cervantes KL, 2021, J PUBLIC HEALTH-UK, V43, P89, DOI 10.1093/pubmed/fdaa129; Romano SD, 2021, MMWR-MORBID MORTAL W, V70, P560, DOI [10.15585/mmwr.mm7015e2, 10.15585/mmwr.mm7015e2externalicon]; Substance Abuse and Mental Health Services Administration, DOUBL JEOP COVID 19; Wilson, 2020, LATINX WORKERS PARTI; Yang AP, 2020, AGING-US, V12, P10059, DOI 10.18632/aging.103255; Youn SJ, 2021, J COMMUNITY PSYCHOL, V49, P737, DOI 10.1002/jcop.22321	36	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2021	385	12					1125	1132		10.1056/NEJMcpc2107350	http://dx.doi.org/10.1056/NEJMcpc2107350			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UQ4IT	34525289	Green Published, Bronze			2022-12-28	WOS:000696029600015
J	da Silva, AV				da Silva, Alexandre Valotta			Poloxamer 188 vs Placebo for Painful Vaso-occlusive Episodes in Children and Adults With Sickle Cell Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[da Silva, Alexandre Valotta] Santa Casa Misericordia Braganca Paulista, R Cel Assis Goncalves 700, BR-12900480 Braganca Paulista, SP, Brazil		da Silva, AV (corresponding author), Santa Casa Misericordia Braganca Paulista, R Cel Assis Goncalves 700, BR-12900480 Braganca Paulista, SP, Brazil.	alexandrevalotta@gmail.com						Ferrari A, 2018, CNS DRUGS, V32, P567, DOI 10.1007/s40263-018-0522-8; Li YX, 2020, PAIN RES MANAG, V2020, DOI 10.1155/2020/3825617; Linde K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001218.pub3; National Institute for Health and Care Excellence, 2021, EV REV PAIN MAN PROG; Robbins MS, 2021, JAMA-J AM MED ASSOC, V325, P1874, DOI 10.1001/jama.2021.1640	5	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2021	326	10					977	977						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UW4LI	34519807				2022-12-28	WOS:000700129100031
J	Limb, M				Limb, Matt			BMJ Awards 2021: Women's health team of the year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												limb@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2021	374								n2156	10.1136/bmj.n2156	http://dx.doi.org/10.1136/bmj.n2156			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ3VV	34503978				2022-12-28	WOS:000702137100010
J	Srinivas, R; Burd, SC; Knaack, HM; Sutherland, RT; Kwiatkowski, A; Glancy, S; Knill, E; Wineland, DJ; Leibfried, D; Wilson, AC; Allcock, DTC; Slichter, DH				Srinivas, R.; Burd, S. C.; Knaack, H. M.; Sutherland, R. T.; Kwiatkowski, A.; Glancy, S.; Knill, E.; Wineland, D. J.; Leibfried, D.; Wilson, A. C.; Allcock, D. T. C.; Slichter, D. H.			High-fidelity laser-free universal control of trapped ion qubits	NATURE			English	Article							QUANTUM; ENTANGLEMENT; MANIPULATION; COMPUTER; GATES	Universal control of multiple qubits-the ability to entangle qubits and to perform arbitrary individual qubit operations(1)-is a fundamental resource for quantum computing(2), simulation(3) and networking(4). Qubits realized in trapped atomic ions have shown the highest-fidelity two-qubit entangling operations(5-7) and single-qubit rotations(8) so far. Universal control of trapped ion qubits has been separately demonstrated using tightly focused laser beams(9-12) or by moving ions with respect to laser beams(13-15), but at lower fidelities. Laser-free entangling methods(16-20) may offer improved scalability by harnessing microwave technology developed for wireless communications, but so far their performance has lagged the best reported laser-based approaches. Here we demonstrate high-fidelity laser-free universal control of two trapped-ion qubits by creating both symmetric and antisymmetric maximally entangled states with fidelities of 1-0.0017+0 and 0.9977-0.0013+0.0010, respectively (68 per cent confidence level), corrected for initialization error. We use a scheme based on radiofrequency magnetic field gradients combined with microwave magnetic fields that is robust against multiple sources of decoherence and usable with essentially any trapped ion species. The scheme has the potential to perform simultaneous entangling operations on multiple pairs of ions in a large-scale trapped-ion quantum processor without increasing control signal power or complexity. Combining this technology with low-power laser light delivered via trap-integrated photonics(21,22) and trap-integrated photon detectors for qubit readout(23,24) provides an opportunity for scalable, high-fidelity, fully chip-integrated trapped-ion quantum computing.	[Srinivas, R.; Burd, S. C.; Knaack, H. M.; Kwiatkowski, A.; Glancy, S.; Knill, E.; Wineland, D. J.; Leibfried, D.; Wilson, A. C.; Allcock, D. T. C.; Slichter, D. H.] NIST, Boulder, CO 80305 USA; [Srinivas, R.; Burd, S. C.; Knaack, H. M.; Kwiatkowski, A.; Wineland, D. J.; Allcock, D. T. C.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Sutherland, R. T.] Lawrence Livermore Natl Lab, Phys Div, Phys & Life Sci, Livermore, CA 94550 USA; [Sutherland, R. T.] Univ Texas San Antonio, Dept Elect & Comp Engn, San Antonio, TX USA; [Sutherland, R. T.] Univ Texas San Antonio, Dept Phys & Astron, San Antonio, TX USA; [Knill, E.] Univ Colorado, Ctr Theory Quantum Matter, Boulder, CO 80309 USA; [Wineland, D. J.; Allcock, D. T. C.] Univ Oregon, Dept Phys, Eugene, OR 97403 USA; [Srinivas, R.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford, England; [Burd, S. C.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); University of Colorado System; University of Colorado Boulder; University of Oregon; University of Oxford; Stanford University	Srinivas, R; Slichter, DH (corresponding author), NIST, Boulder, CO 80305 USA.; Srinivas, R (corresponding author), Univ Colorado, Dept Phys, Boulder, CO 80309 USA.; Srinivas, R (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Oxford, England.	raghavendra.srinivas@colorado.edu; daniel.sLichter@nist.gov	; Allcock, David/C-7582-2013	Kwiatkowski, Alex/0000-0003-1296-589X; Allcock, David/0000-0002-7317-5560; Srinivas, Raghavendra/0000-0002-8462-6072; Sutherland, Robert/0000-0001-5583-5150	US Department of Commerce, NIST [70NANB18H006]; NIST Quantum Information Program; ONR	US Department of Commerce, NIST(National Institute of Standards & Technology (NIST) - USA); NIST Quantum Information Program; ONR(Office of Naval Research)	We thank C. J. Ballance, T. P. Harty, J. P. Gaebler, S. B. Libby, D. M. Lucas, V. M. Schafer and T. R. Tan for helpful discussions. We thank M. Affolter and A. L. Collopy for insightful comments on the manuscript. At the time the work was performed, R.S., S.C.B., H.M.K., A.K., and D.T.C.A. were supported as associates in the Professional Research Experience Program (PREP) operated jointly by the National Institute of Standards and Technology (NIST) and the University of Colorado Boulder under award number 70NANB18H006 from the US Department of Commerce, NIST. This work was supported by the NIST Quantum Information Program and ONR.	Ballance CJ, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.060504; BARENCO A, 1995, PHYS REV A, V52, P3457, DOI 10.1103/PhysRevA.52.3457; Chou CW, 2017, NATURE, V545, P203, DOI 10.1038/nature22338; CIRAC JI, 1995, PHYS REV LETT, V74, P4091, DOI 10.1103/PhysRevLett.74.4091; Clark CR, 2021, PHYS REV LETT, V127, DOI 10.1103/PhysRevLett.127.130505; Craik DPLA, 2017, PHYS REV A, V95, DOI 10.1103/PhysRevA.95.022337; Debnath S, 2016, NATURE, V536, P63, DOI 10.1038/nature18648; Erhard A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13068-7; Gaebler JP, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.060505; Georgescu IM, 2014, REV MOD PHYS, V86, P153, DOI 10.1103/RevModPhys.86.153; Hahn H, 2019, NPJ QUANTUM INFORM, V5, DOI 10.1038/s41534-019-0184-5; Harty TP, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.140501; Harty TP, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.220501; Hayes D, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.020503; Johanning M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.073004; Jozsa R, 1998, GEOMETRIC UNIVERSE, P369; Khromova A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.220502; Kielpinski D, 2002, NATURE, V417, P709, DOI 10.1038/nature00784; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Kozlov MG, 2018, REV MOD PHYS, V90, DOI 10.1103/RevModPhys.90.045005; Leibfried D, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.032324; Leibfried D, 2003, REV MOD PHYS, V75, P281, DOI 10.1103/RevModPhys.75.281; Leibfried D, 2003, NATURE, V422, P412, DOI 10.1038/nature01492; Leibfried D, 1999, PHYS REV A, V60, pR3335, DOI 10.1103/PhysRevA.60.R3335; Matthiesen C, 2021, PHYS REV X, V11, DOI 10.1103/PhysRevX.11.011019; Milburn GJ, 2000, FORTSCHR PHYS, V48, P801, DOI 10.1002/1521-3978(200009)48:9/11<801::AID-PROP801>3.0.CO;2-1; Mintert F, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.257904; Nagerl HC, 1999, PHYS REV A, V60, P145, DOI 10.1103/PhysRevA.60.145; Ospelkaus C, 2011, NATURE, V476, P181, DOI 10.1038/nature10290; Ozeri R, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.042329; Piltz C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5679; Pino JM, 2021, NATURE, V592, P209, DOI 10.1038/s41586-021-03318-4; Ruster T, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.031050; Sackett CA, 2000, NATURE, V404, P256, DOI 10.1038/35005011; Schmidt-Kaler F, 2003, NATURE, V422, P408, DOI 10.1038/nature01494; Setzer W., 2021, FLUORESCENCE DETECTI; Srinivas R, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.163201; Stuart J, 2019, PHYS REV APPL, V11, DOI 10.1103/PhysRevApplied.11.024010; Sutherland RT, 2020, PHYS REV A, V101, DOI 10.1103/PhysRevA.101.042334; Sutherland RT, 2019, NEW J PHYS, V21, DOI 10.1088/1367-2630/ab0be5; Todaro SL, 2021, PHYS REV LETT, V126, DOI 10.1103/PhysRevLett.126.010501; Warring U, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.173002; Weidt S, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.220501; Wright K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13534-2; Zarantonello G, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.260503	55	32	32	7	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 9	2021	597	7875					209	213		10.1038/s41586-021-03809-4	http://dx.doi.org/10.1038/s41586-021-03809-4			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UO6VJ	34497396	Green Submitted			2022-12-28	WOS:000694830500001
J	Xu, Z; Hueckel, T; Irvine, WTM; Sacanna, S				Xu, Zhe; Hueckel, Theodore; Irvine, William T. M.; Sacanna, Stefano			Transmembrane transport in inorganic colloidal cell-mimics	NATURE			English	Article							PARTICLES; BEHAVIOR	Hollow colloidal capsules, each with a single micropore, act as artificial cell-like structures that can capture and release payloads such as solid particles or bacteria from the external environment. A key aspect of living cells is their ability to harvest energy from the environment and use it to pump specific atomic and molecular species in and out of their system-typically against an unfavourable concentration gradient(1). Active transport allows cells to store metabolic energy, extract waste and supply organelles with basic building blocks at the submicrometre scale. Unlike living cells, abiotic systems do not have the delicate biochemical machinery that can be specifically activated to precisely control biological matter(2-5). Here we report the creation of microcapsules that can be brought out of equilibrium by simple global variables (illumination and pH), to capture, concentrate, store and deliver generic microscopic payloads. Borrowing no materials from biology, our design uses hollow colloids serving as spherical cell-membrane mimics, with a well-defined single micropore. Precisely tunable monodisperse capsules are the result of a synthetic self-inflation mechanism and can be produced in bulk quantities. Inside the hollow unit, a photoswitchable catalyst(6) produces a chemical gradient that propagates to the exterior through the membrane's micropore and pumps target objects into the cell, acting as a phoretic tractor beam(7). An entropic energy barrier(8,9) brought about by the micropore's geometry retains the cargo even when the catalyst is switched off. Delivery is accomplished on demand by reversing the sign of the phoretic interaction. Our findings provide a blueprint for developing the next generation of smart materials, autonomous micromachinery and artificial cell-mimics.	[Xu, Zhe; Hueckel, Theodore; Sacanna, Stefano] NYU, Dept Chem, Mol Design Inst, New York, NY 10013 USA; [Irvine, William T. M.] Univ Chicago, Enrico Fermi Inst, Dept Phys, James Franck Inst, Chicago, IL 60637 USA	New York University; University of Chicago	Sacanna, S (corresponding author), NYU, Dept Chem, Mol Design Inst, New York, NY 10013 USA.; Irvine, WTM (corresponding author), Univ Chicago, Enrico Fermi Inst, Dept Phys, James Franck Inst, Chicago, IL 60637 USA.	wtmirvine@uchicago.edu; s.sacanna@nyu.edu	Sacanna, Stefano/ABE-9434-2021	Sacanna, Stefano/0000-0002-8399-3524; Xu, Zhe/0000-0002-8599-079X; irvine, william/0000-0002-4925-2060				Cheng KL, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3009621; Datta SS, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.134302; Dinsmore AD, 2002, SCIENCE, V298, P1006, DOI 10.1126/science.1074868; Fujii S, 2013, P NATL ACAD SCI USA, V110, P16796, DOI 10.1073/pnas.1314585110; Grigoriev IV, 2002, J CHEM PHYS, V116, P9574, DOI 10.1063/1.1475756; Im SH, 2005, NAT MATER, V4, P671, DOI 10.1038/nmat1448; Kar A, 2015, ACS NANO, V9, P746, DOI 10.1021/nn506216b; Kim SH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4068; Kim SH, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/7/075014; Kuijk A, 2011, J AM CHEM SOC, V133, P2346, DOI 10.1021/ja109524h; Li GZ, 2001, J INORG ORGANOMET P, V11, P123, DOI 10.1023/A:1015287910502; Okubo M, 2017, LANGMUIR, V33, P3468, DOI 10.1021/acs.langmuir.7b00232; Opdam J, 2020, SOFT MATTER, V16, P7438, DOI 10.1039/d0sm00942c; Palacci J, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0372; Qiao Y, 2017, NAT CHEM, V9, P110, DOI [10.1038/nchem.2617, 10.1038/NCHEM.2617]; Qiu JC, 2019, ANGEW CHEM INT EDIT, V58, P10606, DOI 10.1002/anie.201904549; Rideau E, 2018, CHEM SOC REV, V47, DOI 10.1039/c8cs00162f; Rodriguez-Arco L, 2017, NAT MATER, V16, P857, DOI [10.1038/NMAT4916, 10.1038/nmat4916]; Sacanna S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2694; Shang LR, 2021, MATTER-US, V4, P95, DOI 10.1016/j.matt.2020.10.003; Shi H, 2019, LANGMUIR, V35, P12150, DOI 10.1021/acs.langmuir.9b01952; Silletta EV, 2018, J PHYS CHEM B, V122, P4931, DOI 10.1021/acs.jpcb.8b01638; SKOU JC, 1992, J BIOENERG BIOMEMBR, V24, P249; SUGIMOTO T, 1993, COLLOID SURFACE A, V70, P167, DOI 10.1016/0927-7757(93)80285-M; Taylor JW, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00177-4; Tweedy L, 2020, SCIENCE, V369, P1075, DOI 10.1126/science.aay9792; van der Wel C, 2017, LANGMUIR, V33, P8174, DOI 10.1021/acs.langmuir.7b01398; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Yang ZJ, 2018, NATURE, V553, P313, DOI 10.1038/nature25137; Yewdall NA, 2018, INTERFACE FOCUS, V8, DOI 10.1098/rsfs.2018.0023; Yin YD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10658; Zhu TF, 2012, P NATL ACAD SCI USA, V109, P9828, DOI 10.1073/pnas.1203212109; Zhu TF, 2009, J AM CHEM SOC, V131, P5705, DOI 10.1021/ja900919c	33	11	12	22	148	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 9	2021	597	7875					220	+		10.1038/s41586-021-03774-y	http://dx.doi.org/10.1038/s41586-021-03774-y			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UQ1FZ	34497391				2022-12-28	WOS:000695818300011
J	Alves, L				Alves, Lise			Brazil sues cigarette manufacturers for public health costs	LANCET			English	Editorial Material																			0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 1	2019	393	10187					2187	2187		10.1016/S0140-6736(19)31230-9	http://dx.doi.org/10.1016/S0140-6736(19)31230-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IB1HV	34509216				2022-12-28	WOS:000470017100010
J	Johannson, KA; Chaudhuri, N; Adegunsoye, A; Wolters, PJ				Johannson, Kerri A.; Chaudhuri, Nazia; Adegunsoye, Ayodeji; Wolters, Paul J.			Treatment of fibrotic interstitial lung disease: current approaches and future directions	LANCET			English	Review							IDIOPATHIC PULMONARY-FIBROSIS; DOUBLE-BLIND; MYCOPHENOLATE-MOFETIL; SYSTEMIC-SCLEROSIS; CONTROLLED-TRIAL; PALLIATIVE CARE; CHRONIC COUGH; PLACEBO; PIRFENIDONE; SAFETY	Fibrotic interstitial lung disease (ILD) represents a large group of pulmonary disorders that are often progressive and associated with high morbidity and early mortality. Important advancements in the past 10 years have enabled a better understanding, characterisation, and treatment of these diseases. This Series paper summarises the current approach to treatment of fibrotic ILDs, both pharmacological and non-pharmacological, including recent discoveries and practice-changing clinical trials. We further outline controversies and challenges, with discussion of evolving concepts and future research directions.	[Johannson, Kerri A.] Univ Calgary, Snyder Inst Chron Dis, Dept Med & Community Hlth Sci, Calgary, AB, Canada; [Chaudhuri, Nazia] Manchester Univ NHS Fdn Trust, Wythenshawe Hosp, North West Lung Ctr, Manchester, Lancs, England; [Chaudhuri, Nazia] Univ Manchester, Div Infect Immun & Resp Med, Manchester, Lancs, England; [Adegunsoye, Ayodeji] Univ Chicago, Sect Pulm & Crit Care Med, Chicago, IL 60637 USA; [Wolters, Paul J.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of Calgary; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester; University of Chicago; University of California System; University of California San Francisco	Johannson, KA (corresponding author), South Hlth Campus, Pulm Diagnost, Calgary, AB T3M 1M4, Canada.	kerri.johannson@ahs.ca	Chaudhuri, Nazia/J-4517-2019	Chaudhuri, Nazia/0000-0003-3325-6996				Adegunsoye A, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.02872-2020; Adegunsoye Ayodeji, 2017, ERJ Open Res, V3, DOI 10.1183/23120541.00016-2017; Barba T, 2019, AUTOIMMUN REV, V18, P113, DOI 10.1016/j.autrev.2018.07.013; Behr J, 2019, AM J RESP CRIT CARE, V200, P1505, DOI 10.1164/rccm.201903-0488OC; Behr J, 2021, LANCET RESP MED, V9, P476, DOI 10.1016/S2213-2600(20)30554-3; Behr J, 2021, LANCET RESP MED, V9, P85, DOI 10.1016/S2213-2600(20)30356-8; Behr J, 2016, LANCET RESP MED, V4, P445, DOI 10.1016/S2213-2600(16)30044-3; Birring SS, 2018, CHEST, V154, P904, DOI 10.1016/j.chest.2018.06.038; Birring SS, 2017, LANCET RESP MED, V5, P806, DOI 10.1016/S2213-2600(17)30310-7; Broen JCA, 2020, NAT REV RHEUMATOL, V16, P167, DOI 10.1038/s41584-020-0374-8; Brown CE, 2016, ANN AM THORAC SOC, V13, P684, DOI 10.1513/AnnalsATS.201510-667OC; Brown KK, 2019, RESP MED, V146, P42, DOI 10.1016/j.rmed.2018.11.012; Collard HR, 2007, CHEST, V131, P897, DOI 10.1378/chest.06-2101; Collard HR, 2016, AM J RESP CRIT CARE, V194, P265, DOI 10.1164/rccm.201604-0801CI; Cosgrove GP, 2021, AM J RESP CRIT CARE, V203; Costabel U, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0866-0; Currow D, 2020, THORAX, V75, P50, DOI 10.1136/thoraxjnl-2019-213681; Dawson JK, 2021, RHEUMATOL INT, V41, P1055, DOI 10.1007/s00296-020-04773-4; Distler O, 2019, NEW ENGL J MED, V380, P2518, DOI 10.1056/NEJMoa1903076; Dowman L, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006322.pub3; Ferreira M, 2020, RESP MED, V172, DOI 10.1016/j.rmed.2020.106146; Fischer A, 2013, J RHEUMATOL, V40, P640, DOI 10.3899/jrheum.121043; Flaherty KR, 2019, NEW ENGL J MED, V381, P1718, DOI 10.1056/NEJMoa1908681; Flaherty KR, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.00230-2018; Flaherty KR, 2002, EUR RESPIR J, V19, P275, DOI 10.1183/09031936.02.00182002; Ge YP, 2015, CLIN RHEUMATOL, V34, P99, DOI 10.1007/s10067-014-2803-z; George PM, 2020, LANCET RESP MED, V8, P925, DOI 10.1016/S2213-2600(20)30355-6; George PM, 2019, LANCET RESP MED, V7, P271, DOI 10.1016/S2213-2600(18)30502-2; Goswami RP, 2021, RHEUMATOLOGY, V60, P557, DOI 10.1093/rheumatology/keaa550; Highland KB, 2021, LANCET RESP MED, V9, P96, DOI 10.1016/S2213-2600(20)30330-1; Holland AE, 2021, ANN AM THORAC SOC, V18, pE12, DOI 10.1513/AnnalsATS.202102-146ST; Holland AE, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-040798; Horton MR, 2012, ANN INTERN MED, V157, P398, DOI 10.7326/0003-4819-157-6-201209180-00003; Hoyles RK, 2006, ARTHRITIS RHEUM-US, V54, P3962, DOI 10.1002/art.22204; Huapaya JA, 2019, CHEST, V156, P896, DOI 10.1016/j.chest.2019.05.023; Jacobs SS, 2020, AM J RESP CRIT CARE, V202, pE121, DOI 10.1164/rccm.202009-3608ST; Jenkins RG, 2015, LANCET RESP MED, V3, P462, DOI 10.1016/S2213-2600(15)00048-X; Juge PA, 2018, NEW ENGL J MED, V379, P2209, DOI 10.1056/NEJMoa1801562; Juge PA, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02314-2016; Justice JN, 2019, EBIOMEDICINE, V40, P554, DOI 10.1016/j.ebiom.2018.12.052; Khanna D, 2020, LANCET RESP MED, V8, P963, DOI 10.1016/S2213-2600(20)30318-0; Khanna D, 2016, LANCET, V387, P2630, DOI 10.1016/S0140-6736(16)00232-4; Kim JW, 2019, BMJ SUPPORT PALLIAT, V9, P130, DOI 10.1136/bmjspcare-2018-001575; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; King TE, 2011, AM J RESP CRIT CARE, V184, P92, DOI 10.1164/rccm.201011-1874OC; KOKKARINEN JI, 1992, AM REV RESPIR DIS, V145, P3, DOI 10.1164/ajrccm/145.1.3; Kolb M, 2018, NEW ENGL J MED, V379, P1722, DOI 10.1056/NEJMoa1811737; Kondoh Y, 2020, AM J RESP CRIT CARE, V201, P1110, DOI 10.1164/rccm.201909-1818OC; Kreuter M, 2020, RESP RES, V21, DOI 10.1186/s12931-020-1298-1; Kreuter M, 2017, LANCET RESP MED, V5, P968, DOI 10.1016/S2213-2600(17)30383-1; Kreuter M, 2016, LANCET RESP MED, V4, P381, DOI [10.1016/S2213-2600(16)00067-9, 10.1016/S2213-2600(16)30235-1]; Kurata I, 2019, INTERNAL MED, V58, P1703, DOI 10.2169/internalmedicine.2226-18; Labirua-Iturburu A, 2013, CLIN EXP RHEUMATOL, V31, P436; Lazor R, 2000, AM J RESP CRIT CARE, V162, P571, DOI 10.1164/ajrccm.162.2.9909015; Lederer DJ, 2018, NEW ENGL J MED, V378, P1811, DOI 10.1056/NEJMra1705751; Lee JS, 2013, LANCET RESP MED, V1, P369, DOI 10.1016/S2213-2600(13)70105-X; Ley B, 2019, AM J RESP CRIT CARE, V200, P1154, DOI 10.1164/rccm.201902-0360OC; Ley B, 2014, AM J PHYSIOL-LUNG C, V307, pL681, DOI 10.1152/ajplung.00014.2014; Lim RK, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.00421-2019; Lindell KO, 2021, ANN AM THORAC SOC, V18, P1811, DOI [10.1513/AnnalsATS.202012-1494OC, 10.1513/AnnalsATS.202012-14940C]; Maher TM, 2020, LANCET RESP MED, V8, P147, DOI 10.1016/S2213-2600(19)30341-8; Maher TM, 2017, LANCET RESP MED, V5, P946, DOI 10.1016/S2213-2600(17)30430-7; Manfredi A, 2018, CLIN EXP RHEUMATOL, V36, P342; Martinez FJ, 2021, JAMA-J AM MED ASSOC, V325, P1841, DOI 10.1001/jama.2021.4956; Mira-Avendano IC, 2013, RESP MED, V107, P890, DOI 10.1016/j.rmed.2013.02.015; Morisset J, 2017, CHEST, V151, P619, DOI 10.1016/j.chest.2016.10.029; Murphy SM, 2016, RHEUMATOLOGY, V55, P2277, DOI 10.1093/rheumatology/kew296; Narvaez J, 2019, ANN RHEUM DIS, V78, DOI 10.1136/annrheumdis-2018-214449; Nathan SD, 2019, LANCET RESP MED, V7, P780, DOI 10.1016/S2213-2600(19)30250-4; Nathan SD, 2019, RESP MED, V153, P44, DOI 10.1016/j.rmed.2019.04.016; Nathan SD, 2017, LANCET RESP MED, V5, P33, DOI 10.1016/S2213-2600(16)30326-5; Newton CA, 2021, CLIN CHEST MED, V42, P357, DOI 10.1016/j.ccm.2021.03.011; Newton CA, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01641-2018; Newton CA, 2019, AM J RESP CRIT CARE, V200, P336, DOI 10.1164/rccm.201809-1646OC; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Park MY, AM J RESP CRIT CARE, V203, pA1897; RAGHU G, 1991, AM REV RESPIR DIS, V144, P291, DOI 10.1164/ajrccm/144.2.291; Raghu G, 2018, LANCET RESP MED, V6, P707, DOI 10.1016/S2213-2600(18)30301-1; Raghu G, 2018, JAMA-J AM MED ASSOC, V319, P2299, DOI 10.1001/jama.2018.6129; Raghu G, 2015, AM J RESP CRIT CARE, V192, pE3, DOI 10.1164/rccm.201506-1063ST; Raghu G, 2013, ANN INTERN MED, V158, P641, DOI 10.7326/0003-4819-158-9-201305070-00003; Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354; Richeldi L, 2020, BMC PULM MED, V20, DOI 10.1186/s12890-019-1030-4; Richeldi L, 2020, LANCET RESP MED, V8, P25, DOI 10.1016/S2213-2600(19)30262-0; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Ryan NM, 2012, LANCET, V380, P1583, DOI 10.1016/S0140-6736(12)60776-4; Ryerson CJ, 2011, RESPIROLOGY, V16, P969, DOI 10.1111/j.1440-1843.2011.01996.x; Scott MKD, 2019, LANCET RESP MED, V7, P497, DOI 10.1016/S2213-2600(18)30508-3; Selman M, 2021, EUR RESPIR J, V58, DOI 10.1183/13993003.04507-2020; Solomon JJ, 2019, ADV THER, V36, P3279, DOI 10.1007/s12325-019-01086-2; Stuart BD, 2014, LANCET RESP MED, V2, P557, DOI 10.1016/S2213-2600(14)70124-9; Tashkin DP, 2006, NEW ENGL J MED, V354, P2655, DOI 10.1056/NEJMoa055120; Tashkin DP, 2016, LANCET RESP MED, V4, P708, DOI 10.1016/S2213-2600(16)30152-7; van Manen Mirjam J G, 2017, Eur Respir J, V50, DOI 10.1183/13993003.01157-2017; Vancheri C, 2018, AM J RESP CRIT CARE, V197, P356, DOI 10.1164/rccm.201706-1301OC; Visca D, 2018, LANCET RESP MED, V6, P759, DOI 10.1016/S2213-2600(18)30289-3; Volkmann ER, 2019, ANN RHEUM DIS, V78, P122, DOI 10.1136/annrheumdis-2018-213708; Waxman A, 2021, NEW ENGL J MED, V384, P325, DOI 10.1056/NEJMoa2008470; Wells AU, 2020, LANCET RESP MED, V8, P453, DOI 10.1016/S2213-2600(20)30036-9; Wilson AM, 2020, JAMA-J AM MED ASSOC, V324, P2282, DOI 10.1001/jama.2020.22960	100	15	16	4	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 16	2021	398	10309					1450	1460		10.1016/S0140-6736(21)01826-2	http://dx.doi.org/10.1016/S0140-6736(21)01826-2		OCT 2021	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WI0TQ	34499866				2022-12-28	WOS:000708080400024
J	Gines, P; Krag, A; Abraldes, JG; Sola, E; Fabrellas, N; Kamath, PS				Gines, Pere; Krag, Aleksander; Abraldes, Juan G.; Sola, Elsa; Fabrellas, Nuria; Kamath, Patrick S.			Liver cirrhosis	LANCET			English	Review							PORTAL-VEIN THROMBOSIS; ACUTE KIDNEY INJURY; TRANSIENT ELASTOGRAPHY; HEPATORENAL-SYNDROME; ACUTE DECOMPENSATION; DIAGNOSTIC-CRITERIA; ALCOHOL-CONSUMPTION; REFRACTORY ASCITES; STRATIFYING RISK; NATURAL-HISTORY	Cirrhosis is widely prevalent worldwide and can be a consequence of different causes, such as obesity, non-alcoholic fatty liver disease, high alcohol consumption, hepatitis B or C infection, autoimmune diseases, cholestatic diseases, and iron or copper overload. Cirrhosis develops after a long period of inflammation that results in replacement of the healthy liver parenchyma with fibrotic tissue and regenerative nodules, leading to portal hypertension. The disease evolves from an asymptomatic phase (compensated cirrhosis) to a symptomatic phase (decompensated cirrhosis), the complications of which often result in hospitalisation, impaired quality of life, and high mortality. Progressive portal hypertension, systemic inflammation, and liver failure drive disease outcomes. The management of liver cirrhosis is centred on the treatment of the causes and complications, and liver transplantation can be required in some cases. In this Seminar, we discuss the disease burden, pathophysiology, and recommendations for the diagnosis and management of cirrhosis and its complications. Future challenges include better screening for early fibrosis or cirrhosis, early identification and reversal of causative factors, and prevention of complications.	[Gines, Pere; Sola, Elsa] Hosp Clin Barcelona, Liver Unit, Barcelona 08036, Spain; [Gines, Pere; Sola, Elsa; Fabrellas, Nuria] Univ Barcelona, Fac Med & Hlth Sci, Barcelona, Spain; [Gines, Pere; Fabrellas, Nuria] Inst Biomed Invest August Pi & Sunyer, Barcelona, Spain; [Gines, Pere; Fabrellas, Nuria] Hepat & Digest Dis Biomed Invest Ctr, Madrid, Spain; [Krag, Aleksander] Odense Univ Hosp, Dept Gastroenterol & Hepatol, Liver Res Ctr, Odense, Denmark; [Krag, Aleksander] Univ Southern Denmark, Inst Clin Res, Odense, Denmark; [Abraldes, Juan G.] Univ Alberta, Div Gastroenterol, Liver Unit, Edmonton, AB, Canada; [Sola, Elsa] Stanford Univ, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Kamath, Patrick S.] Mayo Clin, Coll Med & Sci, Rochester, MN USA	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Alberta; Stanford University; Mayo Clinic	Gines, P (corresponding author), Hosp Clin Barcelona, Liver Unit, Barcelona 08036, Spain.	pgines@clinic.cat		Krag, Aleksander/0000-0002-9598-4932	ISCIII-Subdireccion General de Evaluacion; European Regional Development Fund; Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas; Agency for Management of University [AGAUR 2017_SGR_01281]; National Institutes of Health's National Institute on Alcohol Abuse and Alcoholism [U01AA26974]; FIS [18/01330]; LiverHope [731875]; LiverScreen [847989]	ISCIII-Subdireccion General de Evaluacion; European Regional Development Fund(European Commission); Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas; Agency for Management of University; National Institutes of Health's National Institute on Alcohol Abuse and Alcoholism; FIS(Instituto de Salud Carlos III); LiverHope; LiverScreen	We dedicate this work to the memories of Prof Juan Rodes and Robert W Schier. PG is supported by the grants LiverHope 731875 and LiverScreen 847989 (European Commission Horizon 2020), FIS PI20/00579 (integrated in the Plan Nacional I+D+I and co-funded by ISCIII-Subdireccion General de Evaluacion and European Regional Development Fund), by Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas, and by the Agency for Management of University and Research Grant grant number AGAUR 2017_SGR_01281. NF is supported by the grant FIS 18/01330 (integrated in the Plan Nacional I+D+I and co-funded by ISCIII-Subdireccion General de Evaluacion and European Regional Development Fund). PSK is partly supported by the National Institutes of Health's National Institute on Alcohol Abuse and Alcoholism grant U01AA26974. We acknowledge the support of Nicki van Berckel and Roser Poblet in the preparation of this Seminar and the expert technical assistance of Stine Johansen in drawing figure 2.	Abbafati C, 2020, LANCET, V396, P1204, DOI 10.1016/S0140-6736(20)30925-9; Abraldes JG, 2003, HEPATOLOGY, V37, P902, DOI 10.1053/jhep.2003.50133; Abraldes JG, 2016, GASTROENTEROLOGY, V150, P1160, DOI 10.1053/j.gastro.2016.01.004; Abul-Husn NS, 2018, NEW ENGL J MED, V378, P1096, DOI 10.1056/NEJMoa1712191; Acharya C, 2021, GASTROENTEROLOGY, V160, P556, DOI 10.1053/j.gastro.2020.10.056; Albillos A, 2020, J HEPATOL, V72, P558, DOI 10.1016/j.jhep.2019.10.003; Albillos A, 2017, HEPATOLOGY, V66, P1219, DOI 10.1002/hep.29267; Allen AM, 2016, HEPATOLOGY, V64, P2165, DOI 10.1002/hep.28812; Amer Assoc Study Liver Dis, 2014, J HEPATOL, V61, P642, DOI 10.1016/j.jhep.2014.05.042; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Arroyo V, 1996, HEPATOLOGY, V23, P164, DOI 10.1053/jhep.1996.v23.ajhep0230164; Arroyo V, 2021, J HEPATOL, V74, P670, DOI 10.1016/j.jhep.2020.11.048; Arroyo V, 2020, NEW ENGL J MED, V382, P2137, DOI 10.1056/NEJMra1914900; Asrani SK, 2019, J HEPATOL, V70, P151, DOI 10.1016/j.jhep.2018.09.014; ATTALI P, 1987, ARCH INTERN MED, V147, P1065, DOI 10.1001/archinte.147.6.1065; Augustin S, 2017, HEPATOLOGY, V66, P1980, DOI 10.1002/hep.29363; Bajaj JS, 2008, HEPATOLOGY, V47, P596, DOI 10.1002/hep.22032; Bajaj JS, 2014, J HEPATOL, V60, P940, DOI 10.1016/j.jhep.2013.12.019; Balmer ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008618; Bass NM, 2010, NEW ENGL J MED, V362, P1071, DOI 10.1056/NEJMoa0907893; Berzigotti A, 2017, HEPATOLOGY, V65, P1293, DOI 10.1002/hep.28992; Best LMJ, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013103.pub2; BHATHAL PS, 1985, J HEPATOL, V1, P325, DOI 10.1016/S0168-8278(85)80770-4; Biggins SW, 2021, HEPATOLOGY, V74, P1014, DOI 10.1002/hep.31884; Bosch J, 2020, GUT, V69, P953, DOI 10.1136/gutjnl-2019-318237; Bureau C, 2017, GASTROENTEROLOGY, V152, P157, DOI 10.1053/j.gastro.2016.09.016; Burnham B, 2014, AM J HEALTH BEHAV, V38, P737, DOI 10.5993/AJHB.38.5.11; Campagna F, 2017, HEPATOLOGY, V66, P198, DOI 10.1002/hep.29146; Caraceni P, 2018, LANCET, V391, P2417, DOI 10.1016/S0140-6736(18)30840-7; Garcia-Pagan JC, 2010, NEW ENGL J MED, V362, P2370, DOI 10.1056/NEJMoa0910102; Carlsson B, 2020, ALIMENT PHARM THER, V51, P1305, DOI 10.1111/apt.15738; Cavallin M, 2015, HEPATOLOGY, V62, P567, DOI 10.1002/hep.27709; Cederholm T, 2015, CLIN NUTR, V34, P335, DOI 10.1016/j.clnu.2015.03.001; China L, 2021, NEW ENGL J MED, V384, P808, DOI 10.1056/NEJMoa2022166; Crabb DW, 2020, HEPATOLOGY, V71, P306, DOI 10.1002/hep.30866; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; D'Amico G, 2005, GASTROENTEROLOGY, V129, P1282, DOI 10.1053/j.gastro.2005.07.031; D'Amico G, 2018, J HEPATOL, V68, P563, DOI 10.1016/j.jhep.2017.10.020; de Franchis R, 2015, J HEPATOL, V63, P743, DOI 10.1016/j.jhep.2015.05.022; Dunne PDJ, 2020, ALIMENT PHARM THER, V52, P98, DOI 10.1111/apt.15797; Eddowes PJ, 2019, GASTROENTEROLOGY, V156, P1717, DOI 10.1053/j.gastro.2019.01.042; Elia C, 2015, J HEPATOL, V63, P593, DOI 10.1016/j.jhep.2015.04.004; Emdin CA, 2021, GASTROENTEROLOGY, V160, P1620, DOI 10.1053/j.gastro.2020.12.011; Eslam M, 2020, GASTROENTEROLOGY, V158, P1999, DOI 10.1053/j.gastro.2019.11.312; European Assoc Study Liver, 2019, J HEPATOL, V70, P172, DOI 10.1016/j.jhep.2018.06.024; European Assoc Study Liver, 2018, J HEPATOL, V69, P406, DOI 10.1016/j.jhep.2018.03.024; Fabrellas N, 2020, CLIN TRANSL GASTROEN, V11, DOI 10.14309/ctg.0000000000000159; Fabrellas N, 2020, HEPATOLOGY, V71, P1106, DOI 10.1002/hep.31117; Fabrellas N, 2018, J ADV NURS, V74, P498, DOI 10.1111/jan.13350; Fabrellas N, 2013, NURS RES, V62, P450, DOI 10.1097/NNR.0000000000000001; Fernandez J, 2018, GUT, V67, P1870, DOI 10.1136/gutjnl-2017-314240; Fernandez M, 2009, J HEPATOL, V50, P604, DOI 10.1016/j.jhep.2008.12.011; Fernandez-Varo G, 2016, HEPATOLOGY, V63, P207, DOI 10.1002/hep.28250; Finn RS, 2020, NEW ENGL J MED, V382, P1894, DOI 10.1056/NEJMoa1915745; Forner A, 2018, LANCET, V391, P1301, DOI 10.1016/S0140-6736(18)30010-2; Garcia-Tsao G, 2017, HEPATOLOGY, V65, P310, DOI 10.1002/hep.28906; GINES P, 1987, HEPATOLOGY, V7, P122, DOI 10.1002/hep.1840070124; Gines P, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0022-7; Gluud LL, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003044.pub3; Gunsar F, 2006, ALIMENT PHARM THER, V24, P563, DOI 10.1111/j.1365-2036.2006.03003.x; Hagstrom H, 2021, GUT, V70, P170, DOI 10.1136/gutjnl-2019-320446; Hagstrom H, 2017, J HEPATOL, V67, P1265, DOI 10.1016/j.jhep.2017.07.027; Herrmann E, 2018, HEPATOLOGY, V67, P260, DOI 10.1002/hep.29179; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Hu HL, 2018, CELL, V175, P1591, DOI 10.1016/j.cell.2018.11.013; Huelin P, 2019, HEPATOLOGY, V70, P319, DOI 10.1002/hep.30592; Huelin P, 2017, CLIN GASTROENTEROL H, V15, P438, DOI 10.1016/j.cgh.2016.09.156; Hytiroglou P, 2018, VIRCHOWS ARCH, V473, P15, DOI 10.1007/s00428-018-2340-2; Imajo K, 2022, CLIN GASTROENTEROL H, V20, P908, DOI 10.1016/j.cgh.2020.12.016; Israelsen Mads, 2022, Clin Gastroenterol Hepatol, V20, P1784, DOI 10.1016/j.cgh.2020.11.038; Jalan R, 2014, J HEPATOL, V60, P1310, DOI 10.1016/j.jhep.2014.01.024; Jepsen P, 2008, HEPATOLOGY, V48, P214, DOI 10.1002/hep.22341; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kamath PS, MELD SCORE MODEL END; Kamath PS, 2020, SLEISENGER FORDTRANS, V11th, P1164; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Kim WR, MELDNA MELDNA SCORE; Krowka MJ, 2016, TRANSPLANTATION, V100, P1440, DOI 10.1097/TP.0000000000001229; Li CP, 2003, WORLD J GASTROENTERO, V9, P2832; LLACH J, 1988, GASTROENTEROLOGY, V94, P482, DOI 10.1016/0016-5085(88)90441-6; Llovet JM, 2021, NAT REV GASTRO HEPAT, V18, P293, DOI 10.1038/s41575-020-00395-0; Llovet JM, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-020-00240-3; Loffredo L, 2017, GASTROENTEROLOGY, V153, P480, DOI 10.1053/j.gastro.2017.04.042; Lv Y, 2019, LANCET GASTROENTEROL, V4, P587, DOI 10.1016/S2468-1253(19)30090-1; Martin PY, 1998, NEW ENGL J MED, V339, P533, DOI 10.1056/NEJM199808203390807; Mavilia MG, 2018, J CLIN TRANSL HEPATO, V6, P296, DOI 10.14218/JCTH.2018.00016; McAvoy NC, 2016, ALIMENT PHARM THER, V43, P947, DOI 10.1111/apt.13571; Merion RM, 2005, AM J TRANSPLANT, V5, P307, DOI 10.1111/j.1600-6143.2004.00703.x; Montano-Loza AJ, 2016, J CACHEXIA SARCOPENI, V7, P126, DOI 10.1002/jcsm.12039; Montano-Loza AJ, 2012, CLIN GASTROENTEROL H, V10, P166, DOI 10.1016/j.cgh.2011.08.028; Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042; Mucke MM, 2020, CLIN TRANSL GASTROEN, V11, DOI 10.14309/ctg.0000000000000223; Munteanu M, 2018, ALIMENT PHARM THER, V48, P1117, DOI 10.1111/apt.14990; Nery F, 2015, HEPATOLOGY, V61, P660, DOI 10.1002/hep.27546; Nishikawa H, 2016, INTERNAL MED, V55, P855, DOI 10.2169/internalmedicine.55.6298; Northup PG, 2019, CLIN GASTROENTEROL H, V17, P595, DOI 10.1016/j.cgh.2018.09.043; Papatheodoridi M, 2021, J HEPATOL, V74, P1109, DOI 10.1016/j.jhep.2020.11.050; Park CC, 2017, GASTROENTEROLOGY, V152, P598, DOI 10.1053/j.gastro.2016.10.026; Parker R, 2019, J HEPATOL, V71, P586, DOI 10.1016/j.jhep.2019.05.020; Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623; Petta S, 2018, J HEPATOL, V69, P18, DOI [10.1016/j.jhep.2018.02.015, 10.1016/j.jhep.2018.05.019]; Pfister D, 2021, NATURE, V592, P450, DOI 10.1038/s41586-021-03362-0; Piano S, 2019, GASTROENTEROLOGY, V156, P1368, DOI 10.1053/j.gastro.2018.12.005; Piano S, 2018, LIVER INT, V38, P126, DOI 10.1111/liv.13645; Piano S, 2017, J HEPATOL, V67, P1177, DOI 10.1016/j.jhep.2017.07.008; Pose E, 2021, LIVER INT, V41, P1556, DOI 10.1111/liv.14830; Pose E, 2019, J HEPATOL, V70, P194, DOI 10.1016/j.jhep.2018.07.019; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Ramachandran P, 2019, NATURE, V575, P512, DOI 10.1038/s41586-019-1631-3; Ripoll C, 2007, GASTROENTEROLOGY, V133, P481, DOI 10.1053/j.gastro.2007.05.024; Rose CF, 2020, J HEPATOL, V73, P1526, DOI 10.1016/j.jhep.2020.07.013; Sanchez-Jimenez B, 2018, COCHRANE DB SYST REV, V11; Senzolo M, 2021, J HEPATOL, V75, P442, DOI 10.1016/j.jhep.2021.04.029; Sepanlou SG, 2020, LANCET GASTROENTEROL, V5, P245, DOI 10.1016/S2468-1253(19)30349-8; Seto WK, 2018, LANCET, V392, P2313, DOI 10.1016/S0140-6736(18)31865-8; Shi Y, 2015, HEPATOLOGY, V62, P232, DOI 10.1002/hep.27795; Simon TG, 2021, GUT, V70, P1375, DOI 10.1136/gutjnl-2020-322786; Simpson RF, 2019, LANCET PUBLIC HEALTH, V4, pE41, DOI 10.1016/S2468-2667(18)30230-5; Sitbon O, 2019, LANCET RESP MED, V7, P594, DOI 10.1016/S2213-2600(19)30091-8; Sola E, 2021, J HEPATOL, V74, P200, DOI 10.1016/j.jhep.2020.08.009; Sola E, 2018, J HEPATOL, V69, P1250, DOI 10.1016/j.jhep.2018.08.006; Sola E, 2012, J HEPATOL, V57, P1199, DOI 10.1016/j.jhep.2012.07.020; Sole C, 2021, GASTROENTEROLOGY, V160, P206, DOI 10.1053/j.gastro.2020.08.054; Sort P, 1999, NEW ENGL J MED, V341, P403, DOI 10.1056/NEJM199908053410603; Spearman CW, 2019, LANCET, V394, P1451, DOI 10.1016/S0140-6736(19)32320-7; Sterling R, FIBROSIS 4 FIB 4 IND; Sterling R., NAFLD NONALCOHOLIC F; Stickel F, 2017, J HEPATOL, V66, P195, DOI 10.1016/j.jhep.2016.08.011; Tandon P, 2018, J HEPATOL, V69, P1164, DOI 10.1016/j.jhep.2018.06.017; Tandon P, 2012, LIVER TRANSPLANT, V18, P1209, DOI 10.1002/lt.23495; Tapper EB, 2017, NEW ENGL J MED, V377, P756, DOI 10.1056/NEJMra1610570; Taylor RS, 2020, GASTROENTEROLOGY, V158, P1611, DOI 10.1053/j.gastro.2020.01.043; Thiele M, 2018, GASTROENTEROLOGY, V154, P1369, DOI 10.1053/j.gastro.2018.01.005; Trautwein C, 2015, J HEPATOL, V62, pS15, DOI 10.1016/j.jhep.2015.02.039; Trebicka J, 2021, NAT REV GASTRO HEPAT, V18, P167, DOI 10.1038/s41575-020-00376-3; Tripodi A, 2017, AM J GASTROENTEROL, V112, P274, DOI 10.1038/ajg.2016.498; Tschumperlin DJ, 2018, J CLIN INVEST, V128, P74, DOI 10.1172/JCI93561; Udell JA, 2012, JAMA-J AM MED ASSOC, V307, P832, DOI 10.1001/jama.2012.186; Vaughn-Sandler V, 2014, DIGEST DIS SCI, V59, P681, DOI 10.1007/s10620-013-2942-0; Villanueva C, 2019, LANCET, V393, P1597, DOI 10.1016/S0140-6736(18)31875-0; Villanueva C, 2013, NEW ENGL J MED, V368, P11, DOI 10.1056/NEJMoa1211801; Wanless IR., 2020, CURR HEPATOL REP, V19, P40, DOI [10.1007/s11901-020-00508-y, DOI 10.1007/S11901-020-00508-Y]; Wells M, 2012, ALIMENT PHARM THER, V35, P1267, DOI 10.1111/j.1365-2036.2012.05088.x; WHO, 2021, NONC DIS; Wiest R, 2002, HEPATOLOGY, V35, P478, DOI 10.1053/jhep.2002.31432; Williams R, 2015, LANCET, V386, P2098, DOI 10.1016/S0140-6736(15)00680-7; Wood AM, 2018, LANCET, V391, P1513, DOI 10.1016/S0140-6736(18)30134-X; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zheng J, 2015, RADIOLOGY, V275, P290, DOI 10.1148/radiol.14140828	149	108	108	54	105	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT	2021	398	10308					1359	1376		10.1016/S0140-6736(21)01374-X	http://dx.doi.org/10.1016/S0140-6736(21)01374-X		OCT 2021	18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WE2YJ	34543610				2022-12-28	WOS:000705490300022
J	Cluver, CA; Hiscock, R; Decloedt, EH; Hall, DR; Schell, S; Mol, B; Brownfoot, F; Kaitu'u-Lino, TJ; Walker, SP; Tong, S				Cluver, Catherine A.; Hiscock, Richard; Decloedt, Eric H.; Hall, David R.; Schell, Sonja; Mol, Ben W.; Brownfoot, Fiona; Kaitu'u-Lino, Tu'uhevaha J.; Walker, Susan P.; Tong, Stephen			Use of metformin to prolong gestation in preterm pre-eclampsia: randomised, double blind, placebo controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EARLY-ONSET; MANAGEMENT; RISK	OBJECTIVE To evaluate whether extended release metformin could be used to prolong gestation in women being expectantly managed for preterm pre-eclampsia. DESIGN Randomised, double blind, placebo controlled trial. SETTING Referral hospital in Cape Town, South Africa. PARTICIPANTS 180 women with preterm pre-eclampsia between 26+0 to 31+6 weeks' gestation undergoing expectant management: 90 were randomised to extended release metformin and 90 to placebo. INTERVENTION 3 g of oral extended release metformin or placebo daily, in divided doses, until delivery. MAIN OUTCOME MEASURE The primary outcome was prolongation of gestation. RESULTS Of 180 participants, one woman delivered before taking any trial drug. The median time from randomisation to delivery was 17.7 days (interquartile range 5.4-29.4 days; n=89) in the metformin arm and 10.1 (3.7-24.1; n=90) days in the placebo arm, a median difference of 7.6 days (geometric mean ratio 1.39, 95% confidence interval 0.99 to 1.95; P=0.057). Among those who continued to take the trial drug at any dose, the median prolongation of gestation in the metformin arm was 17.5 (interquartile range 5.4-28.7; n=76) days compared with 7.9 (3.0-22.2; n=74) days in the placebo arm, a median difference of 9.6 days (geometric mean ratio 1.67, 95% confidence interval 1.16 to 2.42). Among those who took the full dosage, the median prolongation of gestation in the metformin arm was 16.3 (interquartile range 4.8-28.8; n=40) days compared with 4.8 (2.5-15.4; n=61) days in the placebo arm, a median difference of 11.5 days (geometric mean ratio 1.85, 95% confidence interval 1.14 to 2.88). Composite maternal, fetal, and neonatal outcomes and circulating concentrations of soluble fms-like tyrosine kinase-1, placental growth factor, and soluble endoglin did not differ. In the metformin arm, birth weight increased non-significantly and length of stay decreased in the neonatal nursery. No serious adverse events related to trial drugs were observed, although diarrhoea was more common in the metformin arm. CONCLUSIONS This trial suggests that extended release metformin can prolong gestation in women with preterm preeclampsia, although further trials are needed. It provides proof of concept that treatment of preterm pre-eclampsia is possible. TRIAL REGISTRATION Pan African Clinical Trial Registry PACTR201608001752102 https://pactr.samrc.ac.za/.	[Cluver, Catherine A.; Hall, David R.; Schell, Sonja] Stellenbosch Univ, Tygerberg Hosp, Dept Obstet & Gynaecol, ZA-7505 Cape Town, South Africa; [Cluver, Catherine A.; Hiscock, Richard; Brownfoot, Fiona; Kaitu'u-Lino, Tu'uhevaha J.; Walker, Susan P.; Tong, Stephen] Univ Melbourne, Dept Obstet & Gynaecol, Translat Obstet Grp, Melbourne, Vic, Australia; [Cluver, Catherine A.; Brownfoot, Fiona; Kaitu'u-Lino, Tu'uhevaha J.; Walker, Susan P.; Tong, Stephen] Mercy Hosp Women, Mercy Perinatal, Heidelberg, Vic, Australia; [Decloedt, Eric H.] Stellenbosch Univ, Tygerberg Hosp, Dept Med, Div Clin Pharmacol, Cape Town, South Africa; [Mol, Ben W.] Monash Univ, Monash Sch Med, Dept Obstet & Gynaecol, Melbourne, Vic, Australia	Stellenbosch University; Tygerberg Hospital; University of Melbourne; Stellenbosch University; Tygerberg Hospital; Monash University	Cluver, CA (corresponding author), Stellenbosch Univ, Tygerberg Hosp, Dept Obstet & Gynaecol, ZA-7505 Cape Town, South Africa.; Cluver, CA (corresponding author), Univ Melbourne, Dept Obstet & Gynaecol, Translat Obstet Grp, Melbourne, Vic, Australia.; Cluver, CA (corresponding author), Mercy Hosp Women, Mercy Perinatal, Heidelberg, Vic, Australia.	cathycluver@sun.ac.za	; Cluver, Catherine/O-7978-2018	Kaitu'u-Lino, Tu'uhevaha/0000-0001-6233-9737; Cluver, Catherine/0000-0002-0406-8964; Decloedt, Eric/0000-0003-1815-5150; Brownfoot, Fiona/0000-0002-1439-7016	Mercy Health Foundation; Peter Joseph Pappas research grant programme; Preeclampsia Foundation; South African Medical Research Council	Mercy Health Foundation; Peter Joseph Pappas research grant programme; Preeclampsia Foundation; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Mercy Health Foundation, Peter Joseph Pappas research grant programme, Preeclampsia Foundation, and South African Medical Research Council self-initiated research grants programme. Merck Healthcare, Darmstadt, Germany donated the study drugs. The National Health and Medical Research Council of Australia provided salary support to BWM, TJK, FB, and ST. CAC received salary support from the Mercy Health Foundation. This was an investigator initiated trial. The funders had no role in the collection, analysis, interpretation of data, writing of the article, or decision to submit the article for publication.	Abalos E, 2013, EUR J OBSTET GYN R B, V170, P1, DOI 10.1016/j.ejogrb.2013.05.005; Ahmed A, 2000, MOL MED, V6, P391, DOI 10.1007/BF03401783; Alqudah A, 2018, DIABETIC MED, V35, P160, DOI 10.1111/dme.13523; Bao LX, 2021, J MATERN-FETAL NEO M, V34, P2741, DOI 10.1080/14767058.2019.1670804; Barbour LA, 2018, AM J OBSTET GYNECOL, V219, DOI 10.1016/j.ajog.2018.06.013; Brown MA, 2018, HYPERTENSION, V72, P24, DOI 10.1161/HYPERTENSIONAHA.117.10803; Brownfoot FC, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.12.019; Chappell LC, 2021, LANCET, V398, P341, DOI 10.1016/S0140-6736(20)32335-7; Cluver C, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025809; Cluver CA, 2018, AM J OBSTET GYNECOL, V219, DOI 10.1016/j.ajog.2018.07.019; Gardosi J, 2018, AM J OBSTET GYNECOL, V218, pS609, DOI 10.1016/j.ajog.2017.12.011; Hall D. R., 2016, Obstetrics and Gynaecology Forum, V26, P22; Hall DR, 2000, BRIT J OBSTET GYNAEC, V107, P1252, DOI 10.1111/j.1471-0528.2000.tb11616.x; Hanem LGE, 2018, J CLIN ENDOCR METAB, V103, P1612, DOI 10.1210/jc.2017-02419; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hu JL, 2019, FUND CLIN PHARMACOL, V33, P649, DOI 10.1111/fcp.12501; Kalafat E, 2018, ULTRASOUND OBST GYN, V52, P706, DOI 10.1002/uog.19084; Kiserud T, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002220; Landi SN, 2019, JAMA PEDIATR, V173, P160, DOI 10.1001/jamapediatrics.2018.4214; Lisonkova S, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.019; Lisonkova S, 2014, OBSTET GYNECOL, V124, P771, DOI 10.1097/AOG.0000000000000472; Moodley J., 2018, Obstetrics and Gynaecology Forum, V28, P28; Paidas MJ, 2020, AM J OBSTET GYNECOL, V223, DOI 10.1016/j.ajog.2020.08.004; Tong S, 2022, AM J OBSTET GYNECOL, V226, pS1157, DOI 10.1016/j.ajog.2020.09.014; Vigil-De Gracia P, 2016, OBSTET GYNECOL, V128, P1181, DOI 10.1097/AOG.0000000000001727; Wang FC, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/6547019	26	14	14	4	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2021	374								n2103	10.1136/bmj.n2103	http://dx.doi.org/10.1136/bmj.n2103			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ1JE	34551918	Green Published, hybrid			2022-12-28	WOS:000701967300007
J	Puel, A; Casanova, JL				Puel, Anne; Casanova, Jean-Laurent			Comment on "Aberrant type 1 immunity drives susceptibility to mucosal fungal infections"	SCIENCE			English	Editorial Material							CHRONIC MUCOCUTANEOUS CANDIDIASIS; INTERFERON-GAMMA; AUTOANTIBODIES	Break et al. (Research Articles, 15 January 2021, eaay5731) suggest that chronic mucocutaneous candidiasis in humans with inborn errors of AIRE and autoimmune polyendocrine syndrome type 1 is due to excessive interferon-gamma production and not to autoantibodies neutralizing interleukin-17 cytokines. We argue that both claims are not conclusively supported by their data and are at odds with 35 years of study.	[Puel, Anne; Casanova, Jean-Laurent] Necker Hosp Sick Children, Necker Branch, Lab Human Genet Infect Dis, INSERM, Paris, France; [Puel, Anne; Casanova, Jean-Laurent] Univ Paris, Imagine Inst, Paris, France; [Puel, Anne; Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, 1230 York Ave, New York, NY 10021 USA; [Casanova, Jean-Laurent] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Puel, A; Casanova, JL (corresponding author), Necker Hosp Sick Children, Necker Branch, Lab Human Genet Infect Dis, INSERM, Paris, France.; Puel, A; Casanova, JL (corresponding author), Univ Paris, Imagine Inst, Paris, France.; Puel, A; Casanova, JL (corresponding author), Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, 1230 York Ave, New York, NY 10021 USA.; Casanova, JL (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.	anne.puel@inserm.fr; casanova@rockefeller.edu	Puel, Anne/H-7305-2017	Puel, Anne/0000-0003-2603-0323; Casanova, Jean-Laurent/0000-0002-7782-4169	French National Research Agency (ANR) under the "Investments for the Future" program [ANR-10-IAHU-01]; LTh-MSMD-CMCD [ANR-18-CE93-0008-01]; Integrative Biology of Emerging Infectious Diseases Laboratoire d'Excellence [ANR-10-LABX-62-IBEID]; GENCOVID project [ANR-20-COVI-003]; NIH [R01AI127564, R01AI088364, UL1TR001866]; Fast Grant from Emergent Ventures, Mercatus Center at George Mason University; Fisher Center for Alzheimer's Research Foundation; Meyer Foundation; French Foundation for Medical Research (FRM) [EQU201903007798]; ANRS [COV05]; Square Foundation; Grandir-Fonds de solidarite pour l'enfance; SCOR Corporate Foundation for Science; Institut National de la Sante et de la Recherche Medicale (INSERM); University of Paris; St. Giles Foundation; Rockefeller University; JBP foundation	French National Research Agency (ANR) under the "Investments for the Future" program(French National Research Agency (ANR)); LTh-MSMD-CMCD; Integrative Biology of Emerging Infectious Diseases Laboratoire d'Excellence; GENCOVID project; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fast Grant from Emergent Ventures, Mercatus Center at George Mason University; Fisher Center for Alzheimer's Research Foundation; Meyer Foundation; French Foundation for Medical Research (FRM)(Fondation pour la Recherche Medicale); ANRS(ANRSFrench National Research Agency (ANR)); Square Foundation; Grandir-Fonds de solidarite pour l'enfance; SCOR Corporate Foundation for Science; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Paris; St. Giles Foundation; Rockefeller University; JBP foundation	We thank all members of the laboratory for helpful discussions. Supported by the French National Research Agency (ANR) under the "Investments for the Future" program (ANR-10-IAHU-01); LTh-MSMD-CMCD (ANR-18-CE93-0008-01); Integrative Biology of Emerging Infectious Diseases Laboratoire d'Excellence (ANR-10-LABX-62-IBEID); GENCOVID project (ANR-20-COVI-003); NIH grants R01AI127564, R01AI088364, and UL1TR001866; a Fast Grant from Emergent Ventures, Mercatus Center at George Mason University; the Fisher Center for Alzheimer's Research Foundation; the Meyer Foundation; the French Foundation for Medical Research (FRM) (EQU201903007798); ANRS-COV05; the Square Foundation; Grandir-Fonds de solidarite pour l'enfance; the SCOR Corporate Foundation for Science; the Institut National de la Sante et de la Recherche Medicale (INSERM); the University of Paris; the St. Giles Foundation; The Rockefeller University; and the JBP foundation.	AKASHI K, 1994, BRIT J HAEMATOL, V87, P243, DOI 10.1111/j.1365-2141.1994.tb04905.x; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585; Belkaya S, 2019, J EXP MED, V216, P1777, DOI 10.1084/jem.20190669; Break TJ, 2021, SCIENCE, V371, P252, DOI 10.1126/science.aay5731; Del Bel KL, 2017, J ALLERGY CLIN IMMUN, V139, P2016, DOI 10.1016/j.jaci.2016.12.957; Hadjadj J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18925-4; Husebye ES, 2018, NEW ENGL J MED, V378, P1132, DOI 10.1056/NEJMra1713301; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Langley RG, 2014, NEW ENGL J MED, V371, P326, DOI 10.1056/NEJMoa1314258; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; NATHAN CF, 1986, NEW ENGL J MED, V315, P6, DOI 10.1056/NEJM198607033150102; Ohyama Y, 1996, ARTHRITIS RHEUM, V39, P1376, DOI 10.1002/art.1780390816; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983	15	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2021	373	6561								10.1126/science.abi5459	http://dx.doi.org/10.1126/science.abi5459			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	US5SK	34529464	Green Accepted			2022-12-28	WOS:000697488600001
J	Roth, MA; Krumholz, MR; Crocker, RM; Celli, S				Roth, Matt A.; Krumholz, Mark R.; Crocker, Roland M.; Celli, Silvia			The diffuse gamma-ray background is dominated by star-forming galaxies	NATURE			English	Article							COSMIC-RAYS; STARBURST; GAS; EMISSION; BREMSSTRAHLUNG; ACCELERATION; ELECTRONS; RADIATION; TRANSPORT	The Fermi Gamma-ray Space Telescope has revealed a diffuse gamma-ray background at energies from 0.1 gigaelectronvolt to 1 teraelectronvolt, which can be separated into emission from our Galaxy and an isotropic, extragalactic component(1). Previous efforts to understand the latter have been hampered by the lack of physical models capable of predicting the gamma-ray emission produced by the many candidate sources, primarily active galactic nuclei(2-5) and star-forming galaxies(6-10), leaving their contributions poorly constrained. Here we present a calculation of the contribution of star-forming galaxies to the gamma-ray background that does not rely on empirical scalings and is instead based on a physical model for the gamma-ray emission produced when cosmic rays accelerated in supernova remnants interact with the interstellar medium(11). After validating the model against local observations, we apply it to the observed cosmological star-forming galaxy population and recover an excellent match to both the total intensity and the spectral slope of the gamma-ray background, demonstrating that star-forming galaxies alone can explain the full diffuse, isotropic gamma-ray background. The diffuse, isotropic background of gamma rays comes mainly from star-forming galaxies, according to a physical model of gamma-ray emission.	[Roth, Matt A.; Krumholz, Mark R.; Crocker, Roland M.] Australian Natl Univ, Res Sch Astron & Astrophys, Canberra, ACT, Australia; [Krumholz, Mark R.] ARC Ctr Excellence All Sky Astrophys Three Dimens, Canberra, ACT, Australia; [Celli, Silvia] Univ Roma La Sapienza, Dipartimento Fis, Rome, Italy; [Celli, Silvia] Ist Nazl Fis Nucl, Rome, Italy	Australian National University; Sapienza University Rome; Istituto Nazionale di Fisica Nucleare (INFN)	Roth, MA (corresponding author), Australian Natl Univ, Res Sch Astron & Astrophys, Canberra, ACT, Australia.	matt.roth@anu.edu.au		Roth, Matt/0000-0002-4204-5026; Krumholz, Mark/0000-0003-3893-854X				Ackermann M, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/1/86; Ackermann M, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/2/164; Ajello M, 2020, ASTROPHYS J, V894, DOI 10.3847/1538-4357/ab86a6; Ajello M, 2015, ASTROPHYS J LETT, V800, DOI 10.1088/2041-8205/800/2/L27; Ando S, 2017, PHYS REV D, V95, DOI 10.1103/PhysRevD.95.123006; Ballet J., 2020, FERMI LARGE AREA TEL; Bell AR, 2013, ASTROPART PHYS, V43, P56, DOI 10.1016/j.astropartphys.2012.05.022; BELL AR, 1978, MON NOT R ASTRON SOC, V182, P147, DOI 10.1093/mnras/182.2.147; Bendo GJ, 2016, MON NOT R ASTRON SOC, V463, P252, DOI 10.1093/mnras/stw1659; Bendo GJ, 2015, MON NOT R ASTRON SOC, V450, pL80, DOI 10.1093/mnrasl/slv053; Berezinsky V, 2016, PHYS REV D, V94, DOI 10.1103/PhysRevD.94.023007; Bethe H, 1934, P R SOC LOND A-CONTA, V146, P0083, DOI 10.1098/rspa.1934.0140; BLANDFORD R, 1987, PHYS REP, V154, P1, DOI 10.1016/0370-1573(87)90134-7; BLUMENTHAL GR, 1970, REV MOD PHYS, V42, P237, DOI 10.1103/RevModPhys.42.237; Bothwell MS, 2011, MON NOT R ASTRON SOC, V415, P1815, DOI 10.1111/j.1365-2966.2011.18829.x; Bothwell MS., 2014, MON NOT R ASTRON SOC, V438, P3608; BRAUN R, 1992, ASTROPHYS J, V386, P120, DOI 10.1086/170998; Caldu-Primo A, 2016, ASTRON J, V151, DOI 10.3847/0004-6256/151/2/34; Caprioli D, 2012, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2012/07/038; Caprioli D, 2011, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2011/05/026; Chabrier G, 2003, PUBL ASTRON SOC PAC, V115, P763, DOI 10.1086/376392; Cherenkov Telescope Array Consortium, 2019, SCI CHERENKOV TELESC; Crain RA, 2010, MON NOT R ASTRON SOC, V407, P1403, DOI 10.1111/j.1365-2966.2010.16985.x; Crocker RM, 2021, MON NOT R ASTRON SOC, V502, P1312, DOI 10.1093/mnras/stab148; Cuoco A, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.063004; Davis BL, 2018, ASTROPHYS J, V869, DOI 10.3847/1538-4357/aae820; Dermer CD, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201220394; DEVAUCOULERS G, 1964, ASTROPHYS J, V139, P899, DOI 10.1086/147824; Di Mauro M, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/2/161; Di Sciascio G, 2016, NUCL PART PHYS P, V279, P166, DOI 10.1016/j.nuclphysbps.2016.10.024; Fang K., 2020, KLEIN NISHINA EFFECT; Fields BD, 2010, ASTROPHYS J LETT, V722, pL199, DOI 10.1088/2041-8205/722/2/L199; Forbes J, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/1/48; Fornasa M, 2015, PHYS REP, V598, P1, DOI 10.1016/j.physrep.2015.09.002; Franceschini A, 2017, ASTRON ASTROPHYS, V603, DOI 10.1051/0004-6361/201629684; Ghisellini G., 2013, RAD PROCESSES HIGH E; GOULD RJ, 1969, PHYS REV, V185, P72, DOI 10.1103/PhysRev.185.72; Heger A, 2003, ASTROPHYS J, V591, P288, DOI 10.1086/375341; IIJIMA T, 1976, PUBL ASTRON SOC JPN, V28, P27; IRSA, NASA IPAC INFR SCI A; Kafexhiu E, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.123014; Kelner SR, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.034018; Kennicutt RC, 1998, ASTROPHYS J, V498, P541, DOI 10.1086/305588; Koekemoer AM, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/2/36; Komis I, 2019, MON NOT R ASTRON SOC, V483, P4020, DOI 10.1093/mnras/sty3354; Kornecki P, 2020, ASTRON ASTROPHYS, V641, DOI 10.1051/0004-6361/202038428; Krumholz MR, 2020, MON NOT R ASTRON SOC, V493, P2817, DOI 10.1093/mnras/staa493; Lacki BC, 2010, ASTROPHYS J, V717, P1, DOI 10.1088/0004-637X/717/1/1; Linden T, 2017, PHYS REV D, V96, DOI 10.1103/PhysRevD.96.083001; Madau P, 2014, ANNU REV ASTRON ASTR, V52, P415, DOI 10.1146/annurev-astro-081811-125615; Magnelli B, 2014, ASTRON ASTROPHYS, V561, DOI 10.1051/0004-6361/201322217; Manconi S, 2020, PHYS REV D, V101, DOI 10.1103/PhysRevD.101.103026; Ott M, 2001, ASTRON ASTROPHYS, V372, P463, DOI 10.1051/0004-6361:20010505; Parkash V, 2018, ASTROPHYS J, V864, DOI 10.3847/1538-4357/aad3b9; Peng FK, 2016, ASTROPHYS J LETT, V821, DOI 10.3847/2041-8205/821/2/L20; Peretti E, 2019, MON NOT R ASTRON SOC, V487, P168, DOI 10.1093/mnras/stz1161; Persic M, 2008, ASTRON ASTROPHYS, V486, P143, DOI 10.1051/0004-6361:200809525; Qu YK, 2019, MON NOT R ASTRON SOC, V490, P758, DOI 10.1093/mnras/stz2651; Rahmani S, 2016, MON NOT R ASTRON SOC, V456, P4128, DOI 10.1093/mnras/stv2951; Razzaque S, 2004, ASTROPHYS J, V613, P1072, DOI 10.1086/423166; Zaurin JR, 2008, MON NOT R ASTRON SOC, V384, P875, DOI 10.1111/j.1365-2966.2007.12658.x; Sakamoto K, 2006, ASTROPHYS J, V636, P685, DOI 10.1086/498075; Schlickeiser R., 2002, ASTR AST LI; Shi Y, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/2/87; Stettner J., 2019, P 36 INT COSMIC RAY, VVolume 36, P1017; Thompson TA, 2008, ASTROPHYS J, V684, P212, DOI 10.1086/589227; van der Wel A, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/1/28; van der Wel A, 2012, ASTROPHYS J SUPPL S, V203, DOI 10.1088/0067-0049/203/2/24; WOOSLEY SE, 1995, ASTROPHYS J SUPPL S, V101, P181, DOI 10.1086/192237; WRIGHT GS, 1990, NASA CONF P, V3098, P321; Xia JQ, 2015, ASTROPHYS J SUPPL S, V217, DOI 10.1088/0067-0049/217/1/15; Yu XL, 2019, MON NOT R ASTRON SOC, V486, P4463, DOI 10.1093/mnras/stz1146	72	15	16	0	33	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 16	2021	597	7876					335	+		10.1038/s41586-021-03802-x	http://dx.doi.org/10.1038/s41586-021-03802-x			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UQ8UQ	34526703	Green Submitted			2022-12-28	WOS:000696334600006
J	Sawaya, MR; Hughes, MP; Rodriguez, JA; Riek, R; Eisenberg, DS				Sawaya, Michael R.; Hughes, Michael P.; Rodriguez, Jose A.; Riek, Roland; Eisenberg, David S.			The expanding amyloid family: Structure, stability, function, and pathogenesis	CELL			English	Review							ATOMIC-RESOLUTION STRUCTURE; RNA-BINDING PROTEINS; CRYO-EM STRUCTURES; ALPHA-SYNUCLEIN; PHASE-SEPARATION; FIBRIL FORMATION; HET-S; PRION; DISEASE; FORM	The hidden world of amyloid biology has suddenly snapped into atomic-level focus, revealing over 80 amyloid protein fibrils, both pathogenic and functional. Unlike globular proteins, amyloid proteins flatten and stack into unbranched fibrils. Stranger still, a single protein sequence can adopt wildly different two-dimensional conformations, yielding distinct fibril polymorphs. Thus, an amyloid protein may define distinct diseases depending on its conformation. At the heart of this conformational variability lies structural frustrations. In functional amyloids, evolution tunes frustration levels to achieve either stability or sensitivity according to the fibril's biological function, accounting for the vast versatility of the amyloid fibril scaffold.	[Sawaya, Michael R.; Hughes, Michael P.; Rodriguez, Jose A.; Eisenberg, David S.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Sawaya, Michael R.; Hughes, Michael P.; Rodriguez, Jose A.; Eisenberg, David S.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Sawaya, Michael R.; Hughes, Michael P.; Rodriguez, Jose A.; Eisenberg, David S.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Sawaya, Michael R.; Hughes, Michael P.; Rodriguez, Jose A.; Eisenberg, David S.] Univ Calif Los Angeles, UCLA DOE Inst, Los Angeles, CA 90095 USA; [Sawaya, Michael R.; Hughes, Michael P.; Rodriguez, Jose A.; Eisenberg, David S.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA; [Riek, Roland] Swiss Fed Inst Technol, Lab Phys Chem, Vladimir Prelog Weg 2, CH-8093 Zurich, Switzerland	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Swiss Federal Institutes of Technology Domain; ETH Zurich	Eisenberg, DS (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.; Eisenberg, DS (corresponding author), Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA.; Eisenberg, DS (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.; Eisenberg, DS (corresponding author), Univ Calif Los Angeles, UCLA DOE Inst, Los Angeles, CA 90095 USA.; Eisenberg, DS (corresponding author), Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu		Hughes, Michael/0000-0002-6239-4151; Sawaya, Michael/0000-0003-0874-9043; Riek, Roland/0000-0002-6333-066X	NIH [AG054022, AG061847, AG070895, AG048120, GM128867]; NSF [MCB 1616265]; DOE [DE-FC02-02ER6342]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); DOE(United States Department of Energy (DOE))	We thank our coworkers for discussions and, in particular, David Boyer for assistance in developing solvation energy maps. We are grateful for support from the NIH (AG054022, AG061847, AG070895, AG048120, and GM128867), NSF (MCB 1616265), and DOE (DE-FC02-02ER6342).	Ader C, 2010, P NATL ACAD SCI USA, V107, P6281, DOI 10.1073/pnas.0910163107; Arakhamia T, 2020, CELL, V180, P633, DOI 10.1016/j.cell.2020.01.027; ASTBURY WILLIAM THOMAS, 1935, BIOCHEM JOUR, V29, P2351; Baba M, 1998, AM J PATHOL, V152, P879; Balbirnie M, 2001, P NATL ACAD SCI USA, V98, P2375, DOI 10.1073/pnas.041617698; Benson MD, 2018, AMYLOID, V25, P215, DOI 10.1080/13506129.2018.1549825; Berson JF, 2003, J CELL BIOL, V161, P521, DOI 10.1083/jcb.200302072; BOLTON W, 1970, NATURE, V228, P551, DOI 10.1038/228551a0; Boyer DR, 2020, P NATL ACAD SCI USA, V117, P3592, DOI 10.1073/pnas.1917914117; Boyer DR, 2019, NAT STRUCT MOL BIOL, V26, P1044, DOI 10.1038/s41594-019-0322-y; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brunello CA, 2020, CELL MOL LIFE SCI, V77, P1721, DOI 10.1007/s00018-019-03349-1; BRYNGELSON JD, 1987, P NATL ACAD SCI USA, V84, P7524, DOI 10.1073/pnas.84.21.7524; Cao Q, 2020, NAT STRUCT MOL BIOL, V27, P653, DOI 10.1038/s41594-020-0435-3; Cao Q, 2019, NAT STRUCT MOL BIOL, V26, P619, DOI 10.1038/s41594-019-0248-4; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Claessen D, 2003, GENE DEV, V17, P1714, DOI 10.1101/gad.264303; COHEN AS, 1959, NATURE, V183, P1202, DOI 10.1038/1831202a0; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Colvin MT, 2016, J AM CHEM SOC, V138, P9663, DOI 10.1021/jacs.6b05129; Dean DN, 2020, J BIOL CHEM, V295, P7544, DOI 10.1074/jbc.RA120.013012; EISENBERG D, 1986, NATURE, V319, P199, DOI 10.1038/319199a0; Eisenberg DS, 2017, ANNU REV BIOCHEM, V86, P69, DOI 10.1146/annurev-biochem-061516-045104; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; Falcon B, 2018, ACTA NEUROPATHOL, V136, P699, DOI 10.1007/s00401-018-1914-z; Falcon B, 2018, NATURE, V561, P137, DOI 10.1038/s41586-018-0454-y; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P1318, DOI 10.1038/nsmb.1930; Gaspar R., 2020, QRB DISCOVERY, V1; Gelenter MD, 2019, NAT STRUCT MOL BIOL, V26, P592, DOI 10.1038/s41594-019-0238-6; Goedert M, 2015, SCIENCE, V349, DOI 10.1126/science.1255555; Goldsbury C, 1999, J MOL BIOL, V285, P33, DOI 10.1006/jmbi.1998.2299; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Greenwald J, 2018, J MOL BIOL, V430, P3735, DOI 10.1016/j.jmb.2018.05.046; Guenther EL, 2018, NAT STRUCT MOL BIOL, V25, P463, DOI 10.1038/s41594-018-0064-2; Guenther EL, 2018, NAT STRUCT MOL BIOL, V25, P311, DOI 10.1038/s41594-018-0045-5; Guerrero-Ferreira R, 2019, ELIFE, V8, DOI 10.7554/eLife.48907; Gui XR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09902-7; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; Guo L, 2018, CELL, V173, P677, DOI 10.1016/j.cell.2018.03.002; GUSTAVSSON A, 1991, BIOCHEM BIOPH RES CO, V175, P1159, DOI 10.1016/0006-291X(91)91687-8; Haslberger T, 2010, BIOCHEM CELL BIOL, V88, P63, DOI [10.1139/O09-118, 10.1139/o09-118]; Hennig S, 2015, J CELL BIOL, V210, P529, DOI 10.1083/jcb.201504117; Hervas R, 2020, SCIENCE, V367, P1230, DOI 10.1126/science.aba3526; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Hughes MP, 2018, SCIENCE, V359, P698, DOI 10.1126/science.aan6398; Hughson AG., 2021, STRUCTURE INFECTIOUS, DOI [10.1101/2021.02.14.431014, DOI 10.1101/2021.02.14.431014]; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JOHNSON KH, 1992, LAB INVEST, V66, P522; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; Kajava AV, 2005, J MOL BIOL, V348, P247, DOI 10.1016/j.jmb.2005.02.029; Kajava AV, 2004, P NATL ACAD SCI USA, V101, P7885, DOI 10.1073/pnas.0402427101; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Li BS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05971-2; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Li LY, 2016, CURR BIOL, V26, P3143, DOI 10.1016/j.cub.2016.09.054; Liberta F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09033-z; Lu JH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17905-y; Macindoe I, 2012, P NATL ACAD SCI USA, V109, pE804, DOI 10.1073/pnas.1114052109; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; McGlinchey RP, 2017, ISR J CHEM, V57, P613, DOI 10.1002/ijch.201600080; Meersman F, 2006, BBA-PROTEINS PROTEOM, V1764, P452, DOI 10.1016/j.bbapap.2005.10.021; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Mompean M, 2018, CELL, V173, P1244, DOI 10.1016/j.cell.2018.03.032; Murray DT, 2017, CELL, V171, P615, DOI 10.1016/j.cell.2017.08.048; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Nespovitaya N, 2016, J AM CHEM SOC, V138, P846, DOI 10.1021/jacs.5b08694; Ni XD, 2019, J MOL BIOL, V431, P3913, DOI 10.1016/j.jmb.2019.07.001; Oelschlegel AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003158; Otzen D, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a033860; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Peng C, 2018, NATURE, V557, P558, DOI 10.1038/s41586-018-0104-4; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Pham CLL, 2014, ESSAYS BIOCHEM, V56, P207, DOI [10.1042/bse0560207, 10.1042/BSE0560207]; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Prusiner SB, 2015, P NATL ACAD SCI USA, V112, pE5308, DOI 10.1073/pnas.1514475112; Riek R, 2016, NATURE, V539, P227, DOI 10.1038/nature20416; Rodriguez JA, 2015, NATURE, V525, P486, DOI 10.1038/nature15368; Rufo CM, 2014, NAT CHEM, V6, P303, DOI [10.1038/NCHEM.1894, 10.1038/nchem.1894]; Saad S, 2017, NAT CELL BIOL, V19, P1202, DOI 10.1038/ncb3600; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Scheres SHW, 2020, CURR OPIN STRUC BIOL, V64, P17, DOI 10.1016/j.sbi.2020.05.011; Schweighauser M, 2020, NATURE, V585, P464, DOI 10.1038/s41586-020-2317-6; Seuring C, 2020, NAT STRUCT MOL BIOL, V27, P1178, DOI 10.1038/s41594-020-00515-z; Shahnawaz M, 2020, NATURE, V578, P273, DOI 10.1038/s41586-020-1984-7; Shi Y, 2021, NATURE, V598, P359, DOI 10.1038/s41586-021-03911-7; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Suzuki G, 2020, ELIFE, V9, DOI 10.7554/eLife.56825; Taneja V, 2007, MOL CELL, V27, P67, DOI 10.1016/j.molcel.2007.05.027; Teng PK, 2012, PROTEIN SCI, V21, P26, DOI 10.1002/pro.754; Tuite MF, 2010, NAT REV MOL CELL BIO, V11, P823, DOI 10.1038/nrm3007; Villali J, 2020, NAT STRUCT MOL BIOL, V27, P540, DOI 10.1038/s41594-020-0416-6; Vogler TO, 2018, NATURE, V563, P508, DOI 10.1038/s41586-018-0665-2; Walti MA, 2017, P NATL ACAD SCI USA, V114, P9104, DOI 10.1073/pnas.1711645114; Walti MA, 2016, P NATL ACAD SCI USA, V113, pE4976, DOI 10.1073/pnas.1600749113; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Xiang SH, 2015, CELL, V163, P829, DOI 10.1016/j.cell.2015.10.040; Yang YS, 2019, CELL, V177, P697, DOI 10.1016/j.cell.2019.02.043; Zhang WJ, 2019, ELIFE, V8, DOI 10.7554/eLife.43584; Zhang WJ, 2020, NATURE, V580, P283, DOI 10.1038/s41586-020-2043-0; Zhao K., 2020, P NATL ACAD SCI US	116	40	40	17	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 16	2021	184	19					4857	4873		10.1016/j.cell.2021.08.013	http://dx.doi.org/10.1016/j.cell.2021.08.013		SEP 2021	17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	WC7PA	34534463	Green Accepted, Bronze			2022-12-28	WOS:000704445100005
J	Rimmer, A				Rimmer, Abi			Covid-19: Government considers mandatory vaccination for healthcare staff in England	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Department of Health and Social Care, 2021, MAK VACC COND DEPL H	1	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2021	374								n2222	10.1136/bmj.n2222	http://dx.doi.org/10.1136/bmj.n2222			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	US1IY	34507951	Bronze			2022-12-28	WOS:000697191000002
J	Peyre, M; Miyagishima, D; Bielle, F; Chapon, F; Sierant, M; Venot, Q; Lerond, J; Marijon, P; Abi-Jaoude, S; Le Van, T; Labreche, K; Houlston, R; Faisant, M; Clemenceau, S; Boch, AL; Nouet, A; Carpentier, A; Boetto, J; Louvi, A; Kalamarides, M				Peyre, Matthieu; Miyagishima, Danielle; Bielle, Franck; Chapon, Francoise; Sierant, Michael; Venot, Quitterie; Lerond, Julie; Marijon, Pauline; Abi-Jaoude, Samiya; Le Van, Tuan; Labreche, Karim; Houlston, Richard; Faisant, Maxime; Clemenceau, Stephane; Boch, Anne-Laure; Nouet, Aurelien; Carpentier, Alexandre; Boetto, Julien; Louvi, Angeliki; Kalamarides, Michel			Somatic PIK3CA Mutations in Sporadic Cerebral Cavernous Malformations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CCM; AKT1; NF2; PROGRESSION; GENETICS; INSIGHTS; PATTERN; GENES; BRAIN; CELLS	Background Cerebral cavernous malformations (CCMs) are common sporadic and inherited vascular malformations of the central nervous system. Although familial CCMs are linked to loss-of-function mutations in KRIT1 (CCM1), CCM2, or PDCD10 (CCM3), the genetic cause of sporadic CCMs, representing 80% of cases, remains incompletely understood. Methods We developed two mouse models harboring mutations identified in human meningiomas with the use of the prostaglandin D2 synthase (PGDS) promoter. We performed targeted DNA sequencing of surgically resected CCMs from patients and confirmed our findings by droplet digital polymerase-chain-reaction analysis. Results We found that in mice expressing one of two common genetic drivers of meningioma - Pik3ca(H1047R) or AKT1(E17K) - in PGDS-positive cells, a spectrum of typical CCMs develops (in 22% and 11% of the mice, respectively) instead of meningiomas, which prompted us to analyze tissue samples from sporadic CCMs from 88 patients. We detected somatic activating PIK3CA and AKT1 mutations in 39% and 1%, respectively, of lesion tissue from the patients. Only 10% of lesions harbored mutations in the CCM genes. We analyzed lesions induced by the activating mutations Pik3ca(H1074R) and AKT1(E17K) in mice and identified the PGDS-expressing pericyte as the probable cell of origin. Conclusions In tissue samples from sporadic CCMs, mutations in PIK3CA were represented to a greater extent than mutations in any other gene. The contribution of somatic mutations in the genes that cause familial CCMs was comparatively small. (Funded by the Fondation ARC pour la Recherche contre le Cancer and others.) Circuitous Route to Understanding CCMs Although their intention was to create a model of meningioma, investigators instead observed the development of cerebral cavernous malformations in their engineered mice, prompting them to test the implicated genes in patients with these malformations.	[Peyre, Matthieu; Clemenceau, Stephane; Boch, Anne-Laure; Nouet, Aurelien; Carpentier, Alexandre; Kalamarides, Michel] Sorbonne Univ, Hop Pitie Salpetriere, AP HP,Dept Neurosurg, INSERM Unite 1127,Ctr Natl Rech Sci Unite Mixte R, Paris, France; [Bielle, Franck] Sorbonne Univ, Hop Pitie Salpetriere, AP HP,Dept Neuropathol, INSERM Unite 1127,Ctr Natl Rech Sci Unite Mixte R, Paris, France; [Peyre, Matthieu; Bielle, Franck; Lerond, Julie; Marijon, Pauline; Abi-Jaoude, Samiya; Le Van, Tuan; Labreche, Karim; Boetto, Julien; Kalamarides, Michel] Paris Brain Inst, Paris, France; [Venot, Quitterie] Hop Necker Enfants Malad, AP HP, INSERM Unite 1151, Inst Necker Enfants Malad, Paris, France; [Chapon, Francoise] Caen Univ, Ctr Hosp Reg Univ CHRU, Caen INSERM Unite COMETE 1075, Dept Pathol, Caen, France; [Faisant, Maxime] CHRU Caen, INSERM, Unite Mixte Rech Sante Unite 1237, Dept Pathol, Caen, France; [Miyagishima, Danielle; Sierant, Michael] Yale Sch Med, Dept Genet, New Haven, CT USA; [Louvi, Angeliki] Yale Sch Med, Dept Neurosurg, New Haven, CT USA; [Louvi, Angeliki] Yale Sch Med, Dept Neurosci, New Haven, CT USA; [Labreche, Karim; Houlston, Richard] Inst Canc Res, Div Genet & Epidemiol, Sutton, Surrey, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Caen Normandie; CHU de Caen NORMANDIE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie; Yale University; Yale University; Yale University; University of London; Institute of Cancer Research - UK	Peyre, M; Kalamarides, M (corresponding author), Hop La Pitie Salpetriere, AP HP, Dept Neurosurg, 47-91 Bd Hop, F-75013 Paris, France.	matthieu.peyre@aphp.fr; michel.kalamarides@aphp.fr		Miyagishima, Danielle/0000-0003-3257-5469; Venot, Quitterie/0000-0001-5964-5370; LEROND, Julie/0000-0002-9005-5771; Bielle, Franck/0000-0001-6564-6388; Peyre, Matthieu/0000-0001-8470-9516; Houlston, Richard/0000-0002-5268-0242				Akers AL, 2009, HUM MOL GENET, V18, P919, DOI 10.1093/hmg/ddn430; Al-Olabi L, 2018, J CLIN INVEST, V128, P1496, DOI 10.1172/JCI98589; Andre F, 2019, NEW ENGL J MED, V380, P1929, DOI 10.1056/NEJMoa1813904; Awad IA, 2019, J NEUROSURG, V131, P1, DOI 10.3171/2019.3.JNS181724; Boetto J, 2018, ONCOGENE, V37, P4955, DOI 10.1038/s41388-018-0328-7; Boulday G, 2011, J EXP MED, V208, P1835, DOI 10.1084/jem.20110571; Cassiani-Ingoni R, 2006, EXP NEUROL, V201, P349, DOI 10.1016/j.expneurol.2006.04.030; Castillo SD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9982; Clark VE, 2013, SCIENCE, V339, P1077, DOI 10.1126/science.1233009; Clarke VE, 2016, NAT GENET, V48, P1253, DOI 10.1038/ng.3651; Couto JA, 2017, AM J HUM GENET, V100, P546, DOI 10.1016/j.ajhg.2017.01.018; D'Angelo R, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/459253; D'Angelo R, 2011, BRAIN PATHOL, V21, P215, DOI 10.1111/j.1750-3639.2010.00441.x; Detter MR, 2018, CIRC RES, V123, P1143, DOI 10.1161/CIRCRESAHA.118.313970; Dieguez-Hurtado R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10643-w; Galvao GD, 2020, WORLD NEUROSURG, V142, P481, DOI 10.1016/j.wneu.2020.06.170; Ganfornina MD, 2005, DEV DYNAM, V232, P191, DOI 10.1002/dvdy.20193; Gault J, 2009, NEUROSURGERY, V65, P138, DOI 10.1227/01.NEU.0000348049.81121.C1; HORIE Y, 1995, PATHOL INT, V45, P530, DOI 10.1111/j.1440-1827.1995.tb03497.x; Kalamarides M, 2011, ONCOGENE, V30, P2333, DOI 10.1038/onc.2010.609; Kalamarides M, 2002, GENE DEV, V16, P1060, DOI 10.1101/gad.226302; Keppler-Noreuil KM, 2016, AM J MED GENET A, V170, P2605, DOI 10.1002/ajmg.a.37737; Lindhurst MJ, 2012, NAT GENET, V44, P928, DOI 10.1038/ng.2332; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Louvi A, 2011, P NATL ACAD SCI USA, V108, P3737, DOI 10.1073/pnas.1012617108; Malinyerno M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10707-x; McDonald DA, 2014, HUM MOL GENET, V23, P4357, DOI 10.1093/hmg/ddu153; Nagasaka T, 2004, HISTOCHEM CELL BIOL, V121, P483, DOI 10.1007/s00418-004-0658-0; Nikolaev SI, 2018, NEW ENGL J MED, V378, P250, DOI 10.1056/NEJMoa1709449; Oda K, 2018, WORLD NEUROSURG, V109, P333, DOI 10.1016/j.wneu.2017.10.040; Ostrom QT, 2017, NEURO-ONCOLOGY, V19, pV1, DOI 10.1093/neuonc/nox158; Peyre M, 2013, ONCOGENE, V32, P4264, DOI 10.1038/onc.2012.436; Peyre M, 2015, ONCOTARGET, V6, P32713, DOI 10.18632/oncotarget.5296; Preusser M, 2018, NAT REV NEUROL, V14, P106, DOI 10.1038/nrneurol.2017.168; Riant F, 2013, MOL SYNDROMOL, V4, P165, DOI 10.1159/000350042; Riant F, 2013, NEUROGENETICS, V14, P133, DOI 10.1007/s10048-013-0362-0; Riant F, 2010, FEBS J, V277, P1070, DOI 10.1111/j.1742-4658.2009.07535.x; RIGAMONTI D, 1988, NEW ENGL J MED, V319, P343, DOI 10.1056/NEJM198808113190605; Sudmeyer M, 2011, J NEUROL, V258, P140, DOI 10.1007/s00415-010-5675-4; Vahidnezhad H, 2016, EXP DERMATOL, V25, P17, DOI 10.1111/exd.12826; Venot Q, 2018, NATURE, V558, P540, DOI 10.1038/s41586-018-0217-9; Wang K, 2020, ARTERIOSCL THROM VAS, V40, P2171, DOI 10.1161/ATVBAHA.120.314586; Wetzel-Strong SE, 2017, J PATHOL, V241, P281, DOI 10.1002/path.4844	43	21	22	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 9	2021	385	11					996	1004		10.1056/NEJMoa2100440	http://dx.doi.org/10.1056/NEJMoa2100440			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UN0RH	34496175	Green Accepted			2022-12-28	WOS:000693730200011
J	Wahlberg, E; Arpaia, R; Seibold, G; Rossi, M; Fumagalli, R; Trabaldo, E; Brookes, NB; Braicovich, L; Caprara, S; Gran, U; Ghiringhelli, G; Bauch, T; Lombardi, F				Wahlberg, Eric; Arpaia, Riccardo; Seibold, Gotz; Rossi, Matteo; Fumagalli, Roberto; Trabaldo, Edoardo; Brookes, Nicholas B.; Braicovich, Lucio; Caprara, Sergio; Gran, Ulf; Ghiringhelli, Giacomo; Bauch, Thilo; Lombardi, Floriana			Restored strange metal phase through suppression of charge density waves in underdoped YBa2Cu3O7-delta	SCIENCE			English	Article							HIGH-TEMPERATURE SUPERCONDUCTORS; NORMAL-STATE; ROTATIONAL SYMMETRY; ORDER; SCATTERING; PSEUDOGAP; STRIPE; FLUCTUATIONS; COMPETITION; DIAGRAM	The normal state of optimally doped cuprates is dominated by the "strange metal" phase that shows a linear temperature (T) dependence of the resistivity persisting down to the lowest T. For underdoped cuprates, this behavior is lost below the pseudogap temperature T*, where charge density waves (CDWs), together with other intertwined local orders, characterize the ground state. We found that the T-linear resistivity of highly strained, ultrathin, underdoped YBa2Cu3O7-delta films is restored when the CDW amplitude, detected by resonant inelastic x-ray scattering, is suppressed. This observation suggests an intimate connection between the onset of CDWs and the departure from T-linear resistivity in underdoped cuprates. Our results illustrate the potential of using strain control to manipulate the ground state of quantum materials.	[Wahlberg, Eric; Arpaia, Riccardo; Trabaldo, Edoardo; Bauch, Thilo; Lombardi, Floriana] Chalmers Univ Technol, Dept Microtechnol & Nanosci, Quantum Device Phys Lab, SE-41296 Gothenburg, Sweden; [Arpaia, Riccardo; Rossi, Matteo; Fumagalli, Roberto; Braicovich, Lucio; Ghiringhelli, Giacomo] Politecn Milan, Dipartimento Fis, I-20133 Milan, Italy; [Seibold, Gotz] BTU Cottbus Senftenberg, Inst Phys, D-03013 Cottbus, Germany; [Brookes, Nicholas B.; Braicovich, Lucio] European Synchrotron, ESRF, F-38043 Grenoble, France; [Caprara, Sergio] Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy; [Caprara, Sergio] CNR ISC, I-00185 Rome, Italy; [Gran, Ulf] Chalmers Univ Technol, Div Subat High Energy & Plasma Phys, SE-41296 Gothenburg, Sweden; [Ghiringhelli, Giacomo] Politecn Milan, Dipartimento Fis, CNR SPIN, I-20133 Milan, Italy; [Rossi, Matteo] SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA	Chalmers University of Technology; Polytechnic University of Milan; Brandenburg University of Technology Cottbus; European Synchrotron Radiation Facility (ESRF); Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); Chalmers University of Technology; Consiglio Nazionale delle Ricerche (CNR); Istituto Superconduttori, Materiali e Dispositivi Innovativi (SPIN-CNR); Polytechnic University of Milan; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Arpaia, R; Lombardi, F (corresponding author), Chalmers Univ Technol, Dept Microtechnol & Nanosci, Quantum Device Phys Lab, SE-41296 Gothenburg, Sweden.; Arpaia, R (corresponding author), Politecn Milan, Dipartimento Fis, I-20133 Milan, Italy.	riccardo.arpaia@chalmers.se; floriana.lombardi@chalmers.se	Wahlberg, Eric/AAY-8511-2020; Caprara, Sergio/M-7683-2013	Wahlberg, Eric/0000-0002-2723-0688; Caprara, Sergio/0000-0001-8041-3232; Rossi, Matteo/0000-0002-4254-0713; Arpaia, Riccardo/0000-0003-4687-2376; Seibold, Goetz/0000-0002-1772-1563; Gran, Ulf/0000-0003-0318-0492	European Union's project NANOCOHYBRI (Cost Action) [CA16218]; European Union's project OXiNEMS (Horizon 2020) [828784]; Knut and Alice Wallenberg foundation [2014.0102]; Swedish Research Council (VR) [2015-04368, 2018-04658, 2020-04945, 2020-05184]; Deutsche Forschungsgemeinschaft [SE 806/19-1]; Italian Ministry of University and Research PRIN project [2017Z8TS5B]; University of Rome Sapienza [RM11816431DBA5AF, RM11916B56802AFE, RM120172A8CC7CC7]	European Union's project NANOCOHYBRI (Cost Action); European Union's project OXiNEMS (Horizon 2020); Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council (VR)(Swedish Research Council); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Italian Ministry of University and Research PRIN project; University of Rome Sapienza	Supported by the European Union's projects NANOCOHYBRI (Cost Action CA16218) and OXiNEMS (Horizon 2020, grant agreement 828784), the Knut and Alice Wallenberg foundation (project 2014.0102), and the Swedish Research Council (VR) under projects 2015-04368 (U.G.), 2018-04658 (F.L.), 2020-04945 (R.A.) and 2020-05184 (T.B.); Deutsche Forschungsgemeinschaft grant SE 806/19-1 (G.S.); Italian Ministry of University and Research PRIN project 2017Z8TS5B (G.G. and S.C.); and the University of Rome Sapienza through projects Ateneo 2018 (grant RM11816431DBA5AF), Ateneo 2019 (grant RM11916B56802AFE), and Ateneo 2020 (grant RM120172A8CC7CC7) (S.C.).	Abrahams E, 2000, P NATL ACAD SCI USA, V97, P5714, DOI 10.1073/pnas.100118797; Alexandradinata A., 2020, ARXIV201000584CONDMA; Ando Y, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.137005; Arpaia R, 2019, SCIENCE, V365, P906, DOI 10.1126/science.aav1315; Arpaia R, 2014, PHYSICA C, V506, P184, DOI 10.1016/j.physc.2014.06.015; Arpaia R, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4866277; Arpaia R, 2019, PHYS REV MATER, V3, DOI 10.1103/PhysRevMaterials.3.114804; Arpaia R, 2018, PHY REV MATER, V2, DOI 10.1103/PhysRevMaterials.2.024804; Arpaia R, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.064525; Barisic N, 2013, P NATL ACAD SCI USA, V110, P12235, DOI 10.1073/pnas.1301989110; Blanco-Canosa S, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.054513; Bluschke M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05434-8; Bourgeois -Hope P., 2019, ARXIV191008126CONDMA; Brookes NB, 2018, NUCL INSTRUM METH A, V903, P175, DOI 10.1016/j.nima.2018.07.001; Bruin JAN, 2013, SCIENCE, V339, P804, DOI 10.1126/science.1227612; Cao Y, 2018, NATURE, V556, P43, DOI 10.1038/nature26160; Charpentier S, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.060503; Comin R, 2015, SCIENCE, V347, P1335, DOI 10.1126/science.1258399; Cyr-Choiniere O, 2018, PHYS REV B, V98, DOI 10.1103/PhysRevB.98.064513; Daou R, 2009, NAT PHYS, V5, P31, DOI [10.1038/nphys1109, 10.1038/NPHYS1109]; Dekkers JM, 2003, APPL PHYS LETT, V83, P5199, DOI 10.1063/1.1633010; Delacretaz LV, 2017, SCIPOST PHYS, V3, DOI 10.21468/SciPostPhys.3.3.025; FENG L, 1989, PHYS REV B, V39, P6914, DOI 10.1103/PhysRevB.39.6914; Fradkin E, 2015, REV MOD PHYS, V87, P457, DOI 10.1103/RevModPhys.87.457; Gannot Y, 2019, PHYS REV B, V100, DOI 10.1103/PhysRevB.100.045128; Ghiringhelli G, 2012, SCIENCE, V337, P821, DOI 10.1126/science.1223532; Hussey NE, 2003, EUR PHYS J B, V31, P495, DOI 10.1140/epjb/e2003-00059-9; JORGENSEN JD, 1990, PHYS REV B, V41, P1863, DOI 10.1103/PhysRevB.41.1863; Kasahara S, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.184519; Keimer B, 2015, NATURE, V518, P179, DOI 10.1038/nature14165; Kim HH, 2018, SCIENCE, V362, P1040, DOI 10.1126/science.aat4708; Kim HH, 2021, PHYS REV LETT, V126, DOI 10.1103/PhysRevLett.126.037002; Komiya S, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.060503; LeBoeuf D, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.054506; Legros A, 2019, NAT PHYS, V15, P142, DOI 10.1038/s41567-018-0334-2; Liang RX, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.180505; Maharaj AV, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.045132; Meevasana W, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.104506; Miao H, 2021, NPJ QUANTUM MATER, V6, DOI 10.1038/s41535-021-00327-4; Nawaz S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.167004; Ono S, 2000, PHYS REV LETT, V85, P638, DOI 10.1103/PhysRevLett.85.638; Peng YY, 2017, NAT PHYS, V13, P1201, DOI 10.1038/NPHYS4248; Seibold G, COMMUN PHYS-UK, V4, P7; Sinchenko AA, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.036601; Souliou SM, 2018, PHYS REV B, V97, DOI 10.1103/PhysRevB.97.020503; Timusk T, 1999, REP PROG PHYS, V62, P61, DOI 10.1088/0034-4885/62/1/002; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Triscone JM, 1997, REP PROG PHYS, V60, P1673, DOI 10.1088/0034-4885/60/12/004; Varma CM, 1997, PHYS REV B, V55, P14554, DOI 10.1103/PhysRevB.55.14554; Vishik IM, 2012, P NATL ACAD SCI USA, V109, P18332, DOI 10.1073/pnas.1209471109; Wahlberg E, RESTORING STRANGE ME, DOI [10.5281/zenodo.4724109(2021), DOI 10.5281/ZENODO.4724109(2021)]; Wang QS, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.187002; Wu J, 2017, NATURE, V547, P432, DOI 10.1038/nature23290; Wu T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7438; Yao H, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.012507; Yu B, 2020, PHYS REV X, V10, DOI 10.1103/PhysRevX.10.021059; Zaanen J, 2019, SCIPOST PHYS, V6, DOI 10.21468/SciPostPhys.6.5.061; Zhang YB, 2020, P NATL ACAD SCI USA, V117, P68, DOI 10.1073/pnas.1910411116	63	7	7	8	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2021	373	6562			SI		1506	+		10.1126/science.abc8372	http://dx.doi.org/10.1126/science.abc8372			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU7LJ	34554788	Green Submitted			2022-12-28	WOS:000698977800049
J	Boere, TM; van Buul, LW; Hopstaken, RM; van Tulder, MW; Twisk, JWMR; Verheij, TJM; Hertogh, CMPM				Boere, Tjarda M.; van Buul, Laura W.; Hopstaken, Rogier M.; van Tulder, Maurits W.; Twisk, Jos W. M. R.; Verheij, Theo J. M.; Hertogh, Cees M. P. M.			Effect of C reactive protein point-of-care testing on antibiotic prescribing for lower respiratory tract infections in nursing home residents: cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PNEUMONIA; PHYSICIAN; GUIDE; PROCALCITONIN; RESISTANCE	OBJECTIVE To evaluate whether C reactive protein point-of -care testing (CRP POCT) safely reduces antibiotic prescribing for lower respiratory tract infections in nursing home residents. DESIGN Pragmatic, cluster randomised controlled trial. SETTING The UPCARE study included 11 nursing home organisations in the Netherlands. PARTICIPANTS 84 physicians from 11 nursing home organisations included 241 participants with suspected lower respiratory tract infections from September 2018 to the end of March 2020. INTERVENTIONS Nursing homes allocated to the intervention group had access to CRP POCT. The control group provided usual care without CRP POCT for patients with suspected lower respiratory tract infections. MAIN OUTCOME MEASURES The primary outcome measure was antibiotic prescribing at initial consultation. Secondary outcome measures were full recovery at three weeks, changes in antibiotic management and additional diagnostics during follow-up at one week and three weeks, and hospital admission and all cause mortality at any point (initial consultation, one week, or three weeks). RESULTS Antibiotics were prescribed at initial consultation for 84 (53.5%) patients in the intervention group and 65 (82.3%) in the control group. Patients in the intervention group had 4.93 higher odds (95% confidence interval 1.91 to 12.73) of not being prescribed antibiotics at initial consultation compared with the control group, irrespective of treating physician and baseline characteristics. The between group difference in antibiotic prescribing at any point from initial consultation to follow-up was 23.6%. Differences in secondary outcomes between the intervention and control groups were 4.4% in full recovery rates at three weeks (86.4% v 90.8%), 2.2% in all cause mortality rates (3.5% v 1.3%), and 0.7% in hospital admission rates (7.2% v 6.5%). The odds of full recovery at three weeks, and the odds of mortality and hospital admission at any point did not significantly differ between groups. CONCLUSIONS CRP POCT for suspected lower respiratory tract infection safely reduced antibiotic prescribing compared with usual care in nursing home residents. The findings suggest that implementing CRP POCT in nursing homes might contribute to reduced antibiotic use in this setting and help to combat antibiotic resistance. TRIAL REGISTRATION Netherlands Trial Register NL5054	[Boere, Tjarda M.; van Buul, Laura W.; Hertogh, Cees M. P. M.] Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Dept Med Older People, Amsterdam UMC,Med Ctr, Amsterdam, Netherlands; [Hopstaken, Rogier M.] Hapert Hoogeloon, Primary Hlth Care Ctr, Hapert, Netherlands; [Hopstaken, Rogier M.] Star Shl Diagnost Ctr, Etten Leur, Netherlands; [Hopstaken, Rogier M.] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Gen Practice, Med Ctr, Maastricht, Netherlands; [van Tulder, Maurits W.] Vrije Univ Amsterdam, Fac Behav & Movement Sci, Amsterdam Movement Sci Res Inst, Amsterdam, Netherlands; [Twisk, Jos W. M. R.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam UMC, Amsterdam, Netherlands; [Verheij, Theo J. M.; Hertogh, Cees M. P. M.] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Verheij, Theo J. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; Maastricht University; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center	van Buul, LW (corresponding author), Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Dept Med Older People, Amsterdam UMC,Med Ctr, Amsterdam, Netherlands.	l.vanbuul@amsterdamumc.nl	van Tulder, Maurits/AAB-9785-2022	van Tulder, Maurits/0000-0002-7589-8471	Netherlands Organisation for Health Research and Development (ZonMw, program Antibiotic Resistance) [541001 004]	Netherlands Organisation for Health Research and Development (ZonMw, program Antibiotic Resistance)	The UPCARE study was funded by the Netherlands Organisation for Health Research and Development (ZonMw, program Antibiotic Resistance, grant No 541001 004) . Orion Diagnostica and Saltro made in total 20 CRP POCT instruments available for the study. The funding bodies had no role in the design of the study, data collection, data analysis, interpretation, or in writing the manuscript or authority over any of these activities.	Andreeva E, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-80; Boere TM, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-5006-0; Brito V, 2008, EUR RESPIR J, V32, P12, DOI 10.1183/09031936.00039908; Butler CC, 2019, NEW ENGL J MED, V381, P111, DOI 10.1056/NEJMoa1803185; Cals JWL, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-15; Cals JWL, 2011, J EVAL CLIN PRACT, V17, P1059, DOI 10.1111/j.1365-2753.2010.01472.x; Cals JWL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1374; Dhawan N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/285983; Du Clos TW, 2000, ANN MED, V32, P274, DOI 10.3109/07853890009011772; Dutch Association of Elderly Care Physicians (Verenso), 2018, RES TRACT INF VULN E; Foushee JA, 2012, J ANTIMICROB CHEMOTH, V67, P2560, DOI 10.1093/jac/dks265; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Hardy V, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012503; Hollaar V, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0231-4; Huang DT, 2018, NEW ENGL J MED, V379, P236, DOI [10.1056/NEJMoa1802670, 10.1056/nejmoa1802670]; Koopmans RTCM, 2017, J AM MED DIR ASSOC, V18, P746, DOI 10.1016/j.jamda.2017.05.013; Koopmans RTCM, 2010, J AM GERIATR SOC, V58, P1807, DOI 10.1111/j.1532-5415.2010.03043.x; Kruse RL, 2005, ANN FAM MED, V3, P422, DOI 10.1370/afm.389; Kuil SD, 2021, CLIN INFECT DIS, V73, pE3867, DOI 10.1093/cid/ciaa1709; Lim CJ, 2014, CLIN INTERV AGING, V9, P165, DOI 10.2147/CIA.S46058; Lim CJ, 2012, MED J AUSTRALIA, V196, P327, DOI 10.5694/mja12.10085; Little P, 2013, LANCET, V382, P1175, DOI 10.1016/S0140-6736(13)60994-0; Loeb M, 2001, J GEN INTERN MED, V16, P376, DOI 10.1046/j.1525-1497.2001.016006376.x; Loeb M, 2006, JAMA-J AM MED ASSOC, V295, P2503, DOI 10.1001/jama.295.21.2503; Mangione-Smith R, 2002, HEALTH SERV RES, V37, P1603, DOI 10.1111/1475-6773.10482; Mills K, 2009, AM FAM PHYSICIAN, V79, P976; Minnaard MC, 2017, CAN MED ASSOC J, V189, pE56, DOI 10.1503/cmaj.151163; Mylotte JM, 2020, J AM MED DIR ASSOC, V21, P308, DOI 10.1016/j.jamda.2019.04.020; Nouvenne A, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0192-7; Porfyridis I, 2014, RESP CARE, V59, P574, DOI 10.4187/respcare.02741; Prestinaci F, 2015, PATHOG GLOB HEALTH, V109, P309, DOI 10.1179/2047773215Y.0000000030; Ricchizzi Enrico, 2018, Euro Surveill, V23, DOI 10.2807/1560-7917.ES.2018.23.46.1800394; Schuetz P, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007498.pub3; Sproston NR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00754; Teepe J, 2017, CAN MED ASSOC J, V189, pE50, DOI 10.1503/cmaj.151364; Ticinesi A, 2017, EUR J INTERN MED, V37, P7, DOI 10.1016/j.ejim.2016.08.026; van Buul LW, 2015, J AM MED DIR ASSOC, V16, P229, DOI 10.1016/j.jamda.2014.10.003; van Buul LW, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-136; van Buul LW, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2012.04.004; van der Steen JT, 2004, ARCH INTERN MED, V164, P224, DOI 10.1001/archinte.164.2.224; van Vugt SF, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2450; Zuidgeest MGP, 2017, J CLIN EPIDEMIOL, V90, P92, DOI 10.1016/j.jclinepi.2017.07.001	42	8	8	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 21	2021	374								n2198	10.1136/bmj.n2198	http://dx.doi.org/10.1136/bmj.n2198			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WA4GB	34548288	hybrid, Green Published			2022-12-28	WOS:000702844100015
J	Derman, BA; Davis, AM				Derman, Benjamin A.; Davis, Andrew M.			Recommendations for Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PREGABALIN; DULOXETINE		[Derman, Benjamin A.] Univ Chicago, Sect Hematol Oncol, Chicago, IL 60637 USA; [Davis, Andrew M.] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Davis, AM (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	adavis@medicine.bsd.uchicago.edu						De Andrade DC, 2017, ONCOLOGIST, V22, P1154, DOI 10.1634/theoncologist.2017-0235; Dorsey SG, 2019, JNCI-J NATL CANCER I, V111, P531, DOI 10.1093/jnci/djz011; Farshchian N, 2018, CANCER CHEMOTH PHARM, V82, P787, DOI 10.1007/s00280-018-3664-y; Hershman DL, 2018, JNCI-J NATL CANCER I, V110, P669, DOI 10.1093/jnci/djx259; Hirayama Y, 2015, INT J CLIN ONCOL, V20, P866, DOI 10.1007/s10147-015-0810-y; Jordan B, 2020, ANN ONCOL, V31, P1306, DOI 10.1016/j.annonc.2020.07.003; Salehifar E, 2020, CLIN DRUG INVEST, V40, P249, DOI 10.1007/s40261-019-00882-6; Seretny M, 2014, PAIN, V155, P2461, DOI 10.1016/j.pain.2014.09.020; Shinde SS, 2016, SUPPORT CARE CANCER, V24, P547, DOI 10.1007/s00520-015-2807-5; Zimmerman C, 2016, SUPPORT CARE CANCER, V24, P1071, DOI 10.1007/s00520-015-2876-5	10	4	4	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2021	326	11					1058	1059		10.1001/jama.2021.7458	http://dx.doi.org/10.1001/jama.2021.7458			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ4IM	34546311				2022-12-28	WOS:000702170600020
J	Shepherd, A				Shepherd, Alison			Rooted in nature's healing powers	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 20	2021	374								n2308	10.1136/bmj.n2308	http://dx.doi.org/10.1136/bmj.n2308			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ1DH	34544695				2022-12-28	WOS:000701952000003
J	Colombo, N; Dubot, C; Lorusso, D; Caceres, MV; Hasegawa, K; Shapira-Frommer, R; Tewari, KS; Salman, P; Usta, EH; Yanez, E; Gumus, M; de Mendoza, MOH; Samouelian, V; Castonguay, V; Arkhipov, A; Toker, S; Li, K; Keefe, SM; Monk, BJ				Colombo, N.; Dubot, C.; Lorusso, D.; Caceres, M., V; Hasegawa, K.; Shapira-Frommer, R.; Tewari, K. S.; Salman, P.; Usta, E. Hoyos; Yanez, E.; Gumus, M.; de Mendoza, M. Olivera Hurtado; Samouelian, V; Castonguay, V; Arkhipov, A.; Toker, S.; Li, K.; Keefe, S. M.; Monk, B. J.		KEYNOTE-826 Investigators	Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHASE-III TRIAL; PACLITAXEL; CISPLATIN; EFFICACY; CRITERIA; SAFETY	BACKGROUND Pembrolizumab has efficacy in programmed death ligand 1 (PD-L1)-positive metastatic or unresectable cervical cancer that has progressed during chemotherapy. We assessed the relative benefit of adding pembrolizumab to chemotherapy with or without bevacizumab. METHODS In a double-blind, phase 3 trial, we randomly assigned patients with persistent, recurrent, or metastatic cervical cancer in a 1:1 ratio to receive pembrolizumab (200 mg) or placebo every 3 weeks for up to 35 cycles plus platinum-based chemotherapy and, per investigator discretion, bevacizumab. The dual primary end points were progression-free survival and overall survival, each tested sequentially in patients with a PD-L1 combined positive score of 1 or more, in the intention-to-treat population, and in patients with a PD-L1 combined positive score of 10 or more. The combined positive score is defined as the number of PD-L1-staining cells divided by the total number of viable tumor cells, multiplied by 100. All results are from the protocol-specified first interim analysis. RESULTS In 548 patients with a PD-L1 combined positive score of 1 or more, median progression-free survival was 10.4 months in the pembrolizumab group and 8.2 months in the placebo group (hazard ratio for disease progression or death, 0.62; 95% confidence interval [CI], 0.50 to 0.77; P<0.001). In 617 patients in the intention-to-treat population, progression-free survival was 10.4 months and 8.2 months, respectively (hazard ratio, 0.65; 95% CI, 0.53 to 0.79; P<0.001). In 317 patients with a PD-Ll combined positive score of 10 or more, progression-free survival was 10.4 months and 8.1 months, respectively (hazard ratio, 0.58; 95% CI, 0.44 to 0.77; P<0.001). Overall survival at 24 months was 53.0% in the pembrolizumab group and 41.7% in the placebo group (hazard ratio for death, 0.64; 95% CI, 0.50 to 0.81; P<0.001), 50.4% and 40.4% (hazard ratio, 0.67; 95% CI, 0.54 to 0.84; P<0.001), and 54.4% and 44.6% (hazard ratio, 0.61; 95% CI, 0.44 to 0.84; P=0.001), respectively. The most common grade 3 to 5 adverse events were anemia (30.3% in the pembrolizumab group and 26.9% in the placebo group) and neutropenia (12.4% and 9.7%, respectively). CONCLUSIONS Progression-free and overall survival were significantly longer with pembrolizumab than with placebo among patients with persistent, recurrent, or metastatic cervical cancer who were also receiving chemotherapy with or without bevacizumab.	[Colombo, N.] Univ Milano Bicocca, Milan, Italy; [Colombo, N.] European Inst Oncol IRCCS, Milan, Italy; [Lorusso, D.] Fdn Policlin Univ A Gemelli IRCCS, Rome, Italy; [Lorusso, D.] Univ Cattolica Sacro Cuore, Rome, Italy; [Dubot, C.] Inst Curie St Cloud, Grp nvestigateurs Nationaux Etud Canc Ovariens, St Cloud, France; [Caceres, M., V] Inst Oncol Angel H Roffo, Buenos Aires, DF, Argentina; [Hasegawa, K.] Saitama Med Univ, Int Med Ctr, Hidaka, Japan; [Shapira-Frommer, R.] Sheba Med Ctr, Ella Lemelbaum Inst Immunooncol, Ramat Gan, Israel; [Tewari, K. S.] Univ Calif Irvine, Orange, CA 92668 USA; [Salman, P.] Oncovida Canc Ctr, Providencia, Chile; [Yanez, E.] Univ La Frontera, Temuco, Chile; [Usta, E. Hoyos] IMAT Inst Med Alta Tecnol Oncomed, Monteria, Colombia; [Gumus, M.] Istanbul Medeniyet Univ Hosp, Istanbul, Turkey; [de Mendoza, M. Olivera Hurtado] Inst Nacl Enfermedades Neoplas, Lima, Peru; [Samouelian, V] Univ Montreal, Ctr Hosp Univ Montreal, Ctr Rech Univ Montreal, Montreal, PQ, Canada; [Castonguay, V] Univ Laval, Ctr Hosp Univ Quebec, Quebec City, PQ, Canada; [Arkhipov, A.] Minist Hlth Russian Federat, Med Rehabil Ctr, Moscow, Russia; [Toker, S.; Li, K.; Keefe, S. M.] Merck, Kenilworth, NJ USA; [Monk, B. J.] Creighton Univ, Univ Arizona, Sch Med, Arizona Oncol US Oncol Network,Coll Med, Phoenix, AZ USA	University of Milano-Bicocca; IRCCS European Institute of Oncology (IEO); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Saitama Medical University; Chaim Sheba Medical Center; University of California System; University of California Irvine; Universidad de La Frontera; Instituto Nacional de Enfermedades Neoplasicas; Universite de Montreal; Laval University; Ministry of Health of the Russian Federation; Merck & Company; Creighton University; University of Arizona	Colombo, N (corresponding author), Univ Milano Bicocca, Dept Med & Surg, Via Ripamonti 435, I-20141 Milan, Italy.; Colombo, N (corresponding author), European Inst Oncol IRCCS, Div Gynecol Oncol, Via Ripamonti 435, I-20141 Milan, Italy.	nicoletta.colombo@ieo.it	Sabatier, Renaud/K-5816-2017; Altundag, Ozden/W-9219-2019	Sabatier, Renaud/0000-0002-5821-682X; Altundag, Ozden/0000-0003-0197-6622	Merck Sharp and Dohme, a subsidiary of Merck	Merck Sharp and Dohme, a subsidiary of Merck	Supported by Merck Sharp and Dohme, a subsidiary of Merck. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.	Choi MC, 2020, CANCERS, V12, DOI 10.3390/cancers12113188; Chung HC, 2019, J CLIN ONCOL, V37, P1470, DOI 10.1200/JCO.18.01265; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Frenel JS, 2017, J CLIN ONCOL, V35, P4035, DOI 10.1200/JCO.2017.74.5471; Friedman CF, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-001126; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Kitagawa R, 2015, J CLIN ONCOL, V33, P2129, DOI 10.1200/JCO.2014.58.4391; Kranawetter M, 2018, INT J GYNECOL CANCER, V28, P1196, DOI 10.1097/IGC.0000000000001291; Kulangara K, 2019, ARCH PATHOL LAB MED, V143, P330, DOI 10.5858/arpa.2018-0043-OA; Lan CY, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.20.01920; Lorusso D, 2020, J CLIN ONCOL, V38; Marth C, 2017, ANN ONCOL, V28, P72, DOI 10.1093/annonc/mdx220; Maurer W, 2013, STAT BIOPHARM RES, V5, P311, DOI 10.1080/19466315.2013.807748; Monk BJ, 2009, J CLIN ONCOL, V27, P4649, DOI 10.1200/JCO.2009.21.8909; Moore DH, 2004, J CLIN ONCOL, V22, P3113, DOI 10.1200/JCO.2004.04.170; National Comprehensive Cancer Network`, 2021, NCCN CLIN PRACTICE G, DOI 10.6004/jnccn.2009.0057; Naumann RW, 2019, ANN ONCOL, V30, P898; Naumann RW, 2019, J CLIN ONCOL, V37, P2825, DOI 10.1200/JCO.19.00739; O'Malley DM, 2021, GYNECOL ONCOL, V163, P274, DOI 10.1016/j.ygyno.2021.08.018; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Rischin D, 2020, GYNECOL ONCOL, V159, P322, DOI 10.1016/j.ygyno.2020.08.026; Santin AD, 2020, GYNECOL ONCOL, V157, P161, DOI 10.1016/j.ygyno.2019.12.034; Skelton WP, 2018, CLIN MED INSIGHTS-ON, V12, DOI 10.1177/1179554918779587; Tamura K, 2019, CANCER SCI, V110, P2894, DOI 10.1111/cas.14148; Tewari KS, 2021, ANN ONCOL, V32, P940, DOI 10.1016/j.annonc.2021.04.009; Tewari KS, 2017, LANCET, V390, P1654, DOI 10.1016/S0140-6736(17)31607-0; Tewari KS, 2014, NEW ENGL J MED, V370, P734, DOI 10.1056/NEJMoa1309748	27	121	124	14	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 11	2021	385	20					1856	1867		10.1056/NEJMoa2112435	http://dx.doi.org/10.1056/NEJMoa2112435		SEP 2021	12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XG4BK	34534429	Bronze			2022-12-28	WOS:000697035300001
J	Wise, J				Wise, Jacqui			Covid-19: Migrants face barriers accessing healthcare during the pandemic, report shows	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Lessard-Phillips L, 2021, MIGRATION VULNERABIL	1	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2021	374								n2296	10.1136/bmj.n2296	http://dx.doi.org/10.1136/bmj.n2296			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WC6LC	34535460	Bronze			2022-12-28	WOS:000704366700004
J	Li, TX; Jiang, SW; Li, LZ; Zhang, Y; Kang, KF; Zhu, JC; Watanabe, K; Taniguchi, T; Chowdhury, D; Fu, L; Shan, J; Mak, KF				Li, Tingxin; Jiang, Shengwei; Li, Lizhong; Zhang, Yang; Kang, Kaifei; Zhu, Jiacheng; Watanabe, Kenji; Taniguchi, Takashi; Chowdhury, Debanjan; Fu, Liang; Shan, Jie; Mak, Kin Fai			Continuous Mott transition in semiconductor moire superlattices	NATURE			English	Article							HUBBARD-MODEL; INSULATOR; METAL; COLLOQUIUM; PHYSICS; STATES	The evolution of a Landau Fermi liquid into a non-magnetic Mott insulator with increasing electronic interactions is one of the most puzzling quantum phase transitions in physics(1-6). The vicinity of the transition is believed to host exotic states of matter such as quantum spin liquids(4-7), exciton condensates(8) and unconventional superconductivity(1). Semiconductor moire materials realize a highly controllable Hubbard model simulator on a triangular lattice(9-22), providing a unique opportunity to drive a metal-insulator transition (MIT) via continuous tuning of the electronic interactions. Here, by electrically tuning the effective interaction strength in MoTe2/WSe2 moire superlattices, we observe a continuous MIT at a fixed filling of one electron per unit cell. The existence of quantum criticality is supported by the scaling collapse of the resistance, a continuously vanishing charge gap as the critical point is approached from the insulating side, and a diverging quasiparticle effective mass from the metallic side. We also observe a smooth evolution of the magnetic susceptibility across the MIT and no evidence of long-range magnetic order down to similar to 5% of the Curie-Weiss temperature. This signals an abundance of low-energy spinful excitations on the insulating side that is further corroborated by the Pomeranchuk effect observed on the metallic side. Our results are consistent with the universal critical theory of a continuous Mott transition in two dimensions(4,23). The interaction strength in moire superlattices is tuned to drive a continuous metal-to-insulator transition at a fixed electron density.	[Li, Tingxin; Li, Lizhong; Kang, Kaifei; Zhu, Jiacheng; Shan, Jie; Mak, Kin Fai] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Jiang, Shengwei; Chowdhury, Debanjan; Shan, Jie; Mak, Kin Fai] Cornell Univ, Lab Atom & Solid State Phys, Ithaca, NY 14850 USA; [Zhang, Yang; Fu, Liang] MIT, Dept Phys, Cambridge, MA 02139 USA; [Watanabe, Kenji; Taniguchi, Takashi] Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan; [Shan, Jie; Mak, Kin Fai] Kavli Inst Cornell Nanoscale Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Massachusetts Institute of Technology (MIT); National Institute for Materials Science	Shan, J; Mak, KF (corresponding author), Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA.; Shan, J; Mak, KF (corresponding author), Cornell Univ, Lab Atom & Solid State Phys, Ithaca, NY 14850 USA.; Shan, J; Mak, KF (corresponding author), Kavli Inst Cornell Nanoscale Sci, Ithaca, NY 14853 USA.	jie.shan@cornell.edu; kinfai.mak@cornell.edu	Zhang, Yang/AAH-8138-2021; Watanabe, Kenji/ABB-2135-2021	Zhang, Yang/0000-0003-4630-5056; Watanabe, Kenji/0000-0003-3701-8119; Li, Tingxin/0000-0002-3572-4530; Jiang, Shengwei/0000-0001-5213-0139; Chowdhury, Debanjan/0000-0003-0758-0282				Abrahams E, 2001, REV MOD PHYS, V73, P251, DOI 10.1103/RevModPhys.73.251; Andrei EY, 2020, NAT MATER, V19, P1265, DOI 10.1038/s41563-020-00840-0; Balents L, 2020, NAT PHYS, V16, P725, DOI 10.1038/s41567-020-0906-9; Balents L, 2010, NATURE, V464, P199, DOI 10.1038/nature08917; Brinkman WF, 1970, PHYS REV B-SOLID ST, V2, P4302, DOI 10.1103/PhysRevB.2.4302; Dobrosavljevic V., 2012, JR CONDUCTOR INSULAT; EMERY VJ, 1995, PHYS REV LETT, V74, P3253, DOI 10.1103/PhysRevLett.74.3253; Florens S, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.035114; Furukawa T, 2015, NAT PHYS, V11, P221, DOI 10.1038/NPHYS3235; Georges A, 1996, REV MOD PHYS, V68, P13, DOI 10.1103/RevModPhys.68.13; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Huang X, 2021, NAT PHYS, V17, P715, DOI 10.1038/s41567-021-01171-w; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; Jin CH, 2021, NAT MATER, V20, P940, DOI 10.1038/s41563-021-00959-8; KADOWAKI K, 1986, SOLID STATE COMMUN, V58, P507, DOI 10.1016/0038-1098(86)90785-4; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Li HY, 2021, NAT MATER, V20, P945, DOI 10.1038/s41563-021-00923-6; Li TX, 2021, NAT NANOTECHNOL, V16, P1068, DOI 10.1038/s41565-021-00955-8; MacNeill D, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.037401; Mishmash RV, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.235140; Morales-Duran N, 2021, PHYS REV B, V103, DOI 10.1103/PhysRevB.103.L241110; Pan HN, 2021, PHYS REV LETT, V127, DOI 10.1103/PhysRevLett.127.096802; Pan HN, 2020, PHYS REV B, V102, DOI 10.1103/PhysRevB.102.201104; Perdew JP, 1997, PHYS REV LETT, V78, P1396, DOI 10.1103/PhysRevLett.78.1396; Qi Y, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.165112; Regan EC, 2020, NATURE, V579, P359, DOI 10.1038/s41586-020-2092-4; Senthil T, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.045109; Shabani S, 2021, NAT PHYS, V17, P720, DOI 10.1038/s41567-021-01174-7; Shimazaki Y, 2020, NATURE, V580, P472, DOI 10.1038/s41586-020-2191-2; Skinner B, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.155111; Spivak B, 2010, REV MOD PHYS, V82, P1743, DOI 10.1103/RevModPhys.82.1743; Szasz A, 2020, PHYS REV X, V10, DOI 10.1103/PhysRevX.10.021042; Tang YH, 2020, NATURE, V579, P353, DOI 10.1038/s41586-020-2085-3; Terletska H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.026401; Vucicevic J, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.075143; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; Wang L, 2020, NAT MATER, V19, P861, DOI 10.1038/s41563-020-0708-6; Wang ZF, 2017, NAT NANOTECHNOL, V12, P144, DOI [10.1038/NNANO.2016, 10.1038/nnano.2016.213]; Werner F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.056401; Wietek A., MOTT INSULATING STAT; Wu FC, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.026402; Xiao D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.196802; Xu Y, 2021, NAT MATER, V20, P645, DOI 10.1038/s41563-020-00888-y; Xu Y, 2020, NATURE, V587, P214, DOI 10.1038/s41586-020-2868-6; Yang HY, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.267204; Yin J, 2019, NAT PHYS, V15, P437, DOI 10.1038/s41567-019-0427-6; ZHANG FC, 1988, PHYS REV B, V37, P3759, DOI 10.1103/PhysRevB.37.3759; Zhang Y, 2020, PHYS REV B, V102, DOI 10.1103/PhysRevB.102.201115	50	57	58	25	102	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 16	2021	597	7876					350	+		10.1038/s41586-021-03853-0	http://dx.doi.org/10.1038/s41586-021-03853-0			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UQ8UQ	34526709	Green Submitted			2022-12-28	WOS:000696334600008
J	Lin, YP; Chiou, CS				Lin, Yu-Pei; Chiou, Chi-Sheng			Fever, arthritis, and painful skin nodules	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DISEASE		[Lin, Yu-Pei] Taipei Med Univ Hosp, Div Endocrinol & Metab, Dept Internal Med, Taipei, Taiwan; [Chiou, Chi-Sheng] Taipei Med Univ Hosp, Div Allergy Immunol & Rheumatol, Dept Internal Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital	Chiou, CS (corresponding author), Taipei Med Univ Hosp, Div Allergy Immunol & Rheumatol, Dept Internal Med, Taipei, Taiwan.	53guyton@gmail.com						Calamia KT, 2009, ARTHRIT RHEUM-ARTHR, V61, P600, DOI 10.1002/art.24423; Direskeneli H, 2001, ANN RHEUM DIS, V60, P996, DOI 10.1136/ard.60.11.996; Kroshinsky, 2020, ERYTHEMA NODOSUM; Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; SILMAN AJ, 1990, LANCET, V335, P1078; Smith EL, 2020, CLIN MANIFESTATIONS	6	0	0	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2021	374								n1956	10.1136/bmj.n1956	http://dx.doi.org/10.1136/bmj.n1956			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YR5CL	34531259				2022-12-28	WOS:000750009400001
J	Rosenberg, A; Arnold, RM; Schenker, Y				Rosenberg, Abby; Arnold, Robert M.; Schenker, Yael			Holding Hope for Patients With Serious Illness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PALLIATIVE CARE		[Rosenberg, Abby] Univ Washington, Sch Med, Dept Pediat, Div Hematol Oncol, Seattle, WA 98195 USA; [Rosenberg, Abby] Seattle Childrens Res Inst, Palliat Care & Resilience Lab, Seattle, WA USA; [Rosenberg, Abby] Univ Washington, Sch Med, Ctr Excellence, Cambia Palliat Care, Seattle, WA USA; [Arnold, Robert M.; Schenker, Yael] Univ Pittsburgh, Sch Med, Dept Med, Div Gen Internal Med,Sect Palliat Care & Med Eth, Pittsburgh, PA 15213 USA; [Arnold, Robert M.; Schenker, Yael] Univ Pittsburgh, Sch Med, Palliat Res Ctr PaRC, Pittsburgh, PA USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rosenberg, A (corresponding author), Seattle Childrens Res Inst, 1920 Terry Ave,CURE-4, Seattle, WA 98101 USA.	abby.rosenberg@seattlechildrens.org						Finkelstein EA, 2021, PSYCHO-ONCOLOGY, V30, P780, DOI 10.1002/pon.5675; Folkman S, 2010, PSYCHO-ONCOLOGY, V19, P901, DOI 10.1002/pon.1836; Jackson VA, 2013, J PALLIAT MED, V16, P894, DOI 10.1089/jpm.2012.0547; Salamanca-Balen N, 2021, PALLIATIVE MED, V35, P710, DOI 10.1177/0269216321994728; Sharot T, 2011, CURR BIOL, V21, pR941, DOI 10.1016/j.cub.2011.10.030; Smith R., 2021, BMJ OPINION; Snyder CR, 2002, J CLIN PSYCHOL, V58, P1003, DOI 10.1002/jclp.10096	7	4	4	2	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 5	2021	326	13					1259	1260		10.1001/jama.2021.14802	http://dx.doi.org/10.1001/jama.2021.14802		SEP 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WD9JC	34529011				2022-12-28	WOS:000696615500003
J	Kumar, A; Hossain, RA; Yost, SA; Bu, W; Wang, YY; Dearborn, AD; Grakoui, A; Cohen, JI; Marcotrigiano, J				Kumar, Ashish; Hossain, Reafa A.; Yost, Samantha A.; Bu, Wei; Wang, Yuanyuan; Dearborn, Altaira D.; Grakoui, Arash; Cohen, Jeffrey, I; Marcotrigiano, Joseph			Structural insights into hepatitis C virus receptor binding and entry	NATURE			English	Article							E2 ENVELOPE GLYCOPROTEIN; EXTRACELLULAR DOMAIN; CD81; IDENTIFICATION; RESIDUES; ELECTROSTATICS; PROTEINS; FUSION; TOOLS; MOTIF	Hepatitis C virus (HCV) infection is a causal agent of chronic liver disease, cirrhosis and hepatocellular carcinoma in humans, and afflicts more than 70 million people worldwide. The HCV envelope glycoproteins E1 and E2 are responsible for the binding of the virus to the host cell, but the exact entry process remains undetermined(1). The majority of broadly neutralizing antibodies block interaction between HCV E2 and the large extracellular loop (LEL) of the cellular receptor CD81 (CD81-LEL)(2). Here we show that low pH enhances the binding of CD81-LEL to E2, and we determine the crystal structure of E2 in complex with an antigen-binding fragment (2A12) and CD81-LEL (E2-2A12-CD81-LEL); E2 in complex with 2A12 (E2-2A12); and CD81-LEL alone. After binding CD81, residues 418-422 in E2 are displaced, which allows for the extension of an internal loop consisting of residues 520-539. Docking of the E2-CD81-LEL complex onto a membrane-embedded, full-length CD81 places the residues Tyr529 and Trp531 of E2 proximal to the membrane. Liposome flotation assays show that low pH and CD81-LEL increase the interaction of E2 with membranes, whereas structure-based mutants of Tyr529, Trp531 and Ile422 in the amino terminus of E2 abolish membrane binding. These data support a model in which acidification and receptor binding result in a conformational change in E2 in preparation for membrane fusion.	[Kumar, Ashish; Hossain, Reafa A.; Wang, Yuanyuan; Dearborn, Altaira D.; Marcotrigiano, Joseph] NIAID, Struct Viror Sect, Lab Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Yost, Samantha A.] Rutgers State Univ, Ctr Adv Biotechnor & Med, Piscataway, NJ USA; [Bu, Wei; Cohen, Jeffrey, I] NIAID, Med Virol Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Grakoui, Arash] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA USA; [Grakoui, Arash] Emory Univ, Yerkes Natl Primate Res Ctr, Div Microbior & Immunor, Emory Vaccine Ctr, Atlanta, GA 30322 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Rutgers State University New Brunswick; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Emory University; Emory University	Marcotrigiano, J (corresponding author), NIAID, Struct Viror Sect, Lab Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	joseph.marcotrigiano@nih.gov	Lv, Yuanjie/AER-0767-2022; Wang, Yuan/HHC-1520-2022; Wang, Yu/GZL-9655-2022; wangwangwang, yuanyaun/HHN-6432-2022	Marcotrigiano, Joseph/0000-0001-7670-7836; Yost, Samantha/0000-0002-8286-2530; Hossain, Reafa/0000-0002-3113-8921	Intramural Research Programs of the National Institute of Allergy and Infectious Diseases; NIH [R01AI136533, R01AI124680, R01AI126890, U19AI159819]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38, DE-AC02-06CH11357]; National Institutes of Health [S10_RR25528, S10_RR028976]	Intramural Research Programs of the National Institute of Allergy and Infectious Diseases; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We acknowledge A. Khan, M. Miller,M. Paskel and L. Tuberty for technical assistance; D. Wu and G. Piszczek for help with the ITC measurements; C. Rice for reagents and advice; and F. Jiang for his dedication to science and friendship. This work was supported by the Intramural Research Programs of the National Institute of Allergy and Infectious Diseases (J.I.C. and J.M.) and NIH grants R01AI136533, R01AI124680, R01AI126890 and U19AI159819 to A.G. Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract numbers W-31-109-Eng-38 (SER-CAT) and DE-AC02-06CH11357 (LRL-CAT). SER-CAT is supported by its member institutions, and equipment grants (S10_RR25528 and S10_RR028976) from the National Institutes of Health.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Allander T, 2000, VIROLOGY, V277, P358, DOI 10.1006/viro.2000.0617; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Boo I, 2012, BIOCHEM J, V443, P85, DOI 10.1042/BJ20110868; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cunha ES, 2017, STRUCTURE, V25, P53, DOI 10.1016/j.str.2016.11.003; Dearborn AD, 2020, CSH PERSPECT MED, V10, DOI 10.1101/cshperspect.a036822; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Drummer HE, 2002, J VIROL, V76, P11143, DOI 10.1128/JVI.76.21.11143-11147.2002; Drummer HE, 2006, J VIROL, V80, P7844, DOI 10.1128/JVI.00029-06; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2018, ACTA CRYSTALLOGR D, V74, P256, DOI 10.1107/S2059798318005119; Flint M, 2006, J VIROL, V80, P11331, DOI 10.1128/JVI.00104-06; Flyak AI, 2020, ELIFE, V9, DOI 10.7554/eLife.53169; Flyak AI, 2018, CELL HOST MICROBE, V24, P703, DOI 10.1016/j.chom.2018.10.009; Gerold G, 2020, CSH PERSPECT MED, V10, DOI 10.1101/cshperspect.a036830; Higginbottom A, 2000, J VIROL, V74, P3642, DOI 10.1128/JVI.74.8.3642-3649.2000; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Khan AG, 2014, NATURE, V509, P381, DOI 10.1038/nature13117; Kielian M, 2014, ANNU REV VIROL, V1, P171, DOI 10.1146/annurev-virology-031413-085521; Kitadokoro K, 2001, EMBO J, V20, P12, DOI 10.1093/emboj/20.1.12; Kong L, 2013, SCIENCE, V342, P1090, DOI 10.1126/science.1243876; Li HF, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-89; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; Rajesh S, 2012, J VIROL, V86, P9606, DOI 10.1128/JVI.00559-12; Rothwang KB, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-46; Sharma NR, 2011, J BIOL CHEM, V286, P30361, DOI 10.1074/jbc.M111.263350; Susa KJ, 2021, SCIENCE, V371, P300, DOI 10.1126/science.abd9836; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Tzarum N, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav1882; Tzarum N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01315; Vasiliauskaite I, 2017, MBIO, V8, DOI 10.1128/mBio.00382-17; White JM, 2016, TRAFFIC, V17, P593, DOI 10.1111/tra.12389; Yost SA, 2019, METHODS MOL BIOL, V1911, P305, DOI 10.1007/978-1-4939-8976-8_21; Zhao HY, 2015, METHODS, V76, P137, DOI 10.1016/j.ymeth.2014.11.012; Zhao Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084346; Zimmerman B, 2016, CELL, V167, P1041, DOI 10.1016/j.cell.2016.09.056	40	9	9	3	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 21	2021	598	7881					521	+		10.1038/s41586-021-03913-5	http://dx.doi.org/10.1038/s41586-021-03913-5		SEP 2021	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WK1SC	34526719	Green Accepted			2022-12-28	WOS:000696175300015
J	Evans, AG; Assi, PE; Al Kassis, S				Evans, Adam G.; Assi, Patrick E.; Al Kassis, Salam			Poloxamer 188 vs Placebo for Painful Vaso-occlusive Episodes in Children and Adults With Sickle Cell Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Evans, Adam G.; Assi, Patrick E.; Al Kassis, Salam] Vanderbilt Univ, Med Ctr, Dept Plast Surg, 1211 Med Ctr Dr, Nashville, TN 37212 USA	Vanderbilt University	Evans, AG (corresponding author), Vanderbilt Univ, Med Ctr, Dept Plast Surg, 1211 Med Ctr Dr, Nashville, TN 37212 USA.	aevans17@email.mmc.edu		Assi, Patrick/0000-0002-3357-548X				Blake P, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-1023-y; Gfrerer L, 2019, PRS-GLOB OPEN, V7, DOI 10.1097/GOX.0000000000002291; Guyuron B, 2000, PLAST RECONSTR SURG, V106, P429, DOI 10.1097/00006534-200008000-00030; Robbins MS, 2021, JAMA-J AM MED ASSOC, V325, P1874, DOI 10.1001/jama.2021.1640; Vincent AJPE, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00089	5	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2021	326	10					977	977		10.1001/jama.2021.11376	http://dx.doi.org/10.1001/jama.2021.11376			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UW4LI	34519805				2022-12-28	WOS:000700129100030
J	Holden, SS; Grandi, FC; Aboubakr, O; Higashikubo, B; Cho, FS; Chang, AH; Forero, AO; Morningstar, AR; Mathur, V; Kuhn, LJ; Suri, P; Sankaranarayanan, S; Andrews-Zwilling, Y; Tenner, AJ; Luthi, A; Aronica, E; Corces, MR; Yednock, T; Paz, JT				Holden, Stephanie S.; Grandi, Fiorella C.; Aboubakr, Oumaima; Higashikubo, Bryan; Cho, Frances S.; Chang, Andrew H.; Forero, Alejandro Osorio; Morningstar, Allison R.; Mathur, Vidhu; Kuhn, Logan J.; Suri, Poojan; Sankaranarayanan, Sethu; Andrews-Zwilling, Yaisa; Tenner, Andrea J.; Luthi, Anita; Aronica, Eleonora; Corces, M. Ryan; Yednock, Ted; Paz, Jeanne T.			Complement factor C1q mediates sleep spindle loss and epileptic spikes after mild brain injury	SCIENCE			English	Article							RECIPROCAL INHIBITORY CONNECTIONS; CORTICOTHALAMIC PROJECTIONS; NETWORK SYNCHRONY; MOUSE MODELS; COMPONENT; ACTIVATION; CIRCUITS; THALAMUS; ORGANIZATION; EXPRESSION	Although traumatic brain injury (TBI) acutely disrupts the cortex, most TBI-related disabilities reflect secondary injuries that accrue over time. The thalamus is a likely site of secondary damage because of its reciprocal connections with the cortex. Using a mouse model of mild TBI (mTBI), we found a chronic increase in C1q expression specifically in the corticothalamic system. Increased C1q expression colocalized with neuron loss and chronic inflammation and correlated with disruption in sleep spindles and emergence of epileptic activities. Blocking C1q counteracted these outcomes, suggesting that C1q is a disease modifier in mTBI. Single-nucleus RNA sequencing demonstrated that microglia are a source of thalamic C1q. The corticothalamic circuit could thus be a new target for treating TBI-related disabilities.	[Holden, Stephanie S.; Cho, Frances S.; Paz, Jeanne T.] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94158 USA; [Holden, Stephanie S.; Grandi, Fiorella C.; Aboubakr, Oumaima; Higashikubo, Bryan; Cho, Frances S.; Chang, Andrew H.; Morningstar, Allison R.; Corces, M. Ryan; Paz, Jeanne T.] Gladstone Inst, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Holden, Stephanie S.; Grandi, Fiorella C.; Cho, Frances S.; Corces, M. Ryan; Paz, Jeanne T.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Forero, Alejandro Osorio; Luthi, Anita] Univ Lausanne, Dept Fundamental Neurosci, CH-1005 Lausanne, Switzerland; [Mathur, Vidhu; Kuhn, Logan J.; Suri, Poojan; Sankaranarayanan, Sethu; Andrews-Zwilling, Yaisa; Yednock, Ted] Annexon Biosci, San Francisco, CA 94080 USA; [Tenner, Andrea J.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Aronica, Eleonora] Univ Amsterdam, Amsterdam UMC, Dept Neuropathol, NL-1105 AZ Amsterdam, Netherlands; [Aronica, Eleonora] Stichting Epilepsie Instellingen Nederland SEIN, NL-2103 SW Heemstede, Netherlands; [Paz, Jeanne T.] Univ Calif San Francisco, Kavli Inst Fundamental Neurosci, San Francisco, CA 94158 USA; [Paz, Jeanne T.] Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of Lausanne; University of California System; University of California Irvine; University of Amsterdam; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Paz, JT (corresponding author), Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94158 USA.; Paz, JT (corresponding author), Gladstone Inst, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.; Paz, JT (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA.; Paz, JT (corresponding author), Univ Calif San Francisco, Kavli Inst Fundamental Neurosci, San Francisco, CA 94158 USA.; Paz, JT (corresponding author), Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94158 USA.	jeanne.paz@gladstone.ucsf.edu	Luthi, Anita/ABE-1411-2021	Cho, Frances/0000-0002-2576-7801; Luthi, Anita/0000-0002-4954-4143; ABOUBAKR, Oumaima/0000-0002-7280-6201; Morningstar, Allison/0000-0002-3857-0450; Osorio-Forero, Alejandro/0000-0003-4341-4206; Grandi, Fiorella/0000-0002-1303-6710; Kuhn, Logan/0000-0002-1149-3213	Department of Defense [EP150038]; National Institutes of Health (NIH) [R01 NS078118, T32-GM007449, R01AG060148]; National Science Foundation (NSF) [1608236, 1144247]; Gladstone Institutes; Michael Prize; Vilcek Prize; Kavli Institute for Fundamental Neuroscience; Achievement Rewards for College Scientists Scholarship; Ford Foundation Dissertation Fellowship; Faculty of Biology and Medicine-University of Lausanne; Weill Foundation; American Epilepsy Society Postdoctoral Research Fellowship; National Institute of Neurological Disorders and Stroke (NINDS) [F31 NS111819-01A1]; UCSF Discovery Fellowship; Epilepsiefonds project [2020-02]; Swiss National Science Foundation [310030-184759]	Department of Defense(United States Department of Defense); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); Gladstone Institutes(University of California System); Michael Prize; Vilcek Prize; Kavli Institute for Fundamental Neuroscience; Achievement Rewards for College Scientists Scholarship; Ford Foundation Dissertation Fellowship; Faculty of Biology and Medicine-University of Lausanne; Weill Foundation; American Epilepsy Society Postdoctoral Research Fellowship; National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); UCSF Discovery Fellowship; Epilepsiefonds project; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded mainly by Department of Defense grant EP150038 to J.T.P., who also had support from the National Institutes of Health (NIH grant R01 NS078118), the National Science Foundation (NSF grant 1608236), Gladstone Institutes, the Michael Prize, the Vilcek Prize, and the Kavli Institute for Fundamental Neuroscience. S.S.H. was supported by an Achievement Rewards for College Scientists Scholarship, a Ford Foundation Dissertation Fellowship, the NIH (grant T32-GM007449), and the Weill Foundation. B.H. was supported by an American Epilepsy Society Postdoctoral Research Fellowship. F.S.C. was supported by the National Institute of Neurological Disorders and Stroke (NINDS grant F31 NS111819-01A1), the NSF (Graduate Research Fellowship 1144247), and by a UCSF Discovery Fellowship. E.A. was supported by Epilepsiefonds project 2020-02. A.L. was supported by the Swiss National Science Foundation (grant 310030-184759). A.O.F. was supported by the Faculty of Biology and Medicine-University of Lausanne doctoral fellowship. A.J.T. was supported by the NIH (grant R01AG060148).	Alawieh A, 2021, J NEUROSCI, V41, P1830, DOI 10.1523/JNEUROSCI.1734-20.2020; Andrade P, 2017, J NEUROTRAUM, V34, P1482, DOI 10.1089/neu.2016.4675; Anton-Bolanos N, 2018, CURR OPIN NEUROBIOL, V52, P33, DOI 10.1016/j.conb.2018.04.018; Aronica E, 2007, NEUROBIOL DIS, V26, P497, DOI 10.1016/j.nbd.2007.01.015; Auladell C, 2000, ANAT EMBRYOL, V201, P169, DOI 10.1007/PL00008238; Beenhakker MP, 2009, NEURON, V62, P612, DOI 10.1016/j.neuron.2009.05.015; Bell JE, 2008, ACTA NEUROPATHOL, V115, P497, DOI 10.1007/s00401-008-0360-8; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Benoit ME, 2013, J BIOL CHEM, V288, P654, DOI 10.1074/jbc.M112.400168; Bialas AR, 2013, NAT NEUROSCI, V16, P1773, DOI 10.1038/nn.3560; BioSpace, 2021, ANN ANN IN PHAS 2 3; BioSpace, ANN ANN IN PHAS 2 3, V2021; BLAKEMORE C, 1990, COLD SPRING HARB SYM, V55, P491; BOURASSA J, 1995, EUR J NEUROSCI, V7, P19, DOI 10.1111/j.1460-9568.1995.tb01016.x; Briggs F, 2008, CURR OPIN NEUROBIOL, V18, P403, DOI 10.1016/j.conb.2008.09.002; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cho FS, 2017, MODELS OF SEIZURES AND EPILEPSY, 2ND EDITION, P273, DOI 10.1016/B978-0-12-804066-9.00019-5; Cho K, 2019, AGING DIS, V10, P652, DOI 10.14336/AD.2019.0118; Clemente-Perez A, 2017, CELL REP, V19, P2130, DOI 10.1016/j.celrep.2017.05.044; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Corces R, 2019, ISOLATION NUCLEI FRO, DOI [10.17504/protocols.io.6t8herw, DOI 10.17504/PROTOCOLS.IO.6T8HERW]; Cruikshank SJ, 2010, NEURON, V65, P230, DOI 10.1016/j.neuron.2009.12.025; Deschenes M, 1998, BRAIN RES REV, V28, P286, DOI 10.1016/S0165-0173(98)00017-4; Destexhe A, 1998, J NEUROPHYSIOL, V79, P999; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Ding, 2016, TRANSLATIONAL RES TR; Fernandez LMJ, 2018, ELIFE, V7, DOI 10.7554/eLife.39111; Golshani P, 2001, P NATL ACAD SCI USA, V98, P4172, DOI 10.1073/pnas.061013698; Grossman EJ, 2016, J NEUROTRAUM, V33, P163, DOI 10.1089/neu.2015.3965; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Hammad A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1066-z; Harris LK, 2001, J NEUROTRAUM, V18, P993, DOI 10.1089/08977150152693692; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Huntsman MM, 1999, SCIENCE, V283, P541, DOI 10.1126/science.283.5401.541; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Krukowski K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123753; Lam YW, 2011, J NEUROSCI, V31, P6791, DOI 10.1523/JNEUROSCI.3073-10.2011; Lansita JA, 2017, INT J TOXICOL, V36, P449, DOI 10.1177/1091581817740873; LEPOW IH, 1963, J EXP MED, V117, P983, DOI 10.1084/jem.117.6.983; Li YQ, 2020, NATURE, V583, P819, DOI 10.1038/s41586-020-2504-5; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lui HS, 2016, CELL, V165, P921, DOI 10.1016/j.cell.2016.04.001; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Mallah K, 2021, ACTA NEUROPATHOL COM, V9, DOI 10.1186/s40478-021-01179-6; Manoach DS, 2016, BIOL PSYCHIAT, V80, P599, DOI 10.1016/j.biopsych.2015.10.003; Martinez-Garcia RI, 2020, NATURE, V583, P813, DOI 10.1038/s41586-020-2512-5; McGinnis CS, 2019, CELL SYST, V8, P329, DOI 10.1016/j.cels.2019.03.003; McGonigal R, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0291-x; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Paz JT, 2015, NAT NEUROSCI, V18, P351, DOI 10.1038/nn.3950; Paz JT, 2011, NAT NEUROSCI, V14, P1167, DOI 10.1038/nn.2896; Pisalyaput K, 2008, J NEUROCHEM, V104, P696, DOI 10.1111/j.1471-4159.2007.05012.x; Ritter-Makinson S, 2019, CELL REP, V26, P54, DOI 10.1016/j.celrep.2018.12.018; ROSS DT, 1993, J NEUROTRAUM, V10, P151, DOI 10.1089/neu.1993.10.151; ROSS DT, 1990, NEUROSCIENCE, V35, P525, DOI 10.1016/0306-4522(90)90327-Z; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Schartz ND, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-02024-8; Schiering IAM, 2014, J NEUROPATH EXP NEUR, V73, P324, DOI 10.1097/NEN.0000000000000056; Scott G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0445-y; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Sohal VS, 2003, J NEUROSCI, V23, P8978; Sohal VS, 2000, J NEUROSCI, V20, P1735; Sorokin JM, 2017, NEURON, V93, P194, DOI 10.1016/j.neuron.2016.11.026; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Talley EM, 1999, J NEUROSCI, V19, P1895; Thrupp N, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108189; van Dijk D, 2018, CELL, V174, P716, DOI 10.1016/j.cell.2018.05.061; Vukojicic A, 2019, CELL REP, V29, P3087, DOI 10.1016/j.celrep.2019.11.013; Wang C, 2020, SCIENCE, V367, P688, DOI 10.1126/science.aaz2288; World Health Organization, 2006, NEUR DIS PUBL HLTH C; Wu T, 2019, CELL REP, V28, P2111, DOI 10.1016/j.celrep.2019.07.060; Wyatt SK, 2017, EXP NEUROL, V295, P184, DOI 10.1016/j.expneurol.2017.06.009; Yilmaz M, 2021, NAT NEUROSCI, V24, P214, DOI 10.1038/s41593-020-00763-8; You ZR, 2007, J CEREBR BLOOD F MET, V27, P1954, DOI 10.1038/sj.jcbfm.9600497; Young MD, 2020, GIGASCIENCE, V9, DOI 10.1093/gigascience/giaa151; Zelek WM, 2019, MOL IMMUNOL, V114, P341, DOI 10.1016/j.molimm.2019.07.030	81	11	12	5	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2021	373	6560							eabj2685	10.1126/science.abj2685	http://dx.doi.org/10.1126/science.abj2685			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UP5RB	34516796	Green Accepted			2022-12-28	WOS:000695436000024
J	Mulcahy, AW; Schwam, D; Rao, PT; Rennane, S; Shetty, K				Mulcahy, Andrew W.; Schwam, Daniel; Rao, Preethi; Rennane, Stephanie; Shetty, Kanaka			Estimated Savings From International Reference Pricing for Prescription Drugs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Mulcahy, Andrew W.; Schwam, Daniel; Rao, Preethi; Rennane, Stephanie] RAND Corp, Arlington, VA USA; [Shetty, Kanaka] RAND Corp, Santa Monica, CA USA	RAND Corporation; RAND Corporation	Mulcahy, AW (corresponding author), 1200 S Hayes St, Arlington, VA 22202 USA.	amulcahy@rand.org		Schwam, Daniel/0000-0003-1831-1483; Rennane, Stephanie/0000-0002-6995-2339	Arnold Ventures	Arnold Ventures	This study was funded by Arnold Ventures.	Brodie M., 2019, KFF TRACKING POLL FE; Keehan SP, 2020, HEALTH AFFAIR, V39, P704, DOI 10.1377/hlthaff.2020.00094; Mulcahy AW, 2021, INT PRESCRIPTION DRU; Yang EJ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.28510	4	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 2	2021	326	17					1744	1745		10.1001/jama.2021.13338	http://dx.doi.org/10.1001/jama.2021.13338		SEP 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WW8DB	34505870	Green Published, Bronze			2022-12-28	WOS:000695637300001
J	Azofeifa, A; Martin, GR; Howard, J				Azofeifa, Alejandro; Martin, Gayatri R.; Howard, John			World Trade Center Health Program, 2012-2020 Implications for Clinicians and Health Care Systems	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Azofeifa, Alejandro; Martin, Gayatri R.; Howard, John] Ctr Dis Control & Prevent, World Trade Ctr Hlth Program, Natl Inst Occupat Safety & Hlth, Washington, DC USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Azofeifa, A (corresponding author), Natl Inst Occupat Safety & Hlth, 395 E St SW,Patriots Plaza 1,Ste 9200, Washington, DC 20201 USA.	aazofeifa@cdc.gov						Azofeifa A, 2021, MMWR SURVEILL SUMM, V70, P1, DOI 10.15585/mmwr.ss7004a1; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P821; Daniels RD, 2021, AM J IND MED, V64, P885, DOI 10.1002/ajim.23267; Murphy J, 2007, STAT MED, V26, P1688, DOI 10.1002/sim.2806; Santiago-Colon A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17197290; World Trade Center Health Program, 2020, US DEP HHS CDC NAT I	6	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 28	2021	326	12					1147	1148		10.1001/jama.2021.15739	http://dx.doi.org/10.1001/jama.2021.15739		SEP 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WC5VU	34499713				2022-12-28	WOS:000694671200001
J	Welsby, D; Price, J; Pye, S; Ekins, P				Welsby, Dan; Price, James; Pye, Steve; Ekins, Paul			Unextractable fossil fuels in a 1.5 degrees C world	NATURE			English	Article							CO2 EMISSIONS; SCENARIO	Parties to the 2015 Paris Agreement pledged to limit global warming to well below 2 degrees C and to pursue efforts to limit the temperature increase to 1.5 degrees C relative to pre-industrial times(1). However, fossil fuels continue to dominate the global energy system and a sharp decline in their use must be realized to keep the temperature increase below 1.5 degrees C (refs. (2-7)). Here we use a global energy systems model(8) to assess the amount of fossil fuels that would need to be left in the ground, regionally and globally, to allow for a 50 per cent probability of limiting warming to 1.5 degrees C. By 2050, we find that nearly 60 per cent of oil and fossil methane gas, and 90 per cent of coal must remain unextracted to keep within a 1.5 degrees C carbon budget. This is a large increase in the unextractable estimates for a 2 degrees C carbon budget(9), particularly for oil, for which an additional 25 per cent of reserves must remain unextracted. Furthermore, we estimate that oil and gas production must decline globally by 3 per cent each year until 2050. This implies that most regions must reach peak production now or during the next decade, rendering many operational and planned fossil fuel projects unviable. We probably present an underestimate of the production changes required, because a greater than 50 per cent probability of limiting warming to 1.5 degrees C requires more carbon to stay in the ground and because of uncertainties around the timely deployment of negative emission technologies at scale. A global energy system model finds that planned fossil fuel extraction is inconsistent with limiting global warming to 1.5 degrees C, because the majority of fossil fuel reserves must stay in the ground.	[Welsby, Dan; Ekins, Paul] UCL, Inst Sustainable Resources, London, England; [Price, James; Pye, Steve] UCL, UCL Energy Inst, London, England	University of London; University College London; University of London; University College London	Welsby, D (corresponding author), UCL, Inst Sustainable Resources, London, England.	daniel.welsby.14@ucl.ac.uk		Pye, Stephen/0000-0003-1793-2552; Welsby, Dan/0000-0002-8800-0229; Price, James/0000-0001-7315-6469				Anderson K, 2016, SCIENCE, V354, P182, DOI 10.1126/science.aah4567; [Anonymous], 2020, WORLD EN OUTL; [Anonymous], 2018, BIOMASS LOW CARBON E; [Anonymous], 2019, NATURAL GAS INFORM 2; [Anonymous], 2020, PRODUCTION GAP REPOR; [Anonymous], 2016, RUSSIAN ENERGY; [Anonymous], 2019, WORLD EN OUTL; [Anonymous], 2014, INTEGRATED ASSESSMEN; [Anonymous], 2018, PETROLEUM RESOURCES; [Anonymous], 2019, OPEC ANN STAT B; [Anonymous], 2016, ENERGY STUDY 2016 RE; [Anonymous], 2020, BP ENERGY OUTLOOK 20; [Anonymous], 2021, PETROSTATES BURNING; [Anonymous], 2020, STAT REV WORLD EN; [Anonymous], 2015, ADOPTION PARIS AGREE; [Anonymous], 2020, FUTURES NOT PLASTICS; [Anonymous], 2013, UNBURNABLE CARBON 20; [Anonymous], 2020, DECLINE FALL SIZE VU; [Anonymous], 2020, ASSUMPTIONS ANN ENER; [Anonymous], 2020, BGR ENERGY STUDY 201; Bauer N, 2020, CLIMATIC CHANGE, V163, P1553, DOI 10.1007/s10584-018-2226-y; Creutzig F, 2015, GCB BIOENERGY, V7, P916, DOI 10.1111/gcbb.12205; Erickson P, 2020, NATURE, V578, pE1, DOI 10.1038/s41586-019-1920-x; Erickson P, 2018, NAT CLIM CHANGE, V8, P1037, DOI 10.1038/s41558-018-0337-0; Fricko O, 2017, GLOBAL ENVIRON CHANG, V42, P251, DOI 10.1016/j.gloenvcha.2016.06.004; Fuss S, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aabf9f; Fuss S, 2014, NAT CLIM CHANGE, V4, P850, DOI 10.1038/nclimate2392; Gautier D., 2017, 2008 CIRCUMARCTIC RE; Godoi JMA, 2021, J PET EXPLOR PROD TE, V11, P1429, DOI 10.1007/s13202-021-01102-8; Green F, 2018, CLIMATIC CHANGE, V150, P73, DOI 10.1007/s10584-018-2162-x; Grubler A, 2018, NAT ENERGY, V3, P515, DOI 10.1038/s41560-018-0172-6; Huppmann D, 2018, NAT CLIM CHANGE, V8, P1027, DOI 10.1038/s41558-018-0317-4; IPCC, 2018, SUMMARY POLICYMAKERS; Laherrere J, 2003, ENERG EXPLOR EXPLOIT, V21, P227, DOI 10.1260/014459803769520061; Lau WWY, 2020, SCIENCE, V369, P1455, DOI 10.1126/science.aba9475; Lazarus M, 2018, CLIMATIC CHANGE, V150, P1, DOI 10.1007/s10584-018-2266-3; Luderer G, 2018, NAT CLIM CHANGE, V8, P626, DOI 10.1038/s41558-018-0198-6; Marangoni G, 2017, NAT CLIM CHANGE, V7, P113, DOI [10.1038/nclimate3199, 10.1038/NCLIMATE3199]; McCollum DL, 2018, NAT ENERGY, V3, P664, DOI 10.1038/s41560-018-0195-z; Mcglade CE, 2013, UNCERTAINTIES OUTLOO; McGlade C, 2015, NATURE, V517, P187, DOI 10.1038/nature14016; Muttitt G, 2020, CLIM POLICY, V20, P1024, DOI 10.1080/14693062.2020.1763900; Newell P, 2020, CLIM POLICY, V20, P1043, DOI 10.1080/14693062.2019.1636759; Piggot G, 2018, CLIM POLICY, V18, P1189, DOI 10.1080/14693062.2018.1494535; Pye S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17679-3; Rogelj J, 2018, SPECIAL REPORT GLOBA; Rogelj J, 2018, NAT CLIM CHANGE, V8, P325, DOI 10.1038/s41558-018-0091-3; Tong D, 2019, NATURE, V572, P373, DOI 10.1038/s41586-019-1364-3	48	113	114	50	76	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 9	2021	597	7875					230	+		10.1038/s41586-021-03821-8	http://dx.doi.org/10.1038/s41586-021-03821-8			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UQ1FZ	34497394	Green Submitted, Bronze			2022-12-28	WOS:000695818300013
J	Wei, N; Kaczorowski, RL; Arceo-Gomez, G; O'Neill, EM; Hayes, RA; Ashman, TL				Wei, Na; Kaczorowski, Rainee L.; Arceo-Gomez, Gerardo; O'Neill, Elizabeth M.; Hayes, Rebecca A.; Ashman, Tia-Lynn			Pollinators contribute to the maintenance of flowering plant diversity	NATURE			English	Article							HETEROSPECIFIC POLLEN RECEIPT; R-PACKAGE; NETWORKS; FACILITATION; EVOLUTION; PATTERNS; COMPETITION; ABUNDANCE; SELECTION; SYSTEMS	Mechanisms that favour rare species are key to the maintenance of diverse communities(1-3). One ofthe most critical tasks for conservation of flowering plant biodiversity is to understand how plant-pollinator interactions contribute to the maintenance of rare species(4-7). Here we show that niche partitioning in pollinator use and asymmetric facilitation confer fitness advantage of rarer species in a biodiversity hotspot using phylogenetic structural equation modelling that integrates plant-pollinator and interspecific pollen transfer networks with floral functional traits. Co-flowering species filtered pollinators via floral traits, and rarer species showed greater pollinator specialization leading to higher pollination-mediated male and female fitness than more abundant species. When plants shared pollinator resources, asymmetric facilitation via pollen transport dynamics benefitted the rarer species at the cost of more abundant species, serving as an alternative diversity-promoting mechanism. Our results emphasize the importance of community-wide plant-pollinator interactions that affect reproduction for biodiversity maintenance.	[Wei, Na; Kaczorowski, Rainee L.; Arceo-Gomez, Gerardo; O'Neill, Elizabeth M.; Hayes, Rebecca A.; Ashman, Tia-Lynn] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Wei, Na] Holden Arboretum, Kirtland, OH 44094 USA; [Arceo-Gomez, Gerardo] East Tennessee State Univ, Dept Biol Sci, Johnson City, TN USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; East Tennessee State University	Wei, N; Ashman, TL (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.; Wei, N (corresponding author), Holden Arboretum, Kirtland, OH 44094 USA.	nwei@holdenfg.org; tia1@pitt.edu	Hayes, Rebecca/GQH-9788-2022	Hayes, Rebecca/0000-0001-6167-201X; Kaczorowski, Rainee/0000-0002-6414-7533	National Science Foundation [DEB 1452386]	National Science Foundation(National Science Foundation (NSF))	We thank J. Baker, D. Chang, A. M. Arters, U. Meenakshinathan, K. Doleski, S. Barratt-Boyes, R. A. Ashman and M. Holden for assistance with stigma pollen identification, floral trait measurements and insect specimen processing; J. Rawlins, J. Pawelek, R. Androw and B. Coulter for insect identification; J. Hyland and V. Verdecia for logistic support at the Carnegie Museum of Natural History; McLaughlin field station staff for logistical support of field work; and the members of the Ashman, Wood and Turcotte laboratories for discussion. This work was supported by the National Science Foundation (DEB 1452386) to T.-L.A.	Adler PB, 2013, ECOL LETT, V16, P1294, DOI 10.1111/ele.12157; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Arceo-Gomez G, 2019, OECOLOGIA, V189, P1041, DOI 10.1007/s00442-019-04379-z; Arceo-Gomez G, 2018, AM J BOT, V105, P1601, DOI 10.1002/ajb2.1144; Arceo-Gomez G, 2018, INT J PLANT SCI, V179, P569, DOI 10.1086/698712; Arceo-Gomez G, 2016, AM J BOT, V103, P396, DOI 10.3732/ajb.1500155; Armbruster WS, 2017, FUNCT ECOL, V31, P88, DOI 10.1111/1365-2435.12783; Ashman TL, 2020, ANN BOT-LONDON, V125, P1003, DOI 10.1093/aob/mcaa012; Ashman TL, 2013, AM J BOT, V100, P1061, DOI 10.3732/ajb.1200496; Ashman TL, 2004, ECOLOGY, V85, P2408, DOI 10.1890/03-8024; Baldwin BG, 2014, ANNU REV ECOL EVOL S, V45, P347, DOI 10.1146/annurev-ecolsys-110512-135847; Barrett SCH, 2002, NAT REV GENET, V3, P274, DOI 10.1038/nrg776; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bastian M, 2009, INT AAAI C WEBL SOC; Benadi G, 2018, J ECOL, V106, P1892, DOI 10.1111/1365-2745.13025; Benadi G, 2012, AM NAT, V179, P157, DOI 10.1086/663685; BENNETT J, 2020, NAT COMMUN, V11; Bergamo PJ, 2020, ECOL LETT, V23, P129, DOI 10.1111/ele.13415; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Csardi G., 2006, INTERJOURNALCOMPLEX, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191; DAFNI A., 1992, POLLINATION ECOLOGY; Dormann C.F., 2008, INTERACTIONS, V8, P8; Fang Q, 2013, ECOLOGY, V94, P1176, DOI 10.1890/12-1634.1; FEINSINGER P, 1981, ECOLOGY, V62, P27, DOI 10.2307/1936664; Fort H, 2016, ECOL LETT, V19, P4, DOI 10.1111/ele.12535; Fox J., 2019, R COMPANION APPL REG; Hayes R. A., MADRONO; Hegland SJ, 2009, ECOL LETT, V12, P184, DOI 10.1111/j.1461-0248.2008.01269.x; Hinchliff CE, 2015, P NATL ACAD SCI USA, V112, P12764, DOI 10.1073/pnas.1423041112; HORN HS, 1966, AM NAT, V100, P419, DOI 10.1086/282436; Hubbell Stephen P., 2001, V32, pi; Kantsa A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03448-w; Keck F, 2016, ECOL EVOL, V6, P2774, DOI 10.1002/ece3.2051; Koski MH, 2015, ARTHROPOD-PLANT INTE, V9, P9, DOI 10.1007/s11829-014-9353-9; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lefcheck JS, 2016, METHODS ECOL EVOL, V7, P573, DOI 10.1111/2041-210X.12512; LEVIN DA, 1970, AM NAT, V104, P455, DOI 10.1086/282680; LLOYD DG, 1979, AM NAT, V113, P67, DOI 10.1086/283365; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Michonneau F, 2016, METHODS ECOL EVOL, V7, P1476, DOI 10.1111/2041-210X.12593; Minnaar C, 2019, ANN BOT-LONDON, V123, P225, DOI 10.1093/aob/mcy167; Moeller DA, 2004, ECOLOGY, V85, P3289, DOI 10.1890/03-0810; Moreira-Hernandez JI, 2019, ANNU REV ECOL EVOL S, V50, P191, DOI 10.1146/annurev-ecolsys-110218-024804; Ohlemuller R, 2008, BIOL LETTERS, V4, P568, DOI 10.1098/rsbl.2008.0097; Ollerton J, 2017, ANNU REV ECOL EVOL S, V48, P353, DOI 10.1146/annurev-ecolsys-110316-022919; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Paradis Emmanuel, 2019, Bioinformatics, V35, P526, DOI 10.1093/bioinformatics/bty633; Patefield W. M., 1981, APPL STAT, V30, P91, DOI DOI 10.2307/2346669; PIMM SL, 1988, AM NAT, V132, P757, DOI 10.1086/284889; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Qian H, 2016, J PLANT ECOL, V9, P233, DOI 10.1093/jpe/rtv047; R Development Core Team, 2009, R LANG ENV STAT COMP; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Rodger JG, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abd3524; Sargent RD, 2006, AM NAT, V167, P67, DOI 10.1086/498433; Sargent RD, 2008, TRENDS ECOL EVOL, V23, P123, DOI 10.1016/j.tree.2007.11.003; Shipley B, 2013, ECOLOGY, V94, P560, DOI 10.1890/12-0976.1; Song CL, 2017, J ANIM ECOL, V86, P1417, DOI 10.1111/1365-2656.12749; Thomson JD, 2019, ANN BOT-LONDON, V123, P303, DOI 10.1093/aob/mcy120; Tur C, 2016, ECOL LETT, V19, P576, DOI 10.1111/ele.12594; Vamosi JC, 2018, ANNU REV PLANT BIOL, V69, P685, DOI 10.1146/annurev-arplant-042817-040348; Vamosi JC, 2006, P NATL ACAD SCI USA, V103, P956, DOI 10.1073/pnas.0507165103; van der Bijl W, 2018, PEERJ, V6, DOI 10.7717/peerj.4718; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wills C, 2006, SCIENCE, V311, P527, DOI 10.1126/science.1117715; Zanne AE, 2014, NATURE, V506, P89, DOI 10.1038/nature12872	70	14	16	50	170	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 30	2021	597	7878					688	+		10.1038/s41586-021-03890-9	http://dx.doi.org/10.1038/s41586-021-03890-9		SEP 2021	23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UZ1UN	34497416	Green Submitted			2022-12-28	WOS:000693875600005
J	Ramsden, CE; Zamora, D; Faurot, KR; MacIntosh, B; Horowitz, M; Keyes, GS; Yuan, ZX; Miller, V; Lynch, C; Honvoh, G; Park, J; Levy, R; Domenichiello, AF; Johnston, A; Majchrzak-Hong, S; Hibbeln, JR; Barrow, DA; Loewke, J; Davis, JM; Mannes, A; Palsson, OS; Suchindran, CM; Gaylord, SA; Mann, JD				Ramsden, Christopher E.; Zamora, Daisy; Faurot, Keturah R.; MacIntosh, Beth; Horowitz, Mark; Keyes, Gregory S.; Yuan, Zhi-Xin; Miller, Vanessa; Lynch, Chanee; Honvoh, Gilson; Park, Jinyoung; Levy, Russell; Domenichiello, Anthony F.; Johnston, Angela; Majchrzak-Hong, Sharon; Hibbeln, Joseph R.; Barrow, David A.; Loewke, James; Davis, John M.; Mannes, Andrew; Palsson, Olafur S.; Suchindran, Chirayath M.; Gaylord, Susan A.; Mann, J. Douglas			Dietary alteration of n-3 and n-6 fatty acids for headache reduction in adults with migraine: randomized controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LINOLEIC-ACID; SPINAL-CORD; PSYCHOMETRIC PROPERTIES; DOCOSAHEXAENOIC ACID; TARGETED ALTERATIONS; INFLAMMATORY PAIN; NEUROPATHIC PAIN; RESOLVIN D1; ACTIVATION; METABOLITES	OBJECTIVE To determine whether dietary interventions that increase n-3 fatty acids with and without reduction in n-6 linoleic acid can alter circulating lipid mediators implicated in headache pathogenesis, and decrease headache in adults with migraine. DESIGN Three arm, parallel group, randomized, modified double blind, controlled trial. SETTING Ambulatory, academic medical center in the United States over 16 weeks. PARTICIPANTS 182 participants (88% women, mean age 38 years) with migraines on 5-20 days per month (67% met criteria for chronic migraine). INTERVENTIONS Three diets designed with eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and linoleic acid altered as controlled variables: H3 diet (n=61)- increase EPA+DHA to 1.5 g/day and maintain linoleic acid at around 7% of energy; H3-L6 diet (n=61)- increase n-3 EPA+DHA to 1.5 g/day and decrease linoleic acid to <= 1.8% of energy; control diet (n=60)- maintain EPA+DHA at <150 mg/day and linoleic acid at around 7% of energy. All participants received foods accounting for two thirds of daily food energy and continued usual care. MAIN OUTCOME MEASURES The primary endpoints (week 16) were the antinociceptive mediator 17-hydroxydocosahexaenoic acid (17-HDHA) in blood and the headache impact test (HIT-6), a six item questionnaire assessing headache impact on quality of life. Headache frequency was assessed daily with an electronic diary. RESULTS In intention-to-treat analyses (n=182), the H3-L6 and H3 diets increased circulating 17-HDHA (log ng/mL) compared with the control diet (baseline adjusted mean difference 0.6, 95% confidence interval 0.2 to 0.9; 0.7, 0.4 to 1.1, respectively). The observed improvement in HIT-6 scores in the H3-L6 and H3 groups was not statistically significant (-1.6, - 4.2 to 1.0, and -1.5, -4.2 to 1.2, respectively). Compared with the control diet, the H3-L6 and H3 diets decreased total headache hours per day (-1.7, - 2.5 to -0.9, and -1.3, -2.1 to -0.5, respectively), moderate to severe headache hours per day (-0.8, - 1.2 to -0.4, and -0.7, -1.1 to -0.3, respectively), and headache days per month (-4.0, -5.2 to -2.7, and -2.0, -3.3 to -0.7, respectively). The H3-L6 diet decreased headache days per month more than the H3 diet (-2.0, -3.2 to -0.8), suggesting additional benefit from lowering dietary linoleic acid. The H3 L6 and H3 diets altered n-3 and n-6 fatty acids and several of their nociceptive oxylipin derivatives in plasma, serum, erythrocytes or immune cells, but did not alter classic headache mediators calcitonin gene related peptide and prostaglandin E2. CONCLUSIONS The H3-L6 and H3 interventions altered bioactive mediators implicated in headache pathogenesis and decreased frequency and severity of headaches, but did not significantly improve quality of life.	[Ramsden, Christopher E.; Zamora, Daisy; Horowitz, Mark; Keyes, Gregory S.; Yuan, Zhi-Xin; Domenichiello, Anthony F.] Natl Inst Aging, Lab Clin Invest, Lipid Peroxidat Unit, Baltimore, MD USA; [Ramsden, Christopher E.; Majchrzak-Hong, Sharon; Hibbeln, Joseph R.; Loewke, James] NIAAA, Intramural Program, NIH, Bethesda, MD USA; [Ramsden, Christopher E.; Faurot, Keturah R.; MacIntosh, Beth; Miller, Vanessa; Lynch, Chanee; Honvoh, Gilson; Park, Jinyoung; Johnston, Angela; Gaylord, Susan A.] Univ N Carolina, Dept Phys Med & Rehabil, UNC Sch Med, Chapel Hill, NC USA; [Zamora, Daisy; Davis, John M.] Univ N Carolina, Dept Psychiat, UNC Sch Med, Chapel Hill, NC USA; [MacIntosh, Beth] Univ N Carolina, Metab & Nutr Res Core, UNC Med Ctr, Chapel Hill, NC USA; [Honvoh, Gilson; Palsson, Olafur S.] Univ N Carolina, Dept Med, UNC Sch Med, Chapel Hill, NC USA; [Levy, Russell; Barrow, David A.] Univ N Carolina, Cytokine Anal Core, UNC Adams Sch Dent, Chapel Hill, NC USA; [Mannes, Andrew] NIH Clin Ctr, Dept Perioperat Med, Bethesda, MD USA; [Suchindran, Chirayath M.] Gillings Sch Global Publ Hlth, Dept Biostat, Chapel Hill, NC USA; [Mann, J. Douglas] Univ N Carolina, Dept Neurol, UNC Sch Med, Chapel Hill, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Ramsden, CE (corresponding author), NIA, Lipid Peroxidat Unit, Lab Clin Invest, NIH, 251 Bayview Blvd, Baltimore, MD 21224 USA.	chris.ramsden@nih.gov	Core, CHAI/AAD-5240-2022; Zamora, Daisy/ABG-5162-2021; Ramsden, Christopher/AAW-9516-2021	Horowitz, Mark/0000-0002-0061-8586; Zamora, Daisy/0000-0003-2114-5156; Mannes, Andrew/0000-0001-5834-5667; Ramsden, Christopher/0000-0002-4058-7630	National Center for Complementary and Integrative Health (NCCIH), National Institutes of Health (NIH) [1R01AT007813-01A1]; National Institute on Aging (NIA); NCCIH [T32 AT003378]; Mayday Fund; UNC Nutrition Obesity Research Center; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH; National Center for Advancing Translational Sciences (NCATS), NIH [UL1TR002489]; National Institute on Alcohol Abuse and Alcoholism; CHAI [DK056350]	National Center for Complementary and Integrative Health (NCCIH), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCCIH; Mayday Fund; UNC Nutrition Obesity Research Center; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Advancing Translational Sciences (NCATS), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); CHAI	This project was funded by grant 1R01AT007813-01A1 from the National Center for Complementary and Integrative Health (NCCIH), National Institutes of Health (NIH; main funding source). Additional support was provided by the intramural programs of the National Institute on Aging (NIA) and the National Institute on Alcohol Abuse and Alcoholism, NCCIH T32 Research Fellowship Program (T32 AT003378), the Mayday Fund, and the UNC Nutrition Obesity Research Center, CHAI Core (grant DK056350), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH. We acknowledge the database support of the NC Translational and Clinical Sciences (NC TraCS) Institute, which is supported by the National Center for Advancing Translational Sciences (NCATS), NIH, through grant UL1TR002489. The funders had no role in considering the study design or in the collection, analysis, interpretation of data, writing of the report, or decision to submit the article for publication.	Antonova M, 2012, CEPHALALGIA, V32, P822, DOI 10.1177/0333102412451360; Bang S, 2012, BRIT J PHARMACOL, V165, P683, DOI 10.1111/j.1476-5381.2011.01568.x; Bang S, 2010, BRIT J PHARMACOL, V161, P707, DOI 10.1111/j.1476-5381.2010.00909.x; Barden AE, 2016, PROSTAG LEUKOTR ESS, V107, P24, DOI 10.1016/j.plefa.2016.03.004; Blasbalg TL, 2011, AM J CLIN NUTR, V93, P950, DOI 10.3945/ajcn.110.006643; BORKOVEC TD, 1972, J BEHAV THER EXP PSY, V3, P257, DOI 10.1016/0005-7916(72)90045-6; Burch R, 2021, HEADACHE, V61, P60, DOI 10.1111/head.14024; Burch RC, 2019, NEUROL CLIN, V37, P631, DOI 10.1016/j.ncl.2019.06.001; Burch RC, 2015, HEADACHE, V55, P21, DOI 10.1111/head.12482; Caligiuri SPB, 2017, AM J PHYSIOL-HEART C, V313, pH903, DOI 10.1152/ajpheart.00201.2017; Cameron AC, 2013, REGRESSION ANAL COUN, VSecond, DOI [10.1017/ CBO9781139013567, DOI 10.1017/CBO9781139013567, 10.1017/CBO9781139013567]; Chai NC, 2014, HEADACHE, V54, P459, DOI 10.1111/head.12297; Chai NC, 2014, HEADACHE, V54, P219, DOI 10.1111/head.12296; Curtis P, 2011, J ALTERN COMPLEM MED, V17, P711, DOI 10.1089/acm.2010.0277; D'Antona L, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-1040-x; DAYTON S, 1966, J LIPID RES, V7, P103; Devilly GJ, 2000, J BEHAV THER EXP PSY, V31, P73, DOI 10.1016/S0005-7916(00)00012-4; Domenichiello AF, 2021, J PAIN, V22, P275, DOI 10.1016/j.jpain.2020.09.001; Domenichiello AF, 2020, PAIN, V161, P2775, DOI 10.1097/j.pain.0000000000001983; Doolen Suzanne, 2020, Neurobiol Pain, V7, P100046, DOI 10.1016/j.ynpai.2020.100046; Fattori V, 2019, BRIT J PHARMACOL, V176, P1728, DOI 10.1111/bph.14647; Fonseca FCS, 2017, J INFLAMM RES, V10, P119, DOI 10.2147/JIR.S142424; FUJIMOTO N, 1992, NEUROSCIENCE, V49, P591, DOI 10.1016/0306-4522(92)90229-U; Green DP, 2016, MOL PAIN, V12, DOI 10.1177/1744806916661725; Green DP, 2013, PAIN, V154, P2512, DOI 10.1016/j.pain.2013.07.040; Hargreaves KM, 2016, J DENT RES, V95, P1117, DOI 10.1177/0022034516653751; Hartung NM, 2019, PROSTAG OTH LIPID M, V141, P22, DOI 10.1016/j.prostaglandins.2019.02.006; Herd CP, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027953; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Ikeda A, 2020, BRAIN RES BULL, V154, P61, DOI 10.1016/j.brainresbull.2019.11.002; Ince H, 2014, ACTA NEUROL SCAND, V130, P188, DOI 10.1111/ane.12263; Jang Y, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-1703-1; Jo YY, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/5259321; Kawata AK, 2005, HEADACHE, V45, P638, DOI 10.1111/j.1526-4610.2005.05130.x; Klein CP, 2014, NEUROPHARMACOLOGY, V86, P57, DOI 10.1016/j.neuropharm.2014.05.043; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; LANDS WEM, 1992, BIOCHIM BIOPHYS ACTA, V1180, P147, DOI 10.1016/0925-4439(92)90063-S; LaPaglia DM, 2018, CEPHALALGIA, V38, P912, DOI 10.1177/0333102417720216; Lattanzi S, 2019, DRUGS, V79, P417, DOI 10.1007/s40265-019-01069-1; Liakh I, 2019, MOLECULES, V24, DOI 10.3390/molecules24081639; Luo X, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00745; MacIntosh BA, 2021, CLIN NUTR, V40, P3859, DOI 10.1016/j.clnu.2021.04.050; MacIntosh BA, 2013, BRIT J NUTR, V110, P559, DOI 10.1017/S0007114512005181; Mann JD, 2018, PROSTAG LEUKOTR ESS, V128, P41, DOI 10.1016/j.plefa.2017.11.002; Merikangas KR, 2013, HEADACHE, V53, P230, DOI 10.1111/head.12038; Morisseau C, 2010, J LIPID RES, V51, P3481, DOI 10.1194/jlr.M006007; Ostermann AI, 2020, PROSTAG OTH LIPID M, V146, DOI 10.1016/j.prostaglandins.2019.106384; Osthues T, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01147; Park CK, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/275126; Park CK, 2011, J NEUROSCI, V31, P18433, DOI 10.1523/JNEUROSCI.4192-11.2011; Parnes Steven M, 2002, Am J Respir Med, V1, P403; Patwardhan AM, 2010, J CLIN INVEST, V120, P1617, DOI 10.1172/JCI41678; Patwardhan AM, 2009, P NATL ACAD SCI USA, V106, P18820, DOI 10.1073/pnas.0905415106; Ramsden CE, 2019, PROSTAG LEUKOTR ESS, V150, P31, DOI 10.1016/j.plefa.2019.09.001; Ramsden CE, 2018, BBA-MOL CELL BIOL L, V1863, P1206, DOI 10.1016/j.bbalip.2018.07.007; Ramsden CE, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal5241; Ramsden CE, 2016, MOL PAIN, V12, DOI 10.1177/1744806916636386; Ramsden CE, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1246; Ramsden CE, 2015, J PAIN, V16, P707, DOI 10.1016/j.jpain.2015.04.007; Ramsden CE, 2015, PAIN, V156, P587, DOI 10.1097/01.j.pain.0000460348.84965.47; Ramsden CE, 2013, PAIN, V154, P2441, DOI 10.1016/j.pain.2013.07.028; Ramsden CE, 2012, PROSTAG LEUKOTR ESS, V87, P135, DOI 10.1016/j.plefa.2012.08.004; Ruparel S, 2013, PAIN, V154, P2363, DOI 10.1016/j.pain.2013.07.011; SASTRY PS, 1985, PROG LIPID RES, V24, P69, DOI 10.1016/0163-7827(85)90011-6; Schwedt TJ, 2021, HEADACHE, V61, P351, DOI 10.1111/head.14056; SERHAN CN, 1989, BIOCHIM BIOPHYS ACTA, V1004, P158, DOI 10.1016/0005-2760(89)90264-6; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Smelt AFH, 2014, CEPHALALGIA, V34, P29, DOI 10.1177/0333102413497599; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Taha AY, 2018, PROSTAG LEUKOTR ESS, V138, P71, DOI 10.1016/j.plefa.2016.05.004; Tepper SJ, 2019, NEUROL CLIN, V37, P727, DOI 10.1016/j.ncl.2019.07.006; Tfelt-Hansen P, 2012, CEPHALALGIA, V32, P6, DOI 10.1177/0333102411417901; Umhau JC, 2009, J LIPID RES, V50, P1259, DOI 10.1194/jlr.M800530-JLR200; Valdes AM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09516-3; Wienecke T, 2010, CEPHALALGIA, V30, P179, DOI 10.1111/j.1468-2982.2009.01923.x; Xu ZZ, 2013, ANN NEUROL, V74, P490, DOI 10.1002/ana.23928; Xu ZZ, 2013, J NEUROIMMUNE PHARM, V8, P37, DOI 10.1007/s11481-012-9394-8; Xu ZZ, 2010, NAT MED, V16, P592, DOI 10.1038/nm.2123; Yuan ZX, 2018, ANAL BIOANAL CHEM, V410, P6009, DOI 10.1007/s00216-018-1222-4; Zhang LL, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00412; Zimmer B, 2018, BBA-MOL CELL BIOL L, V1863, P669, DOI 10.1016/j.bbalip.2018.03.012	81	14	14	3	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2021	374								n1448	10.1136/bmj.n1448	http://dx.doi.org/10.1136/bmj.n1448			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TP4HV	34526307	Green Published, hybrid			2022-12-28	WOS:000677556600003
J	Huang, WJ; MacLean, AM; Sugio, A; Maqbool, A; Busscher, M; Cho, ST; Kamoun, S; Kuo, CH; Immink, RGH; Hogenhout, SA				Huang, Weijie; MacLean, Allyson M.; Sugio, Akiko; Maqbool, Abbas; Busscher, Marco; Cho, Shu-Ting; Kamoun, Sophien; Kuo, Chih-Horng; Immink, Richard G. H.; Hogenhout, Saskia A.			Parasitic modulation of host development by ubiquitin-independent protein degradation	CELL			English	Article							ASTER YELLOWS PHYTOPLASMA; HEMIPTERA CICADELLIDAE ABUNDANCE; MULTIUBIQUITIN-CHAIN-BINDING; TRANSCRIPTION FACTORS; 26S PROTEASOME; FLOWER DEVELOPMENT; DISTINCT DOMAINS; LEAFHOPPER; EFFECTOR; PLANTS	Certain obligate parasites induce complex and substantial phenotypic changes in their hosts in ways that favor their transmission to other trophic levels. However, the mechanisms underlying these changes remain largely unknown. Here we demonstrate how SAP05 protein effectors from insect-vectored plant pathogenic phytoplasmas take control of several plant developmental processes. These effectors simultaneously prolong the host lifespan and induce witches' broom-like proliferations of leaf and sterile shoots, organs colonized by phytoplasmas and vectors, SAP05 acts by mediating the concurrent degradation of SPL and GATA developmental regulators via a process that relies on hijacking the plant ubiquitin receptor RPN10 independent of substrate ubiquitination. RPN10 is highly conserved among eukaryotes, but SAP05 does not bind insect vector RPN10. A two-amino-acid substitution within plant RPN10 generates a functional variant that is resistant to SAP05 activities. Therefore, one effector protein enables obligate parasitic phytoplasmas to induce a plethora of developmental phenotypes in their hosts.	[Huang, Weijie; MacLean, Allyson M.; Sugio, Akiko; Hogenhout, Saskia A.] John Innes Ctr, Dept Crop Genet, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Maqbool, Abbas; Kamoun, Sophien] Univ East Anglia, Sainsbury Lab, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Busscher, Marco; Immink, Richard G. H.] Wageningen Univ & Res, Lab Mol Biol, NL-6708 PB Wageningen, Netherlands; [Busscher, Marco; Immink, Richard G. H.] Wageningen Univ & Res, Biosci, Plant Dev Syst, NL-6708 PB Wageningen, Netherlands; [Cho, Shu-Ting; Kuo, Chih-Horng] Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan; [MacLean, Allyson M.] Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada; [Sugio, Akiko] INRAE, Inst Genet Environm & Plant Protect, F-35650 Le Rheu, France	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia; Wageningen University & Research; Wageningen University & Research; Academia Sinica - Taiwan; University of Ottawa; INRAE	Hogenhout, SA (corresponding author), John Innes Ctr, Dept Crop Genet, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	saskia.hogenhout@jic.ac.uk	Maqbool, Abbas/ABF-8279-2021; Kuo, Chih-Horng/E-2045-2013; Hogenhout, Saskia A/D-9266-2012; Kamoun, Sophien/B-3529-2009; Maqbool, Abbas/G-3191-2016	Kuo, Chih-Horng/0000-0002-2857-0529; Hogenhout, Saskia A/0000-0003-1371-5606; Kamoun, Sophien/0000-0002-0290-0315; MacLean, Allyson/0000-0001-8583-2276; Sugio, Akiko/0000-0002-0970-144X; Huang, Weijie/0000-0001-5208-6713; Maqbool, Abbas/0000-0002-6189-5560; Cho, Shu-Ting/0000-0003-2140-5165	Human Frontier Science Program [RGP0024/2015]; Marie Curie International Incoming Fellowship FP7-PEOPLE-2010-IIF grant [274444]; Biotechnology and Biological Sciences Research Council [BBS/E/J/000PR9797]; John Innes Foundation; Academia Sinica	Human Frontier Science Program(Human Frontier Science Program); Marie Curie International Incoming Fellowship FP7-PEOPLE-2010-IIF grant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Foundation; Academia Sinica(Academia Sinica - Taiwan)	We thank Xiaolan Zhang (China Agricultural University, Beijing) for the han-2 and han-2 p35S::CsHAN1 seeds and Claus Schwechheimer (Technical University of Munich) for gnc gnl gata17 gata17l and p35S::GNC seeds. We are grateful to the John Innes Centre (JIC) Horticultural Services for growing plants, the JIC Entomology Facility for rearing leafhopper and phytoplasma stocks, and JIC Photographic Services for imaging experimental materials. We thank Juan Carlos De la Concepcion and Yasin Dagdas (Gregor Mendel Institute, Vienna, Austria) and Susanne Kandolf (Research Institute of Molecular Pathology, Vienna, Austria) for assistance with proteasome degradation assays. We gratefully acknowledge summer student Luke Sherwin for technical support. The project was supported by Human Frontier Science Program RGP0024/2015 (to S.A.H. and R.G.H.I.) and Marie Curie International Incoming Fellowship FP7-PEOPLE-2010-IIF grant agreement 274444 (to A.M.M.). Additional support was received from Biotechnology and Biological Sciences Research Council grants BBS/E/J/000PR9797 (to S.A.H.); the John Innes Foundation (to S.A.H.); and Academia Sinica intramural funding (to C.K.).	Al-Subhi AM, 2021, PLANT DIS, V105, P2637, DOI 10.1094/PDIS-10-20-2112-RE; Amerik AY, 1997, EMBO J, V16, P4826; Arashida R, 2008, PHYTOPATHOLOGY, V98, P769, DOI 10.1094/PHYTO-98-7-0769; Bai XD, 2006, J BACTERIOL, V188, P3682, DOI 10.1128/JB.188.10.3682-3696.2006; Bai XD, 2009, MOL PLANT MICROBE IN, V22, P18, DOI 10.1094/MPMI-22-1-0018; Beanland L, 2000, ANN ENTOMOL SOC AM, V93, P271, DOI 10.1603/0013-8746(2000)093[0271:IOAYPO]2.0.CO;2; Behringer C, 2014, PLANT PHYSIOL, V166, P293, DOI 10.1104/pp.114.246660; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; CABI, 2018, INVASIVE SPECIES COM; Chamberlain PP, 2019, NAT CHEM BIOL, V15, P937, DOI 10.1038/s41589-019-0362-y; Chang SH, 2018, J EXP BOT, V69, P5389, DOI 10.1093/jxb/ery318; Chen KL, 2019, ANNU REV PLANT BIOL, V70, P667, DOI 10.1146/annurev-arplant-050718-100049; Chung WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062770; Dawkins R., 1982, pi; de Folter S, 2011, METHODS MOL BIOL, V754, P145, DOI 10.1007/978-1-61779-154-3_8; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Ding L, 2015, J EXP BOT, V66, P7075, DOI 10.1093/jxb/erv409; DOI Y., 1967, Annals of the Phytopathological Society of Japan, V33, P259; Drurey C., 2019, CHEMOSENSORY PROTEIN, DOI [10.1101/173278, DOI 10.1101/173278]; Du Toit A, 2014, NAT REV MICROBIOL, V12, P393, DOI 10.1038/nrmicro3283; EPPO, 2021, EPPO GLOB DAT; Farmer LM, 2010, PLANT CELL, V22, P124, DOI 10.1105/tpc.109.072660; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Frost KE, 2013, ENVIRON ENTOMOL, V42, P491, DOI 10.1603/EN12240; Frost KE, 2013, ENVIRON ENTOMOL, V42, P477, DOI 10.1603/EN12239; Fu HY, 1998, J BIOL CHEM, V273, P1970, DOI 10.1074/jbc.273.4.1970; Herbison R, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2805-9; Hipp MS, 2005, MOL CELL BIOL, V25, P3483, DOI 10.1128/MCB.25.9.3483-3491.2005; Hogenhout SA, 2008, MOL PLANT PATHOL, V9, P403, DOI 10.1111/J.1364-3703.2008.00472.X; Hoshi A, 2009, P NATL ACAD SCI USA, V106, P6416, DOI 10.1073/pnas.0813038106; Huang WJ, 2020, MOL PLANT, V13, P1379, DOI 10.1016/j.molp.2020.08.010; Hudson D, 2013, PLANT PHYSIOL, V162, P132, DOI 10.1104/pp.113.217265; Hughes DP, 2019, CURR BIOL, V29, pR45, DOI 10.1016/j.cub.2018.12.001; Huijser P, 2011, DEVELOPMENT, V138, P4117, DOI 10.1242/dev.063511; Iwabuchi N, 2020, MOL PLANT PATHOL, V21, P1322, DOI 10.1111/mpp.12981; Ji CH, 2017, MOL CELLS, V40, P441, DOI 10.14348/molcells.2017.0115; Johnson HJ, 2020, MBIO, V11, DOI 10.1128/mBio.02164-19; Johnson PTJ, 1999, SCIENCE, V284, P802, DOI 10.1126/science.284.5415.802; Kitazawa Y, 2017, J EXP BOT, V68, P2799, DOI 10.1093/jxb/erx158; Le Fevre R, 2015, ANNU REV CELL DEV BI, V31, P201, DOI 10.1146/annurev-cellbio-102314-112502; Lee IM, 2000, ANNU REV MICROBIOL, V54, P221, DOI 10.1146/annurev.micro.54.1.221; Lin YL, 2011, PLANT CELL, V23, P2754, DOI 10.1105/tpc.111.086702; Lu YT, 2014, PLANT PHYSIOL, V164, P1456, DOI 10.1104/pp.113.229740; MacLean AM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001835; MacLean AM, 2011, PLANT PHYSIOL, V157, P831, DOI 10.1104/pp.111.181586; Maejima K, 2014, PLANT J, V78, P541, DOI 10.1111/tpj.12495; Malembic-Maher S, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1007967; Marshall RS, 2015, MOL CELL, V58, P1053, DOI 10.1016/j.molcel.2015.04.023; Mathieu J, 2007, CURR BIOL, V17, P1055, DOI 10.1016/j.cub.2007.05.009; Musetti R, 2013, MOL PLANT MICROBE IN, V26, P379, DOI 10.1094/MPMI-08-12-0207-R; NAULT LR, 1990, MAYDICA, V35, P165; Orlovskis Z, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00885; Oshima K, 2004, NAT GENET, V36, P27, DOI 10.1038/ng1277; Pecher P, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1008035; Pruneda-Paz JL, 2014, CELL REP, V8, P621, DOI 10.1016/j.celrep.2014.06.033; Ranftl QL, 2016, PLANT PHYSIOL, V170, P2295, DOI 10.1104/pp.15.01556; Rani N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1752; Richter R, 2013, PLANT PHYSIOL, V162, P1992, DOI 10.1104/pp.113.219238; Richter R, 2010, GENE DEV, V24, P2093, DOI 10.1101/gad.594910; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Rumpler F, 2015, TRENDS PLANT SCI, V20, P798, DOI 10.1016/j.tplants.2015.08.004; Schapira M, 2019, NAT REV DRUG DISCOV, V18, P949, DOI 10.1038/s41573-019-0047-y; Schmidtke G, 2014, BBA-MOL CELL RES, V1843, P97, DOI 10.1016/j.bbamcr.2013.01.009; Smalle J, 2003, PLANT CELL, V15, P965, DOI 10.1105/tpc.009217; Sugio A, 2011, P NATL ACAD SCI USA, V108, pE1254, DOI 10.1073/pnas.1105664108; Sugio A, 2014, NEW PHYTOL, V202, P838, DOI 10.1111/nph.12721; Sugio A, 2011, ANNU REV PHYTOPATHOL, V49, P175, DOI 10.1146/annurev-phyto-072910-095323; Tan CM, 2016, J EXP BOT, V67, P4415, DOI 10.1093/jxb/erw225; The International Research Programme for Comparative Mycoplasmology Phytoplasma/Spiroplasma Working Team - Phytoplasma Taxonomy Group, 2004, International Journal of Systematic and Evolutionary Microbiology, V54, P1243, DOI 10.1099/ijs.0.02854-0; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang N, 2018, MOL PLANT PATHOL, V19, P2623, DOI 10.1111/mpp.12733; Weintraub PG, 2006, ANNU REV ENTOMOL, V51, P91, DOI 10.1146/annurev.ento.51.110104.151039; Xu ML, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006263; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang JH, 2004, PHYTOPATHOLOGY, V94, P842, DOI 10.1094/PHYTO.2004.94.8.842; Zhang XL, 2013, PLANT CELL, V25, P83, DOI 10.1105/tpc.112.107854	77	24	24	20	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 30	2021	184	20					5201	+		10.1016/j.cell.2021.08.029	http://dx.doi.org/10.1016/j.cell.2021.08.029		OCT 2021	26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	WC7PG	34536345	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000704445700015
J	Huang, WX; Johnston-Peck, AC; Wolter, T; Yang, WCD; Xu, L; Oh, J; Reeves, BA; Zhou, CS; Holtz, ME; Herzing, AA; Lindenberg, AM; Mavrikakis, M; Cargnello, M				Huang, Weixin; Johnston-Peck, Aaron C.; Wolter, Trenton; Yang, Wei-Chang D.; Xu, Lang; Oh, Jinwon; Reeves, Benjamin A.; Zhou, Chengshuang; Holtz, Megan E.; Herzing, Andrew A.; Lindenberg, Aaron M.; Mavrikakis, Manos; Cargnello, Matteo			Steam-created grain boundaries for methane C-H activation in palladium catalysts	SCIENCE			English	Article							TOTAL-ENERGY CALCULATIONS; IN-SITU TEM; CO2 ELECTROREDUCTION; SURFACE; OXIDATION; NANOCRYSTALS; REDUCTION; OXYGEN; NANOPARTICLES; EFFICIENCY	Defects may display high reactivity because the specific arrangement of atoms differs from crystalline surfaces. We demonstrate that high-temperature steam pretreatment of palladium catalysts provides a 12-fold increase in the mass-specific reaction rate for carbon-hydrogen (C-H) activation in methane oxidation compared with conventional pretreatments. Through a combination of experimental and theoretical methods, we demonstrate that an increase in the grain boundary density through crystal twinning is achieved during the steam pretreatment and oxidation and is responsible for the increased reactivity. The grain boundaries are highly stable during reaction and show specific rates at least two orders of magnitude higher than other sites on the palladium on alumina (Pd/Al2O3) catalysts. Theoretical calculations show that strain introduced by the defective structure can enhance C-H bond activation. Introduction of grain boundaries through laser ablation led to further rate increases.	[Huang, Weixin; Reeves, Benjamin A.; Zhou, Chengshuang; Cargnello, Matteo] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Johnston-Peck, Aaron C.; Holtz, Megan E.; Herzing, Andrew A.] NIST, Mat Measurement Lab, Gaithersburg, MD 20899 USA; [Wolter, Trenton; Xu, Lang; Mavrikakis, Manos] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA; [Yang, Wei-Chang D.] NIST, Phys Measurement Lab, Gaithersburg, MD 20899 USA; [Oh, Jinwon; Lindenberg, Aaron M.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA; [Lindenberg, Aaron M.] SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA; [Cargnello, Matteo] SLAC Natl Accelerator Lab, SUNCAT Ctr Interface Sci & Catalysis, Menlo Pk, CA 94025 USA	Stanford University; National Institute of Standards & Technology (NIST) - USA; University of Wisconsin System; University of Wisconsin Madison; National Institute of Standards & Technology (NIST) - USA; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Cargnello, M (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.; Cargnello, M (corresponding author), SLAC Natl Accelerator Lab, SUNCAT Ctr Interface Sci & Catalysis, Menlo Pk, CA 94025 USA.	mcargnello@stanford.edu	Xu, Lang/E-7231-2016; Xu, Lang/ABA-5006-2021; Mavrikakis, Manos/D-5702-2012	Xu, Lang/0000-0001-5959-8797; Xu, Lang/0000-0001-5959-8797; Mavrikakis, Manos/0000-0002-5293-5356; Cargnello, Matteo/0000-0002-7344-9031; Huang, Weixin/0000-0003-1456-4387; Wolter, Trenton/0000-0002-5194-359X; Oh, Jinwon/0000-0001-5162-0953; Herzing, Andrew/0000-0001-5944-2610; Yang, Wei-Chang/0000-0002-7481-7916; Zhou, Chengshuang/0000-0001-5489-6904	Stanford Natural Gas Initiative; US Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences [DE-FG0205ER15731]; National Science Foundation [ECCS-1542152, 1956300]; HydroGEN Advanced Water Splitting Consortium, as part of the Energy Materials Network under the US Department of Energy, Office of Energy Efficiency and Renewable Energy, Hydrogen and Fuel Cell Technologies Office [DE-EE-0008084]; National Energy Research Scientific Computing Center (NERSC), a DOE Office of Science User Facility at Lawrence Berkeley National Laboratory [DEAC02-05CH11231]; DOE [DE-AC02-06CH11357]; US Department of Energy, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division [DE-AC02-76SF00515]	Stanford Natural Gas Initiative; US Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); HydroGEN Advanced Water Splitting Consortium, as part of the Energy Materials Network under the US Department of Energy, Office of Energy Efficiency and Renewable Energy, Hydrogen and Fuel Cell Technologies Office; National Energy Research Scientific Computing Center (NERSC), a DOE Office of Science User Facility at Lawrence Berkeley National Laboratory; DOE(United States Department of Energy (DOE)); US Department of Energy, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE))	funding was provided by the Stanford Natural Gas Initiative. T.W., L.X., and M. M. acknowledge support for the computational modeling work by the US Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences (grant DE-FG0205ER15731). J.O. was supported by the National Science Foundation under grant 1956300. B.A.R. was supported by the HydroGEN Advanced Water Splitting Consortium, established as part of the Energy Materials Network under the US Department of Energy, Office of Energy Efficiency and Renewable Energy, Hydrogen and Fuel Cell Technologies Office, under award DE-EE-0008084. Part of the experimental work was performed at the Stanford Nano Shared Facilities (SNSF), supported by the National Science Foundation under award ECCS-1542152. The computational work was performed in part by using supercomputing resources from the National Energy Research Scientific Computing Center (NERSC), a DOE Office of Science User Facility located at Lawrence Berkeley National Laboratory and operated under contract DEAC02-05CH11231, and from the Center for Nanoscale Materials, a DOE Office of Science User Facility located at Argonne National Laboratory, supported by DOE contract DE-AC02-06CH11357. A.M.L. acknowledges support from the US Department of Energy, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division, under contract DE-AC02-76SF00515.	Avanesian T, 2017, J AM CHEM SOC, V139, P4551, DOI 10.1021/jacs.7b01081; Bengtsson L, 1999, PHYS REV B, V59, P12301, DOI 10.1103/PhysRevB.59.12301; Cargnello M, 2015, J AM CHEM SOC, V137, P6906, DOI 10.1021/jacs.5b03333; Chin YH, 2013, J AM CHEM SOC, V135, P15425, DOI 10.1021/ja405004m; Ciuparu D, 2002, CATAL REV, V44, P593, DOI 10.1081/CR-120015482; Crozier PA, 2015, MRS BULL, V40, P38, DOI 10.1557/mrs.2014.304; de la Penria F., 2019, Hyperspy/Hyperspy: HyperSpy v1.5.2, DOI 10.5281/ ZENODO.3396791; Demoulin O, 2005, J PHYS CHEM B, V109, P20454, DOI 10.1021/jp051874g; Feng XF, 2015, J AM CHEM SOC, V137, P4606, DOI 10.1021/ja5130513; Garcia R. E., 2014, Equilibrium Wulff Shape Generator, DOI 10.4231/D3C53F234; Gholami R, 2015, CATALYSTS, V5, P561, DOI 10.3390/catal5020561; Gilroy KD, 2017, NANO LETT, V17, P3655, DOI 10.1021/acs.nanolett.7b00844; Granados ML, 2006, J CATAL, V239, P410, DOI 10.1016/j.jcat.2006.02.007; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Hammer B, 2006, TOP CATAL, V37, P3, DOI 10.1007/s11244-006-0004-y; Han JY, 2006, SURF SCI, V600, P2752, DOI 10.1016/j.susc.2006.04.042; Haynes W.M., 2014, CRC HDB CHEM PHYS, V95th ed.; Henkelman G, 2000, J CHEM PHYS, V113, P9901, DOI 10.1063/1.1329672; Kan HH, 2009, SURF SCI, V603, P2671, DOI 10.1016/j.susc.2009.06.023; Kilaas R, 1998, J MICROSC-OXFORD, V190, P45, DOI 10.1046/j.1365-2818.1998.3070861.x; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Li CW, 2014, NATURE, V508, P504, DOI 10.1038/nature13249; Li YF, 2017, NANO LETT, V17, P1312, DOI 10.1021/acs.nanolett.6b05287; Li Z, 2019, NAT CATAL, V2, P1107, DOI 10.1038/s41929-019-0365-9; MACKAY AL, 1962, ACTA CRYSTALLOGR, V15, P916, DOI 10.1107/S0365110X6200239X; Mariano RG, 2017, SCIENCE, V358, P1187, DOI 10.1126/science.aao3691; Marks LD, 1996, ULTRAMICROSCOPY, V62, P43, DOI 10.1016/0304-3991(95)00085-2; Martin NM, 2014, ACS CATAL, V4, P3330, DOI 10.1021/cs5010163; Mavrikakis M, 1998, PHYS REV LETT, V81, P2819, DOI 10.1103/PhysRevLett.81.2819; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.16.1746; Montini T, 2016, CHEM REV, V116, P5987, DOI 10.1021/acs.chemrev.5b00603; NEUGEBAUER J, 1992, PHYS REV B, V46, P16067, DOI 10.1103/PhysRevB.46.16067; Nie L, 2017, SCIENCE, V358, P1419, DOI 10.1126/science.aao2109; NIU CM, 1990, J SOLID STATE CHEM, V86, P175, DOI 10.1016/0022-4596(90)90132-H; Nolte P, 2008, SCIENCE, V321, P1654, DOI 10.1126/science.1160845; Padgett E, 2020, ULTRAMICROSCOPY, V214, DOI 10.1016/j.ultramic.2020.112994; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Pingel TN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05055-1; Rogal J, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.075421; Roosen AR, 1998, COMP MATER SCI, V11, P16, DOI 10.1016/S0927-0256(97)00167-5; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Schaffer B, 2015, DIGITAL MICROGRAPH S; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sharma PP, 2015, ANGEW CHEM INT EDIT, V54, P13701, DOI 10.1002/anie.201506062; Sharma R, 2005, J MATER RES, V20, P1695, DOI 10.1557/JMR.2005.0241; Tang C, 2020, ACS CATAL, V10, P2026, DOI 10.1021/acscatal.9b03814; Tao FF, 2016, NANO LETT, V16, P5001, DOI 10.1021/acs.nanolett.6b01718; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Tian N, 2007, SCIENCE, V316, P732, DOI 10.1126/science.1140484; Wang L, 2019, SCIENCE, V363, P870, DOI 10.1126/science.aat8051; Willis JJ, 2017, J AM CHEM SOC, V139, P11989, DOI 10.1021/jacs.7b06260; Zhang DJ, 2017, NANOSCALE, V9, P6327, DOI 10.1039/c6nr08763a; Zhao M, 2018, ACS CATAL, V8, P6948, DOI 10.1021/acscatal.8b00910	55	32	31	56	191	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2021	373	6562			SI		1518	+		10.1126/science.abj5291	http://dx.doi.org/10.1126/science.abj5291			61	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU7LJ	34554810	Green Submitted			2022-12-28	WOS:000698977800052
J	Matthiesen, MI; Shailam, R; Rothermel, H				Matthiesen, Madeleine, I; Shailam, Randheer; Rothermel, Holly			Case 29-2021: A 12-Month-Old Boy with Fever and Developmental Regression	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							JUVENILE IDIOPATHIC ARTHRITIS; CLASSIFICATION	A Boy with Fever and Developmental Regression A 12-month-old boy with Hirschsprung's disease was admitted with fever, generalized weakness, intermittent diffuse rash, and regression of crawling. He had leukocytosis, thrombocytosis, and an elevated erythrocyte sedimentation rate. CT of the abdomen showed diffuse lymphadenopathy. A diagnostic test was performed.	[Matthiesen, Madeleine, I] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Boston, MA 02115 USA; [Matthiesen, Madeleine, I; Rothermel, Holly] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02115 USA; [Shailam, Randheer] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02115 USA; [Matthiesen, Madeleine, I] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Matthiesen, Madeleine, I; Rothermel, Holly] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Shailam, Randheer] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Matthiesen, MI (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Boston, MA 02115 USA.; Matthiesen, MI (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02115 USA.; Matthiesen, MI (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; Matthiesen, MI (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.							[Anonymous], 2020, CDC HLTH AL NETW; Antoon James W, 2018, Hosp Pediatr, V8, P135, DOI 10.1542/hpeds.2017-0098; Antoon JW, 2015, PEDIATR REV, V36, P380, DOI 10.1542/pir.36-9-380; Behrens EM, 2008, J RHEUMATOL, V35, P343; Brunner HI, 2020, ARTHRITIS RHEUMATOL, V72, P2147, DOI 10.1002/art.41436; Clarke RT, 2016, ARCH DIS CHILD, V101, P894, DOI 10.1136/archdischild-2016-311251; De Benedetti F, 2012, NEW ENGL J MED, V367, P2385, DOI 10.1056/NEJMoa1112802; deBenedetti F, 2016, TXB PEDIAT RHEUMATOL, P205; Dewitt EM, 2012, ARTHRIT CARE RES, V64, P1001, DOI 10.1002/acr.21625; Dufort EM, 2020, NEW ENGL J MED, V383, P347, DOI 10.1056/NEJMoa2021756; Giancane G, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00467; Gosain A, 2017, PEDIATR SURG INT, V33, P517, DOI 10.1007/s00383-017-4065-8; Gosain A, 2015, CURR OPIN PEDIATR, V27, P364, DOI 10.1097/MOP.0000000000000210; Gurion R, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/271569; Jiang L, 2020, LANCET INFECT DIS, V20, pE276, DOI 10.1016/S1473-3099(20)30651-4; Kessel C, 2020, ARTHRITIS RHEUMATOL, V72, P210, DOI 10.1002/art.41107; Martini A, 2012, AUTOIMMUN REV, V12, P56, DOI 10.1016/j.autrev.2012.07.022; Martini A, 2012, ANN RHEUM DIS, V71, P1437, DOI 10.1136/annrheumdis-2012-201388; Nigrovic PA, 2014, ARTHRITIS RHEUMATOL, V66, P1405, DOI 10.1002/art.38615; Nigrovic PA, 2011, ARTHRITIS RHEUM-US, V63, P545, DOI 10.1002/art.30128; Norman GR, 2017, ACAD MED, V92, P23, DOI 10.1097/ACM.0000000000001421; Oen KG., 2016, TXB PEDIAT RHEUMATOL, P217; Payne AB, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.16420; Petty RE, 2004, J RHEUMATOL, V31, P390; Ravelli A, 2016, ANN RHEUM DIS, V75, P481, DOI 10.1136/annrheumdis-2015-208982; Ringold S, 2013, ARTHRIT CARE RES, V65, P1551, DOI 10.1002/acr.22087; Szymanski AM, 2020, WORLD J PEDIATR, V16, P177, DOI 10.1007/s12519-019-00237-3; Vastert SJ, 2014, ARTHRITIS RHEUMATOL, V66, P1034, DOI 10.1002/art.38296	28	0	0	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2021	385	13					1220	1229		10.1056/NEJMcpc2107346	http://dx.doi.org/10.1056/NEJMcpc2107346			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UT0EM	34551232				2022-12-28	WOS:000697798600016
J	Pilishvili, T; Gierke, R; Fleming-Dutra, KE; Farrar, JL; Mohr, NM; Talan, DA; Krishnadasan, A; Harland, KK; Smithline, HA; Hou, PC; Lee, LC; Lim, SC; Moran, GJ; Krebs, E; Steele, MT; Beiser, DG; Faine, B; Haran, JP; Nandi, U; Schrading, WA; Chinnock, B; Henning, DJ; Lovecchio, F; Lee, J; Barter, D; Brackney, M; Fridkin, SK; Marceaux-Galli, K; Lim, S; Phipps, EC; Dumyati, G; Pierce, R; Markus, TM; Anderson, DJ; Debes, AK; Lin, MY; Mayer, J; Kwon, JH; Safdar, N; Fischer, M; Singleton, R; Chea, N; Magill, SS; Verani, JR; Schrag, SJ				Pilishvili, T.; Gierke, R.; Fleming-Dutra, K. E.; Farrar, J. L.; Mohr, N. M.; Talan, D. A.; Krishnadasan, A.; Harland, K. K.; Smithline, H. A.; Hou, P. C.; Lee, L. C.; Lim, S. C.; Moran, G. J.; Krebs, E.; Steele, M. T.; Beiser, D. G.; Faine, B.; Haran, J. P.; Nandi, U.; Schrading, W. A.; Chinnock, B.; Henning, D. J.; Lovecchio, F.; Lee, J.; Barter, D.; Brackney, M.; Fridkin, S. K.; Marceaux-Galli, K.; Lim, S.; Phipps, E. C.; Dumyati, G.; Pierce, R.; Markus, T. M.; Anderson, D. J.; Debes, A. K.; Lin, M. Y.; Mayer, J.; Kwon, J. H.; Safdar, N.; Fischer, M.; Singleton, R.; Chea, N.; Magill, S. S.; Verani, J. R.; Schrag, S. J.		Vaccine Effectiveness Healthcare P	Effectiveness of mRNA Covid-19 Vaccine among US Health Care Personnel	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES; INTERIM RECOMMENDATION; SARS-COV-2 INFECTION; ADVISORY-COMMITTEE; BNT162B2; WORKERS	BACKGROUND The prioritization of U.S. health care personnel for early receipt of messenger RNA (mRNA) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), allowed for the evaluation of the effectiveness of these new vaccines in a real-world setting. METHODS We conducted a test-negative case-control study involving health care personnel across 25 U.S. states. Cases were defined on the basis of a positive polymerase-chain-reaction (PCR) or antigen-based test for SARS-CoV-2 and at least one Covid-19-like symptom. Controls were defined on the basis of a negative PCR test for SARS-CoV-2, regardless of symptoms, and were matched to cases according to the week of the test date and site. Using conditional logistic regression with adjustment for age, race and ethnic group, underlying conditions, and exposures to persons with Covid-19, we estimated vaccine effectiveness for partial vaccination (assessed 14 days after receipt of the first dose through 6 days after receipt of the second dose) and complete vaccination (assessed >= 7 days after receipt of the second dose). RESULTS The study included 1482 case participants and 3449 control participants. Vaccine effectiveness for partial vaccination was 77.6% (95% confidence interval [CI], 70.9 to 82.7) with the BNT162b2 vaccine (Pfizer-BioNTech) and 88.9% (95% CI, 78.7 to 94.2) with the mRNA-1273 vaccine (Moderna); for complete vaccination, vaccine effectiveness was 88.8% (95% CI, 84.6 to 91.8) and 96.3% (95% CI, 91.3 to 98.4), respectively. Vaccine effectiveness was similar in subgroups defined according to age (<50 years or >= 50 years), race and ethnic group, presence of underlying conditions, and level of patient contact. Estimates of vaccine effectiveness were lower during weeks 9 through 14 than during weeks 3 through 8 after receipt of the second dose, but confidence intervals overlapped widely. CONCLUSIONS The BNT162b2 and mRNA-1273 vaccines were highly effective under real-world conditions in preventing symptomatic Covid-19 in health care personnel, including those at risk for severe Covid-19 and those in racial and ethnic groups that have been disproportionately affected by the pandemic.	[Pilishvili, T.; Gierke, R.; Fleming-Dutra, K. E.; Farrar, J. L.; Fischer, M.; Chea, N.; Magill, S. S.; Verani, J. R.; Schrag, S. J.] Ctr Dis Control & Prevent, Covid 19 Response Team, Atlanta, GA 30333 USA; [Fridkin, S. K.] Georgia Emerging Infect Program, Atlanta, GA USA; [Fridkin, S. K.] Emory Univ, Sch Med, Atlanta, GA USA; [Mohr, N. M.; Talan, D. A.; Harland, K. K.; Faine, B.] Univ Iowa, Iowa City, IA USA; [Talan, D. A.; Krishnadasan, A.; Moran, G. J.] Olive View, Los Angeles, CA USA; [Talan, D. A.; Krishnadasan, A.; Moran, G. J.] Univ Calif Los Angeles, Ronald Reagan Med Ctr, Los Angeles, CA USA; [Chinnock, B.] Univ Calif San Francisco, Fresno, CA USA; [Lee, J.] Calif Emerging Infect Program, Oakland, CA USA; [Smithline, H. A.] Baystate Med Ctr, Springfield, MA USA; [Hou, P. C.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Haran, J. P.] Univ Massachusetts, Med Ctr, Worcester, MA USA; [Lee, L. C.] Jackson Mem Hosp, Miami, FL 33136 USA; [Lim, S. C.] Louisiana State Univ, Univ Med Ctr, New Orleans, LA USA; [Krebs, E.] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA; [Steele, M. T.] Univ Missouri, Truman Med Ctr, Sch Med, Kansas City, MO USA; [Beiser, D. G.] Univ Chicago, Chicago, IL 60637 USA; [Lin, M. Y.] Rush Univ, Med Ctr, Dept Med, Chicago, IL 60612 USA; [Nandi, U.] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; [Schrading, W. A.] Univ Alabama Birmingham, Birmingham, AL USA; [Henning, D. J.] Univ Washington, Seattle, WA 98195 USA; [Lovecchio, F.] Arizona State Univ, Valleywise Hlth Med Ctr, Phoenix, AZ USA; [Barter, D.] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Brackney, M.] Connecticut Emerging Infect Program, New Haven, CT USA; [Brackney, M.] Yale Sch Publ Hlth, New Haven, CT USA; [Marceaux-Galli, K.] Maryland Dept Hlth, Baltimore, MD USA; [Debes, A. K.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Lim, S.] Minnesota Dept Hlth, Minnesota Emerging Infect Program, St Paul, MN USA; [Phipps, E. C.] Univ New Mexico, Albuquerque, NM 87131 USA; [Phipps, E. C.] New Mexico Emerging Infect Program, Santa Fe, NM USA; [Dumyati, G.] Univ Rochester, Med Ctr, Rochester, MN USA; [Dumyati, G.] New York State Rochester Emerging Infect Program, Rochester, MN USA; [Pierce, R.] Oregon Hlth Author, Publ Hlth Div, Portland, OR USA; [Markus, T. M.] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Anderson, D. J.] Duke Univ, Duke Ctr Antimicrobial Stewardship & Infect Preve, Sch Med, Durham, NC USA; [Mayer, J.] Univ Utah Vet Affairs Salt Lake City Hlth Care Sy, Salt Lake City, UT USA; [Kwon, J. H.] Washington Univ, Div Infect Dis, Sch Med, St Louis, MO 63130 USA; [Safdar, N.] Univ Wisconsin, Madison, WI 53706 USA; [Safdar, N.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA; [Singleton, R.] Alaska Nat Tribal Hlth Consortium, Anchorage, AK USA	Centers for Disease Control & Prevention - USA; Emory University; University of Iowa; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Ronald Reagan UCLA Medical Center; University of California System; University of California San Francisco; University of California San Francisco at Fresno; California Emerging Infections Program; Baystate Medical Center; Harvard University; Brigham & Women's Hospital; University of Massachusetts System; University of Massachusetts Worcester; Louisiana State University System; Jefferson University; University of Missouri System; University of Missouri Kansas City; University of Chicago; Rush University; University of Mississippi; University of Mississippi Medical Center; University of Alabama System; University of Alabama Birmingham; University of Washington; University of Washington Seattle; Arizona State University; Arizona State University-Downtown Phoenix; Colorado Department of Public Health & Environment; Yale University; Johns Hopkins University; Minnesota Department of Health (MHD); University of New Mexico; University of Rochester; Vanderbilt University; Duke University; Washington University (WUSTL); University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; Alaska Native Tribal Health Consortium	Pilishvili, T (corresponding author), Ctr Dis Control & Prevent, Covid 19 Response Team, Atlanta, GA 30333 USA.	tdp4@cdc.gov	Kwon, Jennie/ABD-1475-2021; Mohr, Nicholas/N-1112-2017	Mohr, Nicholas/0000-0003-0497-5828; Beiser, David/0000-0001-9676-087X; Krebs, Elizabeth/0000-0003-4905-9700; Faine, Brett/0000-0002-5759-9857	CDC; Emerging Infections Program; cooperative agreement (Project PREVENT); EMERGEncy ID NET; Denali Commission; SHEPheRD	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Emerging Infections Program; cooperative agreement (Project PREVENT); EMERGEncy ID NET; Denali Commission; SHEPheRD	Supported by the CDC through agreements or contracts with the following partners: a cooperative agreement with the Emerging Infections Program (www.-cdc.-gov/-ncezid/-dpei/-eip/-index.-html), a cooperative agreement (Project PREVENT) with EMERGEncy ID NET (www.-emergencyidnet.-org), an interagency agreement with the Denali Commission, and contracts with SHEPheRD (www.-cdc.-gov/-hai/-research/-safehealthcare.-html).	Abu-Raddad LJ, 2021, NEW ENGL J MED, V385, P187, DOI 10.1056/NEJMc2104974; Amit S, 2021, LANCET, V397, P875, DOI 10.1016/S0140-6736(21)00448-7; Angel Y, 2021, JAMA-J AM MED ASSOC, V325, P2457, DOI 10.1001/jama.2021.7152; [Anonymous], 2021, MON EARL IMP EFF COV; Azamgarhi T, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23927-x; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Bouton Tara C, 2021, medRxiv, DOI 10.1101/2021.03.30.21254655; Centers for Disease Control and Prevention, 2021, UND MED COND ASS HIG; Centers for Disease Control and Prevention, 2020, COVID 19 INT INF PRE; Centers for Disease Control and Prevention, 2021, SYMPT COVID 19; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; Dooling K, 2021, MMWR-MORBID MORTAL W, V69, P1657, DOI 10.15585/mmwr.mm695152e2; Dooling K, 2020, MMWR-MORBID MORTAL W, V69, P1857, DOI [10.15585/mmwr.mm6949e1, 10.15585/mmwr.mm695152e2]; Fabiani M, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.17.2100420; Food and Drug Administration, 2021, FDA APPR 1 COVID 19; Food and Drug Administration, 2020, PFIZ BIONTECH COVID; Food and Drug Administration, 2020, BAHRAIN APPROVES EME; Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3; Goldberg Y., 2021, PROTECTION PREVIOUS, DOI [10.1101/2021.04.20.21255670v1, DOI 10.1101/2021.04.20.21255670V1]; Hall VJ, 2021, LANCET, V397, P1725, DOI 10.1016/S0140-6736(21)00790-X; Havlin J, 2021, J HEART LUNG TRANSPL, V40, P754, DOI 10.1016/j.healun.2021.05.004; Kirzinger A., 2021, KAISER FAMILY FDN WA; Kriss JL, 2021, MMWR-MORBID MORTAL W, V70, P389, DOI 10.15585/mmwr.mm7011e2; Lumley SF, 2021, CLIN INFECT DIS, V73, pE699, DOI 10.1093/cid/ciab004; Pilishvili T, 2021, MMWR-MORBID MORTAL W, V70, P753, DOI 10.15585/mmwr.mm7020e2externalicon; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Pritchard E., 2021, IMPACT VACCINATION S, DOI [10.1101/2021.04.22.21255913v1, DOI 10.1101/2021.04.22.21255913V1]; Rincon-Arevalo H, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abj1031; Shah ASV, MEDRXIV, V2021, DOI [10.1101/2021.03.11.21253275, DOI 10.1101/2021.03.11.21253275]; Skowronski DM, 2021, NEW ENGL J MED, V384, P1576, DOI 10.1056/NEJMc2036242; Swift MD., 2021, CLIN INFECT DIS, V26, pCIAB361; Tenforde MW, 2021, MMWR-MORBID MORTAL W, V70, P1156, DOI 10.15585/mmwr.mm7034e2; Tenforde MW, 2021, MMWR-MORBID MORTAL W, V70, P674, DOI 10.15585/mmwr.mm7018e1; Thompson MG, 2021, MMWR-MORBID MORTAL W, V70, P495, DOI 10.15585/mmwr.mm7013e3; VanderWeele TJ, 2019, EUR J EPIDEMIOL, V34, pCP3, DOI 10.1007/s10654-019-00494-6	35	85	86	7	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2021	385	25							e90	10.1056/NEJMoa2106599	http://dx.doi.org/10.1056/NEJMoa2106599		SEP 2021	13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE4WZ	34551224	Bronze, Green Published			2022-12-28	WOS:000697804900001
J	Dyer, O				Dyer, Owen			Obesity in US children increased at an unprecedented rate during the pandemic	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		CDC, 2021, NUMB STAT HIGH OB PR; CDC, 2021, AD OB PREV MAPS; Hales Craig M, 2020, NCHS Data Brief, P1; Kompaniyets L, 2021, MMWR-MORBID MORTAL W, V70, P355, DOI 10.15585/mmwr.mm7010e4; Lange SJ, 2021, MMWR-MORBID MORTAL W, V70, P1278, DOI 10.15585/mmwr.mm7037a3; Woolford SJ, 2021, JAMA-J AM MED ASSOC, V326, P1434, DOI 10.1001/jama.2021.15036	6	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 21	2021	374								n2332	10.1136/bmj.n2332	http://dx.doi.org/10.1136/bmj.n2332			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WA4GB	34548306	Bronze			2022-12-28	WOS:000702844100016
J	Samarasekera, U				Samarasekera, Udani			Unitaid at 15	LANCET			English	Editorial Material																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 18	2021	398	10305					1032	1033						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	US3YI	34537089				2022-12-28	WOS:000697368600007
J	Lenzer, J; Brownlee, S				Lenzer, Jeanne; Brownlee, Shannon			Should regulatory authorities approve drugs based on surrogate endpoints?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jeanne.lenzer@gmail.com						Belluck P., NEW YORK TIMES; Chen EMY, 2020, JAMA INTERN MED, V180, P912, DOI 10.1001/jamainternmed.2020.1097; Chen EY, 2019, JAMA INTERN MED, V179, P642, DOI 10.1001/jamainternmed.2018.8351; Cherla A, 2021, JAMA INTERN MED, V181, P490, DOI 10.1001/jamainternmed.2020.8441; Corrada MM, 2012, CURR ALZHEIMER RES, V9, P709, DOI 10.2174/156720512801322537; D'Agostino RB, 2011, NEW ENGL J MED, V365, DOI [10.1056/nejmp1106984, 10.1056/NEJMp1106984]; FDA, PRESCR LAB AD; FDA (Food and Drug Administration) FDA, FDA FACTS BIOM SURR; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Food and Drug Administration (FDA), SURR ENDP RES DRUG B; Gyawali B, 2019, JAMA INTERN MED, V179, P906, DOI 10.1001/jamainternmed.2019.0462; Hochhaus A, 2017, NEW ENGL J MED, V376, P917, DOI 10.1056/NEJMoa1609324; Kaltenboeck A, STRENTHENING ACCELER, P2021; Kesselheim AS, 2016, JAMA-J AM MED ASSOC, V315, P1516, DOI 10.1001/jama.2015.16984; Kok PS, 2021, JCO PRECIS ONCOL, V5, P1151, DOI 10.1200/PO.21.00108; Loftus P., 2019, WALL STR J; Mahase E, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1462; Meyers DE, 2021, JAMA INTERN MED, V181, P499, DOI 10.1001/jamainternmed.2020.8588; Powell K, 2021, JAMA ONCOL, V7, P1607, DOI 10.1001/jamaoncol.2021.3046; PRATT CM, 1995, CIRCULATION, V91, P245, DOI 10.1161/01.CIR.91.1.245; Svensson S, 2009, HLTH SKEPTICISM INT	21	10	10	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2021	374								n2059	10.1136/bmj.n2059	http://dx.doi.org/10.1136/bmj.n2059			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UR9HH	34526303				2022-12-28	WOS:000697050400002
J	Talan, DA; Di Saverio, S				Talan, David A.; Di Saverio, Salomone			Treatment of Acute Uncomplicated Appendicitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; ANTIBIOTIC-THERAPY; NONOPERATIVE MANAGEMENT; APPENDECTOMY; SURGERY	Key Clinical Points Treatment of Acute Uncomplicated Appendicitis Patients with acute, localized, uncomplicated appendicitis (approximately 80% of all appendicitis cases) are candidates for appendectomy or nonoperative treatment. Nonoperative treatment includes analgesia, antibiotics for 7 to 10 days, and careful follow-up. With surgery, appendicitis cannot recur, and the incidence of subsequent hospitalization is lower than with nonoperative treatment. Surgery requires general anesthesia and in most instances an overnight hospital stay. Nonoperative treatment is associated with a shorter duration of disability than appendectomy, does not routinely require hospitalization, and is not associated with an increased risk of rupture. Over 5 years, approximately 30 to 40% of patients who had been treated with antibiotics will undergo appendectomy, although rates vary with patient characteristics and practice patterns. Patients with appendicolith who receive nonoperative treatment are more likely than those without an appendicolith to undergo appendectomy. Patients should be informed of the advantages and disadvantages of both strategies and should participate in decision making. Nonoperative Antibiotic Treatment of Acute Appendicitis Treatment for acute uncomplicated appendicitis may involve appendectomy or nonoperative care (pain control, antibiotics, and careful follow-up). The advantages and disadvantages of each should be discussed with the patient. Over 5 years, 30 to 40% of patients who received antibiotics will undergo appendectomy, although the range may vary, depending on patient characteristics and practice patterns.	[Talan, David A.] UCLA Ronald Reagan Med Ctr, Dept Emergency Med, Los Angeles, CA USA; [Talan, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Di Saverio, Salomone] Hosp San Benedetto Tronto, Dept Gen Surg, ASUR Marche, San Benedetto Tronto, Italy	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Ronald Reagan UCLA Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Talan, DA (corresponding author), UCLA, David Geffen Sch Med, Dept Emergency Med, 924 Westwood Blvd,Ste 300, Los Angeles, CA 90095 USA.	dtalan@ucla.edu	Di Saverio, Salomone/G-1437-2012	Di Saverio, Salomone/0000-0001-5685-5022				ADDISS DG, 1990, AM J EPIDEMIOL, V132, P910, DOI 10.1093/oxfordjournals.aje.a115734; American College of Surgeons, 2020, COVID 19 GUID TRIAG; American College of Surgeons, 2017, APP SURG REM APP; Andersson RE, 2013, WORLD J SURG, V37, P974, DOI 10.1007/s00268-012-1856-x; Atema JJ, 2015, BRIT J SURG, V102, P979, DOI 10.1002/bjs.9835; BENNION RS, 1990, ANN SURG, V211, P165, DOI 10.1097/00000658-199002000-00008; Chau DB, 2016, J PEDIATR SURG, V51, P117, DOI 10.1016/j.jpedsurg.2015.10.029; Chou R, 2016, J PAIN, V17, P131, DOI 10.1016/j.jpain.2015.12.008; Di Saverio S, 2020, WORLD J EMERG SURG, V15, DOI 10.1186/s13017-020-00306-3; ERIKSSON S, 1995, BRIT J SURG, V82, P166, DOI 10.1002/bjs.1800820207; Flum DR, 2020, NEW ENGL J MED, V383, P1907, DOI 10.1056/NEJMoa2014320; Flum DR, 2015, NEW ENGL J MED, V372, P1937, DOI 10.1056/NEJMcp1215006; Il Joo J, 2017, AM J MED, V130, P1467, DOI 10.1016/j.amjmed.2017.04.046; Jaschinski T, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001546.pub4; Kadera SP, 2016, J SURG RES, V201, P253, DOI 10.1016/j.jss.2015.11.016; Koike Y, 2014, J PEDIATR SURG, V49, P1116, DOI 10.1016/j.jpedsurg.2014.01.003; Lee Ji Yeon, 2016, J Pediatr Pharmacol Ther, V21, P140, DOI 10.5863/1551-6776-21.2.140; Lefrancois M, 2015, ANN SURG, V261, P1167, DOI 10.1097/SLA.0000000000000795; LoVecchio F, 2021, NEW ENGL J MED, V384, P879, DOI 10.1056/NEJMc2035865; Lowth M., 2019, APPENDICITIS; Lu P, 2019, J SURG ONCOL, V120, P452, DOI 10.1002/jso.25608; Lundholm K, 2017, WORLD J SURG, V41, P2245, DOI 10.1007/s00268-017-3987-6; Mazuski JE, 2017, SURG INFECT, V18, P1, DOI 10.1089/sur.2016.261; Minneci PC, 2020, JAMA-J AM MED ASSOC, V324, P581, DOI 10.1001/jama.2020.10888; Minneci PC, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.5009; O'Connell EP, 2018, IRISH J MED SCI, V187, P1029, DOI 10.1007/s11845-018-1758-5; O'Leary DP, 2021, ANN SURG, V274, P240, DOI 10.1097/SLA.0000000000004785; Oliak D, 2001, DIS COLON RECTUM, V44, P936, DOI 10.1007/BF02235479; Park HC, 2017, BRIT J SURG, V104, P1785, DOI 10.1002/bjs.10660; Park HC, 2014, AM J MED, V127, P562, DOI 10.1016/j.amjmed.2014.01.018; Paudel GR, 2010, J NEPAL MED ASSOC, V49, P295; Ranji SR, 2006, JAMA-J AM MED ASSOC, V296, P1764, DOI 10.1001/jama.296.14.1764; Rud B, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009977.pub2; Salminen P, 2018, JAMA-J AM MED ASSOC, V320, P1259, DOI 10.1001/jama.2018.13201; Salminen P, 2015, JAMA-J AM MED ASSOC, V313, P2340, DOI 10.1001/jama.2015.6154; Schumm MA, 2020, J SURG RES, V255, P77, DOI 10.1016/j.jss.2020.05.028; Schuster KM, 2019, TRAUMA SURG ACUTE CA, V4, DOI 10.1136/tsaco-2018-000281; Singh JP, 2013, ANN ROY COLL SURG, V95, P48, DOI 10.1308/003588413X13511609954851; Sippola S, 2021, JAMA-J AM MED ASSOC, V325, P353, DOI 10.1001/jama.2020.23525; Sippola S, 2020, JAMA SURG, V155, P283, DOI 10.1001/jamasurg.2019.6028; Sippola S, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-023623; Song MY, 2021, EXPERT REV GASTROENT, V15, P657, DOI 10.1080/17474124.2021.1868298; Sprandel KA, 2004, ANTIMICROB AGENTS CH, V48, P4597, DOI 10.1128/AAC.48.12.4597-4605.2004; Talan DA, 2021, ANN EMERG MED, V77, P32, DOI 10.1016/j.annemergmed.2020.08.022; Talan DA, 2019, J TRAUMA ACUTE CARE, V86, P722, DOI 10.1097/TA.0000000000002137; Talan DA, 2017, ANN EMERG MED, V70, P1, DOI 10.1016/j.annemergmed.2016.08.446	46	10	10	3	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2021	385	12					1116	1123		10.1056/NEJMcp2107675	http://dx.doi.org/10.1056/NEJMcp2107675			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ4IT	34525287				2022-12-28	WOS:000696029600013
J	[Anonymous]				[Anonymous]			Oral versus Intravenous Antibiotics for Endocarditis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Oral versus Intravenous Antibiotics for Endocarditis This interactive feature about the treatment of endocarditis offers a case vignette accompanied by two essays supporting a full 6-week course of intravenous antibiotics or a switch from intravenous to oral antibiotics after several weeks.										Baddour LM, 2015, CIRCULATION, V132, P1435, DOI 10.1161/CIR.0000000000000296; Batki SL, 2002, DRUG ALCOHOL DEPEN, V66, P283, DOI 10.1016/S0376-8716(01)00208-3; Bundgaard H, 2019, NEW ENGL J MED, V380, P1373, DOI 10.1056/NEJMc1902096; Chambers HF, 2020, NEW ENGL J MED, V383, P567, DOI 10.1056/NEJMcp2000400; Iversen K, 2019, NEW ENGL J MED, V380, P415, DOI 10.1056/NEJMoa1808312; Le, 2021, CLIN INFECT DIS; Schuckit MA, 2016, NEW ENGL J MED, V375, P357, DOI 10.1056/NEJMra1604339; Serota DP, 2020, INFECT DIS CLIN N AM, V34, P539, DOI 10.1016/j.idc.2020.06.010	8	2	2	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2021	385	12					1141	1143		10.1056/NEJMclde2108866	http://dx.doi.org/10.1056/NEJMclde2108866			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ4IT	34525290				2022-12-28	WOS:000696029600019
J	Kokic, G; Wagner, FR; Chernev, A; Urlaub, H; Cramer, P				Kokic, Goran; Wagner, Felix R.; Chernev, Aleksandar; Urlaub, Henning; Cramer, Patrick			Structural basis of human transcription-DNA repair coupling	NATURE			English	Article							RNA-POLYMERASE-II; UV-SENSITIVE SYNDROME; CRYO-EM; PROTEIN; DAMAGE; ELONGATION; LIGASE; VISUALIZATION; RECOGNITION; COMPLEX	Transcription-coupled DNA repair removes bulky DNA lesions from the genome(1,2) and protects cells against ultraviolet (UV) irradiation(3). Transcription-coupled DNA repair begins when RNA polymerase II (Pol II) stalls at a DNA lesion and recruits the Cockayne syndrome protein CSB, the E3 ubiquitin ligase, CRL4(CSA) and UV-stimulated scaffold protein A (UVSSA)(3). Here we provide five high-resolution structures of Pol II transcription complexes containing human transcription-coupled DNA repair factors and the elongation factors PAF1 complex (PAF) and SPT6. Together with biochemical and published(3,4) data, the structures provide a model for transcription-repair coupling. Stalling of Pol II at a DNA lesion triggers replacement of the elongation factor DSIF by CSB, which binds to PAF and moves upstream DNA to SPT6. The resulting elongation complex, ECTCR, uses the CSA-stimulated translocase activity of CSB to pull on upstream DNA and push Pol II forward. If the lesion cannot be bypassed, CRL4(CSA) spans over the Pol II clamp and ubiquitylates the RPB1 residue K1268, enabling recruitment of TFIIH to UVSSA and DNA repair. Conformational changes in CRL4(CSA) lead to ubiquitylation of CSB and to release of transcription-coupled DNA repair factors before transcription may continue over repaired DNA.	[Kokic, Goran; Wagner, Felix R.; Cramer, Patrick] Max Planck Inst Biophys Chem, Dept Mol Biol, Gottingen, Germany; [Chernev, Aleksandar; Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry, Gottingen, Germany; [Urlaub, Henning] Univ Med Ctr Gottingen, Inst Clin Chem, Bioanalyt Grp, Gottingen, Germany	Max Planck Society; Max Planck Society; University of Gottingen	Cramer, P (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Biol, Gottingen, Germany.	patrick.cramer@mpibpc.mpg.de			Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	Open access funding provided by Max Planck Society.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Anindya R, 2010, MOL CELL, V38, P637, DOI 10.1016/j.molcel.2010.04.017; Baek K, 2021, CURR OPIN STRUC BIOL, V67, P101, DOI 10.1016/j.sbi.2020.10.007; Bernecky C, 2017, NAT STRUCT MOL BIOL, V24, P809, DOI 10.1038/nsmb.3465; Bernecky C, 2016, NATURE, V529, P551, DOI 10.1038/nature16482; Biasini Marco, 2014, Nucleic Acids Res, V42, pW252, DOI 10.1093/nar/gku340; Boeing S, 2016, CELL REP, V15, P1597, DOI 10.1016/j.celrep.2016.04.047; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Citterio E, 1998, J BIOL CHEM, V273, P11844, DOI 10.1074/jbc.273.19.11844; Close D, 2011, J MOL BIOL, V408, P697, DOI 10.1016/j.jmb.2011.03.002; Combe CW, 2015, MOL CELL PROTEOMICS, V14, P1137, DOI 10.1074/mcp.O114.042259; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Doherty AJ, 1996, NUCLEIC ACIDS RES, V24, P2488, DOI 10.1093/nar/24.13.2488; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fei J, 2012, J BIOL CHEM, V287, P35118, DOI 10.1074/jbc.M112.398131; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Gradia SD, 2017, METHOD ENZYMOL, V592, P1, DOI 10.1016/bs.mie.2017.03.008; Gregersen LH, 2018, TRENDS BIOCHEM SCI, V43, P327, DOI 10.1016/j.tibs.2018.02.010; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Groisman R, 2006, GENE DEV, V20, P1429, DOI 10.1101/gad.378206; HENNING KA, 1995, CELL, V82, P555, DOI 10.1016/0092-8674(95)90028-4; Kidmose RT, 2019, IUCRJ, V6, P526, DOI 10.1107/S2052252519007619; Kokic G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10745-5; Kosinski J, 2015, J STRUCT BIOL, V189, P177, DOI 10.1016/j.jsb.2015.01.014; Laine JP, 2006, EMBO J, V25, P387, DOI 10.1038/sj.emboj.7600933; Li WT, 2014, NUCLEIC ACIDS RES, V42, P7069, DOI 10.1093/nar/gku333; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; Misra S, 2002, NATURE, V415, P933, DOI 10.1038/415933a; Nakazawa Y, 2020, CELL, V180, P1228, DOI 10.1016/j.cell.2020.02.010; Nakazawa Y, 2012, NAT GENET, V44, P586, DOI 10.1038/ng.2229; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Ranes M, 2016, NUCLEIC ACIDS RES, V44, P5246, DOI 10.1093/nar/gkw216; Scheres SHW, 2016, METHOD ENZYMOL, V579, P125, DOI 10.1016/bs.mie.2016.04.012; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Schwertman P, 2012, NAT GENET, V44, P598, DOI 10.1038/ng.2230; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Tantin D, 1997, MOL CELL BIOL, V17, P6803, DOI 10.1128/MCB.17.12.6803; van den Boom V, 2004, J CELL BIOL, V166, P27, DOI 10.1083/jcb.200401056; van den Heuvel D, 2021, TRENDS CELL BIOL, V31, P359, DOI 10.1016/j.tcb.2021.02.007; van den Heuvel D, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21520-w; van der Weegen Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15903-8; vanGool AJ, 1997, EMBO J, V16, P4155, DOI 10.1093/emboj/16.14.4155; Vessoni AT, 2020, GENET MOL BIOL, V43, DOI [10.1590/1678-4685-gmb-2019-0085, 10.1590/1678-4685-GMB-2019-0085]; Vidakovic AT, 2020, CELL, V180, P1245, DOI 10.1016/j.cell.2020.02.009; Vos SM, 2020, NAT STRUCT MOL BIOL, V27, P668, DOI 10.1038/s41594-020-0437-1; Vos SM, 2018, NATURE, V560, P607, DOI 10.1038/s41586-018-0440-4; Vos SM, 2016, ELIFE, V5, DOI 10.7554/eLife.14981; Wier AD, 2013, P NATL ACAD SCI USA, V110, P17290, DOI 10.1073/pnas.1314754110; Wilson MD, 2013, BBA-GENE REGUL MECH, V1829, P151, DOI 10.1016/j.bbagrm.2012.08.002; Xu J, 2017, NATURE, V551, P653, DOI 10.1038/nature24658; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Yin J, 2006, NAT PROTOC, V1, P280, DOI 10.1038/nprot.2006.43; Zhang SY, 2021, SCIENCE, V371, P305, DOI 10.1126/science.abf1870; Zhang X, 2012, NAT GENET, V44, P593, DOI 10.1038/ng.2228	65	17	17	2	17	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 14	2021	598	7880					368	+		10.1038/s41586-021-03906-4	http://dx.doi.org/10.1038/s41586-021-03906-4		SEP 2021	25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG7FA	34526721	hybrid, Green Published			2022-12-28	WOS:000696175300010
J	Schwingshackl, L; Balduzzi, S; Beyerbach, J; Brockelmann, N; Werner, SS; Zahringer, J; Nagavci, B; Meerpohl, JJ				Schwingshackl, Lukas; Balduzzi, Sara; Beyerbach, Jessica; Brockelmann, Nils; Werner, Sarah S.; Zaehringer, Jasmin; Nagavci, Blin; Meerpohl, Joerg J.			Evaluating agreement between bodies of evidence from randomised controlled trials and cohort studies in nutrition research: meta-epidemiological study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DOSE-RESPONSE METAANALYSIS; POLYUNSATURATED FATTY-ACIDS; ALPHA-LINOLENIC ACID; ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; DIETARY-INTAKE; VITAMIN-D; PERSPECTIVE NUTRIGRADE; SCORING SYSTEM; RISK	OBJECTIVE To evaluate the agreement between diet-disease effect estimates of bodies of evidence from randomised controlled trials and those from cohort studies in nutrition research, and to investigate potential factors for disagreement. DESIGN Meta-epidemiological study. DATA SOURCES Cochrane Database of Systematic Reviews, and Medline. REVIEW METHODS Population, intervention or exposure, comparator, outcome (PI/ECO) elements from a body of evidence from cohort studies (BoE(CS)) were matched with corresponding elements of a body of evidence from randomised controlled trials (BoE(RCT)). Pooled ratio of risk ratios or difference of mean differences across all diet-disease outcome pairs were calculated. Subgroup analyses were conducted to explore factors for disagreement. Heterogeneity was assessed through I-2 and tau(2). Prediction intervals were calculated to assess the range of possible values for the difference in the results between evidence from randomised controlled trials and evidence from cohort studies in future comparisons. RESULTS 97 diet-disease outcome pairs (that is, matched BoE(RCT) and BoE(CS)) were identified overall. For binary outcomes, the pooled ratio of risk ratios comparing estimates from BoE(RCT) with BoE(CS) was 1.09 (95% confidence interval 1.04 to 1.14; I-2=68%; tau(2)=0.021; 95% prediction interval 0.81 to 1.46). The prediction interval indicated that the difference could be much more substantial, in either direction. We further explored heterogeneity and found that PI/ECO dissimilarities, especially for the comparisons of dietary supplements in randomised controlled trials and nutrient status in cohort studies, explained most of the differences. When the type of intake or exposure between both types of evidence was identical, the estimates were similar. For continuous outcomes, small differences were observed between randomised controlled trials and cohort studies. CONCLUSION On average, the difference in pooled results between estimates from BoE(RCT) and BoE(CS) was small. But wide prediction intervals and some substantial statistical heterogeneity in cohort studies indicate that important differences or potential bias in individual comparisons or studies cannot be excluded. Observed differences were mainly driven by dissimilarities in population, intervention or exposure, comparator, and outcome. These findings could help researchers further understand the integration of such evidence into prospective nutrition evidence syntheses and improve evidence based dietary guidelines.	[Schwingshackl, Lukas; Beyerbach, Jessica; Brockelmann, Nils; Werner, Sarah S.; Zaehringer, Jasmin; Nagavci, Blin; Meerpohl, Joerg J.] Univ Freiburg, Med Ctr, Fac Med, Inst Evidence Med, Freiburg, Germany; [Balduzzi, Sara] Univ Freiburg, Fac Med, Inst Med Biometry & Stat, Med Ctr, Freiburg, Germany; [Meerpohl, Joerg J.] Cochrane Germany Fdn, Cochrane Germany, Freiburg, Germany	University of Freiburg; University of Freiburg	Schwingshackl, L (corresponding author), Univ Freiburg, Med Ctr, Fac Med, Inst Evidence Med, Freiburg, Germany.	schwingshackl@ifem.uni-freiburg.de	Nagavci, Blin/AAW-7370-2020; Schwingshackl, Lukas/AAC-4119-2019	Nagavci, Blin/0000-0002-6626-2842; Schwingshackl, Lukas/0000-0003-3407-7594; Werner, Sarah/0000-0001-6068-3665	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [459430615]; Forschungskommission der Medizinischen Fakultat Freiburg	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); Forschungskommission der Medizinischen Fakultat Freiburg	Funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) -Projektnummer 459430615 and Forschungskommission der Medizinischen Fakultat Freiburg. The funders had no role in considering the study design or in the collection, analysis, interpretation of data, writing of the report, or decision to submit the article for publication.	Abdelhamid AS, 2018, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD012345.pub2, 10.1002/14651858.CD012345.pub3]; Abdelhamid AS, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003177.pub4; Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; Afshin A, 2019, LANCET, V393, P1958, DOI 10.1016/S0140-6736(19)30041-8; Al-Khudairy L, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011114.pub2; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Anglemyer A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000034.pub2; Aune Dagfinn, 2011, BMJ, V343, pd6617, DOI 10.1136/bmj.d6617; Aune D, 2018, AM J CLIN NUTR, V108, P1069, DOI 10.1093/ajcn/nqy097; Avenell A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000227.pub4; Balduzzi S, 2019, EVID-BASED MENT HEAL, V22, P153, DOI 10.1136/ebmental-2019-300117; Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; Ben QW, 2014, GASTROENTEROLOGY, V146, P689, DOI 10.1053/j.gastro.2013.11.003; BJELAKOVIC G, 2014, COCHRANE DB SYST REV, P7469, DOI [10.1002/14651858.cd007470.pub3, DOI 10.1002/14651858.CD007470.PUB3]; Bjelakovic G, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007176.pub2, 10.1590/1516-3180.20151332T1]; Bjelakovic G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007470.pub2; Blencowe H, 2010, INT J EPIDEMIOL, V39, P110, DOI 10.1093/ije/dyq028; Chia AR, 2019, ADV NUTR, V10, P685, DOI 10.1093/advances/nmy123; Chowdhury R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1903; Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788; Cormick G, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010037.pub2; de Souza RJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3978; De-Regil LM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007950.pub2; Doets EL, 2013, EPIDEMIOL REV, V35, P2, DOI 10.1093/epirev/mxs003; El Dib R, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005525.pub3; Estruch R, 2018, NEW ENGL J MED, V378, DOI [10.1056/NEJMoa1800389, 10.1056/nejmoa1800389]; Feng Y, 2017, OSTEOPOROSIS INT, V28, P1641, DOI 10.1007/s00198-017-3955-x; Feng Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08506; Fernandez-Cao JC, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051027; GARLAND M, 1995, J NATL CANCER I, V87, P497, DOI 10.1093/jnci/87.7.497; Goodwill AM, 2017, J AM GERIATR SOC, V65, P2161, DOI 10.1111/jgs.15012; Han JM, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102295; Hartley L, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011472.pub2; Hartley Louise, 2013, Cochrane Database Syst Rev, pCD009874, DOI 10.1002/14651858.CD009874.pub2; Hemmingsen Bianca, 2017, Cochrane Database Syst Rev, V12, pCD003054, DOI 10.1002/14651858.CD003054.pub4; Higgins J.P.T., 2020, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hofmeyr GJ, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001059.pub2, 10.1002/14651858.CD001059.pub4, 10.1002/14651858.CD001059.pub5]; Hooper Lee, 2015, Cochrane Database Syst Rev, pCD011737, DOI 10.1002/14651858.CD011737; Hooper L, 2015, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD011737, 10.1002/14651858.CD011583.pub2]; Hooper L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002137.pub3; Hooper L, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD011834, 10.1002/14651858.CD002137.pub2]; Hossain S, 2019, CLIN NUTR ESPEN, V30, P170, DOI 10.1016/j.clnesp.2018.12.085; Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P39, DOI 10.1001/jama.295.1.39; Hu LM, 2018, CELL PHYSIOL BIOCHEM, V45, P291, DOI 10.1159/000486810; Humphrey LL, 2008, MAYO CLIN PROC, V83, P1203, DOI 10.4065/83.11.1203; Ioannidis JPA, 2018, JAMA-J AM MED ASSOC, V320, P969, DOI 10.1001/jama.2018.11025; Jayedi A, 2018, ADV NUTR, V9, P701, DOI 10.1093/advances/nmy040; Jayedi A, 2019, EUR J CLIN NUTR, V73, P969, DOI 10.1038/s41430-018-0275-y; Jiang H, 2019, AM J CLIN NUTR, V109, P43, DOI 10.1093/ajcn/nqy270; Jin HY, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009350.pub2; Kastorini CM, 2011, J AM COLL CARDIOL, V57, P1299, DOI 10.1016/j.jacc.2010.09.073; Keats EC, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004905.pub6; Kelly SAM, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005051.pub3; Koushik A, 2006, INT J CANCER, V119, P2148, DOI 10.1002/ijc.22076; Kromhout D, 2016, EUR J CLIN NUTR, V70, P869, DOI 10.1038/ejcn.2016.52; Leyvraz M, 2018, INT J EPIDEMIOL, V47, P1796, DOI 10.1093/ije/dyy121; Li J, 2020, AM J CLIN NUTR, V112, P150, DOI 10.1093/ajcn/nqz349; Lu JX, 2016, NUTR CANCER, V68, P1, DOI 10.1080/01635581.2016.1105267; Lucey A, 2016, NUTR BULL, V41, P378, DOI 10.1111/nbu.12241; Maki KC, 2014, ADV NUTR, V5, P7, DOI 10.3945/an.113.004929; Mandel, 1982, CONSENSUS VALUES WEI, DOI [10.6028/ jres.087.022, DOI 10.6028/JRES.087.022]; Mathew MC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004567.pub2; Mente A, 2009, ARCH INTERN MED, V169, P659, DOI 10.1001/archinternmed.2009.38; Mijatovic-Vukas J, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060698; Miller PE, 2014, AM J CLIN NUTR, V100, P765, DOI 10.3945/ajcn.113.082826; Moorthy D., 2013, CONCORDANCE FINDINGS, V6; Moustgaard H, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.l6802; Murad Mohammad Hassan, 2017, Evid Based Med, V22, P139, DOI 10.1136/ebmed-2017-110713; Naude CE, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0244-7; Newberry Sydne J, 2014, Evid Rep Technol Assess (Full Rep), P1, DOI 10.23970/AHRQEPCERTA217; Noto H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055030; Palacios C, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013446; Pan A, 2018, CELL METAB, V27, P489, DOI 10.1016/j.cmet.2018.02.017; Pan A, 2012, AM J CLIN NUTR, V96, P1262, DOI 10.3945/ajcn.112.044040; Rapola JM, 1997, LANCET, V349, P1715, DOI 10.1016/S0140-6736(97)01234-8; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Rees K, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009825.pub3; Rees K, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002128.pub4; Rees K, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009671.pub2; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Rosato V, 2019, EUR J NUTR, V58, P173, DOI 10.1007/s00394-017-1582-0; Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7; Rutjes AWS, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011906.pub2; Sartorius K, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018449; Satija A, 2018, ADV NUTR, V9, P378, DOI 10.1093/advances/nmy030; Savovic J, 2012, ANN INTERN MED, V157, P429, DOI 10.7326/0003-4819-157-6-201209180-00537; Schatzkin A, 2000, NEW ENGL J MED, V342, P1149, DOI 10.1056/NEJM200004203421601; Schlesinger S, 2019, ADV NUTR, V10, P205, DOI 10.1093/advances/nmy092; Schunemann HJ, 2019, J CLIN EPIDEMIOL, V111, P105, DOI 10.1016/j.jclinepi.2018.01.012; Schwingshackl L, 2021, EUR J NUTR, V60, P2893, DOI 10.1007/s00394-020-02464-1; Schwingshackl L, 2018, J ACAD NUTR DIET, V118, P74, DOI 10.1016/j.jand.2017.08.024; Schwingshackl L, 2017, ADV NUTR, V8, P793, DOI 10.3945/an.117.017178; Schwingshackl L, 2017, ADV NUTR, V8, P790, DOI 10.3945/an.117.016469; Schwingshackl L, 2017, ADV NUTR, V8, P27, DOI 10.3945/an.116.013516; Schwingshackl L, 2016, ADV NUTR, V7, P994, DOI 10.3945/an.116.013052; Seidelmann SB, 2018, LANCET PUBLIC HEALTH, V3, pE419, DOI 10.1016/S2468-2667(18)30135-X; Soedamah-Muthu SS, 2012, HYPERTENSION, V60, P1131, DOI 10.1161/HYPERTENSIONAHA.112.195206; Soltani S, 2019, ADV NUTR, V10, P1029, DOI 10.1093/advances/nmz041; STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003; Sterne JAC, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i4919; Sydenham E, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005379.pub3; Adler Alma J, 2014, Cochrane Database Syst Rev, pCD009217, DOI [10.1002/14651858.CD009217, 10.1002/14651858.CD009217.pub3]; Tieu J, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006674.pub3; Tous M, 2020, EUR J CLIN NUTR, V74, P36, DOI 10.1038/s41430-018-0373-x; Trepanowski JF, 2018, ADV NUTR, V9, P367, DOI 10.1093/advances/nmy014; Truswell AS, 2005, EUR J CLIN NUTR, V59, pS150, DOI 10.1038/sj.ejcn.1602189; US Department of Health and Human Services (US DHHS) and USDA, 2015, 2015 2020 DIET GUID, V8th; Usinger L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008118.pub2; Veroniki AA, 2016, RES SYNTH METHODS, V7, P55, DOI 10.1002/jrsm.1164; Vinceti M, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005195.pub4; Wan Y, 2017, ASIA PAC J CLIN NUTR, V26, P939, DOI 10.6133/apjcn.072017.01; Wei JK, 2018, BRIT J NUTR, V119, P83, DOI [10.1017/S0007114517003294, 10.1017/s0007114517003294]; Werner SS, 2021, J CLIN EPIDEMIOL, V135, P54, DOI 10.1016/j.jclinepi.2021.02.010; Wolf HT, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.03.029; Xiang SY, 2020, BIOL TRACE ELEM RES, V195, P55, DOI 10.1007/s12011-019-01847-8; Yao YB, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003430.pub2; Ye EQ, 2012, J NUTR, V142, P1304, DOI 10.3945/jn.111.155325; Yuan YD, 2021, J MATERN-FETAL NEO M, V34, P1576, DOI 10.1080/14767058.2019.1640675; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302; Zhang LQ, 2015, CELL PHYSIOL BIOCHEM, V36, P299, DOI 10.1159/000374072; Zhang X, 2016, EUR J CLIN NUTR, V70, P162, DOI 10.1038/ejcn.2015.78; Zhang Y, 2016, AM J CLIN NUTR, V103, P330, DOI 10.3945/ajcn.115.124081; Zhu YJ, 2019, LIPIDS HEALTH DIS, V18, DOI 10.1186/s12944-019-1035-2	124	15	16	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 15	2021	374								n1864	10.1136/bmj.n1864	http://dx.doi.org/10.1136/bmj.n1864			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UY0UP	34526355	Green Published, hybrid			2022-12-28	WOS:000701248800007
J	Wilkin, S; Miller, AV; Fernandes, R; Spengler, R; Taylor, WTT; Brown, DR; Reich, D; Kennett, DJ; Culleton, BJ; Kunz, L; Fortes, C; Kitova, A; Kuznetsov, P; Epimakhov, A; Zaibert, VF; Outram, AK; Kitov, E; Khokhlov, A; Anthony, D; Boivin, N				Wilkin, Shevan; Miller, Alicia Ventresca; Fernandes, Ricardo; Spengler, Robert; Taylor, William T-T; Brown, Dorcas R.; Reich, David; Kennett, Douglas J.; Culleton, Brendan J.; Kunz, Laura; Fortes, Claudia; Kitova, Aleksandra; Kuznetsov, Pavel; Epimakhov, Andrey; Zaibert, Victor F.; Outram, Alan K.; Kitov, Egor; Khokhlov, Aleksandr; Anthony, David; Boivin, Nicole			Dairying enabled Early Bronze Age Yamnaya steppe expansions	NATURE			English	Article							SECONDARY PRODUCTS REVOLUTION; MASS-SPECTROMETRY; PASTORALISM; EXPLOITATION; SUBSISTENCE; COMPLEXITY; CHRONOLOGY; SELECTION; PATTERNS; ECONOMY	During the Early Bronze Age, populations of the western Eurasian steppe expanded across an immense area of northern Eurasia. Combined archaeological and genetic evidence supports widespread Early Bronze Age population movements out of the Pontic-Caspian steppe that resulted in gene flow across vast distances, linking populations of Yamnaya pastoralists in Scandinavia with pastoral populations (known as the Afanasievo) far to the east in the Altai Mountains(1,2) and Mongolia(3). Although some models hold that this expansion was the outcome of a newly mobile pastoral economy characterized by horse traction, bulk wagon transport(4-6) and regular dietary dependence on meat and milk(5), hard evidence for these economic features has not been found. Here we draw on proteomic analysis of dental calculus from individuals from the western Eurasian steppe to demonstrate a major transition in dairying at the start of the Bronze Age. The rapid onset of ubiquitous dairying at a point in time when steppe populations are known to have begun dispersing offers critical insight into a key catalyst of steppe mobility. The identification of horse milk proteins also indicates horse domestication by the Early Bronze Age, which provides support for its role in steppe dispersals. Our results point to a potential epicentre for horse domestication in the Pontic-Caspian steppe by the third millennium bc, and offer strong support for the notion that the novel exploitation of secondary animal products was a key driver of the expansions of Eurasian steppe pastoralists by the Early Bronze Age.	[Wilkin, Shevan; Miller, Alicia Ventresca; Fernandes, Ricardo; Spengler, Robert; Taylor, William T-T; Boivin, Nicole] Max Planck Inst Sci Human Hist, Dept Archaeol, Jena, Germany; [Wilkin, Shevan] Univ Zurich, Fac Med, Inst Evolutionary Med, Zurich, Switzerland; [Miller, Alicia Ventresca] Univ Michigan, Dept Anthropol, Ann Arbor, MI 48109 USA; [Fernandes, Ricardo] Univ Oxford, Sch Archaeol, Oxford, England; [Fernandes, Ricardo] Masaryk Univ, Fac Arts, Brno, Czech Republic; [Taylor, William T-T] Univ Colorado, Dept Anthropol, Museum Nat Hist, Boulder, CO 80309 USA; [Brown, Dorcas R.; Anthony, David] Hartwick Coll, Dept Anthropol, Oneonta, NY 13820 USA; [Reich, David] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Reich, David] Broad Inst Harvard & MIT, Cambridge, MA USA; [Reich, David] Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA; [Reich, David; Anthony, David] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Kennett, Douglas J.] Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA; [Culleton, Brendan J.] Penn State Univ, Inst Energy, University Pk, PA 16802 USA; [Culleton, Brendan J.] Penn State Univ, Inst Environm, University Pk, PA 16802 USA; [Kunz, Laura; Fortes, Claudia] Univ Zurich, Funct Genom Ctr Rich, ETH Zurich, Zurich, Switzerland; [Kitova, Aleksandra] Russian Acad Sci, Ctr Egyptol Studies, Moscow, Russia; [Kuznetsov, Pavel; Khokhlov, Aleksandr] Samara State Univ Social Sci & Educ, Samara, Russia; [Epimakhov, Andrey] South Ural State Univ, Chelyabinsk, Russia; [Epimakhov, Andrey] Russian Acad Sci, Inst Hist, Ural Branch, Ekaterinburg, Russia; [Epimakhov, Andrey] Russian Acad Sci, Inst Archaeol, Ural Branch, Ekaterinburg, Russia; [Zaibert, Victor F.] Al Farabi Kazakh Natl Univ, Inst Archaeol & Steppe Civilizat, Alma Ata, Kazakhstan; [Outram, Alan K.] Univ Exeter, Dept Archaeol, Exeter, Devon, England; [Kitov, Egor] Russian Acad Sci, Ctr Human Ecol, Inst Ethnol & Anthropol, Moscow, Russia; [Kitov, Egor] Al Farabi Kazakh Natl Univ, Fac Hist Archaeol & Ethnol, Alma Ata, Kazakhstan; [Boivin, Nicole] Univ Queensland, Sch Social Sci, Brisbane, Qld, Australia; [Boivin, Nicole] Univ Calgary, Dept Anthropol & Archaeol, Calgary, AB, Canada; [Boivin, Nicole] Smithsonian Inst, Natl Museum Nat Hist, Dept Anthropol, Washington, DC 20560 USA	University of Geneva; University of Zurich; University of Michigan System; University of Michigan; University of Oxford; Masaryk University Brno; University of Colorado System; University of Colorado Boulder; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; University of California System; University of California Santa Barbara; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Russian Academy of Sciences; Centre Egyptological Studies, Russian Academy of Sciences; Samara State University of Social Sciences & Education; South Ural State University; Russian Academy of Sciences; Russian Academy of Sciences; Al-Farabi Kazakh National University; University of Exeter; Russian Academy of Sciences; N.N. Miklukho-Maklai Institute of Ethnology & Anthropology; Al-Farabi Kazakh National University; University of Queensland; University of Calgary; Smithsonian Institution; Smithsonian National Museum of Natural History	Wilkin, S; Boivin, N (corresponding author), Max Planck Inst Sci Human Hist, Dept Archaeol, Jena, Germany.; Wilkin, S (corresponding author), Univ Zurich, Fac Med, Inst Evolutionary Med, Zurich, Switzerland.; Boivin, N (corresponding author), Univ Queensland, Sch Social Sci, Brisbane, Qld, Australia.; Boivin, N (corresponding author), Univ Calgary, Dept Anthropol & Archaeol, Calgary, AB, Canada.; Boivin, N (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Anthropol, Washington, DC 20560 USA.	wilkin@shh.mpg.de; boivin@shh.mpg.de	Kitov, Egor/Z-6293-2019; Kitov, Egor/F-2489-2017	Kitov, Egor/0000-0002-0159-3288; Kitov, Egor/0000-0002-0159-3288; BOIVIN, NICOLE/0000-0002-7783-4199; Reich, David/0000-0002-7037-5292; Taylor, William/0000-0002-0836-7814; Spengler, Robert/0000-0002-5648-6930; Wilkin, Shevan/0000-0003-0797-6244; Kennett, Douglas/0000-0001-6144-7365	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	Open access funding provided by Max Planck Society.	Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Anthony DW, 2007, HORSE, THE WHEEL, AND LANGUAGE: HOW BRONZE-AGE RIDERS FROM THE EURASIAN STEPPES SHAPED THE MODERN WORLD, P1; Anthony D. W., PRAEHIST Z; Anthony D.W., 2016, BRONZE AGE LANDSCAPE, DOI DOI 10.1186/2041-7136-1-8; Anthony DW, 2015, ANNU REV LINGUIST, V1, P199, DOI 10.1146/annurev-linguist-030514-124812; Anthony DW, 2011, J WORLD PREHIST, V24, P131, DOI 10.1007/s10963-011-9051-9; Bendrey R, 2011, PASTORALISM, V1, DOI 10.1186/2041-7136-1-8; Bleasdale M., 2020, **DATA OBJECT**, DOI 10.5281/zenodo.3698271; Bleasdale M, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20682-3; Burger J, 2020, CURR BIOL, V30, P4307, DOI 10.1016/j.cub.2020.08.033; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Charlton S, 2019, ARCHAEOL ANTHROP SCI, V11, P6183, DOI 10.1007/s12520-019-00911-7; Chechushkov IV, 2018, J WORLD PREHIST, V31, P435, DOI 10.1007/s10963-018-9124-0; Chen Z, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08004-0; Damgaard PD, 2018, SCIENCE, V360, P1422, DOI 10.1126/science.aar7711; Didier J. C., 2009, SINO PLATONIC PAPERS, V192; Fernandes R, 2016, ARCHAEOMETRY, V58, P500, DOI 10.1111/arcm.12193; Fernandes R, 2015, AM J PHYS ANTHROPOL, V158, P325, DOI 10.1002/ajpa.22788; Fernandes R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087436; Frachetti M, 2009, ANTIQUITY, V83, P1023, DOI 10.1017/S0003598X00099324; Frachetti MD, 2012, CURR ANTHROPOL, V53, P2, DOI 10.1086/663692; Gaunitz C, 2018, SCIENCE, V360, P111, DOI 10.1126/science.aao3297; Gerling C., 2015, PREHISTORIC MOBILITY; Gimbutas M., 1982, INDO EUROPEANS 4 3 M, P1, DOI DOI 10.1371/journal.pone.0239861; Gimbutas M., 1997, J INDO EUROPEAN STUD, DOI DOI 10.1073/pnas.1813608115; Greenfield HJ, 2010, WORLD ARCHAEOL, V42, P29, DOI 10.1080/00438240903429722; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Hagan R., 2018, MPI SHH MASCOT REPOR; Hanks BK, 2007, ANTIQUITY, V81, P353, DOI 10.1017/S0003598X00095235; Hanks B, 2018, J ARCHAEOL SCI, V97, P14, DOI 10.1016/j.jas.2018.06.006; Hendy J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06335-6; Jeong C, 2020, CELL, V183, P890, DOI 10.1016/j.cell.2020.10.015; Jeong C, 2018, P NATL ACAD SCI USA, V115, pE11248, DOI 10.1073/pnas.1813608115; Knipper C., 2020, PLOS ONE, V15; Kohl PL, 2007, CAMB WOR ARCHAEOL, P1, DOI 10.1017/CBO9780511618468; Kosintsev P. A., 2006, HORSES HUMANS EVOLUT, P127; Kuznetsov P. F., 2016, BRONZE AGE LANDSCAPE, P71; Levine MA, 1999, J ANTHROPOL ARCHAEOL, V18, P29, DOI 10.1006/jaar.1998.0332; Mallory JP., 1989, SEARCH INDO EUROPEAN, DOI DOI 10.1038/nature11698; Mathieson I, 2015, NATURE, V528, P499, DOI 10.1038/nature16152; Mileto S, 2017, SCI TECHNOL ARCHAEOL, V3, P112, DOI 10.1080/20548923.2018.1443547; Mileto S, 2017, J ARCHAEOL SCI-REP, V13, P67, DOI 10.1016/j.jasrep.2017.03.028; Miller ARV, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-35758-w; Narasimhan VM, 2019, SCIENCE, V365, P999, DOI 10.1126/science.aat7487; Outram AK, 2012, J ARCHAEOL SCI, V39, P2424, DOI 10.1016/j.jas.2012.02.009; Outram AK, 2009, SCIENCE, V323, P1332, DOI 10.1126/science.1168594; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Ramsoe A., 2021, SCI REP-UK, V11; Rassamakin Y., 1999, LATE PREHISTORIC EXP, P59; Reimer PJ, 2020, RADIOCARBON, V62, P725, DOI 10.1017/RDC.2020.41; Reinhold S., 2017, APPROPRIATING INNOVA, P78; Salque M, 2013, NATURE, V493, P522, DOI 10.1038/nature11698; Schulting R. J., 2016, BRONZE AGE LANDSCAPE, P127; SHERRATT A, 1983, WORLD ARCHAEOL, V15, P90, DOI 10.1080/00438243.1983.9979887; Shishlina NI, 2018, RADIOCARBON, V60, P681, DOI 10.1017/RDC.2017.94; Shishlina NI, 2009, RADIOCARBON, V51, P481, DOI 10.1017/S0033822200055879; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Svyatko SV, 2017, RADIOCARBON, V59, P1597, DOI 10.1017/RDC.2017.11; Taylor WTT, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57735-y; Turker C, 2010, P 13 INT C EXTENDING, P717, DOI DOI 10.1145/1739041.1739135; Wang CC, 2021, NATURE, V591, P413, DOI 10.1038/s41586-021-03336-2; Wilkin S, 2020, NAT ECOL EVOL, V4, P346, DOI 10.1038/s41559-020-1120-y	63	13	13	8	30	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 28	2021	598	7882					629	+		10.1038/s41586-021-03798-4	http://dx.doi.org/10.1038/s41586-021-03798-4		SEP 2021	9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	WO9BH	34526723	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000696175300002
J	Schwarzschild, MA; Ascherio, A; Casaceli, C; Curhan, GC; Fitzgerald, R; Kamp, C; Lungu, C; Macklin, EA; Marek, K; Mozaffarian, D; Oakes, D; Rudolph, A; Shoulson, I; Videnovic, A; Scott, B; Gauger, L; Aldred, J; Bixby, M; Ciccarello, J; Gunzler, SA; Henchcliffe, C; Brodsky, M; Keith, K; Hauser, RA; Goetz, C; LeDoux, MS; Hinson, V; Kumar, R; Espay, AJ; Jimenez-Shahed, J; Hunter, C; Christine, C; Daley, A; Leehey, M; de Marcaida, JA; Friedman, JH; Hung, A; Bwala, G; Litvan, I; Simon, DK; Simuni, T; Poon, C; Schiess, MC; Chou, K; Park, A; Bhatti, D; Peterson, C; Criswell, SR; Rosenthal, L; Durphy, J; Shill, HA; Mehta, SH; Ahmed, A; Deik, AF; Fang, JY; Stover, N; Zhang, L; Dewey, RB; Gerald, A; Boyd, JT; Houston, E; Suski, V; Mosovsky, S; Cloud, L; Shah, BB; Saint-Hilaire, M; James, R; Zauber, SE; Reich, S; Shprecher, D; Pahwa, R; Langhammer, A; LaFaver, K; LeWitt, PA; Kaminski, P; Goudreau, J; Russell, D; Houghton, DJ; Laroche, A; Thomas, K; McGraw, M; Mari, Z; Serrano, C; Blindauer, K; Rabin, M; Kurlan, R; Morgan, JC; Soileau, M; Ainslie, M; Bodis-Wollner, I; Schneider, RB; Waters, C; Ratel, AS; Beck, CA; Bolger, P; Callahan, KF; Crotty, GF; Klements, D; Kostrzebski, M; McMahon, GM; Pothier, L; Waikar, SS; Lang, A; Mestre, T				Schwarzschild, Michael A.; Ascherio, Alberto; Casaceli, Cindy; Curhan, Gary C.; Fitzgerald, Rebecca; Kamp, Cornelia; Lungu, Codrin; Macklin, Eric A.; Marek, Kenneth; Mozaffarian, Dariush; Oakes, David; Rudolph, Alice; Shoulson, Ira; Videnovic, Aleksandar; Scott, Burton; Gauger, Lisa; Aldred, Jason; Bixby, Melissa; Ciccarello, Jill; Gunzler, Steven A.; Henchcliffe, Claire; Brodsky, Matthew; Keith, Kellie; Hauser, Robert A.; Goetz, Christopher; LeDoux, Mark S.; Hinson, Vanessa; Kumar, Rajeev; Espay, Alberto J.; Jimenez-Shahed, Joohi; Hunter, Christine; Christine, Chadwick; Daley, Aaron; Leehey, Maureen; de Marcaida, J. Antonelle; Friedman, Joseph Harold; Hung, Albert; Bwala, Grace; Litvan, Irene; Simon, David K.; Simuni, Tanya; Poon, Cynthia; Schiess, Mya C.; Chou, Kelvin; Park, Ariane; Bhatti, Danish; Peterson, Carolyn; Criswell, Susan R.; Rosenthal, Liana; Durphy, Jennifer; Shill, Holly A.; Mehta, Shyamal H.; Ahmed, Anwar; Deik, Andres F.; Fang, John Y.; Stover, Natividad; Zhang, Lin; Dewey, Richard B., Jr.; Gerald, Ashley; Boyd, James T.; Houston, Emily; Suski, Valerie; Mosovsky, Sherri; Cloud, Leslie; Shah, Binit B.; Saint-Hilaire, Marie; James, Raymond; Zauber, Sarah Elizabeth; Reich, Stephen; Shprecher, David; Pahwa, Rajesh; Langhammer, April; LaFaver, Kathrin; LeWitt, Peter A.; Kaminski, Patricia; Goudreau, John; Russell, Doozie; Houghton, David J.; Laroche, Ashley; Thomas, Karen; McGraw, Martha; Mari, Zoltan; Serrano, Carmen; Blindauer, Karen; Rabin, Marcie; Kurlan, Roger; Morgan, John C.; Soileau, Michael; Ainslie, Melissa; Bodis-Wollner, Ivan; Schneider, Ruth B.; Waters, Cheryl; Ratel, Amber Servi; Beck, Christopher A.; Bolger, Patrick; Callahan, Katherine F.; Crotty, Grace F.; Klements, David; Kostrzebski, Melissa; McMahon, Gearoid Michael; Pothier, Lindsay; Waikar, Sushrut S.; Lang, Anthony; Mestre, Tiago		Parkinson Study Grp SURE-PD3 Inves	Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							URIC-ACID LEVELS; SERUM URATE; RISK; PREDICTOR; OXIDASE	Key PointsQuestionDoes treatment with oral inosine for up to 2 years slow progression of Parkinson disease? FindingsIn this randomized clinical trial that included 298 participants with early Parkinson disease, the rate of clinical disease progression as measured by the Movement Disorder Society Unified Parkinson Disease Rating Scale (parts I-III) total score prior to initiation of dopaminergic medication was 11.1 points per year in the inosine group and 9.9 points per year in the placebo group, a difference that was not statistically significant. MeaningUrate-elevating inosine treatment was not clinically beneficial in early Parkinson disease. ImportanceUrate elevation, despite associations with crystallopathic, cardiovascular, and metabolic disorders, has been pursued as a potential disease-modifying strategy for Parkinson disease (PD) based on convergent biological, epidemiological, and clinical data. ObjectiveTo determine whether sustained urate-elevating treatment with the urate precursor inosine slows early PD progression. Design, Participants, and SettingRandomized, double-blind, placebo-controlled, phase 3 trial of oral inosine treatment in early PD. A total of 587 individuals consented, and 298 with PD not yet requiring dopaminergic medication, striatal dopamine transporter deficiency, and serum urate below the population median concentration (<5.8 mg/dL) were randomized between August 2016 and December 2017 at 58 US sites, and were followed up through June 2019. InterventionsInosine, dosed by blinded titration to increase serum urate concentrations to 7.1-8.0 mg/dL (n=149) or matching placebo (n=149) for up to 2 years. Main Outcomes and MeasuresThe primary outcome was rate of change in the Movement Disorder Society Unified Parkinson Disease Rating Scale (MDS-UPDRS; parts I-III) total score (range, 0-236; higher scores indicate greater disability; minimum clinically important difference of 6.3 points) prior to dopaminergic drug therapy initiation. Secondary outcomes included serum urate to measure target engagement, adverse events to measure safety, and 29 efficacy measures of disability, quality of life, cognition, mood, autonomic function, and striatal dopamine transporter binding as a biomarker of neuronal integrity. ResultsBased on a prespecified interim futility analysis, the study closed early, with 273 (92%) of the randomized participants (49% women; mean age, 63 years) completing the study. Clinical progression rates were not significantly different between participants randomized to inosine (MDS-UPDRS score, 11.1 [95% CI, 9.7-12.6] points per year) and placebo (MDS-UPDRS score, 9.9 [95% CI, 8.4-11.3] points per year; difference, 1.26 [95% CI, -0.59 to 3.11] points per year; P=.18). Sustained elevation of serum urate by 2.03 mg/dL (from a baseline level of 4.6 mg/dL; 44% increase) occurred in the inosine group vs a 0.01-mg/dL change in serum urate in the placebo group (difference, 2.02 mg/dL [95% CI, 1.85-2.19 mg/dL]; P<.001). There were no significant differences for secondary efficacy outcomes including dopamine transporter binding loss. Participants randomized to inosine, compared with placebo, experienced fewer serious adverse events (7.4 vs 13.1 per 100 patient-years) but more kidney stones (7.0 vs 1.4 stones per 100 patient-years). Conclusions and RelevanceAmong patients recently diagnosed as having PD, treatment with inosine, compared with placebo, did not result in a significant difference in the rate of clinical disease progression. The findings do not support the use of inosine as a treatment for early PD. Trial RegistrationClinicalTrials.gov Identifier: NCT02642393 This randomized clinical trial assesses whether sustained urate-elevating treatment with the urate precursor inosine, compared with placebo, slows rate of clinical disease progression among patients with early Parkinson disease.	[Schwarzschild, Michael A.] Mass Gen Inst Neurodegenerat Dis, Boston, MA USA; [Schwarzschild, Michael A.; Macklin, Eric A.; Videnovic, Aleksandar; Hung, Albert; Bwala, Grace; Callahan, Katherine F.; Crotty, Grace F.; Klements, David; Pothier, Lindsay] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Ascherio, Alberto] Harvard Sch Publ Hlth, Boston, MA USA; [Casaceli, Cindy; Kamp, Cornelia; Oakes, David; Rudolph, Alice; Schneider, Ruth B.; Bolger, Patrick; Kostrzebski, Melissa] Univ Rochester, Rochester, NY USA; [Curhan, Gary C.; McMahon, Gearoid Michael] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Fitzgerald, Rebecca] Parkinsons Fdn, Parkinsons Fdn Res Advocates, New York, NY USA; [Lungu, Codrin] Natl Inst Neurol Disorders & Stroke, Div Clin Res, Bethesda, MD USA; [Macklin, Eric A.] Harvard Med Sch, Boston, MA 02115 USA; [Marek, Kenneth] Inst Neurodegenerat Disorders, New Haven, CT USA; [Mozaffarian, Dariush] Tufts Med Ctr, Tufts Sch Med, Boston, MA 02111 USA; [Mozaffarian, Dariush] Tufts Med Ctr, Div Cardiol, Boston, MA 02111 USA; [Mozaffarian, Dariush] Friedman Sch Nutr Sci & Policy, Boston, MA USA; [Shoulson, Ira] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Scott, Burton] Duke Univ, Durham, NC USA; [Gauger, Lisa] Duke Med Ctr, Durham, NC USA; [Aldred, Jason; Bixby, Melissa; Ciccarello, Jill] Inland Northwest Res, Spokane, WA USA; [Aldred, Jason] Selkirk Neurol, Spokane, WA USA; [Gunzler, Steven A.] Univ Hosp Cleveland, Med Ctr, Cleveland, OH 44106 USA; [Henchcliffe, Claire] Univ Calif Irvine, Irvine, CA USA; [Henchcliffe, Claire] Weill Cornell Med Coll, New York, NY USA; [Brodsky, Matthew; Keith, Kellie] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Hauser, Robert A.] Univ S Florida, Tampa, FL 33620 USA; [Goetz, Christopher] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [LeDoux, Mark S.] Verac Neurosci LLC, Memphis, TN USA; [Hinson, Vanessa] Med Univ South Carolina, Charleston, SC 29425 USA; [Kumar, Rajeev] Rocky Mt Movement Disorders Ctr, Englewood, CO USA; [Espay, Alberto J.] Univ Cincinnati, Cincinnati, OH USA; [Jimenez-Shahed, Joohi] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Hunter, Christine] Baylor Coll Med, Houston, TX 77030 USA; [Christine, Chadwick; Daley, Aaron] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Leehey, Maureen] Univ Colorado, Denver, CO 80202 USA; [de Marcaida, J. Antonelle] Hartford HealthCare, Ayer Neurosci Inst, Hartford, CT USA; [Friedman, Joseph Harold] Butler Hosp, Providence, RI 02906 USA; [Litvan, Irene] Univ Calif San Diego, San Diego, CA 92103 USA; [Simon, David K.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Simuni, Tanya; Poon, Cynthia; LaFaver, Kathrin] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Schiess, Mya C.] Univ Texas Hlth Sci Ctr Houston, Houston McGovern Med Sch, Houston, TX 77030 USA; [Chou, Kelvin] Univ Michigan, Ann Arbor, MI 48109 USA; [Park, Ariane] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA; [Bhatti, Danish; Peterson, Carolyn] Univ Nebraska Med Ctr, Omaha, NE USA; [Criswell, Susan R.] Washington Univ, Sch Med, St Louis, MO USA; [Rosenthal, Liana] Johns Hopkins Sch Med, Baltimore, MD USA; [Durphy, Jennifer] Albany Med Coll, Albany, NY 12208 USA; [Shill, Holly A.; Shprecher, David] Banner Sun Hlth Res Inst, Sun City, AZ USA; [Shill, Holly A.; Shprecher, David] Univ Arizona, Sch Med, Phoenix, AZ USA; [Mehta, Shyamal H.] Mayo Clin Arizona, Scottsdale, AZ USA; [Ahmed, Anwar] Cleveland Clin, Cleveland, OH 44106 USA; [Deik, Andres F.] Univ Penn, Philadelphia, PA 19104 USA; [Fang, John Y.] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Stover, Natividad] Univ Alabama Birmingham, Birmingham, AL USA; [Zhang, Lin] Univ Calif Davis, Davis, CA USA; [Dewey, Richard B., Jr.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Boyd, James T.] Univ Vermont, Burlington, VT USA; [Houston, Emily] Univ Vermont, Med Ctr, Burlington, VT USA; [Suski, Valerie; Mosovsky, Sherri] Univ Pittsburgh, Pittsburgh, PA USA; [Cloud, Leslie] VCU Parkinsons & Movement Disorders Ctr, Richmond, VA USA; [Shah, Binit B.] Univ Virginia, Charlottesville, VA USA; [Saint-Hilaire, Marie; Waikar, Sushrut S.] Boston Univ, Sch Med, Boston, MA 02118 USA; [James, Raymond; Waikar, Sushrut S.] Boston Med Ctr, Boston, MA USA; [Zauber, Sarah Elizabeth] Indiana Univ, Bloomington, IN USA; [Reich, Stephen] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Pahwa, Rajesh; Langhammer, April] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA; [LeWitt, Peter A.; Kaminski, Patricia] Henry Ford Hosp, West Bloomfield Township, MI USA; [Goudreau, John; Russell, Doozie] Michigan State Univ, E Lansing, MI 48824 USA; [Houghton, David J.] Ochsner Med Ctr, Jefferson, LA USA; [Laroche, Ashley] Ochsner Hlth Syst, Jefferson, LA USA; [Thomas, Karen] Sentara Neurol Specialists, Norfolk, VA USA; [McGraw, Martha] Cent DuPage Hosp, Ctr Movement Disorders & Neurodegenerat Dis, Northwestern Med, Winfield, IL USA; [Mari, Zoltan] Cleveland Clin, Las Vegas, NV USA; [Serrano, Carmen] Univ Puerto Rico, San Juan, PR 00936 USA; [Blindauer, Karen] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Rabin, Marcie; Kurlan, Roger] Atlantic Neurosci Inst, Summit, NJ USA; [Morgan, John C.] Augusta Univ, Augusta, GA USA; [Soileau, Michael] Texas Movement Disorder Specialists, Georgetown, TX USA; [Soileau, Michael] Texas A&M Univ, Scott & White Healthcare, Temple, TX USA; [Ainslie, Melissa] Baylor Scott & White Hlth, Temple, TX USA; [Bodis-Wollner, Ivan] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA; [Waters, Cheryl; Ratel, Amber Servi] Columbia Univ, New York, NY USA; [Beck, Christopher A.] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Lang, Anthony] Univ Toronto, Toronto, ON, Canada; [Lang, Anthony] Toronto Western Hosp, Edmond J Safra Program Parkinsons Dis, Toronto, ON, Canada; [Mestre, Tiago] Univ Ottawa, Ottawa, ON, Canada	Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; University of Rochester; Harvard University; Brigham & Women's Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Harvard University; Harvard Medical School; Tufts Medical Center; Tufts Medical Center; University of Rochester; Duke University; Duke University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; University of California System; University of California Irvine; Cornell University; Oregon Health & Science University; State University System of Florida; University of South Florida; Rush University; Medical University of South Carolina; University System of Ohio; University of Cincinnati; Icahn School of Medicine at Mount Sinai; Baylor College of Medicine; University of California System; University of California San Francisco; University of Colorado System; University of Colorado Denver; Butler Hospital Rhode Island; University of California System; University of California San Diego; Harvard University; Beth Israel Deaconess Medical Center; Northwestern University; Feinberg School of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Michigan System; University of Michigan; University System of Ohio; Ohio State University; University of Nebraska System; University of Nebraska Medical Center; Washington University (WUSTL); Johns Hopkins University; Johns Hopkins Medicine; Albany Medical College; Banner Research; Banner Health; Banner Sun Health Research Institute; University of Arizona; Mayo Clinic; Mayo Clinic Phoenix; Cleveland Clinic Foundation; University of Pennsylvania; Vanderbilt University; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Davis; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Vermont; University of Vermont; University of Vermont Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Virginia Commonwealth University; University of Virginia; Boston University; Boston Medical Center; Indiana University System; Indiana University Bloomington; University System of Maryland; University of Maryland Baltimore; University of Kansas; University of Kansas Medical Center; Henry Ford Health System; Michigan State University; Ochsner Health System; Ochsner Health System; Sentara Healthcare; Northwestern University; Feinberg School of Medicine; Cleveland Clinic Foundation; University of Puerto Rico; Medical College of Wisconsin; University System of Georgia; Augusta University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Baylor Health Care System; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Columbia University; University of Rochester; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Ottawa	Schwarzschild, MA (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Mass Gen Inst Neurodegenerat Dis, 114 16th St, Boston, MA 02129 USA.	michaels@helix.mgh.harvard.edu	Macklin, Eric A/E-2955-2013; Mari, Zoltan/CAG-2209-2022; Lang, Anthony/ABF-8114-2021; Dewey, Richard B/A-4288-2013	Macklin, Eric A/0000-0003-1618-3502; Dewey, Richard B/0000-0002-6615-5035; Poon, Cynthia/0000-0001-9012-9809; LaRoche, Ashley/0000-0003-0197-0853; Gunzler, Steven/0000-0003-2635-9022; LaFaver, Kathrin/0000-0001-5416-894X; Stover, Natividad/0000-0001-9684-1813	NINDS NIH HHS [U01 NS090259, U01 NS089666] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ascherio A, 2009, ARCH NEUROL-CHICAGO, V66, P1460, DOI 10.1001/archneurol.2009.247; Bandres-Ciga S, 2020, ACTA NEUROPATHOL, V140, P341, DOI 10.1007/s00401-020-02181-3; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bhattacharyya S, 2016, MOVEMENT DISORD, V31, P417, DOI 10.1002/mds.26483; Chen XQ, 2013, P NATL ACAD SCI USA, V110, P300, DOI 10.1073/pnas.1217296110; Crotty GF, 2017, EXP NEUROL, V298, P210, DOI 10.1016/j.expneurol.2017.06.017; Davis JW, 1996, AM J EPIDEMIOL, V144, P480, DOI 10.1093/oxfordjournals.aje.a008954; de Lau LML, 2005, ANN NEUROL, V58, P797, DOI 10.1002/ana.20663; Grinnon ST, 2012, CLIN TRIALS, V9, P322, DOI 10.1177/1740774512438980; Guerreiro S, 2009, J NEUROCHEM, V109, P1118, DOI 10.1111/j.1471-4159.2009.06040.x; Hauser RA, 2011, MOVEMENT DISORD, V26, P813, DOI 10.1002/mds.23638; Kia DA, 2018, ANN NEUROL, V84, P191, DOI 10.1002/ana.25294; Kobylecki CJ, 2018, ANN NEUROL, V84, P178, DOI 10.1002/ana.25292; Moccia M, 2015, EUR J NEUROL, V22, P93, DOI 10.1111/ene.12533; Nazeri A, 2015, ANN NEUROL, V78, P731, DOI 10.1002/ana.24504; Poewe W, 2020, NEUROPHARMACOLOGY, V171, DOI 10.1016/j.neuropharm.2020.108085; Romero K, 2019, CTS-CLIN TRANSL SCI, V12, P240, DOI 10.1111/cts.12619; Schwarzschild MA, 2008, ARCH NEUROL-CHICAGO, V65, P716, DOI 10.1001/archneur.2008.65.6.nct70003; Schwarzschild MA, 2019, NEUROLOGY, V93, pE1328, DOI 10.1212/WNL.0000000000008194; Schwarzschild MA, 2014, JAMA NEUROL, V71, P141, DOI 10.1001/jamaneurol.2013.5528; Simon KC, 2014, ANN NEUROL, V76, P862, DOI 10.1002/ana.24281; Sleeman I, 2019, J PARKINSON DIS, V9, P351, DOI 10.3233/JPD-181535; Stephenson D, 2019, J PARKINSON DIS, V9, P825, DOI 10.3233/JPD-199003; Weisskopf MG, 2007, AM J EPIDEMIOL, V166, P561, DOI 10.1093/aje/kwm127; WU XW, 1992, J MOL EVOL, V34, P78, DOI 10.1007/BF00163854; Yamamoto T, 2002, METABOLISM, V51, P438, DOI 10.1053/meta.2002.31322	26	31	31	2	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2021	326	10					926	939		10.1001/jama.2021.10207	http://dx.doi.org/10.1001/jama.2021.10207			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UW4LI	34519802	Green Published, Bronze			2022-12-28	WOS:000700129100012
J	Sittig, DF; Singh, H				Sittig, Dean F.; Singh, Hardeep			Policies to Promote Shared Responsibility for Safer Electronic Health Records	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ERRORS		[Sittig, Dean F.] Univ Texas Houston, Mem Hermann Ctr Healthcare Qual & Safety, Houston, TX 77030 USA; [Sittig, Dean F.] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Houston, TX 77030 USA; [Singh, Hardeep] Michael E DeBakey VA Med Ctr, Ctr Innovat Qual Effectiveness & Safety, Houston, TX USA; [Singh, Hardeep] Baylor Coll Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Baylor College of Medicine	Sittig, DF (corresponding author), Univ Texas Houston, Univ Texas Hlth Sci Ctr Houston, Mem Hermann Ctr Healthcare Qual & Safety, 6410 Fannin St, Houston, TX 77030 USA.	Dean.F.Sittig@uth.tmc.edu	Sittig, Dean/D-2471-2009	Sittig, Dean/0000-0001-5811-8915				Adelman JS, 2019, JAMA-J AM MED ASSOC, V321, P1780, DOI 10.1001/jama.2019.3698; [Anonymous], 2020, FED REGISTER, V85, P84472; [Anonymous], 2021, FED REGISTER, V86, P44774; Classen DC, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.5547; Pacheco TB, 2019, JAMA-J AM MED ASSOC, V322, P2339, DOI 10.1001/jama.2019.17242; SAFER Guides, OFF NAT COOR HLTH IN; Sittig DF, 2018, HEALTHCARE-J DEL SCI, V6, P7, DOI 10.1016/j.hjdsi.2017.06.004; Sittig DF, 2017, JT COMM J QUAL PATIE, V43, P540, DOI 10.1016/j.jcjq.2017.06.005; Sittig DF, 2011, ARCH INTERN MED, V171, P1281, DOI 10.1001/archinternmed.2011.327; Sittig DF, 2016, PATIENT IDENTIFICATI	10	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 19	2021	326	15					1477	1478		10.1001/jama.2021.13945	http://dx.doi.org/10.1001/jama.2021.13945		SEP 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WN1OX	34505867				2022-12-28	WOS:000695637300002
J	Smith, JW				Smith, Jason W.			The Blue Age	SCIENCE			English	Book Review									[Smith, Jason W.] Southern Connecticut State Univ, Dept Hist, New Haven, CT 06515 USA	Connecticut State University System; Southern Connecticut State University	Smith, JW (corresponding author), Southern Connecticut State Univ, Dept Hist, New Haven, CT 06515 USA.	smithj131@southernct.edu						EASTERBROOK G, 2021, THE BLUE AGE	1	0	0	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2021	373	6560					1205	1205		10.1126/science.abj9481	http://dx.doi.org/10.1126/science.abj9481			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UP5RB	34516783				2022-12-28	WOS:000695436000017
J	De Cia, A; Jenkins, EB; Fox, AJ; Ledoux, C; Ramburth-Hurt, T; Konstantopoulou, C; Petitjean, P; Krogager, JK				De Cia, Annalisa; Jenkins, Edward B.; Fox, Andrew J.; Ledoux, Cedric; Ramburth-Hurt, Tanita; Konstantopoulou, Christina; Petitjean, Patrick; Krogager, Jens-Kristian			Large metallicity variations in the Galactic interstellar medium	NATURE			English	Article							CHEMICAL EVOLUTION; ELEMENT DEPLETIONS; ABUNDANCE RATIOS; STAR-FORMATION; IONIZED-GAS; MILKY-WAY; ABSORPTION; GALAXY; DISK; SCALE	The interstellar medium (ISM) comprises gases at different temperatures and densities, including ionized, atomic and molecular species, and dust particles(1). The neutral ISM is dominated by neutral hydrogen(2) and has ionization fractions of up to eight per cent(3). The concentration of chemical elements heavier than helium (metallicity) spans orders of magnitudes in Galactic stars(4), because they formed at different times. However, the gas in the vicinity of the Sun is assumed to be well mixed and to have a solar metallicity in traditional chemical evolution models(5). The ISM chemical abundances can be accurately measured with ultraviolet absorption-line spectroscopy. However, the effects of dust depletion(6-9)-which removes part of the metals from the observable gaseous phase and incorporates it into solid grains-have prevented, until recently, a deeper investigation of the ISM metallicity. Here we report the dust-corrected metallicity of the neutral ISM measured towards 25 stars in our Galaxy. We find large variations in metallicity over a factor of ten (with an average of 55 +/- 7 per cent solar metallicity and a standard deviation of 0.28 dex), including many regions of low metallicity, down to about 17 per cent solar metallicity and possibly below. Pristine gas falling onto the Galactic disk in the form of high-velocity clouds can cause the observed chemical inhomogeneities on scales of tens of parsecs. Our results suggest that this low-metallicity accreting gas does not efficiently mix into the ISM, which may help us understand metallicity deviations in nearby coeval stars. The metallicity of the interstellar medium measured towards 25 stars relatively near the Sun shows large variations, suggesting that infalling pristine gas is not efficiently mixed in the interstellar medium.	[De Cia, Annalisa; Ramburth-Hurt, Tanita; Konstantopoulou, Christina; Krogager, Jens-Kristian] Univ Geneva, Dept Astron, Versoix, Switzerland; [Jenkins, Edward B.] Princeton Univ Observ, Peyton Hall, Princeton, NJ 08544 USA; [Fox, Andrew J.] Space Telescope Sci Inst, AURA ESA, 3700 San Martin Dr, Baltimore, MD 21218 USA; [Ledoux, Cedric] European Southern Observ, Vitacura, Chile; [Petitjean, Patrick] Sorbonne Univ, Inst Astrophys Paris, Paris, France; [Petitjean, Patrick] CNRS, Paris, France	University of Geneva; Princeton University; Space Telescope Science Institute; European Southern Observatory; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS)	De Cia, A (corresponding author), Univ Geneva, Dept Astron, Versoix, Switzerland.	annalisa.decia@unige.ch	; Krogager, Jens-Kristian/E-4384-2015; Jenkins, Edward/P-5684-2014	Konstantopoulou, Christina/0000-0002-4690-0157; De Cia, Annalisa/0000-0003-2082-1626; Fox, Andrew/0000-0003-0724-4115; Krogager, Jens-Kristian/0000-0002-4912-9388; Jenkins, Edward/0000-0003-1892-4423				Andrews SM, 2001, ASTROPHYS J, V552, pL73, DOI 10.1086/320267; [Anonymous], 2016, AA, DOI [10.1051/0004-6361/201629272, DOI 10.1051/0004-6361/201629272]; Arellano-Cordova KZ, 2020, MON NOT R ASTRON SOC, V496, P1051, DOI 10.1093/mnras/staa1523; Balser DS, 2015, ASTROPHYS J, V806, DOI 10.1088/0004-637X/806/2/199; Boisse P, 2019, ASTRON ASTROPHYS, V622, DOI 10.1051/0004-6361/201834308; Bowen DV, 2008, ASTROPHYS J SUPPL S, V176, P59, DOI 10.1086/524773; Brown AGA, 2018, ASTRON ASTROPHYS, V616, DOI 10.1051/0004-6361/201833051; Cashman FH, 2017, ASTROPHYS J SUPPL S, V230, DOI 10.3847/1538-4365/aa6d84; Cheng JY, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/2/149; Chiappini C, 1997, ASTROPHYS J, V477, P765, DOI 10.1086/303726; de Avillez MA, 2002, ASTROPHYS J, V581, P1047, DOI 10.1086/344256; De Cia A, 2016, ASTRON ASTROPHYS, V596, DOI 10.1051/0004-6361/201527895; De Cia A, 2018, ASTRON ASTROPHYS, V613, DOI 10.1051/0004-6361/201833034; De Cia A, 2018, ASTRON ASTROPHYS, V611, DOI 10.1051/0004-6361/201731970; DIPLAS A, 1994, ASTROPHYS J SUPPL S, V93, P211, DOI 10.1086/192052; Draine BT, 2011, PR S ASTROP, P1; EDMUNDS MG, 1975, ASTROPHYS SPACE SCI, V32, P483, DOI 10.1007/BF00643158; EDVARDSSON B, 1993, ASTRON ASTROPHYS, V275, P101; Esteban C, 2018, MON NOT R ASTRON SOC, V478, P2315, DOI 10.1093/mnras/sty1168; Esteban C, 2004, MON NOT R ASTRON SOC, V355, P229, DOI 10.1111/j.1365-2966.2004.08313.x; FIELD GB, 1974, ASTROPHYS J, V187, P453, DOI 10.1086/152654; Fox A, 2017, ASTROPHYS SPACE SC L, V430, pVII; Fox AJ, 2019, ASTROPHYS J, V884, DOI 10.3847/1538-4357/ab40ad; GARNET DR, 1995, ASTROPHYS J, V449, pL77, DOI 10.1086/309620; Gritton JA, 2014, ASTROPHYS J, V795, DOI 10.1088/0004-637X/795/1/99; Heitsch F, 2009, ASTROPHYS J, V698, P1485, DOI 10.1088/0004-637X/698/2/1485; Jenkins EB, 2006, ASTROPHYS J, V637, P548, DOI 10.1086/498226; Jenkins EB, 1996, ASTROPHYS J, V471, P292, DOI 10.1086/177969; JENKINS EB, 1986, ASTROPHYS J, V301, P355, DOI 10.1086/163906; Jenkins EB, 2019, ASTROPHYS J, V872, DOI 10.3847/1538-4357/aafe81; Jenkins EB, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/1/25; Jenkins EB, 2009, ASTROPHYS J, V700, P1299, DOI 10.1088/0004-637X/700/2/1299; Kisielius R, 2015, ASTROPHYS J, V804, DOI 10.1088/0004-637X/804/1/76; Kreckel K, 2019, ASTROPHYS J, V887, DOI 10.3847/1538-4357/ab5115; Kreckel K, 2020, MON NOT R ASTRON SOC, V499, P193, DOI 10.1093/mnras/staa2743; Krogager J.-K., 2018, VOIGTFIT PYTHON PACK; Lehner N, 2011, SCIENCE, V334, P955, DOI 10.1126/science.1209069; Matteucci F., 2012, CHEM EVOLUTION GALAX; McMillan PJ, 2011, MON NOT R ASTRON SOC, V414, P2446, DOI 10.1111/j.1365-2966.2011.18564.x; McWilliam A, 1997, ANNU REV ASTRON ASTR, V35, P503, DOI 10.1146/annurev.astro.35.1.503; Morton DC, 2003, ASTROPHYS J SUPPL S, V149, P205, DOI 10.1086/377639; Nasoudi-Shoar S, 2010, ASTRON ASTROPHYS, V520, DOI 10.1051/0004-6361/200913454; PHILLIPS AP, 1982, MON NOT R ASTRON SOC, V200, P687, DOI 10.1093/mnras/200.3.687; Pilyugin LS, 1996, ASTRON ASTROPHYS, V313, P792; Price RJ, 2001, MON NOT R ASTRON SOC, V328, P555, DOI 10.1046/j.1365-8711.2001.04893.x; Putman ME, 2012, ANNU REV ASTRON ASTR, V50, P491, DOI 10.1146/annurev-astro-081811-125612; Richter P., 2017, GAS ACCRETION ONTO M, V430; Roman-Duval J, 2021, ASTROPHYS J, V910, DOI 10.3847/1538-4357/abdeb6; RUBIN RH, 1993, ASTROPHYS J, V413, P242, DOI 10.1086/172992; SAVAGE BD, 1977, ASTROPHYS J, V216, P291, DOI 10.1086/155471; Savage BD, 1996, ANNU REV ASTRON ASTR, V34, P279, DOI 10.1146/annurev.astro.34.1.279; SAVAGE BD, 1991, ASTROPHYS J, V379, P245, DOI 10.1086/170498; SEMBACH KR, 1992, ASTROPHYS J SUPPL S, V83, P147, DOI 10.1086/191734; Simon-Diaz S, 2011, ASTRON ASTROPHYS, V526, DOI 10.1051/0004-6361/201015512; Simon-Diaz S, 2010, ASTRON ASTROPHYS, V510, DOI 10.1051/0004-6361/200913120; TOSI M, 1988, ASTRON ASTROPHYS, V197, P47; Valencic LA, 2004, ASTROPHYS J, V616, P912, DOI 10.1086/424922; VIEGAS SM, 1995, MON NOT R ASTRON SOC, V276, P268; Wang E, 2021, ASTROPHYS J, V910, DOI 10.3847/1538-4357/abe413; Welty DE, 2020, ASTROPHYS J, V897, DOI 10.3847/1538-4357/ab8f8e; Welty DE, 2010, MON NOT R ASTRON SOC, V404, P1321, DOI 10.1111/j.1365-2966.2010.16386.x; Wendt M, 2021, MON NOT R ASTRON SOC, V502, P3733, DOI 10.1093/mnras/stab049; WHITE SDM, 1983, MON NOT R ASTRON SOC, V203, P603, DOI 10.1093/mnras/203.3.603; Wiseman P, 2017, ASTRON ASTROPHYS, V599, DOI 10.1051/0004-6361/201629228; Wright RJ, 2021, MON NOT R ASTRON SOC, V504, P5702, DOI 10.1093/mnras/stab1057	65	17	17	3	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 9	2021	597	7875					206	+		10.1038/s41586-021-03780-0	http://dx.doi.org/10.1038/s41586-021-03780-0			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UQ1FZ	34497395	Green Submitted			2022-12-28	WOS:000695818300010
J	Schiermeier, Q				Schiermeier, Quirin			THE SCIENCE THAT SUPPORTS CLIMATE LAWSUITS	NATURE			English	News Item																		Barros V, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, pIX; Higham, 2021, GLOBAL TRENDS CLIMAT; IPCC, 2021, CONTRIBUTION WORKING, DOI DOI 10.1007/S10584-021-03233-7; Shen MC, 2020, J CLEAN PROD, V254, DOI 10.1016/j.jclepro.2020.120138; Stuart-Smith RF, 2021, NAT CLIM CHANGE, V11, P651, DOI 10.1038/s41558-021-01086-7	5	5	5	0	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 9	2021	597	7875					169	171		10.1038/d41586-021-02424-7	http://dx.doi.org/10.1038/d41586-021-02424-7			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UQ1FZ	34497398				2022-12-28	WOS:000695818300006
J	Phipatanakul, W; Koutrakis, P; Coull, BA; Petty, CR; Gaffin, JM; Sheehan, WJ; Lai, PS; Bartnikas, LM; Kang, CM; Wolfson, JM; Samnaliev, M; Cunningham, A; Baxi, SN; Permaul, P; Hauptman, M; Trivedi, M; Louisias, M; Liang, LM; Thorne, PS; Metwali, N; Adamkiewicz, G; Israel, E; Baccarelli, AA; Gold, DR				Phipatanakul, Wanda; Koutrakis, Petros; Coull, Brent A.; Petty, Carter R.; Gaffin, Jonathan M.; Sheehan, William J.; Lai, Peggy S.; Bartnikas, Lisa M.; Kang, Choong-Min; Wolfson, Jack M.; Samnaliev, Mihail; Cunningham, Amparito; Baxi, Sachin N.; Permaul, Perdita; Hauptman, Marissa; Trivedi, Michelle; Louisias, Margee; Liang, Liming; Thorne, Peter S.; Metwali, Nervana; Adamkiewicz, Gary; Israel, Elliot; Baccarelli, Andrea A.; Gold, Diane R.		Sch Inner-City Asthma Intervention	Effect of School Integrated Pest Management or Classroom Air Filter Purifiers on Asthma Symptoms in Students With Active Asthma: A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MOUSE ALLERGEN EXPOSURE; INNER-CITY CHILDREN; ENVIRONMENTAL INTERVENTION; MORBIDITY; VALIDATION	Key PointsQuestionDoes use of a school-wide integrated pest management (IPM) program or high-efficiency particulate air (HEPA) filter purifiers in the classrooms reduce asthma symptoms in students with active asthma? FindingsThis factorial randomized clinical trial included 236 students (attending 41 elementary schools with 209 classrooms) randomized to an IPM program at the school level, use of HEPA filter purifiers at the classroom level, or both. Use of the school-wide IPM program resulted in a mean of 1.5 symptom-days with asthma during a 2-week period vs 1.9 symptom-days for no IPM; use of HEPA filter purifiers resulted in a mean of 1.6 symptom-days with asthma vs 1.8 symptom-days for sham HEPA filter purifiers; neither comparison was statistically significant. MeaningAmong children with active asthma, use of a school-wide IPM program or HEPA filter purifiers in the classrooms did not significantly reduce symptom-days with asthma. ImportanceSchool and classroom allergens and particles are associated with asthma morbidity, but the benefit of environmental remediation is not known. ObjectiveTo determine whether use of a school-wide integrated pest management (IPM) program or high-efficiency particulate air (HEPA) filter purifiers in the classrooms improve asthma symptoms in students with active asthma. Design, Setting, and ParticipantsFactorial randomized clinical trial of a school-wide IPM program and HEPA filter purifiers in the classrooms was conducted from 2015 to 2020 (School Inner-City Asthma Intervention Study). There were 236 students with active asthma attending 41 participating urban elementary schools located in the Northeastern US who were randomized to IPM by school and HEPA filter purifiers by classroom. The date of final follow-up was June 20, 2020. InterventionsThe school-wide IPM program consisted of application of rodenticide, sealing entry points, trap placement, targeted cleaning, and brief educational handouts for school staff. Infestation was assessed every 3 months, with additional treatments as needed. Control schools received no IPM, cleaning, or education. Classroom portable HEPA filter purifiers were deployed and the filters were changed every 3 months. Control classrooms received sham HEPA filters that looked and sounded like active HEPA filter purifiers. Randomization was done independently (split-plot design), with matching by the number of enrolled students to ensure a nearly exact 1:1 student ratio for each intervention with 118 students randomized to each group. Participants, investigators, and those assessing outcomes were blinded to the interventions. Main Outcomes and MeasuresThe primary outcome was the number of symptom-days with asthma during a 2-week period. Symptom-days were assessed every 2 months during the 10 months after randomization. ResultsAmong the 236 students who were randomized (mean age, 8.1 [SD, 2.0] years; 113 [48%] female), all completed the trial. At baseline, the 2-week mean was 2.2 (SD, 3.9) symptom-days with asthma and 98% of the classrooms had detectable levels of mouse allergen. The results were pooled because there was no statistically significant difference between the 2 interventions (P=.18 for interaction). During a 2-week period, the mean was 1.5 symptom-days with asthma after use of the school-wide IPM program vs 1.9 symptom-days after no IPM across the school year (incidence rate ratio, 0.71 [95% CI, 0.38-1.33]), which was not statistically significantly different. During a 2-week period, the mean was 1.6 symptom-days with asthma after use of HEPA filter purifiers in the classrooms vs 1.8 symptom-days after use of sham HEPA filter purifiers across the school year (incidence rate ratio, 1.47 [95% CI, 0.79-2.75]), which was not statistically significantly different. There were no intervention-related adverse events. Conclusions and RelevanceAmong children with active asthma, use of a school-wide IPM program or classroom HEPA filter purifiers did not significantly reduce symptom-days with asthma. However, interpretation of the study findings may need to consider allergen levels, particle exposures, and asthma symptoms at baseline. Trial RegistrationClinicalTrials.gov Identifier: NCT02291302 This randomized clinical trial compares use of a school-wide integrated pest management (IPM) program vs use of high-efficiency particulate air (HEPA) filter purifiers in the classrooms for students with active asthma attending urban elementary schools who were randomized to IPM by school and HEPA filter purifiers by classroom.	[Phipatanakul, Wanda; Sheehan, William J.; Bartnikas, Lisa M.; Cunningham, Amparito; Baxi, Sachin N.] Boston Childrens Hosp, Div Allergy & Immunol, Boston, MA USA; [Phipatanakul, Wanda; Gaffin, Jonathan M.; Lai, Peggy S.; Bartnikas, Lisa M.; Baxi, Sachin N.; Hauptman, Marissa; Gold, Diane R.] Harvard Univ, Sch Med, Boston, MA USA; [Koutrakis, Petros; Coull, Brent A.; Kang, Choong-Min; Wolfson, Jack M.; Adamkiewicz, Gary; Israel, Elliot; Gold, Diane R.] Harvard Univ, TH Chan Sch Publ, Dept Environm Hlth, Boston, MA 02115 USA; [Coull, Brent A.; Liang, Liming] Harvard Univ, TH Chan Sch Publ, Dept Biostat, Boston, MA 02115 USA; [Petty, Carter R.; Samnaliev, Mihail] Boston Childrens Hosp, Biostat & Res Design Ctr, Inst Ctr Clin & Translat Res, Boston, MA USA; [Gaffin, Jonathan M.] Boston Childrens Hosp, Div Pulm Med, Boston, MA USA; [Sheehan, William J.] George Washington Univ, Sch Med & Hlth Sci, Childrens Natl Hosp, Washington, DC 20052 USA; [Lai, Peggy S.] Massachusetts Gen Hosp, Div Pulm & Crit Care, Boston, MA 02114 USA; [Permaul, Perdita] Massachusetts Gen Hosp, Div Pediat Allergy & Immunol, Boston, MA 02114 USA; [Permaul, Perdita] New York Presbyterian Hosp Weill Cornell Med, Div Pediat Pulmonol Allergy & Immunol, Dept Pediat, New York, NY USA; [Hauptman, Marissa] Boston Childrens Hosp, Pediat Environm Hlth Ctr, Div Gen Pediat, Boston, MA USA; [Trivedi, Michelle] Univ Massachusetts, Mem Med Sch, Div Pediat Pulmonol, Worcester, MA 01605 USA; [Trivedi, Michelle] Univ Massachusetts, Mem Med Sch, Dept Populat & Quantitat Hlth Sci, Worcester, MA 01605 USA; [Louisias, Margee] Brigham & Womens Hosp, Div Allergy & Immunol, 75 Francis St, Boston, MA 02115 USA; [Thorne, Peter S.; Metwali, Nervana] Univ Iowa, Dept Occupat & Environm Hlth, Iowa City, IA USA; [Israel, Elliot] Brigham & Womens Hosp, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA; [Israel, Elliot] Brigham & Womens Hosp, Div Allergy, 75 Francis St, Boston, MA 02115 USA; [Israel, Elliot] Brigham & Womens Hosp, Div Immunol, 75 Francis St, Boston, MA 02115 USA; [Baccarelli, Andrea A.] Columbia Univ, Sch Publ Hlth, Dept Environm Hlth, New York, NY USA; [Gold, Diane R.] Brigham & Womens Hosp, Dept Lab Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Children's National Health System; George Washington University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; NewYork-Presbyterian Hospital; Harvard University; Boston Children's Hospital; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Brigham & Women's Hospital; University of Iowa; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Columbia University; Harvard University; Brigham & Women's Hospital	Phipatanakul, W (corresponding author), Harvard Med Sch, Boston Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	wanda.phipatanakul@childrens.harvard.edu		GAFFIN, JONATHAN/0000-0003-2213-4504				[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 1993, J Allergy Clin Immunol, V92, P636; [Anonymous], 2011, APPL LONGITUDINAL AN; Busse WW, 2011, NEW ENGL J MED, V364, P1005, DOI 10.1056/NEJMoa1009705; DiMango E, 2016, J ALLER CL IMM-PRACT, V4, P671, DOI 10.1016/j.jaip.2016.01.016; Del-Rio-Navarro BE, 2020, WORLD ALLERGY ORGAN, V13, DOI 10.1016/j.waojou.2019.100092; Goldstein H, 1995, MULTILEVEL STAT MODE, V2nd; Jhun I, 2017, J ALLER CL IMM-PRACT, V5, P154, DOI 10.1016/j.jaip.2016.07.018; Krouse RZ, 2017, J ALLERGY CLIN IMMUN, V139, P1052, DOI 10.1016/j.jaci.2016.08.041; Matsui EC, 2017, JAMA-J AM MED ASSOC, V317, P1027, DOI 10.1001/jama.2016.21048; Morgan WJ, 2004, NEW ENGL J MED, V351, P1068, DOI 10.1056/NEJMoa032097; Olson C, 2021, J ASTHMA, V58, P616, DOI 10.1080/02770903.2019.1709870; Phipatanakul W, 2008, ALLERGY, V63, P1512, DOI 10.1111/j.1398-9995.2008.01679.x; Phipatanakul W, 2000, J ALLERGY CLIN IMMUN, V106, P1075, DOI 10.1067/mai.2000.110795; Phipatanakul W, 2017, CONTEMP CLIN TRIALS, V60, P14, DOI 10.1016/j.cct.2017.06.008; Rabito FA, 2017, J ALLERGY CLIN IMMUN, V140, P565, DOI [10.1016/j.jaci.2016.10.019, 10.1016/j.jaci.2016.12.221]; Redline S, 2004, ANN ALLERG ASTHMA IM, V93, P36, DOI 10.1016/S1081-1206(10)61445-7; Riederer AM, 2021, INDOOR AIR, V31, P454, DOI 10.1111/ina.12753; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Sheehan WJ, 2017, JAMA PEDIATR, V171, P31, DOI 10.1001/jamapediatrics.2016.2543; Szefler S, 2000, NEW ENGL J MED, V343, P1054; Tseloni A, 2004, BRIT J CRIMINOL, V44, P931, DOI 10.1093/bjc/azh047; Wildfire JJ, 2012, J ALLERGY CLIN IMMUN, V129, P694, DOI 10.1016/j.jaci.2011.12.962; Wu TD, 2019, J ALLERGY CLIN IMMUN, V143, P803, DOI 10.1016/j.jaci.2018.10.008	24	11	11	4	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2021	326	9					839	850		10.1001/jama.2021.11559	http://dx.doi.org/10.1001/jama.2021.11559			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ7LK	34547084	Green Published			2022-12-28	WOS:000696242100014
J	Poore, TC; Pantilat, SZ				Poore, Timothy C.; Pantilat, Steven Z.			Inpatient Notes: Palliative Care Consultation-What a Hospitalist Should Know	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Poore, Timothy C.; Pantilat, Steven Z.] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Poore, TC (corresponding author), UCSF Div Palliat Med, Box 0125,521 Parnassus Ave,Floor 05, San Francisco, CA 94143 USA.	Timothy.Poore@ucsf.edu		Pantilat, Steven/0000-0003-1004-7892				Hayes S, 2016, HIGH NEED HIGH COST; Kamal AH, 2017, AM J MED, V130, P113, DOI 10.1016/j.amjmed.2016.08.046; Lupu D, 2018, J PAIN SYMPTOM MANAG, V55, P1221, DOI 10.1016/j.jpainsymman.2018.01.011; Weissman DE, 2011, J PALLIAT MED, V14, P17, DOI 10.1089/jpm.2010.0347	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP	2021	174	9					HO2	HO3		10.7326/M21-3118	http://dx.doi.org/10.7326/M21-3118			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XA5GQ	34543603				2022-12-28	WOS:000720675500002
J	Marcus, A				Marcus, Adam			Paul Greengard Obituary	LANCET			English	Biographical-Item																		GREENGARD P, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 1	2019	393	10187					2194	2194		10.1016/S0140-6736(19)31189-4	http://dx.doi.org/10.1016/S0140-6736(19)31189-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IB1HV	34509218				2022-12-28	WOS:000470017100014
J	Schwalbe-Koda, D; Kwon, S; Paris, C; Bello-Jurado, E; Jensen, Z; Olivetti, E; Willhammar, T; Corma, A; Roman-Leshkov, Y; Moliner, M; Gomez-Bombarelli, R				Schwalbe-Koda, Daniel; Kwon, Soonhyoung; Paris, Cecilia; Bello-Jurado, Estefania; Jensen, Zach; Olivetti, Elsa; Willhammar, Tom; Corma, Avelino; Roman-Leshkov, Yuriy; Moliner, Manuel; Gomez-Bombarelli, Rafael			A priori control of zeolite phase competition and intergrowth with high-throughput simulations	SCIENCE			English	Article							STRUCTURE-DIRECTING AGENTS; CHABAZITE ZEOLITES; GUEST/HOST RELATIONSHIPS; FORCE-FIELD; DESIGN; METHANOL; CONVERSION; POLYMORPH; ALUMINUM; PROGRAM	Zeolites are versatile catalysts and molecular sieves with large topological diversity, but managing phase competition in zeolite synthesis is an empirical, labor-intensive task. In this work, we controlled phase selectivity in templated zeolite synthesis from first principles by combining high-throughput atomistic simulations, literature mining, human-computer interaction, synthesis, and characterization. Proposed binding metrics distilled from more than 586,000 zeolite-molecule simulations reproduced the extracted literature and rationalized framework competition in the design of organic structure-directing agents. Energetic, geometric, and electrostatic descriptors of template molecules were found to regulate synthetic accessibility windows and aluminum distributions in pure-phase zeolites. Furthermore, these parameters allowed us to realize an intergrowth zeolite through a single bi-selective template. The computation-first approach enables control of both zeolite synthesis and structure composition using a priori theoretical descriptors.	[Schwalbe-Koda, Daniel; Jensen, Zach; Olivetti, Elsa; Gomez-Bombarelli, Rafael] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Kwon, Soonhyoung; Roman-Leshkov, Yuriy] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Paris, Cecilia; Bello-Jurado, Estefania; Corma, Avelino; Moliner, Manuel] Univ Politecn Valencia, Inst Tecnol Quim, Consejo Super Invest Cient, E-46022 Valencia, Spain; [Willhammar, Tom] Stockholm Univ, Dept Mat & Environm Chem, SE-10691 Stockholm, Sweden	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Tecnologia Quimica (ITQ); Stockholm University	Moliner, M (corresponding author), Univ Politecn Valencia, Inst Tecnol Quim, Consejo Super Invest Cient, E-46022 Valencia, Spain.	mmoliner@itq.upv.es; rafagb@mit.edu	; CORMA, AVELINO/A-3040-2013; Roman-Leshkov, Yuriy/E-1387-2014; Gomez-Bombarelli, Rafael/A-3726-2016	Moliner, Manuel/0000-0002-5440-716X; Bello, Estefania/0000-0002-2052-3680; Willhammar, Tom/0000-0001-6120-1218; Schwalbe-Koda, Daniel/0000-0001-9176-0854; /0000-0002-8043-2385; CORMA, AVELINO/0000-0002-2232-3527; Roman-Leshkov, Yuriy/0000-0002-0025-4233; Kwon, Soonhyoung/0000-0003-0409-2179; Gomez-Bombarelli, Rafael/0000-0002-9495-8599	Energy Initiative (MITEI); MIT International Science and Technology Initiatives (MISTI) Seed Funds; Spanish government through the "Severo Ochoa" program (MINECO) [SEV-2016-0683]; MCIU/AEI/FEDER, UE [RTI2018-101033-B-I00]; Spanish government [PRE2019-088360]; Designing Materials to Revolutionize and Engineer our Future (DMREF) from the National Science Foundation (NSF) [1922311, 1922372, 1922090]; Office of Naval Research (ONR) [N00014-20-1-2280]; Kwanjeong Educational Fellowship; Department of Defense (DoD) through the National Defense Science Engineering Graduate (NDSEG) fellowship program; Swedish Research Council [2019-05465]; MIT Energy Fellowship; Extreme Science and Engineering Discovery Environment [TG-DMR200068]	Energy Initiative (MITEI); MIT International Science and Technology Initiatives (MISTI) Seed Funds; Spanish government through the "Severo Ochoa" program (MINECO); MCIU/AEI/FEDER, UE; Spanish government(Spanish GovernmentEuropean Commission); Designing Materials to Revolutionize and Engineer our Future (DMREF) from the National Science Foundation (NSF); Office of Naval Research (ONR)(Office of Naval Research); Kwanjeong Educational Fellowship; Department of Defense (DoD) through the National Defense Science Engineering Graduate (NDSEG) fellowship program; Swedish Research Council(Swedish Research CouncilEuropean Commission); MIT Energy Fellowship; Extreme Science and Engineering Discovery Environment	D.S.-K. and R.G.-B. acknowledge the Energy Initiative (MITEI) and MIT International Science and Technology Initiatives (MISTI) Seed Funds. D.S.-K. was also funded by the MIT Energy Fellowship. C.P., E.B.-J., M.M., and A.C. acknowledge financial support by the Spanish government through the "Severo Ochoa" program (SEV-2016-0683, MINECO) and grant RTI2018-101033-B-I00 (MCIU/AEI/FEDER, UE). E.B.-J. acknowledges the Spanish government for an FPI scholarship (PRE2019-088360). Z.J., E.O., S.K., and Y.R.-L. acknowledge partial funding from Designing Materials to Revolutionize and Engineer our Future (DMREF) from the National Science Foundation (NSF); awards 1922311, 1922372, and 1922090; and the Office of Naval Research (ONR) under contract N00014-20-1-2280. S.K. was additionally funded by the Kwanjeong Educational Fellowship. Z.J. was also supported by the Department of Defense (DoD) through the National Defense Science Engineering Graduate (NDSEG) fellowship program. T.W. acknowledges financial support by the Swedish Research Council (grant no. 2019-05465). Computer calculations were executed at the Massachusetts Green HighPerformance Computing Center with support from MIT Research Computing and at the Extreme Science and Engineering Discovery Environment (XSEDE) (53) Expanse through allocation TG-DMR200068.	Argauer R. J., 1969, US Patent, Patent No. [3702886, US3702886 A]; Baerlocher C., 2021, DATABASE ZEOLITE STR; Bates JS, 2019, ACS CATAL, V9, P6146, DOI 10.1021/acscatal.9b01123; Blaiszik B, 2016, JOM-US, V68, P2045, DOI 10.1007/s11837-016-2001-3; Blaiszik B, 2019, MRS COMMUN, V9, P1125, DOI 10.1557/mrc.2019.118; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Boyett RE, 1996, ZEOLITES, V17, P508, DOI 10.1016/S0144-2449(96)00073-5; Burton AW, 2006, MICROPOR MESOPOR MAT, V90, P129, DOI 10.1016/j.micromeso.2005.11.022; Camblor MA, 1997, CHEM COMMUN, P749, DOI 10.1039/a700672a; Cao G., 2006, Chabazite-Containing Molecular Sieve, Its Synthesis and Its Use in the Conversion of Oxygenates to Olefins, Patent No. [7094389B2, 7094389]; Cao G., 2007, US Patent, Patent No. 7754187; Cao G., 2008, US Patent, Patent No. 20080045767; Coley CW, 2018, J CHEM INF MODEL, V58, P252, DOI 10.1021/acs.jcim.7b00622; Corma A, 2004, NATURE, V431, P287, DOI 10.1038/nature02909; Daeyaert F, 2019, P NATL ACAD SCI USA, V116, P3413, DOI 10.1073/pnas.1818763116; Davis T. M., 2014, US Pat., Patent No. 20140147378; Deem MW, 2009, J PHYS CHEM C, V113, P21353, DOI 10.1021/jp906984z; Di Iorio JR, 2020, J AM CHEM SOC, V142, P4807, DOI 10.1021/jacs.9b13817; Di Iorio JR, 2017, ACS CATAL, V7, P6663, DOI 10.1021/acscatal.7b01273; Di Iorio JR, 2016, CHEM MATER, V28, P2236, DOI 10.1021/acs.chemmater.6b00181; Dusselier M, 2015, CHEM MATER, V27, P2695, DOI 10.1021/acs.chemmater.5b00651; Eliasova P, 2015, CHEM SOC REV, V44, P7177, DOI 10.1039/c5cs00045a; Ferri P, 2020, ANGEW CHEM INT EDIT, V59, P19708, DOI 10.1002/anie.202007609; Ferri P, 2019, ACS CATAL, V9, P11542, DOI 10.1021/acscatal.9b04588; Gale JD, 2003, MOL SIMULAT, V29, P291, DOI 10.1080/0892702031000104887; Gale JD, 1997, J CHEM SOC FARADAY T, V93, P629, DOI 10.1039/a606455h; Gallego EM, 2018, CHEM-EUR J, V24, P14631, DOI 10.1002/chem.201803637; Goltl F, 2021, ACS CATAL, V11, P7719, DOI 10.1021/acscatal.1c00691; Gomez-Bombarelli R, 2016, NAT MATER, V15, P1120, DOI [10.1038/nmat4717, 10.1038/NMAT4717]; Guo L, 2018, IND ENG CHEM RES, V57, P10398, DOI 10.1021/acs.iecr.8b02044; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X; Heard CJ, 2019, CHEM SCI, V10, P5705, DOI 10.1039/c9sc00725c; Jensen Z, 2021, ACS CENTRAL SCI, V7, P858, DOI 10.1021/acscentsci.1c00024; Jensen Z, 2019, ACS CENTRAL SCI, V5, P892, DOI 10.1021/acscentsci.9b00193; Kim C, 2008, MICROPOR MESOPOR MAT, V116, P227, DOI 10.1016/j.micromeso.2008.04.008; KOSSLICK H, 1994, J CHEM SOC FARADAY T, V90, P2837, DOI 10.1039/ft9949002837; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; KRESSE G, 1996, COMP MATER SCI, V54, P1116, DOI DOI 10.1016/0927-0256(96)00008-0; Landrum G., 2006, RDKIT OPEN SOURCE CH; Lewis DW, 1996, NATURE, V382, P604, DOI 10.1038/382604a0; Li Y, 2017, CHEM-US, V3, P928, DOI 10.1016/j.chempr.2017.10.009; LOBO RF, 1995, J INCLUS PHENOM MOL, V21, P47; Gallego EM, 2017, SCIENCE, V355, DOI 10.1126/science.aal0121; MAYO SL, 1990, J PHYS CHEM-US, V94, P8897, DOI 10.1021/j100389a010; Millini R, 1998, MICROPOR MESOPOR MAT, V24, P199, DOI 10.1016/S1387-1811(98)00165-6; Moliner M, 2019, ACCOUNTS CHEM RES, V52, P2971, DOI 10.1021/acs.accounts.9b00399; Moliner M, 2013, ANGEW CHEM INT EDIT, V52, P13880, DOI 10.1002/anie.201304713; Muraoka K, 2020, CHEM SCI, V11, P8214, DOI 10.1039/d0sc03075a; Muraoka K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12394-0; Nakagawa Y, 1998, MICROPOR MESOPOR MAT, V22, P69, DOI 10.1016/S1387-1811(98)00106-1; Naraki Y, 2017, MICROPOR MESOPOR MAT, V254, P160, DOI 10.1016/j.micromeso.2017.04.004; Nimlos CT, 2020, CHEM MATER, V32, P9277, DOI 10.1021/acs.chemmater.0c03154; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Pophale R, 2013, J MATER CHEM A, V1, P6750, DOI 10.1039/c3ta10626h; SANDERS MJ, 1984, J CHEM SOC CHEM COMM, P1271, DOI 10.1039/c39840001271; Sastre G, 2005, CHEM MATER, V17, P545, DOI 10.1021/cm049912g; Schmidt JE, 2015, TOP CATAL, V58, P410, DOI 10.1007/s11244-015-0381-1; Schmidt JE, 2014, ANGEW CHEM INT EDIT, V53, P8372, DOI 10.1002/anie.201404076; Schwalbe-Koda D., 2021, DATA SET MAT DATA FA; Schwalbe-Koda D, 2021, J CHEM PHYS, V154, DOI 10.1063/5.0044927; Schwalbe-Koda D, 2021, J PHYS CHEM C, V125, P3009, DOI 10.1021/acs.jpcc.0c10108; Schwalbe-Koda D, 2019, NAT MATER, V18, P1177, DOI 10.1038/s41563-019-0486-1; Smith RL, 2015, APPL CATAL A-GEN, V505, P1, DOI 10.1016/j.apcata.2015.06.027; Thommes M, 2015, PURE APPL CHEM, V87, P1051, DOI 10.1515/pac-2014-1117; Toby BH, 2000, MICROPOR MESOPOR MAT, V39, P77, DOI 10.1016/S1387-1811(00)00178-5; Tosco P, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/s13321-014-0037-3; Treacy MMJ, 2004, MICROPOR MESOPOR MAT, V74, P121, DOI 10.1016/j.micromeso.2004.06.013; TREACY MMJ, 1991, P R SOC-MATH PHYS SC, V433, P499, DOI 10.1098/rspa.1991.0062; Vermeiren W, 2009, TOP CATAL, V52, P1131, DOI 10.1007/s11244-009-9271-8; Villaescusa LA, 1999, ANGEW CHEM INT EDIT, V38, P1997, DOI 10.1002/(SICI)1521-3773(19990712)38:13/14<1997::AID-ANIE1997>3.0.CO;2-U; Wagner P, 2000, J AM CHEM SOC, V122, P263, DOI 10.1021/ja990722u; Wang X, 2015, CHEM COMMUN, V51, P16920, DOI 10.1039/c5cc05980a; Willhammar T, 2012, NAT CHEM, V4, P188, DOI [10.1038/nchem.1253, 10.1038/NCHEM.1253]; Zones S I, 1999, US Patent, Patent No. [5958370, 5958370A]; ZONES SI, 1991, J CHEM SOC FARADAY T, V87, P3709, DOI 10.1039/ft9918703709	77	32	32	28	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2021	374	6565			SI		308	+		10.1126/science.abh3350	http://dx.doi.org/10.1126/science.abh3350			61	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WK7BF	34529493	Green Published, Green Submitted			2022-12-28	WOS:000709878300045
J	Ford, T; Kusi-Mensah, K; Newlove-Delgado, T; Ramchandani, P; Price-Kuehne, F; Rowitch, D				Ford, Tamsin; Kusi-Mensah, Kwabena; Newlove-Delgado, Tamsin; Ramchandani, Paul; Price-Kuehne, Fiona; Rowitch, David			Optimising the health-care experiences of babies, children, and young people	LANCET			English	Editorial Material									[Ford, Tamsin; Kusi-Mensah, Kwabena] Univ Cambridge, Dept Psychiat, Cambridge Biomed Campus, Cambridge CB2 0SZ, England; [Kusi-Mensah, Kwabena] Komfo Anokye Teaching Hosp, Kumasi, Ghana; [Kusi-Mensah, Kwabena] Kwame Nkrumah Univ Sci & Technol, Sch Med & Dent, Dept Behav Sci, PMB, Kumasi, Ghana; [Newlove-Delgado, Tamsin] Univ Exeter, Sch Med, Exeter, Devon, England; [Ramchandani, Paul] Univ Cambridge, Fac Educ, Cambridge, England; [Price-Kuehne, Fiona; Rowitch, David] Univ Cambridge, Dept Paediat, Cambridge Biomed Campus, Cambridge, England	University of Cambridge; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; University of Exeter; University of Cambridge; University of Cambridge	Ford, T (corresponding author), Univ Cambridge, Dept Psychiat, Cambridge Biomed Campus, Cambridge CB2 0SZ, England.	tjf52@medschl.cam.ac.uk	Ramchandani, Paul/O-5340-2014	Ramchandani, Paul/0000-0003-3646-2410; Ford, Tamsin/0000-0001-5295-4904				Dennis C, 2017, J ADV NURS, V73, P361, DOI 10.1111/jan.13178; Department of Health, 2019, NHS LONG TERM PLAN; Dzomeku VM, 2021, BMC NURS, V20, DOI 10.1186/s12912-021-00559-6; Gjaerde LK, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2021-051957; Hargreaves DS, 2018, ARCH DIS CHILD, V103, P486, DOI 10.1136/archdischild-2017-313801; Hargreaves DS, 2012, ARCH DIS CHILD, V97, P661, DOI 10.1136/archdischild-2011-300603; Hysing M, 2007, J CHILD PSYCHOL PSYC, V48, P785, DOI 10.1111/j.1469-7610.2007.01755.x; Mekonnen AG, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1575-7; Munabi-Babigumira S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213511; National Institute for Health and Care Excellence, 2016, TRANSITION CHILDRENS; National Institute for Health and Care Excellence, BAB CHILDR YOUNG PEO; National Institute for Health and Care Excellence, 2012, PAT EXP AD NHS SERV; WHO, 2011, REC AD	13	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 2	2021	398	10307					1201	1203		10.1016/S0140-6736(21)02124-3	http://dx.doi.org/10.1016/S0140-6736(21)02124-3		SEP 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	WC6VF	34559997				2022-12-28	WOS:000704393000006
J	Jones, N				Jones, Nicola			HOW DANGEROUS IS AFRICA'S EXPLOSIVE LAKE KIVU?	NATURE			English	News Item								An unusual lake in central Africa could one day release a vast cloud of greenhouse gases that suffocates millions of people. But researchers can't agree whether the threat is getting worse.										Barenbold F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237836; Halbwachs M, 2020, J AFR EARTH SCI, V167, DOI 10.1016/j.jafrearsci.2019.103575; Hirslund F, 2020, J AFR EARTH SCI, V161, DOI 10.1016/j.jafrearsci.2019.103672; Hirslund F, 2020, J AFR EARTH SCI, V161, DOI 10.1016/j.jafrearsci.2019.103614; Schmid M, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000892; Votava JE, 2017, P NATL ACAD SCI USA, V114, P251, DOI 10.1073/pnas.1609112113	6	4	4	1	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2021	597	7877					466	469		10.1038/d41586-021-02523-5	http://dx.doi.org/10.1038/d41586-021-02523-5			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UW6NQ	34552261	Bronze			2022-12-28	WOS:000700270400007
J	Yamin, R; Jones, AT; Hoffmann, HH; Schafer, A; Kao, KVS; Francis, RL; Sheahan, TP; Baric, RS; Rice, CM; Ravetch, JV; Bournazos, S				Yamin, Rachel; Jones, Andrew T.; Hoffmann, Hans-Heinrich; Schafer, Alexandra; Kao, Kevin S.; Francis, Rebecca L.; Sheahan, Timothy P.; Baric, Ralph S.; Rice, Charles M.; Ravetch, Jeffrey V.; Bournazos, Stylianos			Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy	NATURE			English	Article							NEUTRALIZING ANTIBODIES; EFFECTOR FUNCTIONS; MOUSE MODEL; PROTECTION; RECEPTOR	Monoclonal antibodies with neutralizing activity against SARS-CoV-2 have demonstrated clinical benefits in cases of mild-to-moderate SARS-CoV-2 infection, substantially reducing the risk for hospitalization and severe disease(1-4). Treatment generally requires the administration of high doses of these monoclonal antibodies and has limited efficacy in preventing disease complications or mortality among hospitalized patients with COVID-19(5). Here we report the development and evaluation of anti-SARS-CoV-2 monoclonal antibodies with optimized Fc domains that show superior potency for prevention or treatment of COVID-19. Using several animal disease models of COVID-19(6,7), we demonstrate that selective engagement of activating Fc. receptors results in improved efficacy in both preventing and treating disease-induced weight loss and mortality, significantly reducing the dose required to confer full protection against SARS-CoV-2 challenge and for treatment of pre-infected animals. Our results highlight the importance of Fc. receptor pathways in driving antibody-mediated antiviral immunity and exclude the possibility of pathogenic or disease-enhancing effects of Fc. receptor engagement of anti-SARS-CoV-2 antibodies upon infection. These findings have important implications for the development of Fc-engineered monoclonal antibodies with optimal Fc-effector function and improved clinical efficacy against COVID-19 disease.	[Yamin, Rachel; Jones, Andrew T.; Kao, Kevin S.; Francis, Rebecca L.; Ravetch, Jeffrey V.; Bournazos, Stylianos] Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10021 USA; [Hoffmann, Hans-Heinrich; Rice, Charles M.] Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10021 USA; [Schafer, Alexandra; Sheahan, Timothy P.; Baric, Ralph S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Baric, Ralph S.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA	Rockefeller University; Rockefeller University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Ravetch, JV; Bournazos, S (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10021 USA.	ravetch@rockefeller.edu; sbournazos@rockefeller.edu	Sheahan, Timothy/J-8201-2019; Bournazos, Stylianos/ABH-1578-2021; Francis, Rebecca/GZM-2367-2022	Sheahan, Timothy/0000-0001-9181-2183; Francis, Rebecca/0000-0003-3027-1170; Jones, Andrew/0000-0002-3739-2322; Baric, Ralph/0000-0001-6827-8701; Ravetch, Jeffrey/0000-0003-2024-9041	NIH Core Grant [P30CA008748]; National Institute of Allergy and Infectious Diseases [R01AI137276, R01AI157155, U19AI111825, R01AI145870]; Bill and Melinda Gates Foundation [INV023152]; G. Harold and Leila Y. Mathers Charitable Foundation; Bawd Foundation; Fast Grants, a part of Emergent Ventures at the Mercatus Center, George Mason University; Rockefeller University; Vir Biotechnology	NIH Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); G. Harold and Leila Y. Mathers Charitable Foundation; Bawd Foundation; Fast Grants, a part of Emergent Ventures at the Mercatus Center, George Mason University; Rockefeller University; Vir Biotechnology	We thank P. Smith, E. Lam, R.Peraza, L. Smith, A. M. Mozqueda and T. Martinez for technical assistance and for maintaining and genotyping the mouse colonies used in this study; all the members of the Laboratory of the Molecular Genetics and Immunology (Rockefeller University) for discussions; S. Borghi for providing the recombinant SARS-CoV-2 RBD; P. Bieniasz for providing the HT1080-ACE2 cell line and plasmids for generating pseudoviruses; A. Viale for providing the SARS-CoV-2 NYC clinical isolate; A. Ashbrook andG. McNab foradvice on handling BSL-3 agents and processing of tissues from infected animals; D. Martinez for technical assistance; S. Carrasco; staff from the Laboratory Comparative Pathology for histopathology support (with funding from NIH Core Grant P30CA008748). Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases (R01AI137276, R01AI157155, U19AI111825, and R01AI145870) and the Bill and Melinda Gates Foundation (INV023152). This work was in part made possible with funding from the G. Harold and Leila Y. Mathers Charitable Foundation, the Bawd Foundation and Fast Grants (www.fastgrants.org), a part of Emergent Ventures at the Mercatus Center, George Mason University. We acknowledge support from the Rockefeller University and Vir Biotechnology. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	ACTIV-3 TICO LY-CoV555 Study Grp, 2021, NEW ENGL J MED, V384, P905, DOI 10.1056/NEJMoa2033130; Atyeo C, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.143129; Baum A, 2020, SCIENCE, V370, P1110, DOI 10.1126/science.abe2402; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Bournazos S, 2020, NATURE, V588, P485, DOI 10.1038/s41586-020-2838-z; Bournazos S, 2020, NAT REV IMMUNOL, V20, P633, DOI 10.1038/s41577-020-00410-0; Bournazos S, 2019, P NATL ACAD SCI USA, V116, P20054, DOI 10.1073/pnas.1911842116; Bournazos S, 2019, CURR TOP MICROBIOL, V423, P1, DOI 10.1007/82_2019_149; Bournazos S, 2014, CELL, V158, P1243, DOI 10.1016/j.cell.2014.08.023; Chakraborty S, 2021, NAT IMMUNOL, V22, P67, DOI [10.1038/s41590-020-00828-7, 10.1101/2020.05.15.20103341]; Chen P, 2021, NEW ENGL J MED, V384, P229, DOI 10.1056/NEJMoa2029849; Cleary SJ, 2020, BRIT J PHARMACOL, V177, P4851, DOI 10.1111/bph.15143; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Dougan M, 2021, NEW ENGL J MED, V385, P1382, DOI 10.1056/NEJMoa2102685; Gottlieb RL, 2021, JAMA-J AM MED ASSOC, V325, P632, DOI 10.1001/jama.2021.0202; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Joyner MJ, 2020, J CLIN INVEST, V130, P4791, DOI [10.1172/JCI140200, 10.1101/2020.05.12.20099879]; Larsen MD, 2021, SCIENCE, V371, P907, DOI 10.1126/science.abc8378; Leist SR, 2020, CELL, V183, P1070, DOI 10.1016/j.cell.2020.09.050; Li Dapeng, 2021, bioRxiv, DOI 10.1101/2020.12.31.424729; Lu CL, 2016, SCIENCE, V352, P1001, DOI 10.1126/science.aaf1279; Lucas C, 2021, NAT MED, V27, P1178, DOI 10.1038/s41591-021-01355-0; Martinez DR, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109450; McCann KE, 2017, SCI REP-UK, V7, DOI 10.1038/srep40472; Pietzsch J, 2012, P NATL ACAD SCI USA, V109, P15859, DOI 10.1073/pnas.1213409109; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Schafer A, 2021, J EXP MED, V218, DOI 10.1084/jem.20201993; Schmidt Fabian, 2020, J Exp Med, V217, DOI [10.1101/2020.06.08.140871, 10.1084/jem.20201181]; Sia SF, 2020, NATURE, V583, P834, DOI 10.1038/s41586-020-2342-5; Smith P, 2012, P NATL ACAD SCI USA, V109, P6181, DOI 10.1073/pnas.1203954109; Suryadevara Naveenchandra, 2021, Cell, V184, P2316, DOI [10.1101/2021.01.19.427324, 10.1016/j.cell.2021.03.029]; Taylor PC, 2021, NAT REV IMMUNOL, V21, P382, DOI 10.1038/s41577-021-00542-x; Ullah Irfan, 2021, bioRxiv, DOI 10.1101/2021.03.22.436337; Wang Zijun, 2021, Nature, V592, P616, DOI [10.1038/s41586-021-03324-6, 10.1101/2021.01.15.426911]; Weinreich DM, 2021, NEW ENGL J MED, V384, P238, DOI 10.1056/NEJMoa2035002; Winkler ES, 2021, CELL, V184, P1804, DOI 10.1016/j.cell.2021.02.026; Wu XJ, 2021, ANTIMICROB AGENTS CH, V65, DOI 10.1128/AAC.00350-21	37	42	43	2	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 18	2021	599	7885					465	+		10.1038/s41586-021-04017-w	http://dx.doi.org/10.1038/s41586-021-04017-w		SEP 2021	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WZ6DP	34547765	Green Submitted, Bronze, Green Published, Green Accepted			2022-12-28	WOS:000714336400001
J	Iacobucci, G				Iacobucci, Gareth			Man charged after assaulting staff at GP surgery	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, LACK FACE TO FACE GP; Jha N., TWITTER; Vell T., 2021, TWITTER	3	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 20	2021	374								n2316	10.1136/bmj.n2316	http://dx.doi.org/10.1136/bmj.n2316			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ1DH	34544688				2022-12-28	WOS:000701952000002
J	Roth, A				Roth, Adrian		MPS-WS Berlin 2019	Human microphysiological systems for drug development	SCIENCE			English	Editorial Material									[Roth, Adrian] FHoffmannLa Roche Ltd, Roche Innovat Ctr, Personalized Hlthcare Safety, Product Dev Safety, Basel, Switzerland; [MPS-WS Berlin 2019] Microphysiol Syst Workshop MPS WS, Berlin, Germany	Roche Holding	Roth, A (corresponding author), FHoffmannLa Roche Ltd, Roche Innovat Ctr, Personalized Hlthcare Safety, Product Dev Safety, Basel, Switzerland.	adrian_b.roth@roche.com						Barrile R, 2018, CLIN PHARMACOL THER, V104, P1240, DOI 10.1002/cpt.1054; Chen MB, 2018, P NATL ACAD SCI USA, V115, P7022, DOI 10.1073/pnas.1715932115; Chou DB, 2020, NAT BIOMED ENG, DOI 10.1038/s41551-019-0495-z; Herland A, 2020, NAT BIOMED ENG, DOI 10.1038/s41551-019-0498-9; Hubner J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33462-3; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Jalili-Firoozinezhad S, 2019, NAT BIOMED ENG, V3, P520, DOI 10.1038/s41551-019-0397-0; Jang KJ, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aax5516; Maoz BM, 2018, NAT BIOTECHNOL, V36, P865, DOI 10.1038/nbt.4226; Marx U, 2020, ALTEX-ALTERN ANIM EX, V37, P365, DOI 10.14573/altex.2001241; McAleer CW, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav1386; Park SE, 2019, SCIENCE, V364, P960, DOI 10.1126/science.aaw7894; Ramme AP, 2019, FUTUR SCI OA, V5, DOI 10.2144/fsoa-2019-0065; Schoon J, 2020, ADV SCI, V7, DOI 10.1002/advs.202000412; Si LL, 2021, NAT BIOMED ENG, V5, P815, DOI 10.1038/s41551-021-00718-9	15	12	12	3	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2021	373	6561					1304	1306		10.1126/science.abc3734	http://dx.doi.org/10.1126/science.abc3734			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	US5SK	34529479				2022-12-28	WOS:000697488600024
J	Nikalayevich, E; Verlhac, MH				Nikalayevich, Elvira; Verlhac, Marie-Helene			Selfish centromeres, selfless heterochromatin	CELL			English	Editorial Material								Centromeres are specialized regions on chromosomes recruiting a set of proteins required for faithful chromosome segregation. Differences in centromere strength can potentially bias chromosome segregation toward one of the daughter cells during division. Kumon et al. propose a newmodel of evolutionary impact on the balance of centromere strength.	[Nikalayevich, Elvira; Verlhac, Marie-Helene] PSL Res Univ, Ctr Interdisciplinary Res Biol, Coll France, UMR7241 U1050, F-75005 Paris, France	UDICE-French Research Universities; PSL Research University Paris; College de France	Nikalayevich, E (corresponding author), PSL Res Univ, Ctr Interdisciplinary Res Biol, Coll France, UMR7241 U1050, F-75005 Paris, France.	elvira.nikalayevich@college-de-france.fr		VERLHAC, Marie-Helene/0000-0001-8377-9010; Nikalayevich, Elvira/0000-0001-7841-544X				Akera T, 2019, CELL, V178, P1132, DOI 10.1016/j.cell.2019.07.001; Akera T, 2017, SCIENCE, V358, P668, DOI 10.1126/science.aan0092; Fachinetti D, 2015, DEV CELL, V33, P314, DOI 10.1016/j.devcel.2015.03.020; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Hochwagen A, 2010, CURR BIOL, V20, pR271, DOI 10.1016/j.cub.2010.01.048; Iwata-Otsubo A, 2017, CURR BIOL, V27, P2365, DOI 10.1016/j.cub.2017.06.069; Kumon T, 2021, CELL, V184, P4904, DOI 10.1016/j.cell.2021.07.037; Malik HS, 2001, GENETICS, V157, P1293; Tanno Y, 2010, GENE DEV, V24, P2169, DOI 10.1101/gad.1945310	9	1	1	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 16	2021	184	19					4843	4844		10.1016/j.cell.2021.08.027	http://dx.doi.org/10.1016/j.cell.2021.08.027		SEP 2021	2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	WC7PA	34534461	Green Published, Bronze			2022-12-28	WOS:000704445100002
J	Thomas, SJ; Moreira, ED; Kitchin, N; Absalon, J; Gurtman, A; Lockhart, S; Perez, JL; Marc, GP; Polack, FP; Zerbini, C; Bailey, R; Swanson, KA; Xu, X; Roychoudhury, S; Koury, K; Bouguermouh, S; Kalina, WV; Cooper, D; Frenck, RW; Hammitt, LL; Tureci, O; Nell, H; Schaefer, A; Unal, S; Yang, Q; Liberator, P; Tresnan, DB; Mather, S; Dormitzer, PR; Sahin, U; Gruber, WC; Jansen, KU				Thomas, S. J.; Moreira, E. D., Jr.; Kitchin, N.; Absalon, J.; Gurtman, A.; Lockhart, S.; Perez, J. L.; Marc, G. Perez; Polack, F. P.; Zerbini, C.; Bailey, R.; Swanson, K. A.; Xu, X.; Roychoudhury, S.; Koury, K.; Bouguermouh, S.; Kalina, W., V; Cooper, D.; Frenck, R. W., Jr.; Hammitt, L. L.; Tureci, O.; Nell, H.; Schaefer, A.; Unal, S.; Yang, Q.; Liberator, P.; Tresnan, D. B.; Mather, S.; Dormitzer, P. R.; Sahin, U.; Gruber, W. C.; Jansen, K. U.		C4591001 Clinical Trial Grp	Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								BACKGROUND BNT162b2 is a lipid nanoparticle-formulated, nucleoside-modified RNA vaccine encoding a prefusion-stabilized, membrane-anchored severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) full-length spike protein. BNT162b2 is highly efficacious against coronavirus disease 2019 (Covid-19) and is currently approved, conditionally approved, or authorized for emergency use worldwide. At the time of initial authorization, data beyond 2 months after vaccination were unavailable. METHODS In an ongoing, placebo-controlled, observer-blinded, multinational, pivotal efficacy trial, we randomly assigned 44,165 participants 16 years of age or older and 2264 participants 12 to 15 years of age to receive two 30-mu g doses, at 21 days apart, of BNT162b2 or placebo. The trial end points were vaccine efficacy against laboratory-confirmed Covid-19 and safety, which were both evaluated through 6 months after vaccination. RESULTS BNT162b2 continued to be safe and have an acceptable adverse-event profile. Few participants had adverse events leading to withdrawal from the trial. Vaccine efficacy against Covid-19 was 91.3% (95% confidence interval [CI], 89.0 to 93.2) through 6 months of follow-up among the participants without evidence of previous SARS-CoV-2 infection who could be evaluated. There was a gradual decline in vaccine efficacy. Vaccine efficacy of 86 to 100% was seen across countries and in populations with diverse ages, sexes, race or ethnic groups, and risk factors for Covid-19 among participants without evidence of previous infection with SARS-CoV-2. Vaccine efficacy against severe disease was 96.7% (95% CI, 80.3 to 99.9). In South Africa, where the SARS-CoV-2 variant of concern B.1.351 (or beta) was predominant, a vaccine efficacy of 100% (95% CI, 53.5 to 100) was observed. CONCLUSIONS Through 6 months of follow-up and despite a gradual decline in vaccine efficacy, BNT162b2 had a favorable safety profile and was highly efficacious in preventing Covid-19.	[Thomas, S. J.] SUNY Upstate Med Univ, Syracuse, NY 13210 USA; [Absalon, J.; Gurtman, A.; Swanson, K. A.; Koury, K.; Bouguermouh, S.; Kalina, W., V; Cooper, D.; Yang, Q.; Liberator, P.; Dormitzer, P. R.; Gruber, W. C.; Jansen, K. U.] Pfizer, Vaccine Res & Dev, Pearl River, NY 10965 USA; [Moreira, E. D., Jr.] Assoc Obras Sociais Irma Dulce, Salvador, BA, Brazil; [Moreira, E. D., Jr.] Fundacao Oswaldo Cruz, Salvador, BA, Brazil; [Marc, G. Perez] iTrials Hosp Mil Cent, Buenos Aires, DF, Argentina; [Polack, F. P.] Fdn INFANT, Buenos Aires, DF, Argentina; [Zerbini, C.] Ctr Paulista Invest Clin, Sao Paulo, Brazil; [Kitchin, N.; Lockhart, S.; Bailey, R.] Pfizer, Vaccine Res & Dev, Hurley, England; [Perez, J. L.; Xu, X.] Pfizer, Vaccine Res & Dev, Collegeville, PA USA; [Tresnan, D. B.; Mather, S.] Pfizer, Worldwide Safety Safety Surveillance & Risk Manag, Collegeville, PA USA; [Roychoudhury, S.] Pfizer, Global Prod Dev, Peapack, NJ USA; [Frenck, R. W., Jr.] Cincinnati Childrens Hosp, Cincinnati, OH USA; [Hammitt, L. L.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Tureci, O.; Sahin, U.] BioNTech, Mainz, Germany; [Schaefer, A.] Medizentrum Essen Borbeck, Essen, Germany; [Nell, H.] Karl Bremer Hosp, Tiervlei Trial Ctr, Cape Town, South Africa; [Unal, S.] Hacettepe Univ, Ankara, Turkey; [Tresnan, D. B.; Mather, S.] Worldwide Safety Safety Surveillance & Risk Manag, Groton, CT USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Pfizer; Fundacao Oswaldo Cruz; Pfizer; Pfizer; Pfizer; Pfizer; Cincinnati Children's Hospital Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; BioNTech SE; Hacettepe University	Absalon, J (corresponding author), Pfizer, 401 N Middletown Rd, Pearl River, NY 10965 USA.	judith.absalon@pfizer.com	yavuz, serap şimşek/AAE-2131-2020; Moreira Jr, Edson Duarte/GRF-5620-2022	yavuz, serap şimşek/0000-0002-4675-169X; Moreira Jr, Edson Duarte/0000-0002-7081-8348; Wappner, Diego/0000-0001-9817-1745	BioNTech; Pfizer	BioNTech; Pfizer(Pfizer)	Supported by BioNTech and Pfizer.	Abu-Raddad LJ, 2021, NEW ENGL J MED, V385, P187, DOI 10.1056/NEJMc2104974; [Anonymous], 2007, GUID IND TOX GRAD SC; [Anonymous], 2020, COVID 19 DEV DRUGS B; Baraniuk C, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n912; Baraniuk C, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n743; Bernal JL, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1088; Centers for Disease Control and Prevention, 2021, SARS COV 2 VAR CLASS; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; Food and Drug Administration, 2021, COVID 19 VACC; Frenck RW, 2021, NEW ENGL J MED, V385, P239, DOI 10.1056/NEJMoa2107456; Gallagher KME., 2021, SARS COV 2 T CELL IM, DOI [10.1101/2021.05.03.442455v1, DOI 10.1101/2021.05.03.442455V1]; Goel RR, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abi6950; Haas EJ, 2021, LANCET, V397, P1819, DOI 10.1016/S0140-6736(21)00947-8; Haynes BF, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abe0948; Kariko K, 2008, MOL THER, V16, P1833, DOI 10.1038/mt.2008.200; Knudson CJ, 2021, MOL THER, V29, P2769, DOI 10.1016/j.ymthe.2021.05.011; Liu Y, 2021, NEW ENGL J MED, V385, P472, DOI 10.1056/NEJMc2106083; Liu Y, 2021, NEW ENGL J MED, V384, P1466, DOI 10.1056/NEJMc2102017; Muik A, 2021, SCIENCE, V371, P1152, DOI 10.1126/science.abg6105; Painter MM., 2021, RAPID INDUCTION ANTI, DOI [10.1101/2021.04.21.440862v1, DOI 10.1101/2021.04.21.440862V1]; Pardi N, 2015, J CONTROL RELEASE, V217, P345, DOI 10.1016/j.jconrel.2015.08.007; Pfizer BioNTech, VACC REL BIOL PROD A; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Sahin U, 2021, NATURE, V595, P572, DOI 10.1038/s41586-021-03653-6; Tande AJ., 2021, CLIN INFECT DIS; Tauzin Alexandra, 2021, bioRxiv, DOI 10.1101/2021.03.18.435972; Vasileiou E, 2021, LANCET, V397, P1646, DOI 10.1016/S0140-6736(21)00677-2; Walsh EE, 2020, NEW ENGL J MED, V383, P2439, DOI 10.1056/NEJMoa2027906; Wang PF, 2021, NATURE, V593, P130, DOI 10.1038/s41586-021-03398-2; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Xie XP, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01270-4, 10.1101/2021.01.27.427998]; Zou J, 2021, NPJ VACCINES, V6, DOI 10.1038/s41541-021-00313-8	32	408	408	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 4	2021	385	19					1761	1773		10.1056/NEJMoa2110345	http://dx.doi.org/10.1056/NEJMoa2110345		SEP 2021	13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WR0CF	34525277	Green Published, Bronze			2022-12-28	WOS:000696036700001
J	Khan, AI; Daus, A; Islam, R; Neilson, KM; Lee, HR; Wong, HSP; Pop, E				Khan, Asir Intisar; Daus, Alwin; Islam, Raisul; Neilson, Kathryn M.; Lee, Hye Ryoung; Wong, H-S Philip; Pop, Eric			Ultralow-switching current density multilevel phase-change memory on a flexible substrate	SCIENCE			English	Article							NONVOLATILE MEMORY; TRANSISTORS; RESISTANCE; BI2TE3; FILMS; DRIFT; TIN	Phase-change memory (PCM) is a promising candidate for data storage in flexible electronics, but its high switching current and power are often drawbacks. In this study, we demonstrate a switching current density of similar to 0.1 mega-ampere per square centimeter in flexible superlattice PCM, a value that is one to two orders of magnitude lower than in conventional PCM on flexible or silicon substrates. This reduced switching current density is enabled by heat confinement in the superlattice material, assisted by current confinement in a pore-type device and the thermally insulating flexible substrate. Our devices also show multilevel operation with low resistance drift. The low switching current and good resistance on/off ratio are retained before, during, and after repeated bending and cycling. These results pave the way to low-power memory for flexible electronics and also provide key insights for PCM optimization on conventional silicon substrates.	[Khan, Asir Intisar; Daus, Alwin; Islam, Raisul; Neilson, Kathryn M.; Lee, Hye Ryoung; Wong, H-S Philip; Pop, Eric] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Lee, Hye Ryoung; Pop, Eric] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA; [Pop, Eric] Stanford Univ, Precourt Inst Energy, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Pop, E (corresponding author), Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA.; Pop, E (corresponding author), Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA.; Pop, E (corresponding author), Stanford Univ, Precourt Inst Energy, Stanford, CA 94305 USA.	epop@stantord.edu	Daus, Alwin/U-2147-2019; Khan, Asir Intisar/AAI-4478-2020; Pop, Eric/A-9475-2009	Khan, Asir Intisar/0000-0003-4635-4667; Pop, Eric/0000-0003-0436-8534; Islam, Raisul/0000-0002-1222-6117; Daus, Alwin/0000-0001-7461-3756; Neilson, Kathryn/0000-0003-1061-2919	Stanford Graduate Fellowship; Swiss NSF Early Postdoc Mobility fellowship [P2EZP2_181619]; Beijing Institute of Collaborative Innovation BICI	Stanford Graduate Fellowship(Stanford University); Swiss NSF Early Postdoc Mobility fellowship; Beijing Institute of Collaborative Innovation BICI	This work was performed at the Stanford Nanofabrication Facility (SNF) and Stanford Nano Shared Facilities (SNSF) and is supported in part by member companies of the Stanford Non-volatile Memory Technology Research Initiative (NMTRI). A.I.K. and K.M.N. acknowledge support from the Stanford Graduate Fellowship and A.D. from the Swiss NSF Early Postdoc Mobility fellowship (grant P2EZP2_181619) and the Beijing Institute of Collaborative Innovation BICI). Author	Adnane L, 2017, J APPL PHYS, V122, DOI 10.1063/1.4996218; Bessonov AA, 2015, NAT MATER, V14, P199, DOI [10.1038/NMAT4135, 10.1038/nmat4135]; Boniardi M, 2019, PHYS STATUS SOLIDI-R, V13, DOI 10.1002/pssr.201800634; Cheng CH, 2011, ADV MATER, V23, P902, DOI 10.1002/adma.201002946; Cheng YD, 2019, ADV MATER, V31, DOI 10.1002/adma.201904316; Daus A, 2021, NAT ELECTRON, V4, P495, DOI 10.1038/s41928-021-00598-6; Daus A, 2018, MATERIALS, V11, DOI 10.3390/ma11091672; Daus A, 2017, ADV ELECTRON MATER, V3, DOI 10.1002/aelm.201700309; Ding KY, 2019, SCIENCE, V366, P210, DOI 10.1126/science.aay0291; Faraclas A, 2014, IEEE T ELECTRON DEV, V61, P372, DOI 10.1109/TED.2013.2296305; Feng JL, 2020, ACS APPL MATER INTER, V12, P33397, DOI 10.1021/acsami.0c07973; Gan KJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50816-7; Ghoneim MT, 2015, ELECTRONICS-SWITZ, V4, P424, DOI 10.3390/electronics4030424; Gupta S, 2018, NPJ FLEX ELECTRON, V2, DOI 10.1038/s41528-018-0021-5; Han ST, 2013, ADV MATER, V25, P5425, DOI 10.1002/adma.201301361; Hussain AM, 2016, ADV MATER, V28, P4219, DOI 10.1002/adma.201504236; Ielmini D, 2007, IEEE T ELECTRON DEV, V54, P308, DOI 10.1109/TED.2006.888752; Ielmini D, 2018, NAT ELECTRON, V1, P333, DOI 10.1038/s41928-018-0092-2; Khan AI, 2020, IEEE ELECTR DEVICE L, V41, P1657, DOI 10.1109/LED.2020.3028271; Kim DH, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201806338; Kim SJ, 2011, J MATER CHEM, V21, P14516, DOI 10.1039/c1jm11812a; Krebs D, 2012, J NON-CRYST SOLIDS, V358, P2412, DOI 10.1016/j.jnoncrysol.2011.12.112; Krusin-Elbaum L, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2719148; Kumar D, 2020, IEEE T ELECTRON DEV, V67, P493, DOI 10.1109/TED.2019.2959883; Kwon H, 2021, NANO LETT, V21, P5984, DOI 10.1021/acs.nanolett.1c00947; Lee SM, 1997, J APPL PHYS, V81, P2590, DOI 10.1063/1.363923; Li C, 2018, NAT ELECTRON, V1, P52, DOI 10.1038/s41928-017-0002-z; Li J, 2017, NPG ASIA MATER, V9, DOI 10.1038/am.2017.8; Loong LM, 2016, ADV MATER, V28, P4983, DOI 10.1002/adma.201600062; Lyeo HK, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2359354; MAO ZL, 1995, J APPL PHYS, V78, P2338, DOI 10.1063/1.360152; Momand J, 2017, NANOSCALE, V9, P8774, DOI 10.1039/c7nr01684k; Mun BH, 2015, ACS NANO, V9, P4120, DOI 10.1021/acsnano.5b00230; Neumann CM, 2019, APPL PHYS LETT, V114, DOI 10.1063/1.5080959; Ohyanagi T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.05FF01; Okabe KL, 2019, J APPL PHYS, V125, DOI 10.1063/1.5093907; Park SI, 2009, SCIENCE, V325, P977, DOI 10.1126/science.1175690; Park YJ, 2019, ACS NANO, V13, P3023, DOI 10.1021/acsnano.8b07995; Raoux S, 2014, MRS BULL, V39, P703, DOI 10.1557/mrs.2014.139; Rivera F, 2013, MICROSC MICROANAL, V19, P1080, DOI 10.1017/S1431927613001670; Saito Y, 2019, PURE APPL CHEM, V91, P1777, DOI 10.1515/pac-2019-0105; Saito Y, 2016, AIP ADV, V6, DOI 10.1063/1.4948536; Saito Y, 2015, PHYS STATUS SOLIDI B, V252, P2151, DOI 10.1002/pssb.201552335; Salvatore GA, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201702390; Samie F, 2016, 2016 IEEE 3RD WORLD FORUM ON INTERNET OF THINGS (WF-IOT), P7, DOI 10.1109/WF-IoT.2016.7845499; Sarangan A, 2018, IEEE PHOTONICS J, V10, DOI 10.1109/JPHOT.2018.2796448; Sekitani T, 2009, SCIENCE, V326, P1516, DOI 10.1126/science.1179963; Shen JB, 2019, ACS APPL MATER INTER, V11, P5336, DOI 10.1021/acsami.8b18473; Simpson RE, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3675635; Simpson RE, 2011, NAT NANOTECHNOL, V6, P501, DOI [10.1038/NNANO.2011.96, 10.1038/nnano.2011.96]; Soeya S, 2012, J APPL PHYS, V112, DOI 10.1063/1.4739741; Subramanian B, 2011, SURF COAT TECH, V205, P5014, DOI 10.1016/j.surfcoat.2011.05.004; Suh DS, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3259649; Suhadolnik L, 2019, APPL CATAL B-ENVIRON, V257, DOI 10.1016/j.apcatb.2019.117894; Suri M, 2013, PROCEEDINGS OF THE 2013 IEEE/ACM INTERNATIONAL SYMPOSIUM ON NANOSCALE ARCHITECTURES (NANOARCH), P140, DOI 10.1109/NanoArch.2013.6623059; Nguyen TTT, 2020, APPL PHYS LETT, V117, DOI 10.1063/5.0010274; TSAI W, 1993, J APPL PHYS, V73, P4462, DOI 10.1063/1.352785; Venkatasubramanian R, 1997, J CRYST GROWTH, V170, P817, DOI 10.1016/S0022-0248(96)00656-2; Wang C, 2013, NAT MATER, V12, P899, DOI [10.1038/NMAT3711, 10.1038/nmat3711]; Wong H.-S. P., STANFORD MEMORY TREN; Wong HSP, 2010, P IEEE, V98, P2201, DOI 10.1109/JPROC.2010.2070050; Xu KC, 2019, ADV MATER TECHNOL-US, V4, DOI 10.1002/admt.201800628; Xu T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09533-2; Yu WJ, 2011, ADV MATER, V23, P1889, DOI 10.1002/adma.201004444; Zhang Z, 2012, APPL SURF SCI, V258, P6075, DOI 10.1016/j.apsusc.2012.03.005	65	32	31	37	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2021	373	6560					1243	+		10.1126/science.abj1261	http://dx.doi.org/10.1126/science.abj1261			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UP5RB	34516795				2022-12-28	WOS:000695436000030
J	Pasricha, SR; Hasan, MI; Braat, S; Larson, LM; Tipu, SMMU; Hossain, SJ; Shiraji, S; Baldi, A; Bhuiyan, MSA; Tofail, F; Fisher, J; Grantham-McGregor, S; Simpson, JA; Hamadani, JD; Biggs, BA				Pasricha, S-R; Hasan, M., I; Braat, S.; Larson, L. M.; Tipu, S. M. M-U; Hossain, S. J.; Shiraji, S.; Baldi, A.; Bhuiyan, M. S. A.; Tofail, F.; Fisher, J.; Grantham-McGregor, S.; Simpson, J. A.; Hamadani, J. D.; Biggs, B-A			Benefits and Risks of Iron Interventions in Infants in Rural Bangladesh	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							YOUNG-CHILDREN; NUTRITION INTERVENTIONS; RESPONSIVE STIMULATION; DEFICIENCY ANEMIA; GROWTH; SUPPLEMENTATION; PAKISTAN; HEALTH; TRIAL; WOMEN	Background Universal provision of iron supplements (drops or syrup) or multiple micronutrient powders to young children in low-to-middle-income countries where anemia is prevalent is recommended by the World Health Organization and widely implemented. The functional benefits and safety of these interventions are unclear. Methods We conducted a three-group, double-blind, double-dummy, individually randomized, placebo-controlled trial to assess the immediate and medium-term benefits and risks of 3 months of daily supplementation with iron syrup or iron-containing multiple micronutrient powders, as compared with placebo, in 8-month-old children in rural Bangladesh. The primary outcome was cognitive development, as assessed by the cognitive composite score on the Bayley Scales of Infant and Toddler Development, third edition, immediately after completion of the assigned 3-month regimen; scores range from 55 to 145, with higher scores indicating better cognitive performance. Secondary outcomes included the cognitive composite score at 9 months after completion of the assigned regimen; behavioral, language, and motor development, as well as growth and hematologic markers, immediately after completion and at 9 months after completion; and safety. Results We randomly assigned 3300 infants to receive iron syrup (1101 infants), multiple micronutrient powders (1099), or placebo (1100) daily. After completion of the assigned 3-month regimen, no apparent effect on the cognitive composite score was observed with iron syrup as compared with placebo (mean between-group difference in change in score from baseline, -0.30 points; 95% confidence interval [CI], -1.08 to 0.48) or with multiple micronutrient powders as compared with placebo (mean between-group difference in change in score from baseline, 0.23 points; 95% CI, -0.55 to 1.00). No apparent effect on any other developmental or growth outcome was observed immediately after completion of the assigned regimen or at 9 months after completion. At 9 months after completion of the assigned regimen, the prevalences of anemia, iron deficiency, and iron deficiency anemia increased in all three trial groups but remained lower among the children who received iron syrup or multiple micronutrient powders than among those who received placebo. The risk of serious adverse events and incidence of symptoms of infection were similar in the three trial groups. Conclusions In this trial involving infants in Bangladesh, 3 months of daily supplementation with iron syrup or multiple micronutrient powders did not appear to have an effect on child development or other functional outcomes as compared with placebo. (Funded by the National Health and Medical Research Council of Australia; BRISC Australian New Zealand Clinical Trials Registry number, .) Iron Interventions in Infants in Rural Bangladesh Iron supplements (drops or syrup) or multiple micronutrient powders in young children in low-to-middle-income countries where anemia is prevalent are recommended by the World Health Organization. In this trial involving infants in Bangladesh, 3 months of such interventions did not appear to affect child development or other functional outcomes as compared with placebo.	[Pasricha, S-R; Braat, S.; Larson, L. M.; Baldi, A.] Univ Melbourne, Populat Hlth & Immun Div, Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Pasricha, S-R] Univ Melbourne, Diagnost Haematol, Royal Melbourne Hosp, Parkville, Vic, Australia; [Pasricha, S-R] Univ Melbourne, Clin Haematol, Peter Maccallum Canc Ctr, Parkville, Vic, Australia; [Pasricha, S-R] Univ Melbourne, Royal Melbourne Hosp, Parkville, Vic, Australia; [Pasricha, S-R; Baldi, A.] Univ Melbourne, Dept Med Biol, Peter Doherty Inst Infect & Immun, Parkville, Vic, Australia; [Braat, S.; Larson, L. M.; Shiraji, S.] Univ Melbourne, Dept Med, Peter Doherty Inst Infect & Immun, Parkville, Vic, Australia; [Braat, S.; Larson, L. M.; Shiraji, S.] Univ Melbourne, Dept Infect Dis, Peter Doherty Inst Infect & Immun, Parkville, Vic, Australia; [Braat, S.; Simpson, J. A.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epide Miol & Biostat, Parkville, Vic, Australia; [Biggs, B-A] Royal Melbourne Hosp, Victorian Infect Dis Serv, Parkville, Vic, Australia; [Fisher, J.] Monash Univ, Dept Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Hasan, M., I; Tipu, S. M. M-U; Hossain, S. J.; Shiraji, S.; Bhuiyan, M. S. A.; Tofail, F.; Hamadani, J. D.] Int Ctr Diarrheal Dis Res, Dhaka, Bangladesh; [Larson, L. M.] Univ South Carolina, Arnold Sch Publ Hlth, Dept Hlth Promot Educ & Behav, Columbia, SC 29208 USA; [Grantham-McGregor, S.] UCL, Inst Child Hlth, London, England	University of Melbourne; Walter & Eliza Hall Institute; Royal Melbourne Hospital; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Royal Melbourne Hospital; Monash University; International Centre for Diarrhoeal Disease Research (ICDDR); University of South Carolina System; University of South Carolina Columbia; University of London; University College London	Pasricha, SR (corresponding author), Walter & Eliza Hall Inst Med Res, Populat Hlth & Immun Div, 1G Royal Parade, Parkville, Vic 3052, Australia.	pasricha.s@wehi.edu.au	Pasricha, Sant-Rayn/H-8436-2019	Pasricha, Sant-Rayn/0000-0002-5502-0434; BRAAT, SABINE/0000-0003-1997-3999				[Anonymous], 2017, NUTR AN TOOLS EFF PR; [Anonymous], 2016, WHO GUID US MULT MIC; [Anonymous], 2016, DAIL IR SUPPL CHILDR; [Anonymous], 2001, IR DEF AN ASS PREV C; Attanasio OP, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5785; Braat Sabine, 2020, F1000Res, V9, P427, DOI 10.12688/f1000research.23383.1; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27; Del Rosario C, 2021, ARCH DIS CHILDHOOD-E, V106, P108, DOI 10.1136/archdischild-2020-319063; Dmitrienko A, 2007, PHARM STAT, V6, P171, DOI 10.1002/pst.291; Georgieff MK, 2020, AM J OBSTET GYNECOL, V223, P516, DOI 10.1016/j.ajog.2020.03.006; Global Health Observatory, 2021, PREV AN CHILDR AG 6; Grantham-McGregor S, 2001, J NUTR, V131, p649S, DOI 10.1093/jn/131.2.649S; Hamadani JD, 2019, LANCET GLOB HEALTH, V7, pE366, DOI 10.1016/S2214-109X(18)30535-7; Hamadani JD, 2010, J HEALTH POPUL NUTR, V28, P23, DOI 10.3329/jhpn.v28i1.4520; Hamadani JD, 2020, LANCET GLOB HEALTH, V8, pE1380, DOI 10.1016/S2214-109X(20)30366-1; Hasan MI, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018325; IDJRADINATA P, 1993, LANCET, V341, P1, DOI 10.1016/0140-6736(93)92477-B; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Kemper AR, 2017, AM J CLIN NUTR, V106, p1555S, DOI 10.3945/ajcn.117.155788; Liang K-Y, 2000, SANKHYA INDIAN J S B, P134, DOI [DOI 10.2307/25053123, DOI 10.2337/DB12-0868]; Lind T, 2004, AM J CLIN NUTR, V80, P729; Merrill RD, 2011, J NUTR, V141, P944, DOI 10.3945/jn.111.138628; Pasricha SR, 2021, LANCET, V397, P233, DOI 10.1016/S0140-6736(20)32594-0; Pasricha Sant-Rayn, 2020, Lancet Glob Health, V8, pe1071, DOI 10.1016/S2214-109X(20)30240-0; Pasricha SR, 2013, LANCET GLOB HEALTH, V1, pE77, DOI 10.1016/S2214-109X(13)70046-9; Rezvan PH, 2018, LONGITUD LIFE COURSE, V9, P259, DOI 10.14301/llcs.v9i3.503; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Siu AL, 2015, PEDIATRICS, V136, P746, DOI 10.1542/peds.2015-2567; Soofi S, 2013, LANCET, V382, P29, DOI 10.1016/S0140-6736(13)60437-7; Suchdev PS, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008959.pub3; UNICEF, 2020, GLOB NUTR CLUST GLOB; Yousafzai AK, 2016, LANCET GLOB HEALTH, V4, pE548, DOI 10.1016/S2214-109X(16)30100-0; Yousafzai AK, 2014, LANCET, V384, P1282, DOI 10.1016/S0140-6736(14)60455-4	33	4	4	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 9	2021	385	11					982	995		10.1056/NEJMoa2034187	http://dx.doi.org/10.1056/NEJMoa2034187			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UN0RH	34496174	Green Published			2022-12-28	WOS:000693730200010
J	[Anonymous]				[Anonymous]			Public Health and Private Practice (Reprintrd from JAMA, vol 77, pg 779-782, 1921)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		Billings F, 1921, J AMER MED ASSOC, V76, P349, DOI 10.1001/jama.1921.02630060001001	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2021	326	9					875	875		10.1001/jama.2020.18110	http://dx.doi.org/10.1001/jama.2020.18110			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ7LK	34547089				2022-12-28	WOS:000696242100024
J	Scheiblich, H; Dansokho, C; Mercan, D; Schmidt, SV; Bousset, L; Wischhof, L; Eikens, F; Odainic, A; Spitzer, J; Griep, A; Schwartz, S; Bano, D; Latz, E; Melki, R; Heneka, MT				Scheiblich, Hannah; Dansokho, Cira; Mercan, Dilek; Schmidt, Susanne, V; Bousset, Luc; Wischhof, Lena; Eikens, Frederik; Odainic, Alexandru; Spitzer, Jasper; Griep, Angelika; Schwartz, Stephanie; Bano, Daniele; Latz, Eicke; Melki, Ronald; Heneka, Michael T.			Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes	CELL			English	Article							TO-NEURON TRANSMISSION; RHO KINASE INHIBITION; PARKINSONS-DISEASE; MITOCHONDRIAL TRANSFER; ALZHEIMERS-DISEASE; LONG-TERM; PROTEIN; ACTIVATION; CELLS; MODEL	Microglia are the CNS resident immune cells that react to misfolded proteins through pattern recognition receptor ligation and activation of inflammatory pathways. Here, we studied how microglia handle and cope with alpha-synuclein (alpha-syn) fibrils and their clearance. We found that microglia exposed to alpha-syn establish a cellular network through the formation of F-actin-dependent intercellular connections, which transfer alpha-syn from overloaded microglia to neighboring naive microglia where the alpha-syn cargo got rapidly and effectively degraded. Lowering the alpha-syn burden attenuated the inflammatory profile of microglia and improved their survival, This degradation strategy was compromised in cells carrying the LRRK2 G2019S mutation, We confirmed the intercellular transfer of alpha-syn assemblies in microglia using organotypic slice cultures, 2-photon microscopy, and neuropathology of patients. Together, these data identify a mechanism by which microglia create an "on-demand" functional network in order to improve pathogenic alpha-syn clearance.	[Scheiblich, Hannah; Dansokho, Cira; Mercan, Dilek; Eikens, Frederik; Schwartz, Stephanie; Heneka, Michael T.] Univ Bonn, Dept Neurodegenerat Dis & Geriatr Psychiat Neurol, Med Ctr, D-53127 Bonn, Germany; [Scheiblich, Hannah; Dansokho, Cira; Mercan, Dilek; Wischhof, Lena; Eikens, Frederik; Griep, Angelika; Bano, Daniele; Latz, Eicke; Heneka, Michael T.] German Ctr Neurodegenerat Dis DZNE, D-53127 Bonn, Germany; [Schmidt, Susanne, V; Odainic, Alexandru; Spitzer, Jasper; Latz, Eicke] Univ Bonn, Inst Innate Immun, Med Ctr, D-53127 Bonn, Germany; [Bousset, Luc; Melki, Ronald] CNRS, CEA, MIRCen, Inst Francois Jacob, F-92265 Fontenay Aux Roses, France; [Bousset, Luc; Melki, Ronald] CNRS, Lab Neurodegenerat Dis, F-92265 Fontenay Aux Roses, France; [Heneka, Michael T.] Univ Massachusetts, Div Infect Dis & Immunol, Med Sch, Worcester, MA 01605 USA	University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); University of Massachusetts System; University of Massachusetts Worcester	Heneka, MT (corresponding author), Univ Bonn, Dept Neurodegenerat Dis & Geriatr Psychiat Neurol, Med Ctr, D-53127 Bonn, Germany.; Heneka, MT (corresponding author), German Ctr Neurodegenerat Dis DZNE, D-53127 Bonn, Germany.; Heneka, MT (corresponding author), Univ Massachusetts, Div Infect Dis & Immunol, Med Sch, Worcester, MA 01605 USA.	michael.heneka@ukbonn.de	Mercan, Dilek/HGC-9014-2022; Scheiblich, Hannah/ABC-3883-2021; Latz, Eicke/H-3951-2014	Latz, Eicke/0000-0003-1488-5666; Spitzer, Jasper/0000-0001-9696-2092; Griep, Angelika/0000-0003-2568-9222	Joint Program on Neurodegenerative Diseases (JPND) [01ED1603]; Gemeinnutzige Hertie Stiftung [P1200007]; NIH [R01 AG059752-02]; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [EXC2151-390873048]; European Union's Horizon 2020 research and innovation program; EFPIA Innovative Medicines Initiative 2 [821522]; Parkinson UK; Microscopy Core Facility of the Medical Faculty at the University of Bonn - Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [388171357]	Joint Program on Neurodegenerative Diseases (JPND); Gemeinnutzige Hertie Stiftung; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); European Union's Horizon 2020 research and innovation program; EFPIA Innovative Medicines Initiative 2; Parkinson UK(Parkinson's UK); Microscopy Core Facility of the Medical Faculty at the University of Bonn - Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	This work was supported by funding from the Joint Program on Neurodegenerative Diseases (JPND) to M.T.H. and R.M. (01ED1603) and the Gemeinnutzige Hertie Stiftung to H.S. (P1200007); M.T.H. received further fundings from a NIH grant (R01 AG059752-02) and from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy EXC2151-390873048; R.M. and L.B. also received support from the European Union's Horizon 2020 research and innovation program and EFPIA Innovative Medicines Initiative 2 grant agreement 821522 (PD-MitoQUANT) and Parkinson UK.; The authors would like to thank Prof. Dr. Manuela Neumann and the Tubingen Brain Bank as well as Prof. Dr. Annett Halle and the DZNE Brain Bank Bonn for kindly providing human brain samples. We thank Dr. Pawel Tacik, Dr. Dr. Sergio Castro-Gomez, and Dr. Sarah Bernsen for providing us with patients' blood samples. Many thanks to the patients and their spouses who have volunteered to donate blood. The authors would like to thank Maike Kreutzenbeck and Ulrike Stube for their support regarding RNA isolation and preparation for sequencing. We thank the DZNE light microscope facility (LMF) for providing microscopes and advice and the DZNE Image and Data Analysis Facility (IDAF) for providing analysis computers and software. We thank the Flow Cytometry Core Facility for their help regarding cell sorting and the NGS Core Facility of the University Hospital Bonn for the library preparing and the generation of the sequencing data. We would like to thank the Microscopy Core Facility of the Medical Faculty at the University of Bonn for providing support and instrumentation funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), project number 388171357.	Abounit S, 2016, EMBO J, V35, P2120, DOI 10.15252/embj.201593411; Ahmad T, 2014, EMBO J, V33, P994, DOI 10.1002/embj.201386030; Alarcon-Martinez L, 2020, NATURE, V585, P91, DOI 10.1038/s41586-020-2589-x; Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Arkwright PD, 2010, CELL RES, V20, P72, DOI 10.1038/cr.2009.112; Barcia C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00809; Billingsley KJ, 2019, NPJ PARKINSON DIS, V5, DOI 10.1038/s41531-019-0080-x; Blesa J, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00155; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Brundin P, 2008, NAT REV NEUROSCI, V9, P741, DOI 10.1038/nrn2477; Bukoreshtliev NV, 2009, FEBS LETT, V583, P1481, DOI 10.1016/j.febslet.2009.03.065; Cho YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032778; Choi I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15119-w; Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358; Croft Cara L, 2018, F1000Res, V7, P592, DOI 10.12688/f1000research.14500.1; Croisier E, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-14; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Davis CHO, 2014, P NATL ACAD SCI USA, V111, P9633, DOI 10.1073/pnas.1404651111; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Dieriks BV, 2017, SCI REP-UK, V7, DOI 10.1038/srep42984; Dupont M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00043; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Eugenin EA, 2001, P NATL ACAD SCI USA, V98, P4190, DOI 10.1073/pnas.051634298; Flavin WP, 2017, ACTA NEUROPATHOL, V134, P629, DOI 10.1007/s00401-017-1722-x; Freundt EC, 2012, ANN NEUROL, V72, P517, DOI 10.1002/ana.23747; Gentry EG, 2016, J NEUROSCI, V36, P1316, DOI 10.1523/JNEUROSCI.2336-15.2016; George S, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0335-3; Gerhard A, 2006, NEUROBIOL DIS, V21, P404, DOI 10.1016/j.nbd.2005.08.002; Ghee M, 2005, FEBS J, V272, P4023, DOI 10.1111/j.1742-4658.2005.04776.x; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Grozdanov V, 2019, ANN NEUROL, V86, P593, DOI 10.1002/ana.25557; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; Hefendehl JK, 2012, J NEUROSCI METH, V205, P357, DOI 10.1016/j.jneumeth.2011.10.029; Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705; Hetz C, 2018, MOL CELL, V69, P169, DOI 10.1016/j.molcel.2017.06.017; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Hsieh CH, 2016, CELL STEM CELL, V19, P709, DOI 10.1016/j.stem.2016.08.002; Hu D, 2018, CURR MED SCI, V38, P1012, DOI 10.1007/s11596-018-1977-z; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Keller KE, 2017, INVEST OPHTH VIS SCI, V58, P5298, DOI 10.1167/iovs.17-22732; Lecours C, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00282; Lee HJ, 2008, BIOCHEM BIOPH RES CO, V372, P423, DOI 10.1016/j.bbrc.2008.05.045; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Mollenhauer B, 2011, LANCET NEUROL, V10, P230, DOI 10.1016/S1474-4422(11)70014-X; Okafo G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16600-1; Onfelt B, 2006, J IMMUNOL, V177, P8476, DOI 10.4049/jimmunol.177.12.8476; Panasiuk M, 2018, J VIROL, V92, DOI [10.1128/jvi.00090-18, 10.1128/JVI.00090-18]; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Rodriguez AM, 2018, CELL CYCLE, V17, P712, DOI 10.1080/15384101.2018.1445906; Rostami J, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-021-02158-3; Rostami J, 2017, J NEUROSCI, V37, P11835, DOI 10.1523/JNEUROSCI.0983-17.2017; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Saal KA, 2017, BRAIN PATHOL, V27, P13, DOI 10.1111/bpa.12346; Sarkar S, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00033; Scheiblich H, 2021, J IMMUNOL, V207, P2143, DOI 10.4049/jimmunol.2100035; Sellgren CM, 2017, MOL PSYCHIATR, V22, P170, DOI 10.1038/mp.2016.220; Senol AD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42161-6; Shahmoradian SH, 2019, NAT NEUROSCI, V22, P1099, DOI 10.1038/s41593-019-0423-2; Shi JJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.10; Sisakhtnezhad S, 2015, EUR J CELL BIOL, V94, P429, DOI 10.1016/j.ejcb.2015.06.010; Snyder H, 2003, J BIOL CHEM, V278, P11753, DOI 10.1074/jbc.M208641200; Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tatenhorst L, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0310-y; Tonges L, 2014, GLIA, V62, P217, DOI 10.1002/glia.22601; Tonges L, 2012, BRAIN, V135, P3355, DOI 10.1093/brain/aws254; Wallings RL, 2019, BIOCHEM SOC T, V47, P1581, DOI 10.1042/BST20180463; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n	74	56	56	9	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 30	2021	184	20					5089	+		10.1016/j.cell.2021.09.007	http://dx.doi.org/10.1016/j.cell.2021.09.007		OCT 2021	39	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	WC7PG	34555357	Green Published, hybrid			2022-12-28	WOS:000704445700007
J	Young, BC; Eyre, DW; Kendrick, S; White, C; Smith, S; Beveridge, G; Nonnenmacher, T; Ichofu, F; Hillier, J; Oakley, S; Diamond, I; Rourke, E; Dawe, F; Day, I; Davies, L; Staite, P; Lacey, A; McCrae, J; Jones, F; Kelly, J; Bankiewicz, U; Tunkel, S; Ovens, R; Chapman, D; Bhalla, V; Marks, P; Hicks, N; Fowler, T; Hopkins, S; Yardley, L; Peto, TEA				Young, Bernadette C.; Eyre, David W.; Kendrick, Saroj; White, Chris; Smith, Sylvester; Beveridge, George; Nonnenmacher, Toby; Ichofu, Fegor; Hillier, Joseph; Oakley, Sarah; Diamond, Ian; Rourke, Emma; Dawe, Fiona; Day, Ieuan; Davies, Lisa; Staite, Paul; Lacey, Andrea; McCrae, James; Jones, Ffion; Kelly, Joseph; Bankiewicz, Urszula; Tunkel, Sarah; Ovens, Richard; Chapman, David; Bhalla, Vineta; Marks, Peter; Hicks, Nick; Fowler, Tom; Hopkins, Susan; Yardley, Lucy; Peto, Tim E. A.			Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trial	LANCET			English	Article							OUTBREAKS; COVID-19	Background School-based COVID-19 contacts in England have been asked to self-isolate at home, missing key educational opportunities. We trialled daily testing of contacts as an alternative to assess whether this resulted in similar control of transmission, while allowing more school attendance. Methods We did an open-label, cluster-randomised, controlled trial in secondary schools and further education colleges in England. Schools were randomly assigned (1:1) to self-isolation of school-based COVID-19 contacts for 10 days (control) or to voluntary daily lateral flow device (LFD) testing for 7 days with LFD-negative contacts remaining at school (intervention). Randomisation was stratified according to school type and size, presence of a sixth form, presence of residential students, and proportion of students eligible for free school meals. Group assignment was not masked during procedures or analysis. Coprimary outcomes in all students and staff were COVID-19-related school absence and symptomatic PCR-confirmed COVID-19, adjusted for community case rates, to estimate within-school transmission (non-inferiority margin <50% relative increase). Analyses were done on an intention-to-treat basis using quasi-Poisson regression, also estimating complier average causal effects (CACE). This trial is registered with the ISRCTN registry, ISRCTN18100261. Findings Between March 18 and May 4, 2021, 204 schools were taken through the consent process, during which three decided not to participate further. 201 schools were randomly assigned (control group n=99, intervention group n=102) in the 10-week study (April 19-May 10, 2021), which continued until the pre-appointed stop date (June 27, 2021). 76 control group schools and 86 intervention group schools actively participated; additional national data allowed most non-participating schools to be included in analysis of coprimary outcomes. 2432 (42.4%) of 5763 intervention group contacts participated in daily contact testing. There were 657 symptomatic PCR-confirmed infections during 7782 537 days-at-risk (59.1 per 100 000 per week) in the control group and 740 during 8 379 749 days-at-risk (61.8 per 100 000 per week) in the intervention group (intention-to-treat adjusted incidence rate ratio [aIRR] 0.96 [95% CI 0.75-1.22]; p=0.72; CACE aIRR 0.86 [0.55-1.34]). Among students and staff, there were 59 422 (1.62%) COVID-19-related absences during 3 659017 person-school-days in the control group and 51 541 (1.34%) during 3 845 208 person-school-days in the intervention group (intention-to-treat aIRR 0.80 [95% CI 0.54-1.19]; p=0.27; CACE aIRR 0.61 [0.30-1.23]). Interpretation Daily contact testing of school-based contacts was non-inferior to self-isolation for control of COVID-19 transmission, with similar rates of symptomatic infections among students and staff with both approaches. Infection rates in school-based contacts were low, with very few school contacts testing positive. Daily contact testing should be considered for implementation as a safe alternative to home isolation following school-based exposures. Copyright (C) 2021 Published by Elsevier Ltd. All rights reserved.	[Young, Bernadette C.; Peto, Tim E. A.] Univ Oxford, Nuffield Dept Med, Oxford, England; [Eyre, David W.; Peto, Tim E. A.] Univ Oxford, Natl Inst Hlth Res NIHR, Oxford Biomed Res Ctr, Oxford, England; [Eyre, David W.; Peto, Tim E. A.] Univ Oxford, NIHR Hlth Protect Res Unit Healthcare Associated, Oxford, England; [Eyre, David W.] Univ Oxford, Big Data Inst, Nuffield Dept Populat Hlth, Oxford, England; [Hicks, Nick] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Kendrick, Saroj; White, Chris; Smith, Sylvester; Beveridge, George; Nonnenmacher, Toby; Ichofu, Fegor; Hillier, Joseph; Tunkel, Sarah; Marks, Peter; Hicks, Nick; Fowler, Tom] Dept Hlth & Social Care, London, England; [Oakley, Sarah] Oxford Univ Hosp NHS Fdn Trust, Dept Microbiol, Oxford, England; [Diamond, Ian; Rourke, Emma; Dawe, Fiona; Day, Ieuan; Davies, Lisa; Staite, Paul; Lacey, Andrea; McCrae, James; Jones, Ffion; Kelly, Joseph; Bankiewicz, Urszula] Off Natl Stat, Newport, Gwent, Wales; [Ovens, Richard; Chapman, David; Bhalla, Vineta] Deloitte MCS, London, England; [Hicks, Nick; Hopkins, Susan] Publ Hlth England, London, England; [Fowler, Tom] Queen Mary Univ London, William Harvey Res Inst, London, England; [Yardley, Lucy] Univ Bristol, Hlth Protect Res Unit Behav Sci, Bristol, Avon, England; [Yardley, Lucy] Univ Southampton, Sch Psychol, Southampton, Hants, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Oxford; Oxford University Hospitals NHS Foundation Trust; Deloitte Touche Tohmatsu Limited; Public Health England; University of London; Queen Mary University London; University of Bristol; University of Southampton	Young, BC (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Oxford OX3 9DU, England.	bernadette.young@ndm.ox.ac.uk	Fowler, Tom/AGT-1933-2022; Eyre, David/P-6887-2016	Fowler, Tom/0000-0002-7258-2279; Eyre, David/0000-0001-5095-6367; Hopkins, Susan/0000-0001-5179-5702; Hicks, Nicholas/0000-0002-7214-9678; Yardley, Lucy/0000-0002-3853-883X	UK Government Department of Health and Social Care; UK Government Department for Education and Office for National Statistics; National Institute for Health Research (NIHR) Health Protection Research Unit (HPRU) in Healthcare Associated Infections and Antimicrobial Resistance at Oxford University; Public Health England [NIHR200915]; NIHR Biomedical Research Centre, Oxford; Department of Health and Social Care; NIHR Applied Research Collaboration-West; NIHR HPRU for Behavioural Science and Evaluation; NIHR Southampton Biomedical Research Centre	UK Government Department of Health and Social Care; UK Government Department for Education and Office for National Statistics; National Institute for Health Research (NIHR) Health Protection Research Unit (HPRU) in Healthcare Associated Infections and Antimicrobial Resistance at Oxford University; Public Health England; NIHR Biomedical Research Centre, Oxford(National Institute for Health Research (NIHR)); Department of Health and Social Care; NIHR Applied Research Collaboration-West; NIHR HPRU for Behavioural Science and Evaluation; NIHR Southampton Biomedical Research Centre	We acknowledge all the students and staff at participating schools, as well as ten pilot schools, for contributing to the study, and in particular the study workers at each of the schools. We are thankful to the Microbiology Department of Oxford University Hospitals NHS Foundation Trust for doing PCR testing. Additionally, we acknowledge the support in conducting the study of the Department of Health and Social Care daily contact testing project management team, especially Nichole Solomon, and the Office for National Statistics daily contact testing team. We thank Department for Education colleagues, particularly Sara Cooper, Matt Mawer, and Richard Lumley for their assistance. We thank Sarah Walker for insightful advice. This study was funded by the UK Government Department of Health and Social Care and supported by the UK Government Department for Education and Office for National Statistics. The work was also supported by the National Institute for Health Research (NIHR) Health Protection Research Unit (HPRU) in Healthcare Associated Infections and Antimicrobial Resistance at Oxford University in partnership with Public Health England (NIHR200915) and the NIHR Biomedical Research Centre, Oxford. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR, the Department of Health and Social Care, the Department for Education, the Office for National Statistics, or Public Health England. BCY is an NIHR clinical lecturer. BCY, TEAP, and LY received grants from the Department of Health and Social Care to fund this work. DWE is a Robertson Foundation Fellow. LY is an NIHR Senior Investigator and her research programme is partly supported by NIHR Applied Research Collaboration-West, NIHR HPRU for Behavioural Science and Evaluation, and the NIHR Southampton Biomedical Research Centre.	Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8, 10.1016/S0140-6736(20)30460-8.]; Burgess S., 2020, SCH SKILLS LEARNING; Centre for Education Policy and Equalising Opportunities, 2021, BRIEF NOT SCH ABS PU; Crawley E, 2020, BMJ PAEDIATR OPEN, V4, DOI 10.1136/bmjpo-2020-000701; Denford S, FEASIBILITY ACCEPTAB; Department for Education, SCH COVID 19 OP GUID; Department of Health and Social Care, 2021, LAT FLOW DEV PERF DA; Dinnes J, 2020, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD013705.pub2, 10.1002/14651858.CD013705]; Education Endowment Fund, 2020, SCH CLOS RAP EV ASS; Eyre DW, 2018, NEW ENGL J MED, V379, P1322, DOI 10.1056/NEJMoa1714373; Fernandez-Montero A, 2021, ECLINICALMEDICINE, V37, DOI 10.1016/j.eclinm.2021.100954; Ismail SA, 2021, LANCET INFECT DIS, V21, P344, DOI 10.1016/S1473-3099(20)30882-3; Leber W, 2021, ECLINICALMEDICINE, V38, DOI 10.1016/j.eclinm.2021.101011; Lee LYW, 2022, CLIN INFECT DIS, V74, P407, DOI 10.1093/cid/ciab421; Leng T., 2021, MEDRXIV, DOI [10.1101/2021.02.11.21251587, DOI 10.1101/2021.02.11.21251587]; Love N, MEDRXIV, DOI [10.1101/2021.03.23.21254168, DOI 10.1101/2021.03.23.21254168]; Lumley SF, 2021, ENH EP INV NOS SARS, DOI [10.1101/2021.06.28.21259028, DOI 10.1101/2021.06.28.21259028]; Martin AF, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11135-7; Meredith LW, 2020, LANCET INFECT DIS, V20, P1263, DOI 10.1016/S1473-3099(20)30562-4; Office for National Statistics, 2021, COVID 19 SCH INF SUR; Pekosz A, 2021, CLIN INFECT DIS, V73, pE2861, DOI 10.1093/cid/ciaa1706; Peto T, 2021, ECLINICALMEDICINE, V36, DOI 10.1016/j.eclinm.2021.100924; Price JR, 2017, LANCET INFECT DIS, V17, P207, DOI [10.1016/S1473-3099(16)30413-3, 10.1016/s1473-3099(16)30413-3]; Public Health England, GUID CONT PEOPL CONF; Public Health England, 2021, SARS COV 2 VAR VAR I; Quilty BJ, 2021, LANCET PUBLIC HEALTH, V6, pE175, DOI 10.1016/S2468-2667(20)30308-X; Scientific Advisory Group for Emergencies, 2021, SAGE 83 MIN COR COVI; Scientific Pandemic Influenza Group on Modelling Operational sub-group (SPI-M-O), 2021, WORKPL DAIL CONT TES; Smith LE, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n608; UK Government, 2020, GUID SCH COR COVID 1; Viner RM, 2020, LANCET CHILD ADOLESC, V4, P397, DOI 10.1016/S2352-4642(20)30095-X	31	31	31	1	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 2	2021	398	10307					1217	1229		10.1016/S0140-6736(21)01908-5	http://dx.doi.org/10.1016/S0140-6736(21)01908-5		SEP 2021	13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WC6VF	34534517	Green Submitted, Green Accepted, Green Published, Bronze			2022-12-28	WOS:000704393000020
J	Rood, JE; Regev, A				Rood, Jennifer E.; Regev, Aviv			The legacy of the Human Genome Project	SCIENCE			English	Editorial Material									[Rood, Jennifer E.; Regev, Aviv] Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA	Roche Holding; Genentech	Regev, A (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	aviv.regev.sc@gmail.com						Cano-Gamez E, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00424; Curtis D, 2020, ANN HUM GENET, V84, P313, DOI 10.1111/ahg.12382; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Gibbs RA, 2020, NAT REV GENET, V21, P575, DOI 10.1038/s41576-020-0275-3; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; King EA, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008489; Morganti S, 2019, CRIT REV ONCOL HEMAT, V133, P171, DOI 10.1016/j.critrevonc.2018.11.008; Nurk S., 445798 BIORXIV, V2021; Peterson RE, 2019, CELL, V179, P589, DOI 10.1016/j.cell.2019.08.051; Regev A, 2017, ELIFE, V6, DOI 10.7554/eLife.27041; Smith LD, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a023168; Sulston J., 2002, COMMON THREADA STORY; Tam V, 2019, NAT REV GENET, V20, P467, DOI 10.1038/s41576-019-0127-1	13	6	6	12	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2021	373	6562			SI		1442	1443		10.1126/science.abl5403	http://dx.doi.org/10.1126/science.abl5403			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU7LJ	34554771				2022-12-28	WOS:000698977800031
J	Cohen, IG; Adashi, EY; Gostin, LO				Cohen, I. Glenn; Adashi, Eli Y.; Gostin, Lawrence O.			The Supreme Court, the Texas Abortion Law (SB8), and the Beginning of the End of Roe v Wade?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Cohen, I. Glenn] Harvard Univ, Harvard Law Sch, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, 1525 Massachusetts Ave,Griswold Hall,Room 503, Cambridge, MA 02138 USA; [Adashi, Eli Y.] Brown Univ, Med Sci Med & Biol Sci, Providence, RI 02912 USA; [Gostin, Lawrence O.] Georgetown Univ, Law Ctr, ONeill Inst Natl & Global Hlth Law, Washington, DC USA	Harvard University; Brown University; Georgetown University	Cohen, IG (corresponding author), Harvard Univ, Harvard Law Sch, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, 1525 Massachusetts Ave,Griswold Hall,Room 503, Cambridge, MA 02138 USA.	igcohen@law.harvard.edu						[Anonymous], 1908, EXPARTE YOUNG 209 US; [Anonymous], 2021, ACT RELATING ABORTIO; [Anonymous], 2021, WL; Mitchell JF, 2018, VA LAW REV, V104, P933; Schmidt MS., 2021, NEW YORK TIMES; Tuma M., 2021, THE GUARDIAN 0901; United States v Texas, 2021, US EM MOT TEMP RESTR	7	7	7	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 19	2021	326	15					1473	1474		10.1001/jama.2021.17639	http://dx.doi.org/10.1001/jama.2021.17639		SEP 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WN1OX	34554180	Green Submitted			2022-12-28	WOS:000698780000001
J	Huang, ZJ; Chen, WQ				Huang, Zijing; Chen, Weiqi			Ocular Thelaziasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Huang, Zijing; Chen, Weiqi] Joint Shantou Int Eye Ctr, Shantou, Peoples R China		Huang, ZJ (corresponding author), Joint Shantou Int Eye Ctr, Shantou, Peoples R China.	huangzj@jsiec.org		Huang, Zijing/0000-0003-2909-2538					0	0	0	2	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2021	385	13								10.1056/NEJMicm2032962	http://dx.doi.org/10.1056/NEJMicm2032962		SEP 2021	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UT0EM	34533902				2022-12-28	WOS:000697035200001
J	Kozlov, M				Kozlov, Max			HURRICANE IDA FORCES RESEARCHERS TO RETHINK THEIR FUTURE	NATURE			English	News Item																			0	1	1	2	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 16	2021	597	7876					313	314		10.1038/d41586-021-02456-z	http://dx.doi.org/10.1038/d41586-021-02456-z			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UQ1MU	34504333				2022-12-28	WOS:000695836000010
J	Limb, M				Limb, Matthew			BMJ Awards 2021: Environmental sustainability and climate action team of the year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material											No Org, London, England.	limb@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2021	374								n2201	10.1136/bmj.n2201	http://dx.doi.org/10.1136/bmj.n2201			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WI4KS	34531190	Bronze			2022-12-28	WOS:000708331800001
J	Schneider, KR; Fanzo, JC; Haddad, L; Moncayo, JR				Schneider, Kate R.; Fanzo, Jessica C.; Haddad, Lawrence; Moncayo, Jose Rosero			Global health has a stake in the upcoming UN Food Systems Summit	LANCET			English	Editorial Material							NUTRITION		[Schneider, Kate R.; Fanzo, Jessica C.] Johns Hopkins Univ, Paul H Nitze Sch Adv Int Studies, Baltimore, MD 20036 USA; [Fanzo, Jessica C.] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 20036 USA; [Fanzo, Jessica C.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 20036 USA; [Haddad, Lawrence] Global Alliance Improved Nutr, Geneva, Switzerland; [Moncayo, Jose Rosero] Food & Agr Org United Nations, Rome, Italy	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Food & Agriculture Organization of the United Nations (FAO)	Fanzo, JC (corresponding author), Johns Hopkins Univ, Paul H Nitze Sch Adv Int Studies, Baltimore, MD 20036 USA.; Fanzo, JC (corresponding author), Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 20036 USA.; Fanzo, JC (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 20036 USA.	jfanzo1@jhu.edu	Fanzo, Jessica/HCH-3533-2022	Schneider, Kate/0000-0002-6861-3255				Afshin A, 2019, LANCET, V393, P1958, DOI 10.1016/S0140-6736(19)30041-8; [Anonymous], 2020, LANCET, V396, P649, DOI 10.1016/S0140-6736(20)31856-0; Au L. E., 2015, Journal of the Academy of Nutrition and Dietetics, V115, pA16, DOI 10.1016/j.jand.2015.06.045; Byerlee D, 2019, GLOB FOOD SECUR-AGR, V21, P52, DOI 10.1016/j.gfs.2019.06.002; Clark MA, 2020, SCIENCE, V370, P705, DOI 10.1126/science.aba7357; FAO IFAD UNICEF WFP WHO, 2021, STAT FOOD SEC NUTR W; Frost JC, 2021, CLIN MED, V21, pE272, DOI 10.7861/clinmed.2020-0707; John S, 2021, AM J PUBLIC HEALTH, V111, P27, DOI 10.2105/AJPH.2020.305987; Katz David L, 2018, AMA J Ethics, V20, pE994, DOI 10.1001/amajethics.2018.994; Macaninch Elaine, 2020, BMJ Nutr Prev Health, V3, P40, DOI 10.1136/bmjnph-2019-000049; Mbow C, 2019, IN PRESS, P437, DOI DOI 10.24818/EA/2019/51/281; Micha R, 2018, FOOD NUTR BULL, V39, P175, DOI 10.1177/0379572117752986; Osendarp S., 2021, NAT FOOD, DOI [10.1038/s43016-021-00319-4, DOI 10.1038/s43016-021-00319-4]; Pagliai G, 2021, BRIT J NUTR, V125, P308, DOI 10.1017/S0007114520002688; Pingali P, 2017, GLOB FOOD SECUR-AGR, V15, P77, DOI 10.1016/j.gfs.2017.05.002; Suarez-Balcazar Y, 2018, J PREV INTERV COMMUN, V46, P1, DOI 10.1080/10852352.2018.1386761; Swinburn B, 2015, LANCET, V385, P2534, DOI 10.1016/S0140-6736(14)61747-5; Swinburn BA, 2019, LANCET, V393, P791, DOI 10.1016/S0140-6736(18)32822-8; UN Secretary General, 2021, SECR GEN CALLS LAT I; Vandevijvere S, 2019, OBES REV, V20, P57, DOI 10.1111/obr.12819; Webb P, 2020, NAT FOOD, V1, P584, DOI 10.1038/s43016-020-00161-0; Winter G, 2019, BR J HLTH CARE MANAG, V25, P13	22	0	0	2	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 18	2021	398	10305					1027	1029		10.1016/S0140-6736(21)02047-X	http://dx.doi.org/10.1016/S0140-6736(21)02047-X		SEP 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	US3YI	34508655				2022-12-28	WOS:000697368600005
J	Zeller, M; Gangavarapu, K; Anderson, C; Smither, AR; Vanchiere, JA; Rose, R; Snyder, DJ; Dudas, G; Watts, A; Matteson, NL; Robles-Sikisaka, R; Marshall, M; Feehan, AK; Sabino-Santos, G; Bell-Kareem, AR; Hughes, LD; Alkuzweny, M; Snarski, P; Garcia-Diaz, JG; Scott, RS; Melnik, LI; Klitting, R; McGraw, M; Belda-Ferre, P; DeHoff, P; Sathe, S; Marotz, C; Grubaugh, ND; Nolan, DJ; Drouin, AC; Genemaras, KJ; Chao, K; Topol, S; Spencer, E; Nicholson, L; Aigner, S; Yeo, GW; Farnaes, L; Hobbs, CA; Laurent, LC; Knight, R; Hodcroft, EB; Khan, K; Fusco, DN; Cooper, VS; Lemey, P; Gardner, L; Lamers, SL; Kamil, JP; Garry, RF; Suchard, MA; Andersen, KG				Zeller, Mark; Gangavarapu, Karthik; Anderson, Catelyn; Smither, Allison R.; Vanchiere, John A.; Rose, Rebecca; Snyder, Daniel J.; Dudas, Gytis; Watts, Alexander; Matteson, Nathaniel L.; Robles-Sikisaka, Refugio; Marshall, Maximilian; Feehan, Amy K.; Sabino-Santos, Gilberto; Bell-Kareem, Antoinette R.; Hughes, Laura D.; Alkuzweny, Manar; Snarski, Patricia; Garcia-Diaz Jr, Julia; Scott, Rona S.; Melnik, Lilia, I; Klitting, Raphaelle; McGraw, Michelle; Belda-Ferre, Pedro; DeHoff, Peter; Sathe, Shashank; Marotz, Clarisse; Grubaugh, Nathan D.; Nolan, David J.; Drouin, Arnaud C.; Genemaras, Kaylynn J.; Chao, Karissa; Topol, Sarah; Spencer, Emily; Nicholson, Laura; Aigner, Stefan; Yeo, Gene W.; Farnaes, Lauge; Hobbs, Charlotte A.; Laurent, Louise C.; Knight, Rob; Hodcroft, Emma B.; Khan, Kamran; Fusco, Dahlene N.; Cooper, Vaughn S.; Lemey, Phillipe; Gardner, Lauren; Lamers, Susanna L.; Kamil, Jeremy P.; Garry, Robert F.; Suchard, Marc A.; Andersen, Kristian G.			Emergence of an early SARS-CoV-2 epidemic in the United States	CELL			English	Article							TRANSMISSION; B.1.1.7	The emergence of the COVID-19 epidemic in the United States (U.S.) went largely undetected due to inadequate testing. New Orleans experienced one of the earliest and fastest accelerating outbreaks, coinciding with Mardi Gras. To gain insight into the emergence of SARS-CoV-2 in the U.S. and how large-scale events accelerate transmission, we sequenced SARS-CoV-2 genomes during the first wave of the COVID-19 epidemic in Louisiana. We show that SARS-CoV-2 in Louisiana had limited diversity compared to other U.S. states and that one introduction of SARS-CoV-2 led to almost all of the early transmission in Louisiana. By analyzing mobility and genomic data, we show that SARS-CoV-2 was already present in New Orleans before Mardi Gras, and the festival dramatically accelerated transmission. Our study provides an understanding of how superspreading during large-scale events played a key role during the early outbreak in the U.S. and can greatly accelerate epidemics.	[Zeller, Mark; Gangavarapu, Karthik; Anderson, Catelyn; Matteson, Nathaniel L.; Robles-Sikisaka, Refugio; Alkuzweny, Manar; Klitting, Raphaelle; McGraw, Michelle; Andersen, Kristian G.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Smither, Allison R.; Bell-Kareem, Antoinette R.; Melnik, Lilia, I; Drouin, Arnaud C.; Genemaras, Kaylynn J.; Chao, Karissa; Garry, Robert F.] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA; [Vanchiere, John A.] Louisiana State Univ Hlth Sci Ctr Shreveport, Dept Pediat, Shreveport, LA 71130 USA; [Rose, Rebecca; Nolan, David J.; Lamers, Susanna L.] BioInfoExperts LLC, Thibodaux, LA USA; [Snyder, Daniel J.; Cooper, Vaughn S.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA; [Snyder, Daniel J.; Cooper, Vaughn S.] Univ Pittsburgh, Ctr Evolutionary Biol & Med, Pittsburgh, PA 15219 USA; [Dudas, Gytis] Gothenburg Global Biodivers Ctr GGBC, Gothenburg, Sweden; [Watts, Alexander; Knight, Rob; Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Watts, Alexander; Knight, Rob; Khan, Kamran] Bluedot, Toronto, ON, Canada; [Marshall, Maximilian; Gardner, Lauren] Johns Hopkins Univ, Dept Civil & Syst Engn, Baltimore, MD USA; [Feehan, Amy K.; Garcia-Diaz Jr, Julia] Ochsner Clin Fdn, New Orleans, LA USA; [Sabino-Santos, Gilberto; Fusco, Dahlene N.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Trop Med, New Orleans, LA 70112 USA; [Sabino-Santos, Gilberto] Univ Sao Paulo, Ctr Virol Res, Ribeirao Preto Med Sch, BR-14049900 Ribeirao Preto, SP, Brazil; [Hughes, Laura D.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Snarski, Patricia] Tulane Univ, Sch Med, Heart & Vasc Inst, John W Deming Dept Med, New Orleans, LA 70112 USA; [Snarski, Patricia; Drouin, Arnaud C.] Tulane Univ, Dept Physiol, Sch Med, New Orleans, LA 70112 USA; [Scott, Rona S.; Kamil, Jeremy P.] Louisiana State Univ Hlth Sci Ctr Shreveport, Dept Microbiol & Immunol, Shreveport, LA 71103 USA; [Belda-Ferre, Pedro; Marotz, Clarisse; Laurent, Louise C.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Belda-Ferre, Pedro; Laurent, Louise C.] Univ Calif San Diego, Jacobs Sch Engn, Ctr Microbiome Innovat, La Jolla, CA 92093 USA; [DeHoff, Peter; Hobbs, Charlotte A.] Univ Calif San Diego, Dept Obstet Gynecol & Reprod Sci, La Jolla, CA 92037 USA; [Sathe, Shashank; Aigner, Stefan] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Sathe, Shashank; Aigner, Stefan] Univ Calif San Diego, Stem Cell Program, La Jolla, CA 92093 USA; [Marotz, Clarisse] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Grubaugh, Nathan D.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA; [Genemaras, Kaylynn J.; Chao, Karissa] Tulane Univ, Bioinnovat Program, New Orleans, LA 70118 USA; [Topol, Sarah; Spencer, Emily; Nicholson, Laura; Andersen, Kristian G.] Scripps Res Translat Inst, La Jolla, CA 92037 USA; [Aigner, Stefan] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Yeo, Gene W.; Farnaes, Lauge] Rady Childrens Inst Genom Med, San Diego, CA 92123 USA; [Yeo, Gene W.; Farnaes, Lauge] Rady Childrens Hosp, San Diego, CA 92123 USA; [Laurent, Louise C.] Univ Calif San Diego, Dept Comp Sci & Engn, Jacobs Sch Engn, La Jolla, CA 92093 USA; [Laurent, Louise C.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Hodcroft, Emma B.] Univ Basel, Biozentrum, Basel, Switzerland; [Knight, Rob; Khan, Kamran] Univ Toronto, Dept Med, Toronto, ON, Canada; [Fusco, Dahlene N.] Tulane Univ, Dept Med, Sch Med, 1430 Tulane Ave, New Orleans, LA 70114 USA; [Lemey, Phillipe] Katholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Rega Inst, Louvain, Belgium; [Lemey, Phillipe] Global Virol Network, Baltimore, MD USA; [Garry, Robert F.] Zalgen Labs LLC, Germantown, MD USA; [Suchard, Marc A.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90095 USA; [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	Scripps Research Institute; Tulane University; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Gothenburg; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Johns Hopkins University; Ochsner Health System; Tulane University; Universidade de Sao Paulo; Scripps Research Institute; Tulane University; Tulane University; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography; Yale University; Tulane University; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Basel; University of Toronto; Tulane University; KU Leuven; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zeller, M; Gangavarapu, K (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.	zellerm@scripps.edu; gkarthik@scripps.edu; andersen@scripps.edu	Feehan, Amy/AAU-8537-2020; Drouin, Arnaud/AAA-3390-2022; Dudas, Gytis/H-5968-2019; Yeo, Gene/AAE-7676-2019; Aigner, Stefan/D-1272-2017	Feehan, Amy/0000-0002-2899-0670; Dudas, Gytis/0000-0002-0227-4158; Yeo, Gene/0000-0002-0799-6037; Spencer, Emily/0000-0003-2650-4357; Aigner, Stefan/0000-0002-9511-3328; Anderson, Catelyn/0000-0002-2023-5814; Melnik, Lilia/0000-0002-3247-3158; Knight, Rob/0000-0002-0975-9019	National Institutes of Health [U19AI135995, 3U19AI135995-03S2, UL1TR002550, U01AI151812, U01AI124302, R01AI153044, R01HG006139]; European Research Council under the European Union's Horizon 2020 research and innovation program [725422]; European Union [874850]; Wellcome Trust [206298/Z/17/Z]; Research Foundation-Flanders ("Fonds voor Wetenschappelijk Onderzoek-Vlaanderen'') [G066215N, G0D5117N, G0B9317N]; National Science Foundation Small Business Innovation Research [2027424, 1830867]; NVIDIA Corporation; Advanced Micro Devices, Inc.; CDC BAA contract [75D30120C09795]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council under the European Union's Horizon 2020 research and innovation program; European Union(European Commission); Wellcome Trust(Wellcome Trust); Research Foundation-Flanders ("Fonds voor Wetenschappelijk Onderzoek-Vlaanderen'')(FWO); National Science Foundation Small Business Innovation Research; NVIDIA Corporation; Advanced Micro Devices, Inc.; CDC BAA contract	We thank the administrators of the GISAID database for supporting rapid and transparent sharing of genomic data during the COVID-19 pandemic and all our colleagues sharing data on GISAID. A full list acknowledging the authors submitting genome sequence data used in this study can be found in Table S2. The research leading to these results has received funding from the National Institutes of Health (grants U19AI135995, 3U19AI135995-03S2, UL1TR002550, U01AI151812, U01AI124302, R01AI153044, and R01HG006139), the CDC BAA contract 75D30120C09795, the European Research Council under the European Union's Horizon 2020 research and innovation program (grant agreement no. 725422-ReservoirDOCS), and from the European Union's Horizon 2020 project MOOD (grant agreement no. 874850). The Artic Network receives funding from the Wellcome Trust through project 206298/Z/17/Z. P.L. acknowledges support by the Research Foundation-Flanders ("Fonds voor Wetenschappelijk Onderzoek-Vlaanderen''; G066215N, G0D5117N, and G0B9317N). S.L.L. acknowledges support by the National Science Foundation Small Business Innovation Research grants 2027424 and 1830867. We also gratefully acknowledge support from NVIDIA Corporation and Advanced Micro Devices, Inc., with the donation of parallel computing resources used for this research.	Althouse BM, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000897; Ayres DL, 2019, SYST BIOL, V68, P1052, DOI 10.1093/sysbio/syz020; Bedford Trevor, 2020, medRxiv, DOI [10.1126/science.abc0523, 10.1101/2020.04.02.20051417]; Bloomquist EW, 2010, TRENDS ECOL EVOL, V25, P626, DOI 10.1016/j.tree.2010.08.010; Chang S, 2021, NATURE, V589, P82, DOI 10.1038/s41586-020-2923-3; Dave D, 2021, SOUTH ECON J, V87, P769, DOI 10.1002/soej.12475; Davies Nicholas G, 2021, Science, V372, DOI 10.1126/science.abg3055; Davis Jessica T, 2020, medRxiv, DOI 10.1101/2020.07.06.20140285; Deatherage DE, 2014, METHODS MOL BIOL, V1151, P165, DOI 10.1007/978-1-4939-0554-6_12; Deng XD, 2020, SCIENCE, V369, P582, DOI 10.1126/science.abb9263; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Faria NR, 2021, SCIENCE, V372, P815, DOI [10.1126/science.abh2644Article, 10.1126/science.abh2644, 10.1101/2021.02.26.21252554]; Fauver JR, 2020, CELL, V181, P990, DOI 10.1016/j.cell.2020.04.021; Feehan AK, 2020, EMERG INFECT DIS, V26, P2765, DOI 10.3201/eid2611.203029; Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Galloway SE, 2021, MMWR-MORBID MORTAL W, V70, P95, DOI [10.15585/mmwr.mm7003e2externalicon, 10.15585/mmwr.mm7003e2]; Grubaugh ND, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-018-1618-7; Grubaugh ND, 2019, NAT MICROBIOL, V4, P10, DOI 10.1038/s41564-018-0296-2; Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Jorden MA, 2020, MMWR-MORBID MORTAL W, V69, P680, DOI 10.15585/mmwr.mm6922e1; Jung SM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020523; Koster J, 2012, BIOINFORMATICS, V28, P2520, DOI 10.1093/bioinformatics/bts480; Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Lemieux JE, 2021, SCIENCE, V371, P588, DOI 10.1126/science.abe3261; Lemieux JE., 2020, PHYLOGENETIC ANAL SA, DOI 10.1101/2020.08.23.20178236; Li H., 2013, ARXIV13033997, DOI DOI 10.48550/ARXIV.1303.3997; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Lu Fred S, 2020, medRxiv, DOI 10.1101/2020.04.18.20070821; Maurano Matthew T, 2020, Genome Res, V30, P1781, DOI [10.1101/2020.04.15.20064931, 10.1101/gr.266676.120]; Minh BQ, 2020, MOL BIOL EVOL, V37, P1530, DOI 10.1093/molbev/msaa015; Minin VN, 2008, J MATH BIOL, V56, P391, DOI 10.1007/s00285-007-0120-8; Perkins TA, 2020, P NATL ACAD SCI USA, V117, P22597, DOI 10.1073/pnas.2005476117; Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066; Rambaut A, 2020, NAT MICROBIOL, V5, P1403, DOI 10.1038/s41564-020-0770-5; Sekizuka T, 2020, P NATL ACAD SCI USA, V117, P20198, DOI 10.1073/pnas.2006824117; Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016; Villabona-Arenas CJ, 2020, NAT MICROBIOL, V5, P876, DOI 10.1038/s41564-020-0738-5; Volz E., 2021, MEDRXIV, DOI [10.1101/2020.12.30.20249034, DOI 10.1101/2020.12.30.20249034]; Washington NL, 2021, CELL, V184, P2587, DOI 10.1016/j.cell.2021.03.052; Worobey M, 2020, SCIENCE, V370, P564, DOI 10.1126/science.abc8169; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	47	11	11	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 16	2021	184	19					4939	+		10.1016/j.cell.2021.07.030	http://dx.doi.org/10.1016/j.cell.2021.07.030		SEP 2021	29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	WC7PA	34508652	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000704445100010
J	Cantuaria, ML; Waldorff, FB; Wermuth, L; Pedersen, ER; Poulsen, AH; Thacher, JD; Raaschou-Nielsen, O; Ketzel, M; Khan, J; Valencia, VH; Schmidt, JH; Sorensen, M				Cantuaria, Manuella Lech; Waldorff, Frans Boch; Wermuth, Lene; Pedersen, Ellen Raben; Poulsen, Aslak Harbo; Thacher, Jesse Daniel; Raaschou-Nielsen, Ole; Ketzel, Matthias; Khan, Jibran; Valencia, Victor H.; Schmidt, Jesper Hvass; Sorensen, Mette			Residential exposure to transportation noise in Denmark and incidence of dementia: national cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							AIR-POLLUTION; TRAFFIC NOISE; COGNITIVE IMPAIRMENT; ALCOHOL-CONSUMPTION; ROAD; ANNOYANCE; ASSOCIATION; DISEASE; STRESS; RISK	OBJECTIVE To investigate the association between long term residential exposure to road traffic and railway noise and risk of incident dementia. DESIGN Nationwide prospective register based cohort study. SETTING Denmark. PARTICIPANTS 1 938 994 adults aged >= 60 years living in Denmark between 1 January 2004 and 31 December 2017. MAIN OUTCOME MEASURES Incident cases of all cause dementia and dementia subtypes (Alzheimer's disease, vascular dementia, and Parkinson's disease related dementia), identified from national hospital and prescription registries. RESULTS The study population included 103 500 participants with incident dementia, and of those, 31 219 received a diagnosis of Alzheimer's disease, 8664 of vascular dementia, and 2192 of Parkinson's disease related dementia. Using Cox regression models, 10 year mean exposure to road traffic and railway noise at the most (L(den)max) and least (L(den)min) exposed facades of buildings were associated with a higher risk of all cause dementia. These associations showed a general pattern of higher hazard ratios with higher noise exposure, but with a levelling off or even small declines in risk at higher noise levels. In subtype analyses, both road traffic noise and railway noise were associated with a higher risk of Alzheimer's disease, with hazard ratios of 1.16 (95% confidence interval 1.11 to 1.22) for road Ldenmax >= 65 dB compared with <45 dB, 1.27 (1.22 to 1.34) for road Ldenmin >= 55 dB compared with <40 dB, 1.16 (1.10 to 1.23) for railway L(den)max >= 60 dB compared with <40 dB, and 1.24 (1.17 to 1.30) for railway L(den)min >= 50 dB compared with <40 dB. Road traffic, but not railway, noise was associated with an increased risk of vascular dementia. Results indicated associations between road traffic L(den)min and Parkinson's disease related dementia. CONCLUSIONS This nationwide cohort study found transportation noise to be associated with a higher risk of all cause dementia and dementia subtypes, especially Alzheimer's disease.	[Cantuaria, Manuella Lech; Pedersen, Ellen Raben] Univ Southern Denmark, Maersk McKinney Moller Inst, Odense, Denmark; [Cantuaria, Manuella Lech; Poulsen, Aslak Harbo; Thacher, Jesse Daniel; Raaschou-Nielsen, Ole; Sorensen, Mette] Danish Canc Soc Res Ctr, Diet Genes & Environm, Copenhagen, Denmark; [Waldorff, Frans Boch] Univ Copenhagen, Res Unit Gen Practice, Dept Publ Hlth, Copenhagen, Denmark; [Waldorff, Frans Boch] Univ Copenhagen, Sect Gen Practice, Copenhagen, Denmark; [Waldorff, Frans Boch] Univ Southern Denmark, Dept Publ Hlth, Res Unit Gen Practice, Odense, Denmark; [Wermuth, Lene] Slagelse Hosp, Dept Neurol, Slagelse, Denmark; [Wermuth, Lene] Univ Southern Denmark, Dept Reg Hlth Res, Odense, Denmark; [Raaschou-Nielsen, Ole; Ketzel, Matthias; Khan, Jibran; Valencia, Victor H.] Aarhus Univ, Dept Environm Sci, Roskilde, Denmark; [Ketzel, Matthias] Univ Surrey, Global Ctr Clean Air Res GCARE, Guildford, Surrey, England; [Khan, Jibran] Aarhus Univ, Danish Big Data Ctr Environm & Hlth BERTHA, Roskilde, Denmark; [Schmidt, Jesper Hvass] Odense Univ Hosp, Res Unit ORL Head & Neck Surg & Audiol, Odense, Denmark; [Schmidt, Jesper Hvass] Univ Southern Denmark, Dept Clin Res, Odense, Denmark; [Schmidt, Jesper Hvass] Odense Univ Hosp, Odense Patient Data Explorat Network, OPEN, Odense, Denmark; [Schmidt, Jesper Hvass] Univ Southern Denmark, Dept Clin Res, Fac Hlth Sci, BRIDGE Brain Res Inter Disciplinary Guided Excell, Odense, Denmark; [Sorensen, Mette] Roskilde Univ, Dept Nat Sci & Environm, Roskilde, Denmark	University of Southern Denmark; Danish Cancer Society; University of Copenhagen; University of Copenhagen; University of Southern Denmark; University of Southern Denmark; Aarhus University; University of Surrey; Aarhus University; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Roskilde University	Cantuaria, ML (corresponding author), Univ Southern Denmark, Maersk McKinney Moller Inst, Odense, Denmark.; Cantuaria, ML (corresponding author), Danish Canc Soc Res Ctr, Diet Genes & Environm, Copenhagen, Denmark.	mlca@mmmi.sdu.dk	Raaschou-Nielsen, Ole/GOK-0338-2022; Valencia, Victor/GRJ-9364-2022; Pedersen, Ellen Raben/O-7719-2018; Wermuth, Lene/O-9464-2014; KETZEL, Matthias/K-4246-2015	Raaschou-Nielsen, Ole/0000-0002-1223-0909; Waldorff, Frans Boch/0000-0002-7859-633X; Lech Cantuaria, Manuella/0000-0003-3201-9606; Thacher, Jesse/0000-0003-4908-9715; Valencia Alvear, Victor Hugo/0000-0001-8211-6776; Pedersen, Ellen Raben/0000-0001-9917-9837; Schmidt, Jesper Hvass/0000-0001-7683-1407; Wermuth, Lene/0000-0001-6930-8562; KETZEL, Matthias/0000-0001-9519-1935; Khan, Jibran/0000-0003-2080-2871	William Demant Foundation [18-0964]; Independent Research Fund Denmark [7016-00036B]	William Demant Foundation; Independent Research Fund Denmark	: This work was funded by the William Demant Foundation (grant No: 18-0964) and the Independent Research Fund Denmark (grant No: 7016-00036B) . The funders had no role in the design and conduct of the study; collection, analysis, and interpretation of data, writing of the manuscript, and decision to submit the manuscript for publication.	Andersson J, 2018, ENVIRON RES, V166, P334, DOI 10.1016/j.envres.2018.06.008; Babisch W, 2013, SCI TOTAL ENVIRON, V452, P50, DOI 10.1016/j.scitotenv.2013.02.034; Babisch Wolfgang, 2002, Noise Health, V4, P1; Basner M, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030519; Basner M, 2014, LANCET, V383, P1325, DOI 10.1016/S0140-6736(13)61613-X; Bendtsen H, 1999, SCI TOTAL ENVIRON, V235, P331, DOI 10.1016/S0048-9697(99)00216-8; Bodin T, 2015, INT J ENV RES PUB HE, V12, P1612, DOI 10.3390/ijerph120201612; Carey IM, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022404; Chen H, 2017, ENVIRON INT, V108, P271, DOI 10.1016/j.envint.2017.08.020; Chen ZC, 2014, NEUROSCI BULL, V30, P271, DOI 10.1007/s12264-013-1423-y; Cui B, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1223-4; Danish Health Data Authority, UDV KRON SYGD SVAER; Duong S, 2017, CAN PHARM J, V150, P118, DOI 10.1177/1715163517690745; EU Publ, 2017, SCI ENV POL FUTURE B, V17, P3, DOI [10.2779/016648, DOI 10.2779/016648]; European Environment Agency, 2020, ENV NOIS EUR; Eze IC, 2017, INT J EPIDEMIOL, V46, P1115, DOI 10.1093/ije/dyx020; Foraster M, 2016, ENVIRON INT, V91, P341, DOI 10.1016/j.envint.2016.03.011; Foraster M, 2014, ENVIRON HEALTH PERSP, V122, P1193, DOI 10.1289/ehp.1307156; Fuks KB, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16101790; Gomperts Stephen N, 2016, Continuum (Minneap Minn), V22, P435, DOI 10.1212/CON.0000000000000309; Hanninen O, 2014, ENVIRON HEALTH PERSP, V122, P439, DOI 10.1289/ehp.1206154; Hegewald J, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176175; Herzog J, 2019, BASIC RES CARDIOL, V114, DOI 10.1007/s00395-019-0753-y; Irwin MR, 2019, LANCET NEUROL, V18, P296, DOI 10.1016/S1474-4422(18)30450-2; Jafari Z, 2020, NEUROSCI BIOBEHAV R, V117, P110, DOI 10.1016/j.neubiorev.2019.04.001; Jensen SS, 2019, GIS BASED NATL ROAD; Khan J, 2019, ATMOS ENVIRON, V198, P102, DOI 10.1016/j.atmosenv.2018.10.036; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Killin LOJ, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0342-y; Kroller-Schon S, 2018, EUR HEART J, V39, P3528, DOI 10.1093/eurheartj/ehy333; Levin G., 2017, TECH REP DCE-DAN CEN; Li WL, 2019, ENVIRON RES, V176, DOI 10.1016/j.envres.2019.108537; Lim ASP, 2013, SLEEP, V36, P1027, DOI 10.5665/sleep.2802; Livingston G, 2020, LANCET, V396, P413, DOI 10.1016/S0140-6736(20)30367-6; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Minakawa EN, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040803; Mors O, 2011, SCAND J PUBLIC HEALT, V39, P54, DOI 10.1177/1403494810395825; Munzel T, 2020, ANNU REV PUBL HEALTH, V41, P309, DOI 10.1146/annurev-publhealth-081519-062400; Munzel T, 2018, J AM COLL CARDIOL, V71, P688, DOI 10.1016/j.jacc.2017.12.015; Munzel T, 2017, EUR HEART J, V38, P2838, DOI 10.1093/eurheartj/ehx081; Munzel T, 2017, EUR HEART J, V38, P550, DOI 10.1093/eurheartj/ehw269; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Peters R, 2019, J ALZHEIMERS DIS, V70, pS145, DOI 10.3233/JAD-180631; Phung TKT, 2007, DEMENT GERIATR COGN, V24, P220, DOI 10.1159/000107084; Phung TKT, 2010, DEMENT GERIATR COGN, V29, P146, DOI 10.1159/000269933; Phung TKT, 2009, DEMENT GERIATR COGN, V27, P534, DOI 10.1159/000223664; Pickett J, 2018, INT J GERIATR PSYCH, V33, P900, DOI 10.1002/gps.4868; Plovsing B, 2006, NORD 2000 COMPR OU 1; Prince M., 2016, WORLD ALZHEIMER REPO; Pyko A, 2019, OCCUP ENVIRON MED, V76, P201, DOI 10.1136/oemed-2018-105333; Roswall N, 2018, ENVIRON POLLUT, V236, P983, DOI 10.1016/j.envpol.2017.10.093; Schmidt FP, 2013, EUR HEART J, V34, P3508, DOI 10.1093/eurheartj/eht269; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Seidler AL, 2018, NOISE HEALTH, V20, P152, DOI 10.4103/nah.NAH_7_18; Selander J, 2009, ENVIRON HEALTH PERSP, V117, P1713, DOI 10.1289/ehp.0900933; Sorensen M, 2021, INT J EPIDEMIOL, V50, P1147, DOI 10.1093/ije/dyab024; Sorensen M, 2019, EUR HEART J, V40, P604, DOI 10.1093/eurheartj/ehy768; Strom T., 1997, ROAD TRAFFIC NOISE A; Su DH, 2020, ENVIRON HEALTH PREV, V25, DOI 10.1186/s12199-019-0840-6; Tarantini S, 2017, EXP GERONTOL, V94, P52, DOI 10.1016/j.exger.2016.11.004; Thacher JD, 2020, ENVIRON RES, V187, DOI 10.1016/j.envres.2020.109633; Thacher JD, 2020, ENVIRON RES, V182, DOI 10.1016/j.envres.2019.109051; Tzivian L, 2016, ENVIRON HEALTH PERSP, V124, P1361, DOI 10.1289/ehp.1509824; van Oers JAM, 1999, ALCOHOL ALCOHOLISM, V34, P78, DOI 10.1093/alcalc/34.1.78; Vienneau D, 2019, ENVIRON INT, V123, P399, DOI 10.1016/j.envint.2018.12.015; WHO, 2018, ENV NOIS GUID EUR RE; Yamazaki Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091965; Yu Y, 2020, EPIDEMIOLOGY, V31, P771, DOI 10.1097/EDE.0000000000001249; Yuchi W, 2020, ENVIRON HEALTH-GLOB, V19, DOI 10.1186/s12940-020-0565-4	69	16	16	5	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2021	374								n1954	10.1136/bmj.n1954	http://dx.doi.org/10.1136/bmj.n1954			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ3VV	34497091	hybrid, Green Published			2022-12-28	WOS:000702137100007
J	McCormick, EL; Dralle, DN; Hahm, WJ; Tune, AK; Schmidt, LM; Chadwick, KD; Rempe, DM				McCormick, Erica L.; Dralle, David N.; Hahm, W. Jesse; Tune, Alison K.; Schmidt, Logan M.; Chadwick, K. Dana; Rempe, Daniella M.			Widespread woody plant use of water stored in bedrock	NATURE			English	Article							WEATHERED GRANITIC BEDROCK; STORAGE CAPACITY; FOREST ECOSYSTEMS; MOISTURE USE; SOIL; ROCK; TRANSPIRATION; REGOLITH; ROOTS; TREE	Woody plants across the continental United States make extensive use of water stored in bedrock across diverse climates and biomes. In the past several decades, field studies have shown that woody plants can access substantial volumes of water from the pores and fractures of bedrock(1-3). If, like soil moisture, bedrock water storage serves as an important source of plant-available water, then conceptual paradigms regarding water and carbon cycling may need to be revised to incorporate bedrock properties and processes(4-6). Here we present a lower-bound estimate of the contribution of bedrock water storage to transpiration across the continental United States using distributed, publicly available datasets. Temporal and spatial patterns of bedrock water use across the continental United States indicate that woody plants extensively access bedrock water for transpiration. Plants across diverse climates and biomes access bedrock water routinely and not just during extreme drought conditions. On an annual basis in California, the volumes of bedrock water transpiration exceed the volumes of water stored in human-made reservoirs, and woody vegetation that accesses bedrock water accounts for over 50% of the aboveground carbon stocks in the state. Our findings indicate that plants commonly access rock moisture, as opposed to groundwater, from bedrock and that, like soil moisture, rock moisture is a critical component of terrestrial water and carbon cycling.	[McCormick, Erica L.; Tune, Alison K.; Schmidt, Logan M.; Chadwick, K. Dana; Rempe, Daniella M.] Univ Texas Austin, Jackson Sch Geosci, Dept Geol Sci, Austin, TX 78712 USA; [Dralle, David N.] US Forest Serv, Pacific Southwest Res Stn, Davis, CA USA; [Hahm, W. Jesse] Simon Fraser Univ, Dept Geog, Burnaby, BC, Canada	University of Texas System; University of Texas Austin; United States Department of Agriculture (USDA); United States Forest Service; Simon Fraser University	McCormick, EL (corresponding author), Univ Texas Austin, Jackson Sch Geosci, Dept Geol Sci, Austin, TX 78712 USA.	erica.mccormick@utexas.edu	Chadwick, K. Dana/AGN-9988-2022; Chadwick, K. Dana/G-4643-2013	Chadwick, K. Dana/0000-0002-5633-4865; McCormick, Erica L/0000-0002-7160-398X; Tune, Alison/0000-0003-1870-4981				Anderson MA, 1995, SOIL SCI, V160, P415, DOI 10.1097/00010694-199512000-00007; [Anonymous], 2020, USGS WAT US DAT CAL; [Anonymous], 2019, WATER RESOUR RES, DOI DOI 10.1029/2018WR023903; [Anonymous], 2020, DAIL RES STOR SUMM; [Anonymous], 2019, SOIL SURV STAFF GRID; ARKLEY RJ, 1981, SOIL SCI SOC AM J, V45, P423, DOI 10.2136/sssaj1981.03615995004500020037x; Bornyasz MA, 2005, GEODERMA, V126, P141, DOI 10.1016/j.geoderma.2004.11.023; Brantley SL, 2017, BIOGEOSCIENCES, V14, P5115, DOI 10.5194/bg-14-5115-2017; Cannon W. A., 1911, ROOT HABITS DESERT P, P131; Carriere SD, 2020, SCI TOTAL ENVIRON, V699, DOI 10.1016/j.scitotenv.2019.134332; Chaney NW, 2019, WATER RESOUR RES, V55, P2916, DOI 10.1029/2018WR022797; Corona R, 2020, J HYDROL HYDROMECH, V68, P338, DOI 10.2478/johh-2020-0022; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Daly C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141140; Dammeyer HC, 2016, HYDROL PROCESS, V30, P4568, DOI 10.1002/hyp.10938; David TS, 2004, AGR FOREST METEOROL, V122, P193, DOI 10.1016/j.agrformet.2003.09.014; Davis E. A., 1977, Hydrology and Water Resources in Arizona and the Southwest, V7, P241; Dawson TE, 2020, NEW PHYTOL, V226, P666, DOI 10.1111/nph.16410; Dietrich W.E., 1978, ZIETSCHRIFT GEOMORPH, V29, P191, DOI [10.1130/0091-7613(2001)029, DOI 10.1130/0091-7613(2001)029]; Ding YL, 2021, NEW PHYTOL, V229, P1339, DOI 10.1111/nph.16971; Dralle DN, 2021, HYDROL EARTH SYST SC, V25, P2861, DOI 10.5194/hess-25-2861-2021; Eggemeyer KD, 2009, ECOHYDROLOGY, V2, P81, DOI 10.1002/eco.42; Fan Y, 2017, P NATL ACAD SCI USA, V114, P10572, DOI 10.1073/pnas.1712381114; Friedl M., 2019, NASA EOSDIS L PROCES, DOI [10.5067/MODIS/MCD12Q1.006, DOI 10.5067/MODIS/MCD12Q1.006]; Funk C, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.66; Gan R, 2018, ECOHYDROLOGY, V11, DOI 10.1002/eco.1974; Gorelick N, 2017, REMOTE SENS ENVIRON, V202, P18, DOI 10.1016/j.rse.2017.06.031; Goulden ML, 2019, NAT GEOSCI, V12, P632, DOI 10.1038/s41561-019-0388-5; Graham RC, 1997, SOIL SCI SOC AM J, V61, P516, DOI 10.2136/sssaj1997.03615995006100020021x; Hahm WJ, 2020, WATER RESOUR RES, V56, DOI 10.1029/2020WR027419; Hahm WJ, 2019, GEOPHYS RES LETT, V46, P6544, DOI 10.1029/2019GL083294; Hahm WJ, 2019, WATER RESOUR RES, V55, P3028, DOI 10.1029/2018WR023760; Hall DK, 2016, MODIS TERRA SNOW COV; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Harsch MA, 2009, ECOL LETT, V12, P1040, DOI 10.1111/j.1461-0248.2009.01355.x; Hasenmueller EA, 2017, GEODERMA, V300, P11, DOI 10.1016/j.geoderma.2017.03.020; Hauwert N. M., 2014, Journal of Water Resource and Protection, V6, P869; HELLMERS H, 1955, ECOLOGY, V36, P667, DOI 10.2307/1931305; Hubbert KR, 2001, SOIL SCI SOC AM J, V65, P1255, DOI 10.2136/sssaj2001.6541255x; Jackson RB, 1996, OECOLOGIA, V108, P389, DOI 10.1007/BF00333714; Kapnick S, 2012, CLIM DYNAM, V38, P1885, DOI 10.1007/s00382-011-1089-y; LESHEM B, 1970, BOT GAZ, V131, P99, DOI 10.1086/336518; Litvak M. E., 2010, ECOSYSTEM FUNCTION S, P117; Madakumbura GD, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/abc719; McCole AA, 2007, J HYDROL, V342, P238, DOI 10.1016/j.jhydrol.2007.05.024; McCormick E. L., 2021, DATASET EVIDENCE WID, DOI [10.4211/hs.a2f0d5fd10f14cd189a3465f72cba6f3, DOI 10.4211/HS.A2F0D5FD10F14CD189A3465F72CBA6F3]; McDowell NG, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/ab0921; McEvoy DJ, 2020, EARTHS FUTURE, V8, DOI 10.1029/2020EF001736; Montaldo N, 2021, EARTHS FUTURE, V9, DOI 10.1029/2020EF001870; Nardini A, 2021, NEW PHYTOL, V229, P199, DOI 10.1111/nph.16859; Niemeyer RJ, 2017, J HYDROL, V544, P21, DOI 10.1016/j.jhydrol.2016.11.005; Nimmo JR, 2017, HYDROGEOL J, V25, P421, DOI 10.1007/s10040-016-1496-6; O'Geen A, 2018, VADOSE ZONE J, V17, DOI 10.2136/vzj2018.04.0081; Pedrazas MA, 2021, J GEOPHYS RES-EARTH, V126, DOI 10.1029/2020JF005848; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; QGIS Development Team, 2019, QGIS GEOGR INF SYST; Querejeta JI, 2007, OECOLOGIA, V152, P26, DOI 10.1007/s00442-006-0629-3; RAMBAL S, 1984, OECOLOGIA, V62, P18, DOI 10.1007/BF00377367; Rempe DM, 2018, P NATL ACAD SCI USA, V115, P2664, DOI 10.1073/pnas.1800141115; Rose KL, 2003, OECOLOGIA, V134, P46, DOI 10.1007/s00442-002-1084-4; Ruiz L, 2010, J HYDROL, V380, P460, DOI 10.1016/j.jhydrol.2009.11.020; Salve R, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR012583; Schenk HJ, 2002, J ECOL, V90, P480, DOI 10.1046/j.1365-2745.2002.00682.x; Schenk HJ, 2002, ECOL MONOGR, V72, P311, DOI 10.1890/0012-9615(2002)072[0311:TGBOR]2.0.CO;2; Schwinning S, 2008, OECOLOGIA, V158, P373, DOI 10.1007/s00442-008-1147-2; Schwinning S, 2020, PLANT SOIL, V454, P49, DOI 10.1007/s11104-020-04648-4; Schwinning S, 2010, ECOHYDROLOGY, V3, P238, DOI 10.1002/eco.134; Seyfried MS, 2006, HYDROL PROCESS, V20, P3261, DOI 10.1002/hyp.6331; Singh C, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/abc377; Spawn SA, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0444-4; Sternberg PD, 1996, GEODERMA, V72, P89, DOI 10.1016/0016-7061(96)00019-5; Tune AK, 2020, J GEOPHYS RES-BIOGEO, V125, DOI 10.1029/2020JG005795; Twidwell D, 2014, APPL VEG SCI, V17, P42, DOI 10.1111/avsc.12044; Uhlig D, 2017, BIOGEOSCIENCES, V14, P3111, DOI 10.5194/bg-14-3111-2017; Wald JA, 2013, EARTH SURF PROC LAND, V38, P614, DOI 10.1002/esp.3343; Wang-Erlandsson L, 2016, HYDROL EARTH SYST SC, V20, P1459, DOI 10.5194/hess-20-1459-2016; West AG, 2007, OECOLOGIA, V153, P787, DOI 10.1007/s00442-007-0777-0; Yang LM, 2018, ISPRS J PHOTOGRAMM, V146, P108, DOI 10.1016/j.isprsjprs.2018.09.006; Zhang YQ, 2019, REMOTE SENS ENVIRON, V222, P165, DOI 10.1016/j.rse.2018.12.031; Zwieniecki MA, 1996, SOIL SCI SOC AM J, V60, P1578, DOI 10.2136/sssaj1996.03615995006000050042x	80	33	34	35	120	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 9	2021	597	7875					225	+		10.1038/s41586-021-03761-3	http://dx.doi.org/10.1038/s41586-021-03761-3			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UQ1FZ	34497393	Green Submitted			2022-12-28	WOS:000695818300012
J	Oliver, D				Oliver, David			David Oliver: When organisations' behaviours betray their value statements	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Department of Health and Social Care, 2021, NHS CONST ENGL; Greenhalgh T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009388; Jeyarajah R, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m104; Lencioni PM, 2002, HARVARD BUS REV, V80, P113; National Voices, NAT VIOC VIS PERS CT; NHS Confederation, 2021, NHS STAFF SURV 2020; NHS Digital, 2017, NUMB WRITT COMPL NHS; O'Donnell M., 1997, SCEPTICS MED DICT; Oliver D, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4720; Oxtoby K, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n739; Royal College of General Practitioners, 2021, GP CONS POSTCOVID SH; West M, 2020, KINGS FUND 0209	12	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 8	2021	374								n2164	10.1136/bmj.n2164	http://dx.doi.org/10.1136/bmj.n2164			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UR3BY	34497071	Bronze			2022-12-28	WOS:000696628700005
J	Tan, DHS; Chen, YT; Yang, HD; Bao, W; Sreenarayanan, B; Doux, JM; Li, WK; Lu, BY; Ham, SY; Sayahpour, B; Scharf, J; Wu, EA; Deysher, G; Han, HE; Hah, HJ; Jeong, H; Lee, JB; Chen, Z; Meng, YS				Tan, Darren H. S.; Chen, Yu-Ting; Yang, Hedi; Bao, Wurigumula; Sreenarayanan, Bhagath; Doux, Jean-Marie; Li, Weikang; Lu, Bingyu; Ham, So-Yeon; Sayahpour, Baharak; Scharf, Jonathan; Wu, Erik A.; Deysher, Grayson; Han, Hyea Eun; Hah, Hoe Jin; Jeong, Hyeri; Lee, Jeong Beom; Chen, Zheng; Meng, Ying Shirley			Carbon-free high-loading silicon anodes enabled by sulfide solid electrolytes	SCIENCE			English	Article							LITHIUM-ION BATTERIES; HIGH-ENERGY; MICROPARTICLE ANODES; LI; SI; PARTICLES; CHEMISTRY; CELL	The development of silicon anodes for lithium-ion batteries has been largely impeded by poor interfacial stability against liquid electrolytes. Here, we enabled the stable operation of a 99.9 weight % microsilicon anode by using the interface passivating properties of sulfide solid electrolytes. Bulk and surface characterization, and quantification of interfacial components, showed that such an approach eliminates continuous interfacial growth and irreversible lithium losses. Microsilicon full cells were assembled and found to achieve high areal current density, wide operating temperature range, and high areal loadings for the different cells. The promising performance can be attributed to both the desirable interfacial property between microsilicon and sulfide electrolytes and the distinctive chemomechanical behavior of the lithium-silicon alloy.	[Tan, Darren H. S.; Chen, Yu-Ting; Yang, Hedi; Bao, Wurigumula; Sreenarayanan, Bhagath; Doux, Jean-Marie; Li, Weikang; Lu, Bingyu; Ham, So-Yeon; Sayahpour, Baharak; Scharf, Jonathan; Wu, Erik A.; Deysher, Grayson; Chen, Zheng; Meng, Ying Shirley] Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA; [Han, Hyea Eun; Hah, Hoe Jin; Jeong, Hyeri; Lee, Jeong Beom] LG Energy Solut Ltd, LG Sci Pk,Magokjungang 10 Ro, Seoul 07796, South Korea; [Chen, Zheng] Univ Calif San Diego, Program Chem Engn, La Jolla, CA 92093 USA; [Chen, Zheng; Meng, Ying Shirley] Univ Calif San Diego, Sustainable Power & Energy Ctr SPEC, La Jolla, CA 92093 USA; [Chen, Zheng; Meng, Ying Shirley] Univ Calif San Diego, Program Mat Sci & Engn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Chen, Z; Meng, YS (corresponding author), Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA.; Chen, Z (corresponding author), Univ Calif San Diego, Program Chem Engn, La Jolla, CA 92093 USA.; Chen, Z; Meng, YS (corresponding author), Univ Calif San Diego, Sustainable Power & Energy Ctr SPEC, La Jolla, CA 92093 USA.; Chen, Z; Meng, YS (corresponding author), Univ Calif San Diego, Program Mat Sci & Engn, La Jolla, CA 92093 USA.	zhengchen@eng.ucsd.edu; shmeng@ucsd.edu	Lu, Bingyu/HCH-3826-2022; Chen, Yu-Ting/Y-5241-2018	Lu, Bingyu/0000-0003-3475-4911; /0000-0002-6143-3809; Tan, Darren/0000-0001-6568-4771; Sayahpour, Baharak/0000-0003-0200-6636; Doux, Jean-Marie/0000-0002-9801-4800; Sreenarayanan, Bhagath/0000-0002-2745-7049; Chen, Yu-Ting/0000-0001-9525-8407	LG Energy Solution through the Battery Innovation Contest (BIC) program; Jacob School of Engineering at University of California San Diego; Zable Endowed Chair Fund	LG Energy Solution through the Battery Innovation Contest (BIC) program; Jacob School of Engineering at University of California San Diego; Zable Endowed Chair Fund	This study was financially supported by LG Energy Solution through the Battery Innovation Contest (BIC) program. Z.C. acknowledges funding from the start-up fund support from the Jacob School of Engineering at University of California San Diego. Y.S.M. acknowledges funding support from the Zable Endowed Chair Fund.	An WL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09510-5; Baasner A, 2020, J ELECTROCHEM SOC, V167, DOI 10.1149/1945-7111/ab68d7; Banerjee A, 2020, CHEM REV, V120, P6878, DOI 10.1021/acs.chemrev.0c00101; Berla LA, 2015, J POWER SOURCES, V273, P41, DOI 10.1016/j.jpowsour.2014.09.073; Burkhardt S, 2019, ACS ENERGY LETT, V4, P2117, DOI 10.1021/acsenergylett.9b01579; Cangaz S, 2020, ADV ENERGY MATER, V10, DOI 10.1002/aenm.202001320; Chen JP, 2022, NAT PROD RES, V36, P2386, DOI 10.1080/14786419.2020.1827405; Chen Z, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201401826; Choi S, 2017, SCIENCE, V357, P279, DOI 10.1126/science.aal4373; Ding N, 2009, SOLID STATE IONICS, V180, P222, DOI 10.1016/j.ssi.2008.12.015; Doux JM, 2020, J MATER CHEM A, V8, P5049, DOI 10.1039/c9ta12889a; Doux JM, 2020, ADV ENERGY MATER, V10, DOI 10.1002/aenm.201903253; Fang CC, 2019, NATURE, V572, P511, DOI 10.1038/s41586-019-1481-z; Gao XF, 2019, J ELECTROCHEM ENERGY, V16, DOI 10.1115/1.4040826; Gonzalez AF, 2017, J PHYS CHEM C, V121, P27775, DOI 10.1021/acs.jpcc.7b07793; Hertzberg B, 2011, ELECTROCHEM COMMUN, V13, P818, DOI 10.1016/j.elecom.2011.05.011; Huang G, 2020, ACS NANO, V14, P4374, DOI 10.1021/acsnano.9b09928; Jin Y, 2017, ADV ENERGY MATER, V7, DOI 10.1002/aenm.201700715; Kasemchainan J, 2019, NAT MATER, V18, P1105, DOI 10.1038/s41563-019-0438-9; Kim JK, 2014, SOLID STATE IONICS, V268, P256, DOI 10.1016/j.ssi.2014.10.010; Kulikovsky V, 2008, THIN SOLID FILMS, V516, P5368, DOI 10.1016/j.tsf.2007.07.047; Kwon HJ, 2020, NANO LETT, V20, P625, DOI 10.1021/acs.nanolett.9b04395; Lee YG, 2020, NAT ENERGY, V5, P299, DOI 10.1038/s41560-020-0575-z; Li YZ, 2016, NAT ENERGY, V1, DOI 10.1038/NENERGY.2015.29; Ma Q, 2020, ACS APPL ENERG MATER, V3, P268, DOI 10.1021/acsaem.9b01463; McGrogan FP, 2017, ADV ENERGY MATER, V7, DOI 10.1002/aenm.201602011; Pan K, 2019, J POWER SOURCES, V413, P20, DOI 10.1016/j.jpowsour.2018.12.010; Parikh P, 2019, CHEM MATER, V31, P2535, DOI 10.1021/acs.chemmater.8b05020; Ping WW, 2019, ENERGY STORAGE MATER, V21, P246, DOI 10.1016/j.ensm.2019.06.024; Qiu XY, 2012, PHYS CHEM CHEM PHYS, V14, P2617, DOI 10.1039/c2cp23626e; Randau S, 2020, NAT ENERGY, V5, P259, DOI 10.1038/s41560-020-0565-1; Ren JG, 2013, ENERGY TECHNOL-GER, V1, P77, DOI 10.1002/ente.201200038; Sakabe J, 2018, COMMUN CHEM, V1, DOI 10.1038/s42004-018-0026-y; Schwietert TK, 2020, NAT MATER, V19, P428, DOI 10.1038/s41563-019-0576-0; Shobukawa H, 2016, J MATER CHEM A, V4, P15117, DOI 10.1039/c6ta06447g; Tan DHS, 2019, ACS ENERGY LETT, V4, P2418, DOI 10.1021/acsenergylett.9b01693; Wang C, 2013, NAT CHEM, V5, P1042, DOI [10.1038/nchem.1802, 10.1038/NCHEM.1802]; Wang Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59913-4; Wu EA, 2020, J ELECTROCHEM SOC, V167, DOI 10.1149/1945-7111/abb8b3; Xu RC, 2019, ACS ENERGY LETT, V4, P1073, DOI 10.1021/acsenergylett.9b00430; Xu ZX, 2018, JOULE, V2, P950, DOI 10.1016/j.joule.2018.02.012; Yang Y, 2020, SUSTAIN ENERG FUELS, V4, P1577, DOI 10.1039/c9se01165j; Yoshimura K, 2007, J POWER SOURCES, V174, P653, DOI 10.1016/j.jpowsour.2007.06.115; Yu C, 2018, ACS APPL MATER INTER, V10, P33296, DOI 10.1021/acsami.8b07476; Zhang WB, 2017, ACS APPL MATER INTER, V9, P35888, DOI 10.1021/acsami.7b11530	45	124	124	230	690	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2021	373	6562			SI		1494	+		10.1126/science.abg7217	http://dx.doi.org/10.1126/science.abg7217			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU7LJ	34554780	Green Submitted			2022-12-28	WOS:000698977800047
J	Jaffar, S; Ramaiya, K; Karekezi, C; Sewankambo, N				Jaffar, Shabbar; Ramaiya, Kaushik; Karekezi, Catherine; Sewankambo, Nelson		RESPOND AFRICA Grp	Controlling diabetes and hypertension in sub-Saharan Africa: lessons from HIV programmes	LANCET			English	Editorial Material							PUBLIC-HEALTH APPROACH; ANTIRETROVIRAL THERAPY; BLOOD-PRESSURE; CARE; COMMISSION		[Jaffar, Shabbar] Univ Liverpool Liverpool Sch Trop Med, Dept Int Publ Hlth, Liverpool L3 5QA, Merseyside, England; [Ramaiya, Kaushik] Shree Hindu Mandal Hosp, Dar Es Salaam, Tanzania; [Ramaiya, Kaushik] Tanzania Non Commun Dis Alliance, Dar Es Salaam, Tanzania; [Karekezi, Catherine] Noncommunicable Dis Alliance, Nairobi, Kenya; [Sewankambo, Nelson] Makerere Univ, Sch Med, Kampala, Uganda	Liverpool School of Tropical Medicine; Makerere University	Jaffar, S (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Dept Int Publ Hlth, Liverpool L3 5QA, Merseyside, England.	shabbar.jaffar@lstmed.ac.uk	Lazarus, Jeffrey V./R-6248-2018; Karekezi, Catherine/HGF-2510-2022; Mbanya, Jean Claude N/T-5147-2018	Lazarus, Jeffrey V./0000-0001-9618-2299; Mbanya, Jean Claude N/0000-0001-9651-8653; Kraef, Christian/0000-0002-5224-0335; Smith, Peter/0000-0003-0080-7560				Attaei MW, 2017, LANCET PUBLIC HEALTH, V2, pE411, DOI 10.1016/S2468-2667(17)30141-X; Atun R, 2017, LANCET DIABETES ENDO, V5, P622, DOI 10.1016/S2213-8587(17)30181-X; Bukhman G, 2020, LANCET, V396, P991, DOI 10.1016/S0140-6736(20)31907-3; Enoch J, 2017, HEALTH HUM RIGHTS, V19, P117; Ford N, 2018, LANCET INFECT DIS, V18, pE76, DOI 10.1016/S1473-3099(17)30482-6; Ford N, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-33; Ford N, 2010, CURR OPIN HIV AIDS, V5, P38, DOI 10.1097/COH.0b013e3283339b41; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Hunt D, 2021, LANCET DIABETES ENDO, V9, P325, DOI 10.1016/S2213-8587(21)00111-X; Jaffar S, 2004, B WORLD HEALTH ORGAN, V82, P462; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; Katende D, 2015, TROP MED INT HEALTH, V20, P1385, DOI 10.1111/tmi.12560; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Olsen MH, 2016, LANCET, V388, P2665, DOI 10.1016/S0140-6736(16)31134-5; Peck R, 2014, LANCET GLOB HEALTH, V2, pE285, DOI 10.1016/S2214-109X(14)70033-6; Stanaway JD, 2018, LANCET, V392, P1923, DOI [10.1016/S0140-6736(18)32225-6, 10.1016/s0140-6736(18)32225-6]; Taibbi Matt., 2021, US; UNAIDS, 2021, PREL UNAIDS 2021 EP	19	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 25	2021	398	10306					1111	1113		10.1016/S0140-6736(21)01731-1	http://dx.doi.org/10.1016/S0140-6736(21)01731-1		SEP 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UX3WV	34506744	Green Submitted, Green Accepted			2022-12-28	WOS:000700774500005
J	Iacobucci, G				Iacobucci, Gareth			Ministers should have to seek advice from local doctors before closing services, say leaders	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 22	2021	374								n2336	10.1136/bmj.n2336	http://dx.doi.org/10.1136/bmj.n2336			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WQ2LU	34551982				2022-12-28	WOS:000713652600006
J	Lee, H; Cashin, AG; Lamb, SE; Hopewell, S; Vansteelandt, S; VanderWeele, TJ; MacKinnon, DP; Mansell, G; Collins, GS; Golub, RM; McAuley, JH				Lee, Hopin; Cashin, Aidan G.; Lamb, Sarah E.; Hopewell, Sally; Vansteelandt, Stijn; VanderWeele, Tyler J.; MacKinnon, David P.; Mansell, Gemma; Collins, Gary S.; Golub, Robert M.; McAuley, James H.		AGReMA Grp	A Guideline for Reporting Mediation Analyses of Randomized Trials and Observational Studies The AGReMA Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CAUSAL; IDENTIFIABILITY	This Special Communication describes the methods that were used to develop the guideline, provides a long- and short-form checklist to be used when writing research reports, presents brief explanations for each reporting item, and provides guidance on how to use A Guideline for Reporting Mediation Analyses (AGReMA). Importance Mediation analyses of randomized trials and observational studies can generate evidence about the mechanisms by which interventions and exposures may influence health outcomes. Publications of mediation analyses are increasing, but the quality of their reporting is suboptimal. Objective To develop international, consensus-based guidance for the reporting of mediation analyses of randomized trials and observational studies (A Guideline for Reporting Mediation Analyses; AGReMA). Design, Setting, and Participants The AGReMA statement was developed using the Enhancing Quality and Transparency of Health Research (EQUATOR) methodological framework for developing reporting guidelines. The guideline development process included (1) an overview of systematic reviews to assess the need for a reporting guideline; (2) review of systematic reviews of relevant evidence on reporting mediation analyses; (3) conducting a Delphi survey with panel members that included methodologists, statisticians, clinical trialists, epidemiologists, psychologists, applied clinical researchers, clinicians, implementation scientists, evidence synthesis experts, representatives from the EQUATOR Network, and journal editors (n = 19; June-November 2019); (4) having a consensus meeting (n = 15; April 28-29, 2020); and (5) conducting a 4-week external review and pilot test that included methodologists and potential users of AGReMA (n = 21; November 2020). Results A previously reported overview of 54 systematic reviews of mediation studies demonstrated the need for a reporting guideline. Thirty-three potential reporting items were identified from 3 systematic reviews of mediation studies. Over 3 rounds, the Delphi panelists ranked the importance of these items, provided 60 qualitative comments for item refinement and prioritization, and suggested new items for consideration. All items were reviewed during a 2-day consensus meeting and participants agreed on a 25-item AGReMA statement for studies in which mediation analyses are the primary focus and a 9-item short-form AGReMA statement for studies in which mediation analyses are a secondary focus. These checklists were externally reviewed and pilot tested by 21 expert methodologists and potential users, which led to minor adjustments and consolidation of the checklists. Conclusions and Relevance The AGReMA statement provides recommendations for reporting primary and secondary mediation analyses of randomized trials and observational studies. Improved reporting of studies that use mediation analyses could facilitate peer review and help produce publications that are complete, accurate, transparent, and reproducible. Question What information should be reported in studies that include mediation analyses of randomized trials and observational studies? Findings An international Delphi and consensus process (using the Enhancing Quality and Transparency of Health Research methodological framework) generated a 25-item reporting guideline for primary reports of mediation analyses and a 9-item short form for secondary reports of mediation analyses. Meaning Using the 25-item or 9-item reporting guideline may facilitate peer review and could help ensure that studies using mediation analyses are completely, accurately, and transparently reported.	[Lee, Hopin; Lamb, Sarah E.; Hopewell, Sally; Collins, Gary S.] Univ Oxford, Ctr Stat Med, Nuffield Dept Orthopaed Rheumatol & Musaibskeleta, Oxford, England; [Lee, Hopin] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW, Australia; [Cashin, Aidan G.] Univ New South Wales, Fac Med, Prince Wales Clin Sch, Sydney, NSW, Australia; [Cashin, Aidan G.; McAuley, James H.] Neurosci Res Australia, Sydney, NSW, Australia; [Lamb, Sarah E.] Univ Exeter, Coll Med & Hlth, Med Sch, Exeter, Devon, England; [Vansteelandt, Stijn] Univ Ghent, Dept Appl Math Comp Sci & Stat, Ghent, Belgium; [Vansteelandt, Stijn] London Sch Hyg & Trop Med, Dept Med Stat, London, England; [VanderWeele, Tyler J.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [MacKinnon, David P.] Arizona State Univ, Dept Psychol, Phoenix, AZ USA; [Mansell, Gemma] Aston Univ, Coll Hlth & Life Sci, Birmingham, W Midlands, England; [Collins, Gary S.] Oxford Univ Hosp NHS Fdn Trust, NIHR Oxford Biomed Res Ctr, Oxford, England; [Golub, Robert M.] JAMA Editorial Off, Chicago, IL USA; [Golub, Robert M.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Div Gen Internal Med & Geriatr, Chicago, IL USA; [McAuley, James H.] Univ New South Wales, Fac Med, Sch Hlth Sci, Sydney, NSW, Australia	University of Oxford; University of Newcastle; University of New South Wales Sydney; Neuroscience Research Australia; University of Exeter; Ghent University; University of London; London School of Hygiene & Tropical Medicine; Harvard University; Harvard T.H. Chan School of Public Health; Arizona State University; Arizona State University-Downtown Phoenix; Aston University; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Northwestern University; Feinberg School of Medicine; University of New South Wales Sydney	Lee, H (corresponding author), Univ Oxford, Botnar Res Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Windmill Rd, Oxford OX3 7LD, England.	hopin.lee@ndorms.ox.ac.uk	van Amelsvoort, Ludovic/A-3689-2008; Collins, Gary Stephen/A-2258-2014; MacKinnon, David P./D-8727-2013; McAuley, James Henry/HHC-3949-2022; Goldsmith, Kimberley/B-9107-2011; Henschke, Nicholas/C-2975-2014	van Amelsvoort, Ludovic/0000-0003-0120-1552; Collins, Gary Stephen/0000-0002-2772-2316; McAuley, James Henry/0000-0002-0550-828X; Rijnhart, Judith/0000-0002-1046-3741; Hopewell, Sally/0000-0002-6881-6984; Goldsmith, Kimberley/0000-0002-0620-7868; Lamb, Sarah/0000-0003-4349-7195; Mansell, Gemma/0000-0002-5479-2678; Henschke, Nicholas/0000-0002-9624-2519				Bero L, 2017, JAMA-J AM MED ASSOC, V317, P1723, DOI 10.1001/jama.2017.3854; Boers AMM, 2019, JAMA NEUROL, V76, P194, DOI 10.1001/jamaneurol.2018.3661; Cashin AG, 2021, BMJ EVID-BASED MED, V26, P106, DOI 10.1136/bmjebm-2020-111406; Cashin AG, 2020, BMC MED RES METHODOL, V20, DOI 10.1186/s12874-020-0915-5; Cashin AG, 2019, J CLIN EPIDEMIOL, V111, P60, DOI 10.1016/j.jclinepi.2019.03.005; Fritz MS, 2007, PSYCHOL SCI, V18, P233, DOI 10.1111/j.1467-9280.2007.01882.x; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Hernan MA, 2016, J CLIN EPIDEMIOL, V79, P70, DOI 10.1016/j.jclinepi.2016.04.014; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1055/s-0041-111066, 10.1136/bmj.g1687]; Hrobjartsson A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1119; Imai K, 2010, PSYCHOL METHODS, V15, P309, DOI 10.1037/a0020761; Imai K, 2010, STAT SCI, V25, P51, DOI 10.1214/10-STS321; Lapointe-Shaw L, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0578-7; Lee H, 2019, JAMA-J AM MED ASSOC, V321, P697, DOI 10.1001/jama.2018.21973; Li W, 2017, STAT MED, V36, P3948, DOI 10.1002/sim.7413; Liu Shao-Hsien, 2016, BMC Res Notes, V9, P354, DOI 10.1186/s13104-016-2163-7; MacKinnon D.P., 2012, INTRO STAT MEDIATION; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; Miocevic M, 2018, BEHAV RES METHODS, V50, P285, DOI 10.3758/s13428-017-0870-1; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; National Institute for Health Research, EFFICACY MECH EVALUA; Nielsen L, 2018, BEHAV RES THER, V101, P3, DOI 10.1016/j.brat.2017.07.002; ROBINS JM, 1992, EPIDEMIOLOGY, V3, P143, DOI 10.1097/00001648-199203000-00013; Sharples L, 2020, CLIN TRIALS, V17, P654, DOI 10.1177/1740774520947644; Smith LH, 2019, EPIDEMIOLOGY, V30, P835, DOI 10.1097/EDE.0000000000001064; Stensrud MJ, 2017, ATHEROSCLEROSIS, V265, P29, DOI 10.1016/j.atherosclerosis.2017.07.019; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Stuart, CLARIFYING CAUSAL ME; Vo TT, 2020, J CLIN EPIDEMIOL, V117, P78, DOI 10.1016/j.jclinepi.2019.10.001; Tennant PWG, 2021, INT J EPIDEMIOL, V50, P620, DOI 10.1093/ije/dyaa213; Nguyen TQ, 2021, PSYCHOL METHODS, V26, P255, DOI 10.1037/met0000299; Valeri L, 2016, STAT MED, V35, P4779, DOI 10.1002/sim.7025; VanderWeele T J, 2014, Epidemiol Methods, V2, P95; VanderWeele TJ, 2016, INT J EPIDEMIOL, V45, P1904, DOI 10.1093/ije/dyw277; VanderWeele TJ, 2016, AM J EPIDEMIOL, V183, P869, DOI 10.1093/aje/kww038; Vanderweele TJ, 2013, J AM STAT ASSOC, V108, P469, DOI 10.1080/01621459.2013.779832; VanderWeele TJ, 2012, EPIDEMIOLOGY, V23, P561, DOI 10.1097/EDE.0b013e318258f5e4; VanderWeele TJ, 2011, BIOMETRICS, V67, P1406, DOI 10.1111/j.1541-0420.2011.01619.x; VanderWeele TJ, 2010, SOCIOL METHOD RES, V38, P515, DOI 10.1177/0049124110366236; Vansteelandt S, 2017, EPIDEMIOLOGY, V28, P258, DOI 10.1097/EDE.0000000000000596; Vansteelandt S, 2012, EPIDEMIOLOGY, V23, P889, DOI 10.1097/EDE.0b013e31826d0f6f; Wilkinson Mark D, 2016, Sci Data, V3, P160018, DOI 10.1038/sdata.2016.18	42	40	40	6	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2021	326	11					1045	1056		10.1001/jama.2021.14075	http://dx.doi.org/10.1001/jama.2021.14075			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UZ4IM	34546296	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000702170600018
J	Lhopitallier, L; Kronenberg, A; Meuwly, JY; Locatelli, I; Mueller, Y; Senn, N; D'Acremont, V; Boillat-Blanco, N				Lhopitallier, Loic; Kronenberg, Andreas; Meuwly, Jean-Yves; Locatelli, Isabella; Mueller, Yolanda; Senn, Nicolas; D'Acremont, Valerie; Boillat-Blanco, Noemie			Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: pragmatic cluster randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; GUIDELINES; ULTRASOUND; DIAGNOSIS	OBJECTIVE To assess whether point-of care procalcitonin and lung ultrasonography can safely reduce unnecessary antibiotic treatment in patients with lower respiratory tract infections in primary care. DESIGN Three group, pragmatic cluster randomised controlled trial from September 2018 to March 2020. SETTING 60 Swiss general practices. PARTICIPANTS One general practitioner per practice was included. General practitioners screen all patients with acute cough; patients with clinical pneumonia were included. INTERVENTIONS Randomisation in a 1:1:1 of general practitioners to either antibiotics guided by sequential procalcitonin and lung ultrasonography point-of-care tests (UltraPro; n=152), procalcitonin guided antibiotics (n=195), or usual care (n=122). MAIN OUTCOMES Primary outcome was proportion of patients in each group prescribed an antibiotic by day 28. Secondary outcomes included duration of restricted activities due to lower respiratory tract infection within 14 days. RESULTS 60 general practitioners included 469 patients (median age 53 years (interquartile range 38-66); 278 (59%) were female). Probability of antibiotic prescription at day 28 was lower in the procalcitonin group than in the usual care group (0.40 v 0.70, cluster corrected difference -0.26 (95% confidence interval -0.41 to -0.10)). No significant difference was seen between UltraPro and procalcitonin groups (0.41 v 0.40, -0.03 (-0.17 to 0.12)). The median number of days with restricted activities by day 14 was 4 days in the procalcitonin group and 3 days in the usual care group (difference 1 day (95% confidence interval -0.23 to 2.32); hazard ratio 0.75 (95% confidence interval 0.58 to 0.97)), which did not prove non-inferiority. CONCLUSIONS Compared with usual care, point-of-care procalcitonin led to a 26% absolute reduction in the probability of 28 day antibiotic prescription without affecting patients' safety. Point-of-care lung ultrasonography did not further reduce antibiotic prescription, although a potential added value cannot be excluded, owing to the wide confidence intervals. TRIAL REGISTRATION ClinicalTrials.gov NCT03191071.	[Lhopitallier, Loic; Boillat-Blanco, Noemie] Lausanne Univ Hosp, Infect Dis Serv, Lausanne, Switzerland; [Kronenberg, Andreas] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Kronenberg, Andreas] Medix Gen Practice, Bern, Switzerland; [Meuwly, Jean-Yves] Lausanne Univ Hosp, Dept Radiol, Lausanne, Switzerland; [Locatelli, Isabella; D'Acremont, Valerie] Univ Lausanne, Dept Educ Res & Innovat, Ctr Primary Care & Publ Hlth Unisante, Lausanne, Switzerland; [Mueller, Yolanda; Senn, Nicolas] Univ Lausanne, Ctr Primary Care & Publ Hlth Unisante, Dept Family Med, Lausanne, Switzerland; [D'Acremont, Valerie] Univ Lausanne, Ctr Primary Care & Publ Hlth, Digital Global Hlth Dept, Lausanne, Switzerland; [D'Acremont, Valerie] Swiss Trop & Publ Hlth Inst, Basel, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Lausanne; University of Lausanne; University of Basel; Swiss Tropical & Public Health Institute	Boillat-Blanco, N (corresponding author), Lausanne Univ Hosp, Infect Dis Serv, Lausanne, Switzerland.	noemie.boillat@chuv.ch	Boillat-Blanco, Noémie/GLT-5579-2022	Boillat-Blanco, Noemie/0000-0002-2490-8174; Mueller, Yolanda/0000-0002-8861-4538; Kronenberg, Andreas/0000-0002-0006-7833	Swiss National Science Foundation [407240_167133]; Leenaards Foundation; Brahms GmbH	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Leenaards Foundation; Brahms GmbH	This work was supported in part by the Swiss National Science Foundation (grant 407240_167133) and by an academic award of the Leenaards Foundation (to NB-B) . The funders had no role in considering the study design or in the collection, analysis, interpretation of data, writing of the report, or decision to submit the article for publication. Brahms GmbH, the manufacturer of the BRAHMS PCT direct point-of-care test, supported the study in providing the BRAHMS direct Reader, BRAHMS PCT direct tests, and quality controls free of charge. Brahms GmbH had no other role in the trial.Funding: This work was supported in part by the Swiss National Science Foundation (grant 407240_167133) and by an academic award of the Leenaards Foundation (to NB-B) . The funders had no role in considering the study design or in the collection, analysis, interpretation of data, writing of the report, or decision to submit the article for publication. Brahms GmbH, the manufacturer of the BRAHMS PCT direct point-of-care test, supported the study in providing the BRAHMS direct Reader, BRAHMS PCT direct tests, and quality controls free of charge. Brahms GmbH had no other role in the trial.	Anthierens S, 2015, J GEN INTERN MED, V30, P408, DOI 10.1007/s11606-014-3076-6; Briel M, 2008, ARCH INTERN MED, V168, P2000, DOI 10.1001/archinte.168.18.2000; Burkhardt O, 2010, EUR RESPIR J, V36, P601, DOI 10.1183/09031936.00163309; Cals JWL, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-15; Cals JWL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1374; Campbell MK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5661; Cortellaro F, 2012, EMERG MED J, V29, P19, DOI 10.1136/emj.2010.101584; Federal Office of Public Health and Federal Food Safety and Veterinary Office, 2020, SWISS ANTIBIOTIC RES; Gasquet I, 2003, Sante Publique, V15, P383; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Huang DT, 2018, NEW ENGL J MED, V379, P236, DOI [10.1056/NEJMoa1802670, 10.1056/nejmoa1802670]; Huchon GJ, 1996, EUR RESPIR J, V9, P1590, DOI 10.1183/09031936.96.09081590; Kolditz M, 2015, J INTERN MED, V278, P193, DOI 10.1111/joim.12349; Lhopitallier L, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106100; Lhopitallier L, 2019, BMC PULM MED, V19, DOI 10.1186/s12890-019-0898-3; Lichtenstein DA, 2008, CHEST, V134, P117, DOI 10.1378/chest.07-2800; Masia M, 2005, CHEST, V128, P2223, DOI 10.1378/chest.128.4.2223; Matthias B, 2006, SWISS MED WKLY, V136, P248; Metlay JP, 1997, JAMA-J AM MED ASSOC, V278, P1440, DOI 10.1001/jama.278.17.1440; Schappert Susan M, 2006, Vital Health Stat 13, P1; Schuetz P, 2009, JAMA-J AM MED ASSOC, V302, P1059, DOI 10.1001/jama.2009.1297; Simon L, 2004, CLIN INFECT DIS, V39, P206, DOI 10.1086/421997; Watson L, 2001, FAM PRACT, V18, P553, DOI 10.1093/fampra/18.5.553; Woodhead M, 2011, CLIN MICROBIOL INFEC, V17, pE1, DOI 10.1111/j.1469-0691.2011.03672.x; Ye X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130066	25	12	12	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 21	2021	374								n2132	10.1136/bmj.n2132	http://dx.doi.org/10.1136/bmj.n2132			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WA4GB	34548312	Green Published, hybrid			2022-12-28	WOS:000702844100018
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: How is vaccination affecting hospital admissions and deaths?	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		CO-CIN, 2021, HOSP ADM COVID 19 IM; Egan C., HOSP ADMISSION COVID; Hippisley-Cox J, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2244; Office for National Statistics, 2021, DEATH INVOLV COVID 1; Public Health England, 37 PHS; SAGE, 2021, 95 SAG M COVID 19	6	8	8	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 20	2021	374								n2306	10.1136/bmj.n2306	http://dx.doi.org/10.1136/bmj.n2306			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ1DH	34544731	Bronze			2022-12-28	WOS:000701952000009
J	Tang, WY; Llort, J; Weis, J; Perron, MMG; Basart, S; Li, ZC; Sathyendranath, S; Jackson, T; Rodriguez, ES; Proemse, BC; Bowie, AR; Schallenberg, C; Strutton, PG; Matear, R; Cassar, N				Tang, Weiyi; Llort, Joan; Weis, Jakob; Perron, Morgane M. G.; Basart, Sara; Li, Zuchuan; Sathyendranath, Shubha; Jackson, Thomas; Rodriguez, Estrella Sanz; Proemse, Bernadette C.; Bowie, Andrew R.; Schallenberg, Christina; Strutton, Peter G.; Matear, Richard; Cassar, Nicolas			Widespread phytoplankton blooms triggered by 2019-2020 Australian wildfires	NATURE			English	Article							FIRE EMISSIONS; IRON; CLIMATE; IMPACTS; DUST; SENSITIVITY; SOLUBILITY; REANALYSIS; INJECTION; EVENTS	Droughts and climate-change-driven warming are leading to more frequent and intense wildfires(1-3), arguably contributing to the severe 2019-2020 Australian wildfires(4). The environmental and ecological impacts of the fires include loss of habitats and the emission of substantial amounts of atmospheric aerosols(5-7). Aerosol emissions from wildfires can lead to the atmospheric transport of macronutrients and bio-essential trace metals such as nitrogen and iron, respectively(8-10). It has been suggested that the oceanic deposition of wildfire aerosols can relieve nutrient limitations and, consequently, enhance marine productivity(11,12), but direct observations are lacking. Here we use satellite and autonomous biogeochemical Argo float data to evaluate the effect of 2019-2020 Australian wildfire aerosol deposition on phytoplankton productivity. We find anomalously widespread phytoplankton blooms from December 2019 to March 2020 in the Southern Ocean downwind of Australia. Aerosol samples originating from the Australian wildfires contained a high iron content and atmospheric trajectories show that these aerosols were likely to be transported to the bloom regions, suggesting that the blooms resulted from the fertilization of the iron-limited waters of the Southern Ocean. Climate models project more frequent and severe wildfires in many regions(1-3). A greater appreciation of the links between wildfires, pyrogenic aerosols(13), nutrient cycling and marine photosynthesis could improve our understanding of the contemporary and glacial-interglacial cycling of atmospheric CO2 and the global climate system. Oceanic deposition of wildfire aerosols can enhance marine productivity, as supported here by satellite and in situ profiling floats data showing that emissions from the 2019-2020 Australian wildfires fuelled phytoplankton blooms in the Southern Ocean.	[Tang, Weiyi; Li, Zuchuan; Cassar, Nicolas] Duke Univ, Nicholas Sch Environm, Div Earth & Climate Sci, Durham, NC 27708 USA; [Llort, Joan; Weis, Jakob; Perron, Morgane M. G.; Proemse, Bernadette C.; Bowie, Andrew R.; Schallenberg, Christina; Strutton, Peter G.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Llort, Joan; Basart, Sara] Barcelona Supercomp Ctr, Barcelona, Spain; [Weis, Jakob; Strutton, Peter G.] Univ Tasmania, Australian Res Council Ctr Excellence Climate Ext, Hobart, Tas, Australia; [Li, Zuchuan] Woods Hole Oceanog Inst, Appl Ocean Phys & Engn, Woods Hole, MA USA; [Sathyendranath, Shubha; Jackson, Thomas] Plymouth Marine Lab, Plymouth, Devon, England; [Rodriguez, Estrella Sanz] Univ Tasmania, Australian Ctr Res Separat Sci ACROSS, Sch Nat Sci, Hobart, Tas, Australia; [Bowie, Andrew R.; Schallenberg, Christina] Univ Tasmania, Australian Antarctic Program Partnership, Hobart, Tas, Australia; [Matear, Richard] CSIRO Oceans & Atmosphere, Hobart, Tas, Australia; [Cassar, Nicolas] Univ Brest, LEMAR, IFREMER, CNRS,IRD, Plouzane, France; [Tang, Weiyi] Princeton Univ, Dept Geosci, Princeton, NJ USA	Duke University; University of Tasmania; Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS); University of Tasmania; Woods Hole Oceanographic Institution; Plymouth Marine Laboratory; University of Tasmania; University of Tasmania; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Princeton University	Cassar, N (corresponding author), Duke Univ, Nicholas Sch Environm, Div Earth & Climate Sci, Durham, NC 27708 USA.; Matear, R (corresponding author), CSIRO Oceans & Atmosphere, Hobart, Tas, Australia.; Cassar, N (corresponding author), Univ Brest, LEMAR, IFREMER, CNRS,IRD, Plouzane, France.	richard.matear@csiro.au; nicolas.cassar@duke.edu	Perron, Morgane/HHS-1241-2022; Schallenberg, Christina/N-4187-2017; matear, richard J/C-5133-2011; Llort, Joan/O-2162-2017; Strutton, Peter/C-4466-2011; Bowie, Andrew/C-8677-2013	Schallenberg, Christina/0000-0002-3073-7500; matear, richard J/0000-0002-3225-0800; Weis, Jakob/0000-0002-9493-4888; Llort, Joan/0000-0003-1490-4521; Tang, Weiyi/0000-0002-5334-3993; Perron, Morgane/0000-0001-5424-7138; Sathyendranath, Shubha/0000-0003-3586-192X; Strutton, Peter/0000-0002-2395-9471; Bowie, Andrew/0000-0002-5144-7799; Basart, Sara/0000-0002-9821-8504				Abatzoglou JT, 2019, GEOPHYS RES LETT, V46, P326, DOI 10.1029/2018GL080959; Abram NJ, 2003, SCIENCE, V301, P952, DOI 10.1126/science.1083841; [Anonymous], 2020, NEW WWF REPORT 3 BIL; [Anonymous], 2020, NATL GREENHOUSE GAS; Ardyna M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09973-6; Barkley AE, 2019, P NATL ACAD SCI USA, V116, P16216, DOI 10.1073/pnas.1906091116; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Behrenfeld MJ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002299; Benedetti A, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011115; Bennouna Y, 2020, VALIDATION REPORT CA; Bixby RJ, 2015, FRESHW SCI, V34, P1340, DOI 10.1086/684073; Boss E., 2013, METHODS OCEANOGR, V7, P52, DOI [10.1016/j.mio.2013.11.002, DOI 10.1016/J.MIO.2013.11.002]; Bowman D, 2020, NATURE, V584, P188, DOI 10.1038/d41586-020-02306-4; Bowman DMJS, 2020, NAT REV EARTH ENV, V1, P500, DOI 10.1038/s43017-020-0085-3; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; Brzezinski MA, 2005, LIMNOL OCEANOGR, V50, P810, DOI 10.4319/lo.2005.50.3.0810; Cai W, 2009, GEOPHYS RES LETT, V36, DOI [10.1029/2009GL037604, 10.1029/2009GL039902]; Cai WJ, 2014, NATURE, V510, P254, DOI 10.1038/nature13327; Cassar N, 2011, BIOGEOSCIENCES, V8, P227, DOI 10.5194/bg-8-227-2011; Cassar N, 2007, SCIENCE, V317, P1067, DOI 10.1126/science.1144602; Chen Y, 2017, NAT CLIM CHANGE, V7, P906, DOI 10.1038/s41558-017-0014-8; Cropp RA, 2013, J MARINE SYST, V117, P43, DOI 10.1016/j.jmarsys.2013.02.013; Cutter G., 2017, SAMPLING SAMPLE HAND; de Boyer Montegut C, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002378; Dong S, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2006JC004051; Duce RA, 2008, SCIENCE, V320, P893, DOI 10.1126/science.1150369; Dunne JP, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002390; Duprat LPAM, 2016, NAT GEOSCI, V9, P219, DOI 10.1038/NGEO2633; Gabric AJ, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013545; Guieu C, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022962; Haentjens N, 2017, J GEOPHYS RES-OCEANS, V122, P6583, DOI 10.1002/2017JC012844; Hamilton DS, 2020, GLOBAL BIOGEOCHEM CY, V34, DOI 10.1029/2019GB006448; Han YM, 2020, P NATL ACAD SCI USA, V117, P5184, DOI 10.1073/pnas.1822035117; Hirsch E, 2021, SCIENCE, V371, P1269, DOI 10.1126/science.abe1415; Huang YX, 2015, ATMOS ENVIRON, V121, P86, DOI 10.1016/j.atmosenv.2015.06.002; Inness A, 2019, ATMOS CHEM PHYS, V19, P3515, DOI 10.5194/acp-19-3515-2019; Ito A, 2011, BIOGEOSCIENCES, V8, P1679, DOI 10.5194/bg-8-1679-2011; Ito A, 2020, PROG EARTH PLANET SC, V7, DOI 10.1186/s40645-020-00357-9; Ito A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau7671; Jiang YQ, 2020, J CLIMATE, V33, P3351, DOI [10.1175/JCLI-D-19-0572, 10.1175/JCLI-D-19-0572.1]; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; Kablick GP, 2020, GEOPHYS RES LETT, V47, DOI 10.1029/2020GL088101; Kaiser JW, 2012, BIOGEOSCIENCES, V9, P527, DOI 10.5194/bg-9-527-2012; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Khaykin S, 2020, COMMUN EARTH ENVIRON, V1, DOI 10.1038/s43247-020-00022-5; Laws EA, 2011, LIMNOL OCEANOGR-METH, V9, P593, DOI 10.4319/lom.2011.9.593; Levy RC, 2018, ATMOS MEAS TECH, V11, P4073, DOI 10.5194/amt-11-4073-2018; Li ZC, 2016, GLOBAL BIOGEOCHEM CY, V30, P735, DOI 10.1002/2015GB005314; Lim EP, 2019, NAT GEOSCI, V12, P896, DOI 10.1038/s41561-019-0456-x; Longo AF, 2016, ENVIRON SCI TECHNOL, V50, P6912, DOI 10.1021/acs.est.6b02605; Lovenduski NS, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022727; Mahowald N, 2011, ANNU REV ENV RESOUR, V36, P45, DOI 10.1146/annurev-environ-042009-094507; Marshall GJ, 2003, J CLIMATE, V16, P4134, DOI 10.1175/1520-0442(2003)016<4134:TITSAM>2.0.CO;2; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; McLennan SM, 2001, GEOCHEM GEOPHY GEOSY, V2, DOI 10.1029/2000gc000109; Meskhidze N, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002711; MITCHELL BG, 1991, DEEP-SEA RES, V38, P981, DOI 10.1016/0198-0149(91)90093-U; Morcrette JJ, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011235; Morton PL, 2013, LIMNOL OCEANOGR-METH, V11, P62, DOI 10.4319/lom.2013.11.62; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Perron MMG, 2020, TALANTA, V208, DOI 10.1016/j.talanta.2019.120377; Rodriguez ES, 2020, J CHROMATOGR A, V1610, DOI 10.1016/j.chroma.2019.460557; Saji NH, 2003, CLIM RES, V25, P151, DOI 10.3354/cr025151; Sarmiento JL, 2010, BIOGEOSCIENCES, V7, P3593, DOI 10.5194/bg-7-3593-2010; Sathyendranath S, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19194285; Schlosser JS, 2017, J GEOPHYS RES-ATMOS, V122, P8951, DOI 10.1002/2017JD026547; Shafeeque M, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00386; Shelley RU, 2018, BIOGEOSCIENCES, V15, P2271, DOI 10.5194/bg-15-2271-2018; Shelley RU, 2017, DEEP-SEA RES PT I, V119, P34, DOI 10.1016/j.dsr.2016.11.010; Sholkovitz ER, 2012, GEOCHIM COSMOCHIM AC, V89, P173, DOI 10.1016/j.gca.2012.04.022; Siegel DA, 2014, GLOBAL BIOGEOCHEM CY, V28, P181, DOI 10.1002/2013GB004743; Silsbe GM, 2016, GLOBAL BIOGEOCHEM CY, V30, P1756, DOI 10.1002/2016GB005521; Skea J., CLIMATE CHANGE LAND; Stein AF, 2015, B AM METEOROL SOC, V96, P2059, DOI 10.1175/BAMS-D-14-00110.1; Stein AF, 2009, WEATHER FORECAST, V24, P379, DOI 10.1175/2008WAF2222166.1; Tagliabue A, 2014, NAT GEOSCI, V7, P314, DOI [10.1038/ngeo2101, 10.1038/NGEO2101]; Tatlhego M, 2020, J GEOPHYS RES-ATMOS, V125, DOI 10.1029/2019JD030926; van der Velde IR, 2021, NATURE, V597, P366, DOI 10.1038/s41586-021-03712-y; van der Werf GR, 2017, EARTH SYST SCI DATA, V9, P697, DOI 10.5194/essd-9-697-2017; van Oldenborgh GJ, 2021, NAT HAZARD EARTH SYS, V21, P941, DOI 10.5194/nhess-21-941-2021; Ward M, 2020, NAT ECOL EVOL, V4, P1321, DOI 10.1038/s41559-020-1251-1; Westberry T, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003078	82	37	37	61	173	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 16	2021	597	7876					370	+		10.1038/s41586-021-03805-8	http://dx.doi.org/10.1038/s41586-021-03805-8			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UQ8UQ	34526706	Green Submitted, Green Accepted			2022-12-28	WOS:000696334600012
J	Bunescu, A; Abdelhamid, Y; Gaunt, MJ				Bunescu, Ala; Abdelhamid, Yusra; Gaunt, Matthew J.			Multicomponent alkene azidoarylation by anion-mediated dual catalysis	NATURE			English	Article							INTERMOLECULAR CARBOAMINATION; UNACTIVATED ALKENES; ELECTRON-TRANSFER; AMINOARYLATION; HYDROAMINATION; ACETONITRILE; RADICALS; ACCESS; AMINES; LIGAND	Molecules that contain the beta-arylethylamine motif have applications in the modulation of pain, treatment of neurological disorders and management of opioid addiction, among others, making it a privileged scaffold in drug discovery(1,2). De novo methods for their assembly are reliant on transformations that convert a small class of feedstocks into the target compounds via time-consuming multistep syntheses(3-5). Synthetic invention can drive the investigation of the chemical space around this scaffold to further expand its capabilities in biology(6-9). Here we report the development of a dual catalysis platform that enables a multicomponent coupling of alkenes, aryl electrophiles and a simple nitrogen nucleophile, providing single-step access to synthetically versatile and functionally diverse beta-arylethylamines. Driven by visible light, two discrete copper catalysts orchestrate aryl-radical formation and azido-group transfer, which underpin an alkene azidoarylation process. The process shows broad scope in alkene and aryl components and an azide anion performs a multifaceted role both as a nitrogen source and in mediating the redox-neutral dual catalysis via inner-sphere electron transfer(10,11). The synthetic capabilities of this anion-mediated alkene functionalization process are likely to be of use in a variety of pharmaceutically relevant and wider synthetic applications. A streamlined synthesis of beta-arylethylamines using two distinct copper catalysts is reported, and an azide anion is proposed to both react to form the product and facilitate catalyst regeneration.	[Bunescu, Ala; Abdelhamid, Yusra; Gaunt, Matthew J.] Univ Cambridge, Yusuf Hamied Dept Chem, Cambridge, England	University of Cambridge	Gaunt, MJ (corresponding author), Univ Cambridge, Yusuf Hamied Dept Chem, Cambridge, England.	mjg32@cam.ac.uk		Bunescu, Ala/0000-0002-3880-8182	Herchel Smith Fund at the University of Cambridge; AstraZeneca-University of Cambridge PhD programme for studentship; Royal Society	Herchel Smith Fund at the University of Cambridge; AstraZeneca-University of Cambridge PhD programme for studentship; Royal Society(Royal Society of London)	We thank the Herchel Smith Fund at the University of Cambridge for a postdoctoral fellowship to A.B., the AstraZeneca-University of Cambridge PhD programme for studentship (Y.A.) and the Royal Society for Wolfson Merit Award to M.J.G.	Addie M, 2013, J MED CHEM, V56, P2059, DOI 10.1021/jm301762v; ALFASSI ZB, 1987, J PHYS CHEM-US, V91, P2120, DOI 10.1021/j100292a029; Bard A. J., 1985, STANDARD POTENTIALS; BARTON DHR, 1973, J CHEM SOC CHEM COMM, P781; Boyington AJ, 2019, J AM CHEM SOC, V141, P4147, DOI 10.1021/jacs.9b01077; Bracher F, 2018, SYNOPEN, V2, P96, DOI 10.1055/s-0037-1609449; Brenzovich WE, 2010, ANGEW CHEM INT EDIT, V49, P5519, DOI 10.1002/anie.201002739; Bunescu A, 2017, ANGEW CHEM INT EDIT, V56, P10555, DOI 10.1002/anie.201705353; Caldwell JJ, 2008, J MED CHEM, V51, P2147, DOI 10.1021/jm701437d; Cativiela C, 2007, TETRAHEDRON-ASYMMETR, V18, P569, DOI 10.1016/j.tetasy.2007.02.003; Clayden J, 2011, CHEM COMMUN, V47, P4624, DOI 10.1039/c1cc00049g; Dalley JW, 2009, SEMIN CELL DEV BIOL, V20, P403, DOI 10.1016/j.semcdb.2009.01.002; Estrada JG, 2020, J AM CHEM SOC, V142, P8928, DOI 10.1021/jacs.0c02237; Fischer H, 2001, ANGEW CHEM INT EDIT, V40, P1340, DOI 10.1002/1521-3773(20010417)40:8<1340::AID-ANIE1340>3.0.CO;2-#; Freeman S, 2002, EUR J MED CHEM, V37, P527, DOI 10.1016/S0223-5234(02)01382-X; Fu NK, 2017, SCIENCE, V357, P575, DOI 10.1126/science.aan6206; Fumagalli G, 2013, ORG LETT, V15, P4398, DOI 10.1021/ol401940c; Goel P, 2018, EUR J MED CHEM, V157, P480, DOI 10.1016/j.ejmech.2018.08.017; Hager A, 2016, NAT PROD REP, V33, P491, DOI 10.1039/c5np00096c; HAIM A, 1975, ACCOUNTS CHEM RES, V8, P264, DOI 10.1021/ar50092a002; Hari DP, 2014, ANGEW CHEM INT EDIT, V53, P725, DOI 10.1002/anie.201307051; Heinrich MR, 2009, CHEM-EUR J, V15, P821, DOI 10.1002/chem.200801306; Heinrich MR, 2006, ORG LETT, V8, P3323, DOI 10.1021/ol0611393; Huang XY, 2015, J AM CHEM SOC, V137, P5300, DOI 10.1021/jacs.5b01983; Jiang H, 2020, CHEM SOC REV, V49, P1790, DOI 10.1039/c9cs00692c; Leggans EK, 2012, ORG LETT, V14, P1428, DOI 10.1021/ol300173v; Lerchen A, 2016, ANGEW CHEM INT EDIT, V55, P15166, DOI 10.1002/anie.201608729; Liu Z, 2017, J AM CHEM SOC, V139, P11261, DOI 10.1021/jacs.7b06520; Monos TM, 2018, SCIENCE, V361, P1369, DOI 10.1126/science.aat2117; Muller TE, 2008, CHEM REV, V108, P3795, DOI 10.1021/cr0306788; Nguyen TM, 2014, ANGEW CHEM INT EDIT, V53, P6198, DOI 10.1002/anie.201402443; Odian G., 2004, PRINCIPLES POLYM, P198, DOI [10.1002/047147875X, DOI 10.1002/047147875X.CH3]; Pavlishchuk VV, 2000, INORG CHIM ACTA, V298, P97, DOI 10.1016/S0020-1693(99)00407-7; Qiu J, 2000, MACROMOL CHEM PHYSIC, V201, P1625, DOI 10.1002/1521-3935(20000901)201:14<1625::AID-MACP1625>3.0.CO;2-9; Rorabacher DB, 2004, CHEM REV, V104, P651, DOI 10.1021/cr020630e; Schultz DM, 2012, SYNTHESIS-STUTTGART, V44, P351, DOI 10.1055/s-0031-1289668; Schulze M, 2010, SYNTHETIC COMMUN, V40, P1461, DOI 10.1080/00397910903097302; Suh SE, 2020, J AM CHEM SOC, V142, P11388, DOI 10.1021/jacs.0c05362; Tang W, 2008, J AM CHEM SOC, V130, P10702, DOI 10.1021/ja802290a; van der Puyl VA, 2019, ACS CATAL, V9, P224, DOI 10.1021/acscatal.8b04516; Venkatraman J, 2001, CHEM REV, V101, P3131, DOI 10.1021/cr000053z; Wang DH, 2017, J AM CHEM SOC, V139, P6811, DOI 10.1021/jacs.7b02455; Wang ZB, 2018, NATURE, V563, P379, DOI 10.1038/s41586-018-0669-y; Yang HB, 2017, ACS CATAL, V7, P8441, DOI 10.1021/acscatal.7b03432; Zeng W, 2007, J AM CHEM SOC, V129, P12948, DOI 10.1021/ja0762240; Zhang GZ, 2010, J AM CHEM SOC, V132, P1474, DOI 10.1021/ja909555d; Zhou JR, 2003, J AM CHEM SOC, V125, P14726, DOI 10.1021/ja0389366	47	10	10	12	61	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 28	2021	598	7882					597	+		10.1038/s41586-021-03980-8	http://dx.doi.org/10.1038/s41586-021-03980-8		SEP 2021	8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WO9BH	34517408				2022-12-28	WOS:000709352000001
J	Chen, ZY; Wang, Y; Rebec, SN; Jia, T; Hashimoto, M; Lu, DH; Moritz, B; Moore, RG; Devereaux, TP; Shen, ZX				Chen, Zhuoyu; Wang, Yao; Rebec, Slavko N.; Jia, Tao; Hashimoto, Makoto; Lu, Donghui; Moritz, Brian; Moore, Robert G.; Devereaux, Thomas P.; Shen, Zhi-Xun			Anomalously strong near-neighbor attraction in doped 1D cuprate chains	SCIENCE			English	Article							SPECTRAL FUNCTIONS; HUBBARD-MODEL; SUPERCONDUCTIVITY; SEPARATION	In the cuprates, one-dimensional (1D) chain compounds provide a distinctive opportunity to understand the microscopic physics, owing to the availability of reliable theories. However, progress has been limited by the challenge of controllably doping these materials. We report the synthesis and spectroscopic analysis of the 1D cuprate Ba2-xSrxCuO3+delta over a wide range of hole doping. Our angle-resolved photoemission experiments reveal the doping evolution of the holon and spinon branches. We identify a prominent folding branch whose intensity fails to match predictions of the simple Hubbard model. An additional strong near-neighbor attraction, which may arise from coupling to phonons, quantitatively explains experiments for all accessible doping levels. Considering structural and quantum chemistry similarities among cuprates, this attraction may play a similarly important role in high-temperature cuprate superconductors.	[Chen, Zhuoyu; Rebec, Slavko N.; Jia, Tao; Moritz, Brian; Moore, Robert G.; Devereaux, Thomas P.; Shen, Zhi-Xun] Stanford Inst Mat & Energy Sci, SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Chen, Zhuoyu; Rebec, Slavko N.; Shen, Zhi-Xun] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Chen, Zhuoyu; Rebec, Slavko N.; Jia, Tao; Devereaux, Thomas P.; Shen, Zhi-Xun] Stanford Univ, Geballe Lab Adv Mat, Stanford, CA 94305 USA; [Wang, Yao] Clemson Univ, Dept Phys & Astron, Clemson, SC 29631 USA; [Jia, Tao; Shen, Zhi-Xun] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Hashimoto, Makoto; Lu, Donghui] Stanford Synchrotron Radiat Lightsource, SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Moore, Robert G.] Oak Ridge Natl Lab, Mat Sci & Technol Div, Oak Ridge, TN 37831 USA; [Devereaux, Thomas P.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; Stanford University; Clemson University; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; Stanford University	Devereaux, TP; Shen, ZX (corresponding author), Stanford Inst Mat & Energy Sci, SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA.; Shen, ZX (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.; Devereaux, TP; Shen, ZX (corresponding author), Stanford Univ, Geballe Lab Adv Mat, Stanford, CA 94305 USA.; Shen, ZX (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.; Devereaux, TP (corresponding author), Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA.	tpd@stanford.edu; zxshen@stanford.edu	Moore, Rob/CAG-8039-2022; Wang, Yao/L-8653-2018; Moritz, Brian J/D-7505-2015	Moore, Rob/0000-0002-1608-5411; Wang, Yao/0000-0003-1736-0187; Moritz, Brian J/0000-0002-3747-8484; devereaux, thomas/0000-0001-8072-9237; Lu, Donghui/0000-0002-9708-0443; Hashimoto, Makoto/0000-0003-1689-8997; Jia, Tao/0000-0002-7236-4634	US Department of Energy, Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division [DE-AC02-76SF00515]; US Department of Energy Office of Science User Facility [DE-AC02-05CH11231]; Laboratory Directed Research and Development Program of Oak Ridge National Laboratory; NSF [DMR-2038011]	US Department of Energy, Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); US Department of Energy Office of Science User Facility(United States Department of Energy (DOE)); Laboratory Directed Research and Development Program of Oak Ridge National Laboratory; NSF(National Science Foundation (NSF))	This work was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division, under Contract DE-AC02-76SF00515. This research used resources of the National Energy Research Scientific Computing Center (NERSC), a US Department of Energy Office of Science User Facility operated under Contract no. DE-AC02-05CH11231. R.G.M. acknowledges support by the Laboratory Directed Research and Development Program of Oak Ridge National Laboratory,managed by UT-Battelle, LLC, for the US Department of Energy. Y.W. acknowledges support from NSF award DMR-2038011.	Benthien H, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.256401; Chen Z., 2021, HARVARD DATAVERSE, DOI [10.7910/DVN/5I1WSW, DOI 10.7910/DVN/5I1WSW]; Cuk T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.117003; Fujisawa H, 1999, PHYS REV B, V59, P7358, DOI 10.1103/PhysRevB.59.7358; Gunnarsson O, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.174521; He Y, 2018, SCIENCE, V362, P62, DOI 10.1126/science.aar3394; Johnston S, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.064513; Keimer B, 2015, NATURE, V518, P179, DOI 10.1038/nature14165; Kim BJ, 2006, NAT PHYS, V2, P397, DOI 10.1038/nphys316; Kim C, 1996, PHYS REV LETT, V77, P4054, DOI 10.1103/PhysRevLett.77.4054; Kohno M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.106402; Kung YF, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.155166; Lanzara A, 2001, NATURE, V412, P510, DOI 10.1038/35087518; Lee JJ, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.041104; Lee WS, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.265502; LIEB EH, 1968, PHYS REV LETT, V20, P1445, DOI 10.1103/PhysRevLett.20.1445; LINES DR, 1991, MATER RES BULL, V26, P323, DOI 10.1016/0025-5408(91)90028-K; LIU ZY, 1994, APPL PHYS LETT, V65, P1717, DOI 10.1063/1.112896; Matsueda H, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.241103; Mishchenko AS, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.036402; Nocera A, 2018, PHYS REV B, V97, DOI 10.1103/PhysRevB.97.045146; Penc K, 1997, PHYS REV B, V55, P15475, DOI 10.1103/PhysRevB.55.15475; Penc K, 1996, PHYS REV LETT, V77, P1390, DOI 10.1103/PhysRevLett.77.1390; Sato H, 1997, PHYSICA C, V280, P178, DOI 10.1016/S0921-4534(97)00441-3; Schlappa J, 2012, NATURE, V485, P82, DOI 10.1038/nature10974; Senechal D, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.075129; Senechal D, 2000, PHYS REV LETT, V84, P522, DOI 10.1103/PhysRevLett.84.522; Shen KM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.267002; Slezak C, 2006, PHYS REV B, V73, DOI [10.1103/PhysRevB.73.205122, 10.1103/PhysRevB.205122]; Suzuura H, 1996, PHYS REV LETT, V76, P2579, DOI 10.1103/PhysRevLett.76.2579; VOIT J, 1995, REP PROG PHYS, V58, P977, DOI 10.1088/0034-4885/58/9/002	31	22	23	6	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2021	373	6560					1235	+		10.1126/science.abf5174	http://dx.doi.org/10.1126/science.abf5174			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UP5RB	34516788	Green Submitted			2022-12-28	WOS:000695436000028
J	Former, OH				Former, Ole Hartling			Euthanasia and assisted dying: the illusion of autonomy-an essay by Ole Hartling	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Former, Ole Hartling] Danish Council Eth, Copenhagen, Denmark		Former, OH (corresponding author), Danish Council Eth, Copenhagen, Denmark.	hartling@dadlnet.dk						Biggar N, 2004, AIMING KILL ETHICS S; Hartling O, 2021, BLOOMSBURY, DOI [10.5040/9781350186255, DOI 10.5040/9781350186255]; SULMASY D, 2017, EUTHANASIA ASSISTED, P49	3	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2021	374								n2135	10.1136/bmj.n2135	http://dx.doi.org/10.1136/bmj.n2135			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ3VV	34497048				2022-12-28	WOS:000702137100005
J	Neilan, AM; Valentine, SS; Knopf, AS				Neilan, Anne M.; Valentine, Sheila Salvant; Knopf, Amelia S.			Case 27-2021: A 16-Year-Old Boy Seeking Human Immunodeficiency Virus Prophylaxis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TENOFOVIR DISOPROXIL FUMARATE/EMTRICITABINE; BONE-MINERAL DENSITY; PREEXPOSURE PROPHYLAXIS; YOUNG MEN; HIV TRANSMISSION; ADOLESCENT BOYS; RISK; INFECTION; CONSENT; SEX	An Adolescent Seeking HIV Prophylaxis A 16-year-old boy was seen in the infectious disease clinic for consideration of preexposure prophylaxis against human immunodeficiency virus infection. He identified as a cisgender male and reported having had more than 10 male sexual partners. He requested that the content of the visit remain confidential. Management decisions were made.	[Neilan, Anne M.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Boston, MA 02115 USA; [Neilan, Anne M.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02115 USA; [Valentine, Sheila Salvant] Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis Sexually Transm, Div HIV AIDS Prevent, Atlanta, GA USA; [Knopf, Amelia S.] Indiana Univ, Sch Nursing, Community & Hlth Syst, Indianapolis, IN USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Centers for Disease Control & Prevention - USA; Indiana University System; Indiana University-Purdue University Indianapolis	Neilan, AM (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Boston, MA 02115 USA.; Neilan, AM (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02115 USA.							[Anonymous], 2019, HIV PREV DRUG BILL C; Beauchamp T L, 2012, PRINCIPLES BIOMEDICA; Bonjour JP, 2014, ENDOCR REV, V35, P820, DOI 10.1210/er.2014-1007; Brody JL, 2006, PEDIATRICS, V118, pE356, DOI 10.1542/peds.2005-2589; Brody JL, 2005, J ADOLESCENT HEALTH, V37, P229, DOI 10.1016/j.jadohealth.2004.09.026; Centers for Disease Control and Prevention, 2021, PREEXP PROPH PREP; Centers for Disease Control and Prevention, 2021, STAT LAWS EN MIN PRO; Centers for Disease Control and Prevention, 2020, EST HIV INC PREV US; Department of Health and Human Services, 2016, BELM REP ETH PRINC G; Evans C., 2019, PREEXPOSURE PROPHYLA; Gabel L, 2017, J BONE MINER RES, V32, P250, DOI 10.1002/jbmr.2982; Glidden DV, 2017, JAIDS-J ACQ IMM DEF, V76, P177, DOI 10.1097/QAI.0000000000001475; Hardy WD., 2018, HIVMA COMMENTS USPST; Havens PL, 2019, AIDS RES HUM RETROV, V35, P123, DOI [10.1089/aid.2018.0096, 10.1089/AID.2018.0096]; Havens PL, 2020, CLIN INFECT DIS, V70, P687, DOI 10.1093/cid/ciz486; Havens PL, 2017, CLIN INFECT DIS, V64, P317, DOI 10.1093/cid/ciw765; Hein IM, 2014, JAMA PEDIATR, V168, P1147, DOI 10.1001/jamapediatrics.2014.1694; Hess KL, 2017, ANN EPIDEMIOL, V27, P238, DOI 10.1016/j.annepidem.2017.02.003; Hoffman LF, 2016, J ADOLESCENT HEALTH, V58, P576, DOI 10.1016/j.jadohealth.2016.01.007; Hoopes AJ, 2017, J PRIM CARE COMMUNIT, V8, P332, DOI 10.1177/2150131917730210; Hosek S., 2017, HIV PREEXPOSURE PROP; Hosek SG, 2017, JAMA PEDIATR, V171, P1063, DOI 10.1001/jamapediatrics.2017.2007; Hume M, 2017, J MED ETHICS, V43, P857, DOI 10.1136/medethics-2016-103600; Knopf AS, 2017, J ADOLESCENT HEALTH, V61, P747, DOI 10.1016/j.jadohealth.2017.06.013; Li ZH, 2019, MMWR-MORBID MORTAL W, V68, P267; Lindberg LD, 2016, J ADOLESCENT HEALTH, V58, P621, DOI 10.1016/j.jadohealth.2016.02.004; Macapagal K, 2017, ARCH SEX BEHAV, V46, P1393, DOI 10.1007/s10508-016-0784-5; Marcus JL, 2019, NEW ENGL J MED, V380, P510, DOI 10.1056/NEJMp1810743; Morton MH, 2018, J ADOLESCENT HEALTH, V62, P14, DOI 10.1016/j.jadohealth.2017.10.006; Mulligan K, 2015, CLIN INFECT DIS, V61, P572, DOI 10.1093/cid/civ324; Nelson NP, 2020, MMWR RECOMM REP, V69, P1, DOI 10.15585/mmwr.rr6905a1; Pace JE, 2013, CLIN INFECT DIS, V56, P1149, DOI 10.1093/cid/cis1020; Patel P, 2014, AIDS, V28, P1509, DOI 10.1097/QAD.0000000000000298; Rasberry CN, 2015, J SCH NURS, V31, P334, DOI 10.1177/1059840514557160; Reed JL, 2008, J ADOLESCENT HEALTH, V43, P195, DOI 10.1016/j.jadohealth.2008.01.020; Rojas NL, 2008, J ADOLESCENT HEALTH, V42, P192, DOI 10.1016/j.jadohealth.2007.07.011; Schenk KD, 2014, J ADOLESCENT HEALTH, V54, P654, DOI 10.1016/j.jadohealth.2014.01.014; Spinelli MA, 2019, AIDS RES HUM RETROV, V35, P788, DOI [10.1089/aid.2018.0297, 10.1089/AID.2018.0297]; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; The 192nd General Court of the Commonwealth of Massachusetts, CHAPT 1760 HLTH INS; U.S. Preventive Services Task Force, 2019, FINAL RECOMMENDATION; US Public Health Service, 2017, PREEXP PROPH PREV HI, DOI DOI 10.1016/S0040-4039(01)91800-3; Wallace M, 2018, SAMJ S AFR MED J, V108, P291, DOI [10.7196/SAMJ.2017.v108i4.12909, 10.7196/samj.2018.v108i4.12909, 10.7196/SAMJ.2018.v108i4.12909]; Weber DR, 2013, AM J CLIN NUTR, V98, P49, DOI 10.3945/ajcn.112.053611; Weinbaum Cindy M., 2008, Morbidity and Mortality Weekly Report, V57, P1, DOI 10.1002/hep.22882; WEITHORN LA, 1982, CHILD DEV, V53, P1589, DOI 10.2307/1130087	46	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 9	2021	385	11					1034	1041		10.1056/NEJMcpc1909626	http://dx.doi.org/10.1056/NEJMcpc1909626			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UN0RH	34496178				2022-12-28	WOS:000693730200015
J	Preskill, J				Preskill, John			Steven Weinberg (1933-2021) Titan of theoretical physics	SCIENCE			English	Biographical-Item									[Preskill, John] CALTECH, Div Phys Math & Astron, Pasadena, CA 91125 USA	California Institute of Technology	Preskill, J (corresponding author), CALTECH, Div Phys Math & Astron, Pasadena, CA 91125 USA.	preskill@caltech.edu						PRESKILL J, 1933, PUBLICATION LIST	1	1	1	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2021	373	6559					1092	1092		10.1126/science.abl8187	http://dx.doi.org/10.1126/science.abl8187			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UL8QT	34516845				2022-12-28	WOS:000692910300033
J	Felip, E; Altorki, N; Zhou, C; Csoszi, T; Vynnychenko, I; Goloborodko, O; Luft, A; Akopov, A; Martinez-Marti, A; Kenmotsu, H; Chen, YM; Chella, A; Sugawara, S; Voong, D; Wu, F; Yi, J; Deng, Y; McCleland, M; Bennett, E; Gitlitz, B; Wakelee, H				Felip, Enriqueta; Altorki, Nasser; Zhou, Caicun; Csoszi, Tibor; Vynnychenko, Ihor; Goloborodko, Oleksandr; Luft, Alexander; Akopov, Andrey; Martinez-Marti, Alex; Kenmotsu, Hirotsugu; Chen, Yuh-Min; Chella, Antonio; Sugawara, Shunichi; Voong, David; Wu, Fan; Yi, Jing; Deng, Yu; McCleland, Mark; Bennett, Elizabeth; Gitlitz, Barbara; Wakelee, Heather		IMpower010 Investigators	Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial	LANCET			English	Article							DOCETAXEL; NSCLC	Background Novel adjuvant strategies are needed to optimise outcomes after complete surgical resection in patients with early-stage non-small-cell lung cancer (NSCLC). We aimed to evaluate adjuvant atezolizumab versus best supportive care after adjuvant platinum-based chemotherapy in these patients. Methods IMpower010 was a randomised, multicentre, open-label, phase 3 study done at 227 sites in 22 countries and regions. Eligible patients were 18 years or older with completely resected stage IB (tumours >= 4 cm) to IIIA NSCLC per the Union Internationale Contre le Cancer and American Joint Committee on Cancer staging system (7th edition). Patients were randomly assigned (1:1) by a permuted-block method (block size of four) to receive adjuvant atezolizumab (1200 mg every 21 days; for 16 cycles or 1 year) or best supportive care (observation and regular scans for disease recurrence) after adjuvant platinum-based chemotherapy (one to four cycles). The primary endpoint, investigator-assessed disease-free survival, was tested hierarchically first in the stage II-IIIA population subgroup whose tumours expressed PD-L1 on 1% or more of tumour cells (SP263), then all patients in the stage II-IIIA population, and finally the intention-to-treat (ITT) population (stage IB-IIIA). Safety was evaluated in all patients who were randomly assigned and received atezolizumab or best supportive care. IMpower010 is registered with ClinicalTrials.gov, NCT02486718 (active, not recruiting). Findings Between Oct 7, 2015, and Sept 19, 2018, 1280 patients were enrolled after complete resection. 1269 received adjuvant chemotherapy, of whom 1005 patients were eligible for randomisation to atezolizumab (n=507) or best supportive care (n=498); 495 in each group received treatment. After a median follow-up of 32.2 months (IQR 27.4-38.3) in the stage II-IIIA population, atezolizumab treatment improved disease-free survival compared with best supportive care in patients in the stage II-IIIA population whose tumours expressed PD-L1 on 1% or more of tumour cells (HR 0.66; 95% CI 0.50-0.88; p=0.0039) and in all patients in the stage II-IIIA population (0.79; 0.64-0.96; p=0.020). In the ITT population, HR for disease-free survival was 0.81 (0.67-0.99; p=0.040). Atezolizumab-related grade 3 and 4 adverse events occurred in 53 (11%) of 495 patients and grade 5 events in four patients (1%). Interpretation IMpower010 showed a disease-free survival benefit with atezolizumab versus best supportive care after adjuvant chemotherapy in patients with resected stage II-IIIA NSCLC, with pronounced benefit in the subgroup whose tumours expressed PD-L1 on 1% or more of tumour cells, and no new safety signals. Atezolizumab after adjuvant chemotherapy offers a promising treatment option for patients with resected early-stage NSCLC. Copyright (C) 2021 Elsevier Ltd. All rights reserved.	[Felip, Enriqueta; Martinez-Marti, Alex] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Barcelona 08035, Spain; [Altorki, Nasser] New York Presbyterian Hosp, Div Thorac Surg, Weill Cornell Med, New York, NY USA; [Zhou, Caicun] Tongji Univ, Dept Oncol, Affiliated Shanghai Pulm Hosp, Shanghai, Peoples R China; [Csoszi, Tibor] Jasz Nagykun Szolnok Megyei Hetenyi Geza Korhaz R, Szolnok, Hungary; [Vynnychenko, Ihor] Sumy State Univ, Reg Municipal Inst Sumy Reg Clin Oncol Dispensary, Sumy, Ukraine; [Goloborodko, Oleksandr] MI Zaporizhzhia Reg Clin Oncol Dispensary Zaporiz, Zaporizhzhya, Ukraine; [Luft, Alexander] Leningrad Reg Clin Hosp, Dept Thorac Surg, St Petersburg, Russia; [Akopov, Andrey] Pavlov State Med Univ, Pulmonol Res Inst, St Petersburg, Russia; [Kenmotsu, Hirotsugu] Shizuoka Canc Ctr, Div Thorac Oncol, Shizuoka, Japan; [Chen, Yuh-Min] Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan; [Chen, Yuh-Min] Natl Yang Ming Chiao Tung Univ, Taipei, Taiwan; [Chella, Antonio] Azienda Osped Univ Pisana, Pneumol Unit, Pisa, Italy; [Sugawara, Shunichi] Sendai Kousei Hosp, Dept Pulm Med, Sendai, Miyagi, Japan; [Wu, Fan] Roche China Holding, Shanghai, Peoples R China; [Voong, David; Yi, Jing; Deng, Yu; McCleland, Mark; Bennett, Elizabeth; Gitlitz, Barbara] Genentech Inc, San Francisco, CA USA; [Wakelee, Heather] Stanford Univ, Div Oncol, Dept Med, Sch Med, Stanford, CA USA; [Wakelee, Heather] Stanford Canc Inst, Stanford, CA USA	Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); Cornell University; NewYork-Presbyterian Hospital; Tongji University; Ministry of Education & Science of Ukraine; Sumy State University; Pavlov First Saint Petersburg State Medical University; Shizuoka Cancer Center; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Sendai Kousei Hospital; Roche Holding; Genentech; Stanford University; Stanford Cancer Institute	Felip, E (corresponding author), Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Barcelona 08035, Spain.	efelip@vhio.net	Vynnychenko, Ihor O/E-1684-2012; Akopov, Andrey/N-7267-2019	Vynnychenko, Ihor O/0000-0002-2339-6509; Akopov, Andrey/0000-0001-8698-7018; MARTINEZ-MARTI, ALEX/0000-0002-6714-9526	F Hoffmann-La Roche; Genentech	F Hoffmann-La Roche(Hoffmann-La Roche); Genentech(Roche HoldingGenentech)	F Hoffmann-La Roche and Genentech.	Adams S, 2019, ANN ONCOL, V30, P397, DOI 10.1093/annonc/mdy517; Antonia SJ, 2017, NEW ENGL J MED, V377, P1919, DOI 10.1056/NEJMoa1709937; Ardizzoni A, 2021, J IMMUNOTHER CANCER, V9, DOI 10.1136/jitc-2020-001865; Brahmer JR, 2018, J CLIN ONCOL, V36, P1714, DOI 10.1200/JCO.2017.77.6385; Carbone DP, 2017, NEW ENGL J MED, V376, P2415, DOI 10.1056/NEJMoa1613493; Chaft JE, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.TPS8581; Detterbeck FC, 2009, CHEST, V136, P260, DOI 10.1378/chest.08-0978; Fehrenbacher L, 2016, LANCET, V387, P1837, DOI 10.1016/S0140-6736(16)00587-0; Forde PM, 2021, NIVOLUMAB PLATINUM D; Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005; Ghysen K, 2019, CURR OPIN ONCOL, V31, P13, DOI 10.1097/CCO.0000000000000497; Goldstraw P, 2016, J THORAC ONCOL, V11, P39, DOI 10.1016/j.jtho.2015.09.009; Herbst RS, 2020, NEW ENGL J MED, V383, P1328, DOI 10.1056/NEJMoa1917346; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Kenmotsu H, 2020, J CLIN ONCOL, V38, P2187, DOI 10.1200/JCO.19.02674; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; Lu T, 2019, CANCER MANAG RES, V11, P943, DOI 10.2147/CMAR.S187317; Michielin O, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-000948; Mok TSK, 2019, LANCET, V393, P1819, DOI 10.1016/S0140-6736(18)32409-7; Paz-Ares L, 2017, ANN ONCOL, V28; Peters S, 2021, J THORAC ONCOL, V16, pS258, DOI 10.1016/j.jtho.2021.01.376; Peters S, 2019, ANN ONCOL, V30, P30; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Planchard D, 2018, ANN ONCOL, V29, P192, DOI 10.1093/annonc/mdy275; Postmus PE, 2017, ANN ONCOL, V28, P1, DOI 10.1093/annonc/mdx222; Rebelatto MC, 2016, DIAGN PATHOL, V11, DOI 10.1186/s13000-016-0545-8; Rittmeyer A, 2017, LANCET, V389, P255, DOI 10.1016/S0140-6736(16)32517-X; Socinski MA, 2018, NEW ENGL J MED, V378, P2288, DOI 10.1056/NEJMoa1716948; Spigel DR, 2021, J THORAC ONCOL, V16, pS745, DOI 10.1016/S1556-0864(21)01935-3; Tsao MS, 2018, J THORAC ONCOL, V13, P1302, DOI 10.1016/j.jtho.2018.05.013; Tsuboi M, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.2020.38.18_suppl.LBA5; Vansteenkiste J, 2019, ANN ONCOL, V30, P1244, DOI 10.1093/annonc/mdz175; Vennapusa B, 2019, APPL IMMUNOHISTO M M, V27, P92, DOI 10.1097/PAI.0000000000000594; Wakelee HA, 2017, LANCET ONCOL, V18, P1610, DOI 10.1016/S1470-2045(17)30691-5; Wu YL, 2020, NEW ENGL J MED, V383, P1711, DOI 10.1056/NEJMoa2027071	35	176	180	23	49	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT	2021	398	10308					1344	1357		10.1016/S0140-6736(21)02098-5	http://dx.doi.org/10.1016/S0140-6736(21)02098-5		OCT 2021	14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WE2YJ	34555333				2022-12-28	WOS:000705490300020
J	Ganaie, SS; Schwarz, MM; McMillen, CM; Price, DA; Feng, AX; Albe, JR; Wang, WJ; Miersch, S; Orvedahl, A; Cole, AR; Sentmanat, MF; Mishra, N; Boyles, DA; Koenig, ZT; Kujawa, MR; Demers, MA; Hoehl, RM; Moyle, AB; Wagner, ND; Stubbs, SH; Cardarelli, L; Teyra, J; McElroy, A; Gross, ML; Whelan, SPJ; Doench, J; Cui, XX; Brett, TJ; Sidhu, SS; Virgin, HW; Egawa, T; Leung, DW; Amarasinghe, GK; Hartman, AL				Ganaie, Safder S.; Schwarz, Madeline M.; McMillen, Cynthia M.; Price, David A.; Feng, Annie X.; Albe, Joseph R.; Wang, Wenjie; Miersch, Shane; Orvedahl, Anthony; Cole, Aidan R.; Sentmanat, Monica F.; Mishra, Nawneet; Boyles, Devin A.; Koenig, Zachary T.; Kujawa, Michael R.; Demers, Matthew A.; Hoehl, Ryan M.; Moyle, Austin B.; Wagner, Nicole D.; Stubbs, Sarah H.; Cardarelli, Lia; Teyra, Joan; McElroy, Anita; Gross, Michael L.; Whelan, Sean P. J.; Doench, John; Cui, Xiaoxia; Brett, Tom J.; Sidhu, Sachdev S.; Virgin, Herbert W.; Egawa, Takeshi; Leung, Daisy W.; Amarasinghe, Gaya K.; Hartman, Amy L.			Lrp1 is a host entry factor for Rift Valley fever virus	CELL			English	Article							RECEPTOR-RELATED PROTEIN; DC-SIGN; LIGAND-BINDING; MOSQUITOS; CELL; RAP; ORGANIZATION; OUTBREAK	Rift Valley fever virus (RVFV) is a zoonotic pathogen with pandemic potential. RVFV entry is mediated by the viral glycoprotein (Gn), but host entry factors remain poorly defined. Our genome-wide CRISPR screen identified low-density lipoprotein receptor-related protein 1 (mouse Lrp1/human LRP1), heat shock protein (Grp94), and receptor-associated protein (RAP) as critical host factors for RVFV infection. RVFV Gn directly binds to specific Lrp1 clusters and is glycosylation independent. Exogenous addition of murine RAP domain 3 (mRAP(D3)) and anti-Lrp1 antibodies neutralizes RVFV infection in taxonomically diverse cell lines. Mice treated with mRAP(D3) and infected with pathogenic RVFV are protected from disease and death. A mutant mRAPD3 that binds Lrp1 weakly failed to protect from RVFV infection. Together, these data support Lrp1 as a host entry factor for RVFV infection and define a new target to limit RVFV infections.	[Ganaie, Safder S.; Price, David A.; Feng, Annie X.; Wang, Wenjie; Cole, Aidan R.; Mishra, Nawneet; Virgin, Herbert W.; Egawa, Takeshi; Leung, Daisy W.; Amarasinghe, Gaya K.] Washington Univ, Sch Med St Louis, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Schwarz, Madeline M.; McMillen, Cynthia M.; Albe, Joseph R.; Boyles, Devin A.; Koenig, Zachary T.; Kujawa, Michael R.; Demers, Matthew A.; Hoehl, Ryan M.; McElroy, Anita; Hartman, Amy L.] Univ Pittsburgh, Sch Med, Ctr Vaccine Res, Pittsburgh, PA 15260 USA; [Schwarz, Madeline M.; McMillen, Cynthia M.; Koenig, Zachary T.; Kujawa, Michael R.; Hartman, Amy L.] Univ Pittsburgh, Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15260 USA; [Miersch, Shane; Cardarelli, Lia; Teyra, Joan; Sidhu, Sachdev S.] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Orvedahl, Anthony] Washington Univ, Dept Pediat, Sch Med St Louis, St Louis, MO 63130 USA; [Sentmanat, Monica F.; Cui, Xiaoxia] Washington Univ, Dept Genet, Sch Med St Louis, Genome Engn & iPSC Ctr GEiC, St Louis, MO 63110 USA; [McElroy, Anita] Univ Pittsburgh, Dept Pediat, Div Pediat Infect Dis, Pittsburgh, PA 15260 USA; [Brett, Tom J.; Leung, Daisy W.] Washington Univ, Dept Med, Sch Med St Louis, St Louis, MO USA; [Virgin, Herbert W.] Vir Biotechnol, San Francisco, CA USA; [Moyle, Austin B.; Wagner, Nicole D.; Gross, Michael L.] Washington Univ, Dept Chem, St Louis, MO USA; [Stubbs, Sarah H.] Harvard Med Sch, Dept Microbiol, Boston, MA 02115 USA; [Whelan, Sean P. J.] Washington Univ, Dept Mol Microbiol, St Louis, MO 63110 USA; [Doench, John] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Saint Louis University; Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Toronto; Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Saint Louis University; Washington University (WUSTL); Washington University (WUSTL); Harvard University; Harvard Medical School; Washington University (WUSTL); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Amarasinghe, GK (corresponding author), Washington Univ, Sch Med St Louis, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Hartman, AL (corresponding author), Univ Pittsburgh, Sch Med, Ctr Vaccine Res, Pittsburgh, PA 15260 USA.; Hartman, AL (corresponding author), Univ Pittsburgh, Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15260 USA.	gamarasinghe@wustl.edu; hartman2@pitt.edu	mishra, Nawneet/CAF-8697-2022; Ganaie, Safder/AAB-8857-2022; Ganaie, Safder/AAH-5010-2020; Doench, John G/HCI-9570-2022; Wagner, Nicole/X-5130-2018	Doench, John G/0000-0002-3707-9889; Hartman, Amy/0000-0002-0857-2973; Cole, Aidan/0000-0001-9647-0848; Albe, Joseph/0000-0001-8100-596X; McMillen, Cynthia/0000-0001-9211-7908; Moyle, Austin/0000-0002-3050-8038; Schwarz, Madeline/0000-0002-9038-4655; Wagner, Nicole/0000-0003-3980-4893	NIH [R01AI161765, R21AI163603, R01NS101100, P01AI120943, R01AI123926, R01AI107056, U19AI142784, U19AI10972505, R01AI130152, T32AI060525, T32AI106688, 1K08AI144033, R37 AI059371, R24GM136766, P41GM103422]; Burroughs Wellcome CAMS award [1013362.02]; Pediatric Infectious Diseases Society; St. Jude Children's Research Hospital Fellowship Program in Basic Research; Society for Pediatric Research Physician Scientist Bridging to Success Award; Alzheimer's Association [AARG-16-441560]; Leukemia and Lymphoma Society Scholar Award;  [R42GM1213302]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome CAMS award; Pediatric Infectious Diseases Society; St. Jude Children's Research Hospital Fellowship Program in Basic Research; Society for Pediatric Research Physician Scientist Bridging to Success Award; Alzheimer's Association(Alzheimer's Association); Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); 	We thank members of our groups for discussions and support. We also thank Drs. J. Boon, M. Diamond, and S. Khader for providing critical reagents and for discussion. We thank Dr. A. Schwartz (Washington University School of Medicine) and J. Herz (UT Southwestern) for critical discussions and for their encouragement to embark on studies on Lrp1. We also thank R. Ridings and S. Barrick for coordinating studies between WUSM and Pitt, and E.O.L. Amarasinghe and E.E.L. Amarasinghe for assistance with Figure 1. We thank the Microscopy Resources on the North Quad (MicRoN) core at Harvard Medical School for imaging and image analysis assistance. We thank Bruker for technical and instrument support, and PMI who donated the software used for deconvolution (R42GM1213302 supported the software). We also thank the Genome Engineering and iPSC Center (GEiC) at the Washington University in St. Louis for gRNA validation services. Research was supported by NIH (R01AI161765 and R21AI163603 to G.K.A and A.L.H.; R01NS101100 to A.L.H.; P01AI120943 and R01AI123926 to G.K.A.; R01AI107056 to D.W.L.; U19AI142784 and U19AI10972505 to H.W.V.; R01AI130152 to T.E.; T32AI060525 to C.M.M.; T32AI106688 and 1K08AI144033 to A.O.; R37 AI059371 to S.P.J.W.; R24GM136766 and P41GM103422 to M.L.G.). A.K.M was supported by a Burroughs Wellcome CAMS award (1013362.02). Additional support was provided by the Pediatric Infectious Diseases Society, St. Jude Children's Research Hospital Fellowship Program in Basic Research, and Society for Pediatric Research Physician Scientist Bridging to Success Award to A.O.; Alzheimer's Association (AARG-16-441560 to T.J.B); and The Leukemia and Lymphoma Society Scholar Award to T.E.	Albe JR, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007833; BLASI E, 1987, EUR J IMMUNOL, V17, P1491, DOI 10.1002/eji.1830171016; Brustolin M, 2017, MED VET ENTOMOL, V31, P365, DOI 10.1111/mve.12254; Bu GJ, 1998, TRENDS CELL BIOL, V8, P272, DOI 10.1016/S0962-8924(98)01283-5; Bu GJ, 2001, INT REV CYTOL, V209, P79; Canuel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064145; Cartwright HN, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01962; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; de Boer SM, 2012, J VIROL, V86, P13767, DOI 10.1128/JVI.01364-12; De Nardis C, 2017, J BIOL CHEM, V292, P912, DOI 10.1074/jbc.M116.758862; Dodd KA, 2012, J VIROL, V86, P4204, DOI 10.1128/JVI.07104-11; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Freiberg AN, 2008, J VIROL, V82, P10341, DOI 10.1128/JVI.01191-08; Ganaie SS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006370; Gaudreault NN, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00664; Gommet C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001421; Gonias SL, 2014, AM J PATHOL, V184, P18, DOI 10.1016/j.ajpath.2013.08.029; Hartman AL, 2014, J VIROL, V88, P2235, DOI 10.1128/JVI.02341-13; Hassan OA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001229; Heissig B, 2020, CELL SIGNAL, V75, DOI 10.1016/j.cellsig.2020.109761; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hofmann H, 2013, J VIROL, V87, P4384, DOI 10.1128/JVI.02628-12; Knipe D.M.H., 2013, PETER FIELDS VIROLOG, V6th; Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y; Kuruganti S, 2016, J BIOL CHEM, V291, P447, DOI 10.1074/jbc.M115.665943; Lazic A, 2003, BIOCHEMISTRY-US, V42, P14913, DOI 10.1021/bi035779e; Leger P, 2016, TRAFFIC, V17, P639, DOI 10.1111/tra.12393; Lozach PY, 2011, CELL HOST MICROBE, V10, P75, DOI 10.1016/j.chom.2011.06.007; Madani TA, 2003, CLIN INFECT DIS, V37, P1084, DOI 10.1086/378747; McMillen CM, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau9812; Migliorini MM, 2003, J BIOL CHEM, V278, P17986, DOI 10.1074/jbc.M212592200; Munyua P, 2010, AM J TROP MED HYG, V83, P58, DOI 10.4269/ajtmh.2010.09-0292; Neels JG, 1999, J BIOL CHEM, V274, P31305, DOI 10.1074/jbc.274.44.31305; Odendaal L, 2020, VET PATHOL, V57, P66, DOI 10.1177/0300985819882633; Orvedahl A, 2019, P NATL ACAD SCI USA, V116, P16497, DOI 10.1073/pnas.1822157116; Persson H, 2013, J MOL BIOL, V425, P803, DOI 10.1016/j.jmb.2012.11.037; Phoenix I, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050149; Poirier S, 2015, CELL REP, V13, P2064, DOI 10.1016/j.celrep.2015.11.006; Potere N, 2019, FRONT CARDIOVASC MED, V6, DOI 10.3389/fcvm.2019.00051; Prasad JM, 2015, J BIOL CHEM, V290, P17262, DOI 10.1074/jbc.M115.660084; Rauch JN, 2020, NATURE, V580, P381, DOI 10.1038/s41586-020-2156-5; Riblett AM, 2016, J VIROL, V90, P1414, DOI 10.1128/JVI.02055-15; Rich KM, 2010, AM J TROP MED HYG, V83, P52, DOI 10.4269/ajtmh.2010.09-0291; Rusu M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00254; Scharton D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116722; Stansley B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-115; Turell MJ, 2013, J MED ENTOMOL, V50, P1111, DOI 10.1603/ME13049; Turell MJ, 2008, J AM MOSQUITO CONTR, V24, P502, DOI 10.2987/08-5791.1; Williams GD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02886-w; World Health Organization, 2018, WORKSH PRIOR PATH; Wu Y, 2017, P NATL ACAD SCI USA, V114, pE7564, DOI 10.1073/pnas.1705176114; Xu W, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15576; Zhang R, 2018, NATURE, V557, P570, DOI 10.1038/s41586-018-0121-3	54	10	10	3	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 30	2021	184	20					5163	+		10.1016/j.cell.2021.09.001	http://dx.doi.org/10.1016/j.cell.2021.09.001		OCT 2021	40	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	WC7PG	34559985	Green Accepted, Bronze			2022-12-28	WOS:000704445700012
J	Zhang, KH; Julius, D; Cheng, YF				Zhang, Kaihua; Julius, David; Cheng, Yifan			Structural snapshots of TRPV1 reveal mechanism of polymodal functionality	CELL			English	Article							CAPSAICIN RECEPTOR; ION-CHANNEL; CRYO-EM; SELECTIVITY; ACTIVATION; LIGAND; VISUALIZATION; PREDICTION	Many transient receptor potential (TRP) channels respond to diverse stimuli and conditionally conduct small and large cations. Such functional plasticity is presumably enabled by a uniquely dynamic ion selectivity filter that is regulated by physiological agents. What is currently missing is a ''photo series" of intermediate structural states that directly address this hypothesis and reveal specific mechanisms behind such dynamic channel regulation. Here, we exploit cryoelectron microscopy (cryo-EM) to visualize conformational transitions of the capsaicin receptor, TRPV1, as a model to understand how dynamic transitions of the selectivity filter in response to algogenic agents, including protons, vanilloid agonists, and peptide toxins, permit permeation by small and large organic cations. These structures also reveal mechanisms governing ligand binding sub-states, as well as allosteric coupling between key sites that are proximal to the selectivity filter and cytoplasmic gate. These insights suggest a general framework for understanding how TRP channels function as polymodal signal integrators.	[Zhang, Kaihua; Cheng, Yifan] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Julius, David] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Cheng, Yifan] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Cheng, YF (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.; Julius, D (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA.; Cheng, YF (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	david.julius@ucsf.edu; yifan.cheng@ucsf.edu	Zhang, Kaihua/AAD-7882-2022	Zhang, Kaihua/0000-0003-3734-3624; Cheng, Yifan/0000-0001-9535-0369	NIH [S10OD020054, S10OD021741, R35NS105038, 1R35GM140847]; Human Frontier Science Program Postdoctoral Fellowship	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program Postdoctoral Fellowship(Human Frontier Science Program)	We thank Dr. Alexander Myasnikov for help in optimizing cryo-EM data collection during the initial stage of this project, Dr. Junrui Li for computational support, and Dr. Kenton Swartz andmembers of the Cheng and Julius laboratories for helpful discussions. The UCSF cryo-EM facility is managed by Dr. David Bulkley and Mr. Glenn Gilbert. Cryo-EM equipment at UCSF is partially supported by NIH (S10OD020054, S10OD021741). This work was supported by a Human Frontier Science Program Postdoctoral Fellowship (K.Z.), and NIH grants (R35NS105038 to D.J. and 1R35GM140847 to Y.C.). Y.C. is an investigator of Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Ahern GP, 2005, J NEUROSCI, V25, P5109, DOI 10.1523/JNEUROSCI.0237-05.2005; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Aneiros E, 2011, EMBO J, V30, P994, DOI 10.1038/emboj.2011.19; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bean BP, 2015, NAT NEUROSCI, V18, P1534, DOI 10.1038/nn.4148; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; BEVAN S, 1994, TRENDS NEUROSCI, V17, P509, DOI 10.1016/0166-2236(94)90149-X; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chung MK, 2008, NAT NEUROSCI, V11, P555, DOI 10.1038/nn.2102; Croll TI, 2018, ACTA CRYSTALLOGR D, V74, P519, DOI 10.1107/S2059798318002425; Dang SY, 2019, P NATL ACAD SCI USA, V116, P8869, DOI 10.1073/pnas.1820323116; Dang SY, 2017, NATURE, V552, P426, DOI 10.1038/nature25024; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Deng ZQ, 2020, NAT STRUCT MOL BIOL, V27, P635, DOI 10.1038/s41594-020-0428-2; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Geron M, 2018, P NATL ACAD SCI USA, V115, pE11837, DOI 10.1073/pnas.1809662115; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; van Goor MK, 2020, PROTEIN SCI, V29, P1569, DOI 10.1002/pro.3861; Grinkova YV, 2010, PROTEIN ENG DES SEL, V23, P843, DOI 10.1093/protein/gzq060; Guskov A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13420; Hazan A, 2015, SCI REP-UK, V5, DOI 10.1038/srep12278; Hughes TET, 2019, ELIFE, V8, DOI 10.7554/eLife.49572; Hui KK, 2003, BIOPHYS J, V84, P2957, DOI 10.1016/S0006-3495(03)70022-8; Huynh KW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11130; Janssens A, 2011, J PHYSIOL-LONDON, V589, P4827, DOI 10.1113/jphysiol.2011.216523; Jara-Oseguera A, 2019, ELIFE, V8, DOI 10.7554/eLife.51212; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; King JVL, 2019, CELL, V178, P1362, DOI 10.1016/j.cell.2019.07.014; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McGoldrick LL, 2018, NATURE, V553, P233, DOI 10.1038/nature25182; Munns CH, 2015, J BIOL CHEM, V290, P5707, DOI 10.1074/jbc.M114.597435; Nadezhdin KD, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22507-3; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pumroy RA, 2019, ELIFE, V8, DOI 10.7554/eLife.48792; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Puopolo M, 2013, J NEUROPHYSIOL, V109, P1704, DOI 10.1152/jn.00012.2013; Rohacs T, 2015, PFLUG ARCH EUR J PHY, V467, P1851, DOI 10.1007/s00424-015-1695-3; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Ryu SJ, 2007, J NEUROSCI, V27, P12797, DOI 10.1523/JNEUROSCI.2324-07.2007; Scheres SHW, 2020, ACTA CRYSTALLOGR D, V76, P94, DOI 10.1107/S2059798319016577; SINE SM, 1991, J BIOL CHEM, V266, P19369; Singh AK, 2018, NAT STRUCT MOL BIOL, V25, P805, DOI 10.1038/s41594-018-0108-7; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; Susankova K, 2007, J NEUROSCI, V27, P7578, DOI 10.1523/JNEUROSCI.1956-07.2007; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Wisedchaisri G, 2019, CELL, V178, P993, DOI 10.1016/j.cell.2019.06.031; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhao JH, 2020, NATURE, V585, P141, DOI 10.1038/s41586-020-2480-9; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhou WC, 2022, NEUROCHEM RES, V47, P163, DOI 10.1007/s11064-021-03253-w; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166; Zubcevic L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07117-w; Zubcevic L, 2018, NAT STRUCT MOL BIOL, V25, P405, DOI 10.1038/s41594-018-0059-z; Zubcevic L, 2016, NAT STRUCT MOL BIOL, V23, P180, DOI 10.1038/nsmb.3159	70	34	34	29	117	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 30	2021	184	20					5138	+		10.1016/j.cell.2021.08.012	http://dx.doi.org/10.1016/j.cell.2021.08.012		OCT 2021	25	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	WC7PG	34496225	Bronze, Green Accepted			2022-12-28	WOS:000704445700010
J	Rossi, L				Rossi, Laura			What my coach gave me	SCIENCE			English	Editorial Material									[Rossi, Laura] Delft Univ Technol, Delft, Netherlands	Delft University of Technology	Rossi, L (corresponding author), Delft Univ Technol, Delft, Netherlands.		Rossi, Laura/C-3282-2012	Rossi, Laura/0000-0002-0215-5386					0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2021	373	6562			SI		1546	1546						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU7LJ	34554767				2022-12-28	WOS:000698977800057
J	Zahn, LM				Zahn, Laura M.			THE HUMAN GENOME A RESEARCH ULTRAMARATHON	SCIENCE			English	Editorial Material																			0	2	3	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2021	373	6562			SI		1458	1459						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU7LJ	34554809				2022-12-28	WOS:000698977800039
J	Dyer, O				Dyer, Owen			Covid-19: Rich countries' booster plans will impede global vaccination, experts say	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, INDIAN CIVIL SOC LET; Gennari P, 2021, TRACKING PROGR FOOD; Wise J, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2261	3	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2021	374								n2353	10.1136/bmj.n2353	http://dx.doi.org/10.1136/bmj.n2353			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ1JE	34556471	Bronze			2022-12-28	WOS:000701967300009
J	Mahase, E				Mahase, Elisabeth			Overprescribing: 10% of items dispensed in primary care are inappropriate, review finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 22	2021	374								n2338	10.1136/bmj.n2338	http://dx.doi.org/10.1136/bmj.n2338			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WQ2LU	34551935				2022-12-28	WOS:000713652600005
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Vaccinating children will help end pandemic, says minister	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci G, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2180	1	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2021	374								n2254	10.1136/bmj.n2254	http://dx.doi.org/10.1136/bmj.n2254			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WP7CH	34521631	Bronze			2022-12-28	WOS:000713284400005
J	Bertagnolli, MM; Singh, H				Bertagnolli, Monica M.; Singh, Harpreet			Treatment of Older Adults with Cancer - Addressing Gaps in Evidence	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Treatment of Older Adults with Cancer Older adults with cancer are underrepresented in clinical research. Because of insufficient data, such patients and their physicians must make life-altering treatment decisions without adequate evidence-based guidance.	[Bertagnolli, Monica M.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Singh, Harpreet] US FDA, Silver Spring, MD USA	Harvard University; Brigham & Women's Hospital; US Food & Drug Administration (FDA)	Bertagnolli, MM (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.							Javid SH, 2012, ONCOLOGIST, V17, P1180, DOI 10.1634/theoncologist.2011-0384; Medicine Io, 2013, DELIVERING HIGH QUAL; Muss HB, 2009, NEW ENGL J MED, V360, P2055, DOI 10.1056/NEJMoa0810266; Sarfati D, 2016, CA-CANCER J CLIN, V66, P338, DOI 10.3322/caac.21342; Singh H, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.10009	5	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2021	385	12					1062	1065		10.1056/NEJMp2106089	http://dx.doi.org/10.1056/NEJMp2106089		SEP 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UQ4IT	34506087				2022-12-28	WOS:000694804100001
J	Jaffe, S				Jaffe, Susan			New 9/11 casualties strain health-care programme	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 11	2021	398	10304					942	943		10.1002/ajim.23278	http://dx.doi.org/10.1002/ajim.23278			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UP1FQ	34509221	Green Published			2022-12-28	WOS:000695130500007
J	Singh, S; Vanden Broeck, A; Miller, L; Chaker-Margot, M; Klinge, S				Singh, Sameer; Vanden Broeck, Arnaud; Miller, Linamarie; Chaker-Margot, Malik; Klinge, Sebastian			Nucleolar maturation of the human small subunit processome	SCIENCE			English	Article							PRE-RIBOSOMAL-RNA; CRYO-EM STRUCTURE; BIOGENESIS; GENE; VISUALIZATION; ORIENTATION; PRECURSORS; RESOLUTION	The human small subunit processome mediates early maturation of the small ribosomal subunit by coupling RNA folding to subsequent RNA cleavage and processing steps. We report the high-resolution cryo-electron microscopy structures of maturing human small subunit (SSU) processomes at resolutions of 2.7 to 3.9 angstroms. These structures reveal the molecular mechanisms that enable crucial progressions during SSU processome maturation. RNA folding states within these particles are communicated to and coordinated with key enzymes that drive irreversible steps such as targeted exosome-mediated RNA degradation, protein-guided site-specific endonucleolytic RNA cleavage, and tightly controlled RNA unwinding. These conserved mechanisms highlight the SSU processome's impressive structural plasticity, which endows this 4.5-megadalton nucleolar assembly with the distinctive ability to mature the small ribosomal subunit from within.	[Singh, Sameer; Vanden Broeck, Arnaud; Miller, Linamarie; Chaker-Margot, Malik; Klinge, Sebastian] Rockefeller Univ, Lab Prot & Nucle Acid Chem, New York, NY 10065 USA; [Miller, Linamarie; Chaker-Margot, Malik] Rockefeller Univ, Triinst Training Program Chem Biol, New York, NY 10065 USA; [Chaker-Margot, Malik] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	Rockefeller University; Rockefeller University; University of Basel	Vanden Broeck, A; Klinge, S (corresponding author), Rockefeller Univ, Lab Prot & Nucle Acid Chem, New York, NY 10065 USA.	avanden@rockefeller.edu; klinge@rockefeller.edu		Singh, Sameer/0000-0001-6140-5501; Vanden Broeck, Arnaud/0000-0003-0930-4249; Miller, Linamarie/0000-0001-6680-1810	EMBO long-term fellowship [ALTF 711-2019]; NIH [1DP2GM123459]	EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	A.V.B. is supported by an EMBO long-term fellowship (ALTF 711-2019). S.K. is supported by a NIH New Innovator Award (1DP2GM123459).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Ameismeier M, 2020, NATURE, V587, P683, DOI 10.1038/s41586-020-2929-x; Ameismeier M, 2018, NATURE, V558, P249, DOI 10.1038/s41586-018-0193-0; Armistead J, 2009, AM J HUM GENET, V84, P728, DOI 10.1016/j.ajhg.2009.04.017; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Badertscher L, 2015, CELL REP, V13, P2879, DOI 10.1016/j.celrep.2015.11.061; Barandun J, 2017, NAT STRUCT MOL BIOL, V24, P944, DOI 10.1038/nsmb.3472; Bohnsack KE, 2019, EMBO J, V38, DOI 10.15252/embj.2018100278; Boneberg FM, 2019, RNA, V25, P685, DOI 10.1261/rna.069609.118; Buchan DWA, 2019, NUCLEIC ACIDS RES, V47, pW402, DOI 10.1093/nar/gkz297; Casanal A, 2020, PROTEIN SCI, V29, P1069, DOI 10.1002/pro.3791; Chagnon P, 2002, AM J HUM GENET, V71, P1443, DOI 10.1086/344580; Chaker-Margot M, 2017, SCIENCE, V355, DOI 10.1126/science.aal1880; Chaker-Margot M, 2015, NAT STRUCT MOL BIOL, V22, P920, DOI 10.1038/nsmb.3111; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Cheng JD, 2020, SCIENCE, V369, P1470, DOI 10.1126/science.abb4119; Cheng JD, 2019, MOL CELL, V75, P1256, DOI 10.1016/j.molcel.2019.06.032; Cheng JD, 2017, NAT STRUCT MOL BIOL, V24, P954, DOI 10.1038/nsmb.3476; Choudhury P, 2019, RNA BIOL, V16, P54, DOI 10.1080/15476286.2018.1556149; Concordet JP, 2018, NUCLEIC ACIDS RES, V46, pW242, DOI 10.1093/nar/gky354; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; Du YF, 2020, SCIENCE, V369, P1477, DOI 10.1126/science.aba9690; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farley-Barnes KI, 2019, TRENDS GENET, V35, P754, DOI 10.1016/j.tig.2019.07.004; Farley-Barnes KI, 2018, CELL REP, V22, P1923, DOI 10.1016/j.celrep.2018.01.056; Flygare J, 2007, BLOOD, V109, P980, DOI 10.1182/blood-2006-07-038232; Heymann JB, 2018, PROTEIN SCI, V27, P159, DOI 10.1002/pro.3293; Hunziker M, 2019, ELIFE, V8, DOI 10.7554/eLife.45185; KASS S, 1987, MOL CELL BIOL, V7, P2891, DOI 10.1128/MCB.7.8.2891; Kim JH, 2018, NUCLEIC ACIDS RES, V46, P6712, DOI 10.1093/nar/gky442; Knight JRP, 2013, NUCLEIC ACIDS RES, V41, P4185, DOI 10.1093/nar/gkt129; Kornprobst M, 2016, CELL, V166, P380, DOI 10.1016/j.cell.2016.06.014; Lafontaine DLJ, 2021, NAT REV MOL CELL BIO, V22, P165, DOI 10.1038/s41580-020-0272-6; Lau B, 2021, MOL CELL, V81, P293, DOI 10.1016/j.molcel.2020.11.009; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Maeda N, 2006, BIOCHEM BIOPH RES CO, V339, P41, DOI 10.1016/j.bbrc.2005.10.184; Marneros AG, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003573; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; MICHOT B, 1991, EUR J BIOCHEM, V195, P601, DOI 10.1111/j.1432-1033.1991.tb15743.x; Natchiar SK, 2017, NATURE, V551, P472, DOI 10.1038/nature24482; Paolini NA, 2017, AM J HUM GENET, V100, P506, DOI 10.1016/j.ajhg.2017.01.034; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Pfab J, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2017525118; Popenda M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks339; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Roychowdhury A, 2019, NUCLEIC ACIDS RES, V47, P7548, DOI 10.1093/nar/gkz529; Schrodinger LLC, 2017, PYMOL MOL GRAPHICS S; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sondalle SB, 2014, BBA-MOL BASIS DIS, V1842, P758, DOI 10.1016/j.bbadis.2013.11.004; Sun Q, 2017, ELIFE, V6, DOI 10.7554/eLife.22086; Tafforeau L, 2013, MOL CELL, V51, P539, DOI 10.1016/j.molcel.2013.08.011; Tan YZ, 2017, NAT METHODS, V14, P793, DOI [10.1038/NMETH.4347, 10.1038/nmeth.4347]; Taoka M, 2018, NUCLEIC ACIDS RES, V46, P9289, DOI 10.1093/nar/gky811; Terwilliger TC, 2020, NAT METHODS, V17, P923, DOI 10.1038/s41592-020-0914-9; Thoms M, 2015, CELL, V162, P1029, DOI 10.1016/j.cell.2015.07.060; Ulirsch JC, 2018, AM J HUM GENET, V103, P930, DOI 10.1016/j.ajhg.2018.10.027; Wagner T, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0437-z; Wasmuth EV, 2017, NUCLEIC ACIDS RES, V45, P846, DOI 10.1093/nar/gkw1152; Watkins NJ, 2012, WIRES RNA, V3, P397, DOI 10.1002/wrna.117; Webb B, 2021, METHODS MOL BIOL, V2199, P239, DOI 10.1007/978-1-0716-0892-0_14; Wells GR, 2016, NUCLEIC ACIDS RES, V44, P5399, DOI 10.1093/nar/gkw213; Yang JY, 2020, P NATL ACAD SCI USA, V117, P1496, DOI 10.1073/pnas.1914677117; Yao RW, 2019, MOL CELL, V76, P767, DOI 10.1016/j.molcel.2019.08.014; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang LM, 2016, GENE DEV, V30, P718, DOI 10.1101/gad.274688.115; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhu JY, 2016, MOL CELL BIOL, V36, P965, DOI 10.1128/MCB.00773-15; Zivanov J, 2020, IUCRJ, V7, P253, DOI 10.1107/S2052252520000081; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	76	15	15	3	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2021	373	6560							eabj5338	10.1126/science.abj5338	http://dx.doi.org/10.1126/science.abj5338			59	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UP5RB	34516797	Green Accepted			2022-12-28	WOS:000695436000023
J	Romain, J; Carey, G				Romain, Jonathan; Carey, George			There is nothing holy about agony: religious people and leaders support assisted dying too	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Romain, Jonathan] Maidenhead Synagogue, Maidenhead, Berks, England; [Romain, Jonathan; Carey, George] Dign Dying, London, England; [Carey, George] Clifton, Clifton, NJ 07013 USA		Carey, G (corresponding author), Dign Dying, London, England.; Carey, G (corresponding author), Clifton, Clifton, NJ 07013 USA.	carey.george01@gmail.com						Gregory Andrew, 2021, SUNDAY TIMES; Oregon Health Authority, OR DEATH DIGN ACT 20; Yonder Consulting, LARG EV POLL ASS DYI	3	9	9	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2021	374								n2094	10.1136/bmj.n2094	http://dx.doi.org/10.1136/bmj.n2094			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ3VV	34497050				2022-12-28	WOS:000702137100002
J	Bentham, R; Litchfield, K; Watkins, TBK; Lim, EL; Rosenthal, R; Martinez-Ruiz, C; Hiley, CT; Al Bakir, M; Salgado, R; Moore, DA; Jamal-Hanjani, M; Swanton, C; McGranahan, N				Bentham, Robert; Litchfield, Kevin; Watkins, Thomas B. K.; Lim, Emilia L.; Rosenthal, Rachel; Martinez-Ruiz, Carlos; Hiley, Crispin T.; Al Bakir, Maise; Salgado, Roberto; Moore, David A.; Jamal-Hanjani, Mariam; Swanton, Charles; McGranahan, Nicholas		TRACERx Consortium	Using DNA sequencing data to quantify T cell fraction and therapy response	NATURE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; COPY NUMBER; GENOMIC CHARACTERIZATION; MUTATIONAL LANDSCAPE; BRANCHED EVOLUTION; CTLA-4 BLOCKADE; PD-1 BLOCKADE; HETEROGENEITY; ARCHITECTURE; IPILIMUMAB	The immune microenvironment influences tumour evolution and can be both prognostic and predict response to immunotherapy(1,2). However, measurements of tumour infiltrating lymphocytes (TI Ls) are limited by a shortage of appropriate data. Whole-exome sequencing (WES) of DNA is frequently performed to calculate tumour mutational burden and identify actionable mutations. Here we develop T cell exome TREC tool (T cell ExTRECT), a method for estimation ofT cell fraction from WES samples using a signal from T cell receptor excision circle (TREC) loss during V(D)J recombination of the T cell receptor-alpha gene (TCRA (also known as TRA)). TCRA T cell fraction correlates with orthogonal TIL estimates and is agnosticto sample type. Blood TCRA T cell fraction is higher in females than in males and correlates with both tumour immune infiltrate and presence of bacterial sequencing reads. Tumour TCRA T cell fraction is prognostic in lung adenocarcinoma. Using a meta-analysis of tumour streated with immunotherapy, we show that tumour TCRA T cell fraction predicts immunotherapy response, providing value beyond measuring tumour mutational burden. Applying T cell ExTRECT to a multi-sample pan-cancer cohort reveals a high diversity of the degree of immune infiltration within tumours. Subclonal loss of 12q24.31-32, encompassing SPPL3, is associated with reduced TCRA T cell fraction. T cell ExTRECT provides a cost-effective technique to characterize immune infiltrate alongside somatic changes.	[Bentham, Robert; Martinez-Ruiz, Carlos; McGranahan, Nicholas] UCL, Canc Res UK Lung Canc Ctr Excellence, Canc Genome Evolut Res Grp, Canc Inst, London, England; [Bentham, Robert; Litchfield, Kevin; Lim, Emilia L.; Martinez-Ruiz, Carlos; Hiley, Crispin T.; Moore, David A.; Jamal-Hanjani, Mariam; Swanton, Charles; McGranahan, Nicholas] UCL, Canc Res UK Lung Canc Ctr Excellence, Canc Inst, London, England; [Litchfield, Kevin] UCL, Canc Res UK Lung Canc Ctr Excellence, Tumour Immunogen & Immunosurveillance Lab, Canc Inst, London, England; [Watkins, Thomas B. K.; Lim, Emilia L.; Rosenthal, Rachel; Hiley, Crispin T.; Al Bakir, Maise; Swanton, Charles] Francis Crick Inst, Canc Evolut & Genome Instabil Lab, London, England; [Salgado, Roberto] GZA ZNA, Dept Pathol, Antwerp, Belgium; [Salgado, Roberto] Univ Melbourne, Peter MacCallum Canc Ctr, Div Res, Melbourne, Vic, Australia; [Moore, David A.] Univ Coll London Hosp, Dept Cellular Pathol, London, England; [Moore, David A.; Jamal-Hanjani, Mariam; Swanton, Charles] Univ Coll London Hosp, Dept Med Oncol, London, England; [Jamal-Hanjani, Mariam] UCL, Canc Metastasis Lab, Canc Inst, London, England	Cancer Research UK; University of London; University College London; Cancer Research UK; University of London; University College London; Cancer Research UK; University of London; University College London; Francis Crick Institute; Peter Maccallum Cancer Center; University of Melbourne; University College London Hospitals NHS Foundation Trust; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London	McGranahan, N (corresponding author), UCL, Canc Res UK Lung Canc Ctr Excellence, Canc Genome Evolut Res Grp, Canc Inst, London, England.; McGranahan, N (corresponding author), UCL, Canc Res UK Lung Canc Ctr Excellence, Canc Inst, London, England.	nicholas.mcgranahan.10@ucl.ac.uk	Aerts, Hugo/ABF-2821-2020; Tanic, Miljana/A-5458-2014; McGranahan, Nicholas/ABD-6561-2021; Demeulemeester, Jonas/J-6130-2014; Wilson, Claire/Q-8626-2017; Ottensmeier, Christian/E-8131-2012; Black, James/I-2283-2017	Aerts, Hugo/0000-0002-2122-2003; Tanic, Miljana/0000-0003-3102-776X; McGranahan, Nicholas/0000-0001-9537-4045; Demeulemeester, Jonas/0000-0002-2660-2478; Swanton, Charles/0000-0002-4299-3018; Gimeno Valiente, Francisco/0000-0003-0544-9459; Wilson, Claire/0000-0002-6401-2014; Litchfield, Kevin/0000-0002-3725-0914; Hynds, Robert/0000-0002-2170-8791; Edwards, John/0000-0002-7935-5327; Marrone, Domenic/0000-0003-2058-1693; Escudero, Mickael/0000-0002-1336-815X; Ottensmeier, Christian/0000-0003-3619-1657; Navani, Neal/0000-0002-6412-7516; Middleton, Gary/0000-0001-5695-3474; Pearce, David/0000-0001-8443-2924; Lowe, Helen/0000-0001-8630-378X; READING, JAMES/0000-0001-5381-978X; Black, James/0000-0001-5598-7752; Herrero, Javier/0000-0001-7313-717X; Johnson, Diana/0000-0003-0479-1228	NIHR BRC at University College London Hospitals - UK Medical Research Council [MR/P014712/1, MR/V033077/1]; Rosetrees Trust and Cotswold Trust [A2437]; Cancer Research UK [C11496/A17786]; Francis Crick Institute; UK Medical Research Council [FC001169]; Wellcome Trust; Marie Curie ITN Project PLOIDYNET [607722]; Breast Cancer Research Foundation (BCRF); Royal Society Research Professorships Enhancement Award [RP/EA/180007]; Foulkes Foundation; NovoNordisk Foundation [ID16584]; Rosetrees; NIHR BRC at University College London Hospitals; National Institute for Health Research; Rosetrees Trust; NIHR University College London Hospitals Biomedical Research Centre - Wellcome Trust; Royal Society [211179/Z/18/Z]; CRUK University College London Experimental Cancer Medicine Centre; Royal Society Napier Research Professor; Wellcome Trust - Cancer Research UK; (CRUK Cancer Immunotherapy Catalyst Network); Cancer Research UK Lung Cancer Centre of Excellence; Stoneygate Trusts; CRUK-UCL Centre, Experimental Cancer Medicine Centre; Stand Up To Cancer-LUNGevity-American Lung Association Lung Cancer Interception Dream Team Translational Research Grant [SU2C-AACR-DT23-17]; Stand Up To Cancer is a program of the Entertainment Industry Foundation; Scientific Partner of SU2C; European Research Council (ERC) under the European Union [FP7-THESEUS-617844]; European Commission ITN [607722]; ERC Advanced Grant (PROTEUS) from the European Research Council under the European Union [835297]; European Union [665233, NCT01888601]; University College London [UCL/12/0279, 13/LO/1546]; UCL Cancer Trials Centre; National Human Genome Research Institute; Medical Research Council [MR/L016311/1]; High-Performance Computing at the Francis Crick Institute; UCL Department of Computer Science Cluster; CRUK City of London Centre Award [C7893/A26233]; Bristol-Myers Squibb - Merck and Co.	NIHR BRC at University College London Hospitals - UK Medical Research Council; Rosetrees Trust and Cotswold Trust; Cancer Research UK(Cancer Research UK); Francis Crick Institute; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Marie Curie ITN Project PLOIDYNET; Breast Cancer Research Foundation (BCRF); Royal Society Research Professorships Enhancement Award; Foulkes Foundation; NovoNordisk Foundation(Novo Nordisk FoundationNovocure Limited); Rosetrees(Rosetrees Trust); NIHR BRC at University College London Hospitals; National Institute for Health Research(National Institute for Health Research (NIHR)); Rosetrees Trust(Rosetrees Trust); NIHR University College London Hospitals Biomedical Research Centre - Wellcome Trust; Royal Society(Royal Society of London); CRUK University College London Experimental Cancer Medicine Centre; Royal Society Napier Research Professor; Wellcome Trust - Cancer Research UK(Wellcome TrustCancer Research UK); (CRUK Cancer Immunotherapy Catalyst Network); Cancer Research UK Lung Cancer Centre of Excellence; Stoneygate Trusts; CRUK-UCL Centre, Experimental Cancer Medicine Centre; Stand Up To Cancer-LUNGevity-American Lung Association Lung Cancer Interception Dream Team Translational Research Grant; Stand Up To Cancer is a program of the Entertainment Industry Foundation; Scientific Partner of SU2C; European Research Council (ERC) under the European Union(European Research Council (ERC)); European Commission ITN; ERC Advanced Grant (PROTEUS) from the European Research Council under the European Union; European Union(European Commission); University College London(General Electric); UCL Cancer Trials Centre; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); High-Performance Computing at the Francis Crick Institute; UCL Department of Computer Science Cluster; CRUK City of London Centre Award; Bristol-Myers Squibb - Merck and Co.	R.B. is supported by the NIHR BRC at University College London Hospitals. K.L. is funded by the UK Medical Research Council (MR/P014712/1 and MR/V033077/1), Rosetrees Trust and Cotswold Trust (A2437) and Cancer Research UK (C69256/A30194). T.B.K.W. is supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001169), the UK Medical Research Council (FC001169) and the Wellcome Trust (FC001169) as well as the Marie Curie ITN Project PLOIDYNET (FP7-PEOPLE-2013, 607722), Breast Cancer Research Foundation (BCRF), Royal Society Research Professorships Enhancement Award (RP/EA/180007) and the Foulkes Foundation. E.L.L. receives funding from NovoNordisk Foundation (ID 16584). R.R. is supported by Royal Society Research Professorships Enhancement Award (RP/EA/180007). C.M.-R. is supported by Rosetrees. C.T.H. is supported by the NIHR BRC at University College London Hospitals. M.J.-H. has received funding from Cancer Research UK, National Institute for Health Research, Rosetrees Trust, UKI NETs and NIHR University College London Hospitals Biomedical Research Centre. N.M. is a Sir Henry Dale Fellow, jointly funded by the Wellcome Trust and the Royal Society (Grant Number 211179/Z/18/Z) and also receives funding from Cancer Research UK, Rosetrees and the NIHR BRC at University College London Hospitals and the CRUK University College London Experimental Cancer Medicine Centre. C.S. is a Royal Society Napier Research Professor. His work was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001169), the UK Medical Research Council (FC001169) and the Wellcome Trust (FC001169). C.S. is funded by Cancer Research UK (TRACERx, PEACE and CRUK Cancer Immunotherapy Catalyst Network), Cancer Research UK Lung Cancer Centre of Excellence, the Rosetrees Trust, Butterfield and Stoneygate Trusts, NovoNordisk Foundation (ID16584), Royal Society Research Professorships Enhancement Award (RP/EA/180007), the NIHR BRC at University College London Hospitals, the CRUK-UCL Centre, Experimental Cancer Medicine Centre and the Breast Cancer Research Foundation (BCRF). This research is supported by a Stand Up To Cancer-LUNGevity-American Lung Association Lung Cancer Interception Dream Team Translational Research Grant (SU2C-AACR-DT23-17). Stand Up To Cancer is a program of the Entertainment Industry Foundation. Research grants are administered by the American Association for Cancer Research, the Scientific Partner of SU2C. C.S. also receives funding from the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013) Consolidator Grant (FP7-THESEUS-617844), European Commission ITN (FP7-PloidyNet 607722), an ERC Advanced Grant (PROTEUS) from the European Research Council under the European Union's Horizon 2020 research and innovation programme (835297) and Chromavision from the European Union's Horizon 2020 research and innovation programme (665233). The TRACERx study (Clinicaltrials.gov no: NCT01888601) is sponsored by University College London (UCL/12/0279) and has been approved by an independent Research Ethics Committee (13/LO/1546). TRACERx is funded by Cancer Research UK (C11496/A17786) and coordinated through the Cancer Research UK and UCL Cancer Trials Centre. The results published here are based in part on data generated by The Cancer Genome Atlas pilot project established by the NCI and the National Human Genome Research Institute.; The data were retrieved through the database of Genotypes and Phenotypes (dbGaP) authorization (accession number phs000178.v9.p8). Information about TCGA and the constituent investigators and institutions of the TCGA research network can be found at http://cancergenome.nih.gov/.This project was enabled through access to the MRC eMedLab Medical Bioinformatics infrastructure, supported by the Medical Research Council (MR/L016311/1). In particular, we acknowledge the support of the High-Performance Computing at the Francis Crick Institute as well as the UCL Department of Computer Science Cluster and the support team. In addition, this work was supported by the CRUK City of London Centre Award (C7893/A26233). We thank all investigators, funders and industry partners that supported the generation of the data within this study, as well as patients for their participation. Specifically, we thank Merck & Co, Genentech and Bristol-Myers Squibb for generating the industry datasets used in this study, and E. Van Allen, L. Diaz, T. A. Chan, L. A. Garraway, R. S. Lo, D. F. Bajorin, D. Schadendorf, T. Powles, S.-H. Lee, A. Ribas and S. Ogawa for academic datasets. This work has been funded by Merck and Co. We gratefully acknowledge the patients and their families, the investigators and site personnel who participated in the KEYNOTE-001, -006, -012 and -028 studies.	AbdulJabbar K, 2020, NAT MED, V26, P1054, DOI 10.1038/s41591-020-0900-x; Aran D, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1349-1; Brastianos PK, 2015, CANCER DISCOV, V5, P1164, DOI 10.1158/2159-8290.CD-15-0369; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; Capone I, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00552; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Conforti F, 2021, CLIN CANCER RES, V27, P4311, DOI 10.1158/1078-0432.CCR-21-0136; Cristescu R, 2018, SCIENCE, V362, P197, DOI 10.1126/science.aar3593; Danaher P, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0367-1; Davoli T, 2017, SCIENCE, V355, DOI 10.1126/science.aaf8399; Denkert C, 2016, MODERN PATHOL, V29, P1155, DOI 10.1038/modpathol.2016.109; Favero F, 2015, ANN ONCOL, V26, P64, DOI 10.1093/annonc/mdu479; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Ghandi M, 2019, NATURE, V569, P503, DOI 10.1038/s41586-019-1186-3; Goodman AM, 2017, MOL CANCER THER, V16, P2598, DOI 10.1158/1535-7163.MCT-17-0386; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Harbst K, 2016, CANCER RES, V76, P4765, DOI 10.1158/0008-5472.CAN-15-3476; Hendry S, 2017, ADV ANAT PATHOL, V24, P235, DOI 10.1097/PAP.0000000000000162; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Jongsma MLM, 2021, IMMUNITY, V54, P132, DOI 10.1016/j.immuni.2020.11.003; Kuchenbecker L, 2015, BIOINFORMATICS, V31, P2963, DOI 10.1093/bioinformatics/btv309; Lamy P, 2016, CANCER RES, V76, P5894, DOI 10.1158/0008-5472.CAN-16-0436; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Levy E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30064; Li TW, 2017, CANCER RES, V77, pE108, DOI 10.1158/0008-5472.CAN-17-0307; Litchfield K, 2021, CELL, V184, P596, DOI 10.1016/j.cell.2021.01.002; Lopez S, 2020, NAT GENET, V52, P283, DOI 10.1038/s41588-020-0584-7; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; McDermott DF, 2018, NAT MED, V24, P749, DOI 10.1038/s41591-018-0053-3; Messaoudene M, 2019, ANN ONCOL, V30, P934, DOI 10.1093/annonc/mdz112; Middleton G, 2020, NATURE, V583, P807, DOI 10.1038/s41586-020-2481-8; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Poore GD, 2020, NATURE, V579, P567, DOI 10.1038/s41586-020-2095-1; Racle J, 2017, ELIFE, V6, DOI 10.7554/eLife.26476; Riaz N, 2017, CELL, V171, P934, DOI 10.1016/j.cell.2017.09.028; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Rosenthal R, 2019, NATURE, V567, P479, DOI 10.1038/s41586-019-1032-7; Savas P, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002204; Schadendorf D, 2015, J CLIN ONCOL, V33, P1889, DOI 10.1200/JCO.2014.56.2736; Schwartz LH, 2016, EUR J CANCER, V62, P132, DOI 10.1016/j.ejca.2016.03.081; Seshan V., 2015, DEP EPIDEMIOLOGY BIO, V50; Shim JH, 2020, ANN ONCOL, V31, P902, DOI 10.1016/j.annonc.2020.04.004; Snyder A, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002309; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Suzuki H, 2015, NAT GENET, V47, P458, DOI 10.1038/ng.3273; Turajlic S, 2018, CELL, V173, P595, DOI 10.1016/j.cell.2018.03.043; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; van der Spek J, 2015, J CLIN IMMUNOL, V35, P416, DOI 10.1007/s10875-015-0152-6; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Watkins TBK, 2020, NATURE, V587, P126, DOI 10.1038/s41586-020-2698-6; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Yokoyama A, 2019, NATURE, V565, P312, DOI 10.1038/s41586-018-0811-x	56	8	8	5	33	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2021	597	7877					555	+		10.1038/s41586-021-03894-5	http://dx.doi.org/10.1038/s41586-021-03894-5		SEP 2021	25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UW6NQ	34497419	Green Submitted			2022-12-28	WOS:000693875600002
J	Kuehn, BM				Kuehn, Bridget M.			Developing Partnerships to Streamline Global Food Safety	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2021	326	9					801	801		10.1001/jama.2021.14730	http://dx.doi.org/10.1001/jama.2021.14730			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ7LK	34547094				2022-12-28	WOS:000696242100030
J	Jaillais, Y; Parcy, F				Jaillais, Yvon; Parcy, Francois			Lipid-mediated regulation of flowering time	SCIENCE			English	Editorial Material							ARABIDOPSIS; TEMPERATURE		[Jaillais, Yvon] Univ Lyon, ENS Lyon, CNRS, Lab Reprod & Dev Plantes,INRAE, Lyon, France; [Parcy, Francois] Univ Grenoble Alpes, CNRS, Lab Physiol Cellulaire & Vegetale, CEA,INRAE,IRIG,DBSCI,LPCV, Grenoble, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Jaillais, Y (corresponding author), Univ Lyon, ENS Lyon, CNRS, Lab Reprod & Dev Plantes,INRAE, Lyon, France.	yvon.jaillais@ens-lyon.fr	Parcy, François/G-9177-2011	Parcy, François/0000-0003-2191-500X				Colin LA, 2020, CURR OPIN PLANT BIOL, V53, P1, DOI 10.1016/j.pbi.2019.08.007; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Falcone Deane L., 2004, BMC Plant Biology, V4, P17, DOI 10.1186/1471-2229-4-17; Jin S, 2021, SEMIN CELL DEV BIOL, V109, P20, DOI 10.1016/j.semcdb.2020.05.007; Li Q, 2015, PLANT CELL, V27, P86, DOI 10.1105/tpc.114.134338; Nakamura Y, 2019, ISCIENCE, V21, P577, DOI 10.1016/j.isci.2019.10.045; Nakamura Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4553; Noack LC, 2020, ANNU REV PLANT BIOL, V71, P71, DOI 10.1146/annurev-arplant-081519-035910; Sohn EJ, 2007, P NATL ACAD SCI USA, V104, P18801, DOI 10.1073/pnas.0708236104; Susila H, 2021, SCIENCE, V373, P1137; UEMURA M, 1995, PLANT PHYSIOL, V109, P15, DOI 10.1104/pp.109.1.15; Zhu Y, 2021, J EXP BOT, V72, P2301, DOI 10.1093/jxb/eraa598	12	2	2	12	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2021	373	6559					1086	1087		10.1126/science.abl4883	http://dx.doi.org/10.1126/science.abl4883			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UL8QT	34516850	Green Submitted			2022-12-28	WOS:000692910300029
J	Janiaud, P; Irony, T; Russek-Cohen, E; Goodman, SN				Janiaud, Perrine; Irony, Telba; Russek-Cohen, Estelle; Goodman, Steven N.			US Food and Drug Administration Reasoning in Approval Decisions When Efficacy Evidence Is Borderline, 2013-2018	ANNALS OF INTERNAL MEDICINE			English	Article							FDA APPROVAL	Background: The U.S. Food and Drug Administration (FDA) has substantial flexibility in its approval criteria in the context of life-threatening disease and unmet therapeutic need. Objective: To understand the FDA's evidentiary standards when flexible criteria are employed. Design: Case series. Setting: Applications submitted between 2013 and 2018 that went through multiple review cycles because the evidence for clinical efficacy was initially deemed insufficient. Measurements: Information was obtained from the approval package (available on Drugs@FDA), including advisory committee minutes, FDA reviews, and complete response letters. Results: Of 912 applications reviewed, 117 went through multiple review cycles; only 22 of these faced additional review primarily because of issues related to clinical efficacy. Concerns about the end point, the clinical meaningfulness of the observed effect, and inconsistent results were common bases for initial rejection. In 7 of the 22 cases, the approval did not require new evidence but rather new interpretations of the original evidence. No FDA decisions cited reasoning used in previous decisions. Limitation: The conclusions rely on the authors' interpretation of the FDA statements and on a series of "close calls." Conclusion: The FDA has no mechanism to find or tradition to cite similar cases when weighing evidence for approvals, resulting in standalone, bespoke decisions. These decisions show highly variable criteria for "substantial evidence" when flexible evidential criteria are used, highlighted by the recent approval of aducanumab. A precedential tradition and suitable information system are required for the FDA to improve institutional memory and build upon past decisions. These would increase the FDA's decisional transparency, consistency, and predictability, which are critical to preserving the FDA's most valuable asset, the public's trust. Primary Funding Source: U.S. Food and Drug Administration.	[Janiaud, Perrine] Stanford Univ, Meta Res Innovat Ctr Stanford, Sch Med, Stanford, CA 94305 USA; [Irony, Telba] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Russek-Cohen, Estelle] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Goodman, Steven N.] Stanford Univ, Dept Epidemiol & Populat Hlth, Sch Med, Stanford, CA 94305 USA; [Janiaud, Perrine] Univ Hosp Basel, Spitalstr 12, CH-4031 Basel, Switzerland; [Irony, Telba] Johnson & Johnson, Quantitat Sci, Janssen R&D, 1400 McKean Rd, Spring House, PA 19477 USA	Stanford University; US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); Stanford University; University of Basel; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson USA	Goodman, SN (corresponding author), Stanford Univ, Sch Med, 259 Campus Dr,T265 Redwood Bldg HRP, Stanford, CA 94305 USA.	steve.goodman@stanford.edu		Irony, Telba/0000-0002-2234-319X; Goodman, Steven/0000-0002-3872-5723	U.S. Food and Drug Administration	U.S. Food and Drug Administration	U.S. Food and Drug Administration.	Alexander GC, 2021, ANN INTERN MED, V174, P1303, DOI 10.7326/M21-2603; Belluck P, 2021, NEW YORK TIMES 0610; Buracchio T, 2021, ADUCANUMAB SUMMARY M; Darrow JJ, 2020, JAMA-J AM MED ASSOC, V323, P164, DOI 10.1001/jama.2019.20288; Darrow JJ, 2018, NEW ENGL J MED, V378, P1444, DOI 10.1056/NEJMhpr1713338; DeLoughery EP, 2018, ANN ONCOL, V29, P527, DOI 10.1093/annonc/mdy008; Downing NS, 2014, JAMA-J AM MED ASSOC, V311, P368, DOI 10.1001/jama.2013.282034; Florko N., 2021, STAT 0624; Goodman SN, 2014, JAMA-J AM MED ASSOC, V311, P361, DOI 10.1001/jama.2013.283946; Hatswell AJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011666; Herder M, 2018, JAMA INTERN MED, V178, P1013, DOI 10.1001/jamainternmed.2018.3137; Herper M, 2020, STAT NEWS; Katz Russell, 2004, NeuroRx, V1, P307, DOI 10.1007/BF03206615; Kesselheim AS, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4633; Ladanie A, 2019, J CLIN EPIDEMIOL, V114, P49, DOI 10.1016/j.jclinepi.2019.05.033; MacGregor A, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.9498; Mullard A, 2021, NATURE, V594, P309, DOI 10.1038/d41586-021-01546-2; Pregelj L, 2018, HEALTH AFFAIR, V37, P724, DOI 10.1377/hlthaff.2017.1580; Rathi VK, 2017, OTOLARYNG HEAD NECK, V156, P683, DOI 10.1177/0194599816689666; Razavi M, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.11111; Ross JS, 2015, HEALTH AFFAIR, V34, P681, DOI 10.1377/hlthaff.2014.1160; Sachs R, 2021, HLTH AFFAIRS BL 0610, DOI [10.1377/hblog20210609.921363, DOI 10.1377/HBLOG20210609.921363]; Sacks LV, 2014, JAMA-J AM MED ASSOC, V311, P378, DOI 10.1001/jama.2013.282542; U.S. Food and Drug Administration, 2021, MAN POL PROC; U.S. Food and Drug Administration, 1998, PROV CLIN EV EFF HUM; U.S. Food and Drug Administration, 2015, NDA CLASS COD; U.S. Food and Drug Administration, TABL SURR ENDP WER B; U.S. Food and Drug Administration, 2014, EXP PROGR SER COND D; U.S. Food and Drug Administration, 2019, DEM SUBST EV EFF HUM; U.S. Food and Drug Administration, 2018, BEN RISK ASS DRUG RE; Wallach JD, 2018, CLIN TRIALS, V15, P219, DOI 10.1177/1740774518770648; Wang B, 2013, CLIN PHARMACOL THER, V94, P670, DOI 10.1038/clpt.2013.165; Zhang AD, 2019, MILBANK Q, V97, P796, DOI 10.1111/1468-0009.12403	33	5	5	1	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV	2021	174	11					1603	+		10.7326/M21-2918	http://dx.doi.org/10.7326/M21-2918			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YI2OV	34543584				2022-12-28	WOS:000743694300026
J	Wang, SH; Zhang, YG; Ju, WM; Chen, JM; Cescatti, A; Sardans, J; Janssens, IA; Wu, MS; Berry, JA; Campbell, JE; Fernandez-Martinez, M; Alkama, R; Sitch, S; Smith, WK; Yuan, WP; He, W; Lombardozzi, D; Kautz, M; Zhu, D; Lienert, S; Kato, E; Poulter, B; Sanders, TGM; Kruger, I; Wang, R; Zeng, N; Tian, HQ; Vuichard, N; Jain, AK; Wiltshire, A; Goll, DS; Penuelas, J				Wang, Songhan; Zhang, Yongguang; Ju, Weimin; Chen, Jing M.; Cescatti, Alessandro; Sardans, Jordi; Janssens, Ivan A.; Wu, Mousong; Berry, Joseph A.; Campbell, J. Elliott; Fernandez-Martinez, Marcos; Alkama, Ramdane; Sitch, Stephen; Smith, William K.; Yuan, Wenping; He, Wei; Lombardozzi, Danica; Kautz, Markus; Zhu, Dan; Lienert, Sebastian; Kato, Etsushi; Poulter, Benjamin; Sanders, Tanja G. M.; Krueger, Inken; Wang, Rong; Zeng, Ning; Tian, Hanqin; Vuichard, Nicolas; Jain, Atul K.; Wiltshire, Andy; Goll, Daniel S.; Penuelas, Josep			Response to Comments on "Recent global decline of CO2 fertilization effects on vegetation photosynthesis" COMMENT	SCIENCE			English	Editorial Material							AVHRR	Our study suggests that the global CO2 fertilization effect (CFE) on vegetation photosynthesis has declined during the past four decades. The Comments suggest that the temporal inconsistency in AVHRR data and the attribution method undermine the results' robustness. Here, we provide additional evidence that these arguments did not affect our finding and that the global decline in CFE is robust.	[Wang, Songhan; Zhang, Yongguang; Ju, Weimin; Chen, Jing M.; Wu, Mousong; He, Wei] Nanjing Univ, Int Inst Earth Syst Sci, Nanjing, Peoples R China; [Wang, Songhan; Zhang, Yongguang; Ju, Weimin; Wu, Mousong; He, Wei] Nanjing Univ, Sch Geog & Ocean Sci, Key Lab Land Satellite Remote Sensing Applicat, Jiangsu Prov Key Lab Geog Informat Technol,Minist, Nanjing 210023, Jiangsu, Peoples R China; [Zhang, Yongguang] Minist Educ, Huangshan Pk Ecosyst Observat & Res Stn, Hunagjiang, Peoples R China; [Chen, Jing M.] Univ Toronto, Dept Geog & Planning, Toronto, ON, Canada; [Cescatti, Alessandro; Alkama, Ramdane] European Commiss, Joint Res Ctr JRC, Ispra, Italy; [Sardans, Jordi; Penuelas, Josep] UAB, CSIC, Global Ecol Unit, CREAF, Bellaterra 08193, Catalonia, Spain; [Sardans, Jordi; Penuelas, Josep] CREAF, Cerdanyola Del Valles 08193, Catalonia, Spain; [Janssens, Ivan A.; Fernandez-Martinez, Marcos] Univ Antwerp, Ctr Excellence PLECO Plant & Vegetat Ecol, Dept Biol, Antwerp, Belgium; [Berry, Joseph A.] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; [Campbell, J. Elliott] Univ Calif, Sierra Nevada Res Inst, Merced, CA 95343 USA; [Sitch, Stephen; Wiltshire, Andy] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Smith, William K.] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ USA; [Yuan, Wenping] Sun Yat Sen Univ, Ctr Monsoon & Environm Res, Sch Atmospher Sci, Guangzhou, Peoples R China; [Lombardozzi, Danica] Natl Ctr Atmospher Res, Terr Sci Sect, Boulder, CO USA; [Kautz, Markus] Forest Res Inst Baden Wurttemberg, Freiburg, Germany; [Zhu, Dan; Vuichard, Nicolas; Goll, Daniel S.] CEA CNRS UVSQ, Lab Sci Climat & Environnm, Gif Sur Yvette, France; [Lienert, Sebastian] Univ Bern, Inst Phys, Climate & Environm Phys, Bern, Switzerland; [Lienert, Sebastian] Univ Bern, Oeschger Ctr Climate Change Res, Bern, Switzerland; [Kato, Etsushi] Inst Appl Energy, Tokyo, Japan; [Poulter, Benjamin] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Sanders, Tanja G. M.; Krueger, Inken] Thunen Inst Forest Ecosyst, D-16225 Eberswalde, Germany; [Wang, Rong] Fudan Univ, Dept Environm Sci & Engn, Shanghai 200433, Peoples R China; [Zeng, Ning] Univ Maryland, Dept Atmospher & Ocean Sci, College Pk, MD 20742 USA; [Zeng, Ning] Chinese Acad Sci, LASG, Inst Atmospher Phys, Beijing 100029, Peoples R China; [Tian, Hanqin] Auburn Univ, Sch Forestry & Wildlife Sci, Int Ctr Climate & Global Change Res, Auburn, AL 36849 USA; [Jain, Atul K.] Univ Illinois, Dept Atmospher Sci, Urbana, IL 61801 USA; [Goll, Daniel S.] Univ Augsburg, Inst Geog, Augsburg, Germany	Nanjing University; Nanjing University; University of Toronto; European Commission Joint Research Centre; EC JRC ISPRA Site; Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Consejo Superior de Investigaciones Cientificas (CSIC); Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); University of Antwerp; Carnegie Institution for Science; University of California System; University of California Merced; University of Exeter; University of Arizona; Sun Yat Sen University; National Center Atmospheric Research (NCAR) - USA; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); University of Bern; University of Bern; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Johann Heinrich von Thunen Institute; Fudan University; University System of Maryland; University of Maryland College Park; Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; Auburn University System; Auburn University; University of Illinois System; University of Illinois Urbana-Champaign; University of Augsburg	Zhang, YG (corresponding author), Nanjing Univ, Int Inst Earth Syst Sci, Nanjing, Peoples R China.; Zhang, YG (corresponding author), Nanjing Univ, Sch Geog & Ocean Sci, Key Lab Land Satellite Remote Sensing Applicat, Jiangsu Prov Key Lab Geog Informat Technol,Minist, Nanjing 210023, Jiangsu, Peoples R China.; Zhang, YG (corresponding author), Minist Educ, Huangshan Pk Ecosyst Observat & Res Stn, Hunagjiang, Peoples R China.	yongguang_zhang@nju.edu.cn	Alkama, Ramdane/ABF-9937-2021; Martínez, Marcos Fernández/I-7240-2012; Sitch, Stephen A/F-8034-2015; Jain, Atul/D-2851-2016; Penuelas, Josep/D-9704-2011; Sardans, Jordi/AEM-0228-2022; Janssens, Ivan/P-1331-2014	Alkama, Ramdane/0000-0001-9864-2084; Martínez, Marcos Fernández/0000-0002-5661-3610; Sitch, Stephen A/0000-0003-1821-8561; Jain, Atul/0000-0002-4051-3228; Penuelas, Josep/0000-0002-7215-0150; Sardans, Jordi/0000-0003-2478-0219; Janssens, Ivan/0000-0002-5705-1787; Zhang, Yongguang/0000-0001-8286-300X; Wu, Mousong/0000-0003-1141-3022; He, Wei/0000-0003-0779-2496; ju, weimin/0000-0002-0010-7401; Smith, William/0000-0002-5785-6489; Vuichard, Nicolas/0000-0002-3397-7948; Chen, Jing/0000-0002-8682-1293; wang, songhan/0000-0002-8867-8486	National Key R&D Program of China [2016YFA0600202]; NSFC [42071388]; European Research Council Synergy grant [ERC-SyG-2013-610028 IMBALANCE-P]	National Key R&D Program of China; NSFC(National Natural Science Foundation of China (NSFC)); European Research Council Synergy grant(European Research Council (ERC))	Supported by the National Key R&D Program of China (2016YFA0600202) and the General Program of NSFC (42071388). J.P., I.A.J., J.S., and D.S.G. were supported by European Research Council Synergy grant ERC-SyG-2013-610028 IMBALANCE-P.	Badgley G, 2019, GLOBAL CHANGE BIOL, V25, P3731, DOI 10.1111/gcb.14729; Badgley G, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602244; Baldocchi DD, 2020, J GEOPHYS RES-BIOGEO, V125, DOI 10.1029/2019JG005534; Buermann W, 2018, NATURE, V562, P110, DOI 10.1038/s41586-018-0555-7; Campbell JE, 2017, NATURE, V544, P84, DOI 10.1038/nature22030; Camps-Valls G, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abc7447; Frankenberg C., 2021, SCIENCE, V373; Frankenberg C, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048738; Fu YSH, 2015, NATURE, V526, P104, DOI 10.1038/nature15402; Guanter L, 2014, P NATL ACAD SCI USA, V111, pE1327, DOI 10.1073/pnas.1320008111; Lian X, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax0255; Liu YY, 2015, NAT CLIM CHANGE, V5, P470, DOI [10.1038/nclimate2581, 10.1038/NCLIMATE2581]; Luo Y, 2004, BIOSCIENCE, V54, P731, DOI 10.1641/0006-3568(2004)054[0731:PNLOER]2.0.CO;2; Magney TS, 2019, P NATL ACAD SCI USA, V116, P11640, DOI 10.1073/pnas.1900278116; Moesinger L, 2020, EARTH SYST SCI DATA, V12, P177, DOI 10.5194/essd-12-177-2020; Pedelty J, 2007, INT GEOSCI REMOTE SE, P1021, DOI 10.1109/IGARSS.2007.4422974; Penuelas J, 2017, NAT ECOL EVOL, V1, P1438, DOI 10.1038/s41559-017-0274-8; Pinzon JE, 2014, REMOTE SENS-BASEL, V6, P6929, DOI 10.3390/rs6086929; Potapov P, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600821; Sang Y., 2021, SCIENCE, V373; Sardans J, 2015, GLOBAL ECOL BIOGEOGR, V24, P261, DOI 10.1111/geb.12259; Smith WK, 2020, NEW PHYTOL, V225, P105, DOI 10.1111/nph.16055; Sun Y, 2017, SCIENCE, V358, DOI 10.1126/science.aam5747; Walker AP, 2021, NEW PHYTOL, V229, P2413, DOI 10.1111/nph.16866; Wang SH, 2020, SCIENCE, V370, P1295, DOI 10.1126/science.abb7772; Wu GH, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/ab65cc; Zhu Z., 2021, SCIENCE, V373	27	3	4	21	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2021	373	6562			SI				abg7484	10.1126/science.abg7484	http://dx.doi.org/10.1126/science.abg7484			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU7LJ	34554812	Green Published			2022-12-28	WOS:000698977800004
J	Migliavacca, M; Musavi, T; Mahecha, MD; Nelson, JA; Knauer, J; Baldocchi, DD; Perez-Priego, O; Christiansen, R; Peters, J; Anderson, K; Bahn, M; Black, TA; Blanken, PD; Bonal, D; Buchmann, N; Caldararu, S; Carrara, A; Carvalhais, N; Cescatti, A; Chen, JQ; Cleverly, J; Cremonese, E; Desai, AR; El-Madany, TS; Farella, MM; Fernandez-Martinez, M; Filippa, G; Forkel, M; Galvagno, M; Gomarasca, U; Gough, CM; Gockede, M; Ibrom, A; Ikawa, H; Janssens, IA; Jung, M; Kattge, J; Keenan, TF; Knohl, A; Kobayashi, H; Kraemer, G; Law, BE; Liddell, MJ; Ma, XL; Mammarella, I; Martini, D; Macfarlane, C; Matteucci, G; Montagnani, L; Pabon-Moreno, DE; Panigada, C; Papale, D; Pendall, E; Penuelas, J; Phillips, RP; Reich, PB; Rossini, M; Rotenberg, E; Scott, RL; Stahl, C; Weber, U; Wohlfahrt, G; Wolf, S; Wright, IJ; Yakir, D; Zaehle, S; Reichstein, M				Migliavacca, Mirco; Musavi, Talie; Mahecha, Miguel D.; Nelson, Jacob A.; Knauer, Juergen; Baldocchi, Dennis D.; Perez-Priego, Oscar; Christiansen, Rune; Peters, Jonas; Anderson, Karen; Bahn, Michael; Black, T. Andrew; Blanken, Peter D.; Bonal, Damien; Buchmann, Nina; Caldararu, Silvia; Carrara, Arnaud; Carvalhais, Nuno; Cescatti, Alessandro; Chen, Jiquan; Cleverly, Jamie; Cremonese, Edoardo; Desai, Ankur R.; El-Madany, Tarek S.; Farella, Martha M.; Fernandez-Martinez, Marcos; Filippa, Gianluca; Forkel, Matthias; Galvagno, Marta; Gomarasca, Ulisse; Gough, Christopher M.; Goeckede, Mathias; Ibrom, Andreas; Ikawa, Hiroki; Janssens, Ivan A.; Jung, Martin; Kattge, Jens; Keenan, Trevor F.; Knohl, Alexander; Kobayashi, Hideki; Kraemer, Guido; Law, Beverly E.; Liddell, Michael J.; Ma, Xuanlong; Mammarella, Ivan; Martini, David; Macfarlane, Craig; Matteucci, Giorgio; Montagnani, Leonardo; Pabon-Moreno, Daniel E.; Panigada, Cinzia; Papale, Dario; Pendall, Elise; Penuelas, Josep; Phillips, Richard P.; Reich, Peter B.; Rossini, Micol; Rotenberg, Eyal; Scott, Russell L.; Stahl, Clement; Weber, Ulrich; Wohlfahrt, Georg; Wolf, Sebastian; Wright, Ian J.; Yakir, Dan; Zaehle, Soenke; Reichstein, Markus			The three major axes of terrestrial ecosystem function	NATURE			English	Article							WATER-USE EFFICIENCY; CARBON USE EFFICIENCY; GLOBAL CONVERGENCE; RESPIRATION; NITROGEN; BIOSPHERE; PLANT; PRODUCTIVITY; FORESTS; FLUXES	The leaf economics spectrum(1,2) and the global spectrum of plant forms and functions(3) revealed fundamental axes of variation in plant traits, which represent different ecological strategies that are shaped by the evolutionary development of plant species(2). Ecosystem functions depend on environmental conditions and the traits of species that comprise the ecological communities(4). However, the axes of variation of ecosystem functions are largely unknown, which limits our understanding of how ecosystems respond as a whole to anthropogenic drivers, climate and environmental variability(4,5). Here we derive a set of ecosystem functions(6) from a dataset of surface gas exchange measurements across major terrestrial biomes. We find that most of the variability within ecosystem functions (71.8%) is captured by three key axes. The first axis reflects maximum ecosystem productivity and is mostly explained by vegetation structure. The second axis reflects ecosystem water-use strategies and is jointly explained by variation in vegetation height and climate. The third axis, which represents ecosystem carbon-use efficiency, features a gradient related to aridity, and is explained primarily by variation in vegetation structure. We show that two state-of-the-art land surface models reproduce the first and most important axis of ecosystem functions. However, the models tend to simulate more strongly correlated functions than those observed, which limits their ability to accurately predict the full range of responses to environmental changes in carbon, water and energy cycling in terrestrial ecosystems(7,8).	[Migliavacca, Mirco; Musavi, Talie; Mahecha, Miguel D.; Nelson, Jacob A.; Caldararu, Silvia; Carvalhais, Nuno; El-Madany, Tarek S.; Gomarasca, Ulisse; Goeckede, Mathias; Jung, Martin; Kattge, Jens; Martini, David; Pabon-Moreno, Daniel E.; Weber, Ulrich; Zaehle, Soenke; Reichstein, Markus] Max Planck Inst Biogeochem, Jena, Germany; [Migliavacca, Mirco; Mahecha, Miguel D.; Kattge, Jens; Reichstein, Markus] German Ctr Integrat Biodivers Res iDiv, Halle, Germany; [Mahecha, Miguel D.; Kraemer, Guido] Univ Leipzig, Remote Sensing Ctr Earth Syst Res, Leipzig, Germany; [Mahecha, Miguel D.] UFZ Helmholtz Ctr Environm Res, Leipzig, Germany; [Knauer, Juergen] CSIRO Oceans & Atmosphere, Canberra, ACT, Australia; [Baldocchi, Dennis D.; Keenan, Trevor F.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Perez-Priego, Oscar] Univ Cordoba, Dept Forest Engn, ERSAF Res Grp, Cordoba, Spain; [Christiansen, Rune; Peters, Jonas] Univ Copenhagen, Dept Math Sci, Copenhagen, Denmark; [Anderson, Karen] Univ Exeter, Environm & Sustainabil Inst, Penryn, England; [Bahn, Michael; Wohlfahrt, Georg] Univ Innsbruck, Dept Ecol, Innsbruck, Austria; [Black, T. Andrew] Fac Land & Food Syst, Vancouver, BC, Canada; [Blanken, Peter D.] Univ Colorado, Dept Geog, Boulder, CO 80309 USA; [Bonal, Damien] Univ Lorraine, AgroParisTech, INRAE, UMR Silva, Nancy, France; [Buchmann, Nina; Wolf, Sebastian] Swiss Fed Inst Technol, Dept Environm Syst Sci, Zurich, Switzerland; [Carrara, Arnaud] Fdn Ctr Estudios Ambient Mediterraneo CEAM, Paterna, Spain; [Carvalhais, Nuno] Univ Nova Lisboa, Dept Ciencias & Engn Ambiente, Caparica, Portugal; [Migliavacca, Mirco; Cescatti, Alessandro] European Commiss, Joint Res Ctr JRC, Ispra, Italy; [Chen, Jiquan] Michigan State Univ, Landscape Ecol & Ecosyst Sci LEES Lab, Ctr Global Change & Earth Observat, E Lansing, MI 48824 USA; [Chen, Jiquan] Michigan State Univ, Dept Geog Environm & Spatial Sci, E Lansing, MI 48824 USA; [Cleverly, Jamie] Univ Technol Sydney, Sch Life Sci, Ultimo, NSW, Australia; [Cleverly, Jamie] James Cook Univ, Coll Sci & Engn, Terr Ecosyst Res Network, Cairns, Qld, Australia; [Cremonese, Edoardo; Filippa, Gianluca; Galvagno, Marta] Environm Protect Agcy Aosta Valley, Climate Change Unit, Aosta, Italy; [Desai, Ankur R.] Univ Wisconsin, Dept Atmospher & Ocean Sci, Madison, WI USA; [Farella, Martha M.] Indiana Univ, ONeill Sch Publ & Environm Affairs, Bloomington, IN USA; [Fernandez-Martinez, Marcos; Janssens, Ivan A.] Univ Antwerp, Dept Biol, Res Grp Plant & Ecosyst PLECO, Antwerp, Belgium; [Forkel, Matthias] Tech Univ Dresden, Inst Photogrammetry & Remote Sensing, Dresden, Germany; [Gough, Christopher M.] Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA; [Ibrom, Andreas] Tech Univ Denmark DTU, Dept Environm Engn, Lyngby, Denmark; [Ikawa, Hiroki] Natl Agr & Food Res Org, Inst Agroenvironm Sci, Tsukuba, Ibaraki, Japan; [Keenan, Trevor F.] Lawrence Berkeley Natl Lab, Earth & Environm Sci Area, Berkeley, CA USA; [Knohl, Alexander] Univ Goettingen, Fac Forest Sci & Forest Ecol, Bioclimatol, Gottingen, Germany; [Knohl, Alexander] Univ Goettingen, Ctr Biodivers & Sustainable Land Use CBL, Gottingen, Germany; Japan Agcy Marine Earth Sci & Technol JAMSTEC, Inst Arctic Climate & Environm Res, Res Inst Global Change, Yokohama, Kanagawa, Japan; [Kraemer, Guido] Univ Valencia, Image Proc Lab IPL, Valencia, Spain; [Law, Beverly E.] Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA; [Liddell, Michael J.] James Cook Univ, Ctr Trop Environm & Sustainabil Sci, Cairns, Qld, Australia; [Ma, Xuanlong] Lanzhou Univ, Coll Earth & Environm Sci, Lanzhou, Peoples R China; [Mammarella, Ivan] Univ Helsinki, Inst Atmospher & Earth Syst Res Phys, Fac Sci, Helsinki, Finland; [Macfarlane, Craig] CSIRO Land & Water, Floreat, WA, Australia; [Matteucci, Giorgio] CNR, Ist BioEcon, IBE, Sesto Fiorentino, Italy; [Montagnani, Leonardo] Libera Univ Bolzano, Fac Sci & Tecnol, Bolzano, Italy; [Montagnani, Leonardo] Forest Serv Autonomous Prov Bozen Bolzano, Bolzano, Italy; [Panigada, Cinzia; Rossini, Micol] Univ Milano Bicocca, Dept Earth & Environm Sci DISAT, Milan, Italy; [Papale, Dario] Univ Tuscia, Dept Innovat Biol Agrofood & Forest Syst DIBAF, Viterbo, Italy; [Knauer, Juergen; Pendall, Elise; Reich, Peter B.; Wright, Ian J.] Western Sydney Univ, Hawkesbury Inst Environm, Penrith, NSW, Australia; [Penuelas, Josep] UAB, CSIC, Global Ecol Unit, CREAF, Barcelona, Spain; [Penuelas, Josep] CREAF, Barcelona, Spain; [Phillips, Richard P.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Reich, Peter B.] Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; [Reich, Peter B.] Univ Michigan, Inst Global Change Biol, Ann Arbor, MI 48109 USA; [Reich, Peter B.] Univ Michigan, Sch Environm & Sustainabil, Ann Arbor, MI 48109 USA; [Rotenberg, Eyal; Yakir, Dan] Weizmann Inst Sci, Dept Earth & Planetary Sci, Rehovot, Israel; [Scott, Russell L.] USDA ARS, Southwest Watershed Res Ctr, Tucson, AZ USA; [Stahl, Clement] Univ Guyane, Univ Antilles, CNRS, INRAE,UMR EcoFoG,Cirad,AgroParisTech, Kourou, France; [Wright, Ian J.] Macquarie Univ, Dept Biol Sci, Sydney, NSW, Australia; [Reichstein, Markus] Friedrich Schiller Univ Jena, Michael Stifel Ctr Jena Data Driven & Simulat Sci, Jena, Germany	Max Planck Society; Leipzig University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of California System; University of California Berkeley; Universidad de Cordoba; University of Copenhagen; University of Exeter; University of Innsbruck; University of Colorado System; University of Colorado Boulder; AgroParisTech; INRAE; Universite de Lorraine; Swiss Federal Institutes of Technology Domain; ETH Zurich; Universidade Nova de Lisboa; European Commission Joint Research Centre; EC JRC ISPRA Site; Michigan State University; Michigan State University; University of Technology Sydney; James Cook University; Regional Environmental Protection Agency - Italy; University of Wisconsin System; University of Wisconsin Madison; Indiana University System; Indiana University Bloomington; University of Antwerp; Technische Universitat Dresden; Virginia Commonwealth University; Technical University of Denmark; National Agriculture & Food Research Organization - Japan; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Gottingen; University of Gottingen; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of Valencia; Oregon State University; James Cook University; Lanzhou University; University of Helsinki; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Consiglio Nazionale delle Ricerche (CNR); Istituto per la BioEconomia (IBE-CNR); Free University of Bozen-Bolzano; University of Milano-Bicocca; Tuscia University; Western Sydney University; Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Consejo Superior de Investigaciones Cientificas (CSIC); University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); University of Barcelona; Indiana University System; Indiana University Bloomington; University of Minnesota System; University of Minnesota Twin Cities; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Weizmann Institute of Science; United States Department of Agriculture (USDA); AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; INRAE; Macquarie University; Friedrich Schiller University of Jena	Migliavacca, M; Reichstein, M (corresponding author), Max Planck Inst Biogeochem, Jena, Germany.; Migliavacca, M; Reichstein, M (corresponding author), German Ctr Integrat Biodivers Res iDiv, Halle, Germany.; Migliavacca, M (corresponding author), European Commiss, Joint Res Ctr JRC, Ispra, Italy.; Reichstein, M (corresponding author), Friedrich Schiller Univ Jena, Michael Stifel Ctr Jena Data Driven & Simulat Sci, Jena, Germany.	mmiglia@bgc-jena.mpg.de; mreichstein@bgc-jena.mpg.de	Penuelas, Josep/D-9704-2011; Bahn, Michael/I-3536-2013; Zaehle, Sönke/C-9528-2017; Carrara, Arnaud/ABH-5319-2020; Anderson, Karen/ABC-3524-2021; Wohlfahrt, Georg/D-2409-2009; Law, Beverly Elizabeth/G-3882-2010; Reichstein, Markus/A-7494-2011; Buchmann, Nina/E-6095-2011; Montagnani, Leonardo/F-1837-2016; Martínez, Marcos Fernández/I-7240-2012; Migliavacca, Mirco/J-9986-2019; Papale, Dario/W-7302-2019; Wolf, Sebastian/B-4580-2010; Caldararu, Silvia/AAC-5603-2019; Chen, Jiquan/D-1955-2009; Kattge, Jens/J-8283-2016; Mahecha, Miguel D/F-2443-2010; Phillips, Richard P/C-6429-2009; Cleverly, Jamie Rose/L-2134-2016; Baldocchi, Dennis/A-1625-2009; Forkel, Matthias/O-5592-2019; Goeckede, Mathias/C-1027-2017; Keenan, Trevor F./B-2744-2010; Desai, Ankur R/A-5899-2008; Knohl, Alexander/F-9453-2014; Wright, Ian/G-4979-2012; Mammarella, Ivan/E-7782-2016	Penuelas, Josep/0000-0002-7215-0150; Bahn, Michael/0000-0001-7482-9776; Zaehle, Sönke/0000-0001-5602-7956; Carrara, Arnaud/0000-0002-9095-8807; Anderson, Karen/0000-0002-3289-2598; Wohlfahrt, Georg/0000-0003-3080-6702; Law, Beverly Elizabeth/0000-0002-1605-1203; Reichstein, Markus/0000-0001-5736-1112; Buchmann, Nina/0000-0003-0826-2980; Montagnani, Leonardo/0000-0003-2957-9071; Martínez, Marcos Fernández/0000-0002-5661-3610; Migliavacca, Mirco/0000-0003-3546-8407; Papale, Dario/0000-0001-5170-8648; Wolf, Sebastian/0000-0001-7717-6993; Caldararu, Silvia/0000-0001-5839-6480; Kattge, Jens/0000-0002-1022-8469; Mahecha, Miguel D/0000-0003-3031-613X; Phillips, Richard P/0000-0002-1345-4138; Cleverly, Jamie Rose/0000-0002-2731-7150; Baldocchi, Dennis/0000-0003-3496-4919; Forkel, Matthias/0000-0003-0363-9697; Goeckede, Mathias/0000-0003-2833-8401; Keenan, Trevor F./0000-0002-3347-0258; Desai, Ankur R/0000-0002-5226-6041; Knohl, Alexander/0000-0002-7615-8870; Perez-Priego, Oscar/0000-0002-3138-3177; Ibrom, Andreas/0000-0002-1341-921X; Peters, Jonas/0000-0002-1487-7511; Pabon-Moreno, Daniel E./0000-0003-4058-7339; Christiansen, Rune/0000-0002-8202-1176; Knauer, Jurgen/0000-0002-4947-7067; Gomarasca, Ulisse/0000-0001-7389-7793; Wright, Ian/0000-0001-8338-9143; Rossini, Micol/0000-0002-6052-3140; Mammarella, Ivan/0000-0002-8516-3356	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	Open access funding provided by Max Planck Society.	Anderegg WRL, 2020, SCIENCE, V368, P1327, DOI 10.1126/science.aaz7005; Baldocchi D, 2008, AUST J BOT, V56, P1, DOI 10.1071/BT07151; Besnard S, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aaeaeb; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Breiman L., 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Bruelheide H, 2018, NAT ECOL EVOL, V2, P1906, DOI 10.1038/s41559-018-0699-8; Collalti A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19187-w; De Kauwe MG, 2017, BIOGEOSCIENCES, V14, P4435, DOI 10.5194/bg-14-4435-2017; DeLucia EH, 2007, GLOBAL CHANGE BIOL, V13, P1157, DOI 10.1111/j.1365-2486.2007.01365.x; Diaz S, 2016, NATURE, V529, P167, DOI 10.1038/nature16489; Dray S, 2008, COMPUT STAT DATA AN, V52, P2228, DOI 10.1016/j.csda.2007.07.015; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Eyring V, 2020, GEOSCI MODEL DEV, V13, P3383, DOI 10.5194/gmd-13-3383-2020; Fernandez-Martinez M, 2014, NAT CLIM CHANGE, V4, P471, DOI [10.1038/NCLIMATE2177, 10.1038/nclimate2177]; Flechard CR, 2020, BIOGEOSCIENCES, V17, P1583, DOI 10.5194/bg-17-1583-2020; Fleischer K, 2015, J GEOPHYS RES-BIOGEO, V120, P2542, DOI 10.1002/2015JG002988; Fleischer K, 2019, NAT GEOSCI, V12, P736, DOI 10.1038/s41561-019-0404-9; Friedlingstein P, 2019, EARTH SYST SCI DATA, V11, P1783, DOI 10.5194/essd-11-1783-2019; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Gentine P, 2007, AGR FOREST METEOROL, V143, P13, DOI 10.1016/j.agrformet.2006.11.002; Gilmanov TG, 2010, RANGELAND ECOL MANAG, V63, P16, DOI 10.2111/REM-D-09-00072.1; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Husson F., 2010, EXPLORATORY MULTIVAR, DOI DOI 10.1201/B10345; Janssens IA, 2001, GLOBAL CHANGE BIOL, V7, P269, DOI 10.1046/j.1365-2486.2001.00412.x; Kennedy D, 2019, J ADV MODEL EARTH SY, V11, P485, DOI 10.1029/2018MS001500; Knauer J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201114; Knauer J, 2018, GLOBAL CHANGE BIOL, V24, P694, DOI 10.1111/gcb.13893; Knohl A, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002301; Kraemer G, 2020, BIOGEOSCIENCES, V17, P2397, DOI 10.5194/bg-17-2397-2020; Krich C, 2021, BIOGEOSCIENCES, V18, P2379, DOI 10.5194/bg-18-2379-2021; Krinner G, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2003GB002199; Law BE, 2001, GLOBAL CHANGE BIOL, V7, P755, DOI 10.1046/j.1354-1013.2001.00439.x; Liu Y, 2019, ECOL LETT, V22, P1806, DOI 10.1111/ele.13363; Mahecha MD, 2010, SCIENCE, V329, P838, DOI 10.1126/science.1189587; Manning P, 2018, NAT ECOL EVOL, V2, P427, DOI 10.1038/s41559-017-0461-7; Manzoni S, 2018, BIOGEOSCIENCES, V15, P5929, DOI 10.5194/bg-15-5929-2018; Mauritsen T, 2019, J ADV MODEL EARTH SY, V11, P998, DOI 10.1029/2018MS001400; Medlyn BE, 2011, GLOBAL CHANGE BIOL, V17, P2134, DOI 10.1111/j.1365-2486.2010.02375.x; Meyerholt J, 2018, BIOGEOSCIENCES, V15, P5677, DOI 10.5194/bg-15-5677-2018; Migliavacca M, 2015, GLOBAL CHANGE BIOL, V21, P363, DOI 10.1111/gcb.12671; Migliavacca M, 2011, GLOBAL CHANGE BIOL, V17, P390, DOI 10.1111/j.1365-2486.2010.02243.x; Migliavacca M, 2009, AGR FOREST METEOROL, V149, P1460, DOI 10.1016/j.agrformet.2009.04.003; Musavi T, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0048; Musavi T, 2016, ECOL EVOL, V6, P7352, DOI 10.1002/ece3.2479; Musavi T, 2015, INT J APPL EARTH OBS, V43, P119, DOI 10.1016/j.jag.2015.05.009; Nelson JA, 2020, GLOBAL CHANGE BIOL, V26, P6916, DOI 10.1111/gcb.15314; Nelson JA, 2018, J GEOPHYS RES-BIOGEO, V123, P3617, DOI 10.1029/2018JG004727; Nelson JA, 2018, BIOGEOSCIENCES, V15, P2433, DOI 10.5194/bg-15-2433-2018; Pastorello G, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0534-3; Peres-Neto PR, 2003, ECOLOGY, V84, P2347, DOI 10.1890/00-0634; Peters J, 2016, J R STAT SOC B, V78, P947, DOI 10.1111/rssb.12167; Raddatz TJ, 2007, CLIM DYNAM, V29, P565, DOI 10.1007/s00382-007-0247-8; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Reichstein M, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002035; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Reichstein M, 2014, P NATL ACAD SCI USA, V111, P13697, DOI 10.1073/pnas.1216065111; Richman B., 1988, Tellus, Series B (Chemical and Physical Meteorology), V40B, P50, DOI 10.1111/j.1600-0889.1988.tb00212.x; Ricklefs R.E., 2008, EC NATURE; Ryan MG, 2006, PLANT CELL ENVIRON, V29, P367, DOI 10.1111/j.1365-3040.2005.01478.x; Santoro M, 2021, EARTH SYST SCI DATA, V13, P3927, DOI 10.5194/essd-13-3927-2021; Skubel R, 2015, HYDROL PROCESS, V29, P4100, DOI 10.1002/hyp.10549; Thom A.S., 1975, PRINCIPLES, V1, P57; THOM AS, 1972, Q J ROY METEOR SOC, V98, P124, DOI 10.1002/qj.49709841510; Verhoef A, 1997, J APPL METEOROL, V36, P560, DOI 10.1175/1520-0450(1997)036<0560:SPNOTP>2.0.CO;2; WHITTAKER R H, 1975, P385; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wutzler T, 2018, BIOGEOSCIENCES, V15, P5015, DOI 10.5194/bg-15-5015-2018; Zaehle S, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003522; Zaehle S, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003521; Zaehle S, 2014, NEW PHYTOL, V202, P803, DOI 10.1111/nph.12697; Zaehle S, 2011, NAT GEOSCI, V4, P601, DOI 10.1038/ngeo1207; Zaehle S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041345; Zhou S, 2014, GEOPHYS RES LETT, V41, P5005, DOI 10.1002/2014GL060741	77	28	28	47	218	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 21	2021	598	7881					468	+		10.1038/s41586-021-03939-9	http://dx.doi.org/10.1038/s41586-021-03939-9		SEP 2021	23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WK1SC	34552242	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000698366900004
J	Kuehn, BM				Kuehn, Bridget M.			Increase in Myopia Reported Among Children During COVID-19 Lockdown	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	4	4	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2021	326	11					999	999		10.1001/jama.2021.14475	http://dx.doi.org/10.1001/jama.2021.14475			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ4IM	34546294	Bronze			2022-12-28	WOS:000702170600003
J	Corbett, KS; Nason, MC; Flach, B; Gagne, M; O' Connell, S; Johnston, TS; Shah, SN; Edara, VV; Floyd, K; Lai, LL; McDanal, C; Francica, JR; Flynn, B; Wu, K; Choi, A; Koch, M; Abiona, OM; Werner, AP; Moliva, JI; Andrew, SF; Donaldson, MM; Fintzi, J; Flebbe, DR; Lamb, E; Noe, AT; Nurmukhambetova, ST; Provost, SJ; Cook, A; Dodson, A; Faudree, A; Greenhouse, J; Kar, S; Pessaint, L; Porto, M; Steingrebe, K; Valentin, D; Zouantcha, S; Bock, KW; Minai, M; Nagata, BM; van de Wetering, R; Boyoglu-Barnum, S; Leung, K; Shi, W; Yang, ES; Zhang, Y; Todd, JPM; Wang, LS; Alvarado, GS; Andersen, H; Foulds, KE; Edwards, DK; Mascola, JR; Moore, IN; Lewis, MG; Carfi, A; Monterfiori, D; Suthar, MS; McDermott, A; Roederer, M; Sullivan, NJ; Douek, DC; Graham, BS; Seder, RA				Corbett, Kizzmekia S.; Nason, Martha C.; Flach, Britta; Gagne, Matthew; O' Connell, Sarah; Johnston, Timothy S.; Shah, Shruti N.; Edara, Venkata Viswanadh; Floyd, Katharine; Lai, Lilin; McDanal, Charlene; Francica, Joseph R.; Flynn, Barbara; Wu, Kai; Choi, Angela; Koch, Matthew; Abiona, Olubukola M.; Werner, Anne P.; Moliva, Juan, I; Andrew, Shayne F.; Donaldson, Mitzi M.; Fintzi, Jonathan; Flebbe, Dillon R.; Lamb, Evan; Noe, Amy T.; Nurmukhambetova, Saule T.; Provost, Samantha J.; Cook, Anthony; Dodson, Alan; Faudree, Andrew; Greenhouse, Jack; Kar, Swagata; Pessaint, Laurent; Porto, Maciel; Steingrebe, Katelyn; Valentin, Daniel; Zouantcha, Serge; Bock, Kevin W.; Minai, Mahnaz; Nagata, Bianca M.; van de Wetering, Renee; Boyoglu-Barnum, Seyhan; Leung, Kwanyee; Shi, Wei; Yang, Eun Sung; Zhang, Yi; Todd, John-Paul M.; Wang, Lingshu; Alvarado, Gabriela S.; Andersen, Hanne; Foulds, Kathryn E.; Edwards, Darin K.; Mascola, John R.; Moore, Ian N.; Lewis, Mark G.; Carfi, Andrea; Monterfiori, David; Suthar, Mehul S.; McDermott, Adrian; Roederer, Mario; Sullivan, Nancy J.; Douek, Daniel C.; Graham, Barney S.; Seder, Robert A.			Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates	SCIENCE			English	Article							DIELECTRIC LASER ACCELERATION; SUB-RELATIVISTIC ELECTRONS; OPTICAL-EXCITATIONS; QUANTUM WALKS; LIGHT; NEUTRALIZATION; IMMUNIZATION; GENERATION; INFECTION; COVID-19	Immune correlates of protection can be used as surrogate endpoints for vaccine efficacy. Here, nonhuman primates (NHPs) received either no vaccine or doses ranging from 0.3 to 100 mg of the mRNA-1273 severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2) vaccine. mRNA-1273 vaccination elicited circulating and mucosal antibody responses in a dose-dependent manner. Viral replication was significantly reduced in bronchoalveolar lavages and nasal swabs after SARS-CoV-2 challenge in vaccinated animals and most strongly correlated with levels of anti-S antibody and neutralizing activity. Lower antibody levels were needed for reduction of viral replication in the lower airway than in the upper airway. Passive transfer of mRNA-1273-induced immunoglobulin G to naive hamsters was sufficient to mediate protection. Thus, mRNA-1273 vaccine-induced humoral immune responses are a mechanistic correlate of protection against SARS-CoV-2 in NHPs.	[Corbett, Kizzmekia S.; Flach, Britta; Gagne, Matthew; O' Connell, Sarah; Johnston, Timothy S.; Shah, Shruti N.; Francica, Joseph R.; Flynn, Barbara; Abiona, Olubukola M.; Werner, Anne P.; Moliva, Juan, I; Andrew, Shayne F.; Donaldson, Mitzi M.; Fintzi, Jonathan; Flebbe, Dillon R.; Lamb, Evan; Noe, Amy T.; Nurmukhambetova, Saule T.; Provost, Samantha J.; van de Wetering, Renee; Boyoglu-Barnum, Seyhan; Leung, Kwanyee; Shi, Wei; Yang, Eun Sung; Zhang, Yi; Todd, John-Paul M.; Wang, Lingshu; Alvarado, Gabriela S.; Foulds, Kathryn E.; Mascola, John R.; McDermott, Adrian; Roederer, Mario; Sullivan, Nancy J.; Douek, Daniel C.; Graham, Barney S.; Seder, Robert A.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Nason, Martha C.] NIAID, Biostat Res Branch, Div Clin Res, NIH, Bethesda, MD 20892 USA; [Edara, Venkata Viswanadh; Floyd, Katharine; Lai, Lilin; Suthar, Mehul S.] Emory Univ, Ctr Childhood Infect & Vaccines Childrens Healthc, Emory Vaccine Ctr, Dept Pediat,Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [McDanal, Charlene; Monterfiori, David] Duke Univ, Dept Surg, Med Ctr, Durham, NC 27708 USA; [Wu, Kai; Choi, Angela; Koch, Matthew; Edwards, Darin K.; Carfi, Andrea] Moderna Inc, Cambridge, MA 02139 USA; [Cook, Anthony; Dodson, Alan; Faudree, Andrew; Greenhouse, Jack; Kar, Swagata; Pessaint, Laurent; Porto, Maciel; Steingrebe, Katelyn; Valentin, Daniel; Zouantcha, Serge; Andersen, Hanne; Lewis, Mark G.] Bioqual Inc, Rockville, MD 20850 USA; [Bock, Kevin W.; Minai, Mahnaz; Nagata, Bianca M.; Moore, Ian N.] NIAID, Infect Dis Pathogenesis Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Suthar, Mehul S.] Dept Microbiol & Immunol, Atlanta, GA 30329 USA; [Corbett, Kizzmekia S.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02124 USA; [Francica, Joseph R.] AstraZeneca, Gaithersburg, MD 20878 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Emory University; Duke University; BIOQUAL Inc.; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Harvard T.H. Chan School of Public Health; AstraZeneca	Graham, BS; Seder, RA (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	bgraham@nlh.gov; rseder@mail.nih.gov		van de Wetering, Renee/0000-0001-5330-5113; McDermott, Adrian/0000-0003-0616-9117; Corbett, Kizzmekia/0000-0002-2641-4688; Gagne, Matthew/0000-0001-5526-6162; Elyard, Hanne/0000-0003-1103-9608; Shah, Shruti/0000-0002-0715-3187; Edara, Venkata Viswanadh/0000-0001-9321-7839; Johnston, Timothy/0000-0001-9246-6155; Nason, Martha/0000-0002-0110-881X; Wang, Lingshu/0000-0002-8404-4910; Floyd, Katharine/0000-0002-0866-6961	Intramural Research Program of the VRC, NIAID, NIH; Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority [75A50120C00034]; Undergraduate Scholarship Program, Office of Intramural Training and Education, Office of the Director, NIH; NIAID Research Participation Program; Emory Executive Vice President for Health Affairs Synergy Fund Award; Pediatric Research Alliance Center for Childhood Infections and Vaccines and Children's Healthcare of Atlanta; Woodruff Health Sciences Center 2020 COVID-19 CURE Award	Intramural Research Program of the VRC, NIAID, NIH; Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority; Undergraduate Scholarship Program, Office of Intramural Training and Education, Office of the Director, NIH; NIAID Research Participation Program; Emory Executive Vice President for Health Affairs Synergy Fund Award; Pediatric Research Alliance Center for Childhood Infections and Vaccines and Children's Healthcare of Atlanta; Woodruff Health Sciences Center 2020 COVID-19 CURE Award	This work was supported by the Intramural Research Program of the VRC, NIAID, NIH; Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, Contract 75A50120C00034; Undergraduate Scholarship Program, Office of Intramural Training and Education, Office of the Director, NIH (K.S.C.); NIAID Research Participation Program, administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and NIAID (R.W.); Emory Executive Vice President for Health Affairs Synergy Fund Award (M.S.S.); Pediatric Research Alliance Center for Childhood Infections and Vaccines and Children's Healthcare of Atlanta (M.S.S.); and Woodruff Health Sciences Center 2020 COVID-19 CURE Award (M.S.S.).	ADENYIJONES SCA, 1992, J PEDIATR-US, V120, P686, DOI 10.1016/S0022-3476(05)80228-8; Adiv Y, 2020, CONF LASER ELECTR; AHARONOV Y, 1988, PHYS REV LETT, V60, P1351, DOI 10.1103/PhysRevLett.60.1351; Amiranoff F, 1998, PHYS REV LETT, V81, P995, DOI 10.1103/PhysRevLett.81.995; Arbouet A., 2018, ADV IMAG ELECT PHYS, P1, DOI [10.1016/bs.aiep.2018.06.001, DOI 10.1016/BS.AIEP.2018.06.001]; ASPECT A, 1982, PHYS REV LETT, V49, P91, DOI 10.1103/PhysRevLett.49.91; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Barnett SM, 2018, PHYS REV A, V98, DOI 10.1103/PhysRevA.98.013809; Barwick B, 2009, NATURE, V462, P902, DOI 10.1038/nature08662; Ben Hayun A, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe4270; Berry MV, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/1/015301; Bliokh KY, 2017, PHYS REP, V690, P1, DOI 10.1016/j.physrep.2017.05.006; BRAUNSTEIN SL, 1991, PHYS REV A, V43, P1153, DOI 10.1103/PhysRevA.43.1153; Breuer J, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.134803; Broome MA, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.153602; Chandrashekar A, 2020, SCIENCE, V369, P812, DOI 10.1126/science.abc4776; Cohen-Tannoudji C., 2006, QUANTUM MECH, VI; Corbett K. S., 2020, 145920 BIORXIV; Corbett KS, 2020, NEW ENGL J MED, V383, P1544, DOI 10.1056/NEJMoa2024671; Dadras S, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.070402; Dahan R, 2020, NAT PHYS, V16, P1123, DOI 10.1038/s41567-020-01042-w; Das P, 2019, ULTRAMICROSCOPY, V203, P44, DOI 10.1016/j.ultramic.2018.12.011; Davies NG, 2021, SCIENCE, V372, P149, DOI 10.1126/science.abg3055; Di Giulio V, 2020, OPTICA, V7, P1820, DOI 10.1364/OPTICA.404598; Di Giulio V, 2019, OPTICA, V6, P1524, DOI 10.1364/OPTICA.6.001524; Dimcheff Derek E, 2021, medRxiv, DOI 10.1101/2021.02.25.21252493; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Edara VV, 2021, CELL HOST MICROBE, V29, P516, DOI 10.1016/j.chom.2021.03.009; Einstein A, 1905, ANN PHYS-BERLIN, V17, P132; England RJ, 2014, REV MOD PHYS, V86, P1337, DOI 10.1103/RevModPhys.86.1337; Fajnzylber J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19057-5; Feist A, 2015, NATURE, V521, P200, DOI 10.1038/nature14463; Feizpour A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.133603; Finak G, 2014, BIOSTATISTICS, V15, P87, DOI 10.1093/biostatistics/kxt024; Forni G, 2021, CELL DEATH DIFFER, V28, P626, DOI 10.1038/s41418-020-00720-9; Frampton D, 2021, LANCET INFECT DIS, V21, P1246, DOI 10.1016/S1473-3099(21)00170-5; Francica Joseph R, 2021, bioRxiv, DOI 10.1101/2021.03.02.433390; de Abajo FJG, 2010, REV MOD PHYS, V82, P209, DOI 10.1103/RevModPhys.82.209; de Abajo FJG, 2021, ACS PHOTONICS, V8, P945, DOI 10.1021/acsphotonics.0c01950; Glauber RJ, 2006, REV MOD PHYS, V78, P1267, DOI 10.1103/RevModPhys.78.1267; Gorlach A, 2020, ARXIV201212069QUANTP; Gover A, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.064801; Gover A, 2018, PHYS LETT A, V382, P1550, DOI 10.1016/j.physleta.2018.03.049; Harris NC, 2017, NAT PHOTONICS, V11, P447, DOI [10.1038/nphoton.2017.95, 10.1038/NPHOTON.2017.95]; Henke JW, 2021, NATURE, V600, P653, DOI 10.1038/s41586-021-04197-5; Huang BY, 2021, LANCET MICROBE, V2, pE285, DOI 10.1016/S2666-5247(21)00082-3; Hughes T, 2017, OPT EXPRESS, V25, P15414, DOI 10.1364/OE.25.015414; Hughes TW, 2019, ACS PHOTONICS, V6, P3010, DOI 10.1021/acsphotonics.9b01238; Imai M, 2020, P NATL ACAD SCI USA, V117, P16587, DOI 10.1073/pnas.2009799117; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; de Abajo FJG, 2010, NANO LETT, V10, P1859, DOI 10.1021/nl100613s; JOZSA R, 1994, J MOD OPTIC, V41, P2315, DOI 10.1080/09500349414552171; Karnieli A, 2021, PHYS REV LETT, V127, DOI 10.1103/PhysRevLett.127.060403; Karnieli A, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abf8096; Karski M, 2009, SCIENCE, V325, P174, DOI 10.1126/science.1174436; Katzelnick LC, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006862; Kendon V, 2007, MATH STRUCT COMP SCI, V17, P1169, DOI 10.1017/S0960129507006354; Kfir O, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abf6380; Kfir O, 2020, NATURE, V582, P46, DOI 10.1038/s41586-020-2320-y; Kfir O, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.103602; Kim D, 2020, CELL, V181, P914, DOI 10.1016/j.cell.2020.04.011; Klasse PJ, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe8065; Knyazev E, 2018, NEW J PHYS, V20, DOI 10.1088/1367-2630/aa99b4; Kozak M, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.103203; Kozak M, 2017, OPT EXPRESS, V25, P19195, DOI 10.1364/OE.25.019195; Kozak M, 2017, NUCL INSTRUM METH A, V865, P84, DOI 10.1016/j.nima.2016.12.051; Leedle KJ, 2015, OPT LETT, V40, P4344, DOI 10.1364/OL.40.004344; Liu CZ, 2019, ACS PHOTONICS, V6, P2499, DOI 10.1021/acsphotonics.9b00830; Liu Yang, 2021, N Engl J Med, DOI 10.1056/NEJMc2102017; Logunov DY, 2021, LANCET, V397, P671, DOI 10.1016/S0140-6736(21)00234-8; Loudon R., 2000, QUANTUM THEORY LIGHT; Lvovsky AI, 2009, REV MOD PHYS, V81, P299, DOI 10.1103/RevModPhys.81.299; Marchetti R, 2019, PHOTONICS RES, V7, P201, DOI 10.1364/PRJ.7.000201; Maxwell J. Clerk, 1865, PHILOS T ROY SOC LON, V155, P459, DOI DOI 10.1098/RSTL.1865.0008; McMahan K, 2021, NATURE, V590, DOI 10.1038/s41586-020-03041-6; McMorran BJ, 2011, SCIENCE, V331, P192, DOI 10.1126/science.1198804; Mechel C, 2021, OPTICA, V8, P70, DOI 10.1364/OPTICA.402693; Mercado NB, 2020, NATURE, V586, P583, DOI 10.1038/s41586-020-2607-z; Mitchison G, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.062105; Morimoto Y, 2018, NAT PHYS, V14, P252, DOI 10.1038/s41567-017-0007-6; Munster VJ, 2020, NATURE, V585, P268, DOI [10.1038/s41586-020-2324-7, 10.1101/2020.03.21.001628]; OGRA PL, 1984, REV INFECT DIS, V6, pS361; OGRA PL, 1968, NEW ENGL J MED, V279, P893, DOI 10.1056/NEJM196810242791701; ONORATO IM, 1991, J INFECT DIS, V163, P1, DOI 10.1093/infdis/163.1.1; Pallesen J, 2017, P NATL ACAD SCI USA, V114, pE7348, DOI 10.1073/pnas.1707304114; Pan Y, 2019, ARXIV191011685QUANTP; Pan YM, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.183204; Pan YM, 2019, PHYS REV A, V99, DOI 10.1103/PhysRevA.99.052107; Pardi N, 2018, J EXP MED, V215, P1571, DOI 10.1084/jem.20171450; Park ST, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/12/123028; Peralta EA, 2013, NATURE, V503, P91, DOI 10.1038/nature12664; Perets HB, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.170506; Piazza L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7407; Planas D, 2021, NAT MED, V27, P917, DOI 10.1038/s41591-021-01318-5; Plotkin SA, 2012, CLIN INFECT DIS, V54, P1615, DOI 10.1093/cid/cis238; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Preiss PM, 2015, SCIENCE, V347, P1229, DOI 10.1126/science.1260364; PRENTICE RL, 1989, STAT MED, V8, P431, DOI 10.1002/sim.4780080407; Priebe KE, 2017, NAT PHOTONICS, V11, P793, DOI 10.1038/s41566-017-0045-8; Reinhardt O, 2020, ACS PHOTONICS, V7, P2859, DOI 10.1021/acsphotonics.0c01133; Reiserer A, 2013, SCIENCE, V342, P1349, DOI 10.1126/science.1246164; Rivera N, 2020, NAT REV PHYS, V2, P538, DOI 10.1038/s42254-020-0224-2; Rockx Barry, 2020, Science, V368, P1012, DOI 10.1126/science.abb7314; Ryabov A, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb1393; Ryan CA, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.062317; Sapra NV, 2020, SCIENCE, V367, P79, DOI 10.1126/science.aay5734; Schreiber A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.180403; Schwartz O, 2019, NAT METHODS, V16, P1016, DOI 10.1038/s41592-019-0552-2; SELVADORAY M, 1994, PHYS REV A, V49, P4957, DOI 10.1103/PhysRevA.49.4957; Shaked Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03083-5; Shan D, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22072-9; Shen XY, 2021, NEW ENGL J MED, V384, P2352, DOI 10.1056/NEJMc2103740; Shiloh R, 2018, ULTRAMICROSCOPY, V189, P46, DOI 10.1016/j.ultramic.2018.03.016; SHORE BW, 1993, J MOD OPTIC, V40, P1195, DOI 10.1080/09500349314551321; Shtaif M, 1997, IEEE PHOTONIC TECH L, V9, P904, DOI 10.1109/68.593341; Shtaif M, 1998, IEEE J QUANTUM ELECT, V34, P869, DOI 10.1109/3.668775; SMITH SJ, 1953, PHYS REV, V92, P1069, DOI 10.1103/PhysRev.92.1069; Tajima T., 2020, Reviews of Modern Plasma Physics, V4, DOI 10.1007/s41614-020-0043-z; Talebi N, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/12/123006; Tamir Boaz, 2013, Quanta, V2, P7; Tegally H, 2020, MEDRXIV, DOI [10.1101/2020.12.21.20248640, DOI 10.1101/2020.12.21.20248640]; Tsesses, 2020, CLEO C FTU3B 4; Uchida M, 2010, NATURE, V464, P737, DOI 10.1038/nature08904; Vanacore GM, 2019, NAT MATER, V18, P573, DOI 10.1038/s41563-019-0336-1; Vanacore GM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05021-x; Vanacore GM, 2020, RIV NUOVO CIMENTO, V43, P567, DOI 10.1007/s40766-020-00012-5; Vanderheiden Abigail, 2020, Curr Protoc Immunol, V131, pe116, DOI 10.1002/cpim.116; Verbeeck J, 2010, NATURE, V467, P301, DOI 10.1038/nature09366; Voloch-Bloch N, 2013, NATURE, V494, P331, DOI 10.1038/nature11840; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Wang KP, 2020, NATURE, V582, P50, DOI 10.1038/s41586-020-2321-x; Whitt MA, 2010, J VIROL METHODS, V169, P365, DOI 10.1016/j.jviromet.2010.08.006; Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Wu K, 2021, NEW ENGL J MED, V384, P1468, DOI 10.1056/NEJMc2102179; Yousefi P, 2019, OPT LETT, V44, P1520, DOI 10.1364/OL.44.001520; Yu JY, 2020, SCIENCE, V369, P806, DOI 10.1126/science.abc6284; Zahringer F, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.100503; ZHAORI G, 1988, J INFECT DIS, V158, P160, DOI 10.1093/infdis/158.1.160; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737; Zubairy, 1999, QUANTUM OPT	141	84	84	13	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2021	373	6561					1325	+		10.1126/science.abj0299	http://dx.doi.org/10.1126/science.abj0299			55	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	US5SK	34529476	Green Accepted			2022-12-28	WOS:000697488600058
J	Leslie, AB; Simpson, C; Mander, L				Leslie, Andrew B.; Simpson, Carl; Mander, Luke			Reproductive innovations and pulsed rise in plant complexity	SCIENCE			English	Article							EVOLUTION; DIVERSIFICATION; HISTORY; REEVALUATION; ANGIOSPERMS; POLLINATION; DIVERSITY; SUCCESS; FLOWERS; ORIGIN	Morphological complexity is a notable feature of multicellular life, although whether it evolves gradually or in early bursts is unclear. Vascular plant reproductive structures, such as flowers, are familiar examples of complex morphology. In this study, we use a simple approach based on the number of part types to analyze changes in complexity over time. We find that reproductive complexity increased in two pulses separated by similar to 250 million years of stasis, including an initial rise in the Devonian with the radiation of vascular plants and a pronounced increase in the Late Cretaceous that reflects flowering plant diversification. These pulses are associated with innovations that increased functional diversity, suggesting that shifts in complexity are linked to changes in function regardless of whether they occur early or late in the history of vascular plants.	[Leslie, Andrew B.] Stanford Univ, Geol Sci Dept, 450 Jane Stanford Way,Bldg 320,Room 118, Stanford, CA 94305 USA; [Simpson, Carl] Univ Colorado, Museum Nat Hist, Geol Sci, Campus Box 265, Boulder, CO 80304 USA; [Mander, Luke] Open Univ, Sch Environm Earth & Ecosyst Sci, Milton Keynes MK7 6AA, Bucks, England	Stanford University; University of Colorado System; University of Colorado Boulder; Open University - UK	Leslie, AB (corresponding author), Stanford Univ, Geol Sci Dept, 450 Jane Stanford Way,Bldg 320,Room 118, Stanford, CA 94305 USA.	aleslieb@stanford.edu		Leslie, Andrew/0000-0002-9011-6888; Simpson, Carl/0000-0003-0719-4437				[Anonymous], 1862, VARIOUS CONTRIVANCES; Benson M, 1908, PHILOS T R SOC LON B, V199, P409, DOI 10.1098/rstb.1908.0010; Christenhusz MJM, 2014, ANN BOT-LONDON, V113, P571, DOI 10.1093/aob/mct299; Clark JW, 2018, TRENDS PLANT SCI, V23, P933, DOI 10.1016/j.tplants.2018.07.006; Crepet WL, 2019, INT J PLANT SCI, V180, P800, DOI 10.1086/705001; De La Torre AR, 2017, MOL BIOL EVOL, V34, P1363, DOI 10.1093/molbev/msx069; Deline B, 2018, P NATL ACAD SCI USA, V115, pE8909, DOI 10.1073/pnas.1810575115; Dellinger A.S., 2019, COMMUN BIOL, V2, P453, DOI DOI 10.1038/s42003-019-0725-7; Doyle JA, 2008, INT J PLANT SCI, V169, P816, DOI 10.1086/589887; EDWARDS D, 1992, NATURE, V357, P683, DOI 10.1038/357683a0; Endress PK, 2016, ANN BOT-LONDON, V117, P749, DOI 10.1093/aob/mcv119; Endress PK, 2011, AM J BOT, V98, P370, DOI 10.3732/ajb.1000299; Erwin DH, 2011, SCIENCE, V334, P1091, DOI 10.1126/science.1206375; FOOTE M, 1992, PALEOBIOLOGY, V18, P1, DOI 10.1017/S0094837300012185; Friis E. M., 2011, EARLY FLOWERS ANGIOS; Friis EM, 2007, NATURE, V450, P549, DOI 10.1038/nature06278; Harder LD, 2009, NEW PHYTOL, V183, P530, DOI 10.1111/j.1469-8137.2009.02914.x; Hernandez-Castillo GR, 2001, AM J BOT, V88, P1139, DOI 10.2307/2657097; Hilton J, 2006, J TORREY BOT SOC, V133, P119, DOI 10.3159/1095-5674(2006)133[119:PATBOS]2.0.CO;2; Hopkins MJ, 2015, P NATL ACAD SCI USA, V112, P3758, DOI 10.1073/pnas.1418153112; Hughes M, 2013, P NATL ACAD SCI USA, V110, P13875, DOI 10.1073/pnas.1302642110; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P554, DOI 10.1098/rspb.2010.1004; Kenrick P., 1997, ORIGIN EARLY DIVERSI; KNOLL AH, 1979, SCIENCE, V206, P1400, DOI 10.1126/science.206.4425.1400; Leebens-Mack JH, 2019, NATURE, V574, P679, DOI 10.1038/s41586-019-1693-2; Leslie A. B, 2021, COMPLEXITY CHARACTER, DOI 10.5061/dryad.w0vt4b8qx; Li HT, 2019, NAT PLANTS, V5, P461, DOI 10.1038/s41477-019-0421-0; Marshall CR, 2006, ANNU REV EARTH PL SC, V34, P355, DOI 10.1146/annurev.earth.33.031504.103001; Martinez C, 2017, AM J BOT, V104, P1857, DOI 10.3732/ajb.1700224; Mathews S, 2012, NEW PHYTOL, V194, P910, DOI 10.1111/j.1469-8137.2012.04091.x; McShea D. W., 2010, BIOL 1 LAW TENDENCY; McShea DW, 2016, EVOL BIOL, V43, P531, DOI 10.1007/s11692-015-9323-x; Moles AT, 2005, SCIENCE, V307, P576, DOI 10.1126/science.1104863; NIKLAS KJ, 1985, BOT REV, V51, P328, DOI 10.1007/BF02861079; NIXON KC, 1994, ANN MO BOT GARD, V81, P484, DOI 10.2307/2399901; PHILLIPS TL, 1979, REV PALAEOBOT PALYNO, V27, P239, DOI 10.1016/0034-6667(79)90014-9; Pryer KM, 2004, AM J BOT, V91, P1582, DOI 10.3732/ajb.91.10.1582; R Core Team, 2018, R LANG ENV STAT COMP; Rothwell GW, 2002, AM J BOT, V89, P1447, DOI 10.3732/ajb.89.9.1447; Sauquet H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16047; Simonin KA, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003706; Terry I, 2007, SCIENCE, V318, P70, DOI 10.1126/science.1145147; Traverse A., 1988, Historical Biology, V1, P277; VALENTINE JW, 1994, PALEOBIOLOGY, V20, P131, DOI 10.1017/S0094837300012641; van der Niet T, 2012, TRENDS ECOL EVOL, V27, P353, DOI 10.1016/j.tree.2012.02.002; Wang J, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2013442118; Wellman CH, 2003, NATURE, V425, P282, DOI 10.1038/nature01884; Williams JH, 2008, P NATL ACAD SCI USA, V105, P11259, DOI 10.1073/pnas.0800036105; Zomlefer WB., 1994, GUIDE FLOWERING PLAN	49	6	6	10	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2021	373	6561					1368	+		10.1126/science.abi6984	http://dx.doi.org/10.1126/science.abi6984			105	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	US5SK	34529461	Green Accepted			2022-12-28	WOS:000697488600051
J	Zhao, ST; Zhang, RP; Yu, Q; Ell, J; Ritchie, RO; Minor, AM				Zhao, Shiteng; Zhang, Ruopeng; Yu, Qin; Ell, Jon; Ritchie, Robert O.; Minor, Andrew M.			Cryoforged nanotwinned titanium with ultrahigh strength and ductility	SCIENCE			English	Article							MECHANICAL-PROPERTIES; STRAIN-RATE; PURE TITANIUM; DEFORMATION; METALS; BEHAVIOR; FRACTURE; STEEL; TEMPERATURE	Nanostructured metals are usually strong because the ultrahigh density of internal boundaries restricts the mean free path of dislocations. Usually, they are also more brittle because of their diminished work-hardening ability. Nanotwinned materials, with coherent interfaces of mirror symmetry, can overcome this inherent trade-off. We show a bulk nanostructuring method that produces a multiscale, hierarchical twin architecture in a hexagonal closed-packed, solute-free, and coarse-grained titanium (Ti), with a substantial enhancement of tensile strength and ductility. Pure Ti achieved an ultimate tensile strength of almost 2 gigapascals and a true failure strain close to 100% at 77 kelvin. The multiscale twin structures are thermally stable up to 873 kelvin, which is above the critical temperature for many applications in extreme environments. Our results demonstrate a practical route to achieve attractive mechanical properties in Ti without involving exotic and often expensive alloying elements.	[Zhao, Shiteng; Zhang, Ruopeng; Ell, Jon; Ritchie, Robert O.; Minor, Andrew M.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Zhao, Shiteng; Zhang, Ruopeng; Minor, Andrew M.] Lawrence Berkeley Natl Lab, Natl Ctr Electron Microscopy, Mol Foundry, Berkeley, CA 94720 USA; [Zhao, Shiteng] Beihang Univ, Sch Mat Sci & Engn, Beijing 100191, Peoples R China; [Yu, Qin; Ell, Jon; Ritchie, Robert O.] Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Beihang University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Zhao, ST; Minor, AM (corresponding author), Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA.; Zhao, ST; Minor, AM (corresponding author), Lawrence Berkeley Natl Lab, Natl Ctr Electron Microscopy, Mol Foundry, Berkeley, CA 94720 USA.; Zhao, ST (corresponding author), Beihang Univ, Sch Mat Sci & Engn, Beijing 100191, Peoples R China.	szhao@buaa.edu.cn; aminor@berkeley.edu	Yu, Qin/J-9116-2019; Zhao, Shiteng/L-7907-2018	Yu, Qin/0000-0002-5099-0327; Zhang, Ruopeng/0000-0001-7677-4051; Minor, Andrew/0000-0003-3606-8309; Zhao, Shiteng/0000-0003-4828-9651				Chen Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8036; Cheng Z, 2018, SCIENCE, V362, P559, DOI 10.1126/science.aau1925; Chichili DR, 1998, ACTA MATER, V46, P1025, DOI 10.1016/S1359-6454(97)00287-5; Choi SW, 2018, MAT SCI ENG A-STRUCT, V738, P75, DOI 10.1016/j.msea.2018.09.091; CONRAD H, 1981, PROG MATER SCI, V26, P123, DOI 10.1016/0079-6425(81)90001-3; Cordero ZC, 2016, INT MATER REV, V61, P495, DOI 10.1080/09506608.2016.1191808; Fu RD, 2001, J MATER ENG PERFORM, V10, P456, DOI 10.1361/105994901770344881; Gludovatz B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10602; Gludovatz B, 2014, SCIENCE, V345, P1153, DOI 10.1126/science.1254581; Gray GT, 1997, J PHYS IV, V7, P423, DOI 10.1051/jp4:1997373; Grimes RW, 2008, NAT MATER, V7, P683, DOI 10.1038/nmat2266; Hansen N, 2004, SCRIPTA MATER, V51, P801, DOI 10.1016/j.scriptamat.2004.06.002; Hielscher R, 2008, J APPL CRYSTALLOGR, V41, P1024, DOI 10.1107/S0021889808030112; Hodge AM, 2008, SCRIPTA MATER, V59, P163, DOI 10.1016/j.scriptamat.2008.02.048; Huang Q, 2014, NATURE, V510, P250, DOI 10.1038/nature13381; Jonas JJ, 2011, ACTA MATER, V59, P2046, DOI 10.1016/j.actamat.2010.12.005; Kumar KS, 2003, ACTA MATER, V51, P5743, DOI 10.1016/j.actamat.2003.08.032; Li XY, 2020, NAT REV MATER, V5, P706, DOI 10.1038/s41578-020-0212-2; Li X, 2019, SCIENCE, V364, P733, DOI 10.1126/science.aaw9905; Li ZM, 2016, NATURE, V534, P227, DOI 10.1038/nature17981; Lu K, 2009, SCIENCE, V324, P349, DOI 10.1126/science.1159610; Lu L, 2009, SCIENCE, V323, P607, DOI 10.1126/science.1167641; Lu L, 2000, SCIENCE, V287, P1463, DOI 10.1126/science.287.5457.1463; Lutjering G., 2007, TITANIUM ENG MAT PRO, V2; Lutjering G., 2007, TITANIUM ENG MAT PRO, V2; Lutjering G., 2007, TITANIUM; Ma E, 2004, APPL PHYS LETT, V85, P4932, DOI 10.1063/1.1814431; MECKING H, 1981, ACTA METALL MATER, V29, P1865, DOI 10.1016/0001-6160(81)90112-7; Meyers MA, 2006, PROG MATER SCI, V51, P427, DOI 10.1016/j.pmatsci.2005.08.003; Meyers MA, 2001, ACTA MATER, V49, P4025, DOI 10.1016/S1359-6454(01)00300-7; Miura R., 1983, AUSTENITIC STEELS LO, P287; Mu SJ, 2012, ACTA MATER, V60, P2043, DOI 10.1016/j.actamat.2012.01.014; Otto F, 2013, ACTA MATER, V61, P5743, DOI 10.1016/j.actamat.2013.06.018; Pan QS, 2017, NATURE, V551, P214, DOI 10.1038/nature24266; Pantleon W, 2008, SCRIPTA MATER, V58, P994, DOI 10.1016/j.scriptamat.2008.01.050; Ruidong F., 2001, J MATER ENG PERFORM, V10, P456; Savitzky B. H., 2021, MICROSC MICROANAL, P1; Savitzky BH, 2021, MICROSC MICROANAL, V27, P712, DOI 10.1017/S1431927621000477; Shvindlerman L. S., 1999, CRC MAT SCI TECHNOL; SONG SG, 1995, METALL MATER TRANS A, V26, P2665, DOI 10.1007/BF02669423; Sun JL, 2013, SCRIPTA MATER, V69, P428, DOI 10.1016/j.scriptamat.2013.06.001; Sun LG, 2018, NPJ COMPUT MATER, V4, DOI 10.1038/s41524-018-0062-2; SYN CK, 1976, METALL TRANS A, V7, P1827, DOI 10.1007/BF02654977; TOME CN, 1991, ACTA METALL MATER, V39, P2667, DOI 10.1016/0956-7151(91)90083-D; Topolski K, 2020, J MATER SCI, V55, P4910, DOI 10.1007/s10853-019-04291-0; Valiev R, 2004, NAT MATER, V3, P511, DOI 10.1038/nmat1180; Valiev RZ, 2002, J MATER RES, V17, P5, DOI 10.1557/JMR.2002.0002; Wei YJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4580; WILLIAMS DN, 1952, NATURE, V170, P146, DOI 10.1038/170146a0; Won JW, 2020, SCRIPTA MATER, V178, P94, DOI 10.1016/j.scriptamat.2019.11.009; Wu XL, 2015, P NATL ACAD SCI USA, V112, P14501, DOI 10.1073/pnas.1517193112; Yan FK, 2012, ACTA MATER, V60, P1059, DOI 10.1016/j.actamat.2011.11.009; Yip S, 1998, NATURE, V391, P532, DOI 10.1038/35254; Yuschenko K. A., 1984, ADV CRYOGENIC ENG MA, P271; Yushchenko K. A., 1984, ADV CRYOGENIC ENG MA, P271; Zeltmann SE, 2020, ULTRAMICROSCOPY, V209, DOI 10.1016/j.ultramic.2019.112890; Zeng Z, 2015, ACTA MATER, V98, P313, DOI 10.1016/j.actamat.2015.07.055; Zhang ZJ, 2017, NAT COMMUN, V8, DOI [10.1038/ncomms14390, 10.1038/ncomms14560]; Zhu YT, 2012, PROG MATER SCI, V57, P1, DOI 10.1016/j.pmatsci.2011.05.001	60	58	58	80	241	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2021	373	6561					1363	+		10.1126/science.abe7252	http://dx.doi.org/10.1126/science.abe7252			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	US5SK	34529490				2022-12-28	WOS:000697488600050
J	Bonnemann, CG				Bonnemann, Carsten G.			Designer AAV muscle up	CELL			English	Editorial Material							YIELDS	Directed evolution of AAV capsids has been a successful strategy for generating bespoke serotypes to target gene therapies more specifically to the intended tissue. This has now been achieved for the largest organ, skeletal muscle, by selecting for an RGD containing integrin binding heptamer in a hypervariable region of the capsid of AAV9.	[Bonnemann, Carsten G.] NINDS, Neuromuscular & Neurogenet Disorders Childhood Se, Neurogenet Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Bonnemann, CG (corresponding author), NINDS, Neuromuscular & Neurogenet Disorders Childhood Se, Neurogenet Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	carsten.bonnemann@nih.gov			NINDS/NIH	NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	I would like to thank members of my group as well as outside colleagues for insightful discussions. Research in my own group is supported by intramural funds of the NINDS/NIH.	Deverman BE, 2016, NAT BIOTECHNOL, V34, P204, DOI 10.1038/nbt.3440; Duan DS, 2018, MOL THER, V26, P2337, DOI 10.1016/j.ymthe.2018.07.011; Herrmann AK, 2019, ACS SYNTH BIOL, V8, P194, DOI 10.1021/acssynbio.8b00373; Hordeaux J, 2019, MOL THER, V27, P912, DOI 10.1016/j.ymthe.2019.02.013; Maheshri N, 2006, NAT BIOTECHNOL, V24, P198, DOI 10.1038/nbt1182; Paulk N, 2020, GENET ENG BIOTECHN N; Pipe S, 2019, MOL THER-METH CLIN D, V15, P170, DOI 10.1016/j.omtm.2019.08.015; Tabebordbar M, 2021, CELL, V184, P4919, DOI 10.1016/j.cell.2021.08.028; Wang D, 2019, NAT REV DRUG DISCOV, V18, P358, DOI 10.1038/s41573-019-0012-9; Weinmann J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19230-w; Zinn E, 2015, CELL REP, V12, P1056, DOI 10.1016/j.celrep.2015.07.019	11	2	2	3	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 16	2021	184	19					4845	4847		10.1016/j.cell.2021.08.031	http://dx.doi.org/10.1016/j.cell.2021.08.031		SEP 2021	3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	WC7PA	34534462	Bronze			2022-12-28	WOS:000704445100003
J	Iacobucci, G				Iacobucci, Gareth			Doctors leaders endorse Green New Deal and will lobby for climate action	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Brooks L., BMA DEBATE ACTIONS T	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2021	374								n2283	10.1136/bmj.n2283	http://dx.doi.org/10.1136/bmj.n2283			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WI4KS	34531200				2022-12-28	WOS:000708331800004
J	Gostin, LO; Halabi, SF; Klock, KA				Gostin, Lawrence O.; Halabi, Sam F.; Klock, Kevin A.			An International Agreement on Pandemic Prevention and Preparedness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.; Halabi, Sam F.] Georgetown Univ, Law Ctr, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA; [Klock, Kevin A.] Fdn Natl Inst Hlth, North Bethesda, MD USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Law Ctr, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Klock, Kevin A./0000-0002-5281-2022				Blinken AJ, 2021, JAMA-J AM MED ASSOC, V326, P1255, DOI 10.1001/jama.2021.15611; Burci, 2020, INT ORGAN LAW REV; Gavi, COVAX VACC ROLL; @GHS, 2021, WHO D G DRTEDROS; Gostin LO., 2021, GLOBAL HLTH SECURITY; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kavanagh MM, 2021, JAMA-J AM MED ASSOC, V326, P219, DOI 10.1001/jama.2021.10823; WHO, 2021, GLOB LEAD UN URG CAL; WHO, 2020, WHO LAB BIOS MAN, V4; World Health Organization, 2021, 74 WORLD HLTH ASS WH	10	5	5	6	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 5	2021	326	13					1257	1258		10.1001/jama.2021.16104	http://dx.doi.org/10.1001/jama.2021.16104		SEP 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WD9JC	34524388	Green Submitted, Bronze			2022-12-28	WOS:000696615900002
J	Cantor, A; Dana, T; Griffin, JC; Nelson, HD; Weeks, C; Winthrop, KL; Chou, R				Cantor, Amy; Dana, Tracy; Griffin, Jessica C.; Nelson, Heidi D.; Weeks, Chandler; Winthrop, Kevin L.; Chou, Roger			Screening for Chlamydial and Gonococcal Infections: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							NEISSERIA-GONORRHOEAE; TRACHOMATIS; SEX; MEN; SPECIMENS; PHARYNGEAL; VALIDATION; ADOLESCENT; RESISTANCE; DIAGNOSIS	ImportanceThe 2014 US Preventive Services Task Force (USPSTF) recommendation statement supported the effectiveness of screening for chlamydia and gonorrhea in asymptomatic, sexually active women 24 years or younger and in older women at increased risk for infection, although evidence for screening in men was insufficient. ObjectiveTo update the 2014 USPSTF review on screening for chlamydial and gonococcal infection in adults and adolescents, including those who are pregnant. Data SourcesCochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and Ovid MEDLINE (January 1, 2014, through May 28, 2020) with surveillance through May 21, 2021. Study SelectionRandomized clinical trials and observational studies of screening effectiveness, accuracy of risk stratification and alternative screening methods, accuracy of tests, and screening harms. Data Extraction and SynthesisOne investigator abstracted data; a second checked accuracy. Two investigators independently assessed study quality. Main Outcomes and MeasuresComplications of infection; infection transmission or acquisition; diagnostic accuracy of anatomical site-specific testing and collection methods; screening harms. ResultsTwenty-seven studies were included (N=179515). Chlamydia screening compared with no screening was significantly associated with reduced risk of pelvic inflammatory disease (PID) in 2 of 4 trials and with reduced hospital-diagnosed PID (0.24% vs 0.38%); relative risk, 0.6 [95% CI, 0.4-1.0]), but not clinic-diagnosed PID or epididymitis, in the largest trial. In studies of risk prediction instruments in asymptomatic women, age younger than 22 years demonstrated comparable accuracy to extensive criteria. Sensitivity of chlamydial testing was similar at endocervical (89%-100%) and self- and clinician-collected vaginal (90%-100%) sites for women and at meatal (100%), urethral (99%), and rectal (92%) sites for men but lower at pharyngeal sites (69.2%) for men who have sex with men. Sensitivity of gonococcal testing was 89% or greater for all anatomical samples. False-positive and false-negative testing rates were low across anatomical sites and collection methods. Conclusions and RelevanceScreening for chlamydial infection was significantly associated with a lower risk of PID in young women. Risk prediction criteria demonstrated limited accuracy beyond age. Testing for asymptomatic chlamydial and gonococcal infections was highly accurate at most anatomical sites, including urine and self-collected specimens. Effectiveness of screening in men and during pregnancy, optimal screening intervals, and adverse effects of screening require further evaluation. This systematic review to support the 2021 US Preventive Services Task Force Recommendation Statement on screening for chlamydial and gonococcal infections summarizes published evidence on the benefits and harms of screening for chlamydial and gonococcal infection in adults and adolescents, including those who are pregnant.	[Cantor, Amy; Dana, Tracy; Griffin, Jessica C.; Weeks, Chandler; Chou, Roger] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Northwest Evidence Based Practice Ctr, Portland, OR 97201 USA; [Cantor, Amy] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA; [Cantor, Amy] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; [Nelson, Heidi D.] Kaiser Permanente Bernard J Tyson Sch Med, Pasadena, CA USA; [Winthrop, Kevin L.] Oregon Hlth & Sci Univ, Dept Med, Div Infect Dis, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Kaiser Permanente; Oregon Health & Science University	Cantor, A (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	cantor@ohsu.edu		Cantor, Amy/0000-0002-4467-8484				Annan NT, 2009, SEX TRANSM INFECT, V85, P176, DOI 10.1136/sti.2008.031773; [Anonymous], 2018, PROCEDURE MANUAL; [Anonymous], 2018, SEXUALLY TRANSMITTED; [Anonymous], HIV TRANSGENDER PEOP; [Anonymous], 2014, SEX TRANSM DIS SURV; Arya R, 2005, J Obstet Gynaecol, V25, P364, DOI 10.1080/01443610500118749; Berry L, 2017, J MED MICROBIOL, V66, P134, DOI 10.1099/jmm.0.000428; Cantor A., 2021, SCREENING CHLAMYDIAL; Cecil JA, 2001, J INFECT DIS, V184, P1216, DOI 10.1086/323662; Centers for Disease Control and Prevention, 2021, SEXUALLY TRANSMITTED; Detels R, 2011, SEX TRANSM DIS, V38, P503, DOI 10.1097/OLQ.0b013e318206c288; Falasinnu T, 2016, PREV MED, V89, P51, DOI 10.1016/j.ypmed.2016.04.001; Falasinnu T, 2016, SEX TRANSM INFECT, V92, P12, DOI 10.1136/sextrans-2014-051992; Falasinnu T, 2014, SEX TRANSM DIS, V41, P732, DOI 10.1097/OLQ.0000000000000205; Fang JY, 2008, J PEDIATR ADOL GYNEC, V21, P355, DOI 10.1016/j.jpag.2008.03.010; Glass N., 2005, SCREENING GONORRHEA; Grentzer JM, 2015, CONTRACEPTION, V92, P313, DOI 10.1016/j.contraception.2015.06.012; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hocking JS, 2018, LANCET, V392, P1413, DOI 10.1016/S0140-6736(18)31816-6; Javanbakht M, 2018, SEX TRANSM DIS, V45, P588, DOI [10.1097/OLQ.0000000000000822, 10.1097/olq.0000000000000822]; Jones MLJ, 2019, MMWR-MORBID MORTAL W, V68, P321, DOI 10.15585/mmwr.mm6814a1; KLEIN EJ, 1977, ANN INTERN MED, V86, P340, DOI 10.7326/0003-4819-86-3-340; Kwong JC, 2018, SEX TRANSM INFECT, V94, P151, DOI 10.1136/sextrans-2017-053287; Lavoue V, 2014, SEX TRANSM DIS, V41, P470, DOI 10.1097/OLQ.0000000000000153; Marcus JL, 2011, SEX TRANSM DIS, V38, P922, DOI 10.1097/OLQ.0b013e31822a2b2e; Meyers DS, 2007, ANN INTERN MED, V147, P135, DOI 10.7326/0003-4819-147-2-200707170-00173; Miller WC, 2000, AM J PREV MED, V18, P115, DOI 10.1016/S0749-3797(99)00146-4; Mohammed H, 2016, EMERG INFECT DIS, V22, P88, DOI 10.3201/eid2201.151331; Moyer VA, 2013, ANN INTERN MED, V159, P51, DOI 10.7326/0003-4819-159-1-201307020-00645; Nelson HD., 2001, SCREENING CHLAMYDIAL; Nelson HD., 2014, AHRQ PUBLICATION; Nye MB, 2019, SEX TRANSM INFECT, V95, P87, DOI 10.1136/sextrans-2018-053545; Oakeshott P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1642; Ostergaard L, 2000, CLIN INFECT DIS, V31, P951, DOI 10.1086/318139; Peipert JF, 2003, NEW ENGL J MED, V349, P2424, DOI 10.1056/NEJMcp030542; Pitasi MA, 2019, SEX TRANSM DIS, V46, P112, DOI 10.1097/OLQ.0000000000000917; Schachter J, 2003, J CLIN MICROBIOL, V41, P3784, DOI 10.1128/JCM.41.8.3784-3789.2003; Schoeman SA, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8013; Scholes D, 1996, NEW ENGL J MED, V334, P1362, DOI 10.1056/NEJM199605233342103; Shrier LA, 2004, AM J OBSTET GYNECOL, V190, P654, DOI 10.1016/j.ajog.2003.09.063; Skidmore S, 2008, SEX TRANSM INFECT, V84, P277, DOI 10.1136/sti.2007.029587; Stewart CMW, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8107; Sultan B, 2016, J CLIN MICROBIOL, V54, P650, DOI 10.1128/JCM.02460-15; Unemo M, 2014, CLIN MICROBIOL REV, V27, P587, DOI 10.1128/CMR.00010-14; WIESNER PJ, 1973, NEW ENGL J MED, V288, P181, DOI 10.1056/NEJM197301252880404	45	9	10	2	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2021	326	10					957	966		10.1001/jama.2021.10577	http://dx.doi.org/10.1001/jama.2021.10577			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UW4LI	34519797	Bronze			2022-12-28	WOS:000700129100015
J	Haslam, SA				Haslam, S. Alexander			The Power of Us	SCIENCE			English	Book Review									[Haslam, S. Alexander] Univ Queensland, Psychol & Australian Laureate, St Lucia, Qld 4072, Australia	University of Queensland	Haslam, SA (corresponding author), Univ Queensland, Psychol & Australian Laureate, St Lucia, Qld 4072, Australia.	a.haslam@uq.edu.au	Haslam, Alex/AAA-2512-2019	Haslam, Alex/0000-0001-9523-7921				VANBAVEL JJ, 2021, THE POWER OF US	1	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2021	373	6560					1206	1206		10.1126/science.abl5269	http://dx.doi.org/10.1126/science.abl5269			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UP5RB	34516784				2022-12-28	WOS:000695436000018
J	Draper-Joyce, CJ; Bhola, R; Wang, JN; Bhattarai, A; Nguyen, ATN; Cowie-Kent, I; O'Sullivan, K; Chia, LY; Venugopal, H; Valant, C; Thal, DM; Wootten, D; Panel, N; Carlsson, J; Christie, MJ; White, PJ; Scammells, P; May, LT; Sexton, PM; Danev, R; Miao, YL; Glukhova, A; Imlach, WL; Christopoulos, A				Draper-Joyce, Christopher J.; Bhola, Rebecca; Wang, Jinan; Bhattarai, Apurba; Nguyen, Anh T. N.; Cowie-Kent, India; O'Sullivan, Kelly; Chia, Ling Yeong; Venugopal, Hariprasad; Valant, Celine; Thal, David M.; Wootten, Denise; Panel, Nicolas; Carlsson, Jens; Christie, Macdonald J.; White, Paul J.; Scammells, Peter; May, Lauren T.; Sexton, Patrick M.; Danev, Radostin; Miao, Yinglong; Glukhova, Alisa; Imlach, Wendy L.; Christopoulos, Arthur			Positive allosteric mechanisms of adenosine A(1) receptor-mediated analgesia	NATURE			English	Article							G-PROTEIN; MOLECULAR-DYNAMICS; FORCE-FIELD; EXTRACELLULAR LOOP; STRUCTURAL BASIS; MODULATOR; BINDING; PAIN; VALIDATION; ACTIVATION	The adenosine A(1) receptor (A,R) is a promising therapeutic target for non-opioid analgesic agents to treat neuropathic pain(1,2). However, development of analgesic orthosteric A(1)R agonists has failed because of a lack of sufficient on-target selectivity as well as off-tissue adverse effects(3). Here we show that [2-amino-4-(3,5-bis(trifluoromethyl) phenyl)thiophen-3-yl)(4-chlorophenyl)methanone] (MIPS521), a positive allosteric modulator of the A(1)R, exhibits analgesic efficacy in rats in vivo through modulation of the increased levels of endogenous adenosine that occur in the spinal cord of rats with neuropathic pain. We also report the structure of the co-bound to adenosine, MIPS521 and a G(12) heterotrimer, revealing an extrahelicallipid-detergent-facing allosteric binding pocket that involves transmembrane helixes 1, 6 and 7. Molecular dynamics simulations and ligand kinetic binding experiments support a mechanism whereby MIPS521 stabilizes the adenosine-receptor-G protein complex. This study provides proof of concept for structure-based allosteric drug design of non-opioid analgesic agents that are specific to disease contexts.	[Draper-Joyce, Christopher J.; Nguyen, Anh T. N.; Chia, Ling Yeong; Valant, Celine; Thal, David M.; Wootten, Denise; White, Paul J.; May, Lauren T.; Sexton, Patrick M.; Glukhova, Alisa; Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic, Australia; [Draper-Joyce, Christopher J.; Nguyen, Anh T. N.; Chia, Ling Yeong; Valant, Celine; Thal, David M.; Wootten, Denise; White, Paul J.; May, Lauren T.; Sexton, Patrick M.; Glukhova, Alisa; Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Dept Pharmacol, Parkville, Vic, Australia; [Bhola, Rebecca; Cowie-Kent, India; O'Sullivan, Kelly; Imlach, Wendy L.] Monash Univ, Monash Biomed Discovery Inst, Dept Physiol, Clayton, Vic, Australia; [Wang, Jinan; Bhattarai, Apurba; Miao, Yinglong] Univ Kansas, Ctr Computat Biol, Lawrence, KS 66045 USA; [Wang, Jinan; Bhattarai, Apurba; Miao, Yinglong] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Venugopal, Hariprasad] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Wootten, Denise; Sexton, Patrick M.; Christopoulos, Arthur] Monash Univ, ARC Ctr Cryoelectron Microscopy Membrane Prot, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; [Panel, Nicolas; Carlsson, Jens] Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Uppsala, Sweden; [Christie, Macdonald J.] Univ Sydney, Fac Med & Hlth, Discipline Pharmacol, Camperdown, NSW, Australia; [Scammells, Peter] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, Parkville, Vic, Australia; [Danev, Radostin] Univ Tokyo, Grad Sch Med, Tokyo, Japan; [Draper-Joyce, Christopher J.] Univ Melbourne, Frorey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Glukhova, Alisa] Walter & Eliza Hall Inst Med Res, Struct Biol Div, Parkville, Vic, Australia; [Glukhova, Alisa] Univ Melbourne, Dept Biochem & Pharmacol, Parkville, Vic, Australia	Monash University; Monash University; Monash University; University of Kansas; University of Kansas; Monash University; Monash University; Uppsala University; University of Sydney; Monash University; University of Tokyo; University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne	Glukhova, A; Christopoulos, A (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic, Australia.; Glukhova, A; Christopoulos, A (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Dept Pharmacol, Parkville, Vic, Australia.; Imlach, WL (corresponding author), Monash Univ, Monash Biomed Discovery Inst, Dept Physiol, Clayton, Vic, Australia.; Christopoulos, A (corresponding author), Monash Univ, ARC Ctr Cryoelectron Microscopy Membrane Prot, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia.; Glukhova, A (corresponding author), Walter & Eliza Hall Inst Med Res, Struct Biol Div, Parkville, Vic, Australia.; Glukhova, A (corresponding author), Univ Melbourne, Dept Biochem & Pharmacol, Parkville, Vic, Australia.	glukhova.a@wehi.edu.au; wendy.imlach@monash.edu; arthur.christopoulos@monash.edu	Nguyen, Anh/GPK-4377-2022; Wootten, Denise/ABD-5703-2021; Thal, David/GXH-4911-2022; Nguyen, Anh/GQQ-3393-2022; Imlach, Wendy/G-7609-2011	Nguyen, Anh/0000-0002-6385-0585; Wootten, Denise/0000-0003-4563-1642; Draper-Joyce, Christopher/0000-0003-2055-7706; Glukhova, Alisa/0000-0003-4146-965X; May, Lauren/0000-0002-4412-1707; Valant, Celine/0000-0002-2509-7465; Imlach, Wendy/0000-0002-7521-9969	National Health and Medical Research Council of Australia (NHMRC) [1145420, 1147291, 1050083]; American Heart Association [17SDG33370094]; National Institutes of Health [R01GM132572]; Australian Research Council; Swedish Research Council [2017-04676, VCP171, MIPS521]; MASSIVE HPC facility; Extreme Science and Engineering Discovery Environment supercomputing [TG-MCB180049]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); Swedish Research Council(Swedish Research CouncilEuropean Commission); MASSIVE HPC facility; Extreme Science and Engineering Discovery Environment supercomputing	This work was supported by the National Health and Medical Research Council of Australia (NHMRC) project grants 1145420 and 1147291, NHMRC program grant 1050083, American Heart Association grant 17SDG33370094 and the National Institutes of Health grant R01GM132572. P.M.S., W.L.I. and D.W. are NHMRC Senior Principal Research, Career Development and Senior Research Fellows, respectively. C.J.D.-J., A.G. and D.M.T. are Australian Research Council Discovery Early Career Research Fellows. L.T.M. is an Australian Heart Foundation Future Leaders Fellow. J.C. acknowledges support from the Swedish Research Council (2017-04676). We are grateful to S. Charman and K. White for performing the VCP171 and MIPS521 plasma and liver microsome stability studies. We acknowledge use of facilities within the Monash Ramaciotti Cryo-EM platform. This work was supported by the MASSIVE HPC facility (https://www.massive.org.au) and the Extreme Science and Engineering Discovery Environment supercomputing award TG-MCB180049.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aurelio L, 2009, J MED CHEM, V52, P4543, DOI 10.1021/jm9002582; Baltos JA, 2016, BIOCHEM PHARMACOL, V99, P101, DOI 10.1016/j.bcp.2015.11.013; Bernstein N, 2012, PHYS CHEM CHEM PHYS, V14, P646, DOI 10.1039/c1cp22600b; Bonin RP, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-26; BRUNS RF, 1990, MOL PHARMACOL, V38, P939; Busse JW, 2018, JAMA-J AM MED ASSOC, V320, P2448, DOI 10.1001/jama.2018.18472; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng RKY, 2017, NATURE, V545, P112, DOI 10.1038/nature22309; Childers SR, 2005, J NEUROCHEM, V93, P715, DOI 10.1111/j.1471-4159.2005.03044.x; CHOCA JI, 1987, J PHARMACOL EXP THER, V242, P905; CHOCA JI, 1988, J PHARMACOL EXP THER, V247, P757; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeVree BT, 2016, NATURE, V535, P182, DOI 10.1038/nature18324; Draper-Joyce CJ, 2018, NATURE, V558, P559, DOI 10.1038/s41586-018-0236-6; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Dror RO, 2015, SCIENCE, V348, P1361, DOI 10.1126/science.aaa5264; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GEIGER JD, 1984, J NEUROSCI, V4, P2303; Glukhova A, 2017, CELL, V168, P867, DOI 10.1016/j.cell.2017.01.042; Gramec D, 2014, CHEM RES TOXICOL, V27, P1344, DOI 10.1021/tx500134g; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Imlach WL, 2016, SCI REP-UK, V6, DOI 10.1038/srep37104; Imlach WL, 2015, MOL PHARMACOL, V88, P460, DOI 10.1124/mol.115.099499; Johansson B, 2001, P NATL ACAD SCI USA, V98, P9407, DOI 10.1073/pnas.161292398; King A, 2019, NATURE, V573, pS4, DOI 10.1038/d41586-019-02683-5; King T, 2009, NAT NEUROSCI, V12, P1364, DOI 10.1038/nn.2407; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Leach K, 2010, NEUROPSYCHOPHARMACOL, V35, P855, DOI 10.1038/npp.2009.194; Li XH, 2002, PAIN, V97, P117, DOI 10.1016/S0304-3959(02)00011-8; Liang YL, 2018, ACS PHARMACOL TRANSL, V1, P12, DOI 10.1021/acsptsci.8b00017; Liu XY, 2019, SCIENCE, V364, P1283, DOI 10.1126/science.aaw8981; Lu J, 2017, NAT STRUCT MOL BIOL, V24, P570, DOI 10.1038/nsmb.3417; Maeda S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06002-w; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; Miao YL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35266-x; Miao YL, 2018, P NATL ACAD SCI USA, V115, P3036, DOI 10.1073/pnas.1800756115; Miao YL, 2016, P NATL ACAD SCI USA, V113, P12162, DOI 10.1073/pnas.1614538113; Miao YL, 2015, J CHEM THEORY COMPUT, V11, P3584, DOI 10.1021/acs.jctc.5b00436; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nakamura I, 1997, ANESTHESIOLOGY, V87, P577, DOI 10.1097/00000542-199709000-00018; Nguyen ATN, 2016, MOL PHARMACOL, V90, P703, DOI 10.1124/mol.116.105007; Nguyen ATN, 2016, MOL PHARMACOL, V90, P715, DOI 10.1124/mol.116.105015; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Poon A, 1998, PAIN, V74, P235, DOI 10.1016/S0304-3959(97)00186-3; Ribeiro JA, 2002, PROG NEUROBIOL, V68, P377, DOI 10.1016/S0301-0082(02)00155-7; Robertson N, 2018, NATURE, V553, P111, DOI 10.1038/nature25025; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schorb M, 2019, NAT METHODS, V16, P471, DOI 10.1038/s41592-019-0396-9; Schulte G, 2003, NEUROSCIENCE, V121, P907, DOI 10.1016/S0306-4522(03)00480-9; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Shao ZH, 2019, NAT CHEM BIOL, V15, P1199, DOI 10.1038/s41589-019-0387-2; Storkson RV, 1996, J NEUROSCI METH, V65, P167, DOI 10.1016/0165-0270(95)00164-6; Thal DM, 2018, NATURE, V559, P45, DOI 10.1038/s41586-018-0259-z; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Valant C, 2014, P NATL ACAD SCI USA, V111, P4614, DOI 10.1073/pnas.1320962111; Vanommeslaeghe K, 2015, BBA-GEN SUBJECTS, V1850, P861, DOI 10.1016/j.bbagen.2014.08.004; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3155, DOI 10.1021/ci3003649; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3144, DOI 10.1021/ci300363c; Vincenzi F, 2014, NEUROPHARMACOLOGY, V81, P6, DOI 10.1016/j.neuropharm.2014.01.028; Wang JN, 2019, J PHYS CHEM B, V123, P6462, DOI 10.1021/acs.jpcb.9b04867; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wu ZY, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00055; Yang ZQ, 2002, AM J PHYSIOL-HEART C, V282, pH949, DOI 10.1152/ajpheart.00741.2001; Zhang DD, 2015, NATURE, V520, P317, DOI 10.1038/nature14287; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhuang YW, 2021, CELL RES, V31, P593, DOI 10.1038/s41422-021-00482-0; Zylka MJ, 2011, TRENDS MOL MED, V17, P188, DOI 10.1016/j.molmed.2010.12.006	73	25	24	7	34	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2021	597	7877					571	+		10.1038/s41586-021-03897-2	http://dx.doi.org/10.1038/s41586-021-03897-2		SEP 2021	25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UW6NQ	34497422	Green Accepted			2022-12-28	WOS:000693875600006
J	Pruitt, RN; Locci, F; Wanke, F; Zhang, LS; Saile, SC; Joe, A; Karelina, D; Hua, CL; Frohlich, K; Wan, WL; Hu, MJ; Rao, SF; Stolze, SC; Harzen, A; Gust, AA; Harter, K; Joosten, MHAJ; Thomma, BPHJ; Zhou, JM; Dangl, JL; Weigel, D; Nakagami, H; Oecking, C; El Kasmi, F; Parker, JE; Nurnberger, T				Pruitt, Rory N.; Locci, Federica; Wanke, Friederike; Zhang, Lisha; Saile, Svenja C.; Joe, Anna; Karelina, Darya; Hua, Chenlei; Froehlich, Katja; Wan, Wei-Lin; Hu, Meijuan; Rao, Shaofei; Stolze, Sara C.; Harzen, Anne; Gust, Andrea A.; Harter, Klaus; Joosten, Matthieu H. A. J.; Thomma, Bart P. H. J.; Zhou, Jian-Min; Dangl, Jeffery L.; Weigel, Detlef; Nakagami, Hirofumi; Oecking, Claudia; El Kasmi, Farid; Parker, Jane E.; Nuernberger, Thorsten			The EDS1-PAD4-ADR1 node mediates Arabidopsis pattern-triggered immunity	NATURE			English	Article							RECEPTOR-LIKE PROTEINS; PLANT; VECTORS; KINASE; COMPLEX; DOMAIN; GENES; EDS1; PAD4	Plants deploy cell-surface and intracellular leucine rich-repeat domain (LRR) immune receptors to detect pathogens(1). LRR receptor kinases and LRR receptor proteins at the plasma membrane recognize microorganism-derived molecules to elicit pattern-triggered immunity (PTI), whereas nucleotide-binding LRR proteins detect microbial effectors inside cells to confer effector-triggered immunity (ETI). Although PTI and ETI are initiated in different host cell compartments, they rely on the transcriptional activation of similar sets of genes(2), suggesting pathway convergence upstream of nuclear events. Here we report that PTI triggered by the Arabidopsis LRR receptor protein RLP23 requires signalling-competent dimers of the lipase-like proteins EDS1 and PAD4, and of ADR1 family helper nucleotide-binding LRRs, which are all components of ETI. The cell-surface LRR receptor kinase SOBIR1 links RLP23 with EDS1, PAD4 and ADR1 proteins, suggesting the formation of supramolecular complexes containing PTI receptors and transducers at the inner side of the plasma membrane. We detected similar evolutionary patterns in LRR receptor protein and nucleotide-binding LRR genes across Arabidopsis accessions; overall higher levels of variation in LRR receptor proteins than in LRR receptor kinases are consistent with distinct roles of these two receptor families in plant immunity. We propose that the EDS1-PAD4-ADR1 node is a convergence point for defence signalling cascades, activated by both surface-resident and intracellular LRR receptors, in conferring pathogen immunity.	[Pruitt, Rory N.; Zhang, Lisha; Joe, Anna; Hua, Chenlei; Froehlich, Katja; Wan, Wei-Lin; Gust, Andrea A.; Nuernberger, Thorsten] Univ Tubingen, Ctr Plant Mol Biol ZMBP, Dept Plant Biochem, Tubingen, Germany; [Locci, Federica; Parker, Jane E.] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Cologne, Germany; [Wanke, Friederike; Saile, Svenja C.; Harter, Klaus; Oecking, Claudia; El Kasmi, Farid] Univ Tubingen, Ctr Plant Mol Biol ZMBP, Dept Plant Physiol, Tubingen, Germany; [Karelina, Darya; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany; [Hu, Meijuan; Rao, Shaofei; Zhou, Jian-Min] Chinese Acad Sci, Innovat Acad Seed Design, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing, Peoples R China; [Stolze, Sara C.; Harzen, Anne; Nakagami, Hirofumi] Max Planck Inst Plant Breeding Res, Prote Grp, Cologne, Germany; [Joosten, Matthieu H. A. J.; Thomma, Bart P. H. J.] Wageningen Univ, Lab Phytopathol, Wageningen, Netherlands; [Thomma, Bart P. H. J.; Parker, Jane E.] Cologne Univ, Cluster Excellence Kant Sci CEPLAS, Cologne, Germany; [Dangl, Jeffery L.] Univ N Carolina, Dept Biol, Howard Hughes Med Inst, Chapel Hill, NC 27515 USA; [Nuernberger, Thorsten] Univ Johannesburg, Dept Biochem, Johannesburg, South Africa; [Wan, Wei-Lin] Natl Univ Singapore, Dept BioLogicalSci, Singapore, Singapore; [Rao, Shaofei] Ningbo Univ, Inst Plant Virol, State Key Lab Managing Biot & Chem Threats Qual &, Ningbo, Peoples R China	Eberhard Karls University of Tubingen; Max Planck Society; Eberhard Karls University of Tubingen; Max Planck Society; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Max Planck Society; Wageningen University & Research; University of Cologne; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of Johannesburg; National University of Singapore; Ningbo University	Nurnberger, T (corresponding author), Univ Tubingen, Ctr Plant Mol Biol ZMBP, Dept Plant Biochem, Tubingen, Germany.; Parker, JE (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Cologne, Germany.; Parker, JE (corresponding author), Cologne Univ, Cluster Excellence Kant Sci CEPLAS, Cologne, Germany.; Nurnberger, T (corresponding author), Univ Johannesburg, Dept Biochem, Johannesburg, South Africa.	parker@mpipz.mpg.de; nuernberger@uni-tuebingen.de	Weigel, Detlef/GSJ-0799-2022; Joosten, Matthieu/AAB-5131-2022; El Kasmi, Farid/AHC-5099-2022; Weigel, Detlef/C-1418-2008; Joosten, Matthieu/AAB-5150-2022; Weigel, Detlef/AAR-3312-2021; Nakagami, Hirofumi/A-4122-2011	Weigel, Detlef/0000-0002-2114-7963; Joosten, Matthieu/0000-0002-6243-4547; Weigel, Detlef/0000-0002-2114-7963; Nakagami, Hirofumi/0000-0003-2569-7062; Wanke, Friederike/0000-0001-6080-8800; El Kasmi, Farid/0000-0002-4634-7689; Frohlich, Katja/0000-0002-9491-5927; Zhang, Lisha/0000-0002-8203-2369; Pruitt, Rory/0000-0002-4134-8156; Harzen, Anne/0000-0001-7370-4939; Saile, Svenja/0000-0003-2258-3166	Deutsche Forschungsgemeinschaft (DFG) [Nu 70/15-1]; ERA-CAPS-Grant SICOPID [Nu 70/16-1, CRC-1101, CRC-1403-414786233]; Reinhard Frank Stiftung; Max Planck Society	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); ERA-CAPS-Grant SICOPID; Reinhard Frank Stiftung; Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by Deutsche Forschungsgemeinschaft (DFG) grants Nu 70/15-1 and ERA-CAPS-Grant SICOPID Nu 70/16-1 to T.N.; grant CRC-1101 to K.H., C.O., D.W., F.E.K. and T.N., and grant CRC-1403-414786233 to J.E.P. S. C. Saile was supported by the Reinhard Frank Stiftung (Project 'helperless plant'). F.L., J.E.P., H.N., D.K. and D.W. were supported by the Max Planck Society. We thank S. Harter, M. Fechter, B. Loffelhardt and V. Scholz for assistance with cloning and genotyping; B. Kemmerling for statistical data evaluation; E. Chae for annotation information of NLRs; and P. Schulze-Lefert for the Lysobacter strain Root690.	Albert M, 2010, EUR J CELL BIOL, V89, P200, DOI 10.1016/j.ejcb.2009.11.015; Alonso-Blanco C, 2016, CELL, V166, P481, DOI 10.1016/j.cell.2016.05.063; Bai Y, 2015, NATURE, V528, P364, DOI 10.1038/nature16192; Bhandari DD, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08783-0; Bohm H, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004491; Bottcher C, 2009, PLANT CELL, V21, P1830, DOI 10.1105/tpc.109.066670; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Chen HM, 2008, PLANT PHYSIOL, V146, P368, DOI 10.1104/pp.107.111740; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cui HT, 2017, NEW PHYTOL, V213, P1802, DOI 10.1111/nph.14302; Deutsch EW, 2020, NUCLEIC ACIDS RES, V48, pD1145, DOI 10.1093/nar/gkz984; El Kasmi F, 2017, P NATL ACAD SCI USA, V114, pE7385, DOI 10.1073/pnas.1708288114; Fan L., 2021, GENOTYPING SEQUENCIN, DOI [10.1101/2021.03.04.433884, DOI 10.1101/2021.03.04.433884]; Feehan JM, 2020, CURR OPIN PLANT BIOL, V56, P99, DOI 10.1016/j.pbi.2020.04.006; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Glockner N., 2020, PRIPRINT, DOI [10.1101/722124, DOI 10.1101/722124]; Grefen C, 2012, BIOTECHNIQUES, V53, P311, DOI 10.2144/000113941; Guo YL, 2011, PLANT PHYSIOL, V157, P757, DOI 10.1104/pp.111.181990; Gust AA, 2017, TRENDS PLANT SCI, V22, P779, DOI 10.1016/j.tplants.2017.07.005; Jehle AK, 2013, PLANT CELL, V25, P2330, DOI 10.1105/tpc.113.110833; Jin L, 2017, METHODS MOL BIOL, V1578, P195, DOI 10.1007/978-1-4939-6859-6_16; Joglekar S, 2018, PLANT CELL PHYSIOL, V59, P1592, DOI 10.1093/pcp/pcy106; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Koenig D, 2019, ELIFE, V8, DOI 10.7554/eLife.43606; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Kurup S, 2005, PLANT J, V42, P444, DOI 10.1111/j.1365-313X.2005.02386.x; Lapin D, 2019, PLANT CELL, V31, P2430, DOI 10.1105/tpc.19.00118; Lapin D, 2020, ANNU REV PHYTOPATHOL, V58, P253, DOI 10.1146/annurev-phyto-010820-012840; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liebrand TWH, 2013, P NATL ACAD SCI USA, V110, P10010, DOI 10.1073/pnas.1220015110; Lin ZJD, 2015, PLANT PHYSIOL, V169, P2950, DOI 10.1104/pp.15.01391; Lu Y, 2021, MOL PLANT MICROBE IN, V34, P3, DOI 10.1094/MPMI-08-20-0239-IA; Mehlhorn DG, 2018, METHODS MOL BIOL, V1691, P139, DOI 10.1007/978-1-4939-7389-7_11; Mishina TE, 2006, PLANT PHYSIOL, V141, P1666, DOI 10.1104/pp.106.081257; Monteiro F, 2018, ANNU REV PHYTOPATHOL, V56, P243, DOI 10.1146/annurev-phyto-080417-045817; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Ngou BPM, 2021, NATURE, V592, P110, DOI 10.1038/s41586-021-03315-7; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Rao SF, 2018, PLANT PHYSIOL, V177, P1679, DOI 10.1104/pp.18.00486; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Reuter L., 2021, PREPRINT, DOI [10.1101/2021.04.09.439179, DOI 10.1101/2021.04.09.439179]; Saile SC, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000783; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Sun X., 2021, NAT COMMUN, V12; Thomma BPHJ, 2011, PLANT CELL, V23, P4, DOI 10.1105/tpc.110.082602; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Wagner S, 2013, CELL HOST MICROBE, V14, P619, DOI 10.1016/j.chom.2013.11.006; Wan WL, 2019, CURR OPIN PLANT BIOL, V50, P18, DOI 10.1016/j.pbi.2019.02.001; Wan WL, 2019, NEW PHYTOL, V221, P2080, DOI 10.1111/nph.15497; Wang GD, 2008, PLANT PHYSIOL, V147, P503, DOI 10.1104/pp.108.119487; Willmann R, 2014, METHODS MOL BIOL, V1171, P27, DOI 10.1007/978-1-4939-0922-3_3; Yuan MH, 2021, NATURE, V592, P105, DOI 10.1038/s41586-021-03316-6; Zhang LS, 2021, NAT PLANTS, V7, P1254, DOI 10.1038/s41477-021-00982-2	56	76	78	52	134	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 21	2021	598	7881					495	+		10.1038/s41586-021-03829-0	http://dx.doi.org/10.1038/s41586-021-03829-0		SEP 2021	23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WK1SC	34497423	Green Submitted			2022-12-28	WOS:000695548800001
J	Vredevoogd, DW; Peeper, DS				Vredevoogd, David W.; Peeper, Daniel S.			Enabling oncogenes	SCIENCE			English	Editorial Material							MUTATIONS; SENESCENCE		[Vredevoogd, David W.; Peeper, Daniel S.] Netherlands Canc Inst, Oncode Inst, Div Mol Oncol & Immunol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Peeper, DS (corresponding author), Netherlands Canc Inst, Oncode Inst, Div Mol Oncol & Immunol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	d.peeper@nki.nl						Baggiolini A, 2021, SCIENCE, V373; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Diener J, 2021, STEM CELL TRANSL MED, V10, P522, DOI 10.1002/sctm.20-0351; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Kohler C, 2017, CELL STEM CELL, V21, P679, DOI 10.1016/j.stem.2017.08.003; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Shain AH, 2016, NAT REV CANCER, V16, P345, DOI 10.1038/nrc.2016.37; Tang J, 2020, NATURE, V586, P600, DOI 10.1038/s41586-020-2785-8; Tsoi J, 2018, CANCER CELL, V33, P890, DOI 10.1016/j.ccell.2018.03.017; Vredeveld LCW, 2012, GENE DEV, V26, P1055, DOI 10.1101/gad.187252.112	14	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2021	373	6559					1088	1089		10.1126/science.abl4510	http://dx.doi.org/10.1126/science.abl4510			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UL8QT	34516853				2022-12-28	WOS:000692910300030
J	Bopp, NE; Fernandez, D; Aguilar, PV				Bopp, Nathen E.; Fernandez, Diana; Aguilar, Patricia V.			Closing the Rift: Discovery of a novel virus receptor	CELL			English	Editorial Material								In this issue of Cell, Ganaie et al. reports the identification of LRP1 as a receptor of the highly pathogenic Rift Valley fever virus. By using genome-wide CRISPR-Cas9 screening and functional studies, Ganaie et al. identified LRP1 and several co-factors as essential elements for virus infection.	[Bopp, Nathen E.; Fernandez, Diana; Aguilar, Patricia V.] Univ Texas Med Branch, Dept Pathol, 301 Univ Blvd, Galveston, TX 77550 USA; [Bopp, Nathen E.; Fernandez, Diana; Aguilar, Patricia V.] Univ Texas Med Branch, Inst Human Infect & Immun, 301 Univ Blvd, Galveston, TX 77550 USA; [Fernandez, Diana; Aguilar, Patricia V.] Univ Texas Med Branch, Ctr Trop Dis, 301 Univ Blvd, Galveston, TX 77550 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Aguilar, PV (corresponding author), Univ Texas Med Branch, Dept Pathol, 301 Univ Blvd, Galveston, TX 77550 USA.; Aguilar, PV (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, 301 Univ Blvd, Galveston, TX 77550 USA.; Aguilar, PV (corresponding author), Univ Texas Med Branch, Ctr Trop Dis, 301 Univ Blvd, Galveston, TX 77550 USA.	pvaguila@utmb.edu						Boucher P, 2011, BIOCHEM PHARMACOL, V81, P1, DOI 10.1016/j.bcp.2010.09.018; Cooper JM, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100715; de Boer SM, 2012, J VIROL, V86, P13767, DOI 10.1128/JVI.01364-12; Ganaie SS, 2021, CELL, V184, P5163, DOI 10.1016/j.cell.2021.09.001; Guardado-Calvo P, 2017, SCIENCE, V358, P663, DOI 10.1126/science.aal2712; Gudleski-O'Regan N, 2012, CELL HOST MICROBE, V12, P86, DOI 10.1016/j.chom.2012.05.012; Lozach PY, 2011, CELL HOST MICROBE, V10, P75, DOI 10.1016/j.chom.2011.06.007; Schafer A, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009312; Trees MO, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42803-9; Wright D, 2019, J GEN VIROL, V100, P1187, DOI 10.1099/jgv.0.001296	10	1	1	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 30	2021	184	20					5084	5086		10.1016/j.cell.2021.09.004	http://dx.doi.org/10.1016/j.cell.2021.09.004		OCT 2021	4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	WC7PG	34559984	Bronze			2022-12-28	WOS:000704445700005
J	Iacobucci, G				Iacobucci, Gareth			Medical care will be prioritised in tackling CO2 shortages, says government	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2021	374								n2346	10.1136/bmj.n2346	http://dx.doi.org/10.1136/bmj.n2346			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ1JE	34556487				2022-12-28	WOS:000701967300017
J	Janes, SM; Alrifai, D; Fennell, DA				Janes, Sam M.; Alrifai, Doraid; Fennell, Dean A.			Perspectives on the Treatment of Malignant Pleural Mesothelioma	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PEGYLATED ARGININE DEIMINASE; RANDOMIZED PHASE-III; OPEN-LABEL; ARGININOSUCCINATE SYNTHETASE; EXTRAPLEURAL PNEUMONECTOMY; TALC PLEURODESIS; DOSE-ESCALATION; UNITED-STATES; TRIAL; CHEMOTHERAPY	Mesothelioma Most mesotheliomas originate in the pleura and are due to asbestos exposure. The incidence is decreasing somewhat with asbestos remediation, but mortality remains high in part because of late diagnosis and treatment resistance. Pemetrexed-cisplatin and immune checkpoint inhibitors modestly extend survival.	[Janes, Sam M.; Alrifai, Doraid] UCL, Lungs Living Res Ctr, UCL Resp, 5 Univ St, London WC1E 6JF, England; [Janes, Sam M.] Univ Coll London Hosp, Dept Thorac Med, London, England; [Fennell, Dean A.] Univ Leicester, Leicester, Leics, England	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Leicester	Janes, SM (corresponding author), UCL, Lungs Living Res Ctr, UCL Resp, 5 Univ St, London WC1E 6JF, England.	s.janes@ucl.ac.uk						Adusumilli PS, 2019, CANCER RES, V79, DOI 10.1158/1538-7445.AM2019-CT036; Allen LP, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030531; [Anonymous], 2021, MESOTHELIOMA STAT GR; Ashton M, 2018, CLIN TRANSL RAD ONCO, V8, P45, DOI 10.1016/j.ctro.2017.11.004; Baas P, 2021, LANCET, V397, P375, DOI 10.1016/S0140-6736(20)32714-8; Basu S, 2011, MOL IMAGING BIOL, V13, P801, DOI 10.1007/s11307-010-0426-6; Bayman N, 2019, J CLIN ONCOL, V37, P1200, DOI 10.1200/JCO.18.01678; Beddowes E, 2017, J CLIN ONCOL, V35, P1778, DOI 10.1200/JCO.2016.71.3230; Beebe-Dimmer JL, 2016, CLIN EPIDEMIOL, V8, P743, DOI 10.2147/CLEP.S105396; Bibby AC, 2016, EUR RESPIR REV, V25, P472, DOI 10.1183/16000617.0063-2016; Blum Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09307-6; Brims F, 2019, THORAX, V74, P354, DOI 10.1136/thoraxjnl-2018-212380; Brims FJH, 2016, J THORAC ONCOL, V11, P573, DOI 10.1016/j.jtho.2015.12.108; Bueno R, 2016, NAT GENET, V48, P407, DOI 10.1038/ng.3520; Carbone M, 2007, NAT REV CANCER, V7, P147, DOI 10.1038/nrc2068; Carbone M, 2013, NAT REV CANCER, V13, P153, DOI 10.1038/nrc3459; Carbone M, 2012, J CELL PHYSIOL, V227, P44, DOI 10.1002/jcp.22724; Ceresoli GL, 2019, LANCET ONCOL, V20, P1702, DOI 10.1016/S1470-2045(19)30532-7; Ceresoli GL, 2011, LUNG CANCER, V72, P73, DOI 10.1016/j.lungcan.2010.12.004; Chen TH, 2019, JAMA ONCOL, V5, P779, DOI 10.1001/jamaoncol.2019.0446; Churg A, 2020, MODERN PATHOL, V33, P297, DOI 10.1038/s41379-019-0347-0; Clive AO, 2016, LANCET ONCOL, V17, P1094, DOI 10.1016/S1470-2045(16)30095-X; Courtiol P, 2019, NAT MED, V25, P1519, DOI 10.1038/s41591-019-0583-3; Davies HE, 2012, JAMA-J AM MED ASSOC, V307, P2383, DOI 10.1001/jama.2012.5535; de Gooijer CJ, 2021, LANCET RESP MED, V9, P585, DOI 10.1016/S2213-2600(20)30362-3; Eberst G, 2019, CLIN CANCER RES, V25, P5759, DOI 10.1158/1078-0432.CCR-18-2860; Fennell D, 2019, J THORAC ONCOL, V14, pS755, DOI 10.1016/j.jtho.2019.08.1620; Fennell D, 2021, P WORLD C LUNG CANC; Fennell DA, 2012, ANN ONCOL, V23, P498; Fennell DA, 2021, LANCET RESP MED, V9, P593, DOI 10.1016/S2213-2600(20)30390-8; Fennell DA, 2019, J CLIN ONCOL, V37, P790, DOI 10.1200/JCO.2018.79.0543; Finn RS, 2012, CHEST, V142, P1267, DOI 10.1378/chest.11-3204; Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005; Gomez DR, 2019, J THORAC ONCOL, V14, P1172, DOI 10.1016/j.jtho.2019.03.030; Henderson DW, 2013, J CLIN PATHOL, V66, P847, DOI 10.1136/jclinpath-2012-201303; Hjerpe A, 2015, ACTA CYTOL, V59, P2, DOI 10.1159/000377697; Hmeljaki J, 2018, CANCER DISCOV, V8, P1548, DOI 10.1158/2159-8290.CD-18-0804; Kindler HL, 2018, J CLIN ONCOL, V36, P1343, DOI 10.1200/JCO.2017.76.6394; Kindler HL, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.8502; LaFave LM, 2015, NAT MED, V21, P1344, DOI 10.1038/nm.3947; Lim E, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-038892; Mazurek JM, 2017, MMWR-MORBID MORTAL W, V66, P14, DOI 10.15585/mmwr.mm6608a3; Milano MT, 2010, J THORAC ONCOL, V5, P1841, DOI 10.1097/JTO.0b013e3181f1cf2b; Nicholson AG, 2020, J THORAC ONCOL, V15, P29, DOI 10.1016/j.jtho.2019.08.2506; Nowak A, 2018, J THORAC ONCOL, V13, pS338, DOI 10.1016/j.jtho.2018.08.276; Odgerel CO, 2017, OCCUP ENVIRON MED, V74, P851, DOI 10.1136/oemed-2017-104298; Panou V, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124327; Panou V, 2018, J CLIN ONCOL, V36, P2863, DOI 10.1200/JCO.2018.78.5204; Parker C, 2003, THORAX, V58, P809, DOI 10.1136/thorax.58.9.809; Popat S, 2020, ANN ONCOL, V31, P1734, DOI 10.1016/j.annonc.2020.09.009; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Rimner A, 2020, INT J RADIAT ONCOL, V108, pE928; Rintoul RC, 2014, LANCET, V384, P1118, DOI 10.1016/S0140-6736(14)60418-9; Roe OD, 2015, EUR RESPIR REV, V24, P115, DOI 10.1183/09059180.00007014; Rusch VW, 2016, J THORAC ONCOL, V11, P2112, DOI 10.1016/j.jtho.2016.09.124; Sato T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19040988; Scagliotti GV, 2019, LANCET RESP MED, V7, P569, DOI 10.1016/S2213-2600(19)30139-0; Scherpereel A, 2019, LANCET ONCOL, V20, P239, DOI 10.1016/S1470-2045(18)30765-4; Sekido Y, 2013, CARCINOGENESIS, V34, P1413, DOI 10.1093/carcin/bgt166; Stahel RA, 2015, LANCET ONCOL, V16, P1651, DOI 10.1016/S1470-2045(15)00208-9; Stebbing J, 2009, LUNG CANCER, V63, P94, DOI 10.1016/j.lungcan.2008.04.001; Sterman DH, 2016, CLIN CANCER RES, V22, P3791, DOI 10.1158/1078-0432.CCR-15-2133; Sugarbaker DJ, 2014, ANN SURG, V260, P577, DOI 10.1097/SLA.0000000000000903; Szlosarek PW, 2006, CLIN CANCER RES, V12, P7126, DOI 10.1158/1078-0432.CCR-06-1101; Szlosarek PW, 2017, JAMA ONCOL, V3, P58, DOI 10.1001/jamaoncol.2016.3049; Testa JR, 2011, NAT GENET, V43, P1022, DOI 10.1038/ng.912; Treasure T, 2011, LANCET ONCOL, V12, P763, DOI 10.1016/S1470-2045(11)70149-8; van Meerbeeck JP, 2005, J CLIN ONCOL, V23, P6881, DOI 10.1200/JCO.20005.14.589; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; WAGNER J C, 1960, Br J Ind Med, V17, P260; Wald Ori, 2016, J Vis Surg, V2, P129, DOI 10.21037/jovs.2016.07.12; Woolhouse I, 2018, THORAX, V73, P1, DOI 10.1136/thoraxjnl-2017-211321; Xu JF, 2014, CANCER RES, V74, P4388, DOI 10.1158/0008-5472.CAN-14-1328; Yoshikawa Y, 2012, CANCER SCI, V103, P868, DOI 10.1111/j.1349-7006.2012.02223.x; Zalcman G, 2016, LANCET, V387, P1405, DOI 10.1016/S0140-6736(15)01238-6; Zauderer MG, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.8515	76	23	23	2	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2021	385	13					1207	1218		10.1056/NEJMra1912719	http://dx.doi.org/10.1056/NEJMra1912719			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UT0EM	34551230	Green Published			2022-12-28	WOS:000697798600014
J	Komaroff, AL				Komaroff, Anthony L.			Breakthrough Discovery in Protein Structure Prediction and the Promise of New Treatments	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BIOLOGY		[Komaroff, Anthony L.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Komaroff, AL (corresponding author), Brigham & Womens Hosp, 1620 Tremont St, Boston, MA 02120 USA.	komaroff@hms.harvard.edu						AlQuraishi M, 2021, NATURE, V596, P487, DOI 10.1038/d41586-021-02265-4; [Anonymous], 2021, NATURE, V595, P625, DOI 10.1038/d41586-021-02037-0; Baek M, 2021, SCIENCE, V373, P871, DOI 10.1126/science.abj8754; Callaway E, 2021, NATURE, V595, P635, DOI 10.1038/d41586-021-02025-4; EMBL-EBI, ALPHAFOLD PROT STRUC; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Lupas AN, 2021, BIOCHEM J, V478, P1885, DOI 10.1042/BCJ20200963; Service RF, 2021, SCIENCE, V373, P478, DOI 10.1126/science.373.6554.478; Service RF, 2020, SCIENCE, V370, P1144, DOI 10.1126/science.370.6521.1144; Tunyasuvunakool K, 2021, NATURE, V596, P590, DOI 10.1038/s41586-021-03828-1	10	0	0	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 12	2021	326	14					1369	1370		10.1001/jama.2021.15728	http://dx.doi.org/10.1001/jama.2021.15728		SEP 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WH8VN	34554183				2022-12-28	WOS:000698780000004
J	Kuehn, BM				Kuehn, Bridget M.			Lupus Drug Is Approved Despite Previous Clinical Trial Setback	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2021	326	11					1000	1000		10.1001/jama.2021.15588	http://dx.doi.org/10.1001/jama.2021.15588			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ4IM	34546314				2022-12-28	WOS:000702170600007
J	Li, BT; Smit, EF; Goto, Y; Nakagawa, K; Udagawa, H; Mazieres, J; Nagasaka, M; Bazhenova, L; Saltos, AN; Felip, E; Pacheco, JM; Perol, M; Paz-Ares, L; Saxena, K; Shiga, R; Cheng, YK; Acharyya, S; Vitazka, P; Shahidi, J; Planchard, D; Janne, PA				Li, Bob T.; Smit, Egbert F.; Goto, Yasushi; Nakagawa, Kazuhiko; Udagawa, Hibiki; Mazieres, Julien; Nagasaka, Misako; Bazhenova, Lyudmila; Saltos, Andreas N.; Felip, Enriqueta; Pacheco, Jose M.; Perol, Maurice; Paz-Ares, Luis; Saxena, Kapil; Shiga, Ryota; Cheng, Yingkai; Acharyya, Suddhasatta; Vitazka, Patrik; Shahidi, Javad; Planchard, David; Janne, Pasi A.		DESTINY-Lung01 Trial Investigators	Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTIBODY-DRUG CONJUGATE; PHASE-II TRIAL; HER2 MUTATIONS; KINASE MUTATIONS; DS-8201A; TUMORS; NSCLC; CHEMOTHERAPY; INHIBITOR; DOCETAXEL	BACKGROUND Human epidermal growth factor receptor 2 (HER2)-targeted therapies have not been approved for patients with non-small-cell lung cancer (NSCLC). The efficacy and safety of trastuzumab deruxtecan (formerly DS-8201), a HER2 antibody-drug conjugate, in patients with HER2-mutant NSCLC have not been investigated extensively. METHODS We conducted a multicenter, international, phase 2 study in which trastuzumab deruxtecan (6.4 mg per kilogram of body weight) was administered to patients who had metastatic HER2-mutant NSCLC that was refractory to standard treatment. The primary outcome was objective response as assessed by independent central review. Secondary outcomes included the duration of response, progression-free survival, overall survival, and safety. Biomarkers of HER2 alterations were assessed. RESULTS A total of 91 patients were enrolled. The median duration of follow-up was 13.1 months (range, 0.7 to 29.1). Centrally confirmed objective response occurred in 55% of the patients (95% confidence interval [CI], 44 to 65). The median duration of response was 9.3 months (95% CI, 5.7 to 14.7). Median progression-free survival was 8.2 months (95% CI, 6.0 to 11.9), and median overall survival was 17.8 months (95% CI, 13.8 to 22.1). The safety profile was generally consistent with those from previous studies; grade 3 or higher drug-related adverse events occurred in 46% of patients, the most common event being neutropenia (in 19%). Adjudicated drugrelated interstitial lung disease occurred in 26% of patients and resulted in death in 2 patients. Responses were observed across different HER2 mutation subtypes, as well as in patients with no detectable HER2 expression or HER2 amplification. CONCLUSIONS Trastuzumab deruxtecan showed durable anticancer activity in patients with previously treated HER2-mutant NSCLC. The safety profile included interstitial lung disease that was fatal in two cases. Observed toxic effects were generally consistent with those in previously reported studies.	[Li, Bob T.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Li, Bob T.] Weill Cornell Med, New York, NY USA; [Smit, Egbert F.] Netherlands Canc Inst, Amsterdam, Netherlands; [Goto, Yasushi] Natl Canc Ctr, Tokyo, Japan; [Nakagawa, Kazuhiko] Kindai Univ Hosp, Osaka, Japan; [Udagawa, Hibiki] Natl Canc Ctr East, Kashiwa, Chiba, Japan; [Mazieres, Julien] Ctr Hosp Univ, Toulouse, France; [Perol, Maurice] Ctr Leon Berard, Lyon, France; [Planchard, David] Gustave Roussy, Thorac Grp, Dept Med Oncol, Villejuif, France; [Nagasaka, Misako] Karmanos Canc Inst, Detroit, MI USA; [Bazhenova, Lyudmila] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA; [Saltos, Andreas N.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; [Felip, Enriqueta] Vall dHebron Univ Hosp, Barcelona, Spain; [Felip, Enriqueta] Vall dHebron Inst Oncol, Barcelona, Spain; [Pacheco, Jose M.] Univ Colorado, Aurora, CO USA; [Paz-Ares, Luis] Hosp Univ 12 Octubre, H12O Ctr Nacl Invest Oncol CNIO, Lung Canc Clin Res Unit, Madrid, Spain; [Paz-Ares, Luis] Univ Complutense Madrid, Madrid, Spain; [Saxena, Kapil; Shiga, Ryota; Cheng, Yingkai; Acharyya, Suddhasatta; Vitazka, Patrik; Shahidi, Javad] Daiichi Sankyo, Basking Ridge, NJ USA; [Janne, Pasi A.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Janne, Pasi A.] Beller Ctr Appl Canc Sci, Boston, MA USA	Memorial Sloan Kettering Cancer Center; Cornell University; Netherlands Cancer Institute; National Cancer Center - Japan; National Cancer Center - Japan; CHU de Toulouse; UNICANCER; Centre Leon Berard; UNICANCER; Gustave Roussy; Barbara Ann Karmanos Cancer Institute; University of California System; University of California San Diego; H Lee Moffitt Cancer Center & Research Institute; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); University of Colorado System; University of Colorado Anschutz Medical Campus; Hospital Universitario 12 de Octubre; Complutense University of Madrid; Daiichi Sankyo Company Limited; Harvard University; Dana-Farber Cancer Institute	Li, BT (corresponding author), Mem Sloan Kettering Canc Ctr, Thorac Oncol & Early Drug Dev Serv, 530 E 74th St, New York, NY 10021 USA.	lib1@mskcc.org	MAZIERES, JULIEN/M-3986-2014	Bazhenova, Lyudmila/0000-0001-8764-4359; Smit, Egbert/0000-0002-7329-6995	Daiichi Sankyo; AstraZeneca; National Institutes of Health [P30 CA008748, 1R01CA249666-01A1]	Daiichi Sankyo(Daiichi Sankyo Company Limited); AstraZeneca(AstraZeneca); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by Daiichi Sankyo and AstraZeneca. Dr. Li was also supported by grants from the National Institutes of Health (P30 CA008748 and 1R01CA249666-01A1) to the Memorial Sloan Kettering Cancer Center.	Akamatsu H, 2019, INT J CLIN ONCOL, V24, P731, DOI 10.1007/s10147-019-01431-z; Arcila ME, 2012, CLIN CANCER RES, V18, P4910, DOI 10.1158/1078-0432.CCR-12-0912; Bartley AN, 2016, ARCH PATHOL LAB MED, V140, P1345, DOI 10.5858/arpa.2016-0331-CP; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Doi T, 2017, LANCET ONCOL, V18, P1512, DOI 10.1016/S1470-2045(17)30604-6; Dziadziuszko R, 2019, J THORAC ONCOL, V14, P1086, DOI 10.1016/j.jtho.2019.02.017; Fan Y, 2020, LUNG CANCER, V147, P209, DOI 10.1016/j.lungcan.2020.07.017; Gatzemeier U, 2004, ANN ONCOL, V15, P19, DOI 10.1093/annonc/mdh031; Guisier F, 2020, J THORAC ONCOL, V15, P628, DOI 10.1016/j.jtho.2019.12.129; Hainsworth JD, 2018, J CLIN ONCOL, V36, P536, DOI 10.1200/JCO.2017.75.3780; Howlader N, 2020, NEW ENGL J MED, V383, P640, DOI 10.1056/NEJMoa1916623; Hyman DM, 2018, NATURE, V554, P189, DOI 10.1038/nature25475; Kim So Yeon, 2020, Lung Cancer Manag, V9, pLMT36, DOI 10.2217/lmt-2020-0003; Kris MG, 2015, ANN ONCOL, V26, P1421, DOI 10.1093/annonc/mdv186; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Langer CJ, 2004, J CLIN ONCOL, V22, P1180, DOI 10.1200/JCO.2004.04.105; Li BT, 2020, CANCER DISCOV, V10, P674, DOI 10.1158/2159-8290.CD-20-0215; Li BT, 2018, J CLIN ONCOL, V36, P2532, DOI 10.1200/JCO.2018.77.9777; Mazieres J, 2019, ANN ONCOL, V30, P1321, DOI 10.1093/annonc/mdz167; Mazieres J, 2016, ANN ONCOL, V27, P281, DOI 10.1093/annonc/mdv573; Mazieres J, 2021, J CLIN ONCOL, V39, DOI 10.1200/JCO.2021.39.15_suppl.9015; Mazieres J, 2013, J CLIN ONCOL, V31, P1997, DOI 10.1200/JCO.2012.45.6095; Modi S, 2020, NEW ENGL J MED, V382, P610, DOI 10.1056/NEJMoa1914510; Nakada T, 2019, CHEM PHARM BULL, V67, P173, DOI 10.1248/cpb.c18-00744; Nakagawa K, 2021, J THORAC ONCOL, V16, pS109; Novello S, 2016, ANN ONCOL, V27, pv1, DOI 10.1093/annonc/mdw326; Offin M, 2019, CANCER-AM CANCER SOC, V125, P4380, DOI 10.1002/cncr.32461; Ogitani Y, 2016, CLIN CANCER RES, V22, P5097, DOI 10.1158/1078-0432.CCR-15-2822; Ogitani Y, 2016, CANCER SCI, V107, P1039, DOI 10.1111/cas.12966; Pillai RN, 2017, CANCER-AM CANCER SOC, V123, P4099, DOI 10.1002/cncr.30869; Ricciardi GRR, 2014, J THORAC ONCOL, V9, P1750, DOI 10.1097/JTO.0000000000000379; Robichaux JP, 2019, CANCER CELL, V36, P444, DOI 10.1016/j.ccell.2019.09.001; Rolfo C, 2020, CRIT REV ONCOL HEMAT, V151, DOI 10.1016/j.critrevonc.2020.102978; Shitara K, 2020, NEW ENGL J MED, V382, P2419, DOI 10.1056/NEJMoa2004413; Socinski MA, 2020, ANN ONCOL, V31, pS1188, DOI 10.1016/j.annonc.2020.08.2293; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Tsurutani J, 2020, CANCER DISCOV, V10, P688, DOI 10.1158/2159-8290.CD-19-1014; Wu YL, 2019, ANN ONCOL, V30, P171, DOI 10.1093/annonc/mdy554; Zhou CC, 2020, J CLIN ONCOL, V38, P2753, DOI 10.1200/JCO.20.00297	39	108	111	16	50	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2022	386	3					241	251		10.1056/NEJMoa2112431	http://dx.doi.org/10.1056/NEJMoa2112431		SEP 2021	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YK1UG	34534430	Bronze, Green Accepted			2022-12-28	WOS:000697035400001
J	Esakova, OA; Grove, TL; Yennawar, NH; Arcinas, AJ; Wang, B; Krebs, C; Almo, SC; Booker, SJ				Esakova, Olga A.; Grove, Tyler L.; Yennawar, Neela H.; Arcinas, Arthur J.; Wang, Bo; Krebs, Carsten; Almo, Steven C.; Booker, Squire J.			Structural basis for tRNA methylthiolation by the radical SAM enzyme MiaB	NATURE			English	Article							STRUCTURE REFINEMENT; PROTEIN; RIMO; METHYLTHIOTRANSFERASE; IDENTIFICATION; METHYLATION; THIOLATION; CLUSTER; CONTRIBUTES; INSERTION	Numerous post-transcriptional modifications of transfer RNAs have vital roles in translation. The 2-methylthio-N-6-isopentenyladenosine (ms(2)i(6)A) modification occurs at position 37 (A37) in transfer RNAs that contain adenine in position 36 of the anticodon, and serves to promote efficient A:U codon-anticodon base-pairing and to prevent unintended base pairing by near cognates, thus enhancing translational fidelity(1-4). The ms(2)i(6)A modification is installed onto isopentenyladenosine (i(6)A) by MiaB, a radical S-adenosylmethionine (SAM) methylthiotransferase. As a radical SAM protein, MiaB contains one [Fe4S4](RS) cluster used in the reductive cleavage of SAM to form a 5'-deoxyadenosyl 5'-radical, which is responsible for removing the C-2 hydrogen of the substrate(5). MiaB also contains an auxiliary [Fe4S4](aux) cluster, which has been implicated(6-9) in sulfur transfer to C-2 of i(6)A37. How this transfer takes place is largely unknown. Here we present several structures of MiaB from Bacteroides uniformis. These structures are consistent with a two-step mechanism, in which one molecule of SAM is first used to methylate a bridging mu-sulfido ion of the auxiliary cluster. In the second step, a second SAM molecule is cleaved to a 5'-deoxyadenosyl 5'-radical, which abstracts the C-2 hydrogen of the substrate but only after C-2 has undergone rehybridization from sp(2) to sp(3). This work advances our understanding of how enzymes functionalize inert C-H bonds with sulfur.	[Esakova, Olga A.; Wang, Bo; Krebs, Carsten; Booker, Squire J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Grove, Tyler L.; Almo, Steven C.] Albert Einstein Coll Med, Dept Biochem, New York, NY 10461 USA; [Yennawar, Neela H.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Arcinas, Arthur J.; Krebs, Carsten; Booker, Squire J.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Booker, Squire J.] Penn State Univ, Howard Hughes Med Inst, University Pk, PA 16802 USA; [Arcinas, Arthur J.] AGC Biol, Seattle, WA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Yeshiva University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Howard Hughes Medical Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Esakova, OA; Booker, SJ (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.; Grove, TL (corresponding author), Albert Einstein Coll Med, Dept Biochem, New York, NY 10461 USA.; Booker, SJ (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.; Booker, SJ (corresponding author), Penn State Univ, Howard Hughes Med Inst, University Pk, PA 16802 USA.	tylergrove223@gmail.com; squire@psu.edu	Krebs, Carsten/D-4773-2009; Esakova, Olga/D-9689-2018	Krebs, Carsten/0000-0002-3302-7053; Esakova, Olga/0000-0001-8377-8368; Yennawar, Neela/0000-0001-7278-659X; Arcinas, Arthur/0000-0003-4903-3500	National Institutes of Health (NIH) [GM122595, AI133329, GM-127079, GM118393, GM093342, GM094662]; National Science Foundation [MCB-1716686]; Eberly Family Distinguished Chair in Science; Price Family Foundation; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; National Cancer Institute [ACB-12002]; National Institute of General Medical Sciences [AGM-12006]; NIH [S10 OD012289]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; Howard Hughes Medical Institute; Department of Energy Office of Science User Facility [DE-AC02-05CH11231]; National Institutes of Health, National Institute of General Medical Sciences [P30 GM124169]; Penn State Huck Institutes of the Life Sciences	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Eberly Family Distinguished Chair in Science; Price Family Foundation; DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Department of Energy Office of Science User Facility(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Penn State Huck Institutes of the Life Sciences	This work was supported by the National Institutes of Health (NIH) (GM122595 to S.J.B.; AI133329 to S.C.A. and T.L.G.; GM-127079 to C.K.; and GM118393, GM093342 and GM094662 to S.C.A.), the National Science Foundation (MCB-1716686 to S.J.B.), the Eberly Family Distinguished Chair in Science (S.J.B.), The Price Family Foundation (S.C.A.) and the Penn State Huck Institutes of the Life Sciences (N.H.Y.). S.J.B. is an investigator of the Howard Hughes Medical Institute. This research used resources of the Advanced Photon Source, a US Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357. Use of GM/CA@APS has been funded in whole or in part with Federal funds from the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006). The Eiger 16M detector at GM/CA-XSD was funded by NIH grant S10 OD012289. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (grant 085P1000817). This research also used the resources of the Berkeley Center for Structural Biology supported in part by the Howard Hughes Medical Institute. The Advanced Light Source is a Department of Energy Office of Science User Facility under contract no. DE-AC02-05CH11231. The ALS-ENABLE beamlines are supported in part by the National Institutes of Health, National Institute of General Medical Sciences, grant P30 GM124169.	Abelson J. R., 1979, TRANSFER RNA STRUCTU, V1; Adami R, 2020, INT J BIOL SCI, V16, P3018, DOI 10.7150/ijbs.49302; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; AGRIS PF, 1975, NUCLEIC ACIDS RES, V2, P691, DOI 10.1093/nar/2.5.691; Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; Anantharaman V, 2001, FEMS MICROBIOL LETT, V197, P215, DOI 10.1111/j.1574-6968.2001.tb10606.x; Anton BP, 2008, P NATL ACAD SCI USA, V105, P1826, DOI 10.1073/pnas.0708608105; Anton BP, 2010, NUCLEIC ACIDS RES, V38, P6195, DOI 10.1093/nar/gkq364; Arcinas A. J., 2016, THESIS PENNSYLVANIA; Arragain S, 2010, J BIOL CHEM, V285, P28425, DOI 10.1074/jbc.M110.106831; Arragain S, 2010, J BIOL CHEM, V285, P5792, DOI 10.1074/jbc.M109.065516; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Boccaletto P, 2018, NUCLEIC ACIDS RES, V46, pD303, DOI 10.1093/nar/gkx1030; Chimnaronk S, 2009, BIOCHEMISTRY-US, V48, P5057, DOI 10.1021/bi900337d; CONNOLLY DM, 1991, J BACTERIOL, V173, P1711, DOI 10.1128/jb.173.5.1711-1721.1991; CONNOLLY DM, 1989, J BACTERIOL, V171, P3233, DOI 10.1128/jb.171.6.3233-3246.1989; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Ellis JJ, 2007, PROTEINS, V66, P903, DOI 10.1002/prot.21211; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esberg B, 1999, J BACTERIOL, V181, P7256, DOI 10.1128/JB.181.23.7256-7265.1999; Forouhar F, 2013, NAT CHEM BIOL, V9, P333, DOI [10.1038/NCHEMBIO.1229, 10.1038/nchembio.1229]; Grove TL, 2011, J AM CHEM SOC, V133, P19586, DOI 10.1021/ja207327v; Hernandez HL, 2007, BIOCHEMISTRY-US, V46, P5140, DOI 10.1021/bi7000449; Jones S, 2001, NUCLEIC ACIDS RES, V29, P943, DOI 10.1093/nar/29.4.943; Kim S, 2007, J PHYS CHEM A, V111, P6806, DOI 10.1021/jp070225x; Landgraf BJ, 2016, ANNU REV BIOCHEM, V85, P485, DOI 10.1146/annurev-biochem-060713-035504; Landgraf BJ, 2016, J AM CHEM SOC, V138, P2889, DOI 10.1021/jacs.5b11035; Landgraf BJ, 2013, J AM CHEM SOC, V135, P15404, DOI 10.1021/ja4048448; Lanz ND, 2012, METHOD ENZYMOL, V516, P125, DOI 10.1016/B978-0-12-394291-3.00030-7; Lee TT, 2005, CELL, V120, P599, DOI 10.1016/j.cell.2004.12.037; McCarthy EL, 2018, METHOD ENZYMOL, V606, P217, DOI 10.1016/bs.mie.2018.06.006; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Molle T, 2016, BIOCHEMISTRY-US, V55, P5798, DOI 10.1021/acs.biochem.6b00597; Pierrel F, 2004, J BIOL CHEM, V279, P47555, DOI 10.1074/jbc.M408562200; Reiter V, 2012, NUCLEIC ACIDS RES, V40, P6235, DOI 10.1093/nar/gks240; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Urbonavicius J, 2001, EMBO J, V20, P4863, DOI 10.1093/emboj/20.17.4863; Wei FY, 2015, CELL METAB, V21, P428, DOI 10.1016/j.cmet.2015.01.019; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Zhang B, 2020, J AM CHEM SOC, V142, P1911, DOI 10.1021/jacs.9b11093; Zierhut M, 2004, PHYS CHEM CHEM PHYS, V6, P5178, DOI 10.1039/b411295d	42	10	10	6	109	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2021	597	7877					566	+		10.1038/s41586-021-03904-6	http://dx.doi.org/10.1038/s41586-021-03904-6		SEP 2021	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UW6NQ	34526715	Green Accepted			2022-12-28	WOS:000696175300012
J	Kuehn, BM				Kuehn, Bridget M.			Severe Tuberculosis Surged After Shelter-in-Place Lifted	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2021	326	10					902	902		10.1001/jama.2021.14683	http://dx.doi.org/10.1001/jama.2021.14683			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UW4LI	34519794				2022-12-28	WOS:000700129100027
J	Heacock, B; Fujiie, T; Haun, RW; Henins, A; Hirota, K; Hosobata, T; Huber, MG; Kitaguchi, M; Pushin, DA; Shimizu, H; Takeda, M; Valdillez, R; Yamagata, Y; Young, AR				Heacock, Benjamin; Fujiie, Takuhiro; Haun, Robert W.; Henins, Albert; Hirota, Katsuya; Hosobata, Takuya; Huber, Michael G.; Kitaguchi, Masaaki; Pushin, Dmitry A.; Shimizu, Hirohiko; Takeda, Masahiro; Valdillez, Robert; Yamagata, Yutaka; Young, Albert R.			Pendellosung interferometry probes the neutron charge radius, lattice dynamics, and fifth forces	SCIENCE			English	Article							X-RAY PENDELLOSUNG; ELECTRON SCATTERING LENGTH; FRINGE STRUCTURE; ABSOLUTE MEASUREMENT; THERMAL-NEUTRONS; SILICON; REFLECTIONS; SI; POLARIZABILITY; ANHARMONICITY	Structure factors describe how incident radiation is scattered from materials such as silicon and germanium and characterize the physical interaction between the material and scattered particles. We used neutron Pendellosung interferometry to make precision measurements of the (220) and (400) neutron-silicon structure factors and achieved a factor-of-four improvement in the (111) structure factor uncertainty. These data provide measurements of the silicon Debye-Waller factor at room temperature and the mean square neutron charge radius < r(n)(2)> = 0.1101 +/- 0.0089 square femtometers. Combined with existing measurements of the Debye-Waller factor and charge radius, the measured structure factors also improve constraints on the strength of a Yukawa modification to gravity by an order of magnitude over the 20 picometer-to-10 nanometer length scale range.	[Heacock, Benjamin; Henins, Albert; Huber, Michael G.] NIST, Gaithersburg, MD 20899 USA; [Heacock, Benjamin; Valdillez, Robert; Young, Albert R.] North Carolina State Univ, Dept Phys, Raleigh, NC 27695 USA; [Heacock, Benjamin; Valdillez, Robert; Young, Albert R.] Triangle Univ Nucl Lab, Durham, NC 27708 USA; [Fujiie, Takuhiro; Hirota, Katsuya; Kitaguchi, Masaaki; Shimizu, Hirohiko] Nagoya Univ, Dept Phys, Nagoya, Aichi 4648602, Japan; [Fujiie, Takuhiro; Hosobata, Takuya; Takeda, Masahiro; Yamagata, Yutaka] RIKEN, RIKEN Ctr Adv Photon, Hirosawa 2-1, Wako, Saitama 3510198, Japan; [Haun, Robert W.] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA; [Haun, Robert W.] Tulane Univ, Dept Phys & Engn Phys, New Orleans, LA 70118 USA; [Hirota, Katsuya] High Energy Accelerator Res Org, Tsukuba, Ibaraki 3050801, Japan; [Kitaguchi, Masaaki] Nagoya Univ, Kobayashi Maskawa Inst, Nagoya, Aichi 4648602, Japan; [Pushin, Dmitry A.] Univ Waterloo, Inst Quantum Comp, Waterloo, ON N2L3G1, Canada; [Pushin, Dmitry A.] Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada	National Institute of Standards & Technology (NIST) - USA; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina Chapel Hill; Duke University; Nagoya University; RIKEN; University System of Maryland; University of Maryland College Park; Tulane University; High Energy Accelerator Research Organization (KEK); Nagoya University; University of Waterloo; University of Waterloo	Heacock, B (corresponding author), NIST, Gaithersburg, MD 20899 USA.; Heacock, B (corresponding author), North Carolina State Univ, Dept Phys, Raleigh, NC 27695 USA.; Heacock, B (corresponding author), Triangle Univ Nucl Lab, Durham, NC 27708 USA.	benjamin.heacock@nist.gov	; Hosobata, Takuya/C-9342-2017	Huber, Michael/0000-0002-3795-8445; Fujiie, Takuhiro/0000-0003-0688-580X; Hosobata, Takuya/0000-0002-3174-3232; Shimizu, Hirohiko/0000-0002-8767-6542; Pushin, Dmitry/0000-0002-4594-3403; Kitaguchi, Masaaki/0000-0001-7637-6467; Hirota, Katsuya/0000-0002-1762-2821; Heacock, Benjamin/0000-0002-3478-7935	National Institute of Standards and Technology; US Department of Energy (DOE) [89243019SSC000025, DE-FG02-97ER41042]; National Science Foundation (NSF) [PHY-1307426]; Natural Sciences and Engineering Council of Canada (NSERC); Canada First Research Excellence Fund (CFREF)	National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA); US Department of Energy (DOE)(United States Department of Energy (DOE)); National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada First Research Excellence Fund (CFREF)	This work was supported by The National Institute of Standards and Technology, the US Department of Energy (DOE) under grants 89243019SSC000025 and DE-FG02-97ER41042, the National Science Foundation (NSF) under grant PHY-1307426, the Natural Sciences and Engineering Council of Canada (NSERC) Discovery program, and the Canada First Research Excellence Fund (CFREF).	Adelberger EG, 2003, ANNU REV NUCL PART S, V53, P77, DOI 10.1146/annurev.nucl.53.041002.110503; ALDRED PJE, 1973, PROC R SOC LON SER-A, V332, P223, DOI 10.1098/rspa.1973.0022; ALEKSANDROV YA, 1986, SOV J NUCL PHYS+, V44, P900; Arkani-Hamed N, 1999, PHYS REV D, V59, DOI 10.1103/PhysRevD.59.086004; Arkani-Hamed N, 2002, PHYS REV D, V65, DOI 10.1103/PhysRevD.65.052003; Atac H, 2021, EUR PHYS J A, V57, DOI 10.1140/epja/s10050-021-00389-9; Atac H., 1759, NAT COMMUN, V12; Brax P, 2019, PHYS LETT B, V798, DOI 10.1016/j.physletb.2019.135012; Brax P, 2018, PHYS REV D, V97, DOI 10.1103/PhysRevD.97.115034; CUMMINGS S, 1988, AUST J PHYS, V41, P423, DOI 10.1071/PH880423; DAWSON B, 1967, PROC R SOC LON SER-A, V298, P307, DOI 10.1098/rspa.1967.0105; DEUTSCH M, 1985, ACTA CRYSTALLOGR A, V41, P48, DOI 10.1107/S0108767385000083; DEUTSCH M, 1989, PHYS REV B, V40, P11666, DOI 10.1103/PhysRevB.40.11666; Epelbaum E, 2020, FRONT PHYS-LAUSANNE, V8, DOI 10.3389/fphy.2020.00098; Erba A, 2013, J COMPUT CHEM, V34, P346, DOI 10.1002/jcc.23138; Ewald PP, 1916, ANN PHYS-BERLIN, V49, P1; Fayet P, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.115017; Fedorov VV, 2010, PHYS LETT B, V694, P22, DOI 10.1016/j.physletb.2010.09.033; Fichet S, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.131801; Flensburg C, 1999, PHYS REV B, V60, P284, DOI 10.1103/PhysRevB.60.284; Gentile TR, 2011, PHYS REV C, V83, DOI 10.1103/PhysRevC.83.055203; Greene GL, 2007, PHYS REV C, V75, DOI 10.1103/PhysRevC.75.015501; Haddock CC, 2018, PHYS REV D, V97, DOI 10.1103/PhysRevD.97.062002; HART M, 1966, Z PHYS, V189, P269, DOI 10.1007/BF01332665; HASTINGS JB, 1975, PHYS REV B, V12, P5580, DOI 10.1103/PhysRevB.12.5580; HATTORI H, 1965, J PHYS SOC JPN, V20, P988, DOI 10.1143/JPSJ.20.988; Haun R, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.012501; Heacock B, 2018, REV SCI INSTRUM, V89, DOI 10.1063/1.5008273; Heacock B, 2017, PHYS REV A, V95, DOI 10.1103/PhysRevA.95.013840; Heacock B., Open data for "Pendellosung interferometry probes the neutron charge radius,lattice dynamics, and fifth forces, DOI 10.5281/zenodo.5080965; Heacock B, 2019, ACTA CRYSTALLOGR A, V75, P833, DOI 10.1107/S2053273319011604; Heidenreich RD, 1942, PHYS REV, V62, P291, DOI 10.1103/PhysRev.62.291; Hellman O, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.144301; Ioffe A, 1998, PHYS REV A, V58, P1475, DOI 10.1103/PhysRevA.58.1475; Kamiya Y, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.161101; KATO N, 1959, ACTA CRYSTALLOGR, V12, P787, DOI 10.1107/S0365110X59002262; Kessler EG, 2017, J RES NATL INST STAN, V122, DOI 10.6028/jres.122.024; Kim DS, 2018, P NATL ACAD SCI USA, V115, P1992, DOI 10.1073/pnas.1707745115; Kim DS, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.014307; KOESTER L, 1995, PHYS REV C, V51, P3363, DOI 10.1103/PhysRevC.51.3363; KOESTER L, 1976, PHYS REV LETT, V36, P1021, DOI 10.1103/PhysRevLett.36.1021; Kopecky S, 1997, PHYS REV C, V56, P2229, DOI 10.1103/PhysRevC.56.2229; KROHN VE, 1973, PHYS REV D, V8, P1305, DOI 10.1103/PhysRevD.8.1305; KROHN VE, 1966, PHYS REV, V148, P1303, DOI 10.1103/PhysRev.148.1303; Mohideen U, 1998, PHYS REV LETT, V81, P4549, DOI 10.1103/PhysRevLett.81.4549; Mostepanenko VM, 2020, UNIVERSE-BASEL, V6, DOI 10.3390/universe6090147; Murata J, 2015, CLASSICAL QUANT GRAV, V32, DOI 10.1088/0264-9381/32/3/033001; Nesvizhevsky VV, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.034020; Pokotilovski YN, 2013, PHYS LETT B, V719, P341, DOI 10.1016/j.physletb.2013.01.022; Rauch H., 2015, NEUTRON INTERFEROMET, V12; ROBERTO JB, 1974, PHYS REV B, V9, P2590, DOI 10.1103/PhysRevB.9.2590; Shahi CB, 2016, NUCL INSTRUM METH A, V813, P111, DOI 10.1016/j.nima.2016.01.023; SHULL CG, 1972, PHYS REV LETT, V29, P871, DOI 10.1103/PhysRevLett.29.871; SHULL CG, 1973, Z NATURFORSCH A, VA 28, P657, DOI 10.1515/zna-1973-0519; SHULL CG, 1968, PHYS REV LETT, V21, P1585, DOI 10.1103/PhysRevLett.21.1585; SIPPEL D, 1965, PHYS LETT, V14, P174, DOI 10.1016/0031-9163(65)90570-6; SOMENKOV VA, 1978, SOLID STATE COMMUN, V25, P593, DOI 10.1016/0038-1098(78)91497-7; SPACKMAN MA, 1986, ACTA CRYSTALLOGR A, V42, P271, DOI 10.1107/S0108767386099312; Sparenberg JM, 2002, PHYS REV C, V66, DOI 10.1103/PhysRevC.66.055210; Sparenberg JM, 2003, J ELECTRON SPECTROSC, V129, P315, DOI 10.1016/S0368-2048(03)00084-7; Tanabashi M, 2018, PHYS REV D, V98, DOI 10.1103/PhysRevD.98.030001; TANEMURA S, 1972, ACTA CRYSTALL A-CRYS, VA 28, P69, DOI 10.1107/S0567739472000154; WADA M, 1977, ACTA CRYSTALLOGR A, V33, P161, DOI 10.1107/S0567739477000333; WILLIS BTM, 1969, ACTA CRYSTALL A-CRYS, VA 25, P277, DOI 10.1107/S0567739469000441; Zee A, 2004, PHYS LETT B, V594, P8, DOI 10.1016/j.physletb.2004.04.087	66	2	2	5	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2021	373	6560					1239	+		10.1126/science.abc2794	http://dx.doi.org/10.1126/science.abc2794			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UP5RB	34516785	Green Submitted			2022-12-28	WOS:000695436000029
J	Oliver, D				Oliver, David			David Oliver: What the plan for social care omitted	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Albert A, 2019, PRIME MINISTER B JOH; BBC, 2021, BBC NEWS; Cabinet Office and Prime Minister's Office, 2019, QUEENS SPEECH 2019; Clarke S, 2019, A DILNOT SOCIAL CARE; Health Foundation, 2021, SOC CAR FUND GAP; HM Government, 2021, BUILDING BACK BETTER; Macdonald M., 2020, HLTH SOCIAL CARE WOR; Oliver D, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3203; Oliver D, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l5138; Shembavnekar N., 2022, IS COVID 19 IMPACTIN; Stewart H., GUARDIAN	11	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2021	374								n2227	10.1136/bmj.n2227	http://dx.doi.org/10.1136/bmj.n2227			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	US1IY	34507975	Bronze			2022-12-28	WOS:000697191000008
J	Haniffa, M; Taylor, D; Linnarsson, S; Aronow, BJ; Bader, GD; Barker, RA; Camara, PG; Camp, JG; Chedotal, A; Copp, A; Etchevers, HC; Giacobini, P; Gottgens, B; Guo, GJ; Hupalowska, A; James, KR; Kirby, E; Kriegstein, A; Lundeberg, J; Marioni, JC; Meyer, KB; Niakan, KK; Nilsson, M; Olabi, B; Pe'er, D; Regev, A; Rood, J; Rozenblatt-Rosen, O; Satija, R; Teichmann, SA; Treutlein, B; Vento-Tormo, R; Webb, S				Haniffa, Muzlifah; Taylor, Deanne; Linnarsson, Sten; Aronow, Bruce J.; Bader, Gary D.; Barker, Roger A.; Camara, Pablo G.; Camp, J. Gray; Chedotal, Alain; Copp, Andrew; Etchevers, Heather C.; Giacobini, Paolo; Gottgens, Berthold; Guo, Guoji; Hupalowska, Ania; James, Kylie R.; Kirby, Emily; Kriegstein, Arnold; Lundeberg, Joakim; Marioni, John C.; Meyer, Kerstin B.; Niakan, Kathy K.; Nilsson, Mats; Olabi, Bayanne; Pe'er, Dana; Regev, Aviv; Rood, Jennifer; Rozenblatt-Rosen, Orit; Satija, Rahul; Teichmann, Sarah A.; Treutlein, Barbara; Vento-Tormo, Roser; Webb, Simone		Human Cell Atlas Dev Biol Network	A roadmap for the Human Developmental Cell Atlas	NATURE			English	Article							DE-NOVO MUTATIONS; GENE-EXPRESSION; STEM-CELL; SEGMENTATION CLOCK; SELF-ORGANIZATION; INTACT-TISSUE; ANALYSIS MAPS; REVEALS; MOUSE; INSIGHTS	This Perspective outlines the Human Developmental Cell Atlas initiative, which uses state-of-the-art technologies to map and model human development across gestation, and discusses the early milestones that have been achieved. The Human Developmental Cell Atlas (HDCA) initiative, which is part of the Human Cell Atlas, aims to create a comprehensive reference map of cells during development. This will be critical to understanding normal organogenesis, the effect of mutations, environmental factors and infectious agents on human development, congenital and childhood disorders, and the cellular basis of ageing, cancer and regenerative medicine. Here we outline the HDCA initiative and the challenges of mapping and modelling human development using state-of-the-art technologies to create a reference atlas across gestation. Similar to the Human Genome Project, the HDCA will integrate the output from a growing community of scientists who are mapping human development into a unified atlas. We describe the early milestones that have been achieved and the use of human stem-cell-derived cultures, organoids and animal models to inform the HDCA, especially for prenatal tissues that are hard to acquire. Finally, we provide a roadmap towards a complete atlas of human development.	[Haniffa, Muzlifah; Olabi, Bayanne; Webb, Simone] Newcastle Univ, Biosci Inst, Newcastle Upon Tyne, Tyne & Wear, England; [Haniffa, Muzlifah; James, Kylie R.; Meyer, Kerstin B.; Teichmann, Sarah A.; Vento-Tormo, Roser] Wellcome Sanger Inst, Hinxton, England; [Haniffa, Muzlifah] Newcastle Hosp NHS Fdn Trust, Dept Dermatol, Newcastle Upon Tyne, Tyne & Wear, England; [Haniffa, Muzlifah] Newcastle Hosp NHS Fdn Trust, NIHR Newcastle Biomed Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Taylor, Deanne] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat DBHi, Philadelphia, PA 19104 USA; [Taylor, Deanne] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Linnarsson, Sten] Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Neurobiol, Stockholm, Sweden; [Aronow, Bruce J.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol & Biomed Informat, Cincinnati, OH 45229 USA; [Bader, Gary D.] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Barker, Roger A.; Gottgens, Berthold] Univ Cambridge, Wellcome & MRC Cambridge Stem Cell Inst, Cambridge, England; [Barker, Roger A.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Camara, Pablo G.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Camp, J. Gray] Univ Basel, Inst Mol & Clin Ophthalmol Basel IOB, Basel, Switzerland; [Chedotal, Alain] Sorbonne Univ, Inst Vis, CNRS, INSERM, Paris, France; [Copp, Andrew] UCL Great Ormond St Inst Child Hlth, Dev Biol & Canc Programme, London, England; [Etchevers, Heather C.] Aix Marseille Univ, U1251, INSERM, MMG, Marseille, France; [Giacobini, Paolo] Univ Lille, Lab Dev & Plast Neuroendocrine Brain, INSERM, CHU Lille,Lille Neurosci & Cognit,UMR S 1172, Lille, France; [Gottgens, Berthold] Univ Cambridge, Dept Haematol, Cambridge, England; [Guo, Guoji] Zhejiang Univ, Ctr Stem Cell & Regenerat Med, Sch Med, Hangzhou, Peoples R China; [Hupalowska, Ania; Regev, Aviv; Rood, Jennifer; Rozenblatt-Rosen, Orit] Broad Inst Harvard & MIT, Klarman Cell Observ, Cambridge, MA USA; [Kirby, Emily] McGill Univ, Ctr Genom & Policy, Montreal, PQ, Canada; [Kriegstein, Arnold] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Lundeberg, Joakim] KTH Royal Inst Technol, Sci Life Lab, Solna, Sweden; [Marioni, John C.] Univ Cambridge, Canc Res Inst UK, Cambridge Inst, Cambridge, England; [Niakan, Kathy K.] Francis Crick Inst, London, England; [Niakan, Kathy K.] Univ Cambridge, Ctr Trophoblast Res, Dept Physiol, Cambridge, England; [Nilsson, Mats] Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, Stockholm, Sweden; [Pe'er, Dana] Mem Sloan Kettering Canc Ctr, Computat & Syst Biol Program, Sloan Kettering Inst, 1275 York Ave, New York, NY 10021 USA; [Regev, Aviv] MIT, Dept Biol, Cambridge, MA USA; [Satija, Rahul] NYU, New York Genome Ctr, New York, NY USA; [Teichmann, Sarah A.] Univ Cambridge, Dept Phys, Cavendish Lab, Cambridge, England; [Treutlein, Barbara] Eidgenossische Tech Hsch ETH Zurich, Dept Biosyst Sci & Engn, Basel, Switzerland; [Regev, Aviv; Rozenblatt-Rosen, Orit] Genentech Inc, San Francisco, CA 94080 USA	Newcastle University - UK; Wellcome Trust Sanger Institute; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Karolinska Institutet; Cincinnati Children's Hospital Medical Center; University of Toronto; University of Cambridge; University of Cambridge; University of Pennsylvania; Pennsylvania Medicine; University of Basel; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; University of Cambridge; Zhejiang University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; McGill University; University of California System; University of California San Francisco; Royal Institute of Technology; CRUK Cambridge Institute; University of Cambridge; Francis Crick Institute; University of Cambridge; Stockholm University; Memorial Sloan Kettering Cancer Center; Massachusetts Institute of Technology (MIT); New York University; University of Cambridge; Roche Holding; Genentech	Haniffa, M (corresponding author), Newcastle Univ, Biosci Inst, Newcastle Upon Tyne, Tyne & Wear, England.; Haniffa, M (corresponding author), Wellcome Sanger Inst, Hinxton, England.; Haniffa, M (corresponding author), Newcastle Hosp NHS Fdn Trust, Dept Dermatol, Newcastle Upon Tyne, Tyne & Wear, England.	m.a.haniffa@ncl.ac.uk	Jørgensen, Anne/S-8681-2016; Zaffran, Stéphane/S-7454-2019; Bader, Gary/C-1176-2009; Etchevers, Heather C./B-5813-2012; Giacobini, Paolo/P-9878-2019; ROLLAND, Antoine D/B-2611-2012; Rozenblatt-Rosen, Orit/HDN-4182-2022; Linnarsson, Sten/HCH-3909-2022; Maitre, Jean-Leon/C-4372-2017; Taylor, Deanne/Q-4777-2017; Barbry, Pascal/O-5021-2016; Chalmel, Frederic/L-5360-2018; Chedotal, Alain/F-2750-2017	Jørgensen, Anne/0000-0002-6409-198X; Zaffran, Stéphane/0000-0002-0811-418X; Bader, Gary/0000-0003-0185-8861; Etchevers, Heather C./0000-0003-0201-3799; Giacobini, Paolo/0000-0002-3075-1441; ROLLAND, Antoine D/0000-0002-9758-4406; Maitre, Jean-Leon/0000-0002-3688-1474; Taylor, Deanne/0000-0002-3302-4610; Haniffa, Muzlifah/0000-0002-3927-2084; Kaller Lundberg, Emma/0000-0001-7034-0850; Gonzalez Camara, Pablo/0000-0001-6822-3604; Barbry, Pascal/0000-0001-9632-6483; Camp, Jarrett/0000-0003-3295-1225; Scharfmann, Raphael/0000-0001-7619-337X; Webb, Simone/0000-0003-3058-8952; Aronow, Bruce/0000-0001-5109-6514; Bosio, Andreas/0000-0001-9776-2535; Marioni, John/0000-0001-9092-0852; Copp, Andrew/0000-0002-2544-9117; Chalmel, Frederic/0000-0002-0535-3628; James, Kylie/0000-0002-7107-0650; GITTON, Yorick/0000-0002-6808-6010; Chedotal, Alain/0000-0001-7577-3794				Aldridge S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18158-5; Argelaguet R, 2019, NATURE, V576, P487, DOI 10.1038/s41586-019-1825-8; Artegiani B, 2020, NAT CELL BIOL, V22, P321, DOI 10.1038/s41556-020-0472-5; Asp M, 2019, CELL, V179, P1647, DOI 10.1016/j.cell.2019.11.025; Barker RA, 2017, CELL STEM CELL, V21, P569, DOI 10.1016/j.stem.2017.09.014; Barnat M, 2020, SCIENCE, V369, P787, DOI 10.1126/science.aax3338; Behjati S, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.152561; Belle M, 2017, CELL, V169, DOI 10.1016/j.cell.2017.03.008; Bhaduri A, 2020, NATURE, V578, P142, DOI 10.1038/s41586-020-1962-0; Biswas AB, 2016, RES DEV DISABIL, V53-54, P242, DOI 10.1016/j.ridd.2016.02.010; Blakeley P, 2015, DEVELOPMENT, V142, P3151, DOI 10.1242/dev.123547; BLONDER LX, 1993, AM J HUM BIOL, V5, P245, DOI 10.1002/ajhb.1310050216; Bock C, 2021, NAT BIOTECHNOL, V39, P13, DOI 10.1038/s41587-020-00762-x; Bonneel N., 2018, THESIS SORBONNE U; Briggs JA, 2018, SCIENCE, V360, P980, DOI 10.1126/science.aar5780; Camp JG, 2018, NAT METHODS, V15, P661, DOI 10.1038/s41592-018-0113-0; Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112; Cao JY, 2020, SCIENCE, V370, P808, DOI 10.1126/science.aba7721; Cao JY, 2019, NATURE, V566, P496, DOI 10.1038/s41586-019-0969-x; Cao JY, 2017, SCIENCE, V357, P661, DOI 10.1126/science.aam8940; Carter RA, 2018, CURR BIOL, V28, P2910, DOI 10.1016/j.cub.2018.07.062; Casoni F, 2016, DEVELOPMENT, V143, P3969, DOI 10.1242/dev.139444; Croft B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07784-9; Cui YL, 2019, CELL REP, V26, P1934, DOI 10.1016/j.celrep.2019.01.079; Cusanovich DA, 2018, NATURE, V555, P538, DOI 10.1038/nature25981; D'Gama AM, 2018, NAT NEUROSCI, V21, P1504, DOI 10.1038/s41593-018-0257-3; Deglincerti A, 2016, NATURE, V533, P251, DOI 10.1038/nature17948; Diaz-Cuadros M, 2020, NATURE, V580, P113, DOI 10.1038/s41586-019-1885-9; Domcke S, 2020, SCIENCE, V370, P809, DOI 10.1126/science.aba7612; Dumortier JG, 2019, SCIENCE, V365, P465, DOI 10.1126/science.aaw7709; Elmentaite R., NATURE, DOI [10.1038/s41586-021-03852-1(2021), DOI 10.1038/S41586-021-03852-1(2021)]; Elmentaite R, 2020, DEV CELL, V55, P771, DOI 10.1016/j.devcel.2020.11.010; Fujii M, 2019, GASTROENTEROLOGY, V156, P562, DOI 10.1053/j.gastro.2018.11.048; Gerrelli D, 2015, DEVELOPMENT, V142, P3073, DOI 10.1242/dev.122820; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Gracia M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10720-0; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Haendel M, 2020, NAT REV DRUG DISCOV, V19, P77, DOI 10.1038/d41573-019-00180-y; Han XP, 2020, NATURE, V581, P303, DOI 10.1038/s41586-020-2157-4; Holloway EM, 2021, CELL STEM CELL, V28, P568, DOI 10.1016/j.stem.2020.11.008; Homsy J, 2015, SCIENCE, V350, P1262, DOI 10.1126/science.aac9396; Hovestadt V, 2020, NAT REV CANCER, V20, P42, DOI 10.1038/s41568-019-0223-8; Huang Q, 2020, SCIENCE, V368, P181, DOI 10.1126/science.aba0210; Huisman C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11667-y; Human Cell Atlas, ETHICS; Human Cell Atlas, 2021, REGISTER; Jessa S, 2019, NAT GENET, V51, P1702, DOI 10.1038/s41588-019-0531-7; Kee N, 2017, CELL STEM CELL, V20, P29, DOI 10.1016/j.stem.2016.10.003; Kirst C, 2020, CELL, V180, P780, DOI 10.1016/j.cell.2020.01.028; Koike H, 2019, NATURE, V574, P112, DOI 10.1038/s41586-019-1598-0; La Manno G, 2016, CELL, V167, P566, DOI 10.1016/j.cell.2016.09.027; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lareau CA, 2021, NAT BIOTECHNOL, V39, P451, DOI 10.1038/s41587-020-0645-6; Laughney AM, 2020, NAT MED, V26, P259, DOI 10.1038/s41591-019-0750-6; Lee JY, 2020, NATURE, V582, P399, DOI 10.1038/s41586-020-2352-3; Lee-Six H, 2018, NATURE, V561, P473, DOI 10.1038/s41586-018-0497-0; Lescroart F, 2018, SCIENCE, V359, P1177, DOI 10.1126/science.aao4174; Li L, 2017, CELL STEM CELL, V20, P858, DOI 10.1016/j.stem.2017.03.007; Liu XD, 2021, NATURE, V591, P627, DOI 10.1038/s41586-021-03372-y; Lu YF, 2020, DEV CELL, V53, P473, DOI 10.1016/j.devcel.2020.04.009; Ludwig LS, 2019, CELL, V176, P1325, DOI 10.1016/j.cell.2019.01.022; Ly A, 2008, CELL, V133, P1241, DOI 10.1016/j.cell.2008.05.030; Marton RM, 2020, TRENDS CELL BIOL, V30, P133, DOI 10.1016/j.tcb.2019.11.004; Matsuda M, 2020, SCIENCE, V369, P1450, DOI 10.1126/science.aba7668; Matsuda M, 2020, NATURE, V580, P124, DOI 10.1038/s41586-020-2144-9; McGinnis CS, 2019, NAT METHODS, V16, P619, DOI 10.1038/s41592-019-0433-8; Mereu E, 2020, NAT BIOTECHNOL, V38, P747, DOI 10.1038/s41587-020-0469-4; Morgan Lynn, 2009, ICONS LIFE CULTURAL, DOI DOI 10.1525/9780520944725; Moris N, 2020, NATURE, V582, P410, DOI 10.1038/s41586-020-2383-9; NHGRI & NICHD, 2020, DEV GEN TISS EXPR DG; Nowakowski TJ, 2017, SCIENCE, V358, P1318, DOI 10.1126/science.aap8809; Park JE, 2020, SCIENCE, V367, P868, DOI 10.1126/science.aay3224; Petropoulos S, 2016, CELL, V167, P285, DOI [10.1016/j.cell.2016.08.009, 10.1016/j.cell.2016.03.023]; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pijuan-Sala B, 2019, NATURE, V566, P490, DOI 10.1038/s41586-019-0933-9; Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967; Popescu DM, 2019, NATURE, V574, P365, DOI 10.1038/s41586-019-1652-y; Quadrato G, 2017, NATURE, V545, P48, DOI 10.1038/nature22047; Rayon T, 2020, SCIENCE, V369, P1449, DOI 10.1126/science.aba7667; Regev A, 2017, ELIFE, V6, DOI 10.7554/eLife.27041; Reynolds G, 2021, SCIENCE, V371, P364, DOI 10.1126/science.aba6500; Rood JE, 2019, CELL, V179, P1455, DOI 10.1016/j.cell.2019.11.019; Rosenberg AB, 2018, SCIENCE, V360, P176, DOI 10.1126/science.aam8999; Rossant J, 2017, CELL STEM CELL, V20, P18, DOI 10.1016/j.stem.2016.12.004; Shahbazi MN, 2019, SCIENCE, V364, P948, DOI 10.1126/science.aax0164; Shao Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00236-w; Sharma A, 2020, CELL, V183, P377, DOI 10.1016/j.cell.2020.08.040; Simmons RA, 2009, PEDIATR CLIN N AM, V56, P449, DOI 10.1016/j.pcl.2009.03.004; Simunovic M, 2019, NAT CELL BIOL, V21, P900, DOI 10.1038/s41556-019-0349-7; Sozen B., RECONSTRUCTING HUMAN, DOI [10.1101/2021.03.12.435175(2021, DOI 10.1101/2021.03.12.435175(2021]; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Stahl PL, 2016, SCIENCE, V353, P78, DOI 10.1126/science.aaf2403; Stewart BJ, 2019, SCIENCE, V365, P1461, DOI 10.1126/science.aat5031; Subbaraman N, 2021, NATURE, V591, P510, DOI 10.1038/d41586-021-00695-8; Sungnak W, 2020, NAT MED, V26, P681, DOI 10.1038/s41591-020-0868-6; Suryawanshi H, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau4788; Sylwestrak EL, 2016, CELL, V164, P792, DOI 10.1016/j.cell.2016.01.038; Takahashi J, 2019, REGEN MED, V14, P93, DOI 10.2217/rme-2018-0158; Taylor DM, 2019, DEV CELL, V49, P10, DOI 10.1016/j.devcel.2019.03.001; The HCA Consortium, 2019, HUM CELL ATL WHIT PA; Tiklova K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08453-1; Tirosh I, 2016, NATURE, V539, P309, DOI 10.1038/nature20123; Todorov MI, 2020, NAT METHODS, V17, P442, DOI 10.1038/s41592-020-0792-1; Tyser R. C. V., 2020, BIORXIV, DOI [10.1101/2020.07.21.213512, DOI 10.1101/2020.07.21.213512V1]; Ueda HR, 2020, NAT REV NEUROSCI, V21, P61, DOI 10.1038/s41583-019-0250-1; Utz SG, 2020, CELL, V181, P557, DOI 10.1016/j.cell.2020.03.021; Velmeshev D, 2019, SCIENCE, V364, P685, DOI 10.1126/science.aav8130; Vento-Tormo R, 2018, NATURE, V563, P347, DOI 10.1038/s41586-018-0698-6; Vertesy A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04215-7; Vladoiu MC, 2019, NATURE, V572, P67, DOI 10.1038/s41586-019-1158-7; Wagner DE, 2018, SCIENCE, V360, P981, DOI 10.1126/science.aar4362; Wang X, 2018, SCIENCE, V361, DOI 10.1126/science.aat5691; Warmflash A, 2014, NAT METHODS, V11, P847, DOI [10.1038/NMETH.3016, 10.1038/nmeth.3016]; Wellcome Trust, 2003, SHAR DAT LARG SCAL B; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18; Wimmer RA, 2019, NATURE, V565, P505, DOI 10.1038/s41586-018-0858-8; Yamagishi H, 2003, TRENDS MOL MED, V9, P383, DOI 10.1016/S1471-4914(03)00141-2; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Young MD, 2018, SCIENCE, V361, P594, DOI 10.1126/science.aat1699; Yu LQ, 2021, NATURE, V591, P620, DOI 10.1038/s41586-021-03356-y; Zhang SY, 2019, CURR OPIN IMMUNOL, V59, P88, DOI 10.1016/j.coi.2019.03.008; Zhao S, 2020, CELL, V180, P796, DOI 10.1016/j.cell.2020.01.030	123	34	34	10	50	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 9	2021	597	7875					196	205		10.1038/s41586-021-03620-1	http://dx.doi.org/10.1038/s41586-021-03620-1			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UQ1FZ	34497388	Bronze, Green Submitted			2022-12-28	WOS:000695818300009
J	Liu, CC				Liu, Chang C.			Sense and Sense Ability in a Synthetic Genetic Code	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Liu, Chang C.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA; [Liu, Chang C.] Univ Calif Irvine, Ctr Synthet Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Liu, CC (corresponding author), Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA.; Liu, CC (corresponding author), Univ Calif Irvine, Ctr Synthet Biol, Irvine, CA 92697 USA.							Fredens J, 2019, NATURE, V569, P514, DOI 10.1038/s41586-019-1192-5; Robertson WE, 2021, SCIENCE, V372, P1057, DOI 10.1126/science.abg3029	2	0	0	2	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 9	2021	385	11					1045	1048		10.1056/NEJMcibr2109352	http://dx.doi.org/10.1056/NEJMcibr2109352			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UN0RH	34496180				2022-12-28	WOS:000693730200017
J	Rimmer, A				Rimmer, Abi			A third of ethnic minority staff working in mental health trusts have experienced harassment, bullying, or abuse at work	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2021	374								n2220	10.1136/bmj.n2220	http://dx.doi.org/10.1136/bmj.n2220			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UZ3VV	34503949				2022-12-28	WOS:000702137100019
J	Zhang, Q; Hu, GW; Ma, WL; Li, PN; Krasnok, A; Hillenbrand, R; Alu, A; Qiu, CW				Zhang, Qing; Hu, Guangwei; Ma, Weiliang; Li, Peining; Krasnok, Alex; Hillenbrand, Rainer; Alu, Andrea; Qiu, Cheng-Wei			Interface nano-optics with van der Waals polaritons	NATURE			English	Review							PHONON-POLARITONS; GRAPHENE PLASMONS; BORON-NITRIDE; LIGHT; CRYSTALS; MODES; FIELD; EXCITATION; TRANSPORT; EMISSION	Polaritons are hybrid excitations of matter and photons. In recent years, polaritons in van der Waals nanomaterials-known as van der Waals polaritons-have shown great promise to guide the flow of light at the nanoscale over spectral regions ranging from the visible to the terahertz. A vibrant research field based on manipulating strong light-matter interactions in the form of polaritons, supported by these atomically thin van der Waals nanomaterials, is emerging for advanced nanophotonic and opto-electronic applications. Here we provide an overview of the state of the art of exploiting interface optics-such as refractive optics, meta-optics and moire engineering-for the control of van der Waals polaritons. This enhanced control over van der Waals polaritons at the nanoscale has not only unveiled many new phenomena, but has also inspired valuable applications-including new avenues for nano-imaging, sensing, on-chip optical circuitry, and potentially many others in the years to come. This Review discusses the state of the art of interface optics-including refractive optics, meta-optics and moire engineering-for the control of van der Waals polaritons.	[Zhang, Qing; Hu, Guangwei; Qiu, Cheng-Wei] Natl Univ Singapore, Dept Elect & Comp Engn, Singapore, Singapore; [Ma, Weiliang; Li, Peining] Huazhong Univ Sci & Technol, Wuhan Natl Lab Optoelect, Wuhan, Peoples R China; [Ma, Weiliang; Li, Peining] Huazhong Univ Sci & Technol, Sch Opt & Elect Informat, Wuhan, Peoples R China; [Krasnok, Alex; Alu, Andrea] CUNY, Adv Sci Res Ctr, New York, NY 10021 USA; [Hillenbrand, Rainer] Univ Basque Country, CIC nanoGUNE BRTA, Donostia San Sebastian, Spain; [Hillenbrand, Rainer] Univ Basque Country, Dept Elect & Elect, Donostia San Sebastian, Spain; [Hillenbrand, Rainer] Ikerbasque, Basque Fdn Sci, Bilbao, Spain; [Alu, Andrea] CUNY, Grad Ctr, Phys Program, New York, NY 10010 USA	National University of Singapore; Huazhong University of Science & Technology; Huazhong University of Science & Technology; City University of New York (CUNY) System; University of Basque Country; University of Basque Country; Basque Foundation for Science; City University of New York (CUNY) System	Qiu, CW (corresponding author), Natl Univ Singapore, Dept Elect & Comp Engn, Singapore, Singapore.; Alu, A (corresponding author), CUNY, Adv Sci Res Ctr, New York, NY 10021 USA.; Alu, A (corresponding author), CUNY, Grad Ctr, Phys Program, New York, NY 10010 USA.	aalu@gc.cuny.edu; chengwei.qiu@nus.edu.sg	Hillenbrand, Rainer/N-3428-2016; Hu, Guangwei/O-5997-2016	Hillenbrand, Rainer/0000-0002-1904-4551; Hu, Guangwei/0000-0002-3023-9632; Qiu, Chengwei/0000-0002-6605-500X				Iranzo DA, 2018, SCIENCE, V360, P291, DOI 10.1126/science.aar8438; Alexeev EM, 2019, NATURE, V567, P81, DOI 10.1038/s41586-019-0986-9; Alfaro-Mozaz FJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07795-6; Alfaro-Mozaz FJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15624; Alonso-Gonzalez P, 2014, SCIENCE, V344, P1369, DOI 10.1126/science.1253202; Alonso-Gonzalez P, 2017, NAT NANOTECHNOL, V12, P31, DOI [10.1038/nnano.2016.185, 10.1038/NNANO.2016.185]; Alu A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.016623; Alvarez-Perez G, 2020, ADV MATER, V32, DOI 10.1002/adma.201908176; Alvarez-Perez G, 2019, PHYS REV B, V100, DOI 10.1103/PhysRevB.100.235408; Ambrosio A, 2017, ACS NANO, V11, P8741, DOI 10.1021/acsnano.7b02323; Ansell D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9846; Aoki M, 2007, SOLID STATE COMMUN, V142, P123, DOI 10.1016/j.ssc.2007.02.013; Autore M, 2018, LIGHT-SCI APPL, V7, DOI 10.1038/lsa.2017.172; Basov DN, 2016, SCIENCE, V354, DOI 10.1126/science.aag1992; Brar VW, 2014, NANO LETT, V14, P3876, DOI 10.1021/nl501096s; Brey L, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.256804; Bylinkin A, 2021, NAT PHOTONICS, V15, P197, DOI 10.1038/s41566-020-00725-3; Caldwell JD, 2016, NAT NANOTECHNOL, V11, P9, DOI [10.1038/nnano.2015.305, 10.1038/NNANO.2015.305]; Cao Y, 2018, NATURE, V556, P80, DOI 10.1038/nature26154; Cao Y, 2018, NATURE, V556, P43, DOI 10.1038/nature26160; Chakraborty S, 2016, SCIENCE, V351, P246, DOI 10.1126/science.aad2930; Chaudhary K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12439-4; Chaudhary K, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau7171; Chen JN, 2012, NATURE, V487, P77, DOI 10.1038/nature11254; Chen XZ, 2020, NAT PHYS, V16, P631, DOI 10.1038/s41567-020-0865-1; Cortes CL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14144; Dai S, 2015, NAT NANOTECHNOL, V10, P682, DOI [10.1038/NNANO.2015.131, 10.1038/nnano.2015.131]; Dai S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7963; Dai S, 2014, SCIENCE, V343, P1125, DOI 10.1126/science.1246833; Dai ZG, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19913-4; Dai ZG, 2020, CHEM REV, V120, P6197, DOI 10.1021/acs.chemrev.9b00592; Dias EJC, 2020, LIGHT-SCI APPL, V9, DOI 10.1038/s41377-020-0322-z; Dolado I, 2020, ADV MATER, V32, DOI 10.1002/adma.201906530; Dong WK, 2020, ADV MATER, V32, DOI 10.1002/adma.202002014; Duan JH, 2020, NANO LETT, V20, P5323, DOI 10.1021/acs.nanolett.0c01673; Dubrovkin AM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04168-x; Epstein I, 2020, SCIENCE, V368, P1219, DOI 10.1126/science.abb1570; Farmer DB, 2016, ACS PHOTONICS, V3, P553, DOI 10.1021/acsphotonics.6b00143; Fei Z, 2012, NATURE, V487, P82, DOI 10.1038/nature11253; Follan TG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06858-y; Francescato Y, 2014, ACS PHOTONICS, V1, P437, DOI 10.1021/ph5000117; Giles AJ, 2018, NAT MATER, V17, P134, DOI 10.1038/NMAT5047; Gomez-Diaz JS, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.233901; Govyadinov AA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00056-y; Guerrero-Becerra KA, 2019, PHYS REV B, V100, DOI 10.1103/PhysRevB.100.125434; Hu F, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.247402; Hu F, 2017, NANO LETT, V17, P5423, DOI 10.1021/acs.nanolett.7b02029; Hu F, 2017, NAT PHOTONICS, V11, P356, DOI [10.1038/nphoton.2017.65, 10.1038/NPHOTON.2017.65]; Hu GW, 2020, NATURE, V582, P209, DOI 10.1038/s41586-020-2359-9; Hu GW, 2020, NANO LETT, V20, P3217, DOI 10.1021/acs.nanolett.9b05319; Hu H, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09008-0; Hu H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12334; Huber MA, 2017, NAT NANOTECHNOL, V12, P207, DOI [10.1038/NNANO.2016.261, 10.1038/nnano.2016.261]; Jiang LL, 2018, NAT NANOTECHNOL, V13, P204, DOI 10.1038/s41565-017-0042-6; Jiang LL, 2016, NAT MATER, V15, P840, DOI [10.1038/nmat4653, 10.1038/NMAT4653]; Jin CH, 2019, NATURE, V567, P76, DOI 10.1038/s41586-019-0976-y; Jin DF, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.245301; Ju L, 2015, NATURE, V520, P650, DOI 10.1038/nature14364; Kaminer I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11880; Kennes DM, 2021, NAT PHYS, V17, P155, DOI 10.1038/s41567-020-01154-3; Tran K, 2019, NATURE, V567, P71, DOI 10.1038/s41586-019-0975-z; Khaliji K, 2020, PHYS REV B, V102, DOI 10.1103/PhysRevB.102.125408; Klein M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11186-w; Kloppstech K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14475; Kotov OV, 2019, PHYS REV B, V100, DOI 10.1103/PhysRevB.100.165424; Kumar A, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.041413; Kurman Y, 2018, NAT PHOTONICS, V12, P423, DOI 10.1038/s41566-018-0176-6; Lee IH, 2019, NAT NANOTECHNOL, V14, P313, DOI 10.1038/s41565-019-0363-8; Lee IH, 2018, ACS PHOTONICS, V5, P2208, DOI 10.1021/acsphotonics.8b00062; Lewandowski C, 2019, P NATL ACAD SCI USA, V116, P20869, DOI 10.1073/pnas.1909069116; Li N, 2021, NAT MATER, V20, P43, DOI 10.1038/s41563-020-0763-z; Li PN, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17425-9; Li PN, 2018, SCIENCE, V359, P892, DOI 10.1126/science.aaq1704; Li PN, 2016, NAT MATER, V15, P870, DOI [10.1038/nmat4649, 10.1038/NMAT4649]; Li PN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8507; Li YY, 2019, ACS PHOTONICS, V6, P2562, DOI 10.1021/acsphotonics.9b01037; Lin J, 2013, SCIENCE, V340, P331, DOI 10.1126/science.1233746; Lin X, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.077401; Lin X, 2017, P NATL ACAD SCI USA, V114, P6717, DOI 10.1073/pnas.1701830114; Lin X, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601192; Liu M, 2011, NATURE, V474, P64, DOI 10.1038/nature10067; Liu WJ, 2020, SCIENCE, V370, P600, DOI 10.1126/science.abc4975; Low T, 2017, NAT MATER, V16, P182, DOI [10.1038/NMAT4792, 10.1038/nmat4792]; Low T, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.106802; Lundeberg MB, 2017, NAT MATER, V16, P204, DOI [10.1038/NMAT4755, 10.1038/nmat4755]; Luo Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18109-0; Ma WL, 2021, NATURE, V596, P362, DOI 10.1038/s41586-021-03755-1; Ma WL, 2018, NATURE, V562, P557, DOI 10.1038/s41586-018-0618-9; McGilly LJ, 2020, NAT NANOTECHNOL, V15, P580, DOI 10.1038/s41565-020-0708-3; Nemilentsau A, 2019, PHYS REV B, V99, DOI 10.1103/PhysRevB.99.201405; Nemilentsau A, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.066804; Ni GX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12327-x; Ni GX, 2018, NATURE, V557, P530, DOI 10.1038/s41586-018-0136-9; Ni GX, 2016, NAT PHOTONICS, V10, P244, DOI [10.1038/nphoton.2016.45, 10.1038/NPHOTON.2016.45]; Ni GX, 2015, NAT MATER, V14, P1217, DOI 10.1038/nmat4425; Nikitin AY, 2016, NAT PHOTONICS, V10, P239, DOI [10.1038/nphoton.2016.44, 10.1038/NPHOTON.2016.44]; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Phare CT, 2015, NAT PHOTONICS, V9, P511, DOI [10.1038/nphoton.2015.122, 10.1038/NPHOTON.2015.122]; Rivera N, 2016, SCIENCE, V353, P263, DOI 10.1126/science.aaf6308; Rodrigo D, 2015, SCIENCE, V349, P165, DOI 10.1126/science.aab2051; Rodriguez-Fortuno FJ, 2013, SCIENCE, V340, P328, DOI 10.1126/science.1233739; Rosolen G, 2018, LIGHT-SCI APPL, V7, DOI 10.1038/s41377-018-0065-2; Schurig D, 2006, SCIENCE, V314, P977, DOI 10.1126/science.1133628; Seyler KL, 2019, NATURE, V567, P66, DOI 10.1038/s41586-019-0957-1; Shentcis M, 2020, NAT PHOTONICS, V14, P686, DOI 10.1038/s41566-020-0689-7; Song JCW, 2016, P NATL ACAD SCI USA, V113, P4658, DOI 10.1073/pnas.1519086113; Stauber T, 2020, NANO LETT, V20, P8711, DOI 10.1021/acs.nanolett.0c03519; Sun FS, 2021, NANOSCALE, V13, P4845, DOI 10.1039/d0nr07372e; Sunku SS, 2018, SCIENCE, V362, P1153, DOI 10.1126/science.aau5144; Sunku SS, 2020, NANO LETT, V20, P2958, DOI 10.1021/acs.nanolett.9b04637; Taboada-Gutierrez J, 2020, NAT MATER, V19, P964, DOI 10.1038/s41563-020-0665-0; Tamagnone M., 2019, HIGH QUALITY FACTOR; Tamagnone M, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat7189; Tao J, 2019, CARBON, V150, P136, DOI 10.1016/j.carbon.2019.04.106; Tao J, 2018, CARBON, V133, P249, DOI 10.1016/j.carbon.2018.03.027; Vakil A, 2011, SCIENCE, V332, P1291, DOI 10.1126/science.1202691; Wang C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15001-9; Woessner A, 2017, NPJ 2D MATER APPL, V1, P1, DOI 10.1038/s41699-017-0031-5; Woessner A, 2017, NAT PHOTONICS, V11, P421, DOI [10.1038/nphoton.2017.98, 10.1038/NPHOTON.2017.98]; Woessner A, 2015, NAT MATER, V14, P421, DOI [10.1038/NMAT4169, 10.1038/nmat4169]; Wong LJ, 2016, NAT PHOTONICS, V10, P46, DOI [10.1038/NPHOTON.2015.223, 10.1038/nphoton.2015.223]; Woods CR, 2014, NAT PHYS, V10, P451, DOI [10.1038/NPHYS2954, 10.1038/nphys2954]; Wu SF, 2015, NATURE, V520, P69, DOI 10.1038/nature14290; Xiong L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12778-2; Yan HG, 2013, NAT PHOTONICS, V7, P394, DOI [10.1038/NPHOTON.2013.57, 10.1038/nphoton.2013.57]; Yang Y, 2018, NAT PHYS, V14, P894, DOI 10.1038/s41567-018-0180-2; Yao BC, 2018, NAT PHOTONICS, V12, P22, DOI 10.1038/s41566-017-0054-7; Yoxall E, 2015, NAT PHOTONICS, V9, P674, DOI [10.1038/nphoton.2015.166, 10.1038/NPHOTON.2015.166]; Yuan Z, 2020, ACS PHOTONICS, V7, P2610, DOI 10.1021/acsphotonics.0c00981; Zhang F, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.156801; Zhang Q, 2019, APPL PHYS LETT, V114, DOI 10.1063/1.5098346; Zheng ZB, 2020, NANO LETT, V20, P5301, DOI 10.1021/acs.nanolett.0c01627; Zheng ZB, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav8690; Zheng ZB, 2018, ADV MATER, V30, DOI 10.1002/adma.201705318	134	43	43	60	222	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 9	2021	597	7875					187	195		10.1038/s41586-021-03581-5	http://dx.doi.org/10.1038/s41586-021-03581-5			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UQ1FZ	34497390				2022-12-28	WOS:000695818300008
J	[Anonymous]				[Anonymous]			Seven days in medicine: 1-7 September 2021	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Public Health England, 2021, SEXUALLY TRANSMITTED; Stephenson T., 2021, RES SQUARE, DOI [DOI 10.21203/RS.3.RS-798316/V1, 10.21203/rs.3.rs-798316/v1]	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2021	374								n2188	10.1136/bmj.n2188	http://dx.doi.org/10.1136/bmj.n2188			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WI5RQ	34503955				2022-12-28	WOS:000708417700001
J	Absinta, M; Maric, D; Gharagozloo, M; Garton, T; Smith, MD; Jin, J; Fitzgerald, KC; Song, AY; Liu, PC; Lin, JP; Wu, TX; Johnson, KR; McGavern, DB; Schafer, DP; Calabresi, PA; Reich, DS				Absinta, Martina; Maric, Dragan; Gharagozloo, Marjan; Garton, Thomas; Smith, Matthew D.; Jin, Jing; Fitzgerald, Kathryn C.; Song, Anya; Liu, Poching; Lin, Jing-Ping; Wu, Tianxia; Johnson, Kory R.; McGavern, Dorian B.; Schafer, Dorothy P.; Calabresi, Peter A.; Reich, Daniel S.			A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis	NATURE			English	Article							IRON RIM LESIONS; PATHOLOGY; PROTEIN; CNS	Multiple sclerosis (MS) lesionsthat do not resolve in the months after they form harbour ongoing demyelination and axon degeneration, and are identifiable in vivo by their paramagnetic rims on MRI scans(1-3). Here, to define mechanisms underlying this disabling, progressive neurodegenerative state(4-6) and foster development of new therapeutic agents, we used MRI-informed single-nucleus RNA sequencing to profile the edge of demyelinated white matter lesions at various stages of inflammation. We uncovered notable glial and immune cell diversity, especially at the chronically inflamed lesion edge. We define `microglia inflamed in MS' (MIMS) and `astrocytes inflamed in MS', glial phenotypesthat demonstrate neurodegenerative programming. The MIMS transcriptional profile overlaps with that of microglia in other neurodegenerative diseases, suggesting that primary and secondary neurodegeneration share common mechanisms and could benefit from similar therapeutic approaches. We identify complement component 1q (C1q) as a critical mediator of MIMS activation, validated immunohistochemically in MS tissue, genetically by microglia-specific C1q ablation in mice with experimental autoimmune encephalomyelitis, and therapeutically bytreating chronic experimental autoimmune encephalomyelitis with C1q blockade. C1q inhibition is a potential therapeutic avenue to address chronic white matter inflammation, which could be monitored by longitudinal assessment of its dynamic biomarker, paramagnetic rim lesions, using advanced MRI methods.	[Absinta, Martina; Gharagozloo, Marjan; Garton, Thomas; Smith, Matthew D.; Jin, Jing; Fitzgerald, Kathryn C.; Calabresi, Peter A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Absinta, Martina; Lin, Jing-Ping; Reich, Daniel S.] NINDS, Translat Neuroradiol Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Absinta, Martina] IRCCS, San Raffaere Hosp, Milan, Italy; [Absinta, Martina] Vita Salute San Raffaere Univ, Milan, Italy; [Maric, Dragan] NINDS, Flow & Imaging Cytometry Core Facil, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Song, Anya; Schafer, Dorothy P.] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA USA; [Song, Anya; Schafer, Dorothy P.] Univ Massachusetts, Sch Med, Brudnik Neuropsychiat Inst, Worcester, MA USA; [Liu, Poching] NHLBI, DNA Sequencing & Genom Core, NIH, Bldg 10, Bethesda, MD 20892 USA; [Wu, Tianxia] NINDS, Clin Trials Unit, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Johnson, Kory R.] NINDS, Bioinformat Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [McGavern, Dorian B.] NINDS, Viral Immunol & Intravital Imaging Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Absinta, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.; Absinta, M; Reich, DS (corresponding author), NINDS, Translat Neuroradiol Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.; Absinta, M (corresponding author), IRCCS, San Raffaere Hosp, Milan, Italy.; Absinta, M (corresponding author), Vita Salute San Raffaere Univ, Milan, Italy.	mabsint1@jhmi.edu; danier.reich@nih.gov	Absinta, Martina/AGZ-2380-2022; McGavern, Dorian/HCH-3601-2022	McGavern, Dorian/0000-0001-9568-545X; Fitzgerald, Kathryn/0000-0003-3137-0322; Song, Anya/0000-0002-0885-7530; Garton, Thomas/0000-0001-9352-8530; JIN, JING/0000-0003-1508-8036; Smith, Matthew/0000-0001-6614-569X; Gharagozloo, Marjan/0000-0002-2166-4012; absinta, martina/0000-0003-0276-383X	Intramural Research Program of NINDS; Adelson Medical Research Foundation; Conrad N. Hilton Foundation [17313]; Cariplo Foundation [2019-1677]; DNA Sequencing and Genomics Core (NHLBI/NIH); Annexon Biosciences [ANX-M1.21]; NINDS Translational Neuroradiology Section; NIMH Functional MRI Facility	Intramural Research Program of NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Adelson Medical Research Foundation; Conrad N. Hilton Foundation; Cariplo Foundation(Fondazione Cariplo); DNA Sequencing and Genomics Core (NHLBI/NIH); Annexon Biosciences; NINDS Translational Neuroradiology Section; NIMH Functional MRI Facility	This study was supported by the Intramural Research Program of NINDS, the Adelson Medical Research Foundation (to D.S.R. and D.P.S.), the Conrad N. Hilton Foundation (grant no. 17313 to M.A.) and the Cariplo Foundation (grant no. 2019-1677 to M.A.). We thank Y. Li and Y. Luo from the DNA Sequencing and Genomics Core (NHLBI/NIH); G. Trivellin (NICHD/NIH), who helped with some technical aspects of single nucleus RNA-seq processing; C. Covino from the Advanced Light and Electron Microscopy BioImaging Center (ALEMBIC, Vita-Salute San Raffaele University, Milan), who helped with visualization of multiplex immunofluorescence; T. Yednock and V. Mehta at Annexon Biosciences for providing the anti-C1q monoclonal antibody (ANX-M1.21); G. Nair, P. Sati, E. S. Beck, M. Donadieu, the NINDS Translational Neuroradiology Section and the NIMH Functional MRI Facility for assistance with MRI scanning; I. Cortese, J. Ohayon and the NINDS Neuroimmunology Clinic for outstanding patient care; and D. Bergles, R. Franklin, J. Kipnis and N. Mihelson for fruitful discussion of the results.	Absinta M, 2018, AM J NEURORADIOL, V39, P1233, DOI 10.3174/ajnr.A5660; Absinta M, 2019, JAMA NEUROL, V76, P1474, DOI 10.1001/jamaneurol.2019.2399; Absinta M, 2016, J CLIN INVEST, V126, P2597, DOI 10.1172/JCI86198; Absinta M, 2014, J NEUROPATH EXP NEUR, V73, P780, DOI 10.1097/NEN.0000000000000096; Bagnato F, 2011, BRAIN, V134, P3599, DOI 10.1093/brain/awr278; Bonnardel J, 2019, IMMUNITY, V51, P638, DOI 10.1016/j.immuni.2019.08.017; Breij ECW, 2008, ANN NEUROL, V63, P16, DOI 10.1002/ana.21311; Browaeys R, 2020, NAT METHODS, V17, P159, DOI 10.1038/s41592-019-0667-5; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cignarella F, 2020, ACTA NEUROPATHOL, V140, P513, DOI 10.1007/s00401-020-02193-z; Clayton BLL, 2016, BRAIN RES, V1648, P594, DOI 10.1016/j.brainres.2016.03.046; Comabella M, 2010, NAT REV NEUROL, V6, P499, DOI 10.1038/nrneurol.2010.112; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Dal-Bianco A, 2021, BRAIN, V144, P833, DOI 10.1093/brain/awaa436; Dal-Bianco A, 2017, ACTA NEUROPATHOL, V133, P25, DOI 10.1007/s00401-016-1636-z; Elkjaer ML, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0855-7; Elliott C, 2019, BRAIN, V142, P2787, DOI 10.1093/brain/awz212; Falcao AM, 2018, NAT MED, V24, P1837, DOI 10.1038/s41591-018-0236-y; Fitzgerald KC, 2019, BRAIN, V142, P2722, DOI 10.1093/brain/awz188; Fonseca MI, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0814-9; Hendrickx DAE, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01810; Jackle K, 2020, BRAIN, V143, P2073, DOI 10.1093/brain/awaa158; Jakel S, 2019, NATURE, V566, P543, DOI 10.1038/s41586-019-0903-2; Kaiser T, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0448-18.2019; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kirby L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11638-3; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Krishnaswami SR, 2016, NAT PROTOC, V11, P499, DOI 10.1038/nprot.2016.015; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kuhlmann T, 2017, ACTA NEUROPATHOL, V133, P13, DOI 10.1007/s00401-016-1653-y; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Maggi P, 2021, NEUROLOGY, V97, pE543, DOI 10.1212/WNL.0000000000012326; Maric D, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21735-x; Masuda T, 2019, NATURE, V566, P388, DOI 10.1038/s41586-019-0924-x; Matson, 2018, JOVE-J VIS EXP, V140, P58413; Michailidou I, 2015, ANN NEUROL, V77, P1007, DOI 10.1002/ana.24398; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Patsopoulos NA, 2019, SCIENCE, V365, P1417, DOI 10.1126/science.aav7188; Polman Chris H, 2011, Ann Neurol, V69, P292, DOI 10.1002/ana.22366; Raudvere U, 2019, NUCLEIC ACIDS RES, V47, pW191, DOI 10.1093/nar/gkz369; Reich DS, 2018, NEW ENGL J MED, V378, P169, DOI 10.1056/NEJMra1401483; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Sankowski R, 2019, NAT NEUROSCI, V22, P2098, DOI 10.1038/s41593-019-0532-y; Sati P, 2014, MULT SCLER J, V20, P1464, DOI 10.1177/1352458514525868; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schirmer L, 2019, NATURE, V573, P75, DOI 10.1038/s41586-019-1404-z; Stephan AH, 2013, J NEUROSCI, V33, P13460, DOI 10.1523/JNEUROSCI.1333-13.2013; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; van der Poel M, 2020, J IMMUNOL, V205, P2511, DOI 10.4049/jimmunol.2000130; van der Valk P, 2000, NEUROPATH APPL NEURO, V26, P2, DOI 10.1046/j.1365-2990.2000.00217.x; Werneburg S, 2020, IMMUNITY, V52, P167, DOI 10.1016/j.immuni.2019.12.004; Yao B, 2012, RADIOLOGY, V262, P206, DOI 10.1148/radiol.11110601; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; ZHOU YY, 2019, NAT COMMUN, V10, DOI [10.1038/S41467-019-09234-6, DOI 10.1038/s41587-020-0546-8, DOI 10.1038/S41467-019-09234-6]	55	72	72	31	75	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 30	2021	597	7878					709	714		10.1038/s41586-021-03892-7	http://dx.doi.org/10.1038/s41586-021-03892-7		SEP 2021	6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UZ1UN	34497421	Green Accepted			2022-12-28	WOS:000693875600004
J	Thompson, MG; Stenehjem, E; Grannis, S; Ball, SW; Naleway, AL; Ong, TC; DeSilva, MB; Natarajan, K; Bozio, CH; Lewis, N; Dascomb, K; Dixon, BE; Birch, RJ; Irving, SA; Rao, S; Kharbanda, E; Han, J; Reynolds, S; Goddard, K; Grisel, N; Fadel, WF; Levy, ME; Ferdinands, J; Fireman, B; Arndorfer, J; Valvi, NR; Rowley, EA; Patel, P; Zerbo, O; Griggs, EP; Porter, RM; Demarco, M; Blanton, L; Steffens, A; Zhuang, Y; Olson, N; Barron, M; Shifflett, P; Schrag, SJ; Verani, JR; Fry, A; Gaglani, M; Azziz-Baumgartner, E; Klein, NP				Thompson, M. G.; Stenehjem, E.; Grannis, S.; Ball, S. W.; Naleway, A. L.; Ong, T. C.; DeSilva, M. B.; Natarajan, K.; Bozio, C. H.; Lewis, N.; Dascomb, K.; Dixon, B. E.; Birch, R. J.; Irving, S. A.; Rao, S.; Kharbanda, E.; Han, J.; Reynolds, S.; Goddard, K.; Grisel, N.; Fadel, W. F.; Levy, M. E.; Ferdinands, J.; Fireman, B.; Arndorfer, J.; Valvi, N. R.; Rowley, E. A.; Patel, P.; Zerbo, O.; Griggs, E. P.; Porter, R. M.; Demarco, M.; Blanton, L.; Steffens, A.; Zhuang, Y.; Olson, N.; Barron, M.; Shifflett, P.; Schrag, S. J.; Verani, J. R.; Fry, A.; Gaglani, M.; Azziz-Baumgartner, E.; Klein, N. P.			Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SARS-COV-2 INFECTION; UNITED-STATES; INFLUENZA; BNT162B2; WORKERS; ADULTS	Background There are limited data on the effectiveness of the vaccines against symptomatic coronavirus disease 2019 (Covid-19) currently authorized in the United States with respect to hospitalization, admission to an intensive care unit (ICU), or ambulatory care in an emergency department or urgent care clinic. Methods We conducted a study involving adults (>= 50 years of age) with Covid-19-like illness who underwent molecular testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We assessed 41,552 admissions to 187 hospitals and 21,522 visits to 221 emergency departments or urgent care clinics during the period from January 1 through June 22, 2021, in multiple states. The patients' vaccination status was documented in electronic health records and immunization registries. We used a test-negative design to estimate vaccine effectiveness by comparing the odds of a positive test for SARS-CoV-2 infection among vaccinated patients with those among unvaccinated patients. Vaccine effectiveness was adjusted with weights based on propensity-for-vaccination scores and according to age, geographic region, calendar time (days from January 1, 2021, to the index date for each medical visit), and local virus circulation. Results The effectiveness of full messenger RNA (mRNA) vaccination (>= 14 days after the second dose) was 89% (95% confidence interval [CI], 87 to 91) against laboratory-confirmed SARS-CoV-2 infection leading to hospitalization, 90% (95% CI, 85 to 93) against infection leading to an ICU admission, and 91% (95% CI, 89 to 93) against infection leading to an emergency department or urgent care clinic visit. The effectiveness of full vaccination with respect to a Covid-19-associated hospitalization or emergency department or urgent care clinic visit was similar with the BNT162b2 and mRNA-1273 vaccines and ranged from 81% to 95% among adults 85 years of age or older, persons with chronic medical conditions, and Black or Hispanic adults. The effectiveness of the Ad26.COV2.S vaccine was 68% (95% CI, 50 to 79) against laboratory-confirmed SARS-CoV-2 infection leading to hospitalization and 73% (95% CI, 59 to 82) against infection leading to an emergency department or urgent care clinic visit. Conclusions Covid-19 vaccines in the United States were highly effective against SARS-CoV-2 infection requiring hospitalization, ICU admission, or an emergency department or urgent care clinic visit. This vaccine effectiveness extended to populations that are disproportionately affected by SARS-CoV-2 infection. (Funded by the Centers for Disease Control and Prevention.) Covid-19 Vaccine Effectiveness in Medical Settings A study with a test-negative design analyzed 41,552 admissions to 187 hospitals and 21,522 visits to 221 EDs or urgent care clinics. The mRNA-based vaccines (>= 14 days after the second dose) were highly effective against SARS-CoV-2 infection leading to hospitalization (89%), ICU admission (90%), or an urgent care visit (91%).	[Thompson, M. G.; Bozio, C. H.; Reynolds, S.; Ferdinands, J.; Patel, P.; Griggs, E. P.; Porter, R. M.; Blanton, L.; Steffens, A.; Olson, N.; Schrag, S. J.; Verani, J. R.; Fry, A.; Azziz-Baumgartner, E.] Ctr Dis Control & Prevent, COVID 19 Response Team, Atlanta, GA 30333 USA; [Stenehjem, E.; Dascomb, K.; Grisel, N.; Arndorfer, J.] Intermt Healthcare, Div Infect Dis & Clin Epidemiol, Salt Lake City, UT USA; [Grannis, S.; Dixon, B. E.; Fadel, W. F.; Valvi, N. R.] Regenstrief Inst Hlth Care, Ctr Biomed Informat, Indianapolis, IN USA; [Grannis, S.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Dixon, B. E.; Fadel, W. F.; Valvi, N. R.] Indiana Univ, Richard M Fairbanks Sch Publ Hlth, Indianapolis, IN 46204 USA; [Ball, S. W.; Birch, R. J.; Levy, M. E.; Rowley, E. A.; Demarco, M.; Zhuang, Y.; Shifflett, P.] Westat Corp, Rockville, MD USA; [Naleway, A. L.; Irving, S. A.] Kaiser Permanente Northwest Ctr Hlth Res, Portland, OR USA; [Ong, T. C.; Rao, S.; Barron, M.] Univ Colorado, Dept Med, Anschutz Med Campus, Aurora, CO USA; [DeSilva, M. B.; Kharbanda, E.] HealthPartners Inst, Minneapolis, MN USA; [Natarajan, K.; Han, J.] Columbia Univ, Dept Biomed Informat, Irving Med Ctr, New York, NY USA; [Natarajan, K.] New York Presbyterian Hosp, New York, NY USA; [Lewis, N.; Goddard, K.; Fireman, B.; Zerbo, O.; Klein, N. P.] Kaiser Permanente Northern Calif, Div Res, Vaccine Study Ctr, Oakland, CA USA; [Gaglani, M.] Texas A&M Univ, Coll Med, Baylor Scott & White Hlth, Temple, TX 76508 USA	Centers for Disease Control & Prevention - USA; Intermountain Healthcare; Intermountain Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Westat; Kaiser Permanente; University of Colorado System; University of Colorado Anschutz Medical Campus; Columbia University; NewYork-Presbyterian Hospital; NewYork-Presbyterian Hospital; Kaiser Permanente; Baylor Health Care System; Texas A&M University System	Thompson, MG (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Mailstop A32,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	isq8@cdc.gov	Dixon, Brian E/A-9494-2013; Gaglani, Manjusha/AFQ-6802-2022	Dixon, Brian E/0000-0002-1121-0607; Gaglani, Manjusha/0000-0002-3952-9230; Porter, Rachael/0000-0002-6632-4038; Bozio, Catherine/0000-0001-6566-7138; Irving, Stephanie/0000-0001-7437-6797; Olson, Natalie/0000-0003-2175-4138	Centers for Disease Control and Prevention [75D30120C07986, 75D30120C07765]	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Supported by the Centers for Disease Control and Prevention (contracts 75D30120C07986 to Westat and 75D30120C07765 to Kaiser Foundation Hospitals).	Amit S, 2021, LANCET, V397, P875, DOI 10.1016/S0140-6736(21)00448-7; Andrew MK, 2021, CLIN INTERV AGING, V16, P731, DOI 10.2147/CIA.S295522; Andrew MK, 2020, LANCET, V396, P1942, DOI 10.1016/S0140-6736(20)32481-8; Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Azar KMJ, 2020, HEALTH AFFAIR, V39, P1253, DOI 10.1377/hlthaff.2020.00598; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Bernal JL, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1088; Cassidy EL, 2001, AM J GERIAT PSYCHIAT, V9, P136, DOI 10.1176/appi.ajgp.9.2.136; Cates J, 2020, MMWR-MORBID MORTAL W, V69, P1528, DOI 10.15585/mmwr.mm6942e3; Chua HY, 2020, EPIDEMIOLOGY, V31, P43, DOI 10.1097/EDE.0000000000001116; Chung H, 2021, EFFECTIVENESS BNT162; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; De Serres G, 2013, Euro Surveill, V18; Ferdinands JM, 2019, J INFECT DIS, V220, P1265, DOI 10.1093/infdis/jiy723; Ferdinands JM, 2012, CLIN INFECT DIS, V54, P25, DOI 10.1093/cid/cir750; Ferdinands JM, 2011, VACCINE, V29, P1935, DOI 10.1016/j.vaccine.2010.12.098; Foppa IM, 2016, INT J EPIDEMIOL, V45, P2052, DOI 10.1093/ije/dyw022; Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3; George S, 2014, AM J PUBLIC HEALTH, V104, pE16, DOI 10.2105/AJPH.2013.301706; Gu T, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.25197; Hall VJ, 2021, LANCET, V397, P1725, DOI 10.1016/S0140-6736(21)00790-X; Jackson ML, 2013, VACCINE, V31, P2165, DOI 10.1016/j.vaccine.2013.02.053; Killerby ME, 2020, MMWR-MORBID MORTAL W, V69, P790, DOI 10.15585/mmwr.mm6925e1; Kim L., 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa1012, DOI 10.1093/cid/ciaa1012]; Kwong JC, 2013, CLIN INFECT DIS, V57, P820, DOI 10.1093/cid/cit404; Mansson R, 2007, AM J EPIDEMIOL, V166, P332, DOI 10.1093/aje/kwm069; McCaffrey DF, 2004, PSYCHOL METHODS, V9, P403, DOI 10.1037/1082-989X.9.4.403; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Price-Haywood EG, 2020, NEW ENGL J MED, V382, P2534, DOI 10.1056/NEJMsa2011686; Sadoff J, 2021, NEW ENGL J MED, V384, P2187, DOI 10.1056/NEJMoa2101544; Skowronski DM, 2021, NEW ENGL J MED, V384, P1576, DOI 10.1056/NEJMc2036242; Stokes EK, 2020, MMWR-MORBID MORTAL W, V69, P759, DOI 10.15585/mmwr.mm6924e2; Tenforde MW, 2021, MMWR-MORBID MORTAL W, V70, P674, DOI 10.15585/mmwr.mm7018e1; Thompson MG, 2021, NEW ENGL J MED, V385, P320, DOI 10.1056/NEJMoa2107058; Thompson MG, 2021, MMWR-MORBID MORTAL W, V70, P495, DOI 10.15585/mmwr.mm7013e3; Thompson MG, 2019, CLIN INFECT DIS, V68, P1444, DOI 10.1093/cid/ciy737; Nguyen TL, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0338-0; Wingert A., 2021, BMJ OPEN, V11; Zimmermann P, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00084-18	40	152	152	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2021	385	15					1355	1371		10.1056/NEJMoa2110362	http://dx.doi.org/10.1056/NEJMoa2110362		SEP 2021	17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XP7AB	34496194	Green Published, Bronze			2022-12-28	WOS:000693740200001
J	VanInsberghe, M; van den Berg, J; Andersson-Rolf, A; Clevers, H; van Oudenaarden, A				VanInsberghe, Michael; van den Berg, Jeroen; Andersson-Rolf, Amanda; Clevers, Hans; van Oudenaarden, Alexander			Single-cell Ribo-seq reveals cell cycle-dependent translational pausing	NATURE			English	Article							IN-VIVO; DYNAMICS	Single-cell sequencing methods have enabled in-depth analysis of the diversity of cell types and cell states in a wide range of organisms. These tools focus predominantly on sequencing the genomes(1), epigenomes(2) and transcriptomes(3) of single cells. However, despite recent progress in detecting proteins by mass spectrometry with single-cell resolution', it remains a major challenge to measure translation in individual cells. Here, building on existing protocols(5-7), we have substantially increased the sensitivity of these assaysto enable ribosome profiling in single cells. Integrated with a machine learning approach, this technology achieves single-codon resolution. We validate this method by demonstrating that limitation for a particular amino acid causes ribosome pausing at a subset of the codons encoding the amino acid. Of note, this pausing is only observed in a sub-population of cells correlating to its cell cycle state. We further expand on this phenomenon in non-limiting conditions and detect pronounced GAA pausing during mitosis. Finally, we demonstrate the applicability of this technique to rare primary enteroendocrine cells. This technology provides a first step towards determining the contribution of the translational process to the remarkable diversity between seemingly identical cells.	[VanInsberghe, Michael; van den Berg, Jeroen; Andersson-Rolf, Amanda; Clevers, Hans; van Oudenaarden, Alexander] Royal Netherlands Acad Arts & Sci, Oncode Inst, Hubrecht Inst KNAW, Utrecht, Netherlands; [VanInsberghe, Michael; van den Berg, Jeroen; Andersson-Rolf, Amanda; Clevers, Hans; van Oudenaarden, Alexander] Univ Med Ctr Utrecht, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	VanInsberghe, M; van Oudenaarden, A (corresponding author), Royal Netherlands Acad Arts & Sci, Oncode Inst, Hubrecht Inst KNAW, Utrecht, Netherlands.; VanInsberghe, M; van Oudenaarden, A (corresponding author), Univ Med Ctr Utrecht, Utrecht, Netherlands.	m.vaninsberghe@hubrecht.eu; a.vanoudenaarden@hubrecht.eu			European Research Council [ERC-AdG 742225-IntScOmics]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) TOP award [NWO-CW 714.016.001]; Dutch Cancer Society; University Medical Center Utrecht; Hubrecht Institute; Utrecht University; Netherlands X-omics Initiative (NWO) [184.034.019]	European Research Council(European Research Council (ERC)European Commission); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) TOP award; Dutch Cancer Society(KWF Kankerbestrijding); University Medical Center Utrecht; Hubrecht Institute; Utrecht University; Netherlands X-omics Initiative (NWO)	This work was supported by a European Research Council Advanced grant (ERC-AdG 742225-IntScOmics) and Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) TOP award (NWO-CW 714.016.001). This work is part of the Oncode Institute, which is partly financed by the Dutch Cancer Society. In addition, we thank the Hubrecht Sorting Facility and the Utrecht Sequencing Facility, subsidized by the University Medical Center Utrecht, the Hubrecht Institute, Utrecht University and The Netherlands X-omics Initiative (NWO project 184.034.019); H. Vinas Gaza for assistance in preparing samples; and V. Bhardwaj for discussion on data analysis.	Ahmed S, 2019, BIOINFORMATICS, V35, P47, DOI 10.1093/bioinformatics/bty533; Artieri CG, 2014, GENOME RES, V24, P2011, DOI 10.1101/gr.175893.114; Brannan KW, 2021, NAT METHODS, V18, P507, DOI 10.1038/s41592-021-01128-0; Budnik B, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1547-5; Coldwell MJ, 2013, CELL CYCLE, V12, P3615, DOI 10.4161/cc.26588; Darnell AM, 2018, MOL CELL, V71, P229, DOI 10.1016/j.molcel.2018.06.041; Fang H, 2018, CELL SYST, V6, P180, DOI 10.1016/j.cels.2017.12.007; Frenkel-Morgenstern M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.3; Gehart H, 2019, CELL, V176, P1158, DOI 10.1016/j.cell.2018.12.029; Gerashchenko MV, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw822; Gribble FM, 2016, ANNU REV PHYSIOL, V78, P277, DOI 10.1146/annurev-physiol-021115-105439; Haber AL, 2017, NATURE, V551, P333, DOI 10.1038/nature24489; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Korotkevich G., FAST GENE SET ENRICH, DOI 10.1101/060012v3(2021; Ly T, 2015, ELIFE, V4, DOI 10.7554/eLife.04534; Martinez TF, 2020, NAT CHEM BIOL, V16, P458, DOI 10.1038/s41589-019-0425-0; Miettinen TP, 2019, ELIFE, V8, DOI 10.7554/eLife.44700; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Nedialkova DD, 2015, CELL, V161, P1606, DOI 10.1016/j.cell.2015.05.022; Reid DW, 2015, METHODS, V91, P69, DOI 10.1016/j.ymeth.2015.07.003; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Schuller AP, 2018, NAT REV MOL CELL BIO, V19, P526, DOI 10.1038/s41580-018-0011-4; Shaltiel IA, 2014, P NATL ACAD SCI USA, V111, P7313, DOI 10.1073/pnas.1322021111; Smallwood SA, 2014, NAT METHODS, V11, P817, DOI [10.1038/nmeth.3035, 10.1038/NMETH.3035]; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Stumpf CR, 2013, MOL CELL, V52, P574, DOI 10.1016/j.molcel.2013.09.018; Subramaniam AR, 2013, P NATL ACAD SCI USA, V110, P2419, DOI 10.1073/pnas.1211077110; Tanenbaum ME, 2015, ELIFE, V4, DOI 10.7554/eLife.07957; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Zinshteyn B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003675	31	20	20	7	34	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2021	597	7877					561	+		10.1038/s41586-021-03887-4	http://dx.doi.org/10.1038/s41586-021-03887-4		SEP 2021	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UW6NQ	34497418				2022-12-28	WOS:000693875600001
J	Baggiolini, A; Callahan, SJ; Montal, E; Weiss, JM; Trieu, T; Tagore, MM; Tischfield, SE; Walsh, RM; Suresh, S; Fan, YJ; Campbell, NR; Perlee, SC; Saurat, N; Hunter, MV; Simon-Vermot, T; Huang, TH; Ma, YL; Hollmann, T; Tickoo, SK; Taylor, BS; Khurana, E; Koche, RP; Studer, L; White, RM				Baggiolini, Arianna; Callahan, Scott J.; Montal, Emily; Weiss, Joshua M.; Trieu, Tuan; Tagore, Mohita M.; Tischfield, Sam E.; Walsh, Ryan M.; Suresh, Shruthy; Fan, Yujie; Campbell, Nathaniel R.; Perlee, Sarah C.; Saurat, Nathalie; Hunter, Miranda, V; Simon-Vermot, Theresa; Huang, Ting-Hsiang; Ma, Yilun; Hollmann, Travis; Tickoo, Satish K.; Taylor, Barry S.; Khurana, Ekta; Koche, Richard P.; Studer, Lorenz; White, Richard M.			Developmental chromatin programs determine oncogenic competence in melanoma	SCIENCE			English	Article							NEURAL CREST; CUTANEOUS MELANOMA; CELLS; DIFFERENTIATION; MULTIPOTENCY; PROMOTES	Oncogenes only transform cells under certain cellular contexts, a phenomenon called oncogenic competence. Using a combination of a human pluripotent stem cell-derived cancer model along with zebrafish transgenesis, we demonstrate that the transforming ability of BRAF(V600E) along with additional mutations depends on the intrinsic transcriptional program present in the cell of origin. In both systems, melanocytes are less responsive to mutations, whereas both neural crest and melanoblast populations are readily transformed. Profiling reveals that progenitors have higher expression of chromatin-modifying enzymes such as ATAD2, a melanoma competence factor that forms a complex with SOX10 and allows for expression of downstream oncogenic and neural crest programs. These data suggest that oncogenic competence is mediated by regulation of developmental chromatin factors, which then allow for proper response to those oncogenes.	[Baggiolini, Arianna; Callahan, Scott J.; Walsh, Ryan M.; Fan, Yujie; Saurat, Nathalie; Studer, Lorenz] Mem Sloan Kettering Canc Ctr, Ctr Stem Cell Biol, New York, NY 10065 USA; [Baggiolini, Arianna; Callahan, Scott J.; Walsh, Ryan M.; Fan, Yujie; Saurat, Nathalie; Studer, Lorenz] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Callahan, Scott J.; Montal, Emily; Weiss, Joshua M.; Tagore, Mohita M.; Suresh, Shruthy; Campbell, Nathaniel R.; Perlee, Sarah C.; Hunter, Miranda, V; Simon-Vermot, Theresa; Huang, Ting-Hsiang; Ma, Yilun; White, Richard M.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10065 USA; [Callahan, Scott J.; Perlee, Sarah C.; Studer, Lorenz] Mem Sloan Kettering Canc Ctr, Gerstner Grad Sch Biomed Sci, New York, NY 10065 USA; [Weiss, Joshua M.; Campbell, Nathaniel R.; Ma, Yilun] Weill Cornell Rockefeller Sloan Kettering Triinst, New York, NY 10065 USA; [Trieu, Tuan; Khurana, Ekta] Weill Cornell Med Coll, Inst Computat Biomed, New York, NY 10021 USA; [Trieu, Tuan; Khurana, Ekta] Weill Cornell Med, Dept Physiol & Biophys, 1300 York Ave, New York, NY 10065 USA; [Trieu, Tuan; Khurana, Ekta] Weill Cornell Med, Caryl & Israel Englander Inst Precis Med, New York, NY USA; [Trieu, Tuan; Khurana, Ekta] Weill Cornell Med, Meyer Canc Ctr, New York, NY USA; [Tischfield, Sam E.; Taylor, Barry S.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Tischfield, Sam E.; Taylor, Barry S.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Tischfield, Sam E.; Taylor, Barry S.] Mem Sloan Kettering Canc Ctr, Marie Josee & Henry R Kravis Ctr Mol Oncol, New York, NY 10065 USA; [Fan, Yujie; White, Richard M.] Cornell Univ, Weill Cornell, Grad Sch Med Sci, New York, NY 10065 USA; [Hollmann, Travis; Tickoo, Satish K.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Taylor, Barry S.] Cornell Univ, Joan & Sanford I Weill Med Coll, New York, NY 10021 USA; [Koche, Richard P.] Mem Sloan Kettering Canc Ctr, Ctr Epigenet Res, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center	Studer, L (corresponding author), Mem Sloan Kettering Canc Ctr, Ctr Stem Cell Biol, New York, NY 10065 USA.; Studer, L (corresponding author), Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA.; White, RM (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10065 USA.; Studer, L (corresponding author), Mem Sloan Kettering Canc Ctr, Gerstner Grad Sch Biomed Sci, New York, NY 10065 USA.; White, RM (corresponding author), Cornell Univ, Weill Cornell, Grad Sch Med Sci, New York, NY 10065 USA.	studerl@mskcc.org; whiter@mskcc.org	Studer, Lorenz/ABH-1491-2021	Studer, Lorenz/0000-0003-0741-7987; Hunter, Miranda/0000-0002-6971-1738; Baggiolini, Arianna/0000-0002-2476-561X; Tagore, Mohita/0000-0002-2586-1427; Ma, Yilun/0000-0002-2297-9980; Perlee, Sarah/0000-0003-3295-6755; Weiss, Joshua/0000-0001-7340-4004	Melanoma Research Alliance; NIH [R01CA229215]; NIH Director's New Innovator Award [DP2CA186572]; NIH Mentored Clinical Scientist Research Career Development Award [K08AR055368]; Pershing Square Sohn Foundation; Alan and Sandra Gerry Metastasis Research Initiative at the Memorial Sloan Kettering Cancer Center; Harry J. Lloyd Foundation; Consano; Starr Cancer Consortium; NYSTEM award [DOH01-STEM5-2016-00300]; Starr Stem cell initiative; Kirschstein-NRSA predoctoral fellowship [F31CA196305, F30CA220954, F30CA236442]; Melanoma Research Foundation; Medical Scientist Training Program [T32GM007739]; NRSA [5F32MH116590-02]; Frank Lappin Horsfall, Jr. Fellowship; Molecular and Cell Biology Teaching Grant [T32GM008539]; Individual Predoctoral to Postdoctoral Fellow Transition Award [5K00CA223016-04]; Swiss National Science Foundation Postdoc.mobility fellowship [P2ZHP3_171967, P400PB_180672]; NCI Core Facility Grant [P30 CA008748]; Joanna M. Nicolay Melanoma Foundation Research Scholar Award; Robert B. Catell Fellowship	Melanoma Research Alliance; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Mentored Clinical Scientist Research Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pershing Square Sohn Foundation(Pershing Square Sohn Cancer Research Alliance); Alan and Sandra Gerry Metastasis Research Initiative at the Memorial Sloan Kettering Cancer Center; Harry J. Lloyd Foundation; Consano; Starr Cancer Consortium; NYSTEM award; Starr Stem cell initiative; Kirschstein-NRSA predoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Foundation; Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frank Lappin Horsfall, Jr. Fellowship; Molecular and Cell Biology Teaching Grant; Individual Predoctoral to Postdoctoral Fellow Transition Award; Swiss National Science Foundation Postdoc.mobility fellowship; NCI Core Facility Grant; Joanna M. Nicolay Melanoma Foundation Research Scholar Award; Robert B. Catell Fellowship	This work was supported by awards from the Melanoma Research Alliance (to R.M.W. and L.S.); NIH Research Program Grant R01CA229215, NIH Director's New Innovator Award DP2CA186572, NIH Mentored Clinical Scientist Research Career Development Award K08AR055368, The Pershing Square Sohn Foundation, The Alan and Sandra Gerry Metastasis Research Initiative at the Memorial Sloan Kettering Cancer Center, The Harry J. Lloyd Foundation, Consano, and the Starr Cancer Consortium (to R.M.W.); NYSTEM award DOH01-STEM5-2016-00300 and the Starr Stem cell initiative (to L.S.); Kirschstein-NRSA predoctoral fellowship F31CA196305, Joanna M. Nicolay Melanoma Foundation Research Scholar Award, and the Robert B. Catell Fellowship (to S.J.C.); Kirschstein-NRSA predoctoral fellowship F30CA220954, Melanoma Research Foundation, and Medical Scientist Training Program T32GM007739 (to N.R.C.); NRSA (F32) 5F32MH116590-02 (to R.M.W.); Frank Lappin Horsfall, Jr. Fellowship (to Y.F.); Kirschstein-NRSA predoctoral fellowship F30CA236442, Molecular and Cell Biology Teaching Grant T32GM008539, and Medical Scientist Training Program T32GM007739 (to J.M.W.); Individual Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) 5K00CA223016-04 (to E.M.); the Swiss National Science Foundation Postdoc.mobility fellowship P2ZHP3_171967 and P400PB_180672 (to A.B.); and P30 CA008748 (NCI Core Facility Grant).	Ablain J, 2015, DEV CELL, V32, P756, DOI 10.1016/j.devcel.2015.01.032; Asgharzadeh S, 2006, JNCI-J NATL CANCER I, V98, P1193, DOI 10.1093/jnci/djj330; Boussouar F, 2013, BBA-GENE REGUL MECH, V1829, P1010, DOI 10.1016/j.bbagrm.2013.06.003; BRONNERFRASER M, 1988, NATURE, V335, P161, DOI 10.1038/335161a0; Callahan SJ, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.034561; Ciro M, 2009, CANCER RES, V69, P8491, DOI 10.1158/0008-5472.CAN-09-2131; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Dar AA, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv034; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Haigis KM, 2019, SCIENCE, V363, P1150, DOI 10.1126/science.aaw3472; Hall A, 2013, ONCOTARGET, V4, P584, DOI 10.18632/oncotarget.965; Heppt MV, 2018, J INVEST DERMATOL, V138, P141, DOI 10.1016/j.jid.2017.05.038; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Kaufman CK, 2016, SCIENCE, V351, DOI 10.1126/science.aad2197; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Kohler C, 2017, CELL STEM CELL, V21, P679, DOI 10.1016/j.stem.2017.08.003; Konieczkowski DJ, 2014, CANCER DISCOV, V4, P816, DOI 10.1158/2159-8290.CD-13-0424; Kunz M, 2014, EUR J CELL BIOL, V93, P1, DOI 10.1016/j.ejcb.2013.12.002; Mica Y, 2013, CELL REP, V3, P1140, DOI 10.1016/j.celrep.2013.03.025; Moon H, 2017, CELL STEM CELL, V21, P665, DOI 10.1016/j.stem.2017.09.001; Morozumi Y, 2016, J MOL CELL BIOL, V8, P349, DOI 10.1093/jmcb/mjv060; Muller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6712; Perez-Guijarro E, 2017, CANCER-AM CANCER SOC, V123, P2089, DOI 10.1002/cncr.30684; Shakhova O, 2012, NAT CELL BIOL, V14, P882, DOI 10.1038/ncb2535; Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121; Sun Q, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12733-1; Tsoi J, 2018, CANCER CELL, V33, P890, DOI 10.1016/j.ccell.2018.03.017; Varum S, 2019, CELL STEM CELL, V24, P637, DOI 10.1016/j.stem.2019.03.011; Wang VE, 2019, CLIN CANCER RES, V25, P7202, DOI 10.1158/1078-0432.CCR-18-2779; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; White RM, 2011, NATURE, V471, P518, DOI 10.1038/nature09882; Williams RM, 2019, DEV CELL, V51, P255, DOI 10.1016/j.devcel.2019.10.003; Zingg D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7051	34	26	27	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2021	373	6559					1104	+	eabc1048	10.1126/science.abc1048	http://dx.doi.org/10.1126/science.abc1048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UL8QT	34516843	Green Submitted, Green Accepted			2022-12-28	WOS:000692910300039
J	Luo, LQ				Luo, Liqun			Architectures of neuronal circuits	SCIENCE			English	Review							NERVOUS-SYSTEM; MOSAIC ANALYSIS; PATTERN; SINGLE; ORGANIZATION; EXPRESSION; EVOLUTION; NETWORKS; TASTE; INTERNEURONS	Although individual neurons are the basic unit of the nervous system, they process information by working together in neuronal circuits with specific patterns of synaptic connectivity. Here, I review common circuit motifs and architectural plans used in diverse brain regions and animal species. I also consider how these circuit architectures assemble during development and might have evolved. Understanding how specific patterns of synaptic connectivity can implement specific neural computations will help to bridge the huge gap between the biology of the individual neuron and the function of the entire brain, allow us to better understand the neural basis of behavior, and may inspire new advances in artificial intelligence.	[Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Luo, LQ (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.; Luo, LQ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	lluo@stanford.edu		Luo, Liqun/0000-0001-5467-9264	National Institutes of Health; National Science Foundation; Howard Hughes Medical Institute; Wu Tsai Neurosciences Institute at Stanford University	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Wu Tsai Neurosciences Institute at Stanford University	This work was supported by the National Institutes of Health, the National Science Foundation, the Howard Hughes Medical Institute, and the Wu TsaiNeurosciences Institute at Stanford University.	Abbott LF, 2020, CELL, V182, P1372, DOI 10.1016/j.cell.2020.08.010; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Alon U., 2020, INTRO SYSTEMS BIOL; Arendt D, 2016, NAT REV GENET, V17, P744, DOI 10.1038/nrg.2016.127; AXEL R, 1995, SCI AM, V273, P154, DOI 10.1038/scientificamerican1095-154; BARLOW HB, 1953, J PHYSIOL-LONDON, V119, P69, DOI 10.1113/jphysiol.1953.sp004829; Beier KT, 2015, CELL, V162, P622, DOI 10.1016/j.cell.2015.07.015; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Callaway EM, 2015, J NEUROSCI, V35, P8979, DOI 10.1523/JNEUROSCI.0409-15.2015; Cang JH, 2013, ANNU REV NEUROSCI, V36, P51, DOI 10.1146/annurev-neuro-062012-170341; Caron SJC, 2013, NATURE, V497, P113, DOI 10.1038/nature12063; Cayco-Gajic NA, 2019, NEURON, V101, P584, DOI 10.1016/j.neuron.2019.01.044; Chakraborty M, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0056; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Clark DA, 2014, NAT NEUROSCI, V17, P296, DOI 10.1038/nn.3600; Cohn R, 2015, CELL, V163, P1742, DOI 10.1016/j.cell.2015.11.019; CONSTANTINEPATON M, 1978, SCIENCE, V202, P639, DOI 10.1126/science.309179; COOMBS JS, 1955, J PHYSIOL-LONDON, V130, P396, DOI 10.1113/jphysiol.1955.sp005414; Cowan WM, 1998, NEURON, V20, P413, DOI 10.1016/S0896-6273(00)80985-X; De Zeeuw CI, 2021, NAT NEUROSCI, V24, P160, DOI 10.1038/s41593-020-00754-9; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; Golgi C, 1873, GAZZ MED ITAL LOMBAR, V33, P244; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Hige T, 2015, NEURON, V88, P985, DOI 10.1016/j.neuron.2015.11.003; Hildebrand DGC, 2017, NATURE, V545, P345, DOI 10.1038/nature22356; Hodge RD, 2019, NATURE, V573, P61, DOI 10.1038/s41586-019-1506-7; Hong WZ, 2014, GENETICS, V196, P17, DOI 10.1534/genetics.113.154336; Huang TH, 2017, ELIFE, V6, DOI 10.7554/eLife.32027; Huang ZJ, 2019, NAT REV NEUROSCI, V20, P563, DOI 10.1038/s41583-019-0195-4; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Jacobs GH, 2009, SCI AM, V300, P56, DOI 10.1038/scientificamerican0409-56; Ji XY, 2016, CEREB CORTEX, V26, P2612, DOI 10.1093/cercor/bhv099; Joo WJ, 2013, NEURON, V78, P673, DOI 10.1016/j.neuron.2013.03.022; Kaas J. H., 2020, EVOLUTIONARY NEUROSC, V2; Kebschull JM, 2020, SCIENCE, V370, DOI 10.1126/science.abd5059; Kebschull JM, 2016, NEURON, V91, P975, DOI 10.1016/j.neuron.2016.07.036; Kim CK, 2017, NAT REV NEUROSCI, V18, P222, DOI 10.1038/nrn.2017.15; Kim JS, 2014, NATURE, V509, P331, DOI 10.1038/nature13240; Kohl J, 2018, NATURE, V556, P326, DOI 10.1038/s41586-018-0027-0; Kolodkin AL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001727; Komiyama T, 2007, CELL, V128, P399, DOI 10.1016/j.cell.2006.12.028; Krizhevsky A., P 25 INT C NEUR INF, P1097; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; LANCEJONES C, 1981, PROC R SOC SER B-BIO, V214, P19, DOI 10.1098/rspb.1981.0080; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; LeCun Y., 2015, DEEP LEARNING NATURE, V521, P436, DOI [DOI 10.1038/NATURE14539, 10.1038/nature14539]; Lee J, 2020, NAT NEUROSCI, V23, P1388, DOI 10.1038/s41593-020-00712-5; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee WCA, 2016, NATURE, V532, P370, DOI 10.1038/nature17192; Lerner TN, 2015, CELL, V162, P635, DOI 10.1016/j.cell.2015.07.014; Li F, 2020, ELIFE, V9, DOI 10.7554/eLife.62576; Lin MZ, 2016, NAT NEUROSCI, V19, P1142, DOI 10.1038/nn.4359; Litwin-Kumar A, 2017, NEURON, V93, P1153, DOI 10.1016/j.neuron.2017.01.030; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lo LC, 2011, NEURON, V72, P938, DOI 10.1016/j.neuron.2011.12.002; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Lu J, 2009, PLOS BIOL, V7, P265, DOI 10.1371/journal.pbio.1000032; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Luo L., 2020, PRINCIPLES NEUROBIOL, VSecond; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; Luo LQ, 2018, NEURON, V98, P256, DOI 10.1016/j.neuron.2018.03.040; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MARTIN KAC, 1983, EXP BRAIN RES, V50, P193; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Morris RGM, 1999, BRAIN RES BULL, V50, P437, DOI 10.1016/S0361-9230(99)00182-3; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Nern A, 2015, P NATL ACAD SCI USA, V112, pE2967, DOI 10.1073/pnas.1506763112; Neunuebel JP, 2014, NEURON, V81, P416, DOI 10.1016/j.neuron.2013.11.017; Pederick DT, 2021, SCIENCE, V372, P1068, DOI 10.1126/science.abg1774; Penfield W., 1950, CEREBRAL CORTEX MAN; Peng YR, 2019, CELL, V176, P1222, DOI 10.1016/j.cell.2019.01.004; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Ramon y Cajal S, 1995, HISTOLOGY NERVOUS SY; Ren J, 2018, CELL, V175, P472, DOI 10.1016/j.cell.2018.07.043; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; Roux L, 2015, NEUROPHARMACOLOGY, V88, P10, DOI 10.1016/j.neuropharm.2014.09.011; Sanes JR, 2020, CELL, V181, P536, DOI 10.1016/j.cell.2020.04.008; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Scheffer LK, 2020, ELIFE, V9, DOI 10.7554/eLife.57443; Schwarz LA, 2015, NATURE, V524, P88, DOI 10.1038/nature14600; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shenoy KV, 2013, ANNU REV NEUROSCI, V36, P337, DOI 10.1146/annurev-neuro-062111-150509; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, DOI [DOI 10.1093/ACPROF:OSO/9780195159561.001.1, 10.1093/acprof:oso/9780195159561.001.1]; Sherrington CS, 1925, P R SOC LOND B-CONTA, V97, P519, DOI 10.1098/rspb.1925.0017; STENT GS, 1973, P NATL ACAD SCI USA, V70, P997, DOI 10.1073/pnas.70.4.997; STRYKER MP, 1986, J NEUROSCI, V6, P2117; Swanson L. W., 2012, BRAIN ARCHITECTURE, V2; Swanson LW, 2020, P NATL ACAD SCI USA, V117, P31470, DOI 10.1073/pnas.2017733117; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Talay M, 2017, NEURON, V96, P783, DOI 10.1016/j.neuron.2017.10.011; Tosches MA, 2018, SCIENCE, V360, P881, DOI 10.1126/science.aar4237; Turrigiano GG, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0258; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; von Salvini-Plawen L., 1977, Evolutionary Biology (New York), V10, P207; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang IE, 2016, CURR BIOL, V26, pR1101, DOI 10.1016/j.cub.2016.08.053; Weber F, 2016, NATURE, V538, P51, DOI 10.1038/nature19773; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Zheng ZH, 2018, CELL, V174, P730, DOI 10.1016/j.cell.2018.06.019; Zingg B, 2017, NEURON, V93, P33, DOI 10.1016/j.neuron.2016.11.045; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	117	29	28	31	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2021	373	6559					1103	+	eabg7285	10.1126/science.abg7285	http://dx.doi.org/10.1126/science.abg7285			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UL8QT	34516844	Green Accepted			2022-12-28	WOS:000692910300038
J	Cuchel, M; McGowan, MP				Cuchel, Marina; McGowan, Mary P.			Familial hypercholesterolaemia: too many lost opportunities	LANCET			English	Editorial Material							ADULTS		[Cuchel, Marina] Univ Penn, Perelman Sch Med, Div Translat Med & Human Genet, Philadelphia, PA 19104 USA; [McGowan, Mary P.] Dartmouth Hitchcock Med Ctr, Div Cardiol, Dept Med, Lebanon, NH 03766 USA; [McGowan, Mary P.] FH Fdn Pasadena, Pasadena, CA USA	University of Pennsylvania; Pennsylvania Medicine; Dartmouth College	Cuchel, M (corresponding author), Univ Penn, Perelman Sch Med, Div Translat Med & Human Genet, Philadelphia, PA 19104 USA.	mcuchel@pennmedicine.upenn.edu						deGoma EM, 2016, CIRC-CARDIOVASC GENE, V9, P240, DOI 10.1161/CIRCGENETICS.116.001381; Duell PB, 2019, ATHEROSCLEROSIS, V289, P85, DOI 10.1016/j.atherosclerosis.2019.08.007; EAS Familial Hypercholesterolaemia Studies Colloaboration, LANCET, V2021; Ference BA, 2017, EUR HEART J, V38, P2459, DOI 10.1093/eurheartj/ehx144; Hu PW, 2020, CIRCULATION, V141, P1742, DOI 10.1161/CIRCULATIONAHA.119.044795; Iyen B, 2020, ATHEROSCLEROSIS, V315, P131, DOI 10.1016/j.atherosclerosis.2020.10.895; Khera AV, 2016, J AM COLL CARDIOL, V67, P2578, DOI 10.1016/j.jacc.2016.03.520; Luirink IK, 2019, NEW ENGL J MED, V381, P1547, DOI 10.1056/NEJMoa1816454; McGowan MP, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.013225; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; Perak AM, 2016, CIRCULATION, V134, P9, DOI 10.1161/CIRCULATIONAHA.116.022335; WHO, 1998, FAM HYP REP WHO CONS; Wilemon KA, 2020, JAMA CARDIOL, V5, P217, DOI 10.1001/jamacardio.2019.5173	13	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 6	2021	398	10312					1667	1668		10.1016/S0140-6736(21)01372-6	http://dx.doi.org/10.1016/S0140-6736(21)01372-6		NOV 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WT4SQ	34506745				2022-12-28	WOS:000715856000004
J	Khan, F; Tritschler, T; Kimpton, M; Wells, PS; Kearon, C; Weitz, JI; Buller, HR; Raskob, GE; Ageno, W; Couturaud, F; Prandoni, P; Palareti, G; Legnani, C; Kyrle, PA; Eichinger, S; Eischer, L; Becattini, C; Agnelli, G; Vedovati, MC; Geersing, GJ; Takada, T; Cosmi, B; Aujesky, D; Marconi, L; Palla, A; Siragusa, S; Bradbury, CA; Parpia, S; Mallick, R; Lensing, AWA; Gebel, M; Grosso, MA; Thavorn, K; Hutton, B; Le Gal, G; Fergusson, DA; Rodger, MA				Khan, Faizan; Tritschler, Tobias; Kimpton, Miriam; Wells, Philip S.; Kearon, Clive; Weitz, Jeffrey I.; Buller, Harry R.; Raskob, Gary E.; Ageno, Walter; Couturaud, Francis; Prandoni, Paolo; Palareti, Gualtiero; Legnani, Cristina; Kyrle, Paul A.; Eichinger, Sabine; Eischer, Lisbeth; Becattini, Cecilia; Agnelli, Giancarlo; Vedovati, Maria Cristina; Geersing, Geert-Jan; Takada, Toshihiko; Cosmi, Benilde; Aujesky, Drahomir; Marconi, Letizia; Palla, Antonio; Siragusa, Sergio; Bradbury, Charlotte A.; Parpia, Sameer; Mallick, Ranjeeta; Lensing, Anthonie W. A.; Gebel, Martin; Grosso, Michael A.; Thavorn, Kednapa; Hutton, Brian; Le Gal, Gregoire; Fergusson, Dean A.; Rodger, Marc A.		MAJESTIC Collaborators	Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							INTENSITY WARFARIN THERAPY; RESIDUAL VEIN-THROMBOSIS; VITAMIN-K ANTAGONISTS; D-DIMER; DURATION; RIVAROXABAN; EPISODE; PREVENTION; GUIDE; SCORE	Background: The long-term risk for major bleeding in patients receiving extended (beyond the initial 3 to 6 months) anticoagulant therapy for a first unprovoked venous thromboembolism (VTE) is uncertain. Purpose: To determine the incidence of major bleeding during extended anticoagulation of up to 5 years among patients with a first unprovoked VTE, overall, and in clinically important subgroups. Data Sources: MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials from inception to 23 July 2021. Study Selection: Randomized controlled trials (RCTs) and prospective cohort studies reporting major bleeding among patients with a first unprovoked VTE who were to receive oral anticoagulation for a minimum of 6 additional months after completing at least 3 months of initial anticoagulant treatment. Data Extraction: Two reviewers independently abstracted data and assessed study quality. Unpublished data required for analyses were obtained from authors of included studies. Data Synthesis: Among the 14 RCTs and 13 cohort studies included in the analysis, 9982 patients received a vitamin K antagonist (VKA) and 7220 received a direct oral anticoagulant (DOAC). The incidence of major bleeding per 100 person-years was 1.74 events (95% CI, 1.34 to 2.20 events) with VKAs and 1.12 events (CI, 0.72 to 1.62 events) with DOACs. The 5-year cumulative incidence of major bleeding with VKAs was 6.3% (CI, 3.6% to 10.0%). Among patients receiving either a VKA or a DOAC, the incidence of major bleeding was statistically significantly higher among those who were older than 65 years or had creatinine clearance less than 50 mL/min, a history of bleeding, concomitant use of antiplatelet therapy, or a hemoglobin level less than 100 g/L. The case-fatality rate of major bleeding was 8.3% (CI, 5.1% to 12.2%) with VKAs and 9.7% (CI, 3.2% to 19.2%) with DOACs. Limitation: Data were insufficient to estimate incidence of major bleeding beyond 1 year of extended anticoagulation with DOACs. Conclusion: In patients with a first unprovoked VTE, the long-term risks and consequences of anticoagulant-related major bleeding are considerable. This information will help inform patient prognosis and guide decision making about treatment duration for unprovoked VTE.	[Khan, Faizan; Kimpton, Miriam; Wells, Philip S.; Thavorn, Kednapa; Hutton, Brian; Le Gal, Gregoire] Univ Ottawa, Ottawa, ON, Canada; [Khan, Faizan; Kimpton, Miriam; Wells, Philip S.; Mallick, Ranjeeta; Thavorn, Kednapa; Hutton, Brian; Le Gal, Gregoire; Rodger, Marc A.] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Tritschler, Tobias; Aujesky, Drahomir] Univ Bern, Univ Hosp, Bern, Switzerland; [Kimpton, Miriam; Wells, Philip S.; Le Gal, Gregoire] Ottawa Hosp, Ottawa, ON, Canada; [Kearon, Clive; Weitz, Jeffrey I.] McMaster Univ, Hamilton, ON, Canada; [Kearon, Clive; Weitz, Jeffrey I.] Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada; [Buller, Harry R.] Univ Amsterdam, Med Ctr, Amsterdam Cardiovasc Sci, Amsterdam, Netherlands; [Raskob, Gary E.] Univ Oklahoma, Hlth Sci Ctr, Hudson Coll Publ Hlth, Oklahoma City, OK USA; [Ageno, Walter] Univ Insubria, Varese, Italy; [Couturaud, Francis] Brest Univ Hosp, Brest, France; [Prandoni, Paolo; Palareti, Gualtiero; Legnani, Cristina] Arianna Fdn Anticoagulat, Bologna, Italy; [Kyrle, Paul A.; Eichinger, Sabine; Eischer, Lisbeth] Med Univ Vienna, Vienna, Austria; [Becattini, Cecilia; Agnelli, Giancarlo; Vedovati, Maria Cristina] Univ Perugia, Perugia, Italy; [Geersing, Geert-Jan; Takada, Toshihiko] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Cosmi, Benilde] SantOrsola Malpighi Univ Hosp, Bologna, Italy; [Marconi, Letizia; Palla, Antonio] Univ Pisa, Pisa, Italy; [Bradbury, Charlotte A.] Univ Bristol, Bristol, Avon, England; [Parpia, Sameer] McMaster Univ, Hamilton, ON, Canada; [Lensing, Anthonie W. A.; Gebel, Martin] Bayer, Wuppertal, Germany; [Grosso, Michael A.] Daiichi Sankyo, Basking Ridge, NJ USA; [Fergusson, Dean A.] Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Fergusson, Dean A.] Ottawa Hosp, Ottawa, ON, Canada; [Rodger, Marc A.] McGill Univ, Montreal, PQ, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Bern; University Hospital of Bern; University of Ottawa; Ottawa Hospital Research Institute; McMaster University; McMaster University; University of Amsterdam; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Insubria; CHU Brest; Medical University of Vienna; University of Perugia; Utrecht University; Utrecht University Medical Center; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Pisa; University of Bristol; McMaster University; Daiichi Sankyo Company Limited; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; McGill University	Khan, F (corresponding author), Ottawa Hosp, Ctr Practice Changing Res, Gen Campus,501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.	fakhan@ohri.ca	Tritschler, Tobias/ABH-1772-2021; Kimpton, Miriam/GXV-9259-2022; Gebel, Martin/ABF-4205-2021	Tritschler, Tobias/0000-0002-8775-0511; Kimpton, Miriam/0000-0002-3545-3750; Gebel, Martin/0000-0003-0812-8490; Wells, Philip/0000-0002-8657-8326; Couturaud, Francis/0000-0002-1855-8032				Ageno W, 2016, LANCET HAEMATOL, V3, pE12, DOI 10.1016/S2352-3026(15)00257-4; Agnelli G, 2003, ANN INTERN MED, V139, P19, DOI 10.7326/0003-4819-139-1-200307010-00008; Agnelli G, 2001, NEW ENGL J MED, V345, P165, DOI 10.1056/NEJM200107193450302; Agnelli G, 2013, NEW ENGL J MED, V368, P699, DOI 10.1056/NEJMoa1207541; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Boutitie F, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3036; Bradbury C, 2020, BRIT J HAEMATOL, V188, P962, DOI 10.1111/bjh.16275; Buller HR, 2012, NEW ENGL J MED, V366, P1287, DOI 10.1056/NEJMoa1113572; Chai-Adisaksopha C, 2015, J THROMB HAEMOST, V13, P2012, DOI 10.1111/jth.13139; Cosmi B, 2010, BLOOD, V115, P481, DOI 10.1182/blood-2009-08-237354; Couturaud F, 2019, HAEMATOLOGICA, V104, DOI 10.3324/haematol.2018.210971; Couturaud F, 2015, JAMA-J AM MED ASSOC, V314, P31, DOI 10.1001/jama.2015.7046; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Douketis J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d813; Eischer L, 2009, ANN HEMATOL, V88, P485, DOI 10.1007/s00277-008-0626-1; Geersing GJ, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003142; Heit JA, 2015, NAT REV CARDIOL, V12, P464, DOI 10.1038/nrcardio.2015.83; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hofmann E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162108; Kearon C, 2003, NEW ENGL J MED, V349, P631, DOI 10.1056/NEJMoa035422; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; Kearon C, 2020, BLOOD, V135, P317, DOI 10.1182/blood.2019002364; Kearon C, 2016, CHEST, V149, P315, DOI 10.1016/j.chest.2015.11.026; Kearon C, 2015, ANN INTERN MED, V162, P27, DOI 10.7326/M14-1275; Khan FZ, 2021, LANCET, V398, P64, DOI 10.1016/S0140-6736(20)32658-1; Khan F, 2019, SYST REV-LONDON, V8, DOI 10.1186/s13643-019-1175-5; Khan F, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4363; Kimpton M, 2020, ANN INTERN MED, V172, pHO2, DOI 10.7326/M20-1253; Klok FA, 2020, BLOOD, V135, P724, DOI 10.1182/blood.2019001605; Klok FA, 2015, EUR RESPIR J, V45, P201, DOI 10.1183/09031936.00040714; Konstantinides SV, 2020, EUR HEART J, V41, P543, DOI 10.1093/eurheartj/ehz405; Kreutz R, 2019, THROMB RES, V176, P125, DOI 10.1016/j.thromres.2019.02.010; Kurtoglu M, 2010, J VASC SURG, V52, P1262, DOI 10.1016/j.jvs.2010.06.070; Linkins LA, 2003, ANN INTERN MED, V139, P893, DOI 10.7326/0003-4819-139-11-200312020-00007; Marconi L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004364; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Ortel TL, 2020, BLOOD ADV, V4, P4693, DOI 10.1182/bloodadvances.2020001830; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; Palareti G, 2006, NEW ENGL J MED, V355, P1780, DOI 10.1056/NEJMoa054444; Palareti G, 2014, BLOOD, V124, P196, DOI 10.1182/blood-2014-01-548065; Palla A, 2010, J THROMB HAEMOST, V8, P68, DOI 10.1111/j.1538-7836.2009.03647.x; Poli D, 2013, J THROMB HAEMOST, V11, P1053, DOI 10.1111/jth.12239; Prandoni P, 2017, THROMB RES, V154, P35, DOI 10.1016/j.thromres.2017.04.002; Prandoni P, 2009, ANN INTERN MED, V150, P577, DOI 10.7326/0003-4819-150-9-200905050-00003; Raskob GE, 2014, ARTERIOSCL THROM VAS, V34, P2363, DOI 10.1161/ATVBAHA.114.304488; Raskob G, 2016, LANCET HAEMATOL, V3, pE228, DOI [10.1016/s2352-3026(16)00023-5, 10.1016/S2352-3026(16)00023-5]; Ridker PM, 2003, NEW ENGL J MED, V348, P1425, DOI 10.1056/NEJMoa035029; Rief P, 2018, SEMIN THROMB HEMOST, V44, P348, DOI 10.1055/s-0037-1607433; Rodger MA, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j1065; Schulman S, 2013, NEW ENGL J MED, V368, P709, DOI 10.1056/NEJMoa1113697; Siragusa S, 2011, AM J HEMATOL, V86, P914, DOI 10.1002/ajh.22156; StatsDirect, STATSDIRECT STAT SOF; Tritschler T, 2018, JAMA-J AM MED ASSOC, V320, P1583, DOI 10.1001/jama.2018.14346; van Es N, 2014, BLOOD, V124, P1968, DOI [10.1182/blood-2014-04571232, 10.1182/blood-2014-04-571232]; Vedovati MC, 2020, INT J CARDIOL, V301, P167, DOI 10.1016/j.ijcard.2019.11.105; Veroniki AA, 2016, RES SYNTH METHODS, V7, P55, DOI 10.1002/jrsm.1164; Wang KL, 2019, HEART, V105, P545, DOI 10.1136/heartjnl-2018-313617; Weitz JI, 2017, NEW ENGL J MED, V376, P1211, DOI 10.1056/NEJMoa1700518; Wells G., NEWCASTLE OTTAWA SCA; Wells PS, 2016, BLOOD, V128, DOI 10.1182/blood.V128.22.139.139; Zenati N, 2017, THROMB RES, V151, P83, DOI 10.1016/j.thromres.2016.10.027	61	22	22	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT	2021	174	10					1420	+		10.7326/M21-1094	http://dx.doi.org/10.7326/M21-1094			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XA9CB	34516270				2022-12-28	WOS:000720935700021
J	Neprash, HT; Chernew, ME				Neprash, Hannah T.; Chernew, Michael E.			Physician Practice Interruptions in the Treatment of Medicare Patients During the COVID-19 Pandemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Neprash, Hannah T.] Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, 420 Delaware St SE,MMC 729, Minneapolis, MN 55455 USA; [Chernew, Michael E.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA	University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Harvard Medical School	Neprash, HT (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, 420 Delaware St SE,MMC 729, Minneapolis, MN 55455 USA.	hneprash@umn.edu			Arnold Ventures	Arnold Ventures	This research was supported by Arnold Ventures.	[Anonymous], 2020 SURV AM PHYS CO; Mehrotra A, 2021, IMPACT COVID 19 OUTP; Primary Care Collaborative, QUICK COVID 19 PRIM	3	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 5	2021	326	13					1325	1328		10.1001/jama.2021.16324	http://dx.doi.org/10.1001/jama.2021.16324		SEP 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WD9JC	34542565	Bronze, Green Published			2022-12-28	WOS:000698779000002
J	Bang, YJ; Hu, ZH; Li, Y; Gattu, S; Ruhn, KA; Raj, P; Herz, J; Hooper, LV				Bang, Ye-Ji; Hu, Zehan; Li, Yun; Gattu, Sureka; Ruhn, Kelly A.; Raj, Prithvi; Herz, Joachim; Hooper, Lora, V			Serum amyloid A delivers retinol to intestinal myeloid cells to promote adaptive immunity	SCIENCE			English	Article							MEDIATES CELLULAR UPTAKE; BINDING-PROTEIN; MICROSCALE THERMOPHORESIS; DENDRITIC CELL; T-CELLS; RECEPTOR; TH17; MACROPHAGES; METABOLISM; RESPONSES	Vitamin A and its derivative retinol are essential for the development of intestinal adaptive immunity. Retinoic acid (RA)-producing myeloid cells are central to this process, but how myeloid cells acquire retinol for conversion to RA is unknown. Here, we show that serum amyloid A (SAA) proteins-retinol-binding proteins induced in intestinal epithelial cells by the microbiota-deliver retinol to myeloid cells. We identify low-density lipoprotein (LDL) receptor-related protein 1 (LRP1) as an SAA receptor that endocytoses SAA-retinol complexes and promotes retinol acquisition by RA-producing intestinal myeloid cells. Consequently, SAA and LRP1 are essential for vitamin A-dependent immunity, including B and T cell homing to the intestine and immunoglobulin A production. Our findings identify a key mechanism by which vitamin A promotes intestinal immunity.	[Bang, Ye-Ji; Hu, Zehan; Li, Yun; Gattu, Sureka; Ruhn, Kelly A.; Raj, Prithvi; Hooper, Lora, V] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Herz, Joachim] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Herz, Joachim] Univ Texas Southwestern Med Ctr Dallas, Ctr Translat Neurodegenerat Res, Dallas, TX 75390 USA; [Herz, Joachim] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Herz, Joachim] Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Hooper, Lora, V] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Gattu, Sureka] Reata Pharmaceut Inc, Irving, TX 75063 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hooper, LV (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA.; Hooper, LV (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.	lora.hooper@utsouthwestern.edu		Hu, Zehan/0000-0002-4648-5301; Li, Yun/0000-0002-4755-4305; Herz, Joachim/0000-0002-8506-3400; Bang, Ye-Ji/0000-0003-4009-0824	NIH [R01 DK070855, R37 HL63762, R01 NS108115, R01 NS093382, RF1 AG053391]; Welch Foundation [I-1874]; Walter M. and Helen D. Bader Center for Research on Arthritis and Autoimmune Diseases; Howard Hughes Medical Institute; BrightFocus Foundation [A2016396S]; Crohn's and Colitis Foundation of America Research Fellowship award [509845]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Walter M. and Helen D. Bader Center for Research on Arthritis and Autoimmune Diseases; Howard Hughes Medical Institute(Howard Hughes Medical Institute); BrightFocus Foundation(BrightFocus Foundation); Crohn's and Colitis Foundation of America Research Fellowship award	This work was supported by NIH grant R01 DK070855 (to L.V.H.), Welch Foundation grant I-1874 (to L.V.H.), the Walter M. and Helen D. Bader Center for Research on Arthritis and Autoimmune Diseases (L.V.H.), and the Howard Hughes Medical Institute (L.V.H.). J.H. was supported by NIH grants R37 HL63762, R01 NS108115, R01 NS093382, and RF1 AG053391 and BrightFocus Foundation A2016396S. Y.-J.B. was supported by a Crohn's and Colitis Foundation of America Research Fellowship award (509845).	Alapatt P, 2013, J BIOL CHEM, V288, P1250, DOI 10.1074/jbc.M112.369132; Bhaskaram P, 2002, NUTR REV, V60, pS40, DOI 10.1301/00296640260130722; BLANER WS, 1989, ENDOCR REV, V10, P308, DOI 10.1210/edrv-10-3-308; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Boullier S, 2009, J IMMUNOL, V183, P5879, DOI 10.4049/jimmunol.0901838; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; Bunker JJ, 2015, IMMUNITY, V43, P541, DOI 10.1016/j.immuni.2015.08.007; Cebra J J, 1998, Dev Immunol, V6, P13, DOI 10.1155/1998/68382; Chou CF, 2002, J BIOL CHEM, V277, P25209, DOI 10.1074/jbc.M201947200; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; Derebe MG, 2014, ELIFE, V3, DOI 10.7554/eLife.03206; Forbes SJ, 2011, MBIO, V2, DOI 10.1128/mBio.00042-11; Frey SK, 2011, NUTRIENTS, V3, P27, DOI 10.3390/nu3010027; Gagnon I, 2003, BIOCHEM PHARMACOL, V65, P1685, DOI 10.1016/S0006-2952(03)00150-3; Gattu S, 2019, P NATL ACAD SCI USA, V116, P10911, DOI 10.1073/pnas.1812069116; Goto Y, 2014, IMMUNITY, V40, P594, DOI 10.1016/j.immuni.2014.03.005; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; HERZ J, 1991, J BIOL CHEM, V266, P21232; Hu ZH, 2019, P NATL ACAD SCI USA, V116, P19077, DOI 10.1073/pnas.1910713116; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kolodziejczyk AA, 2019, NAT REV MICROBIOL, V17, P742, DOI 10.1038/s41579-019-0256-8; Koscso B, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aax0062; KOUNNAS MZ, 1993, J BIOL CHEM, V268, P21862; Kuang Z, 2019, SCIENCE, V365, P1428, DOI 10.1126/science.aaw3134; Lee JY, 2020, CELL, V180, P79, DOI 10.1016/j.cell.2019.11.026; Lenting PJ, 1999, J BIOL CHEM, V274, P23734, DOI 10.1074/jbc.274.34.23734; Li YS, 2000, J BIOL CHEM, V275, P37187, DOI 10.1074/jbc.M000490200; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Molenaar R, 2011, J IMMUNOL, V186, P1934, DOI 10.4049/jimmunol.1001672; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Morales-Perez CL, 2016, STRUCTURE, V24, P797, DOI 10.1016/j.str.2016.03.004; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Na YR, 2016, MOL CELLS, V39, P734, DOI 10.14348/molcells.2016.0160; Nolting J, 2009, J EXP MED, V206, P2131, DOI 10.1084/jem.20090639; Panea C, 2015, CELL REP, V12, P1314, DOI 10.1016/j.celrep.2015.07.040; Penkert RR, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01576; Rainard JM, 2018, SLAS DISCOV, V23, P225, DOI 10.1177/2472555217744728; Reigstad CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005842; Rohlmann A, 1996, NAT BIOTECHNOL, V14, P1562, DOI 10.1038/nbt1196-1562; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Scheuermann TH, 2016, ANAL BIOCHEM, V496, P79, DOI 10.1016/j.ab.2015.12.013; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Su J, 1998, J BIOL CHEM, V273, P17910, DOI 10.1074/jbc.273.28.17910; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Sun T, 2020, J IMMUNOL, V204, P1075, DOI 10.4049/jimmunol.1900710; WALDMAN RH, 1972, INFECT IMMUN, V6, P58, DOI 10.1128/IAI.6.1.58-61.1972; WEIGEL PH, 1981, J BIOL CHEM, V256, P2615; Xu C, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3104-y	56	12	13	10	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2021	373	6561					1323	+		10.1126/science.abf9232	http://dx.doi.org/10.1126/science.abf9232			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	US5SK	34529485	Green Accepted			2022-12-28	WOS:000697488600056
J	Break, TJ; Oikonomou, V; Dutzan, N; Desai, JV; Swidergall, M; Freiwald, T; Chauss, D; Harrison, OJ; Alejo, J; Williams, DW; Pittaluga, S; Lee, CCR; Bouladoux, N; Swamydas, M; Hoffman, KW; Greenwell-Wild, T; Bruno, VM; Rosen, LB; Lwin, W; Renteria, A; Pontejo, SM; Shannon, JP; Myles, IA; Olbrich, P; Ferre, EMN; Schmitt, M; Martin, D; Barber, DL; Solis, NV; Notarangelo, LD; Serreze, DV; Matsumoto, M; Hickman, HD; Murphy, PM; Anderson, MS; Lim, JK; Holland, SM; Filler, SG; Afzali, B; Belkaid, Y; Moutsopoulos, NM; Lionakis, MS				Break, Timothy J.; Oikonomou, Vasileios; Dutzan, Nicolas; Desai, Jigar V.; Swidergall, Marc; Freiwald, Tilo; Chauss, Daniel; Harrison, Oliver J.; Alejo, Julie; Williams, Drake W.; Pittaluga, Stefania; Lee, Chyi-Chia R.; Bouladoux, Nicolas; Swamydas, Muthulekha; Hoffman, Kevin W.; Greenwell-Wild, Teresa; Bruno, Vincent M.; Rosen, Lindsey B.; Lwin, Wint; Renteria, Andy; Pontejo, Sergio M.; Shannon, John P.; Myles, Ian A.; Olbrich, Peter; Ferre, Elise M. N.; Schmitt, Monica; Martin, Daniel; Barber, Daniel L.; Solis, Norma V.; Notarangelo, Luigi D.; Serreze, David V.; Matsumoto, Mitsuru; Hickman, Heather D.; Murphy, Philip M.; Anderson, Mark S.; Lim, Jean K.; Holland, Steven M.; Filler, Scott G.; Afzali, Behdad; Belkaid, Yasmine; Moutsopoulos, Niki M.; Lionakis, Michail S.		Genomics Computational Biol Core	Response to Comments on "Aberrant type 1 immunity drives susceptibility to mucosal fungal infections"	SCIENCE			English	Editorial Material							CHRONIC MUCOCUTANEOUS CANDIDIASIS	Puel and Casanova and Kisand et al. challenge our conclusions that interferonopathy and not IL-17/IL-22 autoantibodies promote candidiasis in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. We acknowledge that conclusive evidence for causation is difficult to obtain in complex human diseases. However, our studies clearly document interferonopathy driving mucosal candidiasis with intact IL-17/IL-22 responses in Aire-deficient mice, with strong corroborative evidence in patients.	[Break, Timothy J.; Oikonomou, Vasileios; Desai, Jigar V.; Swamydas, Muthulekha; Renteria, Andy; Ferre, Elise M. N.; Schmitt, Monica; Lionakis, Michail S.] NIAID, Fungal Pathogenesis Sect, Lab Clin Immunol & Microbiol LCIM, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Dutzan, Nicolas; Williams, Drake W.; Greenwell-Wild, Teresa; Moutsopoulos, Niki M.] NIDCR, Oral Immun & Inflammat Sect, Bethesda, MD USA; [Swidergall, Marc; Solis, Norma V.; Filler, Scott G.] Harbor UCLA Med Ctr, Lundquist Inst Biomed Innovat, Torrance, CA 90509 USA; [Swidergall, Marc; Filler, Scott G.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Freiwald, Tilo; Chauss, Daniel; Afzali, Behdad] NIDDK, Immunoregulat Sect, Kidney Dis Branch, Bethesda, MD 20892 USA; [Harrison, Oliver J.; Bouladoux, Nicolas; Belkaid, Yasmine] NIAID, Metaorganism Immun Sect, Lab Immune Syst Biol, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Alejo, Julie; Pittaluga, Stefania; Lee, Chyi-Chia R.] NCI, Lab Pathol, Ctr Canc Res, Bethesda, MD 20892 USA; [Hoffman, Kevin W.; Lim, Jean K.] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Bruno, Vincent M.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Rosen, Lindsey B.; Olbrich, Peter; Holland, Steven M.] NIAID, Immunopathogenesis Sect, LCIM, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Lwin, Wint; Anderson, Mark S.] Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA; [Pontejo, Sergio M.; Murphy, Philip M.] NIAID, Mol Signaling Sect, Lab Mol Immunol, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Shannon, John P.] NIAID, Viral Immun & Pathogenesis Unit, LCIM, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Myles, Ian A.; Hickman, Heather D.] NIAID, Epithelial Therapeut Unit, LCIM, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Martin, Daniel] NIDCR, Genom & Computat Biol Core, Bethesda, MD USA; [Genomics Computational Biol Core] NIDCD, Genom & Computat Biol Core, Bethesda, MD USA; [Barber, Daniel L.] NIAID, T Lymphocyte Biol Sect, Lab Parasit Dis, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Notarangelo, Luigi D.] NIAID, Immune Deficiency Genet Sect, LCIM, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Serreze, David V.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Matsumoto, Mitsuru] Tokushima Univ, Inst Enzyme Res, Div Mol Immunol, Tokushima, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Icahn School of Medicine at Mount Sinai; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Jackson Laboratory; Tokushima University	Lionakis, MS (corresponding author), NIAID, Fungal Pathogenesis Sect, Lab Clin Immunol & Microbiol LCIM, 9000 Rockville Pike, Bethesda, MD 20892 USA.	lionakism@mail.nih.gov	Olbrich, Peter/AAV-3601-2021; Williams, Drake Winslow/N-7788-2017; Oikonomou, Vasileios/ABC-7703-2021; Lionakis, Michail/J-8840-2017; Afzali, Behdad/H-8565-2013	Olbrich, Peter/0000-0001-9853-7903; Williams, Drake Winslow/0000-0002-7718-2098; Lionakis, Michail/0000-0003-4994-9500; PONTEJO, SERGIO/0000-0002-7756-9831; Dutzan, Nicolas/0000-0001-8343-0214; Afzali, Behdad/0000-0003-2968-1156; Freiwald, Tilo/0000-0002-4759-717X	Division of Intramural Research of the NIAID; NIDCR; NCI; NIDDK; NIDCD; NIH [R01DE022600, R01AI124566, R00DE026856]	Division of Intramural Research of the NIAID; NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by the Division of Intramural Research of the NIAID, NIDCR, NCI, NIDDK, and NIDCD, and by NIH grants R01DE022600, R01AI124566 (S.G.F.), and R00DE026856 (M.S.).	Ahlgren KM, 2011, EUR J IMMUNOL, V41, P235, DOI 10.1002/eji.200939883; Break TJ, 2021, SCIENCE, V371, P252, DOI 10.1126/science.aay5731; Conti HR, 2016, CELL HOST MICROBE, V20, P606, DOI 10.1016/j.chom.2016.10.001; Ferre EMN, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88782; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Kaleviste E, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00838; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Kong XF, 2020, J CLIN IMMUNOL, V40, P807, DOI 10.1007/s10875-020-00803-9; Krueger JG, 2019, J ALLERGY CLIN IMMUN, V144, P750, DOI 10.1016/j.jaci.2019.04.029; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Myles IA, 2018, J CLIN INVEST, V128, P3595, DOI 10.1172/JCI121486; Oftedal BE, 2017, AUTOIMMUNITY, V50, P211, DOI 10.1080/08916934.2017.1344972; Orlova EM, 2017, J CLIN ENDOCR METAB, V102, P3546, DOI 10.1210/jc.2017-00139; Puel A., 2021, SCIENCE, V373; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Saunte DM, 2017, BRIT J DERMATOL, V177, P47, DOI 10.1111/bjd.15015; Toubiana J, 2016, BLOOD, V127, P3154, DOI 10.1182/blood-2015-11-679902; Whibley N, 2016, J LEUKOCYTE BIOL, V99, P1153, DOI 10.1189/jlb.4A0915-428R; Wright JF, 2008, J IMMUNOL, V181, P2799, DOI 10.4049/jimmunol.181.4.2799; Wu UI, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz484	22	5	5	4	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2021	373	6561								10.1126/science.abi8835	http://dx.doi.org/10.1126/science.abi8835			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	US5SK	34529475				2022-12-28	WOS:000697488600003
J	Song, QH; Odeh, M; Zuniga-Perez, J; Kante, B; Genevet, P				Song, Qinghua; Odeh, Mutasem; Zuniga-Perez, Jesus; Kante, Boubacar; Genevet, Patrice			Plasmonic topological metasurface by encircling an exceptional point	SCIENCE			English	Article							PHASE; HOLOGRAMS	Resonant scattering, guided mode propagation phase, and/or orientation-dependent phase retardations are the three main mechanisms used to date to conceive optical metasurfaces. Here, we introduce an additional degree of freedom to address optical phase engineering by exploiting the topological features of non-Hermitian matrices operating near their singular points. Choosing metasurface building blocks to encircle a singularity following an arbitrarily closed trajectory in parameter space, we engineered a topologically protected full 2p-phase on a specific reflected polarization channel. The ease of implementation together with its compatibility with other phase-addressing mechanisms bring topological properties into the realm of industrial applications at optical frequencies and prove that metasurface technology represents a convenient test bench to study and validate topological photonic concepts.	[Song, Qinghua; Zuniga-Perez, Jesus; Genevet, Patrice] Univ Cote dAzur, Ctr Rech Heteroepitaxie & Ses Applicat, CNRS, Rue Bernard Gregory, F-06560 Valbonne, France; [Odeh, Mutasem; Kante, Boubacar] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Kante, Boubacar] Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Genevet, P (corresponding author), Univ Cote dAzur, Ctr Rech Heteroepitaxie & Ses Applicat, CNRS, Rue Bernard Gregory, F-06560 Valbonne, France.	patrice.genevet@crhea.cnrs.fr	Genevet, Patrice/HGB-7010-2022	Genevet, Patrice/0000-0003-0216-3885; Zuniga-Perez, Jesus/0000-0002-7154-641X; Odeh, Mutasem/0000-0003-0206-2283	European Union's Horizon 2020 research and innovation program [639109]; Office of Naval Research Young Investigator Award [N00014-17-1-2671]; Laboratory Directed Research and Development Program of Lawrence Berkeley National Laboratory under the US Department of Energy [DE-AC02-05CH11231]	European Union's Horizon 2020 research and innovation program; Office of Naval Research Young Investigator Award(Office of Naval Research); Laboratory Directed Research and Development Program of Lawrence Berkeley National Laboratory under the US Department of Energy(United States Department of Energy (DOE))	P.G. acknowledges funding from the European Union's Horizon 2020 research and innovation program (grant agreement 639109). B.K. acknowledges funding from Office of Naval Research Young Investigator Award (N00014-17-1-2671) and the Laboratory Directed Research and Development Program of Lawrence Berkeley National Laboratory under the US Department of Energy (DE-AC02-05CH11231).	Alaeian H, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.033829; Alu A, 2008, NAT PHOTONICS, V2, P307, DOI 10.1038/nphoton.2008.53; Ben Haim D, 2020, OPT EXPRESS, V28, P17923, DOI 10.1364/OE.392520; Feng L, 2014, SCIENCE, V346, P972, DOI 10.1126/science.1258479; Genevet P, 2015, NAT NANOTECHNOL, V10, P804, DOI [10.1038/nnano.2015.137, 10.1038/NNANO.2015.137]; Gorkunov MV, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.093903; Heiss WD, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/44/444016; Heiss WD, 2001, EUR PHYS J D, V17, P149, DOI 10.1007/s100530170017; Krasnok A, 2019, ADV OPT PHOTONICS, V11, P892, DOI 10.1364/AOP.11.000892; Lawrence M, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.093901; Lin DM, 2014, SCIENCE, V345, P298, DOI 10.1126/science.1253213; Lin Z, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.213901; Miri MA, 2019, SCIENCE, V363, P42, DOI 10.1126/science.aar7709; Ozdemir SK, 2019, NAT MATER, V18, P783, DOI 10.1038/s41563-019-0304-9; Park JH, 2020, NAT PHYS, V16, P462, DOI 10.1038/s41567-020-0796-x; Park SH, 2020, NANOPHOTONICS-BERLIN, V9, P1031, DOI 10.1515/nanoph-2019-0489; Plum E, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4921969; Rechtsman MC, 2017, NATURE, V548, P161, DOI 10.1038/548161a; Regensburger A, 2012, NATURE, V488, P167, DOI 10.1038/nature11298; Song Q, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe1112; Song QH, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23908-0; Song QH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16437-9; Sweeney WR, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.093901; Wang X, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.214302; Yang X, 2019, OPT EXPRESS, V27, P6801, DOI 10.1364/OE.27.006801; Yu NF, 2011, SCIENCE, V334, P333, DOI 10.1126/science.1210713; Zheng GX, 2015, NAT NANOTECHNOL, V10, P308, DOI [10.1038/nnano.2015.2, 10.1038/NNANO.2015.2]	27	32	33	65	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2021	373	6559					1133	+		10.1126/science.abj3179	http://dx.doi.org/10.1126/science.abj3179			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UL8QT	34516834	Green Submitted			2022-12-28	WOS:000692910300046
J	Jiang, DH; Banh, R; El-Din, TMG; Tonggu, L; Lenaeus, MJ; Pomes, R; Zheng, N; Catterall, WA				Jiang, Daohua; Banh, Richard; El-Din, Tamer M. Gamal; Tonggu, Lige; Lenaeus, Michael J.; Pomes, Regis; Zheng, Ning; Catterall, William A.			Open-state structure and pore gating mechanism of the cardiac sodium channel	CELL			English	Article							VOLTAGE-GATED SODIUM; GUI MEMBRANE-BUILDER; PARTICLE MESH EWALD; INACTIVATION GATE; DOMAIN IV; MOLECULAR DETERMINANTS; ALPHA-SUBUNIT; NA+ CHANNELS; SEGMENT IVS6; BINDING	The heartbeat is initiated by voltage-gated sodium channel Na(v)1.5, which opens rapidly and triggers the cardiac action potential; however, the structural basis for pore opening remains unknown. Here, we blocked fast inactivation with a mutation and captured the elusive open-state structure. The fast inactivation gate moves away from its receptor, allowing asymmetric opening of pore-lining S6 segments, which bend and rotate at their intracellular ends to dilate the activation gate to similar to 10 angstrom diameter. Molecular dynamics analyses predict physiological rates of Na+ conductance. The open-state pore blocker propafenone binds in a high-affinity pose, and drug-access pathways are revealed through the open activation gate and fenestrations. Comparison with mutagenesis results provides a structural map of arrhythmia mutations that target the activation and fast inactivation gates. These results give atomic-level insights into molecular events that underlie generation of the action potential, open-state drug block, and fast inactivation of cardiac sodium channels, which initiate the heartbeat.	[Jiang, Daohua; El-Din, Tamer M. Gamal; Tonggu, Lige; Lenaeus, Michael J.; Zheng, Ning; Catterall, William A.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Jiang, Daohua] Chinese Acad Sci, Inst Phys, Lab Soft Matter Phys, Beijing 100190, Peoples R China; [Banh, Richard; Pomes, Regis] Hosp Sick Children, Mol Med, Toronto, ON M5G 0A4, Canada; [Banh, Richard; Pomes, Regis] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Lenaeus, Michael J.] Univ Washington, Dept Med, Div Gen Internal Med, Seattle, WA 98195 USA; [Zheng, Ning] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Chinese Academy of Sciences; Institute of Physics, CAS; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Jiang, DH; Zheng, N; Catterall, WA (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.; Jiang, DH (corresponding author), Chinese Acad Sci, Inst Phys, Lab Soft Matter Phys, Beijing 100190, Peoples R China.; Zheng, N (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	jiangdh@iphy.ac.cn; nzheng@uw.edu; wcatt@uw.edu	Tonggu, Lige/AAV-9723-2020	Tonggu, Lige/0000-0002-0033-556X; Jiang, Daohua/0000-0002-4397-5807; Banh, Richard/0000-0001-7721-3352; Zheng, Ning/0000-0002-1039-1581	National Institutes of Health [R01 HL112808, R35 NS111573]; Howard Hughes Medical Institute; Canadian Institutes of Health Research [MOP130461]; Research Training Centre at the Hospital for Sick Children	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Research Training Centre at the Hospital for Sick Children	This research was supported by National Institutes of Health research grants R01 HL112808 and R35 NS111573 (W.A.C.), the Howard Hughes Medical Institute (N.Z.), Canadian Institutes of Health Research grant MOP130461 (R.P.), and the Research Training Centre at the Hospital for Sick Children (R.B.). Molecular simulations were enabled by supercomputing resources and support provided by WestGrid (https://www.westgrid.ca/), SciNet (https://scinetworksusa.com/a/index.php/home/), and Compute Canada (https://www.computecanada.ca/). We thank Dr. Jin Li (Department of Pharmacology, University of Washington) for technical and editorial support.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahern CA, 2016, J GEN PHYSIOL, V147, P1, DOI 10.1085/jgp.201511492; Aryal P, 2015, J MOL BIOL, V427, P121, DOI 10.1016/j.jmb.2014.07.030; BENNDORF K, 1994, J GEN PHYSIOL, V104, P801, DOI 10.1085/jgp.104.5.801; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Boiteux C, 2014, P NATL ACAD SCI USA, V111, P13057, DOI 10.1073/pnas.1408710111; Boiteux C, 2014, P NATL ACAD SCI USA, V111, P3454, DOI 10.1073/pnas.1320907111; Capes DL, 2013, J GEN PHYSIOL, V142, P101, DOI 10.1085/jgp.201310998; Catterall W.A., 2015, CARDIAC ELECTROPHYSI; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2020, ANNU REV PHARMACOL, V60, P133, DOI 10.1146/annurev-pharmtox-010818-021757; Chanda B, 2002, J GEN PHYSIOL, V120, P629, DOI 10.1085/jgp.20028679; Clairfeuille T, 2019, SCIENCE, V363, P1302, DOI 10.1126/science.aav8573; Clancy CE, 2005, PHYSIOL REV, V85, P33, DOI 10.1152/physrev.00005.2004; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; EAHOLTZ G, 1994, NEURON, V12, P1041, DOI 10.1016/0896-6273(94)90312-3; El-Din TMG, 2018, P NATL ACAD SCI USA, V115, P13111, DOI 10.1073/pnas.1814928115; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Goldin AL, 2003, CURR OPIN NEUROBIOL, V13, P284, DOI 10.1016/S0959-4388(03)00065-5; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; HILLE B, 1977, J GEN PHYSIOL, V69, P497, DOI 10.1085/jgp.69.4.497; Hille B., 2001, IONIC CHANNELS EXCIT, P814; HONDEGHEM LM, 1984, ANNU REV PHARMACOL, V24, P387, DOI 10.1146/annurev.pa.24.040184.002131; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang DH, 2020, CELL, V180, P122, DOI 10.1016/j.cell.2019.11.041; Jo S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000880; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kellenberger S, 1996, J BIOL CHEM, V271, P30971, DOI 10.1074/jbc.271.48.30971; Kellenberger S, 1997, J GEN PHYSIOL, V109, P607, DOI 10.1085/jgp.109.5.607; Kellenberger S, 1997, J GEN PHYSIOL, V109, P589, DOI 10.1085/jgp.109.5.589; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; KOHLHARDT M, 1988, J MEMBRANE BIOL, V102, P105, DOI 10.1007/BF01870449; Lee J, 2019, J CHEM THEORY COMPUT, V15, P775, DOI 10.1021/acs.jctc.8b01066; Lee J, 2016, J CHEM THEORY COMPUT, V12, P405, DOI 10.1021/acs.jctc.5b00935; Lenaeus MJ, 2017, P NATL ACAD SCI USA, V114, pE3051, DOI 10.1073/pnas.1700761114; Lerche H, 1997, J PHYSIOL-LONDON, V505, P345, DOI 10.1111/j.1469-7793.1997.345bb.x; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; McPhee JC, 1998, J BIOL CHEM, V273, P1121, DOI 10.1074/jbc.273.2.1121; MCPHEE JC, 1994, P NATL ACAD SCI USA, V91, P12346, DOI 10.1073/pnas.91.25.12346; MCPHEE JC, 1995, J BIOL CHEM, V270, P12025, DOI 10.1074/jbc.270.20.12025; Neale C, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004303; Nguyen PT, 2019, P NATL ACAD SCI USA, V116, P2945, DOI 10.1073/pnas.1817446116; NOBLE D, 1984, J PHYSIOL-LONDON, V353, P1; Noskov SY, 2008, J MOL BIOL, V377, P804, DOI 10.1016/j.jmb.2008.01.015; Pan XJ, 2019, SCIENCE, V363, P1309, DOI 10.1126/science.aaw2999; Pan XJ, 2018, SCIENCE, V362, DOI 10.1126/science.aau2486; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pless SA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1351; RAGSDALE DS, 1994, SCIENCE, V265, P1724, DOI 10.1126/science.8085162; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; Rohl CA, 1999, BIOCHEMISTRY-US, V38, P855, DOI 10.1021/bi9823380; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Shen HZ, 2019, SCIENCE, V363, P1303, DOI 10.1126/science.aaw2493; Smith MR, 1997, BIOPHYS J, V73, P1885, DOI 10.1016/S0006-3495(97)78219-5; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; VASSILEV P, 1989, P NATL ACAD SCI USA, V86, P8147, DOI 10.1073/pnas.86.20.8147; VASSILEV PM, 1988, SCIENCE, V241, P1658, DOI 10.1126/science.2458625; Venable RM, 2013, J PHYS CHEM B, V117, P10183, DOI 10.1021/jp401512z; WEISS RE, 1986, SCIENCE, V233, P361, DOI 10.1126/science.2425432; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Wisedchaisri G, 2019, CELL, V178, P993, DOI 10.1016/j.cell.2019.06.031; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhou L, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20078-3	74	21	21	3	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 30	2021	184	20					5151	+		10.1016/j.cell.2021.08.021	http://dx.doi.org/10.1016/j.cell.2021.08.021		OCT 2021	23	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	WC7PG	34520724	Green Accepted, Bronze			2022-12-28	WOS:000704445700011
J	Shiloh, R; Illmer, J; Chlouba, T; Yousefi, P; Schonenberger, N; Niedermayer, U; Mittelbach, A; Hommelhoff, P				Shiloh, R.; Illmer, J.; Chlouba, T.; Yousefi, P.; Schonenberger, N.; Niedermayer, U.; Mittelbach, A.; Hommelhoff, P.			Electron phase-space control in photonic chip-based particle acceleration	NATURE			English	Article							LASER ACCELERATION; DEFLECTION; BOSON	In a tiny chip-based particle accelerator, phase-space control of the emerging electron beam demonstrates guiding over a length of nearly 80 micrometres and an indispensable prerequisite to electron acceleration to high energies. Particle accelerators are essential tools in science, hospitals and industry(1-6). Yet their costs and large footprint, ranging in length from metres to several kilometres, limit their use. The recently demonstrated nanophotonics-based acceleration of charged particles can reduce the cost and size of these accelerators by orders of magnitude(7-9). In this approach, a carefully designed nanostructure transfers energy from laser light to the particles in a phase-synchronous manner, accelerating them. To accelerate particles to the megaelectronvolt range and beyond, with minimal particle loss(10,11), the particle beam needs to be confined over extended distances, but the necessary control of the electron beam's phase space has been elusive. Here we demonstrate complex electron phase-space control at optical frequencies in the 225-nanometre narrow channel of a silicon-based photonic nanostructure that is 77.7 micrometres long. In particular, we experimentally show alternating phase focusing(10-13), a particle propagation scheme for minimal-loss transport that could, in principle, be arbitrarily long. We expect this work to enable megaelectronvolt electron-beam generation on a photonic chip, with potential for applications in radiotherapy and compact light sources(9), and other forms of electron phase-space control resulting in narrow energy or zeptosecond-bunched beams(14-16).	[Shiloh, R.; Illmer, J.; Chlouba, T.; Yousefi, P.; Schonenberger, N.; Mittelbach, A.; Hommelhoff, P.] Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Phys, Erlangen, Germany; [Schonenberger, N.; Hommelhoff, P.] Max Planck Inst Sci Light, Erlangen, Germany; [Niedermayer, U.] Tech Univ Darmstadt, Inst Accelerator Sci & Electromagnet Fields TEMF, Darmstadt, Germany	University of Erlangen Nuremberg; Max Planck Society; Technical University of Darmstadt	Shiloh, R; Illmer, J; Hommelhoff, P (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Phys, Erlangen, Germany.; Hommelhoff, P (corresponding author), Max Planck Inst Sci Light, Erlangen, Germany.	roy.shiloh@fau.de; johannes.i.illmer@fau.de; peter.hommelhoff@fau.de	Shiloh, Roy/AAA-8955-2022; Chlouba, Tomas/R-1909-2017	Chlouba, Tomas/0000-0002-8383-1293; Shiloh, Roy/0000-0001-5142-7467; Schonenberger, Norbert/0000-0003-4836-5474				Aad G, 2012, SCIENCE, V338, P1576, DOI 10.1126/science.1232005; [Anonymous], 2018, NAT REV MATER; Black DS, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.264802; Black DS, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.104801; Breuer J, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.134803; Bruning O. S., 2004, CERN2004003V1 LHC; Bucksbaum P, 2013, J PHYS B-AT MOL OPT, V46, DOI 10.1088/0953-4075/46/16/160201; Cesar D, 2018, COMMUN PHYS-UK, V1, DOI 10.1038/s42005-018-0047-y; Chatrchyan S, 2012, SCIENCE, V338, P1569, DOI 10.1126/science.1230816; COURANT ED, 1958, ANN PHYS-NEW YORK, V3, P1, DOI 10.1016/0003-4916(58)90012-5; Cros B., 2018, ADV LINEAR COLLIDER; Egenolf T, 2020, PHYS REV ACCEL BEAMS, V23, DOI 10.1103/PhysRevAccelBeams.23.054402; Egerton RF, 2015, ADV STRUCT CHEM IMAG, V1, DOI 10.1186/s40679-014-0001-3; England RJ, 2014, REV MOD PHYS, V86, P1337, DOI 10.1103/RevModPhys.86.1337; Hirano T, 2020, APPL PHYS LETT, V116, DOI 10.1063/5.0003575; KARZMARK CJ, 1984, MED PHYS, V11, P105, DOI 10.1118/1.595617; Kimura W. D., 2018, 2018 IEEE ADV ACC CO, DOI [10.1109/AAC.2018.8659403, DOI 10.1109/AAC.2018.8659403]; Kozak M, 2018, J APPL PHYS, V124, DOI 10.1063/1.5032093; Kozak M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14342; Leedle KJ, 2018, OPT LETT, V43, P2181, DOI 10.1364/OL.43.002181; Leedle KJ, 2015, OPTICA, V2, P158, DOI 10.1364/OPTICA.2.000158; Lohmann A. W, 1962, ELECTRON ACCELERATIO; McNeur J, 2018, OPTICA, V5, P687, DOI 10.1364/OPTICA.5.000687; Naranjo B, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.164803; Niedermayer U, 2021, PHYS REV APPL, V15, DOI 10.1103/PhysRevApplied.15.L021002; Niedermayer U, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.164801; Niedermayer U, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.214801; PANOFSKY WKH, 1956, REV SCI INSTRUM, V27, P967, DOI 10.1063/1.1715427; Peralta EA, 2013, NATURE, V503, P91, DOI 10.1038/nature12664; Podgorsak E.B., 2005, RAD ONCOLOGY PHYS; Roques-Carmes C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11070-7; Sapra NV, 2020, SCIENCE, V367, P79, DOI 10.1126/science.aay5734; Schonenberger N, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.264803; Shiltsev V, 2021, REV MOD PHYS, V93, DOI 10.1103/RevModPhys.93.015006; SHIMODA K, 1962, APPL OPTICS, V1, P33, DOI 10.1364/AO.1.000033; Staude I, 2012, OPT EXPRESS, V20, P5607, DOI 10.1364/OE.20.005607; Wangler TP., 2008, RF LINEAR ACCELERATO; Wiedemann H., 2015, PARTICLE ACCELERATOR, DOI 10.1007/978-3-319-18317-6; Yousefi P, 2019, OPT LETT, V44, P1520, DOI 10.1364/OL.44.001520; Zhao ZX, 2020, PHOTONICS RES, V8, P1586, DOI 10.1364/PRJ.394127	41	15	16	11	44	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2021	597	7877					498	+		10.1038/s41586-021-03812-9	http://dx.doi.org/10.1038/s41586-021-03812-9			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UW6NQ	34552256	Green Submitted			2022-12-28	WOS:000700270400013
J	Tian, HN; Wu, ZS; Chen, SY; Ao, KV; Huang, WJ; Yaghmaiean, H; Sun, TJ; Xu, F; Zhang, YN; Wang, SC; Li, X; Zhang, YL				Tian, Hainan; Wu, Zhongshou; Chen, Siyu; Ao, Kevin; Huang, Weijie; Yaghmaiean, Hoda; Sun, Tongjun; Xu, Fang; Zhang, Yanjun; Wang, Shucai; Li, Xin; Zhang, Yuelin			Activation of TIR signalling boosts pattern-triggered immunity	NATURE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; CELL-DEATH; PSEUDOMONAS-SYRINGAE; DISEASE RESISTANCE; RECEPTOR; PERCEPTION; RECOGNITION; BACTERIAL; DOWNSTREAM; DOMAINS	Plant immune responses are mainly activated by two types of receptor. Pattern recognition receptors localized on the plasma membrane perceive extracellular microbial features, and nucleotide-binding leucine-rich repeat receptors (NLRs) recognize intracellular effector proteins from pathogens(1). NLRs possessing amino-terminal Toll/interleukin-1 receptor (TIR) domains activate defence responses via the NADase activity of the TIR domain(2,3). Here we report that activation of TIR signalling has a key role in pattern-triggered immunity (PTI) mediated by pattern recognition receptors. TIR signalling mutants exhibit attenuated PTI responses and decreased resistance against pathogens. Consistently, PTI is compromised in plants with reduced NLR levels. Treatment with the PTI elicitor flg22 or nlp20 rapidly induces many genes encoding TIR-domain-containing proteins, which is likely to be responsible for activating TIR signalling during PTI. Overall, our study reveals that activation of TIR signalling is an important mechanism for boosting plant defence during PTI.	[Tian, Hainan; Wu, Zhongshou; Chen, Siyu; Ao, Kevin; Huang, Weijie; Yaghmaiean, Hoda; Sun, Tongjun; Xu, Fang; Li, Xin; Zhang, Yuelin] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Wu, Zhongshou; Ao, Kevin; Sun, Tongjun; Xu, Fang; Li, Xin] Univ British Columbia, Michael Smith Labs, Vancouver, BC, Canada; [Chen, Siyu] Northeast Normal Univ, Key Lab Mol Epigenet MOE, Changchun, Peoples R China; [Chen, Siyu] Northeast Normal Univ, Inst Cytol & Genet, Changchun, Peoples R China; [Chen, Siyu; Wang, Shucai] Linyi Univ, Sch Life Sci, Lab Plant Mol Genet & Crop Gene Editing, Linyi, Shandong, Peoples R China; [Xu, Fang] Shandong Univ, Sch Life Sci, Key Lab Plant Dev & Environm Adaptat Biol, Minist Educ, Qingdao, Peoples R China; [Zhang, Yanjun] Zhejiang Normal Univ, Inst Plant Genet & Dev Biol, Coll Chem & Life Sci, Jinhua, Zhejiang, Peoples R China	University of British Columbia; University of British Columbia; Northeast Normal University - China; Northeast Normal University - China; Linyi University; Shandong University; Zhejiang Normal University	Li, X; Zhang, YL (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.; Li, X (corresponding author), Univ British Columbia, Michael Smith Labs, Vancouver, BC, Canada.	xinli@msl.ubc.ca; yuelin.zhang@ubc.ca	CHEN, SI/GZL-4800-2022; Sun, Tongjun/AGV-6839-2022	Ao, Kevin/0000-0001-9465-9524; Wang, Shucai/0000-0001-7619-2385; Wu, Zhongshou/0000-0001-6687-1675; Huang, Weijie/0000-0003-1272-1297	Natural Sciences and Engineering Research Council (NSERC) Discovery programme of Canada; NSERC-CREATE-PRoTECT; Canadian Foundation for Innovation; National Natural Science Foundation of China [31828008]; Chinese Scholarship Council; Alexander Graham Bell Canada Graduate Scholarship Doctoral Program; University of British Columbia Four-Year Fellowship programme	Natural Sciences and Engineering Research Council (NSERC) Discovery programme of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC-CREATE-PRoTECT; Canadian Foundation for Innovation(Canada Foundation for Innovation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Scholarship Council(China Scholarship Council); Alexander Graham Bell Canada Graduate Scholarship Doctoral Program; University of British Columbia Four-Year Fellowship programme	We thank J. Parker, J. Dangl, J.-M. Zhou, K. Yoshioka and H. Cui for sharing mutant seeds and pathogen strains; L. Tian for help with the high-performance liquid chromatography analysis and biochemical assays; and T. Nuernberger and J. Parker for insightful discussions. This study was financially supported by grants to X.L. and Yuelin Zhang from the Natural Sciences and Engineering Research Council (NSERC) Discovery programme of Canada, NSERC-CREATE-PRoTECT, and the Canadian Foundation for Innovation, a grant to Yanjun Zhang from the National Natural Science Foundation of China (31828008), scholarships to H.T., S.C., W.H. and Z.W. from the Chinese Scholarship Council, and scholarships to K.A. from the Alexander Graham Bell Canada Graduate Scholarship Doctoral Program, and the University of British Columbia Four-Year Fellowship programme.	Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Albert I, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.140, 10.1038/nplants.2015.140]; Bohm H, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004491; Bonardi V, 2011, P NATL ACAD SCI USA, V108, P16463, DOI 10.1073/pnas.1113726108; CENTURY KS, 1995, P NATL ACAD SCI USA, V92, P6597, DOI 10.1073/pnas.92.14.6597; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Feys BJ, 2005, PLANT CELL, V17, P2601, DOI 10.1105/tpc.105.033910; Glazebrook J, 1996, GENETICS, V143, P973; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Hartmann M, 2018, CELL, V173, P456, DOI 10.1016/j.cell.2018.02.049; Horsefield S, 2019, SCIENCE, V365, P793, DOI 10.1126/science.aax1911; Kong Q, 2016, PLANT PHYSIOL, V171, P1344, DOI 10.1104/pp.15.01954; Li FJ, 2014, CELL HOST MICROBE, V16, P748, DOI 10.1016/j.chom.2014.10.018; Li X, 1999, CELL, V98, P329, DOI 10.1016/S0092-8674(00)81962-5; Liang XX, 2018, ANNU REV PLANT BIOL, V69, P267, DOI 10.1146/annurev-arplant-042817-040540; Liebrand TWH, 2014, TRENDS PLANT SCI, V19, P123, DOI 10.1016/j.tplants.2013.10.003; Liu YA, 2016, NEW PHYTOL, V212, P637, DOI 10.1111/nph.14072; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Monaghan J, 2012, CURR OPIN PLANT BIOL, V15, P349, DOI 10.1016/j.pbi.2012.05.006; Ngou BPM, 2021, NATURE, V592, P110, DOI 10.1038/s41586-021-03315-7; Palma K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001137; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Pruitt R. N., 2020, ARABIDOPSIS CELL SUR, DOI [10.1101/2020.11.23.391516, DOI 10.1101/2020.11.23.391516]; Rao SF, 2018, PLANT PHYSIOL, V177, P1679, DOI 10.1104/pp.18.00486; Soneson C., 2016, F1000RES, V4, DOI [10.12688/F1000RESEARCH.7563.2. F1000Research, DOI 10.12688/F1000RESEARCH.7563.2]; Sreekanta S, 2015, NEW PHYTOL, V207, P78, DOI 10.1111/nph.13345; Sun TJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10159; Tian W, 2019, NATURE, V572, P131, DOI 10.1038/s41586-019-1413-y; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Wan L, 2019, SCIENCE, V365, P799, DOI 10.1126/science.aax1771; Wan WL, 2019, NEW PHYTOL, V221, P2080, DOI 10.1111/nph.15497; Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Wu ZS, 2020, EMBO J, V39, DOI 10.15252/embj.2020104915; Wu ZS, 2019, NEW PHYTOL, V222, P938, DOI 10.1111/nph.15665; Xiang TT, 2011, MOL PLANT MICROBE IN, V24, P100, DOI 10.1094/MPMI-04-10-0096; Xu F, 2015, PLANT CELL, V27, P1547, DOI 10.1105/tpc.15.00173; Yi H, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-36; Yoshioka K, 2006, PLANT CELL, V18, P747, DOI 10.1105/tpc.105.038786; Yu X, 2019, CURR BIOL, V29, P3778, DOI 10.1016/j.cub.2019.09.018; Yuan MH, 2021, NATURE, V592, P105, DOI 10.1038/s41586-021-03316-6; Zhang J, 2010, CELL HOST MICROBE, V7, P290, DOI 10.1016/j.chom.2010.03.007; Zhang RX, 2017, NUCLEIC ACIDS RES, V45, P5061, DOI 10.1093/nar/gkx267; Zhang YX, 2010, P NATL ACAD SCI USA, V107, P18220, DOI 10.1073/pnas.1005225107; Zhang YL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11202-z; Zhao CH, 2021, NEW PHYTOL, V230, P1078, DOI 10.1111/nph.17218; Zhou JM, 2020, CELL, V181, P978, DOI 10.1016/j.cell.2020.04.028	48	60	62	43	156	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 21	2021	598	7881					500	+		10.1038/s41586-021-03987-1	http://dx.doi.org/10.1038/s41586-021-03987-1		SEP 2021	23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WK1SC	34544113				2022-12-28	WOS:000706973000001
J	Torjesen, I				Torjesen, Ingrid			New public health body will be responsible for "levelling up" health, health secretary says	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2021	374								n2299	10.1136/bmj.n2299	http://dx.doi.org/10.1136/bmj.n2299			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WC6LC	34535468	Bronze			2022-12-28	WOS:000704366700001
J	van der Velde, IR; van der Werf, GR; Houweling, S; Maasakkers, JD; Borsdorff, T; Landgraf, J; Tol, P; van Kempen, TA; van Hees, R; Hoogeveen, R; Veefkind, JP; Aben, I				van der Velde, Ivar R.; van der Werf, Guido R.; Houweling, Sander; Maasakkers, Joannes D.; Borsdorff, Tobias; Landgraf, Jochen; Tol, Paul; van Kempen, Tim A.; van Hees, Richard; Hoogeveen, Ruud; Veefkind, J. Pepijn; Aben, Ilse			Vast CO2 release from Australian fires in 2019-2020 constrained by satellite	NATURE			English	Article							BIOMASS BURNING EMISSIONS; TRACE GASES; AIR-QUALITY; CLIMATE; CARBON; WILDFIRES; FLUXES; SPACE; MODEL; FUEL	The amount of carbon dioxide released by the Australian wildfires of 2019-2020 is uncertain, but is estimated here using satellite observations of carbon monoxide to be more than twice the amount suggested by fire inventories. Southeast Australia experienced intensive and geographically extensive wildfires during the 2019-2020 summer season(1,2). The fires released substantial amounts of carbon dioxide into the atmosphere(3). However, existing emission estimates based on fire inventories are uncertain(4), and vary by up to a factor of four for this event. Here we constrain emission estimates with the help of satellite observations of carbon monoxide(5), an analytical Bayesian inversion(6) and observed ratios between emitted carbon dioxide and carbon monoxide(7). We estimate emissions of carbon dioxide to be 715 teragrams (range 517-867) from November 2019 to January 2020. This is more than twice the estimate derived by five different fire inventories(8-12), and broadly consistent with estimates based on a bottom-up bootstrap analysis of this fire episode(13). Although fires occur regularly in the savannas in northern Australia, the recent episodes were extremely large in scale and intensity, burning unusually large areas of eucalyptus forest in the southeast(13). The fires were driven partly by climate change(14,15), making better-constrained emission estimates particularly important. This is because the build-up of atmospheric carbon dioxide may become increasingly dependent on fire-driven climate-carbon feedbacks, as highlighted by this event(16).	[van der Velde, Ivar R.; Houweling, Sander; Maasakkers, Joannes D.; Borsdorff, Tobias; Landgraf, Jochen; Tol, Paul; van Kempen, Tim A.; van Hees, Richard; Hoogeveen, Ruud; Aben, Ilse] SRON Netherlands Inst Space Res, Utrecht, Netherlands; [van der Velde, Ivar R.; van der Werf, Guido R.; Houweling, Sander] Vrije Univ, Dept Earth Sci, Amsterdam, Netherlands; [Veefkind, J. Pepijn] Royal Netherlands Meteorol Inst KNMI, De Bilt, Netherlands; [Veefkind, J. Pepijn] Univ Technol, Dept Geosci & Remote Sensing, Delft, Netherlands; [Aben, Ilse] Vrije Univ, Dept Phys & Astron, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Royal Netherlands Meteorological Institute; Eindhoven University of Technology; Vrije Universiteit Amsterdam	van der Velde, IR (corresponding author), SRON Netherlands Inst Space Res, Utrecht, Netherlands.; van der Velde, IR (corresponding author), Vrije Univ, Dept Earth Sci, Amsterdam, Netherlands.	I.R.van.der.Velde@sron.nl	van der Werf, Guido/M-8260-2016	van der Werf, Guido/0000-0001-9042-8630; van Hees, Richard/0000-0002-3846-0753; aben, ilse/0000-0003-2198-0768; van Kempen, Tim/0000-0001-8178-5054; Houweling, Sander/0000-0002-6189-1009				Abram NJ, 2021, COMMUN EARTH ENVIRON, V2, DOI 10.1038/s43247-020-00065-8; Akagi SK, 2011, ATMOS CHEM PHYS, V11, P4039, DOI 10.5194/acp-11-4039-2011; Andreae MO, 2001, GLOBAL BIOGEOCHEM CY, V15, P955, DOI 10.1029/2000GB001382; [Anonymous], 2019, AUSTR GOVT ANN CLIMA; Australian Government Technical Update, 2020, EST GREENH GAS EM BU; Bowman D, 2020, NATURE, V584, P188, DOI 10.1038/d41586-020-02306-4; Bowman DMJS, 2021, PLANT CELL ENVIRON, V44, P347, DOI 10.1111/pce.13916; Clarke HG, 2011, INT J WILDLAND FIRE, V20, P550, DOI 10.1071/WF10070; Darmenov A, 2015, QUICK FIRE EMISSIONS; Guerette EA, 2018, ATMOS CHEM PHYS, V18, P3717, DOI 10.5194/acp-18-3717-2018; Heymann J, 2017, GEOPHYS RES LETT, V44, P1537, DOI 10.1002/2016GL072042; Houghton RA, 2017, GLOBAL BIOGEOCHEM CY, V31, P456, DOI 10.1002/2016GB005546; Huijnen V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26886; Hurst DF, 1996, BIOMASS BURNING GLOB; Ichoku C, 2014, ATMOS CHEM PHYS, V14, P6643, DOI 10.5194/acp-14-6643-2014; Kaiser JW, 2012, BIOGEOSCIENCES, V9, P527, DOI 10.5194/bg-9-527-2012; Lawson SJ, 2015, ATMOS CHEM PHYS, V15, P13393, DOI 10.5194/acp-15-13393-2015; Lohberger S, 2018, GLOBAL CHANGE BIOL, V24, P644, DOI 10.1111/gcb.13841; Lucas C., 2007, Bushfire weather in Southeast Australia: recent trends and projected climate change impacts; Matthews S, 2012, GLOBAL CHANGE BIOL, V18, P3212, DOI 10.1111/j.1365-2486.2012.02768.x; MUNTEAN M, 2018, 29433 EUR EN; Nechita-Banda N, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0307; Pan XH, 2020, ATMOS CHEM PHYS, V20, P969, DOI 10.5194/acp-20-969-2020; Paton-Walsh C, 2014, ATMOS CHEM PHYS, V14, P11313, DOI 10.5194/acp-14-11313-2014; Rea G, 2016, ATMOS ENVIRON, V131, P150, DOI 10.1016/j.atmosenv.2016.01.034; Reisen F, 2018, J GEOPHYS RES-ATMOS, V123, P8301, DOI 10.1029/2018JD028488; Schneising O, 2020, ATMOS CHEM PHYS, V20, P3317, DOI 10.5194/acp-20-3317-2020; SEILER W, 1980, CLIMATIC CHANGE, V2, P207, DOI 10.1007/BF00137988; Shukla P. R., CLIMATE CHANGE LAND; Tarantola A., 2005, INVERSE PROBLEM THEO, V1, P1, DOI DOI 10.1137/1.9780898717921; Taylor KE, 2001, J GEOPHYS RES-ATMOS, V106, P7183, DOI 10.1029/2000JD900719; van der Velde IR, 2021, ATMOS CHEM PHYS, V21, P597, DOI 10.5194/acp-21-597-2021; van der Werf GR, 2017, EARTH SYST SCI DATA, V9, P697, DOI 10.5194/essd-9-697-2017; van Leeuwen TT, 2014, BIOGEOSCIENCES, V11, P7305, DOI 10.5194/bg-11-7305-2014; van Oldenborgh GJ, 2021, NAT HAZARD EARTH SYS, V21, P941, DOI 10.5194/nhess-21-941-2021; Veefkind JP, 2012, REMOTE SENS ENVIRON, V120, P70, DOI 10.1016/j.rse.2011.09.027; Wain A, 2009, DEV ENVIRONM SCI, V8, P535, DOI 10.1016/S1474-8177(08)00023-5; Wiedinmyer C, 2011, GEOSCI MODEL DEV, V4, P625, DOI 10.5194/gmd-4-625-2011; Wooster MJ, 2003, REMOTE SENS ENVIRON, V86, P83, DOI 10.1016/S0034-4257(03)00070-1; Yin Y, 2016, GEOPHYS RES LETT, V43, P10472, DOI 10.1002/2016GL070971; Yokelson RJ, 1999, J GEOPHYS RES-ATMOS, V104, P30109, DOI 10.1029/1999JD900817	41	25	25	21	77	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 16	2021	597	7876					366	+		10.1038/s41586-021-03712-y	http://dx.doi.org/10.1038/s41586-021-03712-y			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UQ8UQ	34526704	Green Published			2022-12-28	WOS:000696334600011
J	Mo, F; Yu, ZY; Li, P; Oh, J; Spolski, R; Zhao, L; Glassman, CR; Yamamoto, TN; Chen, Y; Golebiowski, FM; Hermans, D; Majri-Morrison, S; Picton, LK; Liao, W; Ren, M; Zhuang, XX; Mitra, S; Lin, JX; Gattinoni, L; Powell, JD; Restifo, NP; Garcia, KC; Leonard, WJ				Mo, Fei; Yu, Zhiya; Li, Peng; Oh, Jangsuk; Spolski, Rosanne; Zhao, Liang; Glassman, Caleb R.; Yamamoto, Tori N.; Chen, Yun; Golebiowski, Filip M.; Hermans, Dalton; Majri-Morrison, Sonia; Picton, Lora K.; Liao, Wei; Ren, Min; Zhuang, Xiaoxuan; Mitra, Suman; Lin, Jian-Xin; Gattinoni, Luca; Powell, Jonathan D.; Restifo, Nicholas P.; Garcia, K. Christopher; Leonard, Warren J.			An engineered IL-2 partial agonist promotes CD8(+) T cell stemness	NATURE			English	Article							CHAIN CYTOKINES IL-2; EFFECTOR DIFFERENTIATION; MEMORY; INTERLEUKIN-2; EXHAUSTION; EXPRESSION; RECEPTOR; TIM-3; PD-1; IMMUNOTHERAPY	Adoptive transfer of antigen-specific T cells represents a major advance in cancer immunotherapy, with robust clinical outcomes in some patients(1). Both the number of transferred T cells and their differentiation state are critical determinants of effective responses(2,3). T cells can be expanded with T cell receptor (TCR)-mediated stimulation and interleukin-2, but this can lead to differentiation into effector T cells(4,5) and lower therapeutic efficacy(6), whereas maintenance of a more stem-cell-like state before adoptive transfer is beneficial(7). Here we show that H9T, an engineered interleukin-2 partial agonist, promotes the expansion of CD8(+) T cells without driving terminal differentiation. H9T led to altered STAT5 signalling and mediated distinctive downstream transcriptional, epigenetic and metabolic programs. In addition, H9T treatment sustained the expression of T cell transcription factor 1 (TCF-1) and promoted mitochondrial fitness, thereby facilitating the maintenance of a stem-cell-like state. Moreover, TCR-transgenic and chimeric antigen receptor-modified CD8(+) T cells that were expanded with H9T showed robust anti-tumour activity in vivo in mouse models of melanoma and acute lymphoblastic leukaemia. Thus, engineering cytokine variants with distinctive properties is a promising strategy for creating new molecules with translational potential.	[Mo, Fei; Li, Peng; Oh, Jangsuk; Spolski, Rosanne; Hermans, Dalton; Liao, Wei; Ren, Min; Mitra, Suman; Lin, Jian-Xin; Leonard, Warren J.] NHLBI, Lab Mol Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA; [Mo, Fei; Li, Peng; Oh, Jangsuk; Spolski, Rosanne; Hermans, Dalton; Liao, Wei; Ren, Min; Mitra, Suman; Lin, Jian-Xin; Leonard, Warren J.] NHLBI, Immunol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA; [Yu, Zhiya; Yamamoto, Tori N.; Restifo, Nicholas P.] NCI, Surg Branch, Bldg 10, Bethesda, MD 20892 USA; [Zhao, Liang; Powell, Jonathan D.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Glassman, Caleb R.; Majri-Morrison, Sonia; Picton, Lora K.; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Glassman, Caleb R.; Majri-Morrison, Sonia; Picton, Lora K.; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA; [Picton, Lora K.; Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Chen, Yun; Golebiowski, Filip M.] NIDDK, NIH, Bethesda, MD 20892 USA; [Zhuang, Xiaoxuan] NIAID, Lab Immunogenet, NIH, Rockville, MD USA; [Gattinoni, Luca] NCI, Ctr Canc Res, Bethesda, MD 20892 USA; [Gattinoni, Luca] Regensburg Ctr Intervent Immunol, Dept Funct Immune Cell Modulat, Regensburg, Germany; [Gattinoni, Luca] Univ Regensburg, Regenburg, Germany	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Regensburg	Leonard, WJ (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA.; Leonard, WJ (corresponding author), NHLBI, Immunol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.; Restifo, NP (corresponding author), NCI, Surg Branch, Bldg 10, Bethesda, MD 20892 USA.; Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.; Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA.; Garcia, KC (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	drnickrestifo@gmail.com; kcgarcia@stanford.edu; leonardw@nhlbi.nih.gov	Gattinoni, Luca/A-2281-2008; Leonard, Warren/AAA-1397-2022; Zhao, Liang/I-4777-2015	Gattinoni, Luca/0000-0003-2239-3282; Golebiowski, Filip/0000-0002-8011-2162; Mo, Fei/0000-0002-8601-2568; Restifo, Nicholas P./0000-0003-4229-4580; Yamamoto, Tori/0000-0003-1965-7822; Glassman, Caleb/0000-0002-3342-7989; Zhao, Liang/0000-0002-2126-6778	Division of Intramural Research at the National Heart, Lung, and Blood Institute; Division of Intramural Research at the National Cancer Institute (NCI); National Institutes of Health (NIH) [AI51321, R01AI07761, P41EB028239-01]; Parker Institute of Cancer Immunotherapy; Ludwig Foundation; Mathers Foundation; Howard Hughes Medical Institute; Bloomberg-Kimmel Institute for Cancer Immunotherapy; Intramural Research Program of the NCI; Cancer Moonshot Program for the Center for Cell-Based Therapy at the NCI, NIH; Intramural Research Program of the US NIH, NCI, Center for Cancer Research [ZIABC011480]	Division of Intramural Research at the National Heart, Lung, and Blood Institute; Division of Intramural Research at the National Cancer Institute (NCI); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker Institute of Cancer Immunotherapy; Ludwig Foundation; Mathers Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Bloomberg-Kimmel Institute for Cancer Immunotherapy; Intramural Research Program of the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Moonshot Program for the Center for Cell-Based Therapy at the NCI, NIH; Intramural Research Program of the US NIH, NCI, Center for Cancer Research	We thank R. Ahmed for critical comments; W. Yang and C. Wu for discussions; and the NHLBI DIR Flow Cytometry Core, DNA Sequencing and Genomics Core for assistance with cell sorting and DNA sequencing. The work was supported by the Division of Intramural Research at the National Heart, Lung, and Blood Institute, and by the Division of Intramural Research at the National Cancer Institute (NCI). K.C.G. was supported by National Institutes of Health (NIH) grant AI51321, the Parker Institute of Cancer Immunotherapy, the Ludwig Foundation, the Mathers Foundation and the Howard Hughes Medical Institute. J.D.P was supported by the NIH (R01AI07761, P41EB028239-01) and The Bloomberg-Kimmel Institute for Cancer Immunotherapy. N.P.R was supported by the Intramural Research Program of the NCI and the Cancer Moonshot Program for the Center for Cell-Based Therapy at the NCI, NIH. L.G. was supported by the Intramural Research Program of the US NIH, NCI, Center for Cancer Research (ZIABC011480).	Bijl J, 2005, GENE DEV, V19, P224, DOI 10.1101/gad.1268505; Blank CU, 2019, NAT REV IMMUNOL, V19, P665, DOI 10.1038/s41577-019-0221-9; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Crompton JG, 2014, IMMUNOL REV, V257, P264, DOI 10.1111/imr.12135; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Gattinoni L, 2017, NAT MED, V23, P18, DOI 10.1038/nm.4241; Gattinoni L, 2012, NAT REV CANCER, V12, P671, DOI 10.1038/nrc3322; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Hanada KI, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124405; Hermans D, 2020, P NATL ACAD SCI USA, V117, P6047, DOI 10.1073/pnas.1920413117; Hinrichs CS, 2008, BLOOD, V111, P5326, DOI 10.1182/blood-2007-09-113050; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Jacoby E, 2016, BLOOD, V127, P1361, DOI 10.1182/blood-2015-08-664250; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kinter AL, 2008, J IMMUNOL, V181, P6738, DOI 10.4049/jimmunol.181.10.6738; Kochenderfer JN, 2010, BLOOD, V116, P3875, DOI 10.1182/blood-2010-01-265041; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leonard WJ, 2019, IMMUNITY, V50, P832, DOI 10.1016/j.immuni.2019.03.028; Levin AM, 2012, NATURE, V484, P529, DOI 10.1038/nature10975; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Lin JX, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01477-5; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; Liu DV, 2009, J IMMUNOTHER, V32, P887, DOI 10.1097/CJI.0b013e3181b528da; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI13296; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Mitra S, 2015, IMMUNITY, V42, P826, DOI 10.1016/j.immuni.2015.04.018; Mujib S, 2012, J IMMUNOL, V188, P3745, DOI 10.4049/jimmunol.1102609; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Scott-Browne JP, 2016, IMMUNITY, V45, P1327, DOI 10.1016/j.immuni.2016.10.028; Shah NN, 2019, NAT REV CLIN ONCOL, V16, P372, DOI 10.1038/s41571-019-0184-6; Silva DA, 2019, NATURE, V565, P186, DOI 10.1038/s41586-018-0830-7; Sockolosky JT, 2018, SCIENCE, V359, P1037, DOI 10.1126/science.aar3246; Spolski R, 2018, NAT REV IMMUNOL, V18, P648, DOI 10.1038/s41577-018-0046-y; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sukumar M, 2016, CELL METAB, V23, P63, DOI 10.1016/j.cmet.2015.11.002; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; van der Windt Gerritje J W, 2016, Curr Protoc Immunol, V113, DOI 10.1002/0471142735.im0316bs113; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Vodnala SK, 2019, SCIENCE, V363, P1417, DOI 10.1126/science.aau0135; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Ya Zhiya, 2015, Curr Protoc Immunol, V108, DOI 10.1002/0471142735.im2001s108; Yamamoto TN, 2019, J CLIN INVEST, V129, P1551, DOI 10.1172/JCI121491; Yang Q, 2015, NAT IMMUNOL, V16, P1044, DOI 10.1038/ni.3248; Zhu EF, 2015, CANCER CELL, V27, P489, DOI 10.1016/j.ccell.2015.03.004	56	35	35	11	116	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2021	597	7877					544	+		10.1038/s41586-021-03861-0	http://dx.doi.org/10.1038/s41586-021-03861-0		SEP 2021	25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UW6NQ	34526724	Green Accepted			2022-12-28	WOS:000696175300005
J	Gerada, C				Gerada, Clare			Clare Gerada: From clap to slap-general practice in crisis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gerada, Clare] Hurley Grp, London, England		Gerada, C (corresponding author), Hurley Grp, London, England.	clare.gerada@nhs.net						Gerada C, 2021, BRIT J GEN PRACT, V71, P292, DOI 10.3399/bjgp21X716153; Park S, 2012, BRIT J GEN PRACT, V62, P596, DOI 10.3399/bjgp12X658377; Pugh R, INEWS 0826, V2021; Royal College of General Practitioners, 2013, 2022 GP COMP EV	4	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2021	374								n2224	10.1136/bmj.n2224	http://dx.doi.org/10.1136/bmj.n2224			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WP7CH	34521647	Bronze			2022-12-28	WOS:000713284400010
J	Mahase, E				Mahase, Elisabeth			Covid-19: Bureaucracy and targets are distracting from patient care and should be suspended, say doctors	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mahase E, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2204	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 13	2021	374								n2245	10.1136/bmj.n2245	http://dx.doi.org/10.1136/bmj.n2245			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UR8KQ	34518238	Bronze			2022-12-28	WOS:000696991500013
J	Gurnari, C; Colak, C; Zawit, M; Maciejewski, JP				Gurnari, Carmelo; Colak, Ceylan; Zawit, Misam; Maciejewski, Jaroslaw P.			Chronic Budd-Chiari syndrome in paroxysmal nocturnal haemoglobinuria	LANCET			English	Editorial Material									[Gurnari, Carmelo; Zawit, Misam; Maciejewski, Jaroslaw P.] Cleveland Clin, Translat Haematol & Oncol Res Dept, Taussig Canc Ctr, Cleveland, OH 44195 USA; [Colak, Ceylan] Cleveland Clin, Imaging Inst, Cleveland, OH 44106 USA; [Gurnari, Carmelo] Univ Roma Tor Vergata, Dept Biomed & Prevent Mol Med & Appl Biotechnol, Rome, Italy	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Rome Tor Vergata	Maciejewski, JP (corresponding author), Cleveland Clin, Translat Haematol & Oncol Res Dept, Taussig Canc Ctr, Cleveland, OH 44195 USA.	maciejj@ccf.org	Gurnari, Carmelo/AAH-3671-2021	Gurnari, Carmelo/0000-0001-6829-5544	American-Italian Cancer Foundation Post-Doctoral Research Fellowship; National Institutes of Health; National Heart, Lung, and Blood Institute	American-Italian Cancer Foundation Post-Doctoral Research Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by an American-Italian Cancer Foundation Post-Doctoral Research Fellowship awarded to CG and by the National Institutes of Health, and National Heart, Lung, and Blood Institute in a grant awarded to JPM.		0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 11	2021	398	10304					E14	E14						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UP1FQ	34509232				2022-12-28	WOS:000695130500028
J	Krause, PR; Fleming, TR; Peto, R; Longini, IM; Figueroa, JP; Sterne, JAC; Cravioto, A; Rees, H; Higgins, JPT; Boutron, I; Pan, HC; Gruber, MF; Arora, N; Kazi, F; Gaspar, R; Swaminathan, S; Ryan, MJ; Henao-Restrepo, AM				Krause, Philip R.; Fleming, Thomas R.; Peto, Richard; Longini, Ira M.; Figueroa, J. Peter; Sterne, Jonathan A. C.; Cravioto, Alejandro; Rees, Helen; Higgins, Julian P. T.; Boutron, Isabelle; Pan, Hongchao; Gruber, Marion F.; Arora, Narendra; Kazi, Fatema; Gaspar, Rogerio; Swaminathan, Soumya; Ryan, Michael J.; Henao-Restrepo, Ana-Maria			Considerations in boosting COVID-19 vaccine immune responses	LANCET			English	Editorial Material									[Krause, Philip R.; Gruber, Marion F.] US FDA, Off Vaccines Res & Review, Silver Spring, MD 20993 USA; [Fleming, Thomas R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Peto, Richard] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Longini, Ira M.] Univ Florida, Dept Biostat, Gainesville, FL USA; [Figueroa, J. Peter] Univ West Indies, Mona, Jamaica; [Sterne, Jonathan A. C.; Higgins, Julian P. T.] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, Bristol, Avon, England; [Cravioto, Alejandro] Univ Nacl Autonoma Mexico, Mexico City, DF, Mexico; [Rees, Helen] Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Boutron, Isabelle] Univ Paris, Ctr Res Epidemiol & Stat CRESS, Paris, France; [Pan, Hongchao] Univ Oxford, MRC Populat Hlth Res Unit, Oxford, England; [Arora, Narendra] INCLEN Trust Int, New Delhi, India; [Kazi, Fatema; Gaspar, Rogerio; Swaminathan, Soumya; Ryan, Michael J.; Henao-Restrepo, Ana-Maria] World Hlth Org, CH-1211 Geneva, Switzerland	US Food & Drug Administration (FDA); University of Washington; University of Washington Seattle; University of Oxford; State University System of Florida; University of Florida; University West Indies Mona Jamaica; University of Bristol; Universidad Nacional Autonoma de Mexico; UDICE-French Research Universities; Universite Paris Cite; University of Oxford; World Health Organization	Krause, PR (corresponding author), US FDA, Off Vaccines Res & Review, Silver Spring, MD 20993 USA.; Henao-Restrepo, AM (corresponding author), World Hlth Org, CH-1211 Geneva, Switzerland.	philip.krause@fda.hhs.gov; henaorestropa@who.int	Higgins, Julian PT/H-4008-2011	Higgins, Julian PT/0000-0002-8323-2514; Sterne, Jonathan/0000-0001-8496-6053	National Institute for Health Research (NIHR) Bristol Biomedical Research Centre and NIHR [NF-SI-0617-10145]; NIHR Bristol Biomedical Research Centre; NIHR; UK Research and Innovation; National Institute of Allergy and Infectious Diseases (NIAID) [R01 AI 139761, R56 AI 148284]; NIAID [R37 AI 29168]; Agence Nationale de la Recherche (ANR); WHO; French Ministry of Health	National Institute for Health Research (NIHR) Bristol Biomedical Research Centre and NIHR(National Institute for Health Research (NIHR)); NIHR Bristol Biomedical Research Centre; NIHR(National Institute for Health Research (NIHR)); UK Research and Innovation(UK Research & Innovation (UKRI)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); WHO(World Health Organization); French Ministry of Health	JPTH is a senior investigator (NF-SI-0617-10145) supported by the National Institute for Health Research (NIHR) Bristol Biomedical Research Centre and NIHR Applied Research Collaboration West. JACS is supported by the NIHR Bristol Biomedical Research Centre and grant funding from the NIHR and UK Research and Innovation. IML is supported by the National Institute of Allergy and Infectious Diseases (NIAID) grants R01 AI 139761 and R56 AI 148284. TRF is supported by NIAID R37 AI 29168. The COVID-NMA initiative is supported by the Agence Nationale de la Recherche (ANR), WHO, and the French Ministry of Health. The opinions expressed are those of the authors, and do not necessarily represent the opinions of their respective organisations. The authors thank the following members of the COVID-NMA initiative (http://www.covid-nma.com) for their support with the identification of eligible studies and the extraction of the data: Carolina Grana (Universite de Paris, Cochrane France), Hillary Bonnet (Universite de Paris, Cochrane France), Mauricia Davidson (Universite de Paris, Cochrane France), Gemma Villanueva (Cochrane response), Hanna Bergman (Cochrane response), Brian Buckley (Cochrane response), Elise Cogo (Cochrane response), Katrin Probyn (Cochrane response), Yanina Sguassero (Cochrane response), Jennifer Petkovic (Cochrane response).	Bar-On YM, 2021, BNT162B2 VACCINE BOO; Bruxvoort K, 2021, REAL WORLD EFFECTIVE; Callaway E, 2021, NATURE, V596, P178, DOI 10.1038/d41586-021-02158-6; De Serres G, 2013, Euro Surveill, V18; Gargano JW, 2021, MMWR-MORBID MORTAL W, V70, P977, DOI 10.15585/mmwr.mm7027e2; Ghebreyesus T.D., 2021, WHO DIRECTOR GEN OPE; Griffin JB, 2021, MMWR-MORBID MORTAL W, V70, P1170, DOI 10.15585/mmwr.mm7034e5; Griffith GJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19478-2; Havers FP, COVID 19 ASS HOSPITA, V2021, DOI [10.1101/2021.08.27.21262356, DOI 10.1101/2021.08.27.21262356]; Israeli Ministry of Health, 2021, 2 DOS VACC DAT; Kamar N, 2021, NEW ENGL J MED, V385, P661, DOI 10.1056/NEJMc2108861; Krause PR, 2021, NEW ENGL J MED, V385, P179, DOI 10.1056/NEJMsr2105280; Pan H, IMMUNOGENICITY SAFET, DOI [10.1101/2021.07.23.21261026v1, DOI 10.1101/2021.07.23.21261026V1]; Puranik A, COMP 2 HIGHLY EFFECT, V2021, DOI [10.1101/2021, DOI 10.1101/2021]; Thompson MG, 2021, NEW ENGL J MED, V385, P1355, DOI 10.1056/NEJMoa2110362; Turner JS, 2021, NATURE, V596, P109, DOI 10.1038/s41586-021-03738-2; WHO, 2021, STAT WHO GLOB ADV CO; Wu Kai, PRELIMINARY ANAL SAF, V2021, DOI [10.1101/2021.05.05.21256716v1, DOI 10.1101/2021.05.05.21256716V1]	18	146	146	7	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT	2021	398	10308					1377	1380		10.1016/S0140-6736(21)02046-8	http://dx.doi.org/10.1016/S0140-6736(21)02046-8		OCT 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	WE2YJ	34534516	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000705490300023
J	Bose, R; Ma, CX				Bose, Ron; Ma, Cynthia X.			Breast Cancer, HER2 Mutations, and Overcoming Drug Resistance	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							KINASE INHIBITION; EFFICACY	HER2-Mutated Breast Cancer and Resistance to TKI A recent study suggests that HER2-mutated breast cancer may develop resistance to drugs that inhibit the tyrosine kinase domain of HER2 through developing mutations in HER3, which enhance the dimerization between HER2 and HER3. The HER3 mutations augment signaling. This study supports a specific approach to overcoming mutant-HER3-mediated resistance.	[Bose, Ron] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63110 USA	Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	Bose, R (corresponding author), Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA.							Bose R, 2013, CANCER DISCOV, V3, P224, DOI 10.1158/2159-8290.CD-12-0349; Hanker AB, 2021, CANCER CELL, V39, P1099, DOI 10.1016/j.ccell.2021.06.001; Hyman DM, 2018, NATURE, V554, P189, DOI 10.1038/nature25475; Ma CX, 2017, CLIN CANCER RES, V23, P5687, DOI 10.1158/1078-0432.CCR-17-0900; Smyth LM, 2020, CANCER DISCOV, V10, P198, DOI 10.1158/2159-8290.CD-19-0966; Turner NC, 2020, LANCET ONCOL, V21, P1296, DOI [10.11016/S1470-2045(20)30444-7, 10.1016/S1470-2045(20)30444-7]	6	4	4	1	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2021	385	13					1241	1243		10.1056/NEJMcibr2110552	http://dx.doi.org/10.1056/NEJMcibr2110552			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UT0EM	34551235				2022-12-28	WOS:000697798600020
J	Jones, H				Jones, Helen			BMJ Awards 2021: Cancer care team of the year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2021	374								n2278	10.1136/bmj.n2278	http://dx.doi.org/10.1136/bmj.n2278			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ1JE	34556472				2022-12-28	WOS:000701967300010
J	Duan, J; Xu, PY; Cheng, X; Mao, CY; Croll, T; He, XH; Shi, JJ; Luan, XD; Yin, WC; You, EL; Liu, QF; Zhang, SY; Jiang, HL; Zhang, Y; Jiang, Y; Xu, HE				Duan, Jia; Xu, Peiyu; Cheng, Xi; Mao, Chunyou; Croll, Tristan; He, Xinheng; Shi, Jingjing; Luan, Xiaodong; Yin, Wanchao; You, Erli; Liu, Qiufeng; Zhang, Shuyang; Jiang, Hualiang; Zhang, Yan; Jiang, Yi; Xu, H. Eric			Structures of full-length glycoprotein hormone receptor signalling complexes	NATURE			English	Article							FOLLICLE-STIMULATING-HORMONE; MOLECULAR-DYNAMICS SIMULATIONS; AGONIST; GONADOTROPIN; ACTIVATION; ECTODOMAIN; RESOLUTION; BIOLOGY	Luteinizing hormone and chorionic gonadotropin are glycoprotein hormones that are related to follicle-stimulating hormone and thyroid-stimulating hormone(1,2). Luteinizing hormone and chorionic gonadotropin are essential to human reproduction and are important therapeutic drugs(3-6). They activate the same G-protein-coupled receptor, luteinizing hormone-choriogonadotropin receptor (LHCGR), by binding to the large extracellular domain(3). Here we report four cryo-electron microscopy structures of LHCGR: two structures of the wild-type receptor in the inactive and active states; and two structures of the constitutively active mutated receptor. The active structures are bound to chorionic gonadotropin and the stimulatory G protein (G(s)), and one of the structures also contains Org43553, an allosteric agonist(7). The structures reveal a distinct 'push-and-pull' mechanism of receptor activation, in which the extracellular domain is pushed by the bound hormone and pulled by the extended hinge loop next to the transmembrane domain. A highly conserved 10-residue fragment (P10) from the hinge C-terminal loop at the interface between the extracellular domain and the transmembrane domain functions as a tethered agonist to induce conformational changes in the transmembrane domain and G-protein coupling. Org43553 binds to a pocket of the transmembrane domain and interacts directly with P10, which further stabilizes the active conformation. Together, these structures provide a common model for understanding the signalling of glycoprotein hormone receptors and a basis for drug discovery for endocrine diseases.	[Duan, Jia; Xu, Peiyu; Cheng, Xi; He, Xinheng; Shi, Jingjing; Yin, Wanchao; You, Erli; Liu, Qiufeng; Jiang, Hualiang; Jiang, Yi; Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai, Peoples R China; [Duan, Jia; Xu, Peiyu; Cheng, Xi; He, Xinheng; Shi, Jingjing; Yin, Wanchao; You, Erli; Liu, Qiufeng; Jiang, Hualiang; Jiang, Yi; Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai, Peoples R China; [Duan, Jia; Xu, Peiyu; He, Xinheng; Jiang, Hualiang; Jiang, Yi; Xu, H. Eric] Univ Chinese Acad Sci, Beijing, Peoples R China; [Mao, Chunyou; Zhang, Yan] Zhejiang Univ, Dept Biophys, Sch Med, Sir Run Run Shaw Hosp, Hangzhou, Peoples R China; [Mao, Chunyou; Zhang, Yan] Zhejiang Univ, Dept Pathol, Sch Med, Sir Run Run Shaw Hosp, Hangzhou, Peoples R China; [Mao, Chunyou; Zhang, Yan] Zhejiang Univ, Liangzhu Lab, Med Ctr, Hangzhou, Peoples R China; [Mao, Chunyou; Zhang, Yan] Zhejiang Univ, MOE Frontier Sci Ctr Brain Res & Brain Machine In, Sch Med, Hangzhou, Peoples R China; [Mao, Chunyou; Zhang, Yan] Zheijang Prov Key Lab Immun & Inflammatory Dis, Hangzhou, Peoples R China; [Croll, Tristan] Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge, England; [Luan, Xiaodong; Zhang, Shuyang] Tsinghua Univ, Sch Med, Beijing, Peoples R China; [Luan, Xiaodong; Zhang, Shuyang] Peking Union Med Coll & Chinese Acad Med Sci, Dept Cardiol, Peking Union Med Coll Hosp, Beijing, Peoples R China; [Luan, Xiaodong; Zhang, Shuyang] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Beijing, Peoples R China; [Jiang, Hualiang; Xu, H. Eric] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Mao, Chunyou] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Gen Surg, Sch Med, Hangzhou, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; University of Cambridge; Tsinghua University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Tsinghua University; ShanghaiTech University; Zhejiang University	Jiang, Y; Xu, HE (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai, Peoples R China.; Jiang, Y; Xu, HE (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai, Peoples R China.; Jiang, Y; Xu, HE (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Zhang, Y (corresponding author), Zhejiang Univ, Dept Biophys, Sch Med, Sir Run Run Shaw Hosp, Hangzhou, Peoples R China.; Zhang, Y (corresponding author), Zhejiang Univ, Dept Pathol, Sch Med, Sir Run Run Shaw Hosp, Hangzhou, Peoples R China.; Zhang, Y (corresponding author), Zhejiang Univ, Liangzhu Lab, Med Ctr, Hangzhou, Peoples R China.; Zhang, Y (corresponding author), Zhejiang Univ, MOE Frontier Sci Ctr Brain Res & Brain Machine In, Sch Med, Hangzhou, Peoples R China.; Zhang, Y (corresponding author), Zheijang Prov Key Lab Immun & Inflammatory Dis, Hangzhou, Peoples R China.; Xu, HE (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China.	zhang_yan@zju.edu.cn; yijiang@simm.ac.cn; eric.xu@simm.ac.cn	段, 佳/GZG-2088-2022; Xu, H. Eric/ABD-7487-2021; Zhang, Yan/V-8007-2019	Zhang, Yan/0000-0003-2189-0244; Luan, Xiaodong/0000-0002-1279-5432; Xu, Peiyu/0000-0003-3590-4037; Croll, Tristan/0000-0002-3514-8377; Cheng, Xi/0000-0003-3735-645X; yin, wanchao/0000-0002-6889-4907; Xu, H. Eric/0000-0002-6829-8144; He, Xinheng/0000-0001-7813-5480	Ministry of Science and Technology (China) [2018YFA0507002, 2019YFA0508800]; Shanghai Municipal Science and Technology Major Project [2019SHZDZX02]; CAS Strategic Priority Research Program [XDB08020303]; National Natural Science Foundation of China [31770796, 81922071]; National Science and Technology Major Project 'Key New Drug Creation and Manufacturing Program' [2018ZX09711002]; Wellcome Trust [209407/Z/17/Z]; National Key R&D Program of China [2020YFC0861000]; CAMS Innovation Fund for Medical Sciences [2020-I2M-CoV19-001]; Tsinghua University-Peking University Center for Life Sciences [045-160321001]; Science and Technology Commission of Shanghai Municipal [20431900100]; Jack Ma Foundation [2020-CMKYGG-05]; Shanghai Sailing Program [19YF1457600]; Zhejiang Province Science Fund for Distinguished Young Scholars [LR19H310001]; MOE Frontier Science Center for Brain Science & Brain-Machine Integration, Zhejiang University; Youth Innovation Promotion Association of Chinese Academy of Science [2018319]	Ministry of Science and Technology (China)(Ministry of Science and Technology, China); Shanghai Municipal Science and Technology Major Project; CAS Strategic Priority Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project 'Key New Drug Creation and Manufacturing Program'; Wellcome Trust(Wellcome Trust); National Key R&D Program of China; CAMS Innovation Fund for Medical Sciences; Tsinghua University-Peking University Center for Life Sciences; Science and Technology Commission of Shanghai Municipal(Science & Technology Commission of Shanghai Municipality (STCSM)); Jack Ma Foundation; Shanghai Sailing Program; Zhejiang Province Science Fund for Distinguished Young Scholars; MOE Frontier Science Center for Brain Science & Brain-Machine Integration, Zhejiang University; Youth Innovation Promotion Association of Chinese Academy of Science	The cryo-EM data were collected at the Cryo-Electron Microscopy Research Center, Shanghai Institute of Materia Medica (SIMM) and Shuimu BioSciences. We thank the staff at the SIMM Cryo-Electron Microscopy Research Center and Shuimu BioSciences for their technical support. This work was partially supported by Ministry of Science and Technology (China) grants (2018YFA0507002 to H.E.X. and 2019YFA0508800 to Y.Z.); the Shanghai Municipal Science and Technology Major Project (2019SHZDZX02 to H.E.X.); the CAS Strategic Priority Research Program (XDB08020303 to H.E.X.); the National Natural Science Foundation of China (31770796 to Y.J. and 81922071 to Y.Z.); the National Science and Technology Major Project `Key New Drug Creation and Manufacturing Program' (2018ZX09711002 to Y.J. and H.J.); Wellcome Trust grant 209407/Z/17/Z; the National Key R&D Program of China (2020YFC0861000 to S.Z.); the CAMS Innovation Fund for Medical Sciences (2020-I2M-CoV19-001 to S.Z.); the Tsinghua University-Peking University Center for Life Sciences (045-160321001 to S.Z.); the Science and Technology Commission of Shanghai Municipal (20431900100 to H.J.); the Jack Ma Foundation (2020-CMKYGG-05 to H.J.); Shanghai Sailing Program (19YF1457600 to Q.L.); the Zhejiang Province Science Fund for Distinguished Young Scholars (LR19H310001 to Y.Z.); the MOE Frontier Science Center for Brain Science & Brain-Machine Integration, Zhejiang University (to Y.Z.); and The Youth Innovation Promotion Association of Chinese Academy of Science (2018319 to X.C).	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AOKI KM, 1992, PHYS REV A, V46, P6541, DOI 10.1103/PhysRevA.46.6541; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bruser A, 2016, J BIOL CHEM, V291, P508, DOI 10.1074/jbc.M115.701102; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Carpenter B, 2016, NATURE, V536, P104, DOI 10.1038/nature18966; Casarini L, 2018, ENDOCR REV, V39, P549, DOI 10.1210/er.2018-00065; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; Croll TI, 2018, ACTA CRYSTALLOGR D, V74, P519, DOI 10.1107/S2059798318002425; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan QR, 2005, ENDOCRINE, V26, P179, DOI 10.1385/ENDO:26:3:179; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Fornace ME, 2015, J CHEM THEORY COMPUT, V11, P568, DOI 10.1021/ct5011032; Guvench O, 2011, J CHEM THEORY COMPUT, V7, P3162, DOI 10.1021/ct200328p; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Jiang XL, 2014, J BIOL CHEM, V289, P14273, DOI 10.1074/jbc.M114.549592; Jiang XL, 2014, MOL CELL ENDOCRINOL, V382, P424, DOI 10.1016/j.mce.2013.08.021; Jiang XL, 2012, P NATL ACAD SCI USA, V109, P12491, DOI 10.1073/pnas.1206643109; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kang YY, 2018, NATURE, V558, P553, DOI 10.1038/s41586-018-0215-y; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Liang YL, 2018, ACS PHARMACOL TRANSL, V1, P12, DOI 10.1021/acsptsci.8b00017; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maeda S, 2019, SCIENCE, V364, P552, DOI 10.1126/science.aaw5188; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Nakabayashi K, 2000, J BIOL CHEM, V275, P30264, DOI 10.1074/jbc.M005568200; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; Pall S, 2015, LECT NOTES COMPUT SC, V8759, P3, DOI 10.1007/978-3-319-15976-8_1; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schulze A, 2020, FASEB J, V34, P11243, DOI 10.1096/fj.202000100R; Staus DP, 2016, NATURE, V535, P448, DOI 10.1038/nature18636; Themmen APN, 2000, ENDOCR REV, V21, P551, DOI 10.1210/er.21.5.551; Troppmann B, 2013, HUM REPROD UPDATE, V19, P583, DOI 10.1093/humupd/dmt023; van Koppen CJ, 2008, N-S ARCH PHARMACOL, V378, P503, DOI 10.1007/s00210-008-0318-3; Wang RYR, 2016, ELIFE, V5, DOI 10.7554/eLife.17219; Wortmann L, 2019, J MED CHEM, V62, P10321, DOI 10.1021/acs.jmedchem.9b01382; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	50	10	10	10	50	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 28	2021	598	7882					688	+		10.1038/s41586-021-03924-2	http://dx.doi.org/10.1038/s41586-021-03924-2		SEP 2021	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WO9BH	34552239				2022-12-28	WOS:000698366900010
J	Kise, Y; Kasuya, G; Okamoto, HH; Yamanouchi, D; Kobayashi, K; Kusakizako, T; Nishizawa, T; Nakajo, K; Nureki, O				Kise, Yoshiaki; Kasuya, Go; Okamoto, Hiroyuki H.; Yamanouchi, Daichi; Kobayashi, Kan; Kusakizako, Tsukasa; Nishizawa, Tomohiro; Nakajo, Koichi; Nureki, Osamu			Structural basis of gating modulation of Kv4 channel complexes	NATURE			English	Article							CLOSED-STATE INACTIVATION; TRANSIENT OUTWARD CURRENT; K+ CHANNEL; VOLTAGE SENSOR; 3-DIMENSIONAL STRUCTURE; POTASSIUM CHANNELS; BETA-SUBUNITS; PROTEIN DPPX; I-TO; STOICHIOMETRY	Modulation of voltage-gated potassium (Kv) channels by auxiliary subunits is central to the physiological function of channels in the brain and heart(1,2). Native Kv4 tetrameric channels form macromolecular ternary complexes with two auxiliary beta-subunits-intracellular Kv channel-interacting proteins (KChIPs) and transmembrane dipeptidyl peptidase-related proteins (DPPs)-to evoke rapidly activating and inactivating A-type currents, which prevent the backpropagation of action potentials(1-5). However, the modulatory mechanisms of Kv4 channel complexes remain largely unknown. Here we report cryo-electron microscopy structures of the Kv4.2-DPP6S-KChIP1 dodecamer complex, the Kv4.2-KChIP1 and Kv4.2-DPP6S octamer complexes, and Kv4.2 alone. The structure of the Kv4.2-KChIP1 complex reveals that the intracellular N terminus of Kv4.2 interacts with its C terminus that extends from the S6 gating helix of the neighbouring Kv4.2 subunit. KChIP1 captures both the N and the C terminus of Kv4.2. In consequence, KChIP1 would prevent N-type inactivation and stabilize the S6 conformation to modulate gating of the S6 helices within the tetramer. By contrast, unlike the reported auxiliary subunits of voltage-gated channel complexes, DPP6S interacts with the S1 and S2 helices of the Kv4.2 voltage-sensing domain, which suggests that DPP6S stabilizes the conformation of the S1-S2 helices. DPP6S may therefore accelerate the voltage-dependent movement of the S4 helices. KChIP1 and DPP6S do not directly interact with each other in the Kv4.2-KChIP1-DPP6S ternary complex. Thus, our data suggest that two distinct modes of modulation contribute in an additive manner to evoke A-type currents from the native Kv4 macromolecular complex.	[Kise, Yoshiaki; Okamoto, Hiroyuki H.; Yamanouchi, Daichi; Kobayashi, Kan; Kusakizako, Tsukasa; Nishizawa, Tomohiro; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo, Japan; [Kasuya, Go; Nakajo, Koichi] Jichi Med Univ, Div Integrat Physiol, Dept Physiol, Shimotsuke, Tochigi, Japan; [Kobayashi, Kan] Peptidream, Kawasaki, Kanagawa, Japan; [Nishizawa, Tomohiro] Yokohama City Univ, Grad Sch Med Life Sci, Yokohama, Kanagawa, Japan	University of Tokyo; Jichi Medical University; Yokohama City University	Kise, Y; Nureki, O (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo, Japan.; Kasuya, G (corresponding author), Jichi Med Univ, Div Integrat Physiol, Dept Physiol, Shimotsuke, Tochigi, Japan.	yoshiaki.kise@bs.s.u-toyko.ac.jp; gokasuya@jichi.ac.jp; nureki@bs.s.u-tokyo.ac.jp	Nakajo, Koichi/J-2601-2019; Okamoto, Hiroaki/H-4371-2011	Nakajo, Koichi/0000-0003-0766-7281; Okamoto, Hiroaki/0000-0003-0827-0964; Kise, Yoshiaki/0000-0002-1840-5028; Nureki, Osamu/0000-0003-1813-7008; Kasuya, Go/0000-0003-1756-5764	MEXT [16H06294]; JST Core Research for Evolutional Science and Technology (CREST) [20344981]; KAKENHI [18K06207, 20H03200]; AMED [JP19am01011115, 1110]; Uchang Cho Institute of Science	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST Core Research for Evolutional Science and Technology (CREST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED; Uchang Cho Institute of Science	We thank the members of the O.N. laboratory and the staff scientists at the University of Tokyo's cryo-EM facility, especially Y. Sakamaki, H. Yanagisawa, A. Tsutsumi, M. Kikkawa and R. Danev. This work was supported by a MEXT Grant-in-Aid for Specially Promoted Research (grant number 16H06294) and JST Core Research for Evolutional Science and Technology (CREST) (grant number 20344981) to O.N.; by KAKENHI (grant numbers18K06207 to Y.K. and 20H03200 to G.K.); and by the Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research) from AMED under grant number JP19am01011115 (support number 1110). Y.K. was also supported by Uchang Cho Institute of Science.	Afonine PV, 2013, ACTA CRYSTALLOGR D, V69, P625, DOI 10.1107/S0907444913000462; Amarillo Y, 2008, J PHYSIOL-LONDON, V586, P2093, DOI 10.1113/jphysiol.2007.150540; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Bahring R, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00100; Bahring R, 2011, J PHYSIOL-LONDON, V589, P461, DOI 10.1113/jphysiol.2010.191965; Barghaan J, 2008, BIOPHYS J, V94, P1276, DOI 10.1529/biophysj.107.111344; Barghaan J, 2009, J GEN PHYSIOL, V133, P205, DOI 10.1085/jgp.200810073; Beck EJ, 2002, J PHYSIOL-LONDON, V538, P691, DOI 10.1113/jphysiol.2001.013127; Blunck R, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00166; Callsen B, 2005, J PHYSIOL-LONDON, V568, P397, DOI 10.1113/jphysiol.2005.094359; Catterall WA, 2017, NAT CHEM BIOL, V13, P455, DOI [10.1038/NCHEMBIO.2353, 10.1038/nchembio.2353]; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Covarrubias M, 2008, NEUROCHEM RES, V33, P1558, DOI 10.1007/s11064-008-9650-8; Dixon JE, 1996, CIRC RES, V79, P659, DOI 10.1161/01.RES.79.4.659; Dougherty K, 2008, J GEN PHYSIOL, V131, P257, DOI 10.1085/jgp.200709938; Dougherty K, 2006, J GEN PHYSIOL, V128, P745, DOI 10.1085/jgp.200609668; Dougherty K, 2009, CHANNELS, V3, P122, DOI 10.4161/chan.3.2.8333; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fineberg JD, 2016, SCI REP-UK, V6, DOI 10.1038/srep31131; Fineberg JD, 2012, J GEN PHYSIOL, V140, P513, DOI 10.1085/jgp.201210869; Gebauer M, 2004, BIOPHYS J, V86, P210, DOI 10.1016/S0006-3495(04)74097-7; Jerng HH, 2004, MOL CELL NEUROSCI, V27, P343, DOI 10.1016/j.mcn.2004.06.011; Jerng HH, 2004, BIOPHYS J, V87, P2380, DOI 10.1529/biophysj.104.042358; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kaulin YA, 2008, BIOPHYS J, V94, P1241, DOI 10.1529/biophysj.107.117796; Kaulin YA, 2009, J NEUROSCI, V29, P3242, DOI 10.1523/JNEUROSCI.4767-08.2009; Kim LA, 2004, NEURON, V41, P513, DOI 10.1016/S0896-6273(04)00050-9; Kitazawa M, 2015, J BIOL CHEM, V290, P22724, DOI 10.1074/jbc.M115.646794; Kitazawa M, 2014, J BIOL CHEM, V289, P17597, DOI 10.1074/jbc.M114.563452; Lee CH, 2019, CELL, V179, P1582, DOI 10.1016/j.cell.2019.11.006; Li Y, 2006, NEUROSCIENTIST, V12, P199, DOI 10.1177/1073858406287717; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McCoy JG, 2012, BBA-BIOMEMBRANES, V1818, P272, DOI 10.1016/j.bbamem.2011.09.007; Nadal MS, 2003, NEURON, V37, P449, DOI 10.1016/S0896-6273(02)01185-6; O'Malley HA, 2015, ANNU REV PHYSIOL, V77, P481, DOI 10.1146/annurev-physiol-021014-071846; Pan XJ, 2018, SCIENCE, V362, DOI 10.1126/science.aau2486; Pioletti M, 2006, NAT STRUCT MOL BIOL, V13, P987, DOI 10.1038/nsmb1164; Radicke S, 2006, CARDIOVASC RES, V71, P695, DOI 10.1016/j.cardiores.2006.06.017; Ren XM, 2005, MOL CELL NEUROSCI, V29, P320, DOI 10.1016/j.mcn.2005.02.003; Rivera JF, 2003, NAT NEUROSCI, V6, P243, DOI 10.1038/nn1020; Shen HZ, 2019, SCIENCE, V363, P1303, DOI 10.1126/science.aaw2493; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Strop P, 2004, J MOL BIOL, V343, P1055, DOI 10.1016/j.jmb.2004.09.003; Sun J, 2020, CELL, V180, P340, DOI 10.1016/j.cell.2019.12.003; Tao X, 2019, ELIFE, V8, DOI 10.7554/eLife.51409; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Vardanyan V, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00145; Wang GY, 2006, J GEN PHYSIOL, V127, P391, DOI 10.1085/jgp.200509442; Wang GY, 2005, J GEN PHYSIOL, V126, P55, DOI 10.1085/jgp.200509288; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; WETTWER E, 1994, CIRC RES, V75, P473, DOI 10.1161/01.RES.75.3.473; Wollberg J, 2016, BIOPHYS J, V110, P157, DOI 10.1016/j.bpj.2015.10.046; Zemel BM, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00253	57	13	13	0	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 4	2021	599	7883					158	+		10.1038/s41586-021-03935-z	http://dx.doi.org/10.1038/s41586-021-03935-z		SEP 2021	30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WR3QA	34552243	Green Published, hybrid			2022-12-28	WOS:000698366900009
J	Johnstone, J; Meade, M; Lauzier, F; Marshall, J; Duan, E; Dionne, J; Arabi, YM; Heels-Ansdell, D; Thabane, L; Lamarche, D; Surette, M; Zytaruk, N; Mehta, S; Dodek, P; McIntyre, L; English, S; Rochwerg, B; Karachi, T; Henderson, W; Wood, G; Ovakim, D; Herridge, M; Granton, J; Wilcox, ME; Goffi, A; Stelfox, HT; Niven, D; Muscedere, J; Lamontagne, F; D'Aragon, F; St-Arnaud, C; Ball, I; Nagpal, D; Girard, M; Aslanian, P; Charbonney, E; Williamson, D; Sligl, W; Friedrich, J; Adhikari, NK; Marquis, F; Archambault, P; Khwaja, K; Kristof, A; Kutsogiannis, J; Zarychanski, R; Paunovic, B; Reeve, B; Lellouche, F; Hosek, P; Tsang, J; Binnie, A; Trop, S; Loubani, O; Hall, R; Cirone, R; Reynolds, S; Lysecki, P; Golan, E; Cartin-Ceba, R; Taylor, R; Cook, D				Johnstone, Jennie; Meade, Maureen; Lauzier, Francois; Marshall, John; Duan, Erick; Dionne, Joanna; Arabi, Yaseen M.; Heels-Ansdell, Diane; Thabane, Lehana; Lamarche, Daphnee; Surette, Michael; Zytaruk, Nicole; Mehta, Sangeeta; Dodek, Peter; McIntyre, Lauralyn; English, Shane; Rochwerg, Bram; Karachi, Tim; Henderson, William; Wood, Gordon; Ovakim, Daniel; Herridge, Margaret; Granton, John; Wilcox, M. Elizabeth; Goffi, Alberto; Stelfox, Henry T.; Niven, Daniel; Muscedere, John; Lamontagne, Francois; D'Aragon, Frederick; St-Arnaud, Charles; Ball, Ian; Nagpal, Dave; Girard, Martin; Aslanian, Pierre; Charbonney, Emmanuel; Williamson, David; Sligl, Wendy; Friedrich, Jan; Adhikari, Neill K.; Marquis, Francois; Archambault, Patrick; Khwaja, Kosar; Kristof, Arnold; Kutsogiannis, James; Zarychanski, Ryan; Paunovic, Bojan; Reeve, Brenda; Lellouche, Francois; Hosek, Paul; Tsang, Jennifer; Binnie, Alexandra; Trop, Sebastien; Loubani, Osama; Hall, Richard; Cirone, Robert; Reynolds, Steve; Lysecki, Paul; Golan, Eyal; Cartin-Ceba, Rodrigo; Taylor, Robert; Cook, Deborah		Prevention Severe Pneumonia Endotr; Canadian Critical Care Trials Grp	Effect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLOSTRIDIUM-DIFFICILE INFECTION; ANTIBIOTIC-ASSOCIATED DIARRHEA; PREVENTION; MICROBIOME; GUIDELINES; INPATIENTS; DYSBIOSIS; SOCIETY; SEPSIS; ADULTS	Question Does the probiotic Lactobacillus rhamnosus GG prevent ventilator-associated pneumonia (VAP) among critically ill patients? Findings In this randomized trial involving 2650 patients, no significant difference in VAP incidence was found among patients treated with probiotics compared with placebo (21.9% vs 21.3%, respectively; hazard ratio 1.03; 95% CI 0.87-1.22). Meaning These findings do not support the use of Lactobacillus rhamnosus GG for prevention of ventilator-associated pneumonia in critically ill patients requiring mechanical ventilation. Importance Growing interest in microbial dysbiosis during critical illness has raised questions about the therapeutic potential of microbiome modification with probiotics. Prior randomized trials in this population suggest that probiotics reduce infection, particularly ventilator-associated pneumonia (VAP), although probiotic-associated infections have also been reported. Objective To evaluate the effect of Lactobacillus rhamnosus GG on preventing VAP, additional infections, and other clinically important outcomes in the intensive care unit (ICU). Design, Setting, and Participants Randomized placebo-controlled trial in 44 ICUs in Canada, the United States, and Saudi Arabia enrolling adults predicted to require mechanical ventilation for at least 72 hours. A total of 2653 patients were enrolled from October 2013 to March 2019 (final follow-up, October 2020). Interventions Enteral L rhamnosus GG (1 x 10(10) colony-forming units) (n = 1321) or placebo (n = 1332) twice daily in the ICU. Main Outcomes and Measures The primary outcome was VAP determined by duplicate blinded central adjudication. Secondary outcomes were other ICU-acquired infections including Clostridioides difficile infection, diarrhea, antimicrobial use, ICU and hospital length of stay, and mortality. Results Among 2653 randomized patients (mean age, 59.8 years [SD], 16.5 years), 2650 (99.9%) completed the trial (mean age, 59.8 years [SD], 16.5 years; 1063 women [40.1%.] with a mean Acute Physiology and Chronic Health Evaluation II score of 22.0 (SD, 7.8) and received the study product for a median of 9 days (IQR, 5-15 days). VAP developed among 289 of 1318 patients (21.9%) receiving probiotics vs 284 of 1332 controls (21.3%; hazard ratio [HR], 1.03 (95% CI, 0.87-1.22; P = .73, absolute difference, 0.6%, 95% CI, -2.5% to 3.7%). None of the 20 prespecified secondary outcomes, including other ICU-acquired infections, diarrhea, antimicrobial use, mortality, or length of stay showed a significant difference. Fifteen patients (1.1%) receiving probiotics vs 1 (0.1%) in the control group experienced the adverse event of L rhamnosus in a sterile site or the sole or predominant organism in a nonsterile site (odds ratio, 14.02; 95% CI, 1.79-109.58; P < .001). Conclusions and Relevance Among critically ill patients requiring mechanical ventilation, administration of the probiotic L rhamnosus GG compared with placebo, resulted in no significant difference in the development of ventilator-associated pneumonia. These findings do not support the use of L rhamnosus GG in critically ill patients. This clinical trial assessed whether Lactobacillus rhamnosus GG compared with placebo reduces ventilator-associated pneumonia and other clinically important outcomes for a broad range of critically ill patients.	[Johnstone, Jennie; Marshall, John; Mehta, Sangeeta; Herridge, Margaret; Granton, John; Wilcox, M. Elizabeth; Goffi, Alberto; Friedrich, Jan; Adhikari, Neill K.; Binnie, Alexandra; Cirone, Robert; Golan, Eyal] Univ Toronto, Toronto, ON, Canada; [Meade, Maureen; Duan, Erick; Dionne, Joanna; Heels-Ansdell, Diane; Thabane, Lehana; Lamarche, Daphnee; Surette, Michael; Zytaruk, Nicole; Rochwerg, Bram; Karachi, Tim; Reeve, Brenda; Hosek, Paul; Tsang, Jennifer; Lysecki, Paul; Cook, Deborah] McMaster Univ, Hamilton, ON, Canada; [Lauzier, Francois; Archambault, Patrick; Lellouche, Francois] Univ Laval, Quebec City, PQ, Canada; [Arabi, Yaseen M.] King Saud Bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia; [Dodek, Peter; Henderson, William; Reynolds, Steve] Univ British Columbia, Vancouver, BC, Canada; [McIntyre, Lauralyn; English, Shane] Univ Ottawa, Ottawa, ON, Canada; [Wood, Gordon; Ovakim, Daniel] Univ Victoria, Victoria, BC, Canada; [Stelfox, Henry T.; Niven, Daniel] Univ Calgary, Calgary, AB, Canada; [Muscedere, John] Queens Univ, Kingston, ON, Canada; [Lamontagne, Francois; D'Aragon, Frederick; St-Arnaud, Charles] Univ Sherbrooke, Sherbrooke, PQ, Canada; [Ball, Ian; Nagpal, Dave] Western Univ, London, ON, Canada; [Girard, Martin; Aslanian, Pierre; Charbonney, Emmanuel; Williamson, David; Marquis, Francois; Trop, Sebastien] Univ Montreal, Montreal, PQ, Canada; [Sligl, Wendy; Kutsogiannis, James] Univ Alberta, Edmonton, AB, Canada; [Khwaja, Kosar; Kristof, Arnold] McGill Univ, Montreal, PQ, Canada; [Zarychanski, Ryan; Paunovic, Bojan] Univ Manitoba, Winnipeg, MB, Canada; [Loubani, Osama; Hall, Richard] Dalhousie Univ, Halifax, NS, Canada; [Cartin-Ceba, Rodrigo] Mayo Clin, Rochester, MN USA; [Taylor, Robert] Mercy Hosp, St Louis, MO USA	University of Toronto; McMaster University; Laval University; King Saud Bin Abdulaziz University for Health Sciences; University of British Columbia; University of Ottawa; University of Victoria; University of Calgary; Queens University - Canada; University of Sherbrooke; Western University (University of Western Ontario); Universite de Montreal; University of Alberta; McGill University; University of Manitoba; Dalhousie University; Mayo Clinic; Saint Johns Mercy Medical Center	Cook, D (corresponding author), St Josephs Healthcare, Methods Ctr, 50 Charlton Ave E,Room H327, Hamilton, ON L9H 4A6, Canada.	debcook@mcmaster.ca	Zarychanski, Ryan/AAB-6369-2022; Ball, Ian/GRR-4073-2022; Girard, Martin/AFU-8351-2022	Girard, Martin/0000-0003-2420-0106; Goffi, Alberto/0000-0002-9658-3903; Binnie, Alexandra/0000-0003-2969-8177; Herridge, Margaret/0000-0002-2903-1631; Lamontagne, Francois/0000-0002-0360-3427				Allen SJ, 2013, LANCET, V382, P1249, DOI 10.1016/S0140-6736(13)61218-0; Bafeta A, 2018, ANN INTERN MED, V169, P240, DOI 10.7326/M18-0343; Bassetti M, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2780-3; Batra P, 2020, J INTENSIVE CARE, V8, DOI 10.1186/s40560-020-00487-8; Branch-Elliman W, 2015, AM J RESP CRIT CARE, V192, P57, DOI 10.1164/rccm.201412-2316OC; Calandra T, 2005, CRIT CARE MED, V33, P1538, DOI 10.1097/01.CCM.0000168253.91200.83; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Cook DJ, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1495-x; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Goldenberg JZ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006095.pub3; Grossman RF, 2000, CHEST, V117, p177S, DOI 10.1378/chest.117.4_suppl_2.177S; HAYBITTLE JL, 1971, BRIT J RADIOL, V44, P793, DOI 10.1259/0007-1285-44-526-793; Hempel Susanne, 2011, Evid Rep Technol Assess (Full Rep), P1; Hempel S, 2012, JAMA-J AM MED ASSOC, V307, P1959, DOI 10.1001/jama.2012.3507; Heyland D, 2013, NEW ENGL J MED, V368, P1489, DOI 10.1056/NEJMoa1212722; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Johnston BC, 2018, INFECT CONT HOSP EP, V39, P771, DOI 10.1017/ice.2018.84; Johnstone J, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025228; Johnstone Jennie, 2015, Pilot Feasibility Stud, V1, P19; Kitsios GD, 2017, J CRIT CARE, V38, P84, DOI 10.1016/j.jcrc.2016.09.029; Lamarche D., 2014, CRIT CAR CAN FOR OCT; Lamarche D, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0950-5; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Li GW, 2017, INT J EPIDEMIOL, V46, P746, DOI 10.1093/ije/dyw320; Manzanares W, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1434-y; McClave SA, 2016, JPEN-PARENTER ENTER, V40, P159, DOI [10.1177/0148607115621863, 10.1097/CCM.0000000000001525]; McDonald D, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00199-16; Morrow LE, 2010, AM J RESP CRIT CARE, V182, P1058, DOI 10.1164/rccm.200912-1853OC; Panigrahi P, 2017, NATURE, V548, P407, DOI 10.1038/nature23480; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Petrof EO, 2012, CRIT CARE MED, V40, P3290, DOI 10.1097/CCM.0b013e318260cc33; PUGIN J, 1991, AM REV RESPIR DIS, V143, P1121, DOI 10.1164/ajrccm/143.5_Pt_1.1121; Relman DA, 2015, JAMA-J AM MED ASSOC, V314, P1127, DOI 10.1001/jama.2015.10700; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Salminen MK, 2004, CLIN INFECT DIS, V38, P62, DOI 10.1086/380455; Schandelmaier S, 2020, CAN MED ASSOC J, V192, pE901, DOI 10.1503/cmaj.200077; Thibault R, 2013, CRIT CARE, V17, DOI 10.1186/cc12832; Yelin I, 2019, NAT MED, V25, P1728, DOI 10.1038/s41591-019-0626-9; Yi SH, 2016, AM J INFECT CONTROL, V44, P548, DOI 10.1016/j.ajic.2015.12.001	39	33	36	5	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2021	326	11					1024	1033		10.1001/jama.2021.13355	http://dx.doi.org/10.1001/jama.2021.13355			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ4IM	34546300	Bronze, Green Published			2022-12-28	WOS:000702170600016
J	Kuehn, BM				Kuehn, Bridget M.			India Takes Aim at Eliminating Visceral Leishmaniasis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2021	326	11					999	999		10.1001/jama.2021.15467	http://dx.doi.org/10.1001/jama.2021.15467			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ4IM	34546293				2022-12-28	WOS:000702170600004
J	Limb, M				Limb, Matthew			Compulsory covid vaccination: Loss of care home workers puts beds and care at risk, warn unions and providers	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		NHS England, COV 19 VACC; Rimmer A, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2222	2	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 21	2021	374								n2318	10.1136/bmj.n2318	http://dx.doi.org/10.1136/bmj.n2318			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WA4GB	34548275	Bronze			2022-12-28	WOS:000702844100009
J	Schmidt, F; Weisblum, Y; Rutkowska, M; Poston, D; DaSilva, J; Zhang, FW; Bednarski, E; Cho, A; Schaefer-Babajew, DJ; Gaebler, C; Caskey, M; Nussenzweig, MC; Hatziioannou, T; Bieniasz, PD				Schmidt, Fabian; Weisblum, Yiska; Rutkowska, Magdalena; Poston, Daniel; DaSilva, Justin; Zhang, Fengwen; Bednarski, Eva; Cho, Alice; Schaefer-Babajew, Dennis J.; Gaebler, Christian; Caskey, Marina; Nussenzweig, Michel C.; Hatziioannou, Theodora; Bieniasz, Paul D.			High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape	NATURE			English	Article								The number and variability of the neutralizing epitopes targeted by polyclonal antibodies in individuals who are SARS-CoV-2 convalescent and vaccinated are key determinants of neutralization breadth and the genetic barrier to viral escape(1-4). Using HIV-1 pseudotypes and plasma selection experiments with vesicular stomatitis virus/SARS-CoV-2 chimaeras(5), here we show that multiple neutralizing epitopes, within and outside the receptor-binding domain, are variably targeted by human polyclonal antibodies. Antibody targets coincide with spike sequences that are enriched for diversity in natural SARS-CoV-2 populations. By combining plasma-selected spike substitutions, we generated synthetic 'polymutant' spike protein pseudotypes that resisted polyclonal antibody neutralization to a similar degree as circulating variants of concern. By aggregating variant of concern-associated and antibody-selected spike substitutions into a single polymutant spike protein, we show that 20 naturally occurring mutations in the SARS-CoV-2 spike protein are sufficient to generate pseudotypes with near-complete resistance to the polyclonal neutralizing antibodies generated by individuals who are convalescent or recipients who received an mRNA vaccine. However, plasma from individuals who had been infected and subsequently received mRNA vaccination neutralized pseudotypes bearing this highly resistant SARS-CoV-2 polymutant spike, or diverse sarbecovirus spike proteins. Thus, optimally elicited human polyclonal antibodies against SARS-CoV-2 should be resilient to substantial future SARS-CoV-2 variation and may confer protection against potential future sarbecovirus pandemics.	[Schmidt, Fabian; Weisblum, Yiska; Poston, Daniel; DaSilva, Justin; Zhang, Fengwen; Bednarski, Eva; Hatziioannou, Theodora; Bieniasz, Paul D.] Rockefeller Univ, Lab Retrovirol, 1230 York Ave, New York, NY 10021 USA; [Rutkowska, Magdalena; Nussenzweig, Michel C.; Bieniasz, Paul D.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; [Cho, Alice; Schaefer-Babajew, Dennis J.; Gaebler, Christian; Caskey, Marina; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Hatziioannou, T; Bieniasz, PD (corresponding author), Rockefeller Univ, Lab Retrovirol, 1230 York Ave, New York, NY 10021 USA.; Bieniasz, PD (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.	thatziio@rockefeller.edu; pbieniasz@rockefeller.edu	Gaebler, Christian/GWZ-2628-2022	Gaebler, Christian/0000-0001-7295-8128; Poston, Daniel/0000-0001-9900-6717; DaSilva, Justin/0000-0001-6393-0000; Schaefer-Babajew, Dennis/0000-0002-5380-2950	US National Institutes of Health [R37AI64003, R01AI501111, R01AI78788, P01-AI138398-S1, 2U19AI111825]; Medical Scientist Training Program grant from the NIGMS [T32GM007739]; NIAID [F30AI157898]; Robert S. Wennett Post-Doctoral Fellowship; National Center for Advancing Translational Sciences (National Institutes of Health Clinical and Translational Science Award programme) [UL1 TR001866]; Shapiro-Silverberg Fund for the Advancement of Translational Research	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Scientist Training Program grant from the NIGMS; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Robert S. Wennett Post-Doctoral Fellowship; National Center for Advancing Translational Sciences (National Institutes of Health Clinical and Translational Science Award programme); Shapiro-Silverberg Fund for the Advancement of Translational Research	This work was supported by US National Institutes of Health grants R37AI64003 and R01AI501111 (to P.D.B); R01AI78788 (to T.H.); and P01-AI138398-S1 and 2U19AI111825 (to M.C.N.). D.P. was supported by a Medical Scientist Training Program grant from the NIGMS (T32GM007739) to the Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD Program and by the NIAID (F30AI157898). C.G. was supported by the Robert S. Wennett Post-Doctoral Fellowship, in part by the National Center for Advancing Translational Sciences (National Institutes of Health Clinical and Translational Science Award programme, grant UL1 TR001866), and by the Shapiro-Silverberg Fund for the Advancement of Translational Research. P.D.B. and M.C.N. are Howard Hughes Medical Institute Investigators.	Andreano E, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2103154118; Barnes CO, 2020, CELL, V182, P828, DOI [10.1016/j.cell.2020.06.025, 10.1101/2020.05.28.121533]; Cao YL, 2020, CELL, V182, P73, DOI 10.1016/j.cell.2020.05.025; CERUTTI G, 2021, BIORXIV; Cho A, 2021, NATURE, V600, P517, DOI 10.1038/s41586-021-04060-7; De Oliveira T., 2021, MEDRXIV, DOI [10.1101/2021.03.30.21254323, DOI 10.1101/2021.03.30.21254323]; Fujino T, 2021, EMERG INFECT DIS, V27, P1243, DOI 10.3201/eid2704.210138; Gaebler C, 2021, NATURE, V591, P639, DOI [10.1038/s41586-021-03207-w, 10.1101/2020.11.03.367391]; Gaebler C, 2019, J EXP MED, V216, P2253, DOI 10.1084/jem.20190896; Greaney Allison J, 2021, Cell Host Microbe, V29, P463, DOI 10.1016/j.chom.2021.02.003; Guy AJ, 2018, BIOINFORMATICS, V34, P3942, DOI 10.1093/bioinformatics/bty474; Guy AJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22592-3; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Lam TTY, 2020, NATURE, V583, P282, DOI 10.1038/s41586-020-2169-0; Liu L, 2022, IEEE T KNOWL DATA EN, V34, P2293, DOI [10.1109/TKDE.2020.3004939, 10.1101/2020.06.17.153486]; McCallum M, 2021, CELL, V184, P2332, DOI [10.1016/j.cell.2021.03.028, 10.1101/2021.01.14.426475]; Muecksch F, 2021, IMMUNITY, V54, P1853, DOI 10.1016/j.immuni.2021.07.008; Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024; Robbiani Davide F, 2020, Nature, V584, P437, DOI [10.1101/2020.05.13.092619, 10.1038/s41586-020-2456-9]; Rogers Thomas F, 2020, bioRxiv, DOI 10.1101/2020.05.11.088674; Sauer MM, 2021, NAT STRUCT MOL BIOL, V28, P478, DOI [10.1101/2020.12.29.424482, 10.1038/s41594-021-00596-4]; Schmidt F, 2020, J EXP MED, V217, DOI 10.1084/jem.20201181; Tada Takuya, 2021, bioRxiv, DOI 10.1101/2021.02.18.431897; Tegally H, 2021, NATURE, V592, P438, DOI 10.1038/s41586-021-03402-9; Tortorici MA, 2021, NATURE, V597, P103, DOI 10.1038/s41586-021-03817-4; Volz E, 2021, NATURE, V593, P266, DOI 10.1038/s41586-021-03470-x; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang ZJ, 2021, NATURE, V595, P426, DOI 10.1038/s41586-021-03696-9; Weisblum Yiska, 2020, bioRxiv, DOI 10.1101/2020.07.21.214759; West AP, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25168-4; Wibmer CK, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01285-x, 10.1101/2021.01.18.427166]; Zhang T, 2020, CURR BIOL, V30, P1346, DOI 10.1016/j.cub.2020.03.022; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	33	89	90	5	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 16	2021	600	7889					512	+		10.1038/s41586-021-04005-0	http://dx.doi.org/10.1038/s41586-021-04005-0		SEP 2021	18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XP3FN	34544114	Bronze, Green Submitted, Green Accepted			2022-12-28	WOS:000714336100001
J	Aczel, M				Aczel, Miriam			Saving Us: A Climate Scientist's Case for Hope and Healing in a Divided World	SCIENCE			English	Book Review									[Aczel, Miriam] Univ Calif Berkeley, Calif Inst Energy & Environm, Berkeley, CA 94720 USA; [Aczel, Miriam] Imperial Coll London, Ctr Environm Policy, London SW7 1NE, England	University of California System; University of California Berkeley; Imperial College London	Aczel, M (corresponding author), Univ Calif Berkeley, Calif Inst Energy & Environm, Berkeley, CA 94720 USA.; Aczel, M (corresponding author), Imperial Coll London, Ctr Environm Policy, London SW7 1NE, England.	aczel@berkeley.edu		Aczel, Miriam/0000-0002-9819-7512				HAYHOE K, 2021, SAVING US CLIMATE SC	1	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2021	373	6561					1316	1316						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	US5SK	34529468				2022-12-28	WOS:000697488600031
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Act now or hospital admissions could soar, experts tell government	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 95 SAGE M COVID 19 0; Gov.UK,, 2021, COVID 19 RESP AUT WI; GOV.UK, HEALTHC UK PAT ADM H; Iacobucci G, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2270; Scientific Pandemic Influenza Group on Modelling, CONS STAT COV 19	5	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2021	374								n2285	10.1136/bmj.n2285	http://dx.doi.org/10.1136/bmj.n2285			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WI4KS	34531182	Bronze			2022-12-28	WOS:000708331800005
J	Monti, M; Torbica, A; Mossialos, E; Mckee, M				Monti, Mario; Torbica, Aleksandra; Mossialos, Elias; Mckee, Martin			A new strategy for health and sustainable development in the light of the COVID-19 pandemic	LANCET			English	Editorial Material									[Torbica, Aleksandra] Bocconi Univ, Dept Social & Polit Sci, Milan, Italy; [Monti, Mario] Bocconi Univ, Off President, Milan, Italy; [Mossialos, Elias] London Sch Econ & Polit Sci, Dept Hlth Policy, London, England; [Mckee, Martin] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1H 9SH, England	Bocconi University; Bocconi University; University of London; London School Economics & Political Science; University of London; London School of Hygiene & Tropical Medicine	Mckee, M (corresponding author), London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1H 9SH, England.	martin.mckee@lshtm.ac.uk	Mossialos, Elias/ABE-1301-2021	Torbica, Aleksandra/0000-0001-8938-7608				Bloomer E, 2018, J PUBLIC HEALTH POL, V39, P389, DOI 10.1057/s41271-018-0144-x; Carney M, 2021, VALUES BUILDING BETT; Forman R, 2021, HEALTH POLICY, V125, P553, DOI 10.1016/j.healthpol.2021.03.013; McKee M, 2021, DRAWING LIGHT PANDEM; Pan-European Commission on Health and Sustainable Development, 2021, DRAWING LIGHT PANDEM; Rodrik D, 2000, J ECON PERSPECT, V14, P177, DOI 10.1257/jep.14.1.177; Rogers HL, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18094742; WHO, 2020, ONE HEALTH-AMSTERDAM; World Health Organization, 2021, COVID 19 SHOWS WHY U	9	7	7	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 18	2021	398	10305					1029	1031		10.1016/S0140-6736(21)01995-4	http://dx.doi.org/10.1016/S0140-6736(21)01995-4		SEP 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	US3YI	34516953	Green Published, Bronze			2022-12-28	WOS:000697368600006
J	Tabebordbar, M; Lagerborg, KA; Stanton, A; King, EM; Ye, S; Tellez, L; Krunnfusz, A; Tavakoli, S; Widrick, JJ; Messemer, KA; Troiano, EC; Moghadaszadeh, B; Peacker, BL; Leacock, KA; Horwitz, N; Beggs, AH; Wagers, AJ; Sabeti, PC				Tabebordbar, Mohammadsharif; Lagerborg, Kim A.; Stanton, Alexandra; King, Emily M.; Ye, Simon; Tellez, Liana; Krunnfusz, Allison; Tavakoli, Sahar; Widrick, Jeffrey J.; Messemer, Kathleen A.; Troiano, Emily C.; Moghadaszadeh, Behzad; Peacker, Bryan L.; Leacock, Krystynne A.; Horwitz, Naftali; Beggs, Alan H.; Wagers, Amy J.; Sabeti, Pardis C.			Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species	CELL			English	Article							ADENOASSOCIATED VIRUS; MODEL; SELECTION; SKELETAL; VECTORS; STEM; IDENTIFICATION; FIBRONECTIN; EXPRESSION; EFFICIENT	Replacing or editing disease-causing mutations holds great promise for treating many human diseases. Yet, delivering therapeutic genetic modifiers to specific cells in vivo has been challenging, particularly in large, anatomically distributed tissues such as skeletal muscle. Here, we establish an in vivo strategy to evolve and stringently select capsid variants of adeno-associated viruses (AAVs) that enable potent delivery to desired tissues. Using this method, we identify a class of RGD motif-containing capsids that transduces muscle with superior efficiency and selectivity after intravenous injection in mice and non-human primates. We demonstrate substantially enhanced potency and therapeutic efficacy of these engineered vectors compared to naturally occurring AAV capsids in two mouse models of genetic muscle disease. The top capsid variants from our selection approach show conserved potency for delivery across a variety of inbred mouse strains, and in cynomolgus macaques and human primary myotubes, with transduction dependent on target cell expressed integrin heterodimers.	[Tabebordbar, Mohammadsharif; Lagerborg, Kim A.; Stanton, Alexandra; King, Emily M.; Ye, Simon; Tellez, Liana; Krunnfusz, Allison; Beggs, Alan H.; Sabeti, Pardis C.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Lagerborg, Kim A.] Harvard Med Sch, Harvard Program Biol & Biomed Sci, Boston, MA 02115 USA; [Stanton, Alexandra] Harvard Med Sch, Harvard Program Virol, Boston, MA 02115 USA; [Ye, Simon] MIT, Harvard MIT Hlth Sci & Technol, Cambridge, MA 02139 USA; [Tavakoli, Sahar; Messemer, Kathleen A.; Peacker, Bryan L.; Leacock, Krystynne A.; Horwitz, Naftali; Wagers, Amy J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Tavakoli, Sahar; Messemer, Kathleen A.; Peacker, Bryan L.; Leacock, Krystynne A.; Horwitz, Naftali; Wagers, Amy J.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Tavakoli, Sahar; Messemer, Kathleen A.; Peacker, Bryan L.; Leacock, Krystynne A.; Horwitz, Naftali; Wagers, Amy J.] Harvard Med Sch, Paul F Glenn Ctr Biol Aging, Boston, MA 02115 USA; [Tavakoli, Sahar] Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Tavakoli, Sahar] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Widrick, Jeffrey J.; Troiano, Emily C.; Moghadaszadeh, Behzad; Beggs, Alan H.] Harvard Med Sch, Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Div Genet & Genom, Boston, MA 02115 USA; [Sabeti, Pardis C.] Harvard Univ, FAS Ctr Syst Biol, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Horwitz, Naftali; Wagers, Amy J.] Joslin Diabet Ctr, Sect Islet Cell & Regenerat Biol, Boston, MA 02215 USA; [Sabeti, Pardis C.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard University; Joslin Diabetes Center, Inc.; Howard Hughes Medical Institute	Tabebordbar, M; Sabeti, PC (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Wagers, AJ (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.; Wagers, AJ (corresponding author), Harvard Stem Cell Inst, Cambridge, MA 02138 USA.; Wagers, AJ (corresponding author), Harvard Med Sch, Paul F Glenn Ctr Biol Aging, Boston, MA 02115 USA.; Sabeti, PC (corresponding author), Harvard Univ, FAS Ctr Syst Biol, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.; Wagers, AJ (corresponding author), Joslin Diabet Ctr, Sect Islet Cell & Regenerat Biol, Boston, MA 02215 USA.; Sabeti, PC (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	tabebord@fas.harvard.edu; amy_wagers@harvard.edu; pardis@broadinstitute.org	Sabeti, Pardis/GQH-8610-2022	King, Emily/0000-0002-3489-3682; Moghadaszadeh, Behzad/0000-0001-9787-0106; Stanton, Alexandra/0000-0001-8355-345X; Peacker, Bryan/0000-0002-3347-0629; Lagerborg, Kim/0000-0003-2490-2191	Sarepta Therapeutics; Howard Hughes Medical Institute; Chemical Biology and Therapeutic Sciences program at the Broad Institute; American Society of Gene Cell Therapy; Glenn Foundation; Muscular Dystrophy Association USA [MDA602235]; NIH [U54HD090255, DP1 OD025432]; Herchel Smith graduate fellowship	Sarepta Therapeutics; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Chemical Biology and Therapeutic Sciences program at the Broad Institute; American Society of Gene Cell Therapy; Glenn Foundation; Muscular Dystrophy Association USA(Muscular Dystrophy Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Herchel Smith graduate fellowship	This work was made possible by a generous anonymous philanthropic gift to the P.C.S. lab at the Broad Institute of MIT and Harvard and a sponsored research agreement with Sarepta Therapeutics awarded to M.T. and P.C.S. It was additionally supported by grants from Howard Hughes Medical Institute to P.C.S., a Shark Tank award from the Chemical Biology and Therapeutic Sciences program at the Broad Institute and a career development award from the American Society of Gene & Cell Therapy to M.T., NIH (DP1 OD025432) and Glenn Foundation grants to A.J.W., and MDA602235 from the Muscular Dystrophy Association USA and generous support for therapy development from the Anderson Family Foundation to A.H.B. Mouse genotyping utilized the resources of the Boston Children's Hospital IDDRC Molecular Genetics Core Laboratory funded by NIH U54HD090255. The content is solely the responsibility of the authors and does not necessarily represent the official views of the American Society of Gene & Cell Therapy or other funding agencies. K.A. Lagerborg and A.S. were supported by the Herchel Smith graduate fellowship. We would like to thank Ben Deverman and Ken Chan for providing the Rep-AAP plasmid and for thoughtful discussions and technical assistance; the Harvard Department of Stem Cell and Regenerative Biology-Harvard Stem Cell Institute Flow Cytometry Core for technical assistance; Jan Carette for providing the HEK293FT AAVR KO cells and the HEK293FTWTcontrol; and Aaron Lin, Steve Schaffner, Christopher Edwards, and Kian Sani for providing thoughtful feedback on the manuscript.	Alexander MS, 2014, J CLIN INVEST, V124, P2651, DOI 10.1172/JCI73579; Asokan A, 2006, J VIROL, V80, P8961, DOI 10.1128/JVI.00843-06; Bell CL, 2011, J CLIN INVEST, V121, P2427, DOI 10.1172/JCI57367; Bengtsson NE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14454; Berry GE, 2016, CURR OPIN VIROL, V21, P54, DOI 10.1016/j.coviro.2016.08.001; Borner K, 2020, MOL THER, V28, P1016, DOI 10.1016/j.ymthe.2020.02.009; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Chan S, 2007, AM J PHYSIOL-CELL PH, V293, pC985, DOI 10.1152/ajpcell.00128.2007; Childers MK, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007523; Choudhury SR, 2016, MOL THER, V24, P1247, DOI 10.1038/mt.2016.84; Dalkara D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005708; Deverman BE, 2016, NAT BIOTECHNOL, V34, P204, DOI 10.1038/nbt.3440; DiMattia MA, 2012, J VIROL, V86, P6947, DOI 10.1128/JVI.07232-11; Ding W, 2005, GENE THER, V12, P873, DOI 10.1038/sj.gt.3302527; Duan DS, 2018, MOL THER, V26, P2337, DOI 10.1016/j.ymthe.2018.07.011; Dudek AM, 2018, J VIROL, V92, DOI 10.1128/JVI.02213-17; Elverman M, 2017, MUSCLE NERVE, V56, P943, DOI 10.1002/mus.25658; Gao GP, 2006, MOL THER, V13, P77, DOI 10.1016/j.ymthe.2005.08.017; Goldstein JM, 2019, CELL REP, V27, P1254, DOI 10.1016/j.celrep.2019.03.105; Hakim CH, 2017, MOL THER-METH CLIN D, V6, P216, DOI 10.1016/j.omtm.2017.06.006; Hinderer C, 2018, HUM GENE THER, V29, P285, DOI 10.1089/hum.2018.015; Hordeaux J, 2018, MOL THER, V26, P664, DOI 10.1016/j.ymthe.2018.01.018; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jang MJ, 2018, WIDESPREAD TARGETED, DOI [10.1101/246405, DOI 10.1101/246405]; Korbelin J, 2016, MOL THER, V24, P1050, DOI 10.1038/mt.2016.62; LEVITT N, 1989, GENE DEV, V3, P1019, DOI 10.1101/gad.3.7.1019; Li CW, 2020, NAT REV GENET, V21, P255, DOI 10.1038/s41576-019-0205-4; Li CW, 2016, MOL THER, V24, P53, DOI 10.1038/mt.2015.134; Mack DL, 2017, MOL THER, V25, P839, DOI 10.1016/j.ymthe.2017.02.004; Mendell JR, 2020, JAMA NEUROL, V77, P1122, DOI 10.1001/jamaneurol.2020.1484; Michelfelder S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005122; Morales L, 2020, MOL THER, V28, P1753, DOI 10.1016/j.ymthe.2020.07.009; Muhuri M, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI143780; Murrey DA, 2014, HUM GENE THER CL DEV, V25, P72, DOI 10.1089/humc.2013.208; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Nonnenmacher M, 2021, MOL THER-METH CLIN D, V20, P366, DOI 10.1016/j.omtm.2020.12.006; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Pillay S, 2016, NATURE, V530, P108, DOI 10.1038/nature16465; PYTELA R, 1985, CELL, V40, P191, DOI 10.1016/0092-8674(85)90322-8; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Salva MZ, 2007, MOL THER, V15, P320, DOI 10.1038/sj.mt.6300027; Summerford C, 1999, NAT MED, V5, P78, DOI 10.1038/4768; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tse LV, 2017, P NATL ACAD SCI USA, V114, pE4812, DOI 10.1073/pnas.1704766114; Weinmann J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19230-w; Yang L, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-50; Yang L, 2009, P NATL ACAD SCI USA, V106, P3946, DOI 10.1073/pnas.0813207106; Zhang YF, 2014, HUM MOL GENET, V23, P3180, DOI 10.1093/hmg/ddu028; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	49	51	53	11	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 16	2021	184	19					4919	+		10.1016/j.cell.2021.08.028	http://dx.doi.org/10.1016/j.cell.2021.08.028		SEP 2021	42	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	WC7PA	34506722	hybrid, Green Accepted			2022-12-28	WOS:000704445100009
J	Tollefson, J				Tollefson, Jeff			PIVOTAL CLIMATE SUMMIT DOGGED BY CONCERNS ABOUT COVID AND EQUITY	NATURE			English	News Item																			0	0	0	0	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 16	2021	597	7876					315	315		10.1038/d41586-021-02465-y	http://dx.doi.org/10.1038/d41586-021-02465-y			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UQ1MU	34510158				2022-12-28	WOS:000695836000012
J	Gurkan, UA				Gurkan, Umut A.			Poloxamer 188 vs Placebo for Painful Vaso-occlusive Episodes in Children and Adults With Sickle Cell Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Gurkan, Umut A.] Case Western Reserve Univ, Mech & Aerosp Engn Dept, Cleveland, OH 44106 USA	Case Western Reserve University	Gurkan, UA (corresponding author), Case Western Reserve Univ, 10900 Euclid Ave, Cleveland, OH 44106 USA.	umut@case.edu						Casella JF, 2021, JAMA-J AM MED ASSOC, V325, P1513, DOI 10.1001/jama.2021.3414; Connes P, 2016, BLOOD REV, V30, P111, DOI 10.1016/j.blre.2015.08.005; Gurkan UA, 2021, CURR OPIN HEMATOL, V28, P138, DOI 10.1097/MOH.0000000000000639; Hunter RL, 2010, ANN CLIN LAB SCI, V40, P115; Kucukal E, 2020, AM J HEMATOL, V95, P1246, DOI 10.1002/ajh.25933	5	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2021	326	10					975	975		10.1001/jama.2021.11100	http://dx.doi.org/10.1001/jama.2021.11100			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UW4LI	34519808				2022-12-28	WOS:000700129100028
J	Dyer, O				Dyer, Owen			Covid-19: US imposes mandatory vaccination on two thirds of workforce	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, CBS AP 0828; Clement Scott, 2021, WASH POST; Todd C, 2021, NBC NEWS	3	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 13	2021	374								n2238	10.1136/bmj.n2238	http://dx.doi.org/10.1136/bmj.n2238			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UR8KQ	34518168	Bronze			2022-12-28	WOS:000696991500005
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Children aged 12-15 should be offered vaccine, say UK's chief medical officers	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci G., BMJ-BRIT MED J, V374, pN2180; Tracy Beth Hoeg T, MEDRXIV, V2021, DOI [10.1101/2021.08.30.21262866, DOI 10.1101/2021.08.30.21262866]; UK Chief Medical Officers, 2021, UN VACC CHILDR YOUNG	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 13	2021	374								n2248	10.1136/bmj.n2248	http://dx.doi.org/10.1136/bmj.n2248			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UR8KQ	34518163	Bronze			2022-12-28	WOS:000696991500006
J	Folkmann, AW; Putnam, A; Lee, CF; Seydoux, G				Folkmann, Andrew W.; Putnam, Andrea; Lee, Chiu Fan; Seydoux, Geraldine			Regulation of biomolecular condensates by interfacial protein clusters	SCIENCE			English	Article							PHASE-SEPARATION; P GRANULES; LIQUID DROPLETS; ELEGANS; TRANSITION; EMULSIONS; DYNAMICS; PLATFORM; KINASE; MBK-2	Biomolecular condensates are cellular compartments that can form by phase separation in the absence of limiting membranes. Studying the P granules of Caenorhabditis elegans, we find that condensate dynamics are regulated by protein clusters that adsorb to the condensate interface. Using in vitro reconstitution, live observations, and theory, we demonstrate that localized assembly of P granules is controlled by MEG-3, an intrinsically disordered protein that forms low dynamic assemblies on P granules. Following classic Pickering emulsion theory, MEG-3 clusters lower surface tension and slow down coarsening. During zygote polarization, MEG-3 recruits the DYRK family kinase MBK-2 to accelerate spatially regulated growth of the P granule emulsion. By tuning condensate-cytoplasm exchange, interfacial clusters regulate the structural integrity of biomolecular condensates, reminiscent of the role of lipid bilayers in membrane-bound organelles.	[Folkmann, Andrew W.; Putnam, Andrea; Seydoux, Geraldine] Johns Hopkins Univ, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Folkmann, Andrew W.; Putnam, Andrea; Seydoux, Geraldine] Johns Hopkins Univ, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Lee, Chiu Fan] Imperial Coll London, Dept Bioengn, London SW7 2AZ, England	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Imperial College London	Seydoux, G (corresponding author), Johns Hopkins Univ, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.; Seydoux, G (corresponding author), Johns Hopkins Univ, Howard Hughes Med Inst, Baltimore, MD 21205 USA.	gseydoux@jhmi.edu		Putnam, Andrea/0000-0001-7985-142X; Lee, Chiu Fan/0000-0003-4363-9050; Seydoux, Geraldine/0000-0001-8257-0493				Albert C, 2019, J CONTROL RELEASE, V309, P302, DOI 10.1016/j.jconrel.2019.07.003; Berry J, 2018, REP PROG PHYS, V80, DOI 10.1088/1361-6633/aaa61e; Berry J, 2015, P NATL ACAD SCI USA, V112, pE5237, DOI 10.1073/pnas.1509317112; Berton-Carabin CC, 2015, ANNU REV FOOD SCI T, V6, P263, DOI 10.1146/annurev-food-081114-110822; Boeynaems S, 2018, TRENDS CELL BIOL, V28, P420, DOI 10.1016/j.tcb.2018.02.004; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; BRENNER S, 1974, GENETICS, V77, P71; Bressloff PC, 2020, PHYS REV E, V101, DOI 10.1103/PhysRevE.101.042804; Chen JX, 2016, MOL CELL PROTEOMICS, V15, P1642, DOI 10.1074/mcp.M115.053975; Crowe CD, 2018, INTERFACE FOCUS, V8, DOI 10.1098/rsfs.2018.0032; Dewey DC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5670; Elbaum-Garfinkle S, 2015, P NATL ACAD SCI USA, V112, P7189, DOI 10.1073/pnas.1504822112; Feric M, 2013, NAT CELL BIOL, V15, P1253, DOI 10.1038/ncb2830; Goodarzi F, 2019, CAN J CHEM ENG, V97, P281, DOI 10.1002/cjce.23336; Hampoelz B, 2019, CELL, V179, P671, DOI 10.1016/j.cell.2019.09.022; Hanazawa M, 2011, J CELL BIOL, V192, P929, DOI 10.1083/jcb.201010106; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Jawerth L, 2020, SCIENCE, V370, P1317, DOI 10.1126/science.aaw4951; Jawerth LM, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.258101; Lee C. F., 2021, chiufanlee/Pickering-stabilization, Version v1.0, DOI 10.5281/zenodo.5083065; Lee CYS, 2020, ELIFE, V9, DOI 10.7554/eLife.52896; Lee CF, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.088101; Lee CF, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.041906; Lee DSW, 2021, NAT PHYS, V17, P531, DOI 10.1038/s41567-020-01125-8; Lee JE, 2020, SCIENCE, V367, P527, DOI 10.1126/science.aay7108; LIFSHITZ IM, 1961, J PHYS CHEM SOLIDS, V19, P35, DOI 10.1016/0022-3697(61)90054-3; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; McSwiggen DT, 2019, GENE DEV, V33, P1619, DOI 10.1101/gad.331520.119; Navarro MGJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11241-6; Ngai T., 2014, PARTICLE STABILIZED; Ortiz DG, 2020, ENGINEERING-PRC, V6, P468, DOI 10.1016/j.eng.2019.08.017; Ouyang JPT, 2019, DEV CELL, V50, P716, DOI 10.1016/j.devcel.2019.07.026; Paix A, 2017, METHODS, V121, P86, DOI 10.1016/j.ymeth.2017.03.023; Pang KM, 2004, DEV BIOL, V265, P127, DOI 10.1016/j.ydbio.2003.09.024; Patel A, 2017, SCIENCE, V356, P753, DOI 10.1126/science.aaf6846; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Pawar AB, 2011, SOFT MATTER, V7, P7710, DOI 10.1039/c1sm05457k; Pellettieri J, 2003, DEV CELL, V5, P451, DOI 10.1016/S1534-5807(03)00231-4; Pickering SU, 1907, J CHEM SOC, V91, P2001, DOI 10.1039/ct9079102001; Putnam A, 2019, NAT STRUCT MOL BIOL, V26, P220, DOI 10.1038/s41594-019-0193-2; Quintin S, 2003, EMBO REP, V4, P1175, DOI 10.1038/sj.embor.7400029; Rai AK, 2018, NATURE, V559, P211, DOI 10.1038/s41586-018-0279-8; Ramsden W, 1903, P R SOC LONDON, V72, P156, DOI 10.1098/rspl.1903.0034; Ranganathan S, 2020, ELIFE, V9, DOI 10.7554/eLife.56159; Redwan EM, 2015, CURR PROTEIN PEPT SC, V16, P228, DOI 10.2174/1389203716666150224145900; Rhine K, 2022, METHODS, V197, P74, DOI 10.1016/j.ymeth.2021.02.012; Rosenzweig ESF, 2017, CELL, V171, P148, DOI 10.1016/j.cell.2017.08.008; Rubinstein M, 2001, MACROMOLECULES, V34, P1058, DOI 10.1021/ma0013049; Saha S, 2016, CELL, V166, P1572, DOI 10.1016/j.cell.2016.08.006; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schubert CM, 2000, MOL CELL, V5, P671, DOI 10.1016/S1097-2765(00)80246-4; Sheth U, 2010, DEVELOPMENT, V137, P1305, DOI 10.1242/dev.044255; Smith J, 2016, ELIFE, V5, DOI 10.7554/eLife.21337; Soding J, 2020, TRENDS CELL BIOL, V30, P4, DOI 10.1016/j.tcb.2019.10.006; Tarantino N, 2014, J CELL BIOL, V204, P231, DOI 10.1083/jcb.201307172; Tauber D, 2020, CELL, V180, P411, DOI 10.1016/j.cell.2019.12.031; Taylor P, 1998, ADV COLLOID INTERFAC, V75, P107, DOI 10.1016/S0001-8686(98)00035-9; Tinevez JY, 2017, METHODS, V115, P80, DOI 10.1016/j.ymeth.2016.09.016; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Wang JT, 2014, ELIFE, V3, DOI 10.7554/eLife.04591; Weber CA, 2019, REP PROG PHYS, V82, DOI 10.1088/1361-6633/ab052b; Weber CA, 2017, NEW J PHYS, V19, DOI 10.1088/1367-2630/aa6b84; Wheeler JR, 2016, ELIFE, V5, DOI 10.7554/eLife.18413; Wu YJ, 2019, MOL BIOL CELL, V30, P333, DOI 10.1091/mbc.E18-06-0402; Wurtz JD, 2018, NEW J PHYS, V20, DOI 10.1088/1367-2630/aab549; Wurtz JD, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.078102; Yang YQ, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00287; Zhang GM, 2018, CELL, V174, P1492, DOI 10.1016/j.cell.2018.08.006; Zwicker D, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.012317	69	35	35	12	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2021	373	6560					1218	+		10.1126/science.abg7071	http://dx.doi.org/10.1126/science.abg7071			53	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UP5RB	34516789	Green Accepted, Green Submitted			2022-12-28	WOS:000695436000025
J	Landau, S				Landau, Susan			Digital exposure tools: Design for privacy, efficacy, and equity	SCIENCE			English	Editorial Material									[Landau, Susan] Tufts Univ, Dept Comp Sci, Fletcher Sch, Medford, MA 02155 USA; [Landau, Susan] Tufts Univ, Dept Comp Sci, Sch Engn, Medford, MA 02155 USA; [Landau, Susan] UCL, Dept Comp Sci, London, England	Tufts University; Tufts University; University of London; University College London	Landau, S (corresponding author), Tufts Univ, Dept Comp Sci, Fletcher Sch, Medford, MA 02155 USA.; Landau, S (corresponding author), Tufts Univ, Dept Comp Sci, Sch Engn, Medford, MA 02155 USA.; Landau, S (corresponding author), UCL, Dept Comp Sci, London, England.	susan.landau@tufts.edu			National Science Foundation [CNS 1923528, CNS 1955805]	National Science Foundation(National Science Foundation (NSF))	This work was partially supported by National Science Foundation grants CNS 1923528 and CNS 1955805.	Bagchi K.J., 2020, DIGITAL TOOLS COVID; Bourdeaux M., 2021, FACULTY RES WORKING; Chaulk CP, 2021, J PUBLIC HEALTH MAN, V27, P322, DOI 10.1097/PHH.0000000000001362; Close RM, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMc2023540; Figueroa JF, 2020, HEALTH AFFAIR, V39, P1984, DOI 10.1377/hlthaff.2020.01040; Government of Singapore, TRACETOGETHER SAF TO; Government of the Republic of Ireland HSE, PRIV WE US YOUR DAT; Guiliani N. S., 2020, GOVT SAFEGUARDS TECH; Jian SW, 2020, INT J INFECT DIS, V101, P348, DOI 10.1016/j.ijid.2020.09.1483; Landau Susan, 2020, LAWFARE; Landau Susan., 2021, PEOPLE COUNT CONTACT, DOI [10.3201/eid2709.210754, DOI 10.3201/EID2709.210754]; Leith DJ, 2020, ACM SIGCOMM COMP COM, V50, P66, DOI 10.1145/3431832.3431840; Musicians' Union MU, 2020, UK CLASS MUS SECT HI; Smith LE, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n608; Wymant C, 2021, NATURE, V594, P408, DOI 10.1038/s41586-021-03606-z	15	2	2	2	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2021	373	6560					1202	1204		10.1126/science.abi9852	http://dx.doi.org/10.1126/science.abi9852			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UP5RB	34516819				2022-12-28	WOS:000695436000016
J	Roehr, B				Roehr, Bob			Assisted dying around the world	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												bobroehr@aol.com						Downie J, 2022, DEATH STUD, V46, P1547, DOI 10.1080/07481187.2021.1926631; Government of Canada, 2021, MED ASS DYING; New Zealand Ministry of Health, END LIF CHOIC ACT IM; Roehr B, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k503; Sanz TRV, 2021, J MED ETHICS, DOI 10.1136/medethics-2021-107523	5	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2021	374								n2200	10.1136/bmj.n2200	http://dx.doi.org/10.1136/bmj.n2200			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	US1IY	34507973				2022-12-28	WOS:000697191000004
J	Drent, M; Crouser, ED; Grunewald, J				Drent, Marjolein; Crouser, Elliott D.; Grunewald, Johan			Challenges of Sarcoidosis and Its Management	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SMALL FIBER NEUROPATHY; BRONCHOALVEOLAR; ASSOCIATION; DISEASE; CELLS	Sarcoidosis Sarcoidosis is a lung disease of unknown cause characterized by noncaseating granulomas; the heart and nervous system may also be involved. It is often misdiagnosed; tissue biopsy is needed for a definitive diagnosis. Glucocorticoids are recommended as initial treatment, when needed, but not for long-term care.	[Drent, Marjolein] St Antonius Hosp, Interstitial Lung Dis ILD, Ctr Excellence, Dept Pulmonol, Nieuwegein, Netherlands; [Drent, Marjolein] Maastricht Univ, Dept Pharmacol & Toxicol, Fac Hlth & Life Sci, Maastricht, Netherlands; [Drent, Marjolein] ILD Care Fdn Res Team, Ede, Netherlands; [Crouser, Elliott D.] Ohio State Univ, Div Pulm Crit Care & Sleep Med, Columbus, OH 43210 USA; [Grunewald, Johan] Karolinska Inst, Div Resp Med, Dept Med Solna, Stockholm, Sweden; [Grunewald, Johan] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Grunewald, Johan] Karolinska Univ Hosp, Resp Med Theme Inflammat & Aging, Stockholm, Sweden	St. Antonius Hospital Utrecht; Maastricht University; University System of Ohio; Ohio State University; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Drent, M (corresponding author), ILD Care Fdn, Heideoordlaan 8, NL-6711 NR Ede, Netherlands.	m.-drent@-maastrichtuniversity.-nl	Grunewald, Johan/GQZ-8122-2022; Crouser, Elliott/ABC-2602-2021; Drent, Marjolein/ABA-9526-2020	Drent, Marjolein/0000-0003-1586-0110; Grunewald, Johan/0000-0003-0473-3984				Arkema EV, 2020, CURR OPIN PULM MED, V26, P527, DOI 10.1097/MCP.0000000000000715; Basantsova NY, 2019, NEUROL SCI, V40, P1343, DOI 10.1007/s10072-019-03871-x; Bast A, 2018, CURR OPIN PULM MED, V24, P479, DOI 10.1097/MCP.0000000000000501; Baughman RP, 2013, SARCOIDOSIS VASC DIF, V30, P113; Baughman RP, 2020, SARCOIDOSIS VASC DIF, V37, DOI 10.36141/svdld.v37i3.9362; Baughman RP, 2020, EUR RESPIR REV, V29, DOI 10.1183/16000617.0145-2019; Bennett D, 2019, EXPERT REV RESP MED, V13, P981, DOI 10.1080/17476348.2019.1655401; Boots AW, 2009, RESP MED, V103, P364, DOI 10.1016/j.rmed.2008.10.007; Brito-Zeron P, 2019, CLIN EXP RHEUMATOL, V37, P1052; Broos CE, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.01124-2017; Calender A, 2020, J CLIN MED, V9, DOI 10.3390/jcm9082633; Celada LJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar8356; Chen YL, 2019, GENET EPIDEMIOL, V43, P414, DOI 10.1002/gepi.22196; Crouser ED, 2020, AM J RESP CRIT CARE, V201, pE26, DOI 10.1164/rccm.202002-0251ST; Darlington P, 2020, RESP RES, V21, DOI 10.1186/s12931-020-1327-0; Darlington P, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01450-2019; de Boer A, 2017, INT J FOOD SCI NUTR, V68, P771, DOI 10.1080/09637486.2017.1288199; Drent M, 2020, LUNG, V198, P395, DOI 10.1007/s00408-020-00323-8; Drent M, 2007, SEMIN RESP CRIT CARE, V28, P486, DOI 10.1055/s-2007-991521; Drent M, 2021, LANCET RESP MED, V9, P816, DOI 10.1016/S2213-2600(21)00311-8; Drent M, 2020, J PERS MED, V10, DOI 10.3390/jpm10030097; Eishi Y, 2013, RESPIR INVESTIG, V51, P56, DOI 10.1016/j.resinv.2013.01.001; El Jammal T, 2020, THER CLIN RISK MANAG, V16, P323, DOI 10.2147/TCRM.S192922; Elzbieta R, 2020, BMC PULM MED, V20, DOI 10.1186/s12890-020-01345-x; Eurelings LEM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223897; Gerke AK, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.545413; Gerke AK, 2017, ANN AM THORAC SOC, V14, pS421, DOI 10.1513/AnnalsATS.201707-564OT; Grunewald J, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0096-x; Harper LJ, 2020, AM J RESP CRIT CARE, V201, P955, DOI 10.1164/rccm.201906-1250OC; Hena KM, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16071291; Hena KM, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.537382; Hendriks CMR, 2019, LUNG, V197, P407, DOI 10.1007/s00408-019-00234-3; Hendriks C, 2018, RESP MED, V138, pS24, DOI 10.1016/j.rmed.2017.11.008; Heyder T, 2016, MOL CELL PROTEOMICS, V15, P3017, DOI 10.1074/mcp.M116.060764; Hoitsma E, 2002, LANCET, V359, P2085, DOI 10.1016/S0140-6736(02)08912-2; Huppertz C, 2020, EUR RESPIR J, V55; Iriarte A, 2020, RESP MED, V169, DOI 10.1016/j.rmed.2020.105998; Jain R, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041081; Katchar K, 2003, J INTERN MED, V254, P564, DOI 10.1111/j.1365-2796.2003.01230.x; Keijsers RGM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030890; Kobak S, 2020, LUNG INDIA, V37, P425, DOI 10.4103/lungindia.lungindia_380_19; Kraaijvanger R, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01443; Kudryavtsev I, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57741-0; Le Pavec JM, 2021, EUR RESPIR J, V58, DOI 10.1183/13993003.03358-2020; Lee S, 2020, RESP MED, V173, DOI 10.1016/j.rmed.2020.106161; Levy Andrew, 2018, F1000Res, V7, DOI 10.12688/f1000research.11068.1; Liu HB, 2016, CHEST, V150, P289, DOI 10.1016/j.chest.2016.01.020; Locke LW, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01719; Locke LW, 2019, AM J RESP CELL MOL, V60, P84, DOI 10.1165/rcmb.2018-0053OC; Malkova A, 2020, ERJ OPEN RES, V6, DOI 10.1183/23120541.00155-2020; Masri SC, 2020, CURR CARDIOL REP, V22, DOI 10.1007/s11886-020-01429-4; Medbury HJ, 2013, INT ANGIOL, V32, P74; Miedema JR, 2020, CURR OPIN PULM MED, V26, P598, DOI 10.1097/MCP.0000000000000709; Miyara M, 2006, J EXP MED, V203, P359, DOI 10.1084/jem.20050648; Moller DR, 2017, ANN AM THORAC SOC, V14, pS429, DOI 10.1513/AnnalsATS.201707-565OT; Moor CC, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020390; Mostard RLM, 2011, RESP MED, V105, P1917, DOI 10.1016/j.rmed.2011.08.012; Musaelyan A, 2018, AUTOIMMUN REV, V17, P926, DOI 10.1016/j.autrev.2018.04.004; Obi ON, 2021, EXPERT REV CLIN PHAR, V14, P179, DOI 10.1080/17512433.2021.1878024; Pacheco Y, 2020, TRENDS IMMUNOL, V41, P286, DOI 10.1016/j.it.2020.01.007; Pande A, 2020, EXPERT REV RESP MED, V14, P285, DOI 10.1080/17476348.2020.1707672; Pujades-Rodriguez M, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003432; Rahaghi FF, 2020, EUR RESPIR REV, V29, DOI 10.1183/16000617.0146-2019; Ramstein J, 2016, AM J RESP CRIT CARE, V193, P1281, DOI 10.1164/rccm.201507-1499OC; Rivera NV, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54612-1; Rosenbaum JT, 2009, CLIN IMMUNOL, V132, P174, DOI 10.1016/j.clim.2009.04.010; Saketkoo LA, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11061089; Sawahata M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9010142; Strookappe B, 2016, EXPERT REV RESP MED, V10, P1057, DOI 10.1080/17476348.2016.1227244; Syed H, 2020, SARCOIDOSIS VASC DIF, V37, P87, DOI 10.36141/svdld.v37i2.9599; Tavee J, 2019, CURR OPIN PULM MED, V25, P533, DOI 10.1097/MCP.0000000000000597; Thillai M, 2021, THORAX, V76, P4, DOI 10.1136/thoraxjnl-2019-214348; VERLEDEN S, 2021, CHEST; Voortman M, 2019, LUNG, V197, P155, DOI 10.1007/s00408-019-00206-7; Voortman M, 2017, CURR OPIN PULM MED, V23, P447, DOI 10.1097/MCP.0000000000000413; Zhou ER, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21197398; Ziegenhagen MW, 2003, EUR RESPIR J, V21, P407, DOI 10.1183/09031936.03.00010403	77	52	52	2	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 9	2021	385	11					1018	1032		10.1056/NEJMra2101555	http://dx.doi.org/10.1056/NEJMra2101555			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UN0RH	34496176				2022-12-28	WOS:000693730200013
J	Kuehn, BM				Kuehn, Bridget M.			First Interchangeable Biosimilar Insulin Drug Is Approved	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2021	326	9					801	801		10.1001/jama.2021.14729	http://dx.doi.org/10.1001/jama.2021.14729			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ7LK	34547095				2022-12-28	WOS:000696242100037
J	[Anonymous]				[Anonymous]			Summary for Patients: Bleeding Risk During Extended Anticoagulant Therapy for Venous Thromboembolism	ANNALS OF INTERNAL MEDICINE			English	Editorial Material													Tritschler, Tobias/ABH-1772-2021	Tritschler, Tobias/0000-0002-8775-0511					0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT	2021	174	10								10.7326/P21-0009	http://dx.doi.org/10.7326/P21-0009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XV2CT	34516273				2022-12-28	WOS:000734757300003
J	Fudamoto, Y; Oesch, PA; Schouws, S; Stefanon, M; Smit, R; Bouwens, RJ; Bowler, RAA; Endsley, R; Gonzalez, V; Inami, H; Labbe, I; Stark, D; Aravena, M; Barrufet, L; da Cunha, E; Dayal, P; Ferrara, A; Graziani, L; Hodge, J; Hutter, A; Li, Y; De Looze, I; Nanayakkara, T; Pallottini, A; Riechers, D; Schneider, R; Ucci, G; van der Werf, P; White, C				Fudamoto, Y.; Oesch, P. A.; Schouws, S.; Stefanon, M.; Smit, R.; Bouwens, R. J.; Bowler, R. A. A.; Endsley, R.; Gonzalez, V.; Inami, H.; Labbe, I.; Stark, D.; Aravena, M.; Barrufet, L.; da Cunha, E.; Dayal, P.; Ferrara, A.; Graziani, L.; Hodge, J.; Hutter, A.; Li, Y.; De Looze, I.; Nanayakkara, T.; Pallottini, A.; Riechers, D.; Schneider, R.; Ucci, G.; van der Werf, P.; White, C.			Normal, dust-obscured galaxies in the epoch of reionization	NATURE			English	Article							STAR-FORMING GALAXIES; LUMINOSITY FUNCTION; ALMA SURVEY; EVOLUTION; REDSHIFT; POPULATION; MODEL; MASS	Two serendipitously detected dust-obscured galaxies are reported at z = 6.7 and 7.4, with estimates that such galaxies provide an additional 10-25% contribution to the total star formation rate density at z > 6. Over the past decades, rest-frame ultraviolet (UV) observations have provided large samples of UV luminous galaxies at redshift (z) greater than 6 (refs. (1-3)), during the so-called epoch of reionization. While a few of these UV-identified galaxies revealed substantial dust reservoirs(4-7), very heavily dust-obscured sources at these early times have remained elusive. They are limited to a rare population of extreme starburst galaxies(8-12) and companions of rare quasars(13,14). These studies conclude that the contribution of dust-obscured galaxies to the cosmic star formation rate density at z > 6 is sub-dominant. Recent ALMA and Spitzer observations have identified a more abundant, less extreme population of obscured galaxies at z = 3-6 (refs. (15,16)). However, this population has not been confirmed in the reionization epoch so far. Here, we report the discovery of two dust-obscured star-forming galaxies at z = 6.6813 +/- 0.0005 and z = 7.3521 +/- 0.0005. These objects are not detected in existing rest-frame UV data and were discovered only through their far-infrared [C ii] lines and dust continuum emission as companions to typical UV-luminous galaxies at the same redshift. The two galaxies exhibit lower infrared luminosities and star-formation rates than extreme starbursts, in line with typical star-forming galaxies at z approximate to 7. This population of heavily dust-obscured galaxies appears to contribute 10-25% to the z > 6 cosmic star formation rate density.	[Fudamoto, Y.; Oesch, P. A.; Barrufet, L.] Univ Geneva, Dept Astron, Versoix, Switzerland; [Fudamoto, Y.] Waseda Univ, Res Inst Sci & Engn, Shinjuku Ku, Tokyo, Japan; [Fudamoto, Y.] Natl Astron Observ Japan, Mitaka, Tokyo, Japan; [Oesch, P. A.] Univ Copenhagen, Niels Bohr Inst, Cosm Dawn Ctr DAWN, Copenhagen, Denmark; [Schouws, S.; Stefanon, M.; Bouwens, R. J.; Hodge, J.; van der Werf, P.] Leiden Univ, Leiden Observ, Leiden, Netherlands; [Smit, R.] Liverpool John Moores Univ, Astrophys Res Inst, Liverpool, Merseyside, England; [Bowler, R. A. A.] Univ Oxford, Subdept Astrophys, Denys Wilkinson Bldg, Oxford, England; [Endsley, R.; Stark, D.; White, C.] Univ Arizona, Steward Observ, Tucson, AZ USA; [Gonzalez, V.] Univ Chile, Dept Astron, Santiago, Chile; [Gonzalez, V.] Ctr Astrofis & Tecnol Afines CATA, Santiago, Chile; [Inami, H.] Hiroshima Univ, Hiroshima Astrophys Sci Ctr, Hiroshima, Japan; [Labbe, I.; Nanayakkara, T.] Swinburne Univ Technol, Ctr Astrophys & Supercomp, Hawthorn, Vic, Australia; [Aravena, M.] Univ Diego Portales, Fac Ingn & Ciencias, Nucleo Astron, Santiago, Chile; [da Cunha, E.] Univ Western Australia, Ctr Radio Astron Res, Crawley, WA, Australia; [da Cunha, E.] ARC Ctr Excellence All Sky Astrophys 3 Dimens AST, Canberra, ACT, Australia; [Dayal, P.; Hutter, A.; Ucci, G.] Univ Groningen, Kapteyn Astron Inst, Groningen, Netherlands; [Ferrara, A.; Pallottini, A.] Scuola Normale Super Pisa, Pisa, Italy; [Graziani, L.; Schneider, R.] Sapienza Univ Roma, Dipartimento Fis, Rome, Italy; [Schneider, R.] INAF Osservatorio Astron Roma, Rome, Italy; [Graziani, L.] INAF Osservatorio Astrofis Arcetri, Florence, Italy; [Li, Y.] Penn State Univ, Dept Astron & Astrophys, 525 Davey Lab, University Pk, PA 16802 USA; [Li, Y.] Penn State Univ, Inst Gravitat & Cosmos, University Pk, PA 16802 USA; [De Looze, I.] Univ Ghent, Sterrenkundig Observ, Ghent, Belgium; [De Looze, I.] UCL, Dept Phys & Astron, London, England; [Riechers, D.] Cornell Univ, Ithaca, NY USA; [Schneider, R.] Sapienza Sch Adv Studies, Rome, Italy; [Graziani, L.; Schneider, R.] INFN, Rome, Italy	University of Geneva; Waseda University; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); University of Copenhagen; Niels Bohr Institute; Leiden University; Leiden University - Excl LUMC; Liverpool John Moores University; University of Oxford; University of Arizona; Universidad de Chile; Hiroshima University; Swinburne University of Technology; University Diego Portales; University of Western Australia; University of Groningen; Scuola Normale Superiore di Pisa; Sapienza University Rome; Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Ghent University; University of London; University College London; Cornell University; Istituto Nazionale di Fisica Nucleare (INFN)	Fudamoto, Y (corresponding author), Univ Geneva, Dept Astron, Versoix, Switzerland.; Fudamoto, Y (corresponding author), Waseda Univ, Res Inst Sci & Engn, Shinjuku Ku, Tokyo, Japan.; Fudamoto, Y (corresponding author), Natl Astron Observ Japan, Mitaka, Tokyo, Japan.	yoshinobu.fudamoto@gmail.com	Hutter, Anne/AAY-5687-2020; Bowler, Rebecca/HIK-2775-2022; Graziani, Luca/E-3245-2018; Nanayakkara, Themiya/AAT-6271-2020	Hutter, Anne/0000-0003-3760-461X; Graziani, Luca/0000-0002-9231-1505; Nanayakkara, Themiya/0000-0003-2804-0648; da Cunha, Elisabete/0000-0001-9759-4797; Endsley, Ryan/0000-0003-4564-2771; Inami, Hanae/0000-0003-4268-0393; Hodge, Jacqueline/0000-0001-6586-8845; Smit, Renske/0000-0001-8034-7802; Barrufet, Laia/0000-0003-1641-6185; Oesch, Pascal/0000-0001-5851-6649; Fudamoto, Yoshinobu/0000-0001-7440-8832				Adelberger KL, 2005, ASTROPHYS J, V619, P697, DOI 10.1086/426580; Aihara H, 2018, PUBL ASTRON SOC JPN, V70, DOI 10.1093/pasj/psx081; Bakx TJLC, 2020, MON NOT R ASTRON SOC, V493, P4294, DOI 10.1093/mnras/staa509; Barone-Nugent RL, 2014, ASTROPHYS J, V793, DOI 10.1088/0004-637X/793/1/17; Behrens C, 2018, MON NOT R ASTRON SOC, V477, P552, DOI 10.1093/mnras/sty552; Bethermin M, 2015, ASTRON ASTROPHYS, V573, DOI 10.1051/0004-6361/201425031; Bhowmick AK, 2020, MON NOT R ASTRON SOC, V496, P754, DOI 10.1093/mnras/staa1605; Bouwens RJ, 2015, ASTROPHYS J, V803, DOI 10.1088/0004-637X/803/1/34; Bouwens R. J., REIONIZATION ERA BRI; Bowler RAA, 2020, MON NOT R ASTRON SOC, V493, P2059, DOI 10.1093/mnras/staa313; Bowler RAA, 2018, MON NOT R ASTRON SOC, V481, P1631, DOI 10.1093/mnras/sty2368; Bowler RAA, 2017, MON NOT R ASTRON SOC, V466, P3612, DOI 10.1093/mnras/stw3296; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; Byler N, 2017, ASTROPHYS J, V840, DOI 10.3847/1538-4357/aa6c66; Calzetti D, 2000, ASTROPHYS J, V533, P682, DOI 10.1086/308692; Capak PL, 2015, NATURE, V522, P455, DOI 10.1038/nature14500; Carilli CL, 2013, ANNU REV ASTRON ASTR, V51, P105, DOI 10.1146/annurev-astro-082812-140953; Carnall AC, 2018, MON NOT R ASTRON SOC, V480, P4379, DOI 10.1093/mnras/sty2169; Casey CM, 2018, ASTROPHYS J, V862, DOI 10.3847/1538-4357/aac82d; Casey CM, 2012, MON NOT R ASTRON SOC, V425, P3094, DOI 10.1111/j.1365-2966.2012.21455.x; Charlot S, 2000, ASTROPHYS J, V539, P718, DOI 10.1086/309250; da Cunha E, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/1/13; De Looze I, 2014, ASTRON ASTROPHYS, V568, DOI 10.1051/0004-6361/201322489; De Vis P, 2019, ASTRON ASTROPHYS, V623, DOI 10.1051/0004-6361/201834444; Decarli R, 2017, NATURE, V545, P457, DOI 10.1038/nature22358; Dessauges-Zavadsky M, 2020, ASTRON ASTROPHYS, V643, DOI 10.1051/0004-6361/202038231; Draine BT, 2007, ASTROPHYS J, V657, P810, DOI 10.1086/511055; Dudzeviciute U, 2020, MON NOT R ASTRON SOC, V494, P3828, DOI 10.1093/mnras/staa769; Erben T, 2009, ASTRON ASTROPHYS, V493, P1197, DOI 10.1051/0004-6361:200810426; Faisst A.L., 2020, MON NOT R ASTRON SOC, V498, P4192, DOI [10.1093/mnras/staa2545, DOI 10.1093/MNRAS/STAA2545]; Ferland GJ, 2017, REV MEX ASTRON ASTR, V53, P385; Fudamoto Y, 2020, ASTRON ASTROPHYS, V643, DOI 10.1051/0004-6361/202038163; Graziani L, 2020, MON NOT R ASTRON SOC, V494, P1071, DOI 10.1093/mnras/staa796; Gruppioni C, 2013, MON NOT R ASTRON SOC, V432, P23, DOI 10.1093/mnras/stt308; Hashimoto T, 2019, PUBL ASTRON SOC JPN, V71, DOI 10.1093/pasj/psz049; Jarvis MJ, 2013, MON NOT R ASTRON SOC, V428, P1281, DOI 10.1093/mnras/sts118; Kroupa P, 2002, MON NOT R ASTRON SOC, V336, P1188, DOI 10.1046/j.1365-8711.2002.05848.x; Laporte N, 2017, ASTROPHYS J LETT, V837, DOI 10.3847/2041-8213/aa62aa; Liang LC, 2019, MON NOT R ASTRON SOC, V489, P1397, DOI 10.1093/mnras/stz2134; Madau P, 2014, ANNU REV ASTRON ASTR, V52, P415, DOI 10.1146/annurev-astro-081811-125615; Mancini M, 2016, MON NOT R ASTRON SOC, V462, P3130, DOI 10.1093/mnras/stw1783; Marrone DP, 2018, NATURE, V553, P51, DOI 10.1038/nature24629; Mazzucchelli C, 2019, ASTROPHYS J, V881, DOI 10.3847/1538-4357/ab2f75; McCracken HJ, 2012, ASTRON ASTROPHYS, V544, DOI 10.1051/0004-6361/201219507; Ono Y, 2018, PUBL ASTRON SOC JPN, V70, DOI 10.1093/pasj/psx103; Peebles P. J., 1980, LARGE SCALE STRUCTUR; Qiu YS, 2018, MON NOT R ASTRON SOC, V481, P4885, DOI 10.1093/mnras/sty2633; Riechers DA, 2020, ASTROPHYS J, V895, DOI 10.3847/1538-4357/ab8c48; Riechers DA, 2013, NATURE, V496, P329, DOI 10.1038/nature12050; Schaerer D, 2020, ASTRON ASTROPHYS, V643, DOI 10.1051/0004-6361/202037617; Schreiber C, 2018, ASTRON ASTROPHYS, V609, DOI 10.1051/0004-6361/201731506; Schreiber C, 2015, ASTRON ASTROPHYS, V575, DOI 10.1051/0004-6361/201425017; Scoville N, 2007, ASTROPHYS J SUPPL S, V172, P38, DOI 10.1086/516580; Sommovigo L, 2020, MON NOT R ASTRON SOC, V497, P956, DOI 10.1093/mnras/staa1959; Stefanon M, 2019, ASTROPHYS J, V883, DOI 10.3847/1538-4357/ab3792; Strandet ML, 2017, ASTROPHYS J LETT, V842, DOI 10.3847/2041-8213/aa74b0; Swinbank AM, 2014, MON NOT R ASTRON SOC, V438, P1267, DOI 10.1093/mnras/stt2273; Tamura Y, 2019, ASTROPHYS J, V874, DOI 10.3847/1538-4357/ab0374; Uzgil BD, 2021, ASTROPHYS J, V912, DOI 10.3847/1538-4357/abe86b; Walter F, 2012, NATURE, V486, P233, DOI 10.1038/nature11073; Wang R, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/1/44; Wang T, 2019, NATURE, V572, P211, DOI 10.1038/s41586-019-1452-4; Watson D, 2015, NATURE, V519, P327, DOI 10.1038/nature14164; Whitaker KE, 2017, ASTROPHYS J, V850, DOI 10.3847/1538-4357/aa94ce; Williams CC, 2019, ASTROPHYS J, V884, DOI 10.3847/1538-4357/ab44aa; Zavala JA, 2021, ASTROPHYS J, V909, DOI 10.3847/1538-4357/abdb27	66	27	28	1	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2021	597	7877					489	+		10.1038/s41586-021-03846-z	http://dx.doi.org/10.1038/s41586-021-03846-z			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UW6NQ	34552254	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000700270400012
J	Nathan, P; Hassel, JC; Rutkowski, P; Baurain, JF; Butler, MO; Schlaak, M; Sullivan, RJ; Ochsenreither, S; Dummer, R; Kirkwood, JM; Joshua, AM; Sacco, JJ; Shoushtari, AN; Orloff, M; Piulats, JM; Milhem, M; Salama, AKS; Curti, B; Demidov, L; Gastaud, L; Mauch, C; Yushak, M; Carvajal, RD; Hamid, O; Abdullah, SE; Holland, C; Goodall, H; Piperno-Neumann, S				Nathan, Paul; Hassel, Jessica C.; Rutkowski, Piotr; Baurain, Jean-Francois; Butler, Marcus O.; Schlaak, Max; Sullivan, Ryan J.; Ochsenreither, Sebastian; Dummer, Reinhard; Kirkwood, John M.; Joshua, Anthony M.; Sacco, Joseph J.; Shoushtari, Alexander N.; Orloff, Marlana; Piulats, Josep M.; Milhem, Mohammed; Salama, April K. S.; Curti, Brendan; Demidov, Lev; Gastaud, Lauris; Mauch, Cornelia; Yushak, Melinda; Carvajal, Richard D.; Hamid, Omid; Abdullah, Shaad E.; Holland, Chris; Goodall, Howard; Piperno-Neumann, Sophie		IMCgp100-202 Investigators	Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MULTICENTER; IMCGP100; CRITERIA	Background Uveal melanoma is a disease that is distinct from cutaneous melanoma, with a low tumor mutational burden and a 1-year overall survival of approximately 50% in patients with metastatic uveal melanoma. Data showing a proven overall survival benefit with a systemic treatment are lacking. Tebentafusp is a bispecific protein consisting of an affinity-enhanced T-cell receptor fused to an anti-CD3 effector that can redirect T cells to target glycoprotein 100-positive cells. Methods In this open-label, phase 3 trial, we randomly assigned previously untreated HLA-A*02:01-positive patients with metastatic uveal melanoma in a 2:1 ratio to receive tebentafusp (tebentafusp group) or the investigator's choice of therapy with single-agent pembrolizumab, ipilimumab, or dacarbazine (control group), stratified according to the lactate dehydrogenase level. The primary end point was overall survival. Results A total of 378 patients were randomly assigned to either the tebentafusp group (252 patients) or the control group (126 patients). Overall survival at 1 year was 73% in the tebentafusp group and 59% in the control group (hazard ratio for death, 0.51; 95% confidence interval [CI], 0.37 to 0.71; P<0.001) in the intention-to-treat population. Progression-free survival was also significantly higher in the tebentafusp group than in the control group (31% vs. 19% at 6 months; hazard ratio for disease progression or death, 0.73; 95% CI, 0.58 to 0.94; P=0.01). The most common treatment-related adverse events in the tebentafusp group were cytokine-mediated events (due to T-cell activation) and skin-related events (due to glycoprotein 100-positive melanocytes), including rash (83%), pyrexia (76%), and pruritus (69%). These adverse events decreased in incidence and severity after the first three or four doses and infrequently led to discontinuation of the trial treatment (2%). No treatment-related deaths were reported. Conclusions Treatment with tebentafusp resulted in longer overall survival than the control therapy among previously untreated patients with metastatic uveal melanoma. (Funded by Immunocore; ClinicalTrials.gov number, ; EudraCT number, .) Tebentafusp for Uveal Melanoma Metastatic uveal melanoma is an aggressive disease without an established standard treatment. In a randomized trial that evaluated tebentafusp, a soluble T-cell receptor bispecific protein, overall survival at 1 year was 73% among patients who received tebentafusp, as compared with 59% among those who received the investigator's choice of therapy.	[Nathan, Paul] Mt Vernon Canc Ctr, Northwood HA6 2RN, Middx, England; [Sacco, Joseph J.] Clatterbridge Canc Ctr NHS Fdn Trust, Wirral, Merseyside, England; [Sacco, Joseph J.] Univ Liverpool, Liverpool, Merseyside, England; [Abdullah, Shaad E.; Holland, Chris; Goodall, Howard] Immunocore, Abingdon, Oxon, England; [Hassel, Jessica C.] Univ Hosp Heidelberg, Dept Dermatol, Heidelberg, Germany; [Hassel, Jessica C.] Univ Hosp Heidelberg, Natl Ctr Tumor Dis, Heidelberg, Germany; [Schlaak, Max] Ludwig Maximilian Univ Munich, Univ Hosp, Dept Dermatol & Allergy, Munich, Germany; [Ochsenreither, Sebastian] Charite Comprehens Canc Ctr, Dept Hematol & Oncol, Berlin, Germany; [Mauch, Cornelia] Univ Hosp Cologne, Dept Dermatol, Cologne, Germany; [Mauch, Cornelia] Univ Hosp Cologne, Ctr Integrated Oncol, Cologne, Germany; [Rutkowski, Piotr] Maria Sklodowska Curie Natl Res Inst Oncol, Warsaw, Poland; [Baurain, Jean-Francois] Clin Univ St Luc, Inst Roi Albert II Clin, Brussels, Belgium; [Baurain, Jean-Francois] Catholic Univ Louvain, Brussels, Belgium; [Butler, Marcus O.] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Sullivan, Ryan J.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Dummer, Reinhard] Univ Hosp Zurich, Dept Dermatol, Zurich, Switzerland; [Kirkwood, John M.] Univ Pittsburgh, Hillman Canc Ctr, Med Ctr, Pittsburgh, PA USA; [Orloff, Marlana] Thomas Jefferson Univ Hosp, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Joshua, Anthony M.] St Vincents Hosp, Kinghorn Canc Ctr, Darlinghurst, NSW, Australia; [Shoushtari, Alexander N.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Carvajal, Richard D.] Columbia Univ, Irving Med Ctr, New York, NY USA; [Piulats, Josep M.] Inst Catala Oncol, Inst Invest Biomed Bellvitge, Ctr Invest Biomed Red Oncol, Barcelona, Spain; [Milhem, Mohammed] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA; [Salama, April K. S.] Duke Univ, Durham, NC USA; [Curti, Brendan] Providence Canc Inst, Earle A Chiles Res Inst, Portland, OR USA; [Demidov, Lev] NN Blokhin Canc Res Ctr, Moscow, Russia; [Gastaud, Lauris] Ctr Antoine Lacassagne, Nice, France; [Piperno-Neumann, Sophie] Paris Sci & Letters Res Univ, Inst Curie, Paris, France; [Yushak, Melinda] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Hamid, Omid] Angeles Clin & Res Inst, Los Angeles, CA USA	Mount Vernon Cancer Centre; University of Liverpool; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Cologne; University of Cologne; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Harvard University; Massachusetts General Hospital; University of Zurich; University Zurich Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Jefferson University; St Vincents Hospital Sydney; Memorial Sloan Kettering Cancer Center; Columbia University; NewYork-Presbyterian Hospital; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Iowa; Duke University; N.N. Blokhin Russian Cancer Research Center; UNICANCER; Centre Antoine Lacassagne; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Emory University; Angeles Clinic & Research Institute	Nathan, P (corresponding author), Mt Vernon Canc Ctr, Northwood HA6 2RN, Middx, England.	p.nathan@nhs.net	de la Cruz-Merino, Luis/K-8633-2017; Rutkowski, Piotr/B-3907-2013	de la Cruz-Merino, Luis/0000-0002-5333-0535; Rutkowski, Piotr/0000-0002-8920-5429; Kirkwood, John/0000-0002-3570-4476; Butler, Marcus/0000-0002-9840-7057; Espinosa Arranz, Enrique/0000-0001-6562-7902; Milhem, Mohammed/0000-0003-4663-6824; Nathan, Paul/0000-0002-2327-3250; Schlaak, Max/0000-0002-1663-8098; Kapiteijn, Ellen/0000-0002-4814-6426				Bossi G, 2014, CANCER IMMUNOL IMMUN, V63, P437, DOI 10.1007/s00262-014-1525-z; Boudousquie C, 2017, IMMUNOLOGY, V152, P425, DOI 10.1111/imm.12779; Buder K, 2013, CANCER MED-US, V2, P674, DOI 10.1002/cam4.133; Carvajal RD, 2017, BRIT J OPHTHALMOL, V101, P38, DOI 10.1136/bjophthalmol-2016-309034; Coupland SE, 2013, EYE, V27, P230, DOI 10.1038/eye.2012.255; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Jager MJ, 2020, NAT REV DIS PRIMERS, V6, DOI 10.1038/s41572-020-0158-0; Khoja L, 2019, ANN ONCOL, V30, P1370, DOI 10.1093/annonc/mdz176; Kujala E, 2003, INVEST OPHTH VIS SCI, V44, P4651, DOI 10.1167/iovs.03-0538; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Lee DW, 2019, BIOL BLOOD MARROW TR, V25, P625, DOI 10.1016/j.bbmt.2018.12.758; Liddy N, 2012, NAT MED, V18, P980, DOI 10.1038/nm.2764; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Lorenzo D, 2019, JPN J OPHTHALMOL, V63, P197, DOI 10.1007/s10384-019-00656-9; Lowe KL, 2019, CANCER TREAT REV, V77, P35, DOI 10.1016/j.ctrv.2019.06.001; Piulats JM, 2021, J CLIN ONCOL, V39, P586, DOI 10.1200/JCO.20.00550; Maurer W, 2013, STAT BIOPHARM RES, V5, P311, DOI 10.1080/19466315.2013.807748; Middleton MR, 2020, CLIN CANCER RES, V26, P5869, DOI 10.1158/1078-0432.CCR-20-1247; Milam R. W., 2018, MELANOMA, P273, DOI [10.1007/978-3-319-78310-9_16, DOI 10.1007/978-3-319-78310-9_16]; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Pelster MS, 2021, J CLIN ONCOL, V39, P599, DOI 10.1200/JCO.20.00605; Rantala ES, 2019, MELANOMA RES, V29, P561, DOI 10.1097/CMR.0000000000000575; Sacco JJ, 2020, ANN ONCOL, V31, pS1442, DOI 10.1016/j.annonc.2020.10.552; van der Kooij MK, 2019, CANCERS, V11, DOI 10.3390/cancers11060845; Weis E, 2016, CURR ONCOL, V23, pE57, DOI 10.3747/co.23.2859; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Yarchoan M, 2017, NEW ENGL J MED, V377, P2500, DOI 10.1056/NEJMc1713444	28	108	108	9	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2021	385	13					1196	1206		10.1056/NEJMoa2103485	http://dx.doi.org/10.1056/NEJMoa2103485			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UT0EM	34551229	Green Accepted			2022-12-28	WOS:000697798600013
J	Taylor, L				Taylor, Luke			WHO cuts air pollution limits to save millions of lives	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Department for Environment Food and Rural Affairs, 2019, AIR POLL UK; Dyer C, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4902; Public Health England, 2019, PUBLIC HLTH ENGLAND; Rimmer A, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1558; Travaglio M, 2021, ENVIRON POLLUT, V268, DOI 10.1016/j.envpol.2020.115859; World Health Organisation, 2021, HOUSEHOLD AIR POLLUT	6	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2021	374								n2349	10.1136/bmj.n2349	http://dx.doi.org/10.1136/bmj.n2349			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ1JE	34556465				2022-12-28	WOS:000701967300011
J	Reif, J; Heun-Johnson, H; Tysinger, B; Lakdawalla, D				Reif, Julian; Heun-Johnson, Hanke; Tysinger, Bryan; Lakdawalla, Darius			Measuring the COVID-19 Mortality Burden in the United States	ANNALS OF INTERNAL MEDICINE			English	Article; Early Access							CONSEQUENCES; BENEFITS; OBESITY; RISK	Background: Fully assessing the mortality burden of the COVID-19 pandemic requires measuring years of life lost (YLLs) and accounting for quality-of-life differences. Objective: To measure YLLs and quality-adjusted life-years (QALYs) lost from the COVID-19 pandemic, by age, sex, race/ethnicity, and comorbidity. Design: State-transition microsimulation model. Data Sources: Health and Retirement Study, Panel Study of Income Dynamics, data on excess deaths from the Centers for Disease Control and Prevention, and nursing home death counts from the Centers for Medicare & Medicaid Services. Target Population: U.S. population aged 25 years and older. Time Horizon: Lifetime. Perspective: Individual. Intervention: COVID-19 pandemic through 13 March 2021. Outcome Measures: YLLs and QALYs lost per 10000 per-sons in the population. The estimates account for the age, sex, and race/ethnicity of decedents, along with obesity, smoking behavior, lung disease, heart disease, diabetes, cancer, stroke, hypertension, dementia, and nursing home residence. Results of Base-Case Analysis: The COVID-19 pandemic resulted in 6.62 million QALYs lost (9.08 million YLLs) through 13 March 2021, with 3.6 million (54%) lost by those aged 25 to 64 years. The greatest toll was on Black and Hispanic communities, especially among men aged 65 years or older, who lost 1138 and 1371 QALYs, respectively, per 10000 persons. Absent the pandemic, 38% of decedents would have had average or above-average life expectancies for their subgroup defined by age, sex, and race/ethnicity. Results of Sensitivity Analysis: Accounting for uncertainty in risk factors for death from COVID-19 yielded similar results. Limitation: Estimates may vary depending on assumptions about mortality and quality-of-life projections. Conclusion: Beyond excess deaths alone, the COVID-19 pandemic imposed a greater life expectancy burden on per-sons aged 25 to 64 years, including those with average or above-average life expectancies, and a disproportionate bur-den on Black and Hispanic communities. Primary Funding Source: National Institute on Aging.	[Reif, Julian] Univ Illinois, Dept Finance, Gies Coll Business, 515 East Gregory St, Champaign, IL 61820 USA; [Heun-Johnson, Hanke] Univ Southern Calif, Schaeffer Ctr Hlth Policy & Econ, Sol Price Sch Publ Policy, 635 Downey Way,VPD 312, Los Angeles, CA 90089 USA; [Tysinger, Bryan] Univ Southern Calif, Schaeffer Ctr Hlth Policy & Econ, Sol Price Sch Publ Policy, 635 Downey Way,VPD 514K, Los Angeles, CA 90089 USA; [Lakdawalla, Darius] Univ Southern Calif, Schaeffer Ctr Hlth Policy & Econ, Sch Pharm, 635 Downey Way VPD 414K, Los Angeles, CA 90089 USA; [Lakdawalla, Darius] Univ Southern Calif, Sol Price Sch Publ Policy, 635 Downey Way VPD 414K, Los Angeles, CA 90089 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Lakdawalla, D (corresponding author), Univ Southern Calif, Schaeffer Ctr Hlth Policy & Econ, Sch Pharm, 635 Downey Way VPD 414K, Los Angeles, CA 90089 USA.; Lakdawalla, D (corresponding author), Univ Southern Calif, Sol Price Sch Publ Policy, 635 Downey Way VPD 414K, Los Angeles, CA 90089 USA.	dlakdawa@usc.edu	Lakdawalla, Darius/B-4409-2011; Tysinger, Bryan/S-8166-2019	Lakdawalla, Darius/0000-0001-5934-8042; Tysinger, Bryan/0000-0002-8497-3664; Heun-Johnson, Hanke/0000-0002-4101-2492	National Institute on Aging [1R01AG062277]	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By grant 1R01AG062277 from the National Institute on Aging.	[Anonymous], 2020, HLTH RET STUD; [Anonymous], 2021, PAN STUD INC DYN; Arias Elizabeth, 2020, Natl Vital Stat Rep, V69, P1; Attema AE, 2014, ENCY QUALITY LIFE WE, DOI [10.1007/978-94-007-0753-5_3839, DOI 10.1007/978-94-007-0753-5_3839]; Bhaskaran K, 2021, LANCET REG HEALTH-EU, V6, DOI 10.1016/j.lanepe.2021.100109; Bhattacharya J, 2004, NBER FR HLTH POL RES, P75; Blaylock B., 2015, ESSAYS USE MICROSIMU; Centers for Disease Control and Prevention, VAR PROP; Centers for Disease Control and Prevention, VACC DEM TRENDS; Centers for Medicare & Medicaid Services, COVID 19 NURS HOM DA; Dzau VJ, 2015, LANCET, V385, P2118, DOI 10.1016/S0140-6736(15)60722-X; Elledge SJ, 2020, 2 50000000 PERSON YE, DOI [10.1101/2020.10.18.20214783, DOI 10.1101/2020.10.18.20214783]; GBD, 2020, GLOBAL BURDEN DIS CO; Goldman D, 2010, NATL TAX J, V63, P307, DOI 10.17310/ntj.2010.2.07; Goldman DP, 2013, HEALTH AFFAIR, V32, P1698, DOI 10.1377/hlthaff.2013.0052; Goldman DP, 2011, HEALTH AFFAIR, V30, P84, DOI 10.1377/hlthaff.2009.1056; Goldman DP, 2009, AM J PUBLIC HEALTH, V99, P2096, DOI 10.2105/AJPH.2009.172627; Goldman DP, 2005, HEALTH AFFAIR, V24, pW5R5; Holford TR, 2014, JAMA-J AM MED ASSOC, V311, P164, DOI 10.1001/jama.2013.285112; Jin J, 2021, NAT MED, V27, P264, DOI 10.1038/s41591-020-01191-8; Johansson-Stenman O, 2011, HEALTH ECON, V20, P723, DOI 10.1002/hec.1627; Lakdawalla DN, 2009, HEALTH AFFAIR, V28, pW138, DOI 10.1377/hlthaff.28.1.w138; Lakdawalla DN, 2005, HEALTH AFFAIR, V24, pW5R30, DOI 10.1377/hlthaff.W5.R30; Leaf DE, 2021, HEALTH ECON, V30, P52, DOI 10.1002/hec.4169; Michaud PC, 2012, J HEALTH ECON, V31, P630, DOI 10.1016/j.jhealeco.2012.04.006; Mitra AK, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124392; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008; Quast T, 2020, J PUBLIC HEALTH-UK, V42, P717, DOI 10.1093/pubmed/fdaa159; Snider JT, 2014, AM J HEALTH PROMOT, V28, P218, DOI 10.4278/ajhp.121116-QUAN-561; Social Security Administration, 2016, 2016 ANN REP BOARD T; Tysinger B., 2020, INT J MICROSIMULATIO, V13, P54, DOI [10.34196/IJM.00225, DOI 10.34196/IJM.00225]; Watkins DA, 2017, NEW ENGL J MED, V377, P713, DOI 10.1056/NEJMoa1603693; Wetzler HP, COVID 19 HOW MANY YE, DOI [10.1101/2020.06.08.20050559, DOI 10.1101/2020.06.08.20050559]; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Yanez ND, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09826-8	37	3	3	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.												10.7326/M21-2239	http://dx.doi.org/10.7326/M21-2239		SEP 2021	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XN1NB	34543588	Green Published			2022-12-28	WOS:000729278300001
J	Dyer, C				Dyer, Clare			Doctors can decide if children are able to consent to puberty blockers, say judges	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Dyer C, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4699	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 20	2021	374								n2307	10.1136/bmj.n2307	http://dx.doi.org/10.1136/bmj.n2307			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ1DH	34544798				2022-12-28	WOS:000701952000011
J	Neuhofer, P; Roake, CM; Kim, SJ; Lu, RJ; West, RB; Charville, GW; Artandi, SE				Neuhofer, Patrick; Roake, Caitlin M.; Kim, Stewart J.; Lu, Ryan J.; West, Robert B.; Charville, Gregory W.; Artandi, Steven E.			Acinar cell clonal expansion in pancreas homeostasis and carcinogenesis	NATURE			English	Article							INTRAEPITHELIAL NEOPLASIA; SOMATIC MUTATIONS; CANCER; KRAS; REGENERATION; ORIGIN; NOTCH	Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer deaths worldwide(1). Studies in human tissues and in mouse models have suggested that for many cancers, stem cells sustain early mutations driving tumour development(2,3). For the pancreas, however, mechanisms underlying cellular renewal and initiation of PDAC remain unresolved. Here, using lineage tracing from the endogenous telomerase reverse transcriptase (Tert) locus, we identify a rare TERT-positive subpopulation of pancreatic acinar cells dispersed throughout the exocrine compartment. During homeostasis, these TERThigh acinar cells renew the pancreas by forming expanding clones of acinar cells, whereas randomly marked acinar cells do not form these clones. Specific expression of mutant Kras in TERThigh acinar cells accelerates acinar clone formation and causes transdifferentiation to ductal pre-invasive pancreatic intraepithelial neoplasms by upregulating Ras-MAPK signalling and activating the downstream kinase ERK (phospho-ERK). In resected human pancreatic neoplasms, we find that foci of phospho-ERK-positive acinar cells are common and frequently contain activating KRAS mutations, suggesting that these acinar regions represent an early cancer precursor lesion. These data support a model in which rare TERThigh acinar cells may sustain KRAS mutations, driving acinar cell expansion and creating a field of aberrant cells initiating pancreatic tumorigenesis.	[Neuhofer, Patrick; Roake, Caitlin M.; Kim, Stewart J.; Lu, Ryan J.; Artandi, Steven E.] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA; [Neuhofer, Patrick; Roake, Caitlin M.; Kim, Stewart J.; Lu, Ryan J.; Artandi, Steven E.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Neuhofer, Patrick; Roake, Caitlin M.; Kim, Stewart J.; Lu, Ryan J.; Artandi, Steven E.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [West, Robert B.; Charville, Gregory W.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Stanford Cancer Institute; Stanford University; Stanford University; Stanford University; Stanford University	Artandi, SE (corresponding author), Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA.; Artandi, SE (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.; Artandi, SE (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	sartandi@stanford.edu	Neuhoefer, Patrick/AAD-1567-2020	Neuhoefer, Patrick/0000-0003-3936-383X; Artandi, Steven/0000-0001-5580-7512; Kim, Stewart/0000-0001-7196-0541; West, Robert/0000-0002-8330-8283	NIH [AG056575, CA244114, CA197563]; Emerson Collective; DFG [NE 2006/1-1]; California TRDRP [25FT-0011]; California Institute for Regenerative Medicine	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emerson Collective; DFG(German Research Foundation (DFG)); California TRDRP; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	This work was supported by grants from the NIH (AG056575, CA244114 and CA197563; S.E.A.), the Emerson Collective (S.E.A.), anonymous support (S.E.A.), the DFG (NE 2006/1-1; P.N.), California TRDRP (25FT-0011; P.N.) and the California Institute for Regenerative Medicine (R.J.L.). We thank members of the Artandi laboratory for critical comments and P. Chu from the Stanford Human Pathology/Histology Service Center for technical assistance, and acknowledge the Stanford Functional Genomics Facility and Stanford Shared FACS Facility.	Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Bryant KL, 2014, TRENDS BIOCHEM SCI, V39, P91, DOI 10.1016/j.tibs.2013.12.004; Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; Collins MA, 2014, GASTROENTEROLOGY, V146, P822, DOI 10.1053/j.gastro.2013.11.052; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Flowers BM, 2021, CANCER DISCOV, V11, P660, DOI 10.1158/2159-8290.CD-20-0633; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; Hegyi P, 2004, WORLD J GASTROENTERO, V10, P2003, DOI 10.3748/wjg.v10.i14.2003; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hruban RH, 2000, CLIN CANCER RES, V6, P2969; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Jean-Paul D, 2008, P NATL ACAD SCI USA, V105, P18907, DOI 10.1073/pnas.0810111105; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kanda M, 2012, GASTROENTEROLOGY, V142, P730, DOI 10.1053/j.gastro.2011.12.042; Kopinke D, 2012, DEV BIOL, V362, P57, DOI 10.1016/j.ydbio.2011.11.010; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Lee J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14686; Lin SD, 2018, NATURE, V556, P244, DOI 10.1038/s41586-018-0004-7; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Martincorena I, 2018, SCIENCE, V362, P911, DOI 10.1126/science.aau3879; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; Murtaugh LC, 2015, ANNU REV PHYSIOL, V77, P229, DOI 10.1146/annurev-physiol-021014-071727; Pech MF, 2015, GENE DEV, V29, P2420, DOI 10.1101/gad.271783.115; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Rawla P, 2019, WORLD J ONCOL, V10, P10, DOI 10.14740/wjon1166; Roake CM, 2020, NAT REV MOL CELL BIO, V21, P384, DOI 10.1038/s41580-020-0234-z; Sangiorgi E, 2009, P NATL ACAD SCI USA, V106, P7101, DOI 10.1073/pnas.0902508106; Shi CJ, 2009, MOL CANCER RES, V7, P230, DOI 10.1158/1541-7786.MCR-08-0206; Westphalen CB, 2016, CELL STEM CELL, V18, P441, DOI 10.1016/j.stem.2016.03.016; Ying HQ, 2016, GENE DEV, V30, P355, DOI 10.1101/gad.275776.115	34	9	9	2	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 30	2021	597	7878					715	+		10.1038/s41586-021-03916-2	http://dx.doi.org/10.1038/s41586-021-03916-2		SEP 2021	18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UZ1UN	34526722	Green Accepted			2022-12-28	WOS:000696175300007
J	Mahase, E				Mahase, Elisabeth			NEWS ANALYSIS GPs are being blamed for government failures in primary care, say doctors	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], TIMES; BMA, SUPP YOUR SURG; BMA, 2021, PRESS GEN PRACT; Donnelly L., 2021, TELEGRAPH; Drage M., 2021, DR M DRAGES LATEST U; Hodes S, 2021, BMJ OPINION; Mahase Elisabeth, 2021, BMJ, V374, pn1977, DOI 10.1136/bmj.n1977; Marshall M, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2236; NHS Digital, 2021, APP GEN PRACT; NHS Digital, 2019, APP GEN PRACT; Pearce C, 2021, PULSE; Pemberton M., 2021, SPECTATOR, P12; Walker P., 2021, GUARDIAN JUL	13	12	12	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 13	2021	374								n2234	10.1136/bmj.n2234	http://dx.doi.org/10.1136/bmj.n2234			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UR8KQ	34518166	Bronze			2022-12-28	WOS:000696991500004
J	Miyazaki, K; Miyazaki, KW				Miyazaki, Katsuhiko; Miyazaki, Kayoko W.			Increased serotonin prevents compulsion in addiction	SCIENCE			English	Editorial Material									[Miyazaki, Katsuhiko; Miyazaki, Kayoko W.] Grad Univ, Neural Computat Unit, Okinawa Inst Sci Technol, Okinawa, Japan	Okinawa Institute of Science & Technology Graduate University	Miyazaki, K (corresponding author), Grad Univ, Neural Computat Unit, Okinawa Inst Sci Technol, Okinawa, Japan.	miyazaki@oist.jp						Alsio J, 2021, CEREB CORTEX, V31, P1090, DOI 10.1093/cercor/bhaa277; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Flakowski J., 2021, ZENODO, DOI [10.5281/zenodo.5091499, DOI 10.5281/ZENODO.5091499]; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Luscher C, 2020, NAT REV NEUROSCI, V21, P247, DOI 10.1038/s41583-020-0289-z; Miyazaki K, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc7246; Nautiyal KM, 2015, NEURON, V86, P813, DOI 10.1016/j.neuron.2015.03.041; Pascoli V, 2018, NATURE, V564, P366, DOI 10.1038/s41586-018-0789-4; Pascoli V, 2015, NEURON, V88, DOI 10.1016/j.neuron.2015.10.017; Pelloux Y, 2012, NEUROPSYCHOPHARMACOL, V37, P2505, DOI 10.1038/npp.2012.111; Rocha BA, 1998, NAT NEUROSCI, V1, P132, DOI 10.1038/381; Simmler LD, 2019, ACS CHEM NEUROSCI, V10, P3053, DOI 10.1021/acschemneuro.9b00005; Sora I, 1998, P NATL ACAD SCI USA, V95, P7699, DOI 10.1073/pnas.95.13.7699	14	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2021	373	6560					1197	1198		10.1126/science.abl6285	http://dx.doi.org/10.1126/science.abl6285			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UP5RB	34516803				2022-12-28	WOS:000695436000013
J	Mahase, E				Mahase, Elisabeth			Offer medical cannabis to patients with chronic pain, experts recommend	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		NICE, CANN BAS MED PROD	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 8	2021	374								n2208	10.1136/bmj.n2208	http://dx.doi.org/10.1136/bmj.n2208			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UR3BY	34497049				2022-12-28	WOS:000696628700002
J	Kuehn, BM				Kuehn, Bridget M.			Testing Monoclonal Antibodies for Rabies Prophylaxis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2021	326	9					801	801		10.1001/jama.2021.13757	http://dx.doi.org/10.1001/jama.2021.13757			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ7LK	34547096				2022-12-28	WOS:000696242100029
J	Mateus, J; Dan, JM; Zhang, ZL; Moderbacher, CR; Lammers, M; Goodwin, B; Sette, A; Crotty, S; Weiskopf, D				Mateus, Jose; Dan, Jennifer M.; Zhang, Zeli; Moderbacher, Carolyn Rydyznski; Lammers, Marshall; Goodwin, Benjamin; Sette, Alessandro; Crotty, Shane; Weiskopf, Daniela			Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells	SCIENCE			English	Article							HEALTH-CARE WORKERS; SARS-COV-2 INFECTION; MULTICENTER; ENGLAND	Vaccine-specific CD4(+) T cell, CD8(+) T cell, binding antibody, and neutralizing antibody responses to the 25-mu g Moderna messenger RNA (mRNA)-1273 vaccine were examined over the course of 7 months after immunization, including in multiple age groups, with a particular interest in assessing whether preexisting cross-reactive T cell memory affects vaccine-generated immunity. Vaccine-generated spike-specific memory CD4(+) T cells 6 months after the second dose of the vaccine were comparable in quantity and quality to COVID-19 cases, including the presence of T follicular helper cells and interferon-gamma-expressing cells. Spike-specific CD8(+) T cells were generated in 88% of subjects, with equivalent memory at 6 months post-boost compared with COVID-19 cases. Lastly, subjects with preexisting cross-reactive CD4(+) T cell memory exhibited stronger CD4(+) T cell and antibody responses to the vaccine, demonstrating the biological relevance of severe acute respiratory syndrome coronavirus 2-cross-reactive CD4(+) T cells.	[Mateus, Jose; Dan, Jennifer M.; Zhang, Zeli; Moderbacher, Carolyn Rydyznski; Lammers, Marshall; Goodwin, Benjamin; Sette, Alessandro; Crotty, Shane; Weiskopf, Daniela] La Jolla Inst Immunol LJI, Ctr Infect Dis & Vaccine Res, La Jolla, CA 92037 USA; [Dan, Jennifer M.; Sette, Alessandro; Crotty, Shane] Univ Calif San Diego UCSD, Dept Med, Div Infect Dis & Global Publ Hlth, La Jolla, CA 92037 USA	La Jolla Institute for Immunology; University of California System; University of California San Diego	Sette, A; Crotty, S; Weiskopf, D (corresponding author), La Jolla Inst Immunol LJI, Ctr Infect Dis & Vaccine Res, La Jolla, CA 92037 USA.; Sette, A; Crotty, S (corresponding author), Univ Calif San Diego UCSD, Dept Med, Div Infect Dis & Global Publ Hlth, La Jolla, CA 92037 USA.	alex@lji.org; shane@lji.org; daniela@lji.org	Sette, Alessandro/AFO-8916-2022; Zhang, Zeli/AGP-8221-2022	Weiskopf, Daniela/0000-0003-2968-7371; Goodwin, Benjamin/0000-0002-5485-2861; Dan, Jennifer/0000-0002-1672-0657; Sette, Alessandro/0000-0001-7013-2250; Rydyznski Moderbacher, Carolyn/0000-0002-7965-9902				Abu-Raddad LJ, 2021, ECLINICALMEDICINE, V35, DOI 10.1016/j.eclinm.2021.100861; Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1038/s41591-020-0913-5, 10.1101/2020.03.17.20037713]; Amit S, 2021, LANCET, V397, P875, DOI 10.1016/S0140-6736(21)00448-7; Anderson EJ, 2020, NEW ENGL J MED, V383, P2427, DOI 10.1056/NEJMoa2028436; Anderson EM, 2021, CELL, V184, P1858, DOI 10.1016/j.cell.2021.02.010; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Boyton RJ, 2021, LANCET, V397, P1161, DOI 10.1016/S0140-6736(21)00662-0; Braun J, 2020, NATURE, V587, P270, DOI 10.1038/s41586-020-2598-9; Pro SC, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/763461; Cohen KW, 2021, CELL REP MED, V2, DOI [10.1016/j.xcrm.2021.100354, 10.1101/2021.04.19.21255739]; Corbett KS, 2020, NEW ENGL J MED, V383, P1544, DOI 10.1056/NEJMoa2024671; Crotty S, 2019, IMMUNITY, V50, P1132, DOI 10.1016/j.immuni.2019.04.011; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Doria-Rose N, 2021, NEW ENGL J MED, V384, P2259, DOI 10.1056/NEJMc2103916; Faria NR, 2021, SCIENCE, V372, P815, DOI [10.1126/science.abh2644Article, 10.1126/science.abh2644, 10.1101/2021.02.26.21252554]; Frenck RW, 2021, NEW ENGL J MED, V385, P239, DOI 10.1056/NEJMoa2107456; Gilbert Peter B, 2021, medRxiv, DOI 10.1101/2021.08.09.21261290; Grifoni A, 2021, CELL HOST MICROBE, V29, P1076, DOI 10.1016/j.chom.2021.05.010; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Grifoni A, 2020, CELL HOST MICROBE, V27, P671, DOI 10.1016/j.chom.2020.03.002; Gustafson CE, 2020, J ALLERGY CLIN IMMUN, V145, P1309, DOI 10.1016/j.jaci.2020.03.017; Hall VJ, 2021, LANCET, V397, P1725, DOI 10.1016/S0140-6736(21)00790-X; Hall VJ, 2021, LANCET, V397, P1459, DOI 10.1016/S0140-6736(21)00675-9; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Kotturi MF, 2007, J VIROL, V81, P4928, DOI 10.1128/JVI.02632-06; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Leidi A, 2022, CLIN INFECT DIS, V74, P622, DOI 10.1093/cid/ciab495; Li CS, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24230-5; Lipsitch M, 2020, NAT REV IMMUNOL, V20, P709, DOI 10.1038/s41577-020-00460-4; Lumley SF, 2021, NEW ENGL J MED, V384, P533, DOI 10.1056/NEJMoa2034545; Mateus J, 2020, SCIENCE, V370, P89, DOI 10.1126/science.abd3871; Meckiff BJ, 2020, CELL, V183, P1340, DOI 10.1016/j.cell.2020.10.001; Moderbacher CR, 2020, CELL, V183, P996, DOI 10.1016/j.cell.2020.09.038; Pawlowski C, 2021, MED-CAMBRIDGE, V2, P979, DOI 10.1016/j.medj.2021.06.007; Pegu A, 2021, SCIENCE, V373, P1372, DOI 10.1126/science.abj4176; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Sagar M, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI143380; Sahin U, 2021, NATURE, V595, P572, DOI 10.1038/s41586-021-03653-6; Sette A, 2021, CELL, V184, P861, DOI 10.1016/j.cell.2021.01.007; Sette A, 2020, NAT REV IMMUNOL, V20, P457, DOI 10.1038/s41577-020-0389-z; Soiza RL, 2021, AGE AGEING, V50, P279, DOI 10.1093/ageing/afaa274; Tan AT, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108728; Tauzin A, 2021, CELL HOST MICROBE, V29, P1137, DOI 10.1016/j.chom.2021.06.001; Thomas, 2021, 6 MONTH SAFETY EFFIC, DOI [10.1101/2021.07.28.21261159, DOI 10.1101/2021.07.28.21261159]; US Food and Drug Administration, 2020, VACC REL BIOL PROD A; Wang ZJ, 2021, NATURE, V595, P426, DOI 10.1038/s41586-021-03696-9; Weiskopf D, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd2071; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Zuo JM, 2021, NAT IMMUNOL, V22, P620, DOI 10.1038/s41590-021-00902-8	51	92	92	7	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2021	374	6566					420	+	eabj9853	10.1126/science.abj9853	http://dx.doi.org/10.1126/science.abj9853			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WL2OU	34519540	Green Accepted, Green Submitted			2022-12-28	WOS:000710251800035
J	Renzoni, EA; Poletti, V; Mackintosh, JA				Renzoni, Elisabetta A.; Poletti, Venerino; Mackintosh, John A.			Disease pathology in fibrotic interstitial lung disease: is it all about usual interstitial pneumonia?	LANCET			English	Review							IDIOPATHIC PULMONARY-FIBROSIS; MUC5B PROMOTER POLYMORPHISM; SYSTEMIC-SCLEROSIS; MYCOPHENOLATE-MOFETIL; DOUBLE-BLIND; PATHOGENESIS; SURVIVAL; DIFFERENTIATION; CLASSIFICATION; DIAGNOSIS	The interstitial pneumonias comprise a diverse group of diseases that are typically defined by their cause (either idiopathic or non-idiopathic) and their distinct histopathological features, for which radiology, in the form of high-resolution CT, is often used as a surrogate. One trend, fuelled by the failure of conventional therapies in a subset of patients and the broad-spectrum use of antifibrotic therapies, has been the focus on the progressive fibrosing phenotype of interstitial lung disease. The histological pattern, known as usual interstitial pneumonia, is the archetype of progressive fibrosis. However, it is clear that progressive fibrosis is not exclusive to this histological entity. Techniques including immunohistochemistry and single-cell RNA sequencing are providing pathogenetic insights and, if integrated with traditional histopathology, are likely to have an effect on the pathological classification of interstitial lung disease. This review, which focuses on the histopathology of interstitial lung disease and its relationship with progressive fibrosis, asks the question: is it all about usual interstitial pneumonia?	[Renzoni, Elisabetta A.] Guys & St Thomas NHS Fdn Trust, Royal Brompton & Harefield Clin Grp, Interstitial Lung Dis Unit, London, England; [Renzoni, Elisabetta A.] Imperial Coll London, Natl Heart & Lung Inst, Margaret Turner Warwick Ctr Fibrosing Lung Dis, London, England; [Poletti, Venerino] Aarhus Univ Hosp, Dept Resp Dis & Allergy, Aarhus, Denmark; [Poletti, Venerino] Univ Bologna, GB Morgagni Hosp, Thorac Dis Dept, Forli, Italy; [Mackintosh, John A.] Prince Charles Hosp, Dept Thorac Med, Brisbane, Qld 4032, Australia	Guy's & St Thomas' NHS Foundation Trust; Imperial College London; Aarhus University; University of Bologna; Prince Charles Hospital	Mackintosh, JA (corresponding author), Prince Charles Hosp, Dept Thorac Med, Brisbane, Qld 4032, Australia.	john.mackintosh@health.qld.gov.au		Mackintosh, John/0000-0002-5254-4144				Adams TS, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba1983; Adegunsoye A, 2019, ANN AM THORAC SOC, V16, P580, DOI 10.1513/AnnalsATS.201807-443OC; Ayaub E., 2021, CELL BIOL, DOI [10.1101/2021.01.04.425268, DOI 10.1101/2021.01.04.425268]; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Bonifazi M, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.02135-2019; Brown KK, 2020, EUR RESPIR J, V55; Cecchini MJ, 2021, AM J SURG PATHOL, V45, P871, DOI 10.1097/PAS.0000000000001725; Chambers Rachel C, 2015, Ann Am Thorac Soc, V12 Suppl 1, pS16, DOI 10.1513/AnnalsATS.201410-448MG; Chilosi M, 2010, SARCOIDOSIS VASC DIF, V27, P7; Chilosi M, 2002, LAB INVEST, V82, P1335, DOI 10.1097/01.LAB.0000032380.82232.67; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Chilosi M, 2019, IMMUNOHISTOCHEMISTRY, V1st; Chilosi M, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-95; Chilosi M, 2017, MODERN PATHOL, V30, P26, DOI 10.1038/modpathol.2016.147; Chilosi M, 2013, TRANSL RES, V162, P156, DOI 10.1016/j.trsl.2013.06.004; Churg A, 2007, AM J SURG PATHOL, V31, P277, DOI 10.1097/01.pas.0000213341.70852.9d; Churg A, 2009, AM J SURG PATHOL, V33, P1765, DOI 10.1097/PAS.0b013e3181bb2538; Collins BF, 2018, RESP MED, V144, pS20, DOI 10.1016/j.rmed.2018.08.008; Conti C, 2016, AM J RESP CRIT CARE, V193, P462, DOI 10.1164/rccm.201507-1322LE; De Sadeleer LJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01983-2019; Distler JHW, 2019, NAT REV RHEUMATOL, V15, P705, DOI 10.1038/s41584-019-0322-7; Dotan Y, 2020, ERJ OPEN RES, V6, DOI 10.1183/23120541.00261-2019; Ebata S, 2021, LANCET RHEUMATOL, V3, pE489, DOI 10.1016/S2665-9913(21)00107-7; Ebner L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226084; Fischer A, 2013, J RHEUMATOL, V40, P640, DOI 10.3899/jrheum.121043; Flaherty KR, 2019, NEW ENGL J MED, V381, P1718, DOI 10.1056/NEJMoa1908681; Flaherty KR, 2001, AM J RESP CRIT CARE, V164, P1722, DOI 10.1164/ajrccm.164.9.2103074; Furusawa H, 2020, AM J RESP CRIT CARE, V202, P1430, DOI 10.1164/rccm.202001-0134OC; Gimenez A, 2018, THORAX, V73, P391, DOI 10.1136/thoraxjnl-2017-210035; Goh NS, 2017, ARTHRITIS RHEUMATOL, V69, P1670, DOI 10.1002/art.40130; Guillotin D, 2021, THORAX, V76, P73, DOI 10.1136/thoraxjnl-2020-214902; Habermann AC, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba1972; Hayakawa H, 2002, RESPIROLOGY, V7, P359, DOI 10.1046/j.1440-1843.2002.00406.x; Hoffmann-Vold AM, 2019, EBIOMEDICINE, V50, P379, DOI 10.1016/j.ebiom.2019.10.050; Hsu E, 2011, ARTHRITIS RHEUM-US, V63, P783, DOI 10.1002/art.30159; Huang Y, 2021, AM J RESP CRIT CARE, V204, P197, DOI 10.1164/rccm.202008-3093OC; Hunninghake GM, 2013, NEW ENGL J MED, V368, P2192, DOI 10.1056/NEJMoa1216076; Jacobt J, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.00869-2018; Jones MG, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86375; Kadzik RS, 2012, CELL STEM CELL, V10, P355, DOI 10.1016/j.stem.2012.03.013; Kambouchner M, 2014, HISTOPATHOLOGY, V65, P549, DOI 10.1111/his.12415; Kamiya H, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-031444; Kelly CA, 2014, RHEUMATOLOGY, V53, P1676, DOI 10.1093/rheumatology/keu165; Kropski JA, 2015, AM J RESP CRIT CARE, V191, P417, DOI 10.1164/rccm.201406-1162OC; Latsi PI, 2003, AM J RESP CRIT CARE, V168, P531, DOI 10.1164/rccm.200210-1245OC; Lawson WE, 2011, P NATL ACAD SCI USA, V108, P10562, DOI 10.1073/pnas.1107559108; Lee JS, 2021, HISTOPATHOLOGY, V79, P67, DOI 10.1111/his.14334; Leslie KO, 2007, SEMIN RESP CRIT CARE, V28, P369, DOI 10.1055/s-2007-985609; Lopez-Mejias R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58400-0; Lynch DA, 2018, LANCET RESP MED, V6, P138, DOI 10.1016/S2213-2600(17)30433-2; Mackintosh JA, 2019, SEMIN RESP CRIT CARE, V40, P208, DOI 10.1055/s-0039-1683431; Maher TM, 2020, LANCET RESP MED, V8, P147, DOI 10.1016/S2213-2600(19)30341-8; Mayr CH, 2021, EMBO MOL MED, V13, DOI 10.15252/emmm.202012871; McDonough JE, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131597; McErlean P, 2021, AM J RESP CRIT CARE, V204, P954, DOI 10.1164/rccm.202101-0004OC; Monaghan H, 2004, CHEST, V125, P522, DOI 10.1378/chest.125.2.522; Morisset J, 2017, CHEST, V151, P619, DOI 10.1016/j.chest.2016.10.029; Morse C, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.02441-2018; Nemeth J, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.611728; Neumark N, 2020, AM J PHYSIOL-LUNG C, V319, pL887, DOI 10.1152/ajplung.00451.2020; Newton CA, 2016, EUR RESPIR J, V48, P1710, DOI 10.1183/13993003.00308-2016; Nicholson AG, 2002, AM J RESP CRIT CARE, V166, P173, DOI 10.1164/rccm.2109039; Nunes H, 2015, EUR RESPIR J, V45, P746, DOI 10.1183/09031936.00148613; Ohtani Y, 2005, THORAX, V60, P665, DOI 10.1136/thx.2004.027326; Oldham JM, 2016, EUR RESPIR J, V47, P1767, DOI 10.1183/13993003.01565-2015; Peljto AL, 2012, CHEST, V142, P1584, DOI 10.1378/chest.12-0110; Plantier L, 2011, THORAX, V66, P651, DOI 10.1136/thx.2010.151555; Prasse A, 2019, AM J RESP CRIT CARE, V199, P622, DOI 10.1164/rccm.201712-2551OC; Prassel A, 2009, AM J RESP CRIT CARE, V179, P717, DOI 10.1164/rccm.200808-1201OC; Putman RK, 2016, JAMA-J AM MED ASSOC, V315, P672, DOI 10.1001/jama.2016.0518; Raghu G, 2020, AM J RESP CRIT CARE, V202, pE36, DOI 10.1164/rccm.202005-2032ST; Raghu G, 2018, AM J RESP CRIT CARE, V198, pE44, DOI 10.1164/rccm.201807-1255ST; Reyfman PA, 2019, AM J RESP CRIT CARE, V199, P1517, DOI 10.1164/rccm.201712-2410OC; Richeldi L, 2021, AM J RESP CRIT CARE, V203, P211, DOI 10.1164/rccm.202003-0877OC; Salisbury ML, 2020, AM J RESP CRIT CARE, V201, P1230, DOI 10.1164/rccm.201909-1834OC; Salisbury ML, 2019, CHEST, V155, P699, DOI 10.1016/j.chest.2018.08.1076; Scott MKD, 2019, LANCET RESP MED, V7, P497, DOI 10.1016/S2213-2600(18)30508-3; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Selman M, 2021, EUR RESPIR J, V58, DOI 10.1183/13993003.04507-2020; Selman M, 2016, EUR RESPIR J, V48, P538, DOI 10.1183/13993003.00398-2016; Selman M, 2008, PLOS MED, V5, P373, DOI 10.1371/journal.pmed.0050062; Smith ML, 2020, ARCH PATHOL LAB MED, V144, P1477, DOI 10.5858/arpa.2020-0052-RA; Stock CJ, 2013, THORAX, V68, P436, DOI 10.1136/thoraxjnl-2012-201786; Stock CJW, 2021, J CLIN MED, V10, DOI 10.3390/jcm10071384; Strunz M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17358-3; Tateishi T, 2011, J COMPUT ASSIST TOMO, V35, P272, DOI 10.1097/RCT.0b013e318209c5a6; Thomas AQ, 2002, AM J RESP CRIT CARE, V165, P1322, DOI 10.1164/rccm.200112-123OC; Trahan S, 2008, CHEST, V134, P126, DOI 10.1378/chest.08-0033; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; TURNER-WARWICK MARGARET, 1963, THORAX, V18, P225, DOI 10.1136/thx.18.3.225; Walsh SLF, 2016, LANCET RESP MED, V4, P557, DOI 10.1016/S2213-2600(16)30033-9; Wells AU, 2020, LANCET RESP MED, V8, P453, DOI 10.1016/S2213-2600(20)30036-9; Wright JL, 2020, MODERN PATHOL, V33, P616, DOI 10.1038/s41379-019-0389-3; Wu HJ, 2020, CELL, V180, P107, DOI 10.1016/j.cell.2019.11.027; Xu Y, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.90558	96	7	7	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 16	2021	398	10309					1437	1449		10.1016/S0140-6736(21)01961-9	http://dx.doi.org/10.1016/S0140-6736(21)01961-9		OCT 2021	13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WI0TQ	34499865				2022-12-28	WOS:000708080400023
J	Inker, LA; Eneanya, ND; Coresh, J; Tighiouart, H; Wang, D; Sang, YY; Crews, DC; Doria, A; Estrella, MM; Froissart, M; Grams, ME; Greene, T; Grubb, A; Gudnason, V; Gutierrez, OM; Kalil, R; Karger, AB; Mauer, M; Navis, G; Nelson, RG; Poggio, ED; Rodby, R; Rossing, P; Rule, AD; Selvin, E; Seegmiller, JC; Shlipak, MG; Torres, VE; Yang, W; Ballew, SH; Couture, SJ; Powe, NR; Levey, AS				Inker, Lesley A.; Eneanya, Nwamaka D.; Coresh, Josef; Tighiouart, Hocine; Wang, Dan; Sang, Yingying; Crews, Deidra C.; Doria, Alessandro; Estrella, Michelle M.; Froissart, Marc; Grams, Morgan E.; Greene, Tom; Grubb, Anders; Gudnason, Vilmundur; Gutierrez, Orlando M.; Kalil, Roberto; Karger, Amy B.; Mauer, Michael; Navis, Gerjan; Nelson, Robert G.; Poggio, Emilio D.; Rodby, Roger; Rossing, Peter; Rule, Andrew D.; Selvin, Elizabeth; Seegmiller, Jesse C.; Shlipak, Michael G.; Torres, Vicente E.; Yang, Wei; Ballew, Shoshana H.; Couture, Sara J.; Powe, Neil R.; Levey, Andrew S.		Chronic Kidney Dis Epidemiology Co	New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GLOMERULAR-FILTRATION-RATE; SERUM CREATININE; NATIONAL-HEALTH; CALIBRATION; PREVALENCE	New Equations for Estimating GFR without Race Equations for estimating GFR with serum creatinine overestimate measured GFR in Blacks. The authors report new equations, without race as an inflation factor, using cystatin C and creatinine that reduced errors in estimation between Black participants and non-Black participants. Background Current equations for estimated glomerular filtration rate (eGFR) that use serum creatinine or cystatin C incorporate age, sex, and race to estimate measured GFR. However, race in eGFR equations is a social and not a biologic construct. Methods We developed new eGFR equations without race using data from two development data sets: 10 studies (8254 participants, 31.5% Black) for serum creatinine and 13 studies (5352 participants, 39.7% Black) for both serum creatinine and cystatin C. In a validation data set of 12 studies (4050 participants, 14.3% Black), we compared the accuracy of new eGFR equations to measured GFR. We projected the prevalence of chronic kidney disease (CKD) and GFR stages in a sample of U.S. adults, using current and new equations. Results In the validation data set, the current creatinine equation that uses age, sex, and race overestimated measured GFR in Blacks (median, 3.7 ml per minute per 1.73 m(2) of body-surface area; 95% confidence interval [CI], 1.8 to 5.4) and to a lesser degree in non-Blacks (median, 0.5 ml per minute per 1.73 m(2); 95% CI, 0.0 to 0.9). When the adjustment for Black race was omitted from the current eGFR equation, measured GFR in Blacks was underestimated (median, 7.1 ml per minute per 1.73 m(2); 95% CI, 5.9 to 8.8). A new equation using age and sex and omitting race underestimated measured GFR in Blacks (median, 3.6 ml per minute per 1.73 m(2); 95% CI, 1.8 to 5.5) and overestimated measured GFR in non-Blacks (median, 3.9 ml per minute per 1.73 m(2); 95% CI, 3.4 to 4.4). For all equations, 85% or more of the eGFRs for Blacks and non-Blacks were within 30% of measured GFR. New creatinine-cystatin C equations without race were more accurate than new creatinine equations, with smaller differences between race groups. As compared with the current creatinine equation, the new creatinine equations, but not the new creatinine-cystatin C equations, increased population estimates of CKD prevalence among Blacks and yielded similar or lower prevalence among non-Blacks. Conclusions New eGFR equations that incorporate creatinine and cystatin C but omit race are more accurate and led to smaller differences between Black participants and non-Black participants than new equations without race with either creatinine or cystatin C alone. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases.)	[Inker, Lesley A.; Couture, Sara J.; Levey, Andrew S.] Tufts Med Ctr, Div Nephrol, 800 Washington St,Box 391, Boston, MA 02111 USA; [Tighiouart, Hocine] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA; [Tighiouart, Hocine] Tufts Univ, Tufts Clin & Translat Sci Inst, Boston, MA 02111 USA; [Doria, Alessandro] Joslin Diabet Ctr, Sect Genet & Epidemiol, Boston, MA 02215 USA; [Doria, Alessandro] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Eneanya, Nwamaka D.] Univ Penn, Renal Electrolyte & Hypertens Div, Perelman Sch Med, Philadelphia, PA 19104 USA; [Yang, Wei] Univ Penn, Dept Biostat, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Yang, Wei] Univ Penn, Dept Epidemiol, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Yang, Wei] Univ Penn, Dept Informat, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Coresh, Josef; Wang, Dan; Sang, Yingying; Estrella, Michelle M.; Selvin, Elizabeth; Ballew, Shoshana H.] Johns Hopkins Med Inst, Dept Epidemiol, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Coresh, Josef; Wang, Dan; Sang, Yingying; Estrella, Michelle M.; Selvin, Elizabeth; Ballew, Shoshana H.] Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; [Crews, Deidra C.; Estrella, Michelle M.] Johns Hopkins Univ, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21205 USA; [Kalil, Roberto] Univ Maryland, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21201 USA; [Estrella, Michelle M.; Shlipak, Michael G.] San Francisco Vet Affairs VA Med Ctr, Kidney Hlth Res Collaborat, San Francisco, CA USA; [Estrella, Michelle M.; Shlipak, Michael G.; Powe, Neil R.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Estrella, Michelle M.] San Francisco VA Hlth Care Syst, Div Nephrol, Dept Med, San Francisco, CA USA; [Powe, Neil R.] Priscilla Chan & Mark Zuckerberg San Francisco Ge, Dept Med, San Francisco, CA USA; [Froissart, Marc] CHU Vaudois, Clin Trial Unit, Lausanne, Switzerland; [Greene, Tom] Univ Utah Hlth, Div Biostat, Dept Populat Hlth Sci, Salt Lake City, UT USA; [Grubb, Anders] Lund Univ, Dept Clin Chem & Pharmacol, Inst Lab Med, Lund, Sweden; [Gudnason, Vilmundur] Univ Iceland, Fac Med, Reykjavik, Iceland; [Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Gutierrez, Orlando M.] Univ Alabama Birmingham, Dept Med, Birmingham, AL USA; [Gutierrez, Orlando M.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA; [Karger, Amy B.; Seegmiller, Jesse C.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Mauer, Michael] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Mauer, Michael] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Rule, Andrew D.; Torres, Vicente E.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA; [Navis, Gerjan] Univ Med Ctr Groningen, Fac Med Sci, Groningen, Netherlands; [Nelson, Robert G.] NIDDK, Chron Kidney Dis Sect, NIH, Phoenix, AZ USA; [Poggio, Emilio D.] Cleveland Clin, Dept Hypertens & Nephrol, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA; [Rodby, Roger] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Rossing, Peter] Univ Copenhagen, Steno Diabet Ctr Copenhagen, Copenhagen, Denmark; [Rossing, Peter] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark	Tufts Medical Center; Tufts Medical Center; Tufts University; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; University of California System; University of California San Francisco; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Utah System of Higher Education; University of Utah; Lund University; University of Iceland; Icelandic Heart Association; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; University of Groningen; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Cleveland Clinic Foundation; Rush University; Steno Diabetes Center; University of Copenhagen; University of Copenhagen	Inker, LA (corresponding author), Tufts Med Ctr, Div Nephrol, 800 Washington St,Box 391, Boston, MA 02111 USA.	linker@-tuftsmedicalcenter.org	rossing, peter/AAZ-3415-2021; Eneanya, Nwamaka/AAB-2702-2022; Doria, Alessandro/H-9157-2018; Froissart, Marc/L-7493-2014; Gudnason, Vilmundur/K-6885-2015	rossing, peter/0000-0002-1531-4294; Seegmiller, Jesse/0000-0003-2542-6502; Doria, Alessandro/0000-0002-3830-4304; Grubb, Anders/0000-0002-0125-3662; Froissart, Marc/0000-0002-4010-3173; Karger, Amy/0000-0002-2781-3824; Gudnason, Vilmundur/0000-0001-5696-0084; Eneanya, Amaka/0000-0002-0508-3410; Inker, Lesley/0000-0003-2820-9482	National Institute of Diabetes and Digestive and Kidney Diseases [R01DK097020, 1R01DK116790]	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants (R01DK097020 and 1R01DK116790) to Tufts Medical Center from the National Institute of Diabetes and Digestive and Kidney Diseases.	Agarwal A., 2020, RESPONSE CHAIRMAN NE; Ahmed S, 2021, J GEN INTERN MED, V36, P464, DOI 10.1007/s11606-020-06280-5; Bjork J, 2011, SCAND J CLIN LAB INV, V71, P232, DOI 10.3109/00365513.2011.557086; Centers for Disease Control and Prevention National Center for Health Statistics, 2020, NAT HLTH NUTR EX SUR; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Diao JA, 2021, NEW ENGL J MED, V384, P396, DOI 10.1056/NEJMp2028243; Duggal V, 2021, J AM SOC NEPHROL, V32, P1454, DOI 10.1681/ASN.2020121780; Eneanya ND, 2019, JAMA-J AM MED ASSOC, V322, P113, DOI 10.1001/jama.2019.5774; Flamant M, 2013, AM J KIDNEY DIS, V62, P182, DOI 10.1053/j.ajkd.2013.03.015; Grubb A, 2014, CLIN CHEM, V60, P974, DOI 10.1373/clinchem.2013.220707; Hsu C, 2021, NEW ENGL J MED, V385, P1750, DOI 10.1056/NEJMoa2103753; Inker LA, 2021, AM J KIDNEY DIS, V77, P673, DOI 10.1053/j.ajkd.2020.11.005; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Karger AB, 2021, CLIN CHEM, V67, P425, DOI 10.1093/clinchem/hvaa237; Lee, 2020, AGENCY HEALTHCARE RE; Levey AS, 2021, ANN INTERN MED, V174, P265, DOI 10.7326/M20-6983; Levey AS, 2020, CLIN J AM SOC NEPHRO, V15, P1203, DOI 10.2215/CJN.12791019; Levey AS, 2020, JAMA INTERN MED, V180, P793, DOI 10.1001/jamainternmed.2020.0045; Levey AS, 2020, NAT REV NEPHROL, V16, P51, DOI 10.1038/s41581-019-0191-y; Levey AS, 2017, AM J KIDNEY DIS, V70, P587, DOI 10.1053/j.ajkd.2017.04.012; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Lewis J, 2001, AM J KIDNEY DIS, V38, P744, DOI 10.1053/ajkd.2001.27691; Miller WG, 2018, ADV CHRONIC KIDNEY D, V25, P7, DOI 10.1053/j.ackd.2017.09.013; National Kidney Foundation American Society of Nephrology, 2020, EST TASK FORC REASS; National Kidney Foundation American Society of Nephrology, 2021, REM RAC EST KID FUNC; Pottel H, 2021, ANN INTERN MED, V174, P183, DOI [10.7326/M20-4366, 10.7326/L21-0248]; Pottel H, 2017, NEPHROL DIAL TRANSPL, V32, P497, DOI 10.1093/ndt/gfw425; Pottel H, 2016, NEPHROL DIAL TRANSPL, V31, P798, DOI 10.1093/ndt/gfv454; Powe NR, 2020, JAMA-J AM MED ASSOC, V324, P737, DOI 10.1001/jama.2020.13378; Saran Rajiv, 2019, Am J Kidney Dis, V73, pA7, DOI 10.1053/j.ajkd.2019.01.001; Selvin E, 2007, AM J KIDNEY DIS, V50, P918, DOI 10.1053/j.ajkd.2007.08.020; Selvin E, 2013, AM J KIDNEY DIS, V61, P353, DOI 10.1053/j.ajkd.2012.09.013; Shin JI, 2020, J AM SOC NEPHROL, V31, P1847, DOI 10.1681/ASN.2019101119; Soveri I, 2014, AM J KIDNEY DIS, V64, P411, DOI 10.1053/j.ajkd.2014.04.010; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Stevens LA, 2011, KIDNEY INT, V79, P555, DOI 10.1038/ki.2010.462; Vyas DA, 2020, NEW ENGL J MED, V383, P874, DOI 10.1056/NEJMms2004740	38	267	269	13	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 4	2021	385	19					1737	1749		10.1056/NEJMoa2102953	http://dx.doi.org/10.1056/NEJMoa2102953		SEP 2021	13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WR0CF	34554658	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000698478800001
J	Jones, DS; Podolsky, SH				Jones, David S.; Podolsky, Scott H.			Mask Wars	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Jones, David S.; Podolsky, Scott H.] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Podolsky, Scott H.] Countway Med Lib, Ctr Hist Med, Boston, MA USA; [Jones, David S.] Harvard Univ, Dept Hist Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Jones, DS (corresponding author), Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA.; Jones, DS (corresponding author), Harvard Univ, Dept Hist Sci, Cambridge, MA 02138 USA.			Jones, David/0000-0003-0039-7784					0	1	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2021	385	13					1159	1161		10.1056/NEJMp2112052	http://dx.doi.org/10.1056/NEJMp2112052		SEP 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UT0EM	34534431	Bronze			2022-12-28	WOS:000697035500001
J	Cao, BC; Zhao, ZP; Peng, LL; Shiu, HY; Ding, MN; Song, F; Guan, X; Lee, CK; Huang, J; Zhu, D; Fu, XY; Wong, GCL; Liu, C; Nealson, K; Weiss, PS; Duan, XF; Huang, Y				Cao, Bocheng; Zhao, Zipeng; Peng, Lele; Shiu, Hui-Ying; Ding, Mengning; Song, Frank; Guan, Xun; Lee, Calvin K.; Huang, Jin; Zhu, Dan; Fu, Xiaoyang; Wong, Gerard C. L.; Liu, Chong; Nealson, Kenneth; Weiss, Paul S.; Duan, Xiangfeng; Huang, Yu			Silver nanoparticles boost charge-extraction efficiency in Shewanella microbial fuel cells	SCIENCE			English	Article							EXTRACELLULAR ELECTRON-TRANSFER; WASTE-WATER TREATMENT; HIGH-POWER DENSITY; LACTATE-DEHYDROGENASE; ELECTRICITY; BIOANODE; BIOTECHNOLOGY; METABOLISM; MACHINERY; ANODE	Microbial fuel cells (MFCs) can directly convert the chemical energy stored in organic matter to electricity and are of considerable interest for power generation and wastewater treatment. However, the current MFCs typically exhibit unsatisfactorily low power densities that are largely limited by the sluggish transmembrane and extracellular electron-transfer processes. Here, we report a rational strategy to boost the charge-extraction efficiency in Shewanella MFCs substantially by introducing transmembrane and outer-membrane silver nanoparticles. The resulting Shewanella-silver MFCs deliver a maximum current density of 3.85 milliamperes per square centimeter, power density of 0.66 milliwatts per square centimeter, and single-cell turnover frequency of 8.6 x 10(5) per second, which are all considerably higher than those of the best MFCs reported to date. Additionally, the hybrid MFCs feature an excellent fuel-utilization efficiency, with a coulombic efficiency of 81%.	[Cao, Bocheng; Peng, Lele; Song, Frank; Guan, Xun; Zhu, Dan; Fu, Xiaoyang; Liu, Chong; Weiss, Paul S.; Duan, Xiangfeng] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Cao, Bocheng; Zhao, Zipeng; Shiu, Hui-Ying; Ding, Mengning; Huang, Jin; Weiss, Paul S.; Huang, Yu] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA; [Lee, Calvin K.; Wong, Gerard C. L.; Weiss, Paul S.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA; [Weiss, Paul S.; Duan, Xiangfeng; Huang, Yu] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Nealson, Kenneth] Univ Southern Calif, Dept Earth Sci, Los Angeles, CA 90089 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Southern California	Duan, XF (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.; Huang, Y (corresponding author), Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA.; Duan, XF; Huang, Y (corresponding author), Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA.	xduan@chem.ucla.edu; yhuang@seas.ucla.edu	Zhao, Zipeng/H-4983-2014; Peng, Lele/AAF-4213-2019; Huang, Jin/M-3024-2016; Ding, Mengning/P-6354-2014	Zhao, Zipeng/0000-0003-1135-6742; Peng, Lele/0000-0002-6628-7142; , Frank/0000-0003-3077-4106; Lee, Calvin/0000-0001-6789-0317; Huang, Jin/0000-0002-2882-2634; Cao, Bocheng/0000-0001-5533-5551; Ding, Mengning/0000-0001-6581-3385				Breuer M, 2014, P NATL ACAD SCI USA, V111, P611, DOI 10.1073/pnas.1316156111; Brutinel ED, 2012, APPL ENVIRON MICROB, V78, P8474, DOI 10.1128/AEM.02183-12; Cestellos-Blanco S, 2020, NAT CATAL, V3, P245, DOI 10.1038/s41929-020-0428-y; Ding MN, 2016, ACS NANO, V10, P9919, DOI 10.1021/acsnano.6b03655; El-Naggar MY, 2008, BIOPHYS J, V95, pL10, DOI 10.1529/biophysj.108.134411; El-Naggar MY, 2010, P NATL ACAD SCI USA, V107, P18127, DOI 10.1073/pnas.1004880107; Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3; Fu TD, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15759-y; Hau HH, 2007, ANNU REV MICROBIOL, V61, P237, DOI 10.1146/annurev.micro.61.080706.093257; He ZM, 2012, NANO LETT, V12, P4738, DOI 10.1021/nl302175j; Jiang XC, 2014, NANO LETT, V14, P6737, DOI 10.1021/nl503668q; Kornienko N, 2018, NAT NANOTECHNOL, V13, P890, DOI 10.1038/s41565-018-0251-7; LEVAN KM, 1991, BIOCHEM J, V273, P587, DOI 10.1042/bj2730587; Liu H, 2004, ENVIRON SCI TECHNOL, V38, P2281, DOI 10.1021/es034923g; Liu XW, 2014, ACS APPL MATER INTER, V6, P8158, DOI 10.1021/am500624k; Logan BE, 2006, ENVIRON SCI TECHNOL, V40, P5181, DOI 10.1021/es0605016; Logan BE, 2006, TRENDS MICROBIOL, V14, P512, DOI 10.1016/j.tim.2006.10.003; Logan BE, 2019, NAT REV MICROBIOL, V17, P307, DOI 10.1038/s41579-019-0173-x; Logan BE, 2012, SCIENCE, V337, P686, DOI 10.1126/science.1217412; Logan BE, 2009, NAT REV MICROBIOL, V7, P375, DOI 10.1038/nrmicro2113; Lovley DR, 2006, NAT REV MICROBIOL, V4, P497, DOI 10.1038/nrmicro1442; Lu L, 2018, NAT SUSTAIN, V1, P750, DOI 10.1038/s41893-018-0187-9; Pinchuk GE, 2009, P NATL ACAD SCI USA, V106, P2874, DOI 10.1073/pnas.0806798106; Qiao Y, 2008, ACS NANO, V2, P113, DOI 10.1021/nn700102s; Rabaey K, 2005, TRENDS BIOTECHNOL, V23, P291, DOI 10.1016/j.tibtech.2005.04.008; Ren H, 2015, J POWER SOURCES, V273, P823, DOI 10.1016/j.jpowsour.2014.09.165; Ringeisen BR, 2006, ENVIRON SCI TECHNOL, V40, P2629, DOI 10.1021/es052254w; RULE GS, 1985, J BACTERIOL, V161, P1059, DOI 10.1128/JB.161.3.1059-1068.1985; Schroder U, 2003, ANGEW CHEM INT EDIT, V42, P2880, DOI 10.1002/anie.200350918; Shi L, 2016, NAT REV MICROBIOL, V14, P651, DOI 10.1038/nrmicro.2016.93; Simonsson D, 1997, CHEM SOC REV, V26, P181, DOI 10.1039/cs9972600181; Song RB, 2016, J MATER CHEM A, V4, P14555, DOI 10.1039/c6ta05770e; Wang RW, 2018, ADV MATER, V30, DOI 10.1002/adma.201800618; Wang Y, 2016, ACS NANO, V10, P6331, DOI 10.1021/acsnano.6b02629; Wodke JAH, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.6; Wu XE, 2011, ANGEW CHEM INT EDIT, V50, P427, DOI 10.1002/anie.201002951; Xie X, 2011, NANO LETT, V11, P291, DOI 10.1021/nl103905t; Xiu ZM, 2012, NANO LETT, V12, P4271, DOI 10.1021/nl301934w; Yuan Y, 2013, ENVIRON SCI TECHNOL, V47, P14525, DOI 10.1021/es404163g; Zhang W, 2018, ACS CATAL, V8, P2365, DOI 10.1021/acscatal.7b03843; Zhang YP, 2013, J POWER SOURCES, V239, P169, DOI 10.1016/j.jpowsour.2013.03.115; Zhao C, 2013, J MATER CHEM A, V1, P12587, DOI 10.1039/c3ta12947k; Zhao SL, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500372	43	47	48	94	396	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2021	373	6561					1336	+		10.1126/science.abf3427	http://dx.doi.org/10.1126/science.abf3427			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	US5SK	34529487				2022-12-28	WOS:000697488600044
J	Del Poggetto, E; Ho, IL; Balestrieri, C; Yen, EY; Zhang, SJ; Citron, F; Shah, R; Corti, D; Diaferia, GR; Li, CY; Loponte, S; Carbone, F; Hayakawa, Y; Valenti, G; Jiang, S; Sapio, L; Jiang, H; Dey, P; Gao, SS; Deem, AK; Rose-John, S; Yao, WT; Ying, HQ; Rhim, AD; Genovese, G; Heffernan, TP; Maitra, A; Wang, TC; Wang, LH; Draetta, GF; Carugo, A; Natoli, G; Viale, A				Del Poggetto, Edoardo; Ho, I-Lin; Balestrieri, Chiara; Yen, Er-Yen; Zhang, Shaojun; Citron, Francesca; Shah, Rutvi; Corti, Denise; Diaferia, Giuseppe R.; Li, Chieh-Yuan; Loponte, Sara; Carbone, Federica; Hayakawa, Yoku; Valenti, Giovanni; Jiang, Shan; Sapio, Luigi; Jiang, Hong; Dey, Prasenjit; Gao, Sisi; Deem, Angela K.; Rose-John, Stefan; Yao, Wantong; Ying, Haoqiang; Rhim, Andrew D.; Genovese, Giannicola; Heffernan, Timothy P.; Maitra, Anirban; Wang, Timothy C.; Wang, Linghua; Draetta, Giulio F.; Carugo, Alessandro; Natoli, Gioacchino; Viale, Andrea			Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis	SCIENCE			English	Article							TO-DUCTAL METAPLASIA; DIFFERENTIAL EXPRESSION ANALYSIS; NF-KAPPA-B; ONCOGENIC KRAS; STEM-CELLS; INTRAEPITHELIAL NEOPLASIA; ACINAR; CANCER; ACTIVATION; GROWTH	Inflammation is a major risk factor for pancreatic ductal adenocarcinoma (PDAC). When occurring in the context of pancreatitis, KRAS mutations accelerate tumor development in mouse models. We report that long after its complete resolution, a transient inflammatory event primes pancreatic epithelial cells to subsequent transformation by oncogenic KRAS. Upon recovery from acute inflammation, pancreatic epithelial cells display an enduring adaptive response associated with sustained transcriptional and epigenetic reprogramming. Such adaptation enables the reactivation of acinar-to-ductal metaplasia (ADM) upon subsequent inflammatory events, thereby limiting tissue damage through a rapid decrease of zymogen production. We propose that because activating mutations of KRAS maintain an irreversible ADM, they may be beneficial and under strong positive selection in the context of recurrent pancreatitis.	[Del Poggetto, Edoardo; Ho, I-Lin; Yen, Er-Yen; Zhang, Shaojun; Citron, Francesca; Shah, Rutvi; Corti, Denise; Li, Chieh-Yuan; Loponte, Sara; Carbone, Federica; Jiang, Shan; Sapio, Luigi; Jiang, Hong; Gao, Sisi; Deem, Angela K.; Wang, Linghua; Draetta, Giulio F.; Viale, Andrea] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Ho, I-Lin; Yen, Er-Yen; Shah, Rutvi; Li, Chieh-Yuan] MD Anderson UTHlth Grad Sch Biomed Sci, Houston, TX 77030 USA; [Balestrieri, Chiara] San Raffaele Res Hosp, Expt Hematol Unit, I-20132 Milan, Italy; [Balestrieri, Chiara] IRCCS San Raffaele Sci Inst, Ctr Omics Sci, I-20132 Milan, Italy; [Diaferia, Giuseppe R.; Natoli, Gioacchino] European Inst Oncol IRCCS, Dept Expt Oncol, I-20139 Milan, Italy; [Hayakawa, Yoku; Valenti, Giovanni; Wang, Timothy C.] Columbia Univ, Dept Digest & Liver Dis, Med Ctr, New York, NY 10032 USA; [Dey, Prasenjit] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Rose-John, Stefan] Christian Albrechts Univ Kiel, Dept Biochem, D-24098 Kiel, Germany; [Yao, Wantong] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Ying, Haoqiang] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Rhim, Andrew D.] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA; [Genovese, Giannicola] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Heffernan, Timothy P.; Carugo, Alessandro] Univ Texas MD Anderson Canc Ctr, TRACTION, Houston, TX 77030 USA; [Maitra, Anirban] Univ Texas MD Anderson Canc Ctr, Sheikh Ahmed Ctr Pancreat Canc Res, Houston, TX 77030 USA; [Natoli, Gioacchino] Humanitas Univ, I-20089 Milan, Italy; [Del Poggetto, Edoardo] AXXAM, I-20091 Milan, Italy; [Zhang, Shaojun] Guangdong Acad Med Sci, Med Res Ctr, Guangdong Prov Peoples Hosp, Guangzhou 510080, Peoples R China; [Corti, Denise] F Hoffrrann La Roche Ltd, CH-4070 Basel, Switzerland; [Li, Chieh-Yuan] Mission Bio, San Francisco, CA 94080 USA; [Carbone, Federica] Nerviano Med Sci, I-20014 Nervier, Italy; [Sapio, Luigi] Univ Campania Luigi Vanvitelli, Dept Precis Med, I-80138 Naples, Italy; [Dey, Prasenjit] Roswell Pk Comprehens Canc Ctr, Dept Immunol, Buffalo, NY 14263 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS European Institute of Oncology (IEO); Columbia University; University of Texas System; UTMD Anderson Cancer Center; University of Kiel; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Humanitas University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Universita della Campania Vanvitelli	Viale, A (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA.	aviale@mdanderson.org	Sapio, Luigi/AAH-6334-2021; Citron, Francesca/AAC-2249-2020	Yen, Er-Yen/0000-0003-2918-5419; Citron, Francesca/0000-0002-5896-3008; Li, Chieh-Yuan/0000-0003-1038-5218; Corti, Denise/0000-0002-9841-8143; Shah, Rutvi/0000-0002-2382-9175; Natoli, Gioacchino/0000-0003-0711-2411; Wang, Linghua/0000-0001-9380-0266; Balestrieri, Chiara/0000-0001-7362-3530; Ho, I-Lin/0000-0002-8914-710X	Cancer Research and Prevention Institute of Texas (CPRIT) [RP190599]; Andrew Sabin Family Foundation; V Foundation [V2020-018]; NIH/NCI SPORE in gastrointestinal cancer grant [P50CA221707]; NIH [NIH/NCI R01CA258917]; UT MD Anderson Cancer Center Start-Up Funds; UT MD Anderson Cancer Center Pancreatic Cancer Moon Shot and Pancreatic Cancer Action Network (PanCAN); NIH/NCI [P01 CA117969-12]; Associazione Italiana Ricerca sul Cancro (AIRC); Sheikh Khalifa Foundation; K99 grant [4R00CA218891-03]; European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant [800924]; MD Anderson UTHealth GSBS Pauline Altman-Goldstein Foundation Discovery Fellowship; NCI [CA016672, P30CA16672]	Cancer Research and Prevention Institute of Texas (CPRIT); Andrew Sabin Family Foundation; V Foundation; NIH/NCI SPORE in gastrointestinal cancer grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UT MD Anderson Cancer Center Start-Up Funds; UT MD Anderson Cancer Center Pancreatic Cancer Moon Shot and Pancreatic Cancer Action Network (PanCAN); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Sheikh Khalifa Foundation; K99 grant; European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant; MD Anderson UTHealth GSBS Pauline Altman-Goldstein Foundation Discovery Fellowship; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by Cancer Research and Prevention Institute of Texas (CPRIT) grant RP190599; the Andrew Sabin Family Foundation; the V Foundation (V2020-018); NIH/NCI SPORE in gastrointestinal cancer grant P50CA221707; NIH grant NIH/NCI R01CA258917; UT MD Anderson Cancer Center Start-Up Funds to A.V.; UT MD Anderson Cancer Center Pancreatic Cancer Moon Shot and Pancreatic Cancer Action Network (PanCAN) to G.F.D.; NIH/NCI P01 CA117969-12 to A.V. and G.F.D.; Associazione Italiana Ricerca sul Cancro (AIRC IG and 5x1000 grants) to G.N.; Sheikh Khalifa Foundation to A.M.; K99 grant 4R00CA218891-03 to P.D.; AIRC and the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement no. 800924 to F.Ci.; MD Anderson UTHealth GSBS Pauline Altman-Goldstein Foundation Discovery Fellowship to I.-L.H.; NCI grant CA016672 to the MDACC Sequencing and Microarray Facility; and NCI grant P30CA16672 to the MDACC Flow Cytometry and Cellular Imaging Core Facility.	Agbunag C, 2006, METHOD ENZYMOL, V407, P703, DOI 10.1016/S0076-6879(05)07055-2; Alonso-Curbelo D, 2021, NATURE, V590, DOI 10.1038/s41586-020-03147-x; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Bailey JM, 2016, ONCOGENE, V35, P4282, DOI 10.1038/onc.2015.441; Bailey JM, 2014, GASTROENTEROLOGY, V146, P245, DOI 10.1053/j.gastro.2013.09.050; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Balestrieri C, 2018, CELL, V173, P1150, DOI 10.1016/j.cell.2018.03.081; Bowie J. H., 2013, HDB BIOL ACTIVE PEPT, V2, P338; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cheshier SH, 2007, STEM CELLS DEV, V16, P707, DOI 10.1089/scd.2007.0017; DelGiorno KE, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00088; Deramaudt TB, 2006, MOL CELL BIOL, V26, P4185, DOI 10.1128/MCB.01055-05; Diaferia GR, 2016, EMBO J, V35, P595, DOI 10.15252/embj.201592404; Dobin Alexander, 2015, Curr Protoc Bioinformatics, V51, DOI 10.1002/0471250953.bi1114s51; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Ferguson FM, 2020, NAT CHEM BIOL, V16, P635, DOI 10.1038/s41589-020-0506-0; Friedlander SYG, 2009, CANCER CELL, V16, P379, DOI 10.1016/j.ccr.2009.09.027; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Grapin-Botton A, 2016, DIABETES OBES METAB, V18, P33, DOI 10.1111/dom.12720; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guerra C, 2011, CANCER CELL, V19, P728, DOI 10.1016/j.ccr.2011.05.011; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Halbrook CJ, 2017, CELL MOL GASTROENTER, V3, P99, DOI [10.1016/j.jcmgh.2016.08.006, 10.1016/j.jcmgh.2016.09.009]; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hill M, 2003, J ANAT, V203, P89, DOI 10.1046/j.1469-7580.2003.00195.x; Houbracken I, 2011, GASTROENTEROLOGY, V141, P731, DOI 10.1053/j.gastro.2011.04.050; Kanda M, 2012, GASTROENTEROLOGY, V142, P730, DOI 10.1053/j.gastro.2011.12.042; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Karin M, 2016, NATURE, V529, P307, DOI 10.1038/nature17039; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LEE SL, 1995, J BIOL CHEM, V270, P9971, DOI 10.1074/jbc.270.17.9971; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liou GY, 2013, J CELL BIOL, V202, P563, DOI 10.1083/jcb.201301001; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Maruno T, 2021, ELIFE, V10, DOI 10.7554/eLife.55117; May R, 2010, AM J PHYSIOL-GASTR L, V299, pG303, DOI 10.1152/ajpgi.00146.2010; Mayerle J., 2013, **DROPPED REF**; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Miyatsuka T, 2006, GENE DEV, V20, P1435, DOI 10.1101/gad.1412806; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Naik S, 2017, NATURE, V550, P475, DOI 10.1038/nature24271; Notta F, 2016, NATURE, V538, P378, DOI 10.1038/nature19823; Prevot PP, 2012, GUT, V61, P1723, DOI 10.1136/gutjnl-2011-300266; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Real FX, 2003, GASTROENTEROLOGY, V124, P1958, DOI 10.1016/S0016-5085(03)00389-5; Reichert M, 2013, GENE DEV, V27, P288, DOI 10.1101/gad.204453.112; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodgers JT, 2014, NATURE, V510, P393, DOI 10.1038/nature13255; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; SANDGREN EP, 1990, CELL, V61, P1121, DOI 10.1016/0092-8674(90)90075-P; Savas P, 2018, NAT MED, V24, P986, DOI 10.1038/s41591-018-0078-7; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; Schreiber FS, 2004, GASTROENTEROLOGY, V127, P250, DOI 10.1053/j.gastro.2004.03.058; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Shi G, 2013, ONCOGENE, V32, P1950, DOI 10.1038/onc.2012.210; Steele CW, 2013, BRIT J CANCER, V108, P997, DOI 10.1038/bjc.2013.24; Storz P, 2017, NAT REV GASTRO HEPAT, V14, P296, DOI 10.1038/nrgastro.2017.12; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sureban SM, 2011, CANCER RES, V71, P2328, DOI 10.1158/0008-5472.CAN-10-2738; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Van Laethem JL, 1999, ANN NY ACAD SCI, V880, P210, DOI 10.1111/j.1749-6632.1999.tb09525.x; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; Virchow R, 1863, CELLULAR PATHOLOGY B; Westphalen CB, 2016, CELL STEM CELL, V18, P441, DOI 10.1016/j.stem.2016.03.016; Ying HQ, 2016, GENE DEV, V30, P355, DOI 10.1101/gad.275776.115; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zeiser Robert, 2018, Recent Results Cancer Res, V211, P91, DOI 10.1007/978-3-319-91442-8_7; Zhang L, 2020, CELL, V181, P442, DOI 10.1016/j.cell.2020.03.048; Zhang YQ, 2017, ELIFE, V6, DOI 10.7554/eLife.27388; Zhang YQ, 2013, CANCER RES, V73, P6359, DOI 10.1158/0008-5472.CAN-13-1558-T; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou B, 2017, CELL PHYSIOL BIOCHEM, V44, P1867, DOI 10.1159/000485876; Zhu M, 2019, CELL, V177, P608, DOI 10.1016/j.cell.2019.03.026	87	29	29	10	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2021	373	6561					1326	+		10.1126/science.abj0486	http://dx.doi.org/10.1126/science.abj0486			45	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	US5SK	34529467	Green Accepted			2022-12-28	WOS:000697488600059
J	Kisand, K; Meager, A; Hayday, A; Willcox, N				Kisand, Kai; Meager, Anthony; Hayday, Adrian; Willcox, Nick			Comment on "Aberrant type 1 immunity drives susceptibility to mucosal fungal infections"	SCIENCE			English	Editorial Material							AUTOIMMUNE POLYENDOCRINOPATHY; CANDIDIASIS	Break et al. (Research Articles, 15 January 2021, eaay5731) conclude that T cell overproduction of interferon-gamma causes chronic mucocutaneous candidiasis (CMC), a typical early feature of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). This contradicts studies implicating interleukin IL-17 and IL-22 deficiencies as a cause of CMC. We propose that Break et al. have focused on late-arising events rather than more common primary causes of CMC.	[Kisand, Kai] Univ Tartu, Inst Biomed & Translat Med, Mol Pathol, Tartu, Estonia; [Meager, Anthony] Regaem Consultants, Edgware, Middx, England; [Hayday, Adrian] Kings Coll London, Sch Immunol & Microbial Sci, Peter Gorer Dept Immunobiol, London, England; [Hayday, Adrian] Francis Crick Inst, London, England; [Willcox, Nick] Univ Oxford, Weatherall Inst Mol Med, Dept Clin Neurosci, Oxford, England	University of Tartu; University of London; King's College London; Francis Crick Institute; University of Oxford	Kisand, K (corresponding author), Univ Tartu, Inst Biomed & Translat Med, Mol Pathol, Tartu, Estonia.; Willcox, N (corresponding author), Univ Oxford, Weatherall Inst Mol Med, Dept Clin Neurosci, Oxford, England.	kai.kisand@ut.ee; nick.willcox@imm.ox.ac.uk		HAYDAY, ADRIAN/0000-0002-9495-5793				Bichele R, 2018, EUR J IMMUNOL, V48, P464, DOI 10.1002/eji.201747209; Break TJ, 2021, SCIENCE, V371, P252, DOI 10.1126/science.aay5731; Conti HR, 2014, J EXP MED, V211, P2075, DOI 10.1084/jem.20130877; Ferre EMN, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88782; Gibbons D, 2014, NAT MED, V20, P1206, DOI 10.1038/nm.3670; Jiang WY, 2005, J EXP MED, V202, P805, DOI 10.1084/jem.20050693; Kaleviste E, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00838; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Laakso SM, 2014, AUTOIMMUNITY, V47, P556, DOI 10.3109/08916934.2014.929666; Li J, 2018, MUCOSAL IMMUNOL, V11, P581, DOI 10.1038/mi.2017.97; McGovern E, 2008, EUR ARCH PAEDIATR DE, V9, P236, DOI 10.1007/BF03262642; Meyer S, 2016, CELL, V166, P582, DOI 10.1016/j.cell.2016.06.024; Oftedal BE, 2017, AUTOIMMUNITY, V50, P211, DOI 10.1080/08916934.2017.1344972; Serrano J, 2018, MED ORAL PATOL ORAL, V23, pE391, DOI 10.4317/medoral.22286; Wolff ASB, 2013, J CLIN IMMUNOL, V33, P1341, DOI 10.1007/s10875-013-9938-6	15	2	2	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2021	373	6561								10.1126/science.abi6235	http://dx.doi.org/10.1126/science.abi6235			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	US5SK	34529474				2022-12-28	WOS:000697488600002
J	Limb, M				Limb, Matthew			Patients in England rate emergency services highly but pressures and staff shortages affect some aspects of care, finds survey	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		CQC, 2021, URG EME CAR SURV 202	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2021	374								n2289	10.1136/bmj.n2289	http://dx.doi.org/10.1136/bmj.n2289			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WC6LC	34535453	Bronze			2022-12-28	WOS:000704366700002
J	Casella, JF; Kronsberg, SS; Gorney, RT				Casella, James F.; Kronsberg, Shari S.; Gorney, Rebecca T.			Poloxamer 188 vs Placebo for Painful Vaso-occlusive Episodes in Children and Adults With Sickle Cell Disease Reply	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Casella, James F.; Gorney, Rebecca T.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Kronsberg, Shari S.] Univ Massachusetts, Sch Med, Worcester, MA USA	Johns Hopkins University; University of Massachusetts System; University of Massachusetts Worcester	Casella, JF (corresponding author), Johns Hopkins Univ, Sch Med, Pediat Hematol, 720 Rutland Ave, Baltimore, MD 21205 USA.	jcasella@jhmi.edu						Ballas SK, 2004, HEMOGLOBIN, V28, P85, DOI 10.1081/HEM-120035919; Casella JF, 2021, JAMA-J AM MED ASSOC, V325, P1513, DOI 10.1001/jama.2021.3414; Emanuele M, 2014, DRUGS R&D, V14, P73, DOI 10.1007/s40268-014-0041-0; Kucukal E, 2020, AM J HEMATOL, V95, P1246, DOI 10.1002/ajh.25933; Nader E, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01329	5	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2021	326	10					975	+		10.1001/jama.2021.11103	http://dx.doi.org/10.1001/jama.2021.11103			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UW4LI	34519804				2022-12-28	WOS:000700129100029
J	Anderson, TS; Ayanian, JZ; Souza, J; Landon, BE				Anderson, Timothy S.; Ayanian, John Z.; Souza, Jeffrey; Landon, Bruce E.			Representativeness of Participants Eligible to Be Enrolled in Clinical Trials of Aducanumab for Alzheimer Disease Compared With Medicare Beneficiaries With Alzheimer Disease and Mild Cognitive Impairment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Anderson, Timothy S.] Beth Israel Deaconess Med Ctr, Div Gen Med, 1309 Beacon St, Boston, MA 02246 USA; [Ayanian, John Z.] Univ Michigan, Inst Hlthcare Policy & Innovat, Ann Arbor, MI USA; [Souza, Jeffrey; Landon, Bruce E.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; University of Michigan System; University of Michigan; Harvard University; Harvard Medical School	Anderson, TS (corresponding author), Beth Israel Deaconess Med Ctr, Div Gen Med, 1309 Beacon St, Boston, MA 02246 USA.	tsander1@bidmc.harvard.edu			NIA [L30AG060493, R03AG064373]	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors were supported by the NIA (award P01AG032952). Dr Anderson was supported by grants from the NIA (L30AG060493 and R03AG064373).	Alexander GC, 2021, JAMA-J AM MED ASSOC, V325, P1717, DOI 10.1001/jama.2021.3854; Center for Medicare & Medicaid Services, CHRONIC CONDITIONS D; Lee E, 2019, J ALZHEIMERS DIS, V67, P769, DOI 10.3233/JAD-181005; US Food & Drug Administration, ADUCANUMAB MARKETED	4	20	20	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 26	2021	326	16					1627	1629		10.1001/jama.2021.15286	http://dx.doi.org/10.1001/jama.2021.15286		SEP 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YI2LG	34499725	Green Published, Bronze			2022-12-28	WOS:000694671200002
J	Park, W; Chawla, A; O'Reilly, EM				Park, Wungki; Chawla, Akhil; O'Reilly, Eileen M.			Pancreatic Cancer: A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ADJUVANT CHEMOTHERAPY; OPEN-LABEL; NEOADJUVANT THERAPY; PLUS RADIOTHERAPY; GEMCITABINE; RISK; MULTICENTER; MANAGEMENT; RESECTION; TRIAL	ImportancePancreatic ductal adenocarcinoma (PDAC) is a relatively uncommon cancer, with approximately 60430 new diagnoses expected in 2021 in the US. The incidence of PDAC is increasing by 0.5% to 1.0% per year, and it is projected to become the second-leading cause of cancer-related mortality by 2030. ObservationsEffective screening is not available for PDAC, and most patients present with locally advanced (30%-35%) or metastatic (50%-55%) disease at diagnosis. A multidisciplinary management approach is recommended. Localized pancreas cancer includes resectable, borderline resectable (localized and involving major vascular structures), and locally advanced (unresectable) disease based on the degree of arterial and venous involvement by tumor, typically of the superior mesenteric vessels. For patients with resectable disease at presentation (10%-15%), surgery followed by adjuvant chemotherapy with FOLFIRINOX (fluorouracil, irinotecan, leucovorin, oxaliplatin) represents a standard therapeutic approach with an anticipated median overall survival of 54.4 months, compared with 35 months for single-agent gemcitabine (stratified hazard ratio for death, 0.64 [95% CI, 0.48-0.86]; P=.003). Neoadjuvant systemic therapy with or without radiation followed by evaluation for surgery is an accepted treatment approach for resectable and borderline resectable disease. For patients with locally advanced and unresectable disease due to extensive vascular involvement, systemic therapy followed by radiation is an option for definitive locoregional disease control. For patients with advanced (locally advanced and metastatic) PDAC, multiagent chemotherapy regimens, including FOLFIRINOX, gemcitabine/nab-paclitaxel, and nanoliposomal irinotecan/fluorouracil, all have a survival benefit of 2 to 6 months compared with a single-agent gemcitabine. For the 5% to 7% of patients with a BRCA pathogenic germline variant and metastatic PDAC, olaparib, a poly (adenosine diphosphate [ADB]-ribose) polymerase inhibitor, is a maintenance option that improves progression-free survival following initial platinum-based therapy. Conclusions and RelevanceApproximately 60000 new cases of PDAC are diagnosed per year, and approximately 50% of patients have advanced disease at diagnosis. The incidence of PDAC is increasing. Currently available cytotoxic therapies for advanced disease are modestly effective. For all patients, multidisciplinary management, comprehensive germline testing, and integrated supportive care are recommended. This review summarizes current evidence regarding pathobiology, diagnosis, and management of pancreatic ductal adenocarcinoma.	[Park, Wungki; O'Reilly, Eileen M.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Park, Wungki; O'Reilly, Eileen M.] David M Rubenstein Ctr Pancreat Canc Res, New York, NY USA; [Park, Wungki; O'Reilly, Eileen M.] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Park, Wungki] Parker Inst Canc Immunotherapy, San Francisco, CA USA; [Chawla, Akhil] Northwestern Univ, Feinberg Sch Med, Dept Surg, Northwestern Med Reg Med Grp, Chicago, IL 60611 USA; [Chawla, Akhil] Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA	Memorial Sloan Kettering Cancer Center; Cornell University; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Robert H. Lurie Comprehensive Cancer Center	O'Reilly, EM (corresponding author), Mem Sloan Kettering Canc Ctr, 300 E 66th St,Off 1021, New York, NY 10065 USA.	oreillye@mskcc.org						Aguirre AJ, 2018, CANCER DISCOV, V8, P1096, DOI 10.1158/2159-8290.CD-18-0275; Allen PJ, 2017, ANN SURG, V265, P185, DOI 10.1097/SLA.0000000000001763; [Anonymous], 2021, PANCR CANC VERS 1; [Anonymous], 2019, PANCR AD VERS 1 2020; Aslanian HR, 2020, GASTROENTEROLOGY, V159, P358, DOI 10.1053/j.gastro.2020.03.088; Aung KL, 2018, CLIN CANCER RES, V24, P1344, DOI 10.1158/1078-0432.CCR-17-2994; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Balachandran VP, 2017, NATURE, V551, P512, DOI 10.1038/nature24462; Beatty Gregory L, 2017, Am Soc Clin Oncol Educ Book, V37, P267, DOI 10.14694/EDBK_175232; Bendell JC., 2020, J CLIN ONCOL, V38, DOI [10.1200/JCO.2020.38.4_suppl.TPS788, DOI 10.1200/JCO.2020.38.4_SUPPL.TPS788, 10.1200/JCO.2020.38.4_suppl.TPS788.]; Bosetti C, 2012, ANN ONCOL, V23, P1880, DOI 10.1093/annonc/mdr541; Chawla A, 2020, ANN SURG ONCOL, V27, P1191, DOI 10.1245/s10434-019-08087-z; Conroy T, 2018, NEW ENGL J MED, V379, P2395, DOI 10.1056/NEJMoa1809775; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Correa-Gallego C, 2014, J AM COLL SURGEONS, V218, P129, DOI 10.1016/j.jamcollsurg.2013.09.005; de Rooij T, 2016, ANN SURG, V264, P257, DOI 10.1097/SLA.0000000000001660; DOUGLASS HO, 1988, JNCI-J NATL CANCER I, V80, P751; Drilon A, 2018, NEW ENGL J MED, V378, P731, DOI 10.1056/NEJMoa1714448; Fahrmann JF, 2021, GASTROENTEROLOGY, V160, P1373, DOI 10.1053/j.gastro.2020.11.052; Florou V, 2020, JCO PRECIS ONCOL, V4, P780, DOI 10.1200/PO.20.00052; Genkinger JM, 2009, CANCER EPIDEM BIOMAR, V18, P765, DOI 10.1158/1055-9965.EPI-08-0880; Gilbert JW, 2017, ANN ONCOL, V28, P2067, DOI 10.1093/annonc/mdx180; Glazer ES, 2014, J PAIN SYMPTOM MANAG, V47, P307, DOI 10.1016/j.jpainsymman.2013.03.013; Golan T, 2020, J CLIN ONCOL, V38, P1442, DOI 10.1200/JCO.19.01890; Golan T, 2019, NEW ENGL J MED, V381, P317, DOI 10.1056/NEJMoa1903387; Hackert T, 2015, ANN SURG, V262, P875, DOI 10.1097/SLA.0000000000001462; Hayashi A, 2020, NAT CANCER, V1, P59, DOI 10.1038/s43018-019-0010-1; Heining C, 2018, CANCER DISCOV, V8, P1087, DOI 10.1158/2159-8290.CD-18-0036; Ho WJ, 2020, NAT REV CLIN ONCOL, V17, P527, DOI 10.1038/s41571-020-0363-5; Hu CL, 2018, JCO PRECIS ONCOL, V2, DOI 10.1200/PO.17.00291; Hu CL, 2018, JAMA-J AM MED ASSOC, V319, P2401, DOI 10.1001/jama.2018.6228; Hu ZI, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0448-1; Iodice S, 2008, LANGENBECK ARCH SURG, V393, P535, DOI 10.1007/s00423-007-0266-2; Jang JY, 2018, ANN SURG, V268, P215, DOI 10.1097/SLA.0000000000002705; Johansen D, 2010, CANCER EPIDEM BIOMAR, V19, P2307, DOI 10.1158/1055-9965.EPI-10-0234; Kanda M, 2012, GASTROENTEROLOGY, V142, P730, DOI 10.1053/j.gastro.2011.12.042; Katz MHG, 2021, J CLIN ONCOL, V39, DOI 10.1200/JCO.2021.39.3_suppl.377; Katz MHG, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3441-z; Klinkenbijl JH, 1999, ANN SURG, V230, P776, DOI 10.1097/00000658-199912000-00006; Knox JJ., 2020, CANCER RES, V80; Konstantinidis IT, 2013, ANN SURG ONCOL, V20, P3643, DOI 10.1245/s10434-013-3042-2; Lee JS, 2019, MOL ONCOL, V13, P1623, DOI 10.1002/1878-0261.12537; Loehrer PJ, 2011, J CLIN ONCOL, V29, P4105, DOI 10.1200/JCO.2011.34.8904; Lowery MA, 2017, CLIN CANCER RES, V23, P6094, DOI 10.1158/1078-0432.CCR-17-0899; Moffat GT, 2019, CANCER-AM CANCER SOC, V125, P3927, DOI 10.1002/cncr.32423; Moffitt RA, 2015, NAT GENET, V47, P1168, DOI 10.1038/ng.3398; Mukherjee S, 2013, LANCET ONCOL, V14, P317, DOI 10.1016/S1470-2045(13)70021-4; Murphy JE, 2018, JAMA ONCOL, V4, P963, DOI 10.1001/jamaoncol.2018.0329; Neoptolemos JP, 2017, LANCET, V389, P1011, DOI 10.1016/S0140-6736(16)32409-6; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Nevala-Plagemann C, 2020, NAT REV CLIN ONCOL, V17, P108, DOI 10.1038/s41571-019-0281-6; O'Hara MH, 2021, LANCET ONCOL, V22, P118, DOI 10.1016/S1470-2045(20)30532-5; O'Reilly EM, 2020, J CLIN ONCOL, V38, P1378, DOI 10.1200/JCO.19.02931; O'Reilly EM, 2019, JAMA ONCOL, V5, P1431, DOI 10.1001/jamaoncol.2019.1588; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Oettle H, 2013, JAMA-J AM MED ASSOC, V310, P1473, DOI 10.1001/jama.2013.279201; Ott PA, 2019, J CLIN ONCOL, V37, P318, DOI 10.1200/JCO.2018.78.2276; Owens DK, 2019, JAMA-J AM MED ASSOC, V322, P438, DOI 10.1001/jama.2019.10232; Oyama H, 2020, GASTROENTEROLOGY, V158, P226, DOI 10.1053/j.gastro.2019.08.032; Park W, 2020, CLIN CANCER RES, V26, P3239, DOI 10.1158/1078-0432.CCR-20-0418; Pishvaian MJ, 2020, LANCET ONCOL, V21, P508, DOI 10.1016/S1470-2045(20)30074-7; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Rainone M, 2020, JAMA ONCOL, V6, P764, DOI 10.1001/jamaoncol.2019.5963; Ramacciato G, 2016, ANN SURG ONCOL, V23, P2028, DOI 10.1245/s10434-016-5123-5; Rawla P, 2019, WORLD J ONCOL, V10, P10, DOI 10.14740/wjon1166; Royal RE, 2010, J IMMUNOTHER, V33, P828, DOI 10.1097/CJI.0b013e3181eec14c; Schmidt CM, 2010, ARCH SURG-CHICAGO, V145, P634, DOI 10.1001/archsurg.2010.118; Shindo K, 2017, J CLIN ONCOL, V35, P3382, DOI 10.1200/JCO.2017.72.3502; Siegel RL, 2019, CA-CANCER J CLIN, V69, P7, DOI 10.3322/caac.21551; Sohal DPS, 2021, JAMA ONCOL, V7, P421, DOI 10.1001/jamaoncol.2020.7328; Sultana A, 2007, BRIT J CANCER, V96, P1183, DOI 10.1038/sj.bjc.6603719; Sung H, 2019, LANCET PUBLIC HEALTH, V4, pE137, DOI 10.1016/S2468-2667(18)30267-6; Tanaka M, 2006, PANCREATOLOGY, V6, P17, DOI 10.1159/000090023; Teng MWL, 2015, CANCER RES, V75, P2139, DOI 10.1158/0008-5472.CAN-15-0255; Terhune PG, 1998, CANCER EPIDEM BIOMAR, V7, P515; Tzeng CWD, 2014, HPB, V16, P430, DOI 10.1111/hpb.12154; Uemura S, 2018, PANCREATOLOGY, V18, P601, DOI 10.1016/j.pan.2018.04.015; van der Gaag NA, 2010, NEW ENGL J MED, V362, P129, DOI 10.1056/NEJMoa0903230; Varghese AM, 2021, JNCI-J NATL CANCER I, V113, P1194, DOI 10.1093/jnci/djab038; Vauthey JN, 2009, ANN SURG ONCOL, V16, P1725, DOI 10.1245/s10434-009-0409-5; Vege SS, 2015, GASTROENTEROLOGY, V148, P819, DOI 10.1053/j.gastro.2015.01.015; Versteijne E, 2020, J CLIN ONCOL, V38, P1763, DOI 10.1200/JCO.19.02274; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Walter FM, 2016, LANCET GASTROENTEROL, V1, P298, DOI 10.1016/S2468-1253(16)30079-6; Wang XY, 2014, WORLD J GASTROENTERO, V20, P15580, DOI 10.3748/wjg.v20.i42.15580; Wang YT, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2241-1; Wang-Gillam A, 2016, LANCET, V387, P545, DOI 10.1016/S0140-6736(15)00986-1; Wong MCS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02997-2	90	155	159	86	123	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2021	326	9					851	862		10.1001/jama.2021.13027	http://dx.doi.org/10.1001/jama.2021.13027			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ7LK	34547082	Green Accepted			2022-12-28	WOS:000696242100015
J	Nader, GPD; Aguera-Gonzalez, S; Routet, F; Gratia, M; Maurin, M; Cancila, V; Cadart, C; Palamidessi, A; Ramos, RN; San Roman, M; Gentili, M; Yamada, A; Williart, A; Lodillinsky, C; Lagoutte, E; Villard, C; Viovy, JL; Tripodo, C; Galon, J; Scita, G; Manel, N; Chavrier, P; Piel, M				Nader, Guilherme Pedreira de Freitas; Aguera-Gonzalez, Sonia; Routet, Fiona; Gratia, Matthieu; Maurin, Mathieu; Cancila, Valeria; Cadart, Clotilde; Palamidessi, Andrea; Ramos, Rodrigo Nalio; San Roman, Mabel; Gentili, Matteo; Yamada, Ayako; Williart, Alice; Lodillinsky, Catalina; Lagoutte, Emilie; Villard, Catherine; Viovy, Jean-Louis; Tripodo, Claudio; Galon, Jerome; Scita, Giorgio; Manel, Nicolas; Chavrier, Philippe; Piel, Matthieu			Compromised nuclear envelope integrity drives TREX1-dependent DNA damage and tumor cell invasion	CELL			English	Article							EXONUCLEASE TREX1; IN-SITU; ACTIVATION; RUPTURE; MIGRATION; REPAIR; CGAS; CONFINEMENT; MUTATIONS; SET	Although mutations leading to a compromised nuclear envelope cause diseases such as muscular dystrophies or accelerated aging, the consequences of mechanically induced nuclear envelope ruptures are less known. Here, we show that nuclear envelope ruptures induce DNA damage that promotes senescence in non-transformed cells and induces an invasive phenotype in human breast cancer cells. We find that the endoplasmic reticulum (ER)-associated exonuclease TREX1 translocates into the nucleus after nuclear envelope rupture and is required to induce DNA damage. Inside the mammary duct, cellular crowding leads to nuclear envelope ruptures that generate TREX1 -dependent DNA damage, thereby driving the progression of in situ carcinoma to the invasive stage. DNA damage and nuclear envelope rupture markers were also enriched at the invasive edge of human tumors. We propose that DNA damage in mechanically challenged nuclei could affect the pathophysiology of crowded tissues by modulating proliferation and extracellular matrix degradation of normal and transformed cells.	[Nader, Guilherme Pedreira de Freitas; Aguera-Gonzalez, Sonia; Routet, Fiona; Gratia, Matthieu; Cadart, Clotilde; Williart, Alice; Lagoutte, Emilie; Chavrier, Philippe; Piel, Matthieu] PSL Res Univ, CNRS, UMR 144, Inst Curie, Paris, France; [Nader, Guilherme Pedreira de Freitas; Cadart, Clotilde; Williart, Alice; Piel, Matthieu] PSL Res Univ, CNRS, UMR 144, Inst Pierre Gilles Gennes, Paris, France; [Maurin, Mathieu; San Roman, Mabel; Gentili, Matteo; Manel, Nicolas] PSL Res Univ, INSERM, U932, Inst Curie, Paris, France; [Cancila, Valeria; Tripodo, Claudio] Univ Palermo, Tumor Immunol Unit, Corso Tukory 211, I-90234 Palermo, Italy; [Yamada, Ayako; Villard, Catherine; Viovy, Jean-Louis] Univ PSL, Inst Curie, CNRS, UMR 168, Paris, France; [Lodillinsky, Catalina] Univ Buenos Aires, Inst Oncol Angel H Roffo, Res Area, Buenos Aires, DF, Argentina; [Lodillinsky, Catalina] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina; [Palamidessi, Andrea; Scita, Giorgio] IFOM, FIRC Inst Mol Oncol, Via Adamello 16, I-20139 Milan, Italy; [Palamidessi, Andrea; Scita, Giorgio] Univ Milan, IFOM, Dept Oncol & Hematooncol, Via Adamello 16, I-20139 Milan, Italy; [Ramos, Rodrigo Nalio; Galon, Jerome] Univ Paris, Sorbonne Univ, INSERM,Lab Integrat Canc Immunol, Equipe Labellisee Ligue Canc,Ctr Rech Cordeliers, Paris, France; [Cadart, Clotilde] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Gentili, Matteo] Broad Inst MIT & Harvard, 415 Main St, Cambridge, MA 02142 USA; [Yamada, Ayako] Sorbonne Univ, CNRS, Univ PSL, PASTEUR,Dept Chim,Ecole Normale Super, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; University of Palermo; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); IFOM - FIRC Institute of Molecular Oncology; IFOM - FIRC Institute of Molecular Oncology; University of Milan; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; University of California System; University of California Berkeley; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite	Piel, M (corresponding author), PSL Res Univ, CNRS, UMR 144, Inst Curie, Paris, France.; Piel, M (corresponding author), PSL Res Univ, CNRS, UMR 144, Inst Pierre Gilles Gennes, Paris, France.	nicolas.manel@curie.fr; philippe.chavrier@curie.fr; matthieu.piel@curie.fr	Ramos, Rodrigo N/K-3553-2012; Palamidessi, Andrea/F-1203-2018; Cancila, Valeria/AIE-4354-2022; Tripodo, Claudio/AAB-6004-2022; Yamada, Ayako/E-3119-2019; CHAVRIER, Philippe/B-4707-2010	Ramos, Rodrigo N/0000-0003-1249-4733; Cancila, Valeria/0000-0002-9502-1191; Tripodo, Claudio/0000-0002-0821-6231; Yamada, Ayako/0000-0003-3162-3318; palamidessi, andrea/0000-0002-7134-7023; Cadart, Clotilde/0000-0001-7143-2706; CHAVRIER, Philippe/0000-0002-7351-733X; Scita, Giorgio/0000-0001-7984-1889; Gratia, Matthieu/0000-0003-0286-258X; Williart, Alice/0000-0003-2581-0379; Manel, Nicolas/0000-0002-1481-4430	Institut Pierre-Gilles de Gennes-IPGG [ANR-10-EQPX-34, ANR-10-IDEX-0001-02 PSL, ANR-10-LABX31]; Laboratory of Excellence (LabEx) CelTisPhyBio [ANR 11-LABX-0038]; Fondation pour la Recherche Medicale [FDT20160435078]; Associazione Italiana per la Ricerca sul Cancro [AIRC-IG 18621, AIRC-0IG 22145, 22759]; Italian Ministry of University and Scientific Research (MIUR) [2017HWTP2K]; Institut National Du Cancer [INCA_7905]; INCA [PLBIO 2019-1-PL BIO-07-ICR-1]; INSERM Plan Cancer Single Cell [19CS007-00]; Fondation ARC pour la Recherche contre le Cancer [PGA1 RF20170205408]; Institut Curie; ERCadg CellO [321107]; LABEX DCBIOL [ANR-10-IDEX-0001-02 PSL, ANR-11-LABX-0043, ANR ANR-17-CE15-0025-01, ANR-18-CE92-0022-01, ANR-19CE15-0018-01]; Italian Foundation for Cancer Research (AIRC) Accelerator Award [24296]; Region Ile-de-France; Centre National de la Recherche Scientifique	Institut Pierre-Gilles de Gennes-IPGG; Laboratory of Excellence (LabEx) CelTisPhyBio; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of University and Scientific Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Institut National Du Cancer(Institut National du Cancer (INCA) France); INCA(Institut National du Cancer (INCA) France); INSERM Plan Cancer Single Cell; Fondation ARC pour la Recherche contre le Cancer; Institut Curie; ERCadg CellO; LABEX DCBIOL; Italian Foundation for Cancer Research (AIRC) Accelerator Award; Region Ile-de-France(Region Ile-de-France); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	We thank the flow cytometry and cell sorting facility, the animal facility at the Institut Curie, and the microscopy facility of IPGG for equipment and technical assistance. The authors also thank the Cordeliers Research Center (Paris, France) core facilities for the technical and methodological help. Slide preparations were done at the ''Histology, cell imaging and flow cytometry center". We are also grateful for the training provided by Yanjun Liu regarding the confinement experiments and microfabrication of confinement tools. We thank Titia de Lange and John Maciejowski for providing the guideRNA to generate the TREX1 KO CRISPR cell lines; John Maciejowski, Alexis Lomakin, and Ana-Maria Lennon-Dumenil for suggestions during the writing of this manuscript; Nicolas Carpi for lab management, plasmid amplifications, and computer technical support; Juan-Manuel Garcia Arcos for help in assembling the figures and drawing the graphical abstract; Aastha Mathur for data analysis of the gH2AX-positive nuclei relative to the xenograft edge; Zahraa Alraies for the preparation of cDNA samples for the quantitative RT-PCR analysis; Dipanjan Bhattacharya for developing the method to automatically segment nuclei at IFOM; and Dr. Ines Ferrara for providing technical support for the human tumor samples. We also thank the patients and their families who contributed tissue samples to these studies. This study was supported by the following grants: Institut PierreGilles de Gennes-IPGG (Equipement d'Excellence, ''Investissements d'avenir,'' program ANR-10-EQPX-34 and laboratoire d'excellence, ``Investissements d'avenir'' program ANR-10-IDEX-0001-02 PSL and ANR-10-LABX31); Laboratory of Excellence (LabEx) CelTisPhyBio (ANR 11-LABX-0038 to S.A.-G.); Plan Cancer 2018 ''Single Cells'' (19CS007-00 to F.R.); Fondation pour la Recherche Medicale (FDT20160435078 to C. C.); Associazione Italiana per la Ricerca sul Cancro (AIRC-IG 18621 to G.S., AIRC-0IG 22145 to C.T., and 5XMille 22759 to G. S. and C.T.); the Italian Ministry of University and Scientific Research (MIUR) to G.S. (PRIN: Progetti di Ricerca di Rilevante Interese Nazionale-Bando 2017 2017HWTP2K); Institut National Du Cancer INCA_7905 (MetaCLEM) and INCA PLBIO 2019-1-PL BIO-07-ICR-1; INSERM Plan Cancer Single Cell (19CS007-00); Fondation ARC pour la Recherche contre le Cancer (PGA1 RF20170205408 to P.C.); institutional funding from Institut Curie and Centre National de la Recherche Scientifique to P.C.; ERCadg CellO (FP7-IDEAS-ERC-321107 to J.-L.V.); LABEX DCBIOL (ANR-10-IDEX-0001-02 PSL and ANR-11-LABX-0043 and ANR ANR-17-CE15-0025-01 and ANR-18-CE92-0022-01 and ANR-19CE15-0018-01 to N.M.); INCA PLBIO 2019-1-PL BIO-07-ICR-1, INSERM Plan Cancer Single Cell (19CS007-00 to M.P., N.M., and P.C.), Italian Foundation for Cancer Research (AIRC) Accelerator Award (24296 to C. T.). This work was supported in part by grants from Re ' gion Ile-de-France.	Basit A, 2020, EXP MOL MED, V52, P643, DOI 10.1038/s12276-020-0416-y; Behbod F, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2358; Benci JL, 2019, CELL, V178, P933, DOI 10.1016/j.cell.2019.07.019; Blaha L, 2017, BIOFABRICATION, V9, DOI 10.1088/1758-5090/aa869d; Castagnino A, 2018, ONCOGENE, V37, P6425, DOI 10.1038/s41388-018-0422-x; Cho S, 2019, DEV CELL, V49, P920, DOI 10.1016/j.devcel.2019.04.020; Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; De Vos WH, 2011, HUM MOL GENET, V20, P4175, DOI 10.1093/hmg/ddr344; Denais CM, 2016, SCIENCE, V352, P353, DOI 10.1126/science.aad7297; Earle AJ, 2020, NAT MATER, V19, P464, DOI 10.1038/s41563-019-0563-5; Erdal E, 2017, GENE DEV, V31, P353, DOI 10.1101/gad.289769.116; Feinberg TY, 2018, DEV CELL, V47, P145, DOI 10.1016/j.devcel.2018.08.025; Feng CC, 2018, INT J MOL MED, V41, P3316, DOI 10.3892/ijmm.2018.3522; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gentili M, 2019, CELL REP, V26, P2377, DOI 10.1016/j.celrep.2019.01.105; Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005; Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470; Hatch EM, 2018, CURR OPIN CELL BIOL, V52, P66, DOI 10.1016/j.ceb.2018.02.001; Hatch EM, 2016, J CELL BIOL, V215, P27, DOI 10.1083/jcb.201603053; Infante E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04865-7; Irianto J, 2017, CURR BIOL, V27, P210, DOI 10.1016/j.cub.2016.11.049; Jiang YN, 2019, EXP CELL RES, V381, P165, DOI 10.1016/j.yexcr.2019.05.011; Kang HT, 2017, NAT CHEM BIOL, V13, P616, DOI 10.1038/nchembio.2342; Kim M, 2018, J BREAST CANCER, V21, P197, DOI 10.4048/jbc.2018.21.2.197; Lahaye X, 2013, IMMUNITY, V39, P1132, DOI 10.1016/j.immuni.2013.11.002; Le Berre M, 2014, METHOD CELL BIOL, V121, P213, DOI 10.1016/B978-0-12-800281-0.00014-2; Le Berre M, 2012, INTEGR BIOL-UK, V4, P1406, DOI 10.1039/c2ib20056b; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lee-Kirsch MA, 2007, J MOL MED-JMM, V85, P531, DOI 10.1007/s00109-007-0199-9; Lehtinen DA, 2008, J BIOL CHEM, V283, P31649, DOI 10.1074/jbc.M806155200; Liu HP, 2018, NATURE, V563, P131, DOI 10.1038/s41586-018-0629-6; Liu YJ, 2015, CELL, V160, P659, DOI 10.1016/j.cell.2015.01.007; Lodillinsky C, 2016, ONCOGENE, V35, P344, DOI 10.1038/onc.2015.87; Lusk CP, 2020, CURR OPIN CELL BIOL, V64, P25, DOI 10.1016/j.ceb.2020.01.011; Maciejowski J, 2019, BIORXIV, DOI [10.1101/725366, DOI 10.1101/725366]; Maciejowski J, 2015, CELL, V163, P1641, DOI 10.1016/j.cell.2015.11.054; Malhas A, 2011, TRENDS CELL BIOL, V21, P362, DOI 10.1016/j.tcb.2011.03.008; Malinverno C, 2017, NAT MATER, V16, P587, DOI [10.1038/NMAT4848, 10.1038/nmat4848]; Martinvalet D, 2005, IMMUNITY, V22, P355, DOI 10.1016/j.immuni.2005.02.004; Mayhew TM, 2011, J ANAT, V219, P647, DOI 10.1111/j.1469-7580.2011.01438.x; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; Mohr L, 2021, MOL CELL, V81, P724, DOI 10.1016/j.molcel.2020.12.037; Nader, 2021, CURR OPIN CELL BIOL, DOI [10.1016/j.ceb.2021.01.007, DOI 10.1016/J.CEB.2021.01.007]; Palamidessi A, 2019, NAT MATER, V18, P1252, DOI 10.1038/s41563-019-0425-1; Peng B, 2019, J BIOL CHEM, V294, P7037, DOI 10.1074/jbc.RA119.007897; Raab M, 2016, SCIENCE, V352, P359, DOI 10.1126/science.aad7611; Robijns J, 2018, INT REV CEL MOL BIO, V336, P205, DOI 10.1016/bs.ircmb.2017.07.013; Roman W, 2017, NAT CELL BIOL, V19, P1189, DOI 10.1038/ncb3605; Shah P, 2021, CURR BIOL, V31, P753, DOI 10.1016/j.cub.2020.11.037; Shah P, 2017, TRENDS CELL BIOL, V27, P546, DOI 10.1016/j.tcb.2017.02.008; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Srivastava N, 2021, CURR OPIN CELL BIOL, V70, P100, DOI 10.1016/j.ceb.2021.01.007; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Sun MN, 2012, J MOL CELL BIOL, V4, P304, DOI 10.1093/jmcb/mjs048; Takahashi A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03555-8; Teuliere J, 2005, DEVELOPMENT, V132, P267, DOI 10.1242/dev.01583; Ungricht R, 2015, CURR OPIN CELL BIOL, V34, P135, DOI 10.1016/j.ceb.2015.04.005; Vanpouille-Box C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15618; Vargas JD, 2012, NUCLEUS-PHILA, V3, P88, DOI 10.4161/nucl.18954; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017	60	25	25	6	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 30	2021	184	20					5230	+		10.1016/j.cell.2021.08.035	http://dx.doi.org/10.1016/j.cell.2021.08.035		OCT 2021	39	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	WC7PG	34551315	Bronze, Green Submitted			2022-12-28	WOS:000704445700017
J	Cai, T; Sun, HB; Qiao, J; Zhu, LL; Zhang, F; Zhang, J; Tang, ZJ; Wei, XL; Yang, JG; Yuan, QQ; Wang, WY; Yang, X; Chu, HY; Wang, Q; You, C; Ma, HW; Sun, YX; Li, Y; Li, C; Jiang, HF; Wang, QH; Ma, YH				Cai, Tao; Sun, Hongbing; Qiao, Jing; Zhu, Leilei; Zhang, Fan; Zhang, Jie; Tang, Zijing; Wei, Xinlei; Yang, Jiangang; Yuan, Qianqian; Wang, Wangyin; Yang, Xue; Chu, Huanyu; Wang, Qian; You, Chun; Ma, Hongwu; Sun, Yuanxia; Li, Yin; Li, Can; Jiang, Huifeng; Wang, Qinhong; Ma, Yanhe			Cell-free chemoenzymatic starch synthesis from carbon dioxide	SCIENCE			English	Article							ADP-GLUCOSE PYROPHOSPHORYLASE; SITE-DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; TRIOSEPHOSPHATE ISOMERASE; ENZYMATIC-SYNTHESIS; HIGH-YIELD; FIXATION; DESIGN; GLYCOLALDEHYDE; BIOCHEMISTRY	Starches, a storage form of carbohydrates, are a major source of calories in the human diet and a primary feedstock for bioindustry. We report a chemical-biochemical hybrid pathway for starch synthesis from carbon dioxide (CO2) and hydrogen in a cell-free system. The artificial starch anabolic pathway (ASAP), consisting of 11 core reactions, was drafted by computational pathway design, established through modular assembly and substitution, and optimized by protein engineering of three bottleneck-associated enzymes. In a chemoenzymatic system with spatial and temporal segregation, ASAP, driven by hydrogen, converts CO2 to starch at a rate of 22 nanomoles of CO2 per minute per milligram of total catalyst, an similar to 8.5-fold higher rate than starch synthesis in maize. This approach opens the way toward future chemo-biohybrid starch synthesis from CO2.	[Cai, Tao; Sun, Hongbing; Qiao, Jing; Zhang, Fan; Li, Yin; Wang, Qinhong; Ma, Yanhe] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Dept Strateg & Integrat Res, Tianjin 300308, Peoples R China; [Cai, Tao; Sun, Hongbing; Qiao, Jing; Zhu, Leilei; Zhang, Fan; Zhang, Jie; Tang, Zijing; Wei, Xinlei; Yang, Jiangang; Yuan, Qianqian; Yang, Xue; Chu, Huanyu; Wang, Qian; You, Chun; Ma, Hongwu; Sun, Yuanxia; Li, Yin; Jiang, Huifeng; Wang, Qinhong; Ma, Yanhe] Natl Ctr Technol Innovat Synthet Biol, Tianjin 300308, Peoples R China; [Zhu, Leilei; Zhang, Jie; Tang, Zijing; Wei, Xinlei; Yang, Jiangang; You, Chun; Sun, Yuanxia; Ma, Yanhe] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Natl Engn Lab Ind Enzymes, Tianjin 300308, Peoples R China; [Yuan, Qianqian; Yang, Xue; Chu, Huanyu; Wang, Qian; Ma, Hongwu; Jiang, Huifeng; Wang, Qinhong] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, CAS Key Lab Syst Microbial Biotechnol, Tianjin 300308, Peoples R China; [Wang, Wangyin; Li, Can] Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Catalysis, Dalian 116023, Peoples R China	Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; State Key Laboratory of Catalysis, CAS	Ma, YH (corresponding author), Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Dept Strateg & Integrat Res, Tianjin 300308, Peoples R China.; Ma, YH (corresponding author), Natl Ctr Technol Innovat Synthet Biol, Tianjin 300308, Peoples R China.; Ma, YH (corresponding author), Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Natl Engn Lab Ind Enzymes, Tianjin 300308, Peoples R China.	ma_yh@tib.cas.cn	Li, Yin/C-6644-2009; MA, YAN/HHN-2912-2022	Li, Yin/0000-0003-0995-3070; Cai, Tao/0000-0002-2089-7770; qiao, jing/0000-0001-6581-3094; Zhu, Leilei/0000-0002-7611-099X; sun, hong bing/0000-0003-3733-5202	Tianjin Synthetic Biotechnology Innovation Capacity Improvement Action [TSBICIP-KJGG008]; Key Research Program of the Chinese Academy of Sciences [ZDRW-ZS-2016-3]; Strategic Priority Research Program of the Chinese Academy of Sciences-Precision Seed Design and Breeding [XDA24020103-3]; Tianjin Outstanding Scholar Program; Youth Innovation Promotion Association of CAS [2016165]; National Science Fund for Excellent Young Scholars [31922047]	Tianjin Synthetic Biotechnology Innovation Capacity Improvement Action; Key Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Strategic Priority Research Program of the Chinese Academy of Sciences-Precision Seed Design and Breeding; Tianjin Outstanding Scholar Program; Youth Innovation Promotion Association of CAS; National Science Fund for Excellent Young Scholars	This work was supported by the Tianjin Synthetic Biotechnology Innovation Capacity Improvement Action (grant TSBICIP-KJGG008 to T.C.), the Key Research Program of the Chinese Academy of Sciences (grant ZDRW-ZS-2016-3 to Y.M. and T.C.), the Strategic Priority Research Program of the Chinese Academy of Sciences-Precision Seed Design and Breeding (grant XDA24020103-3 to H.J.), the Tianjin Outstanding Scholar Program (to Y.M.), Youth Innovation Promotion Association of CAS (grant 2016165 to T.C.), and the National Science Fund for Excellent Young Scholars (grant 31922047 to H.	Abt MR, 2020, CURR OPIN PLANT BIOL, V55, P109, DOI 10.1016/j.pbi.2020.03.001; [Anonymous], 2015, IND BIOREFINERIES WH; Avaeva S, 1996, FEBS LETT, V399, P99, DOI 10.1016/S0014-5793(96)01296-3; Bahaji A, 2014, BIOTECHNOL ADV, V32, P87, DOI 10.1016/j.biotechadv.2013.06.006; Bar-Even A, 2010, P NATL ACAD SCI USA, V107, P8889, DOI 10.1073/pnas.0907176107; Bi HP, 2013, APPL MICROBIOL BIOT, V97, P10339, DOI 10.1007/s00253-013-5262-6; Birdja YY, 2019, NAT ENERGY, V4, P732, DOI 10.1038/s41560-019-0450-y; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caspi R, 2016, NUCLEIC ACIDS RES, V44, pD471, DOI 10.1093/nar/gkv1164; Chang A, 2015, NUCLEIC ACIDS RES, V43, pD439, DOI 10.1093/nar/gku1068; Chen FYH, 2020, CELL, V182, P933, DOI 10.1016/j.cell.2020.07.010; Choe H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103111; Chou A, 2019, NAT CHEM BIOL, V15, P900, DOI 10.1038/s41589-019-0328-0; Davis IW, 2009, J MOL BIOL, V385, P381, DOI 10.1016/j.jmb.2008.11.010; Durrant JD, 2014, J CHEM THEORY COMPUT, V10, P5047, DOI 10.1021/ct500381c; Ebrahim A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-74; Erb TJ, 2017, CURR OPIN CHEM BIOL, V37, P56, DOI 10.1016/j.cbpa.2016.12.023; Flamholz A, 2012, NUCLEIC ACIDS RES, V40, pD770, DOI 10.1093/nar/gkr874; FREGERT S, 1984, CONTACT DERMATITIS, V10, P132, DOI 10.1111/j.1600-0536.1984.tb00017.x; Fushinobu S, 2011, NATURE, V478, P538, DOI 10.1038/nature10457; Garrabou X, 2009, ANGEW CHEM INT EDIT, V48, P5521, DOI 10.1002/anie.200902065; Gonzalez-Mondragon E, 2004, BIOCHEMISTRY-US, V43, P3255, DOI 10.1021/bi036077s; Green M, 2021, PROG PHOTOVOLTAICS, V29, P3, DOI 10.1002/pip.3371; Green MA, 2019, PROG PHOTOVOLTAICS, V27, P3, DOI 10.1002/pip.3102; Hadadi N, 2016, ACS SYNTH BIOL, V5, P1155, DOI 10.1021/acssynbio.6b00054; Hakata M, 2012, PLANT BIOTECHNOL J, V10, P1110, DOI 10.1111/j.1467-7652.2012.00741.x; Helaine V, 2015, ADV SYNTH CATAL, V357, P1703, DOI 10.1002/adsc.201500190; Hernandez-Alcantara G, 2002, BIOCHEMISTRY-US, V41, P4230, DOI 10.1021/bi011950f; Hines JK, 2007, J BIOL CHEM, V282, P24697, DOI 10.1074/jbc.M703580200; Iancu CV, 2005, J BIOL CHEM, V280, P19737, DOI 10.1074/jbc.M501011200; Ji XY, 2015, ACS NANO, V9, P4600, DOI 10.1021/acsnano.5b01278; Jo HJ, 2015, FEBS LETT, V589, P1089, DOI 10.1016/j.febslet.2015.03.011; Kadokawa J, 2019, METHOD ENZYMOL, V627, P189, DOI 10.1016/bs.mie.2019.06.009; Kang P, 2014, ANGEW CHEM INT EDIT, V53, P8709, DOI 10.1002/anie.201310722; Keeling PL, 2010, ANNU REV FOOD SCI T, V1, P271, DOI 10.1146/annurev.food.102308.124214; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; Korman TP, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15526; Krog A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059188; Kuehn CS, 1999, J DAIRY SCI, V82, P2746, DOI 10.3168/jds.S0022-0302(99)75531-1; Kumar S. Shiva, 2019, Materials Science for Energy Technologies, V2, P442, DOI 10.1016/j.mset.2019.03.002; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Li J, 2013, PLANT CELL PHYSIOL, V54, P282, DOI 10.1093/pcp/pcs180; Li N, 2011, PLANTA, V233, P241, DOI 10.1007/s00425-010-1296-5; Li SC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-25; Lilkova E, 2015, JYMOL MOL GRAPHICS S; Lu XY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09095-z; Mathur D, 2007, PROTEIN EXPRES PURIF, V52, P373, DOI 10.1016/j.pep.2006.10.006; Meyer CR, 1998, ARCH BIOCHEM BIOPHYS, V352, P247, DOI 10.1006/abbi.1998.0593; Meyer CR, 1998, ARCH BIOCHEM BIOPHYS, V353, P152, DOI 10.1006/abbi.1998.0648; Miller TE, 2020, SCIENCE, V368, P649, DOI 10.1126/science.aaz6802; Molin M, 2003, J BIOL CHEM, V278, P1415, DOI 10.1074/jbc.M203030200; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Ohdan K, 2006, BIOCATAL BIOTRANSFOR, V24, P77, DOI 10.1080/10242420600598152; Poust S, 2015, CHEMBIOCHEM, V16, P1950, DOI 10.1002/cbic.201500228; Ren J, 2016, ACS CATAL, V6, P564, DOI 10.1021/acscatal.5b02529; Rozova ON, 2010, BIOCHEMISTRY-MOSCOW+, V75, P892, DOI 10.1134/S0006297910070114; Saithong T., 2012, J COMPUT SCI SYST BI, V5, P24, DOI [10.4172/jcsb.1000087, DOI 10.4172/JCSB.1000087]; Satanowski A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19564-5; Say RF, 2010, NATURE, V464, P1077, DOI 10.1038/nature08884; Scheffen M, 2021, NAT CATAL, V4, DOI 10.1038/s41929-020-00557-y; Schneider S, 2008, J BIOL CHEM, V283, P30064, DOI 10.1074/jbc.M803184200; Schwander T, 2016, SCIENCE, V354, P900, DOI 10.1126/science.aah5237; Senoura T, 2007, FEBS J, V274, P4550, DOI 10.1111/j.1742-4658.2007.05984.x; Sherkhanov S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18124-1; Shum KT, 2011, BIOCHEMISTRY-US, V50, P3261, DOI 10.1021/bi2001455; Siegel JB, 2015, P NATL ACAD SCI USA, V112, P3704, DOI 10.1073/pnas.1500545112; Singh RK, 2018, ACS CATAL, V8, P11085, DOI 10.1021/acscatal.8b02646; Smith AM, 2005, ANNU REV PLANT BIOL, V56, P73, DOI 10.1146/annurev.arplant.56.032604.144257; Smith CA, 2008, J MOL BIOL, V380, P742, DOI 10.1016/j.jmb.2008.05.023; Sundaram S, 2021, ANGEW CHEM INT EDIT, V60, P16420, DOI 10.1002/anie.202102333; Szekrenyi A, 2015, NAT CHEM, V7, P724, DOI [10.1038/nchem.2321, 10.1038/NCHEM.2321]; Tai YS, 2015, NAT CHEM BIOL, V11, P384, DOI 10.1038/nchembio.1819; Tang MAK, 2014, PROTEIN J, V33, P313, DOI 10.1007/s10930-014-9562-1; Van-Dal ES, 2013, J CLEAN PROD, V57, P38, DOI 10.1016/j.jclepro.2013.06.008; Wang JJ, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701290; Whistler R. L., 1984, STARCH CHEM TECHNOLO, P153; Yang JS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002612; Yang X, 2019, METAB ENG, V56, P142, DOI 10.1016/j.ymben.2019.09.001; Ye RP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13638-9; You C, 2013, P NATL ACAD SCI USA, V110, P7182, DOI 10.1073/pnas.1302420110; You C, 2012, ANGEW CHEM INT EDIT, V51, P8787, DOI 10.1002/anie.201202441; Zhang Y. H. P., 2012, RECENT ADV POSTCOMBU, P275; Zheng HC, 2019, APPL MICROBIOL BIOT, V103, P1441, DOI 10.1007/s00253-018-9509-0; Zhu XG, 2008, CURR OPIN BIOTECH, V19, P153, DOI 10.1016/j.copbio.2008.02.004	84	85	104	442	2016	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2021	373	6562			SI		1523	+		10.1126/science.abh4049	http://dx.doi.org/10.1126/science.abh4049			59	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU7LJ	34554807	Bronze			2022-12-28	WOS:000698977800053
J	Ram, N; Murphy, EE; Suter, SM				Ram, Natalie; Murphy, Erin E.; Suter, Sonia M.			Regulating forensic genetic genealogy	SCIENCE			English	Editorial Material									[Ram, Natalie] Univ Maryland, Carey Sch Law, Baltimore, MD 21250 USA; [Murphy, Erin E.] NYU, Sch Law, New York, NY 10003 USA; [Suter, Sonia M.] George Washington Univ, Sch Law, Washington, DC USA	University System of Maryland; University of Maryland Baltimore; New York University; George Washington University	Ram, N (corresponding author), Univ Maryland, Carey Sch Law, Baltimore, MD 21250 USA.	nram@law.umaryland.edu			Greenwall Foundation Faculty Scholars Grant	Greenwall Foundation Faculty Scholars Grant	Funding was provided by a Greenwall Foundation Faculty Scholars Grant (N.R.).	John P. St., 2020, LOSANGELES TIME 1208; Ram N, 2019, NAT BIOTECHNOL, V37, P707, DOI 10.1038/s41587-019-0172-5; Ram N, 2018, SCIENCE, V360, P1078, DOI 10.1126/science.aau1083; Ram Natalie, 2020, SCITECH LAW, P18; Stern J., 2021, ATLANTIC	5	4	4	2	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2021	373	6562			SI		1444	1446		10.1126/science.abj5724	http://dx.doi.org/10.1126/science.abj5724			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU7LJ	34554804				2022-12-28	WOS:000698977800032
J	Kim, BH; Li, K; Kim, JT; Park, Y; Jang, H; Wang, XJ; Xie, ZQ; Won, SM; Yoon, HJ; Lee, GM; Jang, WJ; Lee, KH; Chung, TS; Jung, YH; Heo, SY; Lee, Y; Kim, J; Cai, TF; Kim, Y; Prasopsukh, P; Yu, YJ; Yu, XG; Avila, R; Luan, HW; Song, HL; Zhu, F; Zhao, Y; Chen, L; Han, SH; Kim, J; Oh, SJ; Lee, H; Lee, CH; Huang, YG; Chamorro, LP; Zhang, YH; Rogers, JA				Kim, Bong Hoon; Li, Kan; Kim, Jin-Tae; Park, Yoonseok; Jang, Hokyung; Wang, Xueju; Xie, Zhaoqian; Won, Sang Min; Yoon, Hong-Joon; Lee, Geumbee; Jang, Woo Jin; Lee, Kun Hyuck; Chung, Ted S.; Jung, Yei Hwan; Heo, Seung Yun; Lee, Yechan; Kim, Juyun; Cai, Tengfei; Kim, Yeonha; Prasopsukh, Poom; Yu, Yongjoon; Yu, Xinge; Avila, Raudel; Luan, Haiwen; Song, Honglie; Zhu, Feng; Zhao, Ying; Chen, Lin; Han, Seung Ho; Kim, Jiwoong; Oh, Soong Ju; Lee, Heon; Lee, Chi Hwan; Huang, Yonggang; Chamorro, Leonardo P.; Zhang, Yihui; Rogers, John A.			Three-dimensional electronic microfliers inspired by wind-dispersed seeds	NATURE			English	Article							LONG-DISTANCE DISPERSAL; COEFFICIENT; DRAG; MASS	With a design inspired by wind-dispersed seeds, a series of three-dimensional passive fliers at the macro-, meso- and microscale are realized that can bear active electronic payloads. Large, distributed collections of miniaturized, wireless electronic devices(1,2) may form the basis of future systems for environmental monitoring(3), population surveillance(4), disease management(5) and other applications that demand coverage over expansive spatial scales. Aerial schemes to distribute the components for such networks are required, and-inspired by wind-dispersed seeds(6)-we examined passive structures designed for controlled, unpowered flight across natural environments or city settings. Techniques in mechanically guided assembly of three-dimensional (3D) mesostructures(7-9) provide access to miniature, 3D fliers optimized for such purposes, in processes that align with the most sophisticated production techniques for electronic, optoelectronic, microfluidic and microelectromechanical technologies. Here we demonstrate a range of 3D macro-, meso- and microscale fliers produced in this manner, including those that incorporate active electronic and colorimetric payloads. Analytical, computational and experimental studies of the aerodynamics of high-performance structures of this type establish a set of fundamental considerations in bio-inspired design, with a focus on 3D fliers that exhibit controlled rotational kinematics and low terminal velocities. An approach that represents these complex 3D structures as discrete numbers of blades captures the essential physics in simple, analytical scaling forms, validated by computational and experimental results. Battery-free, wireless devices and colorimetric sensors for environmental measurements provide simple examples of a wide spectrum of applications of these unusual concepts.	[Kim, Bong Hoon; Kim, Jiwoong] Soongsil Univ, Dept Organ Mat & Fiber Engn, Seoul, South Korea; [Kim, Bong Hoon; Kim, Jiwoong] Soongsil Univ, Dept Smart Wearable Engn, Seoul, South Korea; [Li, Kan] Univ Cambridge, Dept Engn, Cambridge, England; [Li, Kan] Huazhong Univ Sci & Technol, State Key Lab Digital Mfg Equipment & Technol, Wuhan, Peoples R China; [Kim, Jin-Tae; Park, Yoonseok; Yoon, Hong-Joon; Lee, Geumbee; Lee, Kun Hyuck; Chung, Ted S.; Heo, Seung Yun; Yu, Yongjoon; Luan, Haiwen; Rogers, John A.] Northwestern Univ, Querrey Simpson Inst Bioelect, Evanston, IL 60208 USA; [Jang, Hokyung] Univ Wisconsin Madison, Dept Elect & Comp Engn, Madison, WI USA; [Wang, Xueju] Univ Connecticut, Inst Mat Sci, Dept Mat Sci & Engn, Storrs, CT USA; [Xie, Zhaoqian] Dalian Univ Technol, Dept Engn Mech, State Key Lab Struct Anal Ind Equipment, Dalian, Peoples R China; [Xie, Zhaoqian] Dalian Univ Technol, Ningbo Inst, Ningbo, Peoples R China; [Won, Sang Min] Sungkyunkwan Univ, Dept Elect & Comp Engn, Suwon, South Korea; [Jang, Woo Jin; Kim, Juyun; Kim, Yeonha] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Jung, Yei Hwan] Hanyang Univ, Dept Elect Engn, Seoul, South Korea; [Lee, Yechan] Korea Adv Inst Sci & Technol, Dept Chem & Biomol Engn, Daejeon, South Korea; [Cai, Tengfei; Prasopsukh, Poom; Chamorro, Leonardo P.] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA; [Yu, Xinge] City Univ Hong Kong, Dept Biomed Engn, Hong Kong, Peoples R China; [Avila, Raudel; Luan, Haiwen; Huang, Yonggang] Northwestern Univ, Dept Civil & Environm Engn, Evanston, IL 60208 USA; [Avila, Raudel; Luan, Haiwen; Huang, Yonggang; Rogers, John A.] Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA; [Avila, Raudel; Luan, Haiwen; Huang, Yonggang; Rogers, John A.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Song, Honglie; Zhang, Yihui] Tsinghua Univ, Dept Engn Mech, Ctr Flexible Elect Technol, Appl Mech Lab, Beijing, Peoples R China; [Zhu, Feng] Wuhan Univ Technol, Sch Logist Engn, Wuhan, Peoples R China; [Zhao, Ying] Tongji Univ, Sch Aerosp Engn & Appl Mech, Shanghai, Peoples R China; [Chen, Lin] Xi An Jiao Tong Univ, Sch Mat Sci & Engn, State Key Lab Mech Behav Mat, Xian, Peoples R China; [Han, Seung Ho] Korea Elect Technol Inst, Elect Convergence Mat & Device Res Ctr, Seongnam, South Korea; [Oh, Soong Ju; Lee, Heon] Korea Univ, Dept Mat Sci & Engn, Seoul, South Korea; [Lee, Chi Hwan] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Lee, Chi Hwan] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA; [Lee, Chi Hwan] Purdue Univ, Sch Mat Engn, W Lafayette, IN 47907 USA; [Rogers, John A.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Rogers, John A.] Northwestern Univ, Dept Neurol Surg, Evanston, IL 60208 USA; [Rogers, John A.] Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA; [Rogers, John A.] Northwestern Univ, Dept Elect Engn & Comp Sci, Evanston, IL 60208 USA	Soongsil University; Soongsil University; University of Cambridge; Huazhong University of Science & Technology; Northwestern University; University of Wisconsin System; University of Wisconsin Madison; University of Connecticut; Dalian University of Technology; Dalian University of Technology; Sungkyunkwan University (SKKU); University of Illinois System; University of Illinois Urbana-Champaign; Hanyang University; Korea Advanced Institute of Science & Technology (KAIST); University of Illinois System; University of Illinois Urbana-Champaign; City University of Hong Kong; Northwestern University; Northwestern University; Northwestern University; Tsinghua University; Wuhan University of Technology; Tongji University; Xi'an Jiaotong University; Korea Electronics Technology Institute (KETI); Korea University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Northwestern University; Northwestern University; Northwestern University; Northwestern University	Rogers, JA (corresponding author), Northwestern Univ, Querrey Simpson Inst Bioelect, Evanston, IL 60208 USA.; Chamorro, LP (corresponding author), Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA.; Huang, YG (corresponding author), Northwestern Univ, Dept Civil & Environm Engn, Evanston, IL 60208 USA.; Huang, YG; Rogers, JA (corresponding author), Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA.; Huang, YG; Rogers, JA (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.; Zhang, YH (corresponding author), Tsinghua Univ, Dept Engn Mech, Ctr Flexible Elect Technol, Appl Mech Lab, Beijing, Peoples R China.; Rogers, JA (corresponding author), Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.; Rogers, JA (corresponding author), Northwestern Univ, Dept Neurol Surg, Evanston, IL 60208 USA.; Rogers, JA (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.; Rogers, JA (corresponding author), Northwestern Univ, Dept Elect Engn & Comp Sci, Evanston, IL 60208 USA.	y-huang@northwestern.edu; lpchamo@illinois.edu; yihuizhang@tsinghua.edu.cn; jrogers@northwestern.edu	Park, Yoonseok/D-5365-2015; Kan, Li/O-9410-2018; Park, Yoonseok/AAL-6143-2021; Yu, Xinge/ABD-8753-2021; Kim, Bong Hoon/AAS-9495-2021; Xie, Zhaoqian/AAD-5087-2019; Li, Kan/U-8823-2019; Zhao, Ying/AAI-4406-2020; Zhang, Yihui/G-9876-2011; Luan, Haiwen/AAL-3234-2020; Chamorro, Leonardo P/A-4577-2014	Kan, Li/0000-0003-4864-3446; Park, Yoonseok/0000-0002-1702-0986; Yu, Xinge/0000-0003-0522-1171; Kim, Bong Hoon/0000-0002-4610-0176; Xie, Zhaoqian/0000-0003-1320-817X; Li, Kan/0000-0003-4864-3446; Zhao, Ying/0000-0002-6439-1843; Zhang, Yihui/0000-0003-0885-2067; Luan, Haiwen/0000-0003-0722-1108; Kim, Jin-Tae/0000-0001-9933-1931; Jang, Hokyung/0000-0002-7797-9881				AUGSPURGER CK, 1986, AM J BOT, V73, P353, DOI 10.2307/2444078; Belmonte A, 1998, PHYS REV LETT, V81, P345, DOI 10.1103/PhysRevLett.81.345; Binnig J, 2007, J AEROSOL SCI, V38, P325, DOI 10.1016/j.jaerosci.2006.12.001; Chigurupati N, 2002, INT J PHARM, V241, P293, DOI 10.1016/S0378-5173(02)00246-6; Chung HU, 2019, SCIENCE, V363, P947, DOI 10.1126/science.aau0780; Cummins C, 2018, NATURE, V562, P414, DOI 10.1038/s41586-018-0604-2; Fauli RA, 2019, PHYS REV E, V100, DOI 10.1103/PhysRevE.100.013108; Gonzalez-Alcaide G, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05141; GREENE DF, 1993, OIKOS, V67, P69, DOI 10.2307/3545096; Groseclose SL, 2017, ANNU REV PUBL HEALTH, V38, P57, DOI 10.1146/annurev-publhealth-031816-044348; Heo SY, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aau1643; Holzer A, 2008, POWDER TECHNOL, V184, P361, DOI 10.1016/j.powtec.2007.08.021; Jin JX, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34832-7; Kang SK, 2018, ACCOUNTS CHEM RES, V51, P988, DOI 10.1021/acs.accounts.7b00548; Kim BH, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201803149; Kim BH, 2018, ACS NANO, V12, P4164, DOI 10.1021/acsnano.8b00180; Kim JT, 2020, PHYS REV FLUIDS, V5, DOI 10.1103/PhysRevFluids.5.093801; Kim JT, 2020, J FLUID MECH, V891, DOI 10.1017/jfm.2020.148; Kim JT, 2019, PHYS REV FLUIDS, V4, DOI 10.1103/PhysRevFluids.4.064605; Lee G, 2020, MATTER-US, V3, P1031, DOI 10.1016/j.matt.2020.08.021; Nathan R, 2002, NATURE, V418, P409, DOI 10.1038/nature00844; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Pang WB, 2020, NATL SCI REV, V7, P342, DOI 10.1093/nsr/nwz164; Park Y, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abf9153; Rabault J, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.024501; Seale M, 2020, NEW PHYTOL, V225, P653, DOI 10.1111/nph.16110; Shao WJ, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17051033; Wang XJ, 2019, ADV MATER, V31, DOI 10.1002/adma.201805615; Won SM, 2019, ACS NANO, V13, P10972, DOI 10.1021/acsnano.9b02030; Xu S, 2015, SCIENCE, V347, P154, DOI 10.1126/science.1260960; Zhang L, 2013, ATMOS CHEM PHYS, V13, P10005, DOI 10.5194/acp-13-10005-2013; Zhang YH, 2017, NAT REV MATER, V2, DOI 10.1038/natrevmats.2017.19; Zhang YH, 2015, P NATL ACAD SCI USA, V112, P11757, DOI 10.1073/pnas.1515602112; Zhong HJ, 2013, J FLUID MECH, V716, P228, DOI 10.1017/jfm.2012.543	34	49	52	69	235	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2021	597	7877					503	+		10.1038/s41586-021-03847-y	http://dx.doi.org/10.1038/s41586-021-03847-y			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU3OZ	34552257	Green Submitted			2022-12-28	WOS:000698710300002
J	Vinekar, K				Vinekar, Kavita			Pathology of Racism - A Call to Desegregate Teaching Hospitals	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Vinekar, Kavita] Univ Calif Los Angeles, David Geffen Sch Med, VA Greater Angeles Healthcare Syst, Los Angeles, CA 90032 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Vinekar, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, VA Greater Angeles Healthcare Syst, Los Angeles, CA 90032 USA.			Vinekar, Kavita/0000-0003-4971-7697				Dearinger AT, 2008, J GEN INTERN MED, V23, P937, DOI 10.1007/s11606-008-0654-5; Masterson Eileen, 2010, J Grad Med Educ, V2, P467, DOI 10.4300/JGME-D-10-00030.1; Metzl JM, 2014, SOC SCI MED, V103, P126, DOI 10.1016/j.socscimed.2013.06.032; Neff Joshua, 2020, MedEdPORTAL, V16, P10888, DOI 10.15766/mep_2374-8265.10888	4	8	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2021	385	13							e40	10.1056/NEJMpv2113508	http://dx.doi.org/10.1056/NEJMpv2113508			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UT0EM	34551237	Bronze			2022-12-28	WOS:000697798600005
J	Zasedatelev, AV; Baranikov, AV; Sannikov, D; Urbonas, D; Scafirimuto, F; Shishkov, VY; Andrianov, ES; Lozovik, YE; Scherf, U; Stoferle, T; Mahrt, RF; Lagoudakis, PG				Zasedatelev, Anton V.; Baranikov, Anton V.; Sannikov, Denis; Urbonas, Darius; Scafirimuto, Fabio; Shishkov, Vladislav Yu.; Andrianov, Evgeny S.; Lozovik, Yurii E.; Scherf, Ullrich; Stoferle, Thilo; Mahrt, Rainer F.; Lagoudakis, Pavlos G.			Single-photon nonlinearity at room temperature	NATURE			English	Article							QUANTUM; OPTICS; SWITCH; MOLECULE; ATOM	The recent progress in nanotechnology(1,2) and single-molecule spectroscopy(3-5) paves the way for emergent cost-effective organic quantum optical technologies with potential applications in useful devices operating at ambient conditions. We harness a pi-conjugated ladder-type polymer strongly coupled to a microcavity forming hybrid light-matter states, so-called exciton-polaritons, to create exciton-polariton condensates with quantum fluid properties. Obeying Bose statistics, exciton-polaritons exhibit an extreme nonlinearity when undergoing bosonic stimulation(6), which we have managed to trigger at the single-photon level, thereby providing an efficient way for all-optical ultrafast control over the macroscopic condensate wavefunction. Here, we utilize stable excitons dressed with high-energy molecular vibrations, allowing for single-photon nonlinear operation at ambient conditions. This opens new horizons for practical implementations like sub-picosecond switching, amplification and all-optical logic at the fundamental quantum limit. Nonlinearity induced by a single photon is desirable because it can drive power consumption of optical devices to their fundamental quantum limit, and is demonstrated here at room temperature.	[Zasedatelev, Anton V.; Baranikov, Anton V.; Sannikov, Denis; Shishkov, Vladislav Yu.; Andrianov, Evgeny S.; Lozovik, Yurii E.; Lagoudakis, Pavlos G.] Skolkovo Inst Sci & Technol, Ctr Photon & Quantum Mat, Moscow, Russia; [Zasedatelev, Anton V.; Baranikov, Anton V.; Sannikov, Denis; Shishkov, Vladislav Yu.; Andrianov, Evgeny S.; Lozovik, Yurii E.; Lagoudakis, Pavlos G.] Skolkovo Inst Sci & Technol, Labs Hybrid Photon, Moscow, Russia; [Urbonas, Darius; Scafirimuto, Fabio; Stoferle, Thilo; Mahrt, Rainer F.] IBM Res Europe Zurich, Ruschlikon, Switzerland; [Shishkov, Vladislav Yu.; Andrianov, Evgeny S.; Lozovik, Yurii E.] Dukhov Res Inst Automat VNIIA, Moscow, Russia; [Shishkov, Vladislav Yu.; Andrianov, Evgeny S.] Moscow Inst Phys & Technol, Dolgoprudnyi, Russia; [Lozovik, Yurii E.] Inst Spect RAS, Troitsk, Russia; [Lozovik, Yurii E.] Natl Res Univ Higher Sch Econ, Moscow Inst Elect & Math, Moscow, Russia; [Scherf, Ullrich] Berg Univ Wuppertal, Macromol Chem Grp, Wuppertal, Germany; [Scherf, Ullrich] Berg Univ Wuppertal, Inst Polymer Technol, Wuppertal, Germany; [Lagoudakis, Pavlos G.] Univ Southampton, Dept Phys & Astron, Southampton, Hants, England	Skolkovo Institute of Science & Technology; Skolkovo Institute of Science & Technology; Dukhov Research Institute of Automatics (VNIIA); Moscow Institute of Physics & Technology; Russian Academy of Sciences; Institute of Spectroscopy; HSE University (National Research University Higher School of Economics); University of Wuppertal; University of Wuppertal; University of Southampton	Zasedatelev, AV; Lagoudakis, PG (corresponding author), Skolkovo Inst Sci & Technol, Ctr Photon & Quantum Mat, Moscow, Russia.; Zasedatelev, AV; Lagoudakis, PG (corresponding author), Skolkovo Inst Sci & Technol, Labs Hybrid Photon, Moscow, Russia.; Lagoudakis, PG (corresponding author), Univ Southampton, Dept Phys & Astron, Southampton, Hants, England.	a.zasedatelev@skoltech.ru; p.lagoudakis@skoltech.ru	Zasedatelev, Anton/D-8094-2016; Scherf, Ullrich/G-1552-2012; Zasedatelev, Anton/ABD-7202-2021	Scherf, Ullrich/0000-0001-8368-4919; Zasedatelev, Anton/0000-0003-0414-5779; Stoferle, Thilo/0000-0003-0612-7195; Urbonas, Darius/0000-0001-9919-9221				Baranikov A. V, 2020, ALL OPTICAL CASCADAB; Bobrovska N, 2018, ACS PHOTONICS, V5, P111, DOI 10.1021/acsphotonics.7b00283; Carusotto I, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.299; Chang DE, 2014, NAT PHOTONICS, V8, P685, DOI [10.1038/NPHOTON.2014.192, 10.1038/nphoton.2014.192]; Chen W, 2013, SCIENCE, V341, P768, DOI 10.1126/science.1238169; Chikkaraddy R, 2016, NATURE, V535, P127, DOI 10.1038/nature17974; Coles DM, 2011, ADV FUNCT MATER, V21, P3691, DOI 10.1002/adfm.201100756; Daskalakis KS, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.035301; Deng H, 2010, REV MOD PHYS, V82, P1489, DOI 10.1103/RevModPhys.82.1489; Dietrich CP, 2016, LASER PHOTONICS REV, V10, P870, DOI 10.1002/lpor.201500321; Giesz V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11986; Gorniaczyk H, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.053601; Grant RT, 2016, ADV OPT MATER, V4, P1615, DOI 10.1002/adom.201600337; Hacker B, 2016, NATURE, V536, P193, DOI 10.1038/nature18592; Hail CU, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09877-5; Kasprzak J, 2006, NATURE, V443, P409, DOI 10.1038/nature05131; Lerario G, 2017, NAT PHYS, V13, P837, DOI [10.1038/NPHYS4147, 10.1038/nphys4147]; Maser A, 2016, NAT PHOTONICS, V10, P450, DOI [10.1038/nphoton.2016.63, 10.1038/NPHOTON.2016.63]; Peyronel T, 2012, NATURE, V488, P57, DOI 10.1038/nature11361; Plumhof JD, 2014, NAT MATER, V13, P248, DOI [10.1038/nmat3825, 10.1038/NMAT3825]; Reiserer A, 2013, SCIENCE, V342, P1349, DOI 10.1126/science.1246164; Sanvitto D, 2016, NAT MATER, V15, P1061, DOI [10.1038/nmat4668, 10.1038/NMAT4668]; SCHERF U, 1992, MAKROMOL CHEM, V193, P1127; Shomroni I, 2014, SCIENCE, V345, P903, DOI 10.1126/science.1254699; Sun S, 2018, SCIENCE, V361, P57, DOI 10.1126/science.aat3581; Sun Z, 2019, NAT PHOTONICS, V13, P370, DOI 10.1038/s41566-019-0445-z; Tartakovskii AI, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.121302; Tiecke TG, 2014, NATURE, V508, P241, DOI 10.1038/nature13188; Volz T, 2012, NAT PHOTONICS, V6, P605, DOI [10.1038/nphoton.2012.181, 10.1038/NPHOTON.2012.181]; Walmsley IA, 2015, SCIENCE, V348, P525, DOI 10.1126/science.aab0097; Wang DQ, 2019, NAT PHYS, V15, P483, DOI 10.1038/s41567-019-0436-5; Wang DQ, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.021014; Zasedatelev AV, 2019, NAT PHOTONICS, V13, P378, DOI 10.1038/s41566-019-0392-8	33	25	25	19	96	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2021	597	7877					493	+		10.1038/s41586-021-03866-9	http://dx.doi.org/10.1038/s41586-021-03866-9			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU3OZ	34552252	Green Accepted			2022-12-28	WOS:000698710300001
J	Mahase, E				Mahase, Elisabeth			Covid-19: Monoclonal antibody treatment to be rolled out to hospital patients with no antibody response	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mahase E, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2083	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 21	2021	374								n2319	10.1136/bmj.n2319	http://dx.doi.org/10.1136/bmj.n2319			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WA4GB	34548277	Bronze			2022-12-28	WOS:000702844100004
J	Makkar, RR; Yoon, SH; Chakravarty, T; Kapadia, SR; Krishnaswamy, A; Shah, PB; Kaneko, T; Skipper, ER; Rinaldi, M; Babaliaros, V; Vemulapalli, S; Trento, A; Cheng, W; Kodali, S; Mack, MJ; Leon, MB; Thourani, VH				Makkar, Raj R.; Yoon, Sung-Han; Chakravarty, Tarun; Kapadia, Samir R.; Krishnaswamy, Amar; Shah, Pinak B.; Kaneko, Tsuyoshi; Skipper, Eric R.; Rinaldi, Michael; Babaliaros, Vasilis; Vemulapalli, Sreekanth; Trento, Alfredo; Cheng, Wen; Kodali, Susheel; Mack, Michael J.; Leon, Martin B.; Thourani, Vinod H.			Association Between Transcatheter Aortic Valve Replacement for Bicuspid vs Tricuspid Aortic Stenosis and Mortality or Stroke Among Patients at Low Surgical Risk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CITY CARDIOMYOPATHY QUESTIONNAIRE; OUTCOMES; DISEASE	Importance There are limited data on outcomes of transcatheter aortic valve replacement (TAVR) for bicuspid aortic stenosis in patients at low surgical risk. Objective To compare the outcomes of TAVR with a balloon-expandable valve for bicuspid vs tricuspid aortic stenosis in patients who are at low surgical risk. Design, Setting, and Participants Registry-based cohort study of patients undergoing TAVR at 684 US centers. Participants were enrolled in the Society of Thoracic Surgeons (STS)/American College of Cardiology Transcatheter Valve Therapies Registry from June 2015 to October 2020. Among 159 661 patients (7058 bicuspid, 152 603 tricuspid), 37 660 patients (3243 bicuspid and 34 417 tricuspid) who were at low surgical risk (defined as STS risk score <3%) were included in the analysis. Exposures TAVR for bicuspid vs tricuspid aortic stenosis. Main Outcomes and Measures Coprimary outcomes were 30-day and 1-year mortality and stroke. Secondary outcomes included procedural complications and valve hemodynamics. Results Among 159 661 patients (7058 bicuspid; 152 603 tricuspid), 3168 propensity-matched pairs of patients with bicuspid and tricuspid aortic stenosis at low surgical risk were analyzed (mean age, 69 years; 69.8% men; mean [SD] STS-predicted risk of mortality, 1.7% [0.6%] for bicuspid and 1.7% [0.7%] for tricuspid). There was no significant difference between the bicuspid and tricuspid groups' rates of death at 30 days (0.9% vs 0.8%; hazard ratio [HR], 1.18 [95% CI, 0.68-2.03]; P = .55) and at 1 year (4.6% vs 6.6%; HR, 0.75 [95% CI, 0.55-1.02]; P = .06) or stroke at 30 days (1.4% vs 1.2%; HR, 1.14 [95% CI, 0.73-1.78]; P = .55) and at 1 year (2.0% vs 2.1%; HR 1.03 [95% CI, 0.69-1.53]; P = .89).There were no significant differences between the bicuspid and tricuspid groups in procedural complications, valve hemodynamics (aortic valve gradient: 13.2 mm Hg vs 13.5 mm Hg; absolute risk difference [RD], 0.3 mm Hg [95% CI, -0.9 to 0.3 mm Hg]), and moderate or severe paravalvular leak (3.4% vs 2.1%; absolute RD, 1.3% [95% CI, -0.6% to 3.2%]). Conclusions and Relevance In this preliminary, registry-based study of propensity-matched patients at low surgical risk who had undergone TAVR for aortic stenosis, patients treated for bicuspid vs tricuspid aortic stenosis had no significant difference in mortality or stroke at 30 days or 1 year. Because of the potential for selection bias and absence of a control group treated surgically for bicuspid aortic stenosis, randomized trials are needed to adequately assess the efficacy and safety of transcatheter aortic valve replacement for bicuspid aortic stenosis in patients at low surgical risk. This registry-based cohort study compared rates of mortality and stroke at 30 days and 1 year among patients at low surgical risk with bicuspid vs tricuspid aortic stenosis undergoing transcatheter aortic valve replacement (TAVR). Question Are there differences in mortality and stroke between patients at low surgical risk who undergo transcatheter aortic valve replacement (TAVR) for bicuspid compared with tricuspid aortic stenosis? Findings In this registry-based cohort study that included 3168 propensity-matched pairs of patients at low surgical risk undergoing TAVR for bicuspid vs tricuspid aortic stenosis, there was no significant difference in death at 30 days (0.9% vs 0.8%), death at 1 year (4.6% vs 6.6%), stroke at 30 days (1.4% vs 1.2%), or stroke at 1 year (2.0% vs 2.1%). Meaning Patients at low surgical risk who underwent TAVR for bicuspid aortic stenosis compared with tricuspid aortic stenosis had no significant difference in mortality or stroke at 30 days or 1 year. Because of the potential for selection bias, randomized trials would be needed to adequately assess the efficacy and safety of TAVR for bicuspid aortic stenosis.	[Makkar, Raj R.; Yoon, Sung-Han; Chakravarty, Tarun; Trento, Alfredo; Cheng, Wen] Cedars Sinai Med Ctr, Smidt Heart Inst, Los Angeles, CA 90048 USA; [Kapadia, Samir R.; Krishnaswamy, Amar] Cleveland Clin, Heart & Vasc Inst, Cleveland, OH 44106 USA; [Shah, Pinak B.; Kaneko, Tsuyoshi] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Skipper, Eric R.; Rinaldi, Michael] Carolinas Med Ctr, Sanger Heart & Vasc Inst, Charlotte, NC 28203 USA; [Babaliaros, Vasilis] Emory Univ, Sch Med, Atlanta, GA USA; [Vemulapalli, Sreekanth] Duke Univ, Med Ctr, Durham, NC USA; [Kodali, Susheel; Leon, Martin B.] Columbia Univ, Med Ctr, New York, NY USA; [Mack, Michael J.] Baylor Scott & White Hlth, Plano, TX USA; [Thourani, Vinod H.] Piedmont Heart Inst, Atlanta, GA USA	Cedars Sinai Medical Center; Cleveland Clinic Foundation; Harvard University; Brigham & Women's Hospital; Carolinas Medical Center; Emory University; Duke University; Columbia University; Baylor Health Care System; Piedmont Heart Institute	Makkar, RR (corresponding author), Cedars Sinai Heart Inst, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.	Raj.Makkar@cshs.org						Andrei AC, 2015, AM J CARDIOL, V116, P250, DOI 10.1016/j.amjcard.2015.04.017; Bavaria JE, 2014, J THORAC CARDIOV SUR, V147, P590, DOI 10.1016/j.jtcvs.2012.12.087; Bekeredjian R, 2019, EUR HEART J, V40, P1323, DOI 10.1093/eurheartj/ehy699; Borger MA, 2004, J THORAC CARDIOV SUR, V128, P677, DOI 10.1016/j.jtcvs.2004.07.009; Curfman G, 2021, JAMA-J AM MED ASSOC, V325, P540, DOI 10.1001/jama.2021.0109; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Elbadawi A, 2019, JACC-CARDIOVASC INTE, V12, P1811, DOI 10.1016/j.jcin.2019.06.037; Forrest JK, 2021, JAMA CARDIOL, V6, P50, DOI 10.1001/jamacardio.2020.4738; Girdauskas E, 2014, J THORAC CARDIOV SUR, V147, P276, DOI 10.1016/j.jtcvs.2012.11.004; Goland S, 2007, ANN THORAC SURG, V83, P931, DOI 10.1016/j.athoracsur.2006.10.047; Green CP, 2000, J AM COLL CARDIOL, V35, P1245, DOI 10.1016/S0735-1097(00)00531-3; Halim SA, 2020, CIRCULATION, V141, P1071, DOI 10.1161/CIRCULATIONAHA.119.040333; Holmgren A, 2021, EUR J CARDIO-THORAC, V59, P570, DOI 10.1093/ejcts/ezaa348; Husso A, 2021, CLIN RES CARDIOL, V110, P429, DOI 10.1007/s00392-020-01761-3; Itagaki S, 2015, J AM COLL CARDIOL, V65, P2363, DOI 10.1016/j.jacc.2015.03.575; Mack MJ, 2019, NEW ENGL J MED, V380, P1695, DOI 10.1056/NEJMoa1814052; Makkar RR, 2019, JAMA-J AM MED ASSOC, V321, P2193, DOI 10.1001/jama.2019.7108; Masri A, 2017, HEART, V103, P1323, DOI 10.1136/heartjnl-2016-309916; Pettersen KI, 2005, EUR J HEART FAIL, V7, P235, DOI 10.1016/j.ejheart.2004.05.012; Popma JJ, 2019, NEW ENGL J MED, V380, P1706, DOI 10.1056/NEJMoa1816885; Puskas JD, 2017, EUR J CARDIO-THORAC, V52, P432, DOI 10.1093/ejcts/ezx158; Sillesen AS, 2021, JAMA-J AM MED ASSOC, V325, P561, DOI 10.1001/jama.2020.27205; Vemulapalli S, 2019, NEW ENGL J MED, V380, P2541, DOI 10.1056/NEJMsa1901109; Zhao Y, 2014, J BIOPHARM STAT, V24, P229, DOI 10.1080/10543406.2013.860769	24	15	16	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2021	326	11					1034	1044		10.1001/jama.2021.13346	http://dx.doi.org/10.1001/jama.2021.13346			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ4IM	34546301	Green Published, Bronze			2022-12-28	WOS:000702170600017
J	Durand-Reville, TF; Miller, AA; O'Donnell, JP; Wu, XY; Sylvester, MA; Guler, S; Iyer, R; Shapiro, AB; Carter, NM; Velez-Vega, C; Moussa, SH; McLeod, SM; Chen, A; Tanudra, AM; Zhang, J; Comita-Prevoir, J; Romero, JA; Huynh, H; Ferguson, AD; Horanyi, PS; Mayclin, SJ; Heine, HS; Drusano, GL; Cummings, JE; Slayden, RA; Tommasi, RA				Durand-Reville, Thomas F.; Miller, Alita A.; O'Donnell, John P.; Wu, Xiaoyun; Sylvester, Mark A.; Guler, Satenig; Iyer, Ramkumar; Shapiro, Adam B.; Carter, Nicole M.; Velez-Vega, Camilo; Moussa, Samir H.; McLeod, Sarah M.; Chen, April; Tanudra, Angela M.; Zhang, Jing; Comita-Prevoir, Janelle; Romero, Jan A.; Huynh, Hoan; Ferguson, Andrew D.; Horanyi, Peter S.; Mayclin, Stephen J.; Heine, Henry S.; Drusano, George L.; Cummings, Jason E.; Slayden, Richard A.; Tommasi, Ruben A.			Rational design of a new antibiotic class for drug-resistant infections	NATURE			English	Article							PSEUDOMONAS-AERUGINOSA; INHIBITORS; AVIBACTAM; BACTERIA; PROTEIN; PORINS; RULES; ASSAY	The development of new antibiotics to treat infections caused by drug-resistant Gram-negative pathogens is of paramount importance as antibiotic resistance continues to increase worldwide(1). Here we describe a strategy for the rational design of diazabicyclooctane inhibitors of penicillin-binding proteins from Gram-negative bacteria to overcome multiple mechanisms of resistance, including beta-lactamase enzymes, stringent response and outer membrane permeation. Diazabicyclooctane inhibitors retain activity in the presence of beta-lactamases, the primary resistance mechanism associated with beta-lactam therapy in Gram-negative bacteria(2,3). Although the target spectrum of an initial lead was successfully re-engineered to gain in vivo efficacy, its ability to permeate across bacterial outer membranes was insufficient for further development. Notably, the features that enhanced target potency were found to preclude compound uptake. An improved optimization strategy leveraged porin permeation properties concomitant with biochemical potency in the lead-optimization stage. This resulted in ETX0462, which has potent in vitro and in vivo activity against Pseudomonas aeruginosa plus all other Gram-negative ESKAPE pathogens, Stenotrophomonas maltophilia and biothreat pathogens. These attributes, along with a favourable preclinical safety profile, hold promise for the successful clinical development of the first novel Gram-negative chemotype to treat life-threatening antibiotic-resistant infections in more than 25 years.	[Durand-Reville, Thomas F.; Miller, Alita A.; O'Donnell, John P.; Sylvester, Mark A.; Guler, Satenig; Iyer, Ramkumar; Shapiro, Adam B.; Carter, Nicole M.; Velez-Vega, Camilo; Moussa, Samir H.; McLeod, Sarah M.; Chen, April; Tanudra, Angela M.; Zhang, Jing; Comita-Prevoir, Janelle; Romero, Jan A.; Tommasi, Ruben A.] Entasis Therapeut, Waltham, MA 02451 USA; [Wu, Xiaoyun; Velez-Vega, Camilo] Novartis Inst Biomed Res, Cambridge, MA USA; [Guler, Satenig] EMD Serono, Billerica, MA USA; [Zhang, Jing] Janssen Pharmaceut, Raritan, NJ USA; [Romero, Jan A.] Pfizer, Cambridge, MA USA; [Huynh, Hoan] Alkermes, Waltham, MA USA; [Ferguson, Andrew D.] Takeda, Cambridge, MA USA; [Horanyi, Peter S.; Mayclin, Stephen J.] UCB Boston, Bedford, MA USA; [Heine, Henry S.; Drusano, George L.] Inst Therapeut Innovat, Orlando, FL USA; [Cummings, Jason E.; Slayden, Richard A.] Colorado State Univ, Ft Collins, CO 80523 USA	Novartis; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson USA; Pfizer; Alkermes; Colorado State University	Tommasi, RA (corresponding author), Entasis Therapeut, Waltham, MA 02451 USA.	ruben.tommasi@entasistx.com		Moussa, Samir/0000-0001-5348-596X; Shapiro, Adam/0000-0002-2662-6146	ASPR/BARDA [4500002444]; Wellcome Trust; Germany's Federal Ministry of Education and Research (BMBF); DOE Office of Science [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]	ASPR/BARDA; Wellcome Trust(Wellcome TrustEuropean Commission); Germany's Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); DOE Office of Science(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor	We thank D. McKinney, K. Thakur, S. Narayan and Pharmaron for their chemistry support; IHMA and JMI laboratories for microbiological surveillance studies; Neosome Life Sciences for in vivo efficacy studies; MPI Research for preclinical toxicology studies and J. Abendroth for help with crystallography. This research programme was partially supported by the Cooperative Agreement No. 4500002444 from ASPR/BARDA and by awards from Wellcome Trust and Germany's Federal Ministry of Education and Research (BMBF), as administrated by CARB-X. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response, other funders, or CARB-X. This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (grant 085P1000817).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 1999, M26 CLIN LAB STAND I; [Anonymous], 2018, M07 METHODS DILUTION, V11th ed.; Bajaj H, 2017, ACS NANO, V11, P5465, DOI 10.1021/acsnano.6b08613; Bonomo RA, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a025239; Bush K, 2019, NAT REV MICROBIOL, V17, P295, DOI 10.1038/s41579-019-0159-8; Byrne WR, 1998, ANTIMICROB AGENTS CH, V42, P675, DOI 10.1128/AAC.42.3.675; Cadwell J., 2012, ADV PHARMACOEPIDER S, pS1:007, DOI [DOI 10.4172/2167-1052.S1-007:S1, 10.4172/2167-1052.S1-007, 10.4172/2167-1052.S1-007:S1]; Colette P., 2001, Patent Cooperation Treaty, Patent No. [WO/2002/100860, 2002100860]; Dotsch A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031092; Doumith M, 2016, J ANTIMICROB CHEMOTH, V71, P2810, DOI 10.1093/jac/dkw230; Durand-Reville TF, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.104; Ehmann DE, 2012, P NATL ACAD SCI USA, V109, P11663, DOI 10.1073/pnas.1205073109; GERBER AU, 1983, J INFECT DIS, V147, P910, DOI 10.1093/infdis/147.5.910; Goutelle S, 2008, FUND CLIN PHARMACOL, V22, P633, DOI 10.1111/j.1472-8206.2008.00633.x; GUDMUNDSSON S, 1986, J ANTIMICROB CHEMOTH, V18, P67, DOI 10.1093/jac/18.Supplement_E.67; GUYTON AC, 1947, AM J PHYSIOL, V150, P70, DOI 10.1152/ajplegacy.1947.150.1.70; Hancock REW, 2002, ANNU REV MICROBIOL, V56, P17, DOI 10.1146/annurev.micro.56.012302.160310; Hartings Justin M., 2004, Journal of Pharmacological and Toxicological Methods, V49, P39, DOI 10.1016/j.vascn.2003.07.001; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Institute of Laboratory Animal Resources Commission of Life Sciences NRC [M], 1996, GUIDE CARE USE LAB A; Iyer R, 2018, ACS INFECT DIS, V4, P373, DOI 10.1021/acsinfecdis.7b00168; Iyer R, 2017, ACS INFECT DIS, V3, P310, DOI 10.1021/acsinfecdis.6b00197; Kidd JM, 2020, J ANTIMICROB CHEMOTH, V75, P149, DOI 10.1093/jac/dkz414; Kos VN, 2015, ANTIMICROB AGENTS CH, V59, P427, DOI 10.1128/AAC.03954-14; Levy N, 2019, J MED CHEM, V62, P4742, DOI 10.1021/acs.jmedchem.9b00338; Livermore DM, 2017, J ANTIMICROB CHEMOTH, V72, P1373, DOI 10.1093/jac/dkw593; Lomovskaya O, 2001, ANTIMICROB AGENTS CH, V45, P105, DOI 10.1128/AAC.45.1.105-116.2001; Lowther J., 2010, Patent Cooperation Treaty, Patent No. [WO/2010/041112, 2010041112]; May K. R., 1973, Journal of Aerosol Science, V4, P235, DOI 10.1016/0021-8502(73)90006-2; Miller AA, 2020, ACS INFECT DIS, V6, P1389, DOI 10.1021/acsinfecdis.0c00020; Morinaka A, 2015, J ANTIMICROB CHEMOTH, V70, P2779, DOI 10.1093/jac/dkv166; Morris J, 2015, EMERG INFECT DIS, V21, P58, DOI 10.3201/eid2101.131570; Murphy-Benenato KE, 2015, ACS MED CHEM LETT, V6, P537, DOI 10.1021/acsmedchemlett.5b00026; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nonejuie P, 2013, P NATL ACAD SCI USA, V110, P16169, DOI 10.1073/pnas.1311066110; O'Donnell J, 2020, ACS INFECT DIS, V6, P1378, DOI 10.1021/acsinfecdis.0c00019; Penwell WF, 2015, ANTIMICROB AGENTS CH, V59, P1685, DOI 10.1128/AAC.04808-14; Richter MF, 2017, NATURE, V545, P299, DOI 10.1038/nature22308; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Shapiro AB, 2014, ANAL BIOCHEM, V463, P15, DOI 10.1016/j.ab.2014.06.004; Shapiro AB, 2013, ANAL BIOCHEM, V439, P37, DOI 10.1016/j.ab.2013.04.009; Sindhikara DJ, 2012, J COMPUT CHEM, V33, P1536, DOI 10.1002/jcc.22984; Tacconelli E, 2018, LANCET INFECT DIS, V18, P318, DOI [10.1016/S1473-3099(17)30753-3, 10.1016/s1473-3099(17)30753-3]; Turner KH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004518; Velez-Vega C, 2014, J CHEM INF MODEL, V54, P3344, DOI 10.1021/ci500571h; VILJANEN P, 1984, ANTIMICROB AGENTS CH, V25, P701, DOI 10.1128/AAC.25.6.701; Wang DY, 2016, FUTURE MED CHEM, V8, P1063, DOI 10.4155/fmc-2016-0078	51	33	33	36	110	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 30	2021	597	7878					698	+		10.1038/s41586-021-03899-0	http://dx.doi.org/10.1038/s41586-021-03899-0		SEP 2021	20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UZ1UN	34526714				2022-12-28	WOS:000696175300001
J	Keita, AK; Koundouno, FR; Faye, M; Dux, A; Hinzmann, J; Diallo, H; Ayouba, A; Le Marcis, F; Soropogui, B; Ifono, K; Diagne, MM; Sow, MS; Bore, JA; Calvignac-Spencer, S; Vidal, N; Camara, J; Keita, MB; Renevey, A; Diallo, A; Soumah, AK; Millimono, SL; Mari-Saez, A; Diop, M; Dore, A; Soumah, FY; Kourouma, K; Vielle, NJ; Loucoubar, C; Camara, I; Kourouma, K; Annibaldis, G; Bah, A; Thielebein, A; Pahlmann, M; Pullan, ST; Carroll, MW; Quick, J; Formenty, P; Legand, A; Pietro, K; Wiley, MR; Tordo, N; Peyrefitte, C; McCrone, JT; Rambaut, A; Sidibe, Y; Barry, MD; Kourouma, M; Saouromou, CD; Conde, M; Balde, M; Povogui, M; Keita, S; Diakite, M; Bah, MS; Sidibe, A; Diakite, D; Sako, FB; Traore, FA; Ki-Zerbo, GA; Lemey, P; Gunther, S; Kafetzopoulou, LE; Sall, AA; Delaporte, E; Duraffour, S; Faye, O; Leendertz, FH; Peeters, M; Toure, A; Magassouba, NF				Keita, Alpha Kabinet; Koundouno, Fara R.; Faye, Martin; Duex, Ariane; Hinzmann, Julia; Diallo, Haby; Ayouba, Ahidjo; Le Marcis, Frederic; Soropogui, Barre; Ifono, Kekoura; Diagne, Moussa M.; Sow, Mamadou S.; Bore, Joseph A.; Calvignac-Spencer, Sebastien; Vidal, Nicole; Camara, Jacob; Keita, Mamadou B.; Renevey, Annick; Diallo, Amadou; Soumah, Abdoul K.; Millimono, Saa L.; Mari-Saez, Almudena; Diop, Mamadou; Dore, Ahmadou; Soumah, Fode Y.; Kourouma, Kaka; Vielle, Nathalie J.; Loucoubar, Cheikh; Camara, Ibrahima; Kourouma, Karifa; Annibaldis, Giuditta; Bah, Assaitou; Thielebein, Anke; Pahlmann, Meike; Pullan, Steven T.; Carroll, Miles W.; Quick, Joshua; Formenty, Pierre; Legand, Anais; Pietro, Karla; Wiley, Michael R.; Tordo, Noel; Peyrefitte, Christophe; McCrone, John T.; Rambaut, Andrew; Sidibe, Youssouf; Barry, Mamadou D.; Kourouma, Madeleine; Saouromou, Ce D.; Conde, Mamadou; Balde, Moussa; Povogui, Moriba; Keita, Sakoba; Diakite, Mandiou; Bah, Mamadou S.; Sidibe, Amadou; Diakite, Dembo; Sako, Fode B.; Traore, Fode A.; Ki-Zerbo, Georges A.; Lemey, Philippe; Guenther, Stephan; Kafetzopoulou, Liana E.; Sall, Amadou A.; Delaporte, Eric; Duraffour, Sophie; Faye, Ousmane; Leendertz, Fabian H.; Peeters, Martine; Toure, Abdoulaye; Magassouba, N' Faly			Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks	NATURE			English	Article							SEMINAL FLUID; TRANSMISSION; DISEASE; PERSISTENCE; SEQUELAE	Seven years after the declaration of the first epidemic of Ebola virus disease in Guinea, the country faced a new outbreak-between 14 February and 19 June 2021-near the epicentre of the previous epidemic(1,2). Here we use next-generation sequencing to generate complete or near-complete genomes of Zaire ebolavirus from samples obtained from 12 different patients. These genomes form a well-supported phylogenetic cluster with genomes from the previous outbreak, which indicates that the new outbreak was not the result of a new spillover event from an animal reservoir. The 2021 lineage shows considerably lower divergence than would be expected during sustained human-to-human transmission, which suggests a persistent infection with reduced replication or a period of latency. The resurgence of Zaire ebolavirus from humans five years after the end of the previous outbreak of Ebola virus disease reinforces the need for long-term medical and social care for patients who survive the disease, to reduce the risk of re-emergence and to prevent further stigmatization.	[Keita, Alpha Kabinet; Diallo, Haby; Le Marcis, Frederic; Sow, Mamadou S.; Soumah, Abdoul K.; Camara, Ibrahima; Povogui, Moriba; Toure, Abdoulaye] Univ Conakry, Ctr Rech & Format Infectiol Guinee CERFIG, Conakry, Guinea; [Keita, Alpha Kabinet; Ayouba, Ahidjo; Le Marcis, Frederic; Vidal, Nicole; Delaporte, Eric; Peeters, Martine] Montpellier Univ, TransVIHMI, IRD, INSERM, Montpellier, France; [Koundouno, Fara R.; Soropogui, Barre; Ifono, Kekoura; Bore, Joseph A.; Camara, Jacob; Millimono, Saa L.; Dore, Ahmadou; Kourouma, Karifa; Bah, Assaitou; Magassouba, N' Faly] Lab Projet Fievres Hemorrag Guinee PFHG, Conakry, Guinea; [Koundouno, Fara R.; Hinzmann, Julia; Ifono, Kekoura; Renevey, Annick; Millimono, Saa L.; Vielle, Nathalie J.; Kourouma, Karifa; Annibaldis, Giuditta; Thielebein, Anke; Pahlmann, Meike; Guenther, Stephan; Kafetzopoulou, Liana E.; Duraffour, Sophie] Bernhard Nocht Inst Trop Med BNITM, Hamburg, Germany; [Faye, Martin; Diagne, Moussa M.; Diallo, Amadou; Diop, Mamadou; Loucoubar, Cheikh; Peyrefitte, Christophe; Sall, Amadou A.; Faye, Ousmane] Inst Pasteur Dakar IPD, Dakar, Senegal; [Duex, Ariane; Calvignac-Spencer, Sebastien; Mari-Saez, Almudena; Leendertz, Fabian H.] Robert Koch Inst RKI, Berlin, Germany; [Hinzmann, Julia; Renevey, Annick; Thielebein, Anke; Pahlmann, Meike; Guenther, Stephan; Kafetzopoulou, Liana E.; Duraffour, Sophie] German Ctr Infect Res DZIF, Partner Site Hamburg Lubeck Borster Riems, Hamburg, Germany; [Hinzmann, Julia; Pullan, Steven T.; Carroll, Miles W.] UK Hlth Secur Agcy, Natl Infect Serv, Salisbury, Wilts, England; [Le Marcis, Frederic; Sidibe, Amadou] Ecore Natl Super Lyon, Lyon, France; [Sow, Mamadou S.; Soumah, Fode Y.; Balde, Moussa; Diakite, Dembo; Sako, Fode B.; Traore, Fode A.] Hop Natl Donka, Serv Malad Infect & Trop, Conakry, Guinea; [Bore, Joseph A.; Pullan, Steven T.; Carroll, Miles W.] Univ Oxford, Wellcome Trust Ctr Human Genet, Nuffield Dept Med, Oxford, England; [Keita, Mamadou B.; Kourouma, Kaka; Toure, Abdoulaye] Inst Natl Sante Pubr Guinee INSP, Conakry, Guinea; [Vielle, Nathalie J.; Annibaldis, Giuditta; Ki-Zerbo, Georges A.; Guenther, Stephan; Duraffour, Sophie] World Hlth Org WHO, Conakry, Guinea; [Quick, Joshua] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England; [Formenty, Pierre; Legand, Anais] World Hearth Org WHO, Hlth Emergencies Program, Geneva, Switzerland; [Pietro, Karla; Wiley, Michael R.] PraesensBio, Lincoln, NE USA; [Wiley, Michael R.] Univ Nebraska Med Ctr, Omaha, NE USA; [Tordo, Noel] Inst Pasteur Guinee, Conakry, Guinea; [McCrone, John T.; Rambaut, Andrew] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Sidibe, Youssouf; Barry, Mamadou D.; Kourouma, Madeleine; Saouromou, Ce D.; Conde, Mamadou] Hop Reg Nzerekore, Nzerekore, Guinea; [Keita, Sakoba] Agence Natl Securite Sanit, Conakry, Guinea; [Diakite, Mandiou; Bah, Mamadou S.] Minist Sante, Direct Natl Labs, Conakry, Guinea; [Diakite, Mandiou] Univ Gamal Abdel Nasser Conakry, Conakry, Guinea; [Lemey, Philippe; Kafetzopoulou, Liana E.] Katholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Rega Inst, Leuven, Belgium; [Delaporte, Eric] Univ Hosp Montpellier, Infect Dis Dept, Montpellier, France	Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Robert Koch Institute; German Center for Infection Research; University of Oxford; Wellcome Centre for Human Genetics; World Health Organization; University of Birmingham; University of Nebraska System; University of Nebraska Medical Center; University of Edinburgh; KU Leuven; Universite de Montpellier; CHU de Montpellier	Keita, AK (corresponding author), Univ Conakry, Ctr Rech & Format Infectiol Guinee CERFIG, Conakry, Guinea.; Keita, AK (corresponding author), Montpellier Univ, TransVIHMI, IRD, INSERM, Montpellier, France.	alpha-kabinet.keita@umontperrier.fr	faye, Ousmane/GMW-6500-2022; KEITA, Alpha Kabinet/AAR-1586-2020; TORDO, Noël/GQQ-9089-2022; Düx, Ariane/HIK-1574-2022; Ayouba, Ahidjo/G-8775-2017; FAYE, MARTIN/ABA-4738-2020; Le Marcis, Frederic/F-9430-2017	KEITA, Alpha Kabinet/0000-0003-4377-341X; Düx, Ariane/0000-0003-1819-8556; Ayouba, Ahidjo/0000-0002-5081-1632; FAYE, MARTIN/0000-0003-3207-6344; DIALLO, Amadou/0000-0002-8584-9972; Mari Saez, Almudena/0000-0002-5429-8485; Toure, Abdoulaye/0000-0003-2269-6611; DIAGNE, Moussa Moise/0000-0001-5461-5623; Le Marcis, Frederic/0000-0001-8302-0864; Ibrahima, CAMARA/0000-0003-3462-9694	EBO-SURSY Project - European Union; International Mixt Laboratory 'RESPIRE' of IRD (Institut de Recherche pour le Developpement); Montpellier Universite d'Excellence (EBOHEALTH; I-Site MUSE) [ANR-16-IDEX-0006]; Institut National de la Sante et de la Recherche Medicale (INSERM)/REACTing (REsearch and ACTion targeting emerging infectious diseases); German Ministry of Health 'Global Protection Program' project TRICE; program 'EBOVAC3 Bringing a prophylactic Ebola vaccine to licensure' by Innovative Medicine Initiative [800176]; German Federal Ministry of Health through WHO Collaborating Centre for Arbovirus and Hemorrhagic Fever Viruses at the BNITM [ZMV I1-2517WHO005]; German Federal Ministry of Health through Global Health Protection Programme (GHPP) [ZMV I1-2517GHP-704, ZMVI1-2519GHP704]; Coalition for Epidemic Preparedness Innovations (CEPI); Research and Innovation Programme of the European Union under Horizon 2020 grant [871029-EVA-GLOBAL]; GOARN Operational Support Team at WHO/HQ; WHO country office in Guinea; European Research Council under the European Union [725422-ReservoirDOCS]; Wellcome Trust [206298/Z/17/Z]; Research Foundation Flanders ('Fonds voor Wetenschappelijk Onderzoek -Vlaanderen') [G066215N, G0D5117N, G0B9317N]	EBO-SURSY Project - European Union; International Mixt Laboratory 'RESPIRE' of IRD (Institut de Recherche pour le Developpement); Montpellier Universite d'Excellence (EBOHEALTH; I-Site MUSE); Institut National de la Sante et de la Recherche Medicale (INSERM)/REACTing (REsearch and ACTion targeting emerging infectious diseases); German Ministry of Health 'Global Protection Program' project TRICE; program 'EBOVAC3 Bringing a prophylactic Ebola vaccine to licensure' by Innovative Medicine Initiative; German Federal Ministry of Health through WHO Collaborating Centre for Arbovirus and Hemorrhagic Fever Viruses at the BNITM; German Federal Ministry of Health through Global Health Protection Programme (GHPP); Coalition for Epidemic Preparedness Innovations (CEPI); Research and Innovation Programme of the European Union under Horizon 2020 grant; GOARN Operational Support Team at WHO/HQ; WHO country office in Guinea; European Research Council under the European Union(European Research Council (ERC)); Wellcome Trust(Wellcome TrustEuropean Commission); Research Foundation Flanders ('Fonds voor Wetenschappelijk Onderzoek -Vlaanderen')(FWO)	We thank the ANSS and the Ministry of Health of the Republic of Guinea, the healthcare workers (medical doctors, nurses and laboratory technicians) from the treatment centres in Nzerekore and Nongo, Conakry; the laboratory personnel in Guekedou, INSP (Conakry) and CERFIG (Conakry). CERFIG also acknowledges J. Gogarten and bioinformatics support from RKI. The UK Health Security Agency would like to thank Oxford Nanopore Technologies for the donation of reagents and equipment to support the setting up of the sequencing capacity at PFHG. BNITM thanks the ARTIC Network (https://artic.network/).The work of CERFIG and TransVIHMI was supported in part by grants from the EBO-SURSY Project funded by the European Union, International Mixt Laboratory `RESPIRE' of IRD (Institut de Recherche pour le Developpement), Montpellier Universite d'Excellence (EBOHEALTH; I-Site MUSE, ANR-16-IDEX-0006) and Institut National de la Sante et de la Recherche Medicale (INSERM)/REACTing (REsearch and ACTion targeting emerging infectious diseases). The work of the RKI was partly funded by the German Ministry of Health 'Global Protection Program' project TRICE. F.L.M. received funding through the program 'EBOVAC3 Bringing a prophylactic Ebola vaccine to licensure' funded by Innovative Medicine Initiative (grant agreement number 800176) and run by London School of Hygiene and Tropical Medicine and INSERM. The work of PFHG and BNITM was supported by the German Federal Ministry of Health through support of the WHO Collaborating Centre for Arbovirus and Hemorrhagic Fever Viruses at the BNITM (agreement ZMV I1-2517WHO005), and through the Global Health Protection Programme (GHPP, agreements ZMV I1-2517GHP-704 and ZMVI1-2519GHP704), and by the Coalition for Epidemic Preparedness Innovations (CEPI). The work of BNITM and the UK Health Security Agency was further supported by the Research and Innovation Programme of the European Union under Horizon 2020 grant agreement no. 871029-EVA-GLOBAL. The European Mobile Laboratory (EMLab) coordinated by BNITM is a technical partner of the WHO Global Outbreak Alert and Response Network (GOARN) and the deployment of EMLab experts and sequencing capacities to Guinea was coordinated and supported by the GOARN Operational Support Team at WHO/HQ and the WHO country office in Guinea. The research leading to these results has received funding from the European Research Council under the European Union's Horizon 2020 research and innovation programme (grant agreement no. 725422-ReservoirDOCS). The ARTIC Network receives funding from the Wellcome Trust through project 206298/Z/17/Z. P.L. acknowledges support by the Research Foundation Flanders ('Fonds voor Wetenschappelijk Onderzoek -Vlaanderen', G066215N, G0D5117N and G0B9317N).	Adaken C, 2021, NATURE, V590, P468, DOI 10.1038/s41586-020-03146-y; Arias A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew016; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Blackley DJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600378; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Camara I, 2020, PAN AFR MED J, V36, DOI 10.11604/pamj.2020.36.201.24379; Diallo, CLIN INFECT DIS, DOI [10.1093/cid/ciab168(2021, DOI 10.1093/CID/CIAB168(2021]; Diallo B, 2016, CLIN INFECT DIS, V63, P1353, DOI 10.1093/cid/ciw601; Diallo MSK, 2019, LANCET INFECT DIS, V19, P308, DOI 10.1016/S1473-3099(18)30649-2; Diehl WE, 2016, CELL, V167, P1088, DOI 10.1016/j.cell.2016.10.014; Dokubo EK, 2018, LANCET INFECT DIS, V18, P1015, DOI 10.1016/S1473-3099(18)30417-1; Duchene Sebastian, 2020, Virus Evol, V6, pveaa061, DOI 10.1093/ve/veaa061; Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040; Enria L., 2017, BATHPAPERS INT DEV W, V53; Etard JF, 2017, LANCET INFECT DIS, V17, P545, DOI 10.1016/S1473-3099(16)30516-3; Farmer Paul, 2006, AIDS ACCUSATION HAIT; Fischer WA, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx155; Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Glynn JR, 2017, LANCET INFECT DIS, V17, P645, DOI 10.1016/S1473-3099(17)30111-1; Grard G, 2011, J INFECT DIS, V204, pS776, DOI 10.1093/infdis/jir364; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Keita AK, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz482; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Leroy EM, 2009, VECTOR-BORNE ZOONOT, V9, P723, DOI 10.1089/vbz.2008.0167; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu WJ, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz068; Malvy D, 2019, LANCET, V393, P936, DOI 10.1016/S0140-6736(18)33132-5; Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773; Mbala-Kingebeni P, 2021, NEW ENGL J MED, V384, P1240, DOI 10.1056/NEJMoa2024670; Mbala-Kingebeni P, 2019, LANCET INFECT DIS, V19, P641, DOI 10.1016/S1473-3099(19)30124-0; Mbala-Kingebeni P, 2019, LANCET INFECT DIS, V19, P648, DOI 10.1016/S1473-3099(19)30118-5; Mbala-Kingebeni P, 2019, CLIN INFECT DIS, V68, P330, DOI 10.1093/cid/ciy527; Minh BQ, 2020, MOL BIOL EVOL, V37, P1530, DOI 10.1093/molbev/msaa015; Muyembe-Tamfum J. J., 2020, 2 EBOLA VIRUS VARIAN; Pigott DM, 2014, ELIFE, V3, DOI [10.7554/eLife.02851, 10.7554/eLife.04395]; Pini A, 2018, EUROSURVEILLANCE, V23, P20, DOI 10.2807/1560-7917.ES.2018.23.12.17-00140; Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996; Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007; Ronse M, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006885; Sissoko D, 2017, CLIN INFECT DIS, V64, P513, DOI 10.1093/cid/ciw793; Sissoko D, 2017, LANCET GLOB HEALTH, V5, pE80, DOI 10.1016/S2214-109X(16)30243-1; Sneller MC, 2019, NEW ENGL J MED, V380, P924, DOI 10.1056/NEJMoa1805435; Sow S, 2016, Bull Soc Pathol Exot, V109, P309, DOI 10.1007/s13149-016-0510-5; Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016; Thom R, 2021, LANCET INFECT DIS, V21, P507, DOI 10.1016/S1473-3099(20)30736-2; Thorson AE, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003273; Urbanowicz RA, 2016, CELL, V167, P1079, DOI 10.1016/j.cell.2016.10.013; Weidmann M, 2004, J CLIN VIROL, V30, P94, DOI 10.1016/j.jcv.2003.09.004; Wiedemann A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17489-7; Wilkinson A, 2017, CRIT PUBLIC HEALTH, V27, P14, DOI 10.1080/09581596.2016.1252034; World Health Organization, 2016, 2016 SIT REP EB VIR; Worobey M, 2014, NATURE, V508, P254, DOI 10.1038/nature13016	54	40	40	7	31	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2021	597	7877					539	+		10.1038/s41586-021-03901-9	http://dx.doi.org/10.1038/s41586-021-03901-9		SEP 2021	11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU3OZ	34526718	Bronze, Green Accepted			2022-12-28	WOS:000696175300014
J	Lane, R				Lane, Richard			Gagandeep Kang: helping to shape a healthier India	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 11	2021	398	10304					947	947						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UP1FQ	34509223				2022-12-28	WOS:000695130500010
J	Dong, DZ; Hallinan, G; Nakar, E; Ho, AYQ; Hughes, AK; Hotokezaka, K; Myers, ST; De, K; Mooley, KP; Ravi, V; Horesh, A; Kasliwal, MM; Kulkarni, SR				Dong, D. Z.; Hallinan, G.; Nakar, E.; Ho, A. Y. Q.; Hughes, A. K.; Hotokezaka, K.; Myers, S. T.; De, K.; Mooley, K. P.; Ravi, V; Horesh, A.; Kasliwal, M. M.; Kulkarni, S. R.			A transient radio source consistent with a merger-triggered core collapse supernova	SCIENCE			English	Article							EVOLUTION; EMISSION; MASS; SKY	A core collapse supernova occurs when exothermic fusion ceases in the core of a massive star, which is typically caused by exhaustion of nuclear fuel. Theory predicts that fusion could be interrupted earlier by merging of the star with a compact binary companion. We report a luminous radio transient, VT J121001+495647, found in the Very Large Array Sky Survey. The radio emission is consistent with supernova ejecta colliding with a dense shell of material, potentially ejected by binary interaction in the centuries before explosion. We associate the supernova with an archival x-ray transient, which implies that a relativistic jet was launched during the explosion. The combination of an early relativistic jet and late-time dense interaction is consistent with expectations for a merger-driven explosion.	[Dong, D. Z.; Hallinan, G.; Ho, A. Y. Q.; De, K.; Mooley, K. P.; Ravi, V; Kasliwal, M. M.; Kulkarni, S. R.] CALTECH, Div Phys Math & Astron, Inst Technol, Pasadena, CA 91125 USA; [Nakar, E.] Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Ho, A. Y. Q.] Univ Calif Berkeley, Dept Astron, 601 Campbell Hall, Berkeley, CA 94720 USA; [Ho, A. Y. Q.] Miller Inst Basic Res Sci, Berkeley, CA 94720 USA; [Hughes, A. K.] Univ Alberta, Dept Phys, Edmonton, AB T6G 2E1, Canada; [Hotokezaka, K.] Univ Tokyo, Res Ctr Early Universe, Grad Sch Sci, Bunkyo Ku, Tokyo 113033, Japan; [Myers, S. T.; Mooley, K. P.] Natl Radio Astron Observ, Socorro, NM 87801 USA; [Horesh, A.] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel	California Institute of Technology; Tel Aviv University; University of California System; University of California Berkeley; University of Alberta; University of Tokyo; National Radio Astronomy Observatory (NRAO); Hebrew University of Jerusalem	Dong, DZ (corresponding author), CALTECH, Div Phys Math & Astron, Inst Technol, Pasadena, CA 91125 USA.	dillondong@astro.caltech.edu	Hotokezaka, Kenta/AAA-3890-2022	Hughes, Andrew/0000-0003-0764-0687; Nakar, Ehud/0000-0002-4534-7089; Hallinan, Gregg/0000-0002-7083-4049; Dong, Dillon/0000-0001-9584-2531	National Science Foundation (NSF) [AST-1654815]; United States-Israel Binational Science Foundation [2018154]; I-Core Program of the Planning and Budgeting Committee; Israel Science Foundation; ISF [647/18]; GROWTH project - NSF under PIRE [1545949]; NSERC [RGPIN-2016-06569, RGPIN-2021-04001]; Miller Institute for Basic Research in Science at the University of California, Berkeley; JSPS Early-Career Scientists grant [20K14513]; NRAO; Heising-Simons Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); I-Core Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation); ISF(Israel Science Foundation); GROWTH project - NSF under PIRE; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Miller Institute for Basic Research in Science at the University of California, Berkeley(University of California System); JSPS Early-Career Scientists grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NRAO; Heising-Simons Foundation	D.Z.D. and G.H. were supported by National Science Foundation (NSF) grant AST-1654815. G.H., D.Z.D., and A.H. were supported by the United States-Israel Binational Science Foundation (grant 2018154). A.H. also acknowledges support from the I-Core Program of the Planning and Budgeting Committee and the Israel Science Foundation and ISF grant 647/18. A.Y.Q.H. and K.D. were supported by the GROWTH project funded by the NSF under PIRE grant 1545949. A.K.H. was supported by NSERC Discovery Grants RGPIN-2016-06569 and RGPIN-2021-04001. A.Y.Q.H. was supported by the Miller Institute for Basic Research in Science at the University of California, Berkeley. K.H. was supported by JSPS Early-Career Scientists grant 20K14513. S.M. was supported by the NRAO. S.R.K. was supported by the Heising-Simons Foundation.	Aguado DS, 2019, ASTROPHYS J SUPPL S, V240, DOI 10.3847/1538-4365/aaf651; Anderson GE, 2017, MON NOT R ASTRON SOC, V466, P3648, DOI 10.1093/mnras/stw3310; BECKER RH, 1995, ASTROPHYS J, V450, P559, DOI 10.1086/176166; Campana S, 2006, NATURE, V442, P1008, DOI 10.1038/natureO4892; Chandra P, 2020, ASTROPHYS J, V902, DOI 10.3847/1538-4357/abb460; Chevalier RA, 1998, ASTROPHYS J, V499, P810, DOI 10.1086/305676; Chevalier RA, 2012, ASTROPHYS J LETT, V752, DOI 10.1088/2041-8205/752/1/L2; Chugai NN, 2006, ASTROPHYS J, V641, P1051, DOI 10.1086/500539; Corsi A, 2014, ASTROPHYS J, V782, DOI 10.1088/0004-637X/782/1/42; Dong D. Z, 2021, dillon-z-dong/vt1210: initial release, version 1.0, DOI [10.5281/zenodo.5136735, DOI 10.5281/ZENODO.5136735]; Draine BT, 2011, PR S ASTROP, P1; Ghirlanda G, 2015, J HIGH ENERGY ASTROP, V7, P81, DOI 10.1016/j.jheap.2015.04.002; Heng K, 2010, PUBL ASTRON SOC AUST, V27, P23, DOI 10.1071/AS09057; Ho AYQ, 2020, ASTROPHYS J, V895, DOI 10.3847/1538-4357/ab8bcf; Ho AYQ, 2019, ASTROPHYS J, V871, DOI 10.3847/1538-4357/aaf473; Ivanova N, 2013, ASTRON ASTROPHYS REV, V21, DOI 10.1007/s00159-013-0059-2; Klencki J, 2020, ASTRON ASTROPHYS, V638, DOI 10.1051/0004-6361/202037694; Kulkarni SR, 1998, NATURE, V395, P663, DOI 10.1038/27139; Lacy M, 2020, PUBL ASTRON SOC PAC, V132, DOI 10.1088/1538-3873/ab63eb; Langer N, 2012, ANNU REV ASTRON ASTR, V50, P107, DOI 10.1146/annurev-astro-081811-125534; MacLeod M, 2018, ASTROPHYS J, V868, DOI 10.3847/1538-4357/aae9eb; Margutti R, 2017, ASTROPHYS J, V835, DOI 10.3847/1538-4357/835/2/140; Milisavljevic D, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/1/25; Moe M, 2017, ASTROPHYS J SUPPL S, V230, DOI 10.3847/1538-4365/aa6fb6; Orosz JA, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/2/84; Sana H, 2012, SCIENCE, V337, P444, DOI 10.1126/science.1223344; Schroder SL, 2020, ASTROPHYS J, V892, DOI 10.3847/1538-4357/ab7014; Serino M, 2014, PUBL ASTRON SOC JPN, V66, DOI 10.1093/pasj/psu063; Smith N, 2014, ANNU REV ASTRON ASTR, V52, P487, DOI 10.1146/annurev-astro-081913-040025; Soderberg AM, 2008, NATURE, V453, P469, DOI 10.1038/nature06997; Soderberg AM, 2010, NATURE, V463, P513, DOI 10.1038/nature08714; Soker N, 2017, MON NOT R ASTRON SOC, V471, P4849, DOI 10.1093/mnras/stx1978; Sun NC, 2020, MON NOT R ASTRON SOC, V497, P5118, DOI 10.1093/mnras/staa2277; Taam RE, 2000, ANNU REV ASTRON ASTR, V38, P113, DOI 10.1146/annurev.astro.38.1.113; Tauris TM, 2017, ASTROPHYS J, V846, DOI 10.3847/1538-4357/aa7e89; van der Horst AJ, 2007, PHILOS T R SOC A, V365, P1241, DOI 10.1098/rsta.2006.1993; Wu S, 2021, ASTROPHYS J, V906, DOI 10.3847/1538-4357/abc87c	37	14	14	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2021	373	6559					1125	1128		10.1126/science.abg6037	http://dx.doi.org/10.1126/science.abg6037			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UL8QT	34516837	Green Accepted, Green Submitted			2022-12-28	WOS:000692910300044
J	Shimojima, T; Motoyui, Y; Taniuchi, T; Bareille, C; Onari, S; Kontani, H; Nakajima, M; Kasahara, S; Shibauchi, T; Matsuda, Y; Shin, S				Shimojima, T.; Motoyui, Y.; Taniuchi, T.; Bareille, C.; Onari, S.; Kontani, H.; Nakajima, M.; Kasahara, S.; Shibauchi, T.; Matsuda, Y.; Shin, S.			Discovery of mesoscopic nematicity wave in iron-based superconductors	SCIENCE			English	Article							DENSITY-WAVE; TRANSITION; ANISOTROPY; STATE; PHASE	Nematicity is ubiquitous in the electronic phases of iron-based superconductors. The order parameter that characterizes the nematic phase has been investigated in momentum space, but its real-space arrangement remains largely unexplored. We use linear dichroism (LD) in a low-temperature laser-photoemission electron microscope to map out the nematic order parameter of nonmagentic FeSe and antiferromagnetic BaFe2(As0.87P0.13)(2). In contrast to structural domains, which have atomic-scale domain walls, the LD patterns in both materials show peculiar sinusoidal waves of electronic nematicity with wavelengths more than 1000 times as long as the unit cell. Our findings put strong constraints on the theoretical investigation of electronic nematicity.	[Shimojima, T.] RIKEN Ctr Emergent Matter Sci GEMS, Wako, Saitama 3510198, Japan; [Motoyui, Y.; Taniuchi, T.; Bareille, C.; Shin, S.] Univ Tokyo, Inst Solid State Phys QSSP, Kashiwa, Chiba 2778581, Japan; [Taniuchi, T.; Bareille, C.; Shin, S.] Univ Tokyo, Mat Innovat Res Ctr MIRC, Kashiwa, Chiba 2778561, Japan; [Onari, S.; Kontani, H.] Nagoya Univ, Dept Phys, Furo Cho, Nagoya, Aichi 4648602, Japan; [Nakajima, M.] Osaka Univ, Dept Phys, Toyonaka, Osaka 5600043, Japan; [Kasahara, S.; Matsuda, Y.] Kyoto Univ, Dept Phys, Kyoto 6068502, Japan; [Shibauchi, T.] Univ Tokyo, Dept Adv Mat Sci, Kashiwa, Chiba 2778561, Japan; [Shin, S.] Univ Tokyo, Off Univ Prof, Kashiwa, Chiba 2778581, Japan; [Kasahara, S.] Okayama Univ, Res Inst Interdisciplinary Sci, Kita Ku, 3-1-1 Tsushimanaka, Okayama 7008533, Japan	University of Tokyo; University of Tokyo; Nagoya University; Osaka University; Kyoto University; University of Tokyo; University of Tokyo; Okayama University	Shimojima, T (corresponding author), RIKEN Ctr Emergent Matter Sci GEMS, Wako, Saitama 3510198, Japan.; Shin, S (corresponding author), Univ Tokyo, Inst Solid State Phys QSSP, Kashiwa, Chiba 2778581, Japan.; Shin, S (corresponding author), Univ Tokyo, Mat Innovat Res Ctr MIRC, Kashiwa, Chiba 2778561, Japan.; Shin, S (corresponding author), Univ Tokyo, Off Univ Prof, Kashiwa, Chiba 2778581, Japan.	takahiro.shimojima@riken.jp; shin@issp.u-tokyo.ac.jp	Shimojima, Takahiro/D-3888-2017; SHIN, SHIK/ABH-1500-2020; Onari, Seiichiro/C-2759-2015; Kontani, Hiroshi/V-5117-2017; Nakajima, Masamichi/D-5176-2013; Kasahara, Shigeru/H-3064-2014; Shibauchi, Takasada/B-9349-2008	Shimojima, Takahiro/0000-0002-2162-4539; Onari, Seiichiro/0000-0003-3561-8137; Kontani, Hiroshi/0000-0002-8127-7903; Nakajima, Masamichi/0000-0002-1203-4967; Kasahara, Shigeru/0000-0002-6007-9617; Shibauchi, Takasada/0000-0001-5831-4924; Bareille, Cedric/0000-0002-2042-7437	Japan Society for the Promotion of Science [JP19H05824, JP19H05825]; JST CREST [JPMJCR19T5];  [JP18H01175];  [JP21H04443];  [JP18H05227];  [JP19H00649];  [JP19H00651]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); ; ; ; ; 	This work was supported by Grants-in-Aid for Scientific Research (nos. JP18H01175, JP21H04443, JP18H05227, JP19H00649, and JP19H00651) and Innovative Areas "Quantum Liquid Crystals" (nos. JP19H05824 and JP19H05825) from the Japan Society for the Promotion of Science and by JST CREST (JPMJCR19T5).	Achkar AJ, 2016, SCIENCE, V351, P576, DOI 10.1126/science.aad1824; Bohmer AE, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.180505; Chu JH, 2010, SCIENCE, V329, P824, DOI 10.1126/science.1190482; Cox S, 2008, NAT MATER, V7, P25, DOI 10.1038/nmat2071; Dagotto E, 2005, SCIENCE, V309, P257, DOI 10.1126/science.1107559; Fernandes RM, 2014, NAT PHYS, V10, P97, DOI 10.1038/nphys2877; Fernandes RM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.157003; Fradkin E, 2010, ANNU REV CONDEN MA P, V1, P153, DOI 10.1146/annurev-conmatphys-070909-103925; Frandsen BA, 2019, PHYS REV B, V100, DOI 10.1103/PhysRevB.100.020504; Fratini M, 2010, NATURE, V466, P841, DOI 10.1038/nature09260; Glasbrenner JK, 2015, NAT PHYS, V11, P953, DOI [10.1038/nphys3434, 10.1038/NPHYS3434]; Hinkov V, 2008, SCIENCE, V319, P597, DOI 10.1126/science.1152309; Kasahara S, 2012, NATURE, V486, P382, DOI 10.1038/nature11178; Kuo HH, 2016, SCIENCE, V352, P958, DOI 10.1126/science.aab0103; Lai KJ, 2010, SCIENCE, V329, P190, DOI 10.1126/science.1189925; Lin HX, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.267202; Nakajima M, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.104710; Pfau H, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.066402; Sato Y, 2018, P NATL ACAD SCI USA, V115, P1227, DOI 10.1073/pnas.1717331115; Shimojima T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.057002; Shimojima T., 2021, DATA SCI PAPER, DOI [10.5281/zenodo.4885407, DOI 10.5281/ZENODO.4885407]; Sonobe T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20332-1; SOSNOWSKA I, 1982, J PHYS C SOLID STATE, V15, P4835, DOI 10.1088/0022-3719/15/23/020; Suzuki Y, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.205117; Tanatar MA, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.180508; Taniuchi T, 2015, REV SCI INSTRUM, V86, DOI 10.1063/1.4906755; Thewalt E, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.027001; Wang WY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05529-2; Watashige T, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.031022; Watson MD, 2017, NEW J PHYS, V19, DOI 10.1088/1367-2630/aa8a04; Yang F, 2020, NAT PHYS, V16, P514, DOI 10.1038/s41567-020-0826-8; Yi M, 2011, P NATL ACAD SCI USA, V108, P6878, DOI 10.1073/pnas.1015572108; Zhou R, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.060502	34	5	5	7	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2021	373	6559					1122	+		10.1126/science.abd6701	http://dx.doi.org/10.1126/science.abd6701			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UL8QT	34516833	Green Submitted			2022-12-28	WOS:000692910300043
J	Zampieri, FG; Machado, FR; Biondi, RS; Freitas, FGR; Veiga, VC; Figueiredo, RC; Lovato, WJ; Amendola, CP; Assuncao, MSC; Serpa-Neto, A; Paranhos, JLR; Andrade, J; Godoy, MMG; Romano, E; Dal Pizzol, F; Silva, EB; Silva, MML; Machado, MCV; Malbouisson, LMS; Manoel, ALO; Thompson, MM; Figueiredo, LM; Soares, RM; Miranda, TA; de Lima, LM; Santucci,, EV; Correa, TD; Azevedo, LCP; Kellum, JA; Damiani, LP; Silva, NB; Cavalcanti, AB				Zampieri, Fernando G.; Machado, Flavia R.; Biondi, Rodrigo S.; Freitas, Flavio G. R.; Veiga, Viviane C.; Figueiredo, Rodrigo C.; Lovato, Wilson J.; Amendola, Cristina P.; Assuncao, Murillo S. C.; Serpa-Neto, Ary; Paranhos, Jorge L. R.; Andrade, Jose; Godoy, Michele M. G.; Romano, Edson; Dal Pizzol, Felipe; Silva, Emerson B.; Silva, Miqueias M. L.; Machado, Miriam C. V.; Malbouisson, Luiz Marcelo S.; Manoel, Airton L. O.; Thompson, Marlus M.; Figueiredo, Lanese M.; Soares, Rafael M.; Miranda, Tamiris A.; de Lima, Lucas M.; Santucci, Eliana V.; Correa, Thiago D.; Azevedo, Luciano C. P.; Kellum, John A.; Damiani, Lucas P.; Silva, Nilton B.; Cavalcanti, Alexandre B.		BaSICS Investigators BRICNet Memb	Effect of Slower vs Faster Intravenous Fluid Bolus Rates on Mortality in Critically Ill Patients The BaSICS Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTENSIVE-CARE; INFUSION; SALINE; RESUSCITATION	IMPORTANCE Slower intravenous fluid infusion rates could reduce the formation of tissue edema and organ dysfunction in critically ill patients; however, there are no data to support different infusion rates during fluid challenges for important outcomes such as mortality. OBJECTIVE To determine the effect of a slower infusion rate vs control infusion rate on 90-day survival in patients in the intensive care unit (ICU). DESIGN, SETTING, AND PARTICIPANTS Unblinded randomized factorial clinical trial in 75 ICUs in Brazil, involving 11 052 patients requiring at least 1 fluid challenge and with 1 risk factor for worse outcomes were randomized from May 29, 2017, to March 2, 2020. Follow-up was concluded on October 29, 2020. Patients were randomized to 2 different infusion rates (reported in this article) and 2 different fluid types (balanced fluids or saline, reported separately). INTERVENTIONS Patients were randomized to receive fluid challenges at 2 different infusion rates; 5538 to the slower rate (333 mL/h) and 5514 to the control group (999 mL/h). Patients were also randomized to receive balanced solution or 0.9% saline using a factorial design. MAIN OUTCOMES AND MEASURES The primary end pointwas 90-day survival. RESULTS Of all randomized patients, 10 520 (95.2%) were analyzed (mean age, 61.1 years [SD, 17.0 years]; 44.2% were women) after excluding duplicates and consent withdrawals. Patients assigned to the slower rate received a mean of 1162mL on the first day vs 1252 mL for the control group. By day 90, 1406 of 5276 patients (26.6%) in the slower rate group had died vs 1414 of 5244 (27.0%) in the control group (adjusted hazard ratio, 1.03; 95% CI, 0.96-1.11; P = .46). There was no significant interaction between fluid type and infusion rate (P = .98). CONCLUSIONS AND RELEVANCE Among patients in the intensive care unit requiring fluid challenges, infusing at a slower rate compared with a faster rate did not reduce 90-day mortality. These findings do not support the use of a slower infusion rate.	[Zampieri, Fernando G.; Soares, Rafael M.; Miranda, Tamiris A.; Damiani, Lucas P.; Silva, Nilton B.] HCor Res Inst, Rua Abilio Soares 250,12th Floor, Sao Paulo, Brazil; [Zampieri, Fernando G.; Machado, Flavia R.; Biondi, Rodrigo S.; Freitas, Flavio G. R.; Veiga, Viviane C.; Serpa-Neto, Ary; Dal Pizzol, Felipe; Correa, Thiago D.; Azevedo, Luciano C. P.; Cavalcanti, Alexandre B.] Brazilian Res Intens Care Network BRICNet, Sao Paulo, Brazil; [Machado, Flavia R.] Univ Fed Sao Paulo UNIFESP, Dept Anesthesiol Pain & Intens Care, Sao Paulo, Brazil; [Biondi, Rodrigo S.] Inst Cardiol Distrito Fed, Brasilia, DF, Brazil; [Freitas, Flavio G. R.] Hosp SEPACO, Sao Paulo, Brazil; [Veiga, Viviane C.] BPA Beneficencia Portuguesa Sao Paulo, Sao Paulo, Brazil; [Figueiredo, Rodrigo C.] Ctr Univ Espirito Santo UNESC, Hosp Maternidade Sao Jose, Colatina, Brazil; [Lovato, Wilson J.] Univ Sao Paulo, Hosp Clin, Fac Med Ribeirao Preto, Ribeirao Preto, Brazil; [Amendola, Cristina P.] Hosp Canc Barretos, Fundacao Pio 12, Barretos, Brazil; [Assuncao, Murillo S. C.; Serpa-Neto, Ary; Correa, Thiago D.] Hosp Israelita Albert Einstein, Sao Paulo, Brazil; [Paranhos, Jorge L. R.] Santa Casa Misericordia Sao Joao Rei, Sao Joao Dei Rei, Brazil; [Andrade, Jose] Hosp Geral Vitoria Conquista, Vitoria, ES, Brazil; [Godoy, Michele M. G.] Univ Fed Pernambuco, Hosp Clin, Recife, PE, Brazil; [Romano, Edson] HCor, Sao Paulo, Brazil; [Dal Pizzol, Felipe] Hosp Sao Jose, Criciuma, SC, Brazil; [Silva, Emerson B.] Hosp Geral Caxias Sul, Caxias Do Sul, RS, Brazil; [Silva, Miqueias M. L.] Hosp SAMUR, Vitoria, Brazil; [Machado, Miriam C. V.] Ctr Hospitar UNIMED, Joinville, Brazil; [Malbouisson, Luiz Marcelo S.] Univ Sao Paulo, Fac Med, Hosp Clin, Sao Paulo, Brazil; [Manoel, Airton L. O.] Hosp Paulistano, Sao Paulo, Brazil; [Thompson, Marlus M.] Hosp Evangel Cachoeiro Itapemirim, Cachoeiro Do Itapemirim, Brazil; [Figueiredo, Lanese M.] Hosp Distrital Doutor Evandro Ayres Moura, Fortaleza, Ceara, Brazil; [Azevedo, Luciano C. P.] Hosp Sirio Libanes, Sao Paulo, Brazil; [Kellum, John A.] Univ Pittsburgh, Dept Crit Care Med, Ctr Crit Care Nephrol, Pittsburgh, PA USA; [Silva, Nilton B.] Fed Univ Hlth Sci, Sch Med, Porto Alegre, RS, Brazil	Hospital do Coracao - HCor; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Hospital de Cancer de Barretos; Hospital Israelita Albert Einstein; Universidade Federal de Pernambuco; Hospital do Coracao - HCor; Universidade Federal do Rio Grande do Sul; Universidade de Sao Paulo; Hospital Sirio Libanes; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Cavalcanti, AB (corresponding author), HCor Res Inst, Rua Abilio Soares 250,12th Floor, Sao Paulo, Brazil.	abiasi@hcor.com.br	Ravetti, Cecilia Gómez/ABD-7540-2021; Kellum, John A/HCH-2944-2022; Garces, Thiago Santos/M-2623-2018; Taniguchi, Leandro Utino/L-6471-2015; Boschi, Emerson/AHA-5269-2022; Roepke, Roberta Muriel Longo/AAN-6414-2020; Soares, Rafael/GSN-9271-2022; Serpa Neto, Ary/D-1927-2012; Azevedo, Luciano CP/H-2652-2012; Biondi, Rodrigo/H-5212-2016	Ravetti, Cecilia Gómez/0000-0002-6349-3063; Kellum, John A/0000-0003-1995-2653; Garces, Thiago Santos/0000-0002-1670-725X; Taniguchi, Leandro Utino/0000-0003-4384-0408; Boschi, Emerson/0000-0002-0273-4759; Roepke, Roberta Muriel Longo/0000-0003-2214-5166; Serpa Neto, Ary/0000-0003-1520-9387; Azevedo, Luciano CP/0000-0001-6759-3910; Rea-Neto, Alvaro/0000-0001-5524-0907; Biondi, Rodrigo/0000-0002-9242-6062	Brazilian Ministry of Health through the Programa de Desenvolvimento Institucional do Sistema Unico de Saude	Brazilian Ministry of Health through the Programa de Desenvolvimento Institucional do Sistema Unico de Saude	This trial was supported by the Brazilian Ministry of Health through the Programa de Desenvolvimento Institucional do Sistema Unico de Saude. Fluids and logistics were supplied by Baxter Hospitalar.	Cecconi M, 2015, INTENS CARE MED, V41, P1529, DOI 10.1007/s00134-015-3850-x; Damiani Lucas Petri, 2020, Rev. bras. ter. intensiva, V32, P493, DOI [10.5935/0103-507x.20200081, 10.5935/0103-507X.20200081]; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hahn RG, 2016, ACTA ANAESTH SCAND, V60, P569, DOI 10.1111/aas.12686; HAYBITTLE JL, 1971, BRIT J RADIOL, V44, P793, DOI 10.1259/0007-1285-44-526-793; Henderson AC, 2012, RESP PHYSIOL NEUROBI, V180, P331, DOI 10.1016/j.resp.2011.12.013; Hernandez G, 2019, JAMA-J AM MED ASSOC, V321, P654, DOI 10.1001/jama.2019.0071; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Krzych LJ, 2018, CARDIOL J, V25, P254, DOI 10.5603/CJ.a2017.0054; Maitland K, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-68; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Garcia MIM, 2015, INTENS CARE MED, V41, P1247, DOI 10.1007/s00134-015-3898-7; MUIR AL, 1975, J APPL PHYSIOL, V38, P786, DOI 10.1152/jappl.1975.38.5.786; Robertson HT, 2004, J APPL PHYSIOL, V97, P697, DOI 10.1152/japplphysiol.00108.2004; Tatara T, 2007, BRIT J ANAESTH, V99, P212, DOI 10.1093/bja/aem165; Ukor IF, 2017, J CRIT CARE, V41, P254, DOI 10.1016/j.jcrc.2017.05.036; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Zampieri FG, 2021, JAMA-J AM MED ASSOC, V326, P818, DOI 10.1001/jama.2021.11684; Zampieri FG, 2017, CRIT CARE RESUSC, V19, P175	21	20	21	1	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2021	326	9					830	838		10.1001/jama.2021.11444	http://dx.doi.org/10.1001/jama.2021.11444		AUG 2021	9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ7LK	34547081	Green Published, Bronze			2022-12-28	WOS:000684941800003
J	Katzenellenbogen, BS				Katzenellenbogen, Benita S.			Estrogen receptor gets a grip on RNA	CELL			English	Editorial Material							PROLIFERATION; ALPHA; GENE	The nuclear hormone receptor estrogen receptor alpha (ER alpha) is a well-known transcription factor present in many breast cancers, where it promotes cancer progression. In this issue of Cell, Xu et al. report that ER alpha is also an RNA-binding protein and that its post-transcriptional activity enables cancer cell fitness and survival.	[Katzenellenbogen, Benita S.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Katzenellenbogen, Benita S.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Katzenellenbogen, Benita S.] Univ Illinois, Canc Ctr Illinois, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Katzenellenbogen, BS (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.; Katzenellenbogen, BS (corresponding author), Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA.; Katzenellenbogen, BS (corresponding author), Univ Illinois, Canc Ctr Illinois, Urbana, IL 61801 USA.	katzenel@illinois.edu			Breast Cancer Research Foundation [BCRF 20-083, 20-084]; National Institutes of Health [NIH R01 CA220284]; Landfield Cancer Research Fund	Breast Cancer Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Landfield Cancer Research Fund	Research in the B.S.K. laboratory is supported by grants from the Breast Cancer Research Foundation (BCRF 20-083 and 20-084), the National Institutes of Health (NIH R01 CA220284), and the Landfield Cancer Research Fund.	Arnal JF, 2017, PHYSIOL REV, V97, P1045, DOI 10.1152/physrev.00024.2016; Boudreau MW, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abf1383; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Katzenellenbogen JA, 2018, NAT REV CANCER, V18, P377, DOI 10.1038/s41568-018-0001-z; Lanz RB, 1999, CELL, V97, P17, DOI 10.1016/S0092-8674(00)80711-4; Madak-Erdogan Z, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad8170; Madak-Erdogan Z, 2011, MOL CELL BIOL, V31, P226, DOI 10.1128/MCB.00821-10; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McDonnell DP, 2002, SCIENCE, V296, P1642, DOI 10.1126/science.1071884; Xu YC, 2021, CELL, V184, P5215, DOI 10.1016/j.cell.2021.08.036	10	1	1	6	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 30	2021	184	20					5086	5088		10.1016/j.cell.2021.09.012	http://dx.doi.org/10.1016/j.cell.2021.09.012		OCT 2021	4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	WC7PG	34559987	Bronze			2022-12-28	WOS:000704445700006
J	Limb, M				Limb, Matthew			The BMJ Awards 2021: Diagnostics team of the year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2021	374								n2266	10.1136/bmj.n2266	http://dx.doi.org/10.1136/bmj.n2266			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ1JE	34556503				2022-12-28	WOS:000701967300002
J	Richman, B; Hall, M; Schulman, K				Richman, Barak; Hall, Mark; Schulman, Kevin			The No Surprises Act and Informed Financial Consent	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Richman, Barak] Duke Univ, Sch Law, Durham, NC 27706 USA; [Hall, Mark] Wake Forest Univ, Sch Law, Winston Salem, NC 27101 USA; [Hall, Mark] Wake Forest Univ, Sch Med, Winston Salem, NC 27101 USA; [Richman, Barak; Schulman, Kevin] Stanford Univ, Sch Med, Clin Excellence Res Ctr, Stanford, CA 94305 USA; [Schulman, Kevin] Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA	Duke University; Wake Forest University; Wake Forest University; Stanford University; Stanford University	Richman, B (corresponding author), Duke Univ, Sch Law, Durham, NC 27706 USA.; Richman, B (corresponding author), Stanford Univ, Sch Med, Clin Excellence Res Ctr, Stanford, CA 94305 USA.			Hall, Mark A./0000-0001-6277-144X				Chhabra KR, 2021, NEW ENGL J MED, V384, P1381, DOI 10.1056/NEJMp2035905; Joyce A., 2021, ANAL HOSP PRICE TRAN; Kliff S, 2020, NY TIMES; Richman BD, 2017, AM J MANAG CARE, V23, pE100; Richman BD, 2012, NEW ENGL J MED, V367, P396, DOI 10.1056/NEJMp1205225	5	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2021	385	15					1348	1351		10.1056/NEJMp2109971	http://dx.doi.org/10.1056/NEJMp2109971		SEP 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XP7AB	34551226				2022-12-28	WOS:000697804700001
J	Silberner, J				Silberner, Joanne			Covid-19: How Native Americans led the way in the US vaccination effort	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												joanne.silberner@gmail.com						Centers for Disease Control and Prevention, 2021, COV DAT TRACK PERC P	1	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2021	374								n2168	10.1136/bmj.n2168	http://dx.doi.org/10.1136/bmj.n2168			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WC6LC	34535445	Bronze			2022-12-28	WOS:000704366700007
J	Gewin, V; Payne, D				Gewin, Virginia; Payne, David			THE HEART OF THE BLACK STEM PIPELINE	NATURE			English	Editorial Material						Careers; Lab life; Institutions; Society		Historically Black colleges and universities offer personal and professional support that predominantly white US institutions do not. Historically Black colleges and universities offer personal and professional support that predominantly white US institutions do not.											0	0	0	0	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 16	2021	597	7876					435	438		10.1038/d41586-021-02487-6	http://dx.doi.org/10.1038/d41586-021-02487-6			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UT4UD	34518684				2022-12-28	WOS:000698111500003
J	Dyer, O				Dyer, Owen			Covid-19: Hospital may cease giving patient ivermectin, US court rules, as prescriptions soar	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		AMA, 2021, APHA ASHP STAT END U; [Anonymous], RAPID INCREASE IVERM; [Anonymous], 2021, WHO ADVISES IVERMEC; [Anonymous], 2021, MERCK STATEMENT IVE; Caly Leon, 2020, Antiviral Res, V178, P104787, DOI 10.1016/j.antiviral.2020.104787; FDA, 2021, WHY YO SHOULD NOT US; Herbeck D, 2021, BUFFALO NEWS; Keilman J., 2021, THE CHICAGO TRIBUNE; Taylor Josh., 2021, GUARDIAN	9	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2021	374								n2228	10.1136/bmj.n2228	http://dx.doi.org/10.1136/bmj.n2228			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	US1IY	34507970	Bronze			2022-12-28	WOS:000697191000001
J	Mergoum, AM				Mergoum, Anaas Moncef			Amoxicillin Rash in Infectious Mononucleosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mergoum, Anaas Moncef] Univ North Dakota, Sch Med & Hlth Sci, Grand Forks, ND 58202 USA	University of North Dakota Grand Forks	Mergoum, AM (corresponding author), Univ North Dakota, Sch Med & Hlth Sci, Grand Forks, ND 58202 USA.	rajamergoum@hotmail.com		MERGOUM, ANAAS/0000-0001-5172-4824					0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 9	2021	385	11					1033	1033		10.1056/NEJMicm2104358	http://dx.doi.org/10.1056/NEJMicm2104358			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UN0RH	34496177				2022-12-28	WOS:000693730200014
J	Wang, L; Hong, PJ; May, C; Rehman, Y; Oparin, Y; Hong, CJ; Hong, BY; AminiLari, M; Gallo, L; Kaushal, A; Craigie, S; Couban, RJ; Kum, E; Shanthanna, H; Price, I; Upadhye, S; Ware, MA; Campbell, F; Agoritsas, T; Buchbinder, R; Busse, JW				Wang, Li; Hong, Patrick J.; May, Curtis; Rehman, Yasir; Oparin, Yvgeniy; Hong, Chris J.; Hong, Brian Y.; AminiLari, Mahmood; Gallo, Lucas; Kaushal, Alka; Craigie, Samantha; Couban, Rachel J.; Kum, Elena; Shanthanna, Harsha; Price, Ira; Upadhye, Suneel; Ware, Mark A.; Campbell, Fiona; Agoritsas, Thomas; Buchbinder, Rachelle; Busse, Jason W.			Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CHRONIC NEUROPATHIC PAIN; MULTIPLE-SCLEROSIS CAMS; DOUBLE-BLIND; OROMUCOSAL SPRAY; SOCIOECONOMIC BURDEN; ADJUNCTIVE THERAPY; MEDICINAL EXTRACTS; OUTCOME DOMAINS; PARALLEL-GROUP; EFFICACY	OBJECTIVE To determine the benefits and harms of medical cannabis and cannabinoids for chronic pain. DESIGN Systematic review and meta-analysis. DATA SOURCES MEDLINE, EMBASE, AMED, PsycInfo, CENTRAL, CINAHL, PubMed, Web of Science, Cannabis-Med, Epistemonikos, and trial registries up to January 2021. STUDY SELECTION Randomised clinical trials of medical cannabis or cannabinoids versus any non-cannabis control for chronic pain at >= 1 month follow-up. DATA EXTRACTION AND SYNTHESIS Paired reviewers independently assessed risk of bias and extracted data. We performed random-effects models meta-analyses and used GRADE to assess the certainty of evidence. RESULTS A total of 32 trials with 5174 adult patients were included, 29 of which compared medical cannabis or cannabinoids with placebo. Medical cannabis was administered orally (n=30) or topically (n=2). Clinical populations included chronic non-cancer pain (n=28) and cancer related pain (n=4). Length of follow-up ranged from 1 to 5.5 months. Compared with placebo, non-inhaled medical cannabis probably results in a small increase in the proportion of patients experiencing at least the minimally important difference (MID) of 1 cm (on a 10 cm visual analogue scale (VAS)) in pain relief (modelled risk difference (RD) of 10% (95% confidence interval 5% to 15%), based on a weighted mean difference (WMD) of -0.50 cm (95% CI -0.75 to -0.25 cm, moderate certainty)). Medical cannabis taken orally results in a very small improvement in physical functioning (4% modelled RD (0.1% to 8%) for achieving at least the MID of 10 points on the 100-point SF-36 physical functioning scale, WMD of 1.67 points (0.03 to 3.31, high certainty)), and a small improvement in sleep quality (6% modelled RD (2% to 9%) for achieving at least the MID of 1 cm on a 10 cm VAS, WMD of -0.35 cm (-0.55 to -0.14 cm, high certainty)). Medical cannabis taken orally does not improve emotional, role, or social functioning (high certainty). Moderate certainty evidence shows that medical cannabis taken orally probably results in a small increased risk of transient cognitive impairment (RD 2% (0.1% to 6%)), vomiting (RD 3% (0.4% to 6%)), drowsiness (RD 5% (2% to 8%)), impaired attention (RD 3% (1% to 8%)), and nausea (RD 5% (2% to 8%)), but not diarrhoea; while high certainty evidence shows greater increased risk of dizziness (RD 9% (5% to 14%)) for trials with <3 months follow-up versus RD 28% (18% to 43%) for trials with >= 3 months followup; interaction test P=0.003; moderate credibility of subgroup effect). CONCLUSIONS Moderate to high certainty evidence shows that non-inhaled medical cannabis or cannabinoids results in a small to very small improvement in pain relief, physical functioning, and sleep quality among patients with chronic pain, along with several transient adverse side effects, compared with placebo. The accompanying BMJ Rapid Recommendation provides contextualised guidance based on this body of evidence.	[Wang, Li; Oparin, Yvgeniy; Shanthanna, Harsha; Busse, Jason W.] McMaster Univ, Dept Anesthesia, Hamilton, ON, Canada; [Wang, Li; Rehman, Yasir; AminiLari, Mahmood; Craigie, Samantha; Couban, Rachel J.] McMaster Univ, Michael G DeGroote Inst Pain Res & Care, Hamilton, ON, Canada; [Wang, Li; Rehman, Yasir; AminiLari, Mahmood; Kum, Elena; Upadhye, Suneel] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Hong, Patrick J.] Univ Toronto, Dept Anesthesiol & Pain Med, Toronto, ON, Canada; [May, Curtis] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Hong, Chris J.] Univ Toronto, Dept Otolaryngol Head Neck Surg, Toronto, ON, Canada; [Hong, Brian Y.] Univ Toronto, Div Plast Surg, Dept Surg, Toronto, ON, Canada; [Gallo, Lucas] McMaster Univ, Div Plast Surg, Hamilton, ON, Canada; [Kaushal, Alka] Univ Manitoba, Dept Family Med, Winnipeg, MB, Canada; [Price, Ira] McMaster Univ, Dept Med, Div Emergency Med, Hamilton, ON, Canada; [Upadhye, Suneel] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Ware, Mark A.] McGill Univ, Hlth Ctr, Alan Edwards Pain Management Unit, Montreal, PQ, Canada; [Ware, Mark A.] McGill Univ, Dept Family Med & Anesthesia, Montreal, PQ, Canada; [Campbell, Fiona] Univ Toronto, Hosp Sick Children, Dept Anesthesia & Pain Med, Toronto, ON, Canada; [Buchbinder, Rachelle] Monash Univ, Sch Publ Hlth & Preventat Med, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Buchbinder, Rachelle] Cabrini Inst, Monash Dept Clin Epidemiol, Melbourne, Vic, Australia; [Buchbinder, Rachelle] Univ Hosp Geneva, Dept Med, Div Gen Internal Med, Geneva, Switzerland; [Busse, Jason W.] McMaster Univ, Michael G DeGroote Ctr Med Cannabis Res, Hamilton, ON, Canada; [Busse, Jason W.] Chron Pain Ctr Excellence Canadian Vet, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; University of Toronto; University of British Columbia; University of Toronto; University of Toronto; McMaster University; University of Manitoba; McMaster University; McMaster University; McGill University; McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Monash University; Cabrini Health; Monash University; University of Geneva; McMaster University	Wang, L (corresponding author), McMaster Univ, Dept Anesthesia, Hamilton, ON, Canada.; Wang, L (corresponding author), McMaster Univ, Michael G DeGroote Inst Pain Res & Care, Hamilton, ON, Canada.; Wang, L (corresponding author), McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada.	wangli1@mcmaster.ca	Rehman, Yasir/D-5335-2018; Busse, Jason/CAH-3696-2022; Couban, Rachel/AAV-1568-2021; Wang, Li/T-1407-2017	Rehman, Yasir/0000-0002-2817-3638; Busse, Jason/0000-0002-0178-8712; Couban, Rachel/0000-0001-8672-2845; Wang, Li/0000-0003-1585-8846; Kum, Elena/0000-0002-6548-2632	Canadian Institutes of Health Research (CIHR) [FRN 147994]; Australian National Health and Medical Research Council (NHMRC) Senior Principal Research Fellowship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Australian National Health and Medical Research Council (NHMRC) Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by a grant from the Canadian Institutes of Health Research (CIHR) (FRN 147994, Co-PIs: JW Busse, MA Ware) . RB is supported by an Australian National Health and Medical Research Council (NHMRC) Senior Principal Research Fellowship. The funding organisations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.	Akl EA, 2012, J CLIN EPIDEMIOL, V65, P262, DOI 10.1016/j.jclinepi.2011.04.015; Allan GM, 2018, CAN FAM PHYSICIAN, V64, pE78; Allan GM, 2018, CAN FAM PHYSICIAN, V64, P111; Amato L, 2017, EPIDEMIOL PREV, V41, P279, DOI 10.19191/EP17.5-6.AD01.069; Andresen SR, 2016, PAIN, V157, P2097, DOI 10.1097/j.pain.0000000000000623; [Anonymous], 2011, EUCTR201100092631CZ; [Anonymous], 2008, EUCTR200600591011DE; [Anonymous], 2005, EUCTR200400250963GB; [Anonymous], 2007, EUCTR200700213813GB; Australian Government Department of Health Therapeutic Goods Administration, 2017, GUID US MED CANN TRE; Australian Institute of Health and Welfare, 2020, CHRON PAIN AUSTR; Baker WL, 2009, INT J CLIN PRACT, V63, P1426, DOI 10.1111/j.1742-1241.2009.02168.x; Blake DR, 2006, RHEUMATOLOGY, V45, P50, DOI 10.1093/rheumatology/kei183; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Breivik H, 2012, EUR J PAIN, V16, P167, DOI 10.1002/j.1532-2149.2011.00025.x; Busse JW, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2040; Busse JW, 2018, JAMA-J AM MED ASSOC, V320, P2448, DOI 10.1001/jama.2018.18472; Busse JW, 2015, J RHEUMATOL, V42, P1962, DOI 10.3899/jrheum.141440; Chang-Douglass S, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1108; ClinicalTrials.gov, 2012, NCT01599234 STUD EV; ClinicalTrials.gov, 2008, NCT00711646 STUD SAT; ClinicalTrials.gov, 2006, NCT00384410 US CANN; ClinicalTrials.gov, 2006, NCT00710424 STUD SAT; Cobellis L, 2011, EUR J OBSTET GYN R B, V158, P82, DOI 10.1016/j.ejogrb.2011.04.011; Corey-Bloom J, 2012, CAN MED ASSOC J, V184, P1143, DOI 10.1503/cmaj.110837; Cumpston M, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000142; Dahlhamer J, 2018, MMWR-MORBID MORTAL W, V67, P1001, DOI 10.15585/mmwr.mm6736a2; de Vries M, 2017, CLIN GASTROENTEROL H, V15, P1079, DOI 10.1016/j.cgh.2016.09.147; de Vries M, 2016, BRIT J CLIN PHARMACO, V81, P525, DOI 10.1111/bcp.12811; Debray TPA, 2018, RES SYNTH METHODS, V9, P41, DOI 10.1002/jrsm.1266; Duenas M, 2016, J PAIN RES, V9, P457, DOI 10.2147/JPR.S105892; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eibach L, 2021, CLIN PHARMACOL THER, V109, P1055, DOI 10.1002/cpt.2016; Faig-Marti J, 2020, J ORTHOP TRAUMATOL, V21, DOI 10.1186/s10195-019-0540-4; Fairhurst C, 2020, DEV MED CHILD NEUROL, V62, P1031, DOI 10.1111/dmcn.14548; Fallon MT, 2017, BRIT J PAIN, V11, P119, DOI 10.1177/2049463717710042; Frank B, 2008, BRIT MED J, V336, P199, DOI 10.1136/bmj.39429.619653.80; Germini F, 2017, DRUG AGING, V34, P941, DOI 10.1007/s40266-017-0506-2; Giammusso B, 2017, ARCH ITAL UROL ANDRO, V89, P17, DOI 10.4081/aiua.2017.1.17; Gustavsson A, 2012, EUR J PAIN, V16, P289, DOI 10.1016/j.ejpain.2011.07.006; Guyatt GH, 1998, BRIT MED J, V316, P690, DOI 10.1136/bmj.316.7132.690; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Hackshaw A, 2008, EUR RESPIR J, V32, P1141, DOI 10.1183/09031936.00136408; Hauser W, 2018, EUR J PAIN, V22, P455, DOI 10.1002/ejp.1118; Hauser W, 2019, SCHMERZ, V33, P424, DOI 10.1007/s00482-019-0373-3; Hauser W, 2018, EUR J PAIN, V22, P1547, DOI 10.1002/ejp.1297; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Haupts M, 2016, EUR NEUROL, V75, P236, DOI 10.1159/000445943; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hunter D, 2018, OSTEOARTHR CARTILAGE, V26, pS26, DOI 10.1016/j.joca.2018.02.067; IntHout J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-25; Johnson JR, 2010, J PAIN SYMPTOM MANAG, V39, P167, DOI 10.1016/j.jpainsymman.2009.06.008; Karst M, 2003, JAMA-J AM MED ASSOC, V290, P1757, DOI 10.1001/jama.290.13.1757; Killestein J, 2002, NEUROLOGY, V58, P1404, DOI 10.1212/WNL.58.9.1404; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langford RM, 2013, J NEUROL, V260, P984, DOI 10.1007/s00415-012-6739-4; Lichtman AH, 2018, J PAIN SYMPTOM MANAG, V55, P179, DOI 10.1016/j.jpainsymman.2017.09.001; Lynch ME, 2014, J PAIN SYMPTOM MANAG, V47, P166, DOI 10.1016/j.jpainsymman.2013.02.018; Malik Z, 2017, DIS ESOPHAGUS, V30, DOI 10.1111/dote.12455; Markova J, 2019, INT J NEUROSCI, V129, P119, DOI 10.1080/00207454.2018.1481066; Mills SEE, 2019, BRIT J ANAESTH, V123, pE273, DOI 10.1016/j.bja.2019.03.023; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moulin DE, 2014, PAIN RES MANAG, V19, P328; Murad MH., 2015, USERSGUIDE MEDICAL L; Murina F, 2013, J LOW GENIT TRACT DI, V17, P111, DOI 10.1097/LGT.0b013e3182652316; National Institute for Health and Care Excellence, 2019, CANN BAS MED PROD NI; Nitecka-Buchta A, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111886; Notcutt W, 2004, ANAESTHESIA, V59, P440, DOI 10.1111/j.1365-2044.2004.03674.x; Novotna A, 2011, EUR J NEUROL, V18, P1122, DOI 10.1111/j.1468-1331.2010.03328.x; Nurmikko TJ, 2007, PAIN, V133, P210, DOI 10.1016/j.pain.2007.08.028; Park JY, 2017, DRUG ALCOHOL DEPEN, V177, P1, DOI 10.1016/j.drugalcdep.2017.03.009; Phillips Ceri J, 2009, Rev Pain, V3, P2, DOI 10.1177/204946370900300102; Phillips Ceri J, 2006, Expert Rev Pharmacoecon Outcomes Res, V6, P591, DOI 10.1586/14737167.6.5.591; Pini LA, 2012, J HEADACHE PAIN, V13, P677, DOI 10.1007/s10194-012-0490-1; Pinsger M, 2006, WIEN KLIN WOCHENSCHR, V118, P327, DOI 10.1007/s00508-006-0611-4; Portenoy RK, 2012, J PAIN, V13, P438, DOI 10.1016/j.jpain.2012.01.003; Raja SN, 2020, PAIN, V161, P1976, DOI 10.1097/j.pain.0000000000001939; Riva N, 2019, LANCET NEUROL, V18, P155, DOI 10.1016/S1474-4422(18)30406-X; Rog DJ, 2005, NEUROLOGY, V65, P812, DOI 10.1212/01.wnl.0000176753.45410.8b; Sa KN, 2019, PAIN REP, V4, DOI 10.1097/PR9.0000000000000779; Santesso N, 2020, J CLIN EPIDEMIOL, V119, P126, DOI 10.1016/j.jclinepi.2019.10.014; Schandelmaier S, 2020, CAN MED ASSOC J, V192, pE901, DOI 10.1503/cmaj.200077; Schimrigk S, 2017, EUR NEUROL, V78, P320, DOI 10.1159/000481089; Schopflocher D, 2011, PAIN RES MANAG, V16, P445, DOI 10.1155/2011/876306; Schunemann HJ, 2005, HEALTH SERV RES, V40, P593, DOI 10.1111/j.1475-6773.2005.0k375.x; Selvarajah D, 2010, DIABETES CARE, V33, P128, DOI 10.2337/dc09-1029; Serpell M, 2014, EUR J PAIN, V18, P999, DOI 10.1002/j.1532-2149.2013.00445.x; Skrabek RQ, 2008, J PAIN, V9, P164, DOI 10.1016/j.jpain.2007.09.002; Svendsen KB, 2004, BMJ-BRIT MED J, V329, P253, DOI 10.1136/bmj.38149.566979.AE; Thorlund K, 2011, RES SYNTH METHODS, V2, P188, DOI 10.1002/jrsm.46; Toth C, 2012, PAIN, V153, P2073, DOI 10.1016/j.pain.2012.06.024; Treede RD, 2019, PAIN, V160, P19, DOI 10.1097/j.pain.0000000000001384; Treede RD, 2015, PAIN, V156, P1003, DOI 10.1097/j.pain.0000000000000160; Turk DC, 2003, PAIN, V106, P337, DOI 10.1016/j.pain.2003.08.001; Turk DC, 2008, PAIN, V137, P276, DOI 10.1016/j.pain.2007.09.002; van Amerongen G, 2018, CLIN THER, V40, P1467, DOI 10.1016/j.clinthera.2017.01.016; van de Donk T, 2019, PAIN, V160, P860, DOI 10.1097/j.pain.0000000000001464; van Hecke O, 2013, BRIT J ANAESTH, V111, P13, DOI 10.1093/bja/aet123; Wade DT, 2004, MULT SCLER, V10, P434, DOI 10.1191/1352458504ms1082oa; Wan X, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-135; Ward MM, 2014, ARTHRIT CARE RES, V66, P1783, DOI 10.1002/acr.22392; Weber M, 2010, J NEUROL NEUROSUR PS, V81, P1135, DOI 10.1136/jnnp.2009.200642; Wissel J, 2006, J NEUROL, V253, P1337, DOI 10.1007/s00415-006-0218-8; Xu DXH, 2020, CURR PHARM BIOTECHNO, V21, P390, DOI 10.2174/1389201020666191202111534; Zajicek J, 2003, LANCET, V362, P1517, DOI 10.1016/S0140-6736(03)14738-1; Zajicek JP, 2012, J NEUROL NEUROSUR PS, V83, P1125, DOI 10.1136/jnnp-2012-302468; Zajicek JP, 2005, J NEUROL NEUROSUR PS, V76, P1664, DOI 10.1136/jnnp.2005.070136; Zisapel N, 2003, J SLEEP RES, V12, P291, DOI 10.1046/j.0962-1105.2003.00365.x	109	34	35	4	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2021	374								n1034	10.1136/bmj.n1034	http://dx.doi.org/10.1136/bmj.n1034			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ3VV	34497047	Bronze			2022-12-28	WOS:000702137100015
J	Mukamel, RE; Handsaker, RE; Sherman, MA; Barton, AR; Zheng, YM; McCarroll, SA; Loh, PR				Mukamel, Ronen E.; Handsaker, Robert E.; Sherman, Maxwell A.; Barton, Alison R.; Zheng, Yiming; McCarroll, Steven A.; Loh, Po-Ru			Protein-coding repeat polymorphisms strongly shape diverse human phenotypes	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; APOLIPOPROTEIN(A) GENE; GENOTYPE IMPUTATION; TANDEM REPEATS; LIPOPROTEIN(A) CONCENTRATION; LINKAGE DISEQUILIBRIUM; MOLECULAR-BASIS; INTEGRATED MAP; AGGRECAN GENE; COPY NUMBER	Many human proteins contain domains that vary in size or copy number because of variable numbers of tandem repeats (VNTRs) in protein-coding exons. However, the relationships of VNTRs to most phenotypes are unknown because of difficulties in measuring such repetitive elements. We developed methods to estimate VNTR lengths from whole-exome sequencing data and impute VNTR alleles into single-nucleotide polymorphism haplotypes. Analyzing 118 protein-altering VNTRs in 415,280 UK Biobank participants for association with 786 phenotypes identified some of the strongest associations of common variants with human phenotypes, including height, hair morphology, and biomarkers of health. Accounting for large-effect VNTRs further enabled fine-mapping of associations to many more protein-coding mutations in the same genes. These results point to cryptic effects of highly polymorphic common structural variants that have eluded molecular analyses to date.	[Mukamel, Ronen E.; Sherman, Maxwell A.; Barton, Alison R.; Loh, Po-Ru] Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Mukamel, Ronen E.; Sherman, Maxwell A.; Barton, Alison R.; Loh, Po-Ru] Harvard Med Sch, Boston, MA 02115 USA; [Mukamel, Ronen E.; Handsaker, Robert E.; Sherman, Maxwell A.; Barton, Alison R.; Zheng, Yiming; McCarroll, Steven A.; Loh, Po-Ru] Broad Inst Massachusetts Inst Technol MIT & Harva, Program Med & Populat Genet, Boston, MA 02142 USA; [Handsaker, Robert E.; Zheng, Yiming; McCarroll, Steven A.] Broad Inst MIT & Harvard Univ, Stanley Ctr Psychiat Res, Boston, MA 02142 USA; [Handsaker, Robert E.; McCarroll, Steven A.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Sherman, Maxwell A.] MIT, Comp Sci & Artificial Intelligence Lab, Boston, MA USA; [Barton, Alison R.] Harvard Med Sch, Dept Biomed Informat, Bioinformat & Integrat Genom Program, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Mukamel, RE; Loh, PR (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.; Mukamel, RE; Loh, PR (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Mukamel, RE; Handsaker, RE; McCarroll, SA; Loh, PR (corresponding author), Broad Inst Massachusetts Inst Technol MIT & Harva, Program Med & Populat Genet, Boston, MA 02142 USA.; Handsaker, RE; McCarroll, SA (corresponding author), Broad Inst MIT & Harvard Univ, Stanley Ctr Psychiat Res, Boston, MA 02142 USA.; Handsaker, RE; McCarroll, SA (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.	rmukamel@broadinstitute.org; handsake@broadinstitute.org; mccarroll@genetics.med.harvard.edu; poruloh@broadinstitute.org		Loh, Po-Ru/0000-0001-5542-9064; Barton, Alison/0000-0003-0882-0196; McCarroll, Steven/0000-0002-6954-8184; Mukamel, Ronen/0000-0002-9042-9673	National Science Foundation (NSF) [DMS-1939015]; National Institutes of Health (NIH) [K25 HL150334]; NIH [DP2 ES030554, R01 HG006855, F31 MH124393, F31 HL154537, T32 HG 2295-16]; MIT John W. Jarve (1978) Seed Fund for Science Innovation; Burroughs Wellcome Fund Career Award at the Scientific Interfaces; Next Generation Fund at the Broad Institute of MIT and Harvard; Sloan Research Fellowship; Wellcome Trust; Medical Research Council; European Union; Chronic Disease Research Foundation (CDRF); Zoe Global Ltd.; National Institute for Health Research (NIHR); King's College London	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MIT John W. Jarve (1978) Seed Fund for Science Innovation; Burroughs Wellcome Fund Career Award at the Scientific Interfaces; Next Generation Fund at the Broad Institute of MIT and Harvard; Sloan Research Fellowship(Alfred P. Sloan Foundation); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Chronic Disease Research Foundation (CDRF); Zoe Global Ltd.; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); King's College London(General Electric)	R.E.M. was supported by National Science Foundation (NSF) grant DMS-1939015 and National Institutes of Health (NIH) grant K25 HL150334. R.E.H. and S.A.M. were supported by NIH grant R01 HG006855. M.A.S. was supported by the MIT John W. Jarve (1978) Seed Fund for Science Innovation and by NIH fellowship F31 MH124393. A.R.B. was supported by NIH fellowship F31 HL154537 and training grant T32 HG 2295-16. P.-R.L. was supported by NIH grant DP2 ES030554, a Burroughs Wellcome Fund Career Award at the Scientific Interfaces, the Next Generation Fund at the Broad Institute of MIT and Harvard, and a Sloan Research Fellowship. TwinsUK is funded by the Wellcome Trust, Medical Research Council, European Union, Chronic Disease Research Foundation (CDRF), Zoe Global Ltd., and the National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility, and Biomedical Research Centre based at Guy's and St. Thomas' NHS Foundation Trust in partnership with King's College London.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Aguet F, 2020, SCIENCE, V369, P1318, DOI 10.1126/science.aaz1776; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Audano PA, 2019, CELL, V176, P663, DOI 10.1016/j.cell.2018.12.019; Bakhtiari M, 2018, GENOME RES, V28, P1709, DOI 10.1101/gr.235119.118; Barragan I, 2008, ANN HUM GENET, V72, P26, DOI 10.1111/j.1469-1809.2007.00393.x; Barton AR, 2021, NAT GENET, V53, P1260, DOI 10.1038/s41588-021-00892-1; Basmanav FBU, 2016, AM J HUM GENET, V99, P1292, DOI 10.1016/j.ajhg.2016.10.004; Benner C, 2017, AM J HUM GENET, V101, P539, DOI 10.1016/j.ajhg.2017.08.012; Benner C, 2016, BIOINFORMATICS, V32, P1493, DOI 10.1093/bioinformatics/btw018; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Beyter D, 2021, NAT GENET, V53, P779, DOI 10.1038/s41588-021-00865-4; BOERWINKLE E, 1992, J CLIN INVEST, V90, P52, DOI 10.1172/JCI115855; Browning BL, 2016, AM J HUM GENET, V98, P116, DOI 10.1016/j.ajhg.2015.11.020; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Coassin S, 2019, J LIPID RES, V60, P186, DOI 10.1194/jlr.M090381; Coassin S, 2017, EUR HEART J, V38, P1823, DOI 10.1093/eurheartj/ehx174; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; Di Maio S, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00771-0; Doege KJ, 1997, J BIOL CHEM, V272, P13974, DOI 10.1074/jbc.272.21.13974; Dolzhenko E, 2017, GENOME RES, V27, P1895, DOI 10.1101/gr.225672.117; Doyard M, 2018, J MED GENET, V55, P278, DOI 10.1136/jmedgenet-2017-104999; Ebert P, 2021, SCIENCE, V372, P48, DOI 10.1126/science.abf7117; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evani U. S., 2021, HIGH COVERAGE WHOLE, DOI [10.1101/2021.02.06.430068, DOI 10.1101/2021.02.06.430068]; Fowler JC, 2003, HUM GENET, V113, P473, DOI 10.1007/s00439-003-1011-8; Garg P, 2021, AM J HUM GENET, V108, P809, DOI 10.1016/j.ajhg.2021.03.016; Gewartowska O, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109015; Gleghorn L, 2005, AM J HUM GENET, V77, P484, DOI 10.1086/444401; Graff M, 2021, AM J HUM GENET, V108, P564, DOI 10.1016/j.ajhg.2021.02.011; Gudbjartsson DF, 2019, J AM COLL CARDIOL, V74, P2982, DOI 10.1016/j.jacc.2019.10.019; Handsaker RE, 2015, NAT GENET, V47, P296, DOI 10.1038/ng.3200; Handsaker RE, 2011, NAT GENET, V43, P269, DOI 10.1038/ng.768; Horton WE, 1998, OSTEOARTHR CARTILAGE, V6, P245, DOI 10.1053/joca.1998.0117; Jaganathan K, 2019, CELL, V176, P535, DOI 10.1016/j.cell.2018.12.015; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kirby A, 2013, NAT GENET, V45, P299, DOI 10.1038/ng.2543; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kottgen A, 2013, NAT GENET, V45, P145, DOI 10.1038/ng.2500; Kraft HG, 1996, EUR J HUM GENET, V4, P74; Lalioti MD, 1997, NATURE, V386, P847, DOI 10.1038/386847a0; Lauing KL, 2014, DEV BIOL, V396, P224, DOI 10.1016/j.ydbio.2014.10.005; LEE SC, 1993, J BIOL CHEM, V268, P12164; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li N, 2003, GENETICS, V165, P2213; Lim ET, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004494; Listgarten J, 2012, NAT METHODS, V9, P525, DOI 10.1038/nmeth.2037; Liu F, 2018, HUM MOL GENET, V27, P559, DOI 10.1093/hmg/ddx416; Loh PR, 2020, NATURE, V584, P136, DOI 10.1038/s41586-020-2430-6; Loh PR, 2018, NAT GENET, V50, P906, DOI 10.1038/s41588-018-0144-6; Loh PR, 2016, NAT GENET, V48, P1443, DOI 10.1038/ng.3679; Loh PR, 2015, NAT GENET, V47, P1385, DOI 10.1038/ng.3431; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Lu TY, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24378-0; Mack S, 2017, J LIPID RES, V58, P1834, DOI 10.1194/jlr.M076232; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Medland SE, 2009, AM J HUM GENET, V85, P750, DOI 10.1016/j.ajhg.2009.10.009; Mefford J, 2020, J COMPUT BIOL, V27, P599, DOI 10.1089/cmb.2019.0325; Moayyeri A, 2013, TWIN RES HUM GENET, V16, P144, DOI 10.1017/thg.2012.89; Morgan BM, 2020, J LIPID RES, V61, P432, DOI 10.1194/jlr.M094540; Mukamel R. E., 2021, ZENODO, DOI [10.5281/zenodo.4776804, DOI 10.5281/ZENODO.4776804]; Mukamel R. E., 2021, ZENODO, DOI [10.5281/zenodo.4776804, DOI 10.5281/ZENODO.4776804]; Noureen A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121582; Ogorelkova M, 1999, HUM MOL GENET, V8, P2087, DOI 10.1093/hmg/8.11.2087; Okada Y, 2012, NAT GENET, V44, P904, DOI 10.1038/ng.2352; Parson W, 2004, HUM MUTAT, V24, P474, DOI 10.1002/humu.20101; Pasaniuc B, 2014, BIOINFORMATICS, V30, P2906, DOI 10.1093/bioinformatics/btu416; Pedersen BS, 2018, BIOINFORMATICS, V34, P867, DOI 10.1093/bioinformatics/btx699; Rentzsch P, 2019, NUCLEIC ACIDS RES, V47, pD886, DOI 10.1093/nar/gky1016; Said MA, 2021, ARTERIOSCL THROM VAS, V41, P1792, DOI 10.1161/ATVBAHA.120.315300; Schmidt K, 2016, J LIPID RES, V57, P1339, DOI 10.1194/jlr.R067314; Steinert PM, 2003, J BIOL CHEM, V278, P41409, DOI 10.1074/jbc.M302037200; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Sulovari A, 2019, P NATL ACAD SCI USA, V116, P23243, DOI 10.1073/pnas.1912175116; Suzuki K, 1997, J CLIN INVEST, V99, P1361, DOI 10.1172/JCI119295; Taliun D, 2021, NATURE, V590, DOI 10.1038/s41586-021-03205-y; Trinder M., 2020, JAMA CARDIOL; Trinder M, 2021, JAMA CARDIOL, V6, P287, DOI 10.1001/jamacardio.2020.5398; UTERMANN G, 1987, J CLIN INVEST, V80, P458, DOI 10.1172/JCI113093; Van Hout CV, 2020, NATURE, V586, P749, DOI 10.1038/s41586-020-2853-0; Vinall LE, 2002, GASTROENTEROLOGY, V123, P41, DOI 10.1053/gast.2002.34157; Wang G, 2020, J R STAT SOC B, V82, P1273, DOI 10.1111/rssb.12388; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; WHITE AL, 1994, J BIOL CHEM, V269, P9060; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Yap CX, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07862-y; Yengo L, 2018, HUM MOL GENET, V27, P3641, DOI 10.1093/hmg/ddy271; Zekavat SM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04668-w; ZYSOW BR, 1995, ARTERIOSCL THROM VAS, V15, P58, DOI 10.1161/01.ATV.15.1.58	99	23	23	6	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2021	373	6562			SI		1499	+		10.1126/science.abg8289	http://dx.doi.org/10.1126/science.abg8289			86	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UU7LJ	34554798	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000698977800048
